Citrus Sinensis ID: 009364
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 536 | 2.2.26 [Sep-21-2011] | |||||||
| Q9FZ36 | 651 | Mitogen-activated protein | yes | no | 0.901 | 0.741 | 0.616 | 1e-170 | |
| O22040 | 666 | Mitogen-activated protein | yes | no | 0.889 | 0.716 | 0.604 | 1e-165 | |
| O22042 | 651 | Mitogen-activated protein | no | no | 0.934 | 0.769 | 0.586 | 1e-164 | |
| Q54R82 | 942 | Mitogen-activated protein | no | no | 0.505 | 0.287 | 0.521 | 4e-84 | |
| Q56UN5 | 1328 | Mitogen-activated protein | yes | no | 0.498 | 0.201 | 0.496 | 2e-72 | |
| P28829 | 659 | Protein kinase byr2 OS=Sc | yes | no | 0.490 | 0.399 | 0.520 | 3e-72 | |
| E9Q3S4 | 1311 | Mitogen-activated protein | yes | no | 0.485 | 0.198 | 0.501 | 3e-70 | |
| Q9Y2U5 | 619 | Mitogen-activated protein | no | no | 0.593 | 0.513 | 0.446 | 3e-69 | |
| Q61083 | 619 | Mitogen-activated protein | no | no | 0.593 | 0.513 | 0.455 | 7e-69 | |
| Q99759 | 626 | Mitogen-activated protein | no | no | 0.5 | 0.428 | 0.463 | 8e-69 |
| >sp|Q9FZ36|M3K2_ARATH Mitogen-activated protein kinase kinase kinase 2 OS=Arabidopsis thaliana GN=ANP2 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 598 bits (1541), Expect = e-170, Method: Compositional matrix adjust.
Identities = 325/527 (61%), Positives = 378/527 (71%), Gaps = 44/527 (8%)
Query: 1 MQDLFGSVRRSIVFRTTAESTTDAQTANSPTPFSGGNLVERFNSCIRNSRVLSKHISP-- 58
MQDLFGSVRRS+VFR+T T D N P PF L ++ SCIR S V +K SP
Sbjct: 1 MQDLFGSVRRSLVFRST---TDDENQENHPPPFPSL-LADKITSCIRKSMVFAKSQSPPN 56
Query: 59 --SVKMSPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIK 116
+V++ PPIRWRKG+LIG GAFG VYMGMNLDSGELLAVKQVLI +N ASKEK Q HI+
Sbjct: 57 NSTVQIKPPIRWRKGQLIGRGAFGTVYMGMNLDSGELLAVKQVLITSNCASKEKTQAHIQ 116
Query: 117 ELEEEVKLLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTY 176
ELEEEVKLLK+LSHPNIVRYLGTVRE+E+LNILLEFVPGGSISSLL KFG FPE+V+RTY
Sbjct: 117 ELEEEVKLLKNLSHPNIVRYLGTVREDETLNILLEFVPGGSISSLLEKFGAFPESVVRTY 176
Query: 177 TKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGT 236
T QLLLGLEYLHNH IMHRDIKGANILVDN+GCIKLADFGASKQVAELAT+SGAKSMKGT
Sbjct: 177 TNQLLLGLEYLHNHAIMHRDIKGANILVDNQGCIKLADFGASKQVAELATISGAKSMKGT 236
Query: 237 PYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIP 296
PYWMAPEVI QTGHS+SADIWSVGCTVIEM TGK PWSQQY+E+AA+FHIGTTKSHPPIP
Sbjct: 237 PYWMAPEVILQTGHSFSADIWSVGCTVIEMVTGKAPWSQQYKEIAAIFHIGTTKSHPPIP 296
Query: 297 ENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDPVLH--ASVMKSSEILSPSH 354
+N+S A DFLLKCL++EP+LRPTASELLKHPFVTG ++ S M +S PS
Sbjct: 297 DNISSDANDFLLKCLQQEPNLRPTASELLKHPFVTGKQKESASKDLTSFMDNSCSPLPSE 356
Query: 355 VANLESLQMLTSPGSPGSVDICNLDSLSCSRVIVEKLSGSMHGWVTSNSN------DDLC 408
+ N+ S Q TS DICNL SL+C+ EK + + SN+ +D+C
Sbjct: 357 LTNITSYQTSTSDDVG---DICNLGSLTCTLAFPEKSIQNNSLCLKSNNGYDDDDDNDMC 413
Query: 409 QLDQEDFVAGDRKLSSILAPN-DLEKSRNPMCEPSDDWRWKFDGSPEPEKNELKPDSDES 467
+D E+F+ + + L N D +KS + M E SD + KFD +
Sbjct: 414 LIDDENFLTYNGETGPSLDNNTDAKKSCDTMSEISDILKCKFDEN--------------- 458
Query: 468 LKVPASRINASGEEDNGFSFPRGTP-LSEDDDELTESKIKAFLDAKV 513
+ +GE + S P SED++ELTESKIKAFLD K
Sbjct: 459 --------SGNGETETKVSMEVDHPSYSEDENELTESKIKAFLDDKA 497
|
Involved in cortical microtubules organization and stabilization by regulating the phosphorylation state of microtubule-associated proteins such as MAP65-1. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 5 |
| >sp|O22040|ANP1_ARATH Mitogen-activated protein kinase kinase kinase ANP1 OS=Arabidopsis thaliana GN=ANP1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 583 bits (1503), Expect = e-165, Method: Compositional matrix adjust.
Identities = 321/531 (60%), Positives = 379/531 (71%), Gaps = 54/531 (10%)
Query: 1 MQDLFGSVRRSIVFRTTAESTTDAQTANSPTPFSGGNLVERFNSCIRNSRVLSK-HISP- 58
MQD FGSVRRS+VFR +++ D Q P P G L ++ SCIR S++ K SP
Sbjct: 1 MQDFFGSVRRSLVFRPSSDD--DNQENQPPFP---GVLADKITSCIRKSKIFIKPSFSPP 55
Query: 59 ----SVKMSPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDH 114
+V M+PPI WRKG+LIG GAFG VYMGMNLDSGELLAVKQVLIAANFASKEK Q H
Sbjct: 56 PPANTVDMAPPISWRKGQLIGRGAFGTVYMGMNLDSGELLAVKQVLIAANFASKEKTQAH 115
Query: 115 IKELEEEVKLLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMR 174
I+ELEEEVKLLK+LSHPNIVRYLGTVRE+++LNILLEFVPGGSISSLL KFGPFPE+V+R
Sbjct: 116 IQELEEEVKLLKNLSHPNIVRYLGTVREDDTLNILLEFVPGGSISSLLEKFGPFPESVVR 175
Query: 175 TYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMK 234
TYT+QLLLGLEYLHNH IMHRDIKGANILVDNKGCIKLADFGASKQVAELAT++GAKSMK
Sbjct: 176 TYTRQLLLGLEYLHNHAIMHRDIKGANILVDNKGCIKLADFGASKQVAELATMTGAKSMK 235
Query: 235 GTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPP 294
GTPYWMAPEVI QTGHS+SADIWSVGCTVIEM TGK PWSQQY+EVAA+F IGTTKSHPP
Sbjct: 236 GTPYWMAPEVILQTGHSFSADIWSVGCTVIEMVTGKAPWSQQYKEVAAIFFIGTTKSHPP 295
Query: 295 IPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDPVLH--ASVMKSSEILSP 352
IP+ LS AKDFLLKCL++ P+LRPTASELLKHPFV G ++ SV+ + P
Sbjct: 296 IPDTLSSDAKDFLLKCLQEVPNLRPTASELLKHPFVMGKHKESASTDLGSVLNNLSTPLP 355
Query: 353 SHVANLESLQMLTSPGSPGSV-----DICNLDSLSCSRVIVEKLSGSMHGWVTSNSN--- 404
+ N +S +P S D+CN SL+ S V K + + W +++
Sbjct: 356 LQINNTKS--------TPDSTCDDVGDMCNFGSLNYSLVDPVKSIQNKNLWQQNDNGGDE 407
Query: 405 DDLCQLDQEDFVAGDRKLSSILAPN-DLEKSRNPMCEPSDDWRWKFDGSPEPEKNELKPD 463
DD+C +D E+F+ D ++SS L + L+KS + + + S + KFD SP
Sbjct: 408 DDMCLIDDENFLTFDGEMSSTLEKDCHLKKSCDDISDMSIALKSKFDESP---------- 457
Query: 464 SDESLKVPASRINASGEEDNGFSFPRGTP-LSEDDDELTESKIKAFLDAKV 513
+GE+++ S P SEDDDELTESKIKAFLD K
Sbjct: 458 -------------GNGEKESTMSMECDQPSYSEDDDELTESKIKAFLDEKA 495
|
May be involved in an oxidative stress-mediated signaling cascade that phosphorylates downstream MAP kinases MPK3 and MPK6. May suppress auxin signaling that promotes cell cycle. Functionally redundant to ANP2 and ANP3 in the positive regulation of cytokinesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|O22042|M3K3_ARATH Mitogen-activated protein kinase kinase kinase 3 OS=Arabidopsis thaliana GN=ANP3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 577 bits (1487), Expect = e-164, Method: Compositional matrix adjust.
Identities = 308/525 (58%), Positives = 381/525 (72%), Gaps = 24/525 (4%)
Query: 1 MQDLFGSVRRSIVFRTTAESTTDAQTANSPTPFSGGNLVERFNSCIRNSRV--LSKHI-- 56
MQD+ GSVRRS+VFR++ + D + + F G + NS IR+SR+ SK
Sbjct: 1 MQDILGSVRRSLVFRSSL-AGDDGTSGGGLSGFVG-----KINSSIRSSRIGLFSKPPPG 54
Query: 57 --SPSVKMSPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDH 114
+P + +P IRWRKGELIGCGAFGRVYMGMNLDSGELLA+KQVLIA + ASKEK Q H
Sbjct: 55 LPAPRKEEAPSIRWRKGELIGCGAFGRVYMGMNLDSGELLAIKQVLIAPSSASKEKTQGH 114
Query: 115 IKELEEEVKLLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMR 174
I+ELEEEV+LLK+LSHPNIVRYLGTVRE +SLNIL+EFVPGGSISSLL KFG FPE V+
Sbjct: 115 IRELEEEVQLLKNLSHPNIVRYLGTVRESDSLNILMEFVPGGSISSLLEKFGSFPEPVII 174
Query: 175 TYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMK 234
YTKQLLLGLEYLHN+GIMHRDIKGANILVDNKGCI+LADFGASK+V ELATV+GAKSMK
Sbjct: 175 MYTKQLLLGLEYLHNNGIMHRDIKGANILVDNKGCIRLADFGASKKVVELATVNGAKSMK 234
Query: 235 GTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPP 294
GTPYWMAPEVI QTGHS+SADIWSVGCTVIEMATGKPPWS+QYQ+ AA+ HIG TK+HPP
Sbjct: 235 GTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSEQYQQFAAVLHIGRTKAHPP 294
Query: 295 IPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDED--PVLHASVMKSSEILSP 352
IPE+LS +AKDFL+KCL KEP LR +A+ELL+HPFVTG ++ P S+ + ++
Sbjct: 295 IPEDLSPEAKDFLMKCLHKEPSLRLSATELLQHPFVTGKRQEPYPAYRNSLTECGNPITT 354
Query: 353 SHVANLESLQMLTSPGS-PGSVDICNLDSLSCSRVIVEKLSGSMHGWVTSNSNDDLCQLD 411
+ S+ L + G D+C L SL S + +K + S GW +S DDLCQ D
Sbjct: 355 QGMNVRSSINSLIRRSTCSGLKDVCELGSLRSSIIYPQKSNNSGFGWRDGDS-DDLCQTD 413
Query: 412 QEDFVAGDRKLSSILAPN-DLEKSRNPMCEPSDDWRWKFDGSPEPEKNELKPDSDESLKV 470
+D + +++L+ + DL KS NPMC+ +D+W KFD SP+ K++ L
Sbjct: 414 MDDLCNIESVRNNVLSQSTDLNKSFNPMCDSTDNWSCKFDESPKVMKSK-----SNLLSY 468
Query: 471 PASRINAS--GEEDNGFSFPRGTPLSEDDDELTESKIKAFLDAKV 513
AS++ +E+ +F G+ ++EDD + TE KIK+FLD K
Sbjct: 469 QASQLQTGVPCDEETSLTFAGGSSVAEDDYKGTELKIKSFLDEKA 513
|
Involved in cortical microtubules organization and stabilization by regulating the phosphorylation state of microtubule-associated proteins such as MAP65-1. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q54R82|MKKA_DICDI Mitogen-activated protein kinase kinase kinase A OS=Dictyostelium discoideum GN=mkkA PE=1 SV=2 | Back alignment and function description |
|---|
Score = 312 bits (800), Expect = 4e-84, Method: Compositional matrix adjust.
Identities = 143/274 (52%), Positives = 201/274 (73%), Gaps = 3/274 (1%)
Query: 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLL 125
I+W+KG+++G G +G VY+G+N D+GEL AVKQ+ I + S K ++ I +E++++
Sbjct: 168 IKWQKGQILGRGGYGSVYLGLNKDTGELFAVKQLEIV-DINSDPKLKNMILSFSKEIEVM 226
Query: 126 KDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLE 185
+ L H NIVRYLGT ++ L++ LE++PGGSISSLLGKFG F E V++ YTKQ+L GL
Sbjct: 227 RSLRHDNIVRYLGTSLDQSFLSVFLEYIPGGSISSLLGKFGAFSENVIKVYTKQILQGLS 286
Query: 186 YLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVI 245
+LH + I+HRDIKGANIL+D KG +KL+DFG SK + VS KSM+GTPYWMAPEVI
Sbjct: 287 FLHANSIIHRDIKGANILIDTKGIVKLSDFGCSKSFS--GIVSQFKSMQGTPYWMAPEVI 344
Query: 246 RQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKD 305
+QTGH S+DIWS+GC ++EMAT +PPWS + A ++HI ++ S P IP ++S +A D
Sbjct: 345 KQTGHGRSSDIWSLGCVIVEMATAQPPWSNITELAAVMYHIASSNSIPNIPSHMSQEAFD 404
Query: 306 FLLKCLEKEPDLRPTASELLKHPFVTGDDEDPVL 339
FL C +++P RP A++LLKHPF+ D++ L
Sbjct: 405 FLNLCFKRDPKERPDANQLLKHPFIMNLDDNIQL 438
|
Regulates cell-type differentiation and spatial patterning, required for the proper induction and maintenance of prespore cell differentiation. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q56UN5|M3K19_HUMAN Mitogen-activated protein kinase kinase kinase 19 OS=Homo sapiens GN=MAP3K19 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 274 bits (700), Expect = 2e-72, Method: Compositional matrix adjust.
Identities = 138/278 (49%), Positives = 193/278 (69%), Gaps = 11/278 (3%)
Query: 59 SVKMSPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKEL 118
S+K PI W KGE++G GA+G VY G+ G+L+AVKQV A + ++K A+ ++L
Sbjct: 1052 SLKSEEPILWTKGEILGKGAYGTVYCGLT-SQGQLIAVKQV--ALDTSNKLAAEKEYRKL 1108
Query: 119 EEEVKLLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTK 178
+EEV LLK L H NIV YLGT +E +++I +EFVPGGSISS++ +FGP PE V YTK
Sbjct: 1109 QEEVDLLKALKHVNIVAYLGTCLQENTVSIFMEFVPGGSISSIINRFGPLPEMVFCKYTK 1168
Query: 179 QLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGA-----KSM 233
Q+L G+ YLH + ++HRDIKG N+++ G IKL DFG ++++A A ++G KSM
Sbjct: 1169 QILQGVAYLHENCVVHRDIKGNNVMLMPTGIIKLIDFGCARRLA-WAGLNGTHSDMLKSM 1227
Query: 234 KGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKS-H 292
GTPYWMAPEVI ++G+ +DIWS+GCTV EMATGKPP + +AA+F+IG +
Sbjct: 1228 HGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLA-SMDRMAAMFYIGAHRGLM 1286
Query: 293 PPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFV 330
PP+P++ S A DF+ CL ++ RP+A +LLKH F+
Sbjct: 1287 PPLPDHFSENAADFVRMCLTRDQHERPSALQLLKHSFL 1324
|
Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P28829|BYR2_SCHPO Protein kinase byr2 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=byr2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 273 bits (697), Expect = 3e-72, Method: Compositional matrix adjust.
Identities = 141/271 (52%), Positives = 190/271 (70%), Gaps = 8/271 (2%)
Query: 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLL 125
I+W +G LIG G+FG+VY+GMN SGEL+AVKQV++ + SK++ + L E+ LL
Sbjct: 392 IKWIRGALIGSGSFGQVYLGMNASSGELMAVKQVILDSVSESKDRHAKLLDALAGEIALL 451
Query: 126 KDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLE 185
++LSH +IV+YLG+ + LNI LE+VPGGS++ LL +G F E +++ + KQ L GLE
Sbjct: 452 QELSHEHIVQYLGSNLNSDHLNIFLEYVPGGSVAGLLTMYGSFEETLVKNFIKQTLKGLE 511
Query: 186 YLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVS----GAK-SMKGTPYWM 240
YLH+ GI+HRDIKGANILVDNKG IK++DFG SK++ EL + S GA+ S +G+ +WM
Sbjct: 512 YLHSRGIVHRDIKGANILVDNKGKIKISDFGISKKL-ELNSTSTKTGGARPSFQGSSFWM 570
Query: 241 APEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLS 300
APEV++QT H+ DIWS+GC VIEM T K P+ Q + A+F IG P P N+S
Sbjct: 571 APEVVKQTMHTEKTDIWSLGCLVIEMLTSKHPYPNCDQ-MQAIFRIGEN-ILPEFPSNIS 628
Query: 301 VKAKDFLLKCLEKEPDLRPTASELLKHPFVT 331
A DFL K + +LRPTASELL HPFV+
Sbjct: 629 SSAIDFLEKTFAIDCNLRPTASELLSHPFVS 659
|
Serine/threonine protein kinase involved in conjugation and sporulation. It is thought that it phosphorylates the byr1 protein kinase which itself phosphorylate the spk1 kinase. Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|E9Q3S4|M3K19_MOUSE Mitogen-activated protein kinase kinase kinase 19 OS=Mus musculus GN=Map3k19 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 266 bits (680), Expect = 3e-70, Method: Compositional matrix adjust.
Identities = 136/271 (50%), Positives = 187/271 (69%), Gaps = 11/271 (4%)
Query: 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLL 125
I W KGE++G GA+G VY G+ G+L+AVKQV A + + K + ++L+EEV LL
Sbjct: 1042 IFWTKGEILGRGAYGTVYCGLT-SLGQLIAVKQV--ALDTSDKLATEKEYRKLQEEVDLL 1098
Query: 126 KDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLE 185
K L H NIV YLGT EE +L+I +EFVPGGSISS++ +FGP PE V YT+Q+L G+
Sbjct: 1099 KALKHVNIVAYLGTCLEENTLSIFMEFVPGGSISSIINRFGPLPEMVFCKYTRQILQGVA 1158
Query: 186 YLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGA-----KSMKGTPYWM 240
YLH++ ++HRDIKG N+++ G IKL DFG +K++A A ++G KSM+GTPYWM
Sbjct: 1159 YLHDNCVVHRDIKGNNVMLMPTGIIKLIDFGCAKRLA-WAGLNGTHSDMLKSMRGTPYWM 1217
Query: 241 APEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKS-HPPIPENL 299
APEVI ++G+ +DIWS+GCTV EMATGKPP + +AA+F+IG + PP+P
Sbjct: 1218 APEVINESGYGRKSDIWSIGCTVFEMATGKPPLA-SMDRMAAMFYIGAHRGLMPPLPARF 1276
Query: 300 SVKAKDFLLKCLEKEPDLRPTASELLKHPFV 330
S A DF+ CL ++ RP+A +LLKH F+
Sbjct: 1277 SEPAADFVRLCLTRDQHERPSALQLLKHSFL 1307
|
Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9Y2U5|M3K2_HUMAN Mitogen-activated protein kinase kinase kinase 2 OS=Homo sapiens GN=MAP3K2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 263 bits (671), Expect = 3e-69, Method: Compositional matrix adjust.
Identities = 147/329 (44%), Positives = 210/329 (63%), Gaps = 11/329 (3%)
Query: 7 SVRRSIVFRTTAESTTDAQTANSPTPFSGGNLVERFNSCIRNSRVLSKHISPSVKMSP-- 64
S+R + F T S + + ++ TP + + R S I N + ISP + SP
Sbjct: 294 SLRSPVSFSPTDHSLSTSSGSSIFTPEYDDSRIRRRGSDIDNPTLTVMDISPPSR-SPRA 352
Query: 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKL 124
P WR G+L+G GAFGRVY+ ++D+G LAVKQV + K + LE E++L
Sbjct: 353 PTNWRLGKLLGQGAFGRVYLCYDVDTGRELAVKQVQFDPDSPETSK---EVNALECEIQL 409
Query: 125 LKDLSHPNIVRYLGTVR--EEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLL 182
LK+L H IV+Y G +R +E++L+I +E++PGGSI L +G E V R YT+Q+L
Sbjct: 410 LKNLLHERIVQYYGCLRDPQEKTLSIFMEYMPGGSIKDQLKAYGALTENVTRKYTRQILE 469
Query: 183 GLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA-TVSGAKSMKGTPYWMA 241
G+ YLH++ I+HRDIKGANIL D+ G +KL DFGASK++ + + +G KS+ GTPYWM+
Sbjct: 470 GVHYLHSNMIVHRDIKGANILRDSTGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMS 529
Query: 242 PEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSV 301
PEVI G+ ADIWSV CTV+EM T KPPW+ +++ +AA+F I T ++P +P ++S
Sbjct: 530 PEVISGEGYGRKADIWSVACTVVEMLTEKPPWA-EFEAMAAIFKIATQPTNPKLPPHVSD 588
Query: 302 KAKDFLLKCLEKEPDLRPTASELLKHPFV 330
+DF LK + E LRP+A ELL+H FV
Sbjct: 589 YTRDF-LKRIFVEAKLRPSADELLRHMFV 616
|
Component of a protein kinase signal transduction cascade. Regulates the JNK and ERK5 pathways by phosphorylating and activating MAP2K5 and MAP2K7 (By similarity). Plays a role in caveolae kiss-and-run dynamics. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q61083|M3K2_MOUSE Mitogen-activated protein kinase kinase kinase 2 OS=Mus musculus GN=Map3k2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 261 bits (668), Expect = 7e-69, Method: Compositional matrix adjust.
Identities = 150/329 (45%), Positives = 211/329 (64%), Gaps = 11/329 (3%)
Query: 7 SVRRSIVFRTTAESTTDAQTANSPTPFSGGNLVERFNSCIRNSRVLSKHISPSVKMSP-- 64
S R + F T S + + ++ TP + + R S I N + ISP + SP
Sbjct: 294 SFRSPVSFSPTDHSLSTSSGSSVFTPEYDDSRIRRRGSDIDNPTLTVTDISPPSR-SPRA 352
Query: 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKL 124
P WR G+L+G GAFGRVY+ ++D+G LAVKQV N S E +++ + LE E++L
Sbjct: 353 PTNWRLGKLLGQGAFGRVYLCYDVDTGRELAVKQVQF--NPESPETSKE-VNALECEIQL 409
Query: 125 LKDLSHPNIVRYLGTVR--EEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLL 182
LK+L H IV+Y G +R +E++L+I +E PGGSI L +G E V R YT+Q+L
Sbjct: 410 LKNLLHERIVQYYGCLRDPQEKTLSIFMELSPGGSIKDQLKAYGALTENVTRKYTRQILE 469
Query: 183 GLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA-TVSGAKSMKGTPYWMA 241
G+ YLH++ I+HRDIKGANIL D+ G IKL DFGASK++ + + +G KS+ GTPYWM+
Sbjct: 470 GVHYLHSNMIVHRDIKGANILRDSTGNIKLGDFGASKRLQTICLSGTGMKSVTGTPYWMS 529
Query: 242 PEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSV 301
PEVI G+ ADIWSV CTV+EM T KPPW+ +++ +AA+F I T ++P +P ++S
Sbjct: 530 PEVISGEGYGRKADIWSVACTVVEMLTEKPPWA-EFEAMAAIFKIATQPTNPKLPPHVSD 588
Query: 302 KAKDFLLKCLEKEPDLRPTASELLKHPFV 330
+DF LK + E LRP+A ELL+H FV
Sbjct: 589 YTRDF-LKRIFVEAKLRPSAEELLRHMFV 616
|
Component of a protein kinase signal transduction cascade. Regulates the JNK and ERK5 pathways by phosphorylating and activating MAP2K5 and MAP2K7. Plays a role in caveolae kiss-and-run dynamics. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q99759|M3K3_HUMAN Mitogen-activated protein kinase kinase kinase 3 OS=Homo sapiens GN=MAP3K3 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 261 bits (668), Expect = 8e-69, Method: Compositional matrix adjust.
Identities = 128/276 (46%), Positives = 185/276 (67%), Gaps = 8/276 (2%)
Query: 58 PSVKMSPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKE 117
P+ S PI WR+G+L+G GAFGRVY+ ++D+G LA KQV + K +
Sbjct: 352 PTKSPSAPINWRRGKLLGQGAFGRVYLCYDVDTGRELASKQVQFDPDSPETSK---EVSA 408
Query: 118 LEEEVKLLKDLSHPNIVRYLGTVRE--EESLNILLEFVPGGSISSLLGKFGPFPEAVMRT 175
LE E++LLK+L H IV+Y G +R+ E++L I +E++PGGS+ L +G E+V R
Sbjct: 409 LECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRK 468
Query: 176 YTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA-TVSGAKSMK 234
YT+Q+L G+ YLH++ I+HRDIKGANIL D+ G +KL DFGASK++ + + +G +S+
Sbjct: 469 YTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGMRSVT 528
Query: 235 GTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPP 294
GTPYWM+PEVI G+ AD+WS+GCTV+EM T KPPW+ +Y+ +AA+F I T ++P
Sbjct: 529 GTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWA-EYEAMAAIFKIATQPTNPQ 587
Query: 295 IPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFV 330
+P ++S +DFL + E RP+A ELL H F
Sbjct: 588 LPSHISEHGRDFLRRIF-VEARQRPSAEELLTHHFA 622
|
Component of a protein kinase signal transduction cascade. Mediates activation of the NF-kappa-B, AP1 and DDIT3 transcriptional regulators. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 536 | ||||||
| 255542626 | 651 | mitogen activated protein kinase kinase | 0.895 | 0.737 | 0.673 | 0.0 | |
| 225432572 | 686 | PREDICTED: mitogen-activated protein kin | 0.938 | 0.733 | 0.633 | 0.0 | |
| 296088323 | 663 | unnamed protein product [Vitis vinifera] | 0.916 | 0.740 | 0.645 | 0.0 | |
| 449442819 | 688 | PREDICTED: mitogen-activated protein kin | 0.904 | 0.704 | 0.673 | 0.0 | |
| 449529838 | 688 | PREDICTED: mitogen-activated protein kin | 0.904 | 0.704 | 0.673 | 0.0 | |
| 359487737 | 686 | PREDICTED: LOW QUALITY PROTEIN: mitogen- | 0.934 | 0.730 | 0.633 | 0.0 | |
| 42540755 | 686 | mitogen-activated protein kinase kinase | 0.938 | 0.733 | 0.626 | 0.0 | |
| 150036250 | 692 | NPK1-line kinase [Cucumis melo subsp. me | 0.904 | 0.700 | 0.671 | 0.0 | |
| 224111246 | 680 | predicted protein [Populus trichocarpa] | 0.944 | 0.744 | 0.626 | 1e-180 | |
| 356504044 | 662 | PREDICTED: mitogen-activated protein kin | 0.901 | 0.729 | 0.656 | 1e-179 |
| >gi|255542626|ref|XP_002512376.1| mitogen activated protein kinase kinase kinase 3, mapkkk3, mekk3, putative [Ricinus communis] gi|223548337|gb|EEF49828.1| mitogen activated protein kinase kinase kinase 3, mapkkk3, mekk3, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 667 bits (1720), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 349/518 (67%), Positives = 398/518 (76%), Gaps = 38/518 (7%)
Query: 1 MQDLFGSVRRSIVFRTTAESTTDAQTANSPTPFSGGNLVERFNSCIRNSRVLSKHISPSV 60
MQD GSVRRSI FRT + + LVE+ NSCIR SR+ SK SPS+
Sbjct: 1 MQDFLGSVRRSIAFRTPDNNQENNNFNP---------LVEKINSCIRKSRIFSKPSSPSL 51
Query: 61 KMSPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEE 120
M+P IR+RKGELIGCGAFG VYMGMNLDSGELLAVKQVLIAAN A++E+AQ HI+ELEE
Sbjct: 52 PMAPVIRYRKGELIGCGAFGHVYMGMNLDSGELLAVKQVLIAANGATRERAQAHIRELEE 111
Query: 121 EVKLLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQL 180
EVKLLK+LSHPNIVRYLGTV EEE+LNILLEFVPGGSISSLLGKFG FPEAV+RTYT+QL
Sbjct: 112 EVKLLKNLSHPNIVRYLGTVTEEETLNILLEFVPGGSISSLLGKFGSFPEAVIRTYTQQL 171
Query: 181 LLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWM 240
LLGLEYLHN+GIMHRDIKGANILVDNKGCIKLADFGASKQV ELATVSGAKSMKGTPYWM
Sbjct: 172 LLGLEYLHNNGIMHRDIKGANILVDNKGCIKLADFGASKQVVELATVSGAKSMKGTPYWM 231
Query: 241 APEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLS 300
APEVI QTGHS+SADIWSVGCTVIEMATGKPPWSQQYQEVAALF+IG+TKSHP IPE+LS
Sbjct: 232 APEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQYQEVAALFYIGSTKSHPEIPEHLS 291
Query: 301 VKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDD--EDPVLHASVMKSSEILSPSHVANL 358
+AKDFLL+CL+KEP++RP AS+LL+HPFVTG DPV ++++ + L
Sbjct: 292 AEAKDFLLQCLQKEPNMRPDASKLLQHPFVTGQQLVSDPVGTSNMVS---------ILGL 342
Query: 359 ESLQMLTSPGSPGSVDICNLDSLSCSRVIVEKLSGSMHGWVTSNSNDDLCQLDQEDFVAG 418
+S QM P GS+DICNL SLSCS V +KL S W T+NS+DD+CQ+D +DF
Sbjct: 343 DSGQM---PSVSGSMDICNLGSLSCS-VDPKKLLESKDLWRTNNSDDDMCQMDGDDFSPS 398
Query: 419 DR--KLSSILAPNDLEKSRNPMCEPSDDWRWKFDGSPEPEKNELKPDSDESLKVPASRIN 476
KL+S+L +D KS E S DW+ KFD SPEPE+ +K D D+S
Sbjct: 399 TSKVKLNSVLIADDFYKSCYSKHELSGDWKCKFDESPEPEQAGIKLDIDQS--------- 449
Query: 477 ASGEEDNGFSFPRGTPLSEDDDELTESKIKAFLDAKVL 514
+ DN FSFP G SEDDDELTESKI+AFLD K L
Sbjct: 450 ---QRDNNFSFPCGASFSEDDDELTESKIRAFLDEKAL 484
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225432572|ref|XP_002281142.1| PREDICTED: mitogen-activated protein kinase kinase kinase 3 [Vitis vinifera] gi|297737007|emb|CBI26208.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 649 bits (1675), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 336/530 (63%), Positives = 399/530 (75%), Gaps = 27/530 (5%)
Query: 1 MQDLFGSVRRSIVFRTTAESTTDAQTANSPTPFSGGNLVERFNSCIRNSRV--LSKHISP 58
MQD+FGSVRRS+VFR + + P VE+ S IR S + S+
Sbjct: 1 MQDIFGSVRRSLVFRPASGEDGEYGGYGGP--------VEKIWSSIRKSGIGLFSRQ--- 49
Query: 59 SVKMSPPI--------RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEK 110
SV+ PPI RWRKGELIGCGAFGRVYMGMNLDSGELLA+KQV IAAN ASKEK
Sbjct: 50 SVRALPPIPKDEAPSIRWRKGELIGCGAFGRVYMGMNLDSGELLAIKQVSIAANSASKEK 109
Query: 111 AQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPE 170
Q HI+ELEEEVKLLK+LSHPNIVRYLGT RE+ESLNILLEFVPGGSISSLLGKFG FPE
Sbjct: 110 TQAHIRELEEEVKLLKNLSHPNIVRYLGTAREDESLNILLEFVPGGSISSLLGKFGSFPE 169
Query: 171 AVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGA 230
+V+R YTKQLLLGLEYLH +GIMHRDIKGANILVDNKGCIKLADFGASK+V ELAT++GA
Sbjct: 170 SVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATMTGA 229
Query: 231 KSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTK 290
KSMKGTPYWMAPEVI QTGHS+SADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTK
Sbjct: 230 KSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTK 289
Query: 291 SHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDED--PVLHASVMKSSE 348
SHPPIPE+L+ +AKDFLLKCL+KEP+LRP ASELL+HPFV+G+ ++ PV SVM++S
Sbjct: 290 SHPPIPEHLTAEAKDFLLKCLQKEPNLRPAASELLQHPFVSGEYQEPHPVFQTSVMENSG 349
Query: 349 ILSPSHVANLESL--QMLTSPGSPGSVDICNLDSLSCSRVIVEKLSGSMHGWVTSNSNDD 406
+ + +L+S ++ S ++CN+ S+ CS V EK SG+ W ++ +DD
Sbjct: 350 NMMATSETDLKSFPNPVIRRSNCTSSNNVCNMGSVRCSTVYPEKFSGTGPLWGANSCDDD 409
Query: 407 LCQL-DQEDFVAGDR-KLSSILAPNDLEKSRNPMCEPSDDWRWKFDGSPEPEKNELKPDS 464
+CQ+ D++DF+ K S + + L KS NPMCEP+DDW KFD SPE K+ S
Sbjct: 410 MCQIDDKDDFIVHQSVKFGSAILSDHLNKSFNPMCEPTDDWPCKFDESPELTKSGANLSS 469
Query: 465 DESLKVPASRINASGEEDNGFSFPRGTPLSEDDDELTESKIKAFLDAKVL 514
+++ PA AS E +N F+FP G + +DDDE+TESKI+AFLD K L
Sbjct: 470 HQTISKPAGSPRASNERENDFTFPCGPLVGDDDDEVTESKIRAFLDEKAL 519
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296088323|emb|CBI36768.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 643 bits (1659), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 337/522 (64%), Positives = 393/522 (75%), Gaps = 31/522 (5%)
Query: 1 MQDLFGSVRRSIVFRTTAESTTDAQTANSPTPFSGGNLVERFNSCIRNSRVLSKHISPSV 60
MQD+FGSVRRS+V R+ T S G LV++ NSCIR SRV S+ P +
Sbjct: 1 MQDIFGSVRRSLVLRSPDGDDT-----------SPGTLVDKINSCIRKSRVFSRASPPPL 49
Query: 61 ----KMSPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIK 116
+P IR RKGELIGCGAFGRVYMGMNLDSGEL+AVKQVLI + A+KEKAQ HI+
Sbjct: 50 IPKDATAPSIRCRKGELIGCGAFGRVYMGMNLDSGELIAVKQVLITTSNATKEKAQAHIR 109
Query: 117 ELEEEVKLLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTY 176
ELEEEVKLLK+LSHPNIVRYLG VREEE+LNILLEFVPGGSISSLLGKFG FPEAV+R Y
Sbjct: 110 ELEEEVKLLKNLSHPNIVRYLGIVREEETLNILLEFVPGGSISSLLGKFGSFPEAVIRMY 169
Query: 177 TKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGT 236
TKQLLLGL+YLHN+GIMHRDIKGANILVDNKGCIKLADFGASKQV ELAT+SGAKSMKGT
Sbjct: 170 TKQLLLGLDYLHNNGIMHRDIKGANILVDNKGCIKLADFGASKQVVELATISGAKSMKGT 229
Query: 237 PYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIP 296
PYWMAPEVI QTGHS+SADIWSVGCTVIEMATGKPPWSQ+YQEVAALF+IGTTKSHPPIP
Sbjct: 230 PYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQKYQEVAALFYIGTTKSHPPIP 289
Query: 297 ENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDP--VLHASVMKSSEILSPSH 354
+LS +AKDFLLKCL+KEPDLRP A ELLKHPFVTG+ + L SVM++SE +
Sbjct: 290 AHLSAEAKDFLLKCLQKEPDLRPAAYELLKHPFVTGEYNEAQLALQTSVMENSETPVSTS 349
Query: 355 VANLESLQMLTSPGSPGSVDICNLDSLSCSRVIVEKLSGSMHGWVTSNSNDDLCQLDQED 414
NL + + D+C + +LSCS E S S W TS S+ D+CQ+D +D
Sbjct: 350 EENLPNPLL----------DVCEMGNLSCSTGYPEN-SESKPNWGTS-SSIDMCQIDDKD 397
Query: 415 --FVAGDRKLSSILAPNDLEKSRNPMCEPSDDWRWKFDGSPEPEKNELKPDSDESLKVPA 472
+ G+ K +SIL P++ KS NP+ EPS DW + DG+ PE + + D++ SL +PA
Sbjct: 398 DVMMVGEVKFNSILLPDNFNKSFNPISEPSHDWSCEIDGNLRPEHSGMDMDTNPSLDMPA 457
Query: 473 SRINASGEEDNGFSFPRGTPLSEDDDELTESKIKAFLDAKVL 514
S + N FSFP G +SEDDDE+TESKI+ FLD K +
Sbjct: 458 GSSGISNKGGNDFSFPCGPSVSEDDDEVTESKIRDFLDEKAI 499
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449442819|ref|XP_004139178.1| PREDICTED: mitogen-activated protein kinase kinase kinase ANP1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 642 bits (1656), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 352/523 (67%), Positives = 392/523 (74%), Gaps = 38/523 (7%)
Query: 1 MQDLFGSVRRSIVFRTTAESTTDAQTANSPTPFSGGNLVERFNSCIRNSRVLSKHISPSV 60
MQD+F SVRRS+VFR D ++SP G LV++ NS IR SRV S+H S
Sbjct: 1 MQDIFASVRRSLVFRPP----LDNDDSHSPA-IGVGALVDKINSSIRKSRVFSRHSPSSS 55
Query: 61 K-------MSPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQD 113
PPIRWRKGELIGCGAFGRVYMGMNL SGELLAVKQVLIAAN ASKEKAQ
Sbjct: 56 SLPPIPKDTDPPIRWRKGELIGCGAFGRVYMGMNLGSGELLAVKQVLIAANGASKEKAQA 115
Query: 114 HIKELEEEVKLLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVM 173
H++ELEEEVKLLKDLSHPNIVRYLGTVRE++SLNILLEFVPGGSI+SLLGKFG FPEAV+
Sbjct: 116 HVQELEEEVKLLKDLSHPNIVRYLGTVREDDSLNILLEFVPGGSIASLLGKFGAFPEAVL 175
Query: 174 RTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSM 233
RTYTKQLLLGLEYLH +GIMHRDIKGANILVDNKGCIKLADFGASKQV ELAT+SGAKSM
Sbjct: 176 RTYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKQVVELATISGAKSM 235
Query: 234 KGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHP 293
KGTPYWMAPEVI QTGHS+SADIWSVGCT IEMATGKPPWSQQYQEVAALFHIGTTKSHP
Sbjct: 236 KGTPYWMAPEVILQTGHSFSADIWSVGCTFIEMATGKPPWSQQYQEVAALFHIGTTKSHP 295
Query: 294 PIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDPVLHASVMKSSEILSPS 353
PIPE LSV+AKDFLLKCL+KEP+LRPTASELLK + H + E SP
Sbjct: 296 PIPEQLSVEAKDFLLKCLQKEPNLRPTASELLK-----------IFHH--QEPLETHSPQ 342
Query: 354 HVANLESLQMLTSPGSPGSVDICNLDSLSCSRVI-VEKLSGSMHGWVTSNSNDDLCQL-D 411
+ LE M +P PGS DICNLDSL CS+V KL M G NS+D++CQ+ D
Sbjct: 343 CTSELE---MSKTPTHPGSSDICNLDSLRCSKVYSTNKLESDMWG---RNSDDEMCQIDD 396
Query: 412 QEDFVAGDRKLSSILAPNDLEKSRNPMCEPSDDWRWKFDGSPEPEKNELKPDSDESLKVP 471
++DF+ + K+ S + ++ KS NP+CEPSDD KFD SP ++ E P
Sbjct: 397 KDDFMLDEVKIGSSIIHENM-KSYNPICEPSDDEDCKFDRSPVVDRGS---SLHEEALAP 452
Query: 472 ASRINASGEEDNGFSFPRGTPLSEDDDELTESKIKAFLDAKVL 514
S A EE N FSFP G LSED+DELTESKIKAFLD K L
Sbjct: 453 GSCSGAFDEEQN-FSFPSGRSLSEDEDELTESKIKAFLDEKAL 494
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449529838|ref|XP_004171905.1| PREDICTED: mitogen-activated protein kinase kinase kinase ANP1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 642 bits (1655), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 352/523 (67%), Positives = 392/523 (74%), Gaps = 38/523 (7%)
Query: 1 MQDLFGSVRRSIVFRTTAESTTDAQTANSPTPFSGGNLVERFNSCIRNSRVLSKHISPSV 60
MQD+F SVRRS+VFR D ++SP G LV++ NS IR SRV S+H S
Sbjct: 1 MQDIFASVRRSLVFRPP----LDNDDSHSPA-IGVGALVDKINSSIRKSRVFSRHSPSSS 55
Query: 61 K-------MSPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQD 113
PPIRWRKGELIGCGAFGRVYMGMNL SGELLAVKQVLIAAN ASKEKAQ
Sbjct: 56 SLPPIPKDTDPPIRWRKGELIGCGAFGRVYMGMNLGSGELLAVKQVLIAANGASKEKAQA 115
Query: 114 HIKELEEEVKLLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVM 173
H++ELEEEVKLLKDLSHPNIVRYLGTVRE++SLNILLEFVPGGSI+SLLGKFG FPEAV+
Sbjct: 116 HVQELEEEVKLLKDLSHPNIVRYLGTVREDDSLNILLEFVPGGSIASLLGKFGAFPEAVL 175
Query: 174 RTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSM 233
RTYTKQLLLGLEYLH +GIMHRDIKGANILVDNKGCIKLADFGASKQV ELAT+SGAKSM
Sbjct: 176 RTYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKQVVELATISGAKSM 235
Query: 234 KGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHP 293
KGTPYWMAPEVI QTGHS+SADIWSVGCT IEMATGKPPWSQQYQEVAALFHIGTTKSHP
Sbjct: 236 KGTPYWMAPEVILQTGHSFSADIWSVGCTFIEMATGKPPWSQQYQEVAALFHIGTTKSHP 295
Query: 294 PIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDPVLHASVMKSSEILSPS 353
PIPE LSV+AKDFLLKCL+KEP+LRPTASELLK + H + E SP
Sbjct: 296 PIPEQLSVEAKDFLLKCLQKEPNLRPTASELLK-----------IFHH--QEPLETHSPQ 342
Query: 354 HVANLESLQMLTSPGSPGSVDICNLDSLSCSRVI-VEKLSGSMHGWVTSNSNDDLCQL-D 411
+ LE M +P PGS DICNLDSL CS+V KL M G NS+D++CQ+ D
Sbjct: 343 CTSELE---MSKTPTHPGSSDICNLDSLRCSKVYSTNKLESDMWG---RNSDDEMCQIDD 396
Query: 412 QEDFVAGDRKLSSILAPNDLEKSRNPMCEPSDDWRWKFDGSPEPEKNELKPDSDESLKVP 471
++DF+ + K+ S + ++ KS NP+CEPSDD KFD SP ++ E P
Sbjct: 397 KDDFMLDEVKIGSSIIHENM-KSYNPICEPSDDEDCKFDRSPVVDRGS---SLHEEALAP 452
Query: 472 ASRINASGEEDNGFSFPRGTPLSEDDDELTESKIKAFLDAKVL 514
S A EE N FSFP G LSED+DELTESKIKAFLD K L
Sbjct: 453 GSCSGAFDEEQN-FSFPSGRSLSEDEDELTESKIKAFLDEKAL 494
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359487737|ref|XP_003633640.1| PREDICTED: LOW QUALITY PROTEIN: mitogen-activated protein kinase kinase kinase ANP1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 640 bits (1651), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 339/535 (63%), Positives = 399/535 (74%), Gaps = 34/535 (6%)
Query: 1 MQDLFGSVRRSIVFRTTAESTTDAQTANSPTPFSGGNLVERFNSCIRNSRVLSKHISPSV 60
MQD+FGSVRRS+V R+ T S G LV++ NSCIR SRV S+ P +
Sbjct: 1 MQDIFGSVRRSLVLRSPDGDDT-----------SPGTLVDKINSCIRKSRVFSRASPPPL 49
Query: 61 ----KMSPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIK 116
+P IR RKGELIGCGAFGRVYMGMNLDSGEL+AVKQVLI + A+KEKAQ HI+
Sbjct: 50 IPKDATAPSIRCRKGELIGCGAFGRVYMGMNLDSGELIAVKQVLITTSNATKEKAQAHIR 109
Query: 117 ELEEEVKLLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTY 176
ELEEEVKLLK+LSHPNIVRYLG VREEE+LNILLEFVPGGSISSLLGKFG FPEAV+R Y
Sbjct: 110 ELEEEVKLLKNLSHPNIVRYLGIVREEETLNILLEFVPGGSISSLLGKFGSFPEAVIRMY 169
Query: 177 TKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGT 236
TKQLLLGL+YLHN+GIMHRDIKGANILVDNKGCIKLADFGASKQV ELAT+SGAKSMKGT
Sbjct: 170 TKQLLLGLDYLHNNGIMHRDIKGANILVDNKGCIKLADFGASKQVVELATISGAKSMKGT 229
Query: 237 PYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIP 296
PYWMAPEVI QTGHS+SADIWSVGCTVIEMATGKPPWSQ+YQEVAALF+IGTTKSHPPIP
Sbjct: 230 PYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQKYQEVAALFYIGTTKSHPPIP 289
Query: 297 ENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDP--VLHASVMKSSEILSPSH 354
+LS +AKDFLLKCL+KEPDLRP A ELLKHPFVTG+ + L SVM++SE +
Sbjct: 290 AHLSAEAKDFLLKCLQKEPDLRPAAYELLKHPFVTGEYNEAQLALQTSVMENSETPVSTS 349
Query: 355 VANLES-----------LQMLTSPGSPGS--VDICNLDSLSCSRVIVEKLSGSMHGWVTS 401
NL + + ++S + S +D+C + +LSCS E S S W TS
Sbjct: 350 EENLPNPLIIKAFWXCCINCVSSQMTNDSSLLDVCEMGNLSCSTGYPEN-SESKPNWGTS 408
Query: 402 NSNDDLCQLDQED--FVAGDRKLSSILAPNDLEKSRNPMCEPSDDWRWKFDGSPEPEKNE 459
S+ D+CQ+D +D + G+ K +SIL P++ KS NP+ EPS DW + DG+ PE +
Sbjct: 409 -SSIDMCQIDDKDDVMMVGEVKFNSILLPDNFNKSFNPISEPSHDWSCEIDGNLRPEHSG 467
Query: 460 LKPDSDESLKVPASRINASGEEDNGFSFPRGTPLSEDDDELTESKIKAFLDAKVL 514
+ D++ SL +PA S + N FSFP G +SEDDDE+TESKI+ FLD K +
Sbjct: 468 MDMDTNPSLDMPAGSSGISNKGGNDFSFPCGPSVSEDDDEVTESKIRDFLDEKAI 522
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|42540755|gb|AAS19278.1| mitogen-activated protein kinase kinase kinase [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 640 bits (1651), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 332/530 (62%), Positives = 396/530 (74%), Gaps = 27/530 (5%)
Query: 1 MQDLFGSVRRSIVFRTTAESTTDAQTANSPTPFSGGNLVERFNSCIRNSRV--LSKHISP 58
MQD+FGSVRRS+VFR + + P E+ IR S + S+
Sbjct: 1 MQDIFGSVRRSLVFRPASGEDGEYGGYGGP--------AEKIWFSIRKSGIGLFSRQ--- 49
Query: 59 SVKMSPPI--------RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEK 110
SV+ PPI RWRKGELIGCGAFGRVYMGMNLDSGELLA++QV IAAN ASKEK
Sbjct: 50 SVRALPPIPKDEAPSTRWRKGELIGCGAFGRVYMGMNLDSGELLAIRQVSIAANSASKEK 109
Query: 111 AQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPE 170
Q HI+ELEEEVKLLK+LSHPNIVRYLGT RE+ESLNILLEFVPGGSISSLLGKFG FPE
Sbjct: 110 TQAHIRELEEEVKLLKNLSHPNIVRYLGTAREDESLNILLEFVPGGSISSLLGKFGSFPE 169
Query: 171 AVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGA 230
+V+R YTKQLLLGLEYLH +GIMHRDIKGANILVDNKGCIKLADFGASK+V ELAT++GA
Sbjct: 170 SVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATMTGA 229
Query: 231 KSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTK 290
KSMKGTPY MAPEVI QTGHS+SADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTK
Sbjct: 230 KSMKGTPYRMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTK 289
Query: 291 SHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDED--PVLHASVMKSSE 348
SHPPIPE+L+ +AKDFLLKCL+KEP+LRP ASELL+HPFV+G+ ++ PV SVM++S
Sbjct: 290 SHPPIPEHLTAEAKDFLLKCLQKEPNLRPAASELLQHPFVSGEYQEPHPVFQTSVMENSG 349
Query: 349 ILSPSHVANLESL--QMLTSPGSPGSVDICNLDSLSCSRVIVEKLSGSMHGWVTSNSNDD 406
+ + +L+S ++ S ++CN+ S+ CS V EK SG+ W ++ +DD
Sbjct: 350 NMMATSETDLKSFPNPVIRRSNCTSSNNVCNMGSVRCSTVYPEKFSGTGPLWGANSCDDD 409
Query: 407 LCQL-DQEDFVAGDR-KLSSILAPNDLEKSRNPMCEPSDDWRWKFDGSPEPEKNELKPDS 464
+CQ+ D++DF+ K S + + L KS NPMCEP+DDW KFD SPE K+ S
Sbjct: 410 MCQIDDKDDFIVHQSVKFGSAILSDHLNKSFNPMCEPTDDWPCKFDESPELTKSGANLSS 469
Query: 465 DESLKVPASRINASGEEDNGFSFPRGTPLSEDDDELTESKIKAFLDAKVL 514
+++ PA AS E +N F+FP G + +DDDE+TESKI+AFLD K L
Sbjct: 470 HQTISKPAGSPRASNERENDFTFPCGPLVGDDDDEVTESKIRAFLDEKAL 519
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|150036250|gb|ABR67413.1| NPK1-line kinase [Cucumis melo subsp. melo] | Back alignment and taxonomy information |
|---|
Score = 640 bits (1650), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 351/523 (67%), Positives = 393/523 (75%), Gaps = 38/523 (7%)
Query: 1 MQDLFGSVRRSIVFRTTAESTTDAQTANSPTPFSGGNLVERFNSCIRNSRVLSKHISPSV 60
MQD+F SVRRS+VFR D ++SP G LV++ NS IR SRV S+H S
Sbjct: 1 MQDIFASVRRSLVFRPP----LDNDDSHSPA-IGVGALVDKINSSIRKSRVFSRHSPSSS 55
Query: 61 K-------MSPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQD 113
PPIRWRKGELIGCGAFGRVYMGMNL SGELLAVKQVLIAAN ASKEKAQ
Sbjct: 56 SLPPIPKDTDPPIRWRKGELIGCGAFGRVYMGMNLGSGELLAVKQVLIAANGASKEKAQA 115
Query: 114 HIKELEEEVKLLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVM 173
++ELEEEVKLLKDLSHPNIVRYLGTVRE++SLNILLEFVPGGSI+SLLGKFG FPEAV+
Sbjct: 116 QVQELEEEVKLLKDLSHPNIVRYLGTVREDDSLNILLEFVPGGSIASLLGKFGAFPEAVL 175
Query: 174 RTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSM 233
RTYTKQLLLGLEYLH +GIMHRDIKGANILVDNKGCIKLADFGASKQV ELAT+SGAKSM
Sbjct: 176 RTYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKQVVELATISGAKSM 235
Query: 234 KGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHP 293
KGTPYWMAPEVI QTGHS+SADIWSVGCT IEMATGKPPWSQQYQEVAALFHIGTTKSHP
Sbjct: 236 KGTPYWMAPEVILQTGHSFSADIWSVGCTFIEMATGKPPWSQQYQEVAALFHIGTTKSHP 295
Query: 294 PIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDPVLHASVMKSSEILSPS 353
PIPE LSV+AKDFLLKCL+KEP+LRPTASELLK + H + +I SP
Sbjct: 296 PIPEQLSVEAKDFLLKCLQKEPNLRPTASELLK-----------IFHH--QEPLKIYSPQ 342
Query: 354 HVANLESLQMLTSPGSPGSVDICNLDSLSCSRVI-VEKLSGSMHGWVTSNSNDDLCQL-D 411
+ LE M +P PGS DICNLDSLSCS+V KL M G NS+D++CQ+ D
Sbjct: 343 CTSELE---MSKTPTHPGSSDICNLDSLSCSKVYSTNKLESDMWG---RNSDDEMCQIDD 396
Query: 412 QEDFVAGDRKLSSILAPNDLEKSRNPMCEPSDDWRWKFDGSPEPEKNELKPDSDESLKVP 471
++DF+ + K+ S + ++ KS NP+CEPSDD +FD SP ++ E P
Sbjct: 397 KDDFMLDEVKIGSSIIHENM-KSYNPICEPSDDEDCQFDRSPVVDQGS---SLHEEALAP 452
Query: 472 ASRINASGEEDNGFSFPRGTPLSEDDDELTESKIKAFLDAKVL 514
S A EE N FSFP G LSED+DELTESKIKAFLD K L
Sbjct: 453 GSCSGAFDEEQN-FSFPSGRSLSEDEDELTESKIKAFLDEKAL 494
|
Source: Cucumis melo subsp. melo Species: Cucumis melo Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224111246|ref|XP_002315791.1| predicted protein [Populus trichocarpa] gi|222864831|gb|EEF01962.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 637 bits (1642), Expect = e-180, Method: Compositional matrix adjust.
Identities = 331/528 (62%), Positives = 397/528 (75%), Gaps = 22/528 (4%)
Query: 1 MQDLFGSVRRSIVFRTTAESTTDAQTANSPTPFSGGNLVERFNSCIRNSRV--------L 52
MQD+FGSVRRS+VF++T+ A FSG VER S IR SR+
Sbjct: 1 MQDIFGSVRRSLVFKSTSGGGGGEDGA-----FSG--FVERIGSSIRKSRIGLFSKPSIP 53
Query: 53 SKHISPSVKMSPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQ 112
+PPIR RKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAA+ ASKEK Q
Sbjct: 54 PLPPPSKKDDAPPIRCRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAASSASKEKTQ 113
Query: 113 DHIKELEEEVKLLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAV 172
HI+ELEEEVKLLK+LSHPNIVRYLGT RE++SLNILLEFVPGGSISSLLGKFG FPE+V
Sbjct: 114 AHIRELEEEVKLLKNLSHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESV 173
Query: 173 MRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKS 232
+R YTKQLLLGLEYLH +GIMHRDIKGANILVDNKGCIKLADFGASK+V ELAT++GAKS
Sbjct: 174 IRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKS 233
Query: 233 MKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSH 292
MKGTPYWMAPEVI QTGHS+SADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSH
Sbjct: 234 MKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSH 293
Query: 293 PPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDP--VLHASVMKSSEIL 350
PPIPE+LS++AKDFLL+CL++ P+LRP ASELL+HPFVTG+ ++P V SV +S ++
Sbjct: 294 PPIPEHLSIEAKDFLLECLQEVPNLRPAASELLQHPFVTGEYQEPHSVFRNSVRESGNLI 353
Query: 351 SPSHVANLESL--QMLTSPGSPGSVDICNLDSLSCSRVIVEKLSGSMHGWVTSNSNDDLC 408
+ + + NL+S ++ G D+C + S+ S + +KLS S W +N +DD+C
Sbjct: 354 AATGM-NLKSSMNSVIRRSSCAGLKDVCEMGSVKSSIIYPDKLSISRSYWGAANFDDDMC 412
Query: 409 QL-DQEDFVAG-DRKLSSILAPNDLEKSRNPMCEPSDDWRWKFDGSPEPEKNELKPDSDE 466
+ D++DFV G + S +A +DL KS NPMCEP +DW KFD P ++ + +
Sbjct: 413 LIDDKDDFVVGASTRFKSTVASSDLNKSFNPMCEPMEDWPCKFDEDPLFRRSGINLYCSQ 472
Query: 467 SLKVPASRINASGEEDNGFSFPRGTPLSEDDDELTESKIKAFLDAKVL 514
S+ ASG+ + F+FPRG + EDDDE+TESKI+AFLD K +
Sbjct: 473 SIHEVIDSHEASGKGQHDFTFPRGPVMPEDDDEVTESKIRAFLDEKAI 520
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356504044|ref|XP_003520809.1| PREDICTED: mitogen-activated protein kinase kinase kinase ANP1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 634 bits (1636), Expect = e-179, Method: Compositional matrix adjust.
Identities = 346/527 (65%), Positives = 399/527 (75%), Gaps = 44/527 (8%)
Query: 1 MQDLFGSVRRSIVFRTTAESTTDAQTANSPTPFSGGNLVERFNSCIRNSRVLSKHISPSV 60
MQD+FGSVRRS+VFR + E+ + GG+LV++ + CIR+SRV SK PS
Sbjct: 1 MQDIFGSVRRSLVFRGSPENEEASSLG------VGGSLVDKISYCIRSSRVFSKPSPPSP 54
Query: 61 -------KMSPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQD 113
+PPIRWRKGELIGCGAFG+VY+GMNLDSGELLAVKQVLIAA+ A+KEKAQ
Sbjct: 55 PPPSFPKNAAPPIRWRKGELIGCGAFGQVYVGMNLDSGELLAVKQVLIAASNATKEKAQA 114
Query: 114 HIKELEEEVKLLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVM 173
HIKELEEEVKLLKDLSHPNIVRYLGTVREE++LNILLEFVPGGSISSLLGKFG FPEAV+
Sbjct: 115 HIKELEEEVKLLKDLSHPNIVRYLGTVREEDTLNILLEFVPGGSISSLLGKFGAFPEAVI 174
Query: 174 RTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSM 233
RTYTKQLLLGLEYLH +GIMHRDIKGANILVDNKGCIKLADFGASKQV ELAT+SGAKSM
Sbjct: 175 RTYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKQVVELATISGAKSM 234
Query: 234 KGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQY-QEVAALFHIGTTKSH 292
KGTPYWMAPEVI QTGHS+SADIWSVGCTVIEMATGKPPWSQQY QEVAALFHIGTTKSH
Sbjct: 235 KGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQYQQEVAALFHIGTTKSH 294
Query: 293 PPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDPV-LHASVMKSSEILS 351
PPIP++LS AKDFLLKCL+KEP LR +ASELL+HPFVTG+ + + L ++V ++ E S
Sbjct: 295 PPIPDHLSAAAKDFLLKCLQKEPILRSSASELLQHPFVTGEHMNSLPLSSNVTENFEASS 354
Query: 352 PSHVANLESLQMLTSPGSPGSVDICNLDSLSCSRVIVEKLSGSMHGWVTSNSNDDLCQL- 410
PS N + + S +P LD SG+ W SN +DD+C +
Sbjct: 355 PSCAPNDDESFLFRSTVNP-------LD------------SGNKQSWGMSN-DDDMCVID 394
Query: 411 DQEDFVAGDRKLSSILAPNDLEKSRNPMCEPSDDWRWKFDGSPEPEKNELKPDSDESLKV 470
D+EDF D K S ++ N++E S NPM +PSDDW +KFD SPE E + +D S
Sbjct: 395 DKEDFSQSDAKYKSFMSTNNIE-SFNPMSDPSDDWGYKFDASPELENRGVSFGTDVSYMP 453
Query: 471 PASRINASGEEDNG---FSFPRGTPLSEDDDELTESKIKAFLDAKVL 514
P + SG++D G FSFP LSE+DDELTESKIKAFLD K L
Sbjct: 454 P----DQSGDDDKGQKDFSFPGVPSLSEEDDELTESKIKAFLDEKAL 496
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 536 | ||||||
| UNIPROTKB|Q40541 | 690 | Q40541 "Protein kinase" [Nicot | 0.951 | 0.739 | 0.592 | 1.3e-155 | |
| TAIR|locus:2080394 | 651 | NP3 "NPK1-related protein kina | 0.932 | 0.768 | 0.568 | 4.6e-144 | |
| TAIR|locus:2035989 | 666 | NP1 "NPK1-related protein kina | 0.910 | 0.732 | 0.583 | 4.4e-139 | |
| DICTYBASE|DDB_G0283265 | 1267 | mkkA "octicosapeptide/Phox/Bem | 0.5 | 0.211 | 0.516 | 2.4e-73 | |
| TAIR|locus:2024832 | 609 | MAP3KA "mitogen-activated prot | 0.608 | 0.535 | 0.432 | 1.5e-67 | |
| TAIR|locus:2026674 | 883 | YDA "YODA" [Arabidopsis thalia | 0.526 | 0.319 | 0.469 | 1.2e-65 | |
| POMBASE|SPBC1D7.05 | 659 | byr2 "MAP kinase kinase kinase | 0.490 | 0.399 | 0.498 | 7.6e-64 | |
| UNIPROTKB|I3LNQ4 | 620 | MAP3K2 "Uncharacterized protei | 0.593 | 0.512 | 0.434 | 3e-62 | |
| UNIPROTKB|I3LTY6 | 616 | MAP3K2 "Uncharacterized protei | 0.593 | 0.516 | 0.434 | 3e-62 | |
| SGD|S000004354 | 717 | STE11 "Signal transducing MEK | 0.371 | 0.277 | 0.485 | 4.8e-62 |
| UNIPROTKB|Q40541 Q40541 "Protein kinase" [Nicotiana tabacum (taxid:4097)] | Back alignment and assigned GO terms |
|---|
Score = 1517 (539.1 bits), Expect = 1.3e-155, P = 1.3e-155
Identities = 316/533 (59%), Positives = 375/533 (70%)
Query: 1 MQDLFGSVRRSIVFRTTAESTTDAQTANSPTPFSGGNLVERFNSCIRNSRV--LSK-HIS 57
MQD GSVRRS+VF+ + + T A S F G VE+ S IR S + SK H+
Sbjct: 1 MQDFIGSVRRSLVFKQSGDFDTGAAGVGSG--FGG--FVEKLGSSIRKSSIGIFSKAHVP 56
Query: 58 --PSVKMS-----------PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAAN 104
PS+ + PPIRWRKGE+IGCGAFGRVYMGMN+DSGELLA+K+V IA N
Sbjct: 57 ALPSISKAELPAKARKDDTPPIRWRKGEMIGCGAFGRVYMGMNVDSGELLAIKEVSIAMN 116
Query: 105 FASKEKAQDHIXXXXXXXXXXXXXSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGK 164
AS+E+AQ H+ SHPNIVRYLGT RE SLNILLEFVPGGSISSLLGK
Sbjct: 117 GASRERAQAHVRELEEEVNLLKNLSHPNIVRYLGTAREAGSLNILLEFVPGGSISSLLGK 176
Query: 165 FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAEL 224
FG FPE+V+R YTKQLLLGLEYLH +GIMHRDIKGANILVDNKGCIKLADFGASK+V EL
Sbjct: 177 FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVEL 236
Query: 225 ATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALF 284
AT++GAKSMKGTPYWMAPEVI QTGHS+SADIWSVGCT+IEMATGKPPWSQQYQEVAALF
Sbjct: 237 ATMTGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTIIEMATGKPPWSQQYQEVAALF 296
Query: 285 HIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDED--PVLHAS 342
HIGTTKSHPPIPE+LS ++KDFLLKCL+KEP LR +AS LL+HPFVT + ++ P L +S
Sbjct: 297 HIGTTKSHPPIPEHLSAESKDFLLKCLQKEPHLRHSASNLLQHPFVTAEHQEARPFLRSS 356
Query: 343 VMKSSEILSPSHVANLESLQMLTSPGSPGSVDICNLDSLSCSRVIVEKLSGSMHGWVTSN 402
M + E ++ + S+ G D+C + ++ CS V E G W N
Sbjct: 357 FMGNPENMAAQRMDVRTSIIPDMRASCNGLKDVCGVSAVRCSTVYPENSLGKESLWKLGN 416
Query: 403 SNDDLCQLDQEDFVAGDR-KLSSILAPNDLEKSRNPMCEPSDDWRWKFDGSPEPEKNELK 461
S+DD+CQ+D +DF+ G K SS L KS NPMCEP +DW KFD SPE K++
Sbjct: 417 SDDDMCQMDNDDFMFGASVKCSSDLHSPANYKSFNPMCEPDNDWPCKFDESPELTKSQAN 476
Query: 462 PDSDESLKVPASRINASGEEDNGFSFPRGTPLSEDDDELTESKIKAFLDAKVL 514
D++ P + S +ED F+FP G +EDDDELTESKI+AFLD K +
Sbjct: 477 LHYDQATIKPTNNPIMSYKEDLAFTFPSGQSAAEDDDELTESKIRAFLDEKAM 529
|
|
| TAIR|locus:2080394 NP3 "NPK1-related protein kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1408 (500.7 bits), Expect = 4.6e-144, P = 4.6e-144
Identities = 298/524 (56%), Positives = 367/524 (70%)
Query: 1 MQDLFGSVRRSIVFRTTAESTTDAQTANSPTPFSGGNLVERFNSCIRNSRV--LSKHI-- 56
MQD+ GSVRRS+VFR++ D + + F G + NS IR+SR+ SK
Sbjct: 1 MQDILGSVRRSLVFRSSLAGD-DGTSGGGLSGFVG-----KINSSIRSSRIGLFSKPPPG 54
Query: 57 --SPSVKMSPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDH 114
+P + +P IRWRKGELIGCGAFGRVYMGMNLDSGELLA+KQVLIA + ASKEK Q H
Sbjct: 55 LPAPRKEEAPSIRWRKGELIGCGAFGRVYMGMNLDSGELLAIKQVLIAPSSASKEKTQGH 114
Query: 115 IXXXXXXXXXXXXXSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMR 174
I SHPNIVRYLGTVRE +SLNIL+EFVPGGSISSLL KFG FPE V+
Sbjct: 115 IRELEEEVQLLKNLSHPNIVRYLGTVRESDSLNILMEFVPGGSISSLLEKFGSFPEPVII 174
Query: 175 TYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMK 234
YTKQLLLGLEYLHN+GIMHRDIKGANILVDNKGCI+LADFGASK+V ELATV+GAKSMK
Sbjct: 175 MYTKQLLLGLEYLHNNGIMHRDIKGANILVDNKGCIRLADFGASKKVVELATVNGAKSMK 234
Query: 235 GTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPP 294
GTPYWMAPEVI QTGHS+SADIWSVGCTVIEMATGKPPWS+QYQ+ AA+ HIG TK+HPP
Sbjct: 235 GTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSEQYQQFAAVLHIGRTKAHPP 294
Query: 295 IPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDP--VLHASVMKSSEILSP 352
IPE+LS +AKDFL+KCL KEP LR +A+ELL+HPFVTG ++P S+ + ++
Sbjct: 295 IPEDLSPEAKDFLMKCLHKEPSLRLSATELLQHPFVTGKRQEPYPAYRNSLTECGNPITT 354
Query: 353 SHVANLESLQMLTSPGS-PGSVDICNLDSLSCSRVIVEKLSGSMHGWVTSNSNDDLCQLD 411
+ S+ L + G D+C L SL S + +K + S GW +S DDLCQ D
Sbjct: 355 QGMNVRSSINSLIRRSTCSGLKDVCELGSLRSSIIYPQKSNNSGFGWRDGDS-DDLCQTD 413
Query: 412 QEDFVAGDRKLSSILAPN-DLEKSRNPMCEPSDDWRWKFDGSPEPEKNELKPDSDESLKV 470
+D + +++L+ + DL KS NPMC+ +D+W KFD SP+ K++ L
Sbjct: 414 MDDLCNIESVRNNVLSQSTDLNKSFNPMCDSTDNWSCKFDESPKVMKSK-----SNLLSY 468
Query: 471 PASRINASG--EEDNGFSFPRGTPLSEDDDELTESKIKAFLDAK 512
AS++ +E+ +F G+ ++EDD + TE KIK+FLD K
Sbjct: 469 QASQLQTGVPCDEETSLTFAGGSSVAEDDYKGTELKIKSFLDEK 512
|
|
| TAIR|locus:2035989 NP1 "NPK1-related protein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1361 (484.2 bits), Expect = 4.4e-139, P = 4.4e-139
Identities = 301/516 (58%), Positives = 360/516 (69%)
Query: 1 MQDLFGSVRRSIVFRTTAESTTDAQTANSPTPFSGGNLVERFNSCIRNSRVLSK-HISP- 58
MQD FGSVRRS+VFR +++ D N P PF G L ++ SCIR S++ K SP
Sbjct: 1 MQDFFGSVRRSLVFRPSSD---DDNQENQP-PFPGV-LADKITSCIRKSKIFIKPSFSPP 55
Query: 59 ----SVKMSPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDH 114
+V M+PPI WRKG+LIG GAFG VYMGMNLDSGELLAVKQVLIAANFASKEK Q H
Sbjct: 56 PPANTVDMAPPISWRKGQLIGRGAFGTVYMGMNLDSGELLAVKQVLIAANFASKEKTQAH 115
Query: 115 IXXXXXXXXXXXXXSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMR 174
I SHPNIVRYLGTVRE+++LNILLEFVPGGSISSLL KFGPFPE+V+R
Sbjct: 116 IQELEEEVKLLKNLSHPNIVRYLGTVREDDTLNILLEFVPGGSISSLLEKFGPFPESVVR 175
Query: 175 TYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMK 234
TYT+QLLLGLEYLHNH IMHRDIKGANILVDNKGCIKLADFGASKQVAELAT++GAKSMK
Sbjct: 176 TYTRQLLLGLEYLHNHAIMHRDIKGANILVDNKGCIKLADFGASKQVAELATMTGAKSMK 235
Query: 235 GTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPP 294
GTPYWMAPEVI QTGHS+SADIWSVGCTVIEM TGK PWSQQY+EVAA+F IGTTKSHPP
Sbjct: 236 GTPYWMAPEVILQTGHSFSADIWSVGCTVIEMVTGKAPWSQQYKEVAAIFFIGTTKSHPP 295
Query: 295 IPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDPVLH--ASVMKSSEILSP 352
IP+ LS AKDFLLKCL++ P+LRPTASELLKHPFV G ++ SV+ + P
Sbjct: 296 IPDTLSSDAKDFLLKCLQEVPNLRPTASELLKHPFVMGKHKESASTDLGSVLNNLSTPLP 355
Query: 353 SHVANLESLQMLTSPGSPGSVDICNLDSLSCSRVIVEKLSGSMHGWVTSNSN---DDLCQ 409
+ N +S T G D+CN SL+ S V K + + W +++ DD+C
Sbjct: 356 LQINNTKSTPDSTCD-DVG--DMCNFGSLNYSLVDPVKSIQNKNLWQQNDNGGDEDDMCL 412
Query: 410 LDQEDFVAGDRKLSSILAPN-DLEKSRNPMCEPSDDWRWKFDGSP-EPEKNEL------K 461
+D E+F+ D ++SS L + L+KS + + + S + KFD SP EK +
Sbjct: 413 IDDENFLTFDGEMSSTLEKDCHLKKSCDDISDMSIALKSKFDESPGNGEKESTMSMECDQ 472
Query: 462 PD-SDESLKVPASRINASGEEDNGFSFPRGTPLSED 496
P S++ ++ S+I A +E TPL E+
Sbjct: 473 PSYSEDDDELTESKIKAFLDEKAADLKKLQTPLYEE 508
|
|
| DICTYBASE|DDB_G0283265 mkkA "octicosapeptide/Phox/Bem1p domain-containing protein" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 749 (268.7 bits), Expect = 2.4e-73, P = 2.4e-73
Identities = 140/271 (51%), Positives = 193/271 (71%)
Query: 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIXXXXXXXXXX 125
I+W+KG+++G G +G VY+G+N D+GEL AVKQ+ I + S K ++ I
Sbjct: 493 IKWQKGQILGRGGYGSVYLGLNKDTGELFAVKQLEIV-DINSDPKLKNMILSFSKEIEVM 551
Query: 126 XXXSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLE 185
H NIVRYLGT ++ L++ LE++PGGSISSLLGKFG F E V++ YTKQ+L GL
Sbjct: 552 RSLRHDNIVRYLGTSLDQSFLSVFLEYIPGGSISSLLGKFGAFSENVIKVYTKQILQGLS 611
Query: 186 YLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVI 245
+LH + I+HRDIKGANIL+D KG +KL+DFG SK + + VS KSM+GTPYWMAPEVI
Sbjct: 612 FLHANSIIHRDIKGANILIDTKGIVKLSDFGCSKSFSGI--VSQFKSMQGTPYWMAPEVI 669
Query: 246 RQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKD 305
+QTGH S+DIWS+GC ++EMAT +PPWS + A ++HI ++ S P IP ++S +A D
Sbjct: 670 KQTGHGRSSDIWSLGCVIVEMATAQPPWSNITELAAVMYHIASSNSIPNIPSHMSQEAFD 729
Query: 306 FLLKCLEKEPDLRPTASELLKHPFVTGDDED 336
FL C +++P RP A++LLKHPF+ D++
Sbjct: 730 FLNLCFKRDPKERPDANQLLKHPFIMNLDDN 760
|
|
| TAIR|locus:2024832 MAP3KA "mitogen-activated protein kinase kinase kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 686 (246.5 bits), Expect = 1.5e-67, P = 1.5e-67
Identities = 148/342 (43%), Positives = 209/342 (61%)
Query: 49 SRVLSKHISPSVKMSPP--IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFA 106
S V I + SP W+KG+ +G G FG+VY+G N + G++ A+K+V + ++
Sbjct: 193 SAVHGSRIGGGYETSPSGFSTWKKGKFLGSGTFGQVYLGFNSEKGKMCAIKEVKVISD-- 250
Query: 107 SKEKAQDHIXXXXXXXXXXXXXSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFG 166
+ +++ + HPNIV+Y G+ EE+L++ LE+V GGSI LL +G
Sbjct: 251 -DQTSKECLKQLNQEINLLNQLCHPNIVQYYGSELSEETLSVYLEYVSGGSIHKLLKDYG 309
Query: 167 PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELAT 226
F E V++ YT+Q+L GL YLH +HRDIKGANILVD G IKLADFG +K V +T
Sbjct: 310 SFTEPVIQNYTRQILAGLAYLHGRNTVHRDIKGANILVDPNGEIKLADFGMAKHVTAFST 369
Query: 227 VSGAKSMKGTPYWMAPEVIR-QTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFH 285
+ S KG+PYWMAPEV+ Q G++++ DIWS+GCT++EMAT KPPWSQ ++ VAA+F
Sbjct: 370 ML---SFKGSPYWMAPEVVMSQNGYTHAVDIWSLGCTILEMATSKPPWSQ-FEGVAAIFK 425
Query: 286 IGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDPVLHASVMK 345
IG +K P IP++LS AK+F+ CL++ P +RPTAS+LL+HPF+ V S+ K
Sbjct: 426 IGNSKDTPEIPDHLSNDAKNFIRLCLQRNPTVRPTASQLLEHPFLRNTTR--VASTSLPK 483
Query: 346 SSEILSPSHVANLESLQMLTSPGSPGSVDICNLDSLSCSRVI 387
+ S+ N SLQ P PG + N SR I
Sbjct: 484 --DFPPRSYDGNF-SLQPTREP-YPGRLSHDNYAKQPLSRTI 521
|
|
| TAIR|locus:2026674 YDA "YODA" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 668 (240.2 bits), Expect = 1.2e-65, P = 1.2e-65
Identities = 138/294 (46%), Positives = 189/294 (64%)
Query: 62 MSPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFA-SKEKAQDHIXXXXX 120
+SP RW+KG L+G G+FG VY+G N +SGE+ A+K+V + ++ S+E AQ
Sbjct: 394 VSPGSRWKKGRLLGMGSFGHVYLGFNSESGEMCAMKEVTLCSDDPKSRESAQQ----LGQ 449
Query: 121 XXXXXXXXSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQL 180
H NIV+Y G+ ++ L I LE+V GGSI LL ++G F E +R YT+Q+
Sbjct: 450 EISVLSRLRHQNIVQYYGSETVDDKLYIYLEYVSGGSIYKLLQEYGQFGENAIRNYTQQI 509
Query: 181 LLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWM 240
L GL YLH +HRDIKGANILVD G +K+ADFG +K + SG S KG+PYWM
Sbjct: 510 LSGLAYLHAKNTVHRDIKGANILVDPHGRVKVADFGMAKHIT---AQSGPLSFKGSPYWM 566
Query: 241 APEVIRQT-GHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENL 299
APEVI+ + G + + DIWS+GCTV+EMAT KPPWSQ Y+ V A+F IG +K P IP++L
Sbjct: 567 APEVIKNSNGSNLAVDIWSLGCTVLEMATTKPPWSQ-YEGVPAMFKIGNSKELPDIPDHL 625
Query: 300 SVKAKDFLLKCLEKEPDLRPTASELLKHPFVTG--DDEDPVLHASVMKSSEILS 351
S + KDF+ KCL++ P RPTA++LL H FV E P++ ++ + S
Sbjct: 626 SEEGKDFVRKCLQRNPANRPTAAQLLDHAFVRNVMPMERPIVSGEPAEAMNVAS 679
|
|
| POMBASE|SPBC1D7.05 byr2 "MAP kinase kinase kinase Byr2" [Schizosaccharomyces pombe (taxid:4896)] | Back alignment and assigned GO terms |
|---|
Score = 651 (234.2 bits), Expect = 7.6e-64, P = 7.6e-64
Identities = 135/271 (49%), Positives = 182/271 (67%)
Query: 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIXXXXXXXXXX 125
I+W +G LIG G+FG+VY+GMN SGEL+AVKQV++ + SK++ +
Sbjct: 392 IKWIRGALIGSGSFGQVYLGMNASSGELMAVKQVILDSVSESKDRHAKLLDALAGEIALL 451
Query: 126 XXXSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLE 185
SH +IV+YLG+ + LNI LE+VPGGS++ LL +G F E +++ + KQ L GLE
Sbjct: 452 QELSHEHIVQYLGSNLNSDHLNIFLEYVPGGSVAGLLTMYGSFEETLVKNFIKQTLKGLE 511
Query: 186 YLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVS----GAK-SMKGTPYWM 240
YLH+ GI+HRDIKGANILVDNKG IK++DFG SK++ EL + S GA+ S +G+ +WM
Sbjct: 512 YLHSRGIVHRDIKGANILVDNKGKIKISDFGISKKL-ELNSTSTKTGGARPSFQGSSFWM 570
Query: 241 APEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLS 300
APEV++QT H+ DIWS+GC VIEM T K P+ ++ A+F IG P P N+S
Sbjct: 571 APEVVKQTMHTEKTDIWSLGCLVIEMLTSKHPYPN-CDQMQAIFRIGENIL-PEFPSNIS 628
Query: 301 VKAKDFLLKCLEKEPDLRPTASELLKHPFVT 331
A DFL K + +LRPTASELL HPFV+
Sbjct: 629 SSAIDFLEKTFAIDCNLRPTASELLSHPFVS 659
|
|
| UNIPROTKB|I3LNQ4 MAP3K2 "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 636 (228.9 bits), Expect = 3.0e-62, P = 3.0e-62
Identities = 143/329 (43%), Positives = 204/329 (62%)
Query: 7 SVRRSIVFRTTAESTTDAQTANSPTPFSGGNLVERFNSCIRNSRVLSKHISPSVKMSP-- 64
S R + F T S + + ++ TP N + R S I N + ISP + SP
Sbjct: 295 SFRSPVSFSPTDHSLSTSSGSSIFTPEYDENRLRRRGSDIDNPTLTVMDISPPSR-SPRA 353
Query: 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIXXXXXXXXX 124
P WR G+L+G GAFGRVY+ ++D+G LAVKQV + S E +++ +
Sbjct: 354 PTNWRLGKLLGQGAFGRVYLCYDVDTGRELAVKQVQFDPD--SPETSKE-VNALECEIQL 410
Query: 125 XXXXSHPNIVRYLGTVRE--EESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLL 182
H IV+Y G +R+ E++L+I +E++PGGSI L +G E V R YT+Q+L
Sbjct: 411 LKNLLHERIVQYYGCLRDPQEKTLSIFMEYMPGGSIKDQLKAYGALTENVTRKYTRQILE 470
Query: 183 GLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA-TVSGAKSMKGTPYWMA 241
G+ YLH++ I+HRDIKGANIL D+ G +KL DFGASK++ + + +G KS+ GTPYWM+
Sbjct: 471 GVHYLHSNMIVHRDIKGANILRDSTGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMS 530
Query: 242 PEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSV 301
PEVI G+ ADIWSVGCTV+EM T KPPW++ ++ +AA+F I T ++P +P ++S
Sbjct: 531 PEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAE-FEAMAAIFKIATQPTNPKLPPHVSD 589
Query: 302 KAKDFLLKCLEKEPDLRPTASELLKHPFV 330
+DFL K + E LRP+A ELL+H FV
Sbjct: 590 YTRDFL-KRIFVEAKLRPSADELLRHMFV 617
|
|
| UNIPROTKB|I3LTY6 MAP3K2 "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 636 (228.9 bits), Expect = 3.0e-62, P = 3.0e-62
Identities = 143/329 (43%), Positives = 204/329 (62%)
Query: 7 SVRRSIVFRTTAESTTDAQTANSPTPFSGGNLVERFNSCIRNSRVLSKHISPSVKMSP-- 64
S R + F T S + + ++ TP N + R S I N + ISP + SP
Sbjct: 291 SFRSPVSFSPTDHSLSTSSGSSIFTPEYDENRLRRRGSDIDNPTLTVMDISPPSR-SPRA 349
Query: 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIXXXXXXXXX 124
P WR G+L+G GAFGRVY+ ++D+G LAVKQV + S E +++ +
Sbjct: 350 PTNWRLGKLLGQGAFGRVYLCYDVDTGRELAVKQVQFDPD--SPETSKE-VNALECEIQL 406
Query: 125 XXXXSHPNIVRYLGTVRE--EESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLL 182
H IV+Y G +R+ E++L+I +E++PGGSI L +G E V R YT+Q+L
Sbjct: 407 LKNLLHERIVQYYGCLRDPQEKTLSIFMEYMPGGSIKDQLKAYGALTENVTRKYTRQILE 466
Query: 183 GLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA-TVSGAKSMKGTPYWMA 241
G+ YLH++ I+HRDIKGANIL D+ G +KL DFGASK++ + + +G KS+ GTPYWM+
Sbjct: 467 GVHYLHSNMIVHRDIKGANILRDSTGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMS 526
Query: 242 PEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSV 301
PEVI G+ ADIWSVGCTV+EM T KPPW++ ++ +AA+F I T ++P +P ++S
Sbjct: 527 PEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAE-FEAMAAIFKIATQPTNPKLPPHVSD 585
Query: 302 KAKDFLLKCLEKEPDLRPTASELLKHPFV 330
+DFL K + E LRP+A ELL+H FV
Sbjct: 586 YTRDFL-KRIFVEAKLRPSADELLRHMFV 613
|
|
| SGD|S000004354 STE11 "Signal transducing MEK kinase" [Saccharomyces cerevisiae (taxid:4932)] | Back alignment and assigned GO terms |
|---|
Score = 522 (188.8 bits), Expect = 4.8e-62, Sum P(2) = 4.8e-62
Identities = 98/202 (48%), Positives = 142/202 (70%)
Query: 130 HPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHN 189
H NIV Y G +E +LNI LE+VPGGS+SS+L +GPF E+++ +T+Q+L+G+ YLH
Sbjct: 513 HENIVTYYGASQEGGNLNIFLEYVPGGSVSSMLNNYGPFEESLITNFTRQILIGVAYLHK 572
Query: 190 HGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAK-SMKGTPYWMAPEVIRQT 248
I+HRDIKGANIL+D KGC+K+ DFG SK+++ L + S++G+ +WM+PEV++QT
Sbjct: 573 KNIIHRDIKGANILIDIKGCVKITDFGISKKLSPLNKKQNKRASLQGSVFWMSPEVVKQT 632
Query: 249 GHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKDFLL 308
+ ADIWS GC VIEM TGK P+ + ++ A+F IGT + P IP + + K+FL
Sbjct: 633 ATTAKADIWSTGCVVIEMFTGKHPFPD-FSQMQAIFKIGTNTT-PEIPSWATSEGKNFLR 690
Query: 309 KCLEKEPDLRPTASELLKHPFV 330
K E + RP+A ELL+HP++
Sbjct: 691 KAFELDYQYRPSALELLQHPWL 712
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9FZ36 | M3K2_ARATH | 2, ., 7, ., 1, 1, ., 2, 5 | 0.6166 | 0.9011 | 0.7419 | yes | no |
| O22040 | ANP1_ARATH | 2, ., 7, ., 1, 1, ., 2, 5 | 0.6045 | 0.8899 | 0.7162 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | MAP3K | SubName- Full=Chromosome chr5 scaffold_2, whole genome shotgun sequence; (696 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
 | AP3 | SubName- Full=Chromosome chr18 scaffold_1, whole genome shotgun sequence; (226 aa) | • | 0.483 | |||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 536 | |||
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-165 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-151 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-110 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-107 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-105 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-104 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-103 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-102 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-102 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 7e-94 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 7e-92 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 8e-87 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 9e-87 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-86 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-85 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 8e-84 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-80 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-80 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-76 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-72 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-71 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-68 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 9e-68 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 7e-67 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-66 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-66 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-63 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-62 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-61 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-58 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-58 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-57 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-56 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-56 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-56 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 8e-56 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-55 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-54 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-54 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 6e-54 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-53 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 5e-52 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-51 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-51 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-51 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-51 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-50 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 6e-50 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-49 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 7e-49 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-48 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-48 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-48 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-47 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-47 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-47 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-47 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 8e-47 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-46 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-46 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-46 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-46 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-45 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-45 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-45 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-44 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-44 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 9e-44 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-43 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-43 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-43 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-43 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-43 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-43 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-42 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-42 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-41 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-41 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-40 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-40 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-40 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 7e-40 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 9e-40 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-39 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-39 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-39 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 8e-39 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 8e-39 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-38 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-38 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-38 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-37 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-37 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-37 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-37 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 7e-37 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 8e-37 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-36 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-35 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-35 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 7e-35 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 9e-35 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 9e-35 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-34 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-34 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-34 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-34 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 7e-34 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-33 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-33 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-33 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-33 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-33 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 6e-33 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-32 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-32 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-32 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-32 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-32 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-31 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-31 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-31 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-31 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 6e-31 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 8e-31 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 9e-31 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-30 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-30 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-30 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-30 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-30 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-30 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 9e-30 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-29 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-29 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-29 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-29 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-29 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-29 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-29 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-29 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 7e-29 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-28 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-28 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-28 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-28 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-28 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-28 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-28 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 6e-28 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 7e-28 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-27 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-27 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-27 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-27 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 7e-27 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-26 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-26 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-26 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-26 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 8e-26 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-25 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-25 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-25 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-25 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-25 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-25 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-25 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-25 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-25 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 7e-25 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-24 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-24 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-24 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-24 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-24 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-24 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-24 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-24 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-24 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-24 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 6e-24 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 7e-24 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-23 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-23 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-23 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-23 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-23 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-23 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-23 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-23 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-23 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 6e-23 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 7e-23 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 7e-23 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 8e-23 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 9e-23 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-22 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-22 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-22 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-22 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-22 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-22 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-22 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-22 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-22 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-22 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 6e-22 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 6e-22 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 7e-22 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 7e-22 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 8e-22 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 9e-22 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-21 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-21 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-21 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-21 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-21 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-21 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-21 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-21 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-21 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-21 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-21 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-21 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-21 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 7e-21 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 9e-21 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 9e-21 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 9e-21 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-20 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-20 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-20 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-20 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-20 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-20 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-20 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-20 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-20 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-20 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-20 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-20 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 6e-20 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 6e-20 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 6e-20 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 8e-20 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 9e-20 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-19 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-19 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-19 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-19 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-19 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-19 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 8e-19 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 9e-19 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 9e-19 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-18 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-18 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-18 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 6e-18 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 7e-18 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 7e-18 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 7e-18 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-17 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-17 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-17 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-17 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-17 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-17 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 5e-17 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 6e-17 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 8e-16 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 9e-16 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-15 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-15 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-15 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-15 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-15 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-14 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-14 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 5e-14 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 6e-14 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-13 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-13 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-13 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-13 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-13 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-13 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 5e-13 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 7e-13 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-12 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-12 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 8e-12 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 9e-12 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-11 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 2e-11 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 4e-11 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-10 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-08 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 4e-08 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 2e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-07 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 2e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-06 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 4e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-05 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 468 bits (1205), Expect = e-165
Identities = 166/265 (62%), Positives = 208/265 (78%), Gaps = 8/265 (3%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLK 126
RWRKGEL+G G+FG VY G+NLD G+ AVK+V +A + + Q+ +K+LE+E+ LL
Sbjct: 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADD---GQTGQEAVKQLEQEIALLS 57
Query: 127 DLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEY 186
L HPNIV+YLGT REE++L I LE VPGGS++ LL K+G FPE V+R YT+Q+LLGLEY
Sbjct: 58 KLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEY 117
Query: 187 LHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIR 246
LH+ +HRDIKGANILVD G +KLADFG +KQV E S AKS KG+PYWMAPEVI
Sbjct: 118 LHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF---SFAKSFKGSPYWMAPEVIA 174
Query: 247 QTG-HSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKD 305
Q G + +ADIWS+GCTV+EMATGKPPWSQ VAA+F IG +K PPIP++LS +AKD
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG-VAAVFKIGRSKELPPIPDHLSDEAKD 233
Query: 306 FLLKCLEKEPDLRPTASELLKHPFV 330
F+LKCL+++P LRPTA+ELL+HPFV
Sbjct: 234 FILKCLQRDPSLRPTAAELLEHPFV 258
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 434 bits (1118), Expect = e-151
Identities = 150/266 (56%), Positives = 201/266 (75%), Gaps = 8/266 (3%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLK 126
W +GEL+G G+FG VY+ ++ D+GEL+AVK V + +++ ++ LE E+++L
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVEL------SGDSEEELEALEREIRILS 54
Query: 127 DLSHPNIVRYLGTVREEE--SLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGL 184
L HPNIVRY G+ R+EE +LNI LE+V GGS+SSLL KFG PE V+R YT+Q+L GL
Sbjct: 55 SLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGL 114
Query: 185 EYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEV 244
YLH++GI+HRDIKGANILVD+ G +KLADFG +K++ ++ T G S++GTPYWMAPEV
Sbjct: 115 AYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEV 174
Query: 245 IRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAK 304
IR + +ADIWS+GCTVIEMATGKPPWS+ +AAL+ IG++ P IPE+LS +AK
Sbjct: 175 IRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAK 234
Query: 305 DFLLKCLEKEPDLRPTASELLKHPFV 330
DFL KCL ++P RPTA ELL+HPF+
Sbjct: 235 DFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 328 bits (844), Expect = e-110
Identities = 125/260 (48%), Positives = 185/260 (71%), Gaps = 10/260 (3%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH 130
G+LIG GAFG VY G+NL++G+ +A+KQ+ + ++ ++ +K + +E+ LLK+L H
Sbjct: 5 GDLIGRGAFGVVYKGLNLETGDFVAIKQI------SLEKIKEEALKSIMQEIDLLKNLKH 58
Query: 131 PNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNH 190
PNIV+Y+G++ +SL I+LE+ GS+ ++ KFGPFPE+++ Y Q+L GL YLH
Sbjct: 59 PNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ 118
Query: 191 GIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGH 250
G++HRDIK ANIL G +KLADFG + ++ +++ S+ GTPYWMAPEVI +G
Sbjct: 119 GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDD--ASVVGTPYWMAPEVIEMSGA 176
Query: 251 SYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKDFLLKC 310
S ++DIWS+GCTVIE+ TG PP+ +AALF I HPP+PE +S + KDFL++C
Sbjct: 177 STASDIWSLGCTVIELLTGNPPYY-DLNPMAALFRIVQDD-HPPLPEGISPELKDFLMQC 234
Query: 311 LEKEPDLRPTASELLKHPFV 330
+K+P+LRPTA +LLKHP++
Sbjct: 235 FQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 320 bits (821), Expect = e-107
Identities = 140/270 (51%), Positives = 193/270 (71%), Gaps = 9/270 (3%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFA-SKEKAQDHIKELEEEVKLL 125
+W KG LIG G+FG VY+GMN SGEL+AVKQV + + A SK++ + + L E+ LL
Sbjct: 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALL 60
Query: 126 KDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLE 185
K+L H NIV+YLG+ + + LNI LE+VPGGS+++LL +G F E ++R + +Q+L GL
Sbjct: 61 KELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLN 120
Query: 186 YLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAK-----SMKGTPYWM 240
YLHN GI+HRDIKGANILVDNKG IK++DFG SK++ E ++S S++G+ +WM
Sbjct: 121 YLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKL-EANSLSTKTNGARPSLQGSVFWM 179
Query: 241 APEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLS 300
APEV++QT ++ ADIWS+GC V+EM TGK P+ Q + A+F IG + P IP N+S
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ-LQAIFKIG-ENASPEIPSNIS 237
Query: 301 VKAKDFLLKCLEKEPDLRPTASELLKHPFV 330
+A DFL K E + + RPTA+ELLKHPF+
Sbjct: 238 SEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 314 bits (807), Expect = e-105
Identities = 104/264 (39%), Positives = 155/264 (58%), Gaps = 11/264 (4%)
Query: 68 WRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKD 127
+ E +G G+FG+VY+ + +G+L+A+K + K+K + + + E+K+LK
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVI-------KKKKIKKDRERILREIKILKK 53
Query: 128 LSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYL 187
L HPNIVR +E+ L +++E+ GG + LL K G E R Y +Q+L LEYL
Sbjct: 54 LKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYL 113
Query: 188 HNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQ 247
H+ GI+HRD+K NIL+D G +KLADFG ++Q+ + GTP +MAPEV+
Sbjct: 114 HSKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK---LTTFVGTPEYMAPEVLLG 170
Query: 248 TGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPE-NLSVKAKDF 306
G+ + DIWS+G + E+ TGKPP+ Q + IG K P PE ++S +AKD
Sbjct: 171 KGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDL 230
Query: 307 LLKCLEKEPDLRPTASELLKHPFV 330
+ K L K+P+ R TA E L+HPF
Sbjct: 231 IRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 313 bits (803), Expect = e-104
Identities = 135/272 (49%), Positives = 180/272 (66%), Gaps = 9/272 (3%)
Query: 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFAS--KEKAQDHIKELEEEVK 123
+W KGELIG G +GRVY+ +N+ +GE++AVKQV + A A + +D +K L E++
Sbjct: 1 FKWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIE 60
Query: 124 LLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLG 183
LKDL H NIV+YLG EE L+I LE+VPGGSI S L +G F E ++R +T+Q+L G
Sbjct: 61 TLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEG 120
Query: 184 LEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPE 243
L YLH+ GI+HRD+K N+LVD G K++DFG SK+ ++ SM+G+ +WMAPE
Sbjct: 121 LAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180
Query: 244 VIRQTGHSYSA--DIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPE---- 297
VI YSA DIWS+GC V+EM G+ PWS + + +AA+F +G +S PPIP
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE-EAIAAMFKLGNKRSAPPIPPDVSM 239
Query: 298 NLSVKAKDFLLKCLEKEPDLRPTASELLKHPF 329
NLS A DFL C PD RPTA ELL+HPF
Sbjct: 240 NLSPVALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 309 bits (794), Expect = e-103
Identities = 133/271 (49%), Positives = 178/271 (65%), Gaps = 14/271 (5%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLK 126
RW++G IG G FG+VY +NLD+GEL+AVK++ I ++ IKE+ +E+K+L+
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRI------QDNDPKTIKEIADEMKVLE 54
Query: 127 DLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEY 186
L HPN+V+Y G E + I +E+ GG++ LL E V+R YT QLL GL Y
Sbjct: 55 LLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAY 114
Query: 187 LHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGA--KSMKGTPYWMAPEV 244
LH+HGI+HRDIK ANI +D+ G IKL DFG + ++ T G +S+ GTP +MAPEV
Sbjct: 115 LHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEV 174
Query: 245 IRQT---GHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPEN--L 299
I GH +ADIWS+GC V+EMATGK PWS+ E +FH+G PPIP++ L
Sbjct: 175 ITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVG-AGHKPPIPDSLQL 233
Query: 300 SVKAKDFLLKCLEKEPDLRPTASELLKHPFV 330
S + KDFL +CLE +P RPTASELL+HPFV
Sbjct: 234 SPEGKDFLDRCLESDPKKRPTASELLQHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 309 bits (792), Expect = e-102
Identities = 129/267 (48%), Positives = 189/267 (70%), Gaps = 5/267 (1%)
Query: 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKL 124
P WR+G+L+G GAFGRVY+ ++D+G LAVKQV + S E + + LE E++L
Sbjct: 1 PTNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPD--SPE-TKKEVNALECEIQL 57
Query: 125 LKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGL 184
LK+L H IV+Y G +R++E+L+I +E++PGGS+ L +G E V R YT+Q+L G+
Sbjct: 58 LKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGV 117
Query: 185 EYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAEL-ATVSGAKSMKGTPYWMAPE 243
EYLH++ I+HRDIKGANIL D+ G +KL DFGASK++ + ++ +G KS+ GTPYWM+PE
Sbjct: 118 EYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPE 177
Query: 244 VIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKA 303
VI G+ AD+WSVGCTV+EM T KPPW+ +++ +AA+F I T ++P +P ++S A
Sbjct: 178 VISGEGYGRKADVWSVGCTVVEMLTEKPPWA-EFEAMAAIFKIATQPTNPQLPSHVSPDA 236
Query: 304 KDFLLKCLEKEPDLRPTASELLKHPFV 330
++FL + + RP+A ELL+H FV
Sbjct: 237 RNFLRRTFVENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 307 bits (787), Expect = e-102
Identities = 130/269 (48%), Positives = 186/269 (69%), Gaps = 11/269 (4%)
Query: 68 WRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKD 127
W KGE++G GA+G VY G+ + G+L+AVKQV + + + A+ ++L+EEV LLK
Sbjct: 2 WTKGEVLGKGAYGTVYCGL-TNQGQLIAVKQVELDTS--NVLAAEKEYEKLQEEVDLLKS 58
Query: 128 LSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYL 187
L H NIV+YLGT ++ +++I +EFVPGGSISS+L +FGP PE V YTKQ+L G+ YL
Sbjct: 59 LKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYL 118
Query: 188 HNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGA-----KSMKGTPYWMAP 242
HN+ ++HRDIKG N+++ G IKL DFG ++++A + G KSM GTPYWMAP
Sbjct: 119 HNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA-WVGLHGTHSNMLKSMHGTPYWMAP 177
Query: 243 EVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKS-HPPIPENLSV 301
EVI ++G+ +DIWS+GCTV EMATGKPP + +AA+F+IG + P +P++ S
Sbjct: 178 EVINESGYGRKSDIWSIGCTVFEMATGKPPLASM-DRLAAMFYIGAHRGLMPRLPDSFSA 236
Query: 302 KAKDFLLKCLEKEPDLRPTASELLKHPFV 330
A DF+ CL ++ RP+A +LL+H F+
Sbjct: 237 AAIDFVTSCLTRDQHERPSALQLLRHDFL 265
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 286 bits (734), Expect = 7e-94
Identities = 117/266 (43%), Positives = 166/266 (62%), Gaps = 18/266 (6%)
Query: 68 WRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKD 127
+ E IG G FG VY + +G+ +A+K + K ++++ +++ E+++LK
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVI--------KLESKEKKEKIINEIQILKK 53
Query: 128 LSHPNIVRYLGTVREEESLNILLEFVPGGSISSLL-GKFGPFPEAVMRTYTKQLLLGLEY 186
HPNIV+Y G+ +++ L I++EF GGS+ LL E+ + K+LL GLEY
Sbjct: 54 CKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEY 113
Query: 187 LHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIR 246
LH++GI+HRDIK ANIL+ + G +KL DFG S Q+++ +M GTPYWMAPEVI
Sbjct: 114 LHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT---KARNTMVGTPYWMAPEVIN 170
Query: 247 QTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPP---IPENLSVKA 303
+ Y ADIWS+G T IE+A GKPP+S + + ALF I T + PP PE S +
Sbjct: 171 GKPYDYKADIWSLGITAIELAEGKPPYS-ELPPMKALFKIAT--NGPPGLRNPEKWSDEF 227
Query: 304 KDFLLKCLEKEPDLRPTASELLKHPF 329
KDFL KCL+K P+ RPTA +LLKHPF
Sbjct: 228 KDFLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 281 bits (721), Expect = 7e-92
Identities = 119/271 (43%), Positives = 179/271 (66%), Gaps = 11/271 (4%)
Query: 68 WRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKD 127
W KG+ +G GAF Y ++ +G L+AVKQV N +S++ ++ ++ L +E++L+
Sbjct: 2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQ--EEVVEALRKEIRLMAR 59
Query: 128 LSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYL 187
L+HP+I+R LG E+ N+ +E++ GGS+S LL K+G F EAV+ YT+QLL GL YL
Sbjct: 60 LNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYL 119
Query: 188 HNHGIMHRDIKGANILVDNKG-CIKLADFGASKQVAELATVSGAKSMK----GTPYWMAP 242
H + I+HRD+KGAN+L+D+ G +++ADFGA+ ++A A +GA + GT +MAP
Sbjct: 120 HENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA--AKGTGAGEFQGQLLGTIAFMAP 177
Query: 243 EVIRQTGHSYSADIWSVGCTVIEMATGKPPWS--QQYQEVAALFHIGTTKSHPPIPENLS 300
EV+R + S D+WSVGC +IEMAT KPPW+ + +A +F I + + P IPE+LS
Sbjct: 178 EVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLS 237
Query: 301 VKAKDFLLKCLEKEPDLRPTASELLKHPFVT 331
+D L+CLE +P+ RP + ELLKHP
Sbjct: 238 PGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 269 bits (689), Expect = 8e-87
Identities = 110/267 (41%), Positives = 162/267 (60%), Gaps = 15/267 (5%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLK 126
+ E IG G+FG VY ++ + +++A+K + + E+A+D I+++++E++ L
Sbjct: 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDL-------EEAEDEIEDIQQEIQFLS 54
Query: 127 DLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEY 186
P I +Y G+ + L I++E+ GGS LL K G E + +++LLGLEY
Sbjct: 55 QCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLL-KPGKLDETYIAFILREVLLGLEY 113
Query: 187 LHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIR 246
LH G +HRDIK ANIL+ +G +KLADFG S Q+ T+S + GTP+WMAPEVI+
Sbjct: 114 LHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTS--TMSKRNTFVGTPFWMAPEVIK 171
Query: 247 QTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPP-IPENL-SVKAK 304
Q+G+ ADIWS+G T IE+A G+PP S + LF I K++PP + N S K
Sbjct: 172 QSGYDEKADIWSLGITAIELAKGEPPLS-DLHPMRVLFLI--PKNNPPSLEGNKFSKPFK 228
Query: 305 DFLLKCLEKEPDLRPTASELLKHPFVT 331
DF+ CL K+P RP+A ELLKH F+
Sbjct: 229 DFVSLCLNKDPKERPSAKELLKHKFIK 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 268 bits (687), Expect = 9e-87
Identities = 94/268 (35%), Positives = 154/268 (57%), Gaps = 13/268 (4%)
Query: 68 WRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKD 127
+ +G G+FG VY + +G+++AVK + EK++ E +++L+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKK-----RSEKSKKDQTARRE-IRILRR 54
Query: 128 LSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYL 187
LSHPNIVR + +++ L +++E+ GG + L + GP E + Q+L GLEYL
Sbjct: 55 LSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYL 114
Query: 188 HNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIR- 246
H++GI+HRD+K NIL+D G +K+ADFG +K++ + ++ + GTP++MAPEV+
Sbjct: 115 HSNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSS--LTTFVGTPWYMAPEVLLG 172
Query: 247 QTGHSYSADIWSVGCTVIEMATGKPPWSQQ--YQEVAALFHIGTTKSHPPIPENLSVK-- 302
G+ D+WS+G + E+ TGKPP+S + ++ + I P+ S
Sbjct: 173 GNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEE 232
Query: 303 AKDFLLKCLEKEPDLRPTASELLKHPFV 330
AKD + KCL K+P RPTA E+L+HP+
Sbjct: 233 AKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 267 bits (684), Expect = 2e-86
Identities = 130/268 (48%), Positives = 189/268 (70%), Gaps = 8/268 (2%)
Query: 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKL 124
PI WR+G+L+G GAFGRVY+ ++D+G LA KQV S E +++ + LE E++L
Sbjct: 1 PINWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPE--SPETSKE-VSALECEIQL 57
Query: 125 LKDLSHPNIVRYLGTVRE--EESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLL 182
LK+L H IV+Y G +R+ E++L I +E++PGGS+ L +G E+V R YT+Q+L
Sbjct: 58 LKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILE 117
Query: 183 GLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA-TVSGAKSMKGTPYWMA 241
G+ YLH++ I+HRDIKGANIL D+ G +KL DFGASK++ + + +G +S+ GTPYWM+
Sbjct: 118 GMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMS 177
Query: 242 PEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSV 301
PEVI G+ AD+WS+GCTV+EM T KPPW+ +Y+ +AA+F I T ++P +P ++S
Sbjct: 178 PEVISGEGYGRKADVWSLGCTVVEMLTEKPPWA-EYEAMAAIFKIATQPTNPQLPSHISE 236
Query: 302 KAKDFLLKCLEKEPDLRPTASELLKHPF 329
A+DF L C+ E RP+A ELL+HPF
Sbjct: 237 HARDF-LGCIFVEARHRPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 264 bits (677), Expect = 2e-85
Identities = 132/269 (49%), Positives = 185/269 (68%), Gaps = 8/269 (2%)
Query: 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKL 124
P+ WR G+L+G GAFG VY+ + D+G LAVKQV + S+E +++ + LE E++L
Sbjct: 1 PVNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPD--SQETSKE-VNALECEIQL 57
Query: 125 LKDLSHPNIVRYLGTVR--EEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLL 182
LK+L H IV+Y G +R EE+ L+I +E++PGGSI L +G E V R YT+Q+L
Sbjct: 58 LKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQ 117
Query: 183 GLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA-TVSGAKSMKGTPYWMA 241
G+ YLH++ I+HRDIKGANIL D+ G +KL DFGASK++ + + +G KS+ GTPYWM+
Sbjct: 118 GVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMS 177
Query: 242 PEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSV 301
PEVI G+ AD+WSV CTV+EM T KPPW+ +Y+ +AA+F I T + P +P+ +S
Sbjct: 178 PEVISGEGYGRKADVWSVACTVVEMLTEKPPWA-EYEAMAAIFKIATQPTKPMLPDGVSD 236
Query: 302 KAKDFLLKCLEKEPDLRPTASELLKHPFV 330
+DF LK + E RPTA LL+HPFV
Sbjct: 237 ACRDF-LKQIFVEEKRRPTAEFLLRHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 260 bits (666), Expect = 8e-84
Identities = 133/269 (49%), Positives = 186/269 (69%), Gaps = 8/269 (2%)
Query: 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKL 124
P WR G+L+G GAFGRVY+ + D+G LAVKQV + S E +++ + LE E++L
Sbjct: 1 PTNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQF--DPESPETSKE-VNALECEIQL 57
Query: 125 LKDLSHPNIVRYLGTVRE--EESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLL 182
LK+L H IV+Y G +R+ E +L+I +E +PGGSI L +G E V R YT+Q+L
Sbjct: 58 LKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILE 117
Query: 183 GLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA-TVSGAKSMKGTPYWMA 241
G+ YLH++ I+HRDIKGANIL D+ G +KL DFGASK++ + + +G KS+ GTPYWM+
Sbjct: 118 GVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMS 177
Query: 242 PEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSV 301
PEVI G+ ADIWSVGCTV+EM T KPPW+ +++ +AA+F I T ++P +P ++S
Sbjct: 178 PEVISGEGYGRKADIWSVGCTVVEMLTEKPPWA-EFEAMAAIFKIATQPTNPVLPPHVSD 236
Query: 302 KAKDFLLKCLEKEPDLRPTASELLKHPFV 330
+DF LK + E LRP+A ELL+H FV
Sbjct: 237 HCRDF-LKRIFVEAKLRPSADELLRHTFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 252 bits (645), Expect = 2e-80
Identities = 115/264 (43%), Positives = 172/264 (65%), Gaps = 16/264 (6%)
Query: 73 LIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPN 132
++G G +G VY +L + +A+K++ E+ +++ L EE+ L L H N
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEI--------PERDSRYVQPLHEEIALHSYLKHRN 66
Query: 133 IVRYLGTVREEESLNILLEFVPGGSISSLL-GKFGPFP--EAVMRTYTKQLLLGLEYLHN 189
IV+YLG+ E I +E VPGGS+S+LL K+GP E + YTKQ+L GL+YLH+
Sbjct: 67 IVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD 126
Query: 190 HGIMHRDIKGANILVDN-KGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQ- 247
+ I+HRDIKG N+LV+ G +K++DFG SK++A + ++ GT +MAPEVI +
Sbjct: 127 NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC--TETFTGTLQYMAPEVIDKG 184
Query: 248 -TGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKDF 306
G+ ADIWS+GCT++EMATGKPP+ + + AA+F +G K HP IPE+LS +AK+F
Sbjct: 185 PRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNF 244
Query: 307 LLKCLEKEPDLRPTASELLKHPFV 330
+L+C E +PD R +A +LL+ PF+
Sbjct: 245 ILRCFEPDPDKRASAHDLLQDPFL 268
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 250 bits (641), Expect = 4e-80
Identities = 103/266 (38%), Positives = 161/266 (60%), Gaps = 25/266 (9%)
Query: 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHP 131
E +G G++G VY ++ ++G+++A+K V + + ++E+ +E+ +LK P
Sbjct: 9 EKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED----------LQEIIKEISILKQCDSP 58
Query: 132 NIVRYLGTVREEESLNILLEFVPGGSISSLL---GKFGPFPEAVMRTYTKQLLLGLEYLH 188
IV+Y G+ + L I++E+ GS+S ++ K E + Q L GLEYLH
Sbjct: 59 YIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNK--TLTEEEIAAILYQTLKGLEYLH 116
Query: 189 NHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQT 248
++ +HRDIK NIL++ +G KLADFG S Q+ + T++ ++ GTP+WMAPEVI++
Sbjct: 117 SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD--TMAKRNTVIGTPFWMAPEVIQEI 174
Query: 249 GHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPP----IPENLSVKAK 304
G++ ADIWS+G T IEMA GKPP+S + A+F I PP PE S +
Sbjct: 175 GYNNKADIWSLGITAIEMAEGKPPYS-DIHPMRAIFMIPN---KPPPTLSDPEKWSPEFN 230
Query: 305 DFLLKCLEKEPDLRPTASELLKHPFV 330
DF+ KCL K+P+ RP+A +LL+HPF+
Sbjct: 231 DFVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 241 bits (617), Expect = 2e-76
Identities = 107/263 (40%), Positives = 153/263 (58%), Gaps = 18/263 (6%)
Query: 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNI 133
IG G +G VY ++ +GEL+A+K + + + D + +++E+ +LK+ HPNI
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKL--------EPGDDFEIIQQEISMLKECRHPNI 62
Query: 134 VRYLGTVREEESLNILLEFVPGGSISSLLGK-FGPFPEAVMRTYTKQLLLGLEYLHNHGI 192
V Y G+ + L I++E+ GGS+ + GP E + ++ L GL YLH G
Sbjct: 63 VAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGK 122
Query: 193 MHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVI---RQTG 249
+HRDIKGANIL+ G +KLADFG S Q+ AT++ KS GTPYWMAPEV R+ G
Sbjct: 123 IHRDIKGANILLTEDGDVKLADFGVSAQLT--ATIAKRKSFIGTPYWMAPEVAAVERKGG 180
Query: 250 HSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPI---PENLSVKAKDF 306
+ DIW++G T IE+A +PP + + ALF I + PP E S DF
Sbjct: 181 YDGKCDIWALGITAIELAELQPPMFDLH-PMRALFLISKSNFPPPKLKDKEKWSPVFHDF 239
Query: 307 LLKCLEKEPDLRPTASELLKHPF 329
+ KCL K+P RPTA++LL+HPF
Sbjct: 240 IKKCLTKDPKKRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 230 bits (589), Expect = 4e-72
Identities = 93/264 (35%), Positives = 159/264 (60%), Gaps = 16/264 (6%)
Query: 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHP 131
+ IG G+FG+VY+ G+L +K++ ++ N + KE+ ++ EVK+LK L+HP
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLS-NMSEKER-----EDALNEVKILKKLNHP 59
Query: 132 NIVRYLGTVREEESLNILLEFVPGGS----ISSLLGKFGPFPE-AVMRTYTKQLLLGLEY 186
NI++Y + E+ L I++E+ GG I + PFPE ++ + QL L L+Y
Sbjct: 60 NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFV-QLCLALKY 118
Query: 187 LHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIR 246
LH+ I+HRDIK NI + + G +KL DFG SK ++ TV AK++ GTPY+++PE+ +
Sbjct: 119 LHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS--TVDLAKTVVGTPYYLSPELCQ 176
Query: 247 QTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKDF 306
++Y +DIWS+GC + E+ T K P+ + + + L +PPIP S + ++
Sbjct: 177 NKPYNYKSDIWSLGCVLYELCTLKHPF--EGENLLELALKILKGQYPPIPSQYSSELRNL 234
Query: 307 LLKCLEKEPDLRPTASELLKHPFV 330
+ L+K+P+ RP+ +++L+ PF+
Sbjct: 235 VSSLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 230 bits (588), Expect = 1e-71
Identities = 106/266 (39%), Positives = 158/266 (59%), Gaps = 22/266 (8%)
Query: 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHP 131
E IG GA G VY + +G+ +A+K++ + + + + + E+ ++KD HP
Sbjct: 25 EKIGEGASGEVYKATDRATGKEVAIKKMRLR---------KQNKELIINEILIMKDCKHP 75
Query: 132 NIVRYLGTVREEESLNILLEFVPGGSISSLL-GKFGPFPEAVMRTYTKQLLLGLEYLHNH 190
NIV Y + + L +++E++ GGS++ ++ F E + +++L GLEYLH+
Sbjct: 76 NIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ 135
Query: 191 GIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGH 250
++HRDIK NIL+ G +KLADFG + Q+ + S S+ GTPYWMAPEVI++ +
Sbjct: 136 NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE--KSKRNSVVGTPYWMAPEVIKRKDY 193
Query: 251 SYSADIWSVGCTVIEMATGKPPWSQQYQE---VAALFHIGTTKSHPPI--PENLSVKAKD 305
DIWS+G IEMA G+PP Y + ALF I TTK PP+ PE S + KD
Sbjct: 194 GPKVDIWSLGIMCIEMAEGEPP----YLREPPLRALFLI-TTKGIPPLKNPEKWSPEFKD 248
Query: 306 FLLKCLEKEPDLRPTASELLKHPFVT 331
FL KCL K+P+ RP+A ELL+HPF+
Sbjct: 249 FLNKCLVKDPEKRPSAEELLQHPFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 220 bits (563), Expect = 3e-68
Identities = 96/265 (36%), Positives = 154/265 (58%), Gaps = 12/265 (4%)
Query: 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNI 133
+G G+ G VY + +G++ A+K++ + E + K+L E+K L+ P +
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKI----HVDGDE---EFRKQLLRELKTLRSCESPYV 61
Query: 134 VRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHN-HGI 192
V+ G +E ++I+LE++ GGS++ LL K G PE V+ +Q+L GL+YLH I
Sbjct: 62 VKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHI 121
Query: 193 MHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSY 252
+HRDIK +N+L+++KG +K+ADFG SK + T+ + GT +M+PE I+ +SY
Sbjct: 122 IHRDIKPSNLLINSKGEVKIADFGISKVLE--NTLDQCNTFVGTVTYMSPERIQGESYSY 179
Query: 253 SADIWSVGCTVIEMATGKPPWSQ--QYQEVAALFHIGTTKSHPPIPENLSVKAKDFLLKC 310
+ADIWS+G T++E A GK P+ Q + I E S + +DF+ C
Sbjct: 180 AADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISAC 239
Query: 311 LEKEPDLRPTASELLKHPFVTGDDE 335
L+K+P RP+A+ELL+HPF+ D
Sbjct: 240 LQKDPKKRPSAAELLQHPFIKKADN 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 219 bits (559), Expect = 9e-68
Identities = 102/271 (37%), Positives = 155/271 (57%), Gaps = 24/271 (8%)
Query: 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHP 131
E+IG GA VY + L + E +A+K++ + EK Q + EL +EV+ + +HP
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDL-------EKCQTSVDELRKEVQAMSQCNHP 59
Query: 132 NIVRYLGTVREEESLNILLEFVPGGSISSLLG---KFGPFPEAVMRTYTKQLLLGLEYLH 188
N+V+Y + + L +++ ++ GGS+ ++ G EA++ T K++L GLEYLH
Sbjct: 60 NVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH 119
Query: 189 NHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGA--KSMKGTPYWMAPEVIR 246
++G +HRDIK NIL+ G +K+ADFG S +A+ + K+ GTP WMAPEV+
Sbjct: 120 SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVME 179
Query: 247 Q-TGHSYSADIWSVGCTVIEMATGKPPWSQQY-QEVAALFHIGTTKSHPP-IPENLSVKA 303
Q G+ + ADIWS G T IE+ATG P+S+ +V L T ++ PP + K
Sbjct: 180 QVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLML----TLQNDPPSLETGADYKK 235
Query: 304 -----KDFLLKCLEKEPDLRPTASELLKHPF 329
+ + CL+K+P RPTA ELLKH F
Sbjct: 236 YSKSFRKMISLCLQKDPSKRPTAEELLKHKF 266
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 216 bits (552), Expect = 7e-67
Identities = 94/259 (36%), Positives = 143/259 (55%), Gaps = 13/259 (5%)
Query: 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNI 133
+G G+FG+V + D+G+L A+K + K K +H E +L ++HP I
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKV--LKKKKIIKRKEVEHTLT---ERNILSRINHPFI 55
Query: 134 VRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIM 193
V+ + EE L ++LE+ PGG + S L K G F E R Y +++L LEYLH+ GI+
Sbjct: 56 VKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGII 115
Query: 194 HRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYS 253
+RD+K NIL+D G IKL DFG +K+++ S + GTP ++APEV+ G+ +
Sbjct: 116 YRDLKPENILLDADGHIKLTDFGLAKELSS--EGSRTNTFCGTPEYLAPEVLLGKGYGKA 173
Query: 254 ADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEK 313
D WS+G + EM TGKPP+ ++ ++ K PE LS +A+D + L+K
Sbjct: 174 VDWWSLGVLLYEMLTGKPPFYA--EDRKEIYEK-ILKDPLRFPEFLSPEARDLISGLLQK 230
Query: 314 EPDLRPT---ASELLKHPF 329
+P R A E+ HPF
Sbjct: 231 DPTKRLGSGGAEEIKAHPF 249
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 214 bits (546), Expect = 2e-66
Identities = 89/258 (34%), Positives = 141/258 (54%), Gaps = 46/258 (17%)
Query: 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNI 133
+G G FG VY+ + +G+ +A+K + KE + ++EL E+++LK L+HPNI
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKII-------KKEDSSSLLEELLREIEILKKLNHPNI 53
Query: 134 VRYLGTVREEESLNILLEFVPGGSISSLLGK-FGPFPEAVMRTYTKQLLLGLEYLHNHGI 192
V+ G +E L +++E+ GGS+ LL + G E + Q+L GLEYLH++GI
Sbjct: 54 VKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGI 113
Query: 193 MHRDIKGANILVDNK-GCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGH- 250
+HRD+K NIL+D+ G +KLADFG SK + ++ K++ GTP +MAPEV+ G+
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLL--KTIVGTPAYMAPEVLLGKGYY 171
Query: 251 SYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKDFLLKC 310
S +DIWS+G + E+ + KD + K
Sbjct: 172 SEKSDIWSLGVILYELP----------------------------------ELKDLIRKM 197
Query: 311 LEKEPDLRPTASELLKHP 328
L+K+P+ RP+A E+L+H
Sbjct: 198 LQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 215 bits (551), Expect = 2e-66
Identities = 102/287 (35%), Positives = 150/287 (52%), Gaps = 35/287 (12%)
Query: 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVK-QVLIAANFASKEKAQDHIKELEEEV 122
P + E+IG G +G+VY + +G+L+A+K +I D +E++EE
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE----------DEEEEIKEEY 53
Query: 123 KLLKDLS-HPNIVRYLGTVR------EEESLNILLEFVPGGSIS----SLLGKFGPFPEA 171
+L+ S HPNI + G ++ L +++E GGS++ L K E
Sbjct: 54 NILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEE 113
Query: 172 VMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAK 231
+ ++ L GL YLH + ++HRDIKG NIL+ +KL DFG S Q+ +T+
Sbjct: 114 WIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLD--STLGRRN 171
Query: 232 SMKGTPYWMAPEVI-----RQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHI 286
+ GTPYWMAPEVI + +D+WS+G T IE+A GKPP + ALF I
Sbjct: 172 TFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM-HPMRALFKI 230
Query: 287 GTTKSHPPI---PENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFV 330
++ PP PEN S K DF+ +CL K + RP ELL+HPF+
Sbjct: 231 --PRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 207 bits (529), Expect = 3e-63
Identities = 113/286 (39%), Positives = 169/286 (59%), Gaps = 26/286 (9%)
Query: 68 WRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKD 127
+++ ELIG GA+G VY G ++ +G ++A+K + N + + D + +++ EV LL
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKII----NLDTPD---DDVSDIQREVALLSQ 55
Query: 128 LSH---PNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGL 184
L PNI +Y G+ + L I++E+ GGS+ +L+ K GP E + +++L+ L
Sbjct: 56 LRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLM-KAGPIAEKYISVIIREVLVAL 114
Query: 185 EYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKS-MKGTPYWMAPE 243
+Y+H G++HRDIK ANILV N G +KL DFG + A L S +S GTPYWMAPE
Sbjct: 115 KYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVA---ALLNQNSSKRSTFVGTPYWMAPE 171
Query: 244 VIRQTGHSYS--ADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPP-IPEN-L 299
VI + G Y ADIWS+G T+ EMATG PP+S A+ I KS PP + +N
Sbjct: 172 VITE-GKYYDTKADIWSLGITIYEMATGNPPYSDV-DAFRAMMLIP--KSKPPRLEDNGY 227
Query: 300 SVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDPVLHASVMK 345
S ++F+ CL++EP R +A ELLK ++ + PV S++K
Sbjct: 228 SKLLREFVAACLDEEPKERLSAEELLKSKWIKAHSKTPV---SILK 270
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 205 bits (524), Expect = 2e-62
Identities = 107/270 (39%), Positives = 151/270 (55%), Gaps = 23/270 (8%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH 130
GEL G GAFG+VY + ++G A K + S+E+ +D + E++ +L + H
Sbjct: 11 GEL-GDGAFGKVYKAQHKETGLFAAAKII----QIESEEELEDFMVEID----ILSECKH 61
Query: 131 PNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFG-PFPEAVMRTYTKQLLLGLEYLHN 189
PNIV E L IL+EF GG++ S++ + E +R +Q+L L +LH+
Sbjct: 62 PNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHS 121
Query: 190 HGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVI---- 245
H ++HRD+K NIL+ G +KLADFG S + T+ + GTPYWMAPEV+
Sbjct: 122 HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKS--TLQKRDTFIGTPYWMAPEVVACET 179
Query: 246 -RQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPI---PENLSV 301
+ + Y ADIWS+G T+IE+A +PP + + L I KS PP P S
Sbjct: 180 FKDNPYDYKADIWSLGITLIELAQMEPPHH-ELNPMRVLLKI--LKSEPPTLDQPSKWSS 236
Query: 302 KAKDFLLKCLEKEPDLRPTASELLKHPFVT 331
DFL CL K+PD RPTA+ELLKHPFV+
Sbjct: 237 SFNDFLKSCLVKDPDDRPTAAELLKHPFVS 266
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 202 bits (515), Expect = 3e-61
Identities = 111/269 (41%), Positives = 166/269 (61%), Gaps = 14/269 (5%)
Query: 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVK 123
P + K E IG G+FG VY G++ + E++A+K + + E+A+D I+++++E+
Sbjct: 2 PEELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDL-------EEAEDEIEDIQQEIT 54
Query: 124 LLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLG 183
+L P I RY G+ + L I++E++ GGS LL K GP E + T +++L G
Sbjct: 55 VLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLL-KPGPLEETYIATILREILKG 113
Query: 184 LEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPE 243
L+YLH+ +HRDIK AN+L+ +G +KLADFG + Q+ + T + GTP+WMAPE
Sbjct: 114 LDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPE 171
Query: 244 VIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKA 303
VI+Q+ + + ADIWS+G T IE+A G+PP S + + LF I K+ PP E K
Sbjct: 172 VIKQSAYDFKADIWSLGITAIELAKGEPPNSDLH-PMRVLFLI--PKNSPPTLEGQYSKP 228
Query: 304 -KDFLLKCLEKEPDLRPTASELLKHPFVT 331
K+F+ CL K+P RPTA ELLKH F+T
Sbjct: 229 FKEFVEACLNKDPRFRPTAKELLKHKFIT 257
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 194 bits (495), Expect = 3e-58
Identities = 93/271 (34%), Positives = 148/271 (54%), Gaps = 17/271 (6%)
Query: 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNI 133
I GA+GRV++ +G++ A+K V+ A+ K + + ++ E +L P +
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIK-VIKKADMIRK----NQVDQVLTERDILSQAQSPYV 55
Query: 134 VRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIM 193
V+ + + +++L +++E++PGG ++SLL G E V R Y +++L LEYLH++GI+
Sbjct: 56 VKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGII 115
Query: 194 HRDIKGANILVDNKGCIKLADFGASK------QVAELATVSGAKSMKGTPYWMAPEVIRQ 247
HRD+K NIL+D+ G +KL DFG SK Q+ K + GTP ++APEVI
Sbjct: 116 HRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG 175
Query: 248 TGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALF-HIGTTKSHPPIPENLSVKAKDF 306
GHS + D WS+GC + E G PP+ + +F +I K P +S +A D
Sbjct: 176 QGHSKTVDWWSLGCILYEFLVGIPPF--HGETPEEIFQNILNGKIEWPEDVEVSDEAIDL 233
Query: 307 LLKCLEKEPDLRPTA---SELLKHPFVTGDD 334
+ K L +P+ R A E+ HPF G D
Sbjct: 234 ISKLLVPDPEKRLGAKSIEEIKNHPFFKGID 264
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 194 bits (494), Expect = 4e-58
Identities = 91/257 (35%), Positives = 143/257 (55%), Gaps = 12/257 (4%)
Query: 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNI 133
IG G F VY + L G ++A+K+V I +K + QD +KE + LLK L HPN+
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKAR-QDCLKE----IDLLKQLDHPNV 64
Query: 134 VRYLGTVREEESLNILLEFVPGGSISSLLGKFG----PFPEAVMRTYTKQLLLGLEYLHN 189
++YL + E LNI+LE G +S ++ F PE + Y QL LE++H+
Sbjct: 65 IKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS 124
Query: 190 HGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTG 249
IMHRDIK AN+ + G +KL D G + + T A S+ GTPY+M+PE I + G
Sbjct: 125 KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENG 182
Query: 250 HSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIP-ENLSVKAKDFLL 308
+++ +DIWS+GC + EMA + P+ + +L +PP+P ++ S + +D +
Sbjct: 183 YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVS 242
Query: 309 KCLEKEPDLRPTASELL 325
+C+ +P+ RP S +L
Sbjct: 243 RCINPDPEKRPDISYVL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 192 bits (490), Expect = 2e-57
Identities = 106/268 (39%), Positives = 166/268 (61%), Gaps = 14/268 (5%)
Query: 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVK 123
P + K E IG G+FG V+ G++ + +++A+K + + E+A+D I+++++E+
Sbjct: 2 PEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDL-------EEAEDEIEDIQQEIT 54
Query: 124 LLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLG 183
+L P + +Y G+ + L I++E++ GGS LL + GPF E + T K++L G
Sbjct: 55 VLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLL-RAGPFDEFQIATMLKEILKG 113
Query: 184 LEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPE 243
L+YLH+ +HRDIK AN+L+ +G +KLADFG + Q+ + T + GTP+WMAPE
Sbjct: 114 LDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPE 171
Query: 244 VIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPP-IPENLSVK 302
VI+Q+ + ADIWS+G T IE+A G+PP S + + LF I K++PP + S
Sbjct: 172 VIQQSAYDSKADIWSLGITAIELAKGEPPNSDMH-PMRVLFLI--PKNNPPTLTGEFSKP 228
Query: 303 AKDFLLKCLEKEPDLRPTASELLKHPFV 330
K+F+ CL K+P RPTA ELLKH F+
Sbjct: 229 FKEFIDACLNKDPSFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 190 bits (484), Expect = 1e-56
Identities = 107/268 (39%), Positives = 167/268 (62%), Gaps = 14/268 (5%)
Query: 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVK 123
P + K E IG G+FG V+ G++ + +++A+K + + E+A+D I+++++E+
Sbjct: 2 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDL-------EEAEDEIEDIQQEIT 54
Query: 124 LLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLG 183
+L P + +Y G+ ++ L I++E++ GGS LL + GP E + T +++L G
Sbjct: 55 VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-EPGPLDETQIATILREILKG 113
Query: 184 LEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPE 243
L+YLH+ +HRDIK AN+L+ G +KLADFG + Q+ + T + GTP+WMAPE
Sbjct: 114 LDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPE 171
Query: 244 VIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPE-NLSVK 302
VI+Q+ + ADIWS+G T IE+A G+PP S+ + + LF I K++PP E N S
Sbjct: 172 VIKQSAYDSKADIWSLGITAIELAKGEPPHSELH-PMKVLFLI--PKNNPPTLEGNYSKP 228
Query: 303 AKDFLLKCLEKEPDLRPTASELLKHPFV 330
K+F+ CL KEP RPTA ELLKH F+
Sbjct: 229 LKEFVEACLNKEPSFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 189 bits (482), Expect = 2e-56
Identities = 94/274 (34%), Positives = 139/274 (50%), Gaps = 29/274 (10%)
Query: 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHP 131
E IG G+FG V G++L K+ + N KEK Q L EV +L++L HP
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKE-IDYGNMTEKEKQQ-----LVSEVNILRELKHP 59
Query: 132 NIVRYLG--TVREEESLNILLEFVPGGSISSLLGK----FGPFPE-AVMRTYTKQLLLGL 184
NIVRY R ++L I++E+ GG ++ L+ K E + R T QLLL L
Sbjct: 60 NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILT-QLLLAL 118
Query: 185 EYLHN-----HGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYW 239
HN + ++HRD+K ANI +D +KL DFG +K + S AK+ GTPY+
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH--DSSFAKTYVGTPYY 176
Query: 240 MAPEVIRQTGHSYSA--DIWSVGCTVIEMATGKPPWS-QQYQEVAALFHIGTTKSHPPIP 296
M+PE + SY DIWS+GC + E+ PP++ + ++A+ G IP
Sbjct: 177 MSPEQLN--HMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEG---KFRRIP 231
Query: 297 ENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFV 330
S + + + L +PD RP+ ELL+ P +
Sbjct: 232 YRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 189 bits (483), Expect = 3e-56
Identities = 90/284 (31%), Positives = 141/284 (49%), Gaps = 35/284 (12%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH 130
G++IG G+F V + ++ + A+K + KEK ++K +E+EV L + H
Sbjct: 6 GKIIGEGSFSTVVLAKEKETNKEYAIKILDKR--QLIKEKKVKYVK-IEKEV-LTRLNGH 61
Query: 131 PNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNH 190
P I++ T ++EE+L +LE+ P G + + K+G E R Y ++LL LEYLH+
Sbjct: 62 PGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSK 121
Query: 191 GIMHRDIKGANILVDNKGCIKLADFGASK------------QVAELATVSGAKSMK---- 234
GI+HRD+K NIL+D IK+ DFG +K A K+ +
Sbjct: 122 GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFAS 181
Query: 235 --GTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQ--QYQEVAALFH-IGTT 289
GT +++PE++ + S+D+W++GC + +M TGKPP+ +Y F I
Sbjct: 182 FVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL----TFQKI--L 235
Query: 290 KSHPPIPENLSVKAKDFLLKCLEKEPDLRPTAS----ELLKHPF 329
K P N AKD + K L +P R + EL HPF
Sbjct: 236 KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 187 bits (477), Expect = 8e-56
Identities = 108/265 (40%), Positives = 152/265 (57%), Gaps = 23/265 (8%)
Query: 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNI 133
IG G +G VY N+++GEL A+K + + E +D +++E+ ++KD H NI
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKL-------EPGED-FAVVQQEIIMMKDCKHSNI 68
Query: 134 VRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIM 193
V Y G+ + L I +EF GGS+ + GP E+ + +++ L GL YLH+ G M
Sbjct: 69 VAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKM 128
Query: 194 HRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVI---RQTGH 250
HRDIKGANIL+ + G +KLADFG S Q+ AT++ KS GTPYWMAPEV R+ G+
Sbjct: 129 HRDIKGANILLTDNGHVKLADFGVSAQIT--ATIAKRKSFIGTPYWMAPEVAAVERKGGY 186
Query: 251 SYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAK------ 304
+ DIW+VG T IE+A +PP + + ALF + + PP L K K
Sbjct: 187 NQLCDIWAVGITAIELAELQPPMFDLH-PMRALFLMTKSNFQPP---KLKDKMKWSNSFH 242
Query: 305 DFLLKCLEKEPDLRPTASELLKHPF 329
F+ L K P RPTA +LL+HPF
Sbjct: 243 HFVKMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 188 bits (480), Expect = 1e-55
Identities = 103/270 (38%), Positives = 145/270 (53%), Gaps = 17/270 (6%)
Query: 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNI 133
IG G+FG VY ++ + E++A+K++ + S EK QD IKE V+ L+ L HPN
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGK-QSNEKWQDIIKE----VRFLQQLRHPNT 77
Query: 134 VRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIM 193
+ Y G E + +++E+ G + L P E + L GL YLH+H +
Sbjct: 78 IEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERI 137
Query: 194 HRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVI--RQTGHS 251
HRDIK NIL+ G +KLADFG++ + VS A S GTPYWMAPEVI G
Sbjct: 138 HRDIKAGNILLTEPGTVKLADFGSA------SLVSPANSFVGTPYWMAPEVILAMDEGQ- 190
Query: 252 YS--ADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKDFLLK 309
Y D+WS+G T IE+A KPP ++AL+HI S + S ++F+
Sbjct: 191 YDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNDSPTLSSNDWSDYFRNFVDS 249
Query: 310 CLEKEPDLRPTASELLKHPFVTGDDEDPVL 339
CL+K P RP++ ELLKH FV + V+
Sbjct: 250 CLQKIPQDRPSSEELLKHRFVLRERPPTVI 279
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 186 bits (472), Expect = 1e-54
Identities = 107/270 (39%), Positives = 160/270 (59%), Gaps = 23/270 (8%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH 130
GEL G GAFG+VY N ++G L A K + S+E+ +D++ E+E +L +H
Sbjct: 18 GEL-GDGAFGKVYKAKNKETGALAAAKVI----ETKSEEELEDYMVEIE----ILATCNH 68
Query: 131 PNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGP-FPEAVMRTYTKQLLLGLEYLHN 189
P IV+ LG + L I++EF PGG++ +++ + E ++ +Q+L L+YLH+
Sbjct: 69 PYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS 128
Query: 190 HGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVI---- 245
I+HRD+K N+L+ G IKLADFG S + + T+ S GTPYWMAPEV+
Sbjct: 129 MKIIHRDLKAGNVLLTLDGDIKLADFGVSAK--NVKTLQRRDSFIGTPYWMAPEVVMCET 186
Query: 246 -RQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPI---PENLSV 301
+ T + Y ADIWS+G T+IEMA +PP + + L I KS PP P S+
Sbjct: 187 MKDTPYDYKADIWSLGITLIEMAQIEPP-HHELNPMRVLLKIA--KSEPPTLSQPSKWSM 243
Query: 302 KAKDFLLKCLEKEPDLRPTASELLKHPFVT 331
+ +DFL L+K P+ RP+A++LL+HPFV+
Sbjct: 244 EFRDFLKTALDKHPETRPSAAQLLEHPFVS 273
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 183 bits (467), Expect = 5e-54
Identities = 94/302 (31%), Positives = 134/302 (44%), Gaps = 63/302 (20%)
Query: 69 RKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEE-------- 120
K E +G G +G VY + +GE++A+K++ + EE
Sbjct: 2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKI--------------RLDNEEEGIPSTALR 47
Query: 121 EVKLLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQ 179
E+ LLK+L HPNIV+ L + E L ++ E+ + L K GP ++++ Q
Sbjct: 48 EISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQ 106
Query: 180 LLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTP-- 237
LL GL Y H+H I+HRD+K NIL++ G +KLADFG LA G T
Sbjct: 107 LLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFG-------LARAFGIPLRTYTHEV 159
Query: 238 ---YWMAPEVI-RQTGHSYSADIWSVGCTVIEMATGKP--------------------PW 273
++ APE++ +S + DIWSVGC EM TGKP P
Sbjct: 160 VTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPT 219
Query: 274 SQQYQEVAALFHIG-TTKSHPPIP-----ENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327
+ + V L T PP L + D L K L+ P R +A E LKH
Sbjct: 220 EESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279
Query: 328 PF 329
P+
Sbjct: 280 PY 281
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 183 bits (466), Expect = 6e-54
Identities = 112/277 (40%), Positives = 154/277 (55%), Gaps = 23/277 (8%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH 130
GEL G GAFG+VY N ++G L A K + K+++ +++ E+ +L H
Sbjct: 11 GEL-GDGAFGKVYKAQNKETGVLAAAKVI--------DTKSEEELEDYMVEIDILASCDH 61
Query: 131 PNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFG-PFPEAVMRTYTKQLLLGLEYLHN 189
PNIV+ L E +L IL+EF GG++ +++ + P E +R KQ L L YLH
Sbjct: 62 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE 121
Query: 190 HGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVI---- 245
+ I+HRD+K NIL G IKLADFG S + T+ S GTPYWMAPEV+
Sbjct: 122 NKIIHRDLKAGNILFTLDGDIKLADFGVSAK--NTRTIQRRDSFIGTPYWMAPEVVMCET 179
Query: 246 -RQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPI---PENLSV 301
+ + Y AD+WS+G T+IEMA +PP + + L I KS PP P S
Sbjct: 180 SKDRPYDYKADVWSLGITLIEMAQIEPP-HHELNPMRVLLKIA--KSEPPTLAQPSRWSS 236
Query: 302 KAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDPV 338
+ KDFL KCLEK D R T ++LL+HPFVT + P+
Sbjct: 237 EFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSNKPI 273
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 183 bits (466), Expect = 1e-53
Identities = 88/282 (31%), Positives = 148/282 (52%), Gaps = 36/282 (12%)
Query: 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEK--AQDHIKELEEEVKLLKDLS 129
+ +G G+FGRV + + SG+ A+K +L SK K ++ + E ++L+ +
Sbjct: 7 KTLGTGSFGRVMLVRHKGSGKYYALK-IL------SKAKIVKLKQVEHVLNEKRILQSIR 59
Query: 130 HPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHN 189
HP +V G+ +++ +L +++E+VPGG + S L K G FPE V R Y Q++L LEYLH+
Sbjct: 60 HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHS 119
Query: 190 HGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTG 249
I++RD+K N+L+D+ G IK+ DFG +K+V ++ GTP ++APE+I G
Sbjct: 120 LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG-----RTYTLCGTPEYLAPEIILSKG 174
Query: 250 HSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPI-------PENLSVK 302
+ + D W++G + EM G PP+ F + + I P S
Sbjct: 175 YGKAVDWWALGILIYEMLAGYPPF----------FDDNPIQIYEKILEGKVRFPSFFSPD 224
Query: 303 AKDFLLKCLEKEPD-----LRPTASELLKHPFVTGDDEDPVL 339
AKD + L+ + L+ +++ HP+ G D +L
Sbjct: 225 AKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIALL 266
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 177 bits (452), Expect = 5e-52
Identities = 85/265 (32%), Positives = 128/265 (48%), Gaps = 19/265 (7%)
Query: 69 RKGELIGCGAFGRVYMGM----NLDSGELLAVKQVLIAANFASKEKA-QDHIKELEEEVK 123
G+ +G GAFG VY G + +AVK + KE A ++ +E EE
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTL--------KEGASEEEREEFLEEAS 53
Query: 124 LLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLL-GKFGPFPEAVMRTYTKQLLL 182
++K LSHPNIVR LG + E L I+ E++PGG + L + Q+
Sbjct: 54 IMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAK 113
Query: 183 GLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAP 242
G+EYL + +HRD+ N LV +K++DFG S+ + E K WMAP
Sbjct: 114 GMEYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAP 173
Query: 243 EVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQY-QEVAALFHIGTTKSHPPIPENLS 300
E ++ + +D+WS G + E+ T G+ P+ +EV L G P PEN
Sbjct: 174 ESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGY---RLPRPENCP 230
Query: 301 VKAKDFLLKCLEKEPDLRPTASELL 325
+ + +L+C +P+ RPT SEL+
Sbjct: 231 DELYELMLQCWAYDPEDRPTFSELV 255
|
Length = 258 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 176 bits (449), Expect = 1e-51
Identities = 82/271 (30%), Positives = 139/271 (51%), Gaps = 26/271 (9%)
Query: 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNI 133
+G G FGRV + A+K V + Q+HI E ++L++ +HP I
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETG--QQEHIFS---EKEILEECNHPFI 55
Query: 134 VRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIM 193
V+ T ++++ + +L+E+ GG + ++L G F E R Y ++L EYLHN GI+
Sbjct: 56 VKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGII 115
Query: 194 HRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYS 253
+RD+K N+L+D+ G +KL DFG +K+ L + + GTP ++APE+I G+ +S
Sbjct: 116 YRDLKPENLLLDSNGYVKLVDFGFAKK---LKSGQKTWTFCGTPEYVAPEIILNKGYDFS 172
Query: 254 ADIWSVGCTVIEMATGKPPWSQQ-------YQEVAALFHIGTTKSHPPIPENLSVKAKDF 306
D WS+G + E+ TG+PP+ + Y ++ L G + P + AKD
Sbjct: 173 VDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDI--LKGNGKLEF----PNYIDKAAKDL 226
Query: 307 LLKCLEKEPDLR-----PTASELLKHPFVTG 332
+ + L + P+ R ++ KH + G
Sbjct: 227 IKQLLRRNPEERLGNLKGGIKDIKKHKWFNG 257
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 176 bits (448), Expect = 2e-51
Identities = 92/268 (34%), Positives = 146/268 (54%), Gaps = 17/268 (6%)
Query: 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNI 133
+G G G V ++ +G+++AVK + + E Q K++ E+ +L + P I
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLE----INEAIQ---KQILRELDILHKCNSPYI 61
Query: 134 VRYLGTVREEESLNILLEFVPGGSISSLLGK-FGPFPEAVMRTYTKQLLLGLEYLHN-HG 191
V + G ++I +E++ GGS+ +L + G PE ++ +L GL YLH H
Sbjct: 62 VGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK 121
Query: 192 IMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHS 251
I+HRD+K +NILV+++G IKL DFG S Q+ S AK+ GT +MAPE I+ +S
Sbjct: 122 IIHRDVKPSNILVNSRGQIKLCDFGVSGQL----VNSLAKTFVGTSSYMAPERIQGNDYS 177
Query: 252 YSADIWSVGCTVIEMATGK---PPWSQQYQEVAALFHIGTTKSHPPIP-ENLSVKAKDFL 307
+DIWS+G ++IE+ATG+ PP + + L + P +P S +DF+
Sbjct: 178 VKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFV 237
Query: 308 LKCLEKEPDLRPTASELLKHPFVTGDDE 335
CL K+P RP+ ELL+HPF+ +
Sbjct: 238 NLCLIKDPRERPSYKELLEHPFIKKYES 265
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 176 bits (447), Expect = 2e-51
Identities = 102/262 (38%), Positives = 145/262 (55%), Gaps = 17/262 (6%)
Query: 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNI 133
+G G +G VY NL +GEL AVK + K + D +++E+ ++K+ H NI
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKII--------KLEPGDDFSLIQQEIFMVKECKHCNI 68
Query: 134 VRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIM 193
V Y G+ E L I +E+ GGS+ + GP E + ++ L GL YLH+ G M
Sbjct: 69 VAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKM 128
Query: 194 HRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVI---RQTGH 250
HRDIKGANIL+ + G +KLADFG + ++ AT++ KS GTPYWMAPEV + G+
Sbjct: 129 HRDIKGANILLTDNGDVKLADFGVAAKIT--ATIAKRKSFIGTPYWMAPEVAAVEKNGGY 186
Query: 251 SYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPP-IPENL--SVKAKDFL 307
+ DIW+VG T IE+A +PP + + ALF + + PP + + S +F+
Sbjct: 187 NQLCDIWAVGITAIELAELQPPMFDLH-PMRALFLMSKSNFQPPKLKDKTKWSSTFHNFV 245
Query: 308 LKCLEKEPDLRPTASELLKHPF 329
L K P RPTA LL H F
Sbjct: 246 KISLTKNPKKRPTAERLLTHLF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 179 bits (453), Expect = 4e-51
Identities = 112/355 (31%), Positives = 165/355 (46%), Gaps = 36/355 (10%)
Query: 68 WRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKD 127
+R +G G+FG VY+ + +L+A+K + SKE + E+++L
Sbjct: 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVER-----FLREIQILAS 53
Query: 128 LSHP-NIVRYLGTVREEESLNILLEFVPGGSISSLL---GKFGPFPEAVMRTYTKQLLLG 183
L+HP NIV+ ++E SL +++E+V GGS+ LL G+ GP E+ Q+L
Sbjct: 54 LNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSA 113
Query: 184 LEYLHNHGIMHRDIKGANILVDNKGC-IKLADFGASKQVAE----LATVSGAKSMKGTPY 238
LEYLH+ GI+HRDIK NIL+D G +KL DFG +K + + + + + GTP
Sbjct: 114 LEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPG 173
Query: 239 WMAPEVIRQTGH---SYSADIWSVGCTVIEMATGKPPW-----SQQYQEVAALFHIGTTK 290
+MAPEV+ S S+DIWS+G T+ E+ TG PP+ S + + T
Sbjct: 174 YMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP 233
Query: 291 SHPP-----IPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVT------GDDEDPVL 339
S PE +S A D L K L K+P R ++S L H + D D +
Sbjct: 234 SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLK 293
Query: 340 HASVMKSSEILSPSHVANLESLQMLTSPGSPGSVDICNLDSLSCSRVIVEKLSGS 394
L PS A + SL L GS +D N + S
Sbjct: 294 PDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGVSSSPHNS 348
|
Length = 384 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 175 bits (444), Expect = 1e-50
Identities = 97/269 (36%), Positives = 154/269 (57%), Gaps = 15/269 (5%)
Query: 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELE-EEV 122
P ++ + E IG GA G VY +++ +G+ +A+KQ+ N + K KEL E+
Sbjct: 17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQM----NLQQQPK-----KELIINEI 67
Query: 123 KLLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLL 182
++++ HPNIV YL + + L +++E++ GGS++ ++ + E + ++ L
Sbjct: 68 LVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQ 126
Query: 183 GLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAP 242
LE+LH++ ++HRDIK NIL+ G +KL DFG Q+ S +M GTPYWMAP
Sbjct: 127 ALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT--PEQSKRSTMVGTPYWMAP 184
Query: 243 EVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTT-KSHPPIPENLSV 301
EV+ + + DIWS+G IEM G+PP+ + + AL+ I T PE LS
Sbjct: 185 EVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE-NPLRALYLIATNGTPELQNPEKLSA 243
Query: 302 KAKDFLLKCLEKEPDLRPTASELLKHPFV 330
+DFL +CLE + + R +A ELL+HPF+
Sbjct: 244 IFRDFLNRCLEMDVEKRGSAKELLQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 171 bits (437), Expect = 6e-50
Identities = 82/268 (30%), Positives = 135/268 (50%), Gaps = 24/268 (8%)
Query: 69 RKGELIGCGAFGRVYMGM----NLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKL 124
G+ +G GAFG VY G +AVK ++ ++ I+E E ++
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKT-------LKEDASEQQIEEFLREARI 54
Query: 125 LKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGP-FPEAVMRTYTKQLLLG 183
++ L HPN+V+ LG EEE L I++E++ GG + S L K P + + ++ Q+ G
Sbjct: 55 MRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARG 114
Query: 184 LEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVA--ELATVSGAKSMKGTPY-WM 240
+EYL + +HRD+ N LV +K++DFG S+ + + G K P WM
Sbjct: 115 MEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL----PIRWM 170
Query: 241 APEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQY-QEVAALFHIGTTKSHPPIPEN 298
APE +++ + +D+WS G + E+ T G+ P+ +EV G P P N
Sbjct: 171 APESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYR---LPQPPN 227
Query: 299 LSVKAKDFLLKCLEKEPDLRPTASELLK 326
+ D +L+C ++P+ RPT SEL++
Sbjct: 228 CPPELYDLMLQCWAEDPEDRPTFSELVE 255
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 169 bits (431), Expect = 3e-49
Identities = 88/262 (33%), Positives = 142/262 (54%), Gaps = 16/262 (6%)
Query: 73 LIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPN 132
+G G++G VY L + A+K+V + + + KE+ +D + E +++L ++HPN
Sbjct: 7 KLGKGSYGSVYKVKRLSDNQFYALKEVDLG-SMSQKER-EDAVNE----IRILASVNHPN 60
Query: 133 IVRYLGTVREEESLNILLEFVPGGSISSLLGKFG----PFPEAVMRTYTKQLLLGLEYLH 188
I+ Y + L I++E+ P G +S + K PE + QLL GL+ LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 189 NHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQT 248
I+HRD+K ANIL+ +K+ D G SK + + AK+ GTP++MAPEV +
Sbjct: 121 EQKILHRDLKSANILLVANDLVKIGDLGISK----VLKKNMAKTQIGTPHYMAPEVWKGR 176
Query: 249 GHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKDFLL 308
+SY +DIWS+GC + EMAT PP+ + + + L + +PPIP S ++F+
Sbjct: 177 PYSYKSDIWSLGCLLYEMATFAPPF--EARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIR 234
Query: 309 KCLEKEPDLRPTASELLKHPFV 330
L+ +P LRP ++L P V
Sbjct: 235 SMLQVKPKLRPNCDKILASPAV 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 7e-49
Identities = 91/290 (31%), Positives = 143/290 (49%), Gaps = 48/290 (16%)
Query: 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNI 133
IG G +G VY + +GE++A+K+ + +++ K E+KLLK+L+HPNI
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKK------IKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 134 VRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIM 193
++ L R + L ++ EF+ + + PE+++++Y QLL GL + H+HGI+
Sbjct: 61 IKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGIL 120
Query: 194 HRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPY----WM-APEVI-RQ 247
HRD+K N+L++ +G +KLADFG LA G+ T Y W APE++
Sbjct: 121 HRDLKPENLLINTEGVLKLADFG-------LARSFGSPVRPYTHYVVTRWYRAPELLLGD 173
Query: 248 TGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHI----GTT-------------- 289
G+S DIWSVGC E+ + +P + + E+ LF I GT
Sbjct: 174 KGYSTPVDIWSVGCIFAELLSRRPLFPGK-SEIDQLFKIFRTLGTPDPEVWPKFTSLARN 232
Query: 290 -----KSHPPIP-----ENLSVKAKDFLLKCLEKEPDLRPTASELLKHPF 329
+P N S +A D L + L +P R TA + L HP+
Sbjct: 233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPY 282
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 170 bits (431), Expect = 1e-48
Identities = 109/293 (37%), Positives = 157/293 (53%), Gaps = 22/293 (7%)
Query: 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNI 133
IG G+FG VY N + E++AVK++ + + EK QD IKE VK L+ L HPN
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGK-QTNEKWQDIIKE----VKFLQQLKHPNT 83
Query: 134 VRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIM 193
+ Y G +E + +++E+ G + L P E + T L GL YLH+H ++
Sbjct: 84 IEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMI 143
Query: 194 HRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVI---RQTGH 250
HRDIK NIL+ G +KLADFG++ + S A S GTPYWMAPEVI + +
Sbjct: 144 HRDIKAGNILLTEPGQVKLADFGSA------SKSSPANSFVGTPYWMAPEVILAMDEGQY 197
Query: 251 SYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPEN-LSVKAKDFLLK 309
D+WS+G T IE+A KPP ++AL+HI S P + N + + F+
Sbjct: 198 DGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNDS-PTLQSNEWTDSFRGFVDY 255
Query: 310 CLEKEPDLRPTASELLKHPFVTGDDEDPVLHASVMKSSEILSPSHVANLESLQ 362
CL+K P RP ++ELL+H FV D VL + ++ + V L++LQ
Sbjct: 256 CLQKIPQERPASAELLRHDFVRRDRPARVLIDLIQRTKDA-----VRELDNLQ 303
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 167 bits (426), Expect = 3e-48
Identities = 81/266 (30%), Positives = 133/266 (50%), Gaps = 19/266 (7%)
Query: 69 RKGELIGCGAFGRVYMGM----NLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKL 124
G+ +G GAFG VY G +AVK + ++ ++ I+E E ++
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTL-------KEDASEQQIEEFLREARI 54
Query: 125 LKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGP--FPEAVMRTYTKQLLL 182
++ L HPNIV+ LG EEE L I++E++PGG + L K P + + ++ Q+
Sbjct: 55 MRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIAR 114
Query: 183 GLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAP 242
G+EYL + +HRD+ N LV +K++DFG S+ + + K K WMAP
Sbjct: 115 GMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYK-VKGGKLPIRWMAP 173
Query: 243 EVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQY-QEVAALFHIGTTKSHPPIPENLS 300
E +++ + +D+WS G + E+ T G+ P+ EV G P P N
Sbjct: 174 ESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYR---LPKPPNCP 230
Query: 301 VKAKDFLLKCLEKEPDLRPTASELLK 326
+ +L+C ++P+ RPT SEL++
Sbjct: 231 PELYKLMLQCWAEDPEDRPTFSELVE 256
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 168 bits (426), Expect = 5e-48
Identities = 90/260 (34%), Positives = 143/260 (55%), Gaps = 17/260 (6%)
Query: 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNI 133
IG G+ G V + + +G +AVK++ + + Q + L EV +++D HPNI
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDL--------RKQQRRELLFNEVVIMRDYQHPNI 78
Query: 134 VRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIM 193
V + + L +++EF+ GG+++ ++ E + T +L L +LH G++
Sbjct: 79 VEMYSSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVI 137
Query: 194 HRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYS 253
HRDIK +IL+ + G +KL+DFG QV++ V KS+ GTPYWMAPEVI + +
Sbjct: 138 HRDIKSDSILLTSDGRVKLSDFGFCAQVSK--EVPRRKSLVGTPYWMAPEVISRLPYGTE 195
Query: 254 ADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPI---PENLSVKAKDFLLKC 310
DIWS+G VIEM G+PP+ + + A+ I PP +S + + FL +
Sbjct: 196 VDIWSLGIMVIEMVDGEPPYFNE-PPLQAMKRIRDNL--PPKLKNLHKVSPRLRSFLDRM 252
Query: 311 LEKEPDLRPTASELLKHPFV 330
L ++P R TA+ELL HPF+
Sbjct: 253 LVRDPAQRATAAELLNHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 1e-47
Identities = 107/292 (36%), Positives = 157/292 (53%), Gaps = 20/292 (6%)
Query: 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNI 133
IG G+FG VY ++ + E++A+K++ + S EK QD IKE VK L+ + HPN
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGK-QSNEKWQDIIKE----VKFLQRIKHPNS 87
Query: 134 VRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIM 193
+ Y G E + +++E+ G + L P E + T L GL YLH+H ++
Sbjct: 88 IEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMI 147
Query: 194 HRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVI---RQTGH 250
HRDIK NIL+ G +KLADFG++ + S A S GTPYWMAPEVI + +
Sbjct: 148 HRDIKAGNILLTEPGQVKLADFGSA------SIASPANSFVGTPYWMAPEVILAMDEGQY 201
Query: 251 SYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKDFLLKC 310
D+WS+G T IE+A KPP ++AL+HI +S S ++F+ C
Sbjct: 202 DGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNESPTLQSNEWSDYFRNFVDSC 260
Query: 311 LEKEPDLRPTASELLKHPFVTGDDEDPVLHASVMKSSEILSPSHVANLESLQ 362
L+K P RPT+ ELLKH FV + + VL + ++ + V L++LQ
Sbjct: 261 LQKIPQDRPTSEELLKHMFVLRERPETVLIDLIQRTKDA-----VRELDNLQ 307
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 164 bits (418), Expect = 4e-47
Identities = 81/273 (29%), Positives = 129/273 (47%), Gaps = 30/273 (10%)
Query: 72 ELIGCGAFGRVYMGM--NLDSGELL-AVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL 128
+ +G GAFG VY G D AVK + AS+E+ K+ +E +++K L
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLK---EDASEEE----RKDFLKEARVMKKL 53
Query: 129 SHPNIVRYLGTVREEESLNILLEFVPGGSISSLL---------GKFGPFPEAVMRTYTKQ 179
HPN+VR LG EEE L ++LE++ GG + L + + ++ Q
Sbjct: 54 GHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQ 113
Query: 180 LLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTP-- 237
+ G+EYL + +HRD+ N LV +K++DFG S+ V + + G
Sbjct: 114 IAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD---DDYYRKKTGGKLP 170
Query: 238 -YWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQ-QYQEVAALFHIGTTKSHPP 294
WMAPE ++ + +D+WS G + E+ T G P+ +EV G P
Sbjct: 171 IRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG---YRLP 227
Query: 295 IPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327
PE + + +L C + +P+ RPT SEL++
Sbjct: 228 KPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 5e-47
Identities = 94/300 (31%), Positives = 143/300 (47%), Gaps = 68/300 (22%)
Query: 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEE-----EVKLLKDL 128
+G G FG VY+ N ++GEL+A+K++ K+K EE EVK L+ L
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKM--------KKK----FYSWEECMNLREVKSLRKL 54
Query: 129 -SHPNIVRYLGTVREEESLNILLEFVPGGSISSLLG-----KFGPFPEAVMRTYTKQLLL 182
HPNIV+ RE + L + E++ G +L K PF E+V+R+ Q+L
Sbjct: 55 NEHPNIVKLKEVFRENDELYFVFEYMEG----NLYQLMKDRKGKPFSESVIRSIIYQILQ 110
Query: 183 GLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELAT----VSGAKSMKGTPY 238
GL ++H HG HRD+K N+LV +K+ADFG ++++ VS T +
Sbjct: 111 GLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVS-------TRW 163
Query: 239 WMAPEVI-RQTGHSYSADIWSVGCTVIEMATGKP------------------------PW 273
+ APE++ R T +S DIW++GC + E+ T +P W
Sbjct: 164 YRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDW 223
Query: 274 SQQYQEVAAL-FHIGTTKSHPP---IPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPF 329
+ Y+ + L F IP N S +A D + L +P RPTAS+ L+HP+
Sbjct: 224 PEGYKLASKLGFRFPQFAPTSLHQLIP-NASPEAIDLIKDMLRWDPKKRPTASQALQHPY 282
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 164 bits (416), Expect = 6e-47
Identities = 88/258 (34%), Positives = 142/258 (55%), Gaps = 12/258 (4%)
Query: 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNI 133
IG G F VY L + +A+K+V I +K + QD +KE++ LLK L+HPN+
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKAR-QDCVKEID----LLKQLNHPNV 64
Query: 134 VRYLGTVREEESLNILLEFVPGGSISSLLGKFGP----FPEAVMRTYTKQLLLGLEYLHN 189
++YL + E+ LNI+LE G +S ++ F PE + Y QL +E++H+
Sbjct: 65 IKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS 124
Query: 190 HGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTG 249
+MHRDIK AN+ + G +KL D G + + T A S+ GTPY+M+PE I + G
Sbjct: 125 RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENG 182
Query: 250 HSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIP-ENLSVKAKDFLL 308
+++ +DIWS+GC + EMA + P+ + +L +PP+P E+ S K ++ +
Sbjct: 183 YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVS 242
Query: 309 KCLEKEPDLRPTASELLK 326
C+ +PD RP + +
Sbjct: 243 MCIYPDPDQRPDIGYVHQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 164 bits (418), Expect = 8e-47
Identities = 91/280 (32%), Positives = 147/280 (52%), Gaps = 26/280 (9%)
Query: 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNI 133
+G GA G V ++G + A+K + N + K++ E+++ K P I
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQ-------KQILRELEINKSCKSPYI 61
Query: 134 VRYLGTVREEES--LNILLEFVPGGSISSLLGKF----GPFPEAVMRTYTKQLLLGLEYL 187
V+Y G +E S + I +E+ GGS+ S+ K G E V+ + +L GL YL
Sbjct: 62 VKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYL 121
Query: 188 HNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQ 247
H+ I+HRDIK +NIL+ KG +KL DFG S EL S A + GT ++MAPE I+
Sbjct: 122 HSRKIIHRDIKPSNILLTRKGQVKLCDFGVS---GELVN-SLAGTFTGTSFYMAPERIQG 177
Query: 248 TGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPE---------N 298
+S ++D+WS+G T++E+A + P+ + + + + + P PE
Sbjct: 178 KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIK 237
Query: 299 LSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDPV 338
S + KDF+ +CLEK+P RPT ++L+HP++ + V
Sbjct: 238 WSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKKV 277
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 164 bits (416), Expect = 2e-46
Identities = 101/292 (34%), Positives = 156/292 (53%), Gaps = 20/292 (6%)
Query: 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNI 133
IG G+FG VY ++ + E++A+K++ + S EK QD IKE V+ L+ L HPN
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDIIKE----VRFLQKLRHPNT 77
Query: 134 VRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIM 193
++Y G E + +++E+ G + L P E + T L GL YLH+H ++
Sbjct: 78 IQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMI 137
Query: 194 HRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVI---RQTGH 250
HRD+K NIL+ G +KL DFG++ + ++ A GTPYWMAPEVI + +
Sbjct: 138 HRDVKAGNILLSEPGLVKLGDFGSA------SIMAPANXFVGTPYWMAPEVILAMDEGQY 191
Query: 251 SYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKDFLLKC 310
D+WS+G T IE+A KPP ++AL+HI +S + S ++F+ C
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNESPALQSGHWSEYFRNFVDSC 250
Query: 311 LEKEPDLRPTASELLKHPFVTGDDEDPVLHASVMKSSEILSPSHVANLESLQ 362
L+K P RPT+ LLKH FV + V+ + ++ + V L++LQ
Sbjct: 251 LQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDA-----VRELDNLQ 297
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 163 bits (415), Expect = 2e-46
Identities = 93/303 (30%), Positives = 138/303 (45%), Gaps = 70/303 (23%)
Query: 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKE-----LEEEVKLLKDL 128
IG G +G+VY N +GEL+A+K++ + ++ KE E+KLL+ L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRM-----------ENEKEGFPITAIREIKLLQKL 55
Query: 129 SHPNIVRYLGTVREEESLNILL--EFVP---GGSISSLLGKFGPFPEAVMRTYTKQLLLG 183
HPNIVR V + +I + E++ G + S KF E+ ++ Y KQLL G
Sbjct: 56 RHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFT---ESQIKCYMKQLLEG 112
Query: 184 LEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPY----- 238
L+YLH++GI+HRDIKG+NIL++N G +KLADFG ++ Y
Sbjct: 113 LQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYT---------KRNSADYTNRVI 163
Query: 239 --WM-APEVIR-QTGHSYSADIWSVGCTVIEMATGKP--------------------PWS 274
W PE++ T + D+WSVGC + E+ GKP P
Sbjct: 164 TLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTD 223
Query: 275 QQYQEVAALFHIGTTKSHPPIPENL--------SVKAKDFLLKCLEKEPDLRPTASELLK 326
+ + V+ L K P L A D L K L +P R +A + L+
Sbjct: 224 ENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283
Query: 327 HPF 329
H +
Sbjct: 284 HEY 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 2e-46
Identities = 104/285 (36%), Positives = 157/285 (55%), Gaps = 32/285 (11%)
Query: 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVK 123
P W E IG G +G+V+ +N +G AVK + + D +E+E E
Sbjct: 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKIL---------DPIHDIDEEIEAEYN 66
Query: 124 LLKDLS-HPNIVRYLGT-----VREEESLNILLEFVPGGSISSLLGKF----GPFPEAVM 173
+LK LS HPN+V++ G V+ + L ++LE GGS++ L+ F E ++
Sbjct: 67 ILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPII 126
Query: 174 RTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSM 233
+ L+GL++LH + +HRD+KG NIL+ +G +KL DFG S Q+ +T +
Sbjct: 127 AYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLT--STRLRRNTS 184
Query: 234 KGTPYWMAPEVI---RQTGHSYSA--DIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGT 288
GTP+WMAPEVI +Q +Y A D+WS+G T IE+ G PP + + + ALF I
Sbjct: 185 VGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLH-PMRALFKI-- 241
Query: 289 TKSHPPI---PENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFV 330
++ PP PE S + DF+ KCL K+ + RPT S+LL+H F+
Sbjct: 242 PRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 162 bits (411), Expect = 7e-46
Identities = 105/285 (36%), Positives = 152/285 (53%), Gaps = 32/285 (11%)
Query: 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVK 123
P W E IG G +G+VY N G L AVK + + D +E+E E
Sbjct: 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKIL---------DPISDVDEEIEAEYN 70
Query: 124 LLKDLS-HPNIVRYLGTVREEE-----SLNILLEFVPGGSISSL---LGKFGP-FPEAVM 173
+L+ L HPN+V++ G + + L ++LE GGS++ L L G EA++
Sbjct: 71 ILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMI 130
Query: 174 RTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSM 233
LLGL++LHN+ I+HRD+KG NIL+ +G +KL DFG S Q+ +T +
Sbjct: 131 SYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT--STRLRRNTS 188
Query: 234 KGTPYWMAPEVI---RQTGHSYSA--DIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGT 288
GTP+WMAPEVI +Q +SY A D+WS+G T IE+ G PP + V LF I
Sbjct: 189 VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH-PVKTLFKI-- 245
Query: 289 TKSHPPI---PENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFV 330
++ PP PE F+ +CL K+ + RP+ + LL+HPF+
Sbjct: 246 PRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFI 290
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 162 bits (410), Expect = 1e-45
Identities = 95/269 (35%), Positives = 156/269 (57%), Gaps = 15/269 (5%)
Query: 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVK 123
P ++ + E IG GA G VY +++ +G+ +A+KQ+ N + K + I E +
Sbjct: 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQM----NLQQQPKKELIINE----IL 68
Query: 124 LLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLG 183
++++ +PNIV YL + + L +++E++ GGS++ ++ + E + ++ L
Sbjct: 69 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQA 127
Query: 184 LEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPE 243
L++LH++ ++HRDIK NIL+ G +KL DFG Q+ S +M GTPYWMAPE
Sbjct: 128 LDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT--PEQSKRSTMVGTPYWMAPE 185
Query: 244 VIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPI--PENLSV 301
V+ + + DIWS+G IEM G+PP+ + + AL+ I T + P + PE LS
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE-NPLRALYLIATNGT-PELQNPERLSA 243
Query: 302 KAKDFLLKCLEKEPDLRPTASELLKHPFV 330
+DFL +CLE + D R +A ELL+HPF+
Sbjct: 244 VFRDFLNRCLEMDVDRRGSAKELLQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 1e-45
Identities = 78/260 (30%), Positives = 134/260 (51%), Gaps = 14/260 (5%)
Query: 72 ELIGCGAFGRVYMGMNLDSGELLAVKQV-LIAANFASKEKAQDHIKELEEEVKLLKDLSH 130
IG G+FG V+ + + A+KQ+ L N +E+A D E ++L L
Sbjct: 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAID-------EARVLAKLDS 58
Query: 131 PNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFG--PFPEAVMRTYTKQLLLGLEYLH 188
I+RY + ++ LNI++E+ G + LL P PE + + Q+LLGL +LH
Sbjct: 59 SYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH 118
Query: 189 NHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQT 248
+ I+HRDIK N+ +D +K+ D G +K ++ + A ++ GTPY+++PE+
Sbjct: 119 SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS--DNTNFANTIVGTPYYLSPELCEDK 176
Query: 249 GHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKDFLL 308
++ +D+W++G + E TGK P+ Q A + I PP+ + S + +
Sbjct: 177 PYNEKSDVWALGVVLYECCTGKHPFDANNQ-GALILKIIRGV-FPPVSQMYSQQLAQLID 234
Query: 309 KCLEKEPDLRPTASELLKHP 328
+CL K+ RP +LL++P
Sbjct: 235 QCLTKDYRQRPDTFQLLRNP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 6e-45
Identities = 95/269 (35%), Positives = 157/269 (58%), Gaps = 15/269 (5%)
Query: 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVK 123
P ++ + E IG GA G V+ +++ +G+ +A+KQ+ N + K + I E +
Sbjct: 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQI----NLQKQPKKELIINE----IL 68
Query: 124 LLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLG 183
++K+L +PNIV +L + + L +++E++ GGS++ ++ + EA + ++ L
Sbjct: 69 VMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQA 127
Query: 184 LEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPE 243
LE+LH + ++HRDIK N+L+ G +KL DFG Q+ S +M GTPYWMAPE
Sbjct: 128 LEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQIT--PEQSKRSTMVGTPYWMAPE 185
Query: 244 VIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPI--PENLSV 301
V+ + + DIWS+G IEM G+PP+ + + AL+ I T + P + PE LS
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE-NPLRALYLIATNGT-PELQNPEKLSP 243
Query: 302 KAKDFLLKCLEKEPDLRPTASELLKHPFV 330
+DFL +CLE + + R +A ELL+HPF+
Sbjct: 244 IFRDFLNRCLEMDVEKRGSAKELLQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 158 bits (400), Expect = 1e-44
Identities = 81/271 (29%), Positives = 127/271 (46%), Gaps = 36/271 (13%)
Query: 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNI 133
I GAFG VY+ +G+ A+K VL ++ +K + E ++ P +
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIK-VLKKSDMIAKNQV---TNVKAERAIMMIQGESPYV 59
Query: 134 VRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIM 193
+ + + ++ L +++E++ GG +SL+ G PE + Y +++LG+E LH GI+
Sbjct: 60 AKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGII 119
Query: 194 HRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYS 253
HRDIK N+L+D G +KL DFG S+ E K GTP ++APE I G
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NKKFVGTPDYLAPETILGVGDDKM 173
Query: 254 ADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKS------------HPPIPENLSV 301
+D WS+GC + E G PP FH T + + E S
Sbjct: 174 SDWWSLGCVIFEFLFGYPP-----------FHAETPDAVFDNILSRRINWPEEVKEFCSP 222
Query: 302 KAKDFLLKCLEKEPDLRPTAS---ELLKHPF 329
+A D + + L +P R A+ E+ HPF
Sbjct: 223 EAVDLINRLLCMDPAKRLGANGYQEIKSHPF 253
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 1e-44
Identities = 84/290 (28%), Positives = 133/290 (45%), Gaps = 41/290 (14%)
Query: 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIA-ANFASKEKAQDHIKELEEEVKLLKDLSH 130
++G GA+G V N +GE++A+K+ + + K+ A EVK+L+ L H
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTAL-------REVKVLRQLRH 59
Query: 131 PNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNH 190
NIV R + L ++ E+V + L G P +R+Y QLL + Y H+H
Sbjct: 60 ENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH 119
Query: 191 GIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEV-IRQTG 249
I+HRDIK NILV G +KL DFG ++ + S T ++ APE+ + T
Sbjct: 120 NIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-SPLTDYVATRWYRAPELLVGDTN 178
Query: 250 HSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHI-----GTTKSH------------ 292
+ D+W++GC + E+ G+P + ++ L+ I SH
Sbjct: 179 YGKPVDVWAIGCIMAELLDGEPLFPGD-SDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG 237
Query: 293 ---PPIPENLSVKAK----------DFLLKCLEKEPDLRPTASELLKHPF 329
P + S++ + DFL CL +P R T ELL+HP+
Sbjct: 238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPY 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 9e-44
Identities = 81/266 (30%), Positives = 142/266 (53%), Gaps = 26/266 (9%)
Query: 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEK--AQDHIKELEEEVKLLKDLSHP 131
IG GAFG+V + D+ ++ A+K + +K+K + ++ + E ++L++L+HP
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMK-------YMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 132 NIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHG 191
+V + ++EE++ ++++ + GG + L + F E ++ + +++L LEYLH+ G
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG 120
Query: 192 IMHRDIKGANILVDNKGCIKLADFGASKQVA--ELATVSGAKSMKGTPYWMAPEVIRQTG 249
I+HRDIK NIL+D +G + + DF + +V L T S GTP +MAPEV+ + G
Sbjct: 121 IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTT-----STSGTPGYMAPEVLCRQG 175
Query: 250 HSYSADIWSVGCTVIEMATGKPPW----SQQYQEVAALFHIGTTKSHPPIPENLSVKAKD 305
+S + D WS+G T E GK P+ ++ A + P S +A D
Sbjct: 176 YSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQE----TADVLYPATWSTEAID 231
Query: 306 FLLKCLEKEPDLR--PTASELLKHPF 329
+ K LE++P R +L HP+
Sbjct: 232 AINKLLERDPQKRLGDNLKDLKNHPY 257
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 2e-43
Identities = 90/279 (32%), Positives = 147/279 (52%), Gaps = 28/279 (10%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH 130
GE +G G+FGRV + + +GE A+K + K K H+ + E +L +LSH
Sbjct: 23 GETLGTGSFGRVRIAKHKGTGEYYAIK--CLKKREILKMKQVQHVAQ---EKSILMELSH 77
Query: 131 PNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNH 190
P IV + + ++E + LLEFV GG + + L K G FP V + Y +L+L EYLH+
Sbjct: 78 PFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSK 137
Query: 191 GIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGH 250
I++RD+K N+L+DNKG +K+ DFG +K+V + ++ GTP ++APEVI+ GH
Sbjct: 138 DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF-----TLCGTPEYLAPEVIQSKGH 192
Query: 251 SYSADIWSVGCTVIEMATGKPPWSQQ-----YQEVAALFHIGTTKSHPPIPENLSVKAKD 305
+ D W++G + E G PP+ Y+++ A G K P +A+D
Sbjct: 193 GKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILA----GRLK----FPNWFDGRARD 244
Query: 306 FLLKCLEKEP-----DLRPTASELLKHPFVTGDDEDPVL 339
+ L+ + L+ +++ HP+ G + D +
Sbjct: 245 LVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWDKLY 283
|
Length = 329 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 155 bits (392), Expect = 2e-43
Identities = 95/273 (34%), Positives = 146/273 (53%), Gaps = 26/273 (9%)
Query: 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH- 130
EL+G G +G+VY G ++ +G+L A+K + + D +E+++E+ +LK SH
Sbjct: 12 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---------DEEEEIKQEINMLKKYSHH 62
Query: 131 PNIVRYLGTVRE------EESLNILLEFVPGGSISSLLG--KFGPFPEAVMRTYTKQLLL 182
NI Y G + ++ L +++EF GS++ L+ K E + +++L
Sbjct: 63 RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILR 122
Query: 183 GLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAP 242
GL +LH H ++HRDIKG N+L+ +KL DFG S Q+ TV + GTPYWMAP
Sbjct: 123 GLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR--TVGRRNTFIGTPYWMAP 180
Query: 243 EVIR-----QTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPE 297
EVI + + +D+WS+G T IEMA G PP + + ALF I + +
Sbjct: 181 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH-PMRALFLIPRNPAPRLKSK 239
Query: 298 NLSVKAKDFLLKCLEKEPDLRPTASELLKHPFV 330
S K + F+ CL K RPT +L+KHPF+
Sbjct: 240 KWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 155 bits (392), Expect = 2e-43
Identities = 99/275 (36%), Positives = 148/275 (53%), Gaps = 30/275 (10%)
Query: 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH- 130
E++G G +G+VY G ++ +G+L A+K + + +D +E++ E+ +LK SH
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---------EDEEEEIKLEINMLKKYSHH 72
Query: 131 PNIVRYLGTV------REEESLNILLEFVPGGSISSLLG--KFGPFPEAVMRTYTKQLLL 182
NI Y G ++ L +++EF GS++ L+ K E + +++L
Sbjct: 73 RNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILR 132
Query: 183 GLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAP 242
GL +LH H ++HRDIKG N+L+ +KL DFG S Q+ TV + GTPYWMAP
Sbjct: 133 GLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR--TVGRRNTFIGTPYWMAP 190
Query: 243 EVIR-----QTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPP--I 295
EVI + Y +DIWS+G T IEMA G PP + + ALF I ++ PP
Sbjct: 191 EVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMH-PMRALFLI--PRNPPPKLK 247
Query: 296 PENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFV 330
+ S K DF+ CL K RP+ +LLKHPF+
Sbjct: 248 SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 3e-43
Identities = 93/269 (34%), Positives = 155/269 (57%), Gaps = 15/269 (5%)
Query: 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVK 123
P ++ + E IG GA G VY M++ +G+ +A++Q+ N + K + I E +
Sbjct: 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM----NLQQQPKKELIINE----IL 69
Query: 124 LLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLG 183
++++ +PNIV YL + + L +++E++ GGS++ ++ + E + ++ L
Sbjct: 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQA 128
Query: 184 LEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPE 243
LE+LH++ ++HRDIK NIL+ G +KL DFG Q+ S +M GTPYWMAPE
Sbjct: 129 LEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT--PEQSKRSTMVGTPYWMAPE 186
Query: 244 VIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPI--PENLSV 301
V+ + + DIWS+G IEM G+PP+ + + AL+ I T + P + PE LS
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE-NPLRALYLIATNGT-PELQNPEKLSA 244
Query: 302 KAKDFLLKCLEKEPDLRPTASELLKHPFV 330
+DFL +CL+ + + R +A ELL+H F+
Sbjct: 245 IFRDFLNRCLDMDVEKRGSAKELLQHQFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 154 bits (390), Expect = 3e-43
Identities = 86/251 (34%), Positives = 137/251 (54%), Gaps = 12/251 (4%)
Query: 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNI 133
IG G F VY L G +A+K+V I +K + D IKE++ LLK L+HPN+
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKAR-ADCIKEID----LLKQLNHPNV 64
Query: 134 VRYLGTVREEESLNILLEFVPGGSISSLLGKFGP----FPEAVMRTYTKQLLLGLEYLHN 189
++Y + E+ LNI+LE G +S ++ F PE + Y QL LE++H+
Sbjct: 65 IKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS 124
Query: 190 HGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTG 249
+MHRDIK AN+ + G +KL D G + + T A S+ GTPY+M+PE I + G
Sbjct: 125 RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENG 182
Query: 250 HSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIP-ENLSVKAKDFLL 308
+++ +DIWS+GC + EMA + P+ + +L +PP+P ++ S + + +
Sbjct: 183 YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVN 242
Query: 309 KCLEKEPDLRP 319
C+ +P+ RP
Sbjct: 243 MCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 4e-43
Identities = 95/278 (34%), Positives = 150/278 (53%), Gaps = 25/278 (8%)
Query: 74 IGCGAFGRVYMGMNL---DSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH 130
+G GA+G+V++ + D+G+L A+K VL A K K +H + + ++ ++
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMK-VLKKATIVQKAKTAEHTRTERQVLEAVR--RC 64
Query: 131 PNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNH 190
P +V + + L+++L++V GG + + L + F E+ +R Y +++L L++LH
Sbjct: 65 PFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQL 124
Query: 191 GIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSG--AKSMKGTPYWMAPEVIR-- 246
GI++RDIK NIL+D++G + L DFG SK E A S GT +MAPEVIR
Sbjct: 125 GIIYRDIKLENILLDSEGHVVLTDFGLSK---EFLAEEEERAYSFCGTIEYMAPEVIRGG 181
Query: 247 QTGHSYSADIWSVGCTVIEMATGKPPWS-----QQYQEVAALFHIGTTKSHPPIPENLSV 301
GH + D WS+G E+ TG P++ E++ KS PP P+ +S
Sbjct: 182 SGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRI----LKSKPPFPKTMSA 237
Query: 302 KAKDFLLKCLEKEPDLR---PTASELLKHPFVTGDDED 336
+A+DF+ K LEK+P R A E+ HPF G D D
Sbjct: 238 EARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWD 275
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 1e-42
Identities = 79/267 (29%), Positives = 146/267 (54%), Gaps = 14/267 (5%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLK 126
++ K ++G GAFG V++ +L+ +KQ+ + ++ +D + E ++LK
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPV------EQMTKDERLAAQNECQVLK 54
Query: 127 DLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGP--FPEAVMRTYTKQLLLGL 184
LSHPNI+ Y E+++L I++E+ PGG+++ + K E + + Q+LL L
Sbjct: 55 LLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLAL 114
Query: 185 EYLHNHGIMHRDIKGANILVD-NKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPE 243
++H I+HRD+K NIL+D +K +K+ DFG SK L++ S A ++ GTP +++PE
Sbjct: 115 HHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISK---ILSSKSKAYTVVGTPCYISPE 171
Query: 244 VIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKA 303
+ ++ +DIW++GC + E+A+ K + + + AL + + PI + S
Sbjct: 172 LCEGKPYNQKSDIWALGCVLYELASLKRAF--EAANLPALVLKIMSGTFAPISDRYSPDL 229
Query: 304 KDFLLKCLEKEPDLRPTASELLKHPFV 330
+ +L L +P RP S+++ P
Sbjct: 230 RQLILSMLNLDPSKRPQLSQIMAQPIC 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 4e-42
Identities = 95/297 (31%), Positives = 147/297 (49%), Gaps = 41/297 (13%)
Query: 70 KGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKA--QDHIKELEEEVKLLKD 127
++IG GAFG V++ + D+G++ A+K + K ++ I + E +L D
Sbjct: 5 VIKVIGRGAFGEVWLVRDKDTGQVYAMKVL-------RKSDMIKRNQIAHVRAERDILAD 57
Query: 128 LSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYL 187
P IV+ + ++EE L +++E++PGG + +LL + FPE R Y +L+L L+ +
Sbjct: 58 ADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSV 117
Query: 188 HNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAE------------------LATVSG 229
H G +HRDIK NIL+D G IKLADFG K++ + V
Sbjct: 118 HKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRR 177
Query: 230 ---------AKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPW-SQQYQE 279
A S GTP ++APEV+R T + D WS+G + EM G PP+ S QE
Sbjct: 178 RDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE 237
Query: 280 VAA-LFHIGTTKSHPPIPENLSVKAKDFLLKCL-EKEPDLRPTASELLKHPFVTGDD 334
+ + + PP P +S +A D + + L + E L + E+ HPF G D
Sbjct: 238 TYNKIINWKESLRFPPDPP-VSPEAIDLICRLLCDPEDRLG-SFEEIKSHPFFKGID 292
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 2e-41
Identities = 81/263 (30%), Positives = 132/263 (50%), Gaps = 19/263 (7%)
Query: 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQ--DHIKELEEEVKLLKDLSHP 131
+G G +G+V++ D+GE++A+K++ K + ++ + E +L
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRM-------KKSLLFKLNEVRHVLTERDILTTTKSE 61
Query: 132 NIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHG 191
+V+ L +++E L + +E+VPGG +LL G E R Y ++ ++ LH G
Sbjct: 62 WLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG 121
Query: 192 IMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHS 251
+HRD+K N L+D G IKL DFG SK V+ A S+ G+P +MAPEV+R G+
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSK-----GIVTYANSVVGSPDYMAPEVLRGKGYD 176
Query: 252 YSADIWSVGCTVIEMATGKPPWS-QQYQEV-AALFHIGTTKSHPPIPE---NLSVKAKDF 306
++ D WS+GC + E G PP+S E L + T P + NLS +A D
Sbjct: 177 FTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDL 236
Query: 307 LLKCLEKEPDLRPTASELLKHPF 329
+ K + + ++ HPF
Sbjct: 237 ITKLINDPSRRFGSLEDIKNHPF 259
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 2e-41
Identities = 96/260 (36%), Positives = 144/260 (55%), Gaps = 17/260 (6%)
Query: 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNI 133
IG G+ G V + SG +AVK + + + Q + L EV +++D H N+
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDL--------RKQQRRELLFNEVVIMRDYQHQNV 80
Query: 134 VRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIM 193
V + E L +L+EF+ GG+++ ++ + E + T + +L L YLH+ G++
Sbjct: 81 VEMYKSYLVGEELWVLMEFLQGGALTDIVSQT-RLNEEQIATVCESVLQALCYLHSQGVI 139
Query: 194 HRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYS 253
HRDIK +IL+ G +KL+DFG Q+++ V KS+ GTPYWMAPEVI +T +
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCAQISK--DVPKRKSLVGTPYWMAPEVISRTPYGTE 197
Query: 254 ADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPEN---LSVKAKDFLLKC 310
DIWS+G VIEM G+PP+ V A+ + S PP +N +S +DFL +
Sbjct: 198 VDIWSLGIMVIEMVDGEPPYFSD-SPVQAMKRL--RDSPPPKLKNAHKISPVLRDFLERM 254
Query: 311 LEKEPDLRPTASELLKHPFV 330
L +EP R TA ELL HPF+
Sbjct: 255 LTREPQERATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 148 bits (374), Expect = 1e-40
Identities = 87/274 (31%), Positives = 143/274 (52%), Gaps = 23/274 (8%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH 130
EL G G +G VY ++ +G +A+K++ + + + K I EL+ +L
Sbjct: 7 DEL-GKGNYGSVYKVLHRPTGVTMAMKEIRLELDES---KFNQIIMELD----ILHKAVS 58
Query: 131 PNIVRYLGTVREEESLNILLEFVPGGSISSLLG---KFGPFPEAVMRTYTKQLLLGLEYL 187
P IV + G E ++ + +E++ GS+ L PE V+R T ++ GL++L
Sbjct: 59 PYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL 118
Query: 188 -HNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIR 246
H I+HRD+K N+LV+ G +KL DFG S + S AK+ G +MAPE I+
Sbjct: 119 KEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA----SLAKTNIGCQSYMAPERIK 174
Query: 247 QTG------HSYSADIWSVGCTVIEMATGKPPWS-QQYQEVAALFHIGTTKSHPPIPENL 299
G ++ +D+WS+G +++EMA G+ P+ + Y + A P +P
Sbjct: 175 SGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGY 234
Query: 300 SVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333
S A+DF+ KCL K P+ RPT ++LL+HP++
Sbjct: 235 SDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY 268
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 1e-40
Identities = 80/267 (29%), Positives = 138/267 (51%), Gaps = 17/267 (6%)
Query: 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKL 124
PIR ++G GAFG + + L+ K+V + + KE+ ++ E+ +
Sbjct: 4 PIR-----VLGKGAFGEATLYRRTEDDSLVVWKEVNLT-RLSEKER-----RDALNEIVI 52
Query: 125 LKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLG--KFGPFPEAVMRTYTKQLLL 182
L L HPNI+ Y ++ +L I +E+ GG++ + K F E ++ Y Q++
Sbjct: 53 LSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVS 112
Query: 183 GLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAP 242
+ Y+H GI+HRDIK NI + G IKL DFG SK + + S A+++ GTPY+M+P
Sbjct: 113 AVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILG--SEYSMAETVVGTPYYMSP 170
Query: 243 EVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVK 302
E+ + +++ +DIW++GC + E+ T K + L ++ P+ S +
Sbjct: 171 ELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP--LNLVVKIVQGNYTPVVSVYSSE 228
Query: 303 AKDFLLKCLEKEPDLRPTASELLKHPF 329
+ L+++P+ RPTA E+L P
Sbjct: 229 LISLVHSLLQQDPEKRPTADEVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 2e-40
Identities = 85/277 (30%), Positives = 141/277 (50%), Gaps = 23/277 (8%)
Query: 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNI 133
+G G G V ++ +G ++A K V I A K + K++ E++++ + P I
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGA----KSSVR---KQILRELQIMHECRSPYI 65
Query: 134 VRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHN-HGI 192
V + G E ++ + +EF+ GS+ + K GP P ++ ++ GL YL+N H I
Sbjct: 66 VSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRI 125
Query: 193 MHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSY 252
MHRDIK +NILV+++G IKL DFG S ++ S A + GT +M+PE I+ ++
Sbjct: 126 MHRDIKPSNILVNSRGQIKLCDFGVSGELIN----SIADTFVGTSTYMSPERIQGGKYTV 181
Query: 253 SADIWSVGCTVIEMATGKPPWSQQYQEVAA---------LFHIGTTKSHPPIP-ENLSVK 302
+D+WS+G ++IE+A GK P++ + L + P +P +
Sbjct: 182 KSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPED 241
Query: 303 AKDFLLKCLEKEPDLRPTASELLK-HPFVTGDDEDPV 338
+DF+ CL K+P RPT +L PF+ V
Sbjct: 242 LRDFVDACLLKDPTERPTPQQLCAMPPFIQALRASNV 278
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 7e-40
Identities = 87/298 (29%), Positives = 144/298 (48%), Gaps = 49/298 (16%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHI-KELEEEVKLL 125
R+ KG+ +G G + VY + ++G ++A+K++ + +++A+D I E+KLL
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLG----ERKEAKDGINFTALREIKLL 56
Query: 126 KDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLG-KFGPFPEAVMRTYTKQLLLGL 184
++L HPNI+ L + ++N++ EF+ + ++ K A +++Y L GL
Sbjct: 57 QELKHPNIIGLLDVFGHKSNINLVFEFMET-DLEKVIKDKSIVLTPADIKSYMLMTLRGL 115
Query: 185 EYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTP-----YW 239
EYLH++ I+HRD+K N+L+ + G +KLADFG LA G+ + K T ++
Sbjct: 116 EYLHSNWILHRDLKPNNLLIASDGVLKLADFG-------LARSFGSPNRKMTHQVVTRWY 168
Query: 240 MAPEVI---RQTGHSYSADIWSVGCTVIEMATGKP--------------------PWSQQ 276
APE++ R G D+WSVGC E+ P P +
Sbjct: 169 RAPELLFGARHYGV--GVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEEN 226
Query: 277 YQEVAALFHIGTTKSHPPIP-----ENLSVKAKDFLLKCLEKEPDLRPTASELLKHPF 329
+ V +L K PP P S A D L + L P+ R TA + L+HP+
Sbjct: 227 WPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPY 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 9e-40
Identities = 77/266 (28%), Positives = 148/266 (55%), Gaps = 12/266 (4%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLK 126
++ K + IG G+FG+ + + + G+ +K++ I+ + KE+ +E +EV +L
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINIS-KMSPKER-----EESRKEVAVLS 54
Query: 127 DLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLG--KFGPFPEAVMRTYTKQLLLGL 184
++ HPNIV+Y + E +L I++++ GG + + + FPE + + Q+ L L
Sbjct: 55 NMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLAL 114
Query: 185 EYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEV 244
+++H+ I+HRDIK NI + G IKL DFG ++ + +TV A++ GTPY+++PE+
Sbjct: 115 KHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLN--STVELARTCIGTPYYLSPEI 172
Query: 245 IRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAK 304
++ +DIW++GC + EM T K + + L I S+PP+ + S +
Sbjct: 173 CENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKII--RGSYPPVSSHYSYDLR 230
Query: 305 DFLLKCLEKEPDLRPTASELLKHPFV 330
+ + + ++ P RP+ + +L+ F+
Sbjct: 231 NLVSQLFKRNPRDRPSVNSILEKNFI 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 1e-39
Identities = 87/278 (31%), Positives = 145/278 (52%), Gaps = 28/278 (10%)
Query: 73 LIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPN 132
+G G FGRV++ + S A+K + I + K + H+ E ++LK++SHP
Sbjct: 8 TVGTGTFGRVHLVRDRISEHYYALKVMAIPE--VIRLKQEQHVHN---EKRVLKEVSHPF 62
Query: 133 IVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGI 192
I+R T ++ L +L+E+VPGG + S L G F + Y +++ LEYLH+ I
Sbjct: 63 IIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEI 122
Query: 193 MHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSY 252
++RD+K NIL+D +G IKL DFG +K++ ++ GTP ++APEVI+ GH+
Sbjct: 123 VYRDLKPENILLDKEGHIKLTDFGFAKKL-----RDRTWTLCGTPEYLAPEVIQSKGHNK 177
Query: 253 SADIWSVGCTVIEMATGKPPW-----SQQYQEVAALFHIGTTKSHPPIPENLSVKAKDFL 307
+ D W++G + EM G PP+ Y+++ A G + P +L + AKD +
Sbjct: 178 AVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILA----GKLE----FPRHLDLYAKDLI 229
Query: 308 LKCLEKEP-----DLRPTASELLKHPFVTGDDEDPVLH 340
K L + +++ A ++ H + D D V
Sbjct: 230 KKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDDVPQ 267
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 1e-39
Identities = 84/307 (27%), Positives = 141/307 (45%), Gaps = 63/307 (20%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEE------ 120
R++ IG GA G V+ + ++GE +A+K+V ++ LE
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKV--------------ALRRLEGGIPNQA 46
Query: 121 --EVKLLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKF-GPFPEAVMRTYT 177
E+K L+ HP +V+ L +++E++P +S +L P PEA +++Y
Sbjct: 47 LREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYM 105
Query: 178 KQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMK--- 234
+ LL G+ Y+H +GIMHRD+K AN+L+ G +K+ADFG ++ +E +
Sbjct: 106 RMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSE----EEPRLYSHQV 161
Query: 235 GTPYWMAPEVI---RQTGHSYSADIWSVGCTVIEMATGKP-------------------- 271
T ++ APE++ R+ D+W+VGC E+ G P
Sbjct: 162 ATRWYRAPELLYGARKYDP--GVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGT 219
Query: 272 PWSQQYQEVAALFHIG--TTKSHPPIP-----ENLSVKAKDFLLKCLEKEPDLRPTASEL 324
P + + + +L T PIP + S +A D L L +P R +A+E
Sbjct: 220 PNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEA 279
Query: 325 LKHPFVT 331
L+HP+ T
Sbjct: 280 LRHPYFT 286
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 1e-39
Identities = 88/295 (29%), Positives = 147/295 (49%), Gaps = 53/295 (17%)
Query: 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELE-EEVKLLKDLSH 130
L+G G++G V + ++G+++A+K+ L + + +K++ E+++LK L H
Sbjct: 7 GLVGEGSYGMVMKCKHKETGQIVAIKKFL-------ESEDDKMVKKIAMREIRMLKQLRH 59
Query: 131 PNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFP----EAVMRTYTKQLLLGLEY 186
N+V + R ++ L ++ EFV ++L +P E+ +R Y Q+L G+E+
Sbjct: 60 ENLVNLIEVFRRKKRLYLVFEFVD----HTVLDDLEKYPNGLDESRVRKYLFQILRGIEF 115
Query: 187 LHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVA---ELATVSGAKSMKGTPYWMAPE 243
H+H I+HRDIK NILV G +KL DFG ++ +A E+ T A T ++ APE
Sbjct: 116 CHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVA-----TRWYRAPE 170
Query: 244 -VIRQTGHSYSADIWSVGCTVIEMATGKPPW-------------------SQQYQEVAAL 283
++ T + + DIW+VGC V EM TG+P + ++QE+
Sbjct: 171 LLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQK 230
Query: 284 FHIGTTKSHPPIPE---------NLSVKAKDFLLKCLEKEPDLRPTASELLKHPF 329
+ P + E LS D +CL +PD RP++S+LL H F
Sbjct: 231 NPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 8e-39
Identities = 91/277 (32%), Positives = 134/277 (48%), Gaps = 37/277 (13%)
Query: 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL--- 128
IG G G+VY +G ++AVKQ+ N EE ++L DL
Sbjct: 21 GEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN-------------KEENKRILMDLDVV 67
Query: 129 --SH--PNIVRYLGTVREEESLNILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLLG 183
SH P IV+ G + + I +E + + LL + GP PE ++ T ++
Sbjct: 68 LKSHDCPYIVKCYGYFITDSDVFICMELM-STCLDKLLKRIQGPIPEDILGKMTVAIVKA 126
Query: 184 LEYL-HNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKS-MKGTPYWMA 241
L YL HG++HRD+K +NIL+D G +KL DFG S ++ + S AK+ G +MA
Sbjct: 127 LHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD----SKAKTRSAGCAAYMA 182
Query: 242 PEVIR-QTGHS-YS--ADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIP- 296
PE I + Y AD+WS+G +++E+ATG+ P+ E L I + PP
Sbjct: 183 PERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKI--LQEEPPSLP 240
Query: 297 --ENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVT 331
E S F+ CL K+ RP ELL+HPF+
Sbjct: 241 PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIR 277
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 8e-39
Identities = 88/306 (28%), Positives = 134/306 (43%), Gaps = 70/306 (22%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEE--------EV 122
IG GA+G VY +L++G +A+K+V + + EE E+
Sbjct: 4 LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS--------------EEGIPLSTLREI 49
Query: 123 KLLKDL---SHPNIVRYLG-----TVREEESLNILLEFVPGGSISSLLGKFGP--FPEAV 172
LLK L HPNIVR L E L ++ E V +++ L K P
Sbjct: 50 ALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPET 108
Query: 173 MRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKS 232
++ +QLL G+++LH+H I+HRD+K NILV + G +K+ADFG LA + +
Sbjct: 109 IKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFG-------LARIYSFE- 160
Query: 233 MKGTP-----YWMAPEVIRQTGHSYSADIWSVGCTVIEMA-------------------- 267
M T ++ APEV+ Q+ ++ D+WSVGC E+
Sbjct: 161 MALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFD 220
Query: 268 -TGKPPWSQQYQEVAAL---FHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASE 323
G P + + V+ F T +S + + D L K L P R +A E
Sbjct: 221 VIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFE 280
Query: 324 LLKHPF 329
L+HP+
Sbjct: 281 ALQHPY 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 1e-38
Identities = 97/346 (28%), Positives = 152/346 (43%), Gaps = 54/346 (15%)
Query: 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNI 133
IG GAFG V + +D+ L A+K + A + A H+K E +L + + +
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAA--HVKA---ERDILAEADNEWV 63
Query: 134 VRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIM 193
V+ + +++++L +++++PGG + SLL + G F E + R Y +L +E +H G +
Sbjct: 64 VKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFI 123
Query: 194 HRDIKGANILVDNKGCIKLADFG-------------------------------ASKQVA 222
HRDIK NIL+D G IKL DFG +
Sbjct: 124 HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRC 183
Query: 223 ELATVS----------GAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPP 272
L + A S+ GTP ++APEV+ +TG++ D WSVG + EM G+PP
Sbjct: 184 RLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPP 243
Query: 273 WSQQYQEVAALFHIGTTKS-HPPIPENLSVKAKDFLLK-CLEKEPDL-RPTASELLKHPF 329
+ L I + H P LS +A D +L+ C E L + A E+ HPF
Sbjct: 244 FLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLCCGAEDRLGKNGADEIKAHPF 303
Query: 330 VTGDD-EDPVLHASVMKSSEILSPSHVANLESLQMLTSPGSPGSVD 374
G D + +I P+ +N + + P S D
Sbjct: 304 FKGIDFASLIRRQKAPYIPKITHPTDTSNFDPVD----PEKLRSDD 345
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 4e-38
Identities = 92/272 (33%), Positives = 150/272 (55%), Gaps = 21/272 (7%)
Query: 72 ELIGCGAFGRVYMGMNL---DSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL 128
+++G G+FG+V++ + D+G+L A+K VL A K +D ++ E +L ++
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMK-VLKKATL----KVRDRVRTKMER-DILAEV 55
Query: 129 SHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLH 188
+HP IV+ + E L ++L+F+ GG + + L K F E ++ Y +L L L++LH
Sbjct: 56 NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLH 115
Query: 189 NHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQT 248
+ GI++RD+K NIL+D +G IKL DFG SK+ + A S GT +MAPEV+ +
Sbjct: 116 SLGIIYRDLKPENILLDEEGHIKLTDFGLSKE--SIDHEKKAYSFCGTVEYMAPEVVNRR 173
Query: 249 GHSYSADIWSVGCTVIEMATGKPPWS-QQYQEVAALFHIGTTKSHPPIPENLSVKAKDFL 307
GH+ SAD WS G + EM TG P+ + +E + K+ +P+ LS +A+ L
Sbjct: 174 GHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI----LKAKLGMPQFLSPEAQSLL 229
Query: 308 LKCLEKEPDLRPTAS-----ELLKHPFVTGDD 334
++ P R A E+ +HPF + D
Sbjct: 230 RALFKRNPANRLGAGPDGVEEIKRHPFFSTID 261
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 5e-38
Identities = 86/254 (33%), Positives = 131/254 (51%), Gaps = 40/254 (15%)
Query: 121 EVKLLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQL 180
E+K+L + + P IV + G + ++I +E + GGS+ +L K G PE ++ + +
Sbjct: 49 ELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAV 108
Query: 181 LLGLEYLH-NHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYW 239
L GL YL H IMHRD+K +NILV+++G IKL DFG S Q+ + S A S GT +
Sbjct: 109 LRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSY 164
Query: 240 MAPEVIRQTGHSYSADIWSVGCTVIEMATGK----PPWSQQY--------QEVAALFHIG 287
M+PE ++ T ++ +DIWS+G +++EMA G+ PP +++ E A
Sbjct: 165 MSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHR 224
Query: 288 TTKSHPP-------IPENL----------------SVKAKDFLLKCLEKEPDLRPTASEL 324
HPP I E L S + +DF+ KCL+K P R EL
Sbjct: 225 PVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKEL 284
Query: 325 LKHPFVTGDDEDPV 338
KHPF+ + + V
Sbjct: 285 TKHPFIKRAELEEV 298
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 1e-37
Identities = 89/267 (33%), Positives = 140/267 (52%), Gaps = 23/267 (8%)
Query: 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNI 133
IG GA G VY ++ +G L A+K +I N + Q + E+++L+D++HPN+
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALK--VIYGNHEDTVRRQ-----ICREIEILRDVNHPNV 134
Query: 134 VRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIM 193
V+ + +LLEF+ GGS+ F V R Q+L G+ YLH I+
Sbjct: 135 VKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR----QILSGIAYLHRRHIV 190
Query: 194 HRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVI-------R 246
HRDIK +N+L+++ +K+ADFG S+ +A+ T+ S GT +M+PE I
Sbjct: 191 HRDIKPSNLLINSAKNVKIADFGVSRILAQ--TMDPCNSSVGTIAYMSPERINTDLNHGA 248
Query: 247 QTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPP-IPENLSVKAKD 305
G Y+ DIWS+G +++E G+ P+ Q A S PP P S + +
Sbjct: 249 YDG--YAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFRH 306
Query: 306 FLLKCLEKEPDLRPTASELLKHPFVTG 332
F+ CL++EP R +A +LL+HPF+
Sbjct: 307 FISCCLQREPAKRWSAMQLLQHPFILR 333
|
Length = 353 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 2e-37
Identities = 92/261 (35%), Positives = 144/261 (55%), Gaps = 17/261 (6%)
Query: 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNI 133
IG G+ G V + SG+L+AVK++ + + Q + L EV +++D H N+
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDL--------RKQQRRELLFNEVVIMRDYQHENV 79
Query: 134 VRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIM 193
V + + L +++EF+ GG+++ ++ E + +L L LH G++
Sbjct: 80 VEMYNSYLVGDELWVVMEFLEGGALTDIV-THTRMNEEQIAAVCLAVLKALSVLHAQGVI 138
Query: 194 HRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYS 253
HRDIK +IL+ + G +KL+DFG QV++ V KS+ GTPYWMAPE+I + +
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRRKSLVGTPYWMAPELISRLPYGPE 196
Query: 254 ADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENL---SVKAKDFLLKC 310
DIWS+G VIEM G+PP+ + + A+ I + PP +NL S K FL +
Sbjct: 197 VDIWSLGIMVIEMVDGEPPYFNE-PPLKAMKMI--RDNLPPKLKNLHKVSPSLKGFLDRL 253
Query: 311 LEKEPDLRPTASELLKHPFVT 331
L ++P R TA+ELLKHPF+
Sbjct: 254 LVRDPAQRATAAELLKHPFLA 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 2e-37
Identities = 90/273 (32%), Positives = 148/273 (54%), Gaps = 14/273 (5%)
Query: 72 ELIGCGAFGRVYMGMNL---DSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL 128
+++G GA+G+V++ + D+G+L A+K VL A K K +H + ++ ++
Sbjct: 6 KVLGTGAYGKVFLVRKVTGHDTGKLYAMK-VLQKAALVQKAKTVEHTRTERNVLEHVRQ- 63
Query: 129 SHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLH 188
P +V + E L+++L++V GG + + L + F E +R Y+ +++L LE+LH
Sbjct: 64 -SPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLH 122
Query: 189 NHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIR-Q 247
GI++RDIK NIL+D++G + L DFG SK+ S GT +MAPE+IR +
Sbjct: 123 KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS-EEKERTYSFCGTIEYMAPEIIRGK 181
Query: 248 TGHSYSADIWSVGCTVIEMATGKPPWS-QQYQEVAALFHIGTTKSHPPIPENLSVKAKDF 306
GH + D WS+G + E+ TG P++ + + + K PP P + +A+D
Sbjct: 182 GGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDL 241
Query: 307 LLKCLEKEPDLR-----PTASELLKHPFVTGDD 334
L K L K+P R ASE+ +HPF G D
Sbjct: 242 LHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLD 274
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 2e-37
Identities = 92/260 (35%), Positives = 143/260 (55%), Gaps = 17/260 (6%)
Query: 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNI 133
IG G+ G V + +G+ +AVK++ + + Q + L EV +++D H N+
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDL--------RKQQRRELLFNEVVIMRDYHHENV 81
Query: 134 VRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIM 193
V + + L +++EF+ GG+++ ++ E + T +L L YLHN G++
Sbjct: 82 VDMYNSYLVGDELWVVMEFLEGGALTDIV-THTRMNEEQIATVCLSVLRALSYLHNQGVI 140
Query: 194 HRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYS 253
HRDIK +IL+ + G IKL+DFG QV++ V KS+ GTPYWMAPEVI + +
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSK--EVPKRKSLVGTPYWMAPEVISRLPYGTE 198
Query: 254 ADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENL---SVKAKDFLLKC 310
DIWS+G VIEM G+PP+ + + A+ I + PP ++ S + FL
Sbjct: 199 VDIWSLGIMVIEMIDGEPPYFNE-PPLQAMRRI--RDNLPPRVKDSHKVSSVLRGFLDLM 255
Query: 311 LEKEPDLRPTASELLKHPFV 330
L +EP R TA ELL+HPF+
Sbjct: 256 LVREPSQRATAQELLQHPFL 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 7e-37
Identities = 92/270 (34%), Positives = 153/270 (56%), Gaps = 17/270 (6%)
Query: 72 ELIGCGAFGRVYMGMNL---DSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL 128
+++G GA+G+V++ + DSG+L A+K VL A K K +H + E ++L+ +
Sbjct: 6 KVLGTGAYGKVFLVRKVSGHDSGKLYAMK-VLKKATIVQKAKTTEHTRT---ERQVLEHI 61
Query: 129 SH-PNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYL 187
P +V + + L+++L+++ GG + + L + F E ++ Y+ +++L LE+L
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHL 121
Query: 188 HNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIR- 246
H GI++RDIK NIL+D+ G + L DFG SK+ E V A S GT +MAP+++R
Sbjct: 122 HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE-DEVERAYSFCGTIEYMAPDIVRG 180
Query: 247 -QTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVA-ALFHIGTTKSHPPIPENLSVKAK 304
GH + D WS+G + E+ TG P++ ++ + A KS PP P+ +S AK
Sbjct: 181 GDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAK 240
Query: 305 DFLLKCLEKEPDLR----PT-ASELLKHPF 329
D + + L K+P R P+ A E+ KHPF
Sbjct: 241 DIIQRLLMKDPKKRLGCGPSDADEIKKHPF 270
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 8e-37
Identities = 95/286 (33%), Positives = 135/286 (47%), Gaps = 52/286 (18%)
Query: 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH- 130
IG GAFG V ++ SG ++AVK++ + EK Q K L ++ ++ S
Sbjct: 10 GEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD----EKEQ---KRLLMDLDVVMRSSDC 62
Query: 131 PNIVRYLGTVREEESLNILLEFVPGGSISSLLGKF---------GPFPEAVMRTYTKQLL 181
P IV++ G + E I +E + IS L KF PE ++ +
Sbjct: 63 PYIVKFYGALFREGDCWICMELM---DIS--LDKFYKYVYEVLKSVIPEEILGKIAVATV 117
Query: 182 LGLEYLHN-HGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKG--TPY 238
L YL I+HRD+K +NIL+D G IKL DFG S Q+ + S AK+ PY
Sbjct: 118 KALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD----SIAKTRDAGCRPY 173
Query: 239 WMAPEVI---RQTGHSYSADIWSVGCTVIEMATGKPPWS------QQYQEVAALFHIGTT 289
MAPE I + G+ +D+WS+G T+ E+ATGK P+ Q +V
Sbjct: 174 -MAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQV--------V 224
Query: 290 KSHPPIPEN-----LSVKAKDFLLKCLEKEPDLRPTASELLKHPFV 330
K PPI N S +F+ CL K+ RP ELL+HPF+
Sbjct: 225 KGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFI 270
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 1e-36
Identities = 82/265 (30%), Positives = 135/265 (50%), Gaps = 21/265 (7%)
Query: 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHP 131
E++G G G VY +L + +LAVK + + + K++ E+++L P
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQ-------KQIMSELEILYKCDSP 59
Query: 132 NIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHG 191
I+ + G E ++I EF+ GGS L + PE V+ ++ GL YL +
Sbjct: 60 YIIGFYGAFFVENRISICTEFMDGGS----LDVYRKIPEHVLGRIAVAVVKGLTYLWSLK 115
Query: 192 IMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHS 251
I+HRD+K +N+LV+ +G +KL DFG S Q+ S AK+ GT +MAPE I +
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN----SIAKTYVGTNAYMAPERISGEQYG 171
Query: 252 YSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIG-----TTKSHPPIPENL-SVKAKD 305
+D+WS+G + +E+A G+ P+ Q + +L + + P +P S K
Sbjct: 172 IHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVH 231
Query: 306 FLLKCLEKEPDLRPTASELLKHPFV 330
F+ +C+ K+P RP L+ HPF+
Sbjct: 232 FITQCMRKQPKERPAPENLMDHPFI 256
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 3e-35
Identities = 84/297 (28%), Positives = 140/297 (47%), Gaps = 47/297 (15%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQD-HIKELE-EEVKL 124
++ K IG G++G V+ N ++G+++A+K+ + E D IK++ E+++
Sbjct: 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFV--------ESEDDPVIKKIALREIRM 53
Query: 125 LKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGL 184
LK L HPN+V + R + L+++ E+ ++ L PE +++ Q L +
Sbjct: 54 LKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAV 113
Query: 185 EYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMK--GTPYWMAP 242
+ H H +HRD+K NIL+ +G IKL DFG A + T G T ++ AP
Sbjct: 114 NFCHKHNCIHRDVKPENILITKQGQIKLCDFG----FARILTGPGDDYTDYVATRWYRAP 169
Query: 243 EVI-RQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKS---------- 291
E++ T + D+W++GC E+ TG+P W + +V L+ I T
Sbjct: 170 ELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGK-SDVDQLYLIRKTLGDLIPRHQQIF 228
Query: 292 ---------HPPIPE----------NLSVKAKDFLLKCLEKEPDLRPTASELLKHPF 329
P PE N+S A FL CL+ +P R + ELL+HP+
Sbjct: 229 STNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 3e-35
Identities = 91/315 (28%), Positives = 134/315 (42%), Gaps = 65/315 (20%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLK 126
+ +G G FG VY + +G ++A+K++L+ EK I L E +K+LK
Sbjct: 9 DYEILGKLGEGTFGEVYKARQIKTGRVVALKKILM-----HNEKDGFPITALRE-IKILK 62
Query: 127 DLSHPNIVRYLGTV--REEESLNILLEF---VP--GGSISSLLGKFGP---FPEAVMRTY 176
L HPN+V + R ++S P +S LL P E+ ++ Y
Sbjct: 63 KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLEN--PSVKLTESQIKCY 120
Query: 177 TKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFG-------ASKQVAELATVSG 229
QLL G+ YLH + I+HRDIK ANIL+DN+G +K+ADFG
Sbjct: 121 MLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGT 180
Query: 230 AK--SMKGTPYWMAPEVI----RQTGHSYSADIWSVGCTVIEMATGKPPW-----SQQYQ 278
K ++ T ++ PE++ R T + DIW +GC EM T +P Q
Sbjct: 181 RKYTNLVVTRWYRPPELLLGERRYTT---AVDIWGIGCVFAEMFTRRPILQGKSDIDQLH 237
Query: 279 EVAALFHIGT--------------------TKSHPPIPENLSVK----AKDFLLKCLEKE 314
+ L GT ++P E K D L K L +
Sbjct: 238 LIFKL--CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLD 295
Query: 315 PDLRPTASELLKHPF 329
P R TAS+ L+HP+
Sbjct: 296 PYKRLTASDALEHPY 310
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 7e-35
Identities = 90/310 (29%), Positives = 143/310 (46%), Gaps = 56/310 (18%)
Query: 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHP 131
++IG GAFG V + D+G + A+K L + KE+ H++ E +L + +P
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMK-KLRKSEMLEKEQVA-HVRA---ERDILAEADNP 61
Query: 132 NIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHG 191
+V+ + ++E L +++E++PGG + +LL K F E R Y + +L ++ +H G
Sbjct: 62 WVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG 121
Query: 192 IMHRDIKGANILVDNKGCIKLADFGASK---------------QVAELATVSG------- 229
+HRDIK N+L+D KG IKL+DFG +
Sbjct: 122 YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSS 181
Query: 230 --------------AKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPW-- 273
A S GTP ++APEV QTG++ D WS+G + EM G PP+
Sbjct: 182 KRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCS 241
Query: 274 ---SQQYQEVAALFHIGTTKSHPPIPE--NLSVKAKDFLLK-CLEKEPDL-RPTASELLK 326
+ Y+++ K P+ LS +AKD + + C E E L +E+
Sbjct: 242 DNPQETYRKII------NWKETLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGVNEIKS 295
Query: 327 HPFVTGDDED 336
HPF G D +
Sbjct: 296 HPFFKGVDWE 305
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 9e-35
Identities = 81/264 (30%), Positives = 133/264 (50%), Gaps = 18/264 (6%)
Query: 74 IGCGAFGRVYMGMN--LDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHP 131
+G G+FG VY+ + + E L V + + E Q + E +LL L HP
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQ-----EAQLLSKLDHP 62
Query: 132 NIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGP----FPEAVMRTYTKQLLLGLEYL 187
IV++ + E ++ I+ E+ G + L + E + + QLLLG+ Y+
Sbjct: 63 AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYM 122
Query: 188 HNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQ 247
H I+HRD+K NI + N +K+ DFG S+ + + + A + GTPY+M+PE ++
Sbjct: 123 HQRRILHRDLKAKNIFLKNN-LLKIGDFGVSRLL--MGSCDLATTFTGTPYYMSPEALKH 179
Query: 248 TGHSYSADIWSVGCTVIEMATGKPPW-SQQYQEVAALFHIGTTKSHPPIPENLSVKAKDF 306
G+ +DIWS+GC + EM + Q + V G T P +PE S +
Sbjct: 180 QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPT---PSLPETYSRQLNSI 236
Query: 307 LLKCLEKEPDLRPTASELLKHPFV 330
+ L K+P LRP+A+E+L++PF+
Sbjct: 237 MQSMLNKDPSLRPSAAEILRNPFI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 9e-35
Identities = 88/275 (32%), Positives = 147/275 (53%), Gaps = 17/275 (6%)
Query: 73 LIGCGAFGRVYMGMNL---DSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS 129
++G G +G+V+ + D+G++ A+K VL A +K H K E +L+ +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMK-VLKKATIVRNQKDTAHTKA---ERNILEAVK 58
Query: 130 HPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHN 189
HP IV + + L ++LE++ GG + L + G F E Y ++ L LE+LH
Sbjct: 59 HPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQ 118
Query: 190 HGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTG 249
GI++RD+K NIL+D +G +KL DFG K+ TV+ + GT +MAPE++ ++G
Sbjct: 119 QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVT--HTFCGTIEYMAPEILMRSG 176
Query: 250 HSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKDFLLK 309
H + D WS+G + +M TG PP++ + ++ + I K +P L+ +A+D L K
Sbjct: 177 HGKAVDWWSLGALMYDMLTGAPPFTAENRK-KTIDKI--LKGKLNLPPYLTPEARDLLKK 233
Query: 310 CLEKEPDLR-----PTASELLKHPFVTGDDEDPVL 339
L++ P R A+E+ HPF + D +L
Sbjct: 234 LLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDLL 268
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 1e-34
Identities = 88/285 (30%), Positives = 140/285 (49%), Gaps = 51/285 (17%)
Query: 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL--- 128
E +G GA+G V ++ +G ++AVK+ I A S+E+ + LL DL
Sbjct: 7 EELGRGAYGVVDKMRHVPTGTIMAVKR--IRATVNSQEQKR-----------LLMDLDIS 53
Query: 129 ---SH-PNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGP--------FPEAVMRTY 176
P V + G + E + I +E + + L KF PE ++
Sbjct: 54 MRSVDCPYTVTFYGALFREGDVWICMEV-----MDTSLDKFYKKVYDKGLTIPEDILGKI 108
Query: 177 TKQLLLGLEYLH-NHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMK- 234
++ LEYLH ++HRD+K +N+L++ G +KL DFG S + + S AK++
Sbjct: 109 AVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD----SVAKTIDA 164
Query: 235 GTPYWMAPEVI----RQTGHSYSADIWSVGCTVIEMATGKPP---WSQQYQEVAALFHIG 287
G +MAPE I Q G+ +D+WS+G T+IE+ATG+ P W +Q++ +
Sbjct: 165 GCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE-- 222
Query: 288 TTKSHPPIPEN-LSVKAKDFLLKCLEKEPDLRPTASELLKHPFVT 331
+ P +P S + +DF+ KCL+K RP ELL+HPF
Sbjct: 223 --EPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFE 265
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 1e-34
Identities = 89/291 (30%), Positives = 138/291 (47%), Gaps = 41/291 (14%)
Query: 70 KGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELE-EEVKLLKDL 128
K E IG G +G VY G N +G+++A+K++ + E ++ + E+ LLK+L
Sbjct: 4 KIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRL-------ESEEEGVPSTAIREISLLKEL 56
Query: 129 SHPNIVRYLGTVREEESLNILLEFVPGGSISSL--LGKFGPFPEAVMRTYTKQLLLGLEY 186
HPNIV + +E L ++ EF+ L L K ++++Y Q+L G+ +
Sbjct: 57 QHPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILF 116
Query: 187 LHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIR 246
H+ ++HRD+K N+L+DNKG IKLADFG ++ V + + T ++ APEV+
Sbjct: 117 CHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV--TLWYRAPEVLL 174
Query: 247 -QTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHP---------PIP 296
+S DIWS+G EMAT KP + E+ LF I P +P
Sbjct: 175 GSPRYSTPVDIWSIGTIFAEMATKKPLF-HGDSEIDQLFRIFRILGTPTEDVWPGVTSLP 233
Query: 297 E------------------NLSVKAKDFLLKCLEKEPDLRPTASELLKHPF 329
+ NL D L K L +P R +A + L HP+
Sbjct: 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPY 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 2e-34
Identities = 80/264 (30%), Positives = 135/264 (51%), Gaps = 27/264 (10%)
Query: 72 ELIGCGAFGRVYMGMNLDSGE-LLAVKQVLIA-ANFASKEKAQD-HIKELEEEVKLLKD- 127
E +G GAFG VY ++G+ LLA+K++ + F ++ +D I ++ EV ++K+
Sbjct: 6 EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65
Query: 128 LSHPNIVRYLGTVREEESLNILLEFVPGGSI----SSLLGKFGPFPEAVMRTYTKQLLLG 183
L HPNIVRY T E + L I+++ + G + +SL K F E + Q++L
Sbjct: 66 LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA 125
Query: 184 LEYLHNHG-IMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAP 242
L YLH I+HRD+ NI++ + + DFG +KQ + + S+ GT + P
Sbjct: 126 LRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKL---TSVVGTILYSCP 182
Query: 243 EVIRQTGHSYSADIWSVGCTVIEMATGKPPW------SQQYQEVAALFHIGTTKSHPPIP 296
E+++ + AD+W+ GC + +M T +PP+ S + V A++ P+P
Sbjct: 183 EIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYE--------PLP 234
Query: 297 ENL-SVKAKDFLLKCLEKEPDLRP 319
E + S D + CL + + RP
Sbjct: 235 EGMYSEDVTDVITSCLTPDAEARP 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 4e-34
Identities = 77/268 (28%), Positives = 134/268 (50%), Gaps = 26/268 (9%)
Query: 73 LIGCGAFGRVYMGMNLDSGELLAVK----QVLIAANFASKEKAQDHIKELEEEVKLLKDL 128
++G G+FG+V + + EL AVK V++ + + + L +
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGK------- 54
Query: 129 SHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLH 188
HP + + + ++ L ++E+V GG + + + G F E R Y +++LGL++LH
Sbjct: 55 -HPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLH 113
Query: 189 NHGIMHRDIKGANILVDNKGCIKLADFGASKQ-VAELATVSGAKSMKGTPYWMAPEVIRQ 247
GI++RD+K N+L+D++G IK+ADFG K+ + T S + GTP ++APE++
Sbjct: 114 ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTS---TFCGTPDYIAPEILSY 170
Query: 248 TGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPP-IPENLSVKAKDF 306
+ + D W++G + EM G+ P+ ++ LF + P LS +AK
Sbjct: 171 QPYGPAVDWWALGVLLYEMLAGQSPFEGDDED--ELFQ--SILEDEVRYPRWLSKEAKSI 226
Query: 307 LLKCLEKEPDLR----PTA-SELLKHPF 329
L L K P+ R PT ++ HPF
Sbjct: 227 LKSFLTKNPEKRLGCLPTGEQDIKGHPF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 7e-34
Identities = 75/272 (27%), Positives = 133/272 (48%), Gaps = 28/272 (10%)
Query: 74 IGCGAFGRVYMG----MNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS 129
+G G FG+V + + ++GE +AVK + + + H + E E+++L+ L
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSL-------NHSGEEQHRSDFEREIEILRTLD 64
Query: 130 HPNIVRYLGTVRE--EESLNILLEFVPGGSISSLLGKFGP-FPEAVMRTYTKQLLLGLEY 186
H NIV+Y G + SL +++E++P GS+ L + + ++ Q+ G++Y
Sbjct: 65 HENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDY 124
Query: 187 LHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTP-YWMAPEVI 245
L + +HRD+ NILV+++ +K++DFG +K + E K +P +W APE +
Sbjct: 125 LGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECL 184
Query: 246 RQTGHSYSADIWSVGCTVIEMAT-GKPPWS---------QQYQEVAALFH-IGTTKSHP- 293
R + S ++D+WS G T+ E+ T G P S Q + + K
Sbjct: 185 RTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGER 244
Query: 294 -PIPENLSVKAKDFLLKCLEKEPDLRPTASEL 324
P P + + D + C E EP RP+ ++L
Sbjct: 245 LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 1e-33
Identities = 78/262 (29%), Positives = 140/262 (53%), Gaps = 17/262 (6%)
Query: 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNI 133
+G G++G V + + G+ +K+ L N + +E+ K E+E +LL L HPNI
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKK-LNLRNASRRER-----KAAEQEAQLLSQLKHPNI 61
Query: 134 VRYLGTVREEES-LNILLEFVPGGSISSLL----GKFGPFPEAVMRTYTKQLLLGLEYLH 188
V Y + E+ L I++ F GG + L GK PE + + Q+ + L+YLH
Sbjct: 62 VAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKL--LPENQVVEWFVQIAMALQYLH 119
Query: 189 NHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQT 248
I+HRD+K N+ + IK+ D G ++ + + A ++ GTPY+M+PE+
Sbjct: 120 EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDM--ASTLIGTPYYMSPELFSNK 177
Query: 249 GHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKDFLL 308
++Y +D+W++GC V EMAT K ++ +++ +L + PP+P++ S + + +
Sbjct: 178 PYNYKSDVWALGCCVYEMATLKHAFNA--KDMNSLVYRIIEGKLPPMPKDYSPELGELIA 235
Query: 309 KCLEKEPDLRPTASELLKHPFV 330
L K P+ RP+ +L+ P++
Sbjct: 236 TMLSKRPEKRPSVKSILRQPYI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 1e-33
Identities = 77/264 (29%), Positives = 138/264 (52%), Gaps = 17/264 (6%)
Query: 72 ELIGCGAFGRVYMGMNLDSGELLAVKQV-LIAANFASKEKAQDHIKELEEEVKLLKDLSH 130
+ IG G+FG++Y+ E +K++ L KE ++ +EV LL + H
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASK-------KEVILLAKMKH 58
Query: 131 PNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGP--FPEAVMRTYTKQLLLGLEYLH 188
PNIV + + +E L I++E+ GG + + + F E + ++ Q+ LGL+++H
Sbjct: 59 PNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH 118
Query: 189 NHGIMHRDIKGANILVDNKGCI-KLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQ 247
+ I+HRDIK NI + G + KL DFG ++Q+ + ++ A + GTPY+++PE+ +
Sbjct: 119 DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND--SMELAYTCVGTPYYLSPEICQN 176
Query: 248 TGHSYSADIWSVGCTVIEMATGKPPW-SQQYQEVAALFHIGTTKSHPPIPENLSVKAKDF 306
++ DIWS+GC + E+ T K P+ ++ + I P P N S +
Sbjct: 177 RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQL--VLKICQGYFAPISP-NFSRDLRSL 233
Query: 307 LLKCLEKEPDLRPTASELLKHPFV 330
+ + + P RP+ + +LK PF+
Sbjct: 234 ISQLFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 93/313 (29%), Positives = 140/313 (44%), Gaps = 73/313 (23%)
Query: 68 WRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEE------ 121
+ K E IG G +G+VY + ++G+L+A+K+ + E++EE
Sbjct: 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRL---------------EMDEEGIPPTA 47
Query: 122 ---VKLLKDLSH-PNIVRYLGTVREEE-----SLNILLEFVPGGSISSLLGKF------- 165
+ LL+ LS IVR L EE SL ++ E+ + S L KF
Sbjct: 48 LREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEY-----LDSDLKKFMDSNGRG 102
Query: 166 --GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVD-NKGCIKLADFGASKQVA 222
P P ++++ QLL G+ + H HG+MHRD+K N+LVD KG +K+AD G + A
Sbjct: 103 PGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR--A 160
Query: 223 ELATVSGAKSMKGTPYWMAPEVIRQTGH-SYSADIWSVGCTVIEMATGKP--PWSQQYQE 279
V T ++ APEV+ + H S DIWSVGC EM+ +P P + Q+
Sbjct: 161 FSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ 220
Query: 280 VAALFH-IGTTKSH-----------------PPIP-----ENLSVKAKDFLLKCLEKEPD 316
+ +F +GT P +LS + D L K L +P
Sbjct: 221 LLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPA 280
Query: 317 LRPTASELLKHPF 329
R +A L HP+
Sbjct: 281 KRISAKAALTHPY 293
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 3e-33
Identities = 90/296 (30%), Positives = 142/296 (47%), Gaps = 48/296 (16%)
Query: 68 WRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKD 127
++K E IG G +G VY N +GE++A+K+ I + ++ I+E + LLK+
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKK--IRLDTETEGVPSTAIRE----ISLLKE 55
Query: 128 LSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKF------GPFPEAVMRTYTKQLL 181
L+HPNIV+ L + E L ++ EF + L KF P ++++Y QLL
Sbjct: 56 LNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASPLSGIPLPLIKSYLFQLL 110
Query: 182 LGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMA 241
GL + H+H ++HRD+K N+L++ +G IKLADFG ++ A V T ++ A
Sbjct: 111 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEVVTLWYRA 168
Query: 242 PEVIRQTG-HSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHP------- 293
PE++ +S + DIWS+GC EM T + + E+ LF I T P
Sbjct: 169 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD-SEIDQLFRIFRTLGTPDEVVWPG 227
Query: 294 --PIPE------------------NLSVKAKDFLLKCLEKEPDLRPTASELLKHPF 329
+P+ L +D L + L +P+ R +A L HPF
Sbjct: 228 VTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 4e-33
Identities = 85/287 (29%), Positives = 143/287 (49%), Gaps = 38/287 (13%)
Query: 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHP 131
E +G G + VY G N +GE++A+K++ + A + A I+E + L+K+L H
Sbjct: 6 EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTA---IRE----ISLMKELKHE 58
Query: 132 NIVRYLGTVREEESLNILLEFVPGG--SISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHN 189
NIVR + E L ++ E++ G G ++++T QLL G+ + H
Sbjct: 59 NIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118
Query: 190 HGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQT- 248
+ ++HRD+K N+L++ +G +KLADFG ++ V+ + T ++ AP+V+ +
Sbjct: 119 NRVLHRDLKPQNLLINKRGELKLADFGLARAFG--IPVNTFSNEVVTLWYRAPDVLLGSR 176
Query: 249 GHSYSADIWSVGCTVIEMATGKP--PWSQQYQEVAALFHI-GTTKSH------------- 292
+S S DIWSVGC + EM TG+P P + ++ +F I GT
Sbjct: 177 TYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP 236
Query: 293 --PPIP----ENLSVKAK----DFLLKCLEKEPDLRPTASELLKHPF 329
P P + L A D L + L+ P+LR +A + L+HP+
Sbjct: 237 TFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 6e-33
Identities = 73/257 (28%), Positives = 137/257 (53%), Gaps = 17/257 (6%)
Query: 73 LIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPN 132
++G G+FGR + +++S + A+K++ + + ++ E ++ +E LL + HPN
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSR-------KEAVLLAKMKHPN 59
Query: 133 IVRYLGTVREEESLNILLEFVPGG----SISSLLGKFGPFPEAVMRTYTKQLLLGLEYLH 188
IV + + + L I++E+ GG I GK FPE + + Q+ LG++++H
Sbjct: 60 IVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKL--FPEDTILQWFVQMCLGVQHIH 117
Query: 189 NHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQT 248
++HRDIK NI + G +KL DFG+++ + + A + GTPY++ PE+
Sbjct: 118 EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS--PGAYACTYVGTPYYVPPEIWENM 175
Query: 249 GHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKDFLL 308
++ +DIWS+GC + E+ T K P+ Q L S+ P+P + S + + +
Sbjct: 176 PYNNKSDIWSLGCILYELCTLKHPF--QANSWKNLILKVCQGSYKPLPSHYSYELRSLIK 233
Query: 309 KCLEKEPDLRPTASELL 325
+ ++ P RP+A+ +L
Sbjct: 234 QMFKRNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 1e-32
Identities = 90/309 (29%), Positives = 138/309 (44%), Gaps = 74/309 (23%)
Query: 68 WRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELE-------E 120
++K E IG G +G VY + +GE++A+K++ + E E
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLET-------------EDEGVPSTAIR 47
Query: 121 EVKLLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKF------GPFPEAVMR 174
E+ LLK+L+HPNIVR L V E L ++ EF+ L K+ +++
Sbjct: 48 EISLLKELNHPNIVRLLDVVHSENKLYLVFEFL-----DLDLKKYMDSSPLTGLDPPLIK 102
Query: 175 TYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMK 234
+Y QLL G+ Y H+H ++HRD+K N+L+D +G +KLADFG LA G ++
Sbjct: 103 SYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFG-------LARAFGV-PVR 154
Query: 235 G------TPYWMAPEVIRQTGH-SYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHI- 286
T ++ APE++ + S DIWS+GC EM +P + E+ LF I
Sbjct: 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGD-SEIDQLFRIF 213
Query: 287 ---GT-----------------------TKSHPPIPENLSVKAKDFLLKCLEKEPDLRPT 320
GT + + NL D L K L +P R +
Sbjct: 214 RTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRIS 273
Query: 321 ASELLKHPF 329
A L+HP+
Sbjct: 274 AKAALQHPY 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 1e-32
Identities = 75/264 (28%), Positives = 135/264 (51%), Gaps = 16/264 (6%)
Query: 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNI 133
+G G FG V +G++ A K++ + +K + L E+ K+L+ +S I
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKL----DKKRLKKRKGEQMALNEK-KILEKVSSRFI 55
Query: 134 VRYLGTVREEESLNILLEFVPGGSISSLLGKFGP--FPEAVMRTYTKQLLLGLEYLHNHG 191
V ++ L +++ + GG + + G FPEA Y Q++ GLE+LH
Sbjct: 56 VSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR 115
Query: 192 IMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHS 251
I++RD+K N+L+D+ G ++++D G + ++ + G GTP +MAPEV++ +
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGR---AGTPGYMAPEVLQGEVYD 172
Query: 252 YSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHP-PIPENLSVKAKDFLLKC 310
+S D +++GCT+ EM G+ P+ Q+ ++V T P+ S +AKD
Sbjct: 173 FSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEAL 232
Query: 311 LEKEPDLR-----PTASELLKHPF 329
L+K+P+ R +A E+ +HP
Sbjct: 233 LQKDPEKRLGCRGGSADEVREHPL 256
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 2e-32
Identities = 84/293 (28%), Positives = 136/293 (46%), Gaps = 55/293 (18%)
Query: 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEE-----EVKLLKDL 128
IG G F V + +G+ A+K + H K LE+ E++ L+ L
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIK------------CMKKHFKSLEQVNNLREIQALRRL 54
Query: 129 S-HPNIVRYLGTVREEE--SLNILLEFVPGGSISSLL-GKFGPFPEAVMRTYTKQLLLGL 184
S HPNI+R + + + + L ++ E + ++ L+ G+ P PE +++Y QLL L
Sbjct: 55 SPHPNILRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSL 113
Query: 185 EYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEV 244
+++H +GI HRDIK NIL+ + +KLADFG+ + + + S T ++ APE
Sbjct: 114 DHMHRNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYIS---TRWYRAPEC 169
Query: 245 IRQTG-HSYSADIWSVGCTVIEMATGKP--PWSQQY--------------QEVAALFHIG 287
+ G + DIW+VGC E+ + P P + + EV F
Sbjct: 170 LLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKS 229
Query: 288 TTKSH--PP---------IPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPF 329
++ P +P N S + D L K L +PD R TA + L+HP+
Sbjct: 230 RHMNYNFPSKKGTGLRKLLP-NASAEGLDLLKKLLAYDPDERITAKQALRHPY 281
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 2e-32
Identities = 82/277 (29%), Positives = 132/277 (47%), Gaps = 28/277 (10%)
Query: 69 RKGELIGCGAFGRV----YMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKL 124
+K ++G G FG+V Y N +GE++AVK + +E Q + ++E+ +
Sbjct: 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTL-------KRECGQQNTSGWKKEINI 59
Query: 125 LKDLSHPNIVRYLGTVRE--EESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLL 182
LK L H NIV+Y G E + L +++E+VP GS+ L K A + + +Q+
Sbjct: 60 LKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK-LNLAQLLLFAQQICE 118
Query: 183 GLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTP-YWMA 241
G+ YLH+ +HRD+ N+L+DN +K+ DFG +K V E + +P +W A
Sbjct: 119 GMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA 178
Query: 242 PEVIRQTGHSYSADIWSVGCTVIEMATG-----KPPW--------SQQYQEVAALFHIGT 288
E +++ SY++D+WS G T+ E+ T PP Q V L +
Sbjct: 179 VECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE 238
Query: 289 TKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELL 325
P P+N + + C E E RPT L+
Sbjct: 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLI 275
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 5e-32
Identities = 87/295 (29%), Positives = 142/295 (48%), Gaps = 60/295 (20%)
Query: 77 GAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRY 136
G +G VY + +GE++A+K++ + KEK I L E + +L L HPNIV
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKLKM-----EKEKEGFPITSLRE-INILLKLQHPNIV-- 67
Query: 137 LGTVRE------EESLNILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLLGLEYLHN 189
TV+E + + +++E+V + SL+ PF ++ ++ QLL G+ +LH+
Sbjct: 68 --TVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHD 124
Query: 190 HGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKG---TPYWMAPEVIR 246
+ I+HRD+K +N+L++N+G +K+ DFG +++ S K T ++ APE++
Sbjct: 125 NWILHRDLKTSNLLLNNRGILKICDFGLAREYG-----SPLKPYTQLVVTLWYRAPELLL 179
Query: 247 QTGHSYSA--DIWSVGCTVIEMATGKPPWSQQYQEVAALFHI----GT------------ 288
YS D+WSVGC E+ T KP + + E+ L I GT
Sbjct: 180 GAKE-YSTAIDMWSVGCIFAELLTKKPLFPGK-SEIDQLNKIFKLLGTPTEKIWPGFSEL 237
Query: 289 ----TKSHPPIPEN----------LSVKAKDFLLKCLEKEPDLRPTASELLKHPF 329
K+ P N LS D L + L +P R +A + LKHP+
Sbjct: 238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY 292
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 90/284 (31%), Positives = 136/284 (47%), Gaps = 33/284 (11%)
Query: 73 LIGCGAFGRVYMGMNLDSGELLAVK----QVLIAANFASKEKAQDHIKELEEEVKLLKDL 128
LI GA+G VY+ + ++ + A+K Q LI N I+++ E +L
Sbjct: 8 LISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRN---------QIQQVFVERDILTFA 58
Query: 129 SHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLH 188
+P +V + + L +++E+V GG ++LL G P + R Y + +L LEYLH
Sbjct: 59 ENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLH 118
Query: 189 NHGIMHRDIKGANILVDNKGCIKLADFGASK-QVAELAT--VSGA----------KSMKG 235
N+GI+HRD+K N+L+ + G IKL DFG SK + L T G K + G
Sbjct: 119 NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCG 178
Query: 236 TPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFH--IGTTKSHP 293
TP ++APEVI + G+ D W++G + E G P+ E LF I P
Sbjct: 179 TPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE--ELFGQVISDDIEWP 236
Query: 294 PIPENLSVKAKDFLLKCLEKEPDLR---PTASELLKHPFVTGDD 334
E L A+D + + L + P R A E+ +H F G D
Sbjct: 237 EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLD 280
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 84/279 (30%), Positives = 141/279 (50%), Gaps = 29/279 (10%)
Query: 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNI 133
IG G+FG+V + + G+ AVK ++ K+K Q HI + E LLK++ HP +
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVK--VLQKKAILKKKEQKHI--MAERNVLLKNVKHPFL 58
Query: 134 VRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIM 193
V + + + L +L++V GG + L + FPE R Y ++ L YLH+ I+
Sbjct: 59 VGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNII 118
Query: 194 HRDIKGANILVDNKGCIKLADFGASKQ-VAELATVSGAKSMKGTPYWMAPEVIRQTGHSY 252
+RD+K NIL+D++G + L DFG K+ + T S + GTP ++APEV+R+ +
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTS---TFCGTPEYLAPEVLRKQPYDR 175
Query: 253 SADIWSVGCTVIEMATGKPPW-----SQQYQEVAALFHIGTTKSHPP--IPENLSVKAKD 305
+ D W +G + EM G PP+ ++ Y + + P + N+SV A+
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNIL----------NKPLRLKPNISVSARH 225
Query: 306 FLLKCLEKEPDLRPTAS----ELLKHPFVTGDDEDPVLH 340
L L+K+ R A E+ H F + + D +++
Sbjct: 226 LLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDDLVN 264
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 84/304 (27%), Positives = 133/304 (43%), Gaps = 66/304 (21%)
Query: 73 LIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHI---KELEEEVKLLKDLS 129
IG GA+G V ++ +G +A+K++ D + K + E+KLL+ L
Sbjct: 7 PIGSGAYGVVCSAVDKRTGRKVAIKKI---------SNVFDDLIDAKRILREIKLLRHLR 57
Query: 130 HPNIVRYLGTVR-----EEESLNILLEFVPGGSISSLLGKF----GPFPEAVMRTYTKQL 180
H NI+ L +R + + I+ E + + L K P + ++ + Q+
Sbjct: 58 HENIIGLLDILRPPSPEDFNDVYIVTELME-----TDLHKVIKSPQPLTDDHIQYFLYQI 112
Query: 181 LLGLEYLHNHGIMHRDIKGANILVDNKGC-IKLADFGASKQVAELATVSGAKSMKGTPY- 238
L GL+YLH+ ++HRD+K +NILV N C +K+ DFG ++ V G T Y
Sbjct: 113 LRGLKYLHSANVIHRDLKPSNILV-NSNCDLKICDFGLARGVDPDEDEKGFL----TEYV 167
Query: 239 ---WM-APEVIRQTGH-SYSADIWSVGCTVIEMATGKP--------------------PW 273
W APE++ + + + DIWSVGC E+ T KP P
Sbjct: 168 VTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPS 227
Query: 274 SQQYQEVA---ALFHIGTTKSHPPIP-----ENLSVKAKDFLLKCLEKEPDLRPTASELL 325
+ + + A ++ + P P S +A D L K L +P R TA E L
Sbjct: 228 EEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEAL 287
Query: 326 KHPF 329
HP+
Sbjct: 288 AHPY 291
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 4e-31
Identities = 88/299 (29%), Positives = 137/299 (45%), Gaps = 43/299 (14%)
Query: 69 RKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL 128
+K +L+G G GRV++ +G+L A+K VL + K +K + E ++L L
Sbjct: 4 KKIKLLGKGDVGRVFLVRLKGTGKLFALK-VLDKKEMIKRNK----VKRVLTEQEILATL 58
Query: 129 SHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGK--FGPFPEAVMRTYTKQLLLGLEY 186
HP + + + E L +++++ PGG + LL + E V R Y ++LL LEY
Sbjct: 59 DHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEY 118
Query: 187 LHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAE----------------------- 223
LH GI++RD+K NIL+ G I L+DF SKQ
Sbjct: 119 LHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPS 178
Query: 224 --LATVSGAKSMK--GTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE 279
+ +S GT ++APEVI GH + D W++G + EM G P+ ++
Sbjct: 179 ETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD 238
Query: 280 VAALFHIGTTKSHPPIPE--NLSVKAKDFLLKCLEKEPDLR----PTASELLKHPFVTG 332
+I K P +S A+D + K L K+P R A+E+ +HPF G
Sbjct: 239 -ETFSNI--LKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRG 294
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 6e-31
Identities = 78/305 (25%), Positives = 136/305 (44%), Gaps = 64/305 (20%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELE-EEVKLL 125
++ K E IG G +G V+ N ++ E++A+K+V + + + + E+ LL
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRL-------DDDDEGVPSSALREICLL 53
Query: 126 KDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKF-----GPFPEAVMRTYTKQL 180
K+L H NIVR + ++ L ++ E+ L K+ G +++++ QL
Sbjct: 54 KELKHKNIVRLYDVLHSDKKLTLVFEYC-----DQDLKKYFDSCNGDIDPEIVKSFMFQL 108
Query: 181 LLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQV--------AELATVSGAKS 232
L GL + H+H ++HRD+K N+L++ G +KLADFG ++ AE+ T+
Sbjct: 109 LKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTL----- 163
Query: 233 MKGTPYWMAPEVI-RQTGHSYSADIWSVGCTVIEMAT-GKP------------------- 271
++ P+V+ +S S D+WS GC E+A G+P
Sbjct: 164 -----WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG 218
Query: 272 -PWSQQYQEVAALFHIGTTKSHPPIPE------NLSVKAKDFLLKCLEKEPDLRPTASEL 324
P + + V+ L +P L+ +D L L P R +A E
Sbjct: 219 TPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEA 278
Query: 325 LKHPF 329
L+HP+
Sbjct: 279 LQHPY 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 8e-31
Identities = 76/305 (24%), Positives = 136/305 (44%), Gaps = 60/305 (19%)
Query: 73 LIGCGAFGR--VYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH 130
LIG V++ + + L+AVK++ + + SKE +K L++E+ + L H
Sbjct: 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDS--CSKED----LKLLQQEIITSRQLQH 58
Query: 131 PNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGP--FPEAVMRTYTKQLLLGLEYLH 188
PNI+ Y+ + + L ++ + GS LL P PE + K +L L+Y+H
Sbjct: 59 PNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIH 118
Query: 189 NHGIMHRDIKGANILVDNKGCIKLADF---------GASKQVAELATVSGAKSMKGTPYW 239
+ G +HR +K ++IL+ G + L+ G ++V S K++ W
Sbjct: 119 SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNL----PW 174
Query: 240 MAPEVIRQTGHSYSA--DIWSVGCTVIEMATGKPPWSQ---------------------- 275
++PEV++Q Y+ DI+SVG T E+A G P+
Sbjct: 175 LSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKS 234
Query: 276 ---QYQEVAALFHIGTTKSHPPIPENLSVKAK--------DFLLKCLEKEPDLRPTASEL 324
Y++ + ++ HP +++ F+ CL+++P+ RP+AS+L
Sbjct: 235 TYPLYEDSMS--QSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQL 292
Query: 325 LKHPF 329
L H F
Sbjct: 293 LNHSF 297
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 9e-31
Identities = 81/274 (29%), Positives = 137/274 (50%), Gaps = 23/274 (8%)
Query: 73 LIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEK--AQDHIKELEEEVKLLKDLSH 130
L+G G FG V + +G++ A+K + K AQ+ + EEE +L +
Sbjct: 8 LVGRGHFGEVQVVREKATGDIYAMKVM-------KKSVLLAQETVSFFEEERDILSISNS 60
Query: 131 PNIVRYLGTVREEESLNILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLLGLEYLHN 189
P I + +++++L +++E+ PGG + SLL ++ F E + + Y +L+L + +H
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ 120
Query: 190 HGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIR--- 246
G +HRDIK N+L+D G IKLADFG++ ++ V+ +K GTP ++APEV+
Sbjct: 121 MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVN-SKLPVGTPDYIAPEVLTTMN 179
Query: 247 ---QTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALF-HIGTTKSHPPIPENLSVK 302
+ + D WS+G EM G+ P+ + A + +I + PE+ V
Sbjct: 180 GDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE--GTSAKTYNNIMNFQRFLKFPEDPKV- 236
Query: 303 AKDF--LLKCLEKEPDLRPTASELLKHPFVTGDD 334
+ DF L++ L R L HPF + D
Sbjct: 237 SSDFLDLIQSLLCGQKERLGYEGLCCHPFFSKID 270
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 98/328 (29%), Positives = 157/328 (47%), Gaps = 45/328 (13%)
Query: 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHP 131
++IG GAFG V + D+G + A+K +L A+ KE+ + + E +L +
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMK-ILRKADMLEKEQ----VAHIRAERDILVEADGA 61
Query: 132 NIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHG 191
+V+ + +++ +L +++EF+PGG + +LL K E + Y + +L ++ +H G
Sbjct: 62 WVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG 121
Query: 192 IMHRDIKGANILVDNKGCIKLADFGA------------------------------SKQV 221
+HRDIK N+L+D KG +KL+DFG SK+
Sbjct: 122 FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRK 181
Query: 222 AELATVSG---AKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPW-SQQY 277
AE + A S GTP ++APEV QTG++ D WS+G + EM G PP+ S+
Sbjct: 182 AETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETP 241
Query: 278 QEV-AALFHIGTTKSHPP-IPENLSVKAKDFLLK-CLEKEPDLRPTASELLK-HPFVTGD 333
QE + + T PP +P +S KAKD +L+ C + E + E +K HPF G
Sbjct: 242 QETYRKVMNWKETLVFPPEVP--ISEKAKDLILRFCTDSENRIGSNGVEEIKSHPFFEGV 299
Query: 334 DEDPVLHASVMKSSEILSPSHVANLESL 361
D + EI S +N +
Sbjct: 300 DWGHIRERPAAIPIEIKSIDDTSNFDEF 327
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 1e-30
Identities = 73/268 (27%), Positives = 136/268 (50%), Gaps = 25/268 (9%)
Query: 72 ELIGCGAFGRVYMGMNLDSGELLAVK----QVLIAANFASKEKAQDHIKELEEEVKLLKD 127
+L+G G FG+V + +G+ A+K +V+IA +D + E ++L++
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIA---------KDEVAHTLTESRVLQN 51
Query: 128 LSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYL 187
HP + + + + L ++E+ GG + L + F E R Y +++ L YL
Sbjct: 52 TRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYL 111
Query: 188 HNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQ 247
H+ +++RD+K N+++D G IK+ DFG K+ ++ + K+ GTP ++APEV+
Sbjct: 112 HSCDVVYRDLKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTFCGTPEYLAPEVLED 169
Query: 248 TGHSYSADIWSVGCTVIEMATGKPP-WSQQYQEVAALFHIGTTKSHPPIPENLSVKAKDF 306
+ + D W +G + EM G+ P ++Q ++++ L + + P LS +AK
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR----FPRTLSPEAKSL 225
Query: 307 LLKCLEKEPDLR-----PTASELLKHPF 329
L L+K+P R A E+++H F
Sbjct: 226 LAGLLKKDPKQRLGGGPEDAKEIMEHRF 253
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 76/209 (36%), Positives = 119/209 (56%), Gaps = 27/209 (12%)
Query: 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNI 133
IG G +G VY + SGE++A+K+V + E+ I L E + LL +L HPNI
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRM-----DNERDGIPISSLRE-ITLLLNLRHPNI 68
Query: 134 VRYLGTV--REEESLNILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLLGLEYLHNH 190
V V + +S+ +++E+ ++SLL PF E+ ++ QLL GL+YLH +
Sbjct: 69 VELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN 127
Query: 191 GIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSG--AKSMKGTP-----YWMAPE 243
I+HRD+K +N+L+ +KGC+K+ADFG LA G AK M TP ++ APE
Sbjct: 128 FIIHRDLKVSNLLLTDKGCLKIADFG-------LARTYGLPAKPM--TPKVVTLWYRAPE 178
Query: 244 VI-RQTGHSYSADIWSVGCTVIEMATGKP 271
++ T ++ + D+W+VGC + E+ KP
Sbjct: 179 LLLGCTTYTTAIDMWAVGCILAELLAHKP 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 88/320 (27%), Positives = 147/320 (45%), Gaps = 67/320 (20%)
Query: 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHP 131
++IG GAFG V + D+G++ A+K +L + F +D + ++ E +L + P
Sbjct: 7 KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFK-----KDQLAHVKAERDVLAESDSP 61
Query: 132 NIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHG 191
+V + ++ + L +++EF+PGG + ++L K+ F E V R Y + +L +E +H G
Sbjct: 62 WVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG 121
Query: 192 IMHRDIKGANILVDNKGCIKLADFGAS------------KQVAELATVSG---------- 229
+HRDIK NIL+D G IKL+DFG S +++ + +
Sbjct: 122 FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAV 181
Query: 230 -----------------------AKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEM 266
A S GTP ++APE+ Q G+ D WS+G + E
Sbjct: 182 DSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFEC 241
Query: 267 ATGKPPWSQQ-----YQEVAALFHIGTTKSHPPIPEN--LSVKAKDFLLKCLEKEPDL-- 317
G PP+ + Y+++ P++ LSV+A+D L++ L +
Sbjct: 242 LIGWPPFCSENSHETYRKIINWRETLY------FPDDIHLSVEAED-LIRRLITNAENRL 294
Query: 318 -RPTASELLKHPFVTGDDED 336
R A E+ HPF G D D
Sbjct: 295 GRGGAHEIKSHPFFRGVDWD 314
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 4e-30
Identities = 83/275 (30%), Positives = 137/275 (49%), Gaps = 17/275 (6%)
Query: 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNI 133
+G G+FGRV + + + V + K+K DH+ E K+L ++HP
Sbjct: 38 LGTGSFGRVILA-TYKNEDFPPVAIKRFEKSKIIKQKQVDHVFS---ERKILNYINHPFC 93
Query: 134 VRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIM 193
V G+ ++E L ++LEFV GG + L + FP V Y Q++L EYL + I+
Sbjct: 94 VNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIV 153
Query: 194 HRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYS 253
+RD+K N+L+D G IK+ DFG +K V + T ++ GTP ++APE++ GH +
Sbjct: 154 YRDLKPENLLLDKDGFIKMTDFGFAK-VVDTRTY----TLCGTPEYIAPEILLNVGHGKA 208
Query: 254 ADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKDFLLKCL-- 311
AD W++G + E+ G PP+ Y L + + P+ L K + K L
Sbjct: 209 ADWWTLGIFIYEILVGCPPF---YANEPLLIYQKILEGIIYFPKFLDNNCKHLMKKLLSH 265
Query: 312 ---EKEPDLRPTASELLKHPFVTGDDEDPVLHASV 343
++ +L+ A + +HP+ D +LH +V
Sbjct: 266 DLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNV 300
|
Length = 340 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 6e-30
Identities = 82/272 (30%), Positives = 142/272 (52%), Gaps = 27/272 (9%)
Query: 72 ELIGCGAFGRVYMGMNLDSGELLAVK----QVLIAANFASKEKAQDHIKELEEEVKLLKD 127
+L+G G FG+V + SG+ A+K +V+IA +D + E ++LK+
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIA---------KDEVAHTLTESRVLKN 51
Query: 128 LSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYL 187
HP + + + ++ L ++E+V GG + L + F E R Y +++ L+YL
Sbjct: 52 TRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYL 111
Query: 188 HNHGIMHRDIKGANILVDNKGCIKLADFGASKQ-VAELATVSGAKSMKGTPYWMAPEVIR 246
H+ I++RD+K N+++D G IK+ DFG K+ + + AT+ K+ GTP ++APEV+
Sbjct: 112 HSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATM---KTFCGTPEYLAPEVLE 168
Query: 247 QTGHSYSADIWSVGCTVIEMATGKPP-WSQQYQEVAALFHIGTTKSHPPIPENLSVKAKD 305
+ + D W +G + EM G+ P ++Q ++++ L + K P LS AK
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIK----FPRTLSADAKS 224
Query: 306 FLLKCLEKEPDLR-----PTASELLKHPFVTG 332
L L K+P+ R A E+++H F TG
Sbjct: 225 LLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTG 256
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 9e-30
Identities = 91/331 (27%), Positives = 159/331 (48%), Gaps = 59/331 (17%)
Query: 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNI 133
+G G G V+ + SG ++A K + + A + ++ E+++L + + P I
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIR-------NQIIRELQVLHECNSPYI 65
Query: 134 VRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYL-HNHGI 192
V + G + ++I +E + GGS+ +L K G PE ++ + ++ GL YL H I
Sbjct: 66 VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKI 125
Query: 193 MHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSY 252
MHRD+K +NILV+++G IKL DFG S Q+ + S A S GT +M+PE ++ T +S
Sbjct: 126 MHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPERLQGTHYSV 181
Query: 253 SADIWSVGCTVIEMATGK----PPWSQQYQEV---------------------------- 280
+DIWS+G +++EMA G+ PP +++ + +
Sbjct: 182 QSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSY 241
Query: 281 -------AALFHIGTTKSHPPIPE----NLSVKAKDFLLKCLEKEPDLRPTASELLKHPF 329
A+F + + P P+ + +DF+ KCL K P R +L+ H F
Sbjct: 242 GPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAF 301
Query: 330 VTGDDEDPVLHA----SVMKSSEILSPSHVA 356
+ + + V A S + ++ +P+H A
Sbjct: 302 IKRSEAEEVDFAGWLCSTIGLNQPSTPTHAA 332
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 81/278 (29%), Positives = 133/278 (47%), Gaps = 40/278 (14%)
Query: 73 LIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKD----- 127
++G G+FG+V + + E A IK L+++V L D
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFA-------------------IKALKKDVVLEDDDVECT 42
Query: 128 ----------LSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYT 177
HP + T + +E L ++E++ GG + + G F EA R Y
Sbjct: 43 MVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYA 102
Query: 178 KQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTP 237
+++ GL++LH GI++RD+K N+L+D G IK+ADFG K+ + A + GTP
Sbjct: 103 AEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKE--NMNGEGKASTFCGTP 160
Query: 238 YWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPE 297
++APE+++ ++ S D WS G + EM G+ P+ + ++ LF P P
Sbjct: 161 DYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED--ELFD-SILNDRPHFPR 217
Query: 298 NLSVKAKDFLLKCLEKEPDLR-PTASELLKHPFVTGDD 334
+S +AKD L K E++P R ++ +HPF G D
Sbjct: 218 WISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGID 255
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 89/270 (32%), Positives = 135/270 (50%), Gaps = 15/270 (5%)
Query: 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNI 133
IG G FG+VY D+ + A+K VL +K++ I E V+ L D S P I
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMK-VLSKKEIVAKKEVAHTIGERNILVRTLLDES-PFI 58
Query: 134 VRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIM 193
V + + + L ++ +++ GG + L K G F E + Y +L+L LE+LH + I+
Sbjct: 59 VGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIV 118
Query: 194 HRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEV-IRQTGHSY 252
+RD+K NIL+D G I L DFG SK A L + GT ++APEV + + G++
Sbjct: 119 YRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTK 176
Query: 253 SADIWSVGCTVIEMATGKPP-WSQQYQEVAALFHIGTTKSHPPIPEN-LSVKAKDFLLKC 310
D WS+G V EM G P +++ Q++ G + P+N LS + + F+
Sbjct: 177 HVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVR----FPKNVLSDEGRQFVKGL 232
Query: 311 LEKEPDLR----PTASELLKHPFVTGDDED 336
L + P R A EL +HPF D D
Sbjct: 233 LNRNPQHRLGAHRDAVELKEHPFFADIDWD 262
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 90/295 (30%), Positives = 131/295 (44%), Gaps = 54/295 (18%)
Query: 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIK-ELEEEVKLLKDLS--- 129
IG GA+G VY + SG +A+K V + N +D + EV LLK L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTN-------EDGLPLSTVREVALLKRLEAFD 60
Query: 130 HPNIVRYL---GTVREEESLNILLEFVP-GGSISSLLGKFGP--FPEAVMRTYTKQLLLG 183
HPNIVR + T R + + L F + + L K P P ++ +Q L G
Sbjct: 61 HPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRG 120
Query: 184 LEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASK----QVAELATVSGAKSMKGTPYW 239
L++LH + I+HRD+K NILV + G +KLADFG ++ Q+A V T ++
Sbjct: 121 LDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV-------TLWY 173
Query: 240 MAPEVIRQTGHSYSADIWSVGCTVIEM---------------------ATGKPPWSQQYQ 278
APEV+ Q+ ++ D+WSVGC EM G PP +
Sbjct: 174 RAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 233
Query: 279 EVAALFHIGTTKSHPPI----PENLSVKAKDFLLKCLEKEPDLRPTASELLKHPF 329
+V + + P+ PE + LL+ L P R +A L+HPF
Sbjct: 234 DVTLPRGAFSPRGPRPVQSVVPE-IEESGAQLLLEMLTFNPHKRISAFRALQHPF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 1e-29
Identities = 98/328 (29%), Positives = 159/328 (48%), Gaps = 45/328 (13%)
Query: 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHP 131
++IG GAFG V + D+G + A+K +L A+ KE+ + + E +L +
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHVYAMK-ILRKADMLEKEQ----VGHIRAERDILVEADSL 61
Query: 132 NIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHG 191
+V+ + +++ +L +++EF+PGG + +LL K E + Y + +L ++ +H G
Sbjct: 62 WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG 121
Query: 192 IMHRDIKGANILVDNKGCIKLADFGA------------------------------SKQV 221
+HRDIK N+L+D+KG +KL+DFG SK+
Sbjct: 122 FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRK 181
Query: 222 AELATVSG---AKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPW-SQQY 277
AE + A S GTP ++APEV QTG++ D WS+G + EM G PP+ S+
Sbjct: 182 AETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETP 241
Query: 278 QEV-AALFHIGTTKSHPP-IPENLSVKAKDFLLK-CLEKEPDLRPTASELLK-HPFVTGD 333
QE + + T PP +P +S KAKD +L+ C E E + E +K +PF G
Sbjct: 242 QETYKKVMNWKETLIFPPEVP--ISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEGV 299
Query: 334 DEDPVLHASVMKSSEILSPSHVANLESL 361
D + + EI S +N +
Sbjct: 300 DWEHIRERPAAIPIEIKSIDDTSNFDEF 327
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 2e-29
Identities = 81/269 (30%), Positives = 127/269 (47%), Gaps = 36/269 (13%)
Query: 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHP 131
E IG G FG VY G+ L +AVK S K L+E ++LK HP
Sbjct: 1 EKIGKGNFGDVYKGV-LKGNTEVAVKTC------RSTLPPDLKRKFLQEA-EILKQYDHP 52
Query: 132 NIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLL-------LGL 184
NIV+ +G +++ + I++E VPGGS+ + L K + + K+LL G+
Sbjct: 53 NIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRK----KKNRLT--VKKLLQMSLDAAAGM 106
Query: 185 EYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAE-LATVSGAKSMKGTPY-WMAP 242
EYL + +HRD+ N LV +K++DFG S++ + TVS +K P W AP
Sbjct: 107 EYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG--LKQIPIKWTAP 164
Query: 243 EVIRQTGHSYSADIWSVGCTVIEMATGK----PPWS-QQYQEVAALFHIGTTKSHPPIPE 297
E + ++ +D+WS G + E + P S QQ +E I + P P+
Sbjct: 165 EALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRE-----RIESGYRMPA-PQ 218
Query: 298 NLSVKAKDFLLKCLEKEPDLRPTASELLK 326
+ +L+C +P+ RP+ SE+
Sbjct: 219 LCPEEIYRLMLQCWAYDPENRPSFSEIYN 247
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 3e-29
Identities = 79/259 (30%), Positives = 127/259 (49%), Gaps = 13/259 (5%)
Query: 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNI 133
IG G+FG+V D+ + A+K + A+ S+ + + E +L ++ P I
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIR-KAHIVSRSEVTHTLAER----TVLAQVNCPFI 55
Query: 134 VRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIM 193
V + + E L ++L F+ GG + L + G F + R YT +LL LE LH ++
Sbjct: 56 VPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVI 115
Query: 194 HRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYS 253
+RD+K NIL+D +G I L DFG K + + GTP ++APE++ G++ +
Sbjct: 116 YRDLKPENILLDYQGHIALCDFGLCK--LNMKDDDKTNTFCGTPEYLAPELLLGHGYTKA 173
Query: 254 ADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEK 313
D W++G + EM TG PP+ Y E + + P+ AKD L+ L +
Sbjct: 174 VDWWTLGVLLYEMLTGLPPF---YDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSR 230
Query: 314 EPDLR---PTASELLKHPF 329
+P R A E+ HPF
Sbjct: 231 DPTRRLGYNGAQEIKNHPF 249
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 5e-29
Identities = 89/304 (29%), Positives = 138/304 (45%), Gaps = 63/304 (20%)
Query: 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNI 133
IG G +G+VY + D+GEL+A+K+V + EK I + E +K+L+ L+H NI
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVRL-----DNEKEGFPITAIRE-IKILRQLNHRNI 68
Query: 134 VRYLGTV----------REEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLG 183
V V +++ + ++ E++ + L F E ++++ KQLL G
Sbjct: 69 VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEG 128
Query: 184 LEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPY----- 238
L Y H +HRDIK +NIL++NKG IKLADFG LA + ++ + PY
Sbjct: 129 LNYCHKKNFLHRDIKCSNILLNNKGQIKLADFG-------LARLYNSEESR--PYTNKVI 179
Query: 239 --WMAPE--VIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHP- 293
W P ++ + + + D+WS GC + E+ T KP + Q QE+A L I P
Sbjct: 180 TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIF-QANQELAQLELISRLCGSPC 238
Query: 294 --------PIP-------------------ENLSVKAKDFLLKCLEKEPDLRPTASELLK 326
+P + A D L L +P R TA E L
Sbjct: 239 PAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298
Query: 327 HPFV 330
P++
Sbjct: 299 SPWL 302
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 6e-29
Identities = 74/274 (27%), Positives = 128/274 (46%), Gaps = 28/274 (10%)
Query: 74 IGCGAFGRV----YMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS 129
+G G FG+V Y ++GE +AVK + E +HI +L++E+++L++L
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSL-------KPESGGNHIADLKKEIEILRNLY 64
Query: 130 HPNIVRYLGTVREE--ESLNILLEFVPGGSISSLLGK-FGPFPEAVMRTYTKQLLLGLEY 186
H NIV+Y G E+ + +++EF+P GS+ L + Y Q+ G++Y
Sbjct: 65 HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDY 124
Query: 187 LHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTP-YWMAPEVI 245
L + +HRD+ N+LV+++ +K+ DFG +K + K +P +W APE +
Sbjct: 125 LGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL 184
Query: 246 RQTGHSYSADIWSVGCTVIEMAT----GKPPWS---------QQYQEVAALFHIGTTKSH 292
Q+ ++D+WS G T+ E+ T P + V L +
Sbjct: 185 IQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKR 244
Query: 293 PPIPENLSVKAKDFLLKCLEKEPDLRPTASELLK 326
P P N + + KC E +P R T L++
Sbjct: 245 LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 7e-29
Identities = 89/284 (31%), Positives = 140/284 (49%), Gaps = 29/284 (10%)
Query: 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHP 131
++IG G+FG+V + G AVK ++ K+K Q+HI + E LLK+L HP
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVK--VLQKKTILKKKEQNHI--MAERNVLLKNLKHP 56
Query: 132 NIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHG 191
+V + + E L +L++V GG + L + F E R Y ++ + YLH+
Sbjct: 57 FLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN 116
Query: 192 IMHRDIKGANILVDNKGCIKLADFGASKQ-VAELATVSGAKSMKGTPYWMAPEVIRQTGH 250
I++RD+K NIL+D++G + L DFG K+ V T S + GTP ++APEV+R+ +
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTS---TFCGTPEYLAPEVLRKEPY 173
Query: 251 SYSADIWSVGCTVIEMATGKPPW-----SQQYQEVAALFHIGTTKSHPP--IPENLSVKA 303
+ D W +G + EM G PP+ SQ Y + H P +P +V A
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNIL----------HKPLQLPGGKTVAA 223
Query: 304 KDFLLKCLEKEPDLRPTAS----ELLKHPFVTGDDEDPVLHASV 343
D L+ L K+ R A E+ H F + + D + H +
Sbjct: 224 CDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWDDLYHKRI 267
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 84/314 (26%), Positives = 145/314 (46%), Gaps = 30/314 (9%)
Query: 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEK--AQDHIKELEEEVKLLK---DL 128
+G G FG+V + +GEL A+K L K A+D ++ L E ++ +
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIK-AL------KKGDIIARDEVESLMCEKRIFETANSE 59
Query: 129 SHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLH 188
HP +V + E+ + ++E+ GG + + F E Y ++LGL+YLH
Sbjct: 60 RHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLH 118
Query: 189 NHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQT 248
+ I++RD+K N+L+D +G +K+ADFG K+ + + GTP ++APEV+ +T
Sbjct: 119 ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKE--GMGFGDRTSTFCGTPEFLAPEVLTET 176
Query: 249 GHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKDFLL 308
++ + D W +G + EM G+ P+ +E +F P LS +A +
Sbjct: 177 SYTRAVDWWGLGVLIYEMLVGESPFPGDDEE--EVFD-SIVNDEVRYPRFLSREAISIMR 233
Query: 309 KCLEKEPDLR-----PTASELLKHPFVTGDDEDPVLHASVMKS--SEILSPSHVANLES- 360
+ L + P+ R A ++ K PF + D +L + I P V+N +
Sbjct: 234 RLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDLLARKIKPPFVPTIKGPEDVSNFDEE 293
Query: 361 ----LQMLTSPGSP 370
+LT P P
Sbjct: 294 FTSEAPVLTPPREP 307
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 117 bits (293), Expect = 1e-28
Identities = 91/313 (29%), Positives = 140/313 (44%), Gaps = 63/313 (20%)
Query: 70 KGELIGCGAFGRVYMGMNLDSGELLAVK-----QVLIAANFASKEKAQDHIKELEEEVKL 124
K + +G GAFG V + +D+ L A+K VL+ A + +D + E + E
Sbjct: 5 KIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW-- 62
Query: 125 LKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGL 184
+VR + +++++L +++++PGG + SLL + G FPE + R Y +L +
Sbjct: 63 --------VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAV 114
Query: 185 EYLHNHGIMHRDIKGANILVDNKGCIKLA----------------------------DFG 216
E +H G +HRDIK NIL+D G IKL DF
Sbjct: 115 ESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFS 174
Query: 217 AS-----------------KQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSV 259
++ A A S+ GTP ++APEV+ +TG++ D WSV
Sbjct: 175 NEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234
Query: 260 GCTVIEMATGKPPW-SQQYQEVAALFHIGTTKSHPPIPENLSVKAKDFLLK-CLEKEPDL 317
G + EM G+PP+ +Q E T H P LS +A D ++K C E L
Sbjct: 235 GVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRL 294
Query: 318 -RPTASELLKHPF 329
+ A E+ HPF
Sbjct: 295 GKNGADEIKAHPF 307
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 80/283 (28%), Positives = 139/283 (49%), Gaps = 25/283 (8%)
Query: 72 ELIGCGAFGRVYMGMNLDSGELLAVK----QVLIAANFASKEKAQDHIKELEEEVKLLKD 127
+L+G G FG+V + +G A+K +V+IA +D + E ++L++
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA---------KDEVAHTVTESRVLQN 51
Query: 128 LSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYL 187
HP + + + L ++E+ GG + L + F E R Y +++ LEYL
Sbjct: 52 TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 111
Query: 188 HNHGIMHRDIKGANILVDNKGCIKLADFGASKQ-VAELATVSGAKSMKGTPYWMAPEVIR 246
H+ +++RDIK N+++D G IK+ DFG K+ +++ AT+ K+ GTP ++APEV+
Sbjct: 112 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM---KTFCGTPEYLAPEVLE 168
Query: 247 QTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKDF 306
+ + D W +G + EM G+ P+ Q E LF + P LS +AK
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--RLFEL-ILMEEIRFPRTLSPEAKSL 225
Query: 307 LLKCLEKEPDLR-----PTASELLKHPFVTGDDEDPVLHASVM 344
L L+K+P R A E+++H F + V+ ++
Sbjct: 226 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLL 268
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 2e-28
Identities = 76/255 (29%), Positives = 120/255 (47%), Gaps = 13/255 (5%)
Query: 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNI 133
+G G FG V G+ L K+V +A +E KE E ++ L HP I
Sbjct: 3 LGHGNFGSVVKGVYLMKSG----KEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCI 58
Query: 134 VRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIM 193
VR +G V + E L +++E P G + L K P + ++ Q+ +G+ YL + +
Sbjct: 59 VRLIG-VCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFV 117
Query: 194 HRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPY-WMAPEVIRQTGHSY 252
HRD+ N+L+ N+ K++DFG S+ + + A + P W APE I S
Sbjct: 118 HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSS 177
Query: 253 SADIWSVGCTVIEMAT-GKPPWSQ-QYQEVAALFHIGTTKSHPP-IPENLSVKAKDFLLK 309
+D+WS G T+ E + G P+ + + EV A+ G P P+ + +L
Sbjct: 178 KSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIY----SIMLS 233
Query: 310 CLEKEPDLRPTASEL 324
C + P+ RPT SEL
Sbjct: 234 CWKYRPEDRPTFSEL 248
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 75/265 (28%), Positives = 133/265 (50%), Gaps = 22/265 (8%)
Query: 72 ELIGCGAFGRVYMGMNLDSGELLAVK----QVLIAANFASKEKAQDHIKELEEEVKLLKD 127
+++G G+FG+V++ + + A+K V++ + + + L E
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE------ 54
Query: 128 LSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYL 187
HP + T + +E+L ++E++ GG + + F Y +++ GL++L
Sbjct: 55 --HPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFL 112
Query: 188 HNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMK--GTPYWMAPEVI 245
H+ GI++RD+K NIL+D G IK+ADFG K+ + AK+ GTP ++APE++
Sbjct: 113 HSKGIVYRDLKLDNILLDTDGHIKIADFGMCKE----NMLGDAKTCTFCGTPDYIAPEIL 168
Query: 246 RQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKD 305
++ S D WS G + EM G+ P+ +E LF +P P L+ +AKD
Sbjct: 169 LGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE--ELFQ-SIRMDNPCYPRWLTREAKD 225
Query: 306 FLLKCLEKEPDLR-PTASELLKHPF 329
L+K +EP+ R ++ +HPF
Sbjct: 226 ILVKLFVREPERRLGVKGDIRQHPF 250
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 91/305 (29%), Positives = 144/305 (47%), Gaps = 59/305 (19%)
Query: 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKL 124
P R+ + +G GA+G V ++ +GE +A+K+ ++ F S+ A+ +EL L
Sbjct: 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKK--LSRPFQSEIFAKRAYREL----TL 67
Query: 125 LKDLSHPNIVRYLGTVREEESLNILLEF---VP--GGSISSLLGKFGPFPEAVMRTYTKQ 179
LK + H N++ L S + +F +P + ++G P E ++ Q
Sbjct: 68 LKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGH--PLSEDKVQYLVYQ 125
Query: 180 LLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKG---T 236
+L GL+Y+H+ GI+HRD+K N+ V+ +K+ DFG ++ M G T
Sbjct: 126 MLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR--------HADAEMTGYVVT 177
Query: 237 PYWMAPEVIRQTGH-SYSADIWSVGCTVIEMATGK-----------------------PP 272
++ APEVI H + + DIWSVGC + EM TGK P
Sbjct: 178 RWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPE 237
Query: 273 WSQQYQEVAALFHIGTTKSHPPIPE--------NLSVKAKDFLLKCLEKEPDLRPTASEL 324
+ Q+ ++ AA +I KS P P S +A D L K LE + D R TA+E
Sbjct: 238 FVQKLEDKAAKSYI---KSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEA 294
Query: 325 LKHPF 329
L+HP+
Sbjct: 295 LEHPY 299
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 70/202 (34%), Positives = 109/202 (53%), Gaps = 6/202 (2%)
Query: 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHP 131
++IG G+FG+V + G+ AVK ++ K Q HI + E LLK++ HP
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVK--VLQKKIVLNRKEQKHI--MAERNVLLKNVKHP 56
Query: 132 NIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHG 191
+V + + E L +L+FV GG + L + FPE R Y ++ L YLH+
Sbjct: 57 FLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN 116
Query: 192 IMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHS 251
I++RD+K NIL+D++G + L DFG K+ +A + GTP ++APEVIR+ +
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCKE--GIAQSDTTTTFCGTPEYLAPEVIRKQPYD 174
Query: 252 YSADIWSVGCTVIEMATGKPPW 273
+ D W +G + EM G PP+
Sbjct: 175 NTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 6e-28
Identities = 89/312 (28%), Positives = 149/312 (47%), Gaps = 56/312 (17%)
Query: 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKL 124
P R++ +G GA+G+V + +G +A+K+ ++ F S H K E++L
Sbjct: 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKK--LSRPFQSAI----HAKRTYRELRL 67
Query: 125 LKDLSHPNIVRYLGTVREEESLN------ILLEFVPGGSISSLLGKFGPFPEAVMRTYTK 178
LK + H N++ L SL ++ + G +++++ K + ++
Sbjct: 68 LKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIV-KCQKLSDDHIQFLVY 125
Query: 179 QLLLGLEYLHNHGIMHRDIKGANILVDNKGC-IKLADFGASKQVAELATVSGAKSMKGTP 237
Q+L GL+Y+H+ GI+HRD+K +NI V N+ C +K+ DFG ++ + T T
Sbjct: 126 QILRGLKYIHSAGIIHRDLKPSNIAV-NEDCELKILDFGLARHTDDEMT-----GYVATR 179
Query: 238 YWMAPEVIRQTGH-SYSADIWSVGCTVIEMATGKP--PWSQ---QYQEVAALFHIGT--- 288
++ APE++ H + + DIWSVGC + E+ TGK P S Q + + L +GT
Sbjct: 180 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNL--VGTPDE 237
Query: 289 --------------TKSHPPIPE--------NLSVKAKDFLLKCLEKEPDLRPTASELLK 326
+S P +P+ + A D L K L +PD R TA+E L
Sbjct: 238 ELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297
Query: 327 HPFVT--GDDED 336
HP++ D ED
Sbjct: 298 HPYLAEYHDPED 309
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 7e-28
Identities = 92/324 (28%), Positives = 147/324 (45%), Gaps = 78/324 (24%)
Query: 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS-HPN 132
+G GA+G V+ ++ + E++A+K++ A F + AQ +E + L++L HPN
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDA--FRNATDAQRTFRE----IMFLQELGDHPN 68
Query: 133 IVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPE----AVMR------------TY 176
IV+ L ++ E +I L F + E AV+R Y
Sbjct: 69 IVKLLNVIKAENDKDIYLVF--------------EYMETDLHAVIRANILEDVHKRYIMY 114
Query: 177 TKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGT 236
QLL L+Y+H+ ++HRD+K +NIL+++ +KLADFG ++ ++EL + T
Sbjct: 115 --QLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVL--T 170
Query: 237 PY----WM-APEV-IRQTGHSYSADIWSVGCTVIEMATGKP------------------- 271
Y W APE+ + T ++ D+WSVGC + EM GKP
Sbjct: 171 DYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIG 230
Query: 272 -PWSQQYQEVAALFHIGTTKSHPPIPE--------NLSVKAKDFLLKCLEKEPDLRPTAS 322
P ++ + + + F S P P S A D L K L P+ R TA
Sbjct: 231 PPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAE 290
Query: 323 ELLKHPFV---TGDDEDPVLHASV 343
E L+HP+V ++PVL +
Sbjct: 291 EALEHPYVAQFHNPSDEPVLPYPI 314
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 83/309 (26%), Positives = 132/309 (42%), Gaps = 76/309 (24%)
Query: 70 KGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEE--------E 121
K + +G G++ VY G + +G+L+A+K++ + E EE E
Sbjct: 9 KLDKLGEGSYATVYKGRSKLTGQLVALKEIRL---------------EHEEGAPFTAIRE 53
Query: 122 VKLLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPF--PEAVMRTYTKQ 179
LLKDL H NIV + +++L ++ E++ + + G V R + Q
Sbjct: 54 ASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNV-RLFLFQ 111
Query: 180 LLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPY- 238
LL GL Y H ++HRD+K N+L+ +G +KLADFG ++ AKS+ Y
Sbjct: 112 LLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLAR----------AKSVPSKTYS 161
Query: 239 ------WMAPE--VIRQTGHSYSADIWSVGCTVIEMATGKP------------------- 271
W P ++ T +S S D+W VGC EMATG+P
Sbjct: 162 NEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVL 221
Query: 272 --PWSQQYQEVAALFHIGTTKSHPPIPENLSVK---------AKDFLLKCLEKEPDLRPT 320
P + + V++ P L ++ LK L+ EP R +
Sbjct: 222 GTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRIS 281
Query: 321 ASELLKHPF 329
A+E +KHP+
Sbjct: 282 AAEAMKHPY 290
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 2e-27
Identities = 77/237 (32%), Positives = 120/237 (50%), Gaps = 11/237 (4%)
Query: 121 EVKLLKDLSHPNIVRYLGTVREEESLNILLEFVPGG----SISSLLGKFGPFPEAVMRTY 176
E+ L H IV++ + ++ L +++E+ GG I L + PF E +
Sbjct: 115 ELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLL 174
Query: 177 TKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGT 236
Q++L L+ +H+ +MHRD+K ANI + G IKL DFG SKQ ++ ++ A S GT
Sbjct: 175 FYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGT 234
Query: 237 PYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQ-EVAALFHIGTTKSHPPI 295
PY++APE+ + +S AD+WS+G + E+ T P+ Q E+ G + P
Sbjct: 235 PYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYG---KYDPF 291
Query: 296 PENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDPVLHASVMKSSEILSP 352
P +S K L L K P LRPT +LL F+ L +++ SE +SP
Sbjct: 292 PCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYVAN---LFQDIVRHSETISP 345
|
Length = 478 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 83/337 (24%), Positives = 144/337 (42%), Gaps = 63/337 (18%)
Query: 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHP 131
E IG GA+G V ++ SG+ +A+K+ I F A+ ++EL K+L+ H
Sbjct: 11 ENIGSGAYGVVCSAIDTRSGKKVAIKK--IPHAFDVPTLAKRTLREL----KILRHFKHD 64
Query: 132 NIVRYLGTVREEESLNILLEFV---PGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLH 188
NI+ +R + + V + ++ P E +R + QLL GL+Y+H
Sbjct: 65 NIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIH 124
Query: 189 NHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPY-----WMAPE 243
+ ++HRD+K +N+LV+ +++ DFG ++ L++ T Y + APE
Sbjct: 125 SANVIHRDLKPSNLLVNEDCELRIGDFGMAR---GLSSSPTEHKYFMTEYVATRWYRAPE 181
Query: 244 VIRQTG-HSYSADIWSVGCTVIEM---------------------ATGKPPWSQQYQEVA 281
++ ++ + D+WSVGC EM G P +EV
Sbjct: 182 LLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPS-----EEV- 235
Query: 282 ALFHIGTTK---------SHPPIP-----ENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327
L IG+ + P+P S +A D L + L+ +P+ R T + L+H
Sbjct: 236 -LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294
Query: 328 PFVTG---DDEDPVLHASVMKSSEILSPSHVANLESL 361
PF+ D++P E + S E++
Sbjct: 295 PFLAQYHDPDDEPTCPPPFDFDFEAIELSREQLKEAI 331
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 4e-27
Identities = 80/277 (28%), Positives = 137/277 (49%), Gaps = 28/277 (10%)
Query: 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELE-----EEVKLLK 126
++IG GAFG V + + S ++ A+K + SK + IK + EE ++
Sbjct: 49 KVIGRGAFGEVQLVRHKSSKQVYAMKLL-------SKF---EMIKRSDSAFFWEERDIMA 98
Query: 127 DLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEY 186
+ IV+ ++++ L +++E++PGG + +L+ + PE R YT +++L L+
Sbjct: 99 HANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDA 157
Query: 187 LHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIR 246
+H+ G +HRD+K N+L+D G +KLADFG ++ V ++ GTP +++PEV++
Sbjct: 158 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYISPEVLK 216
Query: 247 -QTGHSY---SADIWSVGCTVIEMATGKPP-WSQQYQEVAALFHIGTTKSHPPIPENLSV 301
Q G Y D WSVG + EM G P ++ V I K+ P+++ +
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--VGTYSKIMDHKNSLTFPDDIEI 274
Query: 302 K--AKDFLLKCLEKEPDL--RPTASELLKHPFVTGDD 334
AKD + L R E+ HPF D
Sbjct: 275 SKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQ 311
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 7e-27
Identities = 75/258 (29%), Positives = 116/258 (44%), Gaps = 14/258 (5%)
Query: 71 GELIGCGAFGRVYMGMNLD-SGELLAVKQVLIAANFASKEKAQDHIKEL-EEEVKLLKDL 128
G IG G FG VY G+ + E +AV A K ++E +E +++
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAV------AVKTCKNCTSPSVREKFLQEAYIMRQF 64
Query: 129 SHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFG-PFPEAVMRTYTKQLLLGLEYL 187
HP+IV+ +G + E + I++E P G + S L A + Y+ QL L YL
Sbjct: 65 DHPHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYL 123
Query: 188 HNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQ 247
+ +HRDI N+LV + C+KL DFG S+ + + + A K WMAPE I
Sbjct: 124 ESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED-ESYYKASKGKLPIKWMAPESINF 182
Query: 248 TGHSYSADIWSVGCTVIE-MATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKDF 306
+ ++D+W G + E + G P+ Q + + I P+P N
Sbjct: 183 RRFTSASDVWMFGVCMWEILMLGVKPF-QGVKNNDVIGRI-ENGERLPMPPNCPPTLYSL 240
Query: 307 LLKCLEKEPDLRPTASEL 324
+ KC +P RP +EL
Sbjct: 241 MTKCWAYDPSKRPRFTEL 258
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 1e-26
Identities = 86/317 (27%), Positives = 143/317 (45%), Gaps = 61/317 (19%)
Query: 70 KGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEK---AQDHIKELEEEVKLLK 126
K + +G GAFG V + +D+ L A+K + ++K ++ + ++ E +L
Sbjct: 5 KIKTLGIGAFGEVCLACKVDTHALYAMKTL--------RKKDVLNRNQVAHVKAERDILA 56
Query: 127 DLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEY 186
+ + +V+ + +++++L +++++PGG + SLL + FPE + R Y +L L +E
Sbjct: 57 EADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIES 116
Query: 187 LHNHGIMHRDIKGANILVDNKGCIKLADFGA---------SKQVAELATVSGAKSMKGTP 237
+H G +HRDIK NIL+D G IKL DFG SK + + + SM+ +
Sbjct: 117 VHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIR-QDSMEPSD 175
Query: 238 YW-------------------------------------MAPEVIRQTGHSYSADIWSVG 260
W +APEV+ + G++ D WSVG
Sbjct: 176 LWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235
Query: 261 CTVIEMATGKPPWSQQYQEVAALFHIGTTKS-HPPIPENLSVKAKDFLLK-CLEKEPDL- 317
+ EM G+PP+ L I + H P LS +A D + K C E L
Sbjct: 236 VILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLG 295
Query: 318 RPTASELLKHPFVTGDD 334
R A ++ HPF + D
Sbjct: 296 RNGADDIKAHPFFSEVD 312
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 78/265 (29%), Positives = 121/265 (45%), Gaps = 35/265 (13%)
Query: 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIK-ELEEEVKLLKDLSH 130
E IG G FG V+ G +AVK + +E +K + +E ++LK SH
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVK--------SCRETLPPDLKAKFLQEARILKQYSH 52
Query: 131 PNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLL-------LG 183
PNIVR +G +++ + I++E V GG + L GP R K+L+ G
Sbjct: 53 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGP------RLKVKELIQMVENAAAG 106
Query: 184 LEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPY-WMAP 242
+EYL + +HRD+ N LV K +K++DFG S++ + + MK P W AP
Sbjct: 107 MEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEED-GVYASTGGMKQIPVKWTAP 165
Query: 243 EVIRQTGHSYSADIWSVGCTVIE-MATGKPPW----SQQYQEVAALFHIGTTKSHPPIPE 297
E + +S +D+WS G + E + G P+ +QQ +E P PE
Sbjct: 166 EALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAI------EQGVRLPCPE 219
Query: 298 NLSVKAKDFLLKCLEKEPDLRPTAS 322
+ +C E +P RP+ S
Sbjct: 220 LCPDAVYRLMERCWEYDPGQRPSFS 244
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 3e-26
Identities = 76/278 (27%), Positives = 132/278 (47%), Gaps = 36/278 (12%)
Query: 72 ELIGCGAFGRV----YMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKD 127
+ +G G FG V Y + ++GE++AVK++ + +H+++ E E+++LK
Sbjct: 10 QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKL--------QHSTAEHLRDFEREIEILKS 61
Query: 128 LSHPNIVRYLGTV--REEESLNILLEFVPGGSISSLLGKFGP-FPEAVMRTYTKQLLLGL 184
L H NIV+Y G +L +++E++P GS+ L K + Y Q+ G+
Sbjct: 62 LQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGM 121
Query: 185 EYLHNHGIMHRDIKGANILVDNKGCIKLADFGASK---QVAELATVSGAKSMKGTP-YWM 240
EYL + +HRD+ NILV+++ +K+ DFG +K Q E V + +P +W
Sbjct: 122 EYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKV---REPGESPIFWY 178
Query: 241 APEVIRQTGHSYSADIWSVGCTVIEMAT-----GKPP------WSQQYQEVAALFH---I 286
APE + ++ S ++D+WS G + E+ T PP Q ++H +
Sbjct: 179 APESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL 238
Query: 287 GTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASEL 324
P P + + +C +P RP+ SEL
Sbjct: 239 LKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSEL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 75/268 (27%), Positives = 131/268 (48%), Gaps = 26/268 (9%)
Query: 73 LIGCGAFGRVYMGMNLDSGELLAVK----QVLIAANFASKEKAQDHIKELEEEVKLLKDL 128
++G G+FG+V + + EL A+K V+I D ++ E ++L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQ---------DDDVECTMVEKRVLALP 57
Query: 129 SHPNIVRYL-GTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYL 187
P + L + + L ++E+V GG + + + G F E Y ++ +GL +L
Sbjct: 58 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFL 117
Query: 188 HNHGIMHRDIKGANILVDNKGCIKLADFGASKQ-VAELATVSGAKSMKGTPYWMAPEVIR 246
H+ GI++RD+K N+++D +G IK+ADFG K+ + T ++ GTP ++APE+I
Sbjct: 118 HSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT---TRTFCGTPDYIAPEIIA 174
Query: 247 QTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKDF 306
+ S D W+ G + EM G+PP+ + ++ LF + + P++LS +A
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED--ELFQ-SIMEHNVSYPKSLSKEAVSI 231
Query: 307 LLKCLEKEPDLR----PTASELLK-HPF 329
L K P R PT ++ H F
Sbjct: 232 CKGLLTKHPAKRLGCGPTGERDIREHAF 259
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 8e-26
Identities = 75/308 (24%), Positives = 141/308 (45%), Gaps = 45/308 (14%)
Query: 70 KGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKE------LEEEVK 123
KG +G G +G+V + +G+++A+K+V I K + + E+K
Sbjct: 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72
Query: 124 LLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLG 183
++ ++ H NI+ + E + +N++++ + + ++ + E+ ++ Q+L G
Sbjct: 73 IMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTESQVKCILLQILNG 131
Query: 184 LEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAE---LATVSGAKSMKG----- 235
L LH MHRD+ ANI +++KG K+ADFG +++ T+S ++M+
Sbjct: 132 LNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMT 191
Query: 236 ----TPYWMAPEVIR-QTGHSYSADIWSVGCTVIEMATGKP--PWSQQYQEVAALFHIGT 288
T ++ APE++ + ++ D+WSVGC E+ TGKP P + ++ +F +
Sbjct: 192 SKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLG 251
Query: 289 TKSHPPIPENLSV---------KAKDF--------------LLKCLEKEPDLRPTASELL 325
T + P+ + K KD L L+ P R +A E L
Sbjct: 252 TPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEAL 311
Query: 326 KHPFVTGD 333
KH + D
Sbjct: 312 KHEYFKSD 319
|
Length = 335 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 86/298 (28%), Positives = 143/298 (47%), Gaps = 36/298 (12%)
Query: 73 LIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDH--IKELEEEVKLLKDLS- 129
+IG G++ +V + + + A+K V KE D I ++ E + + S
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVV-------KKELVNDDEDIDWVQTEKHVFEQASN 54
Query: 130 HPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHN 189
HP +V + E L ++E+V GG + + + PE R Y+ ++ L L YLH
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 114
Query: 190 HGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTG 249
GI++RD+K N+L+D++G IKL D+G K+ L + GTP ++APE++R
Sbjct: 115 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE--GLRPGDTTSTFCGTPNYIAPEILRGED 172
Query: 250 HSYSADIWSVGCTVIEMATGKPPW---------SQQYQEVAALFHIGTTKSHPPIPENLS 300
+ +S D W++G + EM G+ P+ Q ++ LF + K IP +LS
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY--LFQVILEK-QIRIPRSLS 229
Query: 301 VKAKDFLLKCLEKEPDLR----PTA--SELLKHPFVTGDDEDPVLHASVMKSSEILSP 352
VKA L L K+P R P +++ HPF D D +M+ +++ P
Sbjct: 230 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD------LMEQKQVVPP 281
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 1e-25
Identities = 80/270 (29%), Positives = 142/270 (52%), Gaps = 16/270 (5%)
Query: 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHP 131
++IG GAFG V + + S ++ A+K + + F +++ EE ++ + P
Sbjct: 49 KVIGRGAFGEVQLVRHKSSQKVYAMK---LLSKFEMIKRSDSAF--FWEERDIMAFANSP 103
Query: 132 NIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHG 191
+V+ ++++ L +++E++PGG + +L+ + PE + YT +++L L+ +H+ G
Sbjct: 104 WVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEVVLALDAIHSMG 162
Query: 192 IMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIR-QTGH 250
++HRD+K N+L+D G +KLADFG ++ E V + GTP +++PEV++ Q G
Sbjct: 163 LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVR-CDTAVGTPDYISPEVLKSQGGD 221
Query: 251 SY---SADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPEN--LSVKAKD 305
Y D WSVG + EM G P+ V I K+ PE+ +S AK+
Sbjct: 222 GYYGRECDWWSVGVFLFEMLVGDTPFYAD-SLVGTYSKIMDHKNSLNFPEDVEISKHAKN 280
Query: 306 FLLKCL-EKEPDL-RPTASELLKHPFVTGD 333
+ L ++E L R E+ +HPF D
Sbjct: 281 LICAFLTDREVRLGRNGVEEIKQHPFFKND 310
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 1e-25
Identities = 80/271 (29%), Positives = 133/271 (49%), Gaps = 18/271 (6%)
Query: 73 LIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEV--KLLKDLSH 130
+IG G FG VY D+G++ A+K L K Q L E + L+
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMK---QGETLALNERIMLSLVSTGDC 56
Query: 131 PNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNH 190
P IV + L+ +L+ + GG + L + G F EA MR Y +++LGLE++HN
Sbjct: 57 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNR 116
Query: 191 GIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGH 250
+++RD+K ANIL+D G ++++D G + ++ + GT +MAPEV+ Q G
Sbjct: 117 FVVYRDLKPANILLDEHGHVRISDLGLACDFSK----KKPHASVGTHGYMAPEVL-QKGV 171
Query: 251 SY--SADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKDFLL 308
+Y SAD +S+GC + ++ G P+ Q + T +P++ S + + L
Sbjct: 172 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE 231
Query: 309 KCLEKEPDLR-----PTASELLKHPFVTGDD 334
L+++ + R A E+ +HPF D
Sbjct: 232 GLLQRDVNRRLGCLGRGAQEVKEHPFFRSLD 262
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 72/265 (27%), Positives = 120/265 (45%), Gaps = 22/265 (8%)
Query: 72 ELIGCGAFGRVYMGMNLDSGE---LLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL 128
++IG G FG V G G+ +A+K + S +K + + E ++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTL----KAGSSDKQRL---DFLTEASIMGQF 62
Query: 129 SHPNIVRYLGTVREEESLNILLEFVPGGSISSLL----GKFGPFPEAVMRTYTKQLLLGL 184
HPNI+R G V + + I+ E++ GS+ L GKF M + + G+
Sbjct: 63 DHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGM---LRGIASGM 119
Query: 185 EYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEV 244
+YL +HRD+ NILV++ K++DFG S+++ + K K W APE
Sbjct: 120 KYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEA 179
Query: 245 IRQTGHSYSADIWSVGCTVIE-MATG-KPPWSQQYQEVAALFHIGTTKSHPPIPENLSVK 302
I + ++D+WS G + E M+ G +P W Q+V G P P +
Sbjct: 180 IAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGY---RLPPPMDCPSA 236
Query: 303 AKDFLLKCLEKEPDLRPTASELLKH 327
+L C +K+ + RPT S+++
Sbjct: 237 LYQLMLDCWQKDRNERPTFSQIVST 261
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 58/153 (37%), Positives = 95/153 (62%), Gaps = 5/153 (3%)
Query: 121 EVKLLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQL 180
E+++L + + P IV + G + ++I +E + GGS+ +L + PE ++ + +
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAV 112
Query: 181 LLGLEYL-HNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYW 239
L GL YL H IMHRD+K +NILV+++G IKL DFG S Q+ + S A S GT +
Sbjct: 113 LRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSY 168
Query: 240 MAPEVIRQTGHSYSADIWSVGCTVIEMATGKPP 272
M+PE ++ T +S +DIWS+G +++E+A G+ P
Sbjct: 169 MSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 87/287 (30%), Positives = 139/287 (48%), Gaps = 37/287 (12%)
Query: 74 IGCGAFGRVYMGMNL-DSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPN 132
IG GA+G+V+ +L + G +A+K+V + + I+E+ ++ L+ HPN
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQT--GEEGMPLSTIREVAV-LRHLETFEHPN 65
Query: 133 IVRY-----LGTVREEESLNILLEFVPGGSISSLLGKFGP-FPEAVMRTYTKQLLLGLEY 186
+VR + E L ++ E V + L P P ++ QLL GL++
Sbjct: 66 VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 125
Query: 187 LHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIR 246
LH+H ++HRD+K NILV + G IKLADFG ++ + ++ S+ T ++ APEV+
Sbjct: 126 LHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT---SVVVTLWYRAPEVLL 182
Query: 247 QTGHSYSADIWSVGCTVIEMATGKP--------------------PWSQQY-QEVAALFH 285
Q+ ++ D+WSVGC EM KP P + + ++VA
Sbjct: 183 QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQ 242
Query: 286 IGTTKSHPPIPE---NLSVKAKDFLLKCLEKEPDLRPTASELLKHPF 329
+KS PI + ++ KD LLKCL P R +A L HP+
Sbjct: 243 AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 71/262 (27%), Positives = 123/262 (46%), Gaps = 16/262 (6%)
Query: 69 RKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL 128
K +++G GAFG VY G+ + GE + ++ +A +E + KE+ +E ++ +
Sbjct: 10 EKIKVLGSGAFGTVYKGVWIPEGEKV---KIPVAIKVLREETSPKANKEILDEAYVMASV 66
Query: 129 SHPNIVRYLGTVREEESLNILLEFVPGGSISSLL----GKFGPFPEAVMRTYTKQLLLGL 184
HP++VR LG + + ++ + +P G + + G + + Q+ G+
Sbjct: 67 DHPHVVRLLG-ICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQ---YLLNWCVQIAKGM 122
Query: 185 EYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEV 244
YL ++HRD+ N+LV +K+ DFG +K + A+ K WMA E
Sbjct: 123 SYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182
Query: 245 IRQTGHSYSADIWSVGCTVIEMAT-GKPPW-SQQYQEVAALFHIGTTKSHPPIPENLSVK 302
I +++ +D+WS G TV E+ T G P+ E+ L G PPI ++
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPI---CTID 239
Query: 303 AKDFLLKCLEKEPDLRPTASEL 324
L+KC + + RPT EL
Sbjct: 240 VYMVLVKCWMIDAESRPTFKEL 261
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 73/262 (27%), Positives = 116/262 (44%), Gaps = 20/262 (7%)
Query: 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHP 131
+ +G G+FG V G SG K + +A +K D + + +E ++ L H
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGG----KVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHE 56
Query: 132 NIVRYLGTVREEESLNILLEFVPGGSISSLLGK--FGPFPEAVMRTYTKQLLLGLEYLHN 189
N++R G V L ++ E P GS+ L K G F + + Y Q+ G+ YL +
Sbjct: 57 NLIRLYGVVLTH-PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES 115
Query: 190 HGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPY-WMAPEVIRQT 248
+HRD+ NIL+ + +K+ DFG + + + + P+ W APE +R
Sbjct: 116 KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTR 175
Query: 249 GHSYSADIWSVGCTVIEMAT-GKPPW-----SQQYQEVAALFHIGTTKSHPPIPENLSVK 302
S+++D+W G T+ EM T G+ PW SQ L I PE
Sbjct: 176 TFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ------ILKKIDKEGERLERPEACPQD 229
Query: 303 AKDFLLKCLEKEPDLRPTASEL 324
+ +L+C P RPT + L
Sbjct: 230 IYNVMLQCWAHNPADRPTFAAL 251
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 75/274 (27%), Positives = 130/274 (47%), Gaps = 24/274 (8%)
Query: 68 WRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELE----EEVK 123
+R ++G G FG V +G++ A K++ EK + ++ E E +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKL---------EKKRIKKRKGEAMALNEKQ 52
Query: 124 LLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGP--FPEAVMRTYTKQLL 181
+L+ ++ +V +++L ++L + GG + + G F E Y ++
Sbjct: 53 ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEIT 112
Query: 182 LGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMA 241
GLE LH I++RD+K NIL+D+ G I+++D G + ++ E T+ G GT +MA
Sbjct: 113 CGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRG---RVGTVGYMA 169
Query: 242 PEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPI-PENLS 300
PEV++ +++S D W +GC + EM GK P+ Q+ ++V K E S
Sbjct: 170 PEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFS 229
Query: 301 VKAKDFLLKCLEKEPDLR-----PTASELLKHPF 329
A+ + L K+P R A E+ HPF
Sbjct: 230 EAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPF 263
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 76/265 (28%), Positives = 133/265 (50%), Gaps = 22/265 (8%)
Query: 72 ELIGCGAFGRVYMGMNLDSGELLAVKQ-----VLIAANFASKEKAQDHIK-ELEEEVKLL 125
+++G G+FG+V + GE AVK VLI D ++ + E+ L
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLI----------DDDVECTMVEKRVLA 50
Query: 126 KDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLE 185
+P + T + +E L ++EF+ GG + + G F Y +++ GL+
Sbjct: 51 LAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQ 110
Query: 186 YLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVI 245
+LH+ GI++RD+K N+++D G IK+ADFG K+ + + A + GTP ++APE++
Sbjct: 111 FLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKE--NVFGDNRASTFCGTPDYIAPEIL 168
Query: 246 RQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKD 305
+ +++S D WS G + EM G+ P+ ++ LF P P ++ ++KD
Sbjct: 169 QGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED--ELFE-SIRVDTPHYPRWITKESKD 225
Query: 306 FLLKCLEKEPDLRPTASELLK-HPF 329
L K E++P R ++ HPF
Sbjct: 226 ILEKLFERDPTRRLGVVGNIRGHPF 250
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 77/272 (28%), Positives = 135/272 (49%), Gaps = 26/272 (9%)
Query: 72 ELIGCGAFGRVYMGMNLDSGELLAVK----QVLIAANFASKEKAQDHIKELEEEVKLLKD 127
+L+G G FG+V + +G A+K +V++A +D + E ++L++
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVA---------KDEVAHTLTENRVLQN 51
Query: 128 LSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYL 187
HP + + + + L ++E+ GG + L + F E R Y +++ L+YL
Sbjct: 52 SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYL 111
Query: 188 HNH-GIMHRDIKGANILVDNKGCIKLADFGASKQ-VAELATVSGAKSMKGTPYWMAPEVI 245
H+ +++RD+K N+++D G IK+ DFG K+ + + AT+ K+ GTP ++APEV+
Sbjct: 112 HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM---KTFCGTPEYLAPEVL 168
Query: 246 RQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKD 305
+ + D W +G + EM G+ P+ Q E LF + P LS +AK
Sbjct: 169 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFEL-ILMEEIRFPRTLSPEAKS 225
Query: 306 FLLKCLEKEPDLR-----PTASELLKHPFVTG 332
L L+K+P R A E+++H F G
Sbjct: 226 LLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAG 257
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 69/269 (25%), Positives = 124/269 (46%), Gaps = 37/269 (13%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH 130
+ +G G FG V++G ++ A+K + +E A + EE K++ LSH
Sbjct: 9 LKELGSGQFGVVHLGKWRGKIDV-AIKMI--------REGAMSE-DDFIEEAKVMMKLSH 58
Query: 131 PNIVRYLGTVREEESLNILLEFVPGGSISSLL----GKFGPFPEAVMRTYTKQLLLGLEY 186
PN+V+ G ++ + I+ E++ G + + L GK G + + +EY
Sbjct: 59 PNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLG---TEWLLDMCSDVCEAMEY 115
Query: 187 LHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVA--ELATVSGAK-SMKGTPYWMAPE 243
L ++G +HRD+ N LV +K++DFG ++ V + + G K +K W PE
Sbjct: 116 LESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVK----WAPPE 171
Query: 244 VIRQTGHSYSADIWSVGCTVIEMAT-GKPPW-----SQQYQEVAALFHIGTTKSHPPIPE 297
V + S +D+WS G + E+ + GK P+ S+ + V+A + + K P
Sbjct: 172 VFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPT--- 228
Query: 298 NLSVKAKDFLLKCLEKEPDLRPTASELLK 326
+ + C ++P+ RP +LL
Sbjct: 229 ----EVYTIMYSCWHEKPEDRPAFKKLLS 253
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 3e-24
Identities = 85/304 (27%), Positives = 152/304 (50%), Gaps = 48/304 (15%)
Query: 54 KHISPSVKMSPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQD 113
K I + SP ++ G +IG G+FG VY + +D+ E +A+K+VL + ++
Sbjct: 54 KMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNR----- 108
Query: 114 HIKELEEEVKLLKDLSHPNIV-----RYLGTVREEES---LNILLEFVPGGSISSLLGKF 165
E+ ++K+L+H NI+ Y ++ E LN+++EF+P ++ + +
Sbjct: 109 -------ELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIP-QTVHKYMKHY 160
Query: 166 G----PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVD-NKGCIKLADFGASKQ 220
P +++ Y+ QL L Y+H+ I HRD+K N+L+D N +KL DFG++K
Sbjct: 161 ARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKN 220
Query: 221 VAELATVSGAKSMK--GTPYWMAPEV-IRQTGHSYSADIWSVGCTVIEMATGKPPWSQQY 277
+ ++G +S+ + ++ APE+ + T ++ D+WS+GC + EM G P +S Q
Sbjct: 221 L-----LAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQS 275
Query: 278 ---QEVAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDD 334
Q V + +GT P + L ++ K PD++P LK F G
Sbjct: 276 SVDQLVRIIQVLGT-----PTEDQLKEMNPNY---ADIKFPDVKPKD---LKKVFPKGTP 324
Query: 335 EDPV 338
+D +
Sbjct: 325 DDAI 328
|
Length = 440 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 76/270 (28%), Positives = 131/270 (48%), Gaps = 16/270 (5%)
Query: 73 LIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEV--KLLKDLSH 130
+IG G FG VY D+G++ A+K + + Q L E + L+
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMK----CLDKKRIKMKQGETLALNERIMLSLVSTGDC 56
Query: 131 PNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNH 190
P IV + L +L+ + GG + L + G F E MR Y +++LGLE++HN
Sbjct: 57 PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNR 116
Query: 191 GIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQ-TG 249
+++RD+K ANIL+D G ++++D G + ++ + GT +MAPEV+++ T
Sbjct: 117 FVVYRDLKPANILLDEHGHVRISDLGLACDFSK----KKPHASVGTHGYMAPEVLQKGTA 172
Query: 250 HSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKDFLLK 309
+ SAD +S+GC + ++ G P+ Q + T + +P++ S + K L
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEG 232
Query: 310 CLEKEPDLR-----PTASELLKHPFVTGDD 334
L+++ R A E+ +H F G D
Sbjct: 233 LLQRDVSKRLGCLGRGAQEVKEHVFFKGID 262
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 87/305 (28%), Positives = 143/305 (46%), Gaps = 35/305 (11%)
Query: 73 LIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDH--IKELEEEVKLLKDLS- 129
+IG G++ +V + + + A+K + KE D I ++ E + + S
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVI-------KKELVNDDEDIDWVQTEKHVFETASN 54
Query: 130 HPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHN 189
HP +V + E L ++EFV GG + + + PE R Y+ ++ L L +LH
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHE 114
Query: 190 HGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTG 249
GI++RD+K N+L+D +G IKL D+G K+ + + GTP ++APE++R
Sbjct: 115 RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE--GIRPGDTTSTFCGTPNYIAPEILRGED 172
Query: 250 HSYSADIWSVGCTVIEMATGKPPW--------SQQYQEVAALFHIGTTKSHPPIPENLSV 301
+ +S D W++G + EM G+ P+ Q E LF + K IP +LSV
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTE-DYLFQVILEKQ-IRIPRSLSV 230
Query: 302 KAKDFLLKCLEKEPDLR------PTASELLKHPFVTGDDEDPVLHASVMKSSEILSPSHV 355
KA L L K+P R ++ HPF D D +++ ++L P
Sbjct: 231 KASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWD------LLEQKQVLPPYK- 283
Query: 356 ANLES 360
N+ES
Sbjct: 284 PNIES 288
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 3e-24
Identities = 77/272 (28%), Positives = 134/272 (49%), Gaps = 30/272 (11%)
Query: 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKA--QDHIKE--LEEEVKLLKD 127
+++G G+FG+V + + E+ A+K VL K+ QD + + E+ L
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIK-VL-------KKDVILQDDDVDCTMTEKRILALA 52
Query: 128 LSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYL 187
HP + + ++ L ++E+V GG + + + F E R Y ++ L L +L
Sbjct: 53 AKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFL 112
Query: 188 HNHGIMHRDIKGANILVDNKGCIKLADFGASKQ-VAELATVSGAKSMKGTPYWMAPEVIR 246
H HG+++RD+K NIL+D +G KLADFG K+ + T + + GTP ++APE+++
Sbjct: 113 HRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTT---TFCGTPDYIAPEILQ 169
Query: 247 QTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPI--PENLSVKAK 304
+ + S D W++G + EM G+PP+ ++ LF + H + P LS +A
Sbjct: 170 ELEYGPSVDWWALGVLMYEMMAGQPPFEADNED--DLFE---SILHDDVLYPVWLSKEAV 224
Query: 305 DFLLKCLEKEPDLR-------PTASELLKHPF 329
L + K P+ R + +HPF
Sbjct: 225 SILKAFMTKNPNKRLGCVASQGGEDAIKQHPF 256
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 84/318 (26%), Positives = 138/318 (43%), Gaps = 72/318 (22%)
Query: 74 IGCGAFGRVY--MGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELE-EEVKLLKDLSH 130
IG G +GRVY N G+ A+K+ F ++ I + E+ LL++L H
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKK------FKGDKEQYTGISQSACREIALLRELKH 61
Query: 131 PNIVRYLGTVRE--EESLNILLEFVPGGSISSLLG--------KFGPFPEAVMRTYTKQL 180
N+V + E ++S+ +L ++ + L K P +++++ Q+
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDY----AEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQI 117
Query: 181 LLGLEYLHNHGIMHRDIKGANILV----DNKGCIKLADFG-ASKQVAELATVSGAKSMKG 235
L G+ YLH++ ++HRD+K ANILV +G +K+ D G A A L ++ +
Sbjct: 118 LNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVV 177
Query: 236 TPYWMAPEVIRQTGHSYSA-DIWSVGCTVIEMATGKPPWSQ-----------QYQEVAAL 283
T ++ APE++ H A DIW++GC E+ T +P + Q ++ +
Sbjct: 178 TIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237
Query: 284 FHI-G--TTKSHPPI---PE--------------------------NLSVKAKDFLLKCL 311
F + G T K P I PE + D L K L
Sbjct: 238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLL 297
Query: 312 EKEPDLRPTASELLKHPF 329
E +P R TA E L+HP+
Sbjct: 298 EYDPTKRITAEEALEHPY 315
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 71/243 (29%), Positives = 123/243 (50%), Gaps = 9/243 (3%)
Query: 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHP 131
++IG G+FG+V + + + AVK ++ K+K + HI + E LLK++ HP
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVK--VLQKKAILKKKEEKHI--MSERNVLLKNVKHP 56
Query: 132 NIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHG 191
+V + + + L +L+++ GG + L + F E R Y ++ L YLH+
Sbjct: 57 FLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN 116
Query: 192 IMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHS 251
I++RD+K NIL+D++G I L DFG K+ E + + GTP ++APEV+ + +
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTT--STFCGTPEYLAPEVLHKQPYD 174
Query: 252 YSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKDFLLKCL 311
+ D W +G + EM G PP+ Y A + + N++ A+ L L
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPPF---YSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLL 231
Query: 312 EKE 314
+K+
Sbjct: 232 QKD 234
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 4e-24
Identities = 73/260 (28%), Positives = 120/260 (46%), Gaps = 36/260 (13%)
Query: 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNI 133
+G G FG V+MG + ++ AVK + K + +E +++K L H +
Sbjct: 14 LGAGQFGEVWMGTWNGTTKV-AVKTL--------KPGTMS-PEAFLQEAQIMKKLRHDKL 63
Query: 134 VRYLGTVREEESLNILLEFVPGGSISSLL----GKFGPFPEAVMRTYTKQLLLGLEYLHN 189
V+ EEE + I+ E++ GS+ L GK P+ V Q+ G+ YL +
Sbjct: 64 VQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVD--MAAQIAEGMAYLES 121
Query: 190 HGIMHRDIKGANILVDNKGCIKLADFGASKQVA--ELATVSGAK-SMKGTPYWMAPEVIR 246
+HRD+ NILV K+ADFG ++ + E GAK +K W APE
Sbjct: 122 RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIK----WTAPEAAN 177
Query: 247 QTGHSYSADIWSVGCTVIEMAT-GKPPW-----SQQYQEVAALFHIGTTKSHPPIPENLS 300
+ +D+WS G + E+ T G+ P+ + ++V + + P P N
Sbjct: 178 YGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRM-------PRPPNCP 230
Query: 301 VKAKDFLLKCLEKEPDLRPT 320
+ D +L+C +K+P+ RPT
Sbjct: 231 EELYDLMLQCWDKDPEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 79/280 (28%), Positives = 139/280 (49%), Gaps = 19/280 (6%)
Query: 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLK-DLSH 130
++G G+FG+V + +SG L AVK ++ + ++ D ++ E ++L +H
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVK--VLKKDVILQD---DDVECTMTEKRILSLARNH 55
Query: 131 PNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNH 190
P + + + + L ++EFV GG + + K F EA R Y ++ L +LH+
Sbjct: 56 PFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK 115
Query: 191 GIMHRDIKGANILVDNKGCIKLADFGASKQ-VAELATVSGAKSMKGTPYWMAPEVIRQTG 249
GI++RD+K N+L+D++G KLADFG K+ + T S + GTP ++APE++++
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTS---TFCGTPDYIAPEILQEML 172
Query: 250 HSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKDFLLK 309
+ S D W++G + EM G P+ + ++ LF P LS A D L
Sbjct: 173 YGPSVDWWAMGVLLYEMLCGHAPFEAENED--DLFE-AILNDEVVYPTWLSQDAVDILKA 229
Query: 310 CLEKEPDLRPTA------SELLKHPFVTGDDEDPVLHASV 343
+ K P +R + +L+HPF D + + +
Sbjct: 230 FMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLNRRQI 269
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 6e-24
Identities = 57/153 (37%), Positives = 94/153 (61%), Gaps = 8/153 (5%)
Query: 179 QLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSG--AKSMKGT 236
Q+LL + ++H+ ++HRDIK ANIL+ + G +KL DFG SK A ATVS ++ GT
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYA--ATVSDDVGRTFCGT 208
Query: 237 PYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWS-QQYQEVAALFHIGTTKSHPPI 295
PY++APE+ R+ +S AD++S+G + E+ T K P+ + +EV H + P+
Sbjct: 209 PYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEV---MHKTLAGRYDPL 265
Query: 296 PENLSVKAKDFLLKCLEKEPDLRPTASELLKHP 328
P ++S + ++ + L +P RP++S+LL P
Sbjct: 266 PPSISPEMQEIVTALLSSDPKRRPSSSKLLNMP 298
|
Length = 496 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 7e-24
Identities = 77/280 (27%), Positives = 122/280 (43%), Gaps = 39/280 (13%)
Query: 72 ELIGCGAFGRVYMG-----MNLDSGELLAVKQVLIAANFASKEKAQDHIKE-LEEEVKLL 125
+G GAFG+V++G + EL+AVK KE A + ++ E E +LL
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVK--------TLKETASNDARKDFEREAELL 62
Query: 126 KDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGP------FPEAVMRTYTKQ 179
+ H NIV++ G E + ++ E++ G ++ L GP P++ M T
Sbjct: 63 TNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLS 122
Query: 180 LLL--------GLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQV--AELATVSG 229
LL G+ YL + +HRD+ N LV +K+ DFG S+ V + V G
Sbjct: 123 QLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGG 182
Query: 230 AKSMKGTPY-WMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQ-QYQEVAALFHI 286
+ P WM PE I + +D+WS G + E+ T GK PW +EV
Sbjct: 183 HTML---PIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQ 239
Query: 287 GTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLK 326
G P + D +L C +++P R ++ +
Sbjct: 240 GRLLQR---PRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 85/301 (28%), Positives = 152/301 (50%), Gaps = 22/301 (7%)
Query: 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHP 131
++IG GAFG V + ++G++ A+K I + ++A+ E +V + D
Sbjct: 7 KVIGRGAFGEVAVVKMKNTGQVYAMK---ILNKWEMLKRAETACFREERDVLVNGDRRWI 63
Query: 132 NIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGP-FPEAVMRTYTKQLLLGLEYLHNH 190
+ Y ++E +L +++++ GG + +LL KF PE + R Y +++L ++ +H
Sbjct: 64 TNLHY--AFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQL 121
Query: 191 GIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTG- 249
G +HRDIK N+L+D G I+LADFG+ ++ TV ++ GTP +++PE+++
Sbjct: 122 GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAV-GTPDYISPEILQAMED 180
Query: 250 ----HSYSADIWSVGCTVIEMATGKPPWSQQYQE--VAALFHIGTTKSH---PPIPENLS 300
+ D WS+G + EM G+ P+ Y E V I K H PP ++S
Sbjct: 181 GKGRYGPECDWWSLGVCMYEMLYGETPF---YAESLVETYGKIMNHKEHFQFPPDVTDVS 237
Query: 301 VKAKDFLLK--CLEKEPDLRPTASELLKHPFVTGDDEDPVLHASVMKSSEILSPSHVANL 358
+AKD + + C + R + HPF G D D + +++ E+ SP+ +N
Sbjct: 238 EEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWDNIRNSTAPYVPEVSSPTDTSNF 297
Query: 359 E 359
+
Sbjct: 298 D 298
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 83/293 (28%), Positives = 131/293 (44%), Gaps = 55/293 (18%)
Query: 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNI 133
+G G + VY G + + L+A+K++ + + A EV LLKDL H NI
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAI-------REVSLLKDLKHANI 66
Query: 134 VRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEA-VMRTYTKQLLLGLEYLHNHGI 192
V + E+SL ++ E++ + L G ++ + QLL GL Y H +
Sbjct: 67 VTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKV 125
Query: 193 MHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPY-------WMAPE-- 243
+HRD+K N+L++ +G +KLADFG ++ AKS+ Y W P
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLAR----------AKSIPTKTYSNEVVTLWYRPPDI 175
Query: 244 VIRQTGHSYSADIWSVGCTVIEMATGKP--PWSQQYQEVAALFHI---GTTKSHPPIPEN 298
++ T +S D+W VGC EM+TG+P P S +++ +F I T ++ P I N
Sbjct: 176 LLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 235
Query: 299 ----------------------LSVKAKDFLLKCLEKEPDLRPTASELLKHPF 329
L + L K L+ E R +A E +KHP+
Sbjct: 236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPY 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 2e-23
Identities = 77/270 (28%), Positives = 140/270 (51%), Gaps = 16/270 (5%)
Query: 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHP 131
++IG GAFG V + + + ++ A+K + + F +++ EE ++ + P
Sbjct: 49 KVIGRGAFGEVQLVRHKSTRKVYAMK---LLSKFEMIKRSDSAF--FWEERDIMAFANSP 103
Query: 132 NIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHG 191
+V+ +++ L +++E++PGG + +L+ + PE R YT +++L L+ +H+ G
Sbjct: 104 WVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIHSMG 162
Query: 192 IMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIR-QTGH 250
+HRD+K N+L+D G +KLADFG ++ + V + GTP +++PEV++ Q G
Sbjct: 163 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR-CDTAVGTPDYISPEVLKSQGGD 221
Query: 251 SY---SADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPE--NLSVKAKD 305
Y D WSVG + EM G P+ V I K+ P+ ++S +AK+
Sbjct: 222 GYYGRECDWWSVGVFLYEMLVGDTPFYAD-SLVGTYSKIMNHKNSLTFPDDNDISKEAKN 280
Query: 306 FLLKCL-EKEPDL-RPTASELLKHPFVTGD 333
+ L ++E L R E+ +H F D
Sbjct: 281 LICAFLTDREVRLGRNGVEEIKRHLFFKND 310
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 2e-23
Identities = 82/270 (30%), Positives = 125/270 (46%), Gaps = 39/270 (14%)
Query: 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIK-ELEEEVKLLKDLSH 130
EL+G G FG V+ G L +AVK KE +K + E ++LK H
Sbjct: 1 ELLGKGNFGEVFKG-TLKDKTPVAVK--------TCKEDLPQELKIKFLSEARILKQYDH 51
Query: 131 PNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLL-------LG 183
PNIV+ +G + + + I++E VPGG S L K TKQL+ G
Sbjct: 52 PNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRK------KKDELKTKQLVKFALDAAAG 105
Query: 184 LEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPY-WMAP 242
+ YL + +HRD+ N LV +K++DFG S+Q E + + +K P W AP
Sbjct: 106 MAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQ--EDDGIYSSSGLKQIPIKWTAP 163
Query: 243 EVIRQTGHSYSADIWSVGCTVIE-MATGKPPW----SQQYQEVAALFHIGTTKSHPP-IP 296
E + +S +D+WS G + E + G P+ +QQ +E G S P P
Sbjct: 164 EALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQV---EKGYRMSCPQKCP 220
Query: 297 ENLSVKAKDFLLKCLEKEPDLRPTASELLK 326
+++ + +C + +P+ RP SEL K
Sbjct: 221 DDVY----KVMQRCWDYKPENRPKFSELQK 246
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 3e-23
Identities = 76/261 (29%), Positives = 134/261 (51%), Gaps = 27/261 (10%)
Query: 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNI 133
+G G FG V++G + A +V I A +D I EE K++ LSHP +
Sbjct: 12 LGSGQFGVVHLG------KWRAQIKVAIKAINEGAMSEEDFI----EEAKVMMKLSHPKL 61
Query: 134 VRYLGTVREEESLNILLEFVPGGSISSLL-GKFGPFPEAVMRTYTKQLLLGLEYLHNHGI 192
V+ G +++ L I+ EF+ G + + L + G + ++ + + + G+EYL +
Sbjct: 62 VQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSF 121
Query: 193 MHRDIKGANILVDNKGCIKLADFGASKQVA--ELATVSGAK-SMKGTPYWMAPEVIRQTG 249
+HRD+ N LV + G +K++DFG ++ V E + SGAK +K W PEV +
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVK----WSPPEVFNFSK 177
Query: 250 HSYSADIWSVGCTVIEMAT-GKPPWSQQ--YQEVAALFHIGTTKSHPPI-PENLSVKAKD 305
+S +D+WS G + E+ T GK P+ ++ Y+ V + ++ P+ S+ +
Sbjct: 178 YSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMI-----SRGFRLYRPKLASMTVYE 232
Query: 306 FLLKCLEKEPDLRPTASELLK 326
+ C ++P+ RPT +ELL+
Sbjct: 233 VMYSCWHEKPEGRPTFAELLR 253
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 4e-23
Identities = 77/267 (28%), Positives = 119/267 (44%), Gaps = 37/267 (13%)
Query: 70 KGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEE---EVKLLK 126
G IG G FG V +G G+ +AVK + +D + E ++
Sbjct: 10 LGATIGKGEFGDVMLGDYR--GQKVAVKCL------------KDDSTAAQAFLAEASVMT 55
Query: 127 DLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLL---- 182
L HPN+V+ LG V + L I+ E++ GS+ L G AV+ T +QL
Sbjct: 56 TLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRG---RAVI-TLAQQLGFALDV 111
Query: 183 --GLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWM 240
G+EYL +HRD+ N+LV K++DFG +K+ A SG +K W
Sbjct: 112 CEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKE-ASQGQDSGKLPVK----WT 166
Query: 241 APEVIRQTGHSYSADIWSVGCTVIEM-ATGKPPWSQQ-YQEVAALFHIGTTKSHPPIPEN 298
APE +R+ S +D+WS G + E+ + G+ P+ + ++V G PE
Sbjct: 167 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRME---APEG 223
Query: 299 LSVKAKDFLLKCLEKEPDLRPTASELL 325
+ + C E +P RPT +L
Sbjct: 224 CPPEVYKVMKDCWELDPAKRPTFKQLR 250
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 4e-23
Identities = 86/299 (28%), Positives = 143/299 (47%), Gaps = 46/299 (15%)
Query: 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKL 124
P R+R + +G GA+G V ++ +G +A+K+ + F S+ A+ +EL +L
Sbjct: 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKK--LYRPFQSELFAKRAYREL----RL 67
Query: 125 LKDLSHPNIVRYLGTVREEESLNILLEF---VP--GGSISSLLGKFGPFPEAVMRTYTKQ 179
LK + H N++ L + SL+ +F +P G + L+ K E ++ Q
Sbjct: 68 LKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLM-KHEKLSEDRIQFLVYQ 126
Query: 180 LLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYW 239
+L GL+Y+H GI+HRD+K N+ V+ +K+ DFG ++Q T S T ++
Sbjct: 127 MLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ-----TDSEMTGYVVTRWY 181
Query: 240 MAPEVIRQTGH-SYSADIWSVGCTVIEMATGKPPW--SQQYQEVAALFHIGTTKSHPPIP 296
APEVI H + + DIWSVGC + EM TGKP + ++ + + T S +
Sbjct: 182 RAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQ 241
Query: 297 ENLSVKAKDFL----------------------LKCLEK----EPDLRPTASELLKHPF 329
+ S AK+++ + LEK + + R TA+E L HP+
Sbjct: 242 KLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPY 300
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 4e-23
Identities = 50/172 (29%), Positives = 88/172 (51%), Gaps = 10/172 (5%)
Query: 168 FPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATV 227
FPE YT Q++ GLE+LH I++RD+K N+L+DN G ++++D G + ++ +
Sbjct: 94 FPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKD--GQ 151
Query: 228 SGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIG 287
S K GTP +MAPE+++ + +S D +++G T+ EM + P+ + ++V +
Sbjct: 152 SKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK-ELK 210
Query: 288 TTKSHPPI--PENLSVKAKDFLLKCLEKEPDLR-----PTASELLKHPFVTG 332
+ + P+ S +K F L K+P+ R L HP
Sbjct: 211 QRILNDSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRD 262
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 5e-23
Identities = 73/305 (23%), Positives = 133/305 (43%), Gaps = 50/305 (16%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLK 126
R+ +GCG+ G V+ ++ D + +AVK++++ +K E+K+++
Sbjct: 6 RYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVL--------TDPQSVKHALREIKIIR 57
Query: 127 DLSHPNIVRYLGTV-----REEESLNILLEFVPGGSISSLLG-------KFGPFPEAVMR 174
L H NIV+ + E + L E + + + GP E R
Sbjct: 58 RLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHAR 117
Query: 175 TYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCI-KLADFGASKQVAELATVSGAKSM 233
+ QLL GL+Y+H+ ++HRD+K AN+ ++ + + K+ DFG ++ V + G S
Sbjct: 118 LFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSE 177
Query: 234 KGTPYWM-APEVIRQ-TGHSYSADIWSVGCTVIEMATGKPPWS-----QQYQEV------ 280
W +P ++ ++ + D+W+ GC EM TGKP ++ +Q Q +
Sbjct: 178 GLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237
Query: 281 -------------AALFHIGTTKSHPPIPE---NLSVKAKDFLLKCLEKEPDLRPTASEL 324
+ + P+ + ++ +A DFL + L P R TA E
Sbjct: 238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEA 297
Query: 325 LKHPF 329
L HP+
Sbjct: 298 LMHPY 302
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 6e-23
Identities = 87/298 (29%), Positives = 136/298 (45%), Gaps = 49/298 (16%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELE-EEVKLL 125
++ K E IG G +G VY + + E +A+K++ + E+ + + E+ LL
Sbjct: 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRL-------EQEDEGVPSTAIREISLL 55
Query: 126 KDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPE-----AVMRTYTKQL 180
K++ H NIVR V E+ L ++ E++ L P+ +++TY Q+
Sbjct: 56 KEMQHGNIVRLQDVVHSEKRLYLVFEYLD----LDLKKHMDSSPDFAKNPRLIKTYLYQI 111
Query: 181 LLGLEYLHNHGIMHRDIKGANILVDNK-GCIKLADFGASKQVAELATVSGAKSMKGTPYW 239
L G+ Y H+H ++HRD+K N+L+D + +KLADFG ++ V T ++
Sbjct: 112 LRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG--IPVRTFTHEVVTLWY 169
Query: 240 MAPEVIRQTGH-SYSADIWSVGCTVIEMATGKP--PWSQQYQEVAALFHI-GTT------ 289
APE++ + H S DIWSVGC EM KP P + E+ +F I GT
Sbjct: 170 RAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWP 229
Query: 290 --------KSHPP----------IPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPF 329
KS P +P L D L K L +P R TA L+H +
Sbjct: 230 GVTSLPDYKSAFPKWPPKDLATVVP-TLEPAGVDLLSKMLRLDPSKRITARAALEHEY 286
|
Length = 294 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 7e-23
Identities = 84/314 (26%), Positives = 139/314 (44%), Gaps = 74/314 (23%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLK 126
R++ IG GA+G V + +G +A+K++ + F + Q ++E+ K+L+
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKI---SPFEHQTFCQRTLREI----KILR 58
Query: 127 DLSHPNIVRYLGTVREE--ESLN---ILLEFVPGGSISSLLGKFGPFPEAVMRT------ 175
H NI+ L +R ES N I+ E + + L K +++T
Sbjct: 59 RFKHENIIGILDIIRPPSFESFNDVYIVQELME-----TDLYK-------LIKTQHLSND 106
Query: 176 ----YTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGC-IKLADFGASKQVAELATVSGA 230
+ Q+L GL+Y+H+ ++HRD+K +N+L+ N C +K+ DFG +A +A
Sbjct: 107 HIQYFLYQILRGLKYIHSANVLHRDLKPSNLLL-NTNCDLKICDFG----LARIADPEHD 161
Query: 231 KSMKGTPY----WM-APEV-IRQTGHSYSADIWSVGCTVIEMATGKP------------- 271
+ T Y W APE+ + G++ + DIWSVGC + EM + +P
Sbjct: 162 HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNL 221
Query: 272 -------PWSQQYQEVA---ALFHIGTTKSHPPIP-----ENLSVKAKDFLLKCLEKEPD 316
P + + A +I + P +P N KA D L K L P
Sbjct: 222 ILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPH 281
Query: 317 LRPTASELLKHPFV 330
R T E L HP++
Sbjct: 282 KRITVEEALAHPYL 295
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 7e-23
Identities = 83/306 (27%), Positives = 128/306 (41%), Gaps = 52/306 (16%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLK 126
++ K IG G FG V+ + + +++A+K+VL+ EK I L E +K+L+
Sbjct: 13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLM-----ENEKEGFPITALRE-IKILQ 66
Query: 127 DLSHPNIVRYL--------GTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTK 178
L H N+V + R + S ++ EF L K F + ++ K
Sbjct: 67 LLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMK 126
Query: 179 QLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKG--- 235
LL GL Y+H + I+HRD+K ANIL+ G +KLADFG ++ + L+ S
Sbjct: 127 MLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFS-LSKNSKPNRYTNRVV 185
Query: 236 TPYWMAPEVI---RQTGHSYSADIWSVGCTVIEMATGKPPW---SQQYQEVAALFHIGT- 288
T ++ PE++ R G D+W GC + EM T P ++Q+Q G+
Sbjct: 186 TLWYRPPELLLGERDYGP--PIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI 243
Query: 289 TKSHPPIPENL-------------------------SVKAKDFLLKCLEKEPDLRPTASE 323
T P + L A D + K L +P R A
Sbjct: 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADT 303
Query: 324 LLKHPF 329
L H F
Sbjct: 304 ALNHDF 309
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 8e-23
Identities = 85/290 (29%), Positives = 134/290 (46%), Gaps = 51/290 (17%)
Query: 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNI 133
+G GAFG V + +G+ +A+K+++ F++ A K E+KLLK L H NI
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIM--KPFSTPVLA----KRTYRELKLLKHLRHENI 71
Query: 134 VRYLGT-VREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGI 192
+ + E + + E + G + LL P + ++ + Q+L GL+Y+H+ G+
Sbjct: 72 ISLSDIFISPLEDIYFVTELL-GTDLHRLL-TSRPLEKQFIQYFLYQILRGLKYVHSAGV 129
Query: 193 MHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKG---TPYWMAPEVIRQTG 249
+HRD+K +NIL++ +K+ DFG LA + + M G T Y+ APE++ T
Sbjct: 130 VHRDLKPSNILINENCDLKICDFG-------LARIQDPQ-MTGYVSTRYYRAPEIM-LTW 180
Query: 250 HSY--SADIWSVGCTVIEMATGKP--------------------PWSQQYQEVAALFHIG 287
Y DIWS GC EM GKP P + + +
Sbjct: 181 QKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLR 240
Query: 288 TTKSHP---PIP-----ENLSVKAKDFLLKCLEKEPDLRPTASELLKHPF 329
+S P P+P +N A D L K L +P R +A+E L HP+
Sbjct: 241 FVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPY 290
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 9e-23
Identities = 79/298 (26%), Positives = 150/298 (50%), Gaps = 16/298 (5%)
Query: 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHP 131
++IG GAFG V + ++ ++ A+K I + ++A+ E +V + D
Sbjct: 7 KVIGRGAFGEVAVVKLKNADKVFAMK---ILNKWEMLKRAETACFREERDVLVNGDNQWI 63
Query: 132 NIVRYLGTVREEESLNILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLLGLEYLHNH 190
+ Y ++E +L +++++ GG + +LL KF PE + R Y ++++ ++ +H
Sbjct: 64 TTLHY--AFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL 121
Query: 191 GIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIR---- 246
+HRDIK NIL+D G I+LADFG+ ++ E TV + ++ GTP +++PE+++
Sbjct: 122 HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQAMED 180
Query: 247 -QTGHSYSADIWSVGCTVIEMATGKPPWSQQ--YQEVAALFHIGTTKSHPPIPENLSVKA 303
+ + D WS+G + EM G+ P+ + + + + P ++S A
Sbjct: 181 GKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDA 240
Query: 304 KDFLLKCL-EKEPDLRPTASE-LLKHPFVTGDDEDPVLHASVMKSSEILSPSHVANLE 359
KD + + + +E L E +HPF TG D D + + E+ SP+ +N +
Sbjct: 241 KDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWDNIRNCEAPYIPEVSSPTDTSNFD 298
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 1e-22
Identities = 71/253 (28%), Positives = 118/253 (46%), Gaps = 22/253 (8%)
Query: 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNI 133
+G G FG V+MG +S ++ AVK + + ++ EE L+K L H +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKV-AVKTL---------KPGTMSVQAFLEEANLMKTLQHDKL 63
Query: 134 VRYLGTVREEESLNILLEFVPGGSISSLL----GKFGPFPEAVMRTYTKQLLLGLEYLHN 189
VR V +EE + I+ E++ GS+ L G P+ + ++ Q+ G+ Y+
Sbjct: 64 VRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLI--DFSAQIAEGMAYIER 121
Query: 190 HGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTG 249
+HRD++ AN+LV K+ADFG ++ V E + + K W APE I
Sbjct: 122 KNYIHRDLRAANVLVSESLMCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGS 180
Query: 250 HSYSADIWSVGCTVIEMAT-GKPPW-SQQYQEVAALFHIGTTKSHPPIPENLSVKAKDFL 307
+ +D+WS G + E+ T GK P+ +V + G P EN + D +
Sbjct: 181 FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM---PRMENCPDELYDIM 237
Query: 308 LKCLEKEPDLRPT 320
C +++ + RPT
Sbjct: 238 KTCWKEKAEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 1e-22
Identities = 74/259 (28%), Positives = 124/259 (47%), Gaps = 28/259 (10%)
Query: 73 LIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDH--IKELEEEVKLLKDLS- 129
+IG G++ +V + + ++ A+K V KE D I ++ E + + S
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVV-------KKELVHDDEDIDWVQTEKHVFEQASS 54
Query: 130 HPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHN 189
+P +V + L +++E+V GG + + + PE R Y ++ + L +LH
Sbjct: 55 NPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHE 114
Query: 190 HGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTG 249
GI++RD+K N+L+D G IKL D+G K+ L + GTP ++APE++R
Sbjct: 115 RGIIYRDLKLDNVLLDADGHIKLTDYGMCKE--GLGPGDTTSTFCGTPNYIAPEILRGEE 172
Query: 250 HSYSADIWSVGCTVIEMATGKPPW----------SQQYQEVAALFHIGTTKSHPPIPENL 299
+ +S D W++G + EM G+ P+ ++ Y LF + K IP L
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDY-----LFQVILEKP-IRIPRFL 226
Query: 300 SVKAKDFLLKCLEKEPDLR 318
SVKA L L K+P R
Sbjct: 227 SVKASHVLKGFLNKDPKER 245
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 1e-22
Identities = 81/273 (29%), Positives = 115/273 (42%), Gaps = 40/273 (14%)
Query: 73 LIGCGAFGRVYMGMNLD-----SGEL-LAVKQVLIAANFASKEKAQDHIKELEEEVKLLK 126
+G GAFG VY G D SG + +AVK + A K KE +E L+
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEK-------KEFLKEAHLMS 54
Query: 127 DLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLL---- 182
+ +HPNIV+ LG E I++E + GG + S L V R L L
Sbjct: 55 NFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRD-----ARVERFGPPLLTLKELL 109
Query: 183 --------GLEYLHNHGIMHRDIKGANILVDNKG-----CIKLADFGASKQVAELATVSG 229
G YL +HRD+ N LV KG +K+ DFG ++ + +
Sbjct: 110 DICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRK 169
Query: 230 AKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPW-SQQYQEVAALFHIG 287
WMAPE + + +D+WS G + E+ T G+ P+ + QEV L H+
Sbjct: 170 EGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEV--LQHV- 226
Query: 288 TTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPT 320
T PEN K + C ++P RPT
Sbjct: 227 TAGGRLQKPENCPDKIYQLMTNCWAQDPSERPT 259
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 2e-22
Identities = 75/278 (26%), Positives = 131/278 (47%), Gaps = 32/278 (11%)
Query: 68 WRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELE----EEVK 123
+R+ ++G G FG V +G++ A K++ EK + ++ E E +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKL---------EKKRIKKRKGESMALNEKQ 52
Query: 124 LLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGP--FPEAVMRTYTKQLL 181
+L+ ++ +V +++L ++L + GG + + G F E Y ++
Sbjct: 53 ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEIC 112
Query: 182 LGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMA 241
GLE LH I++RD+K NIL+D+ G I+++D G + V E T+ G GT +MA
Sbjct: 113 CGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG---RVGTVGYMA 169
Query: 242 PEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQ-----QYQEVAALFHIGTTKSHPPIP 296
PEV++ +++S D W++GC + EM G+ P+ Q + +EV L +
Sbjct: 170 PEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEE----YS 225
Query: 297 ENLSVKAKDFLLKCLEKEPDLR-----PTASELLKHPF 329
E S A+ L K+P R A E+ +HP
Sbjct: 226 EKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPL 263
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 2e-22
Identities = 75/283 (26%), Positives = 129/283 (45%), Gaps = 33/283 (11%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH 130
G+ +G G FG+V V A + + +++L E LLK ++H
Sbjct: 5 GKTLGEGEFGKVVKATAFRLKGRAGYTTV--AVKMLKENASSSELRDLLSEFNLLKQVNH 62
Query: 131 PNIVRYLGTVREEESLNILLEFVPGGSISSLL--------------------GKFGPFPE 170
P++++ G ++ L +++E+ GS+ S L P
Sbjct: 63 PHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDER 122
Query: 171 AV----MRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELAT 226
A+ + ++ Q+ G++YL ++HRD+ N+LV +K++DFG S+ V E
Sbjct: 123 ALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYE--E 180
Query: 227 VSGAKSMKG-TPY-WMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQEVAAL 283
S K KG P WMA E + ++ +D+WS G + E+ T G P+ E L
Sbjct: 181 DSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE--RL 238
Query: 284 FHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLK 326
F++ T PEN S + + +L C ++EPD RPT +++ K
Sbjct: 239 FNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 2e-22
Identities = 69/259 (26%), Positives = 117/259 (45%), Gaps = 25/259 (9%)
Query: 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNI 133
+G G +G VY G+ +AVK + KE + ++E +E ++K++ HPN+
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTL--------KEDTME-VEEFLKEAAVMKEIKHPNL 64
Query: 134 VRYLGTVREEESLNILLEFVPGGSISSLLGKFG--PFPEAVMRTYTKQLLLGLEYLHNHG 191
V+ LG E I+ EF+ G++ L + V+ Q+ +EYL
Sbjct: 65 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN 124
Query: 192 IMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHS 251
+HRD+ N LV +K+ADFG S+ + T + K W APE + S
Sbjct: 125 FIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFS 183
Query: 252 YSADIWSVGCTVIEMAT-GKPPW-----SQQYQEVAALFHIGTTKSHPPIPENLSVKAKD 305
+D+W+ G + E+AT G P+ SQ Y+ + + + + PP K +
Sbjct: 184 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPP-------KVYE 236
Query: 306 FLLKCLEKEPDLRPTASEL 324
+ C + P RP+ +E+
Sbjct: 237 LMRACWQWNPSDRPSFAEI 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 4e-22
Identities = 59/212 (27%), Positives = 102/212 (48%), Gaps = 7/212 (3%)
Query: 117 ELEEEVKLLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAV-MRT 175
E EE K++ LSH +V+ G ++ + I+ E++ G + + L + G + +
Sbjct: 45 EFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLE 104
Query: 176 YTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKG 235
K + G+ YL + +HRD+ N LVD++GC+K++DFG S+ V + S S K
Sbjct: 105 MCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGS-KF 163
Query: 236 TPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQ-QYQEVAALFHIGTTKSHP 293
W PEV+ + S +D+W+ G + E+ + GK P+ + E G P
Sbjct: 164 PVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRP 223
Query: 294 PIPENLSVKAKDFLLKCLEKEPDLRPTASELL 325
+ S K + C ++ + RPT +LL
Sbjct: 224 HLA---SEKVYAIMYSCWHEKAEERPTFQQLL 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 4e-22
Identities = 73/248 (29%), Positives = 117/248 (47%), Gaps = 33/248 (13%)
Query: 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNI 133
+G G + V+ G + + L+A+K++ + + A EV LLK+L H NI
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-------REVSLLKNLKHANI 65
Query: 134 VRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEA-VMRTYTKQLLLGLEYLHNHGI 192
V + E L ++ E++ + L G ++ + QLL GL Y H I
Sbjct: 66 VTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKI 124
Query: 193 MHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPY-------WMAPE-- 243
+HRD+K N+L++ KG +KLADFG ++ AKS+ Y W P
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLAR----------AKSVPTKTYSNEVVTLWYRPPDV 174
Query: 244 VIRQTGHSYSADIWSVGCTVIEMATGKP--PWSQQYQEVAALFHI---GTTKSHPPIPEN 298
++ T +S D+W VGC + EMATG+P P S +E+ +F + T ++ P I N
Sbjct: 175 LLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSN 234
Query: 299 LSVKAKDF 306
++ F
Sbjct: 235 EEFRSYLF 242
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 5e-22
Identities = 74/255 (29%), Positives = 128/255 (50%), Gaps = 27/255 (10%)
Query: 73 LIGCGAFGRVYMGMNLDSGELLAVK----QVLIAANFASKEKAQDHIKE---LEEEVKLL 125
++G G+FG+V + + EL A+K V+I QD E +E+ V L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVI----------QDDDVECTMVEKRVLAL 56
Query: 126 KDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLE 185
+D P + + + + L ++E+V GG + + + G F E Y ++ +GL
Sbjct: 57 QD-KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLF 115
Query: 186 YLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSG--AKSMKGTPYWMAPE 243
+LH GI++RD+K N+++D++G IK+ADFG K+ V G ++ GTP ++APE
Sbjct: 116 FLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKE----HMVDGVTTRTFCGTPDYIAPE 171
Query: 244 VIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKA 303
+I + S D W+ G + EM G+PP+ + ++ LF + + P++LS +A
Sbjct: 172 IIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED--ELFQ-SIMEHNVSYPKSLSKEA 228
Query: 304 KDFLLKCLEKEPDLR 318
+ K P R
Sbjct: 229 VSICKGLMTKHPSKR 243
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 6e-22
Identities = 78/309 (25%), Positives = 133/309 (43%), Gaps = 57/309 (18%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKE---LEEEVK 123
R++ E+IG G++G V ++ +GE +A+K++ +H+ + + E+K
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI---------NDVFEHVSDATRILREIK 51
Query: 124 LLKDLSHPNIVRYLGTV-----REEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTK 178
LL+ L HP+IV + RE + + ++ E + + ++ + +
Sbjct: 52 LLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLY 110
Query: 179 QLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPY 238
QLL L+Y+H + HRD+K NIL + +K+ DFG +A +A ++ T Y
Sbjct: 111 QLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFG----LARVAFNDTPTAIFWTDY 166
Query: 239 -----WMAPEVIRQTGHSYSA--DIWSVGCTVIEMATGKP-------------------- 271
+ APE+ Y+ DIWS+GC E+ TGKP
Sbjct: 167 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGT 226
Query: 272 PWSQQYQEV---AALFHIGTTKSHPPIP-----ENLSVKAKDFLLKCLEKEPDLRPTASE 323
P + V A ++ + + P+P N A L + L +P RPTA E
Sbjct: 227 PSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEE 286
Query: 324 LLKHPFVTG 332
L P+ G
Sbjct: 287 ALADPYFKG 295
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 6e-22
Identities = 80/297 (26%), Positives = 129/297 (43%), Gaps = 56/297 (18%)
Query: 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHP 131
E +G G++ VY G++ +G+L+A+K + + A E LLK L H
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAI-------REASLLKGLKHA 63
Query: 132 NIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHG 191
NIV + +E+L + E++ ++ G +R + QLL GL Y+H
Sbjct: 64 NIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH 123
Query: 192 IMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPY-------WMAPE- 243
I+HRD+K N+L+ G +KLADFG ++ AKS+ Y W P
Sbjct: 124 ILHRDLKPQNLLISYLGELKLADFGLAR----------AKSIPSQTYSSEVVTLWYRPPD 173
Query: 244 -VIRQTGHSYSADIWSVGCTVIEMATGKPPWS------QQYQEVAALFHIGTTKSHP--- 293
++ T +S + DIW GC IEM G+P + +Q +++ + + T + P
Sbjct: 174 VLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVS 233
Query: 294 ------------PIPENLSV---------KAKDFLLKCLEKEPDLRPTASELLKHPF 329
P+ L V KA+D + L P R +A + L HP+
Sbjct: 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPY 290
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 6e-22
Identities = 76/278 (27%), Positives = 124/278 (44%), Gaps = 34/278 (12%)
Query: 71 GELIGCGAFGRVYMG-MNLDSGELL--AVKQVLIAANFASKEKAQDHIKELEEEVKLLKD 127
G+++G G FG V G ++ D G L AVK + E I+E E +KD
Sbjct: 4 GKILGEGEFGSVMEGQLSQDDGSQLKVAVK-TMKLDIHTYSE-----IEEFLSEAACMKD 57
Query: 128 LSHPNIVRYLGTVREEESLN------ILLEFVPGGSISSLL--GKFGPFPEAVMRTYTKQ 179
HPN+++ +G E SL ++L F+ G + S L + G PE + Q
Sbjct: 58 FDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKL----PLQ 113
Query: 180 LLL--------GLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAK 231
LL G+EYL N +HRD+ N ++ + +ADFG SK++ +
Sbjct: 114 TLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGR 173
Query: 232 SMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQ-QYQEVAALFHIGTT 289
K W+A E + ++ +D+W+ G T+ E+AT G+ P+ + E+ G
Sbjct: 174 IAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNR 233
Query: 290 KSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327
PE+ + D + C +P RPT ++L +
Sbjct: 234 LKQ---PEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 99.8 bits (248), Expect = 7e-22
Identities = 84/290 (28%), Positives = 132/290 (45%), Gaps = 45/290 (15%)
Query: 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNI 133
IG G FG V++ + + E K + +EK+Q L EV ++++L H NI
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFCWKAISYRG-LKEREKSQ-----LVIEVNVMRELKHKNI 74
Query: 134 VRYLGTV--REEESLNILLEFVPGGSISSLLGK----FGPFPEAVMRTYTKQLLLGLEYL 187
VRY+ + + L IL+EF G +S + K FG E + T+QLL L Y
Sbjct: 75 VRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYC 134
Query: 188 HN-------HGIMHRDIKGANILV-----------------DNKGCIKLADFGASKQVAE 223
HN ++HRD+K NI + + + K+ DFG SK +
Sbjct: 135 HNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIG- 193
Query: 224 LATVSGAKSMKGTPYWMAPEVIRQTGHSY--SADIWSVGCTVIEMATGKPPWSQQYQEVA 281
S A S GTPY+ +PE++ SY +D+W++GC + E+ +GK P+ + +
Sbjct: 194 --IESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF-HKANNFS 250
Query: 282 ALFHIGTTKSHPPIPENLSVKAKDFLLK-CLEKEPDLRPTASELLKHPFV 330
L I K P +P K + L+K L RP+A + L + +
Sbjct: 251 QL--ISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQII 298
|
Length = 1021 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 7e-22
Identities = 73/270 (27%), Positives = 118/270 (43%), Gaps = 29/270 (10%)
Query: 74 IGCGAFGRVYMGM--NLDSGEL---LAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL 128
+G G+FG VY G+ + GE +A+K V A+ E E ++K+
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASM-------RERIEFLNEASVMKEF 66
Query: 129 SHPNIVRYLGTVREEESLNILLEFVPGGSISSLL----------GKFGPFPEAVMRTYTK 178
+ ++VR LG V + +++E + G + S L GP
Sbjct: 67 NCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAA 126
Query: 179 QLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGT-P 237
++ G+ YL +HRD+ N +V +K+ DFG ++ + E T K KG P
Sbjct: 127 EIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYE--TDYYRKGGKGLLP 184
Query: 238 Y-WMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQEVAALFHIGTTKSHPPI 295
WMAPE ++ + +D+WS G + EMAT + P+ E F I H +
Sbjct: 185 VRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID--GGHLDL 242
Query: 296 PENLSVKAKDFLLKCLEKEPDLRPTASELL 325
PEN K + + C + P +RPT E++
Sbjct: 243 PENCPDKLLELMRMCWQYNPKMRPTFLEIV 272
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 8e-22
Identities = 75/313 (23%), Positives = 139/313 (44%), Gaps = 18/313 (5%)
Query: 68 WRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKD 127
++K +++G GAFG VY G+ + GE + + + A+ KA KE+ +E ++
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN---KEILDEAYVMAS 65
Query: 128 LSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAV----MRTYTKQLLLG 183
+ +P++ R LG ++ ++ + +P G LL + + + + Q+ G
Sbjct: 66 VDNPHVCRLLGICLTS-TVQLITQLMPFGC---LLDYVREHKDNIGSQYLLNWCVQIAKG 121
Query: 184 LEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPE 243
+ YL ++HRD+ N+LV +K+ DFG +K + A+ K WMA E
Sbjct: 122 MNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALE 181
Query: 244 VIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQ-QYQEVAALFHIGTTKSHPPIPENLSV 301
I +++ +D+WS G TV E+ T G P+ E++++ G PPI ++
Sbjct: 182 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPI---CTI 238
Query: 302 KAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDPVLHASVMKSSEILSPSHVANLESL 361
++KC + D RP EL+ + DP + + + PS +
Sbjct: 239 DVYMIMVKCWMIDADSRPKFRELIIE--FSKMARDPQRYLVIQGDERMHLPSPTDSNFYR 296
Query: 362 QMLTSPGSPGSVD 374
++ VD
Sbjct: 297 ALMDEEDMDDVVD 309
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 9e-22
Identities = 68/259 (26%), Positives = 122/259 (47%), Gaps = 10/259 (3%)
Query: 69 RKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL 128
++ +++G GAFG VY G+ + GE + + + N + KA E +E ++ +
Sbjct: 10 KRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKAN---VEFMDEALIMASM 66
Query: 129 SHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGP-FPEAVMRTYTKQLLLGLEYL 187
HP++VR LG V ++ ++ + +P G + + + ++ + Q+ G+ YL
Sbjct: 67 DHPHLVRLLG-VCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYL 125
Query: 188 HNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQ 247
++HRD+ N+LV + +K+ DFG ++ + A K WMA E I
Sbjct: 126 EERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY 185
Query: 248 TGHSYSADIWSVGCTVIEMAT--GKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKD 305
++ +D+WS G T+ E+ T GKP +E+ L G PPI ++
Sbjct: 186 RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPI---CTIDVYM 242
Query: 306 FLLKCLEKEPDLRPTASEL 324
++KC + D RP EL
Sbjct: 243 VMVKCWMIDADSRPKFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 1e-21
Identities = 70/262 (26%), Positives = 118/262 (45%), Gaps = 25/262 (9%)
Query: 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNI 133
+G GAFG+V++ + L + ++ A K+ + + K+ E +LL +L H +I
Sbjct: 13 LGEGAFGKVFLA---ECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 69
Query: 134 VRYLGTVREEESLNILLEFVPGGSISSLLGKFGP-------------FPEAVMRTYTKQL 180
V++ G E + L ++ E++ G ++ L GP ++ M +Q+
Sbjct: 70 VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129
Query: 181 LLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQV--AELATVSGAKSMKGTPY 238
G+ YL + +HRD+ N LV +K+ DFG S+ V + V G +
Sbjct: 130 AAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP--IR 187
Query: 239 WMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQ-QYQEVAALFHIGTTKSHPPIP 296
WM PE I + +D+WS+G + E+ T GK PW Q EV G P
Sbjct: 188 WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQR---P 244
Query: 297 ENLSVKAKDFLLKCLEKEPDLR 318
+ D +L C ++EP +R
Sbjct: 245 RTCPKEVYDLMLGCWQREPHMR 266
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 1e-21
Identities = 74/266 (27%), Positives = 127/266 (47%), Gaps = 24/266 (9%)
Query: 69 RKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL 128
RK +L+G G FG V+ G+ + G+ + ++ +A + +E+ + + + L
Sbjct: 10 RKLKLLGSGVFGTVHKGIWIPEGDSI---KIPVAIKTIQDRSGRQTFQEITDHMLAMGSL 66
Query: 129 SHPNIVRYLGTVREEESLNILLEFVPGGSISSLL----GKFGPFPEAVMRTYTKQLLLGL 184
H IVR LG + SL ++ + P GS+ + P + + Q+ G+
Sbjct: 67 DHAYIVRLLG-ICPGASLQLVTQLSPLGSLLDHVRQHRDSLDP---QRLLNWCVQIAKGM 122
Query: 185 EYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAK---SMKGTPY-WM 240
YL H ++HR++ NIL+ + +++ADFG VA+L K S TP WM
Sbjct: 123 YYLEEHRMVHRNLAARNILLKSDSIVQIADFG----VADLLYPDDKKYFYSEHKTPIKWM 178
Query: 241 APEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQ-QYQEVAALFHIGTTKSHPPIPEN 298
A E I +++ +D+WS G TV EM + G P++ + EV L G + P I
Sbjct: 179 ALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQI--- 235
Query: 299 LSVKAKDFLLKCLEKEPDLRPTASEL 324
++ ++KC + ++RPT EL
Sbjct: 236 CTIDVYMVMVKCWMIDENVRPTFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 1e-21
Identities = 81/302 (26%), Positives = 133/302 (44%), Gaps = 59/302 (19%)
Query: 74 IGCGAFGRVYMGMNLDSGELLAVKQVL-IAANFASKEKAQDHIKELEEEVKLLKDLSHPN 132
IG GAFG V+ + G+ +A+K++ + N S K + E+K+L H N
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVS-------CKRVFRELKMLCFFKHDN 60
Query: 133 IVRYLGTVREE-----ESLNILLEFVPGGSISSLLGKFGPFPEAV----MRTYTKQLLLG 183
++ L ++ E + ++ E + S L K P+ + ++ + Q+L G
Sbjct: 61 VLSALDILQPPHIDPFEEIYVVTEL-----MQSDLHKIIVSPQPLSSDHVKVFLYQILRG 115
Query: 184 LEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKG---TPYWM 240
L+YLH+ GI+HRDIK N+LV++ +K+ DFG +A + +K M T Y+
Sbjct: 116 LKYLHSAGILHRDIKPGNLLVNSNCVLKICDFG----LARVEEPDESKHMTQEVVTQYYR 171
Query: 241 APEVIRQTGHSYSA-DIWSVGCTVIEMATGK---------------------PPWSQQ-Y 277
APE++ + H SA DIWSVGC E+ + P
Sbjct: 172 APEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRS 231
Query: 278 QEVAALFHIGTTKSHPP-------IPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFV 330
A HI PP + + +A L + L +PD R +A++ L HP++
Sbjct: 232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYL 291
Query: 331 TG 332
Sbjct: 292 DE 293
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 2e-21
Identities = 84/305 (27%), Positives = 131/305 (42%), Gaps = 71/305 (23%)
Query: 70 KGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS 129
K E +G G + V+ G + + L+A+K++ + + A EV LLKDL
Sbjct: 10 KLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-------REVSLLKDLK 62
Query: 130 HPNIVRYLGTVREEESLNILLEFVPG---------GSISSLLGKFGPFPEAVMRTYTKQL 180
H NIV V ++SL ++ E++ G+I S+ ++ + Q+
Sbjct: 63 HANIVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHN---------VKIFLYQI 113
Query: 181 LLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPY-- 238
L GL Y H ++HRD+K N+L++ +G +KLADFG ++ AKS+ Y
Sbjct: 114 LRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLAR----------AKSVPTKTYSN 163
Query: 239 -----WMAPEVIRQTGHSYSA--DIWSVGCTVIEMATGKP--PWSQQYQEVAALFHIGTT 289
W P + YS D+W VGC EMA+G+P P S E+ +F + T
Sbjct: 164 EVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGT 223
Query: 290 KSH---PPIPENLSVKAKDF----------------------LLKCLEKEPDLRPTASEL 324
+ P I N K +F L K L+ E R +A E
Sbjct: 224 PTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEA 283
Query: 325 LKHPF 329
+KH +
Sbjct: 284 MKHAY 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 77/291 (26%), Positives = 129/291 (44%), Gaps = 47/291 (16%)
Query: 71 GELIGCGAFGRVYM----------------GMNLDSGELLAVKQVLIAANFASKEKAQDH 114
E +G G FG V++ N D+ L+AVK + A+ ++E
Sbjct: 10 VEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARE----- 64
Query: 115 IKELEEEVKLLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAV-- 172
+ +EVK+L LS PNI R LG + L +++E++ G ++ L K +
Sbjct: 65 --DFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLAC 122
Query: 173 -MRTYTKQLLL--------GLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQV-- 221
++ + LL G+ YL + +HRD+ N LV IK+ADFG S+ +
Sbjct: 123 NSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYS 182
Query: 222 AELATVSGAKSMKGTPY-WMAPEVIRQTGHSYSADIWSVGCTVIEMAT--GKPPWS---- 274
++ V G + P WMA E + + +D+W+ G T+ E+ T + P+
Sbjct: 183 SDYYRVQGRAPL---PIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD 239
Query: 275 QQYQEVAALFHIGTT-KSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASEL 324
QQ E A F + + P P N + +L+C ++ + RPT E+
Sbjct: 240 QQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREI 290
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 2e-21
Identities = 70/249 (28%), Positives = 113/249 (45%), Gaps = 11/249 (4%)
Query: 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNI 133
+G G FG V G+ + KQ+ +A E + E+ E +++ L +P I
Sbjct: 3 LGSGNFGCVKKGV-----YKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYI 57
Query: 134 VRYLGTVREEESLNILLEFVPGGSISSLL-GKFGPFPEAVMRTYTKQLLLGLEYLHNHGI 192
VR +G V E E+L +++E GG ++ L GK + + Q+ +G++YL
Sbjct: 58 VRMIG-VCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNF 116
Query: 193 MHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPY-WMAPEVIRQTGHS 251
+HRD+ N+L+ N+ K++DFG SK + + A+S P W APE I S
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS 176
Query: 252 YSADIWSVGCTVIEMAT--GKPPWSQQYQEVAALFHIGTTKSHPP-IPENLSVKAKDFLL 308
+D+WS G T+ E + KP + EV + G P P + KD +
Sbjct: 177 SRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWI 236
Query: 309 KCLEKEPDL 317
E P+
Sbjct: 237 YKWEDRPNF 245
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 2e-21
Identities = 66/247 (26%), Positives = 127/247 (51%), Gaps = 11/247 (4%)
Query: 73 LIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPN 132
++G G+FG+V + + EL A+K ++ + ++ D ++ E ++L P
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIK--ILKKDVVIQD---DDVECTMVEKRVLALSGKPP 61
Query: 133 IVRYLGTVREE-ESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHG 191
+ L + + + L ++E+V GG + + + G F E Y ++ +GL +LH+ G
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG 121
Query: 192 IMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHS 251
I++RD+K N+++D++G IK+ADFG K+ + K+ GTP ++APE+I +
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCKE--NMWDGVTTKTFCGTPDYIAPEIIAYQPYG 179
Query: 252 YSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKDFLLKCL 311
S D W+ G + EM G+ P+ + ++ LF + + P+++S +A +
Sbjct: 180 KSVDWWAFGVLLYEMLAGQAPFEGEDED--ELFQ-SIMEHNVAYPKSMSKEAVAICKGLM 236
Query: 312 EKEPDLR 318
K P R
Sbjct: 237 TKHPGKR 243
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 2e-21
Identities = 66/275 (24%), Positives = 115/275 (41%), Gaps = 29/275 (10%)
Query: 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNI 133
IG GAFGRV+ G L ++A +E + D + + E L+ + HPNI
Sbjct: 13 IGQGAFGRVFQARAP--GLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNI 70
Query: 134 VRYLGTVREEESLNILLEFVPGGSISSLLGKFGPF-------PEAVMRTYT--------- 177
V+ LG + + +L E++ G ++ L P + R
Sbjct: 71 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCT 130
Query: 178 ------KQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAK 231
KQ+ G+ YL +HRD+ N LV +K+ADFG S+ + ++
Sbjct: 131 EQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASE 190
Query: 232 SMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATG--KPPWSQQYQEVAALFHIGTT 289
+ WM PE I ++ +D+W+ G + E+ + +P + ++EV G
Sbjct: 191 NDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNV 250
Query: 290 KSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASEL 324
S P+N ++ + + C K P RP+ + +
Sbjct: 251 LS---CPDNCPLELYNLMRLCWSKLPSDRPSFASI 282
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 3e-21
Identities = 70/256 (27%), Positives = 122/256 (47%), Gaps = 17/256 (6%)
Query: 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNI 133
IG G FG V++G L+ ++ A+K I S+E + EE +++ LSHP +
Sbjct: 12 IGSGQFGLVWLGYWLEKRKV-AIKT--IREGAMSEE-------DFIEEAQVMMKLSHPKL 61
Query: 134 VRYLGTVREEESLNILLEFVPGGSISSLL-GKFGPFPEAVMRTYTKQLLLGLEYLHNHGI 192
V+ G E + ++ EF+ G +S L + G F + + + G+ YL + +
Sbjct: 62 VQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNV 121
Query: 193 MHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSY 252
+HRD+ N LV +K++DFG ++ V + S + K W +PEV + +S
Sbjct: 122 IHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGT-KFPVKWSSPEVFSFSKYSS 180
Query: 253 SADIWSVGCTVIEM-ATGKPPWSQQYQ-EVAALFHIGTTKSHPPIPENLSVKAKDFLLKC 310
+D+WS G + E+ + GK P+ + EV + G P + S + + C
Sbjct: 181 KSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLA---SQSVYELMQHC 237
Query: 311 LEKEPDLRPTASELLK 326
++ P+ RP+ S LL
Sbjct: 238 WKERPEDRPSFSLLLH 253
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 3e-21
Identities = 57/150 (38%), Positives = 88/150 (58%), Gaps = 13/150 (8%)
Query: 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKD---LSH 130
I GAFG+VY+G ++ +L AVK V +KA K + +V+ +D LS
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVV---------KKADMINKNMVHQVQAERDALALSK 62
Query: 131 -PNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHN 189
P IV +++ ++ +++E++ GG + SLL +G F E + Y ++ L L+YLH
Sbjct: 63 SPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHR 122
Query: 190 HGIMHRDIKGANILVDNKGCIKLADFGASK 219
HGI+HRD+K N+L+ N+G IKL DFG SK
Sbjct: 123 HGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 3e-21
Identities = 73/254 (28%), Positives = 113/254 (44%), Gaps = 16/254 (6%)
Query: 71 GELIGCGAFGRVYMGM--NLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL 128
GEL G G FG V GM S + +AVK I N + +D EL E +++ L
Sbjct: 1 GEL-GSGNFGTVKKGMYKMKKSEKTVAVK---ILKNDNNDPALKD---ELLREANVMQQL 53
Query: 129 SHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLH 188
+P IVR +G + E ES +++E G ++ L K E + Q+ +G++YL
Sbjct: 54 DNPYIVRMIG-ICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLE 112
Query: 189 NHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPY-WMAPEVIRQ 247
+HRD+ N+L+ + K++DFG SK + AK+ P W APE +
Sbjct: 113 ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNY 172
Query: 248 TGHSYSADIWSVGCTVIE-MATGKPPW-SQQYQEVAALFHIGTTKSHPPIPENLSVKAKD 305
S +D+WS G + E + G+ P+ + EV + G P + D
Sbjct: 173 YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQ---RCPPEMYD 229
Query: 306 FLLKCLEKEPDLRP 319
+ C D RP
Sbjct: 230 LMKLCWTYGVDERP 243
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 4e-21
Identities = 65/226 (28%), Positives = 119/226 (52%), Gaps = 14/226 (6%)
Query: 73 LIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPN 132
++G GA+G V + ++ E++A+K+ F E+ ++ + E+K+L+ L N
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKK------FKDSEENEEVKETTLRELKMLRTLKQEN 61
Query: 133 IVRYLGTVREEESLNILLEFVPGGSISSLLGKF--GPFPEAVMRTYTKQLLLGLEYLHNH 190
IV R L ++ E+V + LL + G PE V R+Y QL+ + + H +
Sbjct: 62 IVELKEAFRRRGKLYLVFEYVEKNMLE-LLEEMPNGVPPEKV-RSYIYQLIKAIHWCHKN 119
Query: 191 GIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGH 250
I+HRDIK N+L+ + +KL DFG ++ ++E + + T ++ +PE++ +
Sbjct: 120 DIVHRDIKPENLLISHNDVLKLCDFGFARNLSE-GSNANYTEYVATRWYRSPELLLGAPY 178
Query: 251 SYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIP 296
+ D+WSVGC + E++ G+P + + E+ LF I K P+P
Sbjct: 179 GKAVDMWSVGCILGELSDGQPLFPGE-SEIDQLFTI--QKVLGPLP 221
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 6e-21
Identities = 75/260 (28%), Positives = 121/260 (46%), Gaps = 33/260 (12%)
Query: 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHP 131
+ +G G FG V+MG + +A+K + K+ + + E L+K L HP
Sbjct: 12 KKLGAGQFGEVWMGY-YNGHTKVAIKSL--------KQGSMS-PEAFLAEANLMKQLQHP 61
Query: 132 NIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTK------QLLLGLE 185
+VR L V +E + I+ E++ GS+ L PE + T K Q+ G+
Sbjct: 62 RLVR-LYAVVTQEPIYIITEYMENGSLVDFLKT----PEGIKLTINKLIDMAAQIAEGMA 116
Query: 186 YLHNHGIMHRDIKGANILVDNKGCIKLADFGASK--QVAELATVSGAK-SMKGTPYWMAP 242
++ +HRD++ ANILV C K+ADFG ++ + E GAK +K W AP
Sbjct: 117 FIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIK----WTAP 172
Query: 243 EVIRQTGHSYSADIWSVGCTVIEMAT-GKPPW-SQQYQEVAALFHIGTTKSHPPIPENLS 300
E I + +D+WS G + E+ T G+ P+ EV G P P+N
Sbjct: 173 EAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRM---PRPDNCP 229
Query: 301 VKAKDFLLKCLEKEPDLRPT 320
+ + + C +++P+ RPT
Sbjct: 230 EELYELMRLCWKEKPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 7e-21
Identities = 74/274 (27%), Positives = 127/274 (46%), Gaps = 26/274 (9%)
Query: 68 WRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELE----EEVK 123
+R ++G G FG V +G++ A K++ EK + ++ E E +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKL---------EKKRIKKRKGEAMALNEKR 52
Query: 124 LLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGP--FPEAVMRTYTKQLL 181
+L+ ++ +V +++L ++L + GG + + G F E Y +L
Sbjct: 53 ILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELC 112
Query: 182 LGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMA 241
GLE L I++RD+K NIL+D++G I+++D G + Q+ E TV G GT +MA
Sbjct: 113 CGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRG---RVGTVGYMA 169
Query: 242 PEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIG--TTKSHPPIPENL 299
PEVI +++S D W +GC + EM G+ P+ ++ +E + + E
Sbjct: 170 PEVINNEKYTFSPDWWGLGCLIYEMIQGQSPF-RKRKERVKREEVDRRVKEDQEEYSEKF 228
Query: 300 SVKAKDFLLKCLEKEPDLR-----PTASELLKHP 328
S AK L K P R A+ + +HP
Sbjct: 229 SEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHP 262
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 9e-21
Identities = 75/280 (26%), Positives = 121/280 (43%), Gaps = 30/280 (10%)
Query: 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNI 133
+G GAFG+V++ + L K ++ A A K+ K+ + E +LL +L H +I
Sbjct: 13 LGEGAFGKVFLA---ECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69
Query: 134 VRYLGTVREEESLNILLEFVPGGSISSLLGKFGP----------------FPEAVMRTYT 177
V++ G + + L ++ E++ G ++ L GP + M
Sbjct: 70 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129
Query: 178 KQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQV--AELATVSGAKSMKG 235
Q+ G+ YL + +HRD+ N LV +K+ DFG S+ V + V G +
Sbjct: 130 SQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP- 188
Query: 236 TPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQ-QYQEVAALFHIGTTKSHP 293
WM PE I + +D+WS G + E+ T GK PW Q EV G P
Sbjct: 189 -IRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERP 247
Query: 294 PI-PENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTG 332
+ P+ + D +L C ++EP R E+ K G
Sbjct: 248 RVCPKEVY----DIMLGCWQREPQQRLNIKEIYKILHALG 283
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 9e-21
Identities = 68/263 (25%), Positives = 119/263 (45%), Gaps = 19/263 (7%)
Query: 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHP 131
E+IG G FG V G G+ +++ +A + ++ E ++ HP
Sbjct: 10 EVIGAGEFGEVCRGRLKLPGK----REIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHP 65
Query: 132 NIVRYLGTVREEESLNILLEFVPGGSISSLL----GKFGPFPEAVMRTYTKQLLLGLEYL 187
NI+ G V + + I+ EF+ G++ S L G+F M + + G++YL
Sbjct: 66 NIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGM---LRGIAAGMKYL 122
Query: 188 HNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA---TVSGAKSMKGTPYWMAPEV 244
+HRD+ NILV++ K++DFG S+ + + T + + K W APE
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEA 182
Query: 245 IRQTGHSYSADIWSVGCTVIE-MATG-KPPWSQQYQEVAALFHIGTTKSHPPIPENLSVK 302
I + ++D+WS G + E M+ G +P W Q+V + I PP P +
Sbjct: 183 IAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV--INAIEQDYRLPP-PMDCPTA 239
Query: 303 AKDFLLKCLEKEPDLRPTASELL 325
+L C +K+ + RP +++
Sbjct: 240 LHQLMLDCWQKDRNARPKFGQIV 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 9e-21
Identities = 70/262 (26%), Positives = 121/262 (46%), Gaps = 21/262 (8%)
Query: 73 LIGCGAFGRVYMG-MNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHP 131
+IG G FG V G + L + V + A + K++ ++ E ++ HP
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQR-----RDFLSEASIMGQFDHP 65
Query: 132 NIVRYLGTVREEESLNILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLLGLEYLHNH 190
NI+ G V + + + I+ E++ GS+ + L K G F + + + G++YL +
Sbjct: 66 NIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDM 125
Query: 191 GIMHRDIKGANILVDNKGCIKLADFGASKQVAE----LATVSGAKSMKGTPY-WMAPEVI 245
G +HRD+ NILV++ K++DFG S+ + + T G K P W APE I
Sbjct: 126 GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK----IPIRWTAPEAI 181
Query: 246 RQTGHSYSADIWSVGCTVIE-MATG-KPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKA 303
+ ++D+WS G + E M+ G +P W Q+V G P P +
Sbjct: 182 AYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGY---RLPAPMDCPAAL 238
Query: 304 KDFLLKCLEKEPDLRPTASELL 325
+L C +K+ + RP +++
Sbjct: 239 HQLMLDCWQKDRNERPKFEQIV 260
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 1e-20
Identities = 71/274 (25%), Positives = 129/274 (47%), Gaps = 24/274 (8%)
Query: 68 WRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEE----EVK 123
+R+ ++G G FG V +G++ A K++ EK + ++ E E +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRL---------EKKRIKKRKGESMALNEKQ 52
Query: 124 LLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGP--FPEAVMRTYTKQLL 181
+L+ ++ +V +++L ++L + GG + + G F E Y ++L
Sbjct: 53 ILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEIL 112
Query: 182 LGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMA 241
GLE LH ++RD+K NIL+D+ G I+++D G + ++ E ++ G GT +MA
Sbjct: 113 CGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRG---RVGTVGYMA 169
Query: 242 PEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVA-ALFHIGTTKSHPPIPENLS 300
PEV+ ++ S D W +GC + EM G+ P+ + ++V ++ S
Sbjct: 170 PEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFS 229
Query: 301 VKAKDFLLKCLEKEPDLR-----PTASELLKHPF 329
+AK L K+P R A E+ +HPF
Sbjct: 230 EEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPF 263
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 1e-20
Identities = 68/272 (25%), Positives = 121/272 (44%), Gaps = 35/272 (12%)
Query: 72 ELIGCGAFGRVYMGM----NLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKD 127
E +G AFG++Y G +D +L+A+K + + + + E ++E L+ +
Sbjct: 11 EELGECAFGKIYKGHLYLPGMDHAQLVAIKTL---KDINNPQ----QWGEFQQEASLMAE 63
Query: 128 LSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRT------------ 175
L HPNIV LG V +E+ + +L E++ G + L P + +
Sbjct: 64 LHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDH 123
Query: 176 -----YTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGA 230
Q+ G+EYL +H +H+D+ NIL+ + +K++D G S+++ A
Sbjct: 124 GDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYS-ADYYRV 182
Query: 231 KSMKGTPY-WMAPEVIRQTGHSYSADIWSVGCTVIEMATG--KPPWSQQYQEVAALFHIG 287
+ P WM PE I S +DIWS G + E+ + +P + QEV +
Sbjct: 183 QPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR-- 240
Query: 288 TTKSHPPIPENLSVKAKDFLLKCLEKEPDLRP 319
+ P E+ + + +C ++ P RP
Sbjct: 241 -KRQLLPCSEDCPPRMYSLMTECWQEGPSRRP 271
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 1e-20
Identities = 67/257 (26%), Positives = 117/257 (45%), Gaps = 17/257 (6%)
Query: 70 KGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS 129
K ++IG G FG V+ G+ G K+V +A + ++ E ++ S
Sbjct: 9 KQKVIGAGEFGEVFRGILKMPGR----KEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS 64
Query: 130 HPNIVRYLGTVREEESLNILLEFVPGGSISSLL----GKFGPFPEAVMRTYTKQLLLGLE 185
H NI+R G V + + I+ E++ G++ L G+F + M + + G++
Sbjct: 65 HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGM---LRGIAAGMK 121
Query: 186 YLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPY-WMAPEV 244
YL + +HRD+ NILV++ K++DFG S+ + + + S P W APE
Sbjct: 122 YLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEA 181
Query: 245 IRQTGHSYSADIWSVGCTVIE-MATG-KPPWSQQYQEVAALFHIGTTKSHPPIPENLSVK 302
I + ++D+WS G + E M+ G +P W EV + G P P +
Sbjct: 182 IAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF---RLPAPMDCPSA 238
Query: 303 AKDFLLKCLEKEPDLRP 319
+L+C +++ RP
Sbjct: 239 VYQLMLQCWQQDRARRP 255
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 1e-20
Identities = 74/258 (28%), Positives = 117/258 (45%), Gaps = 25/258 (9%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH 130
GE+IG G FG V G G+ +AVK N AQ + EE ++ L H
Sbjct: 11 GEIIGEGEFGAVLQGEYT--GQKVAVK------NIKCDVTAQAFL----EETAVMTKLHH 58
Query: 131 PNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPF--PEAVMRTYTKQLLLGLEYLH 188
N+VR LG + L I++E + G++ + L G + ++ + G+EYL
Sbjct: 59 KNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE 117
Query: 189 NHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQT 248
+ ++HRD+ NILV G K++DFG ++ G + K W APE ++
Sbjct: 118 SKKLVHRDLAARNILVSEDGVAKVSDFGLAR-----VGSMGVDNSKLPVKWTAPEALKHK 172
Query: 249 GHSYSADIWSVGCTVIEM-ATGKPPWSQ-QYQEVAALFHIGTTKSHPPIPENLSVKAKDF 306
S +D+WS G + E+ + G+ P+ + +EV G + P PE
Sbjct: 173 KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKG-YRMEP--PEGCPADVYVL 229
Query: 307 LLKCLEKEPDLRPTASEL 324
+ C E EP RP+ +L
Sbjct: 230 MTSCWETEPKKRPSFHKL 247
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 2e-20
Identities = 68/261 (26%), Positives = 114/261 (43%), Gaps = 32/261 (12%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH 130
+G G FG V+ G+ + + A+K + K ++ ++EV+ LK L H
Sbjct: 11 ERKLGSGYFGEVWEGLWKNRVRV-AIKIL--------KSDDLLKQQDFQKEVQALKRLRH 61
Query: 131 PNIVRYLGTVREEESLNILLEFVPGGSISSLL----GKFGPFPEAVMRTYTKQLLLGLEY 186
+++ E + I+ E + GS+ + L G+ P + Q+ G+ Y
Sbjct: 62 KHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLI--DMACQVAEGMAY 119
Query: 187 LHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPY-WMAPEVI 245
L +HRD+ NILV K+ADFG ++ + E +S S K PY W APE
Sbjct: 120 LEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLS---SDKKIPYKWTAPEAA 176
Query: 246 RQTGHSYSADIWSVGCTVIEMAT-GKPPW-----SQQYQEVAALFHIGTTKSHPPIPENL 299
S +D+WS G + EM T G+ P+ + Y ++ A + + P +
Sbjct: 177 SHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKI 236
Query: 300 SVKAKDFLLKCLEKEPDLRPT 320
+L+C EP+ RP+
Sbjct: 237 -------MLECWAAEPEDRPS 250
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 2e-20
Identities = 81/305 (26%), Positives = 132/305 (43%), Gaps = 67/305 (21%)
Query: 82 VYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVR 141
VY+ + +G L+ V+ + + ++H+K L+ EV L HPNI+
Sbjct: 16 VYLARHTPTGTLVTVRITDL------ENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFT 69
Query: 142 EEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLG----LEYLHNHGIMHRDI 197
L ++ F+ GS +SLL + FPE + +L G L YLH +G +HR+I
Sbjct: 70 TGSWLWVISPFMAYGSANSLLKTY--FPEGMSEALIGNILFGALRGLNYLHQNGYIHRNI 127
Query: 198 KGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPY-------WMAPEVIRQTGH 250
K ++IL+ G + L+ G S + + AK + P W++PE++RQ +
Sbjct: 128 KASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLY 185
Query: 251 SYS--ADIWSVGCTVIEMATGK------------------PPWSQQY------------- 277
Y+ +DI+SVG T E+ATG+ PP+S
Sbjct: 186 GYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKN 245
Query: 278 ----------QEVAALFHIGTTKS---HPPIPENLSVKAKDFLLKCLEKEPDLRPTASEL 324
+ V A T S P + S ++ + CL+++P+ RP+AS L
Sbjct: 246 SQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSL 305
Query: 325 LKHPF 329
L H F
Sbjct: 306 LSHAF 310
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 2e-20
Identities = 79/302 (26%), Positives = 145/302 (48%), Gaps = 24/302 (7%)
Query: 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHP 131
++IG GAFG V + + + A+K I + ++A+ E V + D
Sbjct: 7 KVIGRGAFGEVAVVKMKHTERIYAMK---ILNKWEMLKRAETACFREERNVLVNGDCQWI 63
Query: 132 NIVRYLGTVREEESLNILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLLGLEYLHNH 190
+ Y ++E L +++++ GG + +LL KF PE + R Y +++L + +H
Sbjct: 64 TTLHY--AFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL 121
Query: 191 GIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQT-- 248
+HRDIK N+L+D G I+LADFG+ ++ + TV + ++ GTP +++PE+++
Sbjct: 122 HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAV-GTPDYISPEILQAMED 180
Query: 249 ---GHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSH------PPIPENL 299
+ D WS+G + EM G+ P+ Y E + + G +H P ++
Sbjct: 181 GMGKYGPECDWWSLGVCMYEMLYGETPF---YAE-SLVETYGKIMNHEERFQFPSHITDV 236
Query: 300 SVKAKDFL--LKCLEKEPDLRPTASELLKHPFVTGDDEDPVLHASVMKSSEILSPSHVAN 357
S +AKD + L C + + + KH F G D + + + ++ SPS +N
Sbjct: 237 SEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWENIRNLEAPYIPDVSSPSDTSN 296
Query: 358 LE 359
+
Sbjct: 297 FD 298
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 2e-20
Identities = 73/267 (27%), Positives = 119/267 (44%), Gaps = 20/267 (7%)
Query: 73 LIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPN 132
+G G FG V++ G + L+ K K ++ E E+ + + LSH N
Sbjct: 12 TLGRGEFGEVFLAKA--KGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKN 69
Query: 133 IVRYLGTVREEESLNILLEFVPGGSISSLL----GKFGPFPEAVMRTYTK-----QLLLG 183
+VR LG RE E ++LE+ G + L K + T K Q+ LG
Sbjct: 70 VVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALG 129
Query: 184 LEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQV--AELATVSGAKSMKGTPY-WM 240
+++L N +HRD+ N LV ++ +K++ SK V +E + A P W+
Sbjct: 130 MDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNAL----IPLRWL 185
Query: 241 APEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQEVAALFHIGTTKSHPPIPENL 299
APE +++ S +D+WS G + E+ T G+ P+ E L + K P+PE
Sbjct: 186 APEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE-EVLNRLQAGKLELPVPEGC 244
Query: 300 SVKAKDFLLKCLEKEPDLRPTASELLK 326
+ + +C P RP+ SEL+
Sbjct: 245 PSRLYKLMTRCWAVNPKDRPSFSELVS 271
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 3e-20
Identities = 75/311 (24%), Positives = 142/311 (45%), Gaps = 49/311 (15%)
Query: 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKL 124
P R++ +G GA+G V + +G +AVK++ + ++ H K E++L
Sbjct: 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL------SRPFQSIIHAKRTYRELRL 69
Query: 125 LKDLSHPNIVRYLGTVREEESLN-----ILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQ 179
LK + H N++ L SL L+ + G +++++ K + ++ Q
Sbjct: 70 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-KCQKLTDDHVQFLIYQ 128
Query: 180 LLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYW 239
+L GL+Y+H+ I+HRD+K +N+ V+ +K+ DFG ++ + T T ++
Sbjct: 129 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWY 183
Query: 240 MAPEVIRQTGH-SYSADIWSVGCTVIEMATGK--------------------PPWSQQYQ 278
APE++ H + + DIWSVGC + E+ TG+ P ++ +
Sbjct: 184 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 243
Query: 279 EVAALFHIGTTKSHPPIPE--------NLSVKAKDFLLKCLEKEPDLRPTASELLKHPFV 330
++++ +S +P+ + A D L K L + D R TA++ L H +
Sbjct: 244 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 303
Query: 331 T---GDDEDPV 338
D++PV
Sbjct: 304 AQYHDPDDEPV 314
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 3e-20
Identities = 66/263 (25%), Positives = 119/263 (45%), Gaps = 16/263 (6%)
Query: 69 RKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL 128
+K +++G GAFG VY G+ + GE + + + + KA KE+ +E ++ +
Sbjct: 10 KKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKAN---KEILDEAYVMAGV 66
Query: 129 SHPNIVRYLGTVREEESLNILLEFVPGGSISSLL----GKFGPFPEAVMRTYTKQLLLGL 184
P + R LG ++ ++ + +P G + + + G + + Q+ G+
Sbjct: 67 GSPYVCRLLGICLTS-TVQLVTQLMPYGCLLDYVRENKDRIG---SQDLLNWCVQIAKGM 122
Query: 185 EYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEV 244
YL ++HRD+ N+LV + +K+ DFG ++ + T A K WMA E
Sbjct: 123 SYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALES 182
Query: 245 IRQTGHSYSADIWSVGCTVIEMAT--GKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVK 302
I ++ +D+WS G TV E+ T KP +E+ L G PP ++
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPP---ICTID 239
Query: 303 AKDFLLKCLEKEPDLRPTASELL 325
++KC + + RP EL+
Sbjct: 240 VYMIMVKCWMIDSECRPRFRELV 262
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 4e-20
Identities = 66/228 (28%), Positives = 106/228 (46%), Gaps = 27/228 (11%)
Query: 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLL 125
++W GE GAFG+V++ + LL + ++ A A KE ++ ++ + E +LL
Sbjct: 9 LKWELGE----GAFGKVFLA---ECHNLLPEQDKMLVAVKALKEASESARQDFQREAELL 61
Query: 126 KDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAV------------- 172
L H +IVR+ G E L ++ E++ G ++ L GP + +
Sbjct: 62 TVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTL 121
Query: 173 --MRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVS-G 229
M Q+ G+ YL + +HRD+ N LV +K+ DFG S+ + G
Sbjct: 122 GQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 181
Query: 230 AKSMKGTPY-WMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQ 275
++M P WM PE I + +DIWS G + E+ T GK PW Q
Sbjct: 182 GRTM--LPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQ 227
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 5e-20
Identities = 69/257 (26%), Positives = 118/257 (45%), Gaps = 31/257 (12%)
Query: 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNI 133
+G G FG V+M + +AVK + + ++ E ++K L H +
Sbjct: 14 LGAGQFGEVWMA-TYNKHTKVAVK---------TMKPGSMSVEAFLAEANVMKTLQHDKL 63
Query: 134 VRYLGTVREEESLNILLEFVPGGSISSLL----GKFGPFPEAVMRTYTKQLLLGLEYLHN 189
V+ L V +E + I+ EF+ GS+ L G P P+ + ++ Q+ G+ ++
Sbjct: 64 VK-LHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLI--DFSAQIAEGMAFIEQ 120
Query: 190 HGIMHRDIKGANILVDNKGCIKLADFGASKQVA--ELATVSGAK-SMKGTPYWMAPEVIR 246
+HRD++ ANILV K+ADFG ++ + E GAK +K W APE I
Sbjct: 121 RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK----WTAPEAIN 176
Query: 247 QTGHSYSADIWSVGCTVIEMAT-GKPPWS--QQYQEVAALFHIGTTKSHPPIPENLSVKA 303
+ +D+WS G ++E+ T G+ P+ + + AL PE L
Sbjct: 177 FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELY--- 233
Query: 304 KDFLLKCLEKEPDLRPT 320
+ +++C + P+ RPT
Sbjct: 234 -NIMMRCWKNRPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 6e-20
Identities = 83/330 (25%), Positives = 144/330 (43%), Gaps = 92/330 (27%)
Query: 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKL 124
R++ + IG GA G V + +G+ +A+K+ ++ F + H K E+ L
Sbjct: 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKK--LSRPFQN----VTHAKRAYRELVL 68
Query: 125 LKDLSHPNIVRYLGTVREEESLN------ILLEFVPGG------------SISSLLGKFG 166
+K ++H NI+ L ++SL +++E + +S LL
Sbjct: 69 MKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLL---- 124
Query: 167 PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELAT 226
Y Q+L G+++LH+ GI+HRD+K +NI+V + +K+ DFG LA
Sbjct: 125 ---------Y--QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-------LAR 166
Query: 227 VSGAKSMKGTP-----YWMAPEVIRQTGHSYSADIWSVGCTVIEMATGK---------PP 272
+G M TP Y+ APEVI G+ + DIWSVGC + EM G
Sbjct: 167 TAGTSFMM-TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQ 225
Query: 273 WSQQYQEVAA-----LFHIGTT-----KSHPP---------IPENL------------SV 301
W++ +++ + + T ++ P P+ L +
Sbjct: 226 WNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKAS 285
Query: 302 KAKDFLLKCLEKEPDLRPTASELLKHPFVT 331
+A+D L K L +P+ R + + L+HP++
Sbjct: 286 QARDLLSKMLVIDPEKRISVDDALQHPYIN 315
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 6e-20
Identities = 76/299 (25%), Positives = 139/299 (46%), Gaps = 46/299 (15%)
Query: 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKL 124
P R++ +G GA+G V + + +AVK++ + ++ H + E++L
Sbjct: 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKL------SRPFQSLIHARRTYRELRL 67
Query: 125 LKDLSHPNIVRYL-----GTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQ 179
LK + H N++ L T E + L+ + G +++++ K + ++ Q
Sbjct: 68 LKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIV-KCQKLSDEHVQFLIYQ 126
Query: 180 LLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYW 239
LL GL+Y+H+ GI+HRD+K +N+ V+ +++ DFG ++Q + T T ++
Sbjct: 127 LLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMT-----GYVATRWY 181
Query: 240 MAPEVIRQTGH-SYSADIWSVGCTVIEMATGKP--PWSQQYQEVAALFHIGTT------- 289
APE++ H + + DIWSVGC + E+ GK P + ++ + + T
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLK 241
Query: 290 -----------KSHPPIPEN--------LSVKAKDFLLKCLEKEPDLRPTASELLKHPF 329
+S P +P+ + A D L K L + D R +ASE L HP+
Sbjct: 242 KISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPY 300
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 6e-20
Identities = 56/210 (26%), Positives = 115/210 (54%), Gaps = 10/210 (4%)
Query: 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNI 133
+G G FG V ++G++ A K++ K+K+ + + LE+E+ L+ ++ P I
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKL---DKKRLKKKSGEKMALLEKEI--LEKVNSPFI 55
Query: 134 VRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRT--YTKQLLLGLEYLHNHG 191
V + L +++ + GG + + G + R Y+ Q+ G+ +LH+
Sbjct: 56 VNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD 115
Query: 192 IMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHS 251
I++RD+K N+L+D++G +L+D G + ++ + T++ GT +MAPE++++ +S
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTIT---QRAGTNGYMAPEILKEEPYS 172
Query: 252 YSADIWSVGCTVIEMATGKPPWSQQYQEVA 281
Y D +++GC++ EM G+ P+ ++VA
Sbjct: 173 YPVDWFAMGCSIYEMVAGRTPFKDHKEKVA 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 8e-20
Identities = 75/256 (29%), Positives = 120/256 (46%), Gaps = 29/256 (11%)
Query: 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNI 133
+G G FG V+MG + +AVK + S E EE +++K L H +
Sbjct: 14 LGNGQFGEVWMGT-WNGNTKVAVKT--LKPGTMSPES-------FLEEAQIMKKLRHDKL 63
Query: 134 VRYLGTVREEESLNILLEFVPGGSISSLL----GKFGPFPEAVMRTYTKQLLLGLEYLHN 189
V+ L V EE + I+ E++ GS+ L G+ P V Q+ G+ Y+
Sbjct: 64 VQ-LYAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLV--DMAAQVAAGMAYIER 120
Query: 190 HGIMHRDIKGANILVDNKGCIKLADFGASKQVA--ELATVSGAK-SMKGTPYWMAPEVIR 246
+HRD++ ANILV + K+ADFG ++ + E GAK +K W APE
Sbjct: 121 MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIK----WTAPEAAL 176
Query: 247 QTGHSYSADIWSVGCTVIEMAT-GKPPW-SQQYQEVAALFHIGTTKSHPPIPENLSVKAK 304
+ +D+WS G + E+ T G+ P+ +EV G P P++ +
Sbjct: 177 YGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM---PCPQDCPISLH 233
Query: 305 DFLLKCLEKEPDLRPT 320
+ +L+C +K+P+ RPT
Sbjct: 234 ELMLQCWKKDPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 9e-20
Identities = 78/273 (28%), Positives = 123/273 (45%), Gaps = 27/273 (9%)
Query: 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIK-ELEEEVKLLKDLSH 130
E +G GAFG+VY G E L+ V I KE A+ ++ E +E +L+ DL H
Sbjct: 11 EELGEGAFGKVYKGELTGPNERLSATSVAIKT---LKENAEPKVQQEFRQEAELMSDLQH 67
Query: 131 PNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPF--PEAVMRTYTK---------- 178
PNIV LG +E+ +L E++ G + L + P A T
Sbjct: 68 PNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFL 127
Query: 179 ----QLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMK 234
Q+ G+EYL +H +HRD+ N LV +K++DFG S+ + A +S
Sbjct: 128 HIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYS-ADYYRVQSKS 186
Query: 235 GTPY-WMAPEVIRQTGHSYSADIWSVGCTVIEMAT--GKPPWSQQYQEVAALFHIGTTKS 291
P WM PE I + +DIWS G + E+ + +P + QEV + ++
Sbjct: 187 LLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR---SRQ 243
Query: 292 HPPIPENLSVKAKDFLLKCLEKEPDLRPTASEL 324
P PE+ + +++C + P RP ++
Sbjct: 244 LLPCPEDCPARVYALMIECWNEIPARRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 2e-19
Identities = 78/257 (30%), Positives = 120/257 (46%), Gaps = 31/257 (12%)
Query: 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNI 133
+G G FG V+MG + +A+K + S E +E +++K L H +
Sbjct: 14 LGQGCFGEVWMG-TWNGTTRVAIKT--LKPGTMSPEA-------FLQEAQVMKKLRHEKL 63
Query: 134 VRYLGTVREEESLNILLEFVPGGSISSLL----GKFGPFPEAVMRTYTKQLLLGLEYLHN 189
V+ L V EE + I+ E++ GS+ L GK+ P+ V Q+ G+ Y+
Sbjct: 64 VQ-LYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV--DMAAQIASGMAYVER 120
Query: 190 HGIMHRDIKGANILVDNKGCIKLADFGASKQVA--ELATVSGAK-SMKGTPYWMAPEVIR 246
+HRD++ ANILV K+ADFG ++ + E GAK +K W APE
Sbjct: 121 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK----WTAPEAAL 176
Query: 247 QTGHSYSADIWSVGCTVIEMAT-GKPPWSQQY-QEVAALFHIGTTKSHPP-IPENLSVKA 303
+ +D+WS G + E+ T G+ P+ +EV G PP PE+L
Sbjct: 177 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL---- 232
Query: 304 KDFLLKCLEKEPDLRPT 320
D + +C KEP+ RPT
Sbjct: 233 HDLMCQCWRKEPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 2e-19
Identities = 57/213 (26%), Positives = 99/213 (46%), Gaps = 35/213 (16%)
Query: 131 PNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNH 190
PN+V + E+S+ ++L+ GG + S + KF PE ++ + ++++ L+ LH
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHRE 104
Query: 191 GIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGH 250
GI+ RD+ NIL+D++G I+L F +V + ++M + APEV +
Sbjct: 105 GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----YCAPEVGGISEE 159
Query: 251 SYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPP---------IPENLSV 301
+ + D WS+G + E+ TGK + HP IPE +S
Sbjct: 160 TEACDWWSLGAILFELLTGK----------------TLVECHPSGINTHTTLNIPEWVSE 203
Query: 302 KAKDFLLKCLEKEPDLRPTA-----SELLKHPF 329
+A+ L + L+ P R A ++ HPF
Sbjct: 204 EARSLLQQLLQFNPTERLGAGVAGVEDIKSHPF 236
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 3e-19
Identities = 71/260 (27%), Positives = 117/260 (45%), Gaps = 36/260 (13%)
Query: 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNI 133
+G G FG V+ G+ ++ + AVK + K D K+ E +++K L HP +
Sbjct: 14 LGAGQFGEVWEGLWNNTTPV-AVKTL--------KPGTMD-PKDFLAEAQIMKKLRHPKL 63
Query: 134 VRYLGTVREEESLNILLEFVPGGSISSLL----GKFGPFPEAVMRTYTKQLLLGLEYLHN 189
++ EE + I+ E + GS+ L G+ P+ + Q+ G+ YL
Sbjct: 64 IQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLI--DMAAQVASGMAYLEA 121
Query: 190 HGIMHRDIKGANILVDNKGCIKLADFGASKQVAE--LATVSGAK-SMKGTPYWMAPEVIR 246
+HRD+ N+LV K+ADFG ++ + E GAK +K W APE
Sbjct: 122 QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIK----WTAPEAAL 177
Query: 247 QTGHSYSADIWSVGCTVIEMAT-GKPPWS-----QQYQEVAALFHIGTTKSHPPIPENLS 300
S +D+WS G + E+ T G+ P+ + Q+V + + P P
Sbjct: 178 YNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRM-------PCPPGCP 230
Query: 301 VKAKDFLLKCLEKEPDLRPT 320
+ D +L C +++PD RPT
Sbjct: 231 KELYDIMLDCWKEDPDDRPT 250
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 3e-19
Identities = 61/204 (29%), Positives = 99/204 (48%), Gaps = 12/204 (5%)
Query: 68 WRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKD 127
+ K E +G G++ VY G + +G+L+A+K + + + A E LLK
Sbjct: 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAI-------REASLLKG 59
Query: 128 LSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYL 187
L H NIV + +E+L ++ E+V + G ++ + QLL GL Y+
Sbjct: 60 LKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYI 119
Query: 188 HNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPE--VI 245
H I+HRD+K N+L+ + G +KLADFG ++ + S S + W P ++
Sbjct: 120 HQRYILHRDLKPQNLLISDTGELKLADFGLARAK---SVPSHTYSNEVVTLWYRPPDVLL 176
Query: 246 RQTGHSYSADIWSVGCTVIEMATG 269
T +S D+W VGC +EM G
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 4e-19
Identities = 80/315 (25%), Positives = 138/315 (43%), Gaps = 67/315 (21%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLK 126
R+++ + IG GA G V + G +AVK++ + + Q H K E+ LLK
Sbjct: 22 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKL------SRPFQNQTHAKRAYRELVLLK 75
Query: 127 DLSHPNIVRYLG------TVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQL 180
++H NI+ L ++ E + + +++E + + + M Q+
Sbjct: 76 CVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELD---HERMSYLLYQM 132
Query: 181 LLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTP--- 237
L G+++LH+ GI+HRD+K +NI+V + +K+ DFG ++ + + TP
Sbjct: 133 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--------TACTNFMMTPYVV 184
Query: 238 --YWMAPEVIRQTGHSYSADIWSVGCTVIEMATGK---------PPWSQ----------- 275
Y+ APEVI G+ + DIWSVGC + E+ G W++
Sbjct: 185 TRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAE 244
Query: 276 -----------------QYQEVA--ALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPD 316
QY ++ LF S + + +A+D L K L +PD
Sbjct: 245 FMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPD 304
Query: 317 LRPTASELLKHPFVT 331
R + E L+HP++T
Sbjct: 305 KRISVDEALRHPYIT 319
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 5e-19
Identities = 79/314 (25%), Positives = 137/314 (43%), Gaps = 63/314 (20%)
Query: 59 SVKMSPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKEL 118
K P IG GA+G V N ++ E +A+K+ IA F ++ A+ ++E+
Sbjct: 4 DTKYVPIKP------IGRGAYGIVCSAKNSETNEKVAIKK--IANAFDNRIDAKRTLREI 55
Query: 119 EEEVKLLKDLSHPNIVRYLGTVR--EEESLN---ILLEFVPGGSISSLLGKFGPFPEAVM 173
KLL+ L H N++ + E+ N I+ E + + ++ +
Sbjct: 56 ----KLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSDDHC 110
Query: 174 RTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSM 233
+ + QLL GL+Y+H+ ++HRD+K +N+L++ +K+ DFG LA + K
Sbjct: 111 QYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG-------LARTTSEKGD 163
Query: 234 KGTPY-----WMAPEVIRQ-TGHSYSADIWSVGCTVIEMATGKP-----PWSQQYQEVAA 282
T Y + APE++ + ++ + D+WSVGC E+ KP + Q + +
Sbjct: 164 FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITE 223
Query: 283 LFHIGT-----------------TKSHPPIPE--------NLSVKAKDFLLKCLEKEPDL 317
L +G+ +S P P + + A D L K L +P
Sbjct: 224 L--LGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSK 281
Query: 318 RPTASELLKHPFVT 331
R T E L HP++
Sbjct: 282 RITVEEALAHPYLA 295
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 8e-19
Identities = 77/272 (28%), Positives = 118/272 (43%), Gaps = 29/272 (10%)
Query: 74 IGCGAFGRVYMG----MNLDSGEL-LAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL 128
+G GAFG VY G + D+ EL +AVK + S++ D + E ++
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTL---PESCSEQDESDFLME----ALIMSKF 66
Query: 129 SHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLL------- 181
+H NIVR +G E ILLE + GG + S L + P PE K LL
Sbjct: 67 NHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVA 126
Query: 182 LGLEYLHNHGIMHRDIKGANILVDNKG---CIKLADFGASKQVAELATV-SGAKSMKGTP 237
G +YL + +HRDI N L+ KG K+ADFG ++ + + G ++M P
Sbjct: 127 KGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAM--LP 184
Query: 238 Y-WMAPEVIRQTGHSYSADIWSVGCTVIE-MATGKPPWSQQYQEVAALFHIGTTKSHPPI 295
WM PE + D+WS G + E + G P+ + + F G + P
Sbjct: 185 IKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDP-- 242
Query: 296 PENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327
P+ + C + P+ RP + +L+
Sbjct: 243 PKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 9e-19
Identities = 51/165 (30%), Positives = 78/165 (47%), Gaps = 9/165 (5%)
Query: 116 KELEEEVKLLKDLSHPNIVRYLGT-VREEESLNILLEFVPGGSISSLLGKFGPFPEAVMR 174
E L L HPNIV L + L + E+VPG ++ +L G P
Sbjct: 23 ARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGALPAGETG 82
Query: 175 TYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKG---CIKLADFGASK-----QVAELAT 226
Q+L L HN GI+HRD+K NI+V G K+ DFG + A++AT
Sbjct: 83 RLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVAT 142
Query: 227 VSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKP 271
++ + GTP + APE +R + ++D+++ G +E TG+
Sbjct: 143 LTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQR 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 9e-19
Identities = 68/276 (24%), Positives = 122/276 (44%), Gaps = 24/276 (8%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS- 129
G+ +G G FG+V M L + + V +A + + + +L E++++K +
Sbjct: 20 GKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 79
Query: 130 HPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGP------------------FPEA 171
H NI+ LG ++ L +++E+ G++ L P F +
Sbjct: 80 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDL 139
Query: 172 VMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAK 231
V TY Q+ G+EYL + +HRD+ N+LV +K+ADFG ++ V +
Sbjct: 140 VSCTY--QVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTT 197
Query: 232 SMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQEVAALFHIGTTK 290
+ + WMAPE + +++ +D+WS G + E+ T G P+ V LF +
Sbjct: 198 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG--IPVEELFKLLKEG 255
Query: 291 SHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLK 326
P N + + + C P RPT +L++
Sbjct: 256 HRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVE 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 2e-18
Identities = 74/266 (27%), Positives = 124/266 (46%), Gaps = 27/266 (10%)
Query: 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEE------EVKLL 125
+IG G FG VY G +DS +++ A K+ + I +LEE E ++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDG----QKIHCAV------KSLNRITDLEEVEQFLKEGIIM 50
Query: 126 KDLSHPNIVRYLG-TVREEESLNILLEFVPGGSISSLLGKFGPFPEAV-MRTYTKQLLLG 183
KD SHPN++ LG + E S ++L ++ G + + + P + + Q+ G
Sbjct: 51 KDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKG 110
Query: 184 LEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQV--AELATVSGAKSMKGTPYWMA 241
+EYL + +HRD+ N ++D +K+ADFG ++ + E +V K WMA
Sbjct: 111 MEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMA 170
Query: 242 PEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQEVAA--LFHIGTTKSHPPIPEN 298
E ++ + +D+WS G + E+ T G PP Y +V + + PE
Sbjct: 171 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPP----YPDVDSFDITVYLLQGRRLLQPEY 226
Query: 299 LSVKAKDFLLKCLEKEPDLRPTASEL 324
+ +L C +P++RPT SEL
Sbjct: 227 CPDPLYEVMLSCWHPKPEMRPTFSEL 252
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 70/281 (24%), Positives = 123/281 (43%), Gaps = 34/281 (12%)
Query: 71 GELIGCGAFGRVY----MGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLK 126
G+ +G G FG+V G++ + V + + A+ + D I E+E L+K
Sbjct: 17 GKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEME----LMK 72
Query: 127 DLS-HPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGP------------------ 167
+ H NI+ LG +E L +++E+ G++ L P
Sbjct: 73 LIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLS 132
Query: 168 FPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATV 227
F + V Y Q+ G+EYL + +HRD+ N+LV +K+ADFG ++ V ++
Sbjct: 133 FKDLVSCAY--QVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYY 190
Query: 228 SGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT--GKPPWSQQYQEVAALFH 285
+ + WMAPE + +++ +D+WS G + E+ T G P +E+ L
Sbjct: 191 KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLR 250
Query: 286 IGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLK 326
G P N + + + +C P RPT +L++
Sbjct: 251 EGHRMDKPS---NCTHELYMLMRECWHAVPTQRPTFKQLVE 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 4e-18
Identities = 70/272 (25%), Positives = 127/272 (46%), Gaps = 28/272 (10%)
Query: 71 GELIGCGAFGRV---YMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKD 127
G ++G G FG V + S + +AVK +L A F+S + I+E E +K+
Sbjct: 4 GRMLGKGEFGSVREAQLKSEDGSFQKVAVK-MLKADIFSSSD-----IEEFLREAACMKE 57
Query: 128 LSHPNIVRYLGTV---REEESLNI---LLEFVPGGSISS--LLGKFG--PF--PEAVMRT 175
HPN+++ +G R + L I +L F+ G + + L+ + G PF P +
Sbjct: 58 FDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVR 117
Query: 176 YTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKG 235
+ + G+EYL + +HRD+ N +++ + +ADFG SK++ + K
Sbjct: 118 FMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 236 TPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQ-QYQEVAALFHIGTTKSHP 293
W+A E + ++ +D+W+ G T+ E+ T G+ P++ + E+ G P
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQP 237
Query: 294 P-IPENLSVKAKDFLLKCLEKEPDLRPTASEL 324
P E++ + + +C EP RP+ L
Sbjct: 238 PDCLEDVY----ELMCQCWSPEPKCRPSFQHL 265
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 6e-18
Identities = 78/295 (26%), Positives = 133/295 (45%), Gaps = 55/295 (18%)
Query: 64 PPIRWRK---GELIGCGAFGRVYM------GMNLDSGELLAVKQVLIAANFASKEKAQDH 114
P + W ++IG G FG+V G+ +D+ A+K++ +ASK+ +D
Sbjct: 2 PVLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDA----AIKRM---KEYASKDDHRDF 54
Query: 115 IKELEEEVKLLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGK---------F 165
ELE KL HPNI+ LG L + +E+ P G++ L K F
Sbjct: 55 AGELEVLCKLG---HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAF 111
Query: 166 GPFPEAVMRTYTKQLLL--------GLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGA 217
+ T + Q LL G++YL +HRD+ NILV K+ADFG
Sbjct: 112 A-IANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 170
Query: 218 SKQVAELATVSGAKSMKGTPY-WMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPW-- 273
S+ V K+M P WMA E + + ++ ++D+WS G + E+ + G P+
Sbjct: 171 SRG----QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 226
Query: 274 ---SQQYQEVAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELL 325
++ Y+++ + + P N + D + +C ++P RP+ +++L
Sbjct: 227 MTCAELYEKLPQGYRLEK-------PLNCDDEVYDLMRQCWREKPYERPSFAQIL 274
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 7e-18
Identities = 82/325 (25%), Positives = 139/325 (42%), Gaps = 35/325 (10%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-S 129
G+ +G G FG+V M + + K V +A + + +L E++++K +
Sbjct: 17 GKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGK 76
Query: 130 HPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGP-----------FPEAVMR---- 174
H NI+ LG ++ L +L+E+ G++ L P PE +
Sbjct: 77 HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDL 136
Query: 175 -TYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSM 233
+ Q+ G+EYL + +HRD+ N+LV +K+ADFG ++ V + +
Sbjct: 137 VSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 234 KGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQEVAALFHIGTTKSH 292
+ WMAPE + +++ +D+WS G + E+ T G P+ V LF +
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG--IPVEELFKLLKEGHR 254
Query: 293 PPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDPVLHASVMKSSEILSP 352
P N + + + +C P RPT +L+ +D D VL +V + E L
Sbjct: 255 MDKPANCTHELYMIMRECWHAVPSQRPTFKQLV-------EDLDRVL--TVTSTDEYLDL 305
Query: 353 SHVANLESLQMLTSPGSPGSVDICN 377
S E SPG P S C+
Sbjct: 306 S--VPFEQY----SPGCPDSPSSCS 324
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 7e-18
Identities = 69/280 (24%), Positives = 124/280 (44%), Gaps = 34/280 (12%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDH-IKELEEEVKLLKDL- 128
G+ +G GAFG+V ++ L + A K+ A + + +L E++++K +
Sbjct: 17 GKPLGEGAFGQVVKA---EAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 73
Query: 129 SHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEA----VMRTYTKQLLL-- 182
H NI+ LG +E L +++E+ G++ L P E R + L
Sbjct: 74 KHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKD 133
Query: 183 ----------GLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAEL----ATVS 228
G+E+L + +HRD+ N+LV +K+ADFG ++ + + T +
Sbjct: 134 LVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTN 193
Query: 229 GAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT--GKPPWSQQYQEVAALFHI 286
G +K WMAPE + +++ +D+WS G + E+ T G P +E+ L
Sbjct: 194 GRLPVK----WMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKE 249
Query: 287 GTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLK 326
G P N + + + C + P RPT +L++
Sbjct: 250 GYRMEKPQ---NCTQELYHLMRDCWHEVPSQRPTFKQLVE 286
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 7e-18
Identities = 70/253 (27%), Positives = 115/253 (45%), Gaps = 23/253 (9%)
Query: 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNI 133
+G G FG V+MG + +A+K + + + +E +++K L H +
Sbjct: 14 LGQGCFGEVWMG-TWNGTTKVAIKTL---------KPGTMMPEAFLQEAQIMKKLRHDKL 63
Query: 134 VRYLGTVREEESLNILLEFVPGGSISSLL----GKFGPFPEAVMRTYTKQLLLGLEYLHN 189
V L V EE + I+ EF+ GS+ L GK+ P+ V Q+ G+ Y+
Sbjct: 64 VP-LYAVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLV--DMAAQIADGMAYIER 120
Query: 190 HGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTG 249
+HRD++ ANILV + K+ADFG ++ + E + + K W APE
Sbjct: 121 MNYIHRDLRAANILVGDNLVCKIADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGR 179
Query: 250 HSYSADIWSVGCTVIEMAT-GKPPWSQQY-QEVAALFHIGTTKSHPPIPENLSVKAKDFL 307
+ +D+WS G + E+ T G+ P+ +EV G P P+ + +
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRM---PCPQGCPESLHELM 236
Query: 308 LKCLEKEPDLRPT 320
C +K+PD RPT
Sbjct: 237 KLCWKKDPDERPT 249
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 1e-17
Identities = 85/324 (26%), Positives = 143/324 (44%), Gaps = 68/324 (20%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDS--GELLAVKQVLIAANFASKEKAQDHIKELEEEVKL 124
R+ + +G GA+G V N ++ E +A+K++ N SK+ K E+KL
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKI---TNVFSKKIL---AKRALRELKL 54
Query: 125 LKDL-SHPNIV-----------RYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAV 172
L+ H NI + EE L+E + ++ P +A
Sbjct: 55 LRHFRGHKNITCLYDMDIVFPGNFNELYLYEE----LMEA----DLHQIIRSGQPLTDAH 106
Query: 173 MRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKS 232
+++ Q+L GL+Y+H+ ++HRD+K N+LV+ +K+ DFG ++ +E A
Sbjct: 107 FQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP-GENAGF 165
Query: 233 MKG---TPYWMAPEV-IRQTGHSYSADIWSVGCTVIEMATGKPPW-SQQYQEVAALFHI- 286
M T ++ APE+ + ++ + D+WSVGC + E+ KP + + Y V L I
Sbjct: 166 MTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDY--VDQLNQIL 223
Query: 287 ---GT-----------------TKSHPPIPE--------NLSVKAKDFLLKCLEKEPDLR 318
GT +S P IP+ N + A D L K L +P R
Sbjct: 224 QVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKR 283
Query: 319 PTASELLKHPFVT---GDDEDPVL 339
+ E L+HP++ D++PV
Sbjct: 284 ISVEEALEHPYLAIWHDPDDEPVC 307
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 1e-17
Identities = 46/147 (31%), Positives = 74/147 (50%), Gaps = 5/147 (3%)
Query: 121 EVKLLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQL 180
E LL++++HP+++R T+ ++L + L + P P KQ+
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQI 166
Query: 181 LLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASK-QVAELATVSGAKSMKGTPYW 239
L GL YLH I+HRD+K NI +++ + + D GA++ V A + A GT
Sbjct: 167 LEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLA----GTVET 222
Query: 240 MAPEVIRQTGHSYSADIWSVGCTVIEM 266
APEV+ + ++ ADIWS G + EM
Sbjct: 223 NAPEVLARDKYNSKADIWSAGIVLFEM 249
|
Length = 357 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 82.2 bits (204), Expect = 2e-17
Identities = 74/262 (28%), Positives = 122/262 (46%), Gaps = 31/262 (11%)
Query: 76 CGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEV-KLLKDLSHPNIV 134
G FG+V + + + +L K + K K + +E V +L+KD +PN +
Sbjct: 26 DGKFGKVSVLKHKPTQKLFVQKII--------KAK---NFNAIEPMVHQLMKD--NPNFI 72
Query: 135 RYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMH 194
+ +V + ++++++ G + LL K G EA ++ +QL+ L LH H I+H
Sbjct: 73 KLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIH 132
Query: 195 RDIKGANILVD-NKGCIKLADFGASKQVAELATVSGAKSM-KGTPYWMAPEVIRQTGHSY 252
DIK N+L D K I L D+G K + G S GT + +PE I+ +
Sbjct: 133 NDIKLENVLYDRAKDRIYLCDYGLCKII-------GTPSCYDGTLDYFSPEKIKGHNYDV 185
Query: 253 SADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTK----SHPPIPENLSVKAKDFLL 308
S D W+VG E+ TGK P+ + E + + P +N+S A DF+
Sbjct: 186 SFDWWAVGVLTYELLTGKHPFKEDEDEE---LDLESLLKRQQKKLPFIKNVSKNANDFVQ 242
Query: 309 KCLEKEPDLR-PTASELLKHPF 329
L+ + R +E++KHPF
Sbjct: 243 SMLKYNINYRLTNYNEIIKHPF 264
|
Length = 267 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 2e-17
Identities = 81/315 (25%), Positives = 133/315 (42%), Gaps = 61/315 (19%)
Query: 64 PPIRWRKGELIGCGAFGRVYM--------------GMNLDSGELLAVKQVLIAANFASKE 109
P E +G G FG V++ N+ G L V ++ + A+K
Sbjct: 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPD-ANKN 61
Query: 110 KAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLL------- 162
D +KE VK+L L PNI+R LG +E+ L ++ E++ G ++ L
Sbjct: 62 ARNDFLKE----VKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDD 117
Query: 163 ----GKFGPFPEAVMRTYTKQLLL--------GLEYLHNHGIMHRDIKGANILVDNKGCI 210
G P + + LL G++YL + +HRD+ N LV I
Sbjct: 118 KEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTI 177
Query: 211 KLADFGASKQV--AELATVSGAKSMKGTPY-WMAPEVIRQTGHSYSADIWSVGCTVIE-- 265
K+ADFG S+ + + + G + P WMA E I + ++D+W+ G T+ E
Sbjct: 178 KIADFGMSRNLYAGDYYRIQGRAVL---PIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
Query: 266 MATGKPPWSQ----QYQEVAALFHIGTTKS-----HPPIPENLSVKAKDFLLKCLEKEPD 316
M + P+ + Q E A F + PP P+ L + +L+C ++
Sbjct: 235 MLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLY----ELMLQCWSRDCR 290
Query: 317 LRPTASELLKHPFVT 331
RP+ S++ H F+T
Sbjct: 291 ERPSFSDI--HAFLT 303
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-17
Identities = 69/278 (24%), Positives = 124/278 (44%), Gaps = 28/278 (10%)
Query: 71 GELIGCGAFGRVYMG--MNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL 128
G+ +G G FG+V M + LD + V +V A + + + +L E++++K +
Sbjct: 23 GKPLGEGCFGQVVMAEAIGLDKEKPNRVTKV--AVKMLKSDATEKDLSDLISEMEMMKMI 80
Query: 129 -SHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGP-----------FPEAVMR-- 174
H NI+ LG ++ L +++E+ G++ L P PE +
Sbjct: 81 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140
Query: 175 ---TYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAK 231
+ Q+ G+EYL + +HRD+ N+LV +K+ADFG ++ + +
Sbjct: 141 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 200
Query: 232 SMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT--GKPPWSQQYQEVAALFHIGTT 289
+ + WMAPE + +++ +D+WS G + E+ T G P +E+ L G
Sbjct: 201 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR 260
Query: 290 KSHPPIPEN-LSVKAKDFLLKCLEKEPDLRPTASELLK 326
P N L + +D C P RPT +L++
Sbjct: 261 MDKPSNCTNELYMMMRD----CWHAVPSQRPTFKQLVE 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 4e-17
Identities = 78/313 (24%), Positives = 136/313 (43%), Gaps = 65/313 (20%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLK 126
R++ + IG GA G V + +A+K++ + + Q H K E+ L+K
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL------SRPFQNQTHAKRAYRELVLMK 71
Query: 127 DLSHPNIVRYLG------TVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQL 180
++H NI+ L ++ E + + +++E + + + M Q+
Sbjct: 72 CVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELD---HERMSYLLYQM 128
Query: 181 LLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKG----T 236
L G+++LH+ GI+HRD+K +NI+V + +K+ DFG LA +G M T
Sbjct: 129 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-------LARTAGTSFMMTPYVVT 181
Query: 237 PYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGK---------PPWSQQYQEVAALFHIG 287
Y+ APEVI G+ + DIWSVGC + EM K W++ +++
Sbjct: 182 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 241
Query: 288 TTKSHPPI-------------------PENL-----------SVKAKDFLLKCLEKEPDL 317
K P + P++L + +A+D L K L +P
Sbjct: 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 301
Query: 318 RPTASELLKHPFV 330
R + E L+HP++
Sbjct: 302 RISVDEALQHPYI 314
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 5e-17
Identities = 64/214 (29%), Positives = 103/214 (48%), Gaps = 26/214 (12%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLK 126
R++ + IG GA G V + +A+K++ + + Q H K E+ L+K
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKL------SRPFQNQTHAKRAYRELVLMK 78
Query: 127 DLSHPNIVRYLGTVREEESLN------ILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQL 180
++H NI+ L ++SL I++E + + + M Q+
Sbjct: 79 CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELD---HERMSYLLYQM 135
Query: 181 LLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKG----T 236
L G+++LH+ GI+HRD+K +NI+V + +K+ DFG LA +G M T
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-------LARTAGTSFMMTPYVVT 188
Query: 237 PYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGK 270
Y+ APEVI G+ + DIWSVGC + EM G
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 6e-17
Identities = 74/277 (26%), Positives = 120/277 (43%), Gaps = 40/277 (14%)
Query: 72 ELIGCGAFGRVYMGM-NLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH 130
++IG G FG+V M D ++ A ++L FAS+ +D ELE KL H
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKML--KEFASENDHRDFAGELEVLCKLGH---H 62
Query: 131 PNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFP--------EAVMRTYTKQLLL 182
PNI+ LG L I +E+ P G++ L K T T Q LL
Sbjct: 63 PNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLL 122
Query: 183 --------GLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMK 234
G++YL +HRD+ N+LV K+ADFG S+ V K+M
Sbjct: 123 QFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRG----EEVYVKKTMG 178
Query: 235 GTPY-WMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPW-----SQQYQEVAALFHIG 287
P WMA E + + ++ +D+WS G + E+ + G P+ ++ Y+++ + +
Sbjct: 179 RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRME 238
Query: 288 TTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASEL 324
P N + + + +C P RP +++
Sbjct: 239 K-------PRNCDDEVYELMRQCWRDRPYERPPFAQI 268
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-16
Identities = 69/270 (25%), Positives = 119/270 (44%), Gaps = 31/270 (11%)
Query: 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKE-LEEEVKLLKDLSH 130
E +G FG+VY G + + V I K+KA+ ++E + E + L H
Sbjct: 11 EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKT---LKDKAEGPLREEFKHEAMMRSRLQH 67
Query: 131 PNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPF-----------------PEAVM 173
PNIV LG V +E+ L+++ + + L P P +
Sbjct: 68 PNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFV 127
Query: 174 RTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQV--AELATVSGAK 231
T Q+ G+E+L +H ++H+D+ N+LV +K +K++D G ++V A+ + G
Sbjct: 128 HIVT-QIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNS 186
Query: 232 SMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEM-ATGKPPW-SQQYQEVAALFHIGTT 289
+ WM+PE I S +DIWS G + E+ + G P+ Q+V +
Sbjct: 187 LLP--IRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR---N 241
Query: 290 KSHPPIPENLSVKAKDFLLKCLEKEPDLRP 319
+ P P++ +L+C + P RP
Sbjct: 242 RQVLPCPDDCPAWVYTLMLECWNEFPSRRP 271
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 8e-16
Identities = 72/276 (26%), Positives = 121/276 (43%), Gaps = 38/276 (13%)
Query: 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHP 131
++IG G FG+V G L + +ASK+ +D ELE KL HP
Sbjct: 1 DVIGEGNFGQVLKARIKKDG-LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH---HP 56
Query: 132 NIVRYLGTVREEESLNILLEFVPGGSISSLLGK---------FGPFPEAVMRTYTKQLLL 182
NI+ LG L + +E+ P G++ L K F ++QLL
Sbjct: 57 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 116
Query: 183 -------GLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKG 235
G++YL +HRD+ NILV K+ADFG S+ V K+M
Sbjct: 117 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG----QEVYVKKTMGR 172
Query: 236 TPY-WMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPW-----SQQYQEVAALFHIGT 288
P WMA E + + ++ ++D+WS G + E+ + G P+ ++ Y+++ + +
Sbjct: 173 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK 232
Query: 289 TKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASEL 324
P N + D + +C ++P RP+ +++
Sbjct: 233 -------PLNCDDEVYDLMRQCWREKPYERPSFAQI 261
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 9e-16
Identities = 77/295 (26%), Positives = 124/295 (42%), Gaps = 64/295 (21%)
Query: 90 SGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESLNIL 149
+GE + V+++ + A + + L+ E+ + K +HPNIV Y T + L ++
Sbjct: 24 TGEYVTVRRINLEAC------TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV 77
Query: 150 LEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLG----LEYLHNHGIMHRDIKGANILVD 205
F+ GS L+ F + + +L G L+Y+H+ G +HR +K ++IL+
Sbjct: 78 TSFMAYGSAKDLICTH--FMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILIS 135
Query: 206 NKGCIKLADFGAS------KQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSA--DIW 257
G + L+ ++ Q + S+K P W++PEV++Q Y A DI+
Sbjct: 136 VDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLP-WLSPEVLQQNLQGYDAKSDIY 194
Query: 258 SVGCTVIEMATGKPPW-----SQQYQE-----VAALFHI--------------------- 286
SVG T E+A G P+ +Q E V L
Sbjct: 195 SVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGL 254
Query: 287 --GTTKSHP----------PIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPF 329
TT S P P S F+ +CL++ PD RP+AS LL H F
Sbjct: 255 GESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF 309
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 69/270 (25%), Positives = 120/270 (44%), Gaps = 25/270 (9%)
Query: 71 GELIGCGAFGRVYMG-MNLDSGEL-LAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL 128
G+ +G G FG V G +N D L +AVK + IA ++ + +D + E +K+
Sbjct: 4 GKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIA--ICTRSEMEDFLSE----AVCMKEF 57
Query: 129 SHPNIVRYLGTV---REEESLN---ILLEFVPGGSISSLL--GKFGP----FPEAVMRTY 176
HPN++R +G E E ++L F+ G + S L + G P ++ +
Sbjct: 58 DHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKF 117
Query: 177 TKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGT 236
+ G+EYL + +HRD+ N +++ + +ADFG SK++ + K
Sbjct: 118 MTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMP 177
Query: 237 PYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPW-SQQYQEVAALFHIGTTKSHPP 294
W+A E + ++ +D+WS G T+ E+AT G+ P+ + E+ G PP
Sbjct: 178 VKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPP 237
Query: 295 IPENLSVKAKDFLLKCLEKEPDLRPTASEL 324
+ + C P RP+ L
Sbjct: 238 ---DCLDGLYSLMSSCWLLNPKDRPSFETL 264
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 1e-15
Identities = 72/272 (26%), Positives = 122/272 (44%), Gaps = 31/272 (11%)
Query: 74 IGCGAFGRVYMGMNLD--SGEL---LAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL 128
+G G+FG VY G D GE +AVK V +A+ +E+ E E ++K
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL--RERI-----EFLNEASVMKGF 66
Query: 129 SHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPE----------AVMRTYTK 178
+ ++VR LG V + + +++E + G + S L P E M
Sbjct: 67 TCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 126
Query: 179 QLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKG-TP 237
++ G+ YL+ +HRD+ N +V + +K+ DFG ++ + E T K KG P
Sbjct: 127 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE--TDYYRKGGKGLLP 184
Query: 238 Y-WMAPEVIRQTGHSYSADIWSVGCTVIEMAT--GKPPWSQQYQEVAALFHIGTTKSHPP 294
WMAPE ++ + S+D+WS G + E+ + +P ++V G
Sbjct: 185 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQ-- 242
Query: 295 IPENLSVKAKDFLLKCLEKEPDLRPTASELLK 326
P+N + D + C + P +RPT E++
Sbjct: 243 -PDNCPERVTDLMRMCWQFNPKMRPTFLEIVN 273
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 66/259 (25%), Positives = 119/259 (45%), Gaps = 27/259 (10%)
Query: 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHP 131
+ IG G FG V +G G +AVK + + AQ + E ++ L H
Sbjct: 12 QTIGKGEFGDVMLGDY--RGNKVAVKCI------KNDATAQAFLAE----ASVMTQLRHS 59
Query: 132 NIVRYLGTVREEE-SLNILLEFVPGGSISSLL---GKFGPFPEAVMRTYTKQLLLGLEYL 187
N+V+ LG + EE+ L I+ E++ GS+ L G+ + +++ ++ + +EYL
Sbjct: 60 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK-FSLDVCEAMEYL 118
Query: 188 HNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQ 247
+ +HRD+ N+LV K++DFG +K+ + S + K W APE +R+
Sbjct: 119 EANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-----STQDTGKLPVKWTAPEALRE 173
Query: 248 TGHSYSADIWSVGCTVIEMAT-GKPPWSQ-QYQEVAALFHIGTTKSHPPIPENLSVKAKD 305
S +D+WS G + E+ + G+ P+ + ++V G P+ D
Sbjct: 174 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD---APDGCPPVVYD 230
Query: 306 FLLKCLEKEPDLRPTASEL 324
+ +C + RP+ +L
Sbjct: 231 VMKQCWHLDAATRPSFLQL 249
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 2e-15
Identities = 70/260 (26%), Positives = 108/260 (41%), Gaps = 21/260 (8%)
Query: 73 LIGCGAFGRVYMG-MNLDSG-ELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH 130
++G G FG + G + L S EL L A + + E L H
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRG------FLAEALTLGQFDH 65
Query: 131 PNIVRYLGTVREEESLNILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLLGLEYLHN 189
NIVR G + ++ I+ E++ G++ S L K G + L G++YL
Sbjct: 66 SNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSE 125
Query: 190 HGIMHRDIKGANILVDNKGCIKLADFG---ASKQVAELATVSGAKSMKGTPYWMAPEVIR 246
G +H+ + +LV++ K++ F K A T+SG K W APE I+
Sbjct: 126 MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSG----KSPVLWAAPEAIQ 181
Query: 247 QTGHSYSADIWSVGCTVIE-MATG-KPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAK 304
S ++D+WS G + E M+ G +P W Q+V G P P N
Sbjct: 182 YHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGF---RLPAPRNCPNLLH 238
Query: 305 DFLLKCLEKEPDLRPTASEL 324
+L C +KE RP S++
Sbjct: 239 QLMLDCWQKERGERPRFSQI 258
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 4e-15
Identities = 70/293 (23%), Positives = 125/293 (42%), Gaps = 46/293 (15%)
Query: 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAV-------KQVLIAANFASKEKAQDHIK 116
P + R E +G G FG V++ E L + VL+A + +
Sbjct: 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARN 62
Query: 117 ELEEEVKLLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTY 176
+ +E+K++ L +PNI+R LG ++ L ++ E++ G ++ L + + T+
Sbjct: 63 DFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQ-----REIESTF 117
Query: 177 TK-----------------QLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASK 219
T Q+ G++YL + +HRD+ N LV N IK+ADFG S+
Sbjct: 118 THANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSR 177
Query: 220 QV--AELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT--GKPPWS- 274
+ + + G + WMA E I + ++D+W+ G T+ EM T + P+S
Sbjct: 178 NLYSGDYYRIQGRAVLP--IRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL 235
Query: 275 ---QQYQEVAALFHIGTTK----SHPPIPENLSVKAKDFLLKCLEKEPDLRPT 320
+Q E F + S P+ + +++C ++ RPT
Sbjct: 236 LSDEQVIENTGEFFRNQGRQIYLSQTPLCPS---PVFKLMMRCWSRDIKDRPT 285
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 67/273 (24%), Positives = 123/273 (45%), Gaps = 23/273 (8%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLI--AANFASKEKAQDHIKELEEEVKL 124
R +L+ G FGR++ G+ L + ++V + + AS + + L +E L
Sbjct: 7 RVTLSDLLQEGTFGRIFYGI-LIDEKPGKEEEVFVKTVKDHAS----EIQVTLLLQESCL 61
Query: 125 LKDLSHPNIVRYLGTVREE-ESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLL- 182
L LSH NI+ L E+ E +L ++ G++ L + + + Q L+
Sbjct: 62 LYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVH 121
Query: 183 -------GLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKG 235
G+ YLH G++H+DI N ++D + +K+ D S+ + + +
Sbjct: 122 MAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENR 181
Query: 236 TPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQ-QYQEVAALFHIGTTKSHP 293
WMA E + +S ++D+WS G + E+ T G+ P+ + E+AA G + P
Sbjct: 182 PVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQP 241
Query: 294 P-IPENLSVKAKDFLLKCLEKEPDLRPTASELL 325
P+ L + C +P+ RP+ S+L+
Sbjct: 242 INCPDELF----AVMACCWALDPEERPSFSQLV 270
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 81/335 (24%), Positives = 133/335 (39%), Gaps = 82/335 (24%)
Query: 64 PPIRWRKGELIGCGAFGRVY----MGMNL-DSGELLAVKQVLIAANFASKEKAQDHIKEL 118
P R R G+++G GAFG+V G++ S +AVK + A AS+ KA L
Sbjct: 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGAT-ASEHKA------L 57
Query: 119 EEEVKLLKDL-SHPNIVRYLGT-VREEESLNILLEF------------------------ 152
E+K+L + +H N+V LG + L +++EF
Sbjct: 58 MSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKS 117
Query: 153 -------------------VPGGSISSLLGKF-------------------GPFPEAVMR 174
+ G S L +F P +
Sbjct: 118 PKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLI 177
Query: 175 TYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMK 234
Y+ Q+ G+E+L + +HRD+ NIL+ +K+ DFG ++ + + S +
Sbjct: 178 CYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSAR 237
Query: 235 GTPYWMAPEVIRQTGHSYSADIWSVGCTVIEM-ATGKPPWS--QQYQEVAALFHIGTTKS 291
WMAPE I ++ +D+WS G + E+ + G P+ Q +E GT
Sbjct: 238 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMR 297
Query: 292 HPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLK 326
PEN + + +L C + +P RPT S L++
Sbjct: 298 ---APENATPEIYRIMLACWQGDPKERPTFSALVE 329
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 5e-14
Identities = 62/267 (23%), Positives = 116/267 (43%), Gaps = 23/267 (8%)
Query: 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNI 133
+G G+FG VY G + G + + +A ++ + E E ++K+ + ++
Sbjct: 14 LGQGSFGMVYEG--IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 71
Query: 134 VRYLGTVREEESLNILLEFVPGGSISSLLGKF----------GPFPEAVMRTYTKQLLLG 183
VR LG V + + +++E + G + S L P M ++ G
Sbjct: 72 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131
Query: 184 LEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKG--TPYWMA 241
+ YL+ + +HRD+ N +V +K+ DFG ++ + E T K KG WM+
Sbjct: 132 MAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE--TDYYRKGGKGLLPVRWMS 189
Query: 242 PEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQEVAALFHI--GTTKSHPPIPEN 298
PE ++ + +D+WS G + E+AT + P+ E F + G P+N
Sbjct: 190 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDK----PDN 245
Query: 299 LSVKAKDFLLKCLEKEPDLRPTASELL 325
+ + C + P +RP+ E++
Sbjct: 246 CPDMLFELMRMCWQYNPKMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 6e-14
Identities = 42/150 (28%), Positives = 73/150 (48%), Gaps = 2/150 (1%)
Query: 121 EVKLLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQL 180
E +L+ ++HP+I++ GT + ++L L K + + +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAAKRN-IAICDILAIERSV 191
Query: 181 LLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWM 240
L ++YLH + I+HRDIK NI +++ G + L DFGA+ ++ + GT
Sbjct: 192 LRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI-NANKYYGWAGTIATN 250
Query: 241 APEVIRQTGHSYSADIWSVGCTVIEMATGK 270
APE++ + + + DIWS G + EMAT
Sbjct: 251 APELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 1e-13
Identities = 51/148 (34%), Positives = 73/148 (49%), Gaps = 2/148 (1%)
Query: 121 EVKLLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGK-FGPFPEAVMRTYTKQ 179
E +LL+ LSHP ++ L VR L L+ + + LG P A + +Q
Sbjct: 210 EARLLRRLSHPAVLALL-DVRVVGGLTCLVLPKYRSDLYTYLGARLRPLGLAQVTAVARQ 268
Query: 180 LLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYW 239
LL ++Y+H GI+HRDIK N+LV+ I L DFGA+ + + GT
Sbjct: 269 LLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDT 328
Query: 240 MAPEVIRQTGHSYSADIWSVGCTVIEMA 267
APEV+ ++ S DIWS G + E A
Sbjct: 329 NAPEVLAGDPYTPSVDIWSAGLVIFEAA 356
|
Length = 461 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 1e-13
Identities = 68/283 (24%), Positives = 123/283 (43%), Gaps = 33/283 (11%)
Query: 72 ELIGCGAFGRVYM----GMN--LD---SGELLAVKQVLIAANFASKEKAQDHIKELEEEV 122
E +G G FG V++ GM +D S ++ + VL+A ++ ++ + +E+
Sbjct: 11 EKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEI 70
Query: 123 KLLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAV---------- 172
K++ L PNI+R L + L ++ E++ G ++ L + P A
Sbjct: 71 KIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYS 130
Query: 173 -MRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQV--AELATVSG 229
+ Q+ G++YL + +HRD+ N LV IK+ADFG S+ + + + G
Sbjct: 131 TLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQG 190
Query: 230 AKSMKGTPY-WMAPEVIRQTGHSYSADIWSVGCTVIEMAT--GKPPWSQQYQE-----VA 281
+ P WM+ E I + ++D+W+ G T+ E+ T + P+SQ E
Sbjct: 191 RAVL---PIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTG 247
Query: 282 ALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASEL 324
F + + P P +L C + RP+ E+
Sbjct: 248 EFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEI 290
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 69/259 (26%), Positives = 113/259 (43%), Gaps = 25/259 (9%)
Query: 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELE--EEVKLLKDLSHP 131
+G G F +Y G+ +L V + K DH L E L+ LSH
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSV-VLKVLGSDHRDSLAFFETASLMSQLSHK 61
Query: 132 NIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYT-KQLLLGLEYLHNH 190
++V+ G +E++ ++ E+V G + L + + KQL L YL +
Sbjct: 62 HLVKLYGVCVRDENI-MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDK 120
Query: 191 GIMHRDIKGANILV----DNKGC---IKLADFGASKQVAELATVSGAKSMKGTPYWMAPE 243
++H ++ G NILV N+G IKL+D G V +S + ++ P W+APE
Sbjct: 121 KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITV-----LSREERVERIP-WIAPE 174
Query: 244 VIRQTGHSYS--ADIWSVGCTVIEMAT-GKPPWSQQYQEVAALFHIGTTKSHPPIPENLS 300
IR S + AD WS G T++E+ + G+ P S F+ + P+P+
Sbjct: 175 CIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFY--QDQHRLPMPDCAE 232
Query: 301 VKAKDFLLKCLEKEPDLRP 319
+ + +C +P RP
Sbjct: 233 LAN--LINQCWTYDPTKRP 249
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 2e-13
Identities = 43/157 (27%), Positives = 72/157 (45%), Gaps = 1/157 (0%)
Query: 116 KELEEEVKLLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRT 175
K E+ +LK +SH I+ + R + ++ +++ + + + + GP P T
Sbjct: 131 KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP-KYKCDLFTYVDRSGPLPLEQAIT 189
Query: 176 YTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKG 235
++LL L YLH GI+HRD+K NI +D L DFGA+ ++ G
Sbjct: 190 IQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSG 249
Query: 236 TPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPP 272
T +PE++ + DIWS G + EM+
Sbjct: 250 TLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 2e-13
Identities = 57/227 (25%), Positives = 101/227 (44%), Gaps = 42/227 (18%)
Query: 70 KGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELE---------E 120
+G +G G +G VY D K++ + +K++E
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDG-----------------KDEKEYALKQIEGTGISMSACR 47
Query: 121 EVKLLKDLSHPNIVRYLGTVREEESLNILLEF----------VPGGSISSLLGKFGPFPE 170
E+ LL++L HPN++ + L F + S K P
Sbjct: 48 EIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPR 107
Query: 171 AVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILV----DNKGCIKLADFGASKQV-AELA 225
+++++ Q+L G+ YLH + ++HRD+K ANILV +G +K+AD G ++ + L
Sbjct: 108 SMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 167
Query: 226 TVSGAKSMKGTPYWMAPEVIRQTGHSYSA-DIWSVGCTVIEMATGKP 271
++ + T ++ APE++ H A DIW++GC E+ T +P
Sbjct: 168 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 214
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 4e-13
Identities = 63/267 (23%), Positives = 121/267 (45%), Gaps = 25/267 (9%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKE-LEEEVKLLKDL- 128
G+ +G GAFG+V + AV +V + K A +E L E+K++ L
Sbjct: 40 GKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKM---LKPTAHSSEREALMSELKIMSHLG 96
Query: 129 SHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGK----FGPFPEAVMRTYTKQLLLGL 184
+H NIV LG + ++ E+ G + + L + F + + +Y Q+ G+
Sbjct: 97 NHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSY--QVAKGM 154
Query: 185 EYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEV 244
+L + +HRD+ N+L+ + +K+ DFG ++ + + + + WMAPE
Sbjct: 155 AFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPES 214
Query: 245 IRQTGHSYSADIWSVGCTVIEMAT-------GKPPWSQQYQEVAALFHIGTTKSHPPIPE 297
I +++ +D+WS G + E+ + G P S+ Y+ + + + PE
Sbjct: 215 IFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQ-------PE 267
Query: 298 NLSVKAKDFLLKCLEKEPDLRPTASEL 324
+ + D + C + +P RPT ++
Sbjct: 268 HAPAEIYDIMKTCWDADPLKRPTFKQI 294
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 5e-13
Identities = 47/167 (28%), Positives = 81/167 (48%), Gaps = 16/167 (9%)
Query: 121 EVKLLKDLSHPNIVRYLGTVREEESLNILLEF----------VPGGSISSLLGKFGPFPE 170
E+ LL++L HPN++ + L F + S K P
Sbjct: 48 EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPR 107
Query: 171 AVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILV----DNKGCIKLADFGASKQV-AELA 225
++++ Q+L G+ YLH + ++HRD+K ANILV +G +K+AD G ++ + L
Sbjct: 108 GMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 167
Query: 226 TVSGAKSMKGTPYWMAPEVIRQTGHSYSA-DIWSVGCTVIEMATGKP 271
++ + T ++ APE++ H A DIW++GC E+ T +P
Sbjct: 168 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 7e-13
Identities = 45/189 (23%), Positives = 74/189 (39%), Gaps = 33/189 (17%)
Query: 156 GSISSLLGKFG-PFPE----AVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCI 210
S++ +L G P E AV Q L L LH + + L+ G
Sbjct: 1 VSLADILEVRGRPLNEEEIWAVCL----QCLGALRELHRQAKSGNILLTWDGLLKLDG-- 54
Query: 211 KLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGK 270
+ + PY+MAPEVI+ ++ ADI+S+G T+ E +
Sbjct: 55 -------------SVAFKTPEQSRPDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYE 101
Query: 271 PPWSQQYQEVAALFHI---GTTKSHPP---IPENLS--VKAKDFLLKCLEKEPDLRPTAS 322
P++++ +E++A+ I G P E +S +DF+ C + P R A+
Sbjct: 102 LPYNEE-RELSAILEILLNGMPADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAAN 160
Query: 323 ELLKHPFVT 331
L H
Sbjct: 161 HYLAHCRAL 169
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 1e-12
Identities = 71/262 (27%), Positives = 116/262 (44%), Gaps = 43/262 (16%)
Query: 117 ELEEEVKLLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVM--- 173
+LE E+ L L+H NI++ +R E + ++ + S + + + + +
Sbjct: 209 QLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQ 268
Query: 174 -RTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKS 232
R KQLL +EY+H+ ++HRDIK NI ++ G I L DFG + E +
Sbjct: 269 TRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPF-EKEREAFDYG 327
Query: 233 MKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT---------GKPPWSQ-------- 275
GT +PE++ G+ DIWS G +++M + G P Q
Sbjct: 328 WVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSL 387
Query: 276 ---------------QYQEVAALFHIGTTKSHPPIPENLSVKAKDF---LLKCLEKEPDL 317
Y + A + H G + PP+ NL + A DF L+K L + L
Sbjct: 388 SVCDEEFPDPPCKLFDYIDSAEIDHAGHSV--PPLIRNLGLPA-DFEYPLVKMLTFDWHL 444
Query: 318 RPTASELLKHPFVTGDDEDPVL 339
RP A+ELL P + ++E+ +L
Sbjct: 445 RPGAAELLALPLFSAEEEEEIL 466
|
Length = 501 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 43/155 (27%), Positives = 73/155 (47%), Gaps = 6/155 (3%)
Query: 176 YTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKG 235
Y+ Q+ G+E+L + +HRD+ NIL+ +K+ DFG ++ + + +
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243
Query: 236 TPYWMAPEVIRQTGHSYSADIWSVGCTVIEM-ATGKPPWSQQY--QEVAALFHIGTTKSH 292
WMAPE I ++ +D+WS G + E+ + G P+ +E GT
Sbjct: 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR- 302
Query: 293 PPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327
P+ + + +L C EP RPT SEL++H
Sbjct: 303 --APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 4e-12
Identities = 90/365 (24%), Positives = 149/365 (40%), Gaps = 75/365 (20%)
Query: 73 LIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPN 132
LIG G G VY+ + +A+K+ I + + + K E K+ DL HP
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKK--IREDLSENPLLK---KRFLREAKIAADLIHPG 63
Query: 133 IVRYLGTVREEESLNILLEFVPGGSISSLLGKF-------GPFPE-----AVMRTYTKQL 180
IV + + + + ++ G ++ SLL E A + + K +
Sbjct: 64 IVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHK-I 122
Query: 181 LLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASK----QVAELATVSGAK----- 231
+EY+H+ G++HRD+K NIL+ G + + D+GA+ + +L + +
Sbjct: 123 CATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182
Query: 232 -SMK------GTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQY------- 277
SM GTP +MAPE + S S DI+++G + +M T P+ ++
Sbjct: 183 SSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYR 242
Query: 278 ------QEVAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLK---HP 328
EVA + IP LS A +K L +P R ++ + LK P
Sbjct: 243 DVILSPIEVA---------PYREIPPFLSQIA----MKALAVDPAERYSSVQELKQDLEP 289
Query: 329 FVTGDDEDPVLHASVMKSSE-------ILSPSHVANLESLQMLTSPGSPGSVDICNLDSL 381
+ G E V + K IL + LES SP S+ I ++S
Sbjct: 290 HLQGSPEWTVKATLMTKKKSCWKFYEPILLSKYFPMLES-----SPAQWYSLMISKIESS 344
Query: 382 SCSRV 386
S +R+
Sbjct: 345 SETRL 349
|
Length = 932 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 8e-12
Identities = 64/268 (23%), Positives = 117/268 (43%), Gaps = 24/268 (8%)
Query: 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNI 133
IG G FG+V +G ++SG QV++ Q+ +K LEE + + L H N+
Sbjct: 3 IGNGWFGKVILG-EVNSG--YTPAQVVVK-ELRVSASVQEQMKFLEE-AQPYRSLQHSNL 57
Query: 134 VRYLGTVREEESLNILLEFVPGGSISSLLGK------FGPFPEAVMRTYTKQLLLGLEYL 187
++ LG E +++EF P G + L P P + R ++ LGL +L
Sbjct: 58 LQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRM-ACEIALGLLHL 116
Query: 188 HNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQ 247
H + +H D+ N L+ +K+ D+G S + + W+APE++ +
Sbjct: 117 HKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDE 176
Query: 248 -------TGHSYSADIWSVGCTVIEM-ATGKPPWSQQYQEVAALFHIGTTKSHPPIPENL 299
+ +++WS+G T+ E+ G P+ E + + + P P L
Sbjct: 177 VHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPR-L 235
Query: 300 SVKAKDFLLKCLEK---EPDLRPTASEL 324
+ D + ++ +P+ RP+A E+
Sbjct: 236 KLPLSDRWYEVMQFCWLQPEQRPSAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 9e-12
Identities = 69/277 (24%), Positives = 122/277 (44%), Gaps = 33/277 (11%)
Query: 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKE-KAQDHIKELEEEVKLLKDLSHPN 132
IG G FG+V +G ++ ++ +V++ AS Q +EV+ ++L+HPN
Sbjct: 3 IGNGWFGKVLLG---EAHRGMSKARVVVKELRASATPDEQL---LFLQEVQPYRELNHPN 56
Query: 133 IVRYLGTVREEESLNILLEFVPGGSISSLLGK------FGPFPEAVMRTYTKQLLLGLEY 186
+++ LG E ++LEF P G + + L + + R ++ GL +
Sbjct: 57 VLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRM-ACEVASGLLW 115
Query: 187 LHNHGIMHRDIKGANILVDNKGCIKLADFG-ASKQVAELATVSGAKSMKGTPY-WMAPEV 244
LH +H D+ N + +K+ D+G A +Q E ++ K P W+APE+
Sbjct: 116 LHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT--KDCHAVPLRWLAPEL 173
Query: 245 IRQTGH-------SYSADIWSVGCTVIEMAT-GKPPWSQQYQEVAALFHIGTTKSHPPIP 296
+ G + ++IWS+G T+ E+ T P+ E + P P
Sbjct: 174 VEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKP 233
Query: 297 ENLSVKAKDFLLKCLE---KEPDLRPTASE---LLKH 327
L +K D + ++ +P+ RPTA E LL +
Sbjct: 234 -QLDLKYSDRWYEVMQFCWLDPETRPTAEEVHELLTY 269
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 43/156 (27%), Positives = 73/156 (46%), Gaps = 6/156 (3%)
Query: 175 TYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMK 234
+Y+ Q+ G+E+L + +HRD+ NIL+ +K+ DFG ++ + + +
Sbjct: 177 SYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 236
Query: 235 GTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT--GKP-PWSQQYQEVAALFHIGTTKS 291
WMAPE I ++ +D+WS G + E+ + P P Q +E GT
Sbjct: 237 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMR 296
Query: 292 HPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327
PE + + +L C P+ RPT SEL++
Sbjct: 297 A---PEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 58/236 (24%), Positives = 94/236 (39%), Gaps = 44/236 (18%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEV---- 122
W+ +LIGCG FG VY + A++ +A I+ LE E
Sbjct: 13 EWKIDKLIGCGGFGCVY--------------ETQCASDHCINNQAVAKIENLENETIVME 58
Query: 123 ----------------KLLKDLSHPNIVRYLGTVREEESLN----ILLEFVPGGSISSLL 162
K + ++ H I +Y G + ILLE + + +
Sbjct: 59 TLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVE-NTKEIF 117
Query: 163 GKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFG-ASKQV 221
+ + +++ K +L LEY+H HGI H DIK NI+VD + D+G AS +
Sbjct: 118 KRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFI 177
Query: 222 AELATVSGAKSMK----GTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPW 273
+ +K K GT Y+ + + D+ S+G +++ A K PW
Sbjct: 178 IHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPW 233
|
Length = 294 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 4e-11
Identities = 64/219 (29%), Positives = 100/219 (45%), Gaps = 24/219 (10%)
Query: 120 EEVKLLKDLSHPNIVRYLGT-VREEESLNILL-EFVPGGSISSLLGK-FGPFPEAVMRTY 176
E L+ +SH ++ G VR E NI++ EFV G + L K G P A T
Sbjct: 65 ETASLMSQVSHIHLAFVHGVCVRGSE--NIMVEEFVEHGPLDVCLRKEKGRVPVAWKITV 122
Query: 177 TKQLLLGLEYLHNHGIMHRDIKGANILVDNKGC-------IKLADFGASKQVAELATVSG 229
+QL L YL + ++H ++ NIL+ G IKL+D G S +S
Sbjct: 123 AQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS-----FTALSR 177
Query: 230 AKSMKGTPYWMAPEVIRQ-TGHSYSADIWSVGCTVIEMA-TGKPPWSQQYQEVAALFHIG 287
+ ++ P W+APE + S +AD WS G T++E+ G+ P ++ F+
Sbjct: 178 EERVERIP-WIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFY-- 234
Query: 288 TTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLK 326
K H +PE + + +CL EP RP+ +L+
Sbjct: 235 -EKKH-RLPEPSCKELATLISQCLTYEPTQRPSFRTILR 271
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 38/153 (24%), Positives = 75/153 (49%), Gaps = 14/153 (9%)
Query: 175 TYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMK 234
++T Q+ G+E+L + +HRD+ N+L+ +K+ DFG ++ + + S
Sbjct: 241 SFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTF 300
Query: 235 GTPYWMAPEVIRQTGHSYSADIWSVGCTVIEM-ATGKPPW------SQQYQEVAALFHIG 287
WMAPE I ++ +D+WS G + E+ + G P+ S Y ++ + + +
Sbjct: 301 LPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMA 360
Query: 288 TTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPT 320
P++ + + D ++KC EP+ RP+
Sbjct: 361 K-------PDHATQEVYDIMVKCWNSEPEKRPS 386
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 63/261 (24%), Positives = 117/261 (44%), Gaps = 24/261 (9%)
Query: 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHP 131
E +G G F +++ G+ + G+ + + + K +++ + E ++ LSH
Sbjct: 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDK-SHRNYSESFFEAASMMSQLSHK 59
Query: 132 NIVRYLGT-VREEESLNILLEFVPGGSISSLLGKFGPFPEAVMR-TYTKQLLLGLEYLHN 189
++V G V +ES+ ++ E+V GS+ + L K + KQL L +L +
Sbjct: 60 HLVLNYGVCVCGDESI-MVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLED 118
Query: 190 HGIMHRDIKGANILVDNKG--------CIKLADFGASKQVAELATVSGAKSMKGTPYWMA 241
G+ H ++ N+L+ + IKL+D G S V + ++ P W+
Sbjct: 119 KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEIL-----LERIP-WVP 172
Query: 242 PEVIRQTGH-SYSADIWSVGCTVIEMATG-KPPWSQQYQEVAALFHIGTTKSHPPIPENL 299
PE I + S +AD WS G T+ E+ +G P S + F+ + P P+
Sbjct: 173 PECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY--EDRHQLPAPKWT 230
Query: 300 SVKAKDFLLKCLEKEPDLRPT 320
+ + +C++ EPD RP+
Sbjct: 231 ELAN--LINQCMDYEPDFRPS 249
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 40/157 (25%), Positives = 77/157 (49%), Gaps = 14/157 (8%)
Query: 176 YTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKG 235
++ Q+ G+E+L + +HRD+ N+L+ +K+ DFG ++ + + S
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL 303
Query: 236 TPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT--GKP----PWSQQ-YQEVAALFHIGT 288
WMAPE I ++ +D+WS G + E+ T G P P ++Q Y + + +
Sbjct: 304 PLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAK 363
Query: 289 TKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELL 325
P + S + + + KC E++ ++RP S+L+
Sbjct: 364 -------PAHASDEIYEIMQKCWEEKFEIRPDFSQLV 393
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 4e-08
Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 24/212 (11%)
Query: 120 EEVKLLKDLSHPNIVRYLGT-VREEESLNILLE-FVPGGSISSLLG-KFGPFPEAVMRTY 176
E +++ +SH +IV G VR+ E NI++E FV G + + K
Sbjct: 53 ETASMMRQVSHKHIVLLYGVCVRDVE--NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKV 110
Query: 177 TKQLLLGLEYLHNHGIMHRDIKGANILVDNKGC-------IKLADFGASKQVAELATVSG 229
KQL L YL + ++H ++ NIL+ +G IKL+D G V +S
Sbjct: 111 AKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITV-----LSR 165
Query: 230 AKSMKGTPYWMAPEVIRQTGH-SYSADIWSVGCTVIEMA-TGKPPWSQQYQEVAALFHIG 287
+ ++ P W+APE + + + S +AD WS G T+ E+ G+ P + F+ G
Sbjct: 166 QECVERIP-WIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEG 224
Query: 288 TTKSHPPIPENLSVKAKDFLLKCLEKEPDLRP 319
P + L+ D + C+ +P+ RP
Sbjct: 225 QCMLVTPSCKELA----DLMTHCMNYDPNQRP 252
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 57/225 (25%), Positives = 94/225 (41%), Gaps = 33/225 (14%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLK 126
R++ L+G G FG+V + E AVK V + K + E +
Sbjct: 130 RFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPAD 189
Query: 127 DLSHPNIVRYLGTVREEESLNILLEFVP--GGSISSLLGKFGPFPEAVMRTYTKQLLLGL 184
I RY + E+ ++ + +P G + + K GPF + Q + L
Sbjct: 190 RFPLMKIQRYF----QNETGHMCI-VMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVAL 244
Query: 185 EYLHNH-GIMHRDIKGANILVDNKG---------------C-IKLADFGA--SKQVAELA 225
+Y H +MH D+K NIL++ C +++ D G ++ + A
Sbjct: 245 DYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHSRTA 304
Query: 226 TVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGK 270
VS T ++ +PEV+ G YS D+WS+GC + E+ TGK
Sbjct: 305 IVS-------TRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342
|
Length = 467 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 35/159 (22%), Positives = 77/159 (48%), Gaps = 14/159 (8%)
Query: 175 TYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMK 234
+++ Q+ G+ +L + +HRD+ NIL+ + K+ DFG ++ + + + +
Sbjct: 218 SFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNAR 277
Query: 235 GTPYWMAPEVIRQTGHSYSADIWSVGCTVIEM-ATGKPPW------SQQYQEVAALFHIG 287
WMAPE I +++ +D+WS G + E+ + G P+ S+ Y+ + + +
Sbjct: 278 LPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRML 337
Query: 288 TTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLK 326
+ + P + D + C + +P RPT ++++
Sbjct: 338 SPECAPS-------EMYDIMKSCWDADPLKRPTFKQIVQ 369
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 2e-07
Identities = 30/82 (36%), Positives = 40/82 (48%), Gaps = 23/82 (28%)
Query: 160 SLLGKFGPFPEA-----------------------VMRTYTKQLLLGLEYLHNHGIMHRD 196
+L GK GPFP V++ +Q+L GL LH GI+HRD
Sbjct: 275 ALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRD 334
Query: 197 IKGANILVDNKGCIKLADFGAS 218
IK N+LV G +K+ DFGA+
Sbjct: 335 IKPENLLVTVDGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 5e-07
Identities = 37/158 (23%), Positives = 70/158 (44%), Gaps = 18/158 (11%)
Query: 176 YTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKG 235
++ Q+ G+++L + +HRD+ N+L+ + K+ DFG ++ + + + +
Sbjct: 217 FSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL 276
Query: 236 TPYWMAPEVIRQTGHSYSADIWSVGCTVIEM-ATGKPPWSQQYQEVAALFHIGTTKSHPP 294
WMAPE I ++ +D+WS G + E+ + GK P Y + +K +
Sbjct: 277 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP----YPGILV-----NSKFYKM 327
Query: 295 IPENLSVKAKDFLLK--------CLEKEPDLRPTASEL 324
+ + DF C EP RPT S++
Sbjct: 328 VKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQI 365
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 59/268 (22%), Positives = 114/268 (42%), Gaps = 25/268 (9%)
Query: 74 IGCGAFGRVYMG-MNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPN 132
IG G FG+V + + D+G V + L AN +SKE Q+ + + ++L+ HPN
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKEL-KANASSKE--QNEFLQQGDPYRILQ---HPN 56
Query: 133 IVRYLGTVREEESLNILLEFVPGGSISSLLG----KFGPFPEAVMRTYTKQLLLGLEYLH 188
I++ LG E ++ E+ G + S L +++ ++ G+ ++H
Sbjct: 57 ILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH 116
Query: 189 NHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVI--R 246
H +H D+ N + + +K+ D+G + + W+APE++
Sbjct: 117 KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEF 176
Query: 247 QTG-----HSYSADIWSVGCTVIEM-ATGKPPWSQQYQEVAALFHIGTTKS----HPPIP 296
G + +++W++G T+ E+ P+S + L H+ + P +
Sbjct: 177 HGGLITAEQTKPSNVWALGVTLWELFENAAQPYS-HLSDREVLNHVIKDQQVKLFKPQLE 235
Query: 297 ENLSVKAKDFLLKCLEKEPDLRPTASEL 324
S + + L C P+ R TA E+
Sbjct: 236 LPYSERWYEVLQFCW-LSPEKRATAEEV 262
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 4e-06
Identities = 35/119 (29%), Positives = 55/119 (46%), Gaps = 7/119 (5%)
Query: 225 ATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALF 284
A V G + + GTP ++APE++ H + D W++G + E TG PP++ E
Sbjct: 533 APVEGERIL-GTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFN---DETPQQV 588
Query: 285 HIGTTKSHPPIP---ENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDPVLH 340
P P E LSV A++ + L +P R EL +HP G D + + +
Sbjct: 589 FQNILNRDIPWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPLFHGVDWENLQN 647
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 4e-06
Identities = 50/172 (29%), Positives = 73/172 (42%), Gaps = 29/172 (16%)
Query: 71 GELIGCGAFGRVYMGM----NLDSGELLAVKQ------VLIAAN----FASKEKAQDHIK 116
G+ +G GAFG VY +K+ V I N A D +
Sbjct: 137 GKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCADFVY 196
Query: 117 ELEEEVKLLKDLSHPNIVRYLGTVREEESLNILL---EFVPGGSISSLLGKFGPFPE--- 170
E V K+ + + RY G E +L L+ EF P LLGK P+
Sbjct: 197 GFLEPVSSKKEDEYWLVWRYEG----ESTLADLMQSKEF-PYNVEPYLLGKVQDLPKGLE 251
Query: 171 ---AVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDN-KGCIKLADFGAS 218
+++T +Q+L L+ LH+ GI+HRD+K NI+ G K+ D GA+
Sbjct: 252 RENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA 303
|
Length = 566 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 47/238 (19%), Positives = 89/238 (37%), Gaps = 52/238 (21%)
Query: 119 EEEVKLLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTK 178
E+ + L HPNIV+ +G R E+ ++ E++ G ++S +L R
Sbjct: 731 SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNLS---WERRRKIAI 787
Query: 179 QLLLGLEYLHNH---GIMHRDIKGANILVDNKG------------CIKLADFGASKQVAE 223
+ L +LH ++ ++ I++D K C F +S
Sbjct: 788 GIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFISSA---- 843
Query: 224 LATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAAL 283
++APE + +DI+ G +IE+ TGK P ++ ++
Sbjct: 844 ---------------YVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSI 888
Query: 284 F----------HIGT-----TKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLK 326
H+ + + +N V+ + L C +P RP A+++LK
Sbjct: 889 VEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLK 946
|
Length = 968 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 536 | |||
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.98 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.95 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.92 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.89 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.89 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.89 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.88 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.87 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.87 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.87 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.86 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.85 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.83 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.83 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.82 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.82 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.8 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.8 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.78 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.77 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.76 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.76 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.7 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.66 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.64 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.62 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.57 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.48 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.45 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.43 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.42 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.42 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.39 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.35 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.28 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.23 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.18 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.99 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.99 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.94 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.93 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.89 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.82 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.79 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.79 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.55 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.54 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.49 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.46 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.42 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.41 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.36 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.13 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.12 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.07 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.07 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.05 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.03 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.99 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.89 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.82 | |
| KOG0027 | 151 | consensus Calmodulin and related proteins (EF-Hand | 97.8 | |
| COG5126 | 160 | FRQ1 Ca2+-binding protein (EF-Hand superfamily) [S | 97.73 | |
| cd05022 | 89 | S-100A13 S-100A13: S-100A13 domain found in protei | 97.67 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.67 | |
| KOG0028 | 172 | consensus Ca2+-binding protein (centrin/caltractin | 97.65 | |
| PF13499 | 66 | EF-hand_7: EF-hand domain pair; PDB: 1TCF_A 2TN4_A | 97.64 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.62 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.61 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.61 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.56 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.48 | |
| cd05026 | 93 | S-100Z S-100Z: S-100Z domain found in proteins sim | 97.45 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.34 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.33 | |
| cd05027 | 88 | S-100B S-100B: S-100B domain found in proteins sim | 97.26 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.25 | |
| PF00036 | 29 | EF-hand_1: EF hand; InterPro: IPR018248 Many calci | 97.25 | |
| COG5126 | 160 | FRQ1 Ca2+-binding protein (EF-Hand superfamily) [S | 97.23 | |
| smart00027 | 96 | EH Eps15 homology domain. Pair of EF hand motifs t | 97.2 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.18 | |
| KOG0027 | 151 | consensus Calmodulin and related proteins (EF-Hand | 97.17 | |
| cd00052 | 67 | EH Eps15 homology domain; found in proteins implic | 97.15 | |
| cd05029 | 88 | S-100A6 S-100A6: S-100A6 domain found in proteins | 97.09 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.94 | |
| cd05023 | 89 | S-100A11 S-100A11: S-100A11 domain found in protei | 96.89 | |
| PF14658 | 66 | EF-hand_9: EF-hand domain | 96.84 | |
| cd05025 | 92 | S-100A1 S-100A1: S-100A1 domain found in proteins | 96.81 | |
| cd05031 | 94 | S-100A10_like S-100A10_like: S-100A10 domain found | 96.72 | |
| PF13833 | 54 | EF-hand_8: EF-hand domain pair; PDB: 3KF9_A 1TTX_A | 96.66 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.57 |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-58 Score=460.14 Aligned_cols=267 Identities=33% Similarity=0.525 Sum_probs=232.7
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE 142 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 142 (536)
...+.|-+.+.||+|+||.|-+|..+.+|+.||||++.......... .......+.+|+++|++|+|||||+++++|..
T Consensus 169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~-~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~ 247 (475)
T KOG0615|consen 169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSR-AIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV 247 (475)
T ss_pred hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccc-cccchhhhHHHHHHHHhcCCCCEEEEeeeeec
Confidence 34467999999999999999999999999999999985443322111 11223447799999999999999999999999
Q ss_pred CCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCC---CcEEEEecCcch
Q 009364 143 EESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNK---GCIKLADFGASK 219 (536)
Q Consensus 143 ~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~---~~vkL~DFGla~ 219 (536)
++..|+||||+.||+|.+.+..++.+.+...+.+++|++.|+.|||++||+||||||+|||+..+ ..+||+|||+|+
T Consensus 248 ~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 248 PDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred CCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhh
Confidence 99999999999999999999999999999999999999999999999999999999999999876 689999999999
Q ss_pred hhhhhhcccCCcccCCCCCCCChhhhhhcCC---CccceEechhHHHHHHhhCCCCCchhhHH--HHHHHhhCCCCCCCC
Q 009364 220 QVAELATVSGAKSMKGTPYWMAPEVIRQTGH---SYSADIWSVGCTVIEMATGKPPWSQQYQE--VAALFHIGTTKSHPP 294 (536)
Q Consensus 220 ~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~---s~k~DIwSlGvil~eLltG~~Pf~~~~~~--~~~~~~~~~~~~~~~ 294 (536)
..++. ..+.+.||||.|.|||++.+.++ ..++||||+|||||.+|+|.+||.+.... ..+.+..+.....++
T Consensus 328 ~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~ 404 (475)
T KOG0615|consen 328 VSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPL 404 (475)
T ss_pred ccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccCh
Confidence 87642 34789999999999999987654 45789999999999999999999876644 345556666677777
Q ss_pred CCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 295 IPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 295 ~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
.+..++.++++||.+||..||++|||++++|+||||...
T Consensus 405 ~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~ 443 (475)
T KOG0615|consen 405 QWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDA 443 (475)
T ss_pred hhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence 888999999999999999999999999999999999754
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-55 Score=457.92 Aligned_cols=257 Identities=34% Similarity=0.659 Sum_probs=229.4
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
.+|..+++||+|||++||.+++..+|+.||+|++.+.... .....+.+.+||+|.+.|+|||||+++++|++.++
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~-----k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~n 92 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLK-----KPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNN 92 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhc-----CcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCc
Confidence 6899999999999999999999999999999998533222 22345678899999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhh
Q 009364 146 LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA 225 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 225 (536)
+|||+|+|+.++|..++++.++++|.+++.+++||+.||.|||+++|+|||||..|+|++++.+|||+|||+|..+...
T Consensus 93 VYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~- 171 (592)
T KOG0575|consen 93 VYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD- 171 (592)
T ss_pred eEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCc-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999988743
Q ss_pred cccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchh-hHHHHHHHhhCCCCCCCCCCCcCcHHHH
Q 009364 226 TVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQ-YQEVAALFHIGTTKSHPPIPENLSVKAK 304 (536)
Q Consensus 226 ~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~-~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 304 (536)
.....+.||||.|.|||++...+++..+||||+|||||.||.|+|||... ..+....+.. ....+|..+|.+++
T Consensus 172 -~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~----~~Y~~P~~ls~~A~ 246 (592)
T KOG0575|consen 172 -GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKL----NEYSMPSHLSAEAK 246 (592)
T ss_pred -ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHh----cCcccccccCHHHH
Confidence 23467899999999999999999999999999999999999999999765 3333333322 23346779999999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 305 DFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 305 dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
+||.+||++||.+|||+++||.|+||...
T Consensus 247 dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g 275 (592)
T KOG0575|consen 247 DLIRKLLRPNPSERPSLDEVLDHPFFKSG 275 (592)
T ss_pred HHHHHHhcCCcccCCCHHHHhcCHhhhCC
Confidence 99999999999999999999999999543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-54 Score=429.26 Aligned_cols=258 Identities=33% Similarity=0.621 Sum_probs=230.7
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc-
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES- 145 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~- 145 (536)
..+.++.||+|..|+||+++|+.+++.+|+|++.. .......+++.+|+++++.++|||||.+||.|..+..
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~-------~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~ 152 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL-------NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEE 152 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc-------cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCce
Confidence 67788999999999999999999999999999832 2234556789999999999999999999999999994
Q ss_pred eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHH-cCCccccCCCCCcccCCCCcEEEEecCcchhhhhh
Q 009364 146 LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHN-HGIMHRDIKGANILVDNKGCIKLADFGASKQVAEL 224 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~-~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 224 (536)
++|+||||+||+|.+++...++++|.....++.++++||.|||+ .+||||||||+|||++..|+|||||||.++.+...
T Consensus 153 isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 153 ISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS 232 (364)
T ss_pred EEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence 99999999999999999988999999999999999999999996 89999999999999999999999999999887653
Q ss_pred hcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchh---hHHHHHHHhhCCCCCCCCCCCc-Cc
Q 009364 225 ATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQ---YQEVAALFHIGTTKSHPPIPEN-LS 300 (536)
Q Consensus 225 ~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~---~~~~~~~~~~~~~~~~~~~~~~-~s 300 (536)
...+++||..|||||.+.+..|+.++||||||+.++|+.+|+.||... ......++........+..|.. +|
T Consensus 233 ----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS 308 (364)
T KOG0581|consen 233 ----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFS 308 (364)
T ss_pred ----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCC
Confidence 457899999999999999999999999999999999999999999763 2244444444445566677776 99
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCCC
Q 009364 301 VKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDE 335 (536)
Q Consensus 301 ~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~~ 335 (536)
+++++||.+||++||.+|||+.|+++|||+++...
T Consensus 309 ~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~ 343 (364)
T KOG0581|consen 309 PEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFED 343 (364)
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccc
Confidence 99999999999999999999999999999986543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-54 Score=429.76 Aligned_cols=273 Identities=33% Similarity=0.571 Sum_probs=235.7
Q ss_pred CCCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeee
Q 009364 62 MSPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVR 141 (536)
Q Consensus 62 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~ 141 (536)
...+..|++.++||+|+||+||+++.+++++.||+|++.++.... ....+...+|..+|..++||+||+++..|+
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~-----~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQ 95 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVE-----KKEVRHTKAERNILSKIKHPFIVKLIYSFQ 95 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhh-----hhhHHHHHHHHHHHHhCCCCcEeeeEEecc
Confidence 345678999999999999999999999999999999985433222 234667889999999999999999999999
Q ss_pred cCCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhh
Q 009364 142 EEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQV 221 (536)
Q Consensus 142 ~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~ 221 (536)
+.+.+|+|+||+.||.|...|++.+.|+|..++.++..|+.||.|||++|||||||||+|||++.+|+++|+|||+++..
T Consensus 96 t~~kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 96 TEEKLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKED 175 (357)
T ss_pred cCCeEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999864
Q ss_pred hhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhh-HHHHHHHhhCCCCCCCCCCCcCc
Q 009364 222 AELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQY-QEVAALFHIGTTKSHPPIPENLS 300 (536)
Q Consensus 222 ~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~-~~~~~~~~~~~~~~~~~~~~~~s 300 (536)
.... ....++|||+.|||||++.+.+|+..+|+||||+++|+|++|.+||.... ......+.... ....+..++
T Consensus 176 ~~~~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k---~~~~p~~ls 250 (357)
T KOG0598|consen 176 LKDG--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK---LPLPPGYLS 250 (357)
T ss_pred ccCC--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc---CCCCCccCC
Confidence 4322 33567999999999999999999999999999999999999999997654 23333222222 234455699
Q ss_pred HHHHHHHHHhcccCCCCCC----CHHHHHhCCCCcCCCCCcchhhccc
Q 009364 301 VKAKDFLLKCLEKEPDLRP----TASELLKHPFVTGDDEDPVLHASVM 344 (536)
Q Consensus 301 ~~~~dLi~~cL~~dP~~Rp----s~~eiL~hp~~~~~~~~~~~~~~~~ 344 (536)
.++++||+++|.+||++|. ++.+|-+||||....++.+....+.
T Consensus 251 ~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l~ 298 (357)
T KOG0598|consen 251 EEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKLS 298 (357)
T ss_pred HHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCCC
Confidence 9999999999999999995 7999999999998887766544443
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-52 Score=419.29 Aligned_cols=263 Identities=31% Similarity=0.581 Sum_probs=229.0
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE 142 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 142 (536)
..-.+|.+.+.||+|+||+||+|+++.++..||||.+.+. .-.....+.+..|+++|+.++|||||.+++++..
T Consensus 7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~------~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~ 80 (429)
T KOG0595|consen 7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKK------KLNKKLVELLLSEIKILKELKHPNIVRLLDCIED 80 (429)
T ss_pred cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhh------ccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEec
Confidence 3445899999999999999999999999999999998421 1134556778899999999999999999999999
Q ss_pred CCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCC------CcEEEEecC
Q 009364 143 EESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNK------GCIKLADFG 216 (536)
Q Consensus 143 ~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~------~~vkL~DFG 216 (536)
++.+|+|||||.||+|.+++++++.+++..++.++.||+.||++||+++||||||||+|||++.. -.+||+|||
T Consensus 81 ~~~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG 160 (429)
T KOG0595|consen 81 DDFIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFG 160 (429)
T ss_pred CCeEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccc
Confidence 99999999999999999999999999999999999999999999999999999999999999865 468999999
Q ss_pred cchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCC
Q 009364 217 ASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIP 296 (536)
Q Consensus 217 la~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 296 (536)
+|+.+.+.. ...+.||+|.|||||++....|+.|+|+||+|+|+|+|++|++||...................+.++
T Consensus 161 fAR~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~ 237 (429)
T KOG0595|consen 161 FARFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLP 237 (429)
T ss_pred hhhhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchh
Confidence 999887543 35689999999999999999999999999999999999999999986543332222222333445566
Q ss_pred CcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCC
Q 009364 297 ENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDD 334 (536)
Q Consensus 297 ~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~ 334 (536)
..++....+|+...|..+|..|.+..+-+.|+++....
T Consensus 238 ~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 238 AELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred hhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 67888888999999999999999999999999987654
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-53 Score=431.38 Aligned_cols=265 Identities=32% Similarity=0.590 Sum_probs=230.3
Q ss_pred CCCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeEeeee
Q 009364 62 MSPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRYLGTV 140 (536)
Q Consensus 62 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~ 140 (536)
...+.+|..++.||.|+|++|++|+++.+++.||||++.+.-. ..+...+.+..|-.+|..| .||.|++|+-.|
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~I-----ike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF 143 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYI-----IKEKKVKYVTREKEALTQLSGHPGIVKLYFTF 143 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHH-----HhhcccchhhHHHHHHHHhhCCCCeEEEEEEe
Confidence 4556789999999999999999999999999999998732211 1223345677888899999 799999999999
Q ss_pred ecCCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchh
Q 009364 141 REEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQ 220 (536)
Q Consensus 141 ~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~ 220 (536)
+++..+|+|+||+++|+|.++|.+.+.|++..++.++.||+.||+|||++|||||||||+|||++.++++||+|||.|+.
T Consensus 144 QD~~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 144 QDEESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred ecccceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeecccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999998
Q ss_pred hhhhhcc-----------cCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHH--HHHHhhC
Q 009364 221 VAELATV-----------SGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEV--AALFHIG 287 (536)
Q Consensus 221 ~~~~~~~-----------~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~--~~~~~~~ 287 (536)
+...... ....+++||..|++||+|.....++.+|||+||||||+|+.|.+||.+..+-. ..++
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~--- 300 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQ--- 300 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHH---
Confidence 7653222 11256899999999999999999999999999999999999999997654322 1222
Q ss_pred CCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCCCC
Q 009364 288 TTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDED 336 (536)
Q Consensus 288 ~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~~~ 336 (536)
.....+|++.++.+++||+++|..||.+|+|+.||.+||||.+..++
T Consensus 301 --~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~ 347 (604)
T KOG0592|consen 301 --ALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWE 347 (604)
T ss_pred --HhcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChh
Confidence 22345788999999999999999999999999999999999876554
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-52 Score=400.42 Aligned_cols=267 Identities=32% Similarity=0.568 Sum_probs=233.5
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE 143 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 143 (536)
.-.+|+..+.||.|+||.|.+++++.+|..||+|++.+.. -....+.+...+|..+|+.+.||+++++++.+.+.
T Consensus 42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~-----vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~ 116 (355)
T KOG0616|consen 42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQK-----VVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDN 116 (355)
T ss_pred chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHH-----HHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccC
Confidence 3357999999999999999999999999999999984321 22234567788999999999999999999999999
Q ss_pred CceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhh
Q 009364 144 ESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAE 223 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 223 (536)
..+|+||||++||.|+.++++.++|++..++.++.||+.||+|||+++|++|||||+|||+|.+|.+||+|||+|+.+..
T Consensus 117 ~~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 117 SNLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred CeEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999988754
Q ss_pred hhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcHHH
Q 009364 224 LATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKA 303 (536)
Q Consensus 224 ~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 303 (536)
.+.+.||||.|+|||++...+|+.++|+|||||++|||+.|.+||..... +.....+. .....+|..+++++
T Consensus 197 -----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-~~iY~KI~--~~~v~fP~~fs~~~ 268 (355)
T KOG0616|consen 197 -----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-IQIYEKIL--EGKVKFPSYFSSDA 268 (355)
T ss_pred -----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-HHHHHHHH--hCcccCCcccCHHH
Confidence 25689999999999999999999999999999999999999999976543 21111111 12335778999999
Q ss_pred HHHHHHhcccCCCCC-----CCHHHHHhCCCCcCCCCCcchhhcc
Q 009364 304 KDFLLKCLEKEPDLR-----PTASELLKHPFVTGDDEDPVLHASV 343 (536)
Q Consensus 304 ~dLi~~cL~~dP~~R-----ps~~eiL~hp~~~~~~~~~~~~~~~ 343 (536)
++||+++|+.|-.+| ....+|..||||....+.......+
T Consensus 269 kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r~i 313 (355)
T KOG0616|consen 269 KDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQRKI 313 (355)
T ss_pred HHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHHHhhccc
Confidence 999999999999999 4678999999999887776655443
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-51 Score=420.14 Aligned_cols=270 Identities=32% Similarity=0.528 Sum_probs=227.5
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE 143 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 143 (536)
...+|+++++||+|+||.||+|+.+.||+.+|+|++.+. .-....+++.+..|-.+|....+|+||++|..|++.
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS-----~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~ 213 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKS-----EMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDK 213 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHH-----HHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCC
Confidence 456899999999999999999999999999999998532 223345677889999999999999999999999999
Q ss_pred CceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhh
Q 009364 144 ESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAE 223 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 223 (536)
+.+||||||++||++..+|.+.+.+++..++.++.+++.||.-||..|+|||||||+|+|||..|++||+|||++.-+..
T Consensus 214 ~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 214 EYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred CeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999854321
Q ss_pred hh-------------------c--cc------C------------------CcccCCCCCCCChhhhhhcCCCccceEec
Q 009364 224 LA-------------------T--VS------G------------------AKSMKGTPYWMAPEVIRQTGHSYSADIWS 258 (536)
Q Consensus 224 ~~-------------------~--~~------~------------------~~~~~Gt~~Y~APEvl~~~~~s~k~DIwS 258 (536)
.. . .. . ..+.+|||.|||||++.+.+|+..||+||
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS 373 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS 373 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence 00 0 00 0 11467999999999999999999999999
Q ss_pred hhHHHHHHhhCCCCCchhhH-HHHHHHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCC---HHHHHhCCCCcCCC
Q 009364 259 VGCTVIEMATGKPPWSQQYQ-EVAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPT---ASELLKHPFVTGDD 334 (536)
Q Consensus 259 lGvil~eLltG~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps---~~eiL~hp~~~~~~ 334 (536)
||||+||||.|.|||..... +....+.........+-...++.+++|||.+||+ ||.+|.. ++||.+||||....
T Consensus 374 LG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~ 452 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVD 452 (550)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCC
Confidence 99999999999999976542 2222222222222223334678999999999999 9999974 99999999999988
Q ss_pred CCcch
Q 009364 335 EDPVL 339 (536)
Q Consensus 335 ~~~~~ 339 (536)
++...
T Consensus 453 W~~l~ 457 (550)
T KOG0605|consen 453 WDHLR 457 (550)
T ss_pred cchhh
Confidence 87553
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-51 Score=425.31 Aligned_cols=263 Identities=30% Similarity=0.527 Sum_probs=224.5
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCC-CCceeeEeeeee
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS-HPNIVRYLGTVR 141 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~ 141 (536)
....+|.+++.||+|+||+|++|.+..+|+.||+|++...... ... ....+.+.+|+.+++.++ ||||+++++++.
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~--~~~-~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~ 90 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVS--SKS-QKLDELIKREISILRRLRSHPNIIRLLEVFA 90 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhccc--ccc-cccchhhHHHHHHHHHhccCCCEeEEEEEEe
Confidence 3456899999999999999999999999999999966322110 011 123455678999999999 999999999999
Q ss_pred cCCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCC-CcEEEEecCcchh
Q 009364 142 EEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNK-GCIKLADFGASKQ 220 (536)
Q Consensus 142 ~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~-~~vkL~DFGla~~ 220 (536)
....+|+|||||.||+|.+++.+.+++.|..++.+++||+.|++|||++||+||||||+|||++.+ +++||+|||++..
T Consensus 91 t~~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 91 TPTKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAI 170 (370)
T ss_pred cCCeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence 999999999999999999999999999999999999999999999999999999999999999999 9999999999987
Q ss_pred hhhhhcccCCcccCCCCCCCChhhhhhcC-C-CccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCc
Q 009364 221 VAELATVSGAKSMKGTPYWMAPEVIRQTG-H-SYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPEN 298 (536)
Q Consensus 221 ~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~-~-s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (536)
.. .......+.|||+.|+|||++.+.. | +.++||||+||+||.|++|+.||.+.... .+... .......+|..
T Consensus 171 ~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~--~l~~k-i~~~~~~~p~~ 245 (370)
T KOG0583|consen 171 SP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP--NLYRK-IRKGEFKIPSY 245 (370)
T ss_pred cC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH--HHHHH-HhcCCccCCCC
Confidence 63 1223467899999999999999877 7 58899999999999999999999874321 11111 22334456667
Q ss_pred C-cHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 299 L-SVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 299 ~-s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
+ |+++++|+++||..||.+|+|+.+|++||||+..
T Consensus 246 ~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~~ 281 (370)
T KOG0583|consen 246 LLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQKE 281 (370)
T ss_pred cCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhccC
Confidence 7 9999999999999999999999999999999863
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-51 Score=412.03 Aligned_cols=263 Identities=49% Similarity=0.899 Sum_probs=225.1
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEE 144 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 144 (536)
..+|..++.||+|+||+||++.+.++|+..|||.+... .. ...+.+.+|+.+|++++|||||+++|......
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~-------~~-~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~ 87 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELE-------DS-PTSESLEREIRILSRLNHPNIVQYYGSSSSRE 87 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecc-------cc-hhHHHHHHHHHHHHhCCCCCEEeeCCcccccc
Confidence 45789999999999999999999999999999988432 11 11567899999999999999999999855544
Q ss_pred --ceeEEEEecCCCCcccccccCC-CCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCC-CCcEEEEecCcchh
Q 009364 145 --SLNILLEFVPGGSISSLLGKFG-PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDN-KGCIKLADFGASKQ 220 (536)
Q Consensus 145 --~~~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~-~~~vkL~DFGla~~ 220 (536)
.++++|||+++|+|.+++.+.+ .+++..++.+.+||++||+|||++|||||||||+|||++. ++.+||+|||+++.
T Consensus 88 ~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~ 167 (313)
T KOG0198|consen 88 NDEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKK 167 (313)
T ss_pred CeeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccc
Confidence 6999999999999999999877 7999999999999999999999999999999999999999 79999999999987
Q ss_pred hhhh-hcccCCcccCCCCCCCChhhhhhc-CCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCc
Q 009364 221 VAEL-ATVSGAKSMKGTPYWMAPEVIRQT-GHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPEN 298 (536)
Q Consensus 221 ~~~~-~~~~~~~~~~Gt~~Y~APEvl~~~-~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (536)
.... ..........||+.|||||++..+ ....++|||||||++.||+||.+||.........++..+.....|.+|..
T Consensus 168 ~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ 247 (313)
T KOG0198|consen 168 LESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDS 247 (313)
T ss_pred cccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcc
Confidence 6631 112234467899999999999863 23459999999999999999999998743334444555555566789999
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCCC
Q 009364 299 LSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDE 335 (536)
Q Consensus 299 ~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~~ 335 (536)
+|.++++||.+|+.+||.+||||.++|+|||......
T Consensus 248 ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 248 LSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred cCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 9999999999999999999999999999999976543
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-51 Score=396.21 Aligned_cols=258 Identities=28% Similarity=0.517 Sum_probs=217.1
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
.+|+...++|+|+||+||+|+++.||+.||||.+. ..+..+...+-..+||++|++++|+|+|.++++|.....
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~------Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrk 75 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFV------ESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRK 75 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeec------cCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcce
Confidence 36888899999999999999999999999999984 333444455667899999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhh
Q 009364 146 LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA 225 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 225 (536)
+++|+|||+..-|.++-.....++.+.++.+++|++.|+.|+|++++|||||||+||||+.+|.+||||||+|+.+..
T Consensus 76 lhLVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-- 153 (396)
T KOG0593|consen 76 LHLVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA-- 153 (396)
T ss_pred eEEEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC--
Confidence 999999998877777766777899999999999999999999999999999999999999999999999999998863
Q ss_pred cccCCcccCCCCCCCChhhhhh-cCCCccceEechhHHHHHHhhCCCCCchhhHH--HHHHHhh-CCC------------
Q 009364 226 TVSGAKSMKGTPYWMAPEVIRQ-TGHSYSADIWSVGCTVIEMATGKPPWSQQYQE--VAALFHI-GTT------------ 289 (536)
Q Consensus 226 ~~~~~~~~~Gt~~Y~APEvl~~-~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~--~~~~~~~-~~~------------ 289 (536)
+....+.++.|.||+|||.+.| ..|+..+||||+||++.||++|.+.|.+...- ...+... +..
T Consensus 154 pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 154 PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence 2334677889999999999987 68999999999999999999999999754321 1111100 000
Q ss_pred ------CCCCCC-------CCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCc
Q 009364 290 ------KSHPPI-------PENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVT 331 (536)
Q Consensus 290 ------~~~~~~-------~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~ 331 (536)
...++- -+.++.-+.||+++||..||.+|++.+|+|.||||.
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd 288 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFD 288 (396)
T ss_pred ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHH
Confidence 000000 135677889999999999999999999999999994
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-50 Score=423.98 Aligned_cols=258 Identities=31% Similarity=0.573 Sum_probs=226.4
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
.-|++++-||.|+-|.|.+|++..||+..|||++.+... ........+.+||-+|+.+.||||+++|+++.+...
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~-----~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~ 86 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSE-----LSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQH 86 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccc-----cccccccchhhhhHHHHHhcCCCeeeeeeeeccCce
Confidence 459999999999999999999999999999999954432 222334568899999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhh
Q 009364 146 LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA 225 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 225 (536)
+|+|.||++||.|++++..++++++.++.++++||+.|+.|||..+|+||||||+|+|++..+++||+|||+|..-.++
T Consensus 87 lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g- 165 (786)
T KOG0588|consen 87 LYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG- 165 (786)
T ss_pred EEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCC-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999754332
Q ss_pred cccCCcccCCCCCCCChhhhhhcCC-CccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcHHHH
Q 009364 226 TVSGAKSMKGTPYWMAPEVIRQTGH-SYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAK 304 (536)
Q Consensus 226 ~~~~~~~~~Gt~~Y~APEvl~~~~~-s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 304 (536)
.-..+.||+|.|.|||++.|.+| +.++||||+|||||.||||+.||.++.-.. ++.. .......+|.+++.+++
T Consensus 166 --klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~--LLlK-V~~G~f~MPs~Is~eaQ 240 (786)
T KOG0588|consen 166 --KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRV--LLLK-VQRGVFEMPSNISSEAQ 240 (786)
T ss_pred --ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHH--HHHH-HHcCcccCCCcCCHHHH
Confidence 23568899999999999999888 789999999999999999999998654322 1111 11233456789999999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhCCCCcCCC
Q 009364 305 DFLLKCLEKEPDLRPTASELLKHPFVTGDD 334 (536)
Q Consensus 305 dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~ 334 (536)
+||++||..||.+|+|.+||++|||+.+..
T Consensus 241 dLLr~ml~VDp~~RiT~~eI~kHP~l~g~~ 270 (786)
T KOG0588|consen 241 DLLRRMLDVDPSTRITTEEILKHPFLSGYT 270 (786)
T ss_pred HHHHHHhccCccccccHHHHhhCchhhcCC
Confidence 999999999999999999999999998754
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-51 Score=385.17 Aligned_cols=260 Identities=29% Similarity=0.476 Sum_probs=229.4
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEE 144 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 144 (536)
.+.|++-+.||+|.|+.||++.+..+|+.+|+|++.... ......+.+.+|+.|-+.|+||||+++.+.+....
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k------~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~ 83 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK------LSARDFQKLEREARICRKLQHPNIVRLHDSIQEES 83 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhh------hccccHHHHHHHHHHHHhcCCCcEeehhhhhcccc
Confidence 457899999999999999999999999999999874321 12235677899999999999999999999999999
Q ss_pred ceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCC---CcEEEEecCcchhh
Q 009364 145 SLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNK---GCIKLADFGASKQV 221 (536)
Q Consensus 145 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~---~~vkL~DFGla~~~ 221 (536)
..|+|+|++.|++|..-|-++.-++|..+..+++||+.||.|+|.+||||||+||+|+|+... .-+||+|||+|..+
T Consensus 84 ~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 84 FHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred eeEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 999999999999998776666778999999999999999999999999999999999999543 36999999999887
Q ss_pred hhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCch-hhHHHHHHHhhCCCCCCCCCCCcCc
Q 009364 222 AELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQ-QYQEVAALFHIGTTKSHPPIPENLS 300 (536)
Q Consensus 222 ~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~-~~~~~~~~~~~~~~~~~~~~~~~~s 300 (536)
... .......|||.|||||+++..+|+..+|||+.|||||.|+.|++||.+ ....+.+.+..+......+.++.++
T Consensus 164 ~~g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is 240 (355)
T KOG0033|consen 164 NDG---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVT 240 (355)
T ss_pred CCc---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCC
Confidence 632 234578899999999999999999999999999999999999999987 4556666666677777777778999
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 301 VKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 301 ~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
+++++||++||..||.+|+|+.|+|+|||+.+.
T Consensus 241 ~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 241 PEAKSLIRRMLTVNPKKRITADEALKHPWICNR 273 (355)
T ss_pred HHHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence 999999999999999999999999999999753
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-51 Score=389.63 Aligned_cols=246 Identities=34% Similarity=0.605 Sum_probs=211.1
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEee-eeecCC
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLG-TVREEE 144 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~-~~~~~~ 144 (536)
..|++.+.||+|+||+||++.+..+|+.+|.|.+.. ..-.......+..|+.+|++|+|||||++++ .|.++.
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f------~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ 92 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQF------GMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDN 92 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcch------hhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccc
Confidence 469999999999999999999999999999998841 2223345667889999999999999999998 455555
Q ss_pred c-eeEEEEecCCCCcccccc----cCCCCCHHHHHHHHHHHHHHHHHHHH--cC--CccccCCCCCcccCCCCcEEEEec
Q 009364 145 S-LNILLEFVPGGSISSLLG----KFGPFPEAVMRTYTKQLLLGLEYLHN--HG--IMHRDIKGANILVDNKGCIKLADF 215 (536)
Q Consensus 145 ~-~~lV~E~~~gg~L~~~l~----~~~~l~~~~~~~i~~qil~aL~yLH~--~~--ivHrDLKp~NILl~~~~~vkL~DF 215 (536)
. ++||||||.+|+|...++ +.+.++|..+|+++.|++.||..||+ .. |+||||||.||+++.+|.|||+||
T Consensus 93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDf 172 (375)
T KOG0591|consen 93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDF 172 (375)
T ss_pred hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccc
Confidence 4 999999999999999885 34579999999999999999999999 44 999999999999999999999999
Q ss_pred CcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCC
Q 009364 216 GASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPI 295 (536)
Q Consensus 216 Gla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 295 (536)
|+++.+....+ ...+.+|||+||+||++.+.+|+.++||||+||++|||+.-.+||.+.. ...+.........+++
T Consensus 173 GL~r~l~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n--~~~L~~KI~qgd~~~~ 248 (375)
T KOG0591|consen 173 GLGRFLSSKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN--LLSLCKKIEQGDYPPL 248 (375)
T ss_pred hhHhHhcchhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc--HHHHHHHHHcCCCCCC
Confidence 99998876433 3568899999999999999999999999999999999999999998762 2222222233355566
Q ss_pred C-CcCcHHHHHHHHHhcccCCCCCCCH
Q 009364 296 P-ENLSVKAKDFLLKCLEKEPDLRPTA 321 (536)
Q Consensus 296 ~-~~~s~~~~dLi~~cL~~dP~~Rps~ 321 (536)
| ..+|.++..||..|+..||++||+.
T Consensus 249 p~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 249 PDEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred cHHHhhhHHHHHHHHHccCCcccCCCc
Confidence 6 7899999999999999999999997
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-50 Score=413.67 Aligned_cols=259 Identities=36% Similarity=0.631 Sum_probs=226.6
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE 142 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 142 (536)
.+...|...+.||+|+.|.||.|....+++.||||.+.+.. +...+.+.+|+.+|+..+|+|||++++.|..
T Consensus 270 dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~--------Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv 341 (550)
T KOG0578|consen 270 DPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK--------QPKKELLLNEILVMRDLHHPNIVNFLDSYLV 341 (550)
T ss_pred ChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEecc--------CCchhhhHHHHHHHHhccchHHHHHHHHhcc
Confidence 34457999999999999999999999999999999985432 2234567899999999999999999999999
Q ss_pred CCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhh
Q 009364 143 EESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVA 222 (536)
Q Consensus 143 ~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~ 222 (536)
.+.+|+||||++||+|.+++.. ..++|.++..|++++++||+|||.+||+|||||.+|||++.+|.+||+|||++.++.
T Consensus 342 ~deLWVVMEym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~ 420 (550)
T KOG0578|consen 342 GDELWVVMEYMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQIS 420 (550)
T ss_pred cceeEEEEeecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccc
Confidence 9999999999999999999877 459999999999999999999999999999999999999999999999999999887
Q ss_pred hhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcHH
Q 009364 223 ELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVK 302 (536)
Q Consensus 223 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 302 (536)
.... ...+.+|||+|||||++....|++++||||||++++||+-|.+||.....-................+..+|+.
T Consensus 421 ~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~ 498 (550)
T KOG0578|consen 421 EEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPE 498 (550)
T ss_pred cccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHH
Confidence 6443 46789999999999999999999999999999999999999999975432222222222333444566789999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHhCCCCcC
Q 009364 303 AKDFLLKCLEKEPDLRPTASELLKHPFVTG 332 (536)
Q Consensus 303 ~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~ 332 (536)
+++|+.+||+.|+.+|++|.++|+||||..
T Consensus 499 ~kdFL~~cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 499 LKDFLDRCLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred HHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence 999999999999999999999999999954
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-49 Score=413.13 Aligned_cols=290 Identities=28% Similarity=0.466 Sum_probs=241.8
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCC-CCceeeEeeeeecC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS-HPNIVRYLGTVREE 143 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~ 143 (536)
-.+|++.++||+|+||+|++|..+.+++.||||++.+..... .+.++....|-+|+.... ||.++.++..|++.
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~-----~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~ 441 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQ-----RDEVESLMCEKRIFELANRHPFLVNLFSCFQTK 441 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceec-----cccHHHHHHHHHHHHHhccCCeEeecccccccC
Confidence 357999999999999999999999999999999986544332 245667778888888774 99999999999999
Q ss_pred CceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhh
Q 009364 144 ESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAE 223 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 223 (536)
+++|+||||+.||++. .+.+.+.|++..++.++..|+.||.|||++||||||||.+|||+|.+|++||+|||+++.--.
T Consensus 442 ~~l~fvmey~~Ggdm~-~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 442 EHLFFVMEYVAGGDLM-HHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG 520 (694)
T ss_pred CeEEEEEEecCCCcEE-EEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCC
Confidence 9999999999999944 444558899999999999999999999999999999999999999999999999999986432
Q ss_pred hhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhH-HHHHHHhhCCCCCCCCCCCcCcHH
Q 009364 224 LATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQ-EVAALFHIGTTKSHPPIPENLSVK 302 (536)
Q Consensus 224 ~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~s~~ 302 (536)
....+.++||||.|||||++.+..|+.++|+|||||+|||||.|..||.+..+ ++...+. ...+.+|..+|.+
T Consensus 521 --~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~----~d~~~yP~~ls~e 594 (694)
T KOG0694|consen 521 --QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIV----NDEVRYPRFLSKE 594 (694)
T ss_pred --CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh----cCCCCCCCcccHH
Confidence 22357799999999999999999999999999999999999999999986544 3333322 2345678899999
Q ss_pred HHHHHHHhcccCCCCCCC-----HHHHHhCCCCcCCCCCcchhhcccccc--ccCChhHHhhhhhhhcccC
Q 009364 303 AKDFLLKCLEKEPDLRPT-----ASELLKHPFVTGDDEDPVLHASVMKSS--EILSPSHVANLESLQMLTS 366 (536)
Q Consensus 303 ~~dLi~~cL~~dP~~Rps-----~~eiL~hp~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~s~q~~t~ 366 (536)
+.++++++|.++|++|.. +.+|.+||||+...++......+..++ .+.+|..+.++........
T Consensus 595 a~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~i~~~~D~snFd~eFt~e~ 665 (694)
T KOG0694|consen 595 AIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVPTIKGPEDVSNFDEEFTSEK 665 (694)
T ss_pred HHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCCcccCChhhhcccchhhhcCC
Confidence 999999999999999985 588999999999888766555554432 3345666666654444333
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-50 Score=407.34 Aligned_cols=258 Identities=31% Similarity=0.525 Sum_probs=213.3
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCC-CCceeeEeeeeecC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS-HPNIVRYLGTVREE 143 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~ 143 (536)
-.||.+.+.||.|+||.||+|+...+|+.||||.+.. +-...++.- -.+|++.|++|+ |||||++.+++.+.
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~------Kf~s~ee~~-nLREvksL~kln~hpniikL~Evi~d~ 81 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKK------KFYSWEECM-NLREVKSLRKLNPHPNIIKLKEVIRDN 81 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHh------hhccHHHHH-HHHHHHHHHhcCCCCcchhhHHHhhcc
Confidence 4589999999999999999999999999999998721 111112222 247999999998 99999999999988
Q ss_pred C-ceeEEEEecCCCCcccccccC-CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhh
Q 009364 144 E-SLNILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQV 221 (536)
Q Consensus 144 ~-~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~ 221 (536)
+ .+|+||||| ..+|+++++.+ +.|++..++.|+.||++||+|+|.+|+.||||||||||+..+..|||+|||+||.+
T Consensus 82 ~~~L~fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 82 DRILYFVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred CceEeeeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccc
Confidence 8 999999999 57899998654 57999999999999999999999999999999999999998889999999999987
Q ss_pred hhhhcccCCcccCCCCCCCChhhhh-hcCCCccceEechhHHHHHHhhCCCCCchhhH--HHHHHHhhCCCCCC------
Q 009364 222 AELATVSGAKSMKGTPYWMAPEVIR-QTGHSYSADIWSVGCTVIEMATGKPPWSQQYQ--EVAALFHIGTTKSH------ 292 (536)
Q Consensus 222 ~~~~~~~~~~~~~Gt~~Y~APEvl~-~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~--~~~~~~~~~~~~~~------ 292 (536)
... ...+.++.|.||+|||+|. ...|+.+.|||++|||++|+.+-++.|.+..+ .+..+.........
T Consensus 161 ~Sk---pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg 237 (538)
T KOG0661|consen 161 RSK---PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG 237 (538)
T ss_pred ccC---CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH
Confidence 653 3467889999999999876 45789999999999999999999999975432 22222221111110
Q ss_pred -----------CC--------CCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 293 -----------PP--------IPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 293 -----------~~--------~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
+. +-++++.++.+||.+||.+||.+||||.|+|+||||+..
T Consensus 238 ~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~ 297 (538)
T KOG0661|consen 238 YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG 297 (538)
T ss_pred HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence 00 113588999999999999999999999999999999854
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-50 Score=410.12 Aligned_cols=255 Identities=34% Similarity=0.603 Sum_probs=226.2
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
.+|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+ ..+....++.+.+|++|++.++|||||.++++|+...+
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K------~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~ 75 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDK------SGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAH 75 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehh------cCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccce
Confidence 368889999999999999999999999999999842 33445667889999999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhh
Q 009364 146 LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA 225 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 225 (536)
+++|+|||.| +|+.++...+.++|+.++.++.|++.||.|||+++|+|||+||.|||+...|.+|+||||+|+.....
T Consensus 76 ~~vVte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~- 153 (808)
T KOG0597|consen 76 LWVVTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN- 153 (808)
T ss_pred EEEEehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccC-
Confidence 9999999976 99999999999999999999999999999999999999999999999999999999999999987653
Q ss_pred cccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcHHHHH
Q 009364 226 TVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKD 305 (536)
Q Consensus 226 ~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 305 (536)
....+.+.|||.|||||++.+.+|+..+|+||+|||+|||++|+|||.... +..+... .......+|...+..+++
T Consensus 154 -t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s--i~~Lv~~-I~~d~v~~p~~~S~~f~n 229 (808)
T KOG0597|consen 154 -TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS--ITQLVKS-ILKDPVKPPSTASSSFVN 229 (808)
T ss_pred -ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH--HHHHHHH-HhcCCCCCcccccHHHHH
Confidence 233567789999999999999999999999999999999999999997542 2222111 123345567799999999
Q ss_pred HHHHhcccCCCCCCCHHHHHhCCCCcC
Q 009364 306 FLLKCLEKEPDLRPTASELLKHPFVTG 332 (536)
Q Consensus 306 Li~~cL~~dP~~Rps~~eiL~hp~~~~ 332 (536)
|++.+|.+||.+|.|..+++.|||+.+
T Consensus 230 fl~gLL~kdP~~RltW~~Ll~HpF~k~ 256 (808)
T KOG0597|consen 230 FLQGLLIKDPAQRLTWTDLLGHPFWKG 256 (808)
T ss_pred HHHHHhhcChhhcccHHHHhcChHHhh
Confidence 999999999999999999999999864
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-49 Score=399.69 Aligned_cols=259 Identities=34% Similarity=0.586 Sum_probs=214.5
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC--
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE-- 143 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~-- 143 (536)
..|+..++||+|+||.||+|++..+|+.||+|.+.... ..........+||.||++|+||||+++.+...+.
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~------~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~ 190 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDN------EKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLS 190 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeeccc------CCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCC
Confidence 46899999999999999999999999999999985432 1223455678999999999999999999998876
Q ss_pred CceeEEEEecCCCCccccccc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhh
Q 009364 144 ESLNILLEFVPGGSISSLLGK-FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVA 222 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~ 222 (536)
..+|+|+|||++ +|.-++.. .-.|++.+++.+++||+.||+|||++||+|||||.+|||||++|.+||+|||+|+.+.
T Consensus 191 ~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 191 GSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred ceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeecc
Confidence 689999999964 66666655 3479999999999999999999999999999999999999999999999999999776
Q ss_pred hhhcccCCcccCCCCCCCChhhhhhc-CCCccceEechhHHHHHHhhCCCCCchhhH--HHHHHHhhCCCC---CCC--C
Q 009364 223 ELATVSGAKSMKGTPYWMAPEVIRQT-GHSYSADIWSVGCTVIEMATGKPPWSQQYQ--EVAALFHIGTTK---SHP--P 294 (536)
Q Consensus 223 ~~~~~~~~~~~~Gt~~Y~APEvl~~~-~~s~k~DIwSlGvil~eLltG~~Pf~~~~~--~~~~~~~~~~~~---~~~--~ 294 (536)
.... ...+..+-|.||+|||+|.|. .|+.++|+||+||||.||++|++.|.+..+ .+..++...... .++ .
T Consensus 270 ~~~~-~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k 348 (560)
T KOG0600|consen 270 PSGS-APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK 348 (560)
T ss_pred CCCC-cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence 5332 235677889999999999874 699999999999999999999999976542 222233222111 111 1
Q ss_pred CC-------------------CcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcC
Q 009364 295 IP-------------------ENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTG 332 (536)
Q Consensus 295 ~~-------------------~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~ 332 (536)
+| ..++..+.+|+..||..||.+|.||.++|+|+||..
T Consensus 349 LP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t 405 (560)
T KOG0600|consen 349 LPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT 405 (560)
T ss_pred CCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence 11 246788889999999999999999999999999943
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=370.83 Aligned_cols=259 Identities=28% Similarity=0.477 Sum_probs=215.3
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
.+|...+.||+|.||.||+|++..+|+.||||.+.... ..........+||+.|+.++|+||+.++++|.....
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~------~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~ 75 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGN------AKDGINRTALREIKLLQELKHPNIIELIDVFPHKSN 75 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccc------cccCccHHHHHHHHHHHHccCcchhhhhhhccCCCc
Confidence 47899999999999999999999999999999985431 111223456789999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccC-CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhh
Q 009364 146 LNILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAEL 224 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 224 (536)
+.||+||++ .+|..+++.. ..++..+++.++.++++||+|||++.|+||||||.|+|++.+|.+||+|||+|+.+...
T Consensus 76 l~lVfEfm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 76 LSLVFEFMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred eEEEEEecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 999999995 7888888654 57899999999999999999999999999999999999999999999999999988754
Q ss_pred hcccCCcccCCCCCCCChhhhhhc-CCCccceEechhHHHHHHhhCCCCCchhh--HHHHHHHhhCCCCCCCCC------
Q 009364 225 ATVSGAKSMKGTPYWMAPEVIRQT-GHSYSADIWSVGCTVIEMATGKPPWSQQY--QEVAALFHIGTTKSHPPI------ 295 (536)
Q Consensus 225 ~~~~~~~~~~Gt~~Y~APEvl~~~-~~s~k~DIwSlGvil~eLltG~~Pf~~~~--~~~~~~~~~~~~~~~~~~------ 295 (536)
... ....+-|.||+|||.+.|. .|+..+||||.|||+.||+-|.|-|.+.. +....++..-.......|
T Consensus 155 ~~~--~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 155 NRI--QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred Ccc--cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence 332 2333789999999998864 68999999999999999999998886543 222333332222111111
Q ss_pred -----------------CCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 296 -----------------PENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 296 -----------------~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
....+.++.||+.+||..||.+|+|+.|+|+|+||...
T Consensus 233 pdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~ 287 (318)
T KOG0659|consen 233 PDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSL 287 (318)
T ss_pred ccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcC
Confidence 13467888999999999999999999999999999864
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-49 Score=376.45 Aligned_cols=263 Identities=28% Similarity=0.482 Sum_probs=234.5
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeEeeeeecCCc
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRYLGTVREEES 145 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~ 145 (536)
+|.-.+.||+|..++|.++.++.+|..+|+|++.........+......+.-..|+.||+++ .||+|+.+.++|+.+..
T Consensus 18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF 97 (411)
T KOG0599|consen 18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAF 97 (411)
T ss_pred hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcch
Confidence 56777889999999999999999999999999987666655555666677788999999998 59999999999999999
Q ss_pred eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhh
Q 009364 146 LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA 225 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 225 (536)
.++|+|.|+.|.|+|++...-.+++...++|++|++.|+.|||.++||||||||+|||++++.++||+|||+|.++.++.
T Consensus 98 ~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~Ge 177 (411)
T KOG0599|consen 98 VFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEPGE 177 (411)
T ss_pred hhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCCch
Confidence 99999999999999999998899999999999999999999999999999999999999999999999999999887654
Q ss_pred cccCCcccCCCCCCCChhhhh------hcCCCccceEechhHHHHHHhhCCCCCchhhHHH-HHHHhhCCCCCCCCCCCc
Q 009364 226 TVSGAKSMKGTPYWMAPEVIR------QTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEV-AALFHIGTTKSHPPIPEN 298 (536)
Q Consensus 226 ~~~~~~~~~Gt~~Y~APEvl~------~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~ 298 (536)
. ....||||+|.|||.+. ..+|+..+|+|++|||+|.|+.|.+||....+-+ ...+..+......+-+.+
T Consensus 178 k---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWad 254 (411)
T KOG0599|consen 178 K---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWAD 254 (411)
T ss_pred h---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhh
Confidence 3 56789999999999985 3467889999999999999999999998765443 344455566666666779
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcC
Q 009364 299 LSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTG 332 (536)
Q Consensus 299 ~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~ 332 (536)
+|...+|||.+||+.||.+|.|++|+|.||||..
T Consensus 255 is~~~KdLIsrlLqVdp~~Ritake~LaHpff~q 288 (411)
T KOG0599|consen 255 ISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ 288 (411)
T ss_pred ccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence 9999999999999999999999999999999953
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=399.38 Aligned_cols=264 Identities=30% Similarity=0.492 Sum_probs=228.9
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCC-CCceeeEeeeee
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS-HPNIVRYLGTVR 141 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~ 141 (536)
.....|++++.||+|.||.||+|+++.+|+.+|+|++.+..... ....+.+.+|+++|+++. |||||.++++|+
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~-----~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e 106 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRG-----KEDREDVRREVAILQQLSGHPNIVQLKDAFE 106 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccc-----cccHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 44568999999999999999999999999999999985432211 124567889999999998 999999999999
Q ss_pred cCCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCC----CcEEEEecCc
Q 009364 142 EEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNK----GCIKLADFGA 217 (536)
Q Consensus 142 ~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~----~~vkL~DFGl 217 (536)
+...+++|||+|.||.|.+.+.+. .+++..+..++.|++.++.|||+.||+||||||+|+|+... +.+|++|||+
T Consensus 107 ~~~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 107 DPDSVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred cCCeEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 999999999999999999998776 49999999999999999999999999999999999999643 4799999999
Q ss_pred chhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH-HHHHHhhCCCCCCCCCC
Q 009364 218 SKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE-VAALFHIGTTKSHPPIP 296 (536)
Q Consensus 218 a~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~ 296 (536)
+..... .......+||+.|+|||++....|+..+||||+||++|.|++|.+||...... ....+..+......+.+
T Consensus 186 a~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w 262 (382)
T KOG0032|consen 186 AKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPW 262 (382)
T ss_pred ceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCc
Confidence 988765 23467889999999999999999999999999999999999999999876533 22233344444555566
Q ss_pred CcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCCC
Q 009364 297 ENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDE 335 (536)
Q Consensus 297 ~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~~ 335 (536)
+.++..+++||++||..||.+|+|+.++|+|||++....
T Consensus 263 ~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~ 301 (382)
T KOG0032|consen 263 DDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGE 301 (382)
T ss_pred cccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCcc
Confidence 789999999999999999999999999999999987533
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-48 Score=384.55 Aligned_cols=265 Identities=32% Similarity=0.508 Sum_probs=225.7
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
..|++.+.||+|.-|+||+|+.+.++..+|+|++.+... .......++..|-+||+.++||.++.||..|+.+..
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l-----~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~ 151 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESL-----ASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKY 151 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHH-----hhhhHHHHHHHHHHHHHhcCCCccchhhheeeccce
Confidence 579999999999999999999999999999999843221 224556778899999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhh
Q 009364 146 LNILLEFVPGGSISSLLGKF--GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAE 223 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 223 (536)
.|+|||||+||+|..+++++ +.|++..++.++..++.||+|||-.|||+|||||+||||.++|+|.|+||.++.....
T Consensus 152 ~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 152 SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 99999999999999988654 5799999999999999999999999999999999999999999999999998754311
Q ss_pred hh---------------------------------c---------------------ccCCcccCCCCCCCChhhhhhcC
Q 009364 224 LA---------------------------------T---------------------VSGAKSMKGTPYWMAPEVIRQTG 249 (536)
Q Consensus 224 ~~---------------------------------~---------------------~~~~~~~~Gt~~Y~APEvl~~~~ 249 (536)
.. . ......++||-.|.|||++.|.+
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 00 0 00122567999999999999999
Q ss_pred CCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCC----HHHHH
Q 009364 250 HSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPT----ASELL 325 (536)
Q Consensus 250 ~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps----~~eiL 325 (536)
++.++|+|+|||++||||.|..||.+...+.............+..+ .++..++|||+++|.+||.+|.. |.||.
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~-~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK 390 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP-EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIK 390 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC-cchhHHHHHHHHHhccChhhhhccccchHHhh
Confidence 99999999999999999999999987654443333333333333333 78999999999999999999998 99999
Q ss_pred hCCCCcCCCCC
Q 009364 326 KHPFVTGDDED 336 (536)
Q Consensus 326 ~hp~~~~~~~~ 336 (536)
+||||.+..|.
T Consensus 391 ~HpFF~gVnWa 401 (459)
T KOG0610|consen 391 RHPFFEGVNWA 401 (459)
T ss_pred cCccccCCChh
Confidence 99999998876
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=393.95 Aligned_cols=257 Identities=32% Similarity=0.588 Sum_probs=221.2
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
.+|++.+.||+|+||.||+|++..+|+.||+|++.... .......+.+.+|+.+++.++||||+++++++...+.
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 92 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKRE-----ILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENR 92 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHH-----HhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCE
Confidence 57999999999999999999999999999999984211 1112345668899999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhh
Q 009364 146 LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA 225 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 225 (536)
+++||||+.||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 93 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~- 171 (329)
T PTZ00263 93 VYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR- 171 (329)
T ss_pred EEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC-
Confidence 9999999999999999988889999999999999999999999999999999999999999999999999998765431
Q ss_pred cccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH-HHHHHhhCCCCCCCCCCCcCcHHHH
Q 009364 226 TVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE-VAALFHIGTTKSHPPIPENLSVKAK 304 (536)
Q Consensus 226 ~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~~ 304 (536)
....+||+.|+|||++.+..++.++|||||||++|+|++|..||...... ....... ....++..++..++
T Consensus 172 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~----~~~~~p~~~~~~~~ 243 (329)
T PTZ00263 172 ----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILA----GRLKFPNWFDGRAR 243 (329)
T ss_pred ----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhc----CCcCCCCCCCHHHH
Confidence 23467999999999999999999999999999999999999999754322 1121111 22345667899999
Q ss_pred HHHHHhcccCCCCCCC-----HHHHHhCCCCcCCCCC
Q 009364 305 DFLLKCLEKEPDLRPT-----ASELLKHPFVTGDDED 336 (536)
Q Consensus 305 dLi~~cL~~dP~~Rps-----~~eiL~hp~~~~~~~~ 336 (536)
+||++||+.||.+||+ +.++++||||....+.
T Consensus 244 ~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~ 280 (329)
T PTZ00263 244 DLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWD 280 (329)
T ss_pred HHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHH
Confidence 9999999999999997 7999999999865433
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=387.97 Aligned_cols=256 Identities=32% Similarity=0.516 Sum_probs=220.0
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
.+|++.+.||+|+||+||+|.+..+|+.||+|++.... .......+.+.+|+.+++.++||||+++++++.+...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 75 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPE-----VIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRF 75 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHH-----HhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCe
Confidence 36899999999999999999999999999999884211 1112334567899999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhh
Q 009364 146 LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA 225 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 225 (536)
+++||||+++|+|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~-- 153 (291)
T cd05612 76 LYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-- 153 (291)
T ss_pred EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC--
Confidence 999999999999999998888999999999999999999999999999999999999999999999999999876542
Q ss_pred cccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH-HHHHHhhCCCCCCCCCCCcCcHHHH
Q 009364 226 TVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE-VAALFHIGTTKSHPPIPENLSVKAK 304 (536)
Q Consensus 226 ~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~~ 304 (536)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||...... ....... ....++..++..++
T Consensus 154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~----~~~~~~~~~~~~~~ 226 (291)
T cd05612 154 ---RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILA----GKLEFPRHLDLYAK 226 (291)
T ss_pred ---CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----CCcCCCccCCHHHH
Confidence 123567999999999999989999999999999999999999999764322 1222111 12345667899999
Q ss_pred HHHHHhcccCCCCCCC-----HHHHHhCCCCcCCCC
Q 009364 305 DFLLKCLEKEPDLRPT-----ASELLKHPFVTGDDE 335 (536)
Q Consensus 305 dLi~~cL~~dP~~Rps-----~~eiL~hp~~~~~~~ 335 (536)
+||++||+.||.+||+ +.++++||||....+
T Consensus 227 ~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~ 262 (291)
T cd05612 227 DLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDW 262 (291)
T ss_pred HHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCH
Confidence 9999999999999995 999999999976443
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=394.98 Aligned_cols=250 Identities=35% Similarity=0.578 Sum_probs=214.2
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcE-EEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCC
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGEL-LAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEE 144 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~-vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 144 (536)
....+.+.||+|+||+||+|.+ .|.. ||+|++... .......+.+.+|+.+|.+++|||||+++|++....
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~------~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~ 112 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDP------DFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPP 112 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEe--CCceeEEEEEecch------hcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 3455667799999999999988 4556 999988321 111122678999999999999999999999999888
Q ss_pred -ceeEEEEecCCCCccccccc--CCCCCHHHHHHHHHHHHHHHHHHHHcC-CccccCCCCCcccCCCC-cEEEEecCcch
Q 009364 145 -SLNILLEFVPGGSISSLLGK--FGPFPEAVMRTYTKQLLLGLEYLHNHG-IMHRDIKGANILVDNKG-CIKLADFGASK 219 (536)
Q Consensus 145 -~~~lV~E~~~gg~L~~~l~~--~~~l~~~~~~~i~~qil~aL~yLH~~~-ivHrDLKp~NILl~~~~-~vkL~DFGla~ 219 (536)
.+++||||+++|+|..++.. .+.++...+..++.||++||.|||+++ ||||||||+|||++.++ ++||+|||+++
T Consensus 113 ~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr 192 (362)
T KOG0192|consen 113 GSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSR 192 (362)
T ss_pred CceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccce
Confidence 79999999999999999977 678999999999999999999999999 99999999999999998 99999999998
Q ss_pred hhhhhhcccCCcccCCCCCCCChhhhh--hcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCC
Q 009364 220 QVAELATVSGAKSMKGTPYWMAPEVIR--QTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPE 297 (536)
Q Consensus 220 ~~~~~~~~~~~~~~~Gt~~Y~APEvl~--~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 297 (536)
...... ...+...||+.|||||++. +..|+.|+||||||+++|||+||..||..... .............+.+|.
T Consensus 193 ~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~~~~v~~~~~Rp~~p~ 269 (362)
T KOG0192|consen 193 EKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQVASAVVVGGLRPPIPK 269 (362)
T ss_pred eecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHhcCCCCCCCc
Confidence 765321 2234478999999999999 66999999999999999999999999987655 333444444556677787
Q ss_pred cCcHHHHHHHHHhcccCCCCCCCHHHHHh
Q 009364 298 NLSVKAKDFLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 298 ~~s~~~~dLi~~cL~~dP~~Rps~~eiL~ 326 (536)
.+++.+..||.+||..||.+||++.+|+.
T Consensus 270 ~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 270 ECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred cCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 89999999999999999999999999976
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-47 Score=392.17 Aligned_cols=253 Identities=28% Similarity=0.481 Sum_probs=215.7
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCceeEEEE
Q 009364 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESLNILLE 151 (536)
Q Consensus 72 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 151 (536)
+.||+|+||.||+|.+..+|+.||+|++.... .........+.+|+.+++.++||||+++++++...+.+++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEV-----IIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHH-----hhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEe
Confidence 46999999999999999999999999884211 1122344567789999999999999999999999999999999
Q ss_pred ecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhcccCCc
Q 009364 152 FVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAK 231 (536)
Q Consensus 152 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 231 (536)
|++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... .....
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~~ 153 (323)
T cd05571 76 YANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GATMK 153 (323)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCccc
Confidence 9999999999988889999999999999999999999999999999999999999999999999998753221 12234
Q ss_pred ccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH-HHHHHhhCCCCCCCCCCCcCcHHHHHHHHHh
Q 009364 232 SMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE-VAALFHIGTTKSHPPIPENLSVKAKDFLLKC 310 (536)
Q Consensus 232 ~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~c 310 (536)
..+||+.|+|||++.+..++.++|||||||++|+|++|..||...... ....... ....++..++.++++||++|
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~----~~~~~p~~~~~~~~~li~~~ 229 (323)
T cd05571 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM----EEIRFPRTLSPEAKSLLAGL 229 (323)
T ss_pred ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHc----CCCCCCCCCCHHHHHHHHHH
Confidence 567999999999999999999999999999999999999999654332 2222211 22346678999999999999
Q ss_pred cccCCCCCC-----CHHHHHhCCCCcCCCC
Q 009364 311 LEKEPDLRP-----TASELLKHPFVTGDDE 335 (536)
Q Consensus 311 L~~dP~~Rp-----s~~eiL~hp~~~~~~~ 335 (536)
|++||++|| ++.++++||||....+
T Consensus 230 L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~ 259 (323)
T cd05571 230 LKKDPKQRLGGGPEDAKEIMEHRFFASINW 259 (323)
T ss_pred ccCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 999999999 8999999999987543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-48 Score=364.29 Aligned_cols=256 Identities=30% Similarity=0.507 Sum_probs=224.9
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE 143 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 143 (536)
..++|++++.||+|.||.||+|+.+.++-.||+|++.+.. -.......++.+|++|-..|+||||+++|++|.+.
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsq-----i~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~ 94 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQ-----ILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS 94 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHH-----HHHhcchhhhhheeEeecccCCccHHhhhhheecc
Confidence 3457999999999999999999999999999999984322 12223456789999999999999999999999999
Q ss_pred CceeEEEEecCCCCcccccc--cCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhh
Q 009364 144 ESLNILLEFVPGGSISSLLG--KFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQV 221 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~--~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~ 221 (536)
..+|+++||.++|++...+. ...++++..++.++.|++.||.|+|.++|+||||||+|+|++..|.+||+|||.+...
T Consensus 95 ~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 95 KRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred ceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 99999999999999999998 6678999999999999999999999999999999999999999999999999998754
Q ss_pred hhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH-HHHHHhhCCCCCCCCCCCcCc
Q 009364 222 AELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE-VAALFHIGTTKSHPPIPENLS 300 (536)
Q Consensus 222 ~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~s 300 (536)
+ .....+.|||..|.|||...+..++..+|+|++|++.||++.|.+||..+... ....+. .....+|..++
T Consensus 175 p----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~----k~~~~~p~~is 246 (281)
T KOG0580|consen 175 P----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIR----KVDLKFPSTIS 246 (281)
T ss_pred C----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHH----HccccCCcccC
Confidence 3 34567899999999999999999999999999999999999999999766522 222221 12234568999
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhCCCCcC
Q 009364 301 VKAKDFLLKCLEKEPDLRPTASELLKHPFVTG 332 (536)
Q Consensus 301 ~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~ 332 (536)
.+++|||.+||.++|.+|.+..|++.|||+..
T Consensus 247 ~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 247 GGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred hhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 99999999999999999999999999999864
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-49 Score=396.55 Aligned_cols=262 Identities=38% Similarity=0.700 Sum_probs=232.0
Q ss_pred CCCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeee
Q 009364 62 MSPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVR 141 (536)
Q Consensus 62 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~ 141 (536)
..+...|+..+.||+|+||.||+|.+..+++.||+|++.+ +.....++.+++|+.+|..++++||.++|+.|.
T Consensus 9 ~~~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~L-------e~~~deIediqqei~~Ls~~~~~~it~yygsyl 81 (467)
T KOG0201|consen 9 IDPELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDL-------EEAEDEIEDIQQEISVLSQCDSPNITEYYGSYL 81 (467)
T ss_pred CCcccccccchhccccccceeeeeeeccccceEEEEEech-------hhcchhhHHHHHHHHHHHhcCcchHHhhhhhee
Confidence 3555678889999999999999999999999999999843 344566788999999999999999999999999
Q ss_pred cCCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhh
Q 009364 142 EEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQV 221 (536)
Q Consensus 142 ~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~ 221 (536)
....++++||||.||++.++++..+.+.+..+..++++++.||.|||..+.+|||||+.|||+..+|.|||+|||.+.++
T Consensus 82 ~g~~LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql 161 (467)
T KOG0201|consen 82 KGTKLWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQL 161 (467)
T ss_pred ecccHHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeee
Confidence 99999999999999999999998888899999999999999999999999999999999999999999999999999887
Q ss_pred hhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcH
Q 009364 222 AELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSV 301 (536)
Q Consensus 222 ~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 301 (536)
.... ....+++|||.|||||++++..|+.++||||||++.|||++|.|||...+. ...+........|.+...+|+
T Consensus 162 ~~~~--~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP--mrvlflIpk~~PP~L~~~~S~ 237 (467)
T KOG0201|consen 162 TNTV--KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP--MRVLFLIPKSAPPRLDGDFSP 237 (467)
T ss_pred echh--hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc--ceEEEeccCCCCCccccccCH
Confidence 6533 334789999999999999999999999999999999999999999977654 122222233345556668999
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCC
Q 009364 302 KAKDFLLKCLEKEPDLRPTASELLKHPFVTGDD 334 (536)
Q Consensus 302 ~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~ 334 (536)
.+++||..||++||+.||+|.++|+|+|+....
T Consensus 238 ~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a~ 270 (467)
T KOG0201|consen 238 PFKEFVEACLDKNPEFRPSAKELLKHKFIKRAK 270 (467)
T ss_pred HHHHHHHHHhhcCcccCcCHHHHhhhHHHHhcC
Confidence 999999999999999999999999999997643
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-48 Score=381.32 Aligned_cols=264 Identities=29% Similarity=0.462 Sum_probs=218.3
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE 142 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 142 (536)
..+.+|...+.||+|+||.|+.|.++.+|+.||||.+. ..-...-..++..+|+++|+.++|+||+.+++++..
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~------~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p 92 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKIL------NPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRP 92 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhh------hhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccc
Confidence 34556777899999999999999999999999999883 112333456778899999999999999999999865
Q ss_pred -----CCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCc
Q 009364 143 -----EESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGA 217 (536)
Q Consensus 143 -----~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGl 217 (536)
-+.+|+|+|+| +.+|...++....+++..+..+++||++||+|+|+.||+||||||.|+|++.++.+||||||+
T Consensus 93 ~~~~~f~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 93 PSRDKFNDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred ccccccceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccc
Confidence 35699999999 789999999888899999999999999999999999999999999999999999999999999
Q ss_pred chhhhhhhcccCCcccCCCCCCCChhhhh-hcCCCccceEechhHHHHHHhhCCCCCchhh--HHHHHHHh---------
Q 009364 218 SKQVAELATVSGAKSMKGTPYWMAPEVIR-QTGHSYSADIWSVGCTVIEMATGKPPWSQQY--QEVAALFH--------- 285 (536)
Q Consensus 218 a~~~~~~~~~~~~~~~~Gt~~Y~APEvl~-~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~--~~~~~~~~--------- 285 (536)
|+...........+.++.|.||+|||++. ...|+.+.||||+|||+.||++|++.|.+.. ..+..+..
T Consensus 172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~ 251 (359)
T KOG0660|consen 172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEED 251 (359)
T ss_pred eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHH
Confidence 99876432223357788999999999865 5689999999999999999999999996432 11111100
Q ss_pred ------------hCCCCCCCC-----CCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 286 ------------IGTTKSHPP-----IPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 286 ------------~~~~~~~~~-----~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
.......++ +.++.++.+.+|+.+||..||.+|+|++|+|.|||+...
T Consensus 252 l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~ 316 (359)
T KOG0660|consen 252 LQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPY 316 (359)
T ss_pred HHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhh
Confidence 011111111 225889999999999999999999999999999999754
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=386.32 Aligned_cols=258 Identities=30% Similarity=0.528 Sum_probs=218.2
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
.+|++.+.||+|+||.||+|.+..+|+.||+|++.... .........+.+|+.+++.++||||+++++++...+.
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~ 75 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSL-----LFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEY 75 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHH-----HhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCE
Confidence 36999999999999999999999999999999984211 1112345667889999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhh
Q 009364 146 LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA 225 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 225 (536)
.|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 76 LYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 999999999999999998888899999999999999999999999999999999999999999999999999876543
Q ss_pred cccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH-HHHHHhh-CCCCCCCCCC---CcCc
Q 009364 226 TVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE-VAALFHI-GTTKSHPPIP---ENLS 300 (536)
Q Consensus 226 ~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~-~~~~~~~-~~~~~~~~~~---~~~s 300 (536)
.....+||+.|+|||++.+..++.++|||||||++|+|++|.+||...... ....... ......+... ..++
T Consensus 154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s 230 (333)
T cd05600 154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLS 230 (333)
T ss_pred ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccC
Confidence 234567999999999999989999999999999999999999999754322 1111111 1111111111 2578
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 301 VKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 301 ~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
.++.+||.+||..+|.+||++.++++||||...
T Consensus 231 ~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 231 DEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred HHHHHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence 999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=380.78 Aligned_cols=255 Identities=24% Similarity=0.465 Sum_probs=223.2
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE 143 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 143 (536)
..-||++.+.||+|+||+|-+|+....|+.||||.|.+. +-+.++.+-.+.+||+||..|+||||+.+|++|++.
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKd-----kIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENk 125 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKD-----KIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENK 125 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhh-----hcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCC
Confidence 345899999999999999999999999999999988432 233445567789999999999999999999999999
Q ss_pred CceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhh
Q 009364 144 ESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAE 223 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 223 (536)
+.+.|||||..+|.|++++...+.+++.+++.+++||++|+.|+|.++++|||||.+|||+|.++++||+|||++..+..
T Consensus 126 dKIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 126 DKIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred ceEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999987765
Q ss_pred hhcccCCcccCCCCCCCChhhhhhcCC-CccceEechhHHHHHHhhCCCCCchhhHHH-HHHHhhCCCCCCCCCCCcCcH
Q 009364 224 LATVSGAKSMKGTPYWMAPEVIRQTGH-SYSADIWSVGCTVIEMATGKPPWSQQYQEV-AALFHIGTTKSHPPIPENLSV 301 (536)
Q Consensus 224 ~~~~~~~~~~~Gt~~Y~APEvl~~~~~-s~k~DIwSlGvil~eLltG~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~s~ 301 (536)
.. ..+++||+|-|.+||+++|.+| ++.+|-|||||+||.|+.|.+||.+..... ...+..+.. ..+.-+.
T Consensus 206 ~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaY-----rEP~~PS 277 (668)
T KOG0611|consen 206 KK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAY-----REPETPS 277 (668)
T ss_pred cc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccc-----cCCCCCc
Confidence 32 3578999999999999999988 789999999999999999999998765332 222222211 1124566
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhCCCCc
Q 009364 302 KAKDFLLKCLEKEPDLRPTASELLKHPFVT 331 (536)
Q Consensus 302 ~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~ 331 (536)
++.-||+.||..||++|.|+.+|..|=|+.
T Consensus 278 dA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 278 DASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred hHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 788999999999999999999999998875
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-47 Score=380.49 Aligned_cols=258 Identities=24% Similarity=0.407 Sum_probs=211.4
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
++|++.+.||+|+||+||+|++..+++.||+|++.... ......+.+.+|+.+++.++||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 74 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSE------ENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGK 74 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccc------ccccchhhHHHHHHHHHhCCCccccchhhhEecCCE
Confidence 37999999999999999999999999999999884321 112234567789999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhh
Q 009364 146 LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA 225 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 225 (536)
+++||||++++.+..+......+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++.......
T Consensus 75 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 75 LYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 99999999998877666656779999999999999999999999999999999999999999999999999998764322
Q ss_pred cccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH--HHHHHhhC-------------CC-
Q 009364 226 TVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE--VAALFHIG-------------TT- 289 (536)
Q Consensus 226 ~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~--~~~~~~~~-------------~~- 289 (536)
. .......||+.|+|||++.+..++.++|||||||++|+|++|++||...... ........ ..
T Consensus 155 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 155 N-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred c-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 1 1233467999999999999888999999999999999999999999653211 11110000 00
Q ss_pred ---CCCC----------CCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCC
Q 009364 290 ---KSHP----------PIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFV 330 (536)
Q Consensus 290 ---~~~~----------~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~ 330 (536)
...+ .....++.++++||++||++||++|||++++|+||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 0000 0112478889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=379.49 Aligned_cols=259 Identities=26% Similarity=0.412 Sum_probs=214.7
Q ss_pred ceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCcee
Q 009364 68 WRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESLN 147 (536)
Q Consensus 68 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 147 (536)
|++.+.||+|+||+||+|.+..+|+.||+|.+.... .........+.+|+.+++.++|+||+++++++.+.+.++
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~-----~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~ 76 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKR-----IKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALC 76 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhh-----hhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEE
Confidence 788999999999999999999999999999874211 111122345678999999999999999999999999999
Q ss_pred EEEEecCCCCccccccc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhh
Q 009364 148 ILLEFVPGGSISSLLGK--FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA 225 (536)
Q Consensus 148 lV~E~~~gg~L~~~l~~--~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 225 (536)
+||||+++|+|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 77 lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 77 LVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred EEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 99999999999887743 3468999999999999999999999999999999999999999999999999987654321
Q ss_pred cccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHH-HHHHhhCCCCCCCCCCCcCcHHHH
Q 009364 226 TVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEV-AALFHIGTTKSHPPIPENLSVKAK 304 (536)
Q Consensus 226 ~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~s~~~~ 304 (536)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ..............++..++.++.
T Consensus 157 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 233 (285)
T cd05631 157 ---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAK 233 (285)
T ss_pred ---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHH
Confidence 1234579999999999999999999999999999999999999997543211 111111111223345667899999
Q ss_pred HHHHHhcccCCCCCCC-----HHHHHhCCCCcCCC
Q 009364 305 DFLLKCLEKEPDLRPT-----ASELLKHPFVTGDD 334 (536)
Q Consensus 305 dLi~~cL~~dP~~Rps-----~~eiL~hp~~~~~~ 334 (536)
+||++||+.||.+||+ ++++++||||....
T Consensus 234 ~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~ 268 (285)
T cd05631 234 SICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNIN 268 (285)
T ss_pred HHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCC
Confidence 9999999999999997 99999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=381.31 Aligned_cols=270 Identities=28% Similarity=0.493 Sum_probs=215.5
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchh------HHHHHHHHHHHHHHHHHhCCCCceeeEee
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKE------KAQDHIKELEEEVKLLKDLSHPNIVRYLG 138 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~------~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~ 138 (536)
-++|++.+.||+|.||+|.+|++..+++.||||++.+........ .....++.+.+||.+|++|.|||||+|++
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 357999999999999999999999999999999985432111100 00122467899999999999999999999
Q ss_pred eeecC--CceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecC
Q 009364 139 TVREE--ESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFG 216 (536)
Q Consensus 139 ~~~~~--~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFG 216 (536)
+..+. +.+|||+|||..|.+...=.....+++.+++.|++.++.||+|||.+|||||||||+|+|++.+|+|||+|||
T Consensus 176 vLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDFG 255 (576)
T KOG0585|consen 176 VLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDFG 255 (576)
T ss_pred eecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeeccc
Confidence 99864 5799999999999987654443339999999999999999999999999999999999999999999999999
Q ss_pred cchhhhhhh---cccCCcccCCCCCCCChhhhhhcC----CCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCC
Q 009364 217 ASKQVAELA---TVSGAKSMKGTPYWMAPEVIRQTG----HSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTT 289 (536)
Q Consensus 217 la~~~~~~~---~~~~~~~~~Gt~~Y~APEvl~~~~----~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~ 289 (536)
.+..+.... ........+|||.|+|||...++. .+.+.||||+||+||.|+.|..||.+...- .....+...
T Consensus 256 Vs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~-~l~~KIvn~ 334 (576)
T KOG0585|consen 256 VSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL-ELFDKIVND 334 (576)
T ss_pred eeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH-HHHHHHhcC
Confidence 987653211 111123478999999999987632 367899999999999999999999765422 122222223
Q ss_pred CCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCCC
Q 009364 290 KSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDE 335 (536)
Q Consensus 290 ~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~~ 335 (536)
....+..+.+.+.++|||++||++||++|++..+|..|||......
T Consensus 335 pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~ 380 (576)
T KOG0585|consen 335 PLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGD 380 (576)
T ss_pred cccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCC
Confidence 3333333468999999999999999999999999999999987643
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-46 Score=392.22 Aligned_cols=264 Identities=31% Similarity=0.500 Sum_probs=214.9
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCce
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESL 146 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 146 (536)
.|++++.||+|+||+||+|++..+++.||+|++.... .........+.+|+.+++.++||||+++++++.+.+.+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~-----~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 76 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKD-----VLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNL 76 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHH-----hhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEE
Confidence 5899999999999999999999999999999984211 11223456788999999999999999999999999999
Q ss_pred eEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhc
Q 009364 147 NILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELAT 226 (536)
Q Consensus 147 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 226 (536)
++||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.....
T Consensus 77 ~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 77 YFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 99999999999999998888899999999999999999999999999999999999999999999999999754321000
Q ss_pred ---------------------------------------------ccCCcccCCCCCCCChhhhhhcCCCccceEechhH
Q 009364 227 ---------------------------------------------VSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGC 261 (536)
Q Consensus 227 ---------------------------------------------~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGv 261 (536)
.......+||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 00012457999999999999989999999999999
Q ss_pred HHHHHhhCCCCCchhhHHHHHH-HhhCCCCCCCCCCCcCcHHHHHHHHHhc--ccCCCCCCCHHHHHhCCCCcCCCC
Q 009364 262 TVIEMATGKPPWSQQYQEVAAL-FHIGTTKSHPPIPENLSVKAKDFLLKCL--EKEPDLRPTASELLKHPFVTGDDE 335 (536)
Q Consensus 262 il~eLltG~~Pf~~~~~~~~~~-~~~~~~~~~~~~~~~~s~~~~dLi~~cL--~~dP~~Rps~~eiL~hp~~~~~~~ 335 (536)
++|+|++|.+||.......... ..........+....+++++++||.+|+ ..+|..|+++.++++||||....+
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~ 313 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDF 313 (381)
T ss_pred HHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCCh
Confidence 9999999999997543322111 1111111122223368999999999955 455566999999999999986543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=390.88 Aligned_cols=264 Identities=30% Similarity=0.469 Sum_probs=214.6
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCce
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESL 146 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 146 (536)
+|++.+.||+|+||+||+|.+..+|+.||+|++.... .........+.+|+.++..++|+||+++++.+.+...+
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~ 76 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKAD-----MLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNL 76 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHH-----HHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeE
Confidence 6899999999999999999999999999999984211 11223456678899999999999999999999999999
Q ss_pred eEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhc
Q 009364 147 NILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELAT 226 (536)
Q Consensus 147 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 226 (536)
|+||||++||+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.+.....
T Consensus 77 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 77 YLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred EEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence 99999999999999998888999999999999999999999999999999999999999999999999999875432110
Q ss_pred c---------------------------------cCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCC
Q 009364 227 V---------------------------------SGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPW 273 (536)
Q Consensus 227 ~---------------------------------~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf 273 (536)
. ......+||+.|+|||++.+..++.++|||||||++|+|++|.+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 0 0012457999999999999999999999999999999999999999
Q ss_pred chhhHH-HHHHHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCC---CCCCHHHHHhCCCCcCCCCC
Q 009364 274 SQQYQE-VAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPD---LRPTASELLKHPFVTGDDED 336 (536)
Q Consensus 274 ~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~---~Rps~~eiL~hp~~~~~~~~ 336 (536)
...... ....+.........+....++.++++||.+|+. +|. .||+++||++||||....+.
T Consensus 237 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~~~ 302 (363)
T cd05628 237 CSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVDWE 302 (363)
T ss_pred CCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCCHH
Confidence 754322 222111111111111112478999999999775 344 46899999999999876543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=389.57 Aligned_cols=257 Identities=29% Similarity=0.468 Sum_probs=219.3
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCC-cEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSG-ELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE 143 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g-~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 143 (536)
-.+|++.+.||+|+||.||+|.+..++ ..||+|++.... .........+.+|+.+++.++||||+++++++.+.
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~ 103 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSK-----IIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE 103 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHH-----hhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC
Confidence 347999999999999999999876654 789999884221 11223456678999999999999999999999999
Q ss_pred CceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhh
Q 009364 144 ESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAE 223 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 223 (536)
+.+++||||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 104 ~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 104 SYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 99999999999999999998888999999999999999999999999999999999999999999999999999876532
Q ss_pred hhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHH-HHHHhhCCCCCCCCCCCcCcHH
Q 009364 224 LATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEV-AALFHIGTTKSHPPIPENLSVK 302 (536)
Q Consensus 224 ~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~s~~ 302 (536)
.....+||+.|+|||++.+..++.++|||||||++|+|++|.+||....... ..... .....++..++..
T Consensus 184 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~----~~~~~~p~~~~~~ 254 (340)
T PTZ00426 184 -----RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKIL----EGIIYFPKFLDNN 254 (340)
T ss_pred -----CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHh----cCCCCCCCCCCHH
Confidence 1235679999999999999889999999999999999999999997654322 11111 1223456778999
Q ss_pred HHHHHHHhcccCCCCCC-----CHHHHHhCCCCcCCCC
Q 009364 303 AKDFLLKCLEKEPDLRP-----TASELLKHPFVTGDDE 335 (536)
Q Consensus 303 ~~dLi~~cL~~dP~~Rp-----s~~eiL~hp~~~~~~~ 335 (536)
++++|++||+.||.+|+ ++.++++||||.+..+
T Consensus 255 ~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~ 292 (340)
T PTZ00426 255 CKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDW 292 (340)
T ss_pred HHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 99999999999999995 8999999999987544
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-46 Score=382.17 Aligned_cols=249 Identities=31% Similarity=0.492 Sum_probs=212.5
Q ss_pred EcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCceeEEEEec
Q 009364 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESLNILLEFV 153 (536)
Q Consensus 74 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 153 (536)
||+|+||+||+|.+..+++.||+|++.... .........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~-----~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAH-----IVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHH-----hhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCC
Confidence 799999999999999999999999884211 112234566778999999999999999999999999999999999
Q ss_pred CCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhcccCCccc
Q 009364 154 PGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSM 233 (536)
Q Consensus 154 ~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 233 (536)
++|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ......
T Consensus 76 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~ 153 (312)
T cd05585 76 NGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTF 153 (312)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Cccccc
Confidence 999999999888889999999999999999999999999999999999999999999999999987533211 223456
Q ss_pred CCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH-HHHHHhhCCCCCCCCCCCcCcHHHHHHHHHhcc
Q 009364 234 KGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE-VAALFHIGTTKSHPPIPENLSVKAKDFLLKCLE 312 (536)
Q Consensus 234 ~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~ 312 (536)
+||+.|+|||++.+..++.++|||||||++|+|++|.+||...... ...... .....++..++.++++||.+||.
T Consensus 154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~li~~~L~ 229 (312)
T cd05585 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKIL----QEPLRFPDGFDRDAKDLLIGLLS 229 (312)
T ss_pred cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHH----cCCCCCCCcCCHHHHHHHHHHcC
Confidence 7999999999999999999999999999999999999999654322 211111 22345667899999999999999
Q ss_pred cCCCCCC---CHHHHHhCCCCcCC
Q 009364 313 KEPDLRP---TASELLKHPFVTGD 333 (536)
Q Consensus 313 ~dP~~Rp---s~~eiL~hp~~~~~ 333 (536)
.||.+|| ++.++++||||...
T Consensus 230 ~dp~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 230 RDPTRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred CCHHHcCCCCCHHHHHcCCCcCCC
Confidence 9999997 58999999999864
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-46 Score=390.33 Aligned_cols=263 Identities=31% Similarity=0.502 Sum_probs=216.4
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
.+|++.+.||+|+||+||+|++..+|+.||||++.... .........+.+|+.+|+.++||||+++++++.+...
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~ 75 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSE-----MLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENY 75 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHH-----hhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCe
Confidence 36999999999999999999999999999999984211 1122345567889999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhh
Q 009364 146 LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA 225 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 225 (536)
+++||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..+....
T Consensus 76 ~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 76 LYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred EEEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 99999999999999999888889999999999999999999999999999999999999999999999999987543211
Q ss_pred cc------------------------------------cCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhC
Q 009364 226 TV------------------------------------SGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATG 269 (536)
Q Consensus 226 ~~------------------------------------~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG 269 (536)
.. ......+||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 00 001135799999999999999999999999999999999999
Q ss_pred CCCCchhhHHH-HHHHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCC---HHHHHhCCCCcCCC
Q 009364 270 KPPWSQQYQEV-AALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPT---ASELLKHPFVTGDD 334 (536)
Q Consensus 270 ~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps---~~eiL~hp~~~~~~ 334 (536)
.+||....... .............+....+++++++||++||. +|.+|++ +.++++||||....
T Consensus 236 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~ 303 (364)
T cd05599 236 YPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVD 303 (364)
T ss_pred CCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCC
Confidence 99997543221 11111111111112223578999999999996 9999998 99999999998654
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-47 Score=380.00 Aligned_cols=264 Identities=34% Similarity=0.611 Sum_probs=220.4
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE 143 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 143 (536)
....|++...||.|.-++||+|+.+.+++.||||++.. ++-......+.+|+..|+.++||||++++..|..+
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inL-------Ekc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~ 96 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINL-------EKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVD 96 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeeh-------hhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEec
Confidence 34589999999999999999999999999999999843 34445578899999999999999999999999999
Q ss_pred CceeEEEEecCCCCcccccccC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhh
Q 009364 144 ESLNILLEFVPGGSISSLLGKF--GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQV 221 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~ 221 (536)
..+|+||.||.+|++.+++... ..++|..+..|+++++.||.|||.+|.||||||+.||||+.+|.|||+|||.+..+
T Consensus 97 ~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l 176 (516)
T KOG0582|consen 97 SELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASL 176 (516)
T ss_pred ceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeee
Confidence 9999999999999999999754 45999999999999999999999999999999999999999999999999987655
Q ss_pred hhhhcc-c-CCcccCCCCCCCChhhhhh--cCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCC------
Q 009364 222 AELATV-S-GAKSMKGTPYWMAPEVIRQ--TGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKS------ 291 (536)
Q Consensus 222 ~~~~~~-~-~~~~~~Gt~~Y~APEvl~~--~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~------ 291 (536)
...... . ...+++|||+|||||++.. .+|+.|+||||||+...||.+|..||.....--..+........
T Consensus 177 ~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~ 256 (516)
T KOG0582|consen 177 FDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSG 256 (516)
T ss_pred cccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCccccc
Confidence 432211 1 1257799999999999754 57999999999999999999999999764322222222221111
Q ss_pred -CCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCC
Q 009364 292 -HPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDD 334 (536)
Q Consensus 292 -~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~ 334 (536)
........+..++.+|..||++||.+|||++++|+|+||....
T Consensus 257 ~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k 300 (516)
T KOG0582|consen 257 LDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK 300 (516)
T ss_pred CChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence 1111234677899999999999999999999999999998654
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-47 Score=371.65 Aligned_cols=259 Identities=30% Similarity=0.486 Sum_probs=212.9
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec--C
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE--E 143 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--~ 143 (536)
..|+.+..|++|+||.||+|+++.+++.||+|.+..... + ...--.-.+||.+|.+++|||||.+-++... -
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmeke-----k-~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~ 149 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKE-----K-EGFPITSLREINILLKARHPNIVEVKEVVVGSNM 149 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccc-----c-CCCcchhHHHHHHHHhcCCCCeeeeEEEEecccc
Confidence 479999999999999999999999999999999854321 1 1112234689999999999999999998764 3
Q ss_pred CceeEEEEecCCCCcccccccCC-CCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhh
Q 009364 144 ESLNILLEFVPGGSISSLLGKFG-PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVA 222 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~ 222 (536)
+.+|+|||||+ -+|..++...+ +|...+++.++.|+++|++|||.+.|+||||||+|+|+++.|.+||+|||+|+.++
T Consensus 150 d~iy~VMe~~E-hDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 150 DKIYIVMEYVE-HDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred ceeeeeHHHHH-hhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhc
Confidence 57999999996 57888887665 89999999999999999999999999999999999999999999999999999887
Q ss_pred hhhcccCCcccCCCCCCCChhhhhhc-CCCccceEechhHHHHHHhhCCCCCchhhH--HHHHHHhh---CCCCCCCC--
Q 009364 223 ELATVSGAKSMKGTPYWMAPEVIRQT-GHSYSADIWSVGCTVIEMATGKPPWSQQYQ--EVAALFHI---GTTKSHPP-- 294 (536)
Q Consensus 223 ~~~~~~~~~~~~Gt~~Y~APEvl~~~-~~s~k~DIwSlGvil~eLltG~~Pf~~~~~--~~~~~~~~---~~~~~~~~-- 294 (536)
.. ....+..+-|.||+|||++.+. .|++++||||+|||+.||++++|.|.+..+ .+..++.. .....++.
T Consensus 229 sp--~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~ 306 (419)
T KOG0663|consen 229 SP--LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS 306 (419)
T ss_pred CC--cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence 53 3446778889999999998864 689999999999999999999999975432 22222222 11111111
Q ss_pred ---------------------CCC-cCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 295 ---------------------IPE-NLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 295 ---------------------~~~-~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
++. .++....+|+..+|..||.+|.||.|+|+|+||...
T Consensus 307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~ 367 (419)
T KOG0663|consen 307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET 367 (419)
T ss_pred ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence 111 256888999999999999999999999999999864
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-46 Score=390.82 Aligned_cols=262 Identities=33% Similarity=0.531 Sum_probs=215.6
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCce
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESL 146 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 146 (536)
+|++.+.||+|+||+||+|++..+++.||+|++.... .........+.+|+.+++.++||||+++++.+.+.+.+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~-----~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~ 76 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKD-----VLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNL 76 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHH-----hhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEE
Confidence 6899999999999999999999999999999884211 11234456788999999999999999999999999999
Q ss_pred eEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhh-
Q 009364 147 NILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA- 225 (536)
Q Consensus 147 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~- 225 (536)
++|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.+....
T Consensus 77 ~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 77 YFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 9999999999999999888889999999999999999999999999999999999999999999999999975331100
Q ss_pred --------------------------------------------cccCCcccCCCCCCCChhhhhhcCCCccceEechhH
Q 009364 226 --------------------------------------------TVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGC 261 (536)
Q Consensus 226 --------------------------------------------~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGv 261 (536)
........+||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 000012457999999999999999999999999999
Q ss_pred HHHHHhhCCCCCchhhHHHHH-HHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCC---HHHHHhCCCCcCCC
Q 009364 262 TVIEMATGKPPWSQQYQEVAA-LFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPT---ASELLKHPFVTGDD 334 (536)
Q Consensus 262 il~eLltG~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps---~~eiL~hp~~~~~~ 334 (536)
++|+|++|.+||......... ...........+....+++++++||.+|+ .+|.+|++ +.++++||||....
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~ 312 (382)
T cd05625 237 ILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTID 312 (382)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCcC
Confidence 999999999999765332211 11111111222223468999999999986 59999997 99999999997654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-46 Score=390.90 Aligned_cols=260 Identities=32% Similarity=0.544 Sum_probs=213.7
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCce
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESL 146 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 146 (536)
+|++.+.||+|+||+||+|.+..+|+.||||++.... .........+.+|+.+++.++||||+++++++.+...+
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~ 76 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSE-----MFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYL 76 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHH-----HHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCee
Confidence 6899999999999999999999999999999884321 11233456788999999999999999999999999999
Q ss_pred eEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhc
Q 009364 147 NILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELAT 226 (536)
Q Consensus 147 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 226 (536)
|+||||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.+.....
T Consensus 77 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 77 YLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 99999999999999998888899999999999999999999999999999999999999999999999999864321000
Q ss_pred c------------c---------------------------------CCcccCCCCCCCChhhhhhcCCCccceEechhH
Q 009364 227 V------------S---------------------------------GAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGC 261 (536)
Q Consensus 227 ~------------~---------------------------------~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGv 261 (536)
. . .....+||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 0 0 001357999999999999989999999999999
Q ss_pred HHHHHhhCCCCCchhhHH-HHHHHhhCCCCCCCCCC--CcCcHHHHHHHHHhcccCCCCC---CCHHHHHhCCCCcCCC
Q 009364 262 TVIEMATGKPPWSQQYQE-VAALFHIGTTKSHPPIP--ENLSVKAKDFLLKCLEKEPDLR---PTASELLKHPFVTGDD 334 (536)
Q Consensus 262 il~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~--~~~s~~~~dLi~~cL~~dP~~R---ps~~eiL~hp~~~~~~ 334 (536)
++|+|++|.+||...... ...... .......++ ..++.++++||.+||. +|.+| +++.++++||||....
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~--~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~~ 312 (377)
T cd05629 237 IMFECLIGWPPFCSENSHETYRKII--NWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGVD 312 (377)
T ss_pred hhhhhhcCCCCCCCCCHHHHHHHHH--ccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCCC
Confidence 999999999999754322 111111 111112222 3578999999999997 67665 5999999999998644
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-46 Score=386.66 Aligned_cols=264 Identities=33% Similarity=0.521 Sum_probs=219.3
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
.+|++.+.||+|+||+||+|++..+|+.||+|++.... .........+.+|+.++..++||||+++++++.+.+.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 75 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSD-----MIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEH 75 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHH-----HhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCe
Confidence 37999999999999999999999999999999984221 1112345667889999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhh
Q 009364 146 LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA 225 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 225 (536)
+++||||+++|+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 76 LYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred EEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 99999999999999999888889999999999999999999999999999999999999999999999999987655322
Q ss_pred ---------------------------cccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhH
Q 009364 226 ---------------------------TVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQ 278 (536)
Q Consensus 226 ---------------------------~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~ 278 (536)
.........||+.|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence 00123356799999999999999999999999999999999999999975442
Q ss_pred HH-HHHHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCC-HHHHHhCCCCcCCCC
Q 009364 279 EV-AALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPT-ASELLKHPFVTGDDE 335 (536)
Q Consensus 279 ~~-~~~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps-~~eiL~hp~~~~~~~ 335 (536)
.. ...+.........+....+++++.+||.+||. ||.+||+ +.++++||||.....
T Consensus 236 ~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~~ 293 (350)
T cd05573 236 QETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGIDW 293 (350)
T ss_pred HHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCCH
Confidence 21 11111111111122223479999999999997 9999999 999999999986543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-46 Score=390.59 Aligned_cols=262 Identities=32% Similarity=0.511 Sum_probs=215.6
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCce
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESL 146 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 146 (536)
+|++.+.||+|+||+||+|++..+|+.||+|++.... .........+.+|+.+|+.++|+||+++++.+.+.+.+
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~-----~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~ 76 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKAD-----VLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNL 76 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHH-----HHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEE
Confidence 6999999999999999999999999999999883211 11123345678899999999999999999999999999
Q ss_pred eEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhh-
Q 009364 147 NILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA- 225 (536)
Q Consensus 147 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~- 225 (536)
++|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 77 ~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 77 YFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence 9999999999999999888889999999999999999999999999999999999999999999999999975331000
Q ss_pred ----------------------------------------cccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHH
Q 009364 226 ----------------------------------------TVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIE 265 (536)
Q Consensus 226 ----------------------------------------~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~e 265 (536)
........+||+.|+|||++.+..++.++|||||||++|+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 0001124579999999999999999999999999999999
Q ss_pred HhhCCCCCchhhHHH-HHHHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCC---CHHHHHhCCCCcCCC
Q 009364 266 MATGKPPWSQQYQEV-AALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRP---TASELLKHPFVTGDD 334 (536)
Q Consensus 266 LltG~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rp---s~~eiL~hp~~~~~~ 334 (536)
|++|++||....... .............+....++.++.+||.+|+ .+|.+|+ ++.++++||||....
T Consensus 237 ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~~ 308 (376)
T cd05598 237 MLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGID 308 (376)
T ss_pred hhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCCC
Confidence 999999997554221 1111111111122233468999999999987 5999999 999999999998643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-46 Score=384.47 Aligned_cols=253 Identities=31% Similarity=0.506 Sum_probs=215.0
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCceeEEEE
Q 009364 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESLNILLE 151 (536)
Q Consensus 72 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 151 (536)
+.||+|+||.||+|.+..+|+.||+|++.... .........+.+|+.+++.++||||+++++++...+.+++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~-----~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEV-----IIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVME 75 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHH-----hhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEe
Confidence 46999999999999999999999999984211 1122345667889999999999999999999999999999999
Q ss_pred ecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhcccCCc
Q 009364 152 FVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAK 231 (536)
Q Consensus 152 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 231 (536)
|+++|+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... .....
T Consensus 76 y~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~ 153 (328)
T cd05593 76 YVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AATMK 153 (328)
T ss_pred CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc--ccccc
Confidence 9999999999988888999999999999999999999999999999999999999999999999998753221 11234
Q ss_pred ccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH-HHHHHhhCCCCCCCCCCCcCcHHHHHHHHHh
Q 009364 232 SMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE-VAALFHIGTTKSHPPIPENLSVKAKDFLLKC 310 (536)
Q Consensus 232 ~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~c 310 (536)
..+||+.|+|||++.+..++.++|||||||++|+|++|..||...... ..... ......++..++.++++||++|
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~----~~~~~~~p~~~~~~~~~li~~~ 229 (328)
T cd05593 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI----LMEDIKFPRTLSADAKSLLSGL 229 (328)
T ss_pred cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHh----ccCCccCCCCCCHHHHHHHHHH
Confidence 567999999999999889999999999999999999999999654322 22221 1123356678999999999999
Q ss_pred cccCCCCCC-----CHHHHHhCCCCcCCCC
Q 009364 311 LEKEPDLRP-----TASELLKHPFVTGDDE 335 (536)
Q Consensus 311 L~~dP~~Rp-----s~~eiL~hp~~~~~~~ 335 (536)
|++||.+|| ++.++++||||....+
T Consensus 230 L~~dP~~R~~~~~~~~~~il~h~~~~~~~~ 259 (328)
T cd05593 230 LIKDPNKRLGGGPDDAKEIMRHSFFTGVNW 259 (328)
T ss_pred cCCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 999999997 8999999999976543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-46 Score=383.62 Aligned_cols=253 Identities=29% Similarity=0.485 Sum_probs=214.5
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCceeEEEE
Q 009364 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESLNILLE 151 (536)
Q Consensus 72 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 151 (536)
+.||+|+||.||+|.+..+|+.||+|++.... .........+.+|+.+++.++||||+++++++...+.+++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEV-----IIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHH-----hhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEe
Confidence 46999999999999999999999999984221 1122344567789999999999999999999999999999999
Q ss_pred ecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhcccCCc
Q 009364 152 FVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAK 231 (536)
Q Consensus 152 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 231 (536)
|+++|+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .....
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~~~ 153 (323)
T cd05595 76 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMK 153 (323)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCC--CCccc
Confidence 9999999999988888999999999999999999999999999999999999999999999999998753221 11234
Q ss_pred ccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH-HHHHHhhCCCCCCCCCCCcCcHHHHHHHHHh
Q 009364 232 SMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE-VAALFHIGTTKSHPPIPENLSVKAKDFLLKC 310 (536)
Q Consensus 232 ~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~c 310 (536)
..+||+.|+|||++.+..++.++|||||||++|+|++|..||...... ....... ....++..+++++++||.+|
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~----~~~~~p~~~~~~~~~li~~~ 229 (323)
T cd05595 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM----EEIRFPRTLSPEAKSLLAGL 229 (323)
T ss_pred cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhc----CCCCCCCCCCHHHHHHHHHH
Confidence 567999999999999889999999999999999999999999654322 2222111 12345678899999999999
Q ss_pred cccCCCCCC-----CHHHHHhCCCCcCCCC
Q 009364 311 LEKEPDLRP-----TASELLKHPFVTGDDE 335 (536)
Q Consensus 311 L~~dP~~Rp-----s~~eiL~hp~~~~~~~ 335 (536)
|++||.+|| ++.++++||||.+..+
T Consensus 230 L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~ 259 (323)
T cd05595 230 LKKDPKQRLGGGPSDAKEVMEHRFFLSINW 259 (323)
T ss_pred ccCCHHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence 999999998 8999999999987543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=377.14 Aligned_cols=255 Identities=28% Similarity=0.449 Sum_probs=206.2
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
.+|++.+.||.|+||+||+|.+..+++.||+|++..... ......+.+|+.+++.++||||+++++++...+.
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 77 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-------EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERC 77 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc-------CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCe
Confidence 479999999999999999999999999999998843211 1112346689999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccC-CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhh
Q 009364 146 LNILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAEL 224 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 224 (536)
.++||||+++ +|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 78 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~ 156 (288)
T cd07871 78 LTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVP 156 (288)
T ss_pred EEEEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCC
Confidence 9999999974 888877654 35799999999999999999999999999999999999999999999999998754321
Q ss_pred hcccCCcccCCCCCCCChhhhhh-cCCCccceEechhHHHHHHhhCCCCCchhhHH--HHHHHhhCCCC-----------
Q 009364 225 ATVSGAKSMKGTPYWMAPEVIRQ-TGHSYSADIWSVGCTVIEMATGKPPWSQQYQE--VAALFHIGTTK----------- 290 (536)
Q Consensus 225 ~~~~~~~~~~Gt~~Y~APEvl~~-~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~--~~~~~~~~~~~----------- 290 (536)
........||+.|+|||++.+ ..++.++||||+||++|+|++|.+||...... ...........
T Consensus 157 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07871 157 --TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSN 234 (288)
T ss_pred --CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccc
Confidence 112334578999999999875 56899999999999999999999999654321 11111100000
Q ss_pred ------CC--------CCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCC
Q 009364 291 ------SH--------PPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFV 330 (536)
Q Consensus 291 ------~~--------~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~ 330 (536)
.. ......++.++++||++||+.||.+|||++|+++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 235 EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 00 00123578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-46 Score=381.20 Aligned_cols=262 Identities=29% Similarity=0.461 Sum_probs=216.7
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
.+|++.+.||+|+||+||+|.+..+|+.||+|++.... .......+.+.+|+.+++.++|+||+++++++.+...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~ 75 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSV-----LLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDN 75 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHH-----hhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCe
Confidence 36999999999999999999999999999999984211 1123345668899999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccC-CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhh
Q 009364 146 LNILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAEL 224 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 224 (536)
+++||||++||+|.+++.+. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 76 LYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred EEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 99999999999999999776 68999999999999999999999999999999999999999999999999999765432
Q ss_pred hcccCCcccCCCCCCCChhhhh------hcCCCccceEechhHHHHHHhhCCCCCchhhHH-H-HHHHhhCCCCCCCCCC
Q 009364 225 ATVSGAKSMKGTPYWMAPEVIR------QTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE-V-AALFHIGTTKSHPPIP 296 (536)
Q Consensus 225 ~~~~~~~~~~Gt~~Y~APEvl~------~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~-~-~~~~~~~~~~~~~~~~ 296 (536)
... ......||+.|+|||++. +..++.++|||||||++|+|++|..||...... . ..+.... .....+..
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~ 233 (330)
T cd05601 156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQ-RFLKFPED 233 (330)
T ss_pred Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCC-CccCCCCC
Confidence 211 223457999999999987 456789999999999999999999999654322 1 1222111 11111223
Q ss_pred CcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCCC
Q 009364 297 ENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDE 335 (536)
Q Consensus 297 ~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~~ 335 (536)
..++.++++||.+||. +|.+|||+.++++||||....+
T Consensus 234 ~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~ 271 (330)
T cd05601 234 PKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDW 271 (330)
T ss_pred CCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCH
Confidence 3689999999999998 9999999999999999986543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-46 Score=378.18 Aligned_cols=260 Identities=28% Similarity=0.438 Sum_probs=206.7
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEE 144 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 144 (536)
..+|++.+.||+|+||+||+|.+..+|+.||+|++.... .......+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 76 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQE-------EEGTPFTAIREASLLKGLKHANIVLLHDIIHTKE 76 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccc-------ccccchhHHHHHHHHhhCCCCCcCeEEEEEecCC
Confidence 468999999999999999999999999999999884221 1111234568999999999999999999999999
Q ss_pred ceeEEEEecCCCCccccccc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhh
Q 009364 145 SLNILLEFVPGGSISSLLGK-FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAE 223 (536)
Q Consensus 145 ~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 223 (536)
..++||||+. ++|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 77 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 155 (303)
T cd07869 77 TLTLVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSV 155 (303)
T ss_pred eEEEEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccC
Confidence 9999999995 566666644 46789999999999999999999999999999999999999999999999999865432
Q ss_pred hhcccCCcccCCCCCCCChhhhhh-cCCCccceEechhHHHHHHhhCCCCCchhhH---HHHHHHhhCCCCCCCC-----
Q 009364 224 LATVSGAKSMKGTPYWMAPEVIRQ-TGHSYSADIWSVGCTVIEMATGKPPWSQQYQ---EVAALFHIGTTKSHPP----- 294 (536)
Q Consensus 224 ~~~~~~~~~~~Gt~~Y~APEvl~~-~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~---~~~~~~~~~~~~~~~~----- 294 (536)
. .......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||..... ................
T Consensus 156 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (303)
T cd07869 156 P--SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVH 233 (303)
T ss_pred C--CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchh
Confidence 1 112345678999999999875 4578999999999999999999999975321 1111111100000000
Q ss_pred -------------CC---------CcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCC
Q 009364 295 -------------IP---------ENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDD 334 (536)
Q Consensus 295 -------------~~---------~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~ 334 (536)
.+ ...+.++++||.+||+.||++|||+.|+++||||....
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~ 295 (303)
T cd07869 234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP 295 (303)
T ss_pred hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence 00 12457889999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-46 Score=382.29 Aligned_cols=260 Identities=26% Similarity=0.406 Sum_probs=207.5
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC---
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE--- 143 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--- 143 (536)
+|++.+.||+|+||.||+|.+..+|+.||+|.+.... ........+.+|+.+++.++||||+++++++...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 74 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF------EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 74 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh------ccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCC
Confidence 6999999999999999999999999999999873211 1112234577899999999999999999988543
Q ss_pred --CceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhh
Q 009364 144 --ESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQV 221 (536)
Q Consensus 144 --~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~ 221 (536)
..+|+||||| +++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 75 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 75 EFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred CCceEEEEEecC-CCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 2489999999 5789998888788999999999999999999999999999999999999999999999999998764
Q ss_pred hhhhc-ccCCcccCCCCCCCChhhhhh--cCCCccceEechhHHHHHHhhCCCCCchhhHHH-HH---------------
Q 009364 222 AELAT-VSGAKSMKGTPYWMAPEVIRQ--TGHSYSADIWSVGCTVIEMATGKPPWSQQYQEV-AA--------------- 282 (536)
Q Consensus 222 ~~~~~-~~~~~~~~Gt~~Y~APEvl~~--~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~-~~--------------- 282 (536)
..... ........||+.|+|||++.+ ..++.++|||||||++|+|++|++||....... ..
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 32211 111235679999999999876 578999999999999999999999996432110 00
Q ss_pred ---------HHhhCCCCCCC---CCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 283 ---------LFHIGTTKSHP---PIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 283 ---------~~~~~~~~~~~---~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
........... ...+.+++.+.+||.+||+.||++|||+.++++||||...
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~ 296 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGL 296 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhc
Confidence 00000000000 1113577889999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=383.85 Aligned_cols=264 Identities=30% Similarity=0.485 Sum_probs=216.0
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCce
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESL 146 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 146 (536)
.|++.+.||+|+||+||+|.+..+|+.||+|++.... .........+.+|+.++..++||||+++++.+.+.+.+
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~ 76 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKAD-----MLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNL 76 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHH-----HhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 6899999999999999999999999999999884211 11223456788899999999999999999999999999
Q ss_pred eEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhc
Q 009364 147 NILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELAT 226 (536)
Q Consensus 147 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 226 (536)
++||||++||+|.+++.+.+.+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++.+.....
T Consensus 77 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 77 YLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred EEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence 99999999999999998888999999999999999999999999999999999999999999999999999875432110
Q ss_pred c---------------------------------cCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCC
Q 009364 227 V---------------------------------SGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPW 273 (536)
Q Consensus 227 ~---------------------------------~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf 273 (536)
. ......+||+.|+|||++.+..++.++|||||||++|+|++|.+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 0 0012457999999999999999999999999999999999999999
Q ss_pred chhhHHH-HHHHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCC---CHHHHHhCCCCcCCCCC
Q 009364 274 SQQYQEV-AALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRP---TASELLKHPFVTGDDED 336 (536)
Q Consensus 274 ~~~~~~~-~~~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rp---s~~eiL~hp~~~~~~~~ 336 (536)
....... .............+....++.++++||.+|+ .||.+|+ ++.++++||||....+.
T Consensus 237 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~~ 302 (360)
T cd05627 237 CSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGVDWG 302 (360)
T ss_pred CCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCCCHH
Confidence 7544321 1111111111111111247899999999987 4999998 48999999999876544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=380.89 Aligned_cols=261 Identities=33% Similarity=0.561 Sum_probs=214.5
Q ss_pred CceeeeEEcccCceEEEEEEEc---CCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeEeeeeec
Q 009364 67 RWRKGELIGCGAFGRVYMGMNL---DSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRYLGTVRE 142 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~ 142 (536)
+|++.+.||+|+||+||+|++. .+|+.||+|++..... .......+.+..|+.+++.+ +|+||+++++++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~----~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAAL----VQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT 76 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHH----hhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec
Confidence 4899999999999999998864 4789999998842211 11123345677899999999 59999999999999
Q ss_pred CCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhh
Q 009364 143 EESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVA 222 (536)
Q Consensus 143 ~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~ 222 (536)
.+.+++||||+++|+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus 77 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 77 EAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence 99999999999999999999888889999999999999999999999999999999999999999999999999987653
Q ss_pred hhhcccCCcccCCCCCCCChhhhhhc-CCCccceEechhHHHHHHhhCCCCCchhhH--HHHHHHhhCCCCCCCCCCCcC
Q 009364 223 ELATVSGAKSMKGTPYWMAPEVIRQT-GHSYSADIWSVGCTVIEMATGKPPWSQQYQ--EVAALFHIGTTKSHPPIPENL 299 (536)
Q Consensus 223 ~~~~~~~~~~~~Gt~~Y~APEvl~~~-~~s~k~DIwSlGvil~eLltG~~Pf~~~~~--~~~~~~~~~~~~~~~~~~~~~ 299 (536)
.... ......+||+.|+|||++.+. .++.++|||||||++|+|++|..||..... ..... ........+.++..+
T Consensus 157 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 234 (332)
T cd05614 157 SEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV-SRRILKCDPPFPSFI 234 (332)
T ss_pred ccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHH-HHHHhcCCCCCCCCC
Confidence 3211 123356799999999999865 478999999999999999999999953210 01111 111112334566788
Q ss_pred cHHHHHHHHHhcccCCCCCC-----CHHHHHhCCCCcCC
Q 009364 300 SVKAKDFLLKCLEKEPDLRP-----TASELLKHPFVTGD 333 (536)
Q Consensus 300 s~~~~dLi~~cL~~dP~~Rp-----s~~eiL~hp~~~~~ 333 (536)
+..+++||.+||+.||++|| ++.++++||||...
T Consensus 235 ~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 235 GPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 99999999999999999999 88999999999764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-46 Score=380.63 Aligned_cols=252 Identities=29% Similarity=0.495 Sum_probs=213.2
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCceeEEEE
Q 009364 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESLNILLE 151 (536)
Q Consensus 72 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 151 (536)
+.||+|+||+||+|.+..+|+.||+|++.... .........+.+|+++++.++||||+++++++.....+++|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~-----~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEV-----IVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVME 75 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHH-----hhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEe
Confidence 46999999999999999999999999984211 1112334566789999999999999999999999999999999
Q ss_pred ecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHH-cCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhcccCC
Q 009364 152 FVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHN-HGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGA 230 (536)
Q Consensus 152 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~-~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 230 (536)
|+++|+|..++...+.+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++..... ....
T Consensus 76 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~~ 153 (325)
T cd05594 76 YANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATM 153 (325)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCC--Cccc
Confidence 99999999999888889999999999999999999997 79999999999999999999999999998753221 1123
Q ss_pred cccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH-HHHHHhhCCCCCCCCCCCcCcHHHHHHHHH
Q 009364 231 KSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE-VAALFHIGTTKSHPPIPENLSVKAKDFLLK 309 (536)
Q Consensus 231 ~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~ 309 (536)
...+||+.|+|||++.+..++.++|||||||++|+|++|..||...... ....... ....++..+++++.+||++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~----~~~~~p~~~~~~~~~li~~ 229 (325)
T cd05594 154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM----EEIRFPRTLSPEAKSLLSG 229 (325)
T ss_pred ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhc----CCCCCCCCCCHHHHHHHHH
Confidence 4567999999999999989999999999999999999999999654332 2222211 2234567889999999999
Q ss_pred hcccCCCCCC-----CHHHHHhCCCCcCCC
Q 009364 310 CLEKEPDLRP-----TASELLKHPFVTGDD 334 (536)
Q Consensus 310 cL~~dP~~Rp-----s~~eiL~hp~~~~~~ 334 (536)
||++||++|+ ++.++++||||.+..
T Consensus 230 ~L~~dP~~R~~~~~~~~~~il~h~~~~~~~ 259 (325)
T cd05594 230 LLKKDPKQRLGGGPDDAKEIMQHKFFAGIV 259 (325)
T ss_pred HhhcCHHHhCCCCCCCHHHHhcCCCcCCCC
Confidence 9999999997 999999999998643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=380.56 Aligned_cols=256 Identities=29% Similarity=0.498 Sum_probs=211.4
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeEeeeeecCCceeEEE
Q 009364 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRYLGTVREEESLNILL 150 (536)
Q Consensus 72 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~ 150 (536)
+.||+|+||.||+|.+..+++.||+|++.... .........+..|..+++.+ +||||+++++++.+...+++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~-----~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKEL-----VNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHH-----hhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEE
Confidence 46999999999999999999999999984211 11223445678899999888 6999999999999999999999
Q ss_pred EecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhcccCC
Q 009364 151 EFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGA 230 (536)
Q Consensus 151 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 230 (536)
||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... .....
T Consensus 76 e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~--~~~~~ 153 (329)
T cd05588 76 EFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR--PGDTT 153 (329)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCcccccccc--CCCcc
Confidence 9999999999988888999999999999999999999999999999999999999999999999999864221 11223
Q ss_pred cccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhh------HHHHHHHhhCCCCCCCCCCCcCcHHHH
Q 009364 231 KSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQY------QEVAALFHIGTTKSHPPIPENLSVKAK 304 (536)
Q Consensus 231 ~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~------~~~~~~~~~~~~~~~~~~~~~~s~~~~ 304 (536)
...+||+.|+|||++.+..++.++|||||||++|+|++|+.||.... .................+|..++.+++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 233 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAS 233 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHH
Confidence 45789999999999999999999999999999999999999995210 000000000011123346678899999
Q ss_pred HHHHHhcccCCCCCCC------HHHHHhCCCCcCCC
Q 009364 305 DFLLKCLEKEPDLRPT------ASELLKHPFVTGDD 334 (536)
Q Consensus 305 dLi~~cL~~dP~~Rps------~~eiL~hp~~~~~~ 334 (536)
+||++||+.||.+|++ +.++++||||....
T Consensus 234 ~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~ 269 (329)
T cd05588 234 SVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNID 269 (329)
T ss_pred HHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCC
Confidence 9999999999999987 79999999997643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=383.48 Aligned_cols=265 Identities=26% Similarity=0.411 Sum_probs=215.8
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE 143 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 143 (536)
...+|++.+.||+|+||+||+|.+..+|+.||+|++.... .........+.+|+.+++.++||||+++++++.+.
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~ 115 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFE-----MIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDD 115 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHH-----hhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 3458999999999999999999999999999999984211 11122334567899999999999999999999999
Q ss_pred CceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhh
Q 009364 144 ESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAE 223 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 223 (536)
..+++||||++||+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 116 KYLYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 999999999999999998865 4689999999999999999999999999999999999999999999999999876543
Q ss_pred hhcccCCcccCCCCCCCChhhhhhc----CCCccceEechhHHHHHHhhCCCCCchhhHH-HHHHHhhCCCCCCCCCCCc
Q 009364 224 LATVSGAKSMKGTPYWMAPEVIRQT----GHSYSADIWSVGCTVIEMATGKPPWSQQYQE-VAALFHIGTTKSHPPIPEN 298 (536)
Q Consensus 224 ~~~~~~~~~~~Gt~~Y~APEvl~~~----~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~ 298 (536)
... ......+||+.|+|||++.+. .++.++|||||||++|+|++|.+||...... ....+.........+....
T Consensus 195 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 273 (370)
T cd05596 195 NGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIE 273 (370)
T ss_pred CCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCC
Confidence 211 123456799999999998753 3789999999999999999999999765322 1111111111111122235
Q ss_pred CcHHHHHHHHHhcccCCCC--CCCHHHHHhCCCCcCCCC
Q 009364 299 LSVKAKDFLLKCLEKEPDL--RPTASELLKHPFVTGDDE 335 (536)
Q Consensus 299 ~s~~~~dLi~~cL~~dP~~--Rps~~eiL~hp~~~~~~~ 335 (536)
++.++++||++||+.+|.+ |+++.++++||||....+
T Consensus 274 ~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~ 312 (370)
T cd05596 274 ISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQW 312 (370)
T ss_pred CCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCCh
Confidence 7999999999999999988 999999999999986543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-45 Score=382.19 Aligned_cols=264 Identities=27% Similarity=0.456 Sum_probs=213.9
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE 143 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 143 (536)
...+|++.+.||+|+||.||+|.+..+++.||+|++.... .........+.+|+.+++.++||||+++++++.++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFE-----MIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD 115 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHH-----hhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence 4468999999999999999999999999999999884211 11122345577899999999999999999999999
Q ss_pred CceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhh
Q 009364 144 ESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAE 223 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 223 (536)
..+|+||||++||+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 116 KYLYMVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence 999999999999999999865 4689999999999999999999999999999999999999999999999999976543
Q ss_pred hhcccCCcccCCCCCCCChhhhhhcC----CCccceEechhHHHHHHhhCCCCCchhhHH-HHHHHhhCCCCCCCCCCCc
Q 009364 224 LATVSGAKSMKGTPYWMAPEVIRQTG----HSYSADIWSVGCTVIEMATGKPPWSQQYQE-VAALFHIGTTKSHPPIPEN 298 (536)
Q Consensus 224 ~~~~~~~~~~~Gt~~Y~APEvl~~~~----~s~k~DIwSlGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~ 298 (536)
.. .......+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||...... ....+.........+....
T Consensus 195 ~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 273 (370)
T cd05621 195 TG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVE 273 (370)
T ss_pred CC-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCccc
Confidence 21 11234667999999999997643 788999999999999999999999754322 1111111111111122235
Q ss_pred CcHHHHHHHHHhcccCCCC--CCCHHHHHhCCCCcCCC
Q 009364 299 LSVKAKDFLLKCLEKEPDL--RPTASELLKHPFVTGDD 334 (536)
Q Consensus 299 ~s~~~~dLi~~cL~~dP~~--Rps~~eiL~hp~~~~~~ 334 (536)
++..+++||.+||..++.+ |+++.++++||||....
T Consensus 274 ~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~ 311 (370)
T cd05621 274 ISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQ 311 (370)
T ss_pred CCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCC
Confidence 7999999999999865544 89999999999998643
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=380.07 Aligned_cols=257 Identities=29% Similarity=0.494 Sum_probs=211.4
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeEeeeeecCCceeEEE
Q 009364 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRYLGTVREEESLNILL 150 (536)
Q Consensus 72 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~ 150 (536)
+.||+|+||+||+|.+..+++.||+|++.... .........+.+|+.++..+ +||||+++++++...+.+++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKEL-----VNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhH-----hcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEE
Confidence 46999999999999999999999999984221 11223345677888888776 7999999999999999999999
Q ss_pred EecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhcccCC
Q 009364 151 EFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGA 230 (536)
Q Consensus 151 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 230 (536)
||+++|+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ....
T Consensus 76 E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~--~~~~ 153 (329)
T cd05618 76 EYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GDTT 153 (329)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCC--CCcc
Confidence 99999999999888888999999999999999999999999999999999999999999999999998753221 1123
Q ss_pred cccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchh------hHHHHHHHhhCCCCCCCCCCCcCcHHHH
Q 009364 231 KSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQ------YQEVAALFHIGTTKSHPPIPENLSVKAK 304 (536)
Q Consensus 231 ~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~------~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 304 (536)
...+||+.|+|||++.+..++.++|||||||++|+|++|..||... ..................+|..++..++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 233 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAA 233 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHH
Confidence 4567999999999999999999999999999999999999999421 0000011111111223346778999999
Q ss_pred HHHHHhcccCCCCCCC------HHHHHhCCCCcCCCC
Q 009364 305 DFLLKCLEKEPDLRPT------ASELLKHPFVTGDDE 335 (536)
Q Consensus 305 dLi~~cL~~dP~~Rps------~~eiL~hp~~~~~~~ 335 (536)
+||++||+.||.+||+ +.++++||||....+
T Consensus 234 ~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~ 270 (329)
T cd05618 234 SVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 270 (329)
T ss_pred HHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 9999999999999998 589999999976543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=378.08 Aligned_cols=259 Identities=30% Similarity=0.506 Sum_probs=216.6
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEE 144 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 144 (536)
..+|++.+.||+|+||.||+|++..+|..+|+|++... ........+.+|+++|+.++||||+++++++...+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 76 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLE-------IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG 76 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecc-------cCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence 46899999999999999999999999999999988421 11233466889999999999999999999999999
Q ss_pred ceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHc-CCccccCCCCCcccCCCCcEEEEecCcchhhhh
Q 009364 145 SLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNH-GIMHRDIKGANILVDNKGCIKLADFGASKQVAE 223 (536)
Q Consensus 145 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~-~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 223 (536)
.+++||||+++|+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 156 (331)
T cd06649 77 EISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (331)
T ss_pred EEEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence 9999999999999999998888899999999999999999999986 699999999999999999999999999876543
Q ss_pred hhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhH-HHHHHHhhCC--------------
Q 009364 224 LATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQ-EVAALFHIGT-------------- 288 (536)
Q Consensus 224 ~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~-~~~~~~~~~~-------------- 288 (536)
. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... +.........
T Consensus 157 ~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (331)
T cd06649 157 S----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPR 232 (331)
T ss_pred c----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcc
Confidence 2 23456799999999999998999999999999999999999999964322 1111111000
Q ss_pred -----------------------------CCCCCCC-CCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCC
Q 009364 289 -----------------------------TKSHPPI-PENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDD 334 (536)
Q Consensus 289 -----------------------------~~~~~~~-~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~ 334 (536)
....+.. ...++.++++||.+||++||++|||+.++++||||+...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 308 (331)
T cd06649 233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE 308 (331)
T ss_pred cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence 0000111 124688999999999999999999999999999997643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=377.42 Aligned_cols=252 Identities=30% Similarity=0.481 Sum_probs=211.8
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeEeeeeecCCceeEEE
Q 009364 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRYLGTVREEESLNILL 150 (536)
Q Consensus 72 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~ 150 (536)
+.||+|+||+||+|.+..+++.||+|++.... .......+.+..|..++..+ +||||+++++++...+.+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDV-----ILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHH-----HhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEE
Confidence 46999999999999999999999999884211 11123345566788888776 6999999999999999999999
Q ss_pred EecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhcccCC
Q 009364 151 EFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGA 230 (536)
Q Consensus 151 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 230 (536)
||++||+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ....
T Consensus 76 Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~--~~~~ 153 (320)
T cd05590 76 EFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--GKTT 153 (320)
T ss_pred cCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC--CCcc
Confidence 99999999999988889999999999999999999999999999999999999999999999999998753221 1123
Q ss_pred cccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH-HHHHHhhCCCCCCCCCCCcCcHHHHHHHHH
Q 009364 231 KSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE-VAALFHIGTTKSHPPIPENLSVKAKDFLLK 309 (536)
Q Consensus 231 ~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~ 309 (536)
...+||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ....+. .....++..++.++++||++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~----~~~~~~~~~~~~~~~~li~~ 229 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL----NDEVVYPTWLSQDAVDILKA 229 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHh----cCCCCCCCCCCHHHHHHHHH
Confidence 4567999999999999989999999999999999999999999754332 222221 12234556789999999999
Q ss_pred hcccCCCCCCCH------HHHHhCCCCcCCC
Q 009364 310 CLEKEPDLRPTA------SELLKHPFVTGDD 334 (536)
Q Consensus 310 cL~~dP~~Rps~------~eiL~hp~~~~~~ 334 (536)
||+.||.+||++ +++++||||....
T Consensus 230 ~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~ 260 (320)
T cd05590 230 FMTKNPTMRLGSLTLGGEEAILRHPFFKELD 260 (320)
T ss_pred HcccCHHHCCCCCCCCCHHHHHcCCCcCCCC
Confidence 999999999998 9999999997654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=376.03 Aligned_cols=258 Identities=26% Similarity=0.433 Sum_probs=216.3
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCC-CceeeEeeeeecCCc
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH-PNIVRYLGTVREEES 145 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~H-pnIv~l~~~~~~~~~ 145 (536)
+|++.+.||+|+||.||+|.+..+++.||+|++..... ......+.+..|+.++..+.| ++|+++++++...+.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~-----~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVI-----IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHh-----hhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCE
Confidence 48899999999999999999999999999998843211 112334567788999999976 568889999999999
Q ss_pred eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhh
Q 009364 146 LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA 225 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 225 (536)
+|+||||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~- 154 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG- 154 (324)
T ss_pred EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCC-
Confidence 9999999999999999988888999999999999999999999999999999999999999999999999998643211
Q ss_pred cccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH-HHHHHhhCCCCCCCCCCCcCcHHHH
Q 009364 226 TVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE-VAALFHIGTTKSHPPIPENLSVKAK 304 (536)
Q Consensus 226 ~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~~ 304 (536)
.......+||+.|+|||++.+..++.++||||+||++|+|++|+.||...... ...... .....++..++.+++
T Consensus 155 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~----~~~~~~~~~~~~~~~ 229 (324)
T cd05587 155 -GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM----EHNVSYPKSLSKEAV 229 (324)
T ss_pred -CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH----cCCCCCCCCCCHHHH
Confidence 11234567999999999999989999999999999999999999999754432 111111 123345678899999
Q ss_pred HHHHHhcccCCCCCCCH-----HHHHhCCCCcCCCC
Q 009364 305 DFLLKCLEKEPDLRPTA-----SELLKHPFVTGDDE 335 (536)
Q Consensus 305 dLi~~cL~~dP~~Rps~-----~eiL~hp~~~~~~~ 335 (536)
+||++||.+||.+|++. .++++||||....+
T Consensus 230 ~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~ 265 (324)
T cd05587 230 SICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDW 265 (324)
T ss_pred HHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 99999999999999976 89999999986543
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=375.22 Aligned_cols=253 Identities=28% Similarity=0.447 Sum_probs=211.9
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeEeeeeecCCceeEEE
Q 009364 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRYLGTVREEESLNILL 150 (536)
Q Consensus 72 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~ 150 (536)
+.||+|+||+||+|++..+|+.||+|++.... .........+..|..++..+ +||||+++++++...+.+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDV-----ILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHH-----hhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEE
Confidence 36999999999999999999999999984211 11123345566788888866 7999999999999999999999
Q ss_pred EecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhcccCC
Q 009364 151 EFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGA 230 (536)
Q Consensus 151 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 230 (536)
||+++|+|..++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ...
T Consensus 76 E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~ 153 (321)
T cd05591 76 EYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTT 153 (321)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCC--ccc
Confidence 999999999999888889999999999999999999999999999999999999999999999999987532211 123
Q ss_pred cccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHH-HHHHhhCCCCCCCCCCCcCcHHHHHHHHH
Q 009364 231 KSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEV-AALFHIGTTKSHPPIPENLSVKAKDFLLK 309 (536)
Q Consensus 231 ~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~s~~~~dLi~~ 309 (536)
...+||+.|+|||++.+..++.++|||||||++|+|++|.+||....... ...+.. .....+..++.++.+||++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~----~~~~~p~~~~~~~~~ll~~ 229 (321)
T cd05591 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILH----DDVLYPVWLSKEAVSILKA 229 (321)
T ss_pred cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHc----CCCCCCCCCCHHHHHHHHH
Confidence 45679999999999999899999999999999999999999997654322 111111 1233456789999999999
Q ss_pred hcccCCCCCC-------CHHHHHhCCCCcCCCC
Q 009364 310 CLEKEPDLRP-------TASELLKHPFVTGDDE 335 (536)
Q Consensus 310 cL~~dP~~Rp-------s~~eiL~hp~~~~~~~ 335 (536)
||++||.+|| ++.++++||||....+
T Consensus 230 ~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~ 262 (321)
T cd05591 230 FMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDW 262 (321)
T ss_pred HhccCHHHcCCCCCCCCCHHHHhcCCccCCCCH
Confidence 9999999999 9999999999976543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-45 Score=374.52 Aligned_cols=255 Identities=29% Similarity=0.505 Sum_probs=211.7
Q ss_pred ceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHH---HhCCCCceeeEeeeeecCC
Q 009364 68 WRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLL---KDLSHPNIVRYLGTVREEE 144 (536)
Q Consensus 68 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL---~~l~HpnIv~l~~~~~~~~ 144 (536)
|++.+.||+|+||.||+|.+..+|+.||||++..... ......+.+.+|+.++ +.++||||+++++++...+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDI-----IARDEVESLMCEKRIFETANSERHPFLVNLFACFQTED 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHh-----hhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCC
Confidence 7889999999999999999999999999999842210 1122344566666554 5678999999999999999
Q ss_pred ceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhh
Q 009364 145 SLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAEL 224 (536)
Q Consensus 145 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 224 (536)
.+|+||||++||+|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 76 ~~~lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 76 HVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EEEEEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 99999999999999888765 57999999999999999999999999999999999999999999999999998653221
Q ss_pred hcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH-HHHHHhhCCCCCCCCCCCcCcHHH
Q 009364 225 ATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE-VAALFHIGTTKSHPPIPENLSVKA 303 (536)
Q Consensus 225 ~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~ 303 (536)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||...... ....+.. ....++..++..+
T Consensus 155 --~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~----~~~~~p~~~~~~~ 228 (324)
T cd05589 155 --GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN----DEVRYPRFLSREA 228 (324)
T ss_pred --CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----CCCCCCCCCCHHH
Confidence 12234578999999999999989999999999999999999999999764322 2221111 1233566789999
Q ss_pred HHHHHHhcccCCCCCC-----CHHHHHhCCCCcCCC
Q 009364 304 KDFLLKCLEKEPDLRP-----TASELLKHPFVTGDD 334 (536)
Q Consensus 304 ~dLi~~cL~~dP~~Rp-----s~~eiL~hp~~~~~~ 334 (536)
.+||.+||+.||.+|| ++.++++||||....
T Consensus 229 ~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~ 264 (324)
T cd05589 229 ISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDIN 264 (324)
T ss_pred HHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCC
Confidence 9999999999999999 799999999997643
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=364.78 Aligned_cols=260 Identities=30% Similarity=0.534 Sum_probs=212.1
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCc-eeeEeeeeecCC
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPN-IVRYLGTVREEE 144 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hpn-Iv~l~~~~~~~~ 144 (536)
..|...+.||+|+||+||+|+++.+|+.||+|++...... +..-....+|+.+|+.++|+| |+++++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~------EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~ 84 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE------EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSN 84 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc------cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecc
Confidence 3577888899999999999999999999999998543221 112234578999999999999 999999998877
Q ss_pred ------ceeEEEEecCCCCcccccccCC----CCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEe
Q 009364 145 ------SLNILLEFVPGGSISSLLGKFG----PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLAD 214 (536)
Q Consensus 145 ------~~~lV~E~~~gg~L~~~l~~~~----~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~D 214 (536)
.+++|+||+ .-+|..++.... .++...++.+++||+.||+|||++||+||||||+||||+++|.+||+|
T Consensus 85 ~~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaD 163 (323)
T KOG0594|consen 85 NHRGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLAD 163 (323)
T ss_pred cccccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeec
Confidence 899999999 578888886654 578889999999999999999999999999999999999999999999
Q ss_pred cCcchhhhhhhcccCCcccCCCCCCCChhhhhhc-CCCccceEechhHHHHHHhhCCCCCchhhH--HHHHHHhhCCCCC
Q 009364 215 FGASKQVAELATVSGAKSMKGTPYWMAPEVIRQT-GHSYSADIWSVGCTVIEMATGKPPWSQQYQ--EVAALFHIGTTKS 291 (536)
Q Consensus 215 FGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~-~~s~k~DIwSlGvil~eLltG~~Pf~~~~~--~~~~~~~~~~~~~ 291 (536)
||+|+...-. ......-++|.+|+|||++.+. .|+...||||+|||++||+++++.|.+..+ ....++.......
T Consensus 164 FGlAra~~ip--~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~ 241 (323)
T KOG0594|consen 164 FGLARAFSIP--MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPN 241 (323)
T ss_pred cchHHHhcCC--cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCC
Confidence 9999965522 2224566799999999999887 789999999999999999999999976543 2222332222111
Q ss_pred CCCCC-------------------------CcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCC
Q 009364 292 HPPIP-------------------------ENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDD 334 (536)
Q Consensus 292 ~~~~~-------------------------~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~ 334 (536)
...|| +..+++..+|+.+||+.+|.+|.|+..+|.||||....
T Consensus 242 e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 242 EKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP 309 (323)
T ss_pred ccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence 11111 22345888999999999999999999999999998654
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-45 Score=374.71 Aligned_cols=253 Identities=31% Similarity=0.554 Sum_probs=212.3
Q ss_pred eEEcccCceEEEEEEEc---CCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCceeE
Q 009364 72 ELIGCGAFGRVYMGMNL---DSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESLNI 148 (536)
Q Consensus 72 ~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 148 (536)
+.||+|+||.||+|.+. .+++.||+|++..... .........+.+|+.+|+.++||||+++++++..++.+|+
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~----~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~l 77 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATI----VRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYL 77 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHH----HhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEE
Confidence 57999999999999864 4789999998842211 1112234556789999999999999999999999999999
Q ss_pred EEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhccc
Q 009364 149 LLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVS 228 (536)
Q Consensus 149 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 228 (536)
||||++||+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... .
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~ 155 (323)
T cd05584 78 ILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG--T 155 (323)
T ss_pred EEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC--C
Confidence 99999999999999888889999999999999999999999999999999999999999999999999986533211 1
Q ss_pred CCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHH-HHHHhhCCCCCCCCCCCcCcHHHHHHH
Q 009364 229 GAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEV-AALFHIGTTKSHPPIPENLSVKAKDFL 307 (536)
Q Consensus 229 ~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~s~~~~dLi 307 (536)
.....+||+.|+|||++.+..++.++|||||||++|+|++|.+||....... ..... .....++..++.++++||
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~li 231 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKIL----KGKLNLPPYLTPEARDLL 231 (323)
T ss_pred cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHH----cCCCCCCCCCCHHHHHHH
Confidence 2345679999999999998889999999999999999999999997643221 11111 122346678899999999
Q ss_pred HHhcccCCCCCC-----CHHHHHhCCCCcCCC
Q 009364 308 LKCLEKEPDLRP-----TASELLKHPFVTGDD 334 (536)
Q Consensus 308 ~~cL~~dP~~Rp-----s~~eiL~hp~~~~~~ 334 (536)
++||++||.+|| ++.++++||||....
T Consensus 232 ~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~ 263 (323)
T cd05584 232 KKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVN 263 (323)
T ss_pred HHHcccCHhHcCCCCCCCHHHHhcCCCcCCCC
Confidence 999999999999 899999999998654
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-45 Score=374.29 Aligned_cols=259 Identities=25% Similarity=0.417 Sum_probs=216.4
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeEeeeeecCCc
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRYLGTVREEES 145 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~ 145 (536)
+|++.+.||+|+||+||+|.+..+++.||+|++.... .......+....|..++..+ .|++|+++++++...+.
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDV-----VIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDR 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHH-----hhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCE
Confidence 4889999999999999999999999999999884321 11122334566677888777 58999999999999999
Q ss_pred eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhh
Q 009364 146 LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA 225 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 225 (536)
+++||||+++|+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred EEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 99999999999999999888889999999999999999999999999999999999999999999999999987533211
Q ss_pred cccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH-HHHHHhhCCCCCCCCCCCcCcHHHH
Q 009364 226 TVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE-VAALFHIGTTKSHPPIPENLSVKAK 304 (536)
Q Consensus 226 ~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~~ 304 (536)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||...... ....+.. ....+|..++.+++
T Consensus 156 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~----~~~~~p~~~s~~~~ 229 (323)
T cd05616 156 --VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME----HNVAYPKSMSKEAV 229 (323)
T ss_pred --CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHh----CCCCCCCcCCHHHH
Confidence 1234567999999999999999999999999999999999999999765432 2221111 22345678999999
Q ss_pred HHHHHhcccCCCCCCC-----HHHHHhCCCCcCCCCC
Q 009364 305 DFLLKCLEKEPDLRPT-----ASELLKHPFVTGDDED 336 (536)
Q Consensus 305 dLi~~cL~~dP~~Rps-----~~eiL~hp~~~~~~~~ 336 (536)
+|+.+||++||.+|++ ..++++||||....+.
T Consensus 230 ~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~ 266 (323)
T cd05616 230 AICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE 266 (323)
T ss_pred HHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHH
Confidence 9999999999999998 4899999999875543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-45 Score=373.53 Aligned_cols=252 Identities=31% Similarity=0.540 Sum_probs=209.2
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHh-CCCCceeeEeeeeecCCceeEEE
Q 009364 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKD-LSHPNIVRYLGTVREEESLNILL 150 (536)
Q Consensus 72 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~-l~HpnIv~l~~~~~~~~~~~lV~ 150 (536)
+.||+|+||+||+|.+..+++.||+|++..... ......+....|..++.. .+||||+++++++.....+++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVV-----LEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-----hhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEE
Confidence 469999999999999999999999999843211 111223444556666665 48999999999999999999999
Q ss_pred EecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhcccCC
Q 009364 151 EFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGA 230 (536)
Q Consensus 151 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 230 (536)
||++||+|..++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ...
T Consensus 76 e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~ 153 (316)
T cd05592 76 EYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKA 153 (316)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Ccc
Confidence 999999999999888889999999999999999999999999999999999999999999999999987543211 223
Q ss_pred cccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH-HHHHHhhCCCCCCCCCCCcCcHHHHHHHHH
Q 009364 231 KSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE-VAALFHIGTTKSHPPIPENLSVKAKDFLLK 309 (536)
Q Consensus 231 ~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~ 309 (536)
...+||+.|+|||++.+..++.++|||||||++|+|++|..||...... ....+. ...+.++..++.++.+||.+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~----~~~~~~~~~~~~~~~~ll~~ 229 (316)
T cd05592 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSIL----NDRPHFPRWISKEAKDCLSK 229 (316)
T ss_pred ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHH----cCCCCCCCCCCHHHHHHHHH
Confidence 4567999999999999989999999999999999999999999754322 211111 12344667889999999999
Q ss_pred hcccCCCCCCCH-HHHHhCCCCcCCC
Q 009364 310 CLEKEPDLRPTA-SELLKHPFVTGDD 334 (536)
Q Consensus 310 cL~~dP~~Rps~-~eiL~hp~~~~~~ 334 (536)
||+.||.+||++ .++++||||....
T Consensus 230 ~l~~~P~~R~~~~~~l~~h~~~~~~~ 255 (316)
T cd05592 230 LFERDPTKRLGVDGDIRQHPFFRGID 255 (316)
T ss_pred HccCCHHHcCCChHHHHcCcccCCCC
Confidence 999999999986 5888999998654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=359.31 Aligned_cols=261 Identities=48% Similarity=0.895 Sum_probs=220.5
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
.+|.+.+.||+|++|.||+|.+..+++.||+|.+..... ..........+.+|+.++++++||||+++++++.....
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~---~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 78 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPD---SPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDET 78 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeeccc---chhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCe
Confidence 469999999999999999999999999999998743211 11222345678899999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhh
Q 009364 146 LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA 225 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 225 (536)
.++|+||+++++|.+++...+.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||+++......
T Consensus 79 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 79 LSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 158 (263)
T ss_pred EEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence 99999999999999999888889999999999999999999999999999999999999999999999999987654321
Q ss_pred ccc-CCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcHHHH
Q 009364 226 TVS-GAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAK 304 (536)
Q Consensus 226 ~~~-~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 304 (536)
... ......|++.|+|||++.+..++.++|||||||++|+|++|+.||....... .............++..++..+.
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 237 (263)
T cd06625 159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA-AIFKIATQPTNPQLPSHVSPDAR 237 (263)
T ss_pred cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH-HHHHHhccCCCCCCCccCCHHHH
Confidence 111 1134568899999999999889999999999999999999999996543221 12222223334556778999999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhCCCC
Q 009364 305 DFLLKCLEKEPDLRPTASELLKHPFV 330 (536)
Q Consensus 305 dLi~~cL~~dP~~Rps~~eiL~hp~~ 330 (536)
++|++||..+|.+|||+.++++||||
T Consensus 238 ~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 238 NFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 99999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=373.47 Aligned_cols=258 Identities=24% Similarity=0.428 Sum_probs=222.1
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
.=|.+.+.||+|.|+.|.+|++.-+|+.||||++.+. .-..-....+..|+..|+.++|||||++|++......
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKT------KlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTK 91 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKT------KLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTK 91 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEeccc------ccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccce
Confidence 3588999999999999999999999999999998421 1112234568899999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccC-CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccC-CCCcEEEEecCcchhhhh
Q 009364 146 LNILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVD-NKGCIKLADFGASKQVAE 223 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~-~~~~vkL~DFGla~~~~~ 223 (536)
+|||+|.-++|+|+++|.++ ..+.|+.++++++||+.|+.|+|...+|||||||+||++. .-|-|||+|||++..+.+
T Consensus 92 lyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 92 LYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred EEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 99999999999999998765 5699999999999999999999999999999999998875 568999999999987765
Q ss_pred hhcccCCcccCCCCCCCChhhhhhcCCC-ccceEechhHHHHHHhhCCCCCchhhH-HHHHHHhhCCCCCCCCCCCcCcH
Q 009364 224 LATVSGAKSMKGTPYWMAPEVIRQTGHS-YSADIWSVGCTVIEMATGKPPWSQQYQ-EVAALFHIGTTKSHPPIPENLSV 301 (536)
Q Consensus 224 ~~~~~~~~~~~Gt~~Y~APEvl~~~~~s-~k~DIwSlGvil~eLltG~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~s~ 301 (536)
+. ...+.||+..|.|||++.|..|+ +++||||||||||.|++|.+||+.... +....+.. -...+|..++.
T Consensus 172 G~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImD----CKYtvPshvS~ 244 (864)
T KOG4717|consen 172 GK---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMD----CKYTVPSHVSK 244 (864)
T ss_pred cc---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhc----ccccCchhhhH
Confidence 43 35789999999999999998885 789999999999999999999975432 22222211 12347789999
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCCCC
Q 009364 302 KAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDED 336 (536)
Q Consensus 302 ~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~~~ 336 (536)
++++||..||..||++|.+.++|..|+|++..+..
T Consensus 245 eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~ 279 (864)
T KOG4717|consen 245 ECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRG 279 (864)
T ss_pred HHHHHHHHHHhcCchhhccHHHHhccccccCCCCC
Confidence 99999999999999999999999999999876543
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-45 Score=372.56 Aligned_cols=253 Identities=31% Similarity=0.484 Sum_probs=208.8
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHH-HHHhCCCCceeeEeeeeecCCceeEEE
Q 009364 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVK-LLKDLSHPNIVRYLGTVREEESLNILL 150 (536)
Q Consensus 72 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~-iL~~l~HpnIv~l~~~~~~~~~~~lV~ 150 (536)
+.||+|+||+||+|.+..+|+.||+|++.... .........+..|.. +++.++||||+++++.+...+.+++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKA-----ILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHH-----HhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEE
Confidence 46999999999999999999999999984221 111122233444444 567899999999999999999999999
Q ss_pred EecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhcccCC
Q 009364 151 EFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGA 230 (536)
Q Consensus 151 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 230 (536)
||++||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ....
T Consensus 76 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~ 153 (323)
T cd05575 76 DYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SKTT 153 (323)
T ss_pred cCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CCcc
Confidence 99999999999988888999999999999999999999999999999999999999999999999998753221 1223
Q ss_pred cccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhH-HHHHHHhhCCCCCCCCCCCcCcHHHHHHHHH
Q 009364 231 KSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQ-EVAALFHIGTTKSHPPIPENLSVKAKDFLLK 309 (536)
Q Consensus 231 ~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~ 309 (536)
...+||+.|+|||++.+..++.++|||||||++|+|++|.+||..... +....... ....++..++..+.+||++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~----~~~~~~~~~~~~~~~li~~ 229 (323)
T cd05575 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILN----KPLRLKPNISVSARHLLEG 229 (323)
T ss_pred ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHc----CCCCCCCCCCHHHHHHHHH
Confidence 456799999999999998999999999999999999999999975432 22111111 1223455789999999999
Q ss_pred hcccCCCCCCCH----HHHHhCCCCcCCCC
Q 009364 310 CLEKEPDLRPTA----SELLKHPFVTGDDE 335 (536)
Q Consensus 310 cL~~dP~~Rps~----~eiL~hp~~~~~~~ 335 (536)
||+.||.+||++ .++++||||....+
T Consensus 230 ~l~~~p~~R~~~~~~~~~il~~~~~~~~~~ 259 (323)
T cd05575 230 LLQKDRTKRLGAKDDFLEIKNHVFFSSINW 259 (323)
T ss_pred HhhcCHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence 999999999987 69999999986543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-45 Score=365.80 Aligned_cols=253 Identities=26% Similarity=0.424 Sum_probs=209.3
Q ss_pred EcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCceeEEEEec
Q 009364 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESLNILLEFV 153 (536)
Q Consensus 74 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 153 (536)
||+|+||+||+|.+..+|+.||+|.+.... .......+.+..|+.+++.++|+||+++++++.....+++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~-----~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKR-----LKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHH-----HhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCC
Confidence 799999999999999999999999884211 111223456778999999999999999999999999999999999
Q ss_pred CCCCcccccc----cCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhcccC
Q 009364 154 PGGSISSLLG----KFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSG 229 (536)
Q Consensus 154 ~gg~L~~~l~----~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 229 (536)
+||+|.+++. ....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..+..... .
T Consensus 76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~ 153 (280)
T cd05608 76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--K 153 (280)
T ss_pred CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--c
Confidence 9999987663 335689999999999999999999999999999999999999999999999999876543221 2
Q ss_pred CcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH--HHHHHhhCCCCCCCCCCCcCcHHHHHHH
Q 009364 230 AKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE--VAALFHIGTTKSHPPIPENLSVKAKDFL 307 (536)
Q Consensus 230 ~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~--~~~~~~~~~~~~~~~~~~~~s~~~~dLi 307 (536)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ...... ........++..++..+.+|+
T Consensus 154 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li 232 (280)
T cd05608 154 TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ-RILNDSVTYPDKFSPASKSFC 232 (280)
T ss_pred ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHH-hhcccCCCCcccCCHHHHHHH
Confidence 33567999999999999999999999999999999999999999653211 111111 111223345667899999999
Q ss_pred HHhcccCCCCCC-----CHHHHHhCCCCcCCC
Q 009364 308 LKCLEKEPDLRP-----TASELLKHPFVTGDD 334 (536)
Q Consensus 308 ~~cL~~dP~~Rp-----s~~eiL~hp~~~~~~ 334 (536)
.+||+.||++|| +++++++||||+...
T Consensus 233 ~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~ 264 (280)
T cd05608 233 EALLAKDPEKRLGFRDGNCDGLRTHPLFRDLN 264 (280)
T ss_pred HHHhcCCHHHhcCCCCCCHHHHhcChhhhcCC
Confidence 999999999999 889999999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-45 Score=372.95 Aligned_cols=252 Identities=28% Similarity=0.493 Sum_probs=209.9
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeEeeeeecCCceeEEE
Q 009364 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRYLGTVREEESLNILL 150 (536)
Q Consensus 72 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~ 150 (536)
+.||+|+||.||+|.+..+|+.||+|++..... ...........|..++..+ +||||+++++++.+.+.+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVV-----LIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-----hhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEE
Confidence 469999999999999999999999999842211 1112334556677777754 8999999999999999999999
Q ss_pred EecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhcccCC
Q 009364 151 EFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGA 230 (536)
Q Consensus 151 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 230 (536)
||+.||+|..++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... ....
T Consensus 76 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~ 153 (316)
T cd05620 76 EFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DNRA 153 (316)
T ss_pred CCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccC--CCce
Confidence 99999999999988788999999999999999999999999999999999999999999999999998643211 1123
Q ss_pred cccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH-HHHHHhhCCCCCCCCCCCcCcHHHHHHHHH
Q 009364 231 KSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE-VAALFHIGTTKSHPPIPENLSVKAKDFLLK 309 (536)
Q Consensus 231 ~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~ 309 (536)
...+||+.|+|||++.+..++.++|||||||++|+|++|..||...... ....... ..+.++..++.++++||++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~li~~ 229 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV----DTPHYPRWITKESKDILEK 229 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh----CCCCCCCCCCHHHHHHHHH
Confidence 4577999999999999999999999999999999999999999754322 2222211 2344566789999999999
Q ss_pred hcccCCCCCCCH-HHHHhCCCCcCCC
Q 009364 310 CLEKEPDLRPTA-SELLKHPFVTGDD 334 (536)
Q Consensus 310 cL~~dP~~Rps~-~eiL~hp~~~~~~ 334 (536)
||+.||.+||++ +++++||||....
T Consensus 230 ~l~~dP~~R~~~~~~~~~h~~f~~~~ 255 (316)
T cd05620 230 LFERDPTRRLGVVGNIRGHPFFKTIN 255 (316)
T ss_pred HccCCHHHcCCChHHHHcCCCcCCCC
Confidence 999999999997 5889999997643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=365.21 Aligned_cols=262 Identities=26% Similarity=0.434 Sum_probs=216.0
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCce
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESL 146 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 146 (536)
+|++.+.||+|+||+||++.+..+++.||+|++.... .........+.+|+.+++.++||||+++++.+...+..
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 75 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKR-----IKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhh-----hhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeE
Confidence 4889999999999999999999999999999883211 11112234567899999999999999999999999999
Q ss_pred eEEEEecCCCCcccccccC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhh
Q 009364 147 NILLEFVPGGSISSLLGKF--GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAEL 224 (536)
Q Consensus 147 ~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 224 (536)
++||||+.+|+|.+++... ..+++..+..++.|++.||.|||++|++||||||+||++++++.++|+|||++......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 76 CLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred EEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 9999999999998887543 46899999999999999999999999999999999999999999999999998765422
Q ss_pred hcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHH-HHHHhhCCCCCCCCCCCcCcHHH
Q 009364 225 ATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEV-AALFHIGTTKSHPPIPENLSVKA 303 (536)
Q Consensus 225 ~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~s~~~ 303 (536)
. .....+|++.|+|||++.+..++.++||||+||++|+|++|..||....... ..............++..++..+
T Consensus 156 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
T cd05605 156 E---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAA 232 (285)
T ss_pred C---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHH
Confidence 1 1234579999999999998889999999999999999999999997543211 11111111122334556789999
Q ss_pred HHHHHHhcccCCCCCC-----CHHHHHhCCCCcCCCCC
Q 009364 304 KDFLLKCLEKEPDLRP-----TASELLKHPFVTGDDED 336 (536)
Q Consensus 304 ~dLi~~cL~~dP~~Rp-----s~~eiL~hp~~~~~~~~ 336 (536)
++||.+||..||.+|| +++++++||||......
T Consensus 233 ~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~ 270 (285)
T cd05605 233 RSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFK 270 (285)
T ss_pred HHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHH
Confidence 9999999999999999 99999999999865443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=376.92 Aligned_cols=255 Identities=31% Similarity=0.550 Sum_probs=209.4
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
..|+..+.||+|+||+||+|.+..+|+.||||++... ........+.+|+++++.++|+||+++++++...+.
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 146 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGN-------HEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGE 146 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecC-------CcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCe
Confidence 4688999999999999999999999999999987321 122334568899999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhh
Q 009364 146 LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA 225 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 225 (536)
+++||||+.+|+|... ...++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+....
T Consensus 147 ~~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 147 IQVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred EEEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence 9999999999998754 335678888999999999999999999999999999999999999999999987654321
Q ss_pred cccCCcccCCCCCCCChhhhhh-----cCCCccceEechhHHHHHHhhCCCCCchhh-HHHHHHHhhCCCCCCCCCCCcC
Q 009364 226 TVSGAKSMKGTPYWMAPEVIRQ-----TGHSYSADIWSVGCTVIEMATGKPPWSQQY-QEVAALFHIGTTKSHPPIPENL 299 (536)
Q Consensus 226 ~~~~~~~~~Gt~~Y~APEvl~~-----~~~s~k~DIwSlGvil~eLltG~~Pf~~~~-~~~~~~~~~~~~~~~~~~~~~~ 299 (536)
.......||+.|+|||++.. ...+.++|||||||++|+|++|+.||.... ..................+..+
T Consensus 223 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (353)
T PLN00034 223 --DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATA 300 (353)
T ss_pred --ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCcc
Confidence 12345679999999998743 234578999999999999999999996322 1111111111222334455688
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 300 SVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 300 s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
+.++++||.+||..||++|||+.|+++||||...
T Consensus 301 ~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 301 SREFRHFISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence 9999999999999999999999999999999865
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-45 Score=374.04 Aligned_cols=253 Identities=28% Similarity=0.470 Sum_probs=212.1
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeEeeeeecCCceeEEE
Q 009364 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRYLGTVREEESLNILL 150 (536)
Q Consensus 72 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~ 150 (536)
+.||+|+||+||+|.+..+++.||+|++.... .......+.+.+|+.++..+ +||||+++++++...+.+++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKEL-----VHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHH-----hhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEE
Confidence 46999999999999999999999999984211 11223456678899999888 6999999999999999999999
Q ss_pred EecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhcccCC
Q 009364 151 EFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGA 230 (536)
Q Consensus 151 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 230 (536)
||++||+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... ....
T Consensus 76 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~ 153 (327)
T cd05617 76 EYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--GDTT 153 (327)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCC--CCce
Confidence 99999999999888788999999999999999999999999999999999999999999999999998743211 1123
Q ss_pred cccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhh--------HHHHHHHhhCCCCCCCCCCCcCcHH
Q 009364 231 KSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQY--------QEVAALFHIGTTKSHPPIPENLSVK 302 (536)
Q Consensus 231 ~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~--------~~~~~~~~~~~~~~~~~~~~~~s~~ 302 (536)
...+||+.|+|||++.+..++.++|||||||++|+|++|..||.... ....... ......+|..++..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~----~~~~~~~p~~~~~~ 229 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI----LEKPIRIPRFLSVK 229 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHH----HhCCCCCCCCCCHH
Confidence 45789999999999999999999999999999999999999995211 1111111 11233466788999
Q ss_pred HHHHHHHhcccCCCCCCC------HHHHHhCCCCcCCCC
Q 009364 303 AKDFLLKCLEKEPDLRPT------ASELLKHPFVTGDDE 335 (536)
Q Consensus 303 ~~dLi~~cL~~dP~~Rps------~~eiL~hp~~~~~~~ 335 (536)
+.++|++||+.||.+|++ +.++++||||....+
T Consensus 230 ~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~ 268 (327)
T cd05617 230 ASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDW 268 (327)
T ss_pred HHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCH
Confidence 999999999999999998 579999999987543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=377.04 Aligned_cols=264 Identities=26% Similarity=0.438 Sum_probs=214.2
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE 143 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 143 (536)
...+|++.+.||+|+||.||+|++..+++.||+|++.... .........+.+|+.+++.++||||+++++++.+.
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~-----~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFE-----MIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHH-----hhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 3468999999999999999999999999999999884211 11122344577899999999999999999999999
Q ss_pred CceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhh
Q 009364 144 ESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAE 223 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 223 (536)
..+++||||++||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~ 194 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 194 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCc
Confidence 999999999999999998865 4689999999999999999999999999999999999999999999999999976543
Q ss_pred hhcccCCcccCCCCCCCChhhhhhcC----CCccceEechhHHHHHHhhCCCCCchhhHH-HHHHHhhCCCCCCCCCCCc
Q 009364 224 LATVSGAKSMKGTPYWMAPEVIRQTG----HSYSADIWSVGCTVIEMATGKPPWSQQYQE-VAALFHIGTTKSHPPIPEN 298 (536)
Q Consensus 224 ~~~~~~~~~~~Gt~~Y~APEvl~~~~----~s~k~DIwSlGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~ 298 (536)
.. .......+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||...... ....+.........+.+..
T Consensus 195 ~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 273 (371)
T cd05622 195 EG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDND 273 (371)
T ss_pred CC-cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCC
Confidence 21 11234567999999999997543 789999999999999999999999754322 1111111111122223347
Q ss_pred CcHHHHHHHHHhcccCCCC--CCCHHHHHhCCCCcCCC
Q 009364 299 LSVKAKDFLLKCLEKEPDL--RPTASELLKHPFVTGDD 334 (536)
Q Consensus 299 ~s~~~~dLi~~cL~~dP~~--Rps~~eiL~hp~~~~~~ 334 (536)
++..+++||.+||..++.+ |+++.++++||||.+..
T Consensus 274 ~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~ 311 (371)
T cd05622 274 ISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 311 (371)
T ss_pred CCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCC
Confidence 8999999999999854443 78999999999997643
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-45 Score=385.30 Aligned_cols=252 Identities=23% Similarity=0.332 Sum_probs=206.6
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
.+|++.+.||+|+||.||+|.+..+++.||+|... ...+.+|+.+|+.++||||+++++++.....
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 157 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------------RGGTATEAHILRAINHPSIIQLKGTFTYNKF 157 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--------------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCe
Confidence 57999999999999999999999999999999641 1235689999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhh
Q 009364 146 LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA 225 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 225 (536)
.++|+|++ +++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 158 ~~lv~e~~-~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 158 TCLILPRY-KTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236 (391)
T ss_pred eEEEEecC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence 99999999 47888888777889999999999999999999999999999999999999999999999999987533211
Q ss_pred cccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhh---------HHHHHHHhh-C--------
Q 009364 226 TVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQY---------QEVAALFHI-G-------- 287 (536)
Q Consensus 226 ~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~---------~~~~~~~~~-~-------- 287 (536)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||.... .....+... +
T Consensus 237 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~ 315 (391)
T PHA03212 237 -ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI 315 (391)
T ss_pred -ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence 112345689999999999999899999999999999999999998764211 001111000 0
Q ss_pred ----------------CCCC---CCCC--CCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 288 ----------------TTKS---HPPI--PENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 288 ----------------~~~~---~~~~--~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
.... .+.+ ...++.++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 382 (391)
T PHA03212 316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI 382 (391)
T ss_pred chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence 0000 0000 01356789999999999999999999999999999764
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-46 Score=356.89 Aligned_cols=255 Identities=29% Similarity=0.442 Sum_probs=216.0
Q ss_pred CCCCceee-eEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeEeeeee
Q 009364 64 PPIRWRKG-ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRYLGTVR 141 (536)
Q Consensus 64 ~~~~y~~~-~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~ 141 (536)
...+|++. ++||-|-.|.|..+.++.+|+.+|+|++. . ....++|+++.-.. .|||||.++++|.
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~------D-------s~KARrEVeLHw~~s~h~~iV~IidVye 125 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL------D-------SPKARREVELHWMASGHPHIVSIIDVYE 125 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHh------c-------CHHHHhHhhhhhhhcCCCceEEeehhhh
Confidence 34566653 57999999999999999999999999872 1 12345777765544 6999999999986
Q ss_pred c----CCceeEEEEecCCCCcccccccCCC--CCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCC---cEEE
Q 009364 142 E----EESLNILLEFVPGGSISSLLGKFGP--FPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKG---CIKL 212 (536)
Q Consensus 142 ~----~~~~~lV~E~~~gg~L~~~l~~~~~--l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~---~vkL 212 (536)
+ ..++.+|||.++||.|+..+..++. |+|.++..|++||..|+.|||+.+|.||||||+|+|....+ .+||
T Consensus 126 Ns~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKL 205 (400)
T KOG0604|consen 126 NSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKL 205 (400)
T ss_pred hhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEe
Confidence 4 4578899999999999999987765 99999999999999999999999999999999999997544 7999
Q ss_pred EecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhh-----HHHHHHHhhC
Q 009364 213 ADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQY-----QEVAALFHIG 287 (536)
Q Consensus 213 ~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~-----~~~~~~~~~~ 287 (536)
+|||+|+.... .....+.|-||+|.|||++....|+..+|+||+|||+|.||+|.+||+.+. ......+..+
T Consensus 206 tDfGFAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~g 282 (400)
T KOG0604|consen 206 TDFGFAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTG 282 (400)
T ss_pred cccccccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhcc
Confidence 99999987553 234678899999999999999999999999999999999999999997653 3344445555
Q ss_pred CCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCC
Q 009364 288 TTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDD 334 (536)
Q Consensus 288 ~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~ 334 (536)
......+-+..+|..++|+|+++|..+|.+|.|+.+++.|||+.+..
T Consensus 283 qy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~ 329 (400)
T KOG0604|consen 283 QYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE 329 (400)
T ss_pred CccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence 55555556678999999999999999999999999999999997653
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=371.23 Aligned_cols=252 Identities=29% Similarity=0.485 Sum_probs=212.2
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeEeeeeecCCceeEEE
Q 009364 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRYLGTVREEESLNILL 150 (536)
Q Consensus 72 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~ 150 (536)
+.||+|+||+||+|.+..+++.||+|++.... .........+..|..+++.+ +||||+++++++...+.+++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDV-----ILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHH-----HhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEE
Confidence 46999999999999999999999999984221 11123345567888888887 6999999999999999999999
Q ss_pred EecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhcccCC
Q 009364 151 EFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGA 230 (536)
Q Consensus 151 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 230 (536)
||++||+|..++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ....
T Consensus 76 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~~~~ 153 (318)
T cd05570 76 EYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG--GVTT 153 (318)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcC--CCcc
Confidence 99999999999988888999999999999999999999999999999999999999999999999998643211 1123
Q ss_pred cccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHH-HHHHhhCCCCCCCCCCCcCcHHHHHHHHH
Q 009364 231 KSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEV-AALFHIGTTKSHPPIPENLSVKAKDFLLK 309 (536)
Q Consensus 231 ~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~s~~~~dLi~~ 309 (536)
...+||+.|+|||++.+..++.++|||||||++|+|++|..||....... ..... .....++..++..+++||++
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~----~~~~~~~~~~~~~~~~li~~ 229 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSIL----EDEVRYPRWLSKEAKSILKS 229 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHH----cCCCCCCCcCCHHHHHHHHH
Confidence 45679999999999999999999999999999999999999997543222 11111 11234566789999999999
Q ss_pred hcccCCCCCCCH-----HHHHhCCCCcCCC
Q 009364 310 CLEKEPDLRPTA-----SELLKHPFVTGDD 334 (536)
Q Consensus 310 cL~~dP~~Rps~-----~eiL~hp~~~~~~ 334 (536)
||..||.+||++ .++++||||....
T Consensus 230 ~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~ 259 (318)
T cd05570 230 FLTKNPEKRLGCLPTGEQDIKGHPFFREID 259 (318)
T ss_pred HccCCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence 999999999999 9999999998654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=369.62 Aligned_cols=263 Identities=27% Similarity=0.442 Sum_probs=212.4
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
.+|++.+.||+|+||+||++.+..+++.||+|++... ........+.+.+|+.+++.++|+||+++++++.+.+.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 75 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKW-----EMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENN 75 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHH-----HHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCe
Confidence 3699999999999999999999999999999998421 11122345567889999999999999999999999999
Q ss_pred eeEEEEecCCCCccccccc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhh
Q 009364 146 LNILLEFVPGGSISSLLGK-FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAEL 224 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 224 (536)
+|+||||++||+|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred EEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 9999999999999999876 457999999999999999999999999999999999999999999999999998765432
Q ss_pred hcccCCcccCCCCCCCChhhhhh-----cCCCccceEechhHHHHHHhhCCCCCchhhH-HH-HHHHhhCCCCCCCCCCC
Q 009364 225 ATVSGAKSMKGTPYWMAPEVIRQ-----TGHSYSADIWSVGCTVIEMATGKPPWSQQYQ-EV-AALFHIGTTKSHPPIPE 297 (536)
Q Consensus 225 ~~~~~~~~~~Gt~~Y~APEvl~~-----~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~-~~-~~~~~~~~~~~~~~~~~ 297 (536)
.. ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... +. ..+.........+....
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 234 (331)
T cd05597 156 GT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVT 234 (331)
T ss_pred CC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccC
Confidence 21 11223569999999999973 4578899999999999999999999965432 21 12221111112222334
Q ss_pred cCcHHHHHHHHHhcccCCCC--CCCHHHHHhCCCCcCCC
Q 009364 298 NLSVKAKDFLLKCLEKEPDL--RPTASELLKHPFVTGDD 334 (536)
Q Consensus 298 ~~s~~~~dLi~~cL~~dP~~--Rps~~eiL~hp~~~~~~ 334 (536)
.++..+++||++||..++++ |+++.++++||||....
T Consensus 235 ~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~ 273 (331)
T cd05597 235 DVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGID 273 (331)
T ss_pred CCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCC
Confidence 58999999999998764444 78999999999997643
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=378.30 Aligned_cols=257 Identities=31% Similarity=0.542 Sum_probs=224.5
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
.+|.+++++|+|+||.+++++++.++..|++|.+....... ...+...+|+.+++++.|||||.+.+.|..++.
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~------~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~ 77 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTE------PERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQ 77 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCc------hhhHHHHHHHHHHHhccCCCeeeeccchhcCCc
Confidence 47999999999999999999999999999999996543221 122367789999999999999999999999998
Q ss_pred -eeEEEEecCCCCcccccccCC--CCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhh
Q 009364 146 -LNILLEFVPGGSISSLLGKFG--PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVA 222 (536)
Q Consensus 146 -~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~ 222 (536)
.+|||+||+||++.+.|.+.+ -|+++.+..|+.|++.|+.|||+++|+|||||+.||+++.++.|||+|||+|+.+.
T Consensus 78 ~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 78 LLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILN 157 (426)
T ss_pred eEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcC
Confidence 999999999999999986544 59999999999999999999999999999999999999999999999999999887
Q ss_pred hhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcHH
Q 009364 223 ELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVK 302 (536)
Q Consensus 223 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 302 (536)
+.. ....+.+|||.||.||++.+.+|+.|+|||||||++|||++-+++|....-. .+..........++|..++.+
T Consensus 158 ~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~--~Li~ki~~~~~~Plp~~ys~e 233 (426)
T KOG0589|consen 158 PED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS--ELILKINRGLYSPLPSMYSSE 233 (426)
T ss_pred Cch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH--HHHHHHhhccCCCCCccccHH
Confidence 643 2356789999999999999999999999999999999999999999765322 111122222356788899999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHhCCCCcC
Q 009364 303 AKDFLLKCLEKEPDLRPTASELLKHPFVTG 332 (536)
Q Consensus 303 ~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~ 332 (536)
++.||+.||.++|..||++.++|.+|.+..
T Consensus 234 l~~lv~~~l~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 234 LRSLVKSMLRKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred HHHHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence 999999999999999999999999988753
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=371.19 Aligned_cols=251 Identities=34% Similarity=0.555 Sum_probs=211.4
Q ss_pred eEEcccCceEEEEEEEc---CCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCceeE
Q 009364 72 ELIGCGAFGRVYMGMNL---DSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESLNI 148 (536)
Q Consensus 72 ~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 148 (536)
+.||+|+||.||++.+. .+|+.||+|++.... ........+.+|+++|++++||||+++++++...+.+|+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 75 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKAT------LKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYL 75 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHH------hhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEE
Confidence 57999999999998763 578999999984211 111223456789999999999999999999999999999
Q ss_pred EEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhccc
Q 009364 149 LLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVS 228 (536)
Q Consensus 149 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 228 (536)
||||+++|+|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... .
T Consensus 76 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~ 153 (318)
T cd05582 76 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--K 153 (318)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--C
Confidence 99999999999999887889999999999999999999999999999999999999999999999999987653321 1
Q ss_pred CCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHH-HHHHhhCCCCCCCCCCCcCcHHHHHHH
Q 009364 229 GAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEV-AALFHIGTTKSHPPIPENLSVKAKDFL 307 (536)
Q Consensus 229 ~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~s~~~~dLi 307 (536)
.....+||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ..... .....++..++..+++||
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~----~~~~~~p~~~~~~~~~li 229 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMIL----KAKLGMPQFLSPEAQSLL 229 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHH----cCCCCCCCCCCHHHHHHH
Confidence 2345679999999999998889999999999999999999999997543221 11111 122345667899999999
Q ss_pred HHhcccCCCCCCC-----HHHHHhCCCCcCCC
Q 009364 308 LKCLEKEPDLRPT-----ASELLKHPFVTGDD 334 (536)
Q Consensus 308 ~~cL~~dP~~Rps-----~~eiL~hp~~~~~~ 334 (536)
++||+.||.+||+ ..++++||||....
T Consensus 230 ~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~ 261 (318)
T cd05582 230 RALFKRNPANRLGAGPDGVEEIKRHPFFSTID 261 (318)
T ss_pred HHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCC
Confidence 9999999999999 78899999998643
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=372.46 Aligned_cols=258 Identities=31% Similarity=0.527 Sum_probs=214.7
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEE 144 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 144 (536)
..+|++.+.||+|+||.||+|.+..+|..+|+|.+... ........+.+|+++++.++||||+++++++...+
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 76 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLE-------IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG 76 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecc-------cCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECC
Confidence 46899999999999999999999999999999987421 11233456889999999999999999999999999
Q ss_pred ceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHc-CCccccCCCCCcccCCCCcEEEEecCcchhhhh
Q 009364 145 SLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNH-GIMHRDIKGANILVDNKGCIKLADFGASKQVAE 223 (536)
Q Consensus 145 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~-~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 223 (536)
.+++||||+++|+|.+++...+.+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++..+..
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 77 EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred EEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 9999999999999999998888899999999999999999999985 799999999999999999999999999876543
Q ss_pred hhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHH-HHHhh----------------
Q 009364 224 LATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVA-ALFHI---------------- 286 (536)
Q Consensus 224 ~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~-~~~~~---------------- 286 (536)
. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||........ .....
T Consensus 157 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (333)
T cd06650 157 S----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPR 232 (333)
T ss_pred h----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccC
Confidence 2 12345799999999999988899999999999999999999999964332111 11000
Q ss_pred -------------------------CCCCCCCCCC-CcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 287 -------------------------GTTKSHPPIP-ENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 287 -------------------------~~~~~~~~~~-~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
......+..+ ...+.++++||.+||++||.+|||+.|+++||||+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 233 PPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred CccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 0000001111 1357889999999999999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=369.71 Aligned_cols=258 Identities=26% Similarity=0.427 Sum_probs=215.2
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCC-CCceeeEeeeeecCCc
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS-HPNIVRYLGTVREEES 145 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~ 145 (536)
+|+..+.||+|+||+||+|.++.+|+.||+|++.... .......+.+..|..++..+. |++|+++++++...+.
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~ 75 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDV-----VIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDR 75 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHH-----hhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCE
Confidence 3778899999999999999999999999999884211 111233455677888888885 5778889999999999
Q ss_pred eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhh
Q 009364 146 LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA 225 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 225 (536)
+|+||||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 76 LYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 99999999999999999888889999999999999999999999999999999999999999999999999987543211
Q ss_pred cccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHH-HHHHhhCCCCCCCCCCCcCcHHHH
Q 009364 226 TVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEV-AALFHIGTTKSHPPIPENLSVKAK 304 (536)
Q Consensus 226 ~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~s~~~~ 304 (536)
......+||+.|+|||++.+..++.++||||+||++|+|++|.+||....... ...+.. ....++..++.+++
T Consensus 156 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~----~~~~~p~~~~~~~~ 229 (323)
T cd05615 156 --VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME----HNVSYPKSLSKEAV 229 (323)
T ss_pred --ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh----CCCCCCccCCHHHH
Confidence 12345679999999999999899999999999999999999999997654321 111111 22345668899999
Q ss_pred HHHHHhcccCCCCCCC-----HHHHHhCCCCcCCCC
Q 009364 305 DFLLKCLEKEPDLRPT-----ASELLKHPFVTGDDE 335 (536)
Q Consensus 305 dLi~~cL~~dP~~Rps-----~~eiL~hp~~~~~~~ 335 (536)
+|+.+||+++|.+|++ ..++++||||....+
T Consensus 230 ~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~ 265 (323)
T cd05615 230 SICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDW 265 (323)
T ss_pred HHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCH
Confidence 9999999999999997 579999999987543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=363.58 Aligned_cols=254 Identities=32% Similarity=0.538 Sum_probs=199.4
Q ss_pred CceeeeEEcccCceEEEEEEEcC-CCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC---CCCceeeEeeeee-
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLD-SGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL---SHPNIVRYLGTVR- 141 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~-~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l---~HpnIv~l~~~~~- 141 (536)
+|++.+.||+|+||+||+|.+.. +|+.||+|.+....... .......+|+.+++.+ +||||+++++++.
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~ 75 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE------GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV 75 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC------CchHHHHHHHHHHHhhcccCCCCcceEEEEEec
Confidence 79999999999999999999864 57889999874322111 1112334566666554 6999999999885
Q ss_pred ----cCCceeEEEEecCCCCcccccccC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEec
Q 009364 142 ----EEESLNILLEFVPGGSISSLLGKF--GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADF 215 (536)
Q Consensus 142 ----~~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DF 215 (536)
....+++||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 76 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 76 SRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred ccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccc
Confidence 3456899999996 6888887543 45899999999999999999999999999999999999999999999999
Q ss_pred CcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhH--HHHHHHhhCCCCCC-
Q 009364 216 GASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQ--EVAALFHIGTTKSH- 292 (536)
Q Consensus 216 Gla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~--~~~~~~~~~~~~~~- 292 (536)
|+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|.+||..... ....+.........
T Consensus 155 g~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~ 231 (290)
T cd07862 155 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 231 (290)
T ss_pred cceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChh
Confidence 998765432 223456799999999999988999999999999999999999999975432 11122111100000
Q ss_pred ---------------------CCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCC
Q 009364 293 ---------------------PPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFV 330 (536)
Q Consensus 293 ---------------------~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~ 330 (536)
..+.+.++..+++||.+||+.||++|||+.++|+||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 01123578889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=378.71 Aligned_cols=270 Identities=33% Similarity=0.587 Sum_probs=231.1
Q ss_pred chhhhhhhccccc-ccccccCCCCCCCCCCCce-------eeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchh
Q 009364 38 LVERFNSCIRNSR-VLSKHISPSVKMSPPIRWR-------KGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKE 109 (536)
Q Consensus 38 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~y~-------~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~ 109 (536)
+.+.+..|++... ...+.++-..+.....-|+ -++.||.|+.|-||+|+. .++.||||++.
T Consensus 88 ~~~GLfgC~rPV~~~iGk~~s~e~k~qq~e~WeiPFe~IsELeWlGSGaQGAVF~Grl--~netVAVKKV~--------- 156 (904)
T KOG4721|consen 88 FLEGLFGCLRPVWTMIGKAYSTEHKQQQEELWEIPFEEISELEWLGSGAQGAVFLGRL--HNETVAVKKVR--------- 156 (904)
T ss_pred HHHHHHhhhHHHHHHhccceeeehhhhhhhhccCCHHHhhhhhhhccCcccceeeeec--cCceehhHHHh---------
Confidence 6666777877642 2334444444444444444 367899999999999975 57899999771
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHH
Q 009364 110 KAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHN 189 (536)
Q Consensus 110 ~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~ 189 (536)
+.-..+|+-|++|+||||+.+.|+|....++|||||||..|.|..+|+...++.......|..+|+.|+.|||.
T Consensus 157 ------elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~ 230 (904)
T KOG4721|consen 157 ------ELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHL 230 (904)
T ss_pred ------hhhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHH
Confidence 11235788999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhC
Q 009364 190 HGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATG 269 (536)
Q Consensus 190 ~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG 269 (536)
++|||||||.-||||..+..|||+|||.++..... .....++||..|||||++++.+.++|+|||||||+|||||||
T Consensus 231 hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~ 307 (904)
T KOG4721|consen 231 HKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTG 307 (904)
T ss_pred hhHhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhc
Confidence 99999999999999999999999999999877654 235678999999999999999999999999999999999999
Q ss_pred CCCCchhhHHHHHHHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCC
Q 009364 270 KPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHP 328 (536)
Q Consensus 270 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp 328 (536)
..||.+-. ....+...+......++|..++..++-||++||+-.|..||++.+||.|-
T Consensus 308 EiPYkdVd-ssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 308 EIPYKDVD-SSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred CCCccccc-hheeEEeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHH
Confidence 99997643 33445666777778889999999999999999999999999999999993
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=369.84 Aligned_cols=252 Identities=29% Similarity=0.497 Sum_probs=209.3
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHh-CCCCceeeEeeeeecCCceeEEE
Q 009364 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKD-LSHPNIVRYLGTVREEESLNILL 150 (536)
Q Consensus 72 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~-l~HpnIv~l~~~~~~~~~~~lV~ 150 (536)
+.||+|+||+||+|++..+++.||+|++..... ...........|..++.. ++||||+++++++.+.+.+++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVV-----LMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-----hhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEE
Confidence 469999999999999999999999999843211 111223445567777775 48999999999999999999999
Q ss_pred EecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhcccCC
Q 009364 151 EFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGA 230 (536)
Q Consensus 151 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 230 (536)
||++||+|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..... ....
T Consensus 76 ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~ 153 (316)
T cd05619 76 EYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG--DAKT 153 (316)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCC--CCce
Confidence 99999999999988788999999999999999999999999999999999999999999999999998643211 1123
Q ss_pred cccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH-HHHHHhhCCCCCCCCCCCcCcHHHHHHHHH
Q 009364 231 KSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE-VAALFHIGTTKSHPPIPENLSVKAKDFLLK 309 (536)
Q Consensus 231 ~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~ 309 (536)
...+||+.|+|||++.+..++.++||||+||++|+|++|..||...... ....... ..+.++..++.++++||.+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~----~~~~~~~~~~~~~~~li~~ 229 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRM----DNPCYPRWLTREAKDILVK 229 (316)
T ss_pred eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----CCCCCCccCCHHHHHHHHH
Confidence 4567999999999999989999999999999999999999999754322 2222211 1233556789999999999
Q ss_pred hcccCCCCCCCHH-HHHhCCCCcCCC
Q 009364 310 CLEKEPDLRPTAS-ELLKHPFVTGDD 334 (536)
Q Consensus 310 cL~~dP~~Rps~~-eiL~hp~~~~~~ 334 (536)
||+.||.+||++. ++++||||....
T Consensus 230 ~l~~~P~~R~~~~~~l~~h~~~~~~~ 255 (316)
T cd05619 230 LFVREPERRLGVKGDIRQHPFFREID 255 (316)
T ss_pred HhccCHhhcCCChHHHHcCcccCCCC
Confidence 9999999999996 899999998754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-46 Score=386.65 Aligned_cols=251 Identities=48% Similarity=0.869 Sum_probs=227.9
Q ss_pred EEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCceeEEEEe
Q 009364 73 LIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESLNILLEF 152 (536)
Q Consensus 73 ~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 152 (536)
+||+|+||+||.|+|..+...+|||.+ .++.....+-+.+||.+.++|+|.|||+++|.+..++.+-|.||-
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEI--------pekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEq 653 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEI--------PEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQ 653 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeec--------ccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeec
Confidence 699999999999999999999999988 334445667789999999999999999999999999999999999
Q ss_pred cCCCCcccccc-cCCCC--CHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccC-CCCcEEEEecCcchhhhhhhccc
Q 009364 153 VPGGSISSLLG-KFGPF--PEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVD-NKGCIKLADFGASKQVAELATVS 228 (536)
Q Consensus 153 ~~gg~L~~~l~-~~~~l--~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~-~~~~vkL~DFGla~~~~~~~~~~ 228 (536)
++||+|.+++. +.+++ .|..+..+.+||++||.|||++.|||||||-+||||+ -.|.+||+|||.++.+....+
T Consensus 654 VPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP-- 731 (1226)
T KOG4279|consen 654 VPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP-- 731 (1226)
T ss_pred CCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCc--
Confidence 99999999986 45787 8999999999999999999999999999999999996 468999999999998765433
Q ss_pred CCcccCCCCCCCChhhhhhc--CCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcHHHHHH
Q 009364 229 GAKSMKGTPYWMAPEVIRQT--GHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKDF 306 (536)
Q Consensus 229 ~~~~~~Gt~~Y~APEvl~~~--~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL 306 (536)
.+.++.||..|||||++..+ +|+.++|||||||.+.||.||+|||..-......++..+-.+.++++|..++.+++.+
T Consensus 732 ~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~F 811 (1226)
T KOG4279|consen 732 CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNF 811 (1226)
T ss_pred cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHH
Confidence 35678999999999999764 6899999999999999999999999876666677888888899999999999999999
Q ss_pred HHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 307 LLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 307 i~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
|.+|+.+||..||+|.++|..||++..
T Consensus 812 ilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 812 ILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred HHHHcCCCcccCccHHHhccCcccccC
Confidence 999999999999999999999999765
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-44 Score=367.09 Aligned_cols=263 Identities=26% Similarity=0.419 Sum_probs=212.5
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCce
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESL 146 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 146 (536)
+|++.+.||+|+||+||++.+..+++.+|+|++.... .........+.+|+.++..++|+||+++++.+.+...+
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 76 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWE-----MLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNL 76 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHH-----HHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEE
Confidence 6899999999999999999999999999999883211 11223344577899999999999999999999999999
Q ss_pred eEEEEecCCCCccccccc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhh
Q 009364 147 NILLEFVPGGSISSLLGK-FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA 225 (536)
Q Consensus 147 ~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 225 (536)
++||||+++|+|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 77 ~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 77 YLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred EEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 999999999999999976 4678999999999999999999999999999999999999999999999999987543321
Q ss_pred cccCCcccCCCCCCCChhhhh-----hcCCCccceEechhHHHHHHhhCCCCCchhhH-H-HHHHHhhCCCCCCCCCCCc
Q 009364 226 TVSGAKSMKGTPYWMAPEVIR-----QTGHSYSADIWSVGCTVIEMATGKPPWSQQYQ-E-VAALFHIGTTKSHPPIPEN 298 (536)
Q Consensus 226 ~~~~~~~~~Gt~~Y~APEvl~-----~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~-~-~~~~~~~~~~~~~~~~~~~ 298 (536)
. ......+||+.|+|||++. ...++.++|||||||++|+|++|+.||..... . ...+.........+.....
T Consensus 157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~ 235 (332)
T cd05623 157 T-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTD 235 (332)
T ss_pred c-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCcccc
Confidence 1 1123457999999999986 34678999999999999999999999975432 1 1122111111112223346
Q ss_pred CcHHHHHHHHHhcccCCCC--CCCHHHHHhCCCCcCCCC
Q 009364 299 LSVKAKDFLLKCLEKEPDL--RPTASELLKHPFVTGDDE 335 (536)
Q Consensus 299 ~s~~~~dLi~~cL~~dP~~--Rps~~eiL~hp~~~~~~~ 335 (536)
++.++++||++||..++.+ |+++.++++||||.+..+
T Consensus 236 ~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~ 274 (332)
T cd05623 236 VSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDW 274 (332)
T ss_pred CCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCH
Confidence 8999999999999765544 689999999999986543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=387.94 Aligned_cols=255 Identities=30% Similarity=0.506 Sum_probs=202.6
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE 142 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 142 (536)
.+..+|++++.||+|+||+||+|.+..+++.||||++.... ....+|+.+|+.++||||+++++++..
T Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------------~~~~~Ei~il~~l~h~niv~l~~~~~~ 130 (440)
T PTZ00036 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------------QYKNRELLIMKNLNHINIIFLKDYYYT 130 (440)
T ss_pred CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------------chHHHHHHHHHhcCCCCCcceeeeEee
Confidence 45568999999999999999999999999999999873211 123469999999999999999887643
Q ss_pred C--------CceeEEEEecCCCCcccccc----cCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCC-c
Q 009364 143 E--------ESLNILLEFVPGGSISSLLG----KFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKG-C 209 (536)
Q Consensus 143 ~--------~~~~lV~E~~~gg~L~~~l~----~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~-~ 209 (536)
. ..+++||||+++ +|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.++ .
T Consensus 131 ~~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~ 209 (440)
T PTZ00036 131 ECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHT 209 (440)
T ss_pred cccccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCc
Confidence 2 246789999975 5655543 446799999999999999999999999999999999999998665 7
Q ss_pred EEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhc-CCCccceEechhHHHHHHhhCCCCCchhhH--HHHHHHhh
Q 009364 210 IKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQT-GHSYSADIWSVGCTVIEMATGKPPWSQQYQ--EVAALFHI 286 (536)
Q Consensus 210 vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~-~~s~k~DIwSlGvil~eLltG~~Pf~~~~~--~~~~~~~~ 286 (536)
+||+|||+|+.+.... .....+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+... ....+...
T Consensus 210 vkL~DFGla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~ 286 (440)
T PTZ00036 210 LKLCDFGSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQV 286 (440)
T ss_pred eeeeccccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 9999999998664321 23456789999999998764 689999999999999999999999975421 11111111
Q ss_pred CCC------------------------CCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 287 GTT------------------------KSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 287 ~~~------------------------~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
... .....+|...+.++++||.+||++||.+|||+.|+|+||||...
T Consensus 287 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 287 LGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357 (440)
T ss_pred hCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence 000 00011344678899999999999999999999999999999753
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=356.67 Aligned_cols=269 Identities=28% Similarity=0.470 Sum_probs=231.8
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
.+|...++||+|.||+|-+++.+.+|+.||+|++.+..... .+....-..|-++|+..+||.+..+-..|+..+.
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviia-----kdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~dr 242 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIA-----KDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDR 242 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheee-----hHHhhhhhhHHHHHHhccCcHHHHhhhhhccCce
Confidence 46888999999999999999999999999999884333222 2334445578899999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhh
Q 009364 146 LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA 225 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 225 (536)
+|+||||+.||.|+..+.+.+.|++..++.+...|+.||.|||+++||+||||.+|.|++.+|++||+|||+++.--.
T Consensus 243 lCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~-- 320 (516)
T KOG0690|consen 243 LCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK-- 320 (516)
T ss_pred EEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhccc--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999875322
Q ss_pred cccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhH-HHHHHHhhCCCCCCCCCCCcCcHHHH
Q 009364 226 TVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQ-EVAALFHIGTTKSHPPIPENLSVKAK 304 (536)
Q Consensus 226 ~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~s~~~~ 304 (536)
....++++||||.|.|||++....|+.++|+|.+||++|||++|+.||..+.. ....++... ...+|..++++++
T Consensus 321 ~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e----d~kFPr~ls~eAk 396 (516)
T KOG0690|consen 321 YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME----DLKFPRTLSPEAK 396 (516)
T ss_pred ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh----hccCCccCCHHHH
Confidence 22346789999999999999999999999999999999999999999986643 344444333 2347889999999
Q ss_pred HHHHHhcccCCCCCC-----CHHHHHhCCCCcCCCCCcchhhcccc
Q 009364 305 DFLLKCLEKEPDLRP-----TASELLKHPFVTGDDEDPVLHASVMK 345 (536)
Q Consensus 305 dLi~~cL~~dP~~Rp-----s~~eiL~hp~~~~~~~~~~~~~~~~~ 345 (536)
.|+..+|.+||++|. .+.+|.+|+||....+.......+..
T Consensus 397 tLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~P 442 (516)
T KOG0690|consen 397 TLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEP 442 (516)
T ss_pred HHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCC
Confidence 999999999999996 48999999999988776655544433
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=368.48 Aligned_cols=252 Identities=30% Similarity=0.462 Sum_probs=207.9
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHH-HHHHhCCCCceeeEeeeeecCCceeEEE
Q 009364 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEV-KLLKDLSHPNIVRYLGTVREEESLNILL 150 (536)
Q Consensus 72 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei-~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 150 (536)
+.||+|+||+||+|++..+|+.||+|++..... ........+..|. .+++.++||||+++++++.+.+..++||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 75 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTI-----LKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVL 75 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHH-----HHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEE
Confidence 469999999999999999999999998842211 1112233444454 4678899999999999999999999999
Q ss_pred EecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhcccCC
Q 009364 151 EFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGA 230 (536)
Q Consensus 151 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 230 (536)
||++||+|...+.+...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..... ....
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~ 153 (321)
T cd05603 76 DYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EETT 153 (321)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CCcc
Confidence 99999999998888788999999999999999999999999999999999999999999999999998753221 1123
Q ss_pred cccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH-HHHHHhhCCCCCCCCCCCcCcHHHHHHHHH
Q 009364 231 KSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE-VAALFHIGTTKSHPPIPENLSVKAKDFLLK 309 (536)
Q Consensus 231 ~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~ 309 (536)
...+||+.|+|||++.+..++.++|||||||++|+|++|.+||...... ...... .....++...+..+.++|.+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~----~~~~~~~~~~~~~~~~li~~ 229 (321)
T cd05603 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNIL----HKPLQLPGGKTVAACDLLVG 229 (321)
T ss_pred ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHh----cCCCCCCCCCCHHHHHHHHH
Confidence 4567999999999999889999999999999999999999999765322 111111 12234566789999999999
Q ss_pred hcccCCCCCCCH----HHHHhCCCCcCCC
Q 009364 310 CLEKEPDLRPTA----SELLKHPFVTGDD 334 (536)
Q Consensus 310 cL~~dP~~Rps~----~eiL~hp~~~~~~ 334 (536)
||++||.+||++ .++++|+||....
T Consensus 230 ~l~~~p~~R~~~~~~~~~~~~~~~~~~~~ 258 (321)
T cd05603 230 LLHKDQRRRLGAKADFLEIKNHVFFSPIN 258 (321)
T ss_pred HccCCHhhcCCCCCCHHHHhCCCCcCCCC
Confidence 999999999875 5999999997644
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=369.47 Aligned_cols=254 Identities=29% Similarity=0.442 Sum_probs=208.3
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHH-HHHHHhCCCCceeeEeeeeecCCceeEEE
Q 009364 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEE-VKLLKDLSHPNIVRYLGTVREEESLNILL 150 (536)
Q Consensus 72 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~E-i~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 150 (536)
+.||+|+||+||+|++..+++.||+|++..... ........+..| ..+++.++||||+++++++...+.+++||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~ 75 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAI-----LKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVL 75 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHH-----HhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEE
Confidence 469999999999999999999999999842211 111122233334 34578889999999999999999999999
Q ss_pred EecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhcccCC
Q 009364 151 EFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGA 230 (536)
Q Consensus 151 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 230 (536)
||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ...
T Consensus 76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~~ 153 (325)
T cd05602 76 DYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GTT 153 (325)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CCc
Confidence 999999999999888889999999999999999999999999999999999999999999999999987543211 123
Q ss_pred cccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH-HHHHHhhCCCCCCCCCCCcCcHHHHHHHHH
Q 009364 231 KSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE-VAALFHIGTTKSHPPIPENLSVKAKDFLLK 309 (536)
Q Consensus 231 ~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~ 309 (536)
...+||+.|+|||++.+..++.++|||||||++|+|++|.+||...... ....... .....+..++..++++|.+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~----~~~~~~~~~~~~~~~li~~ 229 (325)
T cd05602 154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN----KPLQLKPNITNSARHLLEG 229 (325)
T ss_pred ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHh----CCcCCCCCCCHHHHHHHHH
Confidence 4567999999999999999999999999999999999999999754322 1111111 1223455789999999999
Q ss_pred hcccCCCCCCCHH----HHHhCCCCcCCCCC
Q 009364 310 CLEKEPDLRPTAS----ELLKHPFVTGDDED 336 (536)
Q Consensus 310 cL~~dP~~Rps~~----eiL~hp~~~~~~~~ 336 (536)
||++||.+||++. ++++|+||....+.
T Consensus 230 ~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~~ 260 (325)
T cd05602 230 LLQKDRTKRLGAKDDFMEIKNHIFFSPINWD 260 (325)
T ss_pred HcccCHHHCCCCCCCHHHHhcCcccCCCCHH
Confidence 9999999999875 89999999765443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=390.69 Aligned_cols=262 Identities=27% Similarity=0.440 Sum_probs=217.9
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE 142 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 142 (536)
....+|++.+.||+|+||+||+|.+..+|+.||||++... .........+.+|+.++..++|+||+++++.+..
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~------~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~ 102 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDME------GMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAK 102 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecc------cCCHHHHHHHHHHHHHHhcCCCCcEEEeecceec
Confidence 4456999999999999999999999999999999988432 1122345567889999999999999999887753
Q ss_pred CC--------ceeEEEEecCCCCccccccc----CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcE
Q 009364 143 EE--------SLNILLEFVPGGSISSLLGK----FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCI 210 (536)
Q Consensus 143 ~~--------~~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~v 210 (536)
.. .+++||||+++|+|.+++.. ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+
T Consensus 103 ~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~v 182 (496)
T PTZ00283 103 KDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLV 182 (496)
T ss_pred ccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCE
Confidence 32 36899999999999988754 3468999999999999999999999999999999999999999999
Q ss_pred EEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCC
Q 009364 211 KLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTK 290 (536)
Q Consensus 211 kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~ 290 (536)
||+|||+++.+............+||+.|+|||++.+..++.++|||||||++|+|++|..||....... ........
T Consensus 183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~--~~~~~~~~ 260 (496)
T PTZ00283 183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE--VMHKTLAG 260 (496)
T ss_pred EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHhcC
Confidence 9999999987654322223456789999999999999899999999999999999999999997543221 11111122
Q ss_pred CCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcC
Q 009364 291 SHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTG 332 (536)
Q Consensus 291 ~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~ 332 (536)
...+++..+++++++||.+||+.||.+||++.++++|||+..
T Consensus 261 ~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 261 RYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 334567789999999999999999999999999999999864
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=372.74 Aligned_cols=253 Identities=28% Similarity=0.476 Sum_probs=203.8
Q ss_pred CCCCceeeeEEcccCceEEEEEEEc-----CCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeEe
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNL-----DSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRYL 137 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~ 137 (536)
+..+|++++.||+|+||.||+|.+. .+++.||+|++.. .........+.+|+.+|+.+ +||||++++
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~-------~~~~~~~~~~~~E~~~l~~l~~h~niv~~~ 77 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKE-------GATASEHKALMSELKILIHIGNHLNVVNLL 77 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccc-------ccchHHHHHHHHHHHHHHHhccCcceeeEE
Confidence 4568999999999999999999752 3467899998731 11123345688899999999 899999999
Q ss_pred eeeecC-CceeEEEEecCCCCcccccccC---------------------------------------------------
Q 009364 138 GTVREE-ESLNILLEFVPGGSISSLLGKF--------------------------------------------------- 165 (536)
Q Consensus 138 ~~~~~~-~~~~lV~E~~~gg~L~~~l~~~--------------------------------------------------- 165 (536)
+++... ..+++||||+++|+|.+++...
T Consensus 78 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (338)
T cd05102 78 GACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGST 157 (338)
T ss_pred eEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCccc
Confidence 988764 4588999999999998887542
Q ss_pred -----------CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhcccCCcccC
Q 009364 166 -----------GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMK 234 (536)
Q Consensus 166 -----------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~ 234 (536)
.++++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...............
T Consensus 158 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~ 237 (338)
T cd05102 158 NPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSAR 237 (338)
T ss_pred ccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCC
Confidence 247788889999999999999999999999999999999999999999999998654322222223445
Q ss_pred CCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhH--HHHHHHhhCCCCCCCCCCCcCcHHHHHHHHHhc
Q 009364 235 GTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQ--EVAALFHIGTTKSHPPIPENLSVKAKDFLLKCL 311 (536)
Q Consensus 235 Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~--~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~cL 311 (536)
+++.|+|||++.+..++.++|||||||++|+|++ |..||..... ........ ......+..+++.+.+||.+||
T Consensus 238 ~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~cl 314 (338)
T cd05102 238 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKD---GTRMRAPENATPEIYRIMLACW 314 (338)
T ss_pred CCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhc---CCCCCCCCCCCHHHHHHHHHHc
Confidence 6789999999999899999999999999999997 9999975321 22222211 1223345678999999999999
Q ss_pred ccCCCCCCCHHHHHh
Q 009364 312 EKEPDLRPTASELLK 326 (536)
Q Consensus 312 ~~dP~~Rps~~eiL~ 326 (536)
..||.+|||+.++++
T Consensus 315 ~~dp~~RPs~~el~~ 329 (338)
T cd05102 315 QGDPKERPTFSALVE 329 (338)
T ss_pred cCChhhCcCHHHHHH
Confidence 999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=385.92 Aligned_cols=255 Identities=22% Similarity=0.364 Sum_probs=198.7
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCC------CCceeeEe
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS------HPNIVRYL 137 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~------HpnIv~l~ 137 (536)
...+|++.+.||+|+||+||+|.+..+++.||||++.... ........|+.+++.+. |.++++++
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---------~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~ 197 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---------KYTRDAKIEIQFMEKVRQADPADRFPLMKIQ 197 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---------hhHHHHHHHHHHHHHHhhcCcccCcceeeeE
Confidence 3568999999999999999999999999999999883211 11223445666666554 45688999
Q ss_pred eeeecC-CceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHH-cCCccccCCCCCcccCCCC-------
Q 009364 138 GTVREE-ESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHN-HGIMHRDIKGANILVDNKG------- 208 (536)
Q Consensus 138 ~~~~~~-~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~-~~ivHrDLKp~NILl~~~~------- 208 (536)
+++... ..+++|||++ |++|.+++.+.+.+++..++.++.||+.||.|||+ .|||||||||+|||++.++
T Consensus 198 ~~~~~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~ 276 (467)
T PTZ00284 198 RYFQNETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVT 276 (467)
T ss_pred EEEEcCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccc
Confidence 888764 5788999988 78898888888899999999999999999999998 5999999999999998765
Q ss_pred ---------cEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH
Q 009364 209 ---------CIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE 279 (536)
Q Consensus 209 ---------~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~ 279 (536)
.+||+|||.+.... ......+||+.|+|||++.+..|+.++|||||||++|||++|++||......
T Consensus 277 ~~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~ 351 (467)
T PTZ00284 277 NRALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL 351 (467)
T ss_pred ccccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 49999999875422 1234678999999999999999999999999999999999999999643211
Q ss_pred --HHHHHhhCC----------------------CCCCCC--------------C-CCcCcHHHHHHHHHhcccCCCCCCC
Q 009364 280 --VAALFHIGT----------------------TKSHPP--------------I-PENLSVKAKDFLLKCLEKEPDLRPT 320 (536)
Q Consensus 280 --~~~~~~~~~----------------------~~~~~~--------------~-~~~~s~~~~dLi~~cL~~dP~~Rps 320 (536)
...+..... ....+. . ....++.+.+||.+||++||++|||
T Consensus 352 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t 431 (467)
T PTZ00284 352 EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN 431 (467)
T ss_pred HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC
Confidence 111100000 000000 0 0012456789999999999999999
Q ss_pred HHHHHhCCCCcCC
Q 009364 321 ASELLKHPFVTGD 333 (536)
Q Consensus 321 ~~eiL~hp~~~~~ 333 (536)
++|+|+||||...
T Consensus 432 a~e~L~Hp~~~~~ 444 (467)
T PTZ00284 432 ARQMTTHPYVLKY 444 (467)
T ss_pred HHHHhcCcccccc
Confidence 9999999999864
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=366.10 Aligned_cols=264 Identities=25% Similarity=0.380 Sum_probs=213.4
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
++|++.+.||+|+||+||++++..+++.||+|++.... .........+.+|+.++..++|+||+++++++.+.+.
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~ 75 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWE-----MLKRAETACFREERNVLVNGDCQWITTLHYAFQDENY 75 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHH-----HHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 37999999999999999999999999999999884211 1122334557889999999999999999999999999
Q ss_pred eeEEEEecCCCCccccccc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhh
Q 009364 146 LNILLEFVPGGSISSLLGK-FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAEL 224 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 224 (536)
.|+||||++||+|.+++.+ .+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 76 ~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred EEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 9999999999999999976 467999999999999999999999999999999999999999999999999998765432
Q ss_pred hcccCCcccCCCCCCCChhhhhh-----cCCCccceEechhHHHHHHhhCCCCCchhhH-HHHHHHhhCC-CCCCCCCCC
Q 009364 225 ATVSGAKSMKGTPYWMAPEVIRQ-----TGHSYSADIWSVGCTVIEMATGKPPWSQQYQ-EVAALFHIGT-TKSHPPIPE 297 (536)
Q Consensus 225 ~~~~~~~~~~Gt~~Y~APEvl~~-----~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~-~~~~~~~~~~-~~~~~~~~~ 297 (536)
... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... +....+.... ....+....
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 234 (331)
T cd05624 156 GTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHIT 234 (331)
T ss_pred Cce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccc
Confidence 211 1234579999999999876 4678899999999999999999999965432 1111111111 111122224
Q ss_pred cCcHHHHHHHHHhcccCCCC--CCCHHHHHhCCCCcCCCC
Q 009364 298 NLSVKAKDFLLKCLEKEPDL--RPTASELLKHPFVTGDDE 335 (536)
Q Consensus 298 ~~s~~~~dLi~~cL~~dP~~--Rps~~eiL~hp~~~~~~~ 335 (536)
.++.++++||.+||..++++ |++++++++||||....+
T Consensus 235 ~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~ 274 (331)
T cd05624 235 DVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDW 274 (331)
T ss_pred cCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCH
Confidence 57899999999999876654 579999999999986543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=369.54 Aligned_cols=252 Identities=31% Similarity=0.466 Sum_probs=207.6
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHH-HHHhCCCCceeeEeeeeecCCceeEEE
Q 009364 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVK-LLKDLSHPNIVRYLGTVREEESLNILL 150 (536)
Q Consensus 72 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~-iL~~l~HpnIv~l~~~~~~~~~~~lV~ 150 (536)
+.||+|+||+||+|.+..+|+.||+|++..... ........+..|.. +++.++||||+++++++...+.+++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~ 75 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIV-----LNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVL 75 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-----hhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEE
Confidence 469999999999999999999999999843211 11122334445544 567789999999999999999999999
Q ss_pred EecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhcccCC
Q 009364 151 EFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGA 230 (536)
Q Consensus 151 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 230 (536)
||++||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... ....
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~ 153 (325)
T cd05604 76 DFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SDTT 153 (325)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CCCc
Confidence 99999999999988889999999999999999999999999999999999999999999999999998753221 1123
Q ss_pred cccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhH-HHHHHHhhCCCCCCCCCCCcCcHHHHHHHHH
Q 009364 231 KSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQ-EVAALFHIGTTKSHPPIPENLSVKAKDFLLK 309 (536)
Q Consensus 231 ~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~ 309 (536)
...+||+.|+|||++.+..++.++|||||||++|+|++|.+||..... +....... .....++..+..+.++|++
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~ll~~ 229 (325)
T cd05604 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILH----KPLVLRPGASLTAWSILEE 229 (325)
T ss_pred ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHc----CCccCCCCCCHHHHHHHHH
Confidence 456799999999999999999999999999999999999999975432 22221111 1223445789999999999
Q ss_pred hcccCCCCCCCH----HHHHhCCCCcCCC
Q 009364 310 CLEKEPDLRPTA----SELLKHPFVTGDD 334 (536)
Q Consensus 310 cL~~dP~~Rps~----~eiL~hp~~~~~~ 334 (536)
||+.+|.+||++ .++++||||....
T Consensus 230 ll~~~p~~R~~~~~~~~~i~~h~~f~~~~ 258 (325)
T cd05604 230 LLEKDRQRRLGAKEDFLEIQEHPFFESLS 258 (325)
T ss_pred HhccCHHhcCCCCCCHHHHhcCCCcCCCC
Confidence 999999999976 5999999997643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=378.52 Aligned_cols=252 Identities=31% Similarity=0.520 Sum_probs=207.1
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCC-C-----CceeeEeeee
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS-H-----PNIVRYLGTV 140 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~-H-----pnIv~l~~~~ 140 (536)
||.+.+.||+|+||+|.+|.+..|++.||||++. .......+...|+.+|..|+ | -|+|+++++|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiK---------N~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F 257 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIK---------NKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF 257 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeec---------cChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc
Confidence 7899999999999999999999999999999983 22345566778999999997 4 4899999999
Q ss_pred ecCCceeEEEEecCCCCcccccccC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCC--cEEEEecC
Q 009364 141 REEESLNILLEFVPGGSISSLLGKF--GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKG--CIKLADFG 216 (536)
Q Consensus 141 ~~~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~--~vkL~DFG 216 (536)
...+++|||+|.+ +.+|+++++.+ ..++...++.++.||+.||.+||+.||||+||||||||+.+.+ .|||+|||
T Consensus 258 ~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFG 336 (586)
T KOG0667|consen 258 YFRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFG 336 (586)
T ss_pred ccccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecc
Confidence 9999999999999 68999999765 4689999999999999999999999999999999999997654 79999999
Q ss_pred cchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhH--HHHHHHhhCC------
Q 009364 217 ASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQ--EVAALFHIGT------ 288 (536)
Q Consensus 217 la~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~--~~~~~~~~~~------ 288 (536)
.|...... ..+++.+..|+|||++.|.+|+.+.||||||||++||++|.|.|.+..+ .+..+.....
T Consensus 337 SSc~~~q~-----vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~m 411 (586)
T KOG0667|consen 337 SSCFESQR-----VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKM 411 (586)
T ss_pred cccccCCc-----ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHH
Confidence 99876542 2377889999999999999999999999999999999999998864321 1111111000
Q ss_pred ------------C-C----------------------------CCCCCC-----------CcCcHHHHHHHHHhcccCCC
Q 009364 289 ------------T-K----------------------------SHPPIP-----------ENLSVKAKDFLLKCLEKEPD 316 (536)
Q Consensus 289 ------------~-~----------------------------~~~~~~-----------~~~s~~~~dLi~~cL~~dP~ 316 (536)
. . .....| ..-...+.|||++||.+||.
T Consensus 412 L~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~ 491 (586)
T KOG0667|consen 412 LDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPA 491 (586)
T ss_pred HHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCch
Confidence 0 0 000011 01224567999999999999
Q ss_pred CCCCHHHHHhCCCCcCC
Q 009364 317 LRPTASELLKHPFVTGD 333 (536)
Q Consensus 317 ~Rps~~eiL~hp~~~~~ 333 (536)
+|+|+.|+|+||||...
T Consensus 492 ~R~tp~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 492 ERITPAQALNHPFLTGT 508 (586)
T ss_pred hcCCHHHHhcCcccccc
Confidence 99999999999999853
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=388.45 Aligned_cols=256 Identities=29% Similarity=0.450 Sum_probs=215.8
Q ss_pred CCceeeeEEcccCceEEEEEEEcCC-CcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCC
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDS-GELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEE 144 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~-g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 144 (536)
..|.+.+.||+|+||.||+|.+..+ ++.||+|.+... .......+.+|+.+|+.++||||+++++++...+
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--------~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~ 138 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--------DERQAAYARSELHCLAACDHFGIVKHFDDFKSDD 138 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--------CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECC
Confidence 3599999999999999999998877 788999976321 1223345678999999999999999999999999
Q ss_pred ceeEEEEecCCCCccccccc----CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchh
Q 009364 145 SLNILLEFVPGGSISSLLGK----FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQ 220 (536)
Q Consensus 145 ~~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~ 220 (536)
.+++||||++||+|.+++.. ..++++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 139 ~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~ 218 (478)
T PTZ00267 139 KLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQ 218 (478)
T ss_pred EEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCcee
Confidence 99999999999999887643 45789999999999999999999999999999999999999999999999999987
Q ss_pred hhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH-HHHHHhhCCCCCCCCCCCcC
Q 009364 221 VAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE-VAALFHIGTTKSHPPIPENL 299 (536)
Q Consensus 221 ~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~ 299 (536)
+............+||+.|+|||++.+..++.++|||||||++|+|++|..||...... ....... ....+.+..+
T Consensus 219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~---~~~~~~~~~~ 295 (478)
T PTZ00267 219 YSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLY---GKYDPFPCPV 295 (478)
T ss_pred cCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---CCCCCCCccC
Confidence 65432222345678999999999999989999999999999999999999999754322 1111111 2223456678
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcC
Q 009364 300 SVKAKDFLLKCLEKEPDLRPTASELLKHPFVTG 332 (536)
Q Consensus 300 s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~ 332 (536)
+.++++||.+||.+||++||++.+++.|+|+..
T Consensus 296 s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 296 SSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 999999999999999999999999999999853
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=357.70 Aligned_cols=255 Identities=37% Similarity=0.630 Sum_probs=210.3
Q ss_pred ceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCcee
Q 009364 68 WRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESLN 147 (536)
Q Consensus 68 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 147 (536)
|++++.||+|+||+||+|.+..+++.||+|++... ...........+|+.+++.++||||+++++++......+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~------~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~ 74 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKS------EIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLY 74 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEEST------THHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccc------cccccccchhhhhhhcccccccccccccccccccccccc
Confidence 88999999999999999999999999999998432 222222334456999999999999999999999999999
Q ss_pred EEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhcc
Q 009364 148 ILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATV 227 (536)
Q Consensus 148 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 227 (536)
+||||+.+++|.+++...+.+++..+..++.||+.||++||++|++||||||+||+++.++.++|+|||.+..... ..
T Consensus 75 ~v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~~ 152 (260)
T PF00069_consen 75 IVMEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE--NN 152 (260)
T ss_dssp EEEEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTS--TT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--cc
Confidence 9999999999999998778899999999999999999999999999999999999999999999999999875421 11
Q ss_pred cCCcccCCCCCCCChhhhh-hcCCCccceEechhHHHHHHhhCCCCCchhh--HHHHHHHhhC--CCCCCCCCCCcCcHH
Q 009364 228 SGAKSMKGTPYWMAPEVIR-QTGHSYSADIWSVGCTVIEMATGKPPWSQQY--QEVAALFHIG--TTKSHPPIPENLSVK 302 (536)
Q Consensus 228 ~~~~~~~Gt~~Y~APEvl~-~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~--~~~~~~~~~~--~~~~~~~~~~~~s~~ 302 (536)
.......+|+.|+|||++. +..++.++||||||+++|+|++|..||.... .......... ............+..
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEE 232 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHH
Confidence 2244667899999999998 7889999999999999999999999997651 1111111110 000011111223489
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHhCCCC
Q 009364 303 AKDFLLKCLEKEPDLRPTASELLKHPFV 330 (536)
Q Consensus 303 ~~dLi~~cL~~dP~~Rps~~eiL~hp~~ 330 (536)
+.++|.+||+.||++||++.++++||||
T Consensus 233 l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 233 LRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 9999999999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=351.95 Aligned_cols=262 Identities=53% Similarity=0.928 Sum_probs=219.5
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccc-hhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFAS-KEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~-~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
+|.++..||+|+||.||+|.+..+++.+|+|.+........ ........+.+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 58889999999999999999998999999998754322111 22233445778899999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhh
Q 009364 146 LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA 225 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 225 (536)
.++||||+++++|.+++...+.+++..+..++.|++.||.|||++|++||||+|+||+++.++.+||+|||.++......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 99999999999999999888889999999999999999999999999999999999999999999999999988665211
Q ss_pred c----ccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcH
Q 009364 226 T----VSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSV 301 (536)
Q Consensus 226 ~----~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 301 (536)
. ........|++.|+|||++.+..++.++|+|||||++|+|++|..||...... ....... ....+..+..++.
T Consensus 161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~-~~~~~~~~~~~~~ 238 (267)
T cd06628 161 LSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL-QAIFKIG-ENASPEIPSNISS 238 (267)
T ss_pred ccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH-HHHHHHh-ccCCCcCCcccCH
Confidence 1 11122456899999999999888999999999999999999999999754321 1222111 1233456667899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhCCCC
Q 009364 302 KAKDFLLKCLEKEPDLRPTASELLKHPFV 330 (536)
Q Consensus 302 ~~~dLi~~cL~~dP~~Rps~~eiL~hp~~ 330 (536)
.++++|++||++||.+||++.++++||||
T Consensus 239 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 239 EAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 99999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-44 Score=371.54 Aligned_cols=256 Identities=28% Similarity=0.419 Sum_probs=203.4
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEE 144 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 144 (536)
..+|++.+.||+|+||.||+|.+..+|+.||+|++... .........+.+|+.+++.++||||+++++++....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 93 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRP------FQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQK 93 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccc------ccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCC
Confidence 46899999999999999999999999999999987321 111233456778999999999999999999986543
Q ss_pred ------ceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcc
Q 009364 145 ------SLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGAS 218 (536)
Q Consensus 145 ------~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla 218 (536)
.+|+||||+.+ +|...+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 94 SLEEFQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred CccccceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCc
Confidence 47999999965 4555443 35889999999999999999999999999999999999999999999999998
Q ss_pred hhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHH--HHHHh-----------
Q 009364 219 KQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEV--AALFH----------- 285 (536)
Q Consensus 219 ~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~--~~~~~----------- 285 (536)
+..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||....... .....
T Consensus 171 ~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (359)
T cd07876 171 RTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMN 247 (359)
T ss_pred cccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHH
Confidence 754321 12345678999999999999999999999999999999999999996432110 00000
Q ss_pred ---------hCCCCCC-----------------CCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcC
Q 009364 286 ---------IGTTKSH-----------------PPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTG 332 (536)
Q Consensus 286 ---------~~~~~~~-----------------~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~ 332 (536)
....... .......+.++++||.+||+.||++|||+.|+|+||||..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 248 RLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred HHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 0000000 0011234678999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-44 Score=359.23 Aligned_cols=254 Identities=31% Similarity=0.518 Sum_probs=199.6
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC---CCCceeeEeeeeec-
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL---SHPNIVRYLGTVRE- 142 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l---~HpnIv~l~~~~~~- 142 (536)
+|++.+.||+|+||+||+|.+..+|+.||+|.+....... .......+|+.+++.+ +||||+++++++..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~------~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~ 74 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED------GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATS 74 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC------CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccc
Confidence 5899999999999999999999999999999874321111 0112234555555554 79999999998864
Q ss_pred ----CCceeEEEEecCCCCcccccccC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecC
Q 009364 143 ----EESLNILLEFVPGGSISSLLGKF--GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFG 216 (536)
Q Consensus 143 ----~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFG 216 (536)
...+++||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 75 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg 153 (288)
T cd07863 75 RTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFG 153 (288)
T ss_pred cCCCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccC
Confidence 345899999997 5787777553 358999999999999999999999999999999999999999999999999
Q ss_pred cchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH--HHHHHhhCCCC----
Q 009364 217 ASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE--VAALFHIGTTK---- 290 (536)
Q Consensus 217 la~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~--~~~~~~~~~~~---- 290 (536)
+++...... ......||+.|+|||++.+..++.++||||+||++|+|++|.+||...... ...+.......
T Consensus 154 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07863 154 LARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD 230 (288)
T ss_pred ccccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhh
Confidence 987654321 223457899999999999889999999999999999999999999644221 11111110000
Q ss_pred ------------------CCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCC
Q 009364 291 ------------------SHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFV 330 (536)
Q Consensus 291 ------------------~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~ 330 (536)
......+.++..+++||.+||++||++|||+.+++.||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 231 WPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred CcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0001123578889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=374.58 Aligned_cols=259 Identities=25% Similarity=0.426 Sum_probs=208.9
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCC--
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEE-- 144 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~-- 144 (536)
.|++.+.||+|+||+||+|.+..+|+.||+|.+... .......+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 74 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNV------FQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHID 74 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEecccc------ccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCcc
Confidence 367889999999999999999999999999987321 111223456788999999999999999999998776
Q ss_pred ---ceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhh
Q 009364 145 ---SLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQV 221 (536)
Q Consensus 145 ---~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~ 221 (536)
..|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 75 ~~~~~~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 75 PFEEIYVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred ccceEEEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeec
Confidence 7899999995 678888877788999999999999999999999999999999999999999999999999998765
Q ss_pred hhhhcccCCcccCCCCCCCChhhhhhc-CCCccceEechhHHHHHHhhCCCCCchhhHH--HHHHHh-------------
Q 009364 222 AELATVSGAKSMKGTPYWMAPEVIRQT-GHSYSADIWSVGCTVIEMATGKPPWSQQYQE--VAALFH------------- 285 (536)
Q Consensus 222 ~~~~~~~~~~~~~Gt~~Y~APEvl~~~-~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~--~~~~~~------------- 285 (536)
.... ........+|+.|+|||++.+. .++.++||||+||++|+|++|++||...... ...+..
T Consensus 154 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 232 (372)
T cd07853 154 EPDE-SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA 232 (372)
T ss_pred ccCc-cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 4321 1123345689999999999874 4799999999999999999999999643211 110000
Q ss_pred --------hCCCCCCC------CCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 286 --------IGTTKSHP------PIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 286 --------~~~~~~~~------~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
.......+ ......+.++.+||.+||+.||.+|||+.|+|+||||...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 00000000 1234568899999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=370.31 Aligned_cols=250 Identities=31% Similarity=0.478 Sum_probs=204.3
Q ss_pred EcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC---CCCceeeEeeeeecCCceeEEE
Q 009364 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL---SHPNIVRYLGTVREEESLNILL 150 (536)
Q Consensus 74 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l---~HpnIv~l~~~~~~~~~~~lV~ 150 (536)
||+|+||+||+|++..+|+.||+|++.... ............|..++..+ .||||+++++++.....+|+||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~-----~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~ 75 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKE-----IVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVT 75 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHH-----HhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEE
Confidence 799999999999999999999999984211 11112233445566666655 6999999999999999999999
Q ss_pred EecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhcccCC
Q 009364 151 EFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGA 230 (536)
Q Consensus 151 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 230 (536)
||+++|+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... ...
T Consensus 76 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~~ 153 (330)
T cd05586 76 DYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KTT 153 (330)
T ss_pred cCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CCc
Confidence 999999999999888889999999999999999999999999999999999999999999999999987532211 123
Q ss_pred cccCCCCCCCChhhhhhc-CCCccceEechhHHHHHHhhCCCCCchhhH-HHHHHHhhCCCCCCCCCC-CcCcHHHHHHH
Q 009364 231 KSMKGTPYWMAPEVIRQT-GHSYSADIWSVGCTVIEMATGKPPWSQQYQ-EVAALFHIGTTKSHPPIP-ENLSVKAKDFL 307 (536)
Q Consensus 231 ~~~~Gt~~Y~APEvl~~~-~~s~k~DIwSlGvil~eLltG~~Pf~~~~~-~~~~~~~~~~~~~~~~~~-~~~s~~~~dLi 307 (536)
...+||+.|+|||++.+. .++.++|||||||++|+|++|..||..... ........... .++ ..++.++++||
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~----~~~~~~~~~~~~~li 229 (330)
T cd05586 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKV----RFPKNVLSDEGRQFV 229 (330)
T ss_pred cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCC----CCCCccCCHHHHHHH
Confidence 456899999999998754 589999999999999999999999975432 22222222111 122 35789999999
Q ss_pred HHhcccCCCCCC----CHHHHHhCCCCcCCC
Q 009364 308 LKCLEKEPDLRP----TASELLKHPFVTGDD 334 (536)
Q Consensus 308 ~~cL~~dP~~Rp----s~~eiL~hp~~~~~~ 334 (536)
++||++||.+|| ++.++++||||....
T Consensus 230 ~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~ 260 (330)
T cd05586 230 KGLLNRNPQHRLGAHRDAVELKEHPFFADID 260 (330)
T ss_pred HHHcCCCHHHCCCCCCCHHHHhcCccccCCC
Confidence 999999999998 799999999997644
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=358.11 Aligned_cols=254 Identities=35% Similarity=0.564 Sum_probs=206.8
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE 143 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 143 (536)
....|+..+++|.|+||.||+|....+++.||||.+...... -.+|+.+|+.++|||||++..+|...
T Consensus 22 ~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~------------knrEl~im~~l~HpNIV~L~~~f~~~ 89 (364)
T KOG0658|consen 22 VEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY------------KNRELQIMRKLDHPNIVRLLYFFSSS 89 (364)
T ss_pred eEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc------------CcHHHHHHHhcCCcCeeeEEEEEEec
Confidence 345789999999999999999999999999999998533222 23689999999999999998887532
Q ss_pred -----CceeEEEEecCCCCccccccc----CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCC-CcEEEE
Q 009364 144 -----ESLNILLEFVPGGSISSLLGK----FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNK-GCIKLA 213 (536)
Q Consensus 144 -----~~~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~-~~vkL~ 213 (536)
-+..+||||++ .+|..+++. +..++.-.++-++.||++||+|||+.||+||||||.|+|+|.+ |.+|||
T Consensus 90 ~~~d~~~lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKic 168 (364)
T KOG0658|consen 90 TESDEVYLNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKIC 168 (364)
T ss_pred CCCchhHHHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEec
Confidence 24678999996 688877763 5678999999999999999999999999999999999999976 899999
Q ss_pred ecCcchhhhhhhcccCCcccCCCCCCCChhhhhh-cCCCccceEechhHHHHHHhhCCCCCchhhH--HHHHHHhhCCC-
Q 009364 214 DFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQ-TGHSYSADIWSVGCTVIEMATGKPPWSQQYQ--EVAALFHIGTT- 289 (536)
Q Consensus 214 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~-~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~--~~~~~~~~~~~- 289 (536)
|||.|+.+..... ..++..|..|+|||.+.| ..|+.+.||||.|||+.||+-|++.|.+... ....++..-..
T Consensus 169 DFGSAK~L~~~ep---niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~P 245 (364)
T KOG0658|consen 169 DFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTP 245 (364)
T ss_pred cCCcceeeccCCC---ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCC
Confidence 9999998765433 356778999999999876 4789999999999999999999999975431 11111111000
Q ss_pred ----------------------CCC-CCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 290 ----------------------KSH-PPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 290 ----------------------~~~-~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
..+ ..+....++++.+|+.++|..+|.+|.++.|++.||||...
T Consensus 246 t~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdel 312 (364)
T KOG0658|consen 246 TREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDEL 312 (364)
T ss_pred CHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHh
Confidence 000 01345689999999999999999999999999999999754
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=380.54 Aligned_cols=263 Identities=37% Similarity=0.618 Sum_probs=224.0
Q ss_pred CCCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeee
Q 009364 62 MSPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVR 141 (536)
Q Consensus 62 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~ 141 (536)
..+.+.|.|+.-||.|+||+||+|.++.++-.-|.|+|. ....+.++.+.-||.||..++||+||++++.|.
T Consensus 28 lnP~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIe--------tkseEELEDylVEIeILa~CdHP~ivkLl~ayy 99 (1187)
T KOG0579|consen 28 LNPRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIE--------TKSEEELEDYLVEIEILAECDHPVIVKLLSAYY 99 (1187)
T ss_pred CCHHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhc--------ccchhHHhhhhhhhhhhhcCCChHHHHHHHHHh
Confidence 456678999999999999999999999998888889872 344566788889999999999999999999999
Q ss_pred cCCceeEEEEecCCCCccccccc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchh
Q 009364 142 EEESLNILLEFVPGGSISSLLGK-FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQ 220 (536)
Q Consensus 142 ~~~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~ 220 (536)
.++.++++.|||.||-+..++-. ...+.+.++..+++|++.||.|||+++|||||||..|||++-+|.++|+|||.+..
T Consensus 100 ~enkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAK 179 (1187)
T KOG0579|consen 100 FENKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAK 179 (1187)
T ss_pred ccCceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeeccccccc
Confidence 99999999999999998887654 45799999999999999999999999999999999999999999999999998865
Q ss_pred hhhhhcccCCcccCCCCCCCChhhhh-----hcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhC-CCCCCCC
Q 009364 221 VAELATVSGAKSMKGTPYWMAPEVIR-----QTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIG-TTKSHPP 294 (536)
Q Consensus 221 ~~~~~~~~~~~~~~Gt~~Y~APEvl~-----~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~-~~~~~~~ 294 (536)
.. .+.....+++|||+|||||+.. ..+|++++||||||+.|.||..+.||-..-..- ..++.+. ..+....
T Consensus 180 n~--~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM-RVllKiaKSePPTLl 256 (1187)
T KOG0579|consen 180 NK--STRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM-RVLLKIAKSEPPTLL 256 (1187)
T ss_pred ch--hHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH-HHHHHHhhcCCCccc
Confidence 43 2344567899999999999864 568999999999999999999999997543322 2222222 2222333
Q ss_pred CCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCCC
Q 009364 295 IPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDE 335 (536)
Q Consensus 295 ~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~~ 335 (536)
.|..++..+.|++++||.+||..||+++++|+||||++...
T Consensus 257 qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~S 297 (1187)
T KOG0579|consen 257 QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPS 297 (1187)
T ss_pred CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCc
Confidence 56789999999999999999999999999999999986543
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-44 Score=363.86 Aligned_cols=259 Identities=27% Similarity=0.442 Sum_probs=207.2
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEE 144 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 144 (536)
..+|++.+.||+|+||+||+|++..+++.||+|.+..... ......+.+|+.+++.++||||+++++++..++
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 77 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-------EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDK 77 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc-------CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCC
Confidence 3579999999999999999999999999999998843211 111234567999999999999999999999999
Q ss_pred ceeEEEEecCCCCcccccccC-CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhh
Q 009364 145 SLNILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAE 223 (536)
Q Consensus 145 ~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 223 (536)
..++||||+++ +|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 78 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 156 (309)
T cd07872 78 SLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSV 156 (309)
T ss_pred eEEEEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCC
Confidence 99999999975 777766543 4589999999999999999999999999999999999999999999999999875432
Q ss_pred hhcccCCcccCCCCCCCChhhhhh-cCCCccceEechhHHHHHHhhCCCCCchhhHH--HHHHHhhCC------------
Q 009364 224 LATVSGAKSMKGTPYWMAPEVIRQ-TGHSYSADIWSVGCTVIEMATGKPPWSQQYQE--VAALFHIGT------------ 288 (536)
Q Consensus 224 ~~~~~~~~~~~Gt~~Y~APEvl~~-~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~--~~~~~~~~~------------ 288 (536)
.. .......+|+.|+|||++.+ ..++.++|||||||++|+|++|.+||...... .........
T Consensus 157 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07872 157 PT--KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISS 234 (309)
T ss_pred Cc--cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcc
Confidence 11 12234568999999999865 45799999999999999999999999653311 111111000
Q ss_pred --------CCCC-----CCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 289 --------TKSH-----PPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 289 --------~~~~-----~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
.... ......++.++++||.+||+.||.+|||+.|+++||||+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 292 (309)
T cd07872 235 NDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292 (309)
T ss_pred hhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence 0000 01123578899999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=350.04 Aligned_cols=261 Identities=48% Similarity=0.867 Sum_probs=216.8
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCce
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESL 146 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 146 (536)
+|++++.||+|+||+||+|.+ .+|+.+|+|.+...... ..........+.+|+.+++.++|+||+++++++.+....
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~--~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 77 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSN--VLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTI 77 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccc--hhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeE
Confidence 588999999999999999986 47889999987432211 122234456788999999999999999999999999999
Q ss_pred eEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhc
Q 009364 147 NILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELAT 226 (536)
Q Consensus 147 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 226 (536)
++|+||++|++|.+++.+.+++++..++.++.|++.||+|||+.||+|+||+|+||+++.++.++|+|||++........
T Consensus 78 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 78 SIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 99999999999999998878899999999999999999999999999999999999999999999999999876532111
Q ss_pred ----ccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcHH
Q 009364 227 ----VSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVK 302 (536)
Q Consensus 227 ----~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 302 (536)
........|+..|+|||++.+..++.++|||||||++|+|++|..||...................+..+..++.+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAA 237 (265)
T ss_pred cccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHH
Confidence 1112345689999999999988899999999999999999999999965432211111111112334566788999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHhCCCC
Q 009364 303 AKDFLLKCLEKEPDLRPTASELLKHPFV 330 (536)
Q Consensus 303 ~~dLi~~cL~~dP~~Rps~~eiL~hp~~ 330 (536)
+.++|++||.++|.+||++.++++||||
T Consensus 238 ~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 238 AIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=356.77 Aligned_cols=265 Identities=37% Similarity=0.632 Sum_probs=217.3
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE 142 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 142 (536)
.+..+|++.+.||+|+||.||+|.+..+++.+|+|.+.. ......+.+.+|+.+++.++||||+++++.+..
T Consensus 9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~--------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 80 (292)
T cd06644 9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIET--------KSEEELEDYMVEIEILATCNHPYIVKLLGAFYW 80 (292)
T ss_pred CcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEecc--------CCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe
Confidence 455689999999999999999999999999999998732 122345667889999999999999999999999
Q ss_pred CCceeEEEEecCCCCccccccc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhh
Q 009364 143 EESLNILLEFVPGGSISSLLGK-FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQV 221 (536)
Q Consensus 143 ~~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~ 221 (536)
+..+++||||+++++|..++.+ ...+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++...
T Consensus 81 ~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 160 (292)
T cd06644 81 DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKN 160 (292)
T ss_pred CCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceec
Confidence 9999999999999999887654 456899999999999999999999999999999999999999999999999988654
Q ss_pred hhhhcccCCcccCCCCCCCChhhhh-----hcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCC
Q 009364 222 AELATVSGAKSMKGTPYWMAPEVIR-----QTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIP 296 (536)
Q Consensus 222 ~~~~~~~~~~~~~Gt~~Y~APEvl~-----~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 296 (536)
... ........|++.|+|||++. ...++.++|||||||++|+|++|.+||......................+
T Consensus 161 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T cd06644 161 VKT--LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQP 238 (292)
T ss_pred ccc--ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCC
Confidence 321 12233556899999999984 34568899999999999999999999965432211111111112222345
Q ss_pred CcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCCCCc
Q 009364 297 ENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDP 337 (536)
Q Consensus 297 ~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~~~~ 337 (536)
..++.++.++|++||..+|++||++.++++||||......+
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~ 279 (292)
T cd06644 239 SKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNR 279 (292)
T ss_pred cccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccch
Confidence 57889999999999999999999999999999998655443
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=351.06 Aligned_cols=262 Identities=48% Similarity=0.917 Sum_probs=216.3
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec--
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE-- 142 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~-- 142 (536)
|.+|++++.||+|+||.||+|.+..+|..||+|.+..... ..........+.+|+.+++.++||||+++++++..
T Consensus 1 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 77 (266)
T cd06651 1 PINWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPE---SPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRA 77 (266)
T ss_pred CCCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcC---CchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCC
Confidence 4679999999999999999999999999999998743211 11222345678899999999999999999998875
Q ss_pred CCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhh
Q 009364 143 EESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVA 222 (536)
Q Consensus 143 ~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~ 222 (536)
...+++++||+++++|.+++...+.+++...+.++.|++.||+|||++||+||||||+||+++.++.+||+|||+++...
T Consensus 78 ~~~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 78 EKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 35688999999999999999887789999999999999999999999999999999999999999999999999987654
Q ss_pred hhhc-ccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcH
Q 009364 223 ELAT-VSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSV 301 (536)
Q Consensus 223 ~~~~-~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 301 (536)
.... ........|+..|+|||++.+..++.++||||+||++|+|++|..||...... ............+.++..++.
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 236 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM-AAIFKIATQPTNPQLPSHISE 236 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH-HHHHHHhcCCCCCCCchhcCH
Confidence 3211 11123456899999999999888999999999999999999999999754322 222222223334556667889
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhCCCCc
Q 009364 302 KAKDFLLKCLEKEPDLRPTASELLKHPFVT 331 (536)
Q Consensus 302 ~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~ 331 (536)
.++++| +||..+|++||+++++++||||+
T Consensus 237 ~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 237 HARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 999999 67778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=356.14 Aligned_cols=253 Identities=24% Similarity=0.387 Sum_probs=204.2
Q ss_pred EcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCceeEEEEec
Q 009364 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESLNILLEFV 153 (536)
Q Consensus 74 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 153 (536)
||+|+||+||++.+..+|+.||+|.+..... ........+..|+++++.++||||+++++++.....+++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-----~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRL-----KKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHh-----hcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecC
Confidence 7999999999999999999999998832111 11112234556999999999999999999999999999999999
Q ss_pred CCCCcccccccC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhcccCCc
Q 009364 154 PGGSISSLLGKF--GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAK 231 (536)
Q Consensus 154 ~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 231 (536)
+|++|.+++... ..+++..+..++.||+.||+|||+.||+||||||+||+++.++.++|+|||++....... ...
T Consensus 76 ~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~ 152 (277)
T cd05607 76 NGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TIT 152 (277)
T ss_pred CCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eee
Confidence 999998887543 358899999999999999999999999999999999999999999999999987654321 123
Q ss_pred ccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHH--HHHHhhCCCCCCCCCCCcCcHHHHHHHHH
Q 009364 232 SMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEV--AALFHIGTTKSHPPIPENLSVKAKDFLLK 309 (536)
Q Consensus 232 ~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~s~~~~dLi~~ 309 (536)
...||+.|+|||++.+..++.++||||+||++|+|++|..||....... ..................++.++++||.+
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 232 (277)
T cd05607 153 QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRL 232 (277)
T ss_pred ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHH
Confidence 4568999999999998889999999999999999999999996532211 11111111111111224689999999999
Q ss_pred hcccCCCCCCCH----HHHHhCCCCcCCC
Q 009364 310 CLEKEPDLRPTA----SELLKHPFVTGDD 334 (536)
Q Consensus 310 cL~~dP~~Rps~----~eiL~hp~~~~~~ 334 (536)
||++||.+||++ .++++||||....
T Consensus 233 ~L~~~P~~R~~~~~~~~~~~~h~~f~~~~ 261 (277)
T cd05607 233 FLAKKPEDRLGSREKNDDPRKHEFFKTIN 261 (277)
T ss_pred HhccCHhhCCCCccchhhhhcChhhcCCC
Confidence 999999999999 6788999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=357.54 Aligned_cols=259 Identities=26% Similarity=0.422 Sum_probs=212.4
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCce
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESL 146 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 146 (536)
.|++.+.||+|+||+||+|.+..+++.||+|.+.... .........+.+|+.+++.++|+||+++++.+.+.+.+
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~-----~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~ 75 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKR-----IKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDAL 75 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhh-----ccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEE
Confidence 3788899999999999999999999999999873211 01112234566899999999999999999999999999
Q ss_pred eEEEEecCCCCcccccccC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhh
Q 009364 147 NILLEFVPGGSISSLLGKF--GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAEL 224 (536)
Q Consensus 147 ~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 224 (536)
++||||++|++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++......
T Consensus 76 ~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 76 CLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 9999999999999888543 35899999999999999999999999999999999999999999999999998754322
Q ss_pred hcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHH-HHHhhCCCCCCCCCCCcCcHHH
Q 009364 225 ATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVA-ALFHIGTTKSHPPIPENLSVKA 303 (536)
Q Consensus 225 ~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~s~~~ 303 (536)
. ......||+.|+|||++.+..++.++||||+||++|+|++|..||........ ..............+..+++++
T Consensus 156 ~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
T cd05630 156 Q---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDA 232 (285)
T ss_pred c---cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHH
Confidence 1 12345799999999999988999999999999999999999999975321110 0000000111223456789999
Q ss_pred HHHHHHhcccCCCCCCC-----HHHHHhCCCCcCC
Q 009364 304 KDFLLKCLEKEPDLRPT-----ASELLKHPFVTGD 333 (536)
Q Consensus 304 ~dLi~~cL~~dP~~Rps-----~~eiL~hp~~~~~ 333 (536)
++|+++||+.||.+||| +.|+++||||...
T Consensus 233 ~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05630 233 RSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI 267 (285)
T ss_pred HHHHHHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence 99999999999999999 9999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-45 Score=352.35 Aligned_cols=258 Identities=25% Similarity=0.400 Sum_probs=217.0
Q ss_pred eeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCC-CCceeeEeeeeecCCceeEE
Q 009364 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS-HPNIVRYLGTVREEESLNIL 149 (536)
Q Consensus 71 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV 149 (536)
.+.||+|+|+.|--+....+|..||||++.+. ......++.+|++++..++ |+||+.++++|+++..+|||
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq--------~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLV 154 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ--------PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLV 154 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcC--------CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEE
Confidence 67899999999999999999999999998432 1233567889999999995 99999999999999999999
Q ss_pred EEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCC---cEEEEecCcchhhhhhhc
Q 009364 150 LEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKG---CIKLADFGASKQVAELAT 226 (536)
Q Consensus 150 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~---~vkL~DFGla~~~~~~~~ 226 (536)
||-+.||+|...|.++..|+|.++.++++.|+.||.+||.+||.||||||+|||..... -||||||.+...+.....
T Consensus 155 fEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~ 234 (463)
T KOG0607|consen 155 FEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNND 234 (463)
T ss_pred EecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCC
Confidence 99999999999999999999999999999999999999999999999999999997655 589999988765443222
Q ss_pred c-----cCCcccCCCCCCCChhhhh-----hcCCCccceEechhHHHHHHhhCCCCCchhh----------------HHH
Q 009364 227 V-----SGAKSMKGTPYWMAPEVIR-----QTGHSYSADIWSVGCTVIEMATGKPPWSQQY----------------QEV 280 (536)
Q Consensus 227 ~-----~~~~~~~Gt~~Y~APEvl~-----~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~----------------~~~ 280 (536)
. ....+.+|+..|||||+.. ...|+.+||.||||||||.||+|++||.+.. +..
T Consensus 235 ~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~L 314 (463)
T KOG0607|consen 235 CSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKL 314 (463)
T ss_pred CCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHH
Confidence 1 1234678999999999863 3468999999999999999999999996432 223
Q ss_pred HHHHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCCCC
Q 009364 281 AALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDED 336 (536)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~~~ 336 (536)
...+..+.......-+..+|.+++|||..+|..|+.+|.++.++++|||++...+.
T Consensus 315 FesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 315 FESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE 370 (463)
T ss_pred HHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence 33344444444444556899999999999999999999999999999999865443
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=355.50 Aligned_cols=262 Identities=37% Similarity=0.633 Sum_probs=216.3
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE 142 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 142 (536)
.+..+|++.+.||.|+||+||+|.+..++..+|+|++... .....+.+.+|+.+++.++||||+++++.+..
T Consensus 2 ~~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 73 (280)
T cd06611 2 NPNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--------SEEELEDFMVEIDILSECKHPNIVGLYEAYFY 73 (280)
T ss_pred CchhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--------CHHHHHHHHHHHHHHHhCCCCceeEEEEEEec
Confidence 3556899999999999999999999889999999987421 22334567789999999999999999999999
Q ss_pred CCceeEEEEecCCCCcccccccC-CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhh
Q 009364 143 EESLNILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQV 221 (536)
Q Consensus 143 ~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~ 221 (536)
....++||||+++++|.+++.+. ..+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++...
T Consensus 74 ~~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~ 153 (280)
T cd06611 74 ENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKN 153 (280)
T ss_pred CCeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhh
Confidence 99999999999999999998664 56999999999999999999999999999999999999999999999999988764
Q ss_pred hhhhcccCCcccCCCCCCCChhhhhh-----cCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCC
Q 009364 222 AELATVSGAKSMKGTPYWMAPEVIRQ-----TGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIP 296 (536)
Q Consensus 222 ~~~~~~~~~~~~~Gt~~Y~APEvl~~-----~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 296 (536)
.... .......|++.|+|||++.. ..++.++|||||||++|+|++|.+||......................+
T Consensus 154 ~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 231 (280)
T cd06611 154 KSTL--QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQP 231 (280)
T ss_pred cccc--cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCc
Confidence 3321 12334568999999999853 3467899999999999999999999975432211111111111122335
Q ss_pred CcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCC
Q 009364 297 ENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDD 334 (536)
Q Consensus 297 ~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~ 334 (536)
..++.++.++|.+||+.+|.+||++.++++||||....
T Consensus 232 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (280)
T cd06611 232 SKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQS 269 (280)
T ss_pred ccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcccc
Confidence 57889999999999999999999999999999998653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=353.04 Aligned_cols=259 Identities=40% Similarity=0.628 Sum_probs=213.3
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCce
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESL 146 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 146 (536)
-|++.+.||+|+||.||+|.+..++..+++|.+.. ......+.+.+|+.+++.++||||+++++.+......
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~--------~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~ 77 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDT--------KSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNL 77 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCC--------CCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEE
Confidence 47888999999999999999999999999998732 1123355678899999999999999999999999999
Q ss_pred eEEEEecCCCCccccccc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhh
Q 009364 147 NILLEFVPGGSISSLLGK-FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA 225 (536)
Q Consensus 147 ~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 225 (536)
++|+||+++++|..++.+ ..++++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++.......
T Consensus 78 ~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~ 157 (282)
T cd06643 78 WILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 157 (282)
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccc
Confidence 999999999999887754 4679999999999999999999999999999999999999999999999999987653221
Q ss_pred cccCCcccCCCCCCCChhhhh-----hcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCc
Q 009364 226 TVSGAKSMKGTPYWMAPEVIR-----QTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLS 300 (536)
Q Consensus 226 ~~~~~~~~~Gt~~Y~APEvl~-----~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s 300 (536)
.......|++.|+|||++. +..++.++|||||||++|+|++|.+||......................+..++
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
T cd06643 158 --QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWS 235 (282)
T ss_pred --cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccC
Confidence 1233457899999999984 345778999999999999999999999754322111111111122233455788
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCCC
Q 009364 301 VKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDE 335 (536)
Q Consensus 301 ~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~~ 335 (536)
.++++||.+||..||.+||++.++++||||.....
T Consensus 236 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 270 (282)
T cd06643 236 SEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSN 270 (282)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCCCEeccCC
Confidence 99999999999999999999999999999986543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=371.26 Aligned_cols=255 Identities=24% Similarity=0.389 Sum_probs=207.4
Q ss_pred CCceeeeEEcccCceEEEEEEEc--CCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNL--DSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE 143 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~--~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 143 (536)
.+|++.+.||+|+||.||+|... .++..||+|.+.. . ....+|+.+|+.++||||+++++++...
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~-------~------~~~~~E~~il~~l~h~~iv~~~~~~~~~ 158 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTG-------G------KTPGREIDILKTISHRAIINLIHAYRWK 158 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccc-------c------ccHHHHHHHHHhcCCCCccceeeeEeeC
Confidence 47999999999999999999764 3567899997731 1 1245799999999999999999999999
Q ss_pred CceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhh
Q 009364 144 ESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAE 223 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 223 (536)
...++|||++. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 159 ~~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 159 STVCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred CEEEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 99999999995 68888887778899999999999999999999999999999999999999999999999999976654
Q ss_pred hhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhh-----HHHHHHHhh------------
Q 009364 224 LATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQY-----QEVAALFHI------------ 286 (536)
Q Consensus 224 ~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~-----~~~~~~~~~------------ 286 (536)
...........||+.|+|||++.+..++.++|||||||++|+|++|..||.... .....+...
T Consensus 238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~ 317 (392)
T PHA03207 238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG 317 (392)
T ss_pred ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence 322222345679999999999999899999999999999999999999995421 111111110
Q ss_pred ----------CCCCCCC--CCC-----CcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCC
Q 009364 287 ----------GTTKSHP--PIP-----ENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDD 334 (536)
Q Consensus 287 ----------~~~~~~~--~~~-----~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~ 334 (536)
......+ ..+ ...+.++++||++||..||++|||+.++|.||||...+
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~ 382 (392)
T PHA03207 318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEP 382 (392)
T ss_pred chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccc
Confidence 0000000 111 24567889999999999999999999999999998644
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=367.38 Aligned_cols=257 Identities=27% Similarity=0.467 Sum_probs=206.3
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE 143 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 143 (536)
.+.+|++.+.||+|+||+||+|.+..+++.||+|++... .........+.+|+.+|+.++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 86 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRP------FQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPA 86 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCch------hhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccc
Confidence 356899999999999999999999999999999987321 11122345577899999999999999999987543
Q ss_pred ------CceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCc
Q 009364 144 ------ESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGA 217 (536)
Q Consensus 144 ------~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGl 217 (536)
..++++++++ +++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 87 ~~~~~~~~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 87 TSIENFNEVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred ccccccCcEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCcc
Confidence 3578999988 7888877754 5799999999999999999999999999999999999999999999999999
Q ss_pred chhhhhhhcccCCcccCCCCCCCChhhhhh-cCCCccceEechhHHHHHHhhCCCCCchhhH--HHHHHHhhCCC-----
Q 009364 218 SKQVAELATVSGAKSMKGTPYWMAPEVIRQ-TGHSYSADIWSVGCTVIEMATGKPPWSQQYQ--EVAALFHIGTT----- 289 (536)
Q Consensus 218 a~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~-~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~--~~~~~~~~~~~----- 289 (536)
++.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||..... ....+......
T Consensus 165 ~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (343)
T cd07878 165 ARQADD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEV 239 (343)
T ss_pred ceecCC-----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 876543 2345679999999999876 5689999999999999999999999964321 11111100000
Q ss_pred -------------CCCC--------CCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 290 -------------KSHP--------PIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 290 -------------~~~~--------~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
...+ ......++.+.+||.+||..||.+|||+.|+|+||||...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~ 304 (343)
T cd07878 240 LKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304 (343)
T ss_pred HHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence 0000 0112467788999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=348.93 Aligned_cols=263 Identities=49% Similarity=0.883 Sum_probs=215.4
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccch--hHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCC
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASK--EKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEE 144 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~--~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 144 (536)
+|.+.+.||.|+||.||+|.+..+|+.+|+|.+......... .......+.+.+|+.+++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 689999999999999999999999999999987432221111 122334567889999999999999999999999999
Q ss_pred ceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhh
Q 009364 145 SLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAEL 224 (536)
Q Consensus 145 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 224 (536)
.+++||||+++++|.+++.+.+.+++..+..++.||+.||.|||++|++||||+|+||+++.++.++|+|||+++.....
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 99999999999999999988888999999999999999999999999999999999999999999999999998765432
Q ss_pred hcccCCcccCCCCCCCChhhhhhcC--CCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCC----CCCCCCc
Q 009364 225 ATVSGAKSMKGTPYWMAPEVIRQTG--HSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKS----HPPIPEN 298 (536)
Q Consensus 225 ~~~~~~~~~~Gt~~Y~APEvl~~~~--~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~----~~~~~~~ 298 (536)
..........|+..|+|||++.+.. ++.++|+||||+++|+|++|..||...... ........... .......
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 240 (272)
T cd06629 162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI-AAMFKLGNKRSAPPIPPDVSMN 240 (272)
T ss_pred ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH-HHHHHhhccccCCcCCcccccc
Confidence 2222233456899999999987654 789999999999999999999999643221 11111111111 1123345
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHhCCCC
Q 009364 299 LSVKAKDFLLKCLEKEPDLRPTASELLKHPFV 330 (536)
Q Consensus 299 ~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~ 330 (536)
++..++++|.+||.++|.+|||+.++++||||
T Consensus 241 ~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 241 LSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred CCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 78999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=356.25 Aligned_cols=260 Identities=33% Similarity=0.598 Sum_probs=216.7
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE 142 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 142 (536)
.+..+|++.+.||+|+||.||+|.+..+++.||+|.+.... ......+.+|+.+++.+.|+||+++++.+..
T Consensus 17 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~--------~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~ 88 (296)
T cd06654 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--------QPKKELIINEILVMRENKNPNIVNYLDSYLV 88 (296)
T ss_pred CcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCC--------cchHHHHHHHHHHHHhCCCCCEeeEEEEEEe
Confidence 34568999999999999999999999999999999874211 1123557789999999999999999999999
Q ss_pred CCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhh
Q 009364 143 EESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVA 222 (536)
Q Consensus 143 ~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~ 222 (536)
....++||||+++++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++....
T Consensus 89 ~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~ 167 (296)
T cd06654 89 GDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (296)
T ss_pred CCEEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcc
Confidence 9999999999999999998865 568999999999999999999999999999999999999999999999999987654
Q ss_pred hhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcHH
Q 009364 223 ELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVK 302 (536)
Q Consensus 223 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 302 (536)
... .......|++.|+|||.+.+..++.++|||||||++|+|++|++||......................+..++..
T Consensus 168 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (296)
T cd06654 168 PEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI 245 (296)
T ss_pred ccc--cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHH
Confidence 321 112345789999999999988899999999999999999999999975433221111111111222335578899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 303 AKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 303 ~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
+.+||.+||..+|++||++.++++||||...
T Consensus 246 l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 246 FRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred HHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 9999999999999999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=351.81 Aligned_cols=255 Identities=38% Similarity=0.654 Sum_probs=210.7
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEE 144 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 144 (536)
..+|++.+.||+|+||.||+|.+..+++.||+|++... .......+.+|+.+++.++||||+++++.+...+
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~--------~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~ 79 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLE--------PGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRD 79 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecC--------chhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Confidence 35899999999999999999999999999999987421 1122345678999999999999999999999999
Q ss_pred ceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhh
Q 009364 145 SLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAEL 224 (536)
Q Consensus 145 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 224 (536)
.+++||||+++++|.+++...+.+++..++.++.|++.||.|||++|++|+||||+||+++.++.+||+|||++......
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06645 80 KLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT 159 (267)
T ss_pred EEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc
Confidence 99999999999999999988889999999999999999999999999999999999999999999999999998765432
Q ss_pred hcccCCcccCCCCCCCChhhhh---hcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCC--CCcC
Q 009364 225 ATVSGAKSMKGTPYWMAPEVIR---QTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPI--PENL 299 (536)
Q Consensus 225 ~~~~~~~~~~Gt~~Y~APEvl~---~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~ 299 (536)
........|++.|+|||++. ...++.++|+|||||++|+|++|.+||...................+.. ...+
T Consensus 160 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd06645 160 --IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKW 237 (267)
T ss_pred --ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCC
Confidence 12234567999999999984 4567899999999999999999999986433211111111111111111 1256
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHhCCC
Q 009364 300 SVKAKDFLLKCLEKEPDLRPTASELLKHPF 329 (536)
Q Consensus 300 s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~ 329 (536)
+..+.++|.+||..+|++||++.++++|||
T Consensus 238 ~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 238 SNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred CHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 788999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=367.65 Aligned_cols=256 Identities=27% Similarity=0.392 Sum_probs=203.7
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC-
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE- 143 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~- 143 (536)
..+|++.+.||+|+||.||+|.+..+++.||+|.+... .........+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 89 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP------FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK 89 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCc------ccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccc
Confidence 45899999999999999999999999999999987321 11223345677899999999999999999988643
Q ss_pred -----CceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcc
Q 009364 144 -----ESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGAS 218 (536)
Q Consensus 144 -----~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla 218 (536)
...++||||+.+ +|.+.+. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 90 ~~~~~~~~~lv~e~~~~-~l~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~ 166 (355)
T cd07874 90 SLEEFQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_pred cccccceeEEEhhhhcc-cHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCccc
Confidence 357999999965 5555553 35889999999999999999999999999999999999999999999999999
Q ss_pred hhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH--HHHHHhh----------
Q 009364 219 KQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE--VAALFHI---------- 286 (536)
Q Consensus 219 ~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~--~~~~~~~---------- 286 (536)
+..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .......
T Consensus 167 ~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (355)
T cd07874 167 RTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243 (355)
T ss_pred ccCCCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 765432 1234567999999999999989999999999999999999999999643211 0000000
Q ss_pred ----------CCC-----------------CCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcC
Q 009364 287 ----------GTT-----------------KSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTG 332 (536)
Q Consensus 287 ----------~~~-----------------~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~ 332 (536)
... ......+...+.++++||.+||+.||++|||+.|+|+||||..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~ 316 (355)
T cd07874 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINV 316 (355)
T ss_pred hhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhc
Confidence 000 0000112234678899999999999999999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=352.39 Aligned_cols=255 Identities=32% Similarity=0.561 Sum_probs=219.9
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
.+|++.+.||+|+||.||+|.+..+++.||+|++.... .........+.+|++++++++||||+++++++.....
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 75 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAK-----IVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSN 75 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHH-----hhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCe
Confidence 36899999999999999999999999999999874211 1122345678899999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhh
Q 009364 146 LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA 225 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 225 (536)
+++||||+++++|.+++...+.+++..+..++.||+.||.|||++|++||||+|.||+++.++.+||+|||++......
T Consensus 76 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 76 LYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 9999999999999999988889999999999999999999999999999999999999999999999999998765432
Q ss_pred cccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHH-HHHHhhCCCCCCCCCCCcCcHHHH
Q 009364 226 TVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEV-AALFHIGTTKSHPPIPENLSVKAK 304 (536)
Q Consensus 226 ~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~s~~~~ 304 (536)
....+|++.|+|||.+.+..++.++||||||+++|+|++|..||....... ..... .....++..++..++
T Consensus 155 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~----~~~~~~~~~~~~~l~ 226 (290)
T cd05580 155 ----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL----EGKVRFPSFFSPDAK 226 (290)
T ss_pred ----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh----cCCccCCccCCHHHH
Confidence 335579999999999988888999999999999999999999996544221 11111 223456667899999
Q ss_pred HHHHHhcccCCCCCC-----CHHHHHhCCCCcCCC
Q 009364 305 DFLLKCLEKEPDLRP-----TASELLKHPFVTGDD 334 (536)
Q Consensus 305 dLi~~cL~~dP~~Rp-----s~~eiL~hp~~~~~~ 334 (536)
++|.+||..||.+|+ +++++++||||....
T Consensus 227 ~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 261 (290)
T cd05580 227 DLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGID 261 (290)
T ss_pred HHHHHHccCCHHHccCcccCCHHHHHcCcccccCC
Confidence 999999999999999 999999999997644
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-46 Score=355.61 Aligned_cols=257 Identities=35% Similarity=0.619 Sum_probs=224.0
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
.-|.++.+||+|+||.||+|.++.+|..+|||.+.+. ....++..|+.+|++++.|++|++||.|.....
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----------sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sD 102 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----------TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSD 102 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc----------chHHHHHHHHHHHHHcCCchhhhhhhhhccCCc
Confidence 4588999999999999999999999999999988432 335678899999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccc-cCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhh
Q 009364 146 LNILLEFVPGGSISSLLG-KFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAEL 224 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~-~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 224 (536)
+++|||||..|++.+.++ +++++++.++..+++..+.||+|||...-||||||..|||++.+|..||+|||.|-++...
T Consensus 103 LWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT 182 (502)
T KOG0574|consen 103 LWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT 182 (502)
T ss_pred eEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhh
Confidence 999999999999999986 4578999999999999999999999999999999999999999999999999999887653
Q ss_pred hcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhC-CCCCCCCCCCcCcHHH
Q 009364 225 ATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIG-TTKSHPPIPENLSVKA 303 (536)
Q Consensus 225 ~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~ 303 (536)
. ....+..|||.|||||++..-+|+.++||||||+...||..|++||.+...-.. ++.+. .......-|...|.++
T Consensus 183 M--AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA-IFMIPT~PPPTF~KPE~WS~~F 259 (502)
T KOG0574|consen 183 M--AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA-IFMIPTKPPPTFKKPEEWSSEF 259 (502)
T ss_pred H--HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce-eEeccCCCCCCCCChHhhhhHH
Confidence 3 335678999999999999999999999999999999999999999977543322 22221 1222223456789999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHhCCCCcCCCC
Q 009364 304 KDFLLKCLEKEPDLRPTASELLKHPFVTGDDE 335 (536)
Q Consensus 304 ~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~~ 335 (536)
.|+|++||.++|++|-|+.++++|||+.+...
T Consensus 260 ~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g 291 (502)
T KOG0574|consen 260 NDFIRSCLIKKPEERKTALRLCEHTFIKNAPG 291 (502)
T ss_pred HHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCc
Confidence 99999999999999999999999999987643
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-43 Score=343.94 Aligned_cols=254 Identities=29% Similarity=0.524 Sum_probs=215.0
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCce
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESL 146 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 146 (536)
.|.+.+.||+|++|.||+|.+..+|+.|++|.+.... ........+.+|+.+++.++||||+++++.+...+..
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 74 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSK------MNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKL 74 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhh------CCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEE
Confidence 4788899999999999999999999999999874211 1123456688899999999999999999999999999
Q ss_pred eEEEEecCCCCcccccccC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhh
Q 009364 147 NILLEFVPGGSISSLLGKF--GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAEL 224 (536)
Q Consensus 147 ~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 224 (536)
++||||++|++|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||+++.....
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~ 154 (256)
T cd08529 75 NIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN 154 (256)
T ss_pred EEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence 9999999999999998664 57899999999999999999999999999999999999999999999999998765532
Q ss_pred hcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcHHHH
Q 009364 225 ATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAK 304 (536)
Q Consensus 225 ~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 304 (536)
.. ......|++.|+|||++.+..++.++|+|||||++|+|++|..||.......... .......+.++..++..+.
T Consensus 155 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 230 (256)
T cd08529 155 TN--FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALIL--KIIRGVFPPVSQMYSQQLA 230 (256)
T ss_pred cc--hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHcCCCCCCccccCHHHH
Confidence 21 1234578999999999999889999999999999999999999997554322111 1111223445557889999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhCCCC
Q 009364 305 DFLLKCLEKEPDLRPTASELLKHPFV 330 (536)
Q Consensus 305 dLi~~cL~~dP~~Rps~~eiL~hp~~ 330 (536)
++|.+||+.+|++||++.++++|||+
T Consensus 231 ~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 231 QLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HHHHHHccCCcccCcCHHHHhhCCCC
Confidence 99999999999999999999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=357.10 Aligned_cols=256 Identities=34% Similarity=0.570 Sum_probs=213.0
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCce
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESL 146 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 146 (536)
+|++.+.||+|+||.||+|.+..+|..+|+|.+... ........+.+|++++++++||||+++++.+..++.+
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 74 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLE-------IKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEI 74 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccc-------cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEE
Confidence 689999999999999999999999999999987321 1123345678899999999999999999999999999
Q ss_pred eEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHH-cCCccccCCCCCcccCCCCcEEEEecCcchhhhhhh
Q 009364 147 NILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHN-HGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA 225 (536)
Q Consensus 147 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~-~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 225 (536)
++||||++|++|.+++.+.+.+++..+..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++......
T Consensus 75 ~lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 153 (308)
T cd06615 75 SICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 153 (308)
T ss_pred EEEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence 9999999999999999888889999999999999999999998 59999999999999999999999999998755322
Q ss_pred cccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHH-HHHHhhCCC---------------
Q 009364 226 TVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEV-AALFHIGTT--------------- 289 (536)
Q Consensus 226 ~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~-~~~~~~~~~--------------- 289 (536)
.....+|++.|+|||++.+..++.++|+|||||++|+|++|..||....... .........
T Consensus 154 ---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
T cd06615 154 ---MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHP 230 (308)
T ss_pred ---ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCC
Confidence 1345678999999999988889999999999999999999999996432111 111110000
Q ss_pred ------------------CCCCCCC-CcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 290 ------------------KSHPPIP-ENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 290 ------------------~~~~~~~-~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
...+..+ ..++.++++||.+||..+|++|||+.++++||||...
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred CCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 0011111 1367889999999999999999999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=366.62 Aligned_cols=256 Identities=27% Similarity=0.384 Sum_probs=203.4
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC-
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE- 143 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~- 143 (536)
..+|++.+.||+|+||.||+|.+..+++.||||++... .........+.+|+.+++.++||||+++++++...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~ 96 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP------FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQK 96 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcc------ccCchhHHHHHHHHHHHHhcCCCCccccceeecccc
Confidence 46899999999999999999999999999999987321 11123345677899999999999999999987643
Q ss_pred -----CceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcc
Q 009364 144 -----ESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGAS 218 (536)
Q Consensus 144 -----~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla 218 (536)
..+|+||||+.+ +|...+. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 97 ~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 97 SLEEFQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred cccccCeEEEEEeCCCC-CHHHHHH--hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 357999999965 5666554 34788999999999999999999999999999999999999999999999999
Q ss_pred hhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH--HHHHHhhC---------
Q 009364 219 KQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE--VAALFHIG--------- 287 (536)
Q Consensus 219 ~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~--~~~~~~~~--------- 287 (536)
+..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ...+....
T Consensus 174 ~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (364)
T cd07875 174 RTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 250 (364)
T ss_pred cccCCC---CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 765431 1234567999999999999999999999999999999999999999643211 11110000
Q ss_pred -----------CCC-----------------CCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcC
Q 009364 288 -----------TTK-----------------SHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTG 332 (536)
Q Consensus 288 -----------~~~-----------------~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~ 332 (536)
... .........+..+++||.+||+.||.+|||+.|+|+||||..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred hhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 000 000111224568899999999999999999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=374.44 Aligned_cols=254 Identities=25% Similarity=0.354 Sum_probs=204.4
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE 143 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 143 (536)
...+|.+.+.||+|+||.||+|.+..+++.||||... ...+.+|+.+|++++|+||+++++++...
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~--------------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~ 232 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW--------------YASSVHEARLLRRLSHPAVLALLDVRVVG 232 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc--------------ccCHHHHHHHHHHCCCCCCCcEEEEEEEC
Confidence 4568999999999999999999999999999999641 12245799999999999999999999999
Q ss_pred CceeEEEEecCCCCccccccc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhh
Q 009364 144 ESLNILLEFVPGGSISSLLGK-FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVA 222 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~ 222 (536)
+..++|||++. ++|..++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus 233 ~~~~lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~ 311 (461)
T PHA03211 233 GLTCLVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFAR 311 (461)
T ss_pred CEEEEEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecc
Confidence 99999999995 677777654 3579999999999999999999999999999999999999999999999999997654
Q ss_pred hhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchh---------hHHHHHHHhhCCCC--C
Q 009364 223 ELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQ---------YQEVAALFHIGTTK--S 291 (536)
Q Consensus 223 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~---------~~~~~~~~~~~~~~--~ 291 (536)
...........+||+.|+|||++.+..++.++|||||||++|||++|..|+... ...+..++...... .
T Consensus 312 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~ 391 (461)
T PHA03211 312 GSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDE 391 (461)
T ss_pred cccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccccc
Confidence 322211223567999999999999999999999999999999999987654211 11122221111100 0
Q ss_pred ---------------------C-----CCCC--CcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcC
Q 009364 292 ---------------------H-----PPIP--ENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTG 332 (536)
Q Consensus 292 ---------------------~-----~~~~--~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~ 332 (536)
. ..+. ..++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 392 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 392 FPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred CCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 0 0010 135668999999999999999999999999999964
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-43 Score=351.48 Aligned_cols=261 Identities=26% Similarity=0.416 Sum_probs=215.3
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCce
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESL 146 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 146 (536)
.|+..+.||+|+||+||+|.+..+|+.||+|.+.... .........+.+|+.+|+.++|+||+.+++.+...+..
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~ 75 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKR-----IKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhh-----hhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEE
Confidence 3788899999999999999999999999999873211 11112234567899999999999999999999999999
Q ss_pred eEEEEecCCCCcccccccC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhh
Q 009364 147 NILLEFVPGGSISSLLGKF--GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAEL 224 (536)
Q Consensus 147 ~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 224 (536)
++||||+.+++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05632 76 CLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG 155 (285)
T ss_pred EEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence 9999999999998887543 46999999999999999999999999999999999999999999999999998654321
Q ss_pred hcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHH-HHHHhhCCCCCCCCCCCcCcHHH
Q 009364 225 ATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEV-AALFHIGTTKSHPPIPENLSVKA 303 (536)
Q Consensus 225 ~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~s~~~ 303 (536)
.......|++.|+|||++.+..++.++|+|||||++|+|++|..||....... ..............++..++.++
T Consensus 156 ---~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
T cd05632 156 ---ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEA 232 (285)
T ss_pred ---CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHH
Confidence 11234579999999999998899999999999999999999999997543221 11111111222334556789999
Q ss_pred HHHHHHhcccCCCCCCC-----HHHHHhCCCCcCCCC
Q 009364 304 KDFLLKCLEKEPDLRPT-----ASELLKHPFVTGDDE 335 (536)
Q Consensus 304 ~dLi~~cL~~dP~~Rps-----~~eiL~hp~~~~~~~ 335 (536)
.+|+.+||+.||.+||+ +.++++|+||+....
T Consensus 233 ~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~ 269 (285)
T cd05632 233 KSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNF 269 (285)
T ss_pred HHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCH
Confidence 99999999999999999 899999999986543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=350.95 Aligned_cols=253 Identities=31% Similarity=0.539 Sum_probs=209.2
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCce
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESL 146 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 146 (536)
+|++.+.||+|+||.||+|.+..+++.||+|.+... ........+.+|++++++++||||+++++.+...+..
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 74 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLD-------ITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRI 74 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecC-------CChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEE
Confidence 578889999999999999999999999999987421 1122345688899999999999999999999999999
Q ss_pred eEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhc
Q 009364 147 NILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELAT 226 (536)
Q Consensus 147 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 226 (536)
++||||+++++|..+ ..+++..+..++.|++.||.|||+.||+|+||||+|||++.++.+||+|||++..+...
T Consensus 75 ~lv~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-- 148 (279)
T cd06619 75 SICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-- 148 (279)
T ss_pred EEEEecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence 999999999998654 45789999999999999999999999999999999999999999999999998765432
Q ss_pred ccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH-----HHHHHhhCCCCCCCC-CCCcCc
Q 009364 227 VSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE-----VAALFHIGTTKSHPP-IPENLS 300 (536)
Q Consensus 227 ~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~-----~~~~~~~~~~~~~~~-~~~~~s 300 (536)
.....+||+.|+|||++.+..++.++|+|||||++|+|++|..||...... .............+. .....+
T Consensus 149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (279)
T cd06619 149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFS 226 (279)
T ss_pred --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCC
Confidence 234567999999999999888999999999999999999999999642211 001111111111111 123578
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCC
Q 009364 301 VKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDD 334 (536)
Q Consensus 301 ~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~ 334 (536)
++++++|.+||+.+|.+||++.++++||||+...
T Consensus 227 ~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~ 260 (279)
T cd06619 227 EKFVHFITQCMRKQPKERPAPENLMDHPFIVQYN 260 (279)
T ss_pred HHHHHHHHHHhhCChhhCCCHHHHhcCccccccc
Confidence 8999999999999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=344.24 Aligned_cols=254 Identities=38% Similarity=0.663 Sum_probs=214.8
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEE 144 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 144 (536)
.++|++.+.||.|+||.||+|.+..++..+++|.+... . ....+.+|+.+++.++||||+++++.+....
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~-------~---~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~ 71 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE-------E---DLQEIIKEISILKQCDSPYIVKYYGSYFKNT 71 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecH-------H---HHHHHHHHHHHHHhCCCCcEeeeeeeeecCC
Confidence 46899999999999999999999988999999987321 1 1567889999999999999999999999999
Q ss_pred ceeEEEEecCCCCccccccc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhh
Q 009364 145 SLNILLEFVPGGSISSLLGK-FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAE 223 (536)
Q Consensus 145 ~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 223 (536)
.+++++||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++.....
T Consensus 72 ~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~ 151 (256)
T cd06612 72 DLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD 151 (256)
T ss_pred cEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhccc
Confidence 99999999999999999864 45789999999999999999999999999999999999999999999999999887654
Q ss_pred hhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcHHH
Q 009364 224 LATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKA 303 (536)
Q Consensus 224 ~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 303 (536)
... ......|+..|+|||++.+..++.++|||||||++|+|++|++||......................+..++.++
T Consensus 152 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (256)
T cd06612 152 TMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEF 229 (256)
T ss_pred Ccc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHH
Confidence 221 223455899999999999989999999999999999999999999754332221111111122222345678899
Q ss_pred HHHHHHhcccCCCCCCCHHHHHhCCCC
Q 009364 304 KDFLLKCLEKEPDLRPTASELLKHPFV 330 (536)
Q Consensus 304 ~dLi~~cL~~dP~~Rps~~eiL~hp~~ 330 (536)
.++|.+||+.||.+|||+.++++||||
T Consensus 230 ~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 230 NDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=350.26 Aligned_cols=256 Identities=35% Similarity=0.652 Sum_probs=209.4
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeEeeeee
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRYLGTVR 141 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~ 141 (536)
.+..+|++.+.||+|+||.||+|.+..+++.||+|++.... .....+..|+.+++.+ +|+||+++++++.
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---------~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 73 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---------DEEEEIKQEINMLKKYSHHRNIATYYGAFI 73 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---------ccHHHHHHHHHHHHHhcCCCCeeeEeeEEe
Confidence 35568999999999999999999999999999999874211 1124567889999988 6999999999987
Q ss_pred cC------CceeEEEEecCCCCcccccccC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEE
Q 009364 142 EE------ESLNILLEFVPGGSISSLLGKF--GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLA 213 (536)
Q Consensus 142 ~~------~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~ 213 (536)
.. ..+++||||+.+++|.+++... ..+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+
T Consensus 74 ~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~ 153 (272)
T cd06637 74 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLV 153 (272)
T ss_pred ecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEc
Confidence 53 4589999999999999988753 468999999999999999999999999999999999999999999999
Q ss_pred ecCcchhhhhhhcccCCcccCCCCCCCChhhhh-----hcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCC
Q 009364 214 DFGASKQVAELATVSGAKSMKGTPYWMAPEVIR-----QTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGT 288 (536)
Q Consensus 214 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~-----~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~ 288 (536)
|||++....... .......|++.|+|||++. +..++.++||||+||++|+|++|..||........... ...
T Consensus 154 Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~-~~~ 230 (272)
T cd06637 154 DFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL-IPR 230 (272)
T ss_pred cCCCceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH-Hhc
Confidence 999987654321 2234567999999999986 34578899999999999999999999965432222211 111
Q ss_pred CCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCC
Q 009364 289 TKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFV 330 (536)
Q Consensus 289 ~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~ 330 (536)
.......+..++.++++||.+||..+|.+|||+.++++||||
T Consensus 231 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 231 NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 122222334678899999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=360.91 Aligned_cols=249 Identities=24% Similarity=0.425 Sum_probs=190.6
Q ss_pred eeEEcccCceEEEEEEEc--CCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec--CCce
Q 009364 71 GELIGCGAFGRVYMGMNL--DSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE--EESL 146 (536)
Q Consensus 71 ~~~LG~G~fg~Vy~a~~~--~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--~~~~ 146 (536)
++.||+|+||+||+|.++ .+++.||+|.+... . ....+.+|+.+|+.++||||+++++++.. ...+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~------~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 75 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT------G----ISMSACREIALLRELKHPNVISLQKVFLSHADRKV 75 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCC------C----CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEE
Confidence 567999999999999975 46789999987311 0 11235689999999999999999998854 4568
Q ss_pred eEEEEecCCCCccccccc---------CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCccc----CCCCcEEEE
Q 009364 147 NILLEFVPGGSISSLLGK---------FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILV----DNKGCIKLA 213 (536)
Q Consensus 147 ~lV~E~~~gg~L~~~l~~---------~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl----~~~~~vkL~ 213 (536)
++||||+. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 76 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~ 154 (317)
T cd07868 76 WLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA 154 (317)
T ss_pred EEEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEe
Confidence 99999995 577666532 2358999999999999999999999999999999999999 456789999
Q ss_pred ecCcchhhhhhhc-ccCCcccCCCCCCCChhhhhh-cCCCccceEechhHHHHHHhhCCCCCchhhH-----------HH
Q 009364 214 DFGASKQVAELAT-VSGAKSMKGTPYWMAPEVIRQ-TGHSYSADIWSVGCTVIEMATGKPPWSQQYQ-----------EV 280 (536)
Q Consensus 214 DFGla~~~~~~~~-~~~~~~~~Gt~~Y~APEvl~~-~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~-----------~~ 280 (536)
|||+++.+..... ........||+.|+|||++.+ ..++.++||||+||++|+|++|.+||..... ..
T Consensus 155 DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~ 234 (317)
T cd07868 155 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 234 (317)
T ss_pred ecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHH
Confidence 9999986643211 122345678999999999976 4589999999999999999999999953211 01
Q ss_pred HHHHhhCCCC------------C--------------C-------CCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 281 AALFHIGTTK------------S--------------H-------PPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 281 ~~~~~~~~~~------------~--------------~-------~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
..+....... . . .......+.++.+||.+||+.||.+|||++|+|+|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~h 314 (317)
T cd07868 235 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 314 (317)
T ss_pred HHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1111100000 0 0 00011235678999999999999999999999999
Q ss_pred CCC
Q 009364 328 PFV 330 (536)
Q Consensus 328 p~~ 330 (536)
|||
T Consensus 315 p~f 317 (317)
T cd07868 315 PYF 317 (317)
T ss_pred CCC
Confidence 998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=342.93 Aligned_cols=253 Identities=28% Similarity=0.547 Sum_probs=211.5
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec-CCc
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE-EES 145 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~-~~~ 145 (536)
+|++.+.||+|++|.||++.+..+++.||+|.+... .......+.+.+|+++++.++|+|++++++.+.. ...
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~------~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLR------NASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGL 74 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehh------hcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCE
Confidence 489999999999999999999999999999987321 1122334567889999999999999999998764 446
Q ss_pred eeEEEEecCCCCccccccc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhh
Q 009364 146 LNILLEFVPGGSISSLLGK--FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAE 223 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~--~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 223 (536)
+++||||+++++|.+++.. ...+++.+++.++.|++.||.+||++|++||||||+||+++.++.++|+|||++.....
T Consensus 75 ~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~ 154 (257)
T cd08223 75 LYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN 154 (257)
T ss_pred EEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecc
Confidence 8899999999999998865 34689999999999999999999999999999999999999999999999999876543
Q ss_pred hhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHH-HHHHhhCCCCCCCCCCCcCcHH
Q 009364 224 LATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEV-AALFHIGTTKSHPPIPENLSVK 302 (536)
Q Consensus 224 ~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~s~~ 302 (536)
.. .......|++.|+|||++.+..++.++|||||||++|+|++|..||....... ...... ...+..+..++.+
T Consensus 155 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 229 (257)
T cd08223 155 QC--DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIE---GKLPPMPKDYSPE 229 (257)
T ss_pred cC--CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh---cCCCCCccccCHH
Confidence 21 22345678999999999999889999999999999999999999996543221 111111 1223455678999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHhCCCC
Q 009364 303 AKDFLLKCLEKEPDLRPTASELLKHPFV 330 (536)
Q Consensus 303 ~~dLi~~cL~~dP~~Rps~~eiL~hp~~ 330 (536)
+.++|.+||+.+|.+||++.++++||||
T Consensus 230 ~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 230 LGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=354.39 Aligned_cols=260 Identities=34% Similarity=0.614 Sum_probs=217.3
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE 143 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 143 (536)
+..+|++.+.||.|+||.||+|.+..+|+.||+|.+... .....+.+.+|+.+++.++||||+++++++...
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~--------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 88 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQ--------KQPKKELIINEILVMKELKNPNIVNFLDSFLVG 88 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecc--------cCchHHHHHHHHHHHHhcCCCceeeeeeeEecC
Confidence 335799999999999999999999999999999988421 112235677899999999999999999999999
Q ss_pred CceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhh
Q 009364 144 ESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAE 223 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 223 (536)
..+++|+||+++++|..++.. ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 89 ~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~ 167 (296)
T cd06655 89 DELFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP 167 (296)
T ss_pred ceEEEEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence 999999999999999998865 4689999999999999999999999999999999999999999999999999876543
Q ss_pred hhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcHHH
Q 009364 224 LATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKA 303 (536)
Q Consensus 224 ~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 303 (536)
... ......|++.|+|||.+.+..++.++|||||||++|+|++|..||......................+..++..+
T Consensus 168 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (296)
T cd06655 168 EQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIF 245 (296)
T ss_pred ccc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHH
Confidence 221 123457899999999999888999999999999999999999999754322111111111122223455788999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHhCCCCcCCC
Q 009364 304 KDFLLKCLEKEPDLRPTASELLKHPFVTGDD 334 (536)
Q Consensus 304 ~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~ 334 (536)
++||++||..||.+||++.++++||||+...
T Consensus 246 ~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 246 RDFLNRCLEMDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred HHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence 9999999999999999999999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=349.51 Aligned_cols=256 Identities=38% Similarity=0.629 Sum_probs=210.8
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE 142 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 142 (536)
.+..+|++.+.||+|+||.||+|.+..+|+.||+|++... .......+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~--------~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~ 77 (267)
T cd06646 6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLE--------PGDDFSLIQQEIFMVKECKHCNIVAYFGSYLS 77 (267)
T ss_pred CchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecC--------ccchHHHHHHHHHHHHhcCCCCeeeeeEEEEe
Confidence 3445799999999999999999999999999999988421 11223457789999999999999999999999
Q ss_pred CCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhh
Q 009364 143 EESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVA 222 (536)
Q Consensus 143 ~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~ 222 (536)
.+.+++||||+++++|.+++...+++++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++..+.
T Consensus 78 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06646 78 REKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKIT 157 (267)
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeec
Confidence 99999999999999999999877889999999999999999999999999999999999999999999999999987654
Q ss_pred hhhcccCCcccCCCCCCCChhhhh---hcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCC---CCCC
Q 009364 223 ELATVSGAKSMKGTPYWMAPEVIR---QTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSH---PPIP 296 (536)
Q Consensus 223 ~~~~~~~~~~~~Gt~~Y~APEvl~---~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~---~~~~ 296 (536)
... .......|++.|+|||++. ...++.++||||+||++|+|++|.+||........ .......... ....
T Consensus 158 ~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~ 234 (267)
T cd06646 158 ATI--AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFLMSKSNFQPPKLKDK 234 (267)
T ss_pred ccc--cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh-heeeecCCCCCCCCccc
Confidence 321 1233457899999999984 34578899999999999999999999954322111 1111111111 1122
Q ss_pred CcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCC
Q 009364 297 ENLSVKAKDFLLKCLEKEPDLRPTASELLKHPF 329 (536)
Q Consensus 297 ~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~ 329 (536)
..++..+.+||++||..+|++|||++++++|+|
T Consensus 235 ~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 235 TKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred cccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 357889999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=356.47 Aligned_cols=261 Identities=29% Similarity=0.462 Sum_probs=208.9
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
.+|++.+.||.|+||.||+|.+..+++.||+|.+..... ......+.+|+.+++.++||||+++++++...+.
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~ 78 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE-------EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKS 78 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc-------cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCe
Confidence 579999999999999999999999999999998843211 1112345679999999999999999999999999
Q ss_pred eeEEEEecCCCCccccccc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhh
Q 009364 146 LNILLEFVPGGSISSLLGK-FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAEL 224 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 224 (536)
.++||||+. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 79 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 157 (301)
T cd07873 79 LTLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIP 157 (301)
T ss_pred EEEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence 999999996 578777654 356899999999999999999999999999999999999999999999999998754321
Q ss_pred hcccCCcccCCCCCCCChhhhhhc-CCCccceEechhHHHHHHhhCCCCCchhhHH--HHHHHhhCCC------------
Q 009364 225 ATVSGAKSMKGTPYWMAPEVIRQT-GHSYSADIWSVGCTVIEMATGKPPWSQQYQE--VAALFHIGTT------------ 289 (536)
Q Consensus 225 ~~~~~~~~~~Gt~~Y~APEvl~~~-~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~--~~~~~~~~~~------------ 289 (536)
. .......+++.|+|||++.+. .++.++|||||||++|+|++|++||...... ..........
T Consensus 158 ~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (301)
T cd07873 158 T--KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 235 (301)
T ss_pred C--CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcc
Confidence 1 112344678999999998754 5788999999999999999999999654321 1111100000
Q ss_pred -----CCCC--------CCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCCCC
Q 009364 290 -----KSHP--------PIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDED 336 (536)
Q Consensus 290 -----~~~~--------~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~~~ 336 (536)
...+ .....++.++++||.+||+.||.+|||+.++++||||+...++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~~ 295 (301)
T cd07873 236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGER 295 (301)
T ss_pred ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccch
Confidence 0000 1123578899999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=345.76 Aligned_cols=262 Identities=49% Similarity=0.869 Sum_probs=216.2
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC-
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE- 143 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~- 143 (536)
+.+|++++.||+|+||.||.|.+..+|+.||+|.+...... .......+.+.+|+.+++.++||||+++++++.+.
T Consensus 1 ~~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 77 (265)
T cd06652 1 PTNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPES---PETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPM 77 (265)
T ss_pred CCcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCC---cccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCC
Confidence 35799999999999999999999999999999987432111 11223456788999999999999999999988763
Q ss_pred -CceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhh
Q 009364 144 -ESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVA 222 (536)
Q Consensus 144 -~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~ 222 (536)
..+++||||++|++|.+++.+.+.+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||+++...
T Consensus 78 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 78 ERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred CceEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 4688999999999999999877789999999999999999999999999999999999999999999999999987654
Q ss_pred hhhc-ccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcH
Q 009364 223 ELAT-VSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSV 301 (536)
Q Consensus 223 ~~~~-~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 301 (536)
.... ........|+..|+|||++.+..++.++|||||||++|+|++|+.||....... ...........+..+..++.
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 236 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA-AIFKIATQPTNPVLPPHVSD 236 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH-HHHHHhcCCCCCCCchhhCH
Confidence 2111 112334568999999999988889999999999999999999999997543221 22222222334456677889
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhCCCCc
Q 009364 302 KAKDFLLKCLEKEPDLRPTASELLKHPFVT 331 (536)
Q Consensus 302 ~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~ 331 (536)
.+.++|.+||. +|++||+++++++|||+.
T Consensus 237 ~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 237 HCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 99999999995 899999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=343.48 Aligned_cols=257 Identities=64% Similarity=1.130 Sum_probs=218.1
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCce
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESL 146 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 146 (536)
+|+..+.||+|+||+||+|.+..+++.|++|.+...... ...++..+.+.+|+.+++.++|+||+++++++.....+
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~ 77 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDG---QTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNL 77 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEcccc---ccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeE
Confidence 588889999999999999999889999999988532211 11233456788999999999999999999999999999
Q ss_pred eEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhc
Q 009364 147 NILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELAT 226 (536)
Q Consensus 147 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 226 (536)
++|+||+++++|.+++.+...+++..+..++.||+.||+|||+.|++|+||+|+||+++.++.+||+|||++.......
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~- 156 (258)
T cd06632 78 YIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS- 156 (258)
T ss_pred EEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc-
Confidence 9999999999999999887789999999999999999999999999999999999999999999999999987654322
Q ss_pred ccCCcccCCCCCCCChhhhhhcC-CCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcHHHHH
Q 009364 227 VSGAKSMKGTPYWMAPEVIRQTG-HSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKD 305 (536)
Q Consensus 227 ~~~~~~~~Gt~~Y~APEvl~~~~-~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 305 (536)
......|++.|+|||.+.... ++.++|+|||||++|+|++|.+||..... .............+.++..++..+++
T Consensus 157 --~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (258)
T cd06632 157 --FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG-VAAVFKIGRSKELPPIPDHLSDEAKD 233 (258)
T ss_pred --cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH-HHHHHHHHhcccCCCcCCCcCHHHHH
Confidence 234567899999999987766 89999999999999999999999965432 12222222223344566788999999
Q ss_pred HHHHhcccCCCCCCCHHHHHhCCCC
Q 009364 306 FLLKCLEKEPDLRPTASELLKHPFV 330 (536)
Q Consensus 306 Li~~cL~~dP~~Rps~~eiL~hp~~ 330 (536)
++++||..+|.+||++.++++|||+
T Consensus 234 li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 234 FILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HHHHHhhcCcccCcCHHHHhcCCCC
Confidence 9999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=346.68 Aligned_cols=263 Identities=44% Similarity=0.823 Sum_probs=218.8
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCce
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESL 146 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 146 (536)
+|+.++.||+|+||.||+|.+..+++.||+|++..... .........+.+.+|+++++.++|+||+++++++.+.+.+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~--~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRN--TSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHF 78 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccC--CchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeE
Confidence 48889999999999999999999999999998843221 1112223467788999999999999999999999999999
Q ss_pred eEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCC-cEEEEecCcchhhhhhh
Q 009364 147 NILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKG-CIKLADFGASKQVAELA 225 (536)
Q Consensus 147 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~-~vkL~DFGla~~~~~~~ 225 (536)
++|+||++|++|.+++.+.+++++..+..++.||+.||.|||++|++||||+|+||+++.++ .+||+|||.+.......
T Consensus 79 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~ 158 (268)
T cd06630 79 NLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG 158 (268)
T ss_pred EEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence 99999999999999998888899999999999999999999999999999999999998776 69999999987665321
Q ss_pred cc--cCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhh--HHHHHHHhhCCCCCCCCCCCcCcH
Q 009364 226 TV--SGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQY--QEVAALFHIGTTKSHPPIPENLSV 301 (536)
Q Consensus 226 ~~--~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~--~~~~~~~~~~~~~~~~~~~~~~s~ 301 (536)
.. .......||..|+|||++.+..++.++|+||+||++|+|++|..||.... ...............+..+..++.
T Consensus 159 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd06630 159 TGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSP 238 (268)
T ss_pred ccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCH
Confidence 11 11234568999999999988889999999999999999999999996322 111222222222334556678899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhCCCCc
Q 009364 302 KAKDFLLKCLEKEPDLRPTASELLKHPFVT 331 (536)
Q Consensus 302 ~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~ 331 (536)
++++++.+||..+|.+||++.++++||||+
T Consensus 239 ~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 239 GLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 999999999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=344.41 Aligned_cols=257 Identities=38% Similarity=0.643 Sum_probs=212.7
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
++|++.+.||.|+||+||+|.+..++..+|+|++.. .........+.+|+.+++.++|+||+++++.+...+.
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~-------~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDL-------EKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDE 73 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEecc-------CCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCE
Confidence 369999999999999999999988999999998732 1111245678899999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccC---CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhh
Q 009364 146 LNILLEFVPGGSISSLLGKF---GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVA 222 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~---~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~ 222 (536)
.++|||++++++|.+++... ..+++..++.++.|++.||+|||+.|++||||+|+||++++++.++|+|||++..+.
T Consensus 74 ~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~ 153 (267)
T cd06610 74 LWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLA 153 (267)
T ss_pred EEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhc
Confidence 99999999999999998653 458999999999999999999999999999999999999999999999999987765
Q ss_pred hhhccc--CCcccCCCCCCCChhhhhhc-CCCccceEechhHHHHHHhhCCCCCchhhHH--HHHHHhhCCCCCCCCC--
Q 009364 223 ELATVS--GAKSMKGTPYWMAPEVIRQT-GHSYSADIWSVGCTVIEMATGKPPWSQQYQE--VAALFHIGTTKSHPPI-- 295 (536)
Q Consensus 223 ~~~~~~--~~~~~~Gt~~Y~APEvl~~~-~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~--~~~~~~~~~~~~~~~~-- 295 (536)
...... ......|++.|+|||++... .++.++|+|||||++|+|++|..||...... ....... ........
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~ 232 (267)
T cd06610 154 DGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN-DPPSLETGAD 232 (267)
T ss_pred cCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC-CCCCcCCccc
Confidence 432221 22345689999999998876 7899999999999999999999999654321 1111111 11111111
Q ss_pred CCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCC
Q 009364 296 PENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFV 330 (536)
Q Consensus 296 ~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~ 330 (536)
...++..+++++.+||..||.+||++.++++||||
T Consensus 233 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 233 YKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred cccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 13678999999999999999999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=344.54 Aligned_cols=255 Identities=38% Similarity=0.662 Sum_probs=213.9
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEE 144 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 144 (536)
..+|++.+.||.|+||.||+|.+..+++.+|+|++... .....+.+.+|+.+++.++||||+++++.+....
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~--------~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 73 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLE--------PGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRD 73 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcC--------chhhHHHHHHHHHHHHhCCCCChhceEEEEEeCC
Confidence 46899999999999999999999999999999998432 1124567889999999999999999999999999
Q ss_pred ceeEEEEecCCCCcccccccC-CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhh
Q 009364 145 SLNILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAE 223 (536)
Q Consensus 145 ~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 223 (536)
.++++|||+++++|.+++... ..+++..++.++.|++.||.|||++|++||||+|+||+++.++.+||+|||++.....
T Consensus 74 ~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 153 (262)
T cd06613 74 KLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTA 153 (262)
T ss_pred EEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhh
Confidence 999999999999999998765 7899999999999999999999999999999999999999999999999999887654
Q ss_pred hhcccCCcccCCCCCCCChhhhhhc---CCCccceEechhHHHHHHhhCCCCCchhhHH--HHHHHhhCCCCCCCCCCCc
Q 009364 224 LATVSGAKSMKGTPYWMAPEVIRQT---GHSYSADIWSVGCTVIEMATGKPPWSQQYQE--VAALFHIGTTKSHPPIPEN 298 (536)
Q Consensus 224 ~~~~~~~~~~~Gt~~Y~APEvl~~~---~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~--~~~~~~~~~~~~~~~~~~~ 298 (536)
.. .......|+..|+|||++.+. .++.++|+|||||++|+|++|.+||...... ................+..
T Consensus 154 ~~--~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (262)
T cd06613 154 TI--AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEK 231 (262)
T ss_pred hh--hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhh
Confidence 22 123456789999999999776 7889999999999999999999999654322 1111111111111122345
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHhCCC
Q 009364 299 LSVKAKDFLLKCLEKEPDLRPTASELLKHPF 329 (536)
Q Consensus 299 ~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~ 329 (536)
++.+++++|++||..+|..|||+.++++|+|
T Consensus 232 ~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 232 WSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred hhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 6788999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=364.55 Aligned_cols=246 Identities=26% Similarity=0.475 Sum_probs=206.0
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCce
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESL 146 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 146 (536)
.++..+.||+|.||.||+|.+.. ...||+|.+... ....+.+.+|+++|++|+|+|||+++++|..++.+
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~---------~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~pi 276 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEG---------SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPI 276 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcC-CCcccceEEecc---------ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCce
Confidence 35678899999999999998743 347999988421 11234567999999999999999999999998899
Q ss_pred eEEEEecCCCCccccccc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhh
Q 009364 147 NILLEFVPGGSISSLLGK--FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAEL 224 (536)
Q Consensus 147 ~lV~E~~~gg~L~~~l~~--~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 224 (536)
||||||++.|+|.++|.. .+.+...+...++.|||+|++||+++++|||||-..||||++++.+||+|||+|+...+.
T Consensus 277 yIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~ 356 (468)
T KOG0197|consen 277 YIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDD 356 (468)
T ss_pred EEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCC
Confidence 999999999999999986 467899999999999999999999999999999999999999999999999999954432
Q ss_pred hcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhh-HHHHHHHhhCCCCCCCCCCCcCcHH
Q 009364 225 ATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQY-QEVAALFHIGTTKSHPPIPENLSVK 302 (536)
Q Consensus 225 ~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~-~~~~~~~~~~~~~~~~~~~~~~s~~ 302 (536)
. ........-+..|.|||.+....++.++|||||||+||||+| |+.||.+.. .++...+. ...+.+.|..+|++
T Consensus 357 ~-Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le---~GyRlp~P~~CP~~ 432 (468)
T KOG0197|consen 357 E-YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLE---RGYRLPRPEGCPDE 432 (468)
T ss_pred c-eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHh---ccCcCCCCCCCCHH
Confidence 2 222222334567999999999999999999999999999998 888987654 33333333 34455677899999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHh
Q 009364 303 AKDFLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 303 ~~dLi~~cL~~dP~~Rps~~eiL~ 326 (536)
+.++++.||..+|++|||++.+..
T Consensus 433 vY~lM~~CW~~~P~~RPtF~~L~~ 456 (468)
T KOG0197|consen 433 VYELMKSCWHEDPEDRPTFETLRE 456 (468)
T ss_pred HHHHHHHHhhCCcccCCCHHHHHH
Confidence 999999999999999999997653
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=355.47 Aligned_cols=261 Identities=34% Similarity=0.610 Sum_probs=216.3
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE 142 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 142 (536)
.+..+|++.+.||+|+||.||+|.+..+|+.||+|.+.... ....+.+.+|+.+++.++|+||+++++.+..
T Consensus 16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~ 87 (297)
T cd06656 16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ--------QPKKELIINEILVMRENKNPNIVNYLDSYLV 87 (297)
T ss_pred ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc--------cchHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 34468999999999999999999999999999999874211 1123457789999999999999999999999
Q ss_pred CCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhh
Q 009364 143 EESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVA 222 (536)
Q Consensus 143 ~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~ 222 (536)
....++||||+++++|.+++.+ ..+++..+..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++....
T Consensus 88 ~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~ 166 (297)
T cd06656 88 GDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 166 (297)
T ss_pred CCEEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEcc
Confidence 9999999999999999998865 568999999999999999999999999999999999999999999999999987654
Q ss_pred hhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcHH
Q 009364 223 ELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVK 302 (536)
Q Consensus 223 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 302 (536)
... .......|++.|+|||.+.+..++.++|+|||||++|+|++|.+||......................+..++..
T Consensus 167 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (297)
T cd06656 167 PEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAV 244 (297)
T ss_pred CCc--cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHH
Confidence 321 122345789999999999988899999999999999999999999965432111111111111122244578889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHhCCCCcCCC
Q 009364 303 AKDFLLKCLEKEPDLRPTASELLKHPFVTGDD 334 (536)
Q Consensus 303 ~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~ 334 (536)
+++||.+||..+|.+||++.++++||||....
T Consensus 245 ~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 276 (297)
T cd06656 245 FRDFLNRCLEMDVDRRGSAKELLQHPFLKLAK 276 (297)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCchhcccc
Confidence 99999999999999999999999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-43 Score=348.21 Aligned_cols=258 Identities=40% Similarity=0.698 Sum_probs=217.2
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
.+|++.+.||.|+||.||+|.+..+|+.||+|.+... ........+.+|+.+++.++|+||+++++.+.+...
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~-------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 73 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLE-------EAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSK 73 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecc-------ccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCe
Confidence 3788999999999999999999999999999987421 112334567889999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhh
Q 009364 146 LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA 225 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 225 (536)
.++|+||+++++|.+++... ++++..++.++.|++.||.|||+.+++||||+|+||+++.++.++|+|||+++......
T Consensus 74 ~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 74 LWIIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred EEEEEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 99999999999999998764 88999999999999999999999999999999999999999999999999988765422
Q ss_pred cccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCc-CcHHHH
Q 009364 226 TVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPEN-LSVKAK 304 (536)
Q Consensus 226 ~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-~s~~~~ 304 (536)
.......|++.|+|||++.+..++.++|||||||++|+|++|.+||........ .... .....+..+.. ++..+.
T Consensus 153 --~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~ 228 (274)
T cd06609 153 --SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV-LFLI-PKNNPPSLEGNKFSKPFK 228 (274)
T ss_pred --cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH-HHHh-hhcCCCCCcccccCHHHH
Confidence 223456789999999999988899999999999999999999999965432211 1111 11122233334 889999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhCCCCcCCCC
Q 009364 305 DFLLKCLEKEPDLRPTASELLKHPFVTGDDE 335 (536)
Q Consensus 305 dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~~ 335 (536)
+++.+||..+|++|||+.++++||||.....
T Consensus 229 ~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 259 (274)
T cd06609 229 DFVSLCLNKDPKERPSAKELLKHKFIKKAKK 259 (274)
T ss_pred HHHHHHhhCChhhCcCHHHHhhChhhcCCCc
Confidence 9999999999999999999999999986543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=352.19 Aligned_cols=256 Identities=25% Similarity=0.379 Sum_probs=203.3
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcC----------------CCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHh
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLD----------------SGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKD 127 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~----------------~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 127 (536)
+..+|++.+.||+|+||.||+|.+.. ++..||+|++... ........+.+|+.+|..
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~-------~~~~~~~~~~~E~~~l~~ 75 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPD-------ANKNARNDFLKEVKILSR 75 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCC-------CCHHHHHHHHHHHHHHhh
Confidence 34689999999999999999997532 3457999987321 112334568899999999
Q ss_pred CCCCceeeEeeeeecCCceeEEEEecCCCCcccccccC-------------------CCCCHHHHHHHHHHHHHHHHHHH
Q 009364 128 LSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKF-------------------GPFPEAVMRTYTKQLLLGLEYLH 188 (536)
Q Consensus 128 l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~-------------------~~l~~~~~~~i~~qil~aL~yLH 188 (536)
++||||+++++++.+.+..++||||+++|+|.+++... ..+++..+..++.||+.||.|||
T Consensus 76 l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH 155 (304)
T cd05096 76 LKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS 155 (304)
T ss_pred cCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999999887542 23677888999999999999999
Q ss_pred HcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh
Q 009364 189 NHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT 268 (536)
Q Consensus 189 ~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt 268 (536)
++||+||||||+|||++.++.+||+|||+++.+.............++..|+|||++.+..++.++|||||||++|+|++
T Consensus 156 ~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~ 235 (304)
T cd05096 156 SLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235 (304)
T ss_pred HCCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHH
Confidence 99999999999999999999999999999876543322222334556889999999998899999999999999999986
Q ss_pred --CCCCCchhhH-HHHH----HHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHh
Q 009364 269 --GKPPWSQQYQ-EVAA----LFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 269 --G~~Pf~~~~~-~~~~----~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~ 326 (536)
+..||..... .... .............+..++..+.+||.+||..||.+|||+.+|.+
T Consensus 236 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 236 LCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred ccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 5678864321 1111 11111111222344578899999999999999999999999954
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=345.98 Aligned_cols=256 Identities=30% Similarity=0.524 Sum_probs=218.1
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCce
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESL 146 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 146 (536)
+|++.+.||.|+||.||+|.+..+++.||+|++.... .......+.+.+|++++++++||||+++++.+......
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 75 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQK-----CVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENM 75 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhh-----hcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeE
Confidence 5899999999999999999999999999999884211 11123456788999999999999999999999999999
Q ss_pred eEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhc
Q 009364 147 NILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELAT 226 (536)
Q Consensus 147 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 226 (536)
++|+||+.|++|.+++....++++..+..++.||+.||.|||++|++|+||+|+||++++++.++|+|||++.......
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 76 YLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred EEEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence 9999999999999999877789999999999999999999999999999999999999999999999999987654321
Q ss_pred ccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcHHHHHH
Q 009364 227 VSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKDF 306 (536)
Q Consensus 227 ~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL 306 (536)
......|+..|+|||++.+..++.++|+||||+++|+|++|..||......................+..++..+.++
T Consensus 155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (258)
T cd05578 155 --LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDA 232 (258)
T ss_pred --cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHH
Confidence 223456899999999999888999999999999999999999999754421111111111114445667889999999
Q ss_pred HHHhcccCCCCCCCH--HHHHhCCCC
Q 009364 307 LLKCLEKEPDLRPTA--SELLKHPFV 330 (536)
Q Consensus 307 i~~cL~~dP~~Rps~--~eiL~hp~~ 330 (536)
|.+||..||.+||++ .|+++||||
T Consensus 233 i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 233 INKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred HHHHccCChhHcCCccHHHHhcCCCC
Confidence 999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=350.92 Aligned_cols=255 Identities=32% Similarity=0.506 Sum_probs=204.7
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCce
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESL 146 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 146 (536)
+|++.+.||+|++|.||+|.+..+|..||+|.+.... ........+.+|+.+++.++||||+++++++.++..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 74 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLES------EEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRL 74 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccc------ccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeE
Confidence 4889999999999999999999999999999874321 1112235567899999999999999999999999999
Q ss_pred eEEEEecCCCCcccccccC---CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhh
Q 009364 147 NILLEFVPGGSISSLLGKF---GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAE 223 (536)
Q Consensus 147 ~lV~E~~~gg~L~~~l~~~---~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 223 (536)
++||||+. ++|.+++... ..+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 75 ~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 153 (285)
T cd07861 75 YLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI 153 (285)
T ss_pred EEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCC
Confidence 99999997 5777776432 5689999999999999999999999999999999999999999999999999875432
Q ss_pred hhcccCCcccCCCCCCCChhhhhhc-CCCccceEechhHHHHHHhhCCCCCchhhHHH--HHHHhhC-------------
Q 009364 224 LATVSGAKSMKGTPYWMAPEVIRQT-GHSYSADIWSVGCTVIEMATGKPPWSQQYQEV--AALFHIG------------- 287 (536)
Q Consensus 224 ~~~~~~~~~~~Gt~~Y~APEvl~~~-~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~--~~~~~~~------------- 287 (536)
.. .......+++.|+|||++.+. .++.++|||||||++|+|++|++||....... .......
T Consensus 154 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (285)
T cd07861 154 PV--RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTS 231 (285)
T ss_pred Cc--ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchh
Confidence 21 112334678999999998654 57899999999999999999999996543211 1110000
Q ss_pred -----------CCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCC
Q 009364 288 -----------TTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFV 330 (536)
Q Consensus 288 -----------~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~ 330 (536)
...........++.++++||++||+.||.+|||+.++++||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 232 LPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred hHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 0000011123578999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=352.81 Aligned_cols=255 Identities=28% Similarity=0.491 Sum_probs=203.5
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCce
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESL 146 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 146 (536)
+|++.+.||+|+||.||+|.+..+|+.||+|.+.... ........+.+|+.+++.++||||+++++++.+...+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~------~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 74 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD------DDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKL 74 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccc------ccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCce
Confidence 5899999999999999999999999999999884321 1112234566799999999999999999999999999
Q ss_pred eEEEEecCCCCcccccc-cCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhh
Q 009364 147 NILLEFVPGGSISSLLG-KFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA 225 (536)
Q Consensus 147 ~lV~E~~~gg~L~~~l~-~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 225 (536)
++|+||+. ++|.+++. ..+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++......
T Consensus 75 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 75 TLVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred EEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 99999996 46766654 35679999999999999999999999999999999999999999999999999987654321
Q ss_pred cccCCcccCCCCCCCChhhhhhc-CCCccceEechhHHHHHHhhCCCCCchhhH--H-HHHHHhh---------------
Q 009364 226 TVSGAKSMKGTPYWMAPEVIRQT-GHSYSADIWSVGCTVIEMATGKPPWSQQYQ--E-VAALFHI--------------- 286 (536)
Q Consensus 226 ~~~~~~~~~Gt~~Y~APEvl~~~-~~s~k~DIwSlGvil~eLltG~~Pf~~~~~--~-~~~~~~~--------------- 286 (536)
.......+++.|+|||++.+. .++.++|||||||++|+|++|..||..... + ...+...
T Consensus 154 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 154 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred --CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhc
Confidence 122345678999999998764 468999999999999999999888632111 1 1111100
Q ss_pred CCCCCC---------CCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCC
Q 009364 287 GTTKSH---------PPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFV 330 (536)
Q Consensus 287 ~~~~~~---------~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~ 330 (536)
...... ....+.++.++++||++||+.||.+|||+.++++||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 000000 11123578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=348.54 Aligned_cols=257 Identities=28% Similarity=0.511 Sum_probs=209.7
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
++|++.+.||+|+||.||+|.+..+|+.||+|++.... ......+.+.+|+.+++.++|+||+++++++.....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~------~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~ 74 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESE------DDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRK 74 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecc------cCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCE
Confidence 37999999999999999999999999999999874221 111122456789999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhh
Q 009364 146 LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA 225 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 225 (536)
+++||||+++++|..++.....+++..++.++.||+.||.|||+.|++||||||+||+++.++.+||+|||++.......
T Consensus 75 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 75 LHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred EEEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 99999999999998888777789999999999999999999999999999999999999999999999999987664422
Q ss_pred cccCCcccCCCCCCCChhhhhh-cCCCccceEechhHHHHHHhhCCCCCchhhHH--HHHHHhh-CC-------------
Q 009364 226 TVSGAKSMKGTPYWMAPEVIRQ-TGHSYSADIWSVGCTVIEMATGKPPWSQQYQE--VAALFHI-GT------------- 288 (536)
Q Consensus 226 ~~~~~~~~~Gt~~Y~APEvl~~-~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~--~~~~~~~-~~------------- 288 (536)
. ......++..|+|||++.+ ..++.++|||||||++|+|++|.+||.+.... ....... ..
T Consensus 155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07847 155 D--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ 232 (286)
T ss_pred c--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence 1 1234568899999999876 45789999999999999999999999654321 1111100 00
Q ss_pred ----CCCCC--------CCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCC
Q 009364 289 ----TKSHP--------PIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFV 330 (536)
Q Consensus 289 ----~~~~~--------~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~ 330 (536)
..... .....++..+.+||.+||+.+|++||++.|++.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 00000 0113568889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=355.78 Aligned_cols=264 Identities=28% Similarity=0.434 Sum_probs=226.8
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
+.|+.-++||+|+||.||-++-+.||+.||+|.+.+.. -+.+.-.....+|-.+|.+++.+.||.+-..|++.+.
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKR-----iKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~ 259 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKR-----IKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA 259 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHH-----HHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence 46888999999999999999999999999999873211 1112223345688899999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccCC--CCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhh
Q 009364 146 LNILLEFVPGGSISSLLGKFG--PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAE 223 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 223 (536)
+++|+..|.||+|.-+|-+.+ .|+++.+..++.+|+.||.+||+.+||+|||||+|||+|+.|+|+|+|.|+|..+..
T Consensus 260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 999999999999999998776 799999999999999999999999999999999999999999999999999988876
Q ss_pred hhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHH-HHhhCCCCCCCCCCCcCcHH
Q 009364 224 LATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAA-LFHIGTTKSHPPIPENLSVK 302 (536)
Q Consensus 224 ~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~s~~ 302 (536)
... ....+||.+|||||++.+..|+.+.|+|||||++|+|+.|..||....+.+.. .+..........++...|++
T Consensus 340 g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~e 416 (591)
T KOG0986|consen 340 GKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEE 416 (591)
T ss_pred CCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHH
Confidence 443 34558999999999999999999999999999999999999999766544433 22233334455677899999
Q ss_pred HHHHHHHhcccCCCCCC-----CHHHHHhCCCCcCCCCCc
Q 009364 303 AKDFLLKCLEKEPDLRP-----TASELLKHPFVTGDDEDP 337 (536)
Q Consensus 303 ~~dLi~~cL~~dP~~Rp-----s~~eiL~hp~~~~~~~~~ 337 (536)
+++|.+.+|++||.+|. ++.++.+||||...++..
T Consensus 417 akslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~r 456 (591)
T KOG0986|consen 417 AKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRR 456 (591)
T ss_pred HHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhH
Confidence 99999999999999997 567999999998766543
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=349.64 Aligned_cols=263 Identities=30% Similarity=0.461 Sum_probs=215.6
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCce
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESL 146 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 146 (536)
+|++.+.||+|+||.||++.+..+++.||+|.+.... .........+.+|+.+++.++||||+++++.+.....+
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~-----~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 76 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQN-----LILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHL 76 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhh-----hhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEE
Confidence 6899999999999999999999999999999873211 11223456778999999999999999999999999999
Q ss_pred eEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhh-
Q 009364 147 NILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA- 225 (536)
Q Consensus 147 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~- 225 (536)
++||||++|++|.+++...+.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++......
T Consensus 77 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 77 CMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 9999999999999999888889999999999999999999999999999999999999999999999999886321000
Q ss_pred ------------cccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH-HHHHHhhCCCCCC
Q 009364 226 ------------TVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE-VAALFHIGTTKSH 292 (536)
Q Consensus 226 ------------~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~ 292 (536)
.........|++.|+|||.+.+..++.++|+|||||++|+|++|..||.+.... ........ ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~-~~~~ 235 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD-DIEW 235 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-ccCC
Confidence 000112346888999999998888999999999999999999999999754322 22221111 1112
Q ss_pred CCCCCcCcHHHHHHHHHhcccCCCCCCC---HHHHHhCCCCcCCCC
Q 009364 293 PPIPENLSVKAKDFLLKCLEKEPDLRPT---ASELLKHPFVTGDDE 335 (536)
Q Consensus 293 ~~~~~~~s~~~~dLi~~cL~~dP~~Rps---~~eiL~hp~~~~~~~ 335 (536)
+.....++.+++++|.+||+.||++||+ +.++++||||.....
T Consensus 236 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~ 281 (305)
T cd05609 236 PEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDW 281 (305)
T ss_pred CCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCH
Confidence 2223367899999999999999999998 799999999976543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=346.73 Aligned_cols=256 Identities=37% Similarity=0.646 Sum_probs=208.7
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeEeeeee
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRYLGTVR 141 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~ 141 (536)
.+..+|++.+.||.|+||.||+|.+..+++.+|+|++... ......+..|+.+++++ +|+||+++++++.
T Consensus 13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~---------~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 83 (282)
T cd06636 13 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---------EDEEEEIKLEINMLKKYSHHRNIATYYGAFI 83 (282)
T ss_pred ChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC---------hHHHHHHHHHHHHHHHhcCCCcEEEEeeehh
Confidence 4667899999999999999999999999999999987321 12234577889999988 6999999999985
Q ss_pred c------CCceeEEEEecCCCCcccccccC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEE
Q 009364 142 E------EESLNILLEFVPGGSISSLLGKF--GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLA 213 (536)
Q Consensus 142 ~------~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~ 213 (536)
. ...++++|||+++|+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+
T Consensus 84 ~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~ 163 (282)
T cd06636 84 KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLV 163 (282)
T ss_pred cccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEe
Confidence 3 45789999999999999988643 458899999999999999999999999999999999999999999999
Q ss_pred ecCcchhhhhhhcccCCcccCCCCCCCChhhhh-----hcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCC
Q 009364 214 DFGASKQVAELATVSGAKSMKGTPYWMAPEVIR-----QTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGT 288 (536)
Q Consensus 214 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~-----~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~ 288 (536)
|||++....... .......|++.|+|||++. +..++.++|||||||++|+|++|.+||....... .......
T Consensus 164 dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~-~~~~~~~ 240 (282)
T cd06636 164 DFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR-ALFLIPR 240 (282)
T ss_pred eCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh-hhhhHhh
Confidence 999987654211 1234567999999999986 3467889999999999999999999996543221 1111111
Q ss_pred CCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCC
Q 009364 289 TKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFV 330 (536)
Q Consensus 289 ~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~ 330 (536)
..........++.++.+||.+||..||.+|||+.++++||||
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 241 NPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred CCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 111222334688999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=357.01 Aligned_cols=258 Identities=28% Similarity=0.454 Sum_probs=203.3
Q ss_pred eeeEEccc--CceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCcee
Q 009364 70 KGELIGCG--AFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESLN 147 (536)
Q Consensus 70 ~~~~LG~G--~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 147 (536)
+.++||+| +||+||++.+..+|+.||+|.+... .......+.+.+|+.+++.++||||+++++++..++..+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~------~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~ 75 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLE------ACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 75 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechh------hccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEE
Confidence 46789999 7899999999999999999987321 111233456778999999999999999999999999999
Q ss_pred EEEEecCCCCccccccc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhh
Q 009364 148 ILLEFVPGGSISSLLGK--FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA 225 (536)
Q Consensus 148 lV~E~~~gg~L~~~l~~--~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 225 (536)
+||||+++|+|.+++.. ...+++..++.++.|++.||+|||++||+||||||+|||++.++.++++|||.+.......
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~ 155 (327)
T cd08227 76 VVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHG 155 (327)
T ss_pred EEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence 99999999999999864 3458999999999999999999999999999999999999999999999998654432111
Q ss_pred cc-----cCCcccCCCCCCCChhhhhh--cCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhh-CCCC-------
Q 009364 226 TV-----SGAKSMKGTPYWMAPEVIRQ--TGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHI-GTTK------- 290 (536)
Q Consensus 226 ~~-----~~~~~~~Gt~~Y~APEvl~~--~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~-~~~~------- 290 (536)
.. .......++..|+|||++.+ ..++.++|||||||++|+|++|..||............. ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (327)
T cd08227 156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTT 235 (327)
T ss_pred ccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccc
Confidence 00 01123357788999999976 468999999999999999999999996432111110000 0000
Q ss_pred -----------------------------------CCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 291 -----------------------------------SHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 291 -----------------------------------~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
...+....+++++++||.+||+.||.+|||+.++++||||...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 236 IPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred hhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 0001223457889999999999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-43 Score=346.13 Aligned_cols=255 Identities=34% Similarity=0.613 Sum_probs=214.7
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCce
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESL 146 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 146 (536)
+|+..+.||+|+||.||+|.+..+++.+|+|.+... ........+.+|+++++.++||||+++++.+.....+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~-------~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 74 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLE-------INEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDI 74 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecc-------cChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEE
Confidence 578889999999999999999999999999987432 1123446678899999999999999999999999999
Q ss_pred eEEEEecCCCCcccccccC-CCCCHHHHHHHHHHHHHHHHHHHH-cCCccccCCCCCcccCCCCcEEEEecCcchhhhhh
Q 009364 147 NILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLLGLEYLHN-HGIMHRDIKGANILVDNKGCIKLADFGASKQVAEL 224 (536)
Q Consensus 147 ~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~-~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 224 (536)
++|+||+++++|.+++... ..+++..+..++.|++.||+|||+ .|++||||||+||+++.++.++|+|||.+......
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 75 SICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred EEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 9999999999999999765 789999999999999999999999 99999999999999999999999999998766432
Q ss_pred hcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhh---HHHHHHHhhCCCCCCCCCCCc-Cc
Q 009364 225 ATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQY---QEVAALFHIGTTKSHPPIPEN-LS 300 (536)
Q Consensus 225 ~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~---~~~~~~~~~~~~~~~~~~~~~-~s 300 (536)
.. ....|+..|+|||++.+..++.++|||||||++|+|++|..||.... ...............+..+.. ++
T Consensus 155 ~~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (265)
T cd06605 155 LA----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFS 230 (265)
T ss_pred Hh----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcC
Confidence 21 12678999999999999899999999999999999999999996431 111111111111222333333 88
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhCCCCcC
Q 009364 301 VKAKDFLLKCLEKEPDLRPTASELLKHPFVTG 332 (536)
Q Consensus 301 ~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~ 332 (536)
.+++++|.+||..||++|||+.+++.||||+.
T Consensus 231 ~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 231 PDFQDFVNLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred HHHHHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence 99999999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-44 Score=389.72 Aligned_cols=265 Identities=29% Similarity=0.471 Sum_probs=223.3
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE 143 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 143 (536)
...+|+++++||+|+||.|.+++++.+++.||+|++.+... ..+....-|..|-.+|..-+.+=|+.++..|+++
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eM-----lKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEM-----LKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHH-----hhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 34589999999999999999999999999999998832111 1123445677888999888899999999999999
Q ss_pred CceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhh
Q 009364 144 ESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAE 223 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 223 (536)
.++|+||||++||+|..++.+..++|+..++.++..|+.||.-||+.|+|||||||+|||++..|++||+|||.+-.+..
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~ 227 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDA 227 (1317)
T ss_pred cceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999988775
Q ss_pred hhcccCCcccCCCCCCCChhhhh----h-cCCCccceEechhHHHHHHhhCCCCCchhh--HHHHHHHhhCCCCCCCCCC
Q 009364 224 LATVSGAKSMKGTPYWMAPEVIR----Q-TGHSYSADIWSVGCTVIEMATGKPPWSQQY--QEVAALFHIGTTKSHPPIP 296 (536)
Q Consensus 224 ~~~~~~~~~~~Gt~~Y~APEvl~----~-~~~s~k~DIwSlGvil~eLltG~~Pf~~~~--~~~~~~~~~~~~~~~~~~~ 296 (536)
.+.. .....+|||.|++||+|. + +.|+..||+||+||++|||+.|..||+... .....+.........|. .
T Consensus 228 dG~V-~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~-~ 305 (1317)
T KOG0612|consen 228 DGTV-RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPD-E 305 (1317)
T ss_pred CCcE-EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCc-c
Confidence 4443 345778999999999996 2 568999999999999999999999997642 12222222222222221 2
Q ss_pred CcCcHHHHHHHHHhcccCCCCCCC---HHHHHhCCCCcCCCCC
Q 009364 297 ENLSVKAKDFLLKCLEKEPDLRPT---ASELLKHPFVTGDDED 336 (536)
Q Consensus 297 ~~~s~~~~dLi~~cL~~dP~~Rps---~~eiL~hp~~~~~~~~ 336 (536)
..+|.++++||.+++. +|..|.. ++++..||||.+..|+
T Consensus 306 ~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~ 347 (1317)
T KOG0612|consen 306 TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWD 347 (1317)
T ss_pred cccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChh
Confidence 4699999999999996 5888988 9999999999998884
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=349.13 Aligned_cols=257 Identities=31% Similarity=0.554 Sum_probs=213.7
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCce
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESL 146 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 146 (536)
+|++.+.||+|+||.||+|.+..+|..||+|.+... ........+.+|+.+++.++||||+++++.+...+.+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~-------~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 74 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-------LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAV 74 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc-------cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeE
Confidence 688999999999999999999999999999987421 1122345678899999999999999999999999999
Q ss_pred eEEEEecCCCCcccccccC---CCCCHHHHHHHHHHHHHHHHHHHH-cCCccccCCCCCcccCCCCcEEEEecCcchhhh
Q 009364 147 NILLEFVPGGSISSLLGKF---GPFPEAVMRTYTKQLLLGLEYLHN-HGIMHRDIKGANILVDNKGCIKLADFGASKQVA 222 (536)
Q Consensus 147 ~lV~E~~~gg~L~~~l~~~---~~l~~~~~~~i~~qil~aL~yLH~-~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~ 222 (536)
++||||+++++|..++... ..+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+||+|||++..+.
T Consensus 75 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 154 (286)
T cd06622 75 YMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV 154 (286)
T ss_pred EEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9999999999998888653 378999999999999999999997 599999999999999999999999999987653
Q ss_pred hhhcccCCcccCCCCCCCChhhhhhc------CCCccceEechhHHHHHHhhCCCCCchhhH-HHHHHHhhCCCCCCCCC
Q 009364 223 ELATVSGAKSMKGTPYWMAPEVIRQT------GHSYSADIWSVGCTVIEMATGKPPWSQQYQ-EVAALFHIGTTKSHPPI 295 (536)
Q Consensus 223 ~~~~~~~~~~~~Gt~~Y~APEvl~~~------~~s~k~DIwSlGvil~eLltG~~Pf~~~~~-~~~~~~~~~~~~~~~~~ 295 (536)
.. ......|++.|+|||++.+. .++.++|||||||++|+|++|..||..... ..............+.+
T Consensus 155 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd06622 155 AS----LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTL 230 (286)
T ss_pred CC----ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCC
Confidence 21 23345688999999998654 347899999999999999999999964322 22222222222234456
Q ss_pred CCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCC
Q 009364 296 PENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDD 334 (536)
Q Consensus 296 ~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~ 334 (536)
+..++.++.+||.+||..+|.+||++.+++.||||....
T Consensus 231 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 231 PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred CcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 667999999999999999999999999999999997653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=363.38 Aligned_cols=261 Identities=28% Similarity=0.433 Sum_probs=226.2
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE 142 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 142 (536)
.....|.+.+.||+|.|++|.+|++..+|..||||.+.+. .........+.+|+++|+.++|||||+++.+...
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt------~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t 126 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKT------QLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIET 126 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhc------ccChHHHHHHHHHHHHHHhcCCcceeeeeeeeee
Confidence 3345799999999999999999999999999999987421 1122333448899999999999999999999999
Q ss_pred CCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhh
Q 009364 143 EESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVA 222 (536)
Q Consensus 143 ~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~ 222 (536)
...+|+||||+.+|.+++++.+++...+..++.++.|+++|++|||+++|||||||++|||++.+-++||+|||++..+.
T Consensus 127 ~~~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 127 EATLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred cceeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999887
Q ss_pred hhhcccCCcccCCCCCCCChhhhhhcCC-CccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcH
Q 009364 223 ELATVSGAKSMKGTPYWMAPEVIRQTGH-SYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSV 301 (536)
Q Consensus 223 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~-s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 301 (536)
... ..++.||++.|.|||++.+..| ++.+|+||+|+++|.|++|..||.++.-... ..........+|..++.
T Consensus 207 ~~~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~L---r~rvl~gk~rIp~~ms~ 280 (596)
T KOG0586|consen 207 YGL---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKEL---RPRVLRGKYRIPFYMSC 280 (596)
T ss_pred ccc---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccc---cchheeeeecccceeec
Confidence 543 3578999999999999998877 7899999999999999999999987542211 11112223346678899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCCC
Q 009364 302 KAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDE 335 (536)
Q Consensus 302 ~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~~ 335 (536)
++++||+++|..+|.+|++.+++.+|.|.....+
T Consensus 281 dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~ 314 (596)
T KOG0586|consen 281 DCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLE 314 (596)
T ss_pred hhHHHHHHhhccCccccCCHHHhhhhcccchhhh
Confidence 9999999999999999999999999999865433
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=344.14 Aligned_cols=256 Identities=38% Similarity=0.652 Sum_probs=208.4
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeEeeeee
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRYLGTVR 141 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~ 141 (536)
.+.++|++.+.||+|++|.||+|.+..+++.+++|++.... .....+.+|+.+++++ .|+||+++++++.
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---------~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 73 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE---------DEEEEIKEEYNILRKYSNHPNIATFYGAFI 73 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc---------hhHHHHHHHHHHHHHhcCCCChheEEEEEE
Confidence 45679999999999999999999999899999999874211 1235678999999999 6999999999997
Q ss_pred cCC------ceeEEEEecCCCCccccccc----CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEE
Q 009364 142 EEE------SLNILLEFVPGGSISSLLGK----FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIK 211 (536)
Q Consensus 142 ~~~------~~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vk 211 (536)
... .+++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++||||+|+||+++.++.+|
T Consensus 74 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~ 153 (275)
T cd06608 74 KKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVK 153 (275)
T ss_pred ecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEE
Confidence 644 48999999999999988754 35789999999999999999999999999999999999999999999
Q ss_pred EEecCcchhhhhhhcccCCcccCCCCCCCChhhhhh-----cCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhh
Q 009364 212 LADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQ-----TGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHI 286 (536)
Q Consensus 212 L~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~-----~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~ 286 (536)
|+|||++....... .......|++.|+|||++.. ..++.++|||||||++|+|++|.+||....... .....
T Consensus 154 l~d~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~ 230 (275)
T cd06608 154 LVDFGVSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR-ALFKI 230 (275)
T ss_pred ECCCccceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH-HHHHh
Confidence 99999987654321 12345668999999999854 346788999999999999999999996532211 11111
Q ss_pred C-CCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCC
Q 009364 287 G-TTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFV 330 (536)
Q Consensus 287 ~-~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~ 330 (536)
. ........+..++.++++||.+||..||++|||+.++++|||+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 231 PRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred hccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 1 1111122233478899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=365.42 Aligned_cols=265 Identities=37% Similarity=0.625 Sum_probs=224.0
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEE 144 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 144 (536)
...|.-.+-||.|+||-||.|++..+.+.||||.+... .....+....+..|+..|+.++|||+|.+-|+|..+.
T Consensus 25 Eklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsyS-----GKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~ 99 (948)
T KOG0577|consen 25 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYS-----GKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREH 99 (948)
T ss_pred HHHHHHHHHhcCCccceeEEeeccCccceeeeeecccc-----ccccHHHHHHHHHHHHHHHhccCCCcccccceeeccc
Confidence 34577788999999999999999999999999988432 2223345667889999999999999999999999999
Q ss_pred ceeEEEEecCCCCcccccc-cCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhh
Q 009364 145 SLNILLEFVPGGSISSLLG-KFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAE 223 (536)
Q Consensus 145 ~~~lV~E~~~gg~L~~~l~-~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 223 (536)
..||||||| -|+-.|++. ..+++.+.++..|+.+.+.||+|||+.+.||||||..|||+++.|.|||+|||.|....+
T Consensus 100 TaWLVMEYC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P 178 (948)
T KOG0577|consen 100 TAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP 178 (948)
T ss_pred hHHHHHHHH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc
Confidence 999999999 466677664 346899999999999999999999999999999999999999999999999999887654
Q ss_pred hhcccCCcccCCCCCCCChhhhh---hcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCc
Q 009364 224 LATVSGAKSMKGTPYWMAPEVIR---QTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLS 300 (536)
Q Consensus 224 ~~~~~~~~~~~Gt~~Y~APEvl~---~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s 300 (536)
..+++|||+||||||+. .+.|+-++||||||++..||.-.+||.-... .+..++++.....+......+|
T Consensus 179 ------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN-AMSALYHIAQNesPtLqs~eWS 251 (948)
T KOG0577|consen 179 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-AMSALYHIAQNESPTLQSNEWS 251 (948)
T ss_pred ------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch-HHHHHHHHHhcCCCCCCCchhH
Confidence 46789999999999985 5689999999999999999999999976543 3444555544433333456789
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCCCCcchhhc
Q 009364 301 VKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDPVLHAS 342 (536)
Q Consensus 301 ~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~~~~~~~~~ 342 (536)
..+++||..||++-|..|||.+++|+|+|+...-+..++..-
T Consensus 252 ~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp~tvi~dL 293 (948)
T KOG0577|consen 252 DYFRNFVDSCLQKIPQERPTSEELLKHRFVLRERPPTVIMDL 293 (948)
T ss_pred HHHHHHHHHHHhhCcccCCcHHHHhhcchhccCCCchHHHHH
Confidence 999999999999999999999999999999876555554433
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=342.94 Aligned_cols=251 Identities=45% Similarity=0.794 Sum_probs=207.5
Q ss_pred eeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCceeEE
Q 009364 70 KGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESLNIL 149 (536)
Q Consensus 70 ~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 149 (536)
....||+|+||.||+|.+..++..||+|.+.. ......+.+.+|+.+++.++|+||+++++++...+..++|
T Consensus 12 ~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~--------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPE--------RDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ceEEEecCCceEEEEeEecCCCcEEEEEEecC--------CCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 34579999999999999999999999998732 1123345788999999999999999999999999999999
Q ss_pred EEecCCCCcccccccC-CCC--CHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCC-CCcEEEEecCcchhhhhhh
Q 009364 150 LEFVPGGSISSLLGKF-GPF--PEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDN-KGCIKLADFGASKQVAELA 225 (536)
Q Consensus 150 ~E~~~gg~L~~~l~~~-~~l--~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~-~~~vkL~DFGla~~~~~~~ 225 (536)
+||+++++|.+++... ..+ ++..+..++.||+.||+|||++||+||||||+||+++. ++.++|+|||++.......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~ 163 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN 163 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCC
Confidence 9999999999988753 455 88889999999999999999999999999999999976 6799999999987553221
Q ss_pred cccCCcccCCCCCCCChhhhhhcC--CCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcHHH
Q 009364 226 TVSGAKSMKGTPYWMAPEVIRQTG--HSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKA 303 (536)
Q Consensus 226 ~~~~~~~~~Gt~~Y~APEvl~~~~--~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 303 (536)
.......|++.|+|||++.+.. ++.++|||||||++|+|++|.+||...................+.++..++.++
T Consensus 164 --~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (268)
T cd06624 164 --PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEA 241 (268)
T ss_pred --CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHH
Confidence 1123446899999999986543 788999999999999999999999653322222222222233455677889999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHhCCCC
Q 009364 304 KDFLLKCLEKEPDLRPTASELLKHPFV 330 (536)
Q Consensus 304 ~dLi~~cL~~dP~~Rps~~eiL~hp~~ 330 (536)
++|+++||+.+|.+|||+.+++.||||
T Consensus 242 ~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 242 KNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=365.80 Aligned_cols=255 Identities=24% Similarity=0.409 Sum_probs=204.9
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCC-----CcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeEe
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDS-----GELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRYL 137 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~-----g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~ 137 (536)
+..+|++++.||+|+||.||+|.+... +..||+|++... ........+.+|+.+++.+ +|+||++++
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~~E~~il~~l~~h~nIv~~~ 108 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKAS-------AHTDEREALMSELKILSHLGQHKNIVNLL 108 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCC-------CCHHHHHHHHHHHHHHHhhccCCceeeEe
Confidence 345799999999999999999986543 357999987321 1122345678899999999 899999999
Q ss_pred eeeecCCceeEEEEecCCCCcccccccC----------------------------------------------------
Q 009364 138 GTVREEESLNILLEFVPGGSISSLLGKF---------------------------------------------------- 165 (536)
Q Consensus 138 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~---------------------------------------------------- 165 (536)
+++......++|||||++|+|.+++...
T Consensus 109 ~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (374)
T cd05106 109 GACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVS 188 (374)
T ss_pred eEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcc
Confidence 9999999999999999999998877432
Q ss_pred ------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhcc
Q 009364 166 ------------------GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATV 227 (536)
Q Consensus 166 ------------------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 227 (536)
.++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~ 268 (374)
T cd05106 189 SSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY 268 (374)
T ss_pred ccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence 24788889999999999999999999999999999999999999999999998765432221
Q ss_pred cCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcHHHHHH
Q 009364 228 SGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKDF 306 (536)
Q Consensus 228 ~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL 306 (536)
.......+++.|+|||++.+..++.++|||||||++|+|++ |..||........ .............+..++++++++
T Consensus 269 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~l 347 (374)
T cd05106 269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK-FYKMVKRGYQMSRPDFAPPEIYSI 347 (374)
T ss_pred eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH-HHHHHHcccCccCCCCCCHHHHHH
Confidence 12223345678999999998899999999999999999997 9999975432211 111111222334455678999999
Q ss_pred HHHhcccCCCCCCCHHHHHh
Q 009364 307 LLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 307 i~~cL~~dP~~Rps~~eiL~ 326 (536)
|.+||+.||.+|||+.++++
T Consensus 348 i~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 348 MKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred HHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=350.89 Aligned_cols=263 Identities=32% Similarity=0.507 Sum_probs=215.8
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
.+|++.+.||+|+||+||+|.+..+++.||+|.+.... .......+.+.+|+++++.++|+||+++++.+.....
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 75 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKE-----MIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETY 75 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccc-----cchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCE
Confidence 36899999999999999999999999999999884321 1112345678899999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhh
Q 009364 146 LNILLEFVPGGSISSLLGKF--GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAE 223 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 223 (536)
.++||||+.|++|.+++... ..+++..++.++.|++.||+|||+.|++||||||+||+++.++.++|+|||++.....
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 76 LCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 99999999999999998653 5789999999999999999999999999999999999999999999999999875432
Q ss_pred hhcc---------------------------cCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchh
Q 009364 224 LATV---------------------------SGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQ 276 (536)
Q Consensus 224 ~~~~---------------------------~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~ 276 (536)
.... .......||..|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 1110 0112346899999999999888999999999999999999999999654
Q ss_pred hHHHHHHHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCC----HHHHHhCCCCcCCC
Q 009364 277 YQEVAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPT----ASELLKHPFVTGDD 334 (536)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps----~~eiL~hp~~~~~~ 334 (536)
...... ..........+....++..++++|.+||..||++||| +.++++||||++..
T Consensus 236 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~ 296 (316)
T cd05574 236 NRDETF-SNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVN 296 (316)
T ss_pred chHHHH-HHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCC
Confidence 332211 1111111111222237899999999999999999999 99999999998654
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=339.56 Aligned_cols=253 Identities=28% Similarity=0.557 Sum_probs=213.6
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCce
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESL 146 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 146 (536)
+|++.+.||+|+||.||++.+..+|+.||+|.+.... ......+.+.+|+.+++.++||||+++++++...+..
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISK------MSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNL 74 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHh------CChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeE
Confidence 6899999999999999999999999999999884311 1122345678899999999999999999999999999
Q ss_pred eEEEEecCCCCcccccccC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhh
Q 009364 147 NILLEFVPGGSISSLLGKF--GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAEL 224 (536)
Q Consensus 147 ~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 224 (536)
++|+||+.+++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 75 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~ 154 (256)
T cd08218 75 YIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST 154 (256)
T ss_pred EEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcc
Confidence 9999999999999988653 35789999999999999999999999999999999999999999999999998765432
Q ss_pred hcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH-HHHHHhhCCCCCCCCCCCcCcHHH
Q 009364 225 ATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE-VAALFHIGTTKSHPPIPENLSVKA 303 (536)
Q Consensus 225 ~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~ 303 (536)
.. ......|++.|+|||++.+..++.++|+|||||++|+|++|..||...... ..... .....+..+..++.++
T Consensus 155 ~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 229 (256)
T cd08218 155 VE--LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKI---IRGSYPPVSSHYSYDL 229 (256)
T ss_pred hh--hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHH---hcCCCCCCcccCCHHH
Confidence 11 123456899999999999888999999999999999999999999654322 11111 1222344566789999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHhCCCC
Q 009364 304 KDFLLKCLEKEPDLRPTASELLKHPFV 330 (536)
Q Consensus 304 ~dLi~~cL~~dP~~Rps~~eiL~hp~~ 330 (536)
.++|.+||+.+|.+||++.++++||||
T Consensus 230 ~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 230 RNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred HHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=344.29 Aligned_cols=257 Identities=37% Similarity=0.623 Sum_probs=207.6
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeEeeeee
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRYLGTVR 141 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~ 141 (536)
.+..+|++.+.||+|+||.||+|.+..+++.+|+|++... ......+.+|+.+++++ +|||++++++++.
T Consensus 19 ~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~---------~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI---------SDVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred CCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc---------ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 4567899999999999999999999999999999987311 11234566888999988 7999999999987
Q ss_pred cC-----CceeEEEEecCCCCcccccc----cCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEE
Q 009364 142 EE-----ESLNILLEFVPGGSISSLLG----KFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKL 212 (536)
Q Consensus 142 ~~-----~~~~lV~E~~~gg~L~~~l~----~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL 212 (536)
.. ..+++||||++|++|.+++. ....+++..++.++.|++.||.|||+.|++||||||+||+++.++.+||
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl 169 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKL 169 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEE
Confidence 53 35899999999999998875 3457899999999999999999999999999999999999999999999
Q ss_pred EecCcchhhhhhhcccCCcccCCCCCCCChhhhhhc-----CCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhh-
Q 009364 213 ADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQT-----GHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHI- 286 (536)
Q Consensus 213 ~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~-----~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~- 286 (536)
+|||++........ ......|+..|+|||++... .++.++|||||||++|+|++|++||........ ....
T Consensus 170 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~-~~~~~ 246 (291)
T cd06639 170 VDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT-LFKIP 246 (291)
T ss_pred eecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH-HHHHh
Confidence 99999876543211 12345689999999998643 368899999999999999999999975432211 1111
Q ss_pred CCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCc
Q 009364 287 GTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVT 331 (536)
Q Consensus 287 ~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~ 331 (536)
.........+..++..+++||.+||+.+|.+||++.++++||||+
T Consensus 247 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 247 RNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred cCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 111111122445778899999999999999999999999999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=344.55 Aligned_cols=256 Identities=37% Similarity=0.629 Sum_probs=206.7
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeEeeeee
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRYLGTVR 141 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~ 141 (536)
....+|++.+.||+|+||.||+|.+..+++.+|+|++... ......+.+|+.+++.+ +||||+++++++.
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~---------~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 85 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI---------HDIDEEIEAEYNILKALSDHPNVVKFYGMYY 85 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc---------cchHHHHHHHHHHHHHHhcCCCeeeeeeeee
Confidence 4556899999999999999999999999999999986210 11124567899999999 6999999999874
Q ss_pred -----cCCceeEEEEecCCCCcccccc----cCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEE
Q 009364 142 -----EEESLNILLEFVPGGSISSLLG----KFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKL 212 (536)
Q Consensus 142 -----~~~~~~lV~E~~~gg~L~~~l~----~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL 212 (536)
..+.+++||||++|++|.+++. ....+++..++.++.|++.||.|||+.+++||||||+||+++.++.+||
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl 165 (286)
T cd06638 86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKL 165 (286)
T ss_pred ecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEE
Confidence 4457899999999999988764 3356899999999999999999999999999999999999999999999
Q ss_pred EecCcchhhhhhhcccCCcccCCCCCCCChhhhhh-----cCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhC
Q 009364 213 ADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQ-----TGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIG 287 (536)
Q Consensus 213 ~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~-----~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~ 287 (536)
+|||+++...... .......|++.|+|||++.. ..++.++||||+||++|+|++|..||....... ......
T Consensus 166 ~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~-~~~~~~ 242 (286)
T cd06638 166 VDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR-ALFKIP 242 (286)
T ss_pred ccCCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH-HHhhcc
Confidence 9999987654321 12234569999999999853 457889999999999999999999996543211 111111
Q ss_pred C-CCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCC
Q 009364 288 T-TKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFV 330 (536)
Q Consensus 288 ~-~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~ 330 (536)
. .......+..++.++.+||.+||+.||.+|||+.++++|+||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 243 RNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred ccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 1 111222344578899999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=340.89 Aligned_cols=253 Identities=30% Similarity=0.542 Sum_probs=213.9
Q ss_pred EcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCceeEEEEec
Q 009364 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESLNILLEFV 153 (536)
Q Consensus 74 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 153 (536)
||.|+||.||+|.+..+++.+|+|++.... .......+.+.+|+.+++.++||||+++++.+.+....++|+||+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRH-----IVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhc-----chhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecC
Confidence 699999999999999899999999884221 112234467889999999999999999999999999999999999
Q ss_pred CCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhcccCCccc
Q 009364 154 PGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSM 233 (536)
Q Consensus 154 ~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 233 (536)
++++|.+++.+...+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 76 ~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~ 152 (262)
T cd05572 76 LGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTF 152 (262)
T ss_pred CCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccc
Confidence 999999999887889999999999999999999999999999999999999999999999999988765421 12345
Q ss_pred CCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHH-HhhCCCCCCCCCCCcCcHHHHHHHHHhcc
Q 009364 234 KGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAAL-FHIGTTKSHPPIPENLSVKAKDFLLKCLE 312 (536)
Q Consensus 234 ~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~-~~~~~~~~~~~~~~~~s~~~~dLi~~cL~ 312 (536)
.|++.|+|||.+.+..++.++|+||+|+++|+|++|..||.....+.... ...........++...+.+++++|.+||.
T Consensus 153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 232 (262)
T cd05572 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLR 232 (262)
T ss_pred cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHcc
Confidence 78999999999988889999999999999999999999997554111111 11111233445666678999999999999
Q ss_pred cCCCCCCC-----HHHHHhCCCCcCCC
Q 009364 313 KEPDLRPT-----ASELLKHPFVTGDD 334 (536)
Q Consensus 313 ~dP~~Rps-----~~eiL~hp~~~~~~ 334 (536)
.+|.+||+ +.|+++||||....
T Consensus 233 ~~p~~R~~~~~~~~~~l~~~~~~~~~~ 259 (262)
T cd05572 233 RNPEERLGNLKGGIKDIKKHKWFNGFD 259 (262)
T ss_pred CChhhCcCCcccCHHHHhcChhhhCCC
Confidence 99999999 99999999998653
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=359.34 Aligned_cols=258 Identities=29% Similarity=0.487 Sum_probs=212.1
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCC-CCceeeEeeeeecCC
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS-HPNIVRYLGTVREEE 144 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~ 144 (536)
..|++.++||+||.+.||++.... ...||+|.+. ........+..+.+|+.+|.+|+ |.+||++|++-..++
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~------~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~ 433 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVV------LLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDG 433 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCC-CcchhhhHHH------HhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCc
Confidence 469999999999999999998644 4456666542 23334456778999999999995 999999999999999
Q ss_pred ceeEEEEecCCCCcccccccCCC-CCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhh
Q 009364 145 SLNILLEFVPGGSISSLLGKFGP-FPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAE 223 (536)
Q Consensus 145 ~~~lV~E~~~gg~L~~~l~~~~~-l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 223 (536)
.+|+||||- ..+|..+|++... .+...++.+..|++.|+.++|..||||.||||.|+|+- .|.+||+|||+|..+..
T Consensus 434 ~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 434 YLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQP 511 (677)
T ss_pred eEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCc
Confidence 999999986 5789999887654 44467889999999999999999999999999999995 47999999999999888
Q ss_pred hhcccCCcccCCCCCCCChhhhhhcC-----------CCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCC
Q 009364 224 LATVSGAKSMKGTPYWMAPEVIRQTG-----------HSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSH 292 (536)
Q Consensus 224 ~~~~~~~~~~~Gt~~Y~APEvl~~~~-----------~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~ 292 (536)
..+.....+.+||+.||+||.+.... .+.++||||||||||+|+.|++||.........+..+......
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~ 591 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHE 591 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCcc
Confidence 77766677889999999999986432 3578999999999999999999997655455555444443333
Q ss_pred CCCCCcCcHH-HHHHHHHhcccCCCCCCCHHHHHhCCCCcC
Q 009364 293 PPIPENLSVK-AKDFLLKCLEKEPDLRPTASELLKHPFVTG 332 (536)
Q Consensus 293 ~~~~~~~s~~-~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~ 332 (536)
.++|..-+.. +.++++.||.+||++|||..++|+|||++.
T Consensus 592 Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 592 IEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred ccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 3444333333 999999999999999999999999999975
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=345.24 Aligned_cols=242 Identities=18% Similarity=0.257 Sum_probs=202.0
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec----CCcee
Q 009364 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE----EESLN 147 (536)
Q Consensus 72 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~----~~~~~ 147 (536)
..||+|++|.||+|.. +|+.||+|.+... ........+.+.+|+.+|++++||||+++++++.+ ...++
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~ 98 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKF-----HKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLS 98 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEecccc-----ccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceE
Confidence 6799999999999987 7899999987421 11122335678899999999999999999999876 35689
Q ss_pred EEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHc-CCccccCCCCCcccCCCCcEEEEecCcchhhhhhhc
Q 009364 148 ILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNH-GIMHRDIKGANILVDNKGCIKLADFGASKQVAELAT 226 (536)
Q Consensus 148 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~-~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 226 (536)
+||||++||+|.+++.+.+.+++.....++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++.+...
T Consensus 99 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~-- 176 (283)
T PHA02988 99 LILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP-- 176 (283)
T ss_pred EEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc--
Confidence 9999999999999998888899999999999999999999985 9999999999999999999999999998765421
Q ss_pred ccCCcccCCCCCCCChhhhhh--cCCCccceEechhHHHHHHhhCCCCCchhhH-HHHHHHhhCCCCCCCCCCCcCcHHH
Q 009364 227 VSGAKSMKGTPYWMAPEVIRQ--TGHSYSADIWSVGCTVIEMATGKPPWSQQYQ-EVAALFHIGTTKSHPPIPENLSVKA 303 (536)
Q Consensus 227 ~~~~~~~~Gt~~Y~APEvl~~--~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~s~~~ 303 (536)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|..||..... +...... ........+..++..+
T Consensus 177 ---~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~l 251 (283)
T PHA02988 177 ---PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLII--NKNNSLKLPLDCPLEI 251 (283)
T ss_pred ---cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHH--hcCCCCCCCCcCcHHH
Confidence 224568999999999976 6789999999999999999999999976432 2222221 1122344556789999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHhC
Q 009364 304 KDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 304 ~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
++||.+||+.||.+|||+.++++.
T Consensus 252 ~~li~~cl~~dp~~Rps~~ell~~ 275 (283)
T PHA02988 252 KCIVEACTSHDSIKRPNIKEILYN 275 (283)
T ss_pred HHHHHHHhcCCcccCcCHHHHHHH
Confidence 999999999999999999999863
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=362.70 Aligned_cols=249 Identities=24% Similarity=0.364 Sum_probs=199.1
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
.+|++.+.||+|+||.||+|.+..+++.||+|+... .....|+.+++.++||||+++++++.....
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~--------------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 131 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK--------------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAI 131 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc--------------cccHHHHHHHHhCCCCCCcChhheEEeCCe
Confidence 479999999999999999999999999999997421 112358889999999999999999999999
Q ss_pred eeEEEEecCCCCcccccc-cCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhh
Q 009364 146 LNILLEFVPGGSISSLLG-KFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAEL 224 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~-~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 224 (536)
.++||||+. ++|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 132 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 132 TCMVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210 (357)
T ss_pred eEEEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence 999999995 57777664 4567999999999999999999999999999999999999999999999999998743221
Q ss_pred hcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCC-chhh-----------HHHHHHHhh-CCCCC
Q 009364 225 ATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPW-SQQY-----------QEVAALFHI-GTTKS 291 (536)
Q Consensus 225 ~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf-~~~~-----------~~~~~~~~~-~~~~~ 291 (536)
.......||+.|+|||++.+..++.++|||||||++|+|+++..|+ .... ......... .....
T Consensus 211 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 287 (357)
T PHA03209 211 ---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPE 287 (357)
T ss_pred ---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChh
Confidence 1233567999999999999989999999999999999999855443 3210 011111110 00000
Q ss_pred -C--------------------CCC-------CCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcC
Q 009364 292 -H--------------------PPI-------PENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTG 332 (536)
Q Consensus 292 -~--------------------~~~-------~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~ 332 (536)
. .++ ...++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 288 EFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred hcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 0 000 1245677888999999999999999999999999974
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=335.63 Aligned_cols=258 Identities=58% Similarity=1.060 Sum_probs=221.7
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC--C
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE--E 144 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~ 144 (536)
+|++.+.||+|++|.||+|.+..+++.|++|++.... ......+.+.+|+.++++++||||+++++.+... .
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSG------DSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKN 74 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCC
Confidence 5888999999999999999999899999999884321 1134467788999999999999999999999988 8
Q ss_pred ceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhh
Q 009364 145 SLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAEL 224 (536)
Q Consensus 145 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 224 (536)
.+++|+||+++++|.+++.+...+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 75 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 75 TLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred eEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 99999999999999999988779999999999999999999999999999999999999999999999999998876543
Q ss_pred hcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcHHHH
Q 009364 225 ATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAK 304 (536)
Q Consensus 225 ~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 304 (536)
..........++..|+|||.+.+..++.++||||||+++|+|++|..||...................+.++..++..++
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAK 234 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHH
Confidence 22111345678999999999988889999999999999999999999997654222333333333445567778899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhCCCC
Q 009364 305 DFLLKCLEKEPDLRPTASELLKHPFV 330 (536)
Q Consensus 305 dLi~~cL~~dP~~Rps~~eiL~hp~~ 330 (536)
++|.+||+.+|.+||++.++++||||
T Consensus 235 ~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 235 DFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 99999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=338.75 Aligned_cols=257 Identities=51% Similarity=0.920 Sum_probs=214.9
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCce
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESL 146 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 146 (536)
||.+.+.||+|+||.||+|.+..+++.||+|.+.... ......+.+.+|+.+++.++|+||+++++.+...+.+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~------~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~ 74 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQD------NDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKV 74 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcc------cchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEE
Confidence 6899999999999999999999899999999984321 1134567889999999999999999999999999999
Q ss_pred eEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhc
Q 009364 147 NILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELAT 226 (536)
Q Consensus 147 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 226 (536)
++|+||+++++|.+++.+...+++..++.++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++........
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 75 YIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred EEEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 99999999999999998877789999999999999999999999999999999999999999999999999877653222
Q ss_pred ccC--CcccCCCCCCCChhhhhhcC---CCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCC--cC
Q 009364 227 VSG--AKSMKGTPYWMAPEVIRQTG---HSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPE--NL 299 (536)
Q Consensus 227 ~~~--~~~~~Gt~~Y~APEvl~~~~---~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~ 299 (536)
... .....+++.|+|||++.+.. ++.++||||||+++|+|++|..||............... ...+.++. .+
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 233 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHKPPIPDSLQL 233 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCCCCCCccccc
Confidence 111 12356889999999998766 789999999999999999999999643222211111111 22223333 45
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHhCCCC
Q 009364 300 SVKAKDFLLKCLEKEPDLRPTASELLKHPFV 330 (536)
Q Consensus 300 s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~ 330 (536)
+..+.++|++||+.+|.+|||+.+++.|||+
T Consensus 234 ~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 234 SPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred CHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 8999999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=363.57 Aligned_cols=253 Identities=24% Similarity=0.392 Sum_probs=204.4
Q ss_pred CCCceeeeEEcccCceEEEEEEE-----cCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeEee
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMN-----LDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRYLG 138 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~-----~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~ 138 (536)
..+|++++.||+|+||+||+|.+ ..++..||+|++... ......+.+.+|+.+|+.+ +||||+++++
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~-------~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~ 106 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPS-------AHLTEREALMSELKVLSYLGNHINIVNLLG 106 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCC-------cCcHHHHHHHHHHHHHHHhcCCcceeeeee
Confidence 45799999999999999999974 345778999987321 1112345678899999999 8999999999
Q ss_pred eeecCCceeEEEEecCCCCcccccccC-----------------------------------------------------
Q 009364 139 TVREEESLNILLEFVPGGSISSLLGKF----------------------------------------------------- 165 (536)
Q Consensus 139 ~~~~~~~~~lV~E~~~gg~L~~~l~~~----------------------------------------------------- 165 (536)
++......++|||||+||+|.+++...
T Consensus 107 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 186 (375)
T cd05104 107 ACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKR 186 (375)
T ss_pred eeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccc
Confidence 999999999999999999998887532
Q ss_pred ----------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhh
Q 009364 166 ----------------------GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAE 223 (536)
Q Consensus 166 ----------------------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 223 (536)
..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 187 RSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRN 266 (375)
T ss_pred cccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccC
Confidence 1467888999999999999999999999999999999999999999999999976543
Q ss_pred hhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhH--HHHHHHhhCCCCCCCCCCCcCc
Q 009364 224 LATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQ--EVAALFHIGTTKSHPPIPENLS 300 (536)
Q Consensus 224 ~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~--~~~~~~~~~~~~~~~~~~~~~s 300 (536)
...........++..|+|||++.+..++.++|||||||++|+|++ |..||..... ......... .....+...+
T Consensus 267 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 343 (375)
T cd05104 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEG---YRMLSPECAP 343 (375)
T ss_pred cccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhC---ccCCCCCCCC
Confidence 222111223445678999999999999999999999999999998 8999965422 222222221 2233445678
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 301 VKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 301 ~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
.++++||.+||+.||++|||+.++++.
T Consensus 344 ~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 344 SEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=346.71 Aligned_cols=252 Identities=27% Similarity=0.458 Sum_probs=208.9
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCC-----cEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeee
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSG-----ELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTV 140 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g-----~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~ 140 (536)
.+|++.+.||+|+||.||+|.+...+ ..||+|.+.. .........+.+|+.+++.++||||+++++++
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~-------~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~ 77 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKE-------NAEPKVQQEFRQEAELMSDLQHPNIVCLLGVC 77 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEeccc-------CCCHHHHHHHHHHHHHHHhcCCcccceEEEEE
Confidence 36889999999999999999876655 6799998731 11223345688999999999999999999999
Q ss_pred ecCCceeEEEEecCCCCcccccccC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCccc
Q 009364 141 REEESLNILLEFVPGGSISSLLGKF----------------GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILV 204 (536)
Q Consensus 141 ~~~~~~~lV~E~~~gg~L~~~l~~~----------------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl 204 (536)
......+++|||+++|+|.+++... ..+++..+..++.|++.||.|||++|++||||||+||++
T Consensus 78 ~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~ 157 (283)
T cd05048 78 TKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLV 157 (283)
T ss_pred cCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEE
Confidence 9999999999999999999988654 457889999999999999999999999999999999999
Q ss_pred CCCCcEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhH-HHHH
Q 009364 205 DNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQ-EVAA 282 (536)
Q Consensus 205 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~-~~~~ 282 (536)
++++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|+|++ |..||..... +...
T Consensus 158 ~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~ 237 (283)
T cd05048 158 GEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIE 237 (283)
T ss_pred cCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999999999876543222222334567889999999988889999999999999999998 9999975432 2222
Q ss_pred HHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 283 LFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 283 ~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
.+. .......+..++.++.+|+.+||+.||.+||++.+|+++
T Consensus 238 ~i~---~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 238 MIR---SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHH---cCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 222 222334567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=345.69 Aligned_cols=253 Identities=29% Similarity=0.447 Sum_probs=202.7
Q ss_pred EEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHH---HHHHhCCCCceeeEeeeeecCCceeEE
Q 009364 73 LIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEV---KLLKDLSHPNIVRYLGTVREEESLNIL 149 (536)
Q Consensus 73 ~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei---~iL~~l~HpnIv~l~~~~~~~~~~~lV 149 (536)
.||+|+||.||+|.+..+|+.+|+|.+........ .......+|. .++....||||+.+++.+...+..++|
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv 75 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-----QGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFI 75 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccc-----hHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEE
Confidence 48999999999999999999999998743211110 1111122333 334445799999999999999999999
Q ss_pred EEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhcccC
Q 009364 150 LEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSG 229 (536)
Q Consensus 150 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 229 (536)
|||+++|+|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++...... .
T Consensus 76 ~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~----~ 151 (279)
T cd05633 76 LDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----K 151 (279)
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc----C
Confidence 999999999999988888999999999999999999999999999999999999999999999999998654322 1
Q ss_pred CcccCCCCCCCChhhhh-hcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcHHHHHHHH
Q 009364 230 AKSMKGTPYWMAPEVIR-QTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKDFLL 308 (536)
Q Consensus 230 ~~~~~Gt~~Y~APEvl~-~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~ 308 (536)
.....||+.|+|||++. +..++.++||||+||++|+|++|..||.....................++..++.+++++|.
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 231 (279)
T cd05633 152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLE 231 (279)
T ss_pred ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHH
Confidence 23457999999999986 45689999999999999999999999964321111111111122334466788999999999
Q ss_pred HhcccCCCCCC-----CHHHHHhCCCCcCCC
Q 009364 309 KCLEKEPDLRP-----TASELLKHPFVTGDD 334 (536)
Q Consensus 309 ~cL~~dP~~Rp-----s~~eiL~hp~~~~~~ 334 (536)
+||..||.+|| |+.++++||||+...
T Consensus 232 ~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~ 262 (279)
T cd05633 232 GLLQRDVSKRLGCLGRGAQEVKEHVFFKGID 262 (279)
T ss_pred HHhcCCHHHhcCCCCCCHHHHHhCccccCCC
Confidence 99999999999 699999999998744
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=335.77 Aligned_cols=253 Identities=28% Similarity=0.518 Sum_probs=214.7
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCce
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESL 146 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 146 (536)
+|+..+.||.|+||.||.+++..+++.+++|.+.... ........+.+|+.++++++|+||+++++++.+.+..
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~------~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~ 74 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTR------LSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTL 74 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecc------cchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeE
Confidence 6899999999999999999999999999999874221 1123345678999999999999999999999999999
Q ss_pred eEEEEecCCCCcccccccC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhh
Q 009364 147 NILLEFVPGGSISSLLGKF--GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAEL 224 (536)
Q Consensus 147 ~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 224 (536)
+++|||+++++|.+++.+. ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++......
T Consensus 75 ~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~ 154 (256)
T cd08221 75 LIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE 154 (256)
T ss_pred EEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence 9999999999999998764 46899999999999999999999999999999999999999999999999998765432
Q ss_pred hcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH-HHHHHhhCCCCCCCCCCCcCcHHH
Q 009364 225 ATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE-VAALFHIGTTKSHPPIPENLSVKA 303 (536)
Q Consensus 225 ~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~ 303 (536)
.. ......|++.|+|||++.+..++.++|||||||++|+|++|..||...... ....... ....+.+..++.++
T Consensus 155 ~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 229 (256)
T cd08221 155 YS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ---GNYTPVVSVYSSEL 229 (256)
T ss_pred cc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc---CCCCCCccccCHHH
Confidence 21 234567899999999998888899999999999999999999999754322 1111111 22233446789999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHhCCCC
Q 009364 304 KDFLLKCLEKEPDLRPTASELLKHPFV 330 (536)
Q Consensus 304 ~dLi~~cL~~dP~~Rps~~eiL~hp~~ 330 (536)
.++|.+||.++|.+||++.++++|||+
T Consensus 230 ~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 230 ISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=360.79 Aligned_cols=253 Identities=29% Similarity=0.492 Sum_probs=210.4
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE 142 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 142 (536)
.++....++..||+|.||+||+|.+.. .||||++.+.. ...+..+.+++|+.++++-+|.||+-+.|++..
T Consensus 389 Ip~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~------pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~ 459 (678)
T KOG0193|consen 389 IPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDD------PTPEQLQAFKNEVAVLKKTRHENILLFMGACMN 459 (678)
T ss_pred cCHHHhhccceeccccccceeeccccc---ceEEEEEecCC------CCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence 344456789999999999999999854 59999985432 223478899999999999999999999999998
Q ss_pred CCceeEEEEecCCCCcccccccC-CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhh
Q 009364 143 EESLNILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQV 221 (536)
Q Consensus 143 ~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~ 221 (536)
+.. .||+.||+|.+|+.+++-. .+|.......|++||++|+.|||.++|||||||..||++.+++.|||+|||++..-
T Consensus 460 p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk 538 (678)
T KOG0193|consen 460 PPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVK 538 (678)
T ss_pred Cce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeee
Confidence 887 8999999999999998654 46888999999999999999999999999999999999999999999999998765
Q ss_pred hhhhcccCCcccCCCCCCCChhhhhh---cCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCC---CCCCCC
Q 009364 222 AELATVSGAKSMKGTPYWMAPEVIRQ---TGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTT---KSHPPI 295 (536)
Q Consensus 222 ~~~~~~~~~~~~~Gt~~Y~APEvl~~---~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~---~~~~~~ 295 (536)
.............|...|||||+++. .+|+..+||||||+++|||+||..||..+..+ ..++..+.. ......
T Consensus 539 ~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d-qIifmVGrG~l~pd~s~~ 617 (678)
T KOG0193|consen 539 TRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD-QIIFMVGRGYLMPDLSKI 617 (678)
T ss_pred eeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh-heEEEecccccCccchhh
Confidence 44333444556778899999999873 46899999999999999999999999844333 223333332 122224
Q ss_pred CCcCcHHHHHHHHHhcccCCCCCCCHHHHHh
Q 009364 296 PENLSVKAKDFLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 296 ~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~ 326 (536)
..+++.++++|+..||..++++||.+.+||.
T Consensus 618 ~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 618 RSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred hccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 4578889999999999999999999999987
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=342.67 Aligned_cols=255 Identities=29% Similarity=0.463 Sum_probs=210.4
Q ss_pred EcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCceeEEEEec
Q 009364 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESLNILLEFV 153 (536)
Q Consensus 74 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 153 (536)
||+|+||+||+|.+..+|+.||+|.+.... .........+.+|+++++.++||||+++++++...+.+|+||||+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~-----~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKR-----LKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhh-----hhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecC
Confidence 699999999999999999999999874211 111223345568999999999999999999999999999999999
Q ss_pred CCCCcccccccCC--CCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhcccCCc
Q 009364 154 PGGSISSLLGKFG--PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAK 231 (536)
Q Consensus 154 ~gg~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 231 (536)
++++|.+++.+.+ .+++..+..++.|++.||.|||++|++||||+|+||+++.++.+||+|||.+...... ....
T Consensus 76 ~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~ 152 (277)
T cd05577 76 NGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIK 152 (277)
T ss_pred CCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC---Cccc
Confidence 9999999987655 7999999999999999999999999999999999999999999999999998765431 1223
Q ss_pred ccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH-HHHHHhhCCCCCCCCCCCcCcHHHHHHHHHh
Q 009364 232 SMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE-VAALFHIGTTKSHPPIPENLSVKAKDFLLKC 310 (536)
Q Consensus 232 ~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~c 310 (536)
...|+..|+|||++.+..++.++|||||||++|+|++|+.||...... ................+..+++.+.++|.+|
T Consensus 153 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 232 (277)
T cd05577 153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEAL 232 (277)
T ss_pred cccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHH
Confidence 456889999999998888999999999999999999999999654321 1111111122233345667899999999999
Q ss_pred cccCCCCCC-----CHHHHHhCCCCcCCCCC
Q 009364 311 LEKEPDLRP-----TASELLKHPFVTGDDED 336 (536)
Q Consensus 311 L~~dP~~Rp-----s~~eiL~hp~~~~~~~~ 336 (536)
|+.||.+|| ++.++++||||....++
T Consensus 233 l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~ 263 (277)
T cd05577 233 LQKDPEKRLGCRGGSADEVREHPLFKDLNWR 263 (277)
T ss_pred ccCChhHccCCCcccHHHHHhChhhhcCChh
Confidence 999999999 89999999999765443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=352.83 Aligned_cols=249 Identities=24% Similarity=0.425 Sum_probs=190.0
Q ss_pred eeEEcccCceEEEEEEEcC--CCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeee--cCCce
Q 009364 71 GELIGCGAFGRVYMGMNLD--SGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVR--EEESL 146 (536)
Q Consensus 71 ~~~LG~G~fg~Vy~a~~~~--~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~--~~~~~ 146 (536)
+..||+|+||+||+|.+.. ++..||+|.+... .....+.+|+.+++.++||||+++++++. ....+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~----------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 75 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT----------GISMSACREIALLRELKHPNVIALQKVFLSHSDRKV 75 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCC----------CCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeE
Confidence 4689999999999998654 5688999987311 01134568999999999999999999885 35678
Q ss_pred eEEEEecCCCCccccccc---------CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCccc----CCCCcEEEE
Q 009364 147 NILLEFVPGGSISSLLGK---------FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILV----DNKGCIKLA 213 (536)
Q Consensus 147 ~lV~E~~~gg~L~~~l~~---------~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl----~~~~~vkL~ 213 (536)
++||||+. ++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+
T Consensus 76 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~ 154 (317)
T cd07867 76 WLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA 154 (317)
T ss_pred EEEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEe
Confidence 99999996 466655431 2358899999999999999999999999999999999999 456799999
Q ss_pred ecCcchhhhhhhc-ccCCcccCCCCCCCChhhhhh-cCCCccceEechhHHHHHHhhCCCCCchhhHH-----------H
Q 009364 214 DFGASKQVAELAT-VSGAKSMKGTPYWMAPEVIRQ-TGHSYSADIWSVGCTVIEMATGKPPWSQQYQE-----------V 280 (536)
Q Consensus 214 DFGla~~~~~~~~-~~~~~~~~Gt~~Y~APEvl~~-~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~-----------~ 280 (536)
|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|+|+||.+||.....+ .
T Consensus 155 DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~ 234 (317)
T cd07867 155 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQL 234 (317)
T ss_pred eccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHH
Confidence 9999987643211 112345678999999999876 45799999999999999999999999642211 0
Q ss_pred HHHHhhCCCC---------------------------------CCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 281 AALFHIGTTK---------------------------------SHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 281 ~~~~~~~~~~---------------------------------~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
.......... .........+..+.+||.+||+.||.+|||+.|+|+|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h 314 (317)
T cd07867 235 DRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD 314 (317)
T ss_pred HHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence 0000000000 0000112345678899999999999999999999999
Q ss_pred CCC
Q 009364 328 PFV 330 (536)
Q Consensus 328 p~~ 330 (536)
|||
T Consensus 315 p~f 317 (317)
T cd07867 315 PYF 317 (317)
T ss_pred CCC
Confidence 998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=345.20 Aligned_cols=257 Identities=31% Similarity=0.527 Sum_probs=214.6
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
.+|++.+.||+|+||+||+|.+..+|+.||+|++... ......+.+.+|+++++.++||||+++++.+.....
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 77 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIG-------AKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENN 77 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEec-------CcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCE
Confidence 4688999999999999999999999999999987421 112234667899999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHH-cCCccccCCCCCcccCCCCcEEEEecCcchhhhhh
Q 009364 146 LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHN-HGIMHRDIKGANILVDNKGCIKLADFGASKQVAEL 224 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~-~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 224 (536)
+++||||+++++|.+++.+.+.+++..+..++.|++.||.|||+ .+++||||||+||++++++.++|+|||++......
T Consensus 78 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 78 ICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred EEEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 99999999999999999887889999999999999999999997 58999999999999999999999999998654321
Q ss_pred hcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH---------HHHHHhhCCCCCCCCC
Q 009364 225 ATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE---------VAALFHIGTTKSHPPI 295 (536)
Q Consensus 225 ~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~---------~~~~~~~~~~~~~~~~ 295 (536)
......|+..|+|||++.+..++.++|||||||++|+|++|..||...... .............+.+
T Consensus 158 ----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd06620 158 ----IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRL 233 (284)
T ss_pred ----ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCC
Confidence 123467999999999998888999999999999999999999999743221 1111111111112222
Q ss_pred CC-cCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 296 PE-NLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 296 ~~-~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
+. .++.++.+||.+||.+||.+|||+.++++|+||...
T Consensus 234 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 234 PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 22 378899999999999999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=344.37 Aligned_cols=258 Identities=32% Similarity=0.538 Sum_probs=211.9
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
.+|++.+.||+|+||.||+|.+..+++.||+|++... .......+.+.+|+++++.++|+||+++++++...+.
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~------~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 74 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKES------EDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGR 74 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhh------cccccchhHHHHHHHHHHhcCCCCeeehhheEEECCE
Confidence 3799999999999999999999999999999987321 1122334677899999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhh
Q 009364 146 LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA 225 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 225 (536)
.++||||++++.+..+..+...+++..++.++.||+.||.|||++|++||||+|+||+++.++.+||+|||++.......
T Consensus 75 ~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 75 LYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 99999999988887777776779999999999999999999999999999999999999999999999999988765432
Q ss_pred cccCCcccCCCCCCCChhhhhhc-CCCccceEechhHHHHHHhhCCCCCchhhHH--HHHHHhh-C------------CC
Q 009364 226 TVSGAKSMKGTPYWMAPEVIRQT-GHSYSADIWSVGCTVIEMATGKPPWSQQYQE--VAALFHI-G------------TT 289 (536)
Q Consensus 226 ~~~~~~~~~Gt~~Y~APEvl~~~-~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~--~~~~~~~-~------------~~ 289 (536)
. .......|+..|+|||++.+. .++.++||||||+++|+|++|.+||...... ....... . ..
T Consensus 155 ~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 155 A-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP 233 (288)
T ss_pred c-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence 2 123456789999999999887 7899999999999999999999999643211 1110000 0 00
Q ss_pred -----CC---------CCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCC
Q 009364 290 -----KS---------HPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFV 330 (536)
Q Consensus 290 -----~~---------~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~ 330 (536)
.. ...++..++.++++||++||..+|++|||+.++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 00 001233458899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=337.30 Aligned_cols=254 Identities=32% Similarity=0.556 Sum_probs=213.2
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec--CC
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE--EE 144 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--~~ 144 (536)
+|++.+.||.|+||.||+|.+..+|+.+|+|.+... .......+.+.+|+.+++.++||||+++++.+.. ..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~------~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYG------NMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQ 74 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecc------cCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCC
Confidence 588999999999999999999999999999987421 1122334667889999999999999999997754 45
Q ss_pred ceeEEEEecCCCCccccccc----CCCCCHHHHHHHHHHHHHHHHHHH-----HcCCccccCCCCCcccCCCCcEEEEec
Q 009364 145 SLNILLEFVPGGSISSLLGK----FGPFPEAVMRTYTKQLLLGLEYLH-----NHGIMHRDIKGANILVDNKGCIKLADF 215 (536)
Q Consensus 145 ~~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qil~aL~yLH-----~~~ivHrDLKp~NILl~~~~~vkL~DF 215 (536)
..+++|||+++++|.+++.. ..++++..++.++.||+.||.||| +.+++||||||+||+++.++.+||+||
T Consensus 75 ~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~ 154 (265)
T cd08217 75 TLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDF 154 (265)
T ss_pred EEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecc
Confidence 68999999999999998864 367899999999999999999999 899999999999999999999999999
Q ss_pred CcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCC
Q 009364 216 GASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPI 295 (536)
Q Consensus 216 Gla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 295 (536)
|++........ ......|++.|+|||++.+..++.++|+||||+++|+|++|..||....... ..........+.+
T Consensus 155 g~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~ 230 (265)
T cd08217 155 GLAKILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ--LASKIKEGKFRRI 230 (265)
T ss_pred cccccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH--HHHHHhcCCCCCC
Confidence 99887654221 1234578999999999998889999999999999999999999997653221 1111222334456
Q ss_pred CCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCC
Q 009364 296 PENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFV 330 (536)
Q Consensus 296 ~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~ 330 (536)
+..++..+.+++.+||..+|.+||++.+|++|||+
T Consensus 231 ~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 231 PYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred ccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 67889999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=343.00 Aligned_cols=258 Identities=38% Similarity=0.693 Sum_probs=217.1
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
..|+..+.||.|+||.||+|.+..++..||+|++... ........+.+|+.+++.+.||||+++++.+.+...
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~-------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 76 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE-------EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTK 76 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecc-------ccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCE
Confidence 3578889999999999999999999999999987421 112345678899999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhh
Q 009364 146 LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA 225 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 225 (536)
.++||||++||+|.+++.. +++++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++.......
T Consensus 77 ~~lv~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 77 LWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred EEEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence 9999999999999998865 578999999999999999999999999999999999999999999999999987654321
Q ss_pred cccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcHHHHH
Q 009364 226 TVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKD 305 (536)
Q Consensus 226 ~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 305 (536)
.......++..|+|||++.+..++.++|+|||||++|+|++|.+||.......... .......+.++..++..+.+
T Consensus 156 --~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 231 (277)
T cd06640 156 --IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF--LIPKNNPPTLTGEFSKPFKE 231 (277)
T ss_pred --cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh--hhhcCCCCCCchhhhHHHHH
Confidence 12234568899999999998889999999999999999999999997543221111 11112234455678889999
Q ss_pred HHHHhcccCCCCCCCHHHHHhCCCCcCCCC
Q 009364 306 FLLKCLEKEPDLRPTASELLKHPFVTGDDE 335 (536)
Q Consensus 306 Li~~cL~~dP~~Rps~~eiL~hp~~~~~~~ 335 (536)
+|.+||..+|.+||++.++++||||.....
T Consensus 232 li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 261 (277)
T cd06640 232 FIDACLNKDPSFRPTAKELLKHKFIVKNAK 261 (277)
T ss_pred HHHHHcccCcccCcCHHHHHhChHhhhcch
Confidence 999999999999999999999999976543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=343.08 Aligned_cols=257 Identities=30% Similarity=0.519 Sum_probs=208.5
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCce
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESL 146 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 146 (536)
+|++.+.||+|+||.||+|.+..+|+.||+|++.... ........+.+|+.+++.++||||+++++++.....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 74 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRR------LEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGF 74 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccc------ccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCee
Confidence 5899999999999999999999999999999884321 1122345678899999999999999999999999999
Q ss_pred eEEEEecCCCCccccccc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhh
Q 009364 147 NILLEFVPGGSISSLLGK-FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA 225 (536)
Q Consensus 147 ~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 225 (536)
++|+||+ +++|.+++.. ...+++..++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 75 ~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 75 VLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred EEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9999999 9999998854 4679999999999999999999999999999999999999999999999999987664322
Q ss_pred cccCCcccCCCCCCCChhhhhhc-CCCccceEechhHHHHHHhhCCCCCchhhHH--HHHHHhhCCC-------------
Q 009364 226 TVSGAKSMKGTPYWMAPEVIRQT-GHSYSADIWSVGCTVIEMATGKPPWSQQYQE--VAALFHIGTT------------- 289 (536)
Q Consensus 226 ~~~~~~~~~Gt~~Y~APEvl~~~-~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~--~~~~~~~~~~------------- 289 (536)
. .......|+..|+|||++.+. .++.++||||+||++|+|++|.+||...... ..........
T Consensus 154 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 154 P-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred C-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcc
Confidence 1 123345689999999998654 4689999999999999999999888643321 1111110000
Q ss_pred -------CC-----CCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCc
Q 009364 290 -------KS-----HPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVT 331 (536)
Q Consensus 290 -------~~-----~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~ 331 (536)
.. .....+..+..+.+||++||..+|.+|||++++++||||.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 00 0011235678999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=342.12 Aligned_cols=257 Identities=30% Similarity=0.516 Sum_probs=202.2
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHH-HHhCCCCceeeEeeeeecCC
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKL-LKDLSHPNIVRYLGTVREEE 144 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~i-L~~l~HpnIv~l~~~~~~~~ 144 (536)
++|++.+.||+|+||.||+|.+..+|+.||+|.+..... . .....+..|+.+ ++.++||||+++++++....
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~------~-~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~ 73 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN------S-QEQKRLLMDLDISMRSVDCPYTVTFYGALFREG 73 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC------c-HHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCC
Confidence 368999999999999999999999999999998742210 1 112233445554 66678999999999999999
Q ss_pred ceeEEEEecCCCCcccccc----cCCCCCHHHHHHHHHHHHHHHHHHHHc-CCccccCCCCCcccCCCCcEEEEecCcch
Q 009364 145 SLNILLEFVPGGSISSLLG----KFGPFPEAVMRTYTKQLLLGLEYLHNH-GIMHRDIKGANILVDNKGCIKLADFGASK 219 (536)
Q Consensus 145 ~~~lV~E~~~gg~L~~~l~----~~~~l~~~~~~~i~~qil~aL~yLH~~-~ivHrDLKp~NILl~~~~~vkL~DFGla~ 219 (536)
..++||||++ |+|.+++. ....+++..++.++.||+.||+|||++ +++||||||+||+++.++.+||+|||++.
T Consensus 74 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~ 152 (283)
T cd06617 74 DVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISG 152 (283)
T ss_pred cEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccc
Confidence 9999999996 66666553 335689999999999999999999998 99999999999999999999999999987
Q ss_pred hhhhhhcccCCcccCCCCCCCChhhhhh----cCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCC
Q 009364 220 QVAELATVSGAKSMKGTPYWMAPEVIRQ----TGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPI 295 (536)
Q Consensus 220 ~~~~~~~~~~~~~~~Gt~~Y~APEvl~~----~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 295 (536)
...... ......|+..|+|||++.+ ..++.++|+|||||++|+|++|..||............... ...+.+
T Consensus 153 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~ 228 (283)
T cd06617 153 YLVDSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE-EPSPQL 228 (283)
T ss_pred cccccc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHh-cCCCCC
Confidence 654321 1233568999999999865 45688999999999999999999999642211111111111 111222
Q ss_pred C-CcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCC
Q 009364 296 P-ENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDD 334 (536)
Q Consensus 296 ~-~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~ 334 (536)
+ ..++.+++++|.+||..+|.+||++.++++||||....
T Consensus 229 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 229 PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 2 35789999999999999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=347.61 Aligned_cols=257 Identities=34% Similarity=0.528 Sum_probs=212.7
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
..|.....||+|+||.||++.+..++..||||.+.. ......+.+.+|+.+++.++|+||+++++.+...+.
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~--------~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~ 93 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDL--------RKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDE 93 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEec--------chHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCe
Confidence 345667789999999999999999999999998732 122334567899999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhh
Q 009364 146 LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA 225 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 225 (536)
.++||||+++++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 94 ~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~ 172 (292)
T cd06658 94 LWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV 172 (292)
T ss_pred EEEEEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc
Confidence 9999999999999998754 568999999999999999999999999999999999999999999999999987654321
Q ss_pred cccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH-HHHHHhhCCCCCCCCCCCcCcHHHH
Q 009364 226 TVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE-VAALFHIGTTKSHPPIPENLSVKAK 304 (536)
Q Consensus 226 ~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~~ 304 (536)
.......|++.|+|||++.+..++.++|||||||++|+|++|..||...... ........ ..........++..++
T Consensus 173 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 249 (292)
T cd06658 173 --PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDN-LPPRVKDSHKVSSVLR 249 (292)
T ss_pred --ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCCccccccccCHHHH
Confidence 2233457899999999998888999999999999999999999999654321 11111111 1111222335788999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhCCCCcCCC
Q 009364 305 DFLLKCLEKEPDLRPTASELLKHPFVTGDD 334 (536)
Q Consensus 305 dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~ 334 (536)
+++.+||..||.+|||+.++++||||....
T Consensus 250 ~li~~~l~~~P~~Rpt~~~il~~~~~~~~~ 279 (292)
T cd06658 250 GFLDLMLVREPSQRATAQELLQHPFLKLAG 279 (292)
T ss_pred HHHHHHccCChhHCcCHHHHhhChhhhccC
Confidence 999999999999999999999999998544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=335.76 Aligned_cols=253 Identities=30% Similarity=0.542 Sum_probs=213.1
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCce
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESL 146 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 146 (536)
+|++.+.||+|+||.||+|.+..+++.+|+|.+.... ........+.+|+.+++.++||||+++++.+...+..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~------~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 74 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQ------MTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKAL 74 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccc------cccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEE
Confidence 5899999999999999999999999999999884321 1123356788999999999999999999999999999
Q ss_pred eEEEEecCCCCcccccccC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCC-cEEEEecCcchhhhh
Q 009364 147 NILLEFVPGGSISSLLGKF--GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKG-CIKLADFGASKQVAE 223 (536)
Q Consensus 147 ~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~-~vkL~DFGla~~~~~ 223 (536)
++||||+++++|.+++... ..+++..+..++.|++.||+|||++|++||||+|+||+++.++ .+||+|||++.....
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (256)
T cd08220 75 MIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS 154 (256)
T ss_pred EEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence 9999999999999998753 3589999999999999999999999999999999999998654 689999999876643
Q ss_pred hhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcHHH
Q 009364 224 LATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKA 303 (536)
Q Consensus 224 ~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 303 (536)
.. ......|++.|+|||.+.+..++.++||||||+++|+|++|..||........... .......+++..++.++
T Consensus 155 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l 229 (256)
T cd08220 155 KS---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLK--IMSGTFAPISDRYSPDL 229 (256)
T ss_pred Cc---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHH--HHhcCCCCCCCCcCHHH
Confidence 21 12345689999999999988889999999999999999999999975432221111 11222334566789999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHhCCCC
Q 009364 304 KDFLLKCLEKEPDLRPTASELLKHPFV 330 (536)
Q Consensus 304 ~dLi~~cL~~dP~~Rps~~eiL~hp~~ 330 (536)
++++.+||..+|.+|||+.++++||||
T Consensus 230 ~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 230 RQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=339.64 Aligned_cols=251 Identities=23% Similarity=0.390 Sum_probs=205.5
Q ss_pred CCCceeeeEEcccCceEEEEEEEc---CCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeee
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNL---DSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVR 141 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~ 141 (536)
..+|++.+.||+|+||.||+|.+. ..+..||+|.+... ........+.+|+.+++.++||||+++++++.
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~-------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 76 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAG-------CSDKQRRGFLAEALTLGQFDHSNIVRLEGVIT 76 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCC-------CCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEe
Confidence 347999999999999999999765 34678999987321 11233456788999999999999999999999
Q ss_pred cCCceeEEEEecCCCCcccccccC-CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchh
Q 009364 142 EEESLNILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQ 220 (536)
Q Consensus 142 ~~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~ 220 (536)
..+..++||||+++|+|.+++... ..+++..++.++.||+.||+|||++|++||||||+|||++.++.+|++|||.+..
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~ 156 (266)
T cd05064 77 RGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQE 156 (266)
T ss_pred cCCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccc
Confidence 999999999999999999988764 5789999999999999999999999999999999999999999999999998765
Q ss_pred hhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhHH-HHHHHhhCCCCCCCCCCCc
Q 009364 221 VAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQE-VAALFHIGTTKSHPPIPEN 298 (536)
Q Consensus 221 ~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~ 298 (536)
..... ........++..|+|||++.+..++.++|||||||++|+|++ |..||...... ....... ....+.+..
T Consensus 157 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~ 232 (266)
T cd05064 157 DKSEA-IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVED---GFRLPAPRN 232 (266)
T ss_pred ccccc-hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHC---CCCCCCCCC
Confidence 32211 111223345678999999999999999999999999999775 99999754322 2222221 123345678
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHh
Q 009364 299 LSVKAKDFLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 299 ~s~~~~dLi~~cL~~dP~~Rps~~eiL~ 326 (536)
++..+.+++.+||+.+|.+||++.+|++
T Consensus 233 ~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 233 CPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred CCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 8999999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=336.04 Aligned_cols=261 Identities=48% Similarity=0.877 Sum_probs=216.8
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC-
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE- 143 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~- 143 (536)
+.+|++.+.||+|+||.||+|.+..+|+.||+|.+..... ..........+.+|+.+++.++|+||+++++.+.+.
T Consensus 1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~ 77 (264)
T cd06653 1 PVNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPD---SQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPE 77 (264)
T ss_pred CCceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcc---cchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCC
Confidence 3579999999999999999999999999999998743211 111234456788999999999999999999998764
Q ss_pred -CceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhh
Q 009364 144 -ESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVA 222 (536)
Q Consensus 144 -~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~ 222 (536)
..+++|+||+++++|.+++...+.+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||+++...
T Consensus 78 ~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 78 EKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 4588999999999999999877789999999999999999999999999999999999999999999999999988654
Q ss_pred hhhc-ccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcH
Q 009364 223 ELAT-VSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSV 301 (536)
Q Consensus 223 ~~~~-~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 301 (536)
.... ........|+..|+|||++.+..++.++|+|||||++|+|++|.+||...... ............+.+|..++.
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~p~~~~~ 236 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM-AAIFKIATQPTKPMLPDGVSD 236 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH-HHHHHHHcCCCCCCCCcccCH
Confidence 2111 11123456899999999999888999999999999999999999999754322 222222333344557788999
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhCCCC
Q 009364 302 KAKDFLLKCLEKEPDLRPTASELLKHPFV 330 (536)
Q Consensus 302 ~~~dLi~~cL~~dP~~Rps~~eiL~hp~~ 330 (536)
.++++|.+||. +|.+||++.++++|||+
T Consensus 237 ~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 237 ACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 99999999999 57999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=341.63 Aligned_cols=258 Identities=28% Similarity=0.442 Sum_probs=205.5
Q ss_pred EEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCceeEEEEe
Q 009364 73 LIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESLNILLEF 152 (536)
Q Consensus 73 ~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 152 (536)
.||+|+||.||+|.+..+|+.||+|.+........ ............+.+++...||||+++++.+...+.+++||||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK--QGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDL 78 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccc--hhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEec
Confidence 48999999999999999999999998743211100 1011111112234455566899999999999999999999999
Q ss_pred cCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhcccCCcc
Q 009364 153 VPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKS 232 (536)
Q Consensus 153 ~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 232 (536)
+.||+|..++.+.+.+++..++.++.|++.||.|||+.+|+||||||+||+++.++.+||+|||++...... ....
T Consensus 79 ~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~----~~~~ 154 (278)
T cd05606 79 MNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHA 154 (278)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc----CCcC
Confidence 999999999988788999999999999999999999999999999999999999999999999998755321 1234
Q ss_pred cCCCCCCCChhhhhhc-CCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcHHHHHHHHHhc
Q 009364 233 MKGTPYWMAPEVIRQT-GHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKDFLLKCL 311 (536)
Q Consensus 233 ~~Gt~~Y~APEvl~~~-~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~cL 311 (536)
.+|+..|+|||++.+. .++.++||||+||++|+|++|+.||.....................++..++.++.+++.+||
T Consensus 155 ~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l 234 (278)
T cd05606 155 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLL 234 (278)
T ss_pred cCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHh
Confidence 5799999999998754 689999999999999999999999965421111111111122234566678999999999999
Q ss_pred ccCCCCCC-----CHHHHHhCCCCcCCCCC
Q 009364 312 EKEPDLRP-----TASELLKHPFVTGDDED 336 (536)
Q Consensus 312 ~~dP~~Rp-----s~~eiL~hp~~~~~~~~ 336 (536)
..+|.+|| ++.++++||||....+.
T Consensus 235 ~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~ 264 (278)
T cd05606 235 QRDVNRRLGCLGRGAQEVKEHPFFRSLDWQ 264 (278)
T ss_pred hcCHHhccCCCCCCHHHHHhCccccCCCch
Confidence 99999999 99999999999876544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=334.89 Aligned_cols=250 Identities=28% Similarity=0.549 Sum_probs=210.1
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCce
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESL 146 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 146 (536)
+|++.+.||+|+||.||++.+..+++.+|+|.+... ......+.+.+|+.+++.++|+||+++++.+...+.+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~-------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 73 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLP-------KSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHL 73 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcC-------cchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEE
Confidence 588999999999999999999999999999987421 1122345677899999999999999999999999999
Q ss_pred eEEEEecCCCCccccccc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhh
Q 009364 147 NILLEFVPGGSISSLLGK--FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAEL 224 (536)
Q Consensus 147 ~lV~E~~~gg~L~~~l~~--~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 224 (536)
++||||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||.++.....
T Consensus 74 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 153 (255)
T cd08219 74 YIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP 153 (255)
T ss_pred EEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccc
Confidence 999999999999988754 345899999999999999999999999999999999999999999999999998765432
Q ss_pred hcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcHHHH
Q 009364 225 ATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAK 304 (536)
Q Consensus 225 ~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 304 (536)
.. ......|++.|+|||++.+..++.++|+||||+++|+|++|..||........... . ......+.+..++..++
T Consensus 154 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~ 229 (255)
T cd08219 154 GA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILK-V-CQGSYKPLPSHYSYELR 229 (255)
T ss_pred cc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHH-H-hcCCCCCCCcccCHHHH
Confidence 11 12346789999999999988899999999999999999999999975432221111 1 12223345667889999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhC
Q 009364 305 DFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 305 dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
+||.+||+.||.+||++.+++.-
T Consensus 230 ~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 230 SLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHHHHHhCCcccCCCHHHHhhc
Confidence 99999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=344.14 Aligned_cols=256 Identities=32% Similarity=0.535 Sum_probs=208.7
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCce
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESL 146 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 146 (536)
+|++.+.||+|+||.||+|.+..+++.||+|.+.... ......+.+.+|+++++.++||||+++++++......
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 75 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESE------DDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRL 75 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhcc------CcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeE
Confidence 6899999999999999999999899999999873211 1112335577899999999999999999999999999
Q ss_pred eEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhc
Q 009364 147 NILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELAT 226 (536)
Q Consensus 147 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 226 (536)
++|+||++++.|..+......+++..+..++.||+.||+|||+.|++||||+|+||+++.++.++|+|||++.......
T Consensus 76 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~- 154 (286)
T cd07846 76 YLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG- 154 (286)
T ss_pred EEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-
Confidence 9999999999998887766679999999999999999999999999999999999999999999999999987654322
Q ss_pred ccCCcccCCCCCCCChhhhhh-cCCCccceEechhHHHHHHhhCCCCCchhhHH--HHHHHhh-CC--------------
Q 009364 227 VSGAKSMKGTPYWMAPEVIRQ-TGHSYSADIWSVGCTVIEMATGKPPWSQQYQE--VAALFHI-GT-------------- 288 (536)
Q Consensus 227 ~~~~~~~~Gt~~Y~APEvl~~-~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~--~~~~~~~-~~-------------- 288 (536)
.......|+..|+|||++.+ ..++.++|||||||++|+|++|.+||...... ....... ..
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07846 155 -EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL 233 (286)
T ss_pred -cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchH
Confidence 22334568999999999875 34788999999999999999999999643211 0111000 00
Q ss_pred --CCCCC---------CCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCC
Q 009364 289 --TKSHP---------PIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFV 330 (536)
Q Consensus 289 --~~~~~---------~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~ 330 (536)
....+ ...+.++..+++|+.+||..+|.+||++.++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 00000 1124678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=336.30 Aligned_cols=258 Identities=36% Similarity=0.655 Sum_probs=218.1
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCce
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESL 146 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 146 (536)
+|++.+.||+|++|.||+|.+..+|+.||+|++.... .......+.+|+..+..++|+||+++++++......
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDG-------DEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEI 74 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCc-------chHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeE
Confidence 6889999999999999999999999999999874211 113456788999999999999999999999999999
Q ss_pred eEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHH-cCCccccCCCCCcccCCCCcEEEEecCcchhhhhhh
Q 009364 147 NILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHN-HGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA 225 (536)
Q Consensus 147 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~-~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 225 (536)
++||||+++++|.+++.....+++..++.++.|++.||.|||+ .|++||||+|+||+++.++.++|+|||.+.......
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 75 SIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999999999999887889999999999999999999999 999999999999999999999999999987664322
Q ss_pred cccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhH-HHHHHHhhCCCCCCCCCCCc-CcHHH
Q 009364 226 TVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQ-EVAALFHIGTTKSHPPIPEN-LSVKA 303 (536)
Q Consensus 226 ~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~-~s~~~ 303 (536)
. ......++..|+|||.+.+..++.++|+||||+++|+|++|..||..... ..............+..+.. ++..+
T Consensus 155 ~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 232 (264)
T cd06623 155 D--QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEF 232 (264)
T ss_pred C--cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHH
Confidence 1 12245688999999999988899999999999999999999999965431 11111111112233344555 89999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 304 KDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 304 ~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
.++|++||..+|++||++.++++|||++..
T Consensus 233 ~~li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 233 RDFISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred HHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 999999999999999999999999999653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=340.17 Aligned_cols=257 Identities=33% Similarity=0.543 Sum_probs=213.5
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
..|...+.||+|++|.||+|.+..+++.+++|++... .....+.+.+|+.+++.++||||+++++++...+.
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~--------~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~ 90 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR--------KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDE 90 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc--------chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCe
Confidence 4566778999999999999999999999999987321 11223457789999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhh
Q 009364 146 LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA 225 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 225 (536)
.++|+||++|++|.+++.. +++++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||.+.......
T Consensus 91 ~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~ 169 (285)
T cd06648 91 LWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV 169 (285)
T ss_pred EEEEEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC
Confidence 9999999999999999877 678999999999999999999999999999999999999999999999999887654321
Q ss_pred cccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH-HHHHHhhCCCCCCCCCCCcCcHHHH
Q 009364 226 TVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE-VAALFHIGTTKSHPPIPENLSVKAK 304 (536)
Q Consensus 226 ~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~~ 304 (536)
. ......|++.|+|||++.+..++.++|||||||++|+|++|..||...... ........ .......+..++..+.
T Consensus 170 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~ 246 (285)
T cd06648 170 P--RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN-LPPKLKNLHKVSPRLR 246 (285)
T ss_pred c--ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc-CCCCCcccccCCHHHH
Confidence 1 223456899999999999888999999999999999999999999654321 11111111 1111222334789999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhCCCCcCCC
Q 009364 305 DFLLKCLEKEPDLRPTASELLKHPFVTGDD 334 (536)
Q Consensus 305 dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~ 334 (536)
++|.+||+.+|++||++.++++||||.+..
T Consensus 247 ~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 247 SFLDRMLVRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred HHHHHHcccChhhCcCHHHHccCcccccCC
Confidence 999999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=334.31 Aligned_cols=253 Identities=30% Similarity=0.537 Sum_probs=205.5
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHH-HhCCCCceeeEeeeeecCCceeEEE
Q 009364 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLL-KDLSHPNIVRYLGTVREEESLNILL 150 (536)
Q Consensus 72 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL-~~l~HpnIv~l~~~~~~~~~~~lV~ 150 (536)
+.||+|+||.||+|.+..+|+.||+|++.... .........+..|..++ ...+|+||+++++++...+.+++|+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~-----~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSD-----MIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchh-----hhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEE
Confidence 56999999999999999999999999873211 11112223334454443 4558999999999999999999999
Q ss_pred EecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhcccCC
Q 009364 151 EFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGA 230 (536)
Q Consensus 151 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 230 (536)
||++|++|.+++...+.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||+++.... .
T Consensus 77 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~ 150 (260)
T cd05611 77 EYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------N 150 (260)
T ss_pred eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc------c
Confidence 9999999999998888899999999999999999999999999999999999999999999999998875432 2
Q ss_pred cccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH-HHHHHhhCCCCCCCCCCCcCcHHHHHHHHH
Q 009364 231 KSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE-VAALFHIGTTKSHPPIPENLSVKAKDFLLK 309 (536)
Q Consensus 231 ~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~ 309 (536)
....|++.|+|||.+.+..++.++||||||+++|+|++|.+||...... ...................++..+.++|.+
T Consensus 151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 230 (260)
T cd05611 151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINR 230 (260)
T ss_pred ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHH
Confidence 3456899999999998888899999999999999999999999654322 222222222222233444689999999999
Q ss_pred hcccCCCCCCC---HHHHHhCCCCcCCCC
Q 009364 310 CLEKEPDLRPT---ASELLKHPFVTGDDE 335 (536)
Q Consensus 310 cL~~dP~~Rps---~~eiL~hp~~~~~~~ 335 (536)
||+.+|.+||+ ++|++.||||....+
T Consensus 231 ~l~~~p~~R~~~~~~~~~l~~~~~~~~~~ 259 (260)
T cd05611 231 LLCMDPAKRLGANGYQEIKSHPFFKSINW 259 (260)
T ss_pred HccCCHHHccCCCcHHHHHcChHhhcCCC
Confidence 99999999995 589999999976554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=346.55 Aligned_cols=257 Identities=35% Similarity=0.546 Sum_probs=212.1
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCce
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESL 146 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 146 (536)
-|+....||+|+||.||+|.+..+++.||+|++... .....+.+.+|+.+++.++||||+++++.+...+..
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~--------~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~ 93 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLR--------KQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEEL 93 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEec--------ccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeE
Confidence 455566899999999999999989999999987321 112234577899999999999999999999999999
Q ss_pred eEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhc
Q 009364 147 NILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELAT 226 (536)
Q Consensus 147 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 226 (536)
++|+||+++++|..++.. ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 94 ~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~- 171 (297)
T cd06659 94 WVLMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV- 171 (297)
T ss_pred EEEEecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc-
Confidence 999999999999987754 568999999999999999999999999999999999999999999999999987654321
Q ss_pred ccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcHHHHHH
Q 009364 227 VSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKDF 306 (536)
Q Consensus 227 ~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL 306 (536)
.......|++.|+|||++.+..++.++|||||||++|+|++|..||......................+..++..+.++
T Consensus 172 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 250 (297)
T cd06659 172 -PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDF 250 (297)
T ss_pred -ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHH
Confidence 1233567999999999999888999999999999999999999999644322111111111112222344678899999
Q ss_pred HHHhcccCCCCCCCHHHHHhCCCCcCCC
Q 009364 307 LLKCLEKEPDLRPTASELLKHPFVTGDD 334 (536)
Q Consensus 307 i~~cL~~dP~~Rps~~eiL~hp~~~~~~ 334 (536)
|.+||+.+|.+||++.++++||||.+..
T Consensus 251 i~~~l~~~P~~Rps~~~ll~~~~~~~~~ 278 (297)
T cd06659 251 LERMLTREPQERATAQELLDHPFLLQTG 278 (297)
T ss_pred HHHHhcCCcccCcCHHHHhhChhhccCC
Confidence 9999999999999999999999998653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=382.78 Aligned_cols=256 Identities=29% Similarity=0.491 Sum_probs=207.9
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec--
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE-- 142 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~-- 142 (536)
..+|++.+.||+|+||+||+|.+..++..||+|++.... ........+..|+.+|+.++|||||+++++|..
T Consensus 12 l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~------l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~ 85 (1021)
T PTZ00266 12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRG------LKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA 85 (1021)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccc------cCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC
Confidence 358999999999999999999999999999999884321 112334667889999999999999999998854
Q ss_pred CCceeEEEEecCCCCccccccc----CCCCCHHHHHHHHHHHHHHHHHHHHc-------CCccccCCCCCcccCC-----
Q 009364 143 EESLNILLEFVPGGSISSLLGK----FGPFPEAVMRTYTKQLLLGLEYLHNH-------GIMHRDIKGANILVDN----- 206 (536)
Q Consensus 143 ~~~~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qil~aL~yLH~~-------~ivHrDLKp~NILl~~----- 206 (536)
...+||||||+++|+|.++|.. .+.+++..++.|+.||+.||.|||+. +||||||||+||||+.
T Consensus 86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l 165 (1021)
T PTZ00266 86 NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI 165 (1021)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence 3568999999999999998864 35799999999999999999999985 4999999999999964
Q ss_pred ------------CCcEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhh--cCCCccceEechhHHHHHHhhCCCC
Q 009364 207 ------------KGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQ--TGHSYSADIWSVGCTVIEMATGKPP 272 (536)
Q Consensus 207 ------------~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~--~~~s~k~DIwSlGvil~eLltG~~P 272 (536)
.+.+||+|||++..+... ......+||+.|+|||++.+ ..++.++||||||||||+|++|..|
T Consensus 166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~---s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~P 242 (1021)
T PTZ00266 166 GKITAQANNLNGRPIAKIGDFGLSKNIGIE---SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242 (1021)
T ss_pred ccccccccccCCCCceEEccCCcccccccc---ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCC
Confidence 235999999999765432 12345679999999999864 4578999999999999999999999
Q ss_pred CchhhH--HHHHHHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 273 WSQQYQ--EVAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 273 f~~~~~--~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
|..... .....+.. ....+ ....+.++.+||.+||..+|.+||++.|+|.|||+...
T Consensus 243 F~~~~~~~qli~~lk~---~p~lp-i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 243 FHKANNFSQLISELKR---GPDLP-IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred CCcCCcHHHHHHHHhc---CCCCC-cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 964322 12111111 11111 23578999999999999999999999999999999754
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=344.61 Aligned_cols=260 Identities=34% Similarity=0.614 Sum_probs=214.6
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE 143 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 143 (536)
...+|++.+.||+|+||.||+|.+..++..||+|.+... .....+.+.+|+.+++.++||||+++++.+...
T Consensus 17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--------~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~ 88 (293)
T cd06647 17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ--------QQPKKELIINEILVMRENKHPNIVNYLDSYLVG 88 (293)
T ss_pred chhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc--------cchHHHHHHHHHHHHhhcCCCCeeehhheeeeC
Confidence 346899999999999999999999889999999987321 112235678899999999999999999999999
Q ss_pred CceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhh
Q 009364 144 ESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAE 223 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 223 (536)
+..++|+||+++++|.+++.+ ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 89 ~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~ 167 (293)
T cd06647 89 DELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (293)
T ss_pred CcEEEEEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence 999999999999999998865 4588999999999999999999999999999999999999999999999998875543
Q ss_pred hhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcHHH
Q 009364 224 LATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKA 303 (536)
Q Consensus 224 ~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 303 (536)
... ......|++.|+|||.+.+..++.++|+|||||++|+|++|..||......................+..++..+
T Consensus 168 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 245 (293)
T cd06647 168 EQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF 245 (293)
T ss_pred ccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHH
Confidence 221 223456899999999998888999999999999999999999999754322111111111111122344578899
Q ss_pred HHHHHHhcccCCCCCCCHHHHHhCCCCcCCC
Q 009364 304 KDFLLKCLEKEPDLRPTASELLKHPFVTGDD 334 (536)
Q Consensus 304 ~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~ 334 (536)
+++|.+||..+|.+||++.+++.|+||+...
T Consensus 246 ~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 246 RDFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred HHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 9999999999999999999999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=355.77 Aligned_cols=253 Identities=29% Similarity=0.478 Sum_probs=215.8
Q ss_pred eeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCceeEEE
Q 009364 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESLNILL 150 (536)
Q Consensus 71 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 150 (536)
.+.||.|.||+||-|.++.+|+.||||+|.+-.-. ......+++|+.||+.+.||.||.+--.|++.+.+++||
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp------~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVM 642 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFP------TKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVM 642 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCC------CchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEe
Confidence 67899999999999999999999999998432211 122367899999999999999999999999999999999
Q ss_pred EecCCCCccccc-ccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCC---cEEEEecCcchhhhhhhc
Q 009364 151 EFVPGGSISSLL-GKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKG---CIKLADFGASKQVAELAT 226 (536)
Q Consensus 151 E~~~gg~L~~~l-~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~---~vkL~DFGla~~~~~~~~ 226 (536)
|-+.|.-|.-.+ ...+++++...+.++.||+.||.|||-+||+|+||||+|||+.... ++||||||+|+.+++..
T Consensus 643 EKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks- 721 (888)
T KOG4236|consen 643 EKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS- 721 (888)
T ss_pred hhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhh-
Confidence 999654444444 3457899999999999999999999999999999999999996543 89999999999988643
Q ss_pred ccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcHHHHHH
Q 009364 227 VSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKDF 306 (536)
Q Consensus 227 ~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL 306 (536)
-..+.+|||.|.|||++++.+|+.+-||||.|||+|.-++|..||.... ++...+.....-..+.-+..+++++.||
T Consensus 722 --FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE-dIndQIQNAaFMyPp~PW~eis~~Aidl 798 (888)
T KOG4236|consen 722 --FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE-DINDQIQNAAFMYPPNPWSEISPEAIDL 798 (888)
T ss_pred --hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc-chhHHhhccccccCCCchhhcCHHHHHH
Confidence 3568899999999999999999999999999999999999999997653 3333333333344444556899999999
Q ss_pred HHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 307 LLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 307 i~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
|..+|+..-.+|.|.++.|.|||++..
T Consensus 799 In~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 799 INNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred HHHHHHHHHHHhcchHhhccchhhhcc
Confidence 999999999999999999999999864
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=343.64 Aligned_cols=255 Identities=40% Similarity=0.719 Sum_probs=214.1
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCce
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESL 146 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 146 (536)
.|+..+.||+|+||.||+|.+..+++.||+|.+.. .......+.+.+|+.+++.++||||+++++.+......
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~-------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDL-------EEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKL 77 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecc-------ccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCce
Confidence 57788899999999999999999999999998732 11223456788999999999999999999999999999
Q ss_pred eEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhc
Q 009364 147 NILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELAT 226 (536)
Q Consensus 147 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 226 (536)
++||||+++++|.+++.. +.+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 78 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 78 WIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EEEEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 999999999999998865 5789999999999999999999999999999999999999999999999999876543211
Q ss_pred ccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcHHHHHH
Q 009364 227 VSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKDF 306 (536)
Q Consensus 227 ~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL 306 (536)
......|+..|+|||++.+..++.++|+|||||++|+|++|..||........... ......+.++..++..+.++
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l 232 (277)
T cd06642 157 --KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFL--IPKNSPPTLEGQYSKPFKEF 232 (277)
T ss_pred --hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhh--hhcCCCCCCCcccCHHHHHH
Confidence 12335689999999999988899999999999999999999999965432221111 11122333455678899999
Q ss_pred HHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 307 LLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 307 i~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
|.+||..+|.+||++.++++||||...
T Consensus 233 i~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 233 VEACLNKDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred HHHHccCCcccCcCHHHHHHhHHHHHH
Confidence 999999999999999999999999753
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=341.28 Aligned_cols=256 Identities=29% Similarity=0.438 Sum_probs=201.2
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEE 144 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 144 (536)
..+|++.+.||+|+||.||+|.+..+|+.||+|++..... ......+.+|+.+++.++|+||+++++++....
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-------~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 76 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-------EGVPFTAIREASLLKGLKHANIVLLHDIIHTKE 76 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-------CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCC
Confidence 4589999999999999999999999999999998742211 111234567999999999999999999999999
Q ss_pred ceeEEEEecCCCCcccccc-cCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhh
Q 009364 145 SLNILLEFVPGGSISSLLG-KFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAE 223 (536)
Q Consensus 145 ~~~lV~E~~~gg~L~~~l~-~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 223 (536)
..++||||+. +++.+.+. ....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 77 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 155 (291)
T cd07870 77 TLTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSI 155 (291)
T ss_pred eEEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence 9999999996 56655543 345688899999999999999999999999999999999999999999999999875432
Q ss_pred hhcccCCcccCCCCCCCChhhhhhc-CCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhh---CC-----------
Q 009364 224 LATVSGAKSMKGTPYWMAPEVIRQT-GHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHI---GT----------- 288 (536)
Q Consensus 224 ~~~~~~~~~~~Gt~~Y~APEvl~~~-~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~---~~----------- 288 (536)
.. .......+++.|+|||++.+. .++.++|||||||++|+|++|..||.........+... ..
T Consensus 156 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07870 156 PS--QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVS 233 (291)
T ss_pred CC--CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhh
Confidence 11 112344679999999998753 57889999999999999999999996533211111100 00
Q ss_pred --CCCCCC------------CC--CcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCC
Q 009364 289 --TKSHPP------------IP--ENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFV 330 (536)
Q Consensus 289 --~~~~~~------------~~--~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~ 330 (536)
...... .. -..+..+.+++.+||..||.+|||+.|++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 000000 00 0135788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=340.31 Aligned_cols=252 Identities=26% Similarity=0.443 Sum_probs=206.9
Q ss_pred CCceeeeEEcccCceEEEEEEEc----CCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeee
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNL----DSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVR 141 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~----~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~ 141 (536)
..|++.+.||+|+||+||+|.+. .++..+|+|.+.. .........+.+|+.+++.++||||+++++++.
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~-------~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 77 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKD-------INNPQQWGEFQQEASLMAELHHPNIVCLLGVVT 77 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccC-------CCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEe
Confidence 36889999999999999999853 3567899998731 112233456788999999999999999999999
Q ss_pred cCCceeEEEEecCCCCcccccccC-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCccc
Q 009364 142 EEESLNILLEFVPGGSISSLLGKF-----------------GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILV 204 (536)
Q Consensus 142 ~~~~~~lV~E~~~gg~L~~~l~~~-----------------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl 204 (536)
.....++||||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+|||+
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili 157 (283)
T cd05090 78 QEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILI 157 (283)
T ss_pred cCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEE
Confidence 999999999999999999987422 247888899999999999999999999999999999999
Q ss_pred CCCCcEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhH-HHHH
Q 009364 205 DNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQ-EVAA 282 (536)
Q Consensus 205 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~-~~~~ 282 (536)
+.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |.+||..... ....
T Consensus 158 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~ 237 (283)
T cd05090 158 GEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIE 237 (283)
T ss_pred cCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999999999986543222222334556788999999988889999999999999999998 9999965432 2222
Q ss_pred HHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 283 LFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 283 ~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
... .....+.+..++..+++++.+||+.||.+||++.+|+++
T Consensus 238 ~~~---~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 238 MVR---KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHH---cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 222 222334566889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=346.92 Aligned_cols=252 Identities=25% Similarity=0.467 Sum_probs=206.5
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcE----EEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeee
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGEL----LAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTV 140 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~----vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~ 140 (536)
..+|++.+.||+|+||+||+|.+..+|+. ||+|++.. .......+.+.+|+.+++.++||||+++++++
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~-------~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~ 78 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE-------ATSPKANKEILDEAYVMASVDNPHVCRLLGIC 78 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccc-------cCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 45799999999999999999998766664 88887631 11223345678899999999999999999998
Q ss_pred ecCCceeEEEEecCCCCcccccccC-CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcch
Q 009364 141 REEESLNILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASK 219 (536)
Q Consensus 141 ~~~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~ 219 (536)
... ..++|+||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 79 ~~~-~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~ 157 (316)
T cd05108 79 LTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (316)
T ss_pred cCC-CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccc
Confidence 765 577999999999999988764 468899999999999999999999999999999999999999999999999998
Q ss_pred hhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhH-HHHHHHhhCCCCCCCCCCC
Q 009364 220 QVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQ-EVAALFHIGTTKSHPPIPE 297 (536)
Q Consensus 220 ~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~ 297 (536)
.+.............++..|+|||++.+..++.++|||||||++|+|++ |..||.+... ....... .....+.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~---~~~~~~~~~ 234 (316)
T cd05108 158 LLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE---KGERLPQPP 234 (316)
T ss_pred cccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh---CCCCCCCCC
Confidence 7654322222223345678999999999999999999999999999997 9999975432 2222222 222334456
Q ss_pred cCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 298 NLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 298 ~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
.++.++.+++.+||..+|.+||++.+++.+
T Consensus 235 ~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 235 ICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 788999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=335.60 Aligned_cols=255 Identities=32% Similarity=0.565 Sum_probs=209.2
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
.+|++.+.||+|+||.||+|++..+++.||+|.+.... .........+.+|+.+++.++||||+++++++...+.
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 76 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFE-----MMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNE 76 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccc-----cCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCe
Confidence 47999999999999999999999999999999874211 1112334567889999999999999999999999999
Q ss_pred eeEEEEecCCCCccccccc----CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhh
Q 009364 146 LNILLEFVPGGSISSLLGK----FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQV 221 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~ 221 (536)
.++|+||+++|+|.+++.. ...+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++...
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~ 156 (267)
T cd08228 77 LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceec
Confidence 9999999999999888742 345899999999999999999999999999999999999999999999999998765
Q ss_pred hhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCC-CCcCc
Q 009364 222 AELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPI-PENLS 300 (536)
Q Consensus 222 ~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~-~~~~s 300 (536)
..... ......|++.|+|||.+.+..++.++|+||+|+++|+|++|..||...................++. +..++
T Consensus 157 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd08228 157 SSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYS 234 (267)
T ss_pred cchhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcC
Confidence 43221 1234568999999999998889999999999999999999999996543222222221111122222 34678
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 301 VKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 301 ~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
..++++|.+||..+|.+||++.++++.
T Consensus 235 ~~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 235 EKLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 899999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=333.47 Aligned_cols=245 Identities=27% Similarity=0.446 Sum_probs=200.3
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCceeEEEE
Q 009364 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESLNILLE 151 (536)
Q Consensus 72 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 151 (536)
+.||+|+||.||+|.+..+|+.||+|.+.. ....+....+.+|+++++.++||||+++++++......++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~-------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 73 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRE-------TLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 73 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCc-------cCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEe
Confidence 369999999999999999999999998631 1122334567889999999999999999999999999999999
Q ss_pred ecCCCCcccccccC-CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhcccCC
Q 009364 152 FVPGGSISSLLGKF-GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGA 230 (536)
Q Consensus 152 ~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 230 (536)
|+++++|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++............
T Consensus 74 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 153 (252)
T cd05084 74 LVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTG 153 (252)
T ss_pred eccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccC
Confidence 99999999998654 46899999999999999999999999999999999999999999999999998754421111111
Q ss_pred cccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhHH-HHHHHhhCCCCCCCCCCCcCcHHHHHHHH
Q 009364 231 KSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQE-VAALFHIGTTKSHPPIPENLSVKAKDFLL 308 (536)
Q Consensus 231 ~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~~dLi~ 308 (536)
....++..|+|||.+.+..++.++|||||||++|+|++ |.+||...... ....... ......+..++..+.+|+.
T Consensus 154 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~ 230 (252)
T cd05084 154 GMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQ---GVRLPCPELCPDAVYRLME 230 (252)
T ss_pred CCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHc---CCCCCCcccCCHHHHHHHH
Confidence 11223457999999998889999999999999999998 99999644322 2222211 2233456678999999999
Q ss_pred HhcccCCCCCCCHHHHHh
Q 009364 309 KCLEKEPDLRPTASELLK 326 (536)
Q Consensus 309 ~cL~~dP~~Rps~~eiL~ 326 (536)
+||+.+|++|||+.++++
T Consensus 231 ~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 231 RCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred HHcCCChhhCcCHHHHHH
Confidence 999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=339.79 Aligned_cols=260 Identities=24% Similarity=0.404 Sum_probs=208.1
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcC-----CCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEee
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLD-----SGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLG 138 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~ 138 (536)
...+|++.+.||+|+||.||+|.++. .+..||+|.+.. .........+.+|+.+++.++||||+++++
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~-------~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 76 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNE-------SASLRERIEFLNEASVMKGFTCHHVVRLLG 76 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCC-------cCCHHHHHHHHHHHHHHHhCCCCCeeeEEE
Confidence 34689999999999999999997652 355899997631 111122345678999999999999999999
Q ss_pred eeecCCceeEEEEecCCCCcccccccC----------CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCC
Q 009364 139 TVREEESLNILLEFVPGGSISSLLGKF----------GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKG 208 (536)
Q Consensus 139 ~~~~~~~~~lV~E~~~gg~L~~~l~~~----------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~ 208 (536)
++......++||||+++|+|.+++.+. ...+...+..++.|++.||.|||++||+||||||+||+++.++
T Consensus 77 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~ 156 (288)
T cd05061 77 VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDF 156 (288)
T ss_pred EEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCC
Confidence 999999999999999999999998642 2345678889999999999999999999999999999999999
Q ss_pred cEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhH-HHHHHHhh
Q 009364 209 CIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQ-EVAALFHI 286 (536)
Q Consensus 209 ~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~-~~~~~~~~ 286 (536)
.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|+|++ |.+||..... +......
T Consensus 157 ~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~- 235 (288)
T cd05061 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM- 235 (288)
T ss_pred cEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-
Confidence 999999999876543222111223345778999999998889999999999999999998 7889965432 2222221
Q ss_pred CCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHh------CCCCcCC
Q 009364 287 GTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLK------HPFVTGD 333 (536)
Q Consensus 287 ~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~------hp~~~~~ 333 (536)
.......+..++..+++++.+||+.||++|||+.++++ ||||...
T Consensus 236 --~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~ 286 (288)
T cd05061 236 --DGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 286 (288)
T ss_pred --cCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence 12223345577899999999999999999999999987 8998754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=342.99 Aligned_cols=263 Identities=29% Similarity=0.487 Sum_probs=210.8
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCce
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESL 146 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 146 (536)
+|++.+.||+|+||.||+|.+..+|+.||+|.+....... ........+..|+.+++.++|+||+++++++.+.+..
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~---~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~ 77 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKE---AKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNI 77 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEecccccc---ccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEE
Confidence 5889999999999999999999999999999985322110 0112334567899999999999999999999999999
Q ss_pred eEEEEecCCCCcccccccCC-CCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhh
Q 009364 147 NILLEFVPGGSISSLLGKFG-PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA 225 (536)
Q Consensus 147 ~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 225 (536)
++||||+ +|+|.+++.... .+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||+++......
T Consensus 78 ~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 78 NLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred EEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 9999999 999999997765 79999999999999999999999999999999999999999999999999987664321
Q ss_pred cccCCcccCCCCCCCChhhhhh-cCCCccceEechhHHHHHHhhCCCCCchhhHH--HHHHHhhCCC-------------
Q 009364 226 TVSGAKSMKGTPYWMAPEVIRQ-TGHSYSADIWSVGCTVIEMATGKPPWSQQYQE--VAALFHIGTT------------- 289 (536)
Q Consensus 226 ~~~~~~~~~Gt~~Y~APEvl~~-~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~--~~~~~~~~~~------------- 289 (536)
.......+++.|+|||++.+ ..++.++|||||||++|+|++|.+||...... ..........
T Consensus 157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (298)
T cd07841 157 --RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLP 234 (298)
T ss_pred --ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccc
Confidence 12233457889999999865 45789999999999999999998888643211 1111110000
Q ss_pred -----CC-----CCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCCC
Q 009364 290 -----KS-----HPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDE 335 (536)
Q Consensus 290 -----~~-----~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~~ 335 (536)
.. ........+..+.+||.+||.+||++|||+.++++||||++...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~ 290 (298)
T cd07841 235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPA 290 (298)
T ss_pred ccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCC
Confidence 00 00112356788999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=338.47 Aligned_cols=256 Identities=39% Similarity=0.709 Sum_probs=214.7
Q ss_pred ceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCcee
Q 009364 68 WRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESLN 147 (536)
Q Consensus 68 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 147 (536)
|++.+.||.|+||.||+|.+..+++.||+|.+.. .........+.+|+.+++.++||||+++++.+......+
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~-------~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 78 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDL-------EEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLW 78 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEecc-------ccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEE
Confidence 6788899999999999999988999999998732 112234467889999999999999999999999999999
Q ss_pred EEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhcc
Q 009364 148 ILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATV 227 (536)
Q Consensus 148 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 227 (536)
+||||+++++|.+++.. ..+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++..+....
T Consensus 79 lv~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-- 155 (277)
T cd06641 79 IIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-- 155 (277)
T ss_pred EEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccch--
Confidence 99999999999998865 568999999999999999999999999999999999999999999999999987654321
Q ss_pred cCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcHHHHHHH
Q 009364 228 SGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKDFL 307 (536)
Q Consensus 228 ~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi 307 (536)
.......|+..|+|||.+.+...+.++|+|||||++|+|++|..||.......... .......+.++..++.++.++|
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~i 233 (277)
T cd06641 156 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLF--LIPKNNPPTLEGNYSKPLKEFV 233 (277)
T ss_pred hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHH--HHhcCCCCCCCcccCHHHHHHH
Confidence 11234568999999999988888999999999999999999999996543221111 1111223345567889999999
Q ss_pred HHhcccCCCCCCCHHHHHhCCCCcCCCC
Q 009364 308 LKCLEKEPDLRPTASELLKHPFVTGDDE 335 (536)
Q Consensus 308 ~~cL~~dP~~Rps~~eiL~hp~~~~~~~ 335 (536)
.+||..+|.+||++.++++||||.....
T Consensus 234 ~~~l~~~p~~Rp~~~~~l~~~~~~~~~~ 261 (277)
T cd06641 234 EACLNKEPSFRPTAKELLKHKFIVRFAK 261 (277)
T ss_pred HHHccCChhhCcCHHHHHhCHHHhhhhh
Confidence 9999999999999999999999976533
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=335.80 Aligned_cols=254 Identities=26% Similarity=0.429 Sum_probs=208.5
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCC-----CcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEee
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDS-----GELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLG 138 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~-----g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~ 138 (536)
...+|++.+.||+|+||.||+|.+... +..||+|.+.. .........+.+|+.+++.++||||+++++
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~-------~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~ 76 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNE-------NASMRERIEFLNEASVMKEFNCHHVVRLLG 76 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCC-------ccCHHHHHHHHHHHHHHHhCCCCceeEEEE
Confidence 345899999999999999999988644 37899998731 111122345778999999999999999999
Q ss_pred eeecCCceeEEEEecCCCCcccccccC----------CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCC
Q 009364 139 TVREEESLNILLEFVPGGSISSLLGKF----------GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKG 208 (536)
Q Consensus 139 ~~~~~~~~~lV~E~~~gg~L~~~l~~~----------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~ 208 (536)
++......++||||+++|+|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++
T Consensus 77 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~ 156 (277)
T cd05032 77 VVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDL 156 (277)
T ss_pred EEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCC
Confidence 999999999999999999999988542 2467889999999999999999999999999999999999999
Q ss_pred cEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhHH-HHHHHhh
Q 009364 209 CIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQE-VAALFHI 286 (536)
Q Consensus 209 ~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~~-~~~~~~~ 286 (536)
.+||+|||+++.+.............++..|+|||.+.+..++.++|||||||++|+|++ |.+||...... ......
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~- 235 (277)
T cd05032 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI- 235 (277)
T ss_pred CEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh-
Confidence 999999999886654322222334557889999999988889999999999999999998 99999654322 222222
Q ss_pred CCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 287 GTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 287 ~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
.......+..++.++.++|.+||+.+|.+|||+.+++..
T Consensus 236 --~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~ 274 (277)
T cd05032 236 --DGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSS 274 (277)
T ss_pred --cCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 223344566789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=331.43 Aligned_cols=253 Identities=36% Similarity=0.682 Sum_probs=216.6
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCce
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESL 146 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 146 (536)
+|++.+.||.|+||.||++.+..++..||+|++.... ........+.+|+++++.++|||++++++.+......
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~------~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~ 74 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSN------MSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKL 74 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeeccc------CChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEE
Confidence 5889999999999999999999899999999884211 1123455678899999999999999999999999999
Q ss_pred eEEEEecCCCCcccccccC----CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhh
Q 009364 147 NILLEFVPGGSISSLLGKF----GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVA 222 (536)
Q Consensus 147 ~lV~E~~~gg~L~~~l~~~----~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~ 222 (536)
++|+||+++++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+....
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~ 154 (258)
T cd08215 75 CIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLS 154 (258)
T ss_pred EEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecc
Confidence 9999999999999988653 679999999999999999999999999999999999999999999999999987665
Q ss_pred hhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhH-HHHHHHhhCCCCCCCCCCCcCcH
Q 009364 223 ELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQ-EVAALFHIGTTKSHPPIPENLSV 301 (536)
Q Consensus 223 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~s~ 301 (536)
... .......|++.|+|||.+.+..++.++|+||+|+++|+|++|..||..... ...... .......++..++.
T Consensus 155 ~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 229 (258)
T cd08215 155 STV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKI---LKGQYPPIPSQYSS 229 (258)
T ss_pred cCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHH---hcCCCCCCCCCCCH
Confidence 432 123345789999999999988899999999999999999999999965432 222211 12234456668899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhCCCC
Q 009364 302 KAKDFLLKCLEKEPDLRPTASELLKHPFV 330 (536)
Q Consensus 302 ~~~dLi~~cL~~dP~~Rps~~eiL~hp~~ 330 (536)
.+.+++.+||..+|.+|||+.++|+||||
T Consensus 230 ~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 230 ELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 99999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=338.88 Aligned_cols=253 Identities=23% Similarity=0.408 Sum_probs=204.6
Q ss_pred CCCceeeeEEcccCceEEEEEEEc-----CCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeee
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNL-----DSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGT 139 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~ 139 (536)
..+|++.+.||+|+||+||+|.+. .++..||+|.+.. .........+.+|+.+++.++||||++++++
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~-------~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~ 77 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNE-------AASMRERIEFLNEASVMKEFNCHHVVRLLGV 77 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccc-------cCCHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Confidence 457999999999999999999864 2456899998631 1111233457889999999999999999999
Q ss_pred eecCCceeEEEEecCCCCcccccccC----------CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCc
Q 009364 140 VREEESLNILLEFVPGGSISSLLGKF----------GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGC 209 (536)
Q Consensus 140 ~~~~~~~~lV~E~~~gg~L~~~l~~~----------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~ 209 (536)
+......++||||+++|+|.+++.+. ..++...+..++.|++.||.|||+.|++||||||+||+++.++.
T Consensus 78 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~ 157 (277)
T cd05062 78 VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT 157 (277)
T ss_pred EcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCC
Confidence 99999999999999999999988642 23567888999999999999999999999999999999999999
Q ss_pred EEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhHH-HHHHHhhC
Q 009364 210 IKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQE-VAALFHIG 287 (536)
Q Consensus 210 vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~~-~~~~~~~~ 287 (536)
+||+|||+++...............+++.|+|||++.+..++.++|||||||++|+|++ |..||...... ......
T Consensus 158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~-- 235 (277)
T cd05062 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM-- 235 (277)
T ss_pred EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH--
Confidence 99999999876543222222223456788999999998889999999999999999999 78999654322 222211
Q ss_pred CCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 288 TTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 288 ~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
.......+..++..+++++.+||+.||.+|||+.+++++
T Consensus 236 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 236 -EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred -cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 122234556788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=360.38 Aligned_cols=266 Identities=30% Similarity=0.519 Sum_probs=220.2
Q ss_pred CCCCCCCCCCc-eeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeE
Q 009364 58 PSVKMSPPIRW-RKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRY 136 (536)
Q Consensus 58 ~~~~~~~~~~y-~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l 136 (536)
..+...+..|| +....||+|+|-+||+|.|..+|-.||.-.+.... ........+++..|+.+|+.|+||||+++
T Consensus 31 ~~ve~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d----~~q~~~~leR~~~Ev~lLKsL~H~NIirf 106 (632)
T KOG0584|consen 31 EFVEKDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRD----VTQSPEELERLYSEVHLLKSLKHPNIIRF 106 (632)
T ss_pred cccccCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHH----hhcChHHHHHHHHHHHHHccCCCCceeee
Confidence 34455667777 45778999999999999999999999876553221 22334556889999999999999999999
Q ss_pred eeeeecCCc--eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--CccccCCCCCcccCC-CCcEE
Q 009364 137 LGTVREEES--LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHG--IMHRDIKGANILVDN-KGCIK 211 (536)
Q Consensus 137 ~~~~~~~~~--~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~--ivHrDLKp~NILl~~-~~~vk 211 (536)
|+++.+... +.+|+|.+..|+|..|+++.+..+...++.|++||+.||.|||++. |||||||.+||+|+. .|.||
T Consensus 107 y~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VK 186 (632)
T KOG0584|consen 107 YDSWVDTDNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVK 186 (632)
T ss_pred eeheecCCCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCcee
Confidence 999987665 8899999999999999999999999999999999999999999985 999999999999975 58999
Q ss_pred EEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCC
Q 009364 212 LADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKS 291 (536)
Q Consensus 212 L~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~ 291 (536)
|+|+|+|+..... .....+|||.|||||++. ..|++.+||||||+++.||.|+..||..-......+........
T Consensus 187 IGDLGLAtl~r~s----~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiK 261 (632)
T KOG0584|consen 187 IGDLGLATLLRKS----HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIK 261 (632)
T ss_pred ecchhHHHHhhcc----ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCC
Confidence 9999999876532 245688999999999998 68999999999999999999999999754332222222222222
Q ss_pred CCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 292 HPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 292 ~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
+..+...-.+++++||.+||.. ...|||+.|+|+||||...
T Consensus 262 P~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 262 PAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred HHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 2234444578999999999999 9999999999999999875
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=327.36 Aligned_cols=252 Identities=44% Similarity=0.728 Sum_probs=211.6
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCce
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESL 146 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 146 (536)
.|++.+.||+|++|.||++.+..+++.+++|++.... ......+.+|+.+++.++|+||+++++.+......
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~--------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 72 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLES--------KEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDEL 72 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccc--------hhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeE
Confidence 4788999999999999999999899999999883211 13456788999999999999999999999999999
Q ss_pred eEEEEecCCCCcccccccC-CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhh
Q 009364 147 NILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA 225 (536)
Q Consensus 147 ~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 225 (536)
++++||+++++|.+++... ..+++..+..++.|++.||++||++|++||||+|+||+++.++.++|+|||.+.......
T Consensus 73 ~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 152 (253)
T cd05122 73 WIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK 152 (253)
T ss_pred EEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccc
Confidence 9999999999999998775 679999999999999999999999999999999999999999999999999987765432
Q ss_pred cccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcHHHHH
Q 009364 226 TVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKD 305 (536)
Q Consensus 226 ~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 305 (536)
. .....|+..|+|||++.+..++.++||||||+++|+|++|..||......................+..++..+.+
T Consensus 153 ~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (253)
T cd05122 153 A---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKD 229 (253)
T ss_pred c---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHH
Confidence 1 3456789999999999988889999999999999999999999975422111111111111111222234889999
Q ss_pred HHHHhcccCCCCCCCHHHHHhCCC
Q 009364 306 FLLKCLEKEPDLRPTASELLKHPF 329 (536)
Q Consensus 306 Li~~cL~~dP~~Rps~~eiL~hp~ 329 (536)
+|.+||+.||++|||+.++++|||
T Consensus 230 ~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 230 FLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HHHHHccCChhhCCCHHHHhcCCC
Confidence 999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=340.61 Aligned_cols=255 Identities=29% Similarity=0.510 Sum_probs=201.9
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
.+|++.+.||+|++|.||+|.+..+++.||+|.+..... ......+.+|+.+++.++|+||+++++++.+...
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 77 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE-------EGAPFTAIREASLLKDLKHANIVTLHDIIHTKKT 77 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc-------cCCchhHHHHHHHHhhCCCcceeeEEEEEecCCe
Confidence 579999999999999999999999999999998843211 1111235579999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccC-CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhh
Q 009364 146 LNILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAEL 224 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 224 (536)
.++||||+. ++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus 78 ~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 156 (291)
T cd07844 78 LTLVFEYLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVP 156 (291)
T ss_pred EEEEEecCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence 999999997 4888877653 46899999999999999999999999999999999999999999999999998754321
Q ss_pred hcccCCcccCCCCCCCChhhhhh-cCCCccceEechhHHHHHHhhCCCCCchhhH---HHHHHHhhCCCC----------
Q 009364 225 ATVSGAKSMKGTPYWMAPEVIRQ-TGHSYSADIWSVGCTVIEMATGKPPWSQQYQ---EVAALFHIGTTK---------- 290 (536)
Q Consensus 225 ~~~~~~~~~~Gt~~Y~APEvl~~-~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~---~~~~~~~~~~~~---------- 290 (536)
. .......+++.|+|||++.+ ..++.++||||+||++|+|++|.+||..... ............
T Consensus 157 ~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07844 157 S--KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSS 234 (291)
T ss_pred C--ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhh
Confidence 1 11223357889999999875 4578999999999999999999999964321 111111000000
Q ss_pred ----------CC--C---CCCCcCc--HHHHHHHHHhcccCCCCCCCHHHHHhCCCC
Q 009364 291 ----------SH--P---PIPENLS--VKAKDFLLKCLEKEPDLRPTASELLKHPFV 330 (536)
Q Consensus 291 ----------~~--~---~~~~~~s--~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~ 330 (536)
.. . .....++ .++.++|.+||+.+|.+|||+.++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 00 0 0001234 788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=339.16 Aligned_cols=251 Identities=27% Similarity=0.456 Sum_probs=205.9
Q ss_pred CCceeeeEEcccCceEEEEEEEcC-----CCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeee
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLD-----SGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTV 140 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~ 140 (536)
.+|.+.+.||+|+||.||+|.+.. +++.||+|.+.. ....+..+.+.+|+++|+.++|+||+++++++
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~-------~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 77 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKE-------TASNDARKDFEREAELLTNFQHENIVKFYGVC 77 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecc-------cCCHHHHHHHHHHHHHHHhcCCCCchheeeEE
Confidence 468889999999999999998753 367899998732 11122346788999999999999999999999
Q ss_pred ecCCceeEEEEecCCCCcccccccC--------------CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCC
Q 009364 141 REEESLNILLEFVPGGSISSLLGKF--------------GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDN 206 (536)
Q Consensus 141 ~~~~~~~lV~E~~~gg~L~~~l~~~--------------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~ 206 (536)
......++||||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.
T Consensus 78 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~ 157 (280)
T cd05049 78 TEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGY 157 (280)
T ss_pred ecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcC
Confidence 9999999999999999999988643 34788999999999999999999999999999999999999
Q ss_pred CCcEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhH-HHHHHH
Q 009364 207 KGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQ-EVAALF 284 (536)
Q Consensus 207 ~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~-~~~~~~ 284 (536)
++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|+|++ |..||..... ......
T Consensus 158 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~ 237 (280)
T cd05049 158 DLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECI 237 (280)
T ss_pred CCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 99999999999875432221111233446788999999999999999999999999999998 9999865432 222222
Q ss_pred hhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHh
Q 009364 285 HIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 285 ~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~ 326 (536)
. .......+..++..+++++.+||+.||.+||++.|+++
T Consensus 238 ~---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 238 T---QGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred H---cCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 2 12223345578999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=338.83 Aligned_cols=254 Identities=25% Similarity=0.453 Sum_probs=207.9
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCC-----CcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeEe
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDS-----GELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRYL 137 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~-----g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~ 137 (536)
...+|++.+.||+|+||.||+|.+... ...+|+|.+.. .........+.+|+.+++.+ +|+||++++
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~-------~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 82 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKD-------DATEKDLSDLVSEMEMMKMIGKHKNIINLL 82 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccC-------CCCHHHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence 345799999999999999999987643 37899998732 11123345678899999999 799999999
Q ss_pred eeeecCCceeEEEEecCCCCccccccc----------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCC
Q 009364 138 GTVREEESLNILLEFVPGGSISSLLGK----------------FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGAN 201 (536)
Q Consensus 138 ~~~~~~~~~~lV~E~~~gg~L~~~l~~----------------~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~N 201 (536)
+++...+.++++|||+++|+|..++.. ...+++..+..++.||+.||.|||++||+||||||+|
T Consensus 83 ~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~N 162 (293)
T cd05053 83 GVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARN 162 (293)
T ss_pred EEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceee
Confidence 999999999999999999999988853 2468899999999999999999999999999999999
Q ss_pred cccCCCCcEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhH-H
Q 009364 202 ILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQ-E 279 (536)
Q Consensus 202 ILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~-~ 279 (536)
|+++.++.+||+|||+++.+.............++..|+|||++.+..++.++|||||||++|+|++ |..||..... +
T Consensus 163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 242 (293)
T cd05053 163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 242 (293)
T ss_pred EEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence 9999999999999999987654322222233345678999999998899999999999999999997 9999965432 2
Q ss_pred HHHHHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 280 VAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
....... ......+..++..+.+|+.+||..||.+|||+.+++++
T Consensus 243 ~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 243 LFKLLKE---GYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHHHHc---CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 2222221 22334556788999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=329.20 Aligned_cols=254 Identities=49% Similarity=0.975 Sum_probs=218.2
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCce
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESL 146 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 146 (536)
+|++.+.||+|++|.||+|.+..+++.||+|.+.... ........+.+|++++++++|+|++++++++.+.+..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEK------IKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSL 74 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccc------cCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEE
Confidence 5889999999999999999999999999999884321 1123456788999999999999999999999999999
Q ss_pred eEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhc
Q 009364 147 NILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELAT 226 (536)
Q Consensus 147 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 226 (536)
++||||+++++|.+++.....+++..++.++.|++.||.|||++||+||||+|+||+++.++.++|+|||++........
T Consensus 75 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 75 YIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred EEEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 99999999999999998888899999999999999999999999999999999999999999999999999987654322
Q ss_pred ccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcHHHHHH
Q 009364 227 VSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKDF 306 (536)
Q Consensus 227 ~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL 306 (536)
......|+..|+|||.+.+..++.++||||+|+++|+|++|..||...... ....... ....+.++..++..++++
T Consensus 155 --~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~~ 230 (254)
T cd06627 155 --DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM-AALFRIV-QDDHPPLPEGISPELKDF 230 (254)
T ss_pred --cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHh-ccCCCCCCCCCCHHHHHH
Confidence 123456899999999998888899999999999999999999999654321 1111111 233445677889999999
Q ss_pred HHHhcccCCCCCCCHHHHHhCCCC
Q 009364 307 LLKCLEKEPDLRPTASELLKHPFV 330 (536)
Q Consensus 307 i~~cL~~dP~~Rps~~eiL~hp~~ 330 (536)
+.+||..+|++|||+.++++||||
T Consensus 231 i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 231 LMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred HHHHHhCChhhCcCHHHHhcCCCC
Confidence 999999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=341.21 Aligned_cols=259 Identities=36% Similarity=0.631 Sum_probs=210.1
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE 142 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 142 (536)
.+..+|++.+.||+|+||+||+|.+..+|+.||+|++.... .........+.+|+.+++.++||||+++++++..
T Consensus 12 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~-----~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~ 86 (307)
T cd06607 12 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSG-----KQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR 86 (307)
T ss_pred CcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccc-----cCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe
Confidence 44567999999999999999999999999999999873211 1122334567899999999999999999999999
Q ss_pred CCceeEEEEecCCCCcccccc-cCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhh
Q 009364 143 EESLNILLEFVPGGSISSLLG-KFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQV 221 (536)
Q Consensus 143 ~~~~~lV~E~~~gg~L~~~l~-~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~ 221 (536)
.+..++||||+. |++.+++. ..+.+++..+..++.||+.||.|||+.||+||||+|+||+++.++.+||+|||++...
T Consensus 87 ~~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~ 165 (307)
T cd06607 87 EHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLV 165 (307)
T ss_pred CCeEEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceec
Confidence 999999999997 56655554 3457899999999999999999999999999999999999999999999999998654
Q ss_pred hhhhcccCCcccCCCCCCCChhhhh---hcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCc
Q 009364 222 AELATVSGAKSMKGTPYWMAPEVIR---QTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPEN 298 (536)
Q Consensus 222 ~~~~~~~~~~~~~Gt~~Y~APEvl~---~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (536)
.. .....|++.|+|||++. ...++.++||||||+++|+|++|.+||......... ............+..
T Consensus 166 ~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~ 238 (307)
T cd06607 166 SP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-YHIAQNDSPTLSSND 238 (307)
T ss_pred CC------CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHH-HHHhcCCCCCCCchh
Confidence 32 23456889999999874 356788999999999999999999999654322211 111111111112335
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCC
Q 009364 299 LSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDD 334 (536)
Q Consensus 299 ~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~ 334 (536)
++..++++|.+||..+|.+||++.+++.||||....
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 239 WSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred hCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence 788999999999999999999999999999998654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=340.53 Aligned_cols=255 Identities=31% Similarity=0.545 Sum_probs=204.5
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCce
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESL 146 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 146 (536)
+|++.+.||.|++|.||+|.+..+|+.||||.+.... ........+.+|++++++++||||+++++++.+....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~------~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 74 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT------ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL 74 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccc------cccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcE
Confidence 4889999999999999999999999999999874221 1112234677899999999999999999999999999
Q ss_pred eEEEEecCCCCccccccc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhh
Q 009364 147 NILLEFVPGGSISSLLGK--FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAEL 224 (536)
Q Consensus 147 ~lV~E~~~gg~L~~~l~~--~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 224 (536)
++||||+. ++|..++.. ...+++..++.++.|++.||+|||+.|++||||+|+||+++.++.+||+|||++......
T Consensus 75 ~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~ 153 (284)
T cd07860 75 YLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 153 (284)
T ss_pred EEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 99999995 678877744 356899999999999999999999999999999999999999999999999998765432
Q ss_pred hcccCCcccCCCCCCCChhhhhhcC-CCccceEechhHHHHHHhhCCCCCchhhHH--HHHHHhhCCCC-----------
Q 009364 225 ATVSGAKSMKGTPYWMAPEVIRQTG-HSYSADIWSVGCTVIEMATGKPPWSQQYQE--VAALFHIGTTK----------- 290 (536)
Q Consensus 225 ~~~~~~~~~~Gt~~Y~APEvl~~~~-~s~k~DIwSlGvil~eLltG~~Pf~~~~~~--~~~~~~~~~~~----------- 290 (536)
. .......+++.|+|||++.+.. ++.++|||||||++|+|+||+.||...... ...........
T Consensus 154 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07860 154 V--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSL 231 (284)
T ss_pred c--cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHH
Confidence 1 1123345789999999887644 588999999999999999999999643211 11111100000
Q ss_pred -------------CCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCC
Q 009364 291 -------------SHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFV 330 (536)
Q Consensus 291 -------------~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~ 330 (536)
....+...++.+++++|.+||+.||.+|||+.++++||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 232 PDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 0001123578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=336.49 Aligned_cols=257 Identities=33% Similarity=0.533 Sum_probs=208.0
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC--
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE-- 143 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~-- 143 (536)
++|+..+.||.|++|.||+|.+..+++.+|+|.+... ........+.+|+++++.++||||+++++++...
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~-------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 73 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTD-------PNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESS 73 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecC-------CchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCC
Confidence 3688999999999999999999999999999987421 1113346678899999999999999999988653
Q ss_pred CceeEEEEecCCCCcccccc----cCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcch
Q 009364 144 ESLNILLEFVPGGSISSLLG----KFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASK 219 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~----~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~ 219 (536)
..+++||||+++++|.+++. ....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~ 153 (287)
T cd06621 74 SSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSG 153 (287)
T ss_pred CeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccc
Confidence 46899999999999988764 23568999999999999999999999999999999999999999999999999986
Q ss_pred hhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhh------HHHHHHHhhCCCCCCC
Q 009364 220 QVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQY------QEVAALFHIGTTKSHP 293 (536)
Q Consensus 220 ~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~------~~~~~~~~~~~~~~~~ 293 (536)
..... ......++..|+|||.+.+..++.++|||||||++|+|++|..||.... .+..............
T Consensus 154 ~~~~~----~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd06621 154 ELVNS----LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELK 229 (287)
T ss_pred ccccc----ccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhc
Confidence 54321 1224568899999999998899999999999999999999999997541 1111111111111111
Q ss_pred -CC--CCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 294 -PI--PENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 294 -~~--~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
.. ....++.+.++|.+||..+|.+|||+.|+++||||...
T Consensus 230 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 272 (287)
T cd06621 230 DEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ 272 (287)
T ss_pred cCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence 11 12356789999999999999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=336.88 Aligned_cols=256 Identities=38% Similarity=0.705 Sum_probs=211.5
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCC---CCceeeEeeeeecC
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS---HPNIVRYLGTVREE 143 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~---HpnIv~l~~~~~~~ 143 (536)
.|++.+.||+|+||.||+|.+..+|+.||+|.+... ........+.+|+.+++.+. |||++++++++...
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~-------~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~ 74 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLD-------TPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKG 74 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCC-------CCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeC
Confidence 478889999999999999999999999999987321 11223456778999999886 99999999999999
Q ss_pred CceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhh
Q 009364 144 ESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAE 223 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 223 (536)
...++||||++|++|.+++.. +.+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++.....
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 75 PRLWIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred CEEEEEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 999999999999999998865 5789999999999999999999999999999999999999999999999999876654
Q ss_pred hhcccCCcccCCCCCCCChhhhhh-cCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCC-cCcH
Q 009364 224 LATVSGAKSMKGTPYWMAPEVIRQ-TGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPE-NLSV 301 (536)
Q Consensus 224 ~~~~~~~~~~~Gt~~Y~APEvl~~-~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-~~s~ 301 (536)
.. .......|+..|+|||.+.+ ..++.++|+|||||++|+|++|.+||......... .... ....+.++. .++.
T Consensus 154 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~ 229 (277)
T cd06917 154 NS--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM-MLIP-KSKPPRLEDNGYSK 229 (277)
T ss_pred Cc--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh-hccc-cCCCCCCCcccCCH
Confidence 22 12334578999999999865 45689999999999999999999999654322111 1111 112223333 3788
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCC
Q 009364 302 KAKDFLLKCLEKEPDLRPTASELLKHPFVTGDD 334 (536)
Q Consensus 302 ~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~ 334 (536)
++.+++.+||+.||.+||++.++++|+||+...
T Consensus 230 ~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 230 LLREFVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 999999999999999999999999999997654
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=351.23 Aligned_cols=254 Identities=27% Similarity=0.459 Sum_probs=204.1
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcC-----CCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeEe
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLD-----SGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRYL 137 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~ 137 (536)
+.++|++.+.||+|+||.||+|.+.. +++.||+|++.. .......+.+..|+.+++++ +|+||++++
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~-------~~~~~~~~~~~~E~~~~~~l~~h~niv~~~ 77 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKE-------GATASEYKALMTELKILIHIGHHLNVVNLL 77 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccC-------CCCHHHHHHHHHHHHHHHhhccCcchhhee
Confidence 45689999999999999999997543 457899998731 11123345677899999999 799999999
Q ss_pred eeeec-CCceeEEEEecCCCCcccccccC---------------------------------------------------
Q 009364 138 GTVRE-EESLNILLEFVPGGSISSLLGKF--------------------------------------------------- 165 (536)
Q Consensus 138 ~~~~~-~~~~~lV~E~~~gg~L~~~l~~~--------------------------------------------------- 165 (536)
+++.. ...++++|||+++|+|.+++...
T Consensus 78 ~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (337)
T cd05054 78 GACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVE 157 (337)
T ss_pred eeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcc
Confidence 98864 45788999999999998887431
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhcccCCcccCC
Q 009364 166 ----------GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKG 235 (536)
Q Consensus 166 ----------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~G 235 (536)
.++++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+.............+
T Consensus 158 ~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~ 237 (337)
T cd05054 158 EDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 237 (337)
T ss_pred cchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCC
Confidence 2578899999999999999999999999999999999999999999999999987643222122234456
Q ss_pred CCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhh--HHHHHHHhhCCCCCCCCCCCcCcHHHHHHHHHhcc
Q 009364 236 TPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQY--QEVAALFHIGTTKSHPPIPENLSVKAKDFLLKCLE 312 (536)
Q Consensus 236 t~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~--~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~ 312 (536)
+..|+|||++.+..++.++|||||||++|+|++ |..||.... +........ ......+...+.++.+++.+||+
T Consensus 238 ~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~~cl~ 314 (337)
T cd05054 238 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKE---GTRMRAPEYATPEIYSIMLDCWH 314 (337)
T ss_pred CccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhc---cCCCCCCccCCHHHHHHHHHHcc
Confidence 788999999999999999999999999999998 999996532 112222211 12223455788999999999999
Q ss_pred cCCCCCCCHHHHHhC
Q 009364 313 KEPDLRPTASELLKH 327 (536)
Q Consensus 313 ~dP~~Rps~~eiL~h 327 (536)
.+|++||++.++++|
T Consensus 315 ~~p~~RPs~~ell~~ 329 (337)
T cd05054 315 NNPEDRPTFSELVEI 329 (337)
T ss_pred CChhhCcCHHHHHHH
Confidence 999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=338.57 Aligned_cols=258 Identities=31% Similarity=0.465 Sum_probs=205.6
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCC-CCceeeEeeeeecCCc
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS-HPNIVRYLGTVREEES 145 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~ 145 (536)
+|...+.||+|+||.||++.+..+|+.+|+|.+... ........+.+|+.++.++. |+||+++++++..+..
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~-------~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~ 77 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRST-------VDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGD 77 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhc-------cChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCc
Confidence 466778899999999999999999999999987321 11133456788999999996 9999999999999999
Q ss_pred eeEEEEecCCCCccccc-----ccCCCCCHHHHHHHHHHHHHHHHHHHHc-CCccccCCCCCcccCCCCcEEEEecCcch
Q 009364 146 LNILLEFVPGGSISSLL-----GKFGPFPEAVMRTYTKQLLLGLEYLHNH-GIMHRDIKGANILVDNKGCIKLADFGASK 219 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l-----~~~~~l~~~~~~~i~~qil~aL~yLH~~-~ivHrDLKp~NILl~~~~~vkL~DFGla~ 219 (536)
.+++|||+. +++.++. .....+++..+..++.|++.||+|||+. |++||||||+||+++.++.+||+|||+++
T Consensus 78 ~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 156 (288)
T cd06616 78 CWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISG 156 (288)
T ss_pred EEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhH
Confidence 999999985 4444332 2236799999999999999999999985 99999999999999999999999999987
Q ss_pred hhhhhhcccCCcccCCCCCCCChhhhhhc---CCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCC---CCCCC
Q 009364 220 QVAELATVSGAKSMKGTPYWMAPEVIRQT---GHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGT---TKSHP 293 (536)
Q Consensus 220 ~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~---~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~---~~~~~ 293 (536)
.+.... ......|++.|+|||++.+. .++.++|||||||++|+|++|++||............... .....
T Consensus 157 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd06616 157 QLVDSI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSN 233 (288)
T ss_pred HhccCC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCC
Confidence 654321 12344689999999999876 6899999999999999999999999654322112111111 11111
Q ss_pred CCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCCC
Q 009364 294 PIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDE 335 (536)
Q Consensus 294 ~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~~ 335 (536)
..+..++.++.+||.+||+++|.+|||+.++++||||+....
T Consensus 234 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~~ 275 (288)
T cd06616 234 SEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEE 275 (288)
T ss_pred cCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchhh
Confidence 223458899999999999999999999999999999976443
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=331.77 Aligned_cols=254 Identities=30% Similarity=0.568 Sum_probs=211.0
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCce
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESL 146 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 146 (536)
+|.+.+.||+|+||.||+|.+..+|..+|+|.+.... ......+.+.+|+.+++.++|+||+++++.+......
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~------~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~ 74 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTK------MPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRL 74 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhh------ccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeE
Confidence 5889999999999999999999999999999874311 1112345677899999999999999999999999999
Q ss_pred eEEEEecCCCCcccccccCC--CCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCC-cEEEEecCcchhhhh
Q 009364 147 NILLEFVPGGSISSLLGKFG--PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKG-CIKLADFGASKQVAE 223 (536)
Q Consensus 147 ~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~-~vkL~DFGla~~~~~ 223 (536)
++|+||+++++|.+++.... .+++..+..++.|++.||.|||+++++|+||||+||+++.++ .+||+|||.+.....
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (257)
T cd08225 75 FIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND 154 (257)
T ss_pred EEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence 99999999999999886543 479999999999999999999999999999999999998886 569999999876643
Q ss_pred hhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcHHH
Q 009364 224 LATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKA 303 (536)
Q Consensus 224 ~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 303 (536)
.. .......|++.|+|||++.+..++.++|+|||||++|+|++|..||.......... .. ...........++.++
T Consensus 155 ~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~ 230 (257)
T cd08225 155 SM--ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVL-KI-CQGYFAPISPNFSRDL 230 (257)
T ss_pred Cc--ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHH-HH-hcccCCCCCCCCCHHH
Confidence 22 11234568999999999988889999999999999999999999997543221111 11 1122233455788999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHhCCCC
Q 009364 304 KDFLLKCLEKEPDLRPTASELLKHPFV 330 (536)
Q Consensus 304 ~dLi~~cL~~dP~~Rps~~eiL~hp~~ 330 (536)
+++|.+||..+|++|||+.++++||||
T Consensus 231 ~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 231 RSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=391.60 Aligned_cols=263 Identities=49% Similarity=0.843 Sum_probs=230.9
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE 142 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 142 (536)
.-..||..+..||.|.||.||-|.+..+|+..|+|.+.+.... ......+.+|.++|..++|||+|++||+-.+
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~------~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvH 1305 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD------HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVH 1305 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc------cccCcchHHHHHHHHhccCccccccCceeec
Confidence 4456899999999999999999999999999999998654432 3445678899999999999999999999999
Q ss_pred CCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhh
Q 009364 143 EESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVA 222 (536)
Q Consensus 143 ~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~ 222 (536)
.+..+|.||||.||+|.+++...+..+|...+.+..|++.|++|||+.|||||||||+||+++.+|.+|++|||.|..+.
T Consensus 1306 Rekv~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1306 REKVYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred HHHHHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEec
Confidence 99999999999999999999987888899999999999999999999999999999999999999999999999998876
Q ss_pred hhhc--ccCCcccCCCCCCCChhhhhh---cCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCC
Q 009364 223 ELAT--VSGAKSMKGTPYWMAPEVIRQ---TGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPE 297 (536)
Q Consensus 223 ~~~~--~~~~~~~~Gt~~Y~APEvl~~---~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 297 (536)
.... ....+...|||.|||||++.+ .+...++|||||||++.||+||+.||..-..+...+++.+ ....|.+|.
T Consensus 1386 ~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~-~gh~Pq~P~ 1464 (1509)
T KOG4645|consen 1386 NNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVA-AGHKPQIPE 1464 (1509)
T ss_pred CchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHh-ccCCCCCch
Confidence 5321 122356789999999999975 4578899999999999999999999987766666665554 345677888
Q ss_pred cCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcC
Q 009364 298 NLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTG 332 (536)
Q Consensus 298 ~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~ 332 (536)
.+|.+.++||.+||..||++|-++.|+++|-|-..
T Consensus 1465 ~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1465 RLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred hhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccc
Confidence 99999999999999999999999999999987643
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=336.77 Aligned_cols=256 Identities=32% Similarity=0.581 Sum_probs=216.5
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCC-CCceeeEeeeeecCCc
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS-HPNIVRYLGTVREEES 145 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~ 145 (536)
+|.+.+.||+|+||.||+|.+..+|+.||+|++.... .........+.+|+.+++.+. ||||+++++++.....
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-----~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~ 76 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQ-----LIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEEN 76 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHh-----ccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCce
Confidence 6899999999999999999999999999999874211 111233466788999999998 9999999999999999
Q ss_pred eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhh
Q 009364 146 LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA 225 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 225 (536)
.++||||+.+++|.+++.+.+.+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 77 LYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence 99999999999999999888899999999999999999999999999999999999999999999999999987655322
Q ss_pred cc------------------cCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhC
Q 009364 226 TV------------------SGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIG 287 (536)
Q Consensus 226 ~~------------------~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~ 287 (536)
.. .......|+..|+|||++.+..++.++||||||+++++|++|..||........ .....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~ 235 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT-FQKIL 235 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH-HHHHH
Confidence 11 122345688999999999888899999999999999999999999975432111 11111
Q ss_pred CCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCH----HHHHhCCCC
Q 009364 288 TTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTA----SELLKHPFV 330 (536)
Q Consensus 288 ~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~----~eiL~hp~~ 330 (536)
.....++..+++.+.+||.+||+.+|.+||++ .++++||||
T Consensus 236 --~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 236 --KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred --hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 22334566789999999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=330.39 Aligned_cols=246 Identities=31% Similarity=0.528 Sum_probs=208.5
Q ss_pred eEEcccCceEEEEEEEcCC---CcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCceeE
Q 009364 72 ELIGCGAFGRVYMGMNLDS---GELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESLNI 148 (536)
Q Consensus 72 ~~LG~G~fg~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 148 (536)
+.||+|+||.||+|.+... +..||+|.+... ......+.+.+|+.+++.++|+||+++++++.....+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~-------~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 73 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKED-------ASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYL 73 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccc-------cchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEE
Confidence 4699999999999999866 899999987321 111245678899999999999999999999999999999
Q ss_pred EEEecCCCCcccccccC---------CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcch
Q 009364 149 LLEFVPGGSISSLLGKF---------GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASK 219 (536)
Q Consensus 149 V~E~~~gg~L~~~l~~~---------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~ 219 (536)
||||+++++|.+++... ..+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||.+.
T Consensus 74 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~ 153 (262)
T cd00192 74 VLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSR 153 (262)
T ss_pred EEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccc
Confidence 99999999999999875 779999999999999999999999999999999999999999999999999998
Q ss_pred hhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhHH-HHHHHhhCCCCCCCCCCC
Q 009364 220 QVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQE-VAALFHIGTTKSHPPIPE 297 (536)
Q Consensus 220 ~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~ 297 (536)
...............+++.|+|||.+.+..++.++|||||||++|+|++ |..||...... ...... .......+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~ 230 (262)
T cd00192 154 DVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLR---KGYRLPKPE 230 (262)
T ss_pred ccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH---cCCCCCCCc
Confidence 7654332222345568899999999998889999999999999999999 69999765322 222221 133445567
Q ss_pred cCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 298 NLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 298 ~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
.++.++.+++.+||..+|.+|||+.|++++
T Consensus 231 ~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 231 YCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred cCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 889999999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=355.99 Aligned_cols=255 Identities=25% Similarity=0.404 Sum_probs=205.7
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCC-----CcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCC-CCceeeE
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDS-----GELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS-HPNIVRY 136 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~-----g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l 136 (536)
.+..+|+++++||+|+||.||+|.+... +..||+|++... ......+.+.+|+++|+++. ||||+++
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~-------~~~~~~~~~~~Ei~~l~~l~~HpnIv~l 106 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPT-------ARSSEKQALMSELKIMTHLGPHLNIVNL 106 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCC-------CChHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 3456899999999999999999987433 357999987321 11223456889999999996 9999999
Q ss_pred eeeeecCCceeEEEEecCCCCcccccccC---------------------------------------------------
Q 009364 137 LGTVREEESLNILLEFVPGGSISSLLGKF--------------------------------------------------- 165 (536)
Q Consensus 137 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~--------------------------------------------------- 165 (536)
++++.....+++|||||++|+|.+++.+.
T Consensus 107 ~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (400)
T cd05105 107 LGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTT 186 (400)
T ss_pred EEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccc
Confidence 99999999999999999999998876432
Q ss_pred ---------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCC
Q 009364 166 ---------------------------------------------GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGA 200 (536)
Q Consensus 166 ---------------------------------------------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~ 200 (536)
..+++..+..++.||+.||+|||++||+||||||+
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~ 266 (400)
T cd05105 187 QYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAAR 266 (400)
T ss_pred ccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChH
Confidence 23677888999999999999999999999999999
Q ss_pred CcccCCCCcEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhHH
Q 009364 201 NILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQE 279 (536)
Q Consensus 201 NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~~ 279 (536)
|||++.++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 267 Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~ 346 (400)
T cd05105 267 NVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD 346 (400)
T ss_pred hEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh
Confidence 99999999999999999876543222222334457889999999998899999999999999999997 99999654321
Q ss_pred --HHHHHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 280 --VAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 280 --~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
...... .......+..++.++++++.+||+.||++||++.++.+.
T Consensus 347 ~~~~~~~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~ 393 (400)
T cd05105 347 STFYNKIK---SGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDI 393 (400)
T ss_pred HHHHHHHh---cCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHH
Confidence 111111 122334556789999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=337.43 Aligned_cols=253 Identities=25% Similarity=0.389 Sum_probs=206.1
Q ss_pred CCCceeeeEEcccCceEEEEEEEcC-----CCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeee
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLD-----SGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGT 139 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~ 139 (536)
..+|.+.+.||+|+||.||+|.+.. ++..||+|.+.. .........+.+|+.+++.++|+||++++++
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~-------~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 77 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPE-------SCSEQDESDFLMEALIMSKFNHQNIVRLIGV 77 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCC-------CCCHHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 4579999999999999999999987 778899997632 1112223457789999999999999999999
Q ss_pred eecCCceeEEEEecCCCCcccccccCC-------CCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCC---c
Q 009364 140 VREEESLNILLEFVPGGSISSLLGKFG-------PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKG---C 209 (536)
Q Consensus 140 ~~~~~~~~lV~E~~~gg~L~~~l~~~~-------~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~---~ 209 (536)
+.+....++||||++|++|.+++...+ .+++..+..++.||+.||+|||+++++||||||+||+++.++ .
T Consensus 78 ~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~ 157 (277)
T cd05036 78 SFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRV 157 (277)
T ss_pred EccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcc
Confidence 999999999999999999999886543 488999999999999999999999999999999999998765 6
Q ss_pred EEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhh-HHHHHHHhhC
Q 009364 210 IKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQY-QEVAALFHIG 287 (536)
Q Consensus 210 vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~-~~~~~~~~~~ 287 (536)
+||+|||+++.+.............+++.|+|||++.+..++.++|||||||++|+|++ |..||.... .........
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~- 236 (277)
T cd05036 158 AKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTG- 236 (277)
T ss_pred eEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc-
Confidence 99999999886632211111122334568999999998899999999999999999997 999997543 222222221
Q ss_pred CCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 288 TTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 288 ~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
......+..++..+.+++.+||+.+|++|||+.++++|
T Consensus 237 --~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 237 --GGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred --CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 12234566789999999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=338.52 Aligned_cols=250 Identities=28% Similarity=0.478 Sum_probs=204.9
Q ss_pred CCceeeeEEcccCceEEEEEEEc-----CCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeee
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNL-----DSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTV 140 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~ 140 (536)
.+|.+.+.||+|+||+||++.+. .++..+|+|.+.. ........+.+|+.++++++||||+++++++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~--------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 76 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD--------ASDNARKDFHREAELLTNLQHEHIVKFYGVC 76 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCC--------cCHHHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 46889999999999999999853 3456789998731 1223355688999999999999999999999
Q ss_pred ecCCceeEEEEecCCCCcccccccCC-------------CCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCC
Q 009364 141 REEESLNILLEFVPGGSISSLLGKFG-------------PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNK 207 (536)
Q Consensus 141 ~~~~~~~lV~E~~~gg~L~~~l~~~~-------------~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~ 207 (536)
...+.+++||||+++++|.+++...+ .+++..+..++.|++.||+|||++|++||||||+|||++.+
T Consensus 77 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~ 156 (288)
T cd05093 77 VEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN 156 (288)
T ss_pred ecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence 99999999999999999999886433 48999999999999999999999999999999999999999
Q ss_pred CcEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhH-HHHHHHh
Q 009364 208 GCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQ-EVAALFH 285 (536)
Q Consensus 208 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~-~~~~~~~ 285 (536)
+.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|+|++ |.+||..... .......
T Consensus 157 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~ 236 (288)
T cd05093 157 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 236 (288)
T ss_pred CcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 9999999999876543222222233446788999999998889999999999999999998 9999965432 2222222
Q ss_pred hCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHh
Q 009364 286 IGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 286 ~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~ 326 (536)
.. .....+..++.++.+|+.+||+.||.+|||+.+++.
T Consensus 237 ~~---~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 237 QG---RVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred cC---CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 21 223345578899999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=333.44 Aligned_cols=253 Identities=25% Similarity=0.436 Sum_probs=207.6
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCC---CcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeee
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDS---GELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVR 141 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~ 141 (536)
+.+|++.+.||+|+||+||+|.+..+ ...||+|.+... ........+.+|+.+++.++||||+++++++.
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~-------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 75 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAG-------SSDKQRLDFLTEASIMGQFDHPNIIRLEGVVT 75 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCC-------CChHHHHHHHHHHHHHHhCCCCCcceEeEEEe
Confidence 45799999999999999999998654 457999987321 12233456778999999999999999999999
Q ss_pred cCCceeEEEEecCCCCcccccccC-CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchh
Q 009364 142 EEESLNILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQ 220 (536)
Q Consensus 142 ~~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~ 220 (536)
..+..++||||+++++|.+++... +.+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||+++.
T Consensus 76 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~ 155 (266)
T cd05033 76 KSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRR 155 (266)
T ss_pred cCCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhc
Confidence 999999999999999999998653 4789999999999999999999999999999999999999999999999999987
Q ss_pred hhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhH-HHHHHHhhCCCCCCCCCCCc
Q 009364 221 VAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQ-EVAALFHIGTTKSHPPIPEN 298 (536)
Q Consensus 221 ~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~ 298 (536)
..............+++.|+|||.+.+..++.++||||||+++|+|++ |..||..... ........ ....+.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~ 232 (266)
T cd05033 156 LEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVED---GYRLPPPMD 232 (266)
T ss_pred ccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHc---CCCCCCCCC
Confidence 652222111223345678999999998899999999999999999998 9999964432 22222221 122334567
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 299 LSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 299 ~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
++..+.+|+.+||+.+|++||++.+++++
T Consensus 233 ~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 233 CPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 89999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=333.28 Aligned_cols=251 Identities=26% Similarity=0.445 Sum_probs=202.9
Q ss_pred ceeeeEEcccCceEEEEEEEcCC---CcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCC
Q 009364 68 WRKGELIGCGAFGRVYMGMNLDS---GELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEE 144 (536)
Q Consensus 68 y~~~~~LG~G~fg~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 144 (536)
|++++.||+|+||.||+|....+ +..||+|.+... .........+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~------~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 74 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLD------IHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEAS 74 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccC------cCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCC
Confidence 56889999999999999987653 478999987321 112234567889999999999999999999886554
Q ss_pred c------eeEEEEecCCCCccccccc------CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEE
Q 009364 145 S------LNILLEFVPGGSISSLLGK------FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKL 212 (536)
Q Consensus 145 ~------~~lV~E~~~gg~L~~~l~~------~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL 212 (536)
. .++||||+++|+|..++.. ...+++..+..++.|++.||.|||++|++||||||+||++++++.+||
T Consensus 75 ~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl 154 (273)
T cd05035 75 SLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCV 154 (273)
T ss_pred ccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEE
Confidence 4 7999999999999888732 236899999999999999999999999999999999999999999999
Q ss_pred EecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhHH-HHHHHhhCCCC
Q 009364 213 ADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQE-VAALFHIGTTK 290 (536)
Q Consensus 213 ~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~~-~~~~~~~~~~~ 290 (536)
+|||+++.+.............++..|+|||++.+..++.++|||||||++|+|++ |.+||...... ...... ..
T Consensus 155 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~---~~ 231 (273)
T cd05035 155 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLR---HG 231 (273)
T ss_pred CCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---cC
Confidence 99999886643322222223345678999999988889999999999999999999 89999654322 222221 12
Q ss_pred CCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 291 SHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 291 ~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
.....+..++.++.+++.+||+.||.+|||+.+++++
T Consensus 232 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 232 NRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2344566889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=336.45 Aligned_cols=244 Identities=27% Similarity=0.431 Sum_probs=200.5
Q ss_pred CceeeeEE--cccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeEeeeeecC
Q 009364 67 RWRKGELI--GCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRYLGTVREE 143 (536)
Q Consensus 67 ~y~~~~~L--G~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~ 143 (536)
+|++.+.+ |.|+||.||++.+..++..+|+|.+.... . .. .|+.....+ +||||+++++.+...
T Consensus 15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~-------~----~~--~e~~~~~~~~~h~~iv~~~~~~~~~ 81 (267)
T PHA03390 15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKN-------F----NA--IEPMVHQLMKDNPNFIKLYYSVTTL 81 (267)
T ss_pred hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhh-------c----ch--hhHHHHHHhhcCCCEEEEEEEEecC
Confidence 45555555 99999999999999999999999873210 0 00 122222222 699999999999999
Q ss_pred CceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCC-cEEEEecCcchhhh
Q 009364 144 ESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKG-CIKLADFGASKQVA 222 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~-~vkL~DFGla~~~~ 222 (536)
+.+++||||+++++|.+++.....+++..++.++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++....
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 161 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG 161 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence 99999999999999999998877999999999999999999999999999999999999999988 99999999987543
Q ss_pred hhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHH---HHHHhhCCCCCCCCCCCcC
Q 009364 223 ELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEV---AALFHIGTTKSHPPIPENL 299 (536)
Q Consensus 223 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~---~~~~~~~~~~~~~~~~~~~ 299 (536)
. .....|++.|+|||++.+..++.++||||+||++|+|++|..||....... ....... ......++.+
T Consensus 162 ~------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 233 (267)
T PHA03390 162 T------PSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ--QKKLPFIKNV 233 (267)
T ss_pred C------CccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh--cccCCccccc
Confidence 2 234568999999999998899999999999999999999999996433221 1111111 2233455579
Q ss_pred cHHHHHHHHHhcccCCCCCCC-HHHHHhCCCCc
Q 009364 300 SVKAKDFLLKCLEKEPDLRPT-ASELLKHPFVT 331 (536)
Q Consensus 300 s~~~~dLi~~cL~~dP~~Rps-~~eiL~hp~~~ 331 (536)
++.+++||.+||+.+|.+||+ ++++|+||||.
T Consensus 234 ~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 234 SKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred CHHHHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence 999999999999999999996 69999999996
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=337.07 Aligned_cols=256 Identities=25% Similarity=0.375 Sum_probs=206.9
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCC----------------cEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSG----------------ELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL 128 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g----------------~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l 128 (536)
..+|++.+.||+|+||.||+|.+...+ ..||+|.+... ........+.+|+.+++.+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~-------~~~~~~~~~~~e~~~l~~l 76 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPD-------ASDNAREDFLKEVKILSRL 76 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCc-------cCHHHHHHHHHHHHHHHhc
Confidence 357999999999999999999876544 56799987321 1123456788999999999
Q ss_pred CCCceeeEeeeeecCCceeEEEEecCCCCcccccccCC-----------CCCHHHHHHHHHHHHHHHHHHHHcCCccccC
Q 009364 129 SHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFG-----------PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDI 197 (536)
Q Consensus 129 ~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~-----------~l~~~~~~~i~~qil~aL~yLH~~~ivHrDL 197 (536)
+||||+++++++..++..++||||+.+++|.+++.+.. .+++..++.++.|++.||+|||++|++||||
T Consensus 77 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dl 156 (296)
T cd05051 77 SDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDL 156 (296)
T ss_pred CCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccc
Confidence 99999999999999999999999999999999987655 6899999999999999999999999999999
Q ss_pred CCCCcccCCCCcEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh--CCCCCch
Q 009364 198 KGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT--GKPPWSQ 275 (536)
Q Consensus 198 Kp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt--G~~Pf~~ 275 (536)
||+||+++.++.++|+|||+++...............+++.|+|||++.+..++.++|||||||++|+|++ |..||..
T Consensus 157 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~ 236 (296)
T cd05051 157 ATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236 (296)
T ss_pred chhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence 99999999999999999999876543222222334557789999999998889999999999999999998 7788864
Q ss_pred hhH-HHHHHHhh----CCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 276 QYQ-EVAALFHI----GTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 276 ~~~-~~~~~~~~----~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
... ........ .......+.+..++.++.+|+.+||+.||.+|||+.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~ 293 (296)
T cd05051 237 LTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLF 293 (296)
T ss_pred cChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHH
Confidence 321 21111111 11122223345678999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=335.54 Aligned_cols=261 Identities=37% Similarity=0.632 Sum_probs=217.8
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE 142 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 142 (536)
.....|++.+.||+|+||.||+|.+..++..|++|++..... ....+.+|+.+++.++|+||+++++.+..
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 86 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---------NKELIINEILIMKDCKHPNIVDYYDSYLV 86 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---------hHHHHHHHHHHHHHCCCCCeeEEEEEEEE
Confidence 455679999999999999999999988899999998842211 34567789999999999999999999999
Q ss_pred CCceeEEEEecCCCCcccccccCC-CCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhh
Q 009364 143 EESLNILLEFVPGGSISSLLGKFG-PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQV 221 (536)
Q Consensus 143 ~~~~~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~ 221 (536)
....++|+||+++++|.+++.... .+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~ 166 (286)
T cd06614 87 GDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQL 166 (286)
T ss_pred CCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhh
Confidence 999999999999999999998766 8999999999999999999999999999999999999999999999999988655
Q ss_pred hhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcH
Q 009364 222 AELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSV 301 (536)
Q Consensus 222 ~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 301 (536)
..... ......+++.|+|||++.+..++.++|+|||||++|+|++|..||......................+..++.
T Consensus 167 ~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (286)
T cd06614 167 TKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSP 244 (286)
T ss_pred ccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCH
Confidence 43211 1234568899999999988889999999999999999999999997543322111111111111122334789
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCC
Q 009364 302 KAKDFLLKCLEKEPDLRPTASELLKHPFVTGDD 334 (536)
Q Consensus 302 ~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~ 334 (536)
.++++|.+||+.+|.+||++.++++|+||....
T Consensus 245 ~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 277 (286)
T cd06614 245 EFKDFLNKCLVKDPEKRPSAEELLQHPFLKKAC 277 (286)
T ss_pred HHHHHHHHHhccChhhCcCHHHHhhChHhhccC
Confidence 999999999999999999999999999998743
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=332.98 Aligned_cols=249 Identities=26% Similarity=0.433 Sum_probs=207.5
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
..|.+.+.||+|+||.||+|.+..+++.||+|.+.. . ......+.+|+++++.++|+||+++++++..+..
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~-------~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 76 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-------D--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 76 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecC-------C--chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCC
Confidence 458899999999999999999999999999998731 1 1224567789999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhh
Q 009364 146 LNILLEFVPGGSISSLLGKF--GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAE 223 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 223 (536)
+++||||+++++|.+++... ..+++..++.++.|++.||+|||++|++||||||+||++++++.+||+|||++.....
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 77 FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156 (263)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence 99999999999999988643 3589999999999999999999999999999999999999999999999999876643
Q ss_pred hhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhH-HHHHHHhhCCCCCCCCCCCcCcH
Q 009364 224 LATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQ-EVAALFHIGTTKSHPPIPENLSV 301 (536)
Q Consensus 224 ~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~s~ 301 (536)
... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||..... +....... ......+..++.
T Consensus 157 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 232 (263)
T cd05052 157 DTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK---GYRMERPEGCPP 232 (263)
T ss_pred cee-eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC---CCCCCCCCCCCH
Confidence 211 11122334678999999998899999999999999999998 9999965432 22222221 223455678899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 302 KAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 302 ~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
++.++|.+||+.||.+|||+.++++.
T Consensus 233 ~~~~li~~cl~~~p~~Rp~~~~l~~~ 258 (263)
T cd05052 233 KVYELMRACWQWNPSDRPSFAEIHQA 258 (263)
T ss_pred HHHHHHHHHccCCcccCCCHHHHHHH
Confidence 99999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=330.82 Aligned_cols=251 Identities=36% Similarity=0.634 Sum_probs=209.0
Q ss_pred EcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCceeEEEEec
Q 009364 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESLNILLEFV 153 (536)
Q Consensus 74 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 153 (536)
||.|+||.||+|.+..+|+.+|+|++... ........+.+.+|+.++++++||||+++++.+......++|+||+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~-----~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKA-----DMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecch-----hhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecC
Confidence 68999999999999999999999987321 1112345567889999999999999999999999999999999999
Q ss_pred CCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhc------c
Q 009364 154 PGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELAT------V 227 (536)
Q Consensus 154 ~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~------~ 227 (536)
++++|.+++.+.+.+++..+..++.||+.||.|||++|++||||+|+||+++.++.++|+|||++........ .
T Consensus 76 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 76 PGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 9999999998877899999999999999999999999999999999999999999999999999875432211 0
Q ss_pred cCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHH-HHHHhhCCCCCCCCCCCc--CcHHHH
Q 009364 228 SGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEV-AALFHIGTTKSHPPIPEN--LSVKAK 304 (536)
Q Consensus 228 ~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~--~s~~~~ 304 (536)
.......+++.|+|||++.+..++.++||||||+++|+|++|..||....... ....... . ..++.. ++..+.
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~--~--~~~~~~~~~~~~~~ 231 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNG--K--IEWPEDVEVSDEAI 231 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--C--cCCCccccCCHHHH
Confidence 12234568899999999988889999999999999999999999996543322 1111111 1 122223 489999
Q ss_pred HHHHHhcccCCCCCCCH---HHHHhCCCCcCC
Q 009364 305 DFLLKCLEKEPDLRPTA---SELLKHPFVTGD 333 (536)
Q Consensus 305 dLi~~cL~~dP~~Rps~---~eiL~hp~~~~~ 333 (536)
+++++||+.+|.+|||+ .++|+||||...
T Consensus 232 ~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~ 263 (265)
T cd05579 232 DLISKLLVPDPEKRLGAKSIEEIKNHPFFKGI 263 (265)
T ss_pred HHHHHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence 99999999999999999 999999999754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=330.29 Aligned_cols=254 Identities=33% Similarity=0.606 Sum_probs=209.6
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
.+|++.+.||+|+||.||+|.+..+|+.||+|.+..... ......+.+.+|++++++++|+||+++++.+...+.
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-----~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~ 76 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEM-----MDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNE 76 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccc-----cchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCe
Confidence 479999999999999999999998999999998743211 112234668899999999999999999999999999
Q ss_pred eeEEEEecCCCCccccccc----CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhh
Q 009364 146 LNILLEFVPGGSISSLLGK----FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQV 221 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~ 221 (536)
.++||||+++|+|..++.. ...+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++...
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~ 156 (267)
T cd08224 77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeec
Confidence 9999999999999988753 345899999999999999999999999999999999999999999999999998765
Q ss_pred hhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCC-cCc
Q 009364 222 AELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPE-NLS 300 (536)
Q Consensus 222 ~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-~~s 300 (536)
.... .......|++.|+|||++.+..++.++|||||||++|+|++|..||...................++.+. .++
T Consensus 157 ~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd08224 157 SSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYS 234 (267)
T ss_pred cCCC--cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcC
Confidence 4321 1123456899999999999888999999999999999999999999654322222222111222333333 678
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHh
Q 009364 301 VKAKDFLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 301 ~~~~dLi~~cL~~dP~~Rps~~eiL~ 326 (536)
..+.++|.+||..+|.+|||+.+|++
T Consensus 235 ~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 235 EELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 89999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=337.09 Aligned_cols=257 Identities=32% Similarity=0.519 Sum_probs=201.8
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCC-CCceeeEeeeeecCC
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS-HPNIVRYLGTVREEE 144 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~ 144 (536)
++|++.+.||+|+||.||+|.+..+|+.||+|.+.... ........+.+|+.+++.+. ||||+++++++....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~------~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~ 74 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEM------DEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEE 74 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhc------cccCCchHHHHHHHHHHHccCCCCccceeeeEeecC
Confidence 36999999999999999999999999999999873211 11112345678999999995 699999999988766
Q ss_pred c-----eeEEEEecCCCCccccccc-----CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCC-CCcEEEE
Q 009364 145 S-----LNILLEFVPGGSISSLLGK-----FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDN-KGCIKLA 213 (536)
Q Consensus 145 ~-----~~lV~E~~~gg~L~~~l~~-----~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~-~~~vkL~ 213 (536)
. .|+||||+++ +|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+
T Consensus 75 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~ 153 (295)
T cd07837 75 KNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIA 153 (295)
T ss_pred CCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEe
Confidence 5 8999999975 77777643 245899999999999999999999999999999999999998 8899999
Q ss_pred ecCcchhhhhhhcccCCcccCCCCCCCChhhhhh-cCCCccceEechhHHHHHHhhCCCCCchhhH--HHHHHHhhCCCC
Q 009364 214 DFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQ-TGHSYSADIWSVGCTVIEMATGKPPWSQQYQ--EVAALFHIGTTK 290 (536)
Q Consensus 214 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~-~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~--~~~~~~~~~~~~ 290 (536)
|||+++.+.... .......+++.|+|||++.+ ..++.++|||||||++|+|++|.+||..... ....+.......
T Consensus 154 dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~ 231 (295)
T cd07837 154 DLGLGRAFSIPV--KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTP 231 (295)
T ss_pred ecccceecCCCc--cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 999987553211 11223457899999998865 4578999999999999999999999964321 111111110000
Q ss_pred C---------------CC--------CCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCc
Q 009364 291 S---------------HP--------PIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVT 331 (536)
Q Consensus 291 ~---------------~~--------~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~ 331 (536)
. .+ ...+.++.++.+||.+||.+||.+||++.+++.||||.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred ChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 0 00 01135788999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=337.67 Aligned_cols=251 Identities=25% Similarity=0.412 Sum_probs=206.1
Q ss_pred CceeeeEEcccCceEEEEEEEcCC-----CcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeee
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDS-----GELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVR 141 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~-----g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~ 141 (536)
+|++.+.||+|+||.||+|.+..+ +..||+|++... ........+.+|+.++..++||||+++++++.
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~-------~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~ 78 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDK-------AEGPLREEFKHEAMMRSRLQHPNIVCLLGVVT 78 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCC-------CCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc
Confidence 578899999999999999987543 578999987321 11223456788999999999999999999999
Q ss_pred cCCceeEEEEecCCCCccccccc----------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccC
Q 009364 142 EEESLNILLEFVPGGSISSLLGK----------------FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVD 205 (536)
Q Consensus 142 ~~~~~~lV~E~~~gg~L~~~l~~----------------~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~ 205 (536)
.....++++||+.+++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+++
T Consensus 79 ~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~ 158 (283)
T cd05091 79 KEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVF 158 (283)
T ss_pred CCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEec
Confidence 99999999999999999888742 13478888999999999999999999999999999999999
Q ss_pred CCCcEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhHH-HHHH
Q 009364 206 NKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQE-VAAL 283 (536)
Q Consensus 206 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~~-~~~~ 283 (536)
+++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|+|++ |.+||...... ....
T Consensus 159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05091 159 DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM 238 (283)
T ss_pred CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 999999999999886543322222334456789999999988889999999999999999998 88898654332 2222
Q ss_pred HhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 284 FHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 284 ~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
.. .....+.+..++..+.+|+.+||+.+|.+||++.+|+..
T Consensus 239 i~---~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 239 IR---NRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HH---cCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 22 222344567899999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=342.64 Aligned_cols=261 Identities=31% Similarity=0.484 Sum_probs=205.2
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE 143 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 143 (536)
+..+|++.+.||+|+||.||+|.+..+|+.||+|++..... .........+|+.+++.++|+||+++++++...
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNE------RDGIPISSLREITLLLNLRHPNIVELKEVVVGK 78 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccC------CCCCcchhhHHHHHHHhCCCCCCcceEEEEecC
Confidence 45689999999999999999999999999999998743211 011122345799999999999999999998755
Q ss_pred --CceeEEEEecCCCCccccccc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchh
Q 009364 144 --ESLNILLEFVPGGSISSLLGK-FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQ 220 (536)
Q Consensus 144 --~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~ 220 (536)
+.+++||||+. ++|.+++.. ...+++..++.++.||+.||+|||+.|++||||||+||+++.++.+||+|||++..
T Consensus 79 ~~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~ 157 (309)
T cd07845 79 HLDSIFLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLART 157 (309)
T ss_pred CCCeEEEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeee
Confidence 56899999996 477777654 36789999999999999999999999999999999999999999999999999876
Q ss_pred hhhhhcccCCcccCCCCCCCChhhhhh-cCCCccceEechhHHHHHHhhCCCCCchhhHH--HHHHHhhCCC---CC---
Q 009364 221 VAELATVSGAKSMKGTPYWMAPEVIRQ-TGHSYSADIWSVGCTVIEMATGKPPWSQQYQE--VAALFHIGTT---KS--- 291 (536)
Q Consensus 221 ~~~~~~~~~~~~~~Gt~~Y~APEvl~~-~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~--~~~~~~~~~~---~~--- 291 (536)
..... .......+++.|+|||++.+ ..++.++|||||||++|+|++|.+||...... ...+...... ..
T Consensus 158 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
T cd07845 158 YGLPA--KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPG 235 (309)
T ss_pred cCCcc--CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchh
Confidence 64321 11223346888999999865 45789999999999999999999999644321 1111110000 00
Q ss_pred --------C---C--C------CCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 292 --------H---P--P------IPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 292 --------~---~--~------~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
. . . .....++++.+||.+||+.||++|||+.++++||||...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~ 296 (309)
T cd07845 236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK 296 (309)
T ss_pred hhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence 0 0 0 012358889999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=346.56 Aligned_cols=260 Identities=26% Similarity=0.440 Sum_probs=204.5
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC-
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE- 143 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~- 143 (536)
..+|++.+.||+|+||.||+|.+..+|+.||+|++.. .........+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~-------~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 76 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISP-------FEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPS 76 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecc-------cccchhHHHHHHHHHHHHhCCCCCcCchhheeeccc
Confidence 4689999999999999999999999999999998731 11112345567899999999999999999887644
Q ss_pred ----CceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcch
Q 009364 144 ----ESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASK 219 (536)
Q Consensus 144 ----~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~ 219 (536)
...++|+||+. ++|..++.. +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++
T Consensus 77 ~~~~~~~~lv~e~~~-~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 77 FESFNDVYIVQELME-TDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred ccccceEEEEehhcc-cCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECccccee
Confidence 35799999996 577777644 579999999999999999999999999999999999999999999999999987
Q ss_pred hhhhhhccc-CCcccCCCCCCCChhhhhh-cCCCccceEechhHHHHHHhhCCCCCchhhHH--HHHHHhhC--------
Q 009364 220 QVAELATVS-GAKSMKGTPYWMAPEVIRQ-TGHSYSADIWSVGCTVIEMATGKPPWSQQYQE--VAALFHIG-------- 287 (536)
Q Consensus 220 ~~~~~~~~~-~~~~~~Gt~~Y~APEvl~~-~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~--~~~~~~~~-------- 287 (536)
......... ......||+.|+|||++.+ ..++.++||||+||++|+|++|++||...... ........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 234 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDL 234 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence 654322111 1234578999999998754 46899999999999999999999999643210 00000000
Q ss_pred -------------CCCCCCC-----CCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 288 -------------TTKSHPP-----IPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 288 -------------~~~~~~~-----~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
....... ..+..+.++.+||.+||+.+|.+|||+.++++||||...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 0000000 113568889999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=339.66 Aligned_cols=258 Identities=27% Similarity=0.429 Sum_probs=199.9
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCC-
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEE- 144 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~- 144 (536)
.+|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.++||||+++++++....
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 85 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE------KEGFPITALREIKILQLLKHENVVNLIEICRTKAT 85 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC------cCCchhHHHHHHHHHHhCCCCCccceEEEEecccc
Confidence 479999999999999999999999999999998743211 1111234557999999999999999999887654
Q ss_pred -------ceeEEEEecCCCCcccccccC-CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecC
Q 009364 145 -------SLNILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFG 216 (536)
Q Consensus 145 -------~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFG 216 (536)
..++||||+. ++|.+++... ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.+||+|||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 86 PYNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred cccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCC
Confidence 3599999996 5777666543 378999999999999999999999999999999999999999999999999
Q ss_pred cchhhhhhhcc--cCCcccCCCCCCCChhhhhhc-CCCccceEechhHHHHHHhhCCCCCchhhHHH--HHHHhhCCCCC
Q 009364 217 ASKQVAELATV--SGAKSMKGTPYWMAPEVIRQT-GHSYSADIWSVGCTVIEMATGKPPWSQQYQEV--AALFHIGTTKS 291 (536)
Q Consensus 217 la~~~~~~~~~--~~~~~~~Gt~~Y~APEvl~~~-~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~--~~~~~~~~~~~ 291 (536)
++......... .......++..|+|||++.+. .++.++||||||+++|+|++|.+||....... ..+........
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 98765432111 112345678899999998764 46889999999999999999999996543211 11111000000
Q ss_pred ------------------CCC---------CCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCC
Q 009364 292 ------------------HPP---------IPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFV 330 (536)
Q Consensus 292 ------------------~~~---------~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~ 330 (536)
... .+...+..+++||.+||..||.+|||++++++||||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 000 011235678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=334.88 Aligned_cols=251 Identities=29% Similarity=0.471 Sum_probs=197.9
Q ss_pred ceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCC-CCceeeEeeeeecC--C
Q 009364 68 WRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS-HPNIVRYLGTVREE--E 144 (536)
Q Consensus 68 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~--~ 144 (536)
|++.+.||+|+||.||+|.+..+++.||+|.+.... .... .....+|+.++.++. |+||+++++++.+. +
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~------~~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 73 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHF------KSLE-QVNNLREIQALRRLSPHPNILRLIEVLFDRKTG 73 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhcc------CCch-hhhHHHHHHHHhhcCCCCCccceEEEEecCCCC
Confidence 678899999999999999999999999999873211 0111 122346888888885 99999999999987 8
Q ss_pred ceeEEEEecCCCCccccccc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhh
Q 009364 145 SLNILLEFVPGGSISSLLGK-FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAE 223 (536)
Q Consensus 145 ~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 223 (536)
.+++||||+. |+|.+.+.. ...+++..++.++.|++.||.|||++|++||||||+||+++. +.+||+|||+++....
T Consensus 74 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~ 151 (282)
T cd07831 74 RLALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYS 151 (282)
T ss_pred cEEEEEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence 8999999997 466666654 457899999999999999999999999999999999999999 9999999999876543
Q ss_pred hhcccCCcccCCCCCCCChhhhhh-cCCCccceEechhHHHHHHhhCCCCCchhhHH--HHHHHhhC-------------
Q 009364 224 LATVSGAKSMKGTPYWMAPEVIRQ-TGHSYSADIWSVGCTVIEMATGKPPWSQQYQE--VAALFHIG------------- 287 (536)
Q Consensus 224 ~~~~~~~~~~~Gt~~Y~APEvl~~-~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~--~~~~~~~~------------- 287 (536)
.. ......+++.|+|||++.+ ..++.++|||||||++|+|++|.+||...... ........
T Consensus 152 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07831 152 KP---PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRK 228 (282)
T ss_pred CC---CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcc
Confidence 22 1234568999999998754 45688999999999999999999999643211 11111000
Q ss_pred CCCCCC-----------CCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCC
Q 009364 288 TTKSHP-----------PIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFV 330 (536)
Q Consensus 288 ~~~~~~-----------~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~ 330 (536)
...... .....++..+++||.+||.++|.+||++.++++||||
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 000000 1123568999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=332.05 Aligned_cols=254 Identities=32% Similarity=0.566 Sum_probs=208.7
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
.+|++.+.||+|+||.||+|.+..+|+.+|+|.+.... .........+.+|+.+++.++||||+++++++...+.
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~-----~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~ 76 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFD-----LMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNE 76 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehh-----hhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCe
Confidence 36888999999999999999999999999999874211 1122334577889999999999999999999999999
Q ss_pred eeEEEEecCCCCccccccc----CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhh
Q 009364 146 LNILLEFVPGGSISSLLGK----FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQV 221 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~ 221 (536)
.+++|||+++++|.+++.. ...+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++...
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd08229 77 LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhcc
Confidence 9999999999999988753 356899999999999999999999999999999999999999999999999998765
Q ss_pred hhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCC-CCCcCc
Q 009364 222 AELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPP-IPENLS 300 (536)
Q Consensus 222 ~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~-~~~~~s 300 (536)
..... ......|++.|+|||++.+..++.++|+||||+++|+|++|..||...................++ .+..++
T Consensus 157 ~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd08229 157 SSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYS 234 (267)
T ss_pred ccCCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCccccc
Confidence 43221 123457899999999999888999999999999999999999999654322222221111111222 234688
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHh
Q 009364 301 VKAKDFLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 301 ~~~~dLi~~cL~~dP~~Rps~~eiL~ 326 (536)
..++++|.+||..||.+|||+.+|++
T Consensus 235 ~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 235 EELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 89999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=339.53 Aligned_cols=256 Identities=29% Similarity=0.497 Sum_probs=205.1
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC--
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE-- 143 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~-- 143 (536)
.+|++.+.||.|+||.||+|.+..+++.+|+|.+..... .......+.+|+.+++.++||||+++++++...
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~------~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 78 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKE------KEGFPITSLREINILLKLQHPNIVTVKEVVVGSNL 78 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccc------cccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCC
Confidence 468899999999999999999999999999998843211 112234566899999999999999999998877
Q ss_pred CceeEEEEecCCCCcccccccC-CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhh
Q 009364 144 ESLNILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVA 222 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~ 222 (536)
...++||||+. ++|.+++... ..+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||++....
T Consensus 79 ~~~~lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 79 DKIYMVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred CcEEEEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 89999999996 5888887654 458999999999999999999999999999999999999999999999999988665
Q ss_pred hhhcccCCcccCCCCCCCChhhhhhc-CCCccceEechhHHHHHHhhCCCCCchhhHH--HHHHHhhC------------
Q 009364 223 ELATVSGAKSMKGTPYWMAPEVIRQT-GHSYSADIWSVGCTVIEMATGKPPWSQQYQE--VAALFHIG------------ 287 (536)
Q Consensus 223 ~~~~~~~~~~~~Gt~~Y~APEvl~~~-~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~--~~~~~~~~------------ 287 (536)
... .......+++.|+|||++.+. .++.++|||||||++|+|++|.+||...... ...+....
T Consensus 158 ~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (293)
T cd07843 158 SPL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFS 235 (293)
T ss_pred CCc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhh
Confidence 421 122345678999999998764 4689999999999999999999999643211 11110000
Q ss_pred -----C---------CCCCCCCCCc-CcHHHHHHHHHhcccCCCCCCCHHHHHhCCCC
Q 009364 288 -----T---------TKSHPPIPEN-LSVKAKDFLLKCLEKEPDLRPTASELLKHPFV 330 (536)
Q Consensus 288 -----~---------~~~~~~~~~~-~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~ 330 (536)
. ......++.. ++..+++||++||+.+|++|||+.|+++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 0 0001112222 58889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=347.61 Aligned_cols=262 Identities=26% Similarity=0.459 Sum_probs=209.2
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec--
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE-- 142 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~-- 142 (536)
..+|++.+.||+|+||.||+|.+..+|+.||+|++.... ........+.+|+.+|+.++||||+++++++..
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 77 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAF------DVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG 77 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccc------ccccchHHHHHHHHHHHhcCCCCccCHHHhccccC
Confidence 368999999999999999999999999999999874211 111234566789999999999999999998763
Q ss_pred --CCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchh
Q 009364 143 --EESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQ 220 (536)
Q Consensus 143 --~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~ 220 (536)
...+++||||+. |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus 78 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 78 ADFKDVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred CCCceEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEeccccccee
Confidence 346899999995 68999888778899999999999999999999999999999999999999999999999999876
Q ss_pred hhhhhcc--cCCcccCCCCCCCChhhhhh-cCCCccceEechhHHHHHHhhCCCCCchhhHH--HHHHHhh---------
Q 009364 221 VAELATV--SGAKSMKGTPYWMAPEVIRQ-TGHSYSADIWSVGCTVIEMATGKPPWSQQYQE--VAALFHI--------- 286 (536)
Q Consensus 221 ~~~~~~~--~~~~~~~Gt~~Y~APEvl~~-~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~--~~~~~~~--------- 286 (536)
....... .......|+..|+|||++.+ ..++.++|||||||++|+|++|++||...... .......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence 5432211 11234578999999999865 46899999999999999999999999643211 0000000
Q ss_pred ------------CCCCCCCC-----CCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 287 ------------GTTKSHPP-----IPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 287 ------------~~~~~~~~-----~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
........ ..+..+.+++++|++||+.+|.+||++.+++.||||.+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~ 300 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQY 300 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhc
Confidence 00001111 124578999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=347.53 Aligned_cols=257 Identities=26% Similarity=0.396 Sum_probs=204.0
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE 143 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 143 (536)
...+|++.+.||+|+||.||+|.+..+|+.||+|.+... .........+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 87 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRP------FQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQ 87 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcc------ccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccC
Confidence 346899999999999999999999999999999987311 11122345567899999999999999999988643
Q ss_pred ------CceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCc
Q 009364 144 ------ESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGA 217 (536)
Q Consensus 144 ------~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGl 217 (536)
...|+||||+. ++|.+.+... +++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+
T Consensus 88 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 88 KSLEEFQDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CCccccCcEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCcc
Confidence 35799999995 5777776543 89999999999999999999999999999999999999999999999999
Q ss_pred chhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH--HHHHHh----------
Q 009364 218 SKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE--VAALFH---------- 285 (536)
Q Consensus 218 a~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~--~~~~~~---------- 285 (536)
++...... ......|++.|+|||++.+..++.++|||||||++|+|++|+.||...... ...+..
T Consensus 165 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (353)
T cd07850 165 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM 241 (353)
T ss_pred ceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 97654321 133456899999999999999999999999999999999999999643210 000000
Q ss_pred ------------hCCCCCCC----------------CCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcC
Q 009364 286 ------------IGTTKSHP----------------PIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTG 332 (536)
Q Consensus 286 ------------~~~~~~~~----------------~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~ 332 (536)
........ ..+...+..+++||.+||+.||++|||+.|+|+||||..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~ 316 (353)
T cd07850 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV 316 (353)
T ss_pred HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence 00000000 001235677899999999999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=337.01 Aligned_cols=250 Identities=27% Similarity=0.451 Sum_probs=204.9
Q ss_pred CCceeeeEEcccCceEEEEEEEc-----CCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeee
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNL-----DSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTV 140 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~ 140 (536)
.+|.+.+.||+|+||.||+|.+. .++..+++|.+. .......+.+.+|+.+++.++|+||+++++++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~--------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 76 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALK--------DPTLAARKDFQREAELLTNLQHEHIVKFYGVC 76 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecC--------CccHHHHHHHHHHHHHHhcCCCCCcceEEEEE
Confidence 46889999999999999999854 345678888762 12223345678899999999999999999999
Q ss_pred ecCCceeEEEEecCCCCcccccccC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCccc
Q 009364 141 REEESLNILLEFVPGGSISSLLGKF----------------GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILV 204 (536)
Q Consensus 141 ~~~~~~~lV~E~~~gg~L~~~l~~~----------------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl 204 (536)
......++||||+++++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 77 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~ 156 (291)
T cd05094 77 GDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLV 156 (291)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE
Confidence 9999999999999999999998643 237899999999999999999999999999999999999
Q ss_pred CCCCcEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhH-HHHH
Q 009364 205 DNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQ-EVAA 282 (536)
Q Consensus 205 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~-~~~~ 282 (536)
+.++.+||+|||++................|++.|+|||++.+..++.++|||||||++|+|++ |.+||..... +...
T Consensus 157 ~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 236 (291)
T cd05094 157 GANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE 236 (291)
T ss_pred ccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999876543222222334557889999999998899999999999999999998 9999865432 2222
Q ss_pred HHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHh
Q 009364 283 LFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 283 ~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~ 326 (536)
... .......+..++..+.+++.+||+.+|.+|||+.++++
T Consensus 237 ~~~---~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 237 CIT---QGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HHh---CCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 221 22233345567899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=337.96 Aligned_cols=250 Identities=24% Similarity=0.416 Sum_probs=202.2
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEE--EEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeEeeeee
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELL--AVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRYLGTVR 141 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~v--AiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~ 141 (536)
..+|++.+.||+|+||.||+|.+..+|..+ |+|.+. ..........+.+|+.++.++ +||||+++++++.
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~-------~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~ 78 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-------EYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE 78 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEec-------ccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEEC
Confidence 347899999999999999999988877654 666542 111223446678899999999 8999999999999
Q ss_pred cCCceeEEEEecCCCCcccccccCC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccC
Q 009364 142 EEESLNILLEFVPGGSISSLLGKFG----------------PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVD 205 (536)
Q Consensus 142 ~~~~~~lV~E~~~gg~L~~~l~~~~----------------~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~ 205 (536)
..+.+++||||+++|+|.+++.+.+ .+++..++.++.||+.||+|||++|++||||||+|||++
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~ 158 (303)
T cd05088 79 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG 158 (303)
T ss_pred CCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEec
Confidence 9999999999999999999886432 578999999999999999999999999999999999999
Q ss_pred CCCcEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhHH-HHHH
Q 009364 206 NKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQE-VAAL 283 (536)
Q Consensus 206 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~~-~~~~ 283 (536)
.++.+||+|||++....... ......++..|+|||++.+..++.++|||||||++|+|+| |.+||...... ....
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~ 235 (303)
T cd05088 159 ENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 235 (303)
T ss_pred CCCcEEeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHH
Confidence 99999999999986432111 1112234677999999988889999999999999999998 99999654322 2221
Q ss_pred HhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 284 FHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 284 ~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
. ........+..++.++.+||.+||+.+|.+||++.+++.+
T Consensus 236 ~---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 236 L---PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred H---hcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1 1122233445678999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=346.37 Aligned_cols=259 Identities=25% Similarity=0.405 Sum_probs=208.0
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC-
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE- 143 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~- 143 (536)
..+|++.+.||+|+||+||+|.+..+|+.||+|.+.... ........+.+|+.+++.++|+||+++++++...
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~ 77 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAF------DNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPH 77 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccc------cccchhHHHHHHHHHHHhcCCCCccchHHheeccc
Confidence 458999999999999999999999999999999873211 1112234566899999999999999999987644
Q ss_pred ----CceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcch
Q 009364 144 ----ESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASK 219 (536)
Q Consensus 144 ----~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~ 219 (536)
...++|+||+. ++|.+++...+.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.
T Consensus 78 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 78 REAFNDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred ccccCcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 34799999995 7888888888889999999999999999999999999999999999999999999999999987
Q ss_pred hhhhhhcccCCcccCCCCCCCChhhhhh-cCCCccceEechhHHHHHHhhCCCCCchhhHH--HHHHH------------
Q 009364 220 QVAELATVSGAKSMKGTPYWMAPEVIRQ-TGHSYSADIWSVGCTVIEMATGKPPWSQQYQE--VAALF------------ 284 (536)
Q Consensus 220 ~~~~~~~~~~~~~~~Gt~~Y~APEvl~~-~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~--~~~~~------------ 284 (536)
...... .......|+..|+|||++.+ ..++.++|||||||++|+|++|.+||...... .....
T Consensus 157 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07858 157 TTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG 234 (337)
T ss_pred ccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence 654321 22334568999999998865 46899999999999999999999999643210 00000
Q ss_pred -----------hhCCCC---CCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcC
Q 009364 285 -----------HIGTTK---SHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTG 332 (536)
Q Consensus 285 -----------~~~~~~---~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~ 332 (536)
...... ......+.++.++++||++||+.+|.+|||+.++++||||..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~ 296 (337)
T cd07858 235 FIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS 296 (337)
T ss_pred hcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence 000000 001123468899999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=342.07 Aligned_cols=258 Identities=26% Similarity=0.463 Sum_probs=202.1
Q ss_pred CceeeeEEcccCceEEEEEEEcC--CCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC-
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLD--SGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE- 143 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~--~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~- 143 (536)
+|++.+.||+|+||.||+|.+.. +++.||+|.+..... ........+.+|+.+++.++||||+++++++.+.
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKE-----QYTGISQSACREIALLRELKHENVVSLVEVFLEHA 75 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccc-----cccCccHHHHHHHHHHHhcCCCCccceEEEEeCCC
Confidence 58899999999999999999988 899999998843210 1112234567899999999999999999999988
Q ss_pred -CceeEEEEecCCCCccccccc-----CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCC----CCcEEEE
Q 009364 144 -ESLNILLEFVPGGSISSLLGK-----FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDN----KGCIKLA 213 (536)
Q Consensus 144 -~~~~lV~E~~~gg~L~~~l~~-----~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~----~~~vkL~ 213 (536)
..+++||||+.+ +|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+
T Consensus 76 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~ 154 (316)
T cd07842 76 DKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIG 154 (316)
T ss_pred CceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEEC
Confidence 789999999965 56555432 236899999999999999999999999999999999999999 8999999
Q ss_pred ecCcchhhhhhhc-ccCCcccCCCCCCCChhhhhhc-CCCccceEechhHHHHHHhhCCCCCchhhHHH-----------
Q 009364 214 DFGASKQVAELAT-VSGAKSMKGTPYWMAPEVIRQT-GHSYSADIWSVGCTVIEMATGKPPWSQQYQEV----------- 280 (536)
Q Consensus 214 DFGla~~~~~~~~-~~~~~~~~Gt~~Y~APEvl~~~-~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~----------- 280 (536)
|||+++....... ........+|+.|+|||++.+. .++.++|||||||++|+|++|.+||.......
T Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (316)
T cd07842 155 DLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQL 234 (316)
T ss_pred CCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHH
Confidence 9999886543222 1123345789999999988764 57899999999999999999999996432111
Q ss_pred HHHHhhCC---------------------CCCCCCCC-----------CcCcHHHHHHHHHhcccCCCCCCCHHHHHhCC
Q 009364 281 AALFHIGT---------------------TKSHPPIP-----------ENLSVKAKDFLLKCLEKEPDLRPTASELLKHP 328 (536)
Q Consensus 281 ~~~~~~~~---------------------~~~~~~~~-----------~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp 328 (536)
..+..... ......++ ...+.++.++|.+||+.||++|||+.|+++||
T Consensus 235 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~ 314 (316)
T cd07842 235 ERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHP 314 (316)
T ss_pred HHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCC
Confidence 00000000 00001111 15677899999999999999999999999999
Q ss_pred CC
Q 009364 329 FV 330 (536)
Q Consensus 329 ~~ 330 (536)
||
T Consensus 315 ~f 316 (316)
T cd07842 315 YF 316 (316)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=334.97 Aligned_cols=254 Identities=30% Similarity=0.563 Sum_probs=203.8
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCce
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESL 146 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 146 (536)
+|++.+.||.|++|.||+|++..+|+.||+|++..... ......+.+|+.+++.++|+||+++++.+...+..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 73 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-------EGTPSTAIREISLMKELKHENIVRLHDVIHTENKL 73 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc-------ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcE
Confidence 58999999999999999999999999999998843211 11234456799999999999999999999999999
Q ss_pred eEEEEecCCCCcccccccC---CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhh
Q 009364 147 NILLEFVPGGSISSLLGKF---GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAE 223 (536)
Q Consensus 147 ~lV~E~~~gg~L~~~l~~~---~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 223 (536)
++||||+++ +|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||++++++.++|+|||+++....
T Consensus 74 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~ 152 (284)
T cd07836 74 MLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGI 152 (284)
T ss_pred EEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcC
Confidence 999999975 777776543 3689999999999999999999999999999999999999999999999999876543
Q ss_pred hhcccCCcccCCCCCCCChhhhhhc-CCCccceEechhHHHHHHhhCCCCCchhhHH--HHHHHhhCC------------
Q 009364 224 LATVSGAKSMKGTPYWMAPEVIRQT-GHSYSADIWSVGCTVIEMATGKPPWSQQYQE--VAALFHIGT------------ 288 (536)
Q Consensus 224 ~~~~~~~~~~~Gt~~Y~APEvl~~~-~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~--~~~~~~~~~------------ 288 (536)
.. .......+++.|+|||++.+. .++.++|||||||++|+|++|.+||...... .........
T Consensus 153 ~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07836 153 PV--NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ 230 (284)
T ss_pred Cc--cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhc
Confidence 21 112345678999999998664 5688999999999999999999999643211 111111000
Q ss_pred -CCCCC-----------CCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCC
Q 009364 289 -TKSHP-----------PIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFV 330 (536)
Q Consensus 289 -~~~~~-----------~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~ 330 (536)
..... .+.+.++..++++|.+||+.||.+||++.++++||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 231 LPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred CchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 00000 0113567889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=331.87 Aligned_cols=251 Identities=24% Similarity=0.404 Sum_probs=200.0
Q ss_pred ceeeeEEcccCceEEEEEEEcCCCc--EEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC--
Q 009364 68 WRKGELIGCGAFGRVYMGMNLDSGE--LLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE-- 143 (536)
Q Consensus 68 y~~~~~LG~G~fg~Vy~a~~~~~g~--~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~-- 143 (536)
|.+++.||+|+||.||+|.+..++. .+|+|.+... .......+.+.+|+.+++.++|+||+++++++...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~------~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 74 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIA------ICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVE 74 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccC------cCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCc
Confidence 3567899999999999999877765 6899987321 11223456778899999999999999999976432
Q ss_pred ----CceeEEEEecCCCCcccccc------cCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEE
Q 009364 144 ----ESLNILLEFVPGGSISSLLG------KFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLA 213 (536)
Q Consensus 144 ----~~~~lV~E~~~gg~L~~~l~------~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~ 213 (536)
...+++|||+.+|+|.+++. ....+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+
T Consensus 75 ~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~ 154 (272)
T cd05075 75 SEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVA 154 (272)
T ss_pred ccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEEC
Confidence 25789999999999988763 22358999999999999999999999999999999999999999999999
Q ss_pred ecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhH-HHHHHHhhCCCCC
Q 009364 214 DFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQ-EVAALFHIGTTKS 291 (536)
Q Consensus 214 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~-~~~~~~~~~~~~~ 291 (536)
|||+++.+.............+++.|+|||++.+..++.++|||||||++|+|++ |..||..... ........ ..
T Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~---~~ 231 (272)
T cd05075 155 DFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQ---GN 231 (272)
T ss_pred CCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc---CC
Confidence 9999987653222111223456788999999999899999999999999999999 8999965432 22222221 12
Q ss_pred CCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 292 HPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 292 ~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
....+..++..++++|.+||+.||.+|||+.+++++
T Consensus 232 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 232 RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 223455788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=337.06 Aligned_cols=254 Identities=31% Similarity=0.545 Sum_probs=204.6
Q ss_pred ceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCcee
Q 009364 68 WRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESLN 147 (536)
Q Consensus 68 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 147 (536)
|++.+.||.|++|.||+|.+..+|..||+|++.... ........+.+|+.+++.++|||++++++++.+.+..+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~------~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~ 74 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLET------EDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLY 74 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccc------ccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEE
Confidence 677899999999999999999999999999874321 11122345678999999999999999999999999999
Q ss_pred EEEEecCCCCcccccccCC--CCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhh
Q 009364 148 ILLEFVPGGSISSLLGKFG--PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA 225 (536)
Q Consensus 148 lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 225 (536)
+||||+. ++|.+++.... .+++..+..++.|++.||+|||+++++||||+|+||+++.++.++|+|||++.......
T Consensus 75 iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~ 153 (283)
T cd07835 75 LVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV 153 (283)
T ss_pred EEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc
Confidence 9999994 68988886655 78999999999999999999999999999999999999999999999999987553211
Q ss_pred cccCCcccCCCCCCCChhhhhhc-CCCccceEechhHHHHHHhhCCCCCchhhH--HHHHHHhh----------------
Q 009364 226 TVSGAKSMKGTPYWMAPEVIRQT-GHSYSADIWSVGCTVIEMATGKPPWSQQYQ--EVAALFHI---------------- 286 (536)
Q Consensus 226 ~~~~~~~~~Gt~~Y~APEvl~~~-~~s~k~DIwSlGvil~eLltG~~Pf~~~~~--~~~~~~~~---------------- 286 (536)
.......+++.|+|||++.+. .++.++|||||||++|+|++|.+||..... ........
T Consensus 154 --~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07835 154 --RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLP 231 (283)
T ss_pred --cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhch
Confidence 112334578999999988654 568999999999999999999999964321 11111110
Q ss_pred --------CCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCC
Q 009364 287 --------GTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFV 330 (536)
Q Consensus 287 --------~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~ 330 (536)
............++..+.++|.+||+.||.+|||+.++++||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 232 DYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 00001111234678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=367.49 Aligned_cols=249 Identities=25% Similarity=0.420 Sum_probs=202.7
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCC-CCceeeEeee-eec-
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS-HPNIVRYLGT-VRE- 142 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~-~~~- 142 (536)
.+++|.+.|.+|||+.||+|++...|..||+|++... .+...+.+.+||.+|+.|+ |+|||.+++. ...
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--------de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~ 108 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--------DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINR 108 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--------CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccc
Confidence 4789999999999999999999988899999998531 3456788999999999996 9999999993 221
Q ss_pred -----CCceeEEEEecCCCCcccccccC--CCCCHHHHHHHHHHHHHHHHHHHHcC--CccccCCCCCcccCCCCcEEEE
Q 009364 143 -----EESLNILLEFVPGGSISSLLGKF--GPFPEAVMRTYTKQLLLGLEYLHNHG--IMHRDIKGANILVDNKGCIKLA 213 (536)
Q Consensus 143 -----~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~--ivHrDLKp~NILl~~~~~vkL~ 213 (536)
...++|.||||.||.|-+++.++ ..|++.++++|+.|+++|+++||..+ |||||||-|||||+.+|+.|||
T Consensus 109 ~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLC 188 (738)
T KOG1989|consen 109 SSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLC 188 (738)
T ss_pred cCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeC
Confidence 23578999999999999999743 46999999999999999999999998 9999999999999999999999
Q ss_pred ecCcchhhhhhhc-cc------CCcccCCCCCCCChhhh---hhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHH
Q 009364 214 DFGASKQVAELAT-VS------GAKSMKGTPYWMAPEVI---RQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAAL 283 (536)
Q Consensus 214 DFGla~~~~~~~~-~~------~~~~~~Gt~~Y~APEvl---~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~ 283 (536)
|||.+...-.... .. .--...-|+.|+|||++ .+.+.++|+|||+|||+||-|+....||+..... .
T Consensus 189 DFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l--a- 265 (738)
T KOG1989|consen 189 DFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL--A- 265 (738)
T ss_pred cccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce--e-
Confidence 9998864321110 00 00123369999999986 4778899999999999999999999999765211 1
Q ss_pred HhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 284 FHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 284 ~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
+.......+-.+.++..+++||+.||+.||.+||++-|++.+
T Consensus 266 --Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 266 --ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred --EEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 111122222225899999999999999999999999999874
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=335.94 Aligned_cols=248 Identities=31% Similarity=0.541 Sum_probs=199.0
Q ss_pred eeeeEEcccCceEEEEEEEc----CCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCC
Q 009364 69 RKGELIGCGAFGRVYMGMNL----DSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEE 144 (536)
Q Consensus 69 ~~~~~LG~G~fg~Vy~a~~~----~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 144 (536)
.+.+.||.|+||.||+|.+. ..+..|+||.+. ........+.+.+|++.+++++||||++++|++...+
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~-------~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~ 74 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILK-------PSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENE 74 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEES-------TTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSS
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEec-------cccccccceeeeecccccccccccccccccccccccc
Confidence 46789999999999999987 456789999882 1122234677889999999999999999999999888
Q ss_pred ceeEEEEecCCCCcccccccC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhh
Q 009364 145 SLNILLEFVPGGSISSLLGKF--GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVA 222 (536)
Q Consensus 145 ~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~ 222 (536)
..++|+||+++|+|.+++... ..+++..+..|+.||+.||.|||+++++||+|+++||+++.++.+||+|||++....
T Consensus 75 ~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~ 154 (259)
T PF07714_consen 75 PLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPIS 154 (259)
T ss_dssp SEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 899999999999999999876 679999999999999999999999999999999999999999999999999987763
Q ss_pred hhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhHHH-HHHHhhCCCCCCCCCCCcCc
Q 009364 223 ELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQEV-AALFHIGTTKSHPPIPENLS 300 (536)
Q Consensus 223 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~s 300 (536)
............+...|+|||++.+..++.++||||||+++|||++ |..||....... ..... .....+.+..++
T Consensus 155 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~ 231 (259)
T PF07714_consen 155 EKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLK---QGQRLPIPDNCP 231 (259)
T ss_dssp TSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHH---TTEETTSBTTSB
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccceeccchh
Confidence 2222222234456788999999999889999999999999999999 789997643322 22222 222344566889
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHh
Q 009364 301 VKAKDFLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 301 ~~~~dLi~~cL~~dP~~Rps~~eiL~ 326 (536)
..+.++|.+||..||.+|||+.++++
T Consensus 232 ~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 232 KDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 99999999999999999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=329.21 Aligned_cols=248 Identities=28% Similarity=0.485 Sum_probs=202.8
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEE 144 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 144 (536)
+..|++.+.||+|+||.||+|.+. ++..+|+|.+... . .....+.+|+.+++.++||||+++++++....
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~------~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 72 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEG------A---MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQK 72 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEec-cCceEEEEecccC------C---ccHHHHHHHHHHHHHCCCCCceeEEEEEccCC
Confidence 356899999999999999999875 4567999976311 1 11245778999999999999999999999999
Q ss_pred ceeEEEEecCCCCccccccc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhh
Q 009364 145 SLNILLEFVPGGSISSLLGK-FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAE 223 (536)
Q Consensus 145 ~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 223 (536)
..++||||+++|+|.+++.. .+.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||.++....
T Consensus 73 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~ 152 (256)
T cd05114 73 PLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD 152 (256)
T ss_pred CEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCC
Confidence 99999999999999998864 35689999999999999999999999999999999999999999999999999876543
Q ss_pred hhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhH-HHHHHHhhCCCCCCCCCCCcCcH
Q 009364 224 LATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQ-EVAALFHIGTTKSHPPIPENLSV 301 (536)
Q Consensus 224 ~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~s~ 301 (536)
.... ......++..|+|||++.+..++.++||||||+++|+|++ |++||..... +........ .....+...+.
T Consensus 153 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~---~~~~~~~~~~~ 228 (256)
T cd05114 153 DEYT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRG---FRLYRPKLASM 228 (256)
T ss_pred Ccee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC---CCCCCCCCCCH
Confidence 2111 1223345678999999988889999999999999999999 9999965432 222222211 12234556788
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHh
Q 009364 302 KAKDFLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 302 ~~~dLi~~cL~~dP~~Rps~~eiL~ 326 (536)
.+.+++.+||+.+|.+||++.++++
T Consensus 229 ~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 229 TVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHH
Confidence 9999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=332.18 Aligned_cols=253 Identities=25% Similarity=0.442 Sum_probs=205.5
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCc----EEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeee
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGE----LLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGT 139 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~----~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~ 139 (536)
...+|++.+.||+|+||+||+|.+..+|. .||+|++.. .........+.+|+.+++.++||||++++++
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~-------~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~ 77 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRE-------NTSPKANKEILDEAYVMAGVGSPYVCRLLGI 77 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecC-------CCCHHHHHHHHHHHHHHHhcCCCCCceEEEE
Confidence 34579999999999999999999877776 478998731 1122334567889999999999999999999
Q ss_pred eecCCceeEEEEecCCCCccccccc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcc
Q 009364 140 VREEESLNILLEFVPGGSISSLLGK-FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGAS 218 (536)
Q Consensus 140 ~~~~~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla 218 (536)
+... ..++++||+++|+|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+|||+++++.+||+|||++
T Consensus 78 ~~~~-~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~ 156 (279)
T cd05109 78 CLTS-TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLA 156 (279)
T ss_pred EcCC-CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCce
Confidence 8754 57899999999999999876 356899999999999999999999999999999999999999999999999999
Q ss_pred hhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhH-HHHHHHhhCCCCCCCCCC
Q 009364 219 KQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQ-EVAALFHIGTTKSHPPIP 296 (536)
Q Consensus 219 ~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~-~~~~~~~~~~~~~~~~~~ 296 (536)
+.+.............+++.|+|||++.+..++.++|||||||++|||++ |.+||..... ........ ....+.+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~---~~~~~~~ 233 (279)
T cd05109 157 RLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEK---GERLPQP 233 (279)
T ss_pred eecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC---CCcCCCC
Confidence 87643222111223345678999999998889999999999999999998 9999965432 22222222 1223345
Q ss_pred CcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 297 ENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 297 ~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
..++.++.++|.+||..||++||++.++++.
T Consensus 234 ~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~ 264 (279)
T cd05109 234 PICTIDVYMIMVKCWMIDSECRPRFRELVDE 264 (279)
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 5789999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=335.79 Aligned_cols=259 Identities=30% Similarity=0.482 Sum_probs=204.3
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
.+|++.+.||+|++|+||+|.+..+|+.||+|.+.... ........+.+|+++++.++||||+++++++.....
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 75 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQ------EDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKR 75 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcc------ccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCe
Confidence 47999999999999999999999999999999873211 111223457789999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccCC--CCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCC-CCcEEEEecCcchhhh
Q 009364 146 LNILLEFVPGGSISSLLGKFG--PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDN-KGCIKLADFGASKQVA 222 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~-~~~vkL~DFGla~~~~ 222 (536)
+++||||++ ++|.+++.... .+++..++.++.||+.||+|||++|++||||+|+||+++. ++.+||+|||++....
T Consensus 76 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~ 154 (294)
T PLN00009 76 LYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (294)
T ss_pred EEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence 999999995 57776665433 3578889999999999999999999999999999999985 4579999999987553
Q ss_pred hhhcccCCcccCCCCCCCChhhhhhc-CCCccceEechhHHHHHHhhCCCCCchhhH--HHHHHHhhCCCC---------
Q 009364 223 ELATVSGAKSMKGTPYWMAPEVIRQT-GHSYSADIWSVGCTVIEMATGKPPWSQQYQ--EVAALFHIGTTK--------- 290 (536)
Q Consensus 223 ~~~~~~~~~~~~Gt~~Y~APEvl~~~-~~s~k~DIwSlGvil~eLltG~~Pf~~~~~--~~~~~~~~~~~~--------- 290 (536)
.. ........|++.|+|||++.+. .++.++||||+||++|+|++|.+||..... ............
T Consensus 155 ~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (294)
T PLN00009 155 IP--VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVT 232 (294)
T ss_pred CC--ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccc
Confidence 32 1112345678999999998763 578999999999999999999999964322 111111110000
Q ss_pred -------CCCC--------CCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 291 -------SHPP--------IPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 291 -------~~~~--------~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
..+. ..+.++.++.++|.+||+.+|++||++.++++||||...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred cchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence 0000 123578899999999999999999999999999999754
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=339.30 Aligned_cols=253 Identities=25% Similarity=0.431 Sum_probs=205.2
Q ss_pred CCCceeeeEEcccCceEEEEEEEcC-------CCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeE
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLD-------SGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRY 136 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~-------~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l 136 (536)
..+|.+++.||+|+||.||+|.+.. ++..+|+|.+.. .........+.+|+.+++.+ +||||+++
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~-------~~~~~~~~~~~~e~~~l~~l~~h~~i~~~ 89 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKS-------DATEKDLSDLISEMEMMKMIGKHKNIINL 89 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccC-------CCChHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence 3589999999999999999998643 235699998731 11123345678899999999 79999999
Q ss_pred eeeeecCCceeEEEEecCCCCcccccccC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCC
Q 009364 137 LGTVREEESLNILLEFVPGGSISSLLGKF----------------GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGA 200 (536)
Q Consensus 137 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~----------------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~ 200 (536)
++++......++||||+++|+|.+++... ..++...+..++.|++.||+|||++|++||||||+
T Consensus 90 ~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~ 169 (307)
T cd05098 90 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAAR 169 (307)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHH
Confidence 99999999999999999999999998653 24788899999999999999999999999999999
Q ss_pred CcccCCCCcEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhH-
Q 009364 201 NILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQ- 278 (536)
Q Consensus 201 NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~- 278 (536)
||+++.++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 170 Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~ 249 (307)
T cd05098 170 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 249 (307)
T ss_pred heEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence 99999999999999999876543221111222334578999999998889999999999999999998 8899965432
Q ss_pred HHHHHHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 279 EVAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
+....... ......+..++.++++||.+||..+|.+|||+.+++++
T Consensus 250 ~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 250 ELFKLLKE---GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHHHHc---CCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 22222221 22334566789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=327.52 Aligned_cols=249 Identities=28% Similarity=0.465 Sum_probs=204.8
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE 143 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 143 (536)
...+|++.+.||+|+||.||+|.+. ++..||+|.+... ....+.+.+|+.+++.++|+||+++++.+...
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~---------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPG---------TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE 73 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCC---------chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 3468999999999999999999864 5677999986311 11235678899999999999999999999999
Q ss_pred CceeEEEEecCCCCccccccc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhh
Q 009364 144 ESLNILLEFVPGGSISSLLGK--FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQV 221 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~~--~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~ 221 (536)
+..++||||+++|+|.+++.. ...+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+++..
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 153 (261)
T cd05072 74 EPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVI 153 (261)
T ss_pred CCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceec
Confidence 999999999999999998864 356888999999999999999999999999999999999999999999999999865
Q ss_pred hhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhHH-HHHHHhhCCCCCCCCCCCcC
Q 009364 222 AELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQE-VAALFHIGTTKSHPPIPENL 299 (536)
Q Consensus 222 ~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~ 299 (536)
..... .......++..|+|||++.+..++.++|||||||++|+|++ |..||...... ........ ...+.+..+
T Consensus 154 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~ 229 (261)
T cd05072 154 EDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG---YRMPRMENC 229 (261)
T ss_pred CCCce-eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcC---CCCCCCCCC
Confidence 43221 11223446778999999998889999999999999999998 99999654322 22222111 122334578
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHh
Q 009364 300 SVKAKDFLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 300 s~~~~dLi~~cL~~dP~~Rps~~eiL~ 326 (536)
+.++.+++.+||..+|++||++.++++
T Consensus 230 ~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 230 PDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=332.02 Aligned_cols=251 Identities=27% Similarity=0.452 Sum_probs=203.5
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcE----EEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeee
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGEL----LAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVR 141 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~----vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~ 141 (536)
.+|++.+.||+|+||+||+|.+..+|+. +++|.+. .........++..|+.+++.+.||||+++++++.
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~-------~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~ 79 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQ-------DRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP 79 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecc-------cccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC
Confidence 4789999999999999999999888775 5555541 1112234456778888999999999999999876
Q ss_pred cCCceeEEEEecCCCCccccccc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchh
Q 009364 142 EEESLNILLEFVPGGSISSLLGK-FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQ 220 (536)
Q Consensus 142 ~~~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~ 220 (536)
. ...++++||+++|+|.+++.. .+.+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||+++.
T Consensus 80 ~-~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~ 158 (279)
T cd05111 80 G-ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADL 158 (279)
T ss_pred C-CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCcccee
Confidence 4 557899999999999999965 45789999999999999999999999999999999999999999999999999986
Q ss_pred hhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhH-HHHHHHhhCCCCCCCCCCCc
Q 009364 221 VAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQ-EVAALFHIGTTKSHPPIPEN 298 (536)
Q Consensus 221 ~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~ 298 (536)
..............|+..|+|||++.+..++.++|||||||++|||++ |..||..... ......... .....+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~ 235 (279)
T cd05111 159 LYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKG---ERLAQPQI 235 (279)
T ss_pred ccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC---CcCCCCCC
Confidence 543222222334557788999999998889999999999999999998 9999976432 222333222 22234456
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 299 LSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 299 ~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
++.++.+++.+||..||.+|||+.++++.
T Consensus 236 ~~~~~~~li~~c~~~~p~~Rps~~el~~~ 264 (279)
T cd05111 236 CTIDVYMVMVKCWMIDENVRPTFKELANE 264 (279)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 78899999999999999999999999773
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=371.93 Aligned_cols=257 Identities=23% Similarity=0.330 Sum_probs=204.4
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
.+|++.+.||+|+||.||+|.+..+|+.||+|++.... .......+++.+|+.+++.++||||+++++++.+.+.
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l-----~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~ 76 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDL-----SENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDP 76 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECccc-----ccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCE
Confidence 47999999999999999999999999999999884211 1112334568889999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccC-----------CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEe
Q 009364 146 LNILLEFVPGGSISSLLGKF-----------GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLAD 214 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~-----------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~D 214 (536)
.++||||++||+|.+++... ..++...+..++.||+.||+|||++||+||||||+|||++.+|.+||+|
T Consensus 77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiD 156 (932)
T PRK13184 77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILD 156 (932)
T ss_pred EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEe
Confidence 99999999999999887531 2345667889999999999999999999999999999999999999999
Q ss_pred cCcchhhhhhh----------------cccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhH
Q 009364 215 FGASKQVAELA----------------TVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQ 278 (536)
Q Consensus 215 FGla~~~~~~~----------------~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~ 278 (536)
||+++...... ........+||+.|+|||++.+..++.++|||||||++|+|+||..||.....
T Consensus 157 FGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~ 236 (932)
T PRK13184 157 WGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG 236 (932)
T ss_pred cCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcch
Confidence 99997652110 00112235799999999999999999999999999999999999999965332
Q ss_pred HHHHHHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 279 EVAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
....................+++.+.+++.+||..||++||+..+.+.+
T Consensus 237 ~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 237 RKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred hhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 2111111111111111124688999999999999999999887666543
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=336.05 Aligned_cols=256 Identities=25% Similarity=0.381 Sum_probs=202.8
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCC--------------cEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCC
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSG--------------ELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS 129 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g--------------~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~ 129 (536)
+..+|++.+.||+|+||.||+|.+..++ ..||+|.+.. .........+.+|++++++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~-------~~~~~~~~~~~~ei~~l~~l~ 75 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRA-------DVTKTARNDFLKEIKIMSRLK 75 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCC-------CCCHHHHHHHHHHHHHHHhCC
Confidence 3468999999999999999999875432 3589998732 111233456889999999999
Q ss_pred CCceeeEeeeeecCCceeEEEEecCCCCcccccccCC------------CCCHHHHHHHHHHHHHHHHHHHHcCCccccC
Q 009364 130 HPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFG------------PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDI 197 (536)
Q Consensus 130 HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~------------~l~~~~~~~i~~qil~aL~yLH~~~ivHrDL 197 (536)
|+||+++++++......++||||+++++|.+++.... .+++..+..++.|++.||+|||++|++||||
T Consensus 76 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dl 155 (295)
T cd05097 76 NPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDL 155 (295)
T ss_pred CCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeecccc
Confidence 9999999999999999999999999999998875431 3688889999999999999999999999999
Q ss_pred CCCCcccCCCCcEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh--CCCCCch
Q 009364 198 KGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT--GKPPWSQ 275 (536)
Q Consensus 198 Kp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt--G~~Pf~~ 275 (536)
||+||+++.++.+||+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||..
T Consensus 156 kp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~ 235 (295)
T cd05097 156 ATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL 235 (295)
T ss_pred ChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence 99999999999999999999876543222222223445778999999998889999999999999999988 6778864
Q ss_pred hhH-HHH----HHHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHh
Q 009364 276 QYQ-EVA----ALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 276 ~~~-~~~----~~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~ 326 (536)
... ... ..............+..++..+++|+.+||..||.+|||+.+|++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 236 LSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred cChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 321 111 111111122223345567899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=334.06 Aligned_cols=250 Identities=27% Similarity=0.462 Sum_probs=203.6
Q ss_pred CceeeeEEcccCceEEEEEEEcC-----CCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeee
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLD-----SGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVR 141 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~ 141 (536)
+|++.+.||+|+||.||+|.+.. ....+|+|.+.. .........+.+|+.+++.++||||+++++.+.
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~-------~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 73 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKE-------NASSSELRDLLSEFNLLKQVNHPHVIKLYGACS 73 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCC-------CCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEe
Confidence 47889999999999999998753 235688887631 112233467889999999999999999999999
Q ss_pred cCCceeEEEEecCCCCcccccccC------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCccccC
Q 009364 142 EEESLNILLEFVPGGSISSLLGKF------------------------GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDI 197 (536)
Q Consensus 142 ~~~~~~lV~E~~~gg~L~~~l~~~------------------------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDL 197 (536)
..+..++|+||+.+|+|.+++... ..+++..++.++.|++.||.|||++|++||||
T Consensus 74 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~di 153 (290)
T cd05045 74 QDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDL 153 (290)
T ss_pred cCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhh
Confidence 999999999999999999886432 34788899999999999999999999999999
Q ss_pred CCCCcccCCCCcEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchh
Q 009364 198 KGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQ 276 (536)
Q Consensus 198 Kp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~ 276 (536)
||+|||+++++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||...
T Consensus 154 kp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 233 (290)
T cd05045 154 AARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 233 (290)
T ss_pred hhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCC
Confidence 99999999999999999999876543222212233456778999999988889999999999999999998 99999754
Q ss_pred hH-HHHHHHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHh
Q 009364 277 YQ-EVAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 277 ~~-~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~ 326 (536)
.. ....... .......+..++.++.+++.+||+.+|.+||++.++++
T Consensus 234 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 234 APERLFNLLK---TGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred CHHHHHHHHh---CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 32 2222222 12233456678999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=336.34 Aligned_cols=255 Identities=33% Similarity=0.545 Sum_probs=210.4
Q ss_pred ceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCcee
Q 009364 68 WRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESLN 147 (536)
Q Consensus 68 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 147 (536)
|.....||+|+||.||++.+..+|+.||+|.+.. ........+.+|+.+++.++|+||+++++.+...+..+
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~--------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 93 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDL--------RKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELW 93 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecc--------cchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEE
Confidence 4445679999999999999999999999998732 11223456888999999999999999999999999999
Q ss_pred EEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhcc
Q 009364 148 ILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATV 227 (536)
Q Consensus 148 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 227 (536)
+||||+++++|.+++.. +.+++..++.++.|++.||+|||++|++||||+|+||+++.++.++|+|||++.......
T Consensus 94 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-- 170 (292)
T cd06657 94 VVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-- 170 (292)
T ss_pred EEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccc--
Confidence 99999999999988754 568999999999999999999999999999999999999999999999999887554321
Q ss_pred cCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhH-HHHHHHhhCCCCCCCCCCCcCcHHHHHH
Q 009364 228 SGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQ-EVAALFHIGTTKSHPPIPENLSVKAKDF 306 (536)
Q Consensus 228 ~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~s~~~~dL 306 (536)
.......|++.|+|||++.+..++.++|+||+||++|+|++|.+||..... ......... ..........++..+.++
T Consensus 171 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~l 249 (292)
T cd06657 171 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN-LPPKLKNLHKVSPSLKGF 249 (292)
T ss_pred ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhh-CCcccCCcccCCHHHHHH
Confidence 122345689999999999888889999999999999999999999965422 111222111 111112234678899999
Q ss_pred HHHhcccCCCCCCCHHHHHhCCCCcCCC
Q 009364 307 LLKCLEKEPDLRPTASELLKHPFVTGDD 334 (536)
Q Consensus 307 i~~cL~~dP~~Rps~~eiL~hp~~~~~~ 334 (536)
+.+||..+|.+||++.++++||||....
T Consensus 250 i~~~l~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 250 LDRLLVRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred HHHHHhCCcccCcCHHHHhcChHHhccC
Confidence 9999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=333.01 Aligned_cols=250 Identities=25% Similarity=0.411 Sum_probs=203.4
Q ss_pred CCceeeeEEcccCceEEEEEEEc-----CCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeee
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNL-----DSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTV 140 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~ 140 (536)
.+|++.+.||+|+||.||+|... .++..+|+|.+.. ........+.+|+++++.++|+||+++++++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~--------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 76 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE--------ASESARQDFQREAELLTVLQHQHIVRFYGVC 76 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCc--------CCHHHHHHHHHHHHHHhcCCCCCCceEEEEE
Confidence 36788999999999999999743 3567899997631 1223356788999999999999999999999
Q ss_pred ecCCceeEEEEecCCCCcccccccCC---------------CCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccC
Q 009364 141 REEESLNILLEFVPGGSISSLLGKFG---------------PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVD 205 (536)
Q Consensus 141 ~~~~~~~lV~E~~~gg~L~~~l~~~~---------------~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~ 205 (536)
......++||||+++|+|.+++...+ .+++..+..++.||+.||+|||++|++||||||+|||++
T Consensus 77 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~ 156 (280)
T cd05092 77 TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVG 156 (280)
T ss_pred ecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEc
Confidence 99999999999999999999886542 478999999999999999999999999999999999999
Q ss_pred CCCcEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhHH-HHHH
Q 009364 206 NKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQE-VAAL 283 (536)
Q Consensus 206 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~~-~~~~ 283 (536)
+++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|+|++ |.+||...... ....
T Consensus 157 ~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 236 (280)
T cd05092 157 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIEC 236 (280)
T ss_pred CCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHH
Confidence 999999999999875533221111223345788999999998899999999999999999998 99999654322 2211
Q ss_pred HhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHh
Q 009364 284 FHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 284 ~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~ 326 (536)
.. .......+..+++.+.+||.+||+.||.+||++.++++
T Consensus 237 ~~---~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 237 IT---QGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HH---cCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 11 11223345678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=337.16 Aligned_cols=255 Identities=25% Similarity=0.422 Sum_probs=205.5
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcC-------CCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCcee
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLD-------SGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIV 134 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~-------~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv 134 (536)
.+..+|.+++.||+|+||.||+|.+.. .+..+|+|.+.. .........+.+|+.+++.+ +||||+
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~-------~~~~~~~~~~~~E~~~l~~l~~h~~iv 81 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKD-------NATDKDLADLISEMELMKLIGKHKNII 81 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCC-------CCChHHHHHHHHHHHHHHhccCCCCee
Confidence 345689999999999999999997642 345799998731 11123355678899999999 699999
Q ss_pred eEeeeeecCCceeEEEEecCCCCcccccccC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCC
Q 009364 135 RYLGTVREEESLNILLEFVPGGSISSLLGKF----------------GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIK 198 (536)
Q Consensus 135 ~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~----------------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLK 198 (536)
++++++.....+++||||+++|+|.+++... ..+++..+..++.||+.||.|||++|++|||||
T Consensus 82 ~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlk 161 (314)
T cd05099 82 NLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLA 161 (314)
T ss_pred eEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecccc
Confidence 9999999999999999999999999988543 347888999999999999999999999999999
Q ss_pred CCCcccCCCCcEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhh
Q 009364 199 GANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQY 277 (536)
Q Consensus 199 p~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~ 277 (536)
|+|||++.++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus 162 p~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~ 241 (314)
T cd05099 162 ARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP 241 (314)
T ss_pred ceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999986643222111222334568999999998889999999999999999999 899996543
Q ss_pred H-HHHHHHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 278 Q-EVAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 278 ~-~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
. +....... ......+..++.++++||.+||..+|.+|||+.++++.
T Consensus 242 ~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 289 (314)
T cd05099 242 VEELFKLLRE---GHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEA 289 (314)
T ss_pred HHHHHHHHHc---CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 2 22222221 12234456788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=324.51 Aligned_cols=252 Identities=34% Similarity=0.563 Sum_probs=214.0
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCce
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESL 146 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 146 (536)
+|++.+.||+|+||.||++.+..+|+.+|+|.+.... ........+.+|+.+++.++|+||+++++++......
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGS------MSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKL 74 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhh------ccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEE
Confidence 5889999999999999999999999999999874211 1123345667899999999999999999999999999
Q ss_pred eEEEEecCCCCccccccc----CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhh
Q 009364 147 NILLEFVPGGSISSLLGK----FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVA 222 (536)
Q Consensus 147 ~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~ 222 (536)
++|+||+++++|.+++.+ ...+++..++.++.|++.||+|||+.|++||||+|+||+++.++.+||+|||++....
T Consensus 75 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~ 154 (256)
T cd08530 75 CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLK 154 (256)
T ss_pred EEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhc
Confidence 999999999999998865 3568999999999999999999999999999999999999999999999999988765
Q ss_pred hhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcHH
Q 009364 223 ELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVK 302 (536)
Q Consensus 223 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 302 (536)
.. ......|++.|+|||.+.+..++.++|+||||+++|+|++|+.||.......... .......+..+..++.+
T Consensus 155 ~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 228 (256)
T cd08530 155 KN----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRY--KVQRGKYPPIPPIYSQD 228 (256)
T ss_pred cC----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHhcCCCCCCchhhCHH
Confidence 43 2234568999999999998889999999999999999999999997654322111 11223334455678999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHhCCCC
Q 009364 303 AKDFLLKCLEKEPDLRPTASELLKHPFV 330 (536)
Q Consensus 303 ~~dLi~~cL~~dP~~Rps~~eiL~hp~~ 330 (536)
+++++.+||..+|.+||++.++++||++
T Consensus 229 ~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 229 LQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=327.24 Aligned_cols=245 Identities=26% Similarity=0.402 Sum_probs=200.4
Q ss_pred EEcccCceEEEEEEE--cCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCceeEEE
Q 009364 73 LIGCGAFGRVYMGMN--LDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESLNILL 150 (536)
Q Consensus 73 ~LG~G~fg~Vy~a~~--~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 150 (536)
.||+|+||.||+|.+ ..++..+|+|++... .......+.+.+|+.+++.++||||+++++++.. +..++||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 74 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKND------NNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVM 74 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCC------CCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEE
Confidence 589999999999965 456889999987321 1122345678889999999999999999998864 5678999
Q ss_pred EecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhccc-C
Q 009364 151 EFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVS-G 229 (536)
Q Consensus 151 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~-~ 229 (536)
||+++|+|.+++...+.+++..+..++.|++.||.|||++||+||||||.||+++.++.+||+|||+++......... .
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 75 ELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 999999999999887889999999999999999999999999999999999999999999999999987654322211 1
Q ss_pred CcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhH-HHHHHHhhCCCCCCCCCCCcCcHHHHHHH
Q 009364 230 AKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQ-EVAALFHIGTTKSHPPIPENLSVKAKDFL 307 (536)
Q Consensus 230 ~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~s~~~~dLi 307 (536)
.....+++.|+|||.+.+..++.++|||||||++|+|++ |.+||..... .....+.. ...++.+..+++++++||
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~---~~~~~~~~~~~~~l~~li 231 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIES---GERMECPQRCPPEMYDLM 231 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHC---CCCCCCCCCCCHHHHHHH
Confidence 122334678999999988889999999999999999998 9999975432 22222222 223456678999999999
Q ss_pred HHhcccCCCCCCCHHHHHhC
Q 009364 308 LKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 308 ~~cL~~dP~~Rps~~eiL~h 327 (536)
.+||+.||.+||++.+|.+.
T Consensus 232 ~~~~~~~p~~Rp~~~~i~~~ 251 (257)
T cd05116 232 KLCWTYGVDERPGFAVVELR 251 (257)
T ss_pred HHHhccCchhCcCHHHHHHH
Confidence 99999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=341.20 Aligned_cols=260 Identities=29% Similarity=0.446 Sum_probs=211.3
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCC--
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEE-- 144 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~-- 144 (536)
||++.+.||.|+||.||+|.+..+|+.||+|.+... .......+.+.+|+.+++.++|+||+++++++....
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~------~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNV------FDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPE 74 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccc------cccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcc
Confidence 689999999999999999999989999999987421 111234466888999999999999999999988775
Q ss_pred ---ceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhh
Q 009364 145 ---SLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQV 221 (536)
Q Consensus 145 ---~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~ 221 (536)
.+|+||||+. ++|.+++.+...+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++...
T Consensus 75 ~~~~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 75 DFNDVYIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred cccceEEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 7899999997 588888887778999999999999999999999999999999999999999999999999998876
Q ss_pred hhhhc-ccCCcccCCCCCCCChhhhhhc-CCCccceEechhHHHHHHhhCCCCCchhhHH--HHHHHhhCCC--------
Q 009364 222 AELAT-VSGAKSMKGTPYWMAPEVIRQT-GHSYSADIWSVGCTVIEMATGKPPWSQQYQE--VAALFHIGTT-------- 289 (536)
Q Consensus 222 ~~~~~-~~~~~~~~Gt~~Y~APEvl~~~-~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~--~~~~~~~~~~-------- 289 (536)
..... ........+++.|+|||++.+. .++.++|+|||||++|+|++|.+||...... ...+......
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 233 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence 54221 0113345689999999999887 7899999999999999999999999644321 1111110000
Q ss_pred ------------------CCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 290 ------------------KSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 290 ------------------~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
.......+.++.++.+||.+||+++|.+||++.++++||||...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence 00011123578899999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=336.14 Aligned_cols=252 Identities=23% Similarity=0.399 Sum_probs=205.3
Q ss_pred CCCceeeeEEcccCceEEEEEEEc-----CCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeEee
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNL-----DSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRYLG 138 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~ 138 (536)
.++|++.+.||+|+||.||+|.+. .++..+|+|.+.. .......+.+.+|+.+++++ +||||+++++
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~-------~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 106 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKP-------TAHSSEREALMSELKIMSHLGNHENIVNLLG 106 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCc-------cCChHHHHHHHHHHHHHHhccCCCCcceEEE
Confidence 357999999999999999999752 3456899998731 11123346788999999999 7999999999
Q ss_pred eeecCCceeEEEEecCCCCcccccccCC--CCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecC
Q 009364 139 TVREEESLNILLEFVPGGSISSLLGKFG--PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFG 216 (536)
Q Consensus 139 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFG 216 (536)
.+...+..++||||+++|+|.+++.... .+++..+..++.|++.||.|||++||+|+||||+|||++.++.+||+|||
T Consensus 107 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 107 ACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred EEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCc
Confidence 9999999999999999999999986533 38999999999999999999999999999999999999999999999999
Q ss_pred cchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhHH--HHHHHhhCCCCCCC
Q 009364 217 ASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQE--VAALFHIGTTKSHP 293 (536)
Q Consensus 217 la~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~~--~~~~~~~~~~~~~~ 293 (536)
+++...............+++.|+|||++.+..++.++||||+||++|+|++ |.+||...... ....... ....
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~---~~~~ 263 (302)
T cd05055 187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE---GYRM 263 (302)
T ss_pred ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHc---CCcC
Confidence 9876543322112223456788999999998889999999999999999998 99999654321 1122211 1222
Q ss_pred CCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHh
Q 009364 294 PIPENLSVKAKDFLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 294 ~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~ 326 (536)
..+...+.++.+|+.+||.++|++|||+.++++
T Consensus 264 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 264 AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 344567899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=328.10 Aligned_cols=248 Identities=26% Similarity=0.412 Sum_probs=207.2
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEE 144 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 144 (536)
..+|++.+.||.|+||.||+|.+.. +..+|+|++.. ........+.+|+.+++.++|+||+++++++....
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~--------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 75 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKS--------DDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGE 75 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccc--------cchhhHHHHHHHHHHHhcCCCcchhheeeeEecCC
Confidence 3468999999999999999999877 88999998732 11223456788999999999999999999999999
Q ss_pred ceeEEEEecCCCCcccccccC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhh
Q 009364 145 SLNILLEFVPGGSISSLLGKF--GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVA 222 (536)
Q Consensus 145 ~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~ 222 (536)
.+++||||+++++|.+++... ..+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||.+....
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~ 155 (261)
T cd05148 76 PVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIK 155 (261)
T ss_pred CeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcC
Confidence 999999999999999998753 468999999999999999999999999999999999999999999999999987654
Q ss_pred hhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhH-HHHHHHhhCCCCCCCCCCCcCc
Q 009364 223 ELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQ-EVAALFHIGTTKSHPPIPENLS 300 (536)
Q Consensus 223 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~s 300 (536)
... .......++..|+|||++.+..++.++|||||||++|+|++ |..||..... +...... .....+.+..++
T Consensus 156 ~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~ 230 (261)
T cd05148 156 EDV--YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT---AGYRMPCPAKCP 230 (261)
T ss_pred Ccc--ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH---hCCcCCCCCCCC
Confidence 321 11223446778999999988889999999999999999998 8999965432 2222222 122334556889
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHh
Q 009364 301 VKAKDFLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 301 ~~~~dLi~~cL~~dP~~Rps~~eiL~ 326 (536)
..+.++|.+||+.||.+|||+.++++
T Consensus 231 ~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 231 QEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 99999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=326.36 Aligned_cols=249 Identities=27% Similarity=0.435 Sum_probs=203.3
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEE 144 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 144 (536)
+.+|++.+.||+|+||+||+|.+.. +..+|+|.+... . .....+.+|+.+++.++||||+++++++....
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~------~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 72 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEG------S---MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQR 72 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCC------c---ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 4578999999999999999997653 456999987311 1 11245778999999999999999999999999
Q ss_pred ceeEEEEecCCCCcccccccC-CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhh
Q 009364 145 SLNILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAE 223 (536)
Q Consensus 145 ~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 223 (536)
..++||||+.+|+|.+++... ..+++..++.++.||+.||+|||+.|++|+||||+||+++.++.+||+|||.++....
T Consensus 73 ~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~ 152 (256)
T cd05113 73 PIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD 152 (256)
T ss_pred CcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCC
Confidence 999999999999999998653 4689999999999999999999999999999999999999999999999999876543
Q ss_pred hhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhH-HHHHHHhhCCCCCCCCCCCcCcH
Q 009364 224 LATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQ-EVAALFHIGTTKSHPPIPENLSV 301 (536)
Q Consensus 224 ~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~s~ 301 (536)
... .......++..|+|||++.+..++.++|||||||++|+|++ |..||..... ......... .....+...+.
T Consensus 153 ~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 228 (256)
T cd05113 153 DEY-TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQG---LRLYRPHLASE 228 (256)
T ss_pred Cce-eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcC---CCCCCCCCCCH
Confidence 211 11122345678999999998889999999999999999998 9999965432 222222211 22234456789
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 302 KAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 302 ~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
.+++++.+||..+|.+||++.+++++
T Consensus 229 ~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 229 KVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 99999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=344.08 Aligned_cols=254 Identities=27% Similarity=0.442 Sum_probs=202.1
Q ss_pred CCCCceeeeEEcccCceEEEEEEE-----cCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeEe
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMN-----LDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRYL 137 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~-----~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~ 137 (536)
+..+|++++.||+|+||+||+|.+ ..+++.||||.+... ........+.+|+.+|.++ +||||++++
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~~E~~~l~~l~~h~niv~~~ 77 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-------ATHSEHRALMSELKILIHIGHHLNVVNLL 77 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccC-------CChHHHHHHHHHHHHHHhccCCccHhhhc
Confidence 456899999999999999999984 356789999987321 1123345678899999999 689999999
Q ss_pred eeeecC-CceeEEEEecCCCCcccccccC---------------------------------------------------
Q 009364 138 GTVREE-ESLNILLEFVPGGSISSLLGKF--------------------------------------------------- 165 (536)
Q Consensus 138 ~~~~~~-~~~~lV~E~~~gg~L~~~l~~~--------------------------------------------------- 165 (536)
+++... ..+++|||||++|+|.+++...
T Consensus 78 ~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (343)
T cd05103 78 GACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKS 157 (343)
T ss_pred ceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCc
Confidence 988654 4678999999999999887532
Q ss_pred ----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhcccC
Q 009364 166 ----------------GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSG 229 (536)
Q Consensus 166 ----------------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 229 (536)
..++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 237 (343)
T cd05103 158 LSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR 237 (343)
T ss_pred cccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhh
Confidence 2367778889999999999999999999999999999999999999999999876533222112
Q ss_pred CcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhH--HHHHHHhhCCCCCCCCCCCcCcHHHHHH
Q 009364 230 AKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQ--EVAALFHIGTTKSHPPIPENLSVKAKDF 306 (536)
Q Consensus 230 ~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~--~~~~~~~~~~~~~~~~~~~~~s~~~~dL 306 (536)
.....+++.|+|||++.+..++.++|||||||++|+|++ |..||..... ........ ......+...++++.++
T Consensus 238 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 314 (343)
T cd05103 238 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE---GTRMRAPDYTTPEMYQT 314 (343)
T ss_pred cCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhc---cCCCCCCCCCCHHHHHH
Confidence 223446778999999988899999999999999999997 9999965321 12222111 12233455678899999
Q ss_pred HHHhcccCCCCCCCHHHHHhC
Q 009364 307 LLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 307 i~~cL~~dP~~Rps~~eiL~h 327 (536)
+.+||+.||.+|||+.++++|
T Consensus 315 ~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 315 MLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred HHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=334.11 Aligned_cols=249 Identities=23% Similarity=0.401 Sum_probs=201.6
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCc--EEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeEeeeeec
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGE--LLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRYLGTVRE 142 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~--~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~ 142 (536)
++|++.+.||+|+||.||+|.+..++. .+++|.+.. .......+.+.+|+.+++++ +||||+++++++..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~-------~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 74 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKE-------FASENDHRDFAGELEVLCKLGHHPNIINLLGACEN 74 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccc-------cCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc
Confidence 478999999999999999999877765 468876621 11122345678899999999 79999999999999
Q ss_pred CCceeEEEEecCCCCcccccccC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCC
Q 009364 143 EESLNILLEFVPGGSISSLLGKF----------------GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDN 206 (536)
Q Consensus 143 ~~~~~lV~E~~~gg~L~~~l~~~----------------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~ 206 (536)
...+++||||+++|+|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~ 154 (297)
T cd05089 75 RGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGE 154 (297)
T ss_pred CCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECC
Confidence 99999999999999999988543 24888999999999999999999999999999999999999
Q ss_pred CCcEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhHH-HHHHH
Q 009364 207 KGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQE-VAALF 284 (536)
Q Consensus 207 ~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~~-~~~~~ 284 (536)
++.+||+|||++...... ........+..|+|||++.+..++.++|||||||++|+|++ |..||...... .....
T Consensus 155 ~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~ 231 (297)
T cd05089 155 NLASKIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKL 231 (297)
T ss_pred CCeEEECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 999999999998643211 01111223567999999998889999999999999999997 99999654322 22221
Q ss_pred hhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 285 HIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 285 ~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
........+..++..+++||.+||..+|.+|||++++++.
T Consensus 232 ---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 232 ---PQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred ---hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1122334556789999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=331.94 Aligned_cols=256 Identities=25% Similarity=0.391 Sum_probs=202.7
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcC----------------CCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHh
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLD----------------SGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKD 127 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~----------------~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 127 (536)
+..+|++.+.||+|+||.||++.+.. ++..+|+|++... ........+.+|+.+++.
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~-------~~~~~~~~~~~E~~~l~~ 75 (296)
T cd05095 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED-------ANKNARNDFLKEIKIMSR 75 (296)
T ss_pred ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc-------CCHHHHHHHHHHHHHHHh
Confidence 34679999999999999999986432 3457899987321 122334578899999999
Q ss_pred CCCCceeeEeeeeecCCceeEEEEecCCCCcccccccCC-----------CCCHHHHHHHHHHHHHHHHHHHHcCCcccc
Q 009364 128 LSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFG-----------PFPEAVMRTYTKQLLLGLEYLHNHGIMHRD 196 (536)
Q Consensus 128 l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~-----------~l~~~~~~~i~~qil~aL~yLH~~~ivHrD 196 (536)
++|+||+++++++...+..++||||+++|+|.+++.... .+++..+..++.|++.||+|||++|++|||
T Consensus 76 l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~d 155 (296)
T cd05095 76 LKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRD 155 (296)
T ss_pred CCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeeccc
Confidence 999999999999999999999999999999999886532 367788999999999999999999999999
Q ss_pred CCCCCcccCCCCcEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh--CCCCCc
Q 009364 197 IKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT--GKPPWS 274 (536)
Q Consensus 197 LKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt--G~~Pf~ 274 (536)
|||+|||++.++.++|+|||+++.+.............+++.|+|||+..+..++.++|||||||++|+|++ |..||.
T Consensus 156 lkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~ 235 (296)
T cd05095 156 LATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYS 235 (296)
T ss_pred CChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcc
Confidence 999999999999999999999876543222111223345678999999888889999999999999999998 778986
Q ss_pred hhhH-HH----HHHHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHh
Q 009364 275 QQYQ-EV----AALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 275 ~~~~-~~----~~~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~ 326 (536)
.... +. .............+.+..++..+.+|+.+||+.||.+||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 236 QLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred ccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 4321 11 1111111112223345578899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=335.54 Aligned_cols=253 Identities=25% Similarity=0.449 Sum_probs=205.8
Q ss_pred CCCceeeeEEcccCceEEEEEEEc-------CCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeE
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNL-------DSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRY 136 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~-------~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l 136 (536)
..+|.+.+.||+|+||.||+|++. .++..||+|.+. ..........+.+|+.+++.+ +||||+++
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~-------~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~ 86 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLK-------DDATEKDLSDLVSEMEMMKMIGKHKNIINL 86 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecc-------cccchHHHHHHHHHHHHHHhhccCCCchhe
Confidence 457999999999999999999753 234579999762 112223456788999999999 79999999
Q ss_pred eeeeecCCceeEEEEecCCCCcccccccC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCC
Q 009364 137 LGTVREEESLNILLEFVPGGSISSLLGKF----------------GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGA 200 (536)
Q Consensus 137 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~----------------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~ 200 (536)
++++......++||||+++|+|.+++.+. ..++...+..++.||+.||.|||++|++||||||+
T Consensus 87 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~ 166 (304)
T cd05101 87 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAAR 166 (304)
T ss_pred eEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccc
Confidence 99999999999999999999999988653 24678889999999999999999999999999999
Q ss_pred CcccCCCCcEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhh-H
Q 009364 201 NILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQY-Q 278 (536)
Q Consensus 201 NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~-~ 278 (536)
||+++.++.+||+|||+++.+.............+++.|+|||++.+..++.++|||||||++|+|++ |..||.... .
T Consensus 167 Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 246 (304)
T cd05101 167 NVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 246 (304)
T ss_pred eEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH
Confidence 99999999999999999987654322222233456788999999998889999999999999999998 888886542 2
Q ss_pred HHHHHHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 279 EVAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
+....... ......+..++..+++||.+||..+|.+|||+.++++.
T Consensus 247 ~~~~~~~~---~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 247 ELFKLLKE---GHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHHHHc---CCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 22222221 12233456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=332.08 Aligned_cols=262 Identities=32% Similarity=0.550 Sum_probs=213.2
Q ss_pred CceeeeEEcccCceEEEEEEEc---CCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeEeeeeec
Q 009364 67 RWRKGELIGCGAFGRVYMGMNL---DSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRYLGTVRE 142 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~ 142 (536)
+|++.+.||.|+||.||+|.+. .+|+.||+|++..... .......+.+.+|+.+++.+ +|+||+++++.+..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~----~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATI----VQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 76 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhh----hhcchHHHHHHHHHHHHHhcccCCChhceeeEeec
Confidence 4889999999999999999875 4789999998742111 11112345677899999999 59999999999999
Q ss_pred CCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhh
Q 009364 143 EESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVA 222 (536)
Q Consensus 143 ~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~ 222 (536)
+..+++||||+++++|.+++....++++..+..++.||+.||.|||+.|++||||+|+|||++.++.+||+|||++....
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 77 DTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred CCeEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence 99999999999999999999888889999999999999999999999999999999999999999999999999987654
Q ss_pred hhhcccCCcccCCCCCCCChhhhhhc--CCCccceEechhHHHHHHhhCCCCCchhh--HHHHHHHhhCCCCCCCCCCCc
Q 009364 223 ELATVSGAKSMKGTPYWMAPEVIRQT--GHSYSADIWSVGCTVIEMATGKPPWSQQY--QEVAALFHIGTTKSHPPIPEN 298 (536)
Q Consensus 223 ~~~~~~~~~~~~Gt~~Y~APEvl~~~--~~s~k~DIwSlGvil~eLltG~~Pf~~~~--~~~~~~~~~~~~~~~~~~~~~ 298 (536)
.... .......|+..|+|||.+.+. .++.++||||||+++|+|++|..||.... ......... .....++++..
T Consensus 157 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 234 (290)
T cd05613 157 EDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRR-ILKSEPPYPQE 234 (290)
T ss_pred cccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHH-hhccCCCCCcc
Confidence 3211 122346689999999998753 46889999999999999999999995321 111111111 11223445667
Q ss_pred CcHHHHHHHHHhcccCCCCCC-----CHHHHHhCCCCcCCC
Q 009364 299 LSVKAKDFLLKCLEKEPDLRP-----TASELLKHPFVTGDD 334 (536)
Q Consensus 299 ~s~~~~dLi~~cL~~dP~~Rp-----s~~eiL~hp~~~~~~ 334 (536)
++..+.+++++||..||.+|| ++.++++||||....
T Consensus 235 ~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 235 MSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 899999999999999999997 899999999998754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=340.73 Aligned_cols=255 Identities=29% Similarity=0.489 Sum_probs=199.9
Q ss_pred eEEccc--CceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCceeEE
Q 009364 72 ELIGCG--AFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESLNIL 149 (536)
Q Consensus 72 ~~LG~G--~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 149 (536)
..||+| +||+||+|.+..+|+.||+|++... .......+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~------~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v 77 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLE------NCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVI 77 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccc------cCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEE
Confidence 346666 9999999999999999999987421 11223457788999999999999999999999999999999
Q ss_pred EEecCCCCcccccccC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhcc
Q 009364 150 LEFVPGGSISSLLGKF--GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATV 227 (536)
Q Consensus 150 ~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 227 (536)
+||+.+++|.+++.+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++++|||.+.........
T Consensus 78 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~ 157 (328)
T cd08226 78 SPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK 157 (328)
T ss_pred EecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence 9999999999988764 35899999999999999999999999999999999999999999999999865433221110
Q ss_pred c-----CCcccCCCCCCCChhhhhhc--CCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCC-----------
Q 009364 228 S-----GAKSMKGTPYWMAPEVIRQT--GHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTT----------- 289 (536)
Q Consensus 228 ~-----~~~~~~Gt~~Y~APEvl~~~--~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~----------- 289 (536)
. ......++..|+|||++.+. .++.++|||||||++|+|++|.+||................
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd08226 158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFP 237 (328)
T ss_pred ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccc
Confidence 0 01112356779999999763 47899999999999999999999996543221111110000
Q ss_pred ---------------------------------CCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcC
Q 009364 290 ---------------------------------KSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTG 332 (536)
Q Consensus 290 ---------------------------------~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~ 332 (536)
....+.+..++..+++||++||+.||.+|||+.++|+||||..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~ 313 (328)
T cd08226 238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQ 313 (328)
T ss_pred hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHH
Confidence 0001112346778999999999999999999999999999964
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=327.36 Aligned_cols=248 Identities=25% Similarity=0.418 Sum_probs=202.2
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
.+|++.+.||+|+||.||+|.+. ++..+|+|.+... .. ....+.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~------~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREG------AM---SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRP 73 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccC------CC---CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence 46889999999999999999875 5678999987311 11 12346679999999999999999999999999
Q ss_pred eeEEEEecCCCCccccccc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhh
Q 009364 146 LNILLEFVPGGSISSLLGK-FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAEL 224 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 224 (536)
.++||||++|++|.+++.. ...+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+++.....
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~ 153 (256)
T cd05059 74 IFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD 153 (256)
T ss_pred eEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccc
Confidence 9999999999999999865 346899999999999999999999999999999999999999999999999998765432
Q ss_pred hcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhH-HHHHHHhhCCCCCCCCCCCcCcHH
Q 009364 225 ATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQ-EVAALFHIGTTKSHPPIPENLSVK 302 (536)
Q Consensus 225 ~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~s~~ 302 (536)
... ......++..|+|||++.+..++.++|||||||++|+|++ |.+||..... +...... .......+..++.+
T Consensus 154 ~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 229 (256)
T cd05059 154 QYT-SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVS---AGYRLYRPKLAPTE 229 (256)
T ss_pred ccc-ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH---cCCcCCCCCCCCHH
Confidence 111 1112234567999999998899999999999999999999 8999965432 2222221 12223445678999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 303 AKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 303 ~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
+.+++.+||..+|++|||+.++++.
T Consensus 230 ~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 230 VYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HHHHHHHHhcCChhhCcCHHHHHHH
Confidence 9999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=335.50 Aligned_cols=259 Identities=31% Similarity=0.501 Sum_probs=200.0
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC-
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE- 143 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~- 143 (536)
..+|++.+.||+|+||.||+|.+..+++.+|+|++...... ......+.+|+++++.++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK------DGFPITALREIKILKKLKHPNVVPLIDMAVERP 80 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCC------CCcchhHHHHHHHHHhcCCCCccchhhheeccc
Confidence 46899999999999999999999999999999988532211 01123456899999999999999999987543
Q ss_pred -------CceeEEEEecCCCCcccccc-cCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEec
Q 009364 144 -------ESLNILLEFVPGGSISSLLG-KFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADF 215 (536)
Q Consensus 144 -------~~~~lV~E~~~gg~L~~~l~-~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DF 215 (536)
..+++||||+.+ ++...+. ....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 81 DKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred ccccccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcC
Confidence 346999999965 5555544 3457999999999999999999999999999999999999999999999999
Q ss_pred Ccchhhhhhhcc---------cCCcccCCCCCCCChhhhhhc-CCCccceEechhHHHHHHhhCCCCCchhhHH--HHHH
Q 009364 216 GASKQVAELATV---------SGAKSMKGTPYWMAPEVIRQT-GHSYSADIWSVGCTVIEMATGKPPWSQQYQE--VAAL 283 (536)
Q Consensus 216 Gla~~~~~~~~~---------~~~~~~~Gt~~Y~APEvl~~~-~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~--~~~~ 283 (536)
|+++........ .......|++.|+|||++.+. .++.++|||||||++|+|++|.+||...... ...+
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~ 239 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999765432211 111234678899999988654 5789999999999999999999999644321 1111
Q ss_pred HhhCCCC------------------CCCCC-------CCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCC
Q 009364 284 FHIGTTK------------------SHPPI-------PENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFV 330 (536)
Q Consensus 284 ~~~~~~~------------------~~~~~-------~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~ 330 (536)
....... ..... ....+..+.++|.+||+.||.+|||+.+++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 1110000 00000 12345778899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=316.44 Aligned_cols=257 Identities=29% Similarity=0.428 Sum_probs=205.3
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE 142 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 142 (536)
....||++.+.||+|||+.||+++...++..||+|.+... ..+..+...+|+...++++||||++++++...
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~--------~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~ 89 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH--------SQEDIEEALREIDNHRKFNSPNVLRLVDHQLR 89 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeecc--------chHHHHHHHHHHHHHHhhCCcchHHHHHHHHH
Confidence 3456999999999999999999999999999999998532 23456778899999999999999999988754
Q ss_pred CC-----ceeEEEEecCCCCcccccccC----CCCCHHHHHHHHHHHHHHHHHHHHcC--CccccCCCCCcccCCCCcEE
Q 009364 143 EE-----SLNILLEFVPGGSISSLLGKF----GPFPEAVMRTYTKQLLLGLEYLHNHG--IMHRDIKGANILVDNKGCIK 211 (536)
Q Consensus 143 ~~-----~~~lV~E~~~gg~L~~~l~~~----~~l~~~~~~~i~~qil~aL~yLH~~~--ivHrDLKp~NILl~~~~~vk 211 (536)
+. ..||++.|...|+|.+.+... ..+++.++..|+.+|++||++||+.. ++||||||.|||+.+.+.++
T Consensus 90 ~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~v 169 (302)
T KOG2345|consen 90 EEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPV 169 (302)
T ss_pred hhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceE
Confidence 44 499999999999999987543 36999999999999999999999998 99999999999999999999
Q ss_pred EEecCcchhhhhhhcc-------cCCcccCCCCCCCChhhhhh---cCCCccceEechhHHHHHHhhCCCCCchhhHHHH
Q 009364 212 LADFGASKQVAELATV-------SGAKSMKGTPYWMAPEVIRQ---TGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVA 281 (536)
Q Consensus 212 L~DFGla~~~~~~~~~-------~~~~~~~Gt~~Y~APEvl~~---~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~ 281 (536)
|.|||.++...-.... +.-..-..|..|+|||.+.- ...++++|||||||+||.|+.|.-||....+.-.
T Consensus 170 l~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg 249 (302)
T KOG2345|consen 170 LMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGG 249 (302)
T ss_pred EEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCC
Confidence 9999998765321110 00112235889999999864 4568999999999999999999999965433111
Q ss_pred HHH-hhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 282 ALF-HIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 282 ~~~-~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
.+. .........+-...+|..+.+||+.||+.||.+||++.+++.+
T Consensus 250 SlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 250 SLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred eEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 100 0111111112223489999999999999999999999999875
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=329.08 Aligned_cols=253 Identities=30% Similarity=0.519 Sum_probs=201.0
Q ss_pred CCc-eeeeEEcccCceEEEEEE----EcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeee
Q 009364 66 IRW-RKGELIGCGAFGRVYMGM----NLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTV 140 (536)
Q Consensus 66 ~~y-~~~~~LG~G~fg~Vy~a~----~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~ 140 (536)
.|| ++.+.||+|+||+||++. ...++..||+|.+... ........+.+|+.+|+.++||||+++++++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 75 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRE-------CGQQNTSGWKKEINILKTLYHENIVKYKGCC 75 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccc-------cChHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 355 899999999999998764 3457889999987321 1112345677899999999999999999987
Q ss_pred ecC--CceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcc
Q 009364 141 REE--ESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGAS 218 (536)
Q Consensus 141 ~~~--~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla 218 (536)
... ..+++||||+++++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 76 ~~~~~~~~~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~ 154 (283)
T cd05080 76 SEQGGKGLQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLA 154 (283)
T ss_pred ecCCCceEEEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccc
Confidence 653 458899999999999999876 46999999999999999999999999999999999999999999999999998
Q ss_pred hhhhhhhcccC-CcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHH-------------
Q 009364 219 KQVAELATVSG-AKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALF------------- 284 (536)
Q Consensus 219 ~~~~~~~~~~~-~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~------------- 284 (536)
+.......... .....++..|+|||++.+..++.++|||||||++|+|++|..||...........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05080 155 KAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLI 234 (283)
T ss_pred cccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhh
Confidence 86653222111 1223456779999999888899999999999999999999999854322111111
Q ss_pred hhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHh
Q 009364 285 HIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 285 ~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~ 326 (536)
.........+.+..++.++.+++.+||+.+|++|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 235 ELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 001111223345678899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=341.51 Aligned_cols=259 Identities=27% Similarity=0.488 Sum_probs=203.0
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE 143 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 143 (536)
...+|++.+.||.|+||.||+|.+..+|+.||+|.+.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~--------~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~ 74 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD--------PQSVKHALREIKIIRRLDHDNIVKVYEVLGPS 74 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC--------CchHHHHHHHHHHHHhcCCCcchhhHhhhccc
Confidence 3578999999999999999999999999999999874321 12345677899999999999999999876543
Q ss_pred --------------CceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCC-CC
Q 009364 144 --------------ESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDN-KG 208 (536)
Q Consensus 144 --------------~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~-~~ 208 (536)
...++||||+. ++|.+++.. +.+++..++.++.||+.||.|||+.||+||||||+||+++. ++
T Consensus 75 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~ 152 (342)
T cd07854 75 GSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDL 152 (342)
T ss_pred ccccccccccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCc
Confidence 35789999996 588877754 56899999999999999999999999999999999999974 55
Q ss_pred cEEEEecCcchhhhhhhccc-CCcccCCCCCCCChhhhhh-cCCCccceEechhHHHHHHhhCCCCCchhhHH--HHHHH
Q 009364 209 CIKLADFGASKQVAELATVS-GAKSMKGTPYWMAPEVIRQ-TGHSYSADIWSVGCTVIEMATGKPPWSQQYQE--VAALF 284 (536)
Q Consensus 209 ~vkL~DFGla~~~~~~~~~~-~~~~~~Gt~~Y~APEvl~~-~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~--~~~~~ 284 (536)
.+||+|||+++......... ......|+..|+|||++.+ ..++.++|||||||++|+|++|..||...... .....
T Consensus 153 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~ 232 (342)
T cd07854 153 VLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLIL 232 (342)
T ss_pred eEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 78999999987653221111 1123457899999998754 56788999999999999999999999643211 11110
Q ss_pred hh----------------------CCCCCC---CCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcC
Q 009364 285 HI----------------------GTTKSH---PPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTG 332 (536)
Q Consensus 285 ~~----------------------~~~~~~---~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~ 332 (536)
.. ...... ......++.++++||.+||+.||.+|||+.++++||||+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~ 305 (342)
T cd07854 233 ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC 305 (342)
T ss_pred HhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence 00 000000 0112357889999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=338.61 Aligned_cols=269 Identities=27% Similarity=0.436 Sum_probs=209.1
Q ss_pred CCCCcee-eeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHH------HHHHHHHHHHHHHhCCCCceeeE
Q 009364 64 PPIRWRK-GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQD------HIKELEEEVKLLKDLSHPNIVRY 136 (536)
Q Consensus 64 ~~~~y~~-~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~------~~~~~~~Ei~iL~~l~HpnIv~l 136 (536)
...||.. .+.||+|+||+||+|.+..+|+.||+|++.............. ....+.+|+.+++.++|+||+++
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 85 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL 85 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence 3457764 5789999999999999999999999998743221110000000 11246789999999999999999
Q ss_pred eeeeecCCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecC
Q 009364 137 LGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFG 216 (536)
Q Consensus 137 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFG 216 (536)
++++...+..++||||+. |+|.+++.....+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||
T Consensus 86 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg 164 (335)
T PTZ00024 86 VDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFG 164 (335)
T ss_pred eEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCcc
Confidence 999999999999999996 6899988877889999999999999999999999999999999999999999999999999
Q ss_pred cchhhhhhh------------cccCCcccCCCCCCCChhhhhhc-CCCccceEechhHHHHHHhhCCCCCchhhHH--HH
Q 009364 217 ASKQVAELA------------TVSGAKSMKGTPYWMAPEVIRQT-GHSYSADIWSVGCTVIEMATGKPPWSQQYQE--VA 281 (536)
Q Consensus 217 la~~~~~~~------------~~~~~~~~~Gt~~Y~APEvl~~~-~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~--~~ 281 (536)
++....... .........+++.|+|||++.+. .++.++|||||||++|+|++|.+||...... ..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~ 244 (335)
T PTZ00024 165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLG 244 (335)
T ss_pred ceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 987654110 00112234578899999998764 4689999999999999999999999654321 11
Q ss_pred HHHhhCCCCCC-----------------------CCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 282 ALFHIGTTKSH-----------------------PPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 282 ~~~~~~~~~~~-----------------------~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
.+......... .......+.++.++|.+||+.+|.+|||++++|.||||+..
T Consensus 245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~ 319 (335)
T PTZ00024 245 RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSD 319 (335)
T ss_pred HHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCC
Confidence 11111000000 00123467889999999999999999999999999999865
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=323.35 Aligned_cols=244 Identities=30% Similarity=0.492 Sum_probs=199.4
Q ss_pred eEEcccCceEEEEEEEcCCC---cEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCceeE
Q 009364 72 ELIGCGAFGRVYMGMNLDSG---ELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESLNI 148 (536)
Q Consensus 72 ~~LG~G~fg~Vy~a~~~~~g---~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 148 (536)
+.||+|+||.||+|.+..++ ..+|+|.+.. .......+.+.+|+.+++.+.|+||+++++++. ....++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~-------~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 72 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQ-------EHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLML 72 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEeccc-------ccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEE
Confidence 46999999999999876554 7899998732 111134466788999999999999999999876 456899
Q ss_pred EEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhccc
Q 009364 149 LLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVS 228 (536)
Q Consensus 149 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 228 (536)
||||+++|+|.+++.+...+++..+..++.|++.||+|||+.|++||||||+|||++.++.+||+|||+++.........
T Consensus 73 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 73 VMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred EEEeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 99999999999999887789999999999999999999999999999999999999999999999999998764432211
Q ss_pred C-CcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhH-HHHHHHhhCCCCCCCCCCCcCcHHHHH
Q 009364 229 G-AKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQ-EVAALFHIGTTKSHPPIPENLSVKAKD 305 (536)
Q Consensus 229 ~-~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~s~~~~d 305 (536)
. .....++..|+|||.+.+..++.++|||||||++|+|++ |.+||..... ........ ......+..++..+++
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~ 229 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLES---GERLPRPEECPQEIYS 229 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc---CCcCCCCCCCCHHHHH
Confidence 1 112224567999999998899999999999999999998 9999965432 22222221 2233456678999999
Q ss_pred HHHHhcccCCCCCCCHHHHHh
Q 009364 306 FLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 306 Li~~cL~~dP~~Rps~~eiL~ 326 (536)
+|.+||..+|.+||++.++++
T Consensus 230 li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 230 IMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred HHHHHhcCChhhCcCHHHHHH
Confidence 999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=339.53 Aligned_cols=258 Identities=29% Similarity=0.492 Sum_probs=208.2
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE 142 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 142 (536)
..+.+|++.+.||+|+||.||+|.+..+|..||+|++... .........+.+|+.+|+.++||||+++++++..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 85 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRP------FQSELFAKRAYRELRLLKHMKHENVIGLLDVFTP 85 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccc------ccchHHHHHHHHHHHHHHhcCCCCccceeeeecC
Confidence 3567899999999999999999999999999999987321 1112234567789999999999999999999876
Q ss_pred CC------ceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecC
Q 009364 143 EE------SLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFG 216 (536)
Q Consensus 143 ~~------~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFG 216 (536)
.. .+++||||+ |++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||
T Consensus 86 ~~~~~~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 86 DLSLDRFHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred CccccccceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecc
Confidence 54 358999999 7888888764 679999999999999999999999999999999999999999999999999
Q ss_pred cchhhhhhhcccCCcccCCCCCCCChhhhhh-cCCCccceEechhHHHHHHhhCCCCCchhhHH--HHHHHhhCCC----
Q 009364 217 ASKQVAELATVSGAKSMKGTPYWMAPEVIRQ-TGHSYSADIWSVGCTVIEMATGKPPWSQQYQE--VAALFHIGTT---- 289 (536)
Q Consensus 217 la~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~-~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~--~~~~~~~~~~---- 289 (536)
++..... ......+++.|+|||++.+ ..++.++|+|||||++|+|++|.+||...... ..........
T Consensus 164 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 238 (343)
T cd07880 164 LARQTDS-----EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE 238 (343)
T ss_pred ccccccc-----CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 9876532 1234568999999999876 45789999999999999999999999643211 1111110000
Q ss_pred ----------------------CCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 290 ----------------------KSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 290 ----------------------~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
.........++..+.++|.+||+.||.+|||+.++++||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 239 FVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred HHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 00011224678899999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=357.40 Aligned_cols=267 Identities=24% Similarity=0.305 Sum_probs=194.9
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCC-cEEEEEEEeeh--------hhc-cchhHHHHHHHHHHHHHHHHHhCCCCceee
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSG-ELLAVKQVLIA--------ANF-ASKEKAQDHIKELEEEVKLLKDLSHPNIVR 135 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g-~~vAiK~i~~~--------~~~-~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~ 135 (536)
.+|++.+.||+|+||+||+|..+... ...+.|.+... ... ............+.+|+.+|+.++||||++
T Consensus 148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 227 (501)
T PHA03210 148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK 227 (501)
T ss_pred hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence 58999999999999999998765432 22222211000 000 000111223456789999999999999999
Q ss_pred EeeeeecCCceeEEEEecCCCCccccccc-----CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcE
Q 009364 136 YLGTVREEESLNILLEFVPGGSISSLLGK-----FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCI 210 (536)
Q Consensus 136 l~~~~~~~~~~~lV~E~~~gg~L~~~l~~-----~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~v 210 (536)
+++++...+..|+|++++. ++|..++.. ........++.++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 228 l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~v 306 (501)
T PHA03210 228 IEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKI 306 (501)
T ss_pred EeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCE
Confidence 9999999999999999984 566655432 1234467788999999999999999999999999999999999999
Q ss_pred EEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCC-Cchhh----HHHHHHHh
Q 009364 211 KLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPP-WSQQY----QEVAALFH 285 (536)
Q Consensus 211 kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~P-f~~~~----~~~~~~~~ 285 (536)
||+|||+++.+..... ......+||+.|+|||++.+..++.++|||||||++|||++|..+ |.... ......+.
T Consensus 307 kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~ 385 (501)
T PHA03210 307 VLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIID 385 (501)
T ss_pred EEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHH
Confidence 9999999987643221 122346799999999999999999999999999999999998754 43211 11111111
Q ss_pred hCCC---------------------C-CCCCC-----CCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCC
Q 009364 286 IGTT---------------------K-SHPPI-----PENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDD 334 (536)
Q Consensus 286 ~~~~---------------------~-~~~~~-----~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~ 334 (536)
.... . ....+ ...++.++.++|.+||+.||.+|||+.|+|.||||....
T Consensus 386 ~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~ 461 (501)
T PHA03210 386 SLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEE 461 (501)
T ss_pred hcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCC
Confidence 0000 0 00000 113566788899999999999999999999999997654
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=326.37 Aligned_cols=262 Identities=25% Similarity=0.450 Sum_probs=203.5
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCc----EEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeee
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGE----LLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVR 141 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~----~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~ 141 (536)
..|++...||+|+||.||+|...+++. .+|||.+.-... ....-....+|+.+++.++||||+.+..+|.
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd------~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl 97 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD------GTGISMSACREIALLRELKHPNVISLVKVFL 97 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC------CCCcCHHHHHHHHHHHHhcCCcchhHHHHHh
Confidence 468999999999999999997665543 689998732111 1112234568999999999999999999998
Q ss_pred c-CCceeEEEEecCCCCccccccc-----CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCC----CcEE
Q 009364 142 E-EESLNILLEFVPGGSISSLLGK-----FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNK----GCIK 211 (536)
Q Consensus 142 ~-~~~~~lV~E~~~gg~L~~~l~~-----~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~----~~vk 211 (536)
. +..+++++||.+. +|...|+- .+.++...++.|+.||+.|+.|||++.|+||||||.||||..+ |.||
T Consensus 98 ~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 98 SHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred ccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeE
Confidence 7 8899999999964 66666632 2468999999999999999999999999999999999999877 8999
Q ss_pred EEecCcchhhhhhh-cccCCcccCCCCCCCChhhhhhc-CCCccceEechhHHHHHHhhCCCCCchhh-----------H
Q 009364 212 LADFGASKQVAELA-TVSGAKSMKGTPYWMAPEVIRQT-GHSYSADIWSVGCTVIEMATGKPPWSQQY-----------Q 278 (536)
Q Consensus 212 L~DFGla~~~~~~~-~~~~~~~~~Gt~~Y~APEvl~~~-~~s~k~DIwSlGvil~eLltG~~Pf~~~~-----------~ 278 (536)
|+|||+++.+...- +.......+-|.+|+|||.+.|. .|+.+.|||++|||+.||+|-.|.|.+.. .
T Consensus 177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~d 256 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHD 256 (438)
T ss_pred eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHH
Confidence 99999999886432 22234456779999999998875 68999999999999999999888774321 2
Q ss_pred HHHHHHhhCCCCCCCCCC--------------------------------CcCcHHHHHHHHHhcccCCCCCCCHHHHHh
Q 009364 279 EVAALFHIGTTKSHPPIP--------------------------------ENLSVKAKDFLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~--------------------------------~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~ 326 (536)
.+..++..........|| ..-++.+.+|+.+||+.||.+|+|++|+|+
T Consensus 257 Ql~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle 336 (438)
T KOG0666|consen 257 QLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE 336 (438)
T ss_pred HHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence 222333322222111111 112344679999999999999999999999
Q ss_pred CCCCcCCC
Q 009364 327 HPFVTGDD 334 (536)
Q Consensus 327 hp~~~~~~ 334 (536)
|+||+...
T Consensus 337 h~yF~~d~ 344 (438)
T KOG0666|consen 337 HPYFTEDP 344 (438)
T ss_pred ccccccCC
Confidence 99998764
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=342.54 Aligned_cols=255 Identities=31% Similarity=0.486 Sum_probs=199.5
Q ss_pred CCCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeee
Q 009364 62 MSPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVR 141 (536)
Q Consensus 62 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~ 141 (536)
...+++|.-...||+|+||.||+|.- .+|..||||.+.. ...+. .+++.+|+.++.+++|||+|+++|+|.
T Consensus 71 ~~AT~~Fs~~~~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~-------~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~ 141 (361)
T KOG1187|consen 71 RKATNNFSESNLIGEGGFGTVYKGVL-SDGTVVAVKRLSS-------NSGQG-EREFLNEVEILSRLRHPNLVKLLGYCL 141 (361)
T ss_pred HHHHhCCchhcceecCCCeEEEEEEE-CCCCEEEEEEecC-------CCCcc-hhHHHHHHHHHhcCCCcCcccEEEEEe
Confidence 45557888889999999999999985 4558999997631 11111 345999999999999999999999999
Q ss_pred cCC-ceeEEEEecCCCCcccccccCC--CCCHHHHHHHHHHHHHHHHHHHHcC---CccccCCCCCcccCCCCcEEEEec
Q 009364 142 EEE-SLNILLEFVPGGSISSLLGKFG--PFPEAVMRTYTKQLLLGLEYLHNHG---IMHRDIKGANILVDNKGCIKLADF 215 (536)
Q Consensus 142 ~~~-~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~~---ivHrDLKp~NILl~~~~~vkL~DF 215 (536)
+.+ ..+||+||+++|+|.+++.... +++|..+.+|+.++++||+|||+.. ||||||||+|||+|.+.+.||+||
T Consensus 142 e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDF 221 (361)
T KOG1187|consen 142 EGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDF 221 (361)
T ss_pred cCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCc
Confidence 988 4999999999999999987655 8999999999999999999999864 999999999999999999999999
Q ss_pred CcchhhhhhhcccCCccc-CCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhh----HHHHH----HHhh
Q 009364 216 GASKQVAELATVSGAKSM-KGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQY----QEVAA----LFHI 286 (536)
Q Consensus 216 Gla~~~~~~~~~~~~~~~-~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~----~~~~~----~~~~ 286 (536)
|+|+..... .....+. .||.+|+|||++..+..+.++|||||||+|.||+||+.|..... ..... ....
T Consensus 222 GLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~ 299 (361)
T KOG1187|consen 222 GLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE 299 (361)
T ss_pred cCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence 999655431 1111222 79999999999998899999999999999999999998876321 11111 1111
Q ss_pred CC--CCCCCCCC-CcC-----cHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 287 GT--TKSHPPIP-ENL-----SVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 287 ~~--~~~~~~~~-~~~-----s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
.. ....+.+. ... -..+..+..+|++.+|..||++.|+++.
T Consensus 300 ~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~ 348 (361)
T KOG1187|consen 300 GKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKE 348 (361)
T ss_pred cchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHH
Confidence 10 00111111 122 2235578899999999999999998653
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=332.78 Aligned_cols=256 Identities=38% Similarity=0.634 Sum_probs=206.6
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCce
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESL 146 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 146 (536)
.|...+.||+|+||+||+|.+..+|+.||+|++.... .........+.+|+.+++.++|||++++++++.+....
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~-----~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 96 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSG-----KQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTA 96 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccc-----cCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEE
Confidence 4666788999999999999999999999999874321 11223345678899999999999999999999999999
Q ss_pred eEEEEecCCCCcccccc-cCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhh
Q 009364 147 NILLEFVPGGSISSLLG-KFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA 225 (536)
Q Consensus 147 ~lV~E~~~gg~L~~~l~-~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 225 (536)
++||||+. |++.+++. ...++++..+..++.||+.||.|||++|++||||+|+||+++.++.+||+|||++....
T Consensus 97 ~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~--- 172 (313)
T cd06633 97 WLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS--- 172 (313)
T ss_pred EEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC---
Confidence 99999996 56666654 34578999999999999999999999999999999999999999999999999875432
Q ss_pred cccCCcccCCCCCCCChhhhh---hcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcHH
Q 009364 226 TVSGAKSMKGTPYWMAPEVIR---QTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVK 302 (536)
Q Consensus 226 ~~~~~~~~~Gt~~Y~APEvl~---~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 302 (536)
......|+..|+|||++. +..++.++|||||||++|+|++|.+||......... ...............++..
T Consensus 173 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 248 (313)
T cd06633 173 ---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-YHIAQNDSPTLQSNEWTDS 248 (313)
T ss_pred ---CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHhcCCCCCCccccCHH
Confidence 123567899999999984 456788999999999999999999999654321111 1111111111223457788
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHhCCCCcCCCC
Q 009364 303 AKDFLLKCLEKEPDLRPTASELLKHPFVTGDDE 335 (536)
Q Consensus 303 ~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~~ 335 (536)
+++|+.+||+++|.+||++.++++||||+....
T Consensus 249 l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~~ 281 (313)
T cd06633 249 FRGFVDYCLQKIPQERPASAELLRHDFVRRDRP 281 (313)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCcccCCCch
Confidence 999999999999999999999999999986543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=325.58 Aligned_cols=252 Identities=25% Similarity=0.469 Sum_probs=205.1
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCc---EEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeee
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGE---LLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVR 141 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~---~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~ 141 (536)
+.+|++++.||+|+||.||+|.+..++. .+|+|.+... ......+.+.+|+.+++.++||||+++++++.
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~-------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 75 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAG-------YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT 75 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCC-------CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 4579999999999999999999875543 7999987321 11233467888999999999999999999999
Q ss_pred cCCceeEEEEecCCCCcccccccC-CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchh
Q 009364 142 EEESLNILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQ 220 (536)
Q Consensus 142 ~~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~ 220 (536)
..+..++||||+++++|.+++... +.+++..+..++.|++.||.|||++|++||||||+|||++.++.++|+|||++..
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd05066 76 KSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRV 155 (267)
T ss_pred cCCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccc
Confidence 999999999999999999998654 4689999999999999999999999999999999999999999999999999987
Q ss_pred hhhhhccc-CCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhH-HHHHHHhhCCCCCCCCCCC
Q 009364 221 VAELATVS-GAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQ-EVAALFHIGTTKSHPPIPE 297 (536)
Q Consensus 221 ~~~~~~~~-~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~ 297 (536)
+....... ......++..|+|||++.+..++.++|+|||||++|++++ |..||..... +....... ....+.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~ 232 (267)
T cd05066 156 LEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEE---GYRLPAPM 232 (267)
T ss_pred cccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhC---CCcCCCCC
Confidence 65322111 1112233568999999998889999999999999999886 9999965432 22222211 12234455
Q ss_pred cCcHHHHHHHHHhcccCCCCCCCHHHHHh
Q 009364 298 NLSVKAKDFLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 298 ~~s~~~~dLi~~cL~~dP~~Rps~~eiL~ 326 (536)
.++..+++++.+||+++|.+||++.++++
T Consensus 233 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 233 DCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred CCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 78899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=302.06 Aligned_cols=257 Identities=29% Similarity=0.524 Sum_probs=207.2
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCce
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESL 146 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 146 (536)
+|...++||+|+||+||+|+++.+++.||+|.+....... ..-....+||-+|+.++|.|||+++++...+..+
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrldddde------gvpssalreicllkelkhknivrl~dvlhsdkkl 76 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDE------GVPSSALREICLLKELKHKNIVRLHDVLHSDKKL 76 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCC------CCcHHHHHHHHHHHHhhhcceeehhhhhccCcee
Confidence 5778899999999999999999999999999986543221 1223456899999999999999999999999999
Q ss_pred eEEEEecCCCCccccccc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhh
Q 009364 147 NILLEFVPGGSISSLLGK-FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA 225 (536)
Q Consensus 147 ~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 225 (536)
.+|+|||. .+|..+... ++.+..+.++.++.|+++||.++|++++.||||||.|.||+.+|++||+|||+++.++-..
T Consensus 77 tlvfe~cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipv 155 (292)
T KOG0662|consen 77 TLVFEFCD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV 155 (292)
T ss_pred EEeHHHhh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence 99999995 566655543 4678999999999999999999999999999999999999999999999999999776422
Q ss_pred cccCCcccCCCCCCCChhhhhhc-CCCccceEechhHHHHHHhh-CCCCCchhh--HHHHHHHhhCCCCCCCCCC-----
Q 009364 226 TVSGAKSMKGTPYWMAPEVIRQT-GHSYSADIWSVGCTVIEMAT-GKPPWSQQY--QEVAALFHIGTTKSHPPIP----- 296 (536)
Q Consensus 226 ~~~~~~~~~Gt~~Y~APEvl~~~-~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~--~~~~~~~~~~~~~~~~~~~----- 296 (536)
.....-+-|.+|++|.++.+. -|+.+.|+||.|||+.|+.. |++.|.+.. .....++..........||
T Consensus 156 --rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~l 233 (292)
T KOG0662|consen 156 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKL 233 (292)
T ss_pred --EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccC
Confidence 223344579999999999875 47999999999999999986 777786543 2233333322221111111
Q ss_pred -------------------CcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcC
Q 009364 297 -------------------ENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTG 332 (536)
Q Consensus 297 -------------------~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~ 332 (536)
+.++..-+||++++|.-+|.+|++++.+++||||..
T Consensus 234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d 288 (292)
T KOG0662|consen 234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSD 288 (292)
T ss_pred CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccc
Confidence 244556789999999999999999999999999974
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=330.16 Aligned_cols=252 Identities=26% Similarity=0.423 Sum_probs=204.0
Q ss_pred CCCceeeeEEcccCceEEEEEEEcC-----CCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeee
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLD-----SGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGT 139 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~ 139 (536)
..+|++.+.||+|+||.||+|.+.. ++..||+|.+.. .........+.+|+.+++.+.||||++++++
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~-------~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~ 76 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKE-------EASADMQADFQREAALMAEFDHPNIVKLLGV 76 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCC-------CcCHHHHHHHHHHHHHHHhcCCCchheEEEE
Confidence 4579999999999999999998743 678999998732 1112334568889999999999999999999
Q ss_pred eecCCceeEEEEecCCCCcccccccC----------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCccccC
Q 009364 140 VREEESLNILLEFVPGGSISSLLGKF----------------------GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDI 197 (536)
Q Consensus 140 ~~~~~~~~lV~E~~~gg~L~~~l~~~----------------------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDL 197 (536)
+......++||||+++|+|.+++... ..+++..++.++.||+.||.|||++|++||||
T Consensus 77 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl 156 (288)
T cd05050 77 CAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDL 156 (288)
T ss_pred EcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccc
Confidence 99999999999999999999888532 24678889999999999999999999999999
Q ss_pred CCCCcccCCCCcEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchh
Q 009364 198 KGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQ 276 (536)
Q Consensus 198 Kp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~ 276 (536)
||+||+++.++.++|+|||++..+.............+++.|+|||++.+..++.++|||||||++|+|++ |..||...
T Consensus 157 ~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~ 236 (288)
T cd05050 157 ATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM 236 (288)
T ss_pred cHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999876543221111223345678999999998899999999999999999997 88898643
Q ss_pred h-HHHHHHHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHh
Q 009364 277 Y-QEVAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 277 ~-~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~ 326 (536)
. .+........ .....+..++.++.+||.+||+.+|.+|||+.|+++
T Consensus 237 ~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 237 AHEEVIYYVRDG---NVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred CHHHHHHHHhcC---CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 2 2222222211 222345678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=332.27 Aligned_cols=258 Identities=37% Similarity=0.634 Sum_probs=209.1
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
..|...+.||+|+||.||+|.+..+|..+|+|.+.... .........+.+|+.+++.++|||++++++++.....
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 99 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSG-----KQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHT 99 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCC-----CCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCe
Confidence 34788899999999999999999999999999874211 1122344568889999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccc-cCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhh
Q 009364 146 LNILLEFVPGGSISSLLG-KFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAEL 224 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~-~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 224 (536)
.++||||+.| +|.+++. ...++++..+..++.|++.||.|||++||+||||+|+||+++.++.+||+|||++.....
T Consensus 100 ~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~- 177 (317)
T cd06635 100 AWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP- 177 (317)
T ss_pred EEEEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC-
Confidence 9999999975 6666654 356789999999999999999999999999999999999999999999999998865432
Q ss_pred hcccCCcccCCCCCCCChhhhh---hcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcH
Q 009364 225 ATVSGAKSMKGTPYWMAPEVIR---QTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSV 301 (536)
Q Consensus 225 ~~~~~~~~~~Gt~~Y~APEvl~---~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 301 (536)
.....|++.|+|||++. +..++.++|||||||++|+|++|.+||........ ................++.
T Consensus 178 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 251 (317)
T cd06635 178 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQNESPTLQSNEWSD 251 (317)
T ss_pred -----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH-HHHHHhccCCCCCCccccH
Confidence 23456899999999974 45688999999999999999999999865432211 1111111112222346788
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCCCC
Q 009364 302 KAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDED 336 (536)
Q Consensus 302 ~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~~~ 336 (536)
.+++||.+||+.+|.+||++.++++|+|+......
T Consensus 252 ~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 286 (317)
T cd06635 252 YFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPE 286 (317)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHhChhhhccCcc
Confidence 99999999999999999999999999999765443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=324.09 Aligned_cols=248 Identities=26% Similarity=0.408 Sum_probs=203.5
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEE 144 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 144 (536)
..+|++.+.||+|++|.||+|.+. +++.||+|.+.... ...+.+.+|+.++++++||||+++++++...+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~---------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 74 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT---------MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEE 74 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCc---------ccHHHHHHHHHHHHHCCCCCccceeEEEecCC
Confidence 457999999999999999999864 45789999873211 11345778999999999999999999999999
Q ss_pred ceeEEEEecCCCCcccccccCC--CCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhh
Q 009364 145 SLNILLEFVPGGSISSLLGKFG--PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVA 222 (536)
Q Consensus 145 ~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~ 222 (536)
..++||||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++...
T Consensus 75 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 154 (261)
T cd05068 75 PIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIK 154 (261)
T ss_pred CeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEcc
Confidence 9999999999999999986643 68999999999999999999999999999999999999999999999999988765
Q ss_pred hhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhHH-HHHHHhhCCCCCCCCCCCcCc
Q 009364 223 ELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQE-VAALFHIGTTKSHPPIPENLS 300 (536)
Q Consensus 223 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~s 300 (536)
.... .......++..|+|||++.+..++.++|||||||++|+|++ |..||...... ....... ....+.+..++
T Consensus 155 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~ 230 (261)
T cd05068 155 EDIY-EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQ---GYRMPCPPGCP 230 (261)
T ss_pred CCcc-cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc---CCCCCCCCcCC
Confidence 3211 11112223457999999998889999999999999999999 99999764332 2222111 12233456788
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHh
Q 009364 301 VKAKDFLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 301 ~~~~dLi~~cL~~dP~~Rps~~eiL~ 326 (536)
..+.+++.+||+.+|.+||++.++++
T Consensus 231 ~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 231 KELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 99999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=338.20 Aligned_cols=252 Identities=25% Similarity=0.448 Sum_probs=204.4
Q ss_pred CCceeeeEEcccCceEEEEEEEcCC-------CcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeEe
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDS-------GELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRYL 137 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~-------g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~ 137 (536)
.+|++++.||+|+||.||+|.+... +..||+|.+.. .........+.+|+.+++++ +||||++++
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~-------~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 84 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKD-------DATDKDLSDLVSEMEMMKMIGKHKNIINLL 84 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccc-------ccCHHHHHHHHHHHHHHHhhcCCCCeeeee
Confidence 4799999999999999999986532 23689997631 11223456788999999999 799999999
Q ss_pred eeeecCCceeEEEEecCCCCcccccccC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCC
Q 009364 138 GTVREEESLNILLEFVPGGSISSLLGKF----------------GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGAN 201 (536)
Q Consensus 138 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~----------------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~N 201 (536)
+++......+++|||+++|+|.+++.+. ..++...+..++.|++.||.|||++|++||||||+|
T Consensus 85 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N 164 (334)
T cd05100 85 GACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARN 164 (334)
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccce
Confidence 9999999999999999999999988643 246778889999999999999999999999999999
Q ss_pred cccCCCCcEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhh-HH
Q 009364 202 ILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQY-QE 279 (536)
Q Consensus 202 ILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~-~~ 279 (536)
||++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||.... .+
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 244 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 244 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999876543222212223345678999999999899999999999999999998 889996543 22
Q ss_pred HHHHHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 280 VAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
...... .......+..++.++.+||.+||+.+|.+|||+.+++++
T Consensus 245 ~~~~~~---~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 245 LFKLLK---EGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHH---cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 222222 122334556788999999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=332.54 Aligned_cols=257 Identities=30% Similarity=0.476 Sum_probs=202.2
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCC-
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEE- 144 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~- 144 (536)
.+|++.+.||+|+||.||+|.+..+|+.||+|.+..... .......+.+|+.+++.++||||+++++++.+..
T Consensus 7 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~------~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~ 80 (302)
T cd07864 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE------KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQD 80 (302)
T ss_pred hhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc------ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcch
Confidence 479999999999999999999999999999998843211 1112245668999999999999999999987655
Q ss_pred ---------ceeEEEEecCCCCccccccc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEe
Q 009364 145 ---------SLNILLEFVPGGSISSLLGK-FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLAD 214 (536)
Q Consensus 145 ---------~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~D 214 (536)
.+++|+||+++ ++...+.. ...+++..++.++.||+.||+|||++||+||||||+||++++++.+||+|
T Consensus 81 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 81 ALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred hhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCc
Confidence 78999999976 55555543 45789999999999999999999999999999999999999999999999
Q ss_pred cCcchhhhhhhcccCCcccCCCCCCCChhhhhh-cCCCccceEechhHHHHHHhhCCCCCchhhH--HHHHHHhhCCCC-
Q 009364 215 FGASKQVAELATVSGAKSMKGTPYWMAPEVIRQ-TGHSYSADIWSVGCTVIEMATGKPPWSQQYQ--EVAALFHIGTTK- 290 (536)
Q Consensus 215 FGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~-~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~--~~~~~~~~~~~~- 290 (536)
||++........ .......++..|+|||++.+ ..++.++|||||||++|+|++|++||..... ....+.......
T Consensus 160 fg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~ 238 (302)
T cd07864 160 FGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC 238 (302)
T ss_pred ccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 999876543221 11223356888999998865 3578999999999999999999999964321 111111110000
Q ss_pred --CC----------------------CCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCC
Q 009364 291 --SH----------------------PPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFV 330 (536)
Q Consensus 291 --~~----------------------~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~ 330 (536)
.+ ......++..+.++|.+||..||.+||++.+++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 239 PAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred hhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 00 01123468899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=328.66 Aligned_cols=254 Identities=28% Similarity=0.488 Sum_probs=203.1
Q ss_pred CceeeeEEcccCceEEEEEEE----cCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec
Q 009364 67 RWRKGELIGCGAFGRVYMGMN----LDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE 142 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~----~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 142 (536)
-|++.+.||+|+||.||+|.. ..++..||+|.+.. .........+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~-------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 77 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKP-------ESGGNHIADLKKEIEILRNLYHENIVKYKGICTE 77 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCc-------cccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEec
Confidence 478899999999999999974 45788999998731 1122334678899999999999999999999877
Q ss_pred C--CceeEEEEecCCCCcccccccC-CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcch
Q 009364 143 E--ESLNILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASK 219 (536)
Q Consensus 143 ~--~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~ 219 (536)
. ...++||||++|++|.+++.+. ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+++
T Consensus 78 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 78 DGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred CCCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccc
Confidence 5 5689999999999999998654 468999999999999999999999999999999999999999999999999988
Q ss_pred hhhhhhcc-cCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHH-------------HHHHh
Q 009364 220 QVAELATV-SGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEV-------------AALFH 285 (536)
Q Consensus 220 ~~~~~~~~-~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~-------------~~~~~ 285 (536)
.+...... .......|+..|+|||++.+..++.++|||||||++|+|+++..|+....... .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR 237 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence 65432211 11234567788999999988889999999999999999999877653211100 00111
Q ss_pred hCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 286 IGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 286 ~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
........+.+..++..+.+||.+||+.+|.+|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 238 VLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred HHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 111112334456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=324.86 Aligned_cols=252 Identities=25% Similarity=0.451 Sum_probs=204.8
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCc---EEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGE---LLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE 142 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~---~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 142 (536)
..|++.+.||+|+||.||+|.+..+++ .||+|.+.. .........+..|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~-------~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 76 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKS-------GYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK 76 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCC-------CCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECC
Confidence 358999999999999999999887665 599998732 1122345678899999999999999999999999
Q ss_pred CCceeEEEEecCCCCccccccc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhh
Q 009364 143 EESLNILLEFVPGGSISSLLGK-FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQV 221 (536)
Q Consensus 143 ~~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~ 221 (536)
....++||||+++|+|.+++.. .+.+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++...
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~ 156 (269)
T cd05065 77 SRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 156 (269)
T ss_pred CCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCcccccc
Confidence 9999999999999999998865 356899999999999999999999999999999999999999999999999998765
Q ss_pred hhhhcccCCcccC---CCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhH-HHHHHHhhCCCCCCCCCC
Q 009364 222 AELATVSGAKSMK---GTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQ-EVAALFHIGTTKSHPPIP 296 (536)
Q Consensus 222 ~~~~~~~~~~~~~---Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~-~~~~~~~~~~~~~~~~~~ 296 (536)
............. ++..|+|||++.+..++.++|||||||++|||++ |..||..... +...... .....+.+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~---~~~~~~~~ 233 (269)
T cd05065 157 EDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE---QDYRLPPP 233 (269)
T ss_pred ccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHH---cCCcCCCc
Confidence 4322111111111 2457999999998899999999999999999886 9999965432 2222221 11223345
Q ss_pred CcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 297 ENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 297 ~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
..++..+.+++.+||..+|.+||++.+++..
T Consensus 234 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 264 (269)
T cd05065 234 MDCPTALHQLMLDCWQKDRNARPKFGQIVST 264 (269)
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 5788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=320.79 Aligned_cols=246 Identities=37% Similarity=0.603 Sum_probs=210.5
Q ss_pred EcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCceeEEEEec
Q 009364 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESLNILLEFV 153 (536)
Q Consensus 74 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 153 (536)
||+|+||.||++.+..+++.+|+|++.... .........+..|+.+++.++|+||+++++.+......++||||+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKK-----IIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhh-----hcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecC
Confidence 699999999999998889999999874321 111234567888999999999999999999999999999999999
Q ss_pred CCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhcccCCccc
Q 009364 154 PGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSM 233 (536)
Q Consensus 154 ~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 233 (536)
++++|.+++.....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++....... ......
T Consensus 76 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~ 153 (250)
T cd05123 76 PGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTF 153 (250)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCC
Confidence 999999999887789999999999999999999999999999999999999999999999999987654321 123456
Q ss_pred CCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHH-HHHHhhCCCCCCCCCCCcCcHHHHHHHHHhcc
Q 009364 234 KGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEV-AALFHIGTTKSHPPIPENLSVKAKDFLLKCLE 312 (536)
Q Consensus 234 ~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~ 312 (536)
.|+..|+|||.+.+...+.++|+||||+++|+|++|..||....... ..... .....++...+..+.++|++||.
T Consensus 154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~----~~~~~~~~~~~~~l~~~i~~~l~ 229 (250)
T cd05123 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKIL----KDPLRFPEFLSPEARDLISGLLQ 229 (250)
T ss_pred cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh----cCCCCCCCCCCHHHHHHHHHHhc
Confidence 78999999999988888999999999999999999999996554221 11111 13345667789999999999999
Q ss_pred cCCCCCCCH---HHHHhCCCC
Q 009364 313 KEPDLRPTA---SELLKHPFV 330 (536)
Q Consensus 313 ~dP~~Rps~---~eiL~hp~~ 330 (536)
.||++||++ .++++||||
T Consensus 230 ~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 230 KDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred CCHhhCCCcccHHHHHhCCCC
Confidence 999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=325.04 Aligned_cols=248 Identities=26% Similarity=0.431 Sum_probs=201.1
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE 143 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 143 (536)
+..+|++.+.||+|+||.||+|.+..+ ..||+|.+.... ...+.+.+|+.+++.++||||+++++.+. .
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~---------~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~ 72 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT---------MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-E 72 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCc---------cCHHHHHHHHHHHHhCCCCCcceEEEEEC-C
Confidence 345799999999999999999988655 469999873211 11245778999999999999999999875 4
Q ss_pred CceeEEEEecCCCCcccccccC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhh
Q 009364 144 ESLNILLEFVPGGSISSLLGKF--GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQV 221 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~ 221 (536)
...++||||+++|+|.+++.+. ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||.++.+
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~ 152 (262)
T cd05071 73 EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI 152 (262)
T ss_pred CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeec
Confidence 5689999999999999998653 35789999999999999999999999999999999999999999999999999765
Q ss_pred hhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhHH-HHHHHhhCCCCCCCCCCCcC
Q 009364 222 AELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQE-VAALFHIGTTKSHPPIPENL 299 (536)
Q Consensus 222 ~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~ 299 (536)
..... .......++..|+|||++.+..++.++|||||||++|+|++ |.+||...... ...... .....+.+..+
T Consensus 153 ~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~ 228 (262)
T cd05071 153 EDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE---RGYRMPCPPEC 228 (262)
T ss_pred ccccc-ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHh---cCCCCCCcccc
Confidence 43221 11223456778999999988889999999999999999999 88899654322 222111 11223345578
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHh
Q 009364 300 SVKAKDFLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 300 s~~~~dLi~~cL~~dP~~Rps~~eiL~ 326 (536)
+..+.+||.+||++||.+||++.++++
T Consensus 229 ~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 229 PESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred CHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=327.41 Aligned_cols=253 Identities=26% Similarity=0.399 Sum_probs=205.3
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcC----CCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeee
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLD----SGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGT 139 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~----~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~ 139 (536)
...+|++.+.||+|+||.||+|.+.. ++..|++|.+. ..........+.+|+.+++.++||||++++++
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~-------~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~ 76 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVK-------DHASEIQVTLLLQESCLLYGLSHQNILPILHV 76 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEcc-------CCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 34689999999999999999999876 35789999763 11223345667889999999999999999998
Q ss_pred eec-CCceeEEEEecCCCCcccccccC--------CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcE
Q 009364 140 VRE-EESLNILLEFVPGGSISSLLGKF--------GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCI 210 (536)
Q Consensus 140 ~~~-~~~~~lV~E~~~gg~L~~~l~~~--------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~v 210 (536)
+.. ....++++||+++|+|.+++... ..+++..+..++.|++.||+|||+++++||||||+||+++.++.+
T Consensus 77 ~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~ 156 (280)
T cd05043 77 CIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQV 156 (280)
T ss_pred EecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcE
Confidence 765 56789999999999999988543 458999999999999999999999999999999999999999999
Q ss_pred EEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhH-HHHHHHhhCC
Q 009364 211 KLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQ-EVAALFHIGT 288 (536)
Q Consensus 211 kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~-~~~~~~~~~~ 288 (536)
||+|||+++.+.............++..|+|||++.+..++.++|||||||++|++++ |.+||..... +.......
T Consensus 157 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-- 234 (280)
T cd05043 157 KITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKD-- 234 (280)
T ss_pred EECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHc--
Confidence 9999999986543222111223456778999999998889999999999999999999 9999975432 22222221
Q ss_pred CCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHh
Q 009364 289 TKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 289 ~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~ 326 (536)
......+..++.++.+++.+||..||++|||+.++++
T Consensus 235 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 235 -GYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred -CCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 1222344567899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=327.18 Aligned_cols=253 Identities=32% Similarity=0.539 Sum_probs=200.2
Q ss_pred ceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC---CCCceeeEeeeeecCC
Q 009364 68 WRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL---SHPNIVRYLGTVREEE 144 (536)
Q Consensus 68 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l---~HpnIv~l~~~~~~~~ 144 (536)
|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.+ .||||+++++++...+
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 74 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS------EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPR 74 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc------cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeecc
Confidence 6789999999999999999988899999998843221 111123455677766655 6999999999998877
Q ss_pred c-----eeEEEEecCCCCcccccccCC--CCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCc
Q 009364 145 S-----LNILLEFVPGGSISSLLGKFG--PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGA 217 (536)
Q Consensus 145 ~-----~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGl 217 (536)
. ++++|||+. ++|.+++.... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||+
T Consensus 75 ~~~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~ 153 (287)
T cd07838 75 TDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGL 153 (287)
T ss_pred CCCCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCc
Confidence 6 999999996 47888776533 589999999999999999999999999999999999999999999999999
Q ss_pred chhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH--HHHHHhhCCCCC----
Q 009364 218 SKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE--VAALFHIGTTKS---- 291 (536)
Q Consensus 218 a~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~--~~~~~~~~~~~~---- 291 (536)
+....... ......++..|+|||++.+..++.++|+|||||++|+|++|.+||...... ...+........
T Consensus 154 ~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07838 154 ARIYSFEM---ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEW 230 (287)
T ss_pred ceeccCCc---ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhc
Confidence 87654322 123345789999999999888999999999999999999999999654321 111111100000
Q ss_pred ------------------CCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCC
Q 009364 292 ------------------HPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFV 330 (536)
Q Consensus 292 ------------------~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~ 330 (536)
.......++..+.++|.+||+.||.+||++.+++.||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 231 PRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred CCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 000112456788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=325.81 Aligned_cols=252 Identities=27% Similarity=0.456 Sum_probs=206.8
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCc----EEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeee
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGE----LLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGT 139 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~----~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~ 139 (536)
...+|++.+.||+|+||+||+|.+..+|+ .+|+|.+... ........+.+|+.+++.++||||++++++
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~-------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 77 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREE-------TSPKANKEILDEAYVMASVDHPHVVRLLGI 77 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCC-------CCHHHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 44689999999999999999999877665 5888876321 123345678899999999999999999999
Q ss_pred eecCCceeEEEEecCCCCcccccccC-CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcc
Q 009364 140 VREEESLNILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGAS 218 (536)
Q Consensus 140 ~~~~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla 218 (536)
+.. ...++||||+++|+|.+++... ..+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||++
T Consensus 78 ~~~-~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~ 156 (279)
T cd05057 78 CLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLA 156 (279)
T ss_pred Eec-CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccc
Confidence 987 7899999999999999988763 46899999999999999999999999999999999999999999999999999
Q ss_pred hhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhH-HHHHHHhhCCCCCCCCCC
Q 009364 219 KQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQ-EVAALFHIGTTKSHPPIP 296 (536)
Q Consensus 219 ~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~-~~~~~~~~~~~~~~~~~~ 296 (536)
+.+.............++..|+|||.+....++.++|+|||||++|+|++ |..||..... +....... ....+.+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~---~~~~~~~ 233 (279)
T cd05057 157 KLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEK---GERLPQP 233 (279)
T ss_pred ccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC---CCCCCCC
Confidence 87653322211222334678999999988889999999999999999998 9999976432 22222221 2233445
Q ss_pred CcCcHHHHHHHHHhcccCCCCCCCHHHHHh
Q 009364 297 ENLSVKAKDFLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 297 ~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~ 326 (536)
...+..+.+++.+||..+|..||++.++++
T Consensus 234 ~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 234 PICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred CCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=346.14 Aligned_cols=253 Identities=25% Similarity=0.383 Sum_probs=203.9
Q ss_pred CCCceeeeEEcccCceEEEEEEEc-----CCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCC-CCceeeEee
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNL-----DSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS-HPNIVRYLG 138 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~ 138 (536)
..+|.+++.||+|+||.||+|++. .+++.||+|++... ........+.+|+.+|.++. ||||+++++
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~-------~~~~~~~~~~~E~~~l~~l~~H~niv~~~~ 108 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKST-------ARSSEKQALMSELKIMSHLGPHLNIVNLLG 108 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCC-------CChhHHHHHHHHHHHHHhcCCCCCeEEEEE
Confidence 346888999999999999999864 34578999998321 11222346788999999997 999999999
Q ss_pred eeecCCceeEEEEecCCCCcccccccCC----------------------------------------------------
Q 009364 139 TVREEESLNILLEFVPGGSISSLLGKFG---------------------------------------------------- 166 (536)
Q Consensus 139 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~---------------------------------------------------- 166 (536)
++......++||||+++|+|.+++.+.+
T Consensus 109 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (401)
T cd05107 109 ACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESAD 188 (401)
T ss_pred EEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccC
Confidence 9999999999999999999998875421
Q ss_pred ----------------------------------------------CCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCC
Q 009364 167 ----------------------------------------------PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGA 200 (536)
Q Consensus 167 ----------------------------------------------~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~ 200 (536)
.+++..+..++.||+.||.|||++|++||||||+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~ 268 (401)
T cd05107 189 YVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAAR 268 (401)
T ss_pred ccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcc
Confidence 3566778889999999999999999999999999
Q ss_pred CcccCCCCcEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhH-
Q 009364 201 NILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQ- 278 (536)
Q Consensus 201 NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~- 278 (536)
|||++.++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~ 348 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN 348 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence 99999999999999999876533222122234467889999999998889999999999999999998 8999964321
Q ss_pred H-HHHHHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 279 E-VAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 279 ~-~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
+ ....... ......+..++.++.+|+.+||..+|.+||++.+|++.
T Consensus 349 ~~~~~~~~~---~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 349 EQFYNAIKR---GYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHHHHHHc---CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 1 1122111 12334566789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=322.85 Aligned_cols=243 Identities=25% Similarity=0.417 Sum_probs=196.6
Q ss_pred EcccCceEEEEEEEc--CCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCceeEEEE
Q 009364 74 IGCGAFGRVYMGMNL--DSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESLNILLE 151 (536)
Q Consensus 74 LG~G~fg~Vy~a~~~--~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 151 (536)
||+|+||.||+|.+. .++..||+|++.. .......+.+.+|+.+++.++||||+++++++.. ...++|||
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~-------~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e 74 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKN-------ENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVME 74 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEccc-------ccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEE
Confidence 899999999999765 4456799998732 1112334568899999999999999999998864 57899999
Q ss_pred ecCCCCccccccc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhcccC-
Q 009364 152 FVPGGSISSLLGK-FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSG- 229 (536)
Q Consensus 152 ~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~- 229 (536)
|+++|+|.+++.. ...+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++...........
T Consensus 75 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 75 MASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred eCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 9999999998864 45789999999999999999999999999999999999999999999999999876543222111
Q ss_pred CcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhH-HHHHHHhhCCCCCCCCCCCcCcHHHHHHH
Q 009364 230 AKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQ-EVAALFHIGTTKSHPPIPENLSVKAKDFL 307 (536)
Q Consensus 230 ~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~s~~~~dLi 307 (536)
.....+++.|+|||++.+..++.++|||||||++|+|++ |..||..... ........ ......+..+++++.++|
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~li 231 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQ---GKRLDCPAECPPEMYALM 231 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHC---CCCCCCCCCCCHHHHHHH
Confidence 112234678999999988889999999999999999996 9999975432 22222222 223446678899999999
Q ss_pred HHhcccCCCCCCCHHHHHhC
Q 009364 308 LKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 308 ~~cL~~dP~~Rps~~eiL~h 327 (536)
.+||..+|++||++.++++.
T Consensus 232 ~~c~~~~~~~Rp~~~~i~~~ 251 (257)
T cd05115 232 KDCWIYKWEDRPNFAKVEER 251 (257)
T ss_pred HHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=331.36 Aligned_cols=257 Identities=36% Similarity=0.634 Sum_probs=208.7
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE 143 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 143 (536)
+...|...+.||+|+||.||+|++..+++.+|+|.+.... .........+.+|+++++.++|+|++++++++...
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 87 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSG-----KQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE 87 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEeccc-----ccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcC
Confidence 4456888899999999999999999999999999874211 11223345677899999999999999999999999
Q ss_pred CceeEEEEecCCCCcccccc-cCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhh
Q 009364 144 ESLNILLEFVPGGSISSLLG-KFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVA 222 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~-~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~ 222 (536)
...++||||+. |++.+++. ...++++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++....
T Consensus 88 ~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 166 (308)
T cd06634 88 HTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (308)
T ss_pred CeeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeec
Confidence 99999999996 57766653 44568999999999999999999999999999999999999999999999999986543
Q ss_pred hhhcccCCcccCCCCCCCChhhhh---hcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcC
Q 009364 223 ELATVSGAKSMKGTPYWMAPEVIR---QTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENL 299 (536)
Q Consensus 223 ~~~~~~~~~~~~Gt~~Y~APEvl~---~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (536)
. .....|++.|+|||++. ...++.++|||||||++|+|++|..||......... ...............+
T Consensus 167 ~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~ 239 (308)
T cd06634 167 P------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-YHIAQNESPALQSGHW 239 (308)
T ss_pred C------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHH-HHHhhcCCCCcCcccc
Confidence 2 23456899999999985 345788999999999999999999998654322111 1111111112223468
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 300 SVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 300 s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
+..+++||++||..+|.+||++.++++|||+...
T Consensus 240 ~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 240 SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred cHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 8899999999999999999999999999999764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=326.16 Aligned_cols=254 Identities=27% Similarity=0.498 Sum_probs=200.9
Q ss_pred CCceeeeEEcccCceEEEEEE----EcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeee
Q 009364 66 IRWRKGELIGCGAFGRVYMGM----NLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVR 141 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~----~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~ 141 (536)
.+|++.+.||+|+||+||+|. +..++..||+|.+.. ......+.+.+|+++++.++||||+++++++.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~--------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 75 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQH--------STAEHLRDFEREIEILKSLQHDNIVKYKGVCY 75 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEecc--------CCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEc
Confidence 478999999999999999997 345788999998732 12233567889999999999999999999865
Q ss_pred c--CCceeEEEEecCCCCcccccccC-CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcc
Q 009364 142 E--EESLNILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGAS 218 (536)
Q Consensus 142 ~--~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla 218 (536)
. ...+++||||+++|+|.+++.+. ..+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++
T Consensus 76 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~ 155 (284)
T cd05081 76 SAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLT 155 (284)
T ss_pred cCCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccc
Confidence 3 35689999999999999998654 46899999999999999999999999999999999999999999999999999
Q ss_pred hhhhhhhcccC-CcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHH--------------H
Q 009364 219 KQVAELATVSG-AKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAA--------------L 283 (536)
Q Consensus 219 ~~~~~~~~~~~-~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~--------------~ 283 (536)
+.......... .....++..|+|||++.+..++.++|||||||++|+|++|..|+......... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05081 156 KVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHL 235 (284)
T ss_pred ccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHH
Confidence 87643221111 11223445699999999888999999999999999999988776432211110 0
Q ss_pred HhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 284 FHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 284 ~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
..........+.+..++.++.+||.+||..+|++|||+.++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 279 (284)
T cd05081 236 IELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQ 279 (284)
T ss_pred HHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 01111112233456788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=338.94 Aligned_cols=258 Identities=27% Similarity=0.477 Sum_probs=208.0
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE 143 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 143 (536)
.+.+|++.+.||+|+||.||+|.+..+++.||+|++... .........+.+|+.+++.+.||||+++++++...
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~------~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 86 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRP------FQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPA 86 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccc------cchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcc
Confidence 456899999999999999999999999999999987321 11122345567899999999999999999988765
Q ss_pred Cc------eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCc
Q 009364 144 ES------LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGA 217 (536)
Q Consensus 144 ~~------~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGl 217 (536)
.. .++|+||+ +++|.+++.. ..+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||+
T Consensus 87 ~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 87 SSLEDFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccccccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccc
Confidence 54 89999999 6799888875 5799999999999999999999999999999999999999999999999999
Q ss_pred chhhhhhhcccCCcccCCCCCCCChhhhhh-cCCCccceEechhHHHHHHhhCCCCCchhhHH--HHHHHhhCC------
Q 009364 218 SKQVAELATVSGAKSMKGTPYWMAPEVIRQ-TGHSYSADIWSVGCTVIEMATGKPPWSQQYQE--VAALFHIGT------ 288 (536)
Q Consensus 218 a~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~-~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~--~~~~~~~~~------ 288 (536)
+...... .....+++.|+|||++.+ ..++.++|||||||++|+|++|++||...... ...+.....
T Consensus 165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 239 (343)
T cd07851 165 ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEEL 239 (343)
T ss_pred ccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Confidence 8765432 344568999999999865 36789999999999999999999999643211 111111000
Q ss_pred -----------------CCCC---CCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCC
Q 009364 289 -----------------TKSH---PPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDD 334 (536)
Q Consensus 289 -----------------~~~~---~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~ 334 (536)
.... ......++..+.+||.+||+.||.+|||+.++++||||....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~ 305 (343)
T cd07851 240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYH 305 (343)
T ss_pred HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccC
Confidence 0000 011234688999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=336.10 Aligned_cols=257 Identities=25% Similarity=0.437 Sum_probs=204.5
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE 143 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 143 (536)
.+.+|.+.+.||+|+||.||+|.+..+|+.||+|++... .......+.+.+|+.++++++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~------~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP------FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCc------chhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 457899999999999999999999999999999987321 11112235577899999999999999999988643
Q ss_pred ------CceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCc
Q 009364 144 ------ESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGA 217 (536)
Q Consensus 144 ------~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGl 217 (536)
...+++++++ |++|.+++.. ..+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||+
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~ 166 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGL 166 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccc
Confidence 3477888887 7888887765 4699999999999999999999999999999999999999999999999999
Q ss_pred chhhhhhhcccCCcccCCCCCCCChhhhhh-cCCCccceEechhHHHHHHhhCCCCCchhhHH--HHHHHhhC-------
Q 009364 218 SKQVAELATVSGAKSMKGTPYWMAPEVIRQ-TGHSYSADIWSVGCTVIEMATGKPPWSQQYQE--VAALFHIG------- 287 (536)
Q Consensus 218 a~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~-~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~--~~~~~~~~------- 287 (536)
++.... ......|++.|+|||++.+ ..++.++|||||||++|+|++|.+||...... ........
T Consensus 167 ~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (345)
T cd07877 167 ARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 241 (345)
T ss_pred cccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 875432 2334578999999999876 56789999999999999999999999643211 11110000
Q ss_pred ----------------CCC---CCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 288 ----------------TTK---SHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 288 ----------------~~~---~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
... .........++++++||.+||+.||.+||++.++++||||++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~ 306 (345)
T cd07877 242 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 306 (345)
T ss_pred HhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhc
Confidence 000 0001112468889999999999999999999999999999853
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=323.75 Aligned_cols=256 Identities=30% Similarity=0.545 Sum_probs=207.2
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCce
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESL 146 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 146 (536)
||.+.+.||+|+||+||++.+..++..+++|++...... .........+..|+.+++.++||||+++++.+.+....
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVG---ELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAF 77 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEecccccc---ccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCce
Confidence 689999999999999999999888777777765321110 11112233466789999999999999999999999999
Q ss_pred eEEEEecCCCCccccccc----CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhh
Q 009364 147 NILLEFVPGGSISSLLGK----FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVA 222 (536)
Q Consensus 147 ~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~ 222 (536)
++|+||+++++|.+++.. ...+++..++.++.|++.||.|||++|++|+||+|+||+++. +.+||+|||++....
T Consensus 78 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 78 CIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999999988753 356899999999999999999999999999999999999975 579999999987654
Q ss_pred hhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcHH
Q 009364 223 ELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVK 302 (536)
Q Consensus 223 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 302 (536)
... .......|++.|+|||.+.+..++.++|+||||+++|+|++|..||........ ... ......+..+..++.+
T Consensus 157 ~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~ 232 (260)
T cd08222 157 GSC--DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSV-VLR-IVEGPTPSLPETYSRQ 232 (260)
T ss_pred CCc--ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH-HHH-HHcCCCCCCcchhcHH
Confidence 321 122345689999999999888889999999999999999999999965432111 111 1122334456678899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHhCCCC
Q 009364 303 AKDFLLKCLEKEPDLRPTASELLKHPFV 330 (536)
Q Consensus 303 ~~dLi~~cL~~dP~~Rps~~eiL~hp~~ 330 (536)
+.++|.+||..+|.+||++.++++||||
T Consensus 233 ~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 233 LNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 9999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=329.04 Aligned_cols=254 Identities=33% Similarity=0.585 Sum_probs=205.2
Q ss_pred ceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCcee
Q 009364 68 WRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESLN 147 (536)
Q Consensus 68 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 147 (536)
|++.+.||+|++|.||+|.+..+|+.+++|.+.... ........+.+|+.+++.++|+||+++++++......+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 74 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRF------ESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLY 74 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccc------ccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEE
Confidence 567889999999999999999899999999873211 11123456778999999999999999999999999999
Q ss_pred EEEEecCCCCccccccc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhc
Q 009364 148 ILLEFVPGGSISSLLGK-FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELAT 226 (536)
Q Consensus 148 lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 226 (536)
+|+||+++ +|.+++.. ...+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||.+.......
T Consensus 75 ~v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~- 152 (283)
T cd05118 75 LVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV- 152 (283)
T ss_pred EEEeccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence 99999975 77776655 4689999999999999999999999999999999999999999999999999987665432
Q ss_pred ccCCcccCCCCCCCChhhhhhc-CCCccceEechhHHHHHHhhCCCCCchhhH--HHHHHHhhCCC--------------
Q 009364 227 VSGAKSMKGTPYWMAPEVIRQT-GHSYSADIWSVGCTVIEMATGKPPWSQQYQ--EVAALFHIGTT-------------- 289 (536)
Q Consensus 227 ~~~~~~~~Gt~~Y~APEvl~~~-~~s~k~DIwSlGvil~eLltG~~Pf~~~~~--~~~~~~~~~~~-------------- 289 (536)
.......++..|+|||.+.+. .++.++|+|||||++|+|++|++||..... ...........
T Consensus 153 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05118 153 -RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLAR 231 (283)
T ss_pred -ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhh
Confidence 112335688999999998876 789999999999999999999999964332 11111110000
Q ss_pred -----------CCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCC
Q 009364 290 -----------KSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFV 330 (536)
Q Consensus 290 -----------~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~ 330 (536)
.......+.++.+++++|.+||.+||.+||++.++++||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 00001223578899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=364.82 Aligned_cols=149 Identities=36% Similarity=0.601 Sum_probs=135.2
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
.+|++.+.||+|+||+||+|.+..+++.||||++..... ........+..|+.+++.++||||+++++++.....
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~-----~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~ 78 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADM-----INKNMVHQVQAERDALALSKSPFIVHLYYSLQSANN 78 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhc-----cCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCE
Confidence 479999999999999999999999999999999843211 112334667889999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcch
Q 009364 146 LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASK 219 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~ 219 (536)
+|+||||+.|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 79 ~~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 79 VYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999999999888889999999999999999999999999999999999999999999999999886
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=322.77 Aligned_cols=247 Identities=26% Similarity=0.451 Sum_probs=200.9
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEE 144 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 144 (536)
..+|++.+.||+|+||.||+|.+. ++..+|+|.+.... . ....+.+|+.+++.++|+||+++++++. ..
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~------~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~ 73 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGT------M---SPESFLEEAQIMKKLRHDKLVQLYAVVS-EE 73 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCC------C---CHHHHHHHHHHHHhcCCCceEEEEeEEC-CC
Confidence 457999999999999999999765 56679999873211 1 1235778999999999999999999875 45
Q ss_pred ceeEEEEecCCCCcccccccC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhh
Q 009364 145 SLNILLEFVPGGSISSLLGKF--GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVA 222 (536)
Q Consensus 145 ~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~ 222 (536)
..+++|||+++++|.+++... ..+++..++.++.|++.||.|||++|++||||||+||++++++.++|+|||++....
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05070 74 PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIE 153 (260)
T ss_pred CcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeecc
Confidence 688999999999999988653 458999999999999999999999999999999999999999999999999987654
Q ss_pred hhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhH-HHHHHHhhCCCCCCCCCCCcCc
Q 009364 223 ELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQ-EVAALFHIGTTKSHPPIPENLS 300 (536)
Q Consensus 223 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~s 300 (536)
.... .......++..|+|||++.+..++.++|||||||++|+|++ |.+||..... +...... .....+.+...+
T Consensus 154 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~ 229 (260)
T cd05070 154 DNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE---RGYRMPCPQDCP 229 (260)
T ss_pred Cccc-ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH---cCCCCCCCCcCC
Confidence 3211 11223345678999999988889999999999999999999 8999965432 2222221 122334566789
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHh
Q 009364 301 VKAKDFLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 301 ~~~~dLi~~cL~~dP~~Rps~~eiL~ 326 (536)
..+++|+.+||.++|.+|||+.++++
T Consensus 230 ~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 230 ISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHHHHHHHHHcccCcccCcCHHHHHH
Confidence 99999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=339.66 Aligned_cols=261 Identities=28% Similarity=0.483 Sum_probs=206.4
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeEeeeeecC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRYLGTVREE 143 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~ 143 (536)
..+|++.+.||+|+||.||+|.+..+|+.+|+|.+.... ........+.+|+.+++.+ +||||+++++++...
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~ 79 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAF------RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAE 79 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeecccc------CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccC
Confidence 357999999999999999999999899999999873210 1112234566899999999 999999999988653
Q ss_pred --CceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhh
Q 009364 144 --ESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQV 221 (536)
Q Consensus 144 --~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~ 221 (536)
...++||||+. ++|..++... .+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 80 ~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 80 NDKDIYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred CCceEEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 36899999996 5888888764 7889999999999999999999999999999999999999999999999999866
Q ss_pred hhhhcc---cCCcccCCCCCCCChhhhhh-cCCCccceEechhHHHHHHhhCCCCCchhhHH--HHHHHhh---------
Q 009364 222 AELATV---SGAKSMKGTPYWMAPEVIRQ-TGHSYSADIWSVGCTVIEMATGKPPWSQQYQE--VAALFHI--------- 286 (536)
Q Consensus 222 ~~~~~~---~~~~~~~Gt~~Y~APEvl~~-~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~--~~~~~~~--------- 286 (536)
...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|++||...... .......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI 237 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 543221 12334568999999998754 45789999999999999999999999642211 0000000
Q ss_pred -----------------CCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 287 -----------------GTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 287 -----------------~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
..........+.++.++.++|.+||+.||.+|||+.++++|||++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 00001111223478999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=342.05 Aligned_cols=263 Identities=33% Similarity=0.506 Sum_probs=216.6
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCce
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESL 146 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 146 (536)
-|...+.||-|+||.|.++...+|...||+|.+.++. ...+.....++.|-.||...+.+-||+||..|.+.+++
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaD-----Vl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnL 704 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKAD-----VLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNL 704 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHH-----HHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCce
Confidence 3778899999999999999999999999999884322 22344566788999999999999999999999999999
Q ss_pred eEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhc
Q 009364 147 NILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELAT 226 (536)
Q Consensus 147 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 226 (536)
|+||+|++||++..+|.+.+-|+|..++.++..+..|+++.|..|+|||||||+|||||.+|++||+|||+++-+.+...
T Consensus 705 YFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHd 784 (1034)
T KOG0608|consen 705 YFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 784 (1034)
T ss_pred EEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999865432110
Q ss_pred cc----------------------------------------CCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHH
Q 009364 227 VS----------------------------------------GAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEM 266 (536)
Q Consensus 227 ~~----------------------------------------~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eL 266 (536)
.. .....+||+.|+|||++...+|+..||+||.|||||||
T Consensus 785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em 864 (1034)
T KOG0608|consen 785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEM 864 (1034)
T ss_pred cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHH
Confidence 00 01246799999999999999999999999999999999
Q ss_pred hhCCCCCchhhHHHHH-HHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCC---CHHHHHhCCCCcCCCC
Q 009364 267 ATGKPPWSQQYQEVAA-LFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRP---TASELLKHPFVTGDDE 335 (536)
Q Consensus 267 ltG~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rp---s~~eiL~hp~~~~~~~ 335 (536)
+.|.+||-........ .+..-......+...++|.++.+||.++.+ +++.|. .++|+..||||...+.
T Consensus 865 ~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkgIDf 936 (1034)
T KOG0608|consen 865 LVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKGIDF 936 (1034)
T ss_pred hhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCccccccch
Confidence 9999999654321110 001111122334556899999999988764 577886 4778999999987653
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=327.58 Aligned_cols=263 Identities=33% Similarity=0.555 Sum_probs=211.8
Q ss_pred CceeeeEEcccCceEEEEEEEc---CCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeEeeeeec
Q 009364 67 RWRKGELIGCGAFGRVYMGMNL---DSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRYLGTVRE 142 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~ 142 (536)
+|++.+.||+|+||.||+|.+. .+++.||+|++..... .........+.+|+.++.++ +||||+++++.+..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~----~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~ 76 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATI----VQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT 76 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHH----HhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec
Confidence 4889999999999999999864 4678999998742111 11123345678899999999 59999999999999
Q ss_pred CCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhh
Q 009364 143 EESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVA 222 (536)
Q Consensus 143 ~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~ 222 (536)
...+++||||+++|+|.+++.....+++..++.++.|++.||.|||+.|++||||||.||+++.++.++|+|||+++...
T Consensus 77 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 77 DTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred CCEEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence 99999999999999999998877789999999999999999999999999999999999999999999999999987654
Q ss_pred hhhcccCCcccCCCCCCCChhhhhhcC--CCccceEechhHHHHHHhhCCCCCchhhH--HHHHHHhhCCCCCCCCCCCc
Q 009364 223 ELATVSGAKSMKGTPYWMAPEVIRQTG--HSYSADIWSVGCTVIEMATGKPPWSQQYQ--EVAALFHIGTTKSHPPIPEN 298 (536)
Q Consensus 223 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~--~s~k~DIwSlGvil~eLltG~~Pf~~~~~--~~~~~~~~~~~~~~~~~~~~ 298 (536)
.... .......|++.|+|||.+.+.. .+.++||||||+++|+|++|..||..... ........ ......+.+..
T Consensus 157 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 234 (288)
T cd05583 157 AEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRR-ILKSKPPFPKT 234 (288)
T ss_pred cccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHH-HHccCCCCCcc
Confidence 3211 1123456899999999987654 78899999999999999999999953211 11111111 11223455667
Q ss_pred CcHHHHHHHHHhcccCCCCCCC---HHHHHhCCCCcCCCC
Q 009364 299 LSVKAKDFLLKCLEKEPDLRPT---ASELLKHPFVTGDDE 335 (536)
Q Consensus 299 ~s~~~~dLi~~cL~~dP~~Rps---~~eiL~hp~~~~~~~ 335 (536)
++..++++|.+||+.||++||| +.++|+||||+...+
T Consensus 235 ~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~ 274 (288)
T cd05583 235 MSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDW 274 (288)
T ss_pred cCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCH
Confidence 8899999999999999999998 567799999987544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=322.78 Aligned_cols=253 Identities=25% Similarity=0.438 Sum_probs=205.0
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCc---EEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeee
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGE---LLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVR 141 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~---~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~ 141 (536)
+.+|+..+.||+|+||.||+|.+..++. .+|+|.+... ........+.+|+++++.++||||+++++++.
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~-------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 76 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPG-------YTEKQRQDFLSEASIMGQFSHHNIIRLEGVVT 76 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEecccc-------CCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEc
Confidence 3478899999999999999999876654 7999987321 11223456788999999999999999999999
Q ss_pred cCCceeEEEEecCCCCccccccc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchh
Q 009364 142 EEESLNILLEFVPGGSISSLLGK-FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQ 220 (536)
Q Consensus 142 ~~~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~ 220 (536)
..+..++||||+++++|.+++.. .+.+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||++..
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 156 (268)
T cd05063 77 KFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRV 156 (268)
T ss_pred cCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCcccee
Confidence 99999999999999999999865 35789999999999999999999999999999999999999999999999999876
Q ss_pred hhhhhcccC-CcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhH-HHHHHHhhCCCCCCCCCCC
Q 009364 221 VAELATVSG-AKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQ-EVAALFHIGTTKSHPPIPE 297 (536)
Q Consensus 221 ~~~~~~~~~-~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~ 297 (536)
......... ......++.|+|||++.+..++.++|||||||++|+|++ |..||..... +....+.. ....+.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~---~~~~~~~~ 233 (268)
T cd05063 157 LEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIND---GFRLPAPM 233 (268)
T ss_pred cccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhc---CCCCCCCC
Confidence 543211111 111223457999999998889999999999999999997 9999965432 22222221 22333445
Q ss_pred cCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 298 NLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 298 ~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
.++.++.+++.+||..+|.+||++.++++.
T Consensus 234 ~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~ 263 (268)
T cd05063 234 DCPSAVYQLMLQCWQQDRARRPRFVDIVNL 263 (268)
T ss_pred CCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=332.92 Aligned_cols=263 Identities=27% Similarity=0.439 Sum_probs=221.0
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeEeeeeecCC
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRYLGTVREEE 144 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~ 144 (536)
.+|..+.+||+|+||+|.+|..+.+.+.||||++.+....... .++--..|-++|... +-|.++.++..|++-+
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdD-----Dvectm~EKrvLAL~~kppFL~qlHScFQTmD 423 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDD-----DVECTMVEKRVLALPGKPPFLVQLHSCFQTMD 423 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecC-----cccceehhhhheecCCCCchHHHHHHHhhhhh
Confidence 4678899999999999999999999999999988554433222 122233455666655 4789999999999999
Q ss_pred ceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhh
Q 009364 145 SLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAEL 224 (536)
Q Consensus 145 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 224 (536)
.+|+||||+.||+|...|++.++|-|..+..++..|+-||-+||++|||+||||.+|||++.+|++||+|||+++.--.
T Consensus 424 RLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~- 502 (683)
T KOG0696|consen 424 RLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF- 502 (683)
T ss_pred heeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccccc-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999874221
Q ss_pred hcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHH-HHHHhhCCCCCCCCCCCcCcHHH
Q 009364 225 ATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEV-AALFHIGTTKSHPPIPENLSVKA 303 (536)
Q Consensus 225 ~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~s~~~ 303 (536)
....+.++||||.|+|||++.-.+|+.++|+||+||+||||+.|.+||.+..++. ...+.. ....+|..+|.++
T Consensus 503 -~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~e----hnvsyPKslSkEA 577 (683)
T KOG0696|consen 503 -DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIME----HNVSYPKSLSKEA 577 (683)
T ss_pred -CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH----ccCcCcccccHHH
Confidence 2233678999999999999999999999999999999999999999998765432 222211 1234778999999
Q ss_pred HHHHHHhcccCCCCCCCH-----HHHHhCCCCcCCCCCcch
Q 009364 304 KDFLLKCLEKEPDLRPTA-----SELLKHPFVTGDDEDPVL 339 (536)
Q Consensus 304 ~dLi~~cL~~dP~~Rps~-----~eiL~hp~~~~~~~~~~~ 339 (536)
.++.+..|.+.|.+|... .+|-.||||+..++....
T Consensus 578 v~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E 618 (683)
T KOG0696|consen 578 VAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLE 618 (683)
T ss_pred HHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHh
Confidence 999999999999999753 689999999988776443
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=335.15 Aligned_cols=260 Identities=26% Similarity=0.403 Sum_probs=203.8
Q ss_pred CceeeeEEcccCceEEEEEEEcCC--CcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeEeeeeec-
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDS--GELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRYLGTVRE- 142 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~--g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~- 142 (536)
+|++.+.||+|+||.||+|.+..+ +..||+|.+.... ......+.+.+|+.+++++ +||||+++++.+..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 74 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF------SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVF 74 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc------ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeec
Confidence 588999999999999999999888 8999999873211 1112234567899999999 59999999986532
Q ss_pred ---CCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcch
Q 009364 143 ---EESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASK 219 (536)
Q Consensus 143 ---~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~ 219 (536)
....++++||+. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++
T Consensus 75 ~~~~~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 75 PGNFNELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred cccCCcEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 245788899885 7898888877889999999999999999999999999999999999999999999999999998
Q ss_pred hhhhhhcc--cCCcccCCCCCCCChhhhhh-cCCCccceEechhHHHHHHhhCCCCCchhhHH--HHHHH----------
Q 009364 220 QVAELATV--SGAKSMKGTPYWMAPEVIRQ-TGHSYSADIWSVGCTVIEMATGKPPWSQQYQE--VAALF---------- 284 (536)
Q Consensus 220 ~~~~~~~~--~~~~~~~Gt~~Y~APEvl~~-~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~--~~~~~---------- 284 (536)
.+...... .......||+.|+|||++.+ ..++.++||||+||++|+|++|.+||...... .....
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 65432211 11234578999999998765 46899999999999999999999999643210 00000
Q ss_pred -------------hhCCC---CCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 285 -------------HIGTT---KSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 285 -------------~~~~~---~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
..... .........++..+.+|+.+||+.||.+|||+.++++|||++.-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~ 298 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW 298 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence 00000 00111223568899999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=349.23 Aligned_cols=246 Identities=25% Similarity=0.414 Sum_probs=208.7
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeEeeeeecC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRYLGTVREE 143 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~ 143 (536)
...|.+...+|.|+||.|..+.+..+++.+++|++... .....+|+.++... +||||+++.+++.+.
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~------------~~~~~~e~~~~~~~~~h~niv~~~~v~~~~ 388 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR------------ADDNQDEIPISLLVRDHPNIVKSHDVYEDG 388 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccc------------ccccccccchhhhhcCCCcceeecceecCC
Confidence 56788888899999999999999999999999998322 11233566555544 799999999999999
Q ss_pred CceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCccc-CCCCcEEEEecCcchhhh
Q 009364 144 ESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILV-DNKGCIKLADFGASKQVA 222 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl-~~~~~vkL~DFGla~~~~ 222 (536)
...|+|||++.|+.+.+.+.....+. ..+..|++||+.|+.|||++|||||||||+|||+ ++.|+++|+|||.++...
T Consensus 389 ~~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 389 KEIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE 467 (612)
T ss_pred ceeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence 99999999999999998887766555 7888999999999999999999999999999999 688999999999998765
Q ss_pred hhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcHH
Q 009364 223 ELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVK 302 (536)
Q Consensus 223 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 302 (536)
.. ..+.|-|..|.|||++....|+++|||||||++||+||+|+.||........ +.... ..+.+...+|..
T Consensus 468 ~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~e-i~~~i---~~~~~s~~vS~~ 538 (612)
T KOG0603|consen 468 RS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIE-IHTRI---QMPKFSECVSDE 538 (612)
T ss_pred hh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHH-HHHhh---cCCccccccCHH
Confidence 43 3456778999999999999999999999999999999999999976544422 22111 223344789999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHhCCCCcC
Q 009364 303 AKDFLLKCLEKEPDLRPTASELLKHPFVTG 332 (536)
Q Consensus 303 ~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~ 332 (536)
+++||++||+.||.+||++.+++.||||..
T Consensus 539 AKdLl~~LL~~dP~~Rl~~~~i~~h~w~~~ 568 (612)
T KOG0603|consen 539 AKDLLQQLLQVDPALRLGADEIGAHPWFLS 568 (612)
T ss_pred HHHHHHHhccCChhhCcChhhhccCcchhc
Confidence 999999999999999999999999999943
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=332.99 Aligned_cols=256 Identities=27% Similarity=0.448 Sum_probs=197.9
Q ss_pred eeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCceeEE
Q 009364 70 KGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESLNIL 149 (536)
Q Consensus 70 ~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 149 (536)
+++.+|.| |.||.+++..+|+.||+|++... .........+.+|+.+++.++|+||+++++++...+..+++
T Consensus 6 i~~~~~~~--~~v~~~~~~~~~~~~avK~~~~~------~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 77 (314)
T cd08216 6 IGKCFEDL--MIVHLAKHKPTNTLVAVKKINLD------SCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVV 77 (314)
T ss_pred hhHhhcCC--ceEEEEEecCCCCEEEEEEEecc------ccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEE
Confidence 34444444 55555556679999999998421 11233456788999999999999999999999999999999
Q ss_pred EEecCCCCcccccccC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhc-
Q 009364 150 LEFVPGGSISSLLGKF--GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELAT- 226 (536)
Q Consensus 150 ~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~- 226 (536)
|||+++|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||.+........
T Consensus 78 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~ 157 (314)
T cd08216 78 SPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKR 157 (314)
T ss_pred EeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccc
Confidence 9999999999998753 4689999999999999999999999999999999999999999999999998865432111
Q ss_pred ----ccCCcccCCCCCCCChhhhhh--cCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhC-C-----------
Q 009364 227 ----VSGAKSMKGTPYWMAPEVIRQ--TGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIG-T----------- 288 (536)
Q Consensus 227 ----~~~~~~~~Gt~~Y~APEvl~~--~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~-~----------- 288 (536)
........++..|+|||++.+ ..++.++||||+||++|+|++|..||.............. .
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (314)
T cd08216 158 QRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYP 237 (314)
T ss_pred ccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchh
Confidence 111234457889999999876 3588999999999999999999999975321111100000 0
Q ss_pred -------------------CCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 289 -------------------TKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 289 -------------------~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
..........++.++.+|+.+||+.||.+|||+.++|+||||...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~ 301 (314)
T cd08216 238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC 301 (314)
T ss_pred hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence 000011123456788999999999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=320.28 Aligned_cols=247 Identities=32% Similarity=0.564 Sum_probs=205.3
Q ss_pred eeeeEEcccCceEEEEEEEcCCC----cEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCC
Q 009364 69 RKGELIGCGAFGRVYMGMNLDSG----ELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEE 144 (536)
Q Consensus 69 ~~~~~LG~G~fg~Vy~a~~~~~g----~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 144 (536)
++.+.||.|+||.||+|.+..++ ..||+|.+... ......+.+..|+.+++.++|+||+++++++.+.+
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~-------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 74 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKED-------ADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEE 74 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCC-------CChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence 46788999999999999998766 89999987321 11124567889999999999999999999999999
Q ss_pred ceeEEEEecCCCCcccccccCCC--CCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhh
Q 009364 145 SLNILLEFVPGGSISSLLGKFGP--FPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVA 222 (536)
Q Consensus 145 ~~~lV~E~~~gg~L~~~l~~~~~--l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~ 222 (536)
..+++|||+++++|.+++..... +++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++....
T Consensus 75 ~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~ 154 (258)
T smart00219 75 PLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY 154 (258)
T ss_pred eeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecc
Confidence 99999999999999999876544 8999999999999999999999999999999999999999999999999987765
Q ss_pred hhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhH-HHHHHHhhCCCCCCCCCCCcCc
Q 009364 223 ELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQ-EVAALFHIGTTKSHPPIPENLS 300 (536)
Q Consensus 223 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~s 300 (536)
...... .....+++.|+|||.+.+..++.++|||||||++|+|++ |.+||..... ........ ......+..++
T Consensus 155 ~~~~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~ 230 (258)
T smart00219 155 DDDYYK-KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKK---GYRLPKPENCP 230 (258)
T ss_pred cccccc-cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc---CCCCCCCCcCC
Confidence 432211 112337889999999988889999999999999999998 8899865332 22222221 22334455689
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHh
Q 009364 301 VKAKDFLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 301 ~~~~dLi~~cL~~dP~~Rps~~eiL~ 326 (536)
.++.+++.+||..||.+|||+.|+++
T Consensus 231 ~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 231 PEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 99999999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=319.62 Aligned_cols=246 Identities=28% Similarity=0.463 Sum_probs=200.7
Q ss_pred eEEcccCceEEEEEEEcC-CCc--EEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCceeE
Q 009364 72 ELIGCGAFGRVYMGMNLD-SGE--LLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESLNI 148 (536)
Q Consensus 72 ~~LG~G~fg~Vy~a~~~~-~g~--~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 148 (536)
+.||+|++|.||+|.+.. +++ .||+|.+.. .......+.+.+|+.++++++||||+++++.+.. ...++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~-------~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~ 72 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKS-------DKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMM 72 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCC-------cccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEE
Confidence 468999999999998865 333 689998732 1111456778899999999999999999999988 88999
Q ss_pred EEEecCCCCcccccccCC--CCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhc
Q 009364 149 LLEFVPGGSISSLLGKFG--PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELAT 226 (536)
Q Consensus 149 V~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 226 (536)
||||+++++|.+++.+.. .+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||+++.+.....
T Consensus 73 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 152 (257)
T cd05040 73 VTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED 152 (257)
T ss_pred EEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEecccccccccccccc
Confidence 999999999999987653 689999999999999999999999999999999999999999999999999987654221
Q ss_pred cc-CCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhH-HHHHHHhhCCCCCCCCCCCcCcHHH
Q 009364 227 VS-GAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQ-EVAALFHIGTTKSHPPIPENLSVKA 303 (536)
Q Consensus 227 ~~-~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~s~~~ 303 (536)
.. ......++..|+|||++.+..++.++|||||||++|+|++ |..||..... +....... .......+..++..+
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 230 (257)
T cd05040 153 HYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDK--EGERLERPEACPQDI 230 (257)
T ss_pred ceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh--cCCcCCCCccCCHHH
Confidence 11 1123457889999999998899999999999999999998 9999964322 22221111 222333455788999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHhC
Q 009364 304 KDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 304 ~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
.+++.+||..+|++||++.++++.
T Consensus 231 ~~li~~~l~~~p~~Rps~~~~~~~ 254 (257)
T cd05040 231 YNVMLQCWAHNPADRPTFAALREF 254 (257)
T ss_pred HHHHHHHCCCCcccCCCHHHHHHH
Confidence 999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=322.22 Aligned_cols=247 Identities=23% Similarity=0.402 Sum_probs=191.0
Q ss_pred eEEcccCceEEEEEEEc--CCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCceeEE
Q 009364 72 ELIGCGAFGRVYMGMNL--DSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESLNIL 149 (536)
Q Consensus 72 ~~LG~G~fg~Vy~a~~~--~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 149 (536)
+.||+|+||.||+|... .++..+|+|.+... ........+.+|+.+++.++||||+++++.+.+....++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 73 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVS-------ASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLV 73 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCC-------CChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEE
Confidence 35899999999999764 34567999976321 1112234677899999999999999999999999999999
Q ss_pred EEecCCCCcccccccC-----CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhh
Q 009364 150 LEFVPGGSISSLLGKF-----GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAEL 224 (536)
Q Consensus 150 ~E~~~gg~L~~~l~~~-----~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 224 (536)
|||+++|+|.+++... ...++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+++.....
T Consensus 74 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~ 153 (269)
T cd05087 74 MEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKE 153 (269)
T ss_pred EECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCc
Confidence 9999999999988642 24567788899999999999999999999999999999999999999999998654332
Q ss_pred hcccCCcccCCCCCCCChhhhhhc-------CCCccceEechhHHHHHHhh-CCCCCchhhHHHHHHHhh--C-CCCCCC
Q 009364 225 ATVSGAKSMKGTPYWMAPEVIRQT-------GHSYSADIWSVGCTVIEMAT-GKPPWSQQYQEVAALFHI--G-TTKSHP 293 (536)
Q Consensus 225 ~~~~~~~~~~Gt~~Y~APEvl~~~-------~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~--~-~~~~~~ 293 (536)
..........|++.|+|||++.+. .++.++|||||||++|+|++ |..||............. . .....+
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (269)
T cd05087 154 DYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKP 233 (269)
T ss_pred ceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCC
Confidence 221222345678899999998642 35789999999999999996 999996533221111111 1 111122
Q ss_pred CCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHh
Q 009364 294 PIPENLSVKAKDFLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 294 ~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~ 326 (536)
......+..+.+++++|| .+|.+|||+.+|+.
T Consensus 234 ~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 234 RLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred ccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 333457888999999999 68999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=320.68 Aligned_cols=249 Identities=27% Similarity=0.444 Sum_probs=204.9
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE 143 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 143 (536)
...+|++.+.||+|+||.||+|.+. ++..+|+|.+.... ...+.+.+|+.+++.++|+||+++++++...
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~---------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT---------MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEE 73 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc---------cCHHHHHHHHHHHhhCCCCCEeeeeeeeecC
Confidence 3468999999999999999999865 56789999873211 1134577899999999999999999999998
Q ss_pred CceeEEEEecCCCCcccccccC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhh
Q 009364 144 ESLNILLEFVPGGSISSLLGKF--GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQV 221 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~ 221 (536)
...++||||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++..+
T Consensus 74 ~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~ 153 (261)
T cd05034 74 EPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLI 153 (261)
T ss_pred CceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceec
Confidence 9999999999999999998654 36899999999999999999999999999999999999999999999999998766
Q ss_pred hhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhHH-HHHHHhhCCCCCCCCCCCcC
Q 009364 222 AELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQE-VAALFHIGTTKSHPPIPENL 299 (536)
Q Consensus 222 ~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~ 299 (536)
..... .......++..|+|||.+.+..++.++|||||||++|+|++ |+.||...... ..... ......+.+...
T Consensus 154 ~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~ 229 (261)
T cd05034 154 EDDEY-TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQV---ERGYRMPRPPNC 229 (261)
T ss_pred cchhh-hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---HcCCCCCCCCCC
Confidence 53211 11223335678999999998889999999999999999998 99999654322 11111 112233445567
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHh
Q 009364 300 SVKAKDFLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 300 s~~~~dLi~~cL~~dP~~Rps~~eiL~ 326 (536)
+.++.+++.+||+.+|.+||++.++++
T Consensus 230 ~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 230 PEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=321.44 Aligned_cols=248 Identities=27% Similarity=0.477 Sum_probs=202.1
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE 143 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 143 (536)
...+|++.+.||+|+||.||+|.. .+++.||+|.+.... .....+.+|+.+++.++|+||+++++++. .
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~---------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~ 72 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGS---------MSPEAFLAEANLMKQLQHPRLVRLYAVVT-Q 72 (260)
T ss_pred chHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCC---------CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-c
Confidence 345799999999999999999985 467889999873211 11245778999999999999999999874 4
Q ss_pred CceeEEEEecCCCCcccccccC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhh
Q 009364 144 ESLNILLEFVPGGSISSLLGKF--GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQV 221 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~ 221 (536)
...++||||+.+++|.+++... ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++...
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 152 (260)
T cd05067 73 EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLI 152 (260)
T ss_pred CCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeec
Confidence 5789999999999999987543 46899999999999999999999999999999999999999999999999998765
Q ss_pred hhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhH-HHHHHHhhCCCCCCCCCCCcC
Q 009364 222 AELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQ-EVAALFHIGTTKSHPPIPENL 299 (536)
Q Consensus 222 ~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~ 299 (536)
..... .......++..|+|||++.+..++.++|||||||++|+|++ |++||..... ....... .....+.+...
T Consensus 153 ~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~ 228 (260)
T cd05067 153 EDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLE---RGYRMPRPDNC 228 (260)
T ss_pred CCCCc-ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHH---cCCCCCCCCCC
Confidence 42111 11223446778999999998889999999999999999999 9999965432 2222221 12233455678
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHh
Q 009364 300 SVKAKDFLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 300 s~~~~dLi~~cL~~dP~~Rps~~eiL~ 326 (536)
+.++.++|.+||+.+|++||+++++++
T Consensus 229 ~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 229 PEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=323.32 Aligned_cols=268 Identities=27% Similarity=0.454 Sum_probs=221.5
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeEeeeeecCC
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRYLGTVREEE 144 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~ 144 (536)
..|++.++||+|+|++|.+++.+.+.+.||+|++.+.- -...+.+.-++.|-.+.... +||.+|-++..|+++.
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel-----~nddedidwvqtek~vfe~asn~pflvglhscfqtes 324 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKEL-----VNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTES 324 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHh-----cCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccc
Confidence 47999999999999999999999999999999873211 11122344455666666655 6999999999999999
Q ss_pred ceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhh
Q 009364 145 SLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAEL 224 (536)
Q Consensus 145 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 224 (536)
.+++|.||++||+|.-.+++.+++|++.++.+...|+.||.|||+.|||+||||..|||++..|++||+|+|+++.--
T Consensus 325 rlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l-- 402 (593)
T KOG0695|consen 325 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL-- 402 (593)
T ss_pred eEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCC--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999987422
Q ss_pred hcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCch-----hhHHHHHHHhhCCCCCCCCCCCcC
Q 009364 225 ATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQ-----QYQEVAALFHIGTTKSHPPIPENL 299 (536)
Q Consensus 225 ~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~-----~~~~~~~~~~~~~~~~~~~~~~~~ 299 (536)
.....+.++||||.|.|||++.+..|+.++|+|+|||+++||+.|+.||.- ........+..........+|..+
T Consensus 403 ~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprsl 482 (593)
T KOG0695|consen 403 GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSL 482 (593)
T ss_pred CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccccccee
Confidence 223346789999999999999999999999999999999999999999951 111111111111112234578889
Q ss_pred cHHHHHHHHHhcccCCCCCC------CHHHHHhCCCCcCCCCCcchh
Q 009364 300 SVKAKDFLLKCLEKEPDLRP------TASELLKHPFVTGDDEDPVLH 340 (536)
Q Consensus 300 s~~~~dLi~~cL~~dP~~Rp------s~~eiL~hp~~~~~~~~~~~~ 340 (536)
|..+..+++..|++||++|. .+.++..|+||+...++...+
T Consensus 483 svkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leq 529 (593)
T KOG0695|consen 483 SVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQ 529 (593)
T ss_pred ehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhh
Confidence 99999999999999999995 478999999999877764433
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=354.16 Aligned_cols=252 Identities=29% Similarity=0.514 Sum_probs=212.1
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcC-----CCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEee
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLD-----SGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLG 138 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~ 138 (536)
+..+-+..+.||+|+||+||+|+-.. ....||||.+. .....+...+|++|+++|..++|||||+++|
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LK-------d~a~~~~~~dF~REaeLla~l~H~nIVrLlG 556 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALK-------DKAENQARQDFRREAELLAELQHPNIVRLLG 556 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhc-------ccccHHHHHHHHHHHHHHHhccCCCeEEEEE
Confidence 34456678899999999999997542 34679999872 2333446788999999999999999999999
Q ss_pred eeecCCceeEEEEecCCCCcccccccC--------------CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCccc
Q 009364 139 TVREEESLNILLEFVPGGSISSLLGKF--------------GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILV 204 (536)
Q Consensus 139 ~~~~~~~~~lV~E~~~gg~L~~~l~~~--------------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl 204 (536)
+|..++.+++|+|||..|+|..+|... .+++..+...|+.||+.|+.||-++.+|||||-..|+||
T Consensus 557 VC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLV 636 (774)
T KOG1026|consen 557 VCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLV 636 (774)
T ss_pred EEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhcee
Confidence 999999999999999999999988433 237888999999999999999999999999999999999
Q ss_pred CCCCcEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchh-hHHHHH
Q 009364 205 DNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQ-YQEVAA 282 (536)
Q Consensus 205 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~-~~~~~~ 282 (536)
.++-.|||+|||+++.+-............-..+|||||.+..+.+++++||||+||+|||+++ |+.||.+. .+++..
T Consensus 637 ge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe 716 (774)
T KOG1026|consen 637 GENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIE 716 (774)
T ss_pred ccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHH
Confidence 9999999999999987654333222223334678999999999999999999999999999998 99999764 455666
Q ss_pred HHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHH
Q 009364 283 LFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELL 325 (536)
Q Consensus 283 ~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL 325 (536)
.+..+.. .+.|++++.++.+|+..||+.+|++||++.||-
T Consensus 717 ~i~~g~l---L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 717 CIRAGQL---LSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred HHHcCCc---ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 6555443 567789999999999999999999999999983
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=324.40 Aligned_cols=238 Identities=24% Similarity=0.409 Sum_probs=192.6
Q ss_pred eEEcccCceEEEEEEEcCCCcE-------EEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCC
Q 009364 72 ELIGCGAFGRVYMGMNLDSGEL-------LAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEE 144 (536)
Q Consensus 72 ~~LG~G~fg~Vy~a~~~~~g~~-------vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 144 (536)
+.||+|+||+||+|.+...+.. +|+|.+. .......+.+.+|+.+++.+.||||+++++++....
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~--------~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~ 72 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLD--------KSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGD 72 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhc--------chhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCC
Confidence 3699999999999998665543 7777652 122234556788999999999999999999999999
Q ss_pred ceeEEEEecCCCCcccccccCC-CCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCc--------EEEEec
Q 009364 145 SLNILLEFVPGGSISSLLGKFG-PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGC--------IKLADF 215 (536)
Q Consensus 145 ~~~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~--------vkL~DF 215 (536)
..++||||+++|+|..++...+ .+++..+..++.||+.||+|||++||+||||||+||+++.++. ++++||
T Consensus 73 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~ 152 (258)
T cd05078 73 ESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP 152 (258)
T ss_pred CcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccc
Confidence 9999999999999999987644 5899999999999999999999999999999999999987764 699999
Q ss_pred CcchhhhhhhcccCCcccCCCCCCCChhhhhh-cCCCccceEechhHHHHHHhhCC-CCCchhhHHHHHHHhhCCCCCCC
Q 009364 216 GASKQVAELATVSGAKSMKGTPYWMAPEVIRQ-TGHSYSADIWSVGCTVIEMATGK-PPWSQQYQEVAALFHIGTTKSHP 293 (536)
Q Consensus 216 Gla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~-~~~s~k~DIwSlGvil~eLltG~-~Pf~~~~~~~~~~~~~~~~~~~~ 293 (536)
|++..... .....+++.|+|||++.+ ..++.++|||||||++|+|++|. +||............. ...
T Consensus 153 g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~----~~~ 222 (258)
T cd05078 153 GISITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYE----DRH 222 (258)
T ss_pred ccccccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHH----ccc
Confidence 98865432 234568899999999986 45799999999999999999994 6665433222111111 123
Q ss_pred CCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 294 PIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 294 ~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
.++...+.++.+||.+||+.||++|||++++++.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 223 QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 4555677899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=324.51 Aligned_cols=255 Identities=33% Similarity=0.562 Sum_probs=204.2
Q ss_pred ceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC--Cc
Q 009364 68 WRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE--ES 145 (536)
Q Consensus 68 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~~ 145 (536)
|++.+.||.|+||.||+|.+..+|+.+|+|.+.... ........+.+|+.+++.++|+|++++++++... ..
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 74 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN------EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGS 74 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc------ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCc
Confidence 678899999999999999999999999999985321 1122335577899999999999999999999988 89
Q ss_pred eeEEEEecCCCCcccccccC-CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhh
Q 009364 146 LNILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAEL 224 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 224 (536)
.++|+||++ ++|.+++... ..+++..++.++.||+.||+|||+.|++|+||||+||++++++.+||+|||++......
T Consensus 75 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 75 IYMVFEYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred EEEEecccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 999999997 4888877654 57999999999999999999999999999999999999999999999999998766543
Q ss_pred hcccCCcccCCCCCCCChhhhhh-cCCCccceEechhHHHHHHhhCCCCCchhhHHH--HHHHhhCCCC---CC------
Q 009364 225 ATVSGAKSMKGTPYWMAPEVIRQ-TGHSYSADIWSVGCTVIEMATGKPPWSQQYQEV--AALFHIGTTK---SH------ 292 (536)
Q Consensus 225 ~~~~~~~~~~Gt~~Y~APEvl~~-~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~--~~~~~~~~~~---~~------ 292 (536)
.. .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||....... .......... .+
T Consensus 154 ~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07840 154 NS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL 232 (287)
T ss_pred Cc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccc
Confidence 21 11234457889999998765 457899999999999999999999996543211 1111110000 00
Q ss_pred ---------C--------CCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCC
Q 009364 293 ---------P--------PIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFV 330 (536)
Q Consensus 293 ---------~--------~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~ 330 (536)
. .+...++..+.++|++||..+|.+||++.++++||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 0 0111138889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=317.22 Aligned_cols=245 Identities=27% Similarity=0.470 Sum_probs=200.4
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCceeEEEE
Q 009364 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESLNILLE 151 (536)
Q Consensus 72 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 151 (536)
++||+|+||.||+|.+.. ++.||+|.+... ........+.+|+++++.++|+||+++++++......++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~-------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 72 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRST-------LPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVME 72 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEecccc-------CCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEE
Confidence 369999999999999877 999999987321 111344678899999999999999999999999999999999
Q ss_pred ecCCCCccccccc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhcccCC
Q 009364 152 FVPGGSISSLLGK-FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGA 230 (536)
Q Consensus 152 ~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 230 (536)
|+.+++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++............
T Consensus 73 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 152 (251)
T cd05041 73 LVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD 152 (251)
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecc
Confidence 9999999999855 356889999999999999999999999999999999999999999999999998765422111111
Q ss_pred cccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhHHH-HHHHhhCCCCCCCCCCCcCcHHHHHHHH
Q 009364 231 KSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQEV-AALFHIGTTKSHPPIPENLSVKAKDFLL 308 (536)
Q Consensus 231 ~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~s~~~~dLi~ 308 (536)
....++..|+|||++.+..++.++|+|||||++|+|++ |..||....... ..... .......+..++.++.+++.
T Consensus 153 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~ 229 (251)
T cd05041 153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIE---SGYRMPAPQLCPEEIYRLML 229 (251)
T ss_pred ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHh---cCCCCCCCccCCHHHHHHHH
Confidence 22334667999999988889999999999999999999 899996543222 22211 11223345678899999999
Q ss_pred HhcccCCCCCCCHHHHHhC
Q 009364 309 KCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 309 ~cL~~dP~~Rps~~eiL~h 327 (536)
+||..+|.+|||+.++++.
T Consensus 230 ~~l~~~p~~Rp~~~ell~~ 248 (251)
T cd05041 230 QCWAYDPENRPSFSEIYNE 248 (251)
T ss_pred HHhccChhhCcCHHHHHHH
Confidence 9999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=322.42 Aligned_cols=242 Identities=25% Similarity=0.442 Sum_probs=194.9
Q ss_pred eEEcccCceEEEEEEEcCCCc--EEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeEeeeeecCCceeE
Q 009364 72 ELIGCGAFGRVYMGMNLDSGE--LLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRYLGTVREEESLNI 148 (536)
Q Consensus 72 ~~LG~G~fg~Vy~a~~~~~g~--~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~l 148 (536)
+.||+|+||.||+|.+..+|. .+|+|.+. ........+.+.+|+.+++++ +||||+++++++.....+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~-------~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 73 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-------EYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 73 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcc-------ccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceE
Confidence 358999999999999988776 45777662 111223345678899999999 79999999999999999999
Q ss_pred EEEecCCCCcccccccCC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEE
Q 009364 149 LLEFVPGGSISSLLGKFG----------------PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKL 212 (536)
Q Consensus 149 V~E~~~gg~L~~~l~~~~----------------~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL 212 (536)
||||+++|+|.+++.... .+++..+..++.|++.||+|||++|++||||||+||+++.++.+||
T Consensus 74 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl 153 (270)
T cd05047 74 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKI 153 (270)
T ss_pred EEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEE
Confidence 999999999999886432 4788999999999999999999999999999999999999999999
Q ss_pred EecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhH-HHHHHHhhCCCC
Q 009364 213 ADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQ-EVAALFHIGTTK 290 (536)
Q Consensus 213 ~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~-~~~~~~~~~~~~ 290 (536)
+|||++....... .......++.|+|||++.+..++.++|||||||++|+|++ |..||..... ....... ..
T Consensus 154 ~dfgl~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~---~~ 227 (270)
T cd05047 154 ADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP---QG 227 (270)
T ss_pred CCCCCccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHh---CC
Confidence 9999986432211 1112234667999999988889999999999999999997 9999965432 2222111 11
Q ss_pred CCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHh
Q 009364 291 SHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 291 ~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~ 326 (536)
.....+..++.++.+|+.+||..+|.+|||+.+++.
T Consensus 228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 228 YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 222345568889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=318.87 Aligned_cols=244 Identities=28% Similarity=0.464 Sum_probs=205.1
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEE 144 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 144 (536)
..+|++.+.||.|+||.||+|.. .|+.||+|.+... . ...+.+.+|+.+++.++|+||+++++++.+..
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~-------~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 73 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDD-------S--TAAQAFLAEASVMTTLRHPNLVQLLGVVLQGN 73 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccc-------h--hHHHHHHHHHHHHHhcCCcceeeeEEEEcCCC
Confidence 45789999999999999999976 4889999988321 1 13567888999999999999999999999999
Q ss_pred ceeEEEEecCCCCcccccccCC--CCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhh
Q 009364 145 SLNILLEFVPGGSISSLLGKFG--PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVA 222 (536)
Q Consensus 145 ~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~ 222 (536)
..++||||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||.++...
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~ 153 (256)
T cd05039 74 PLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEAS 153 (256)
T ss_pred CeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccc
Confidence 9999999999999999987655 68999999999999999999999999999999999999999999999999987663
Q ss_pred hhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhHH-HHHHHhhCCCCCCCCCCCcCc
Q 009364 223 ELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQE-VAALFHIGTTKSHPPIPENLS 300 (536)
Q Consensus 223 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~s 300 (536)
.. .....++..|+|||++.+..++.++||||||+++|+|++ |..||...... ....... ......+..++
T Consensus 154 ~~-----~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~ 225 (256)
T cd05039 154 QG-----QDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEK---GYRMEAPEGCP 225 (256)
T ss_pred cc-----cccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc---CCCCCCccCCC
Confidence 21 112345677999999988889999999999999999997 99999655322 2222211 12234456789
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 301 VKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 301 ~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
+.+.++|.+||..+|.+|||+.++++.
T Consensus 226 ~~~~~li~~~l~~~p~~Rp~~~~l~~~ 252 (256)
T cd05039 226 PEVYKVMKDCWELDPAKRPTFKQLREQ 252 (256)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=322.23 Aligned_cols=246 Identities=24% Similarity=0.394 Sum_probs=190.8
Q ss_pred EEcccCceEEEEEEEcC--CCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCceeEEE
Q 009364 73 LIGCGAFGRVYMGMNLD--SGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESLNILL 150 (536)
Q Consensus 73 ~LG~G~fg~Vy~a~~~~--~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 150 (536)
.||+|+||+||+|.... ....+|+|.+.. .........+.+|+.+++.++||||+++++.+.....+++||
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~-------~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~ 74 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRA-------SATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVL 74 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCc-------cCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEE
Confidence 58999999999996533 345788886521 111233456778999999999999999999999999999999
Q ss_pred EecCCCCcccccccCC-----CCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhh
Q 009364 151 EFVPGGSISSLLGKFG-----PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA 225 (536)
Q Consensus 151 E~~~gg~L~~~l~~~~-----~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 225 (536)
||+++|+|.+++.... ..++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 154 (269)
T cd05042 75 EFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPED 154 (269)
T ss_pred EeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccch
Confidence 9999999999986532 24677889999999999999999999999999999999999999999999986543221
Q ss_pred cccCCcccCCCCCCCChhhhhh-------cCCCccceEechhHHHHHHhh-CCCCCchhhHHH--HHHHhhCC-CCCCCC
Q 009364 226 TVSGAKSMKGTPYWMAPEVIRQ-------TGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQEV--AALFHIGT-TKSHPP 294 (536)
Q Consensus 226 ~~~~~~~~~Gt~~Y~APEvl~~-------~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~~~--~~~~~~~~-~~~~~~ 294 (536)
.........+++.|+|||++.. ..++.++|||||||++|+|++ |.+||....... ........ ....+.
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (269)
T cd05042 155 YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQ 234 (269)
T ss_pred heeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCc
Confidence 1111233456788999999753 356789999999999999999 788986543221 11111111 122334
Q ss_pred CCCcCcHHHHHHHHHhcccCCCCCCCHHHHHh
Q 009364 295 IPENLSVKAKDFLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 295 ~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~ 326 (536)
++..++..+.+++..|| .||.+|||++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 235 LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred ccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 55678899999999999 59999999999986
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=319.97 Aligned_cols=247 Identities=25% Similarity=0.413 Sum_probs=200.1
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEE 144 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 144 (536)
..+|++.+.||+|+||.||+|.+..+ ..+|+|.+.... ...+.+.+|+.+++.++|+|++++++++. ..
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~---------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~ 73 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT---------MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EE 73 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC---------ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CC
Confidence 35799999999999999999987554 469999763211 11245678999999999999999999875 45
Q ss_pred ceeEEEEecCCCCcccccccC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhh
Q 009364 145 SLNILLEFVPGGSISSLLGKF--GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVA 222 (536)
Q Consensus 145 ~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~ 222 (536)
..++||||+.+|+|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||++++++.++|+|||+++...
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05069 74 PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIE 153 (260)
T ss_pred CcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEcc
Confidence 688999999999999998653 347899999999999999999999999999999999999999999999999987654
Q ss_pred hhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhHHH-HHHHhhCCCCCCCCCCCcCc
Q 009364 223 ELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQEV-AALFHIGTTKSHPPIPENLS 300 (536)
Q Consensus 223 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~s 300 (536)
.... .......++..|+|||++.+..++.++|||||||++|+|++ |.+||....... ..... .....+.+...+
T Consensus 154 ~~~~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~ 229 (260)
T cd05069 154 DNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE---RGYRMPCPQGCP 229 (260)
T ss_pred CCcc-cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---cCCCCCCCcccC
Confidence 3211 11223346778999999988889999999999999999999 999997643322 22111 122334556789
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHh
Q 009364 301 VKAKDFLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 301 ~~~~dLi~~cL~~dP~~Rps~~eiL~ 326 (536)
..+++++++||.+||.+||++.++++
T Consensus 230 ~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 230 ESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHH
Confidence 99999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=337.36 Aligned_cols=255 Identities=29% Similarity=0.503 Sum_probs=201.9
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEE 144 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 144 (536)
..+|.+.+.||+|+||.||+|.+..+|+.||+|++.... ........+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 87 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPF------QSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAV 87 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcc------ccccchhHHHHHHHHHHhcCCCCccchhheecccc
Confidence 358999999999999999999999999999999874211 11122345678999999999999999999987543
Q ss_pred ------ceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcc
Q 009364 145 ------SLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGAS 218 (536)
Q Consensus 145 ------~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla 218 (536)
.+++|+||+. .+|..++. ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 88 SGDEFQDFYLVMPYMQ-TDLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred cCCCCceEEEEecccc-cCHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 4689999995 46665542 46899999999999999999999999999999999999999999999999998
Q ss_pred hhhhhhhcccCCcccCCCCCCCChhhhhh-cCCCccceEechhHHHHHHhhCCCCCchhhH--HHHHHHhhCC-------
Q 009364 219 KQVAELATVSGAKSMKGTPYWMAPEVIRQ-TGHSYSADIWSVGCTVIEMATGKPPWSQQYQ--EVAALFHIGT------- 288 (536)
Q Consensus 219 ~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~-~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~--~~~~~~~~~~------- 288 (536)
+.... ......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||..... ..........
T Consensus 165 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (342)
T cd07879 165 RHADA-----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFV 239 (342)
T ss_pred cCCCC-----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 75432 1234568899999999876 4688999999999999999999999975421 1111111000
Q ss_pred --------------CCC--C---CCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 289 --------------TKS--H---PPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 289 --------------~~~--~---~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
... . ....+..+.++++||.+||+.||.+||++.+++.||||...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred HHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 000 0 00113567889999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=320.00 Aligned_cols=242 Identities=25% Similarity=0.448 Sum_probs=199.8
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeee-cCC
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVR-EEE 144 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~-~~~ 144 (536)
.+|++.+.||+|+||.||+|.. .|..+|+|.+.. . ...+.+.+|+.+++.++|+|++++++++. ...
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~-------~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKN-------D---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 73 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCC-------C---chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCC
Confidence 4789999999999999999976 478899998731 1 12345778999999999999999999754 556
Q ss_pred ceeEEEEecCCCCcccccccCC--CCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhh
Q 009364 145 SLNILLEFVPGGSISSLLGKFG--PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVA 222 (536)
Q Consensus 145 ~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~ 222 (536)
..++||||+++++|.+++.+.+ .+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+++...
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~ 153 (256)
T cd05082 74 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 153 (256)
T ss_pred ceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecc
Confidence 7899999999999999986543 48899999999999999999999999999999999999999999999999987543
Q ss_pred hhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhH-HHHHHHhhCCCCCCCCCCCcCc
Q 009364 223 ELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQ-EVAALFHIGTTKSHPPIPENLS 300 (536)
Q Consensus 223 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~s 300 (536)
.. .....++..|+|||++.+..++.++|||||||++|+|++ |++||..... ........ ......+..++
T Consensus 154 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~ 225 (256)
T cd05082 154 ST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK---GYKMDAPDGCP 225 (256)
T ss_pred cc-----CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc---CCCCCCCCCCC
Confidence 21 223445678999999998889999999999999999997 9999965322 22222221 12334556889
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 301 VKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 301 ~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
+.++++|.+||+.+|.+|||+.+++++
T Consensus 226 ~~~~~li~~~l~~~p~~Rpt~~~l~~~ 252 (256)
T cd05082 226 PVVYDVMKQCWHLDAATRPSFLQLREQ 252 (256)
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=327.59 Aligned_cols=258 Identities=31% Similarity=0.506 Sum_probs=203.2
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeEeeeeecC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRYLGTVREE 143 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~ 143 (536)
-..|++.+.||+|+||.||+|.+..+++.||+|.+... ........+..|+.++... .||||+++++++.+.
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~-------~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~ 86 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRT-------GNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITD 86 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEecc-------CChHHHHHHHHHHHHHHhccCCCchHhhheeeecC
Confidence 35789999999999999999999988999999988421 1112234455667666666 599999999999999
Q ss_pred CceeEEEEecCCCCccccccc-CCCCCHHHHHHHHHHHHHHHHHHHH-cCCccccCCCCCcccCCCCcEEEEecCcchhh
Q 009364 144 ESLNILLEFVPGGSISSLLGK-FGPFPEAVMRTYTKQLLLGLEYLHN-HGIMHRDIKGANILVDNKGCIKLADFGASKQV 221 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~-~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~ 221 (536)
...++||||+. +++.+++.. .+.+++..+..++.||+.||+|||+ .||+||||+|+||+++.++.+||+|||++..+
T Consensus 87 ~~~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 87 SDVFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRL 165 (296)
T ss_pred CeEEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence 99999999984 566666544 4578999999999999999999997 59999999999999999999999999998765
Q ss_pred hhhhcccCCcccCCCCCCCChhhhhhcC----CCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhC-CCCCCCCCC
Q 009364 222 AELATVSGAKSMKGTPYWMAPEVIRQTG----HSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIG-TTKSHPPIP 296 (536)
Q Consensus 222 ~~~~~~~~~~~~~Gt~~Y~APEvl~~~~----~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~-~~~~~~~~~ 296 (536)
..... .....|++.|+|||++.+.. ++.++||||||+++|+|++|+.||.............. ......+..
T Consensus 166 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (296)
T cd06618 166 VDSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPN 242 (296)
T ss_pred cCCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCC
Confidence 43211 22345788999999987543 78899999999999999999999965322211111111 111111222
Q ss_pred CcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 297 ENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 297 ~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
..++.++++||.+||..||.+||++.++++||||...
T Consensus 243 ~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 279 (296)
T cd06618 243 EGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY 279 (296)
T ss_pred CCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence 3578899999999999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=322.50 Aligned_cols=245 Identities=29% Similarity=0.465 Sum_probs=198.2
Q ss_pred eEEcccCceEEEEEEEcCCC------cEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 72 ELIGCGAFGRVYMGMNLDSG------ELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 72 ~~LG~G~fg~Vy~a~~~~~g------~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
+.||+|+||.||+|.+...+ +.+|+|.+.. .........+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~-------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 73 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRK-------GATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEP 73 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhc-------ccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCC
Confidence 36999999999999876543 6899997631 1112334567889999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccC-------CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCC-----cEEEE
Q 009364 146 LNILLEFVPGGSISSLLGKF-------GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKG-----CIKLA 213 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~-------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~-----~vkL~ 213 (536)
.++||||+++++|.+++... ..+++..+..++.|++.||.|||+++++|+||||+||+++.++ .++|+
T Consensus 74 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~ 153 (269)
T cd05044 74 QYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIG 153 (269)
T ss_pred eEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEEC
Confidence 99999999999999988532 3478899999999999999999999999999999999999877 89999
Q ss_pred ecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhH-HHHHHHhhCCCCC
Q 009364 214 DFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQ-EVAALFHIGTTKS 291 (536)
Q Consensus 214 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~-~~~~~~~~~~~~~ 291 (536)
|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||..... +..... ....
T Consensus 154 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~---~~~~ 230 (269)
T cd05044 154 DFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHV---TAGG 230 (269)
T ss_pred CcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHH---hcCC
Confidence 9999876543222222233456788999999998899999999999999999998 9999964332 221111 1122
Q ss_pred CCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHh
Q 009364 292 HPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 292 ~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~ 326 (536)
....+..++..+.+||.+||..+|.+||++.++++
T Consensus 231 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 231 RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 33445678899999999999999999999999976
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=320.31 Aligned_cols=251 Identities=28% Similarity=0.474 Sum_probs=203.3
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCC---CcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeee
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDS---GELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVR 141 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~ 141 (536)
..+|.+.+.||+|+||.||+|.+... ...||+|..... ......+.+.+|+.+++.++||||+++++++.
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~-------~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~ 77 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNC-------TSPSVREKFLQEAYIMRQFDHPHIVKLIGVIT 77 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCc-------CCHHHHHHHHHHHHHHHhCCCCchhceeEEEc
Confidence 35689999999999999999987654 356899977321 11234467888999999999999999999887
Q ss_pred cCCceeEEEEecCCCCcccccccC-CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchh
Q 009364 142 EEESLNILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQ 220 (536)
Q Consensus 142 ~~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~ 220 (536)
+ ...++||||+++|+|.+++.+. ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||+++.
T Consensus 78 ~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~ 156 (270)
T cd05056 78 E-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRY 156 (270)
T ss_pred C-CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeee
Confidence 5 4578999999999999998764 3589999999999999999999999999999999999999999999999999876
Q ss_pred hhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhHH-HHHHHhhCCCCCCCCCCCc
Q 009364 221 VAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQE-VAALFHIGTTKSHPPIPEN 298 (536)
Q Consensus 221 ~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~ 298 (536)
...... .......+++.|+|||.+.+..++.++|||||||++|+|++ |..||...... ...... .......+..
T Consensus 157 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~---~~~~~~~~~~ 232 (270)
T cd05056 157 LEDESY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIE---NGERLPMPPN 232 (270)
T ss_pred cccccc-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH---cCCcCCCCCC
Confidence 543211 11223335578999999988889999999999999999986 99999654322 121111 1223345668
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 299 LSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 299 ~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
++..+.++|.+||..+|.+|||+.+++..
T Consensus 233 ~~~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 233 CPPTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 89999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=322.28 Aligned_cols=252 Identities=27% Similarity=0.453 Sum_probs=205.8
Q ss_pred CCceeeeEEcccCceEEEEEEEcC-----CCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeee
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLD-----SGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTV 140 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~ 140 (536)
.+|++.+.||+|+||+||+|+.+. +.+.+++|.+.. .........+.+|+.++++++|+||+++++++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~-------~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 77 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQK-------TKDENLQSEFRRELDMFRKLSHKNVVRLLGLC 77 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCC-------ccchHHHHHHHHHHHHHHhcCCcceeeeEEEE
Confidence 578999999999999999999754 346788887621 12223456788999999999999999999999
Q ss_pred ecCCceeEEEEecCCCCcccccccCC---------CCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEE
Q 009364 141 REEESLNILLEFVPGGSISSLLGKFG---------PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIK 211 (536)
Q Consensus 141 ~~~~~~~lV~E~~~gg~L~~~l~~~~---------~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vk 211 (536)
.+....++||||+++|+|.+++.... .+++..+..++.|++.||+|||++||+||||||+||+++.++.++
T Consensus 78 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~ 157 (275)
T cd05046 78 REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVK 157 (275)
T ss_pred CCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEE
Confidence 99999999999999999999987655 689999999999999999999999999999999999999999999
Q ss_pred EEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhHH-HHHHHhhCCC
Q 009364 212 LADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQE-VAALFHIGTT 289 (536)
Q Consensus 212 L~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~~-~~~~~~~~~~ 289 (536)
|+|||++...... .........+++.|+|||.+.+..++.++|||||||++|+|++ |..||...... ...... ..
T Consensus 158 l~~~~~~~~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~--~~ 234 (275)
T cd05046 158 VSLLSLSKDVYNS-EYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQ--AG 234 (275)
T ss_pred EcccccccccCcc-cccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHH--cC
Confidence 9999998654321 1112234456788999999988888999999999999999998 88899643222 222211 11
Q ss_pred CCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 290 KSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 290 ~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
......+..++..+.+++.+||..+|.+|||+.+++.+
T Consensus 235 ~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 235 KLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 22223455788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=316.65 Aligned_cols=244 Identities=27% Similarity=0.465 Sum_probs=198.2
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCceeEEEE
Q 009364 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESLNILLE 151 (536)
Q Consensus 72 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 151 (536)
++||+|+||.||+|.. .++..+|+|.+.. .........+.+|+.+++.++||||+++++++......++|||
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~-------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 72 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKE-------DLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVME 72 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCC-------cCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEE
Confidence 3699999999999985 4688999998731 1112233457789999999999999999999999999999999
Q ss_pred ecCCCCccccccc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhcccCC
Q 009364 152 FVPGGSISSLLGK-FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGA 230 (536)
Q Consensus 152 ~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 230 (536)
|+++++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++........ ...
T Consensus 73 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~ 151 (250)
T cd05085 73 LVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSS 151 (250)
T ss_pred CCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccccc-ccC
Confidence 9999999998864 34688999999999999999999999999999999999999999999999999875432211 111
Q ss_pred cccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhHHH-HHHHhhCCCCCCCCCCCcCcHHHHHHHH
Q 009364 231 KSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQEV-AALFHIGTTKSHPPIPENLSVKAKDFLL 308 (536)
Q Consensus 231 ~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~s~~~~dLi~ 308 (536)
....+++.|+|||++.+..++.++|||||||++|+|++ |..||....... ..... .......+..++..+.+++.
T Consensus 152 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~ 228 (250)
T cd05085 152 GLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE---KGYRMSCPQKCPDDVYKVMQ 228 (250)
T ss_pred CCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH---cCCCCCCCCCCCHHHHHHHH
Confidence 22345677999999998889999999999999999998 999996543221 11111 12223445678999999999
Q ss_pred HhcccCCCCCCCHHHHHhC
Q 009364 309 KCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 309 ~cL~~dP~~Rps~~eiL~h 327 (536)
+||..+|++||++.++++.
T Consensus 229 ~~l~~~p~~Rp~~~~l~~~ 247 (250)
T cd05085 229 RCWDYKPENRPKFSELQKE 247 (250)
T ss_pred HHcccCcccCCCHHHHHHH
Confidence 9999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=320.11 Aligned_cols=238 Identities=23% Similarity=0.361 Sum_probs=189.9
Q ss_pred eEEcccCceEEEEEEEcCC------------CcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeee
Q 009364 72 ELIGCGAFGRVYMGMNLDS------------GELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGT 139 (536)
Q Consensus 72 ~~LG~G~fg~Vy~a~~~~~------------g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~ 139 (536)
+.||+|+||+||+|..... ...+|+|++. .........+.+|+.+++.++||||++++++
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~--------~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~ 72 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLD--------PSHRDISLAFFETASMMRQVSHKHIVLLYGV 72 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecC--------hhhhhHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 3689999999999975322 2357888762 1222344567889999999999999999999
Q ss_pred eecCCceeEEEEecCCCCccccccc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCc-------EE
Q 009364 140 VREEESLNILLEFVPGGSISSLLGK-FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGC-------IK 211 (536)
Q Consensus 140 ~~~~~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~-------vk 211 (536)
+......++||||+++|+|..++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++. +|
T Consensus 73 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~ 152 (262)
T cd05077 73 CVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIK 152 (262)
T ss_pred EecCCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeE
Confidence 9999999999999999999888764 356899999999999999999999999999999999999987664 89
Q ss_pred EEecCcchhhhhhhcccCCcccCCCCCCCChhhhh-hcCCCccceEechhHHHHHHh-hCCCCCchhhHHHHHHHhhCCC
Q 009364 212 LADFGASKQVAELATVSGAKSMKGTPYWMAPEVIR-QTGHSYSADIWSVGCTVIEMA-TGKPPWSQQYQEVAALFHIGTT 289 (536)
Q Consensus 212 L~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~-~~~~s~k~DIwSlGvil~eLl-tG~~Pf~~~~~~~~~~~~~~~~ 289 (536)
++|||++..... .....|+..|+|||++. +..++.++|||||||++|+|+ +|..||...............
T Consensus 153 l~d~g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~- 225 (262)
T cd05077 153 LSDPGIPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQ- 225 (262)
T ss_pred eCCCCCCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHhcC-
Confidence 999998865432 23456889999999986 467899999999999999998 588998654322211111111
Q ss_pred CCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 290 KSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 290 ~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
.......+.++++||.+||+.||.+||++.+|+++
T Consensus 226 ---~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 226 ---CMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred ---ccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 11222346789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=323.06 Aligned_cols=252 Identities=33% Similarity=0.551 Sum_probs=200.8
Q ss_pred ceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCC-CCceeeEeeeeecCCce
Q 009364 68 WRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS-HPNIVRYLGTVREEESL 146 (536)
Q Consensus 68 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~ 146 (536)
|++.+.||+|++|+||+|....+++.||+|.+..... ........+|+..+++++ |+||+++++++...+..
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~-------~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 73 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFY-------SWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDEL 73 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhcc-------chhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcE
Confidence 6788999999999999999998999999998732111 011123346888999998 99999999999999999
Q ss_pred eEEEEecCCCCcccccccCC--CCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhh
Q 009364 147 NILLEFVPGGSISSLLGKFG--PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAEL 224 (536)
Q Consensus 147 ~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 224 (536)
++||||+ +|+|.+++.... .+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 74 ~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (283)
T cd07830 74 YFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR 152 (283)
T ss_pred EEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCC
Confidence 9999999 888988886654 7899999999999999999999999999999999999999999999999998765432
Q ss_pred hcccCCcccCCCCCCCChhhhh-hcCCCccceEechhHHHHHHhhCCCCCchhhH--HHHHHHhhCCCC-----------
Q 009364 225 ATVSGAKSMKGTPYWMAPEVIR-QTGHSYSADIWSVGCTVIEMATGKPPWSQQYQ--EVAALFHIGTTK----------- 290 (536)
Q Consensus 225 ~~~~~~~~~~Gt~~Y~APEvl~-~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~--~~~~~~~~~~~~----------- 290 (536)
. ......|+..|+|||++. +..++.++|+||||+++|+|++|.+||..... ............
T Consensus 153 ~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07830 153 P---PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKL 229 (283)
T ss_pred C---CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhh
Confidence 1 123456899999999875 44578999999999999999999999954321 111111000000
Q ss_pred --------------CCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCC
Q 009364 291 --------------SHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFV 330 (536)
Q Consensus 291 --------------~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~ 330 (536)
.........+.+++++|++||+.+|.+|||+.|++.||||
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 230 ASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred hccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 0000112336889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=332.05 Aligned_cols=258 Identities=29% Similarity=0.462 Sum_probs=206.7
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE 142 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 142 (536)
...++|++.+.||.|+||.||+|.+..+|+.||+|.+.... ......+.+.+|+.+++.++||||+++++++..
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 80 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPF------STPVLAKRTYRELKLLKHLRHENIISLSDIFIS 80 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccc------cccchhHHHHHHHHHHHhcCCCCeeeEeeeEec
Confidence 35678999999999999999999999999999999874211 111233557789999999999999999999865
Q ss_pred -CCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhh
Q 009364 143 -EESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQV 221 (536)
Q Consensus 143 -~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~ 221 (536)
....++|+||+ +++|..++.. .++++..+..++.|++.||.|||++||+||||+|.||+++.++.+||+|||++...
T Consensus 81 ~~~~~~lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~ 158 (328)
T cd07856 81 PLEDIYFVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQ 158 (328)
T ss_pred CCCcEEEEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCcccccccc
Confidence 56789999998 6788877764 56889999999999999999999999999999999999999999999999998754
Q ss_pred hhhhcccCCcccCCCCCCCChhhhhh-cCCCccceEechhHHHHHHhhCCCCCchhhHHH--H---H-------------
Q 009364 222 AELATVSGAKSMKGTPYWMAPEVIRQ-TGHSYSADIWSVGCTVIEMATGKPPWSQQYQEV--A---A------------- 282 (536)
Q Consensus 222 ~~~~~~~~~~~~~Gt~~Y~APEvl~~-~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~--~---~------------- 282 (536)
.. ......+++.|+|||++.+ ..++.++|||||||++|+|++|.+||....... . .
T Consensus 159 ~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (328)
T cd07856 159 DP-----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI 233 (328)
T ss_pred CC-----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 32 1234568899999998765 568999999999999999999999996432110 0 0
Q ss_pred -------HHhhCCCCCCCC---CCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 283 -------LFHIGTTKSHPP---IPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 283 -------~~~~~~~~~~~~---~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
...........+ ..+.++..++++|++||+.+|++||++.+++.||||...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~ 294 (328)
T cd07856 234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPY 294 (328)
T ss_pred cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccc
Confidence 000000000111 123578899999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=359.67 Aligned_cols=257 Identities=25% Similarity=0.448 Sum_probs=213.7
Q ss_pred CCCCCCCCceeeeEEcccCceEEEEEEEcCCCc-----EEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCcee
Q 009364 60 VKMSPPIRWRKGELIGCGAFGRVYMGMNLDSGE-----LLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIV 134 (536)
Q Consensus 60 ~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~-----~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv 134 (536)
+...+..+-...+.||+|+||.||.|....... .||+|.+. +....+...++.+|..+|+.++|||||
T Consensus 686 lp~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~-------~~~~~~~~~~Fl~Ea~~m~~f~HpNiv 758 (1025)
T KOG1095|consen 686 LPEVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLK-------RLSSEQEVSDFLKEALLMSKFDHPNIV 758 (1025)
T ss_pred cccCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecc-------ccCCHHHHHHHHHHHHHHhcCCCccee
Confidence 334556678889999999999999998764332 48888873 233346678899999999999999999
Q ss_pred eEeeeeecCCceeEEEEecCCCCcccccccC-------CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCC
Q 009364 135 RYLGTVREEESLNILLEFVPGGSISSLLGKF-------GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNK 207 (536)
Q Consensus 135 ~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~-------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~ 207 (536)
+++|++.+....+|++|||+||+|..+|++. ..++..+...++.||++|+.||+++++|||||-..|+|++..
T Consensus 759 ~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~ 838 (1025)
T KOG1095|consen 759 SLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDER 838 (1025)
T ss_pred eEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeeccc
Confidence 9999999999999999999999999999765 358899999999999999999999999999999999999999
Q ss_pred CcEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhHH-HHHHHh
Q 009364 208 GCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQE-VAALFH 285 (536)
Q Consensus 208 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~~-~~~~~~ 285 (536)
..|||+|||+|+.+.............-...|||||.+..+.++.|+|||||||++||++| |..||.+.... +.....
T Consensus 839 r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~ 918 (1025)
T KOG1095|consen 839 RVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVL 918 (1025)
T ss_pred CcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHH
Confidence 9999999999995443222221112223467999999999999999999999999999999 89999776543 332222
Q ss_pred hCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHh
Q 009364 286 IGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 286 ~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~ 326 (536)
.+. +.+.|..++..+.++|.+||+.+|+.||++..|++
T Consensus 919 ~gg---RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 919 EGG---RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred hCC---ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 222 55677899999999999999999999999999998
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=342.33 Aligned_cols=263 Identities=28% Similarity=0.446 Sum_probs=226.2
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCce
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESL 146 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 146 (536)
+.+++..||-|+||.|-++........+|+|++.+... ......+.+..|-++|..++.|.||++|..|.++..+
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hI-----VdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyv 495 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHI-----VDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYV 495 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhc-----cchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhh
Confidence 45677789999999999998766555689998743221 1223456688999999999999999999999999999
Q ss_pred eEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhc
Q 009364 147 NILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELAT 226 (536)
Q Consensus 147 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 226 (536)
|++||-|-||.|+..+..++.|.+..++.++..+++|++|||++|||+|||||+|.+++.+|-+||.|||+|+.+...
T Consensus 496 YmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g-- 573 (732)
T KOG0614|consen 496 YMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG-- 573 (732)
T ss_pred hhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccC--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999998754
Q ss_pred ccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcHHHHHH
Q 009364 227 VSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKDF 306 (536)
Q Consensus 227 ~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL 306 (536)
..+.++||||.|.|||++.+.+++.++|.||||+++|||++|.|||.+..+-. ....+........+|..++..+.+|
T Consensus 574 -~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmk-tYn~ILkGid~i~~Pr~I~k~a~~L 651 (732)
T KOG0614|consen 574 -RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMK-TYNLILKGIDKIEFPRRITKTATDL 651 (732)
T ss_pred -CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHH-HHHHHHhhhhhhhcccccchhHHHH
Confidence 34678999999999999999999999999999999999999999998754322 1111222223445778999999999
Q ss_pred HHHhcccCCCCCCC-----HHHHHhCCCCcCCCCCcc
Q 009364 307 LLKCLEKEPDLRPT-----ASELLKHPFVTGDDEDPV 338 (536)
Q Consensus 307 i~~cL~~dP~~Rps-----~~eiL~hp~~~~~~~~~~ 338 (536)
|+++...+|.+|.. ..+|.+|.||.+.++...
T Consensus 652 ik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdwegl 688 (732)
T KOG0614|consen 652 IKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGL 688 (732)
T ss_pred HHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhh
Confidence 99999999999986 899999999998877643
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=325.35 Aligned_cols=254 Identities=34% Similarity=0.579 Sum_probs=205.5
Q ss_pred ceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCcee
Q 009364 68 WRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESLN 147 (536)
Q Consensus 68 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 147 (536)
|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+..|+.+++.++|+||+++++++......+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~------~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 74 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN------EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLY 74 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc------ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceE
Confidence 667889999999999999999999999999884321 11122345678999999999999999999999999999
Q ss_pred EEEEecCCCCcccccccC-CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhc
Q 009364 148 ILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELAT 226 (536)
Q Consensus 148 lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 226 (536)
+|+||+. ++|.+++.+. ..+++..+..++.|++.||+|||++||+||||+|+||++++++.+||+|||+++.......
T Consensus 75 ~v~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 75 LVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred EEecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 9999997 5899998775 5799999999999999999999999999999999999999999999999999876543221
Q ss_pred ccCCcccCCCCCCCChhhhhhc-CCCccceEechhHHHHHHhhCCCCCchhhHH--HHHHHhhC------------C---
Q 009364 227 VSGAKSMKGTPYWMAPEVIRQT-GHSYSADIWSVGCTVIEMATGKPPWSQQYQE--VAALFHIG------------T--- 288 (536)
Q Consensus 227 ~~~~~~~~Gt~~Y~APEvl~~~-~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~--~~~~~~~~------------~--- 288 (536)
......++..|+|||++.+. .++.++|||||||++|+|++|.+||...... ...+.... .
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07829 154 --TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPD 231 (282)
T ss_pred --ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccc
Confidence 22334567889999998776 7899999999999999999999999654311 11111000 0
Q ss_pred -CCCCC--------CCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCC
Q 009364 289 -TKSHP--------PIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFV 330 (536)
Q Consensus 289 -~~~~~--------~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~ 330 (536)
....+ ...+..+..+.++|++||..||++||++.++++||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 232 YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred ccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 00000 0112457889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=361.17 Aligned_cols=256 Identities=27% Similarity=0.460 Sum_probs=204.5
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeee------
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTV------ 140 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~------ 140 (536)
.|+..++||+||||.||+++++-+|+.||||+|... . .......+.+|+.+|.+|+|||||+++..+
T Consensus 480 DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~------~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~ 552 (1351)
T KOG1035|consen 480 DFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLK------A-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAE 552 (1351)
T ss_pred hhHHHHHhcCCCCceEEEEeecccchhhhhhhccCc------h-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCc
Confidence 577899999999999999999999999999998532 2 344566788999999999999999998533
Q ss_pred ---------------------------------------------------e---------------------c------
Q 009364 141 ---------------------------------------------------R---------------------E------ 142 (536)
Q Consensus 141 ---------------------------------------------------~---------------------~------ 142 (536)
. +
T Consensus 553 ~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~ 632 (1351)
T KOG1035|consen 553 LTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSN 632 (1351)
T ss_pred cccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccc
Confidence 0 0
Q ss_pred ---------------------------C--------CceeEEEEecCCCCcccccccCCCC-CHHHHHHHHHHHHHHHHH
Q 009364 143 ---------------------------E--------ESLNILLEFVPGGSISSLLGKFGPF-PEAVMRTYTKQLLLGLEY 186 (536)
Q Consensus 143 ---------------------------~--------~~~~lV~E~~~gg~L~~~l~~~~~l-~~~~~~~i~~qil~aL~y 186 (536)
+ ..+||=||||+..++.+++..+... ....+|++++||+.||+|
T Consensus 633 tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 633 TSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAY 712 (1351)
T ss_pred ccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHH
Confidence 0 1367889999998888888776554 477889999999999999
Q ss_pred HHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhh----------------hhcccCCcccCCCCCCCChhhhhhcC-
Q 009364 187 LHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAE----------------LATVSGAKSMKGTPYWMAPEVIRQTG- 249 (536)
Q Consensus 187 LH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~----------------~~~~~~~~~~~Gt~~Y~APEvl~~~~- 249 (536)
+|+.|||||||||.||+++.++.|||+|||+|+.... .......+..+||.-|+|||++.+..
T Consensus 713 IH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~ 792 (1351)
T KOG1035|consen 713 IHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS 792 (1351)
T ss_pred HHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence 9999999999999999999999999999999987220 00111234678999999999997654
Q ss_pred --CCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCC--CCCcCcHHHHHHHHHhcccCCCCCCCHHHHH
Q 009364 250 --HSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPP--IPENLSVKAKDFLLKCLEKEPDLRPTASELL 325 (536)
Q Consensus 250 --~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL 325 (536)
|+.|+|||||||||+||+. ||....+....+..........+ ++..--+.-+.+|+.||+.||.+||||.|+|
T Consensus 793 ~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL 869 (1351)
T KOG1035|consen 793 NKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELL 869 (1351)
T ss_pred ccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHh
Confidence 9999999999999999996 68766655544444332222222 2333445567899999999999999999999
Q ss_pred hCCCCcC
Q 009364 326 KHPFVTG 332 (536)
Q Consensus 326 ~hp~~~~ 332 (536)
++.||..
T Consensus 870 ~s~llpp 876 (1351)
T KOG1035|consen 870 NSELLPP 876 (1351)
T ss_pred hccCCCc
Confidence 9999975
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=327.60 Aligned_cols=252 Identities=25% Similarity=0.477 Sum_probs=203.5
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCc----EEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeee
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGE----LLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTV 140 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~----~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~ 140 (536)
..+|+..+.||+|+||.||+|.+..+|. .+|+|.+.. .........+.+|+.+++.++||||+++++++
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~-------~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~ 78 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNE-------TTGPKANVEFMDEALIMASMDHPHLVRLLGVC 78 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccc-------cCCHHHHHHHHHHHHHHHhCCCCCcccEEEEE
Confidence 3468899999999999999999887776 467776621 11122234578899999999999999999998
Q ss_pred ecCCceeEEEEecCCCCcccccccC-CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcch
Q 009364 141 REEESLNILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASK 219 (536)
Q Consensus 141 ~~~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~ 219 (536)
... ..++++||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++
T Consensus 79 ~~~-~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~ 157 (303)
T cd05110 79 LSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (303)
T ss_pred cCC-CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccc
Confidence 754 467999999999999998664 368999999999999999999999999999999999999999999999999998
Q ss_pred hhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhh-HHHHHHHhhCCCCCCCCCCC
Q 009364 220 QVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQY-QEVAALFHIGTTKSHPPIPE 297 (536)
Q Consensus 220 ~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~-~~~~~~~~~~~~~~~~~~~~ 297 (536)
...............++..|+|||++.+..++.++|||||||++|+|++ |..||.... .......... ...+.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~---~~~~~~~ 234 (303)
T cd05110 158 LLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKG---ERLPQPP 234 (303)
T ss_pred cccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCC---CCCCCCC
Confidence 6653322222233456788999999998899999999999999999997 899996542 2333333222 2233445
Q ss_pred cCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 298 NLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 298 ~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
.++..+.+++.+||..+|++||++.++++.
T Consensus 235 ~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 235 ICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=318.77 Aligned_cols=229 Identities=27% Similarity=0.433 Sum_probs=192.9
Q ss_pred cCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCceeEEEEecCCC
Q 009364 77 GAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESLNILLEFVPGG 156 (536)
Q Consensus 77 G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg 156 (536)
|.||.||++.+..+|+.||+|.+.... ...+|...+....||||+++++++......++||||++||
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 70 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGG 70 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCC
Confidence 899999999999999999999884211 1123344445567999999999999999999999999999
Q ss_pred CcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhcccCCcccCCC
Q 009364 157 SISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGT 236 (536)
Q Consensus 157 ~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt 236 (536)
+|.+++.+...+++..+..++.|++.||.|||++||+||||||+||+++.++.++++|||.+...... .....++
T Consensus 71 ~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~ 145 (237)
T cd05576 71 KLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVE 145 (237)
T ss_pred CHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcC
Confidence 99999987778999999999999999999999999999999999999999999999999987655431 2234567
Q ss_pred CCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCC
Q 009364 237 PYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPD 316 (536)
Q Consensus 237 ~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~ 316 (536)
..|+|||.+.+..++.++|+||+||++|+|++|..||....... .......++..++..+++||.+||+.||.
T Consensus 146 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~li~~~l~~dp~ 218 (237)
T cd05576 146 NMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-------NTHTTLNIPEWVSEEARSLLQQLLQFNPT 218 (237)
T ss_pred ccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-------ccccccCCcccCCHHHHHHHHHHccCCHH
Confidence 88999999988889999999999999999999999875432111 01112235567899999999999999999
Q ss_pred CCCCH-----HHHHhCCCC
Q 009364 317 LRPTA-----SELLKHPFV 330 (536)
Q Consensus 317 ~Rps~-----~eiL~hp~~ 330 (536)
+||++ .++++||||
T Consensus 219 ~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 219 ERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred HhcCCCccchHHHHcCCCC
Confidence 99986 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=321.94 Aligned_cols=236 Identities=25% Similarity=0.379 Sum_probs=189.0
Q ss_pred EEcccCceEEEEEEEcCC------------------------CcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC
Q 009364 73 LIGCGAFGRVYMGMNLDS------------------------GELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL 128 (536)
Q Consensus 73 ~LG~G~fg~Vy~a~~~~~------------------------g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l 128 (536)
.||+|+||.||+|....+ ...||+|++. .........+.+|+.+++.+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~--------~~~~~~~~~~~~~~~~~~~l 73 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLD--------PSHRDIALAFFETASLMSQV 73 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecC--------hHHHHHHHHHHHHHHHHhcC
Confidence 599999999999975322 2357888762 11223345677889999999
Q ss_pred CCCceeeEeeeeecCCceeEEEEecCCCCccccccc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCC
Q 009364 129 SHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGK-FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNK 207 (536)
Q Consensus 129 ~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~ 207 (536)
+||||+++++++......++||||+++|+|..++.+ .+.+++..+..++.||+.||+|||++||+||||||+|||++..
T Consensus 74 ~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~ 153 (274)
T cd05076 74 SHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARL 153 (274)
T ss_pred CCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEecc
Confidence 999999999999999999999999999999988864 4678999999999999999999999999999999999999764
Q ss_pred C-------cEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhh-cCCCccceEechhHHHHHHh-hCCCCCchhhH
Q 009364 208 G-------CIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQ-TGHSYSADIWSVGCTVIEMA-TGKPPWSQQYQ 278 (536)
Q Consensus 208 ~-------~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~-~~~s~k~DIwSlGvil~eLl-tG~~Pf~~~~~ 278 (536)
+ .+|++|||++..... .....++..|+|||++.+ ..++.++|||||||++|+|+ +|..||.....
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~ 227 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALS------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP 227 (274)
T ss_pred CcccCccceeeecCCcccccccc------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh
Confidence 4 489999998754322 123457888999998875 56899999999999999984 79999965432
Q ss_pred HH-HHHHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 279 EV-AALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 279 ~~-~~~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
.. ...... ....+...+..+.++|.+||+.+|.+|||+.+++++
T Consensus 228 ~~~~~~~~~-----~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 228 SEKERFYEK-----KHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HHHHHHHHh-----ccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 21 122111 122334556789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=316.48 Aligned_cols=249 Identities=27% Similarity=0.486 Sum_probs=202.8
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEE 144 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 144 (536)
+.+|++.+.||+|+||.||+|.+. ++..+|+|.+.... . ....+.+|+++++.++||||+++++++....
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~------~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGA------M---SEEDFIEEAQVMMKLSHPKLVQLYGVCTERS 72 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCC------C---CHHHHHHHHHHHHhCCCCCeeeEEEEEccCC
Confidence 457899999999999999999875 46789999873211 0 1234678999999999999999999999999
Q ss_pred ceeEEEEecCCCCcccccccC-CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhh
Q 009364 145 SLNILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAE 223 (536)
Q Consensus 145 ~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 223 (536)
..++||||+.+++|.+++... +.+++..++.++.|++.||+|||+.|++||||||+||+++.++.+||+|||+++....
T Consensus 73 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 152 (256)
T cd05112 73 PICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLD 152 (256)
T ss_pred ceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeeccc
Confidence 999999999999999988653 5689999999999999999999999999999999999999999999999999875533
Q ss_pred hhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhH-HHHHHHhhCCCCCCCCCCCcCcH
Q 009364 224 LATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQ-EVAALFHIGTTKSHPPIPENLSV 301 (536)
Q Consensus 224 ~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~s~ 301 (536)
... .......++..|+|||++.+..++.++|||||||++|+|++ |.+||..... ......... .....+...+.
T Consensus 153 ~~~-~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 228 (256)
T cd05112 153 DQY-TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAG---FRLYKPRLASQ 228 (256)
T ss_pred Ccc-cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCC---CCCCCCCCCCH
Confidence 211 11123345678999999998889999999999999999998 9999965432 222222111 12223445789
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 302 KAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 302 ~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
.+.+|+.+||+.+|++|||+.+++++
T Consensus 229 ~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 229 SVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HHHHHHHHHcccChhhCCCHHHHHHh
Confidence 99999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=317.40 Aligned_cols=246 Identities=27% Similarity=0.461 Sum_probs=193.2
Q ss_pred eEEcccCceEEEEEEEcC---CCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeee-cCCcee
Q 009364 72 ELIGCGAFGRVYMGMNLD---SGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVR-EEESLN 147 (536)
Q Consensus 72 ~~LG~G~fg~Vy~a~~~~---~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~-~~~~~~ 147 (536)
+.||+|+||.||+|.+.. .+..+|+|.+.. .......+.+.+|+.+++.++||||+++++++. .++..+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~-------~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 73 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNR-------ITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPL 73 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCc-------cCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcE
Confidence 368999999999998754 345799997621 111233466778999999999999999999765 455688
Q ss_pred EEEEecCCCCcccccccC-CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhc
Q 009364 148 ILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELAT 226 (536)
Q Consensus 148 lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 226 (536)
+||||+.+|+|.+++.+. ...++..+..++.||+.||.|||+.+++||||||+|||++.++.+||+|||+++.+.....
T Consensus 74 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~ 153 (262)
T cd05058 74 VVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY 153 (262)
T ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcc
Confidence 999999999999998653 4467788889999999999999999999999999999999999999999999875532111
Q ss_pred --ccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhH-HHHHHHhhCCCCCCCCCCCcCcHH
Q 009364 227 --VSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQ-EVAALFHIGTTKSHPPIPENLSVK 302 (536)
Q Consensus 227 --~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~s~~ 302 (536)
........+++.|+|||++.+..++.++|||||||++|+|++ |.+||..... ....... .......+..++..
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 230 (262)
T cd05058 154 YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLL---QGRRLLQPEYCPDP 230 (262)
T ss_pred eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh---cCCCCCCCCcCCHH
Confidence 111223456788999999988899999999999999999999 5667754322 1111111 12233345567889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 303 AKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 303 ~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
+.+++.+||..+|++||++.++++.
T Consensus 231 ~~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 231 LYEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred HHHHHHHHcCCChhhCCCHHHHHHH
Confidence 9999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=314.16 Aligned_cols=248 Identities=25% Similarity=0.458 Sum_probs=201.5
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE 143 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 143 (536)
...+|++.+.||+|+||.||+|.+. .+..+|+|.+.. . ......+.+|+.+++.++|+||+++++.+..
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~-------~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~- 72 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKP-------G--SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK- 72 (260)
T ss_pred cccceeEEeEecCccceEEEEEEec-CCccEEEEecCC-------C--hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-
Confidence 3458999999999999999999754 556799997731 1 1224567889999999999999999999887
Q ss_pred CceeEEEEecCCCCcccccccC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhh
Q 009364 144 ESLNILLEFVPGGSISSLLGKF--GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQV 221 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~ 221 (536)
...+++|||+++++|.+++.+. ..++...+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||.+...
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~ 152 (260)
T cd05073 73 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVI 152 (260)
T ss_pred CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeec
Confidence 7789999999999999998653 45788889999999999999999999999999999999999999999999998765
Q ss_pred hhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhHH-HHHHHhhCCCCCCCCCCCcC
Q 009364 222 AELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQE-VAALFHIGTTKSHPPIPENL 299 (536)
Q Consensus 222 ~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~ 299 (536)
..... .......++..|+|||++.+..++.++|+|||||++|+|++ |.+||...... ....... ....+.+...
T Consensus 153 ~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~ 228 (260)
T cd05073 153 EDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER---GYRMPRPENC 228 (260)
T ss_pred cCCCc-ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC---CCCCCCcccC
Confidence 43211 11223345678999999998889999999999999999998 99999754322 2222211 1222344578
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHh
Q 009364 300 SVKAKDFLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 300 s~~~~dLi~~cL~~dP~~Rps~~eiL~ 326 (536)
+.++.+++.+||+++|++||++.++++
T Consensus 229 ~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 229 PEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred CHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 899999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=324.25 Aligned_cols=254 Identities=29% Similarity=0.424 Sum_probs=204.4
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCC--C----ceeeEee
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH--P----NIVRYLG 138 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~H--p----nIv~l~~ 138 (536)
..||.+++.+|+|+||.|-.+.+..++..||||++. ......+...-|+++|.++.+ | -+|.+.+
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik---------~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~ 158 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIK---------NVDKYREAALIEIEVLQKINESDPNGKFRCVQMRD 158 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHH---------HHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeeh
Confidence 568999999999999999999999999999999872 233455667789999999942 2 3788889
Q ss_pred eeecCCceeEEEEecCCCCcccccccC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCC----------
Q 009364 139 TVREEESLNILLEFVPGGSISSLLGKF--GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDN---------- 206 (536)
Q Consensus 139 ~~~~~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~---------- 206 (536)
+|.-.++.|||+|.+ |-++++++..+ .+++...++.+++||+.++++||+++++|.||||+|||+.+
T Consensus 159 wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k 237 (415)
T KOG0671|consen 159 WFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPK 237 (415)
T ss_pred hhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccC
Confidence 999999999999998 77999999765 47999999999999999999999999999999999999831
Q ss_pred ----------CCcEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchh
Q 009364 207 ----------KGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQ 276 (536)
Q Consensus 207 ----------~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~ 276 (536)
+..|+|+|||.|+.-.+. ..+.+.|..|+|||++.+-+++..|||||+||||+||.+|...|+..
T Consensus 238 ~~~~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtH 312 (415)
T KOG0671|consen 238 KKVCFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTH 312 (415)
T ss_pred CccceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccC
Confidence 225899999999865443 35678999999999999999999999999999999999999999643
Q ss_pred h--HHHHHHHhhCC----------------CCCCCCCCC-------------------------cCcHHHHHHHHHhccc
Q 009364 277 Y--QEVAALFHIGT----------------TKSHPPIPE-------------------------NLSVKAKDFLLKCLEK 313 (536)
Q Consensus 277 ~--~~~~~~~~~~~----------------~~~~~~~~~-------------------------~~s~~~~dLi~~cL~~ 313 (536)
. +....+..+.. ......|+. ....++.|||++||..
T Consensus 313 en~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~f 392 (415)
T KOG0671|consen 313 ENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEF 392 (415)
T ss_pred CcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHcc
Confidence 3 21111100000 000111111 1123567999999999
Q ss_pred CCCCCCCHHHHHhCCCCcCC
Q 009364 314 EPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 314 dP~~Rps~~eiL~hp~~~~~ 333 (536)
||.+|+|+.|+|.||||...
T Consensus 393 DP~~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 393 DPARRITLREALSHPFFARL 412 (415)
T ss_pred CccccccHHHHhcCHHhhcC
Confidence 99999999999999999753
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=336.73 Aligned_cols=250 Identities=32% Similarity=0.533 Sum_probs=207.6
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCc---E-EEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGE---L-LAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE 142 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~---~-vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 142 (536)
+-.+.++||+|+||.||+|..+..+. . ||+|.... ........+.++.+|.++|+.++|||||++||+...
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~-----~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~ 232 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKG-----SSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL 232 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecc-----cccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC
Confidence 34456899999999999998775432 3 89998732 122345678889999999999999999999999999
Q ss_pred CCceeEEEEecCCCCcccccccCC-CCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhh
Q 009364 143 EESLNILLEFVPGGSISSLLGKFG-PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQV 221 (536)
Q Consensus 143 ~~~~~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~ 221 (536)
...+++|||+|.||+|.+++++.+ .++..+...++.+.+.||+|||+++++||||-.+|+|++.++.+||+|||+++.-
T Consensus 233 ~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 233 EEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAG 312 (474)
T ss_pred CCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCC
Confidence 999999999999999999998877 4999999999999999999999999999999999999999999999999998764
Q ss_pred hhhhcccCCc-ccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhHH-HHHHHhhCCCCCCCCCCCc
Q 009364 222 AELATVSGAK-SMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQE-VAALFHIGTTKSHPPIPEN 298 (536)
Q Consensus 222 ~~~~~~~~~~-~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~ 298 (536)
..... .. ...-...|+|||.+....|+.++|||||||++||+++ |..||.+.... +...+ .......+.+..
T Consensus 313 ~~~~~---~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI--~~~~~r~~~~~~ 387 (474)
T KOG0194|consen 313 SQYVM---KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKI--VKNGYRMPIPSK 387 (474)
T ss_pred cceee---ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHH--HhcCccCCCCCC
Confidence 32111 11 1124678999999999999999999999999999999 88899765432 22222 122334456668
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHh
Q 009364 299 LSVKAKDFLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 299 ~s~~~~dLi~~cL~~dP~~Rps~~eiL~ 326 (536)
.+.++..++.+||..+|+.||++.++.+
T Consensus 388 ~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 388 TPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred CHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 8999999999999999999999999976
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=314.69 Aligned_cols=234 Identities=26% Similarity=0.419 Sum_probs=190.2
Q ss_pred eEEcccCceEEEEEEEcCCC----------cEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeee
Q 009364 72 ELIGCGAFGRVYMGMNLDSG----------ELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVR 141 (536)
Q Consensus 72 ~~LG~G~fg~Vy~a~~~~~g----------~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~ 141 (536)
+.||+|+||.||+|.+..++ ..+++|.+.. .... ...+.+|+.+++.++||||+++++++.
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~--------~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~ 71 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGS--------DHRD-SLAFFETASLMSQLSHKHLVKLYGVCV 71 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeecccc--------chhh-HHHHHHHHHHHHcCCCcchhheeeEEe
Confidence 36999999999999998776 3477776521 1111 466788999999999999999999998
Q ss_pred cCCceeEEEEecCCCCcccccccCC-CCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCC-------cEEEE
Q 009364 142 EEESLNILLEFVPGGSISSLLGKFG-PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKG-------CIKLA 213 (536)
Q Consensus 142 ~~~~~~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~-------~vkL~ 213 (536)
. ...++||||+++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+
T Consensus 72 ~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~ 150 (259)
T cd05037 72 R-DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLS 150 (259)
T ss_pred c-CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeC
Confidence 8 77899999999999999987655 789999999999999999999999999999999999999887 79999
Q ss_pred ecCcchhhhhhhcccCCcccCCCCCCCChhhhhhc--CCCccceEechhHHHHHHhh-CCCCCchhhHH-HHHHHhhCCC
Q 009364 214 DFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQT--GHSYSADIWSVGCTVIEMAT-GKPPWSQQYQE-VAALFHIGTT 289 (536)
Q Consensus 214 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~--~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~~-~~~~~~~~~~ 289 (536)
|||++..... .....++..|+|||++.+. .++.++|||||||++|+|++ |..||...... ...... .
T Consensus 151 Dfg~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~---~ 221 (259)
T cd05037 151 DPGIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ---D 221 (259)
T ss_pred CCCccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh---c
Confidence 9999876543 2234577889999999876 78999999999999999999 58888654221 111111 1
Q ss_pred CCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHh
Q 009364 290 KSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 290 ~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~ 326 (536)
. ...+......+.++|.+||..+|.+|||+.++++
T Consensus 222 ~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 222 Q--HRLPMPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred C--CCCCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 1 1122223478999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=318.48 Aligned_cols=254 Identities=28% Similarity=0.498 Sum_probs=203.0
Q ss_pred CCceeeeEEcccCceEEEEEEEcC----CCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeee
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLD----SGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVR 141 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~----~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~ 141 (536)
..|++.+.||+|+||.||+|.... +++.+|+|++... ........+.+|+++++.+.|+||+++++++.
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~-------~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~ 76 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHS-------GEEQHRSDFEREIEILRTLDHENIVKYKGVCE 76 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccc-------cchHHHHHHHHHHHHHHhCCCCChheEEeeee
Confidence 467888999999999999998643 4889999987321 11134567889999999999999999999987
Q ss_pred c--CCceeEEEEecCCCCcccccccCC-CCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcc
Q 009364 142 E--EESLNILLEFVPGGSISSLLGKFG-PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGAS 218 (536)
Q Consensus 142 ~--~~~~~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla 218 (536)
. ....++||||+++++|.+++.... .+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++
T Consensus 77 ~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 156 (284)
T cd05038 77 KPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLA 156 (284)
T ss_pred cCCCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccc
Confidence 7 557899999999999999987644 6899999999999999999999999999999999999999999999999999
Q ss_pred hhhhhhhccc-CCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHH-------------HHHH
Q 009364 219 KQVAELATVS-GAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEV-------------AALF 284 (536)
Q Consensus 219 ~~~~~~~~~~-~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~-------------~~~~ 284 (536)
.......... ......++..|+|||.+.+..++.++|||||||++|+|++|..||....... ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05038 157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL 236 (284)
T ss_pred cccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH
Confidence 8765322111 1112345667999999988889999999999999999999999985432111 0111
Q ss_pred hhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHh
Q 009364 285 HIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 285 ~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~ 326 (536)
.........+.+..++.++.+|+.+||..+|.+|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 237 ELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 111111222334567889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=326.14 Aligned_cols=265 Identities=28% Similarity=0.442 Sum_probs=220.3
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeee-cCC
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVR-EEE 144 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~-~~~ 144 (536)
.||-++.+||+|||+.||+|.+....++||||+-.+...+.. ++.....+...+|..|.+.|.||.||++|++|. +.+
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~Wrd-EKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRD-EKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhh-HhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 589999999999999999999999999999998766655543 334456777889999999999999999999997 556
Q ss_pred ceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHc--CCccccCCCCCcccCC---CCcEEEEecCcch
Q 009364 145 SLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNH--GIMHRDIKGANILVDN---KGCIKLADFGASK 219 (536)
Q Consensus 145 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~--~ivHrDLKp~NILl~~---~~~vkL~DFGla~ 219 (536)
.+|-|+|||+|.+|.-++++++.+++.+++.|+.||+.||.||.+. .|||-||||.|||+.+ -|.+||+|||+++
T Consensus 542 sFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSK 621 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSK 621 (775)
T ss_pred cceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhh
Confidence 7899999999999999999999999999999999999999999987 4999999999999954 4689999999999
Q ss_pred hhhhhhcc-----cCCcccCCCCCCCChhhhhh----cCCCccceEechhHHHHHHhhCCCCCchhhH--HHHHHHhh--
Q 009364 220 QVAELATV-----SGAKSMKGTPYWMAPEVIRQ----TGHSYSADIWSVGCTVIEMATGKPPWSQQYQ--EVAALFHI-- 286 (536)
Q Consensus 220 ~~~~~~~~-----~~~~~~~Gt~~Y~APEvl~~----~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~--~~~~~~~~-- 286 (536)
.+...... .-+....||.||++||.+-- ...+.++||||+|||+|+.+.|+.||..+.. ++.....+
T Consensus 622 IMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlk 701 (775)
T KOG1151|consen 622 IMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILK 701 (775)
T ss_pred hccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhc
Confidence 88653222 12345679999999998742 2468999999999999999999999975432 22221111
Q ss_pred CCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcC
Q 009364 287 GTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTG 332 (536)
Q Consensus 287 ~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~ 332 (536)
......++ .+.++.++++||++||+..-+.|....++..||||..
T Consensus 702 AtEVqFP~-KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 702 ATEVQFPP-KPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred ceeccCCC-CCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 11222222 3479999999999999999999999999999999974
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=316.84 Aligned_cols=251 Identities=23% Similarity=0.401 Sum_probs=198.4
Q ss_pred ceeeeEEcccCceEEEEEEEcC---CCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCC
Q 009364 68 WRKGELIGCGAFGRVYMGMNLD---SGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEE 144 (536)
Q Consensus 68 y~~~~~LG~G~fg~Vy~a~~~~---~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 144 (536)
|++.+.||+|+||.||+|.+.. ++..||+|++... .......+.+.+|+++++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~------~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 74 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKAD------IFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSR 74 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccc------cCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 6778899999999999998653 5789999987321 111233566788999999999999999999886432
Q ss_pred ------ceeEEEEecCCCCccccccc------CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEE
Q 009364 145 ------SLNILLEFVPGGSISSLLGK------FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKL 212 (536)
Q Consensus 145 ------~~~lV~E~~~gg~L~~~l~~------~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL 212 (536)
..+++++|+.+|+|.+++.. ...++...+..++.||+.||+|||++||+||||||+||+++.++.+||
T Consensus 75 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl 154 (273)
T cd05074 75 AKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCV 154 (273)
T ss_pred CCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEE
Confidence 24788999999999877532 125788999999999999999999999999999999999999999999
Q ss_pred EecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhHH-HHHHHhhCCCC
Q 009364 213 ADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQE-VAALFHIGTTK 290 (536)
Q Consensus 213 ~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~~-~~~~~~~~~~~ 290 (536)
+|||+++...............+++.|++||.+.+..++.++|||||||++|+|++ |.+||...... ........
T Consensus 155 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~--- 231 (273)
T cd05074 155 ADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG--- 231 (273)
T ss_pred CcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcC---
Confidence 99999886543222222233446678999999998889999999999999999999 89999654322 22222111
Q ss_pred CCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 291 SHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 291 ~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
.....+...+..+.+++.+||..+|.+|||+.+++++
T Consensus 232 ~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 232 NRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1223345678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=313.01 Aligned_cols=241 Identities=28% Similarity=0.492 Sum_probs=198.5
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
.+|++.+.||+|+||.||++. .+++.||+|.+... .....+.+|+.+++.++||||+++++++... .
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~----------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~ 72 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCD----------VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-G 72 (254)
T ss_pred HHceeeeeeccCCCCceEecc--cCCCceEEEeecCc----------chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-C
Confidence 468999999999999999986 47889999987321 1124577899999999999999999998765 4
Q ss_pred eeEEEEecCCCCcccccccCC--CCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhh
Q 009364 146 LNILLEFVPGGSISSLLGKFG--PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAE 223 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 223 (536)
.++||||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 73 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~ 152 (254)
T cd05083 73 LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSM 152 (254)
T ss_pred cEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccc
Confidence 789999999999999986543 588999999999999999999999999999999999999999999999999875432
Q ss_pred hhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhH-HHHHHHhhCCCCCCCCCCCcCcH
Q 009364 224 LATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQ-EVAALFHIGTTKSHPPIPENLSV 301 (536)
Q Consensus 224 ~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~s~ 301 (536)
. ......+..|+|||.+.+..++.++|+|||||++|+|++ |.+||..... +....... ......+..++.
T Consensus 153 ~-----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 224 (254)
T cd05083 153 G-----VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEK---GYRMEPPEGCPA 224 (254)
T ss_pred c-----CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhC---CCCCCCCCcCCH
Confidence 1 122345678999999988889999999999999999997 9999965432 22222221 122334557889
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 302 KAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 302 ~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
.+.+++++||+.+|.+||++.++++.
T Consensus 225 ~~~~li~~~l~~~p~~Rp~~~~l~~~ 250 (254)
T cd05083 225 DVYVLMTSCWETEPKKRPSFHKLREK 250 (254)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=313.72 Aligned_cols=246 Identities=21% Similarity=0.355 Sum_probs=188.8
Q ss_pred EEcccCceEEEEEEEcCCC--cEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCceeEEE
Q 009364 73 LIGCGAFGRVYMGMNLDSG--ELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESLNILL 150 (536)
Q Consensus 73 ~LG~G~fg~Vy~a~~~~~g--~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 150 (536)
.||+|+||+||+|....++ ..+++|.+.. .......+.+.+|+.+++.++||||+++++.+......++||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~-------~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~ 74 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKA-------NASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVF 74 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecC-------CCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEE
Confidence 5999999999999754332 3456665521 111233467888999999999999999999999999999999
Q ss_pred EecCCCCcccccccC----CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhc
Q 009364 151 EFVPGGSISSLLGKF----GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELAT 226 (536)
Q Consensus 151 E~~~gg~L~~~l~~~----~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 226 (536)
||+++|+|.+++.+. ..+++..++.++.||+.||+|||+++++||||||+|||++.++.+||+|||++........
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~ 154 (268)
T cd05086 75 EYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY 154 (268)
T ss_pred ecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchh
Confidence 999999999988653 3466777889999999999999999999999999999999999999999998764322111
Q ss_pred ccCCcccCCCCCCCChhhhhh-------cCCCccceEechhHHHHHHhh-CCCCCchhhH-HH-HHHHhhC-CCCCCCCC
Q 009364 227 VSGAKSMKGTPYWMAPEVIRQ-------TGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQ-EV-AALFHIG-TTKSHPPI 295 (536)
Q Consensus 227 ~~~~~~~~Gt~~Y~APEvl~~-------~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~-~~-~~~~~~~-~~~~~~~~ 295 (536)
.......+|++.|+|||++.. ..++.++|||||||++|+|++ |.+||..... +. ....... .....+.+
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (268)
T cd05086 155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQL 234 (268)
T ss_pred hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCcc
Confidence 122335678999999999753 235789999999999999997 5778854322 21 1111111 11223445
Q ss_pred CCcCcHHHHHHHHHhcccCCCCCCCHHHHHh
Q 009364 296 PENLSVKAKDFLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 296 ~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~ 326 (536)
+..++..+.+++..|| .+|.+||++.++++
T Consensus 235 ~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 235 ELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred CCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 5568899999999999 67999999999976
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=314.18 Aligned_cols=256 Identities=28% Similarity=0.490 Sum_probs=205.7
Q ss_pred CceeeeEEcccCceEEEEEEEcC-CCcEEEEEEEeehhhccc--hhHHHHHHHHHHHHHHHHHh-CCCCceeeEeeeeec
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLD-SGELLAVKQVLIAANFAS--KEKAQDHIKELEEEVKLLKD-LSHPNIVRYLGTVRE 142 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~-~g~~vAiK~i~~~~~~~~--~~~~~~~~~~~~~Ei~iL~~-l~HpnIv~l~~~~~~ 142 (536)
.|++.+.||+|+||.||+|.+.. +++.+|+|.+........ +.........+.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 37888999999999999999887 688999998753221111 11223345667788888875 799999999999999
Q ss_pred CCceeEEEEecCCCCcccccc----cCCCCCHHHHHHHHHHHHHHHHHHHH-cCCccccCCCCCcccCCCCcEEEEecCc
Q 009364 143 EESLNILLEFVPGGSISSLLG----KFGPFPEAVMRTYTKQLLLGLEYLHN-HGIMHRDIKGANILVDNKGCIKLADFGA 217 (536)
Q Consensus 143 ~~~~~lV~E~~~gg~L~~~l~----~~~~l~~~~~~~i~~qil~aL~yLH~-~~ivHrDLKp~NILl~~~~~vkL~DFGl 217 (536)
.+..++||||++|++|.+++. ....+++..++.++.|++.||.|||+ .|++||||+|+||+++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 999999999999999988763 33568999999999999999999996 6899999999999999999999999999
Q ss_pred chhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH-HHHHHhhCCCCCCCCCC
Q 009364 218 SKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE-VAALFHIGTTKSHPPIP 296 (536)
Q Consensus 218 a~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~ 296 (536)
+....... ......|+..|+|||++.+..++.++|+||||+++|+|++|.+||...... ...... .....+...
T Consensus 161 ~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~ 235 (269)
T cd08528 161 AKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIV--EAVYEPLPE 235 (269)
T ss_pred eeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHh--hccCCcCCc
Confidence 87654322 234567899999999999888999999999999999999999999654322 111111 111112222
Q ss_pred CcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 297 ENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 297 ~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
..++..+.++|++||+.||.+||++.|+..+
T Consensus 236 ~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 236 GMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred ccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 3678999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=303.74 Aligned_cols=257 Identities=29% Similarity=0.514 Sum_probs=205.9
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeEeeeeecCC
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRYLGTVREEE 144 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~ 144 (536)
+..+.+..||.|+-|+|++++.+.+|...|||.+. +..+.+..+++...+.++... ..|+||+.+|+|..+.
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~-------rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~ 164 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMR-------RTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNT 164 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeec-------ccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCc
Confidence 34456778999999999999999999999999984 333445566777777776655 4899999999999999
Q ss_pred ceeEEEEecCCCCcccccc-cCCCCCHHHHHHHHHHHHHHHHHHHHc-CCccccCCCCCcccCCCCcEEEEecCcchhhh
Q 009364 145 SLNILLEFVPGGSISSLLG-KFGPFPEAVMRTYTKQLLLGLEYLHNH-GIMHRDIKGANILVDNKGCIKLADFGASKQVA 222 (536)
Q Consensus 145 ~~~lV~E~~~gg~L~~~l~-~~~~l~~~~~~~i~~qil~aL~yLH~~-~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~ 222 (536)
..++.||.|. ..+..++. -.++++|..+-++...++.||.||.++ ||+|||+||+|||+|..|++||||||++-.+-
T Consensus 165 dV~IcMelMs-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlv 243 (391)
T KOG0983|consen 165 DVFICMELMS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV 243 (391)
T ss_pred hHHHHHHHHH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceee
Confidence 9999999883 44444443 346799999999999999999999875 89999999999999999999999999987654
Q ss_pred hhhcccCCcccCCCCCCCChhhhh---hcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCC--C
Q 009364 223 ELATVSGAKSMKGTPYWMAPEVIR---QTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIP--E 297 (536)
Q Consensus 223 ~~~~~~~~~~~~Gt~~Y~APEvl~---~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~ 297 (536)
+.. ..+...|-+.|||||.+. ...|+..+||||||+.++||.||..||.....+...+-.... ...+.++ .
T Consensus 244 dSk---AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln-~ePP~L~~~~ 319 (391)
T KOG0983|consen 244 DSK---AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN-EEPPLLPGHM 319 (391)
T ss_pred ccc---ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-cCCCCCCccc
Confidence 322 234456899999999985 346889999999999999999999999874333222211111 1122222 3
Q ss_pred cCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCC
Q 009364 298 NLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDD 334 (536)
Q Consensus 298 ~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~ 334 (536)
.+|+++++|+..||++|+.+||...++|+|||+....
T Consensus 320 gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 320 GFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE 356 (391)
T ss_pred CcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence 5899999999999999999999999999999997544
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=318.11 Aligned_cols=260 Identities=22% Similarity=0.283 Sum_probs=190.6
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCC---CcEEEEEEEeehhhccchhHH---HHHHHHHHHHHHHHHhCCCCceeeEe
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDS---GELLAVKQVLIAANFASKEKA---QDHIKELEEEVKLLKDLSHPNIVRYL 137 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~ 137 (536)
...+|++.+.||+|+||+||+|.+..+ +..+|+|+..........+.. .........+...+..+.|+||++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 346899999999999999999998877 677788764321111000000 00011122344456677899999999
Q ss_pred eeeecCC----ceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEE
Q 009364 138 GTVREEE----SLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLA 213 (536)
Q Consensus 138 ~~~~~~~----~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~ 213 (536)
+.+.... ..+++++++. .++.+.+......++..++.++.|++.||+|||+++|+||||||+|||++.++.++|+
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~ 168 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYII 168 (294)
T ss_pred EeeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEE
Confidence 8765443 3467788773 4666666655567889999999999999999999999999999999999999999999
Q ss_pred ecCcchhhhhhhcc-----cCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhH--HHH-----
Q 009364 214 DFGASKQVAELATV-----SGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQ--EVA----- 281 (536)
Q Consensus 214 DFGla~~~~~~~~~-----~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~--~~~----- 281 (536)
|||+|+.+...... .......||+.|+|||++.+..++.++|||||||++|+|++|.+||..... ...
T Consensus 169 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~ 248 (294)
T PHA02882 169 DYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKC 248 (294)
T ss_pred EcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHH
Confidence 99999866421110 112335699999999999999999999999999999999999999965421 111
Q ss_pred HHHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHh
Q 009364 282 ALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~ 326 (536)
....... ... .....++..+.++++.||..+|++||++.++++
T Consensus 249 ~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 249 DFIKRLH-EGK-IKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHHHHhh-hhh-hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 0111101 111 112366889999999999999999999999976
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=340.02 Aligned_cols=259 Identities=19% Similarity=0.268 Sum_probs=180.3
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCC----CcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeee
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDS----GELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGT 139 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~----g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~ 139 (536)
...+|.+.+.||+|+||.||+|.+..+ +..||+|.+... ... +....+ .++...+.+++.++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~------~~~----e~~~~e--~l~~~~~~~~~~~~~~ 197 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEY------GAV----EIWMNE--RVRRACPNSCADFVYG 197 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEeccc------chh----HHHHHH--HHHhhchhhHHHHHHh
Confidence 456899999999999999999999988 999999986311 000 001111 1122222222222211
Q ss_pred ------eecCCceeEEEEecCCCCcccccccCCC--------------------CCHHHHHHHHHHHHHHHHHHHHcCCc
Q 009364 140 ------VREEESLNILLEFVPGGSISSLLGKFGP--------------------FPEAVMRTYTKQLLLGLEYLHNHGIM 193 (536)
Q Consensus 140 ------~~~~~~~~lV~E~~~gg~L~~~l~~~~~--------------------l~~~~~~~i~~qil~aL~yLH~~~iv 193 (536)
......+++|+||+.+++|.+++..... ..+..+..++.||+.||.|||++||+
T Consensus 198 ~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIi 277 (566)
T PLN03225 198 FLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIV 277 (566)
T ss_pred hhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEE
Confidence 2456679999999999999988764321 12344668999999999999999999
Q ss_pred cccCCCCCcccCC-CCcEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhc----------------------CC
Q 009364 194 HRDIKGANILVDN-KGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQT----------------------GH 250 (536)
Q Consensus 194 HrDLKp~NILl~~-~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~----------------------~~ 250 (536)
||||||+|||++. ++.+||+|||+|+.+..... ......+||+.|+|||++... .+
T Consensus 278 HRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~ 356 (566)
T PLN03225 278 HRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNL 356 (566)
T ss_pred eCcCCHHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccC
Confidence 9999999999985 57999999999986543221 234567899999999976432 23
Q ss_pred CccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCC-----------CCCCC------CCCCcCcHHHHHHHHHhccc
Q 009364 251 SYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGT-----------TKSHP------PIPENLSVKAKDFLLKCLEK 313 (536)
Q Consensus 251 s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~-----------~~~~~------~~~~~~s~~~~dLi~~cL~~ 313 (536)
+.++|||||||+||||+++..|+..........+.... ....+ ...........+||.+||++
T Consensus 357 ~~k~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~ 436 (566)
T PLN03225 357 PDRFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRF 436 (566)
T ss_pred CCCcccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccC
Confidence 45679999999999999988776543322221111100 00000 01112234456999999999
Q ss_pred CCCCCCCHHHHHhCCCCcCCCC
Q 009364 314 EPDLRPTASELLKHPFVTGDDE 335 (536)
Q Consensus 314 dP~~Rps~~eiL~hp~~~~~~~ 335 (536)
||++|||+.++|+||||+....
T Consensus 437 dP~kR~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 437 KGRQRISAKAALAHPYFDREGL 458 (566)
T ss_pred CcccCCCHHHHhCCcCcCCCCc
Confidence 9999999999999999987544
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=307.54 Aligned_cols=264 Identities=28% Similarity=0.453 Sum_probs=206.3
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec---
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE--- 142 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--- 142 (536)
..|+...+||+|.||.||+|+.+++|+.||+|++... . .....-....+|+++|..|+|+|++.++++|..
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlme-----n-eKeGfpitalreikiL~~lkHenv~nliEic~tk~T 90 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLME-----N-EKEGFPITALREIKILQLLKHENVVNLIEICRTKAT 90 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHh-----c-cccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccC
Confidence 4688889999999999999999999999999976431 1 111223345689999999999999999998753
Q ss_pred -----CCceeEEEEecCCCCcccccccC-CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecC
Q 009364 143 -----EESLNILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFG 216 (536)
Q Consensus 143 -----~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFG 216 (536)
...+|+|+.+|+ -+|.-++... .+++..++.+++.+++.||.|+|++.|+|||+|++|+||+.+|.+||+|||
T Consensus 91 p~~r~r~t~ylVf~~ce-hDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 91 PTNRDRATFYLVFDFCE-HDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred CcccccceeeeeHHHhh-hhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccc
Confidence 235899999996 4666666554 579999999999999999999999999999999999999999999999999
Q ss_pred cchhhhhhhc--ccCCcccCCCCCCCChhhhhhc-CCCccceEechhHHHHHHhhCCCCCchhhHHH--HHH---HhhCC
Q 009364 217 ASKQVAELAT--VSGAKSMKGTPYWMAPEVIRQT-GHSYSADIWSVGCTVIEMATGKPPWSQQYQEV--AAL---FHIGT 288 (536)
Q Consensus 217 la~~~~~~~~--~~~~~~~~Gt~~Y~APEvl~~~-~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~--~~~---~~~~~ 288 (536)
+++.+..... ....+..+-|.+|++||.+.|. .|+++.|||+.|||+.+|+||.+.|+++.+.. ..+ .....
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t 249 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT 249 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence 9987653222 1224456679999999998864 68999999999999999999999997654321 111 11111
Q ss_pred CCCCC--------------CCCC-------------cCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCCCC
Q 009364 289 TKSHP--------------PIPE-------------NLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDED 336 (536)
Q Consensus 289 ~~~~~--------------~~~~-------------~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~~~ 336 (536)
...++ +++. .-++++.+|+.++|..||.+|+++.++|+|.||..+...
T Consensus 250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP 324 (376)
T ss_pred cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence 11111 1111 123477899999999999999999999999999876543
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=336.68 Aligned_cols=260 Identities=37% Similarity=0.649 Sum_probs=219.6
Q ss_pred CCCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeEeeee
Q 009364 62 MSPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRYLGTV 140 (536)
Q Consensus 62 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~ 140 (536)
..+.+.|++.+.||.|.+|+||+++++.+|+..|+|+.... .+..++++.|.++|+.+ .|||++.+||+|
T Consensus 15 pdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~---------~d~deEiE~eynil~~~~~hpnv~~fyg~~ 85 (953)
T KOG0587|consen 15 PDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT---------EDEEEEIELEYNMLKKYSHHPNVATFYGAF 85 (953)
T ss_pred CCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC---------ccccHHHHHHHHHHHhccCCCCcceEEEEE
Confidence 35667899999999999999999999999999999987322 12235667889999988 599999999998
Q ss_pred e-----cCCceeEEEEecCCCCcccccccC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEE
Q 009364 141 R-----EEESLNILLEFVPGGSISSLLGKF--GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLA 213 (536)
Q Consensus 141 ~-----~~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~ 213 (536)
. .++.+|||||||.||+..|++++. ..+.|..+..|++.++.|+.+||.+.++|||||-.|||++.+|.|||+
T Consensus 86 ~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 86 IKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred EEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEe
Confidence 5 456899999999999999998653 568899999999999999999999999999999999999999999999
Q ss_pred ecCcchhhhhhhcccCCcccCCCCCCCChhhhhhc-----CCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCC
Q 009364 214 DFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQT-----GHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGT 288 (536)
Q Consensus 214 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~-----~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~ 288 (536)
|||.+.++.. +.....+.+|||.|||||++... .|+..+|+||||++..||--|.||+.+.......+.....
T Consensus 166 DFGvSaQlds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRN 243 (953)
T KOG0587|consen 166 DFGVSAQLDS--TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN 243 (953)
T ss_pred eeeeeeeeec--ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCC
Confidence 9999988764 34456788999999999998643 4678899999999999999999999887654333222222
Q ss_pred CCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcC
Q 009364 289 TKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTG 332 (536)
Q Consensus 289 ~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~ 332 (536)
.+....-|...+.++.++|..||.+|-.+||+..++|+|||+..
T Consensus 244 PPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 244 PPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred CCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence 22222346778999999999999999999999999999999983
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=318.39 Aligned_cols=259 Identities=27% Similarity=0.393 Sum_probs=211.0
Q ss_pred CCCCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeee
Q 009364 61 KMSPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTV 140 (536)
Q Consensus 61 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~ 140 (536)
...+-.+..++++||+|-||.|.+|.- ..+..||+|.+.. .......+.+.+|+++|.+|+||||++++|+|
T Consensus 533 ~EfPRs~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~-------~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC 604 (807)
T KOG1094|consen 533 VEFPRSRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRP-------DATKNARNDFLKEIKILSRLKHPNIVELLGVC 604 (807)
T ss_pred hhcchhheehhhhhcCcccceeEEEEe-cCceEEEEeecCc-------ccchhHHHHHHHHHHHHhccCCCCeeEEEeee
Confidence 445556788999999999999999974 4569999998832 22223457899999999999999999999999
Q ss_pred ecCCceeEEEEecCCCCcccccccCC--CCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcc
Q 009364 141 REEESLNILLEFVPGGSISSLLGKFG--PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGAS 218 (536)
Q Consensus 141 ~~~~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla 218 (536)
..++.+++|+||+++|+|.+++.++. ...-....+|+.||+.|++||.+.++|||||.+.|+|++.++++||+|||++
T Consensus 605 ~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgms 684 (807)
T KOG1094|consen 605 VQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMS 684 (807)
T ss_pred ecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccc
Confidence 99999999999999999999997763 2344455679999999999999999999999999999999999999999999
Q ss_pred hhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHh--hCCCCCchhhHHHH-----HHHhhCCCCC
Q 009364 219 KQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMA--TGKPPWSQQYQEVA-----ALFHIGTTKS 291 (536)
Q Consensus 219 ~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLl--tG~~Pf~~~~~~~~-----~~~~~~~~~~ 291 (536)
+.+-...........+-...|||||.+.-+.++.++|+|+||+++||++ +...||.+...+.. ..........
T Consensus 685 R~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~ 764 (807)
T KOG1094|consen 685 RNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQV 764 (807)
T ss_pred cccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcce
Confidence 8665433333233445568899999999889999999999999999976 57889976543321 1222222233
Q ss_pred CCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 292 HPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 292 ~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
....|.-++..+.+||.+||..|.++||+++++-.|
T Consensus 765 ~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~ 800 (807)
T KOG1094|consen 765 VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLF 800 (807)
T ss_pred eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHH
Confidence 445677899999999999999999999999999554
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=298.96 Aligned_cols=257 Identities=31% Similarity=0.441 Sum_probs=202.0
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHH-HhCCCCceeeEeeeeecCC
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLL-KDLSHPNIVRYLGTVREEE 144 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL-~~l~HpnIv~l~~~~~~~~ 144 (536)
.+.+-...||.|+||+|++-.++.+|+..|||.|... ......+++..|.... +.-+.||||++||.+..++
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~-------n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EG 136 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSN-------NIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEG 136 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeec-------cchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCC
Confidence 3556677899999999999999999999999998421 1233445666777654 4457999999999999999
Q ss_pred ceeEEEEecCCCCccccc-----ccCCCCCHHHHHHHHHHHHHHHHHHHHc-CCccccCCCCCcccCCCCcEEEEecCcc
Q 009364 145 SLNILLEFVPGGSISSLL-----GKFGPFPEAVMRTYTKQLLLGLEYLHNH-GIMHRDIKGANILVDNKGCIKLADFGAS 218 (536)
Q Consensus 145 ~~~lV~E~~~gg~L~~~l-----~~~~~l~~~~~~~i~~qil~aL~yLH~~-~ivHrDLKp~NILl~~~~~vkL~DFGla 218 (536)
..|+.||.|. -+|..+- .+...++|.-+..|....+.||.||... +|||||+||+|||++..|.|||||||++
T Consensus 137 dcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIc 215 (361)
T KOG1006|consen 137 DCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGIC 215 (361)
T ss_pred ceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccch
Confidence 9999999994 4543322 2446799999999999999999999865 8999999999999999999999999998
Q ss_pred hhhhhhhcccCCcccCCCCCCCChhhhh--hcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhh--CCCCC-C-
Q 009364 219 KQVAELATVSGAKSMKGTPYWMAPEVIR--QTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHI--GTTKS-H- 292 (536)
Q Consensus 219 ~~~~~~~~~~~~~~~~Gt~~Y~APEvl~--~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~--~~~~~-~- 292 (536)
-.+... ...+.-.|-..|||||.+. +.+|+-++|+||||++|||+.||+.|+.....-...+... +..+. .
T Consensus 216 GqLv~S---iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~ 292 (361)
T KOG1006|consen 216 GQLVDS---IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLF 292 (361)
T ss_pred HhHHHH---HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecC
Confidence 766432 1234456889999999985 3468999999999999999999999997655432222221 11111 0
Q ss_pred CCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 293 PPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 293 ~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
..-.-+++..++.+|.-||.+|-..||...+++++||++-.
T Consensus 293 ~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y 333 (361)
T KOG1006|consen 293 DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY 333 (361)
T ss_pred cccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence 11113588999999999999999999999999999999754
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=326.83 Aligned_cols=200 Identities=33% Similarity=0.560 Sum_probs=174.3
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCC-
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEE- 144 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~- 144 (536)
.-|...+.||+|+||.||+|+++.+|+.||||.+... ......+...+|+++|++++|+|||+++++-++..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~-------~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~ 85 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKE-------SSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFL 85 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhh-------cccchHHHHHHHHHHHHHcCchhhhhhcccCCcccc
Confidence 4678889999999999999999999999999987321 12233566789999999999999999998866543
Q ss_pred -----ceeEEEEecCCCCcccccccC---CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccC--CCC--cEEE
Q 009364 145 -----SLNILLEFVPGGSISSLLGKF---GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVD--NKG--CIKL 212 (536)
Q Consensus 145 -----~~~lV~E~~~gg~L~~~l~~~---~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~--~~~--~vkL 212 (536)
...+|||||.||+|..++.+. ..+++.+...++..+..||.|||++||+||||||.||++- .+| .-||
T Consensus 86 ~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKL 165 (732)
T KOG4250|consen 86 GLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKL 165 (732)
T ss_pred CcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEee
Confidence 567999999999999999754 4699999999999999999999999999999999999984 334 5799
Q ss_pred EecCcchhhhhhhcccCCcccCCCCCCCChhhhh-hcCCCccceEechhHHHHHHhhCCCCCch
Q 009364 213 ADFGASKQVAELATVSGAKSMKGTPYWMAPEVIR-QTGHSYSADIWSVGCTVIEMATGKPPWSQ 275 (536)
Q Consensus 213 ~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~-~~~~s~k~DIwSlGvil~eLltG~~Pf~~ 275 (536)
+|||.|+.+.+.. ...+..||+.|.+||++. ...|+..+|.|||||++|+..||..||..
T Consensus 166 tDfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p 226 (732)
T KOG4250|consen 166 TDFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP 226 (732)
T ss_pred ecccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence 9999999887654 467899999999999998 48899999999999999999999999953
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=291.59 Aligned_cols=242 Identities=38% Similarity=0.667 Sum_probs=201.9
Q ss_pred CceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCceeEEEEecCCCC
Q 009364 78 AFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESLNILLEFVPGGS 157 (536)
Q Consensus 78 ~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~ 157 (536)
+||.||+|.+..+|+.+|+|++.... .....+.+.+|+..++.++|+||+++++.+......++++||+.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~-------~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~ 73 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEK-------IKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGD 73 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccc-------cccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCC
Confidence 68999999998889999999884211 11115678899999999999999999999999999999999999999
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhcccCCcccCCCC
Q 009364 158 ISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTP 237 (536)
Q Consensus 158 L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~ 237 (536)
|.+++.....++...++.++.+++.++.|||+.|++|+||+|.||+++.++.++|+|||.+....... ......|+.
T Consensus 74 L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~ 150 (244)
T smart00220 74 LFDLLKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTP 150 (244)
T ss_pred HHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCc
Confidence 99998876668999999999999999999999999999999999999999999999999988765422 234567899
Q ss_pred CCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCch-hh-HHHHHHHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCC
Q 009364 238 YWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQ-QY-QEVAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEP 315 (536)
Q Consensus 238 ~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~-~~-~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP 315 (536)
.|+|||.+.+..++.++||||||+++|+|++|..||.. .. ............ ........++.++.+++.+||..+|
T Consensus 151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p 229 (244)
T smart00220 151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKP-PFPPPEWKISPEAKDLIRKLLVKDP 229 (244)
T ss_pred CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCC-CCccccccCCHHHHHHHHHHccCCc
Confidence 99999999988899999999999999999999999965 22 222222221111 1111111288999999999999999
Q ss_pred CCCCCHHHHHhCCCC
Q 009364 316 DLRPTASELLKHPFV 330 (536)
Q Consensus 316 ~~Rps~~eiL~hp~~ 330 (536)
.+||++.++++||||
T Consensus 230 ~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 230 EKRLTAEEALQHPFF 244 (244)
T ss_pred hhccCHHHHhhCCCC
Confidence 999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=316.69 Aligned_cols=268 Identities=21% Similarity=0.267 Sum_probs=188.6
Q ss_pred CCCCceeeeEEcccCceEEEEEEEc----------------CCCcEEEEEEEeehhhccchhHH------HHHHHHHHHH
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNL----------------DSGELLAVKQVLIAANFASKEKA------QDHIKELEEE 121 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~----------------~~g~~vAiK~i~~~~~~~~~~~~------~~~~~~~~~E 121 (536)
..++|++.++||+|+||+||+|.+. ..++.||||.+............ ....+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 4568999999999999999999753 24567999987432111000000 0111223456
Q ss_pred HHHHHhCCCCce-----eeEeeeeec--------CCceeEEEEecCCCCcccccccC-----------------------
Q 009364 122 VKLLKDLSHPNI-----VRYLGTVRE--------EESLNILLEFVPGGSISSLLGKF----------------------- 165 (536)
Q Consensus 122 i~iL~~l~HpnI-----v~l~~~~~~--------~~~~~lV~E~~~gg~L~~~l~~~----------------------- 165 (536)
+.++.+++|.++ ++++++|.. .+..++||||+++++|.+++...
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777766554 667776643 35689999999999998887532
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhcccCCcccCCCCCCCChhh
Q 009364 166 -GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEV 244 (536)
Q Consensus 166 -~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEv 244 (536)
..+++..++.++.|++.||.|||+.+|+||||||+|||++.++.+||+|||+++........ ......+|+.|+|||+
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~aPE~ 381 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSPPEE 381 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeChhh
Confidence 12356678899999999999999999999999999999999999999999998754332111 1122335899999998
Q ss_pred hhhcC--------------------C--CccceEechhHHHHHHhhCCC-CCchhh---HH-------HHHHHhhCCCCC
Q 009364 245 IRQTG--------------------H--SYSADIWSVGCTVIEMATGKP-PWSQQY---QE-------VAALFHIGTTKS 291 (536)
Q Consensus 245 l~~~~--------------------~--s~k~DIwSlGvil~eLltG~~-Pf~~~~---~~-------~~~~~~~~~~~~ 291 (536)
+.... | ..+.||||+|||+|+|++|.. ||.... .+ ...+........
T Consensus 382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~ 461 (507)
T PLN03224 382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKY 461 (507)
T ss_pred hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCC
Confidence 75322 1 235799999999999999985 764311 00 011111111122
Q ss_pred CCCCCCcCcHHHHHHHHHhcccCC---CCCCCHHHHHhCCCCcC
Q 009364 292 HPPIPENLSVKAKDFLLKCLEKEP---DLRPTASELLKHPFVTG 332 (536)
Q Consensus 292 ~~~~~~~~s~~~~dLi~~cL~~dP---~~Rps~~eiL~hp~~~~ 332 (536)
........++.++||+.+||.++| .+|+|+.|+|+||||..
T Consensus 462 ~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 462 DFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred CcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 223345789999999999999876 68999999999999964
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=316.86 Aligned_cols=255 Identities=25% Similarity=0.409 Sum_probs=211.3
Q ss_pred CCceeeeEEcccCceEEEEEEEcCC-C--cEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDS-G--ELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE 142 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~-g--~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 142 (536)
.+.++.++||+|+||.|++|.|... | -.||||.+... ........|.+|+.+|.+|+|+|+++|||+..+
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d-------~l~~~mddflrEas~M~~L~H~hliRLyGvVl~ 182 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDD-------SLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD 182 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCC-------ccchhHHHHHHHHHHHHhccCcceeEEeeeecc
Confidence 3566788999999999999998753 3 46899988321 122366789999999999999999999999988
Q ss_pred CCceeEEEEecCCCCccccccc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchh
Q 009364 143 EESLNILLEFVPGGSISSLLGK--FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQ 220 (536)
Q Consensus 143 ~~~~~lV~E~~~gg~L~~~l~~--~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~ 220 (536)
....+|||++++|+|.+.|.+ ...|.......++.||+.|+.||.++++|||||-..|+|+.....|||+|||+.+.
T Consensus 183 -qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRa 261 (1039)
T KOG0199|consen 183 -QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRA 261 (1039)
T ss_pred -chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceec
Confidence 678899999999999999876 35688899999999999999999999999999999999999999999999999998
Q ss_pred hhhhhcccCCcc-cCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhHHHHHHHhhCCCCCCCCCCCc
Q 009364 221 VAELATVSGAKS-MKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQEVAALFHIGTTKSHPPIPEN 298 (536)
Q Consensus 221 ~~~~~~~~~~~~-~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (536)
++.....+.+.. ..-...|+|||.++...++.++|||++||.+|||+| |..||.+.... .+++........+-|+.
T Consensus 262 Lg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~--qIL~~iD~~erLpRPk~ 339 (1039)
T KOG0199|consen 262 LGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI--QILKNIDAGERLPRPKY 339 (1039)
T ss_pred cCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH--HHHHhccccccCCCCCC
Confidence 876544333222 223457999999999999999999999999999998 78999764321 22233335555667789
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHhCCCC
Q 009364 299 LSVKAKDFLLKCLEKEPDLRPTASELLKHPFV 330 (536)
Q Consensus 299 ~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~ 330 (536)
++.++.+++++||..+|..|||+..|.+.-+.
T Consensus 340 csedIY~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 340 CSEDIYQIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred ChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence 99999999999999999999999999755443
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=312.14 Aligned_cols=245 Identities=30% Similarity=0.525 Sum_probs=201.3
Q ss_pred eeeEEcccCceEEEEEEEcCC--Cc--EEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 70 KGELIGCGAFGRVYMGMNLDS--GE--LLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 70 ~~~~LG~G~fg~Vy~a~~~~~--g~--~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
..+.||.|.||.||.|....- |+ .||||.... .-..+..+.+..|..+|+.++|||||+++|+|.+. .
T Consensus 393 l~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~-------d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P 464 (974)
T KOG4257|consen 393 LKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKT-------DCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-P 464 (974)
T ss_pred HHHhhcCCcccceeeeEecccccCcceeeeeehhcc-------CCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-c
Confidence 466899999999999987532 33 477776521 12223456788999999999999999999999865 5
Q ss_pred eeEEEEecCCCCcccccccC-CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhh
Q 009364 146 LNILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAEL 224 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 224 (536)
.+||||.++-|.|..+++.+ ..++......++.||+.||+|||++++|||||-..|||+.....|||+|||+++.+...
T Consensus 465 ~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~ 544 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDD 544 (974)
T ss_pred eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence 89999999999999999765 46888889999999999999999999999999999999999999999999999988764
Q ss_pred hcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcHHH
Q 009364 225 ATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKA 303 (536)
Q Consensus 225 ~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 303 (536)
.... .....-..-|||||.++-..++.++|||.|||++||++. |..||.+-... ..+.......+.+.|+++++.+
T Consensus 545 ~yYk-aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs--DVI~~iEnGeRlP~P~nCPp~L 621 (974)
T KOG4257|consen 545 AYYK-ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS--DVIGHIENGERLPCPPNCPPAL 621 (974)
T ss_pred chhh-ccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc--ceEEEecCCCCCCCCCCCChHH
Confidence 3322 222223456999999998899999999999999999876 99999764322 1222334456778899999999
Q ss_pred HHHHHHhcccCCCCCCCHHHHH
Q 009364 304 KDFLLKCLEKEPDLRPTASELL 325 (536)
Q Consensus 304 ~dLi~~cL~~dP~~Rps~~eiL 325 (536)
..|+.+||..+|.+||.+.++.
T Consensus 622 YslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 622 YSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred HHHHHHHhccCcccCCcHHHHH
Confidence 9999999999999999998764
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=324.61 Aligned_cols=248 Identities=31% Similarity=0.538 Sum_probs=199.3
Q ss_pred eeeEEcccCceE-EEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeEeeeeecCCcee
Q 009364 70 KGELIGCGAFGR-VYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRYLGTVREEESLN 147 (536)
Q Consensus 70 ~~~~LG~G~fg~-Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~ 147 (536)
-.+++|.|+-|+ ||+|.. .|+.||||.+. .+....+.+||..|+.- .|||||++|+.-.+....|
T Consensus 513 ~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll-----------~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~Y 579 (903)
T KOG1027|consen 513 PKEILGYGSNGTVVFRGVY--EGREVAVKRLL-----------EEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLY 579 (903)
T ss_pred cHHHcccCCCCcEEEEEee--CCceehHHHHh-----------hHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEE
Confidence 346789999876 788865 78899999762 23445678999999988 5999999999999999999
Q ss_pred EEEEecCCCCcccccccCC-C---CCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCC---CC--cEEEEecCcc
Q 009364 148 ILLEFVPGGSISSLLGKFG-P---FPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDN---KG--CIKLADFGAS 218 (536)
Q Consensus 148 lV~E~~~gg~L~~~l~~~~-~---l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~---~~--~vkL~DFGla 218 (536)
|..|.| ..+|.+++...+ . ......+.++.|++.||++||+.+||||||||.||||+. ++ .++|+|||++
T Consensus 580 IalELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfgls 658 (903)
T KOG1027|consen 580 IALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLS 658 (903)
T ss_pred EEehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccc
Confidence 999999 589999997741 1 111345788999999999999999999999999999976 33 7999999999
Q ss_pred hhhhhhhc-ccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhC-CCCCchhhHHHHHHHhhCCCCCCCCCC
Q 009364 219 KQVAELAT-VSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATG-KPPWSQQYQEVAALFHIGTTKSHPPIP 296 (536)
Q Consensus 219 ~~~~~~~~-~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 296 (536)
+++..... .....+..||-+|+|||++.....+.++|||||||++|+.++| ..||.+......++......... +.
T Consensus 659 Kkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L~~--L~ 736 (903)
T KOG1027|consen 659 KKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTLVH--LE 736 (903)
T ss_pred cccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccceee--ec
Confidence 98875432 2334567899999999999998888999999999999999986 89998877665554432221111 11
Q ss_pred CcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 297 ENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 297 ~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
.....++++||.+|+.++|..||+|.++|.||+|-..
T Consensus 737 ~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ 773 (903)
T KOG1027|consen 737 PLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDS 773 (903)
T ss_pred cCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence 1222289999999999999999999999999999643
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=307.47 Aligned_cols=243 Identities=28% Similarity=0.462 Sum_probs=205.7
Q ss_pred eeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCceeEE
Q 009364 70 KGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESLNIL 149 (536)
Q Consensus 70 ~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 149 (536)
..++||-|.||.||.|.|+.-.-.||||.+. .....++++..|..+|+.++|||+|+++|+|..+..+|||
T Consensus 271 MkhKLGGGQYGeVYeGvWKkyslTvAVKtLK---------EDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIi 341 (1157)
T KOG4278|consen 271 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---------EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYII 341 (1157)
T ss_pred eeeccCCCcccceeeeeeeccceeeehhhhh---------hcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEE
Confidence 4568999999999999999988999999872 2224578899999999999999999999999999999999
Q ss_pred EEecCCCCcccccccCC--CCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhcc
Q 009364 150 LEFVPGGSISSLLGKFG--PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATV 227 (536)
Q Consensus 150 ~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 227 (536)
+|||..|+|.+++.+.. .++.-....++.||..|+.||..+++|||||-..|.|+.++..||++|||+++.+... +.
T Consensus 342 TEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgD-TY 420 (1157)
T KOG4278|consen 342 TEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGD-TY 420 (1157)
T ss_pred EecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCC-ce
Confidence 99999999999998654 3666677889999999999999999999999999999999999999999999987643 22
Q ss_pred cCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhh-HHHHHHHhhCCCCCCCCCCCcCcHHHHH
Q 009364 228 SGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQY-QEVAALFHIGTTKSHPPIPENLSVKAKD 305 (536)
Q Consensus 228 ~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~-~~~~~~~~~~~~~~~~~~~~~~s~~~~d 305 (536)
.......-..-|.|||-|.-..++.|+|||+|||+|||+.| |-.||.+.. ..+..++. ...+..-|.+|++.+.+
T Consensus 421 TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLE---kgyRM~~PeGCPpkVYe 497 (1157)
T KOG4278|consen 421 TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLE---KGYRMDGPEGCPPKVYE 497 (1157)
T ss_pred ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHh---ccccccCCCCCCHHHHH
Confidence 22222223567999999988889999999999999999998 778887643 33333433 33455667899999999
Q ss_pred HHHHhcccCCCCCCCHHHHH
Q 009364 306 FLLKCLEKEPDLRPTASELL 325 (536)
Q Consensus 306 Li~~cL~~dP~~Rps~~eiL 325 (536)
|++.||+++|..||+++++-
T Consensus 498 LMraCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 498 LMRACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred HHHHHhcCCcccCccHHHHH
Confidence 99999999999999999874
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=297.59 Aligned_cols=270 Identities=29% Similarity=0.455 Sum_probs=205.4
Q ss_pred cccccccCCCCCCCCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCC
Q 009364 50 RVLSKHISPSVKMSPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS 129 (536)
Q Consensus 50 ~~~~~~~~~~~~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~ 129 (536)
+....+...........||-+.++||-|.|++||+|.|..+.++||+|++. ..+...+....||++|++++
T Consensus 62 ~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvK---------SAqhYtEaAlDEIklL~~v~ 132 (590)
T KOG1290|consen 62 RKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVK---------SAQHYTEAALDEIKLLQQVR 132 (590)
T ss_pred hcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEe---------hhhHHHHHHHHHHHHHHHHH
Confidence 334445555566677789999999999999999999999999999999983 34456677889999999883
Q ss_pred -----C---CceeeEeeeeec----CCceeEEEEecCCCCccccccc--CCCCCHHHHHHHHHHHHHHHHHHHHc-CCcc
Q 009364 130 -----H---PNIVRYLGTVRE----EESLNILLEFVPGGSISSLLGK--FGPFPEAVMRTYTKQLLLGLEYLHNH-GIMH 194 (536)
Q Consensus 130 -----H---pnIv~l~~~~~~----~~~~~lV~E~~~gg~L~~~l~~--~~~l~~~~~~~i~~qil~aL~yLH~~-~ivH 194 (536)
| ..||+|++.|.. ..++|+|+|++ |.+|..+|.. .+.++...++.|++||+.||.|||.. ||||
T Consensus 133 ~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIH 211 (590)
T KOG1290|consen 133 EGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIH 211 (590)
T ss_pred hcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccc
Confidence 3 369999999964 45899999999 7888888864 46799999999999999999999975 9999
Q ss_pred ccCCCCCcccCCCC------------------------------------------------------------------
Q 009364 195 RDIKGANILVDNKG------------------------------------------------------------------ 208 (536)
Q Consensus 195 rDLKp~NILl~~~~------------------------------------------------------------------ 208 (536)
.||||+|||+..+.
T Consensus 212 TDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~ 291 (590)
T KOG1290|consen 212 TDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGL 291 (590)
T ss_pred cCCCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccc
Confidence 99999999983100
Q ss_pred --------------------------------------------------------------------------------
Q 009364 209 -------------------------------------------------------------------------------- 208 (536)
Q Consensus 209 -------------------------------------------------------------------------------- 208 (536)
T Consensus 292 ~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~ 371 (590)
T KOG1290|consen 292 EGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSP 371 (590)
T ss_pred ccccccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCc
Confidence
Q ss_pred --------------------cEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh
Q 009364 209 --------------------CIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT 268 (536)
Q Consensus 209 --------------------~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt 268 (536)
.|||+|||-|..+... .+.-+.|..|+||||+.+.+|++.+||||++|++|||+|
T Consensus 372 ~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~kh-----FT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaT 446 (590)
T KOG1290|consen 372 GTIASNPLVNPDIPLPECDIRVKIADLGNACWVHKH-----FTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELAT 446 (590)
T ss_pred cccccccccCCCCCCCccceeEEEeeccchhhhhhh-----hchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhc
Confidence 1344555544443321 223446888999999999999999999999999999999
Q ss_pred CCCCCchh--------hHHHHHHHhh----------------------------CCCCCCC---------CCCCcCcHHH
Q 009364 269 GKPPWSQQ--------YQEVAALFHI----------------------------GTTKSHP---------PIPENLSVKA 303 (536)
Q Consensus 269 G~~Pf~~~--------~~~~~~~~~~----------------------------~~~~~~~---------~~~~~~s~~~ 303 (536)
|...|... ...+..++.. ...+.++ .|+..-..++
T Consensus 447 GDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~f 526 (590)
T KOG1290|consen 447 GDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQF 526 (590)
T ss_pred CceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHH
Confidence 99998521 1111111110 0001110 1223345567
Q ss_pred HHHHHHhcccCCCCCCCHHHHHhCCCCcCCC
Q 009364 304 KDFLLKCLEKEPDLRPTASELLKHPFVTGDD 334 (536)
Q Consensus 304 ~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~ 334 (536)
.+|+.-||+.+|++||||.++|+|||+....
T Consensus 527 sdFL~PmLef~PeKR~tA~~cl~hPwLn~~~ 557 (590)
T KOG1290|consen 527 SDFLSPMLEFDPEKRPTAAQCLKHPWLNPVA 557 (590)
T ss_pred HHHHHHHHhcCccccccHHHHhcCccccCCC
Confidence 7999999999999999999999999997543
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=316.86 Aligned_cols=252 Identities=26% Similarity=0.486 Sum_probs=213.5
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCC---cEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeee
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSG---ELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVR 141 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g---~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~ 141 (536)
+....+.++||.|.||.||+|+.+..| ..||||.+.. .-.+.....|..|..||-+.+||||++|-|+..
T Consensus 628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~-------GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVT 700 (996)
T KOG0196|consen 628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKA-------GYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVT 700 (996)
T ss_pred hhheEEEEEEecccccceecccccCCCCcceeEEEeeecc-------CccHHHHhhhhhhhhhcccCCCCcEEEEEEEEe
Confidence 345678999999999999999988766 4799998832 223345678999999999999999999999999
Q ss_pred cCCceeEEEEecCCCCcccccccC-CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchh
Q 009364 142 EEESLNILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQ 220 (536)
Q Consensus 142 ~~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~ 220 (536)
......||+|||++|+|..+|+++ +.|+..++..+++.|+.|++||-+.|+|||||-..||||+.+-.+|++|||+++.
T Consensus 701 ks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRv 780 (996)
T KOG0196|consen 701 KSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 780 (996)
T ss_pred cCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceee
Confidence 999999999999999999999754 6799999999999999999999999999999999999999999999999999997
Q ss_pred hhhhhcccCCcccCC--CCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhh-HHHHHHHhhCCCCCCCCCC
Q 009364 221 VAELATVSGAKSMKG--TPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQY-QEVAALFHIGTTKSHPPIP 296 (536)
Q Consensus 221 ~~~~~~~~~~~~~~G--t~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~-~~~~~~~~~~~~~~~~~~~ 296 (536)
+.+.. ....++..| ...|.|||.+....++.++||||+|++|||.++ |..||.+.. +++...+..+ ...+-|
T Consensus 781 ledd~-~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~g---yRLPpP 856 (996)
T KOG0196|consen 781 LEDDP-EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQG---YRLPPP 856 (996)
T ss_pred cccCC-CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhc---cCCCCC
Confidence 76543 222333333 467999999999999999999999999999775 999986653 4555444433 344556
Q ss_pred CcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 297 ENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 297 ~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
.+++..+.+|+..||++|-.+||.+.||+.+
T Consensus 857 mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 857 MDCPAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 6999999999999999999999999999875
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=286.04 Aligned_cols=258 Identities=26% Similarity=0.448 Sum_probs=203.4
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCC--
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEE-- 144 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~-- 144 (536)
+.+-.+.||.|+||.||.+.|..+|+.||+|++.- -...-...+.+.+|+++|...+|.|++..+++..-..
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pn------vfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~d 127 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPN------VFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPS 127 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcch------HHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCch
Confidence 44556789999999999999999999999998721 1122234678899999999999999999988776432
Q ss_pred ---ceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhh
Q 009364 145 ---SLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQV 221 (536)
Q Consensus 145 ---~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~ 221 (536)
.+|+++|.+ ..+|...|-....++...++-+++||++||+|||+.||.||||||.|.|++.+..+||||||+++.-
T Consensus 128 fFqEiYV~TELm-QSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARve 206 (449)
T KOG0664|consen 128 FFQELYVLTELM-QSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTW 206 (449)
T ss_pred HHHHHHHHHHHH-HhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEeccccccccc
Confidence 578899988 6789999988889999999999999999999999999999999999999999999999999999865
Q ss_pred hhhhcccCCcccCCCCCCCChhhhhhc-CCCccceEechhHHHHHHhhCCCCCchhh--HHHHHHHhh------------
Q 009364 222 AELATVSGAKSMKGTPYWMAPEVIRQT-GHSYSADIWSVGCTVIEMATGKPPWSQQY--QEVAALFHI------------ 286 (536)
Q Consensus 222 ~~~~~~~~~~~~~Gt~~Y~APEvl~~~-~~s~k~DIwSlGvil~eLltG~~Pf~~~~--~~~~~~~~~------------ 286 (536)
...... .++.-+-|.+|+|||++.|. .|+.++||||.|||+.||+.++..|..+. +....+...
T Consensus 207 e~d~~~-hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~A 285 (449)
T KOG0664|consen 207 DQRDRL-NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYA 285 (449)
T ss_pred chhhhh-hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHH
Confidence 443322 23344568999999999875 68999999999999999999999886432 111111000
Q ss_pred ---------CCCCCCCCC--------CCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcC
Q 009364 287 ---------GTTKSHPPI--------PENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTG 332 (536)
Q Consensus 287 ---------~~~~~~~~~--------~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~ 332 (536)
......+.. +..-..+..+++.++|..||.+|.+.++++.|++...
T Consensus 286 CEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e 348 (449)
T KOG0664|consen 286 CEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEE 348 (449)
T ss_pred hhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccc
Confidence 000111111 1233456778999999999999999999999999753
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=313.25 Aligned_cols=261 Identities=38% Similarity=0.648 Sum_probs=222.6
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE 142 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 142 (536)
.+..+|++.+.+|.|+||.||+|+++.+++..|+|++...+. .....++.|+-+++.++|||||.+++.|..
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~--------dd~~~iqqei~~~~dc~h~nivay~gsylr 83 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG--------DDFSGIQQEIGMLRDCRHPNIVAYFGSYLR 83 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCC--------ccccccccceeeeecCCCcChHHHHhhhhh
Confidence 677899999999999999999999999999999999954332 334567789999999999999999999999
Q ss_pred CCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhh
Q 009364 143 EESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVA 222 (536)
Q Consensus 143 ~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~ 222 (536)
...+++.||||.||+|.+.-.-.+++++.++..+.+..++|++|||+.|-+|||||-.|||+++.|.+|++|||.+..+.
T Consensus 84 ~dklwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqit 163 (829)
T KOG0576|consen 84 RDKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQIT 163 (829)
T ss_pred hcCcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhh
Confidence 99999999999999999998888999999999999999999999999999999999999999999999999999987765
Q ss_pred hhhcccCCcccCCCCCCCChhhh---hhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCC--CCCCCCCCC
Q 009364 223 ELATVSGAKSMKGTPYWMAPEVI---RQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGT--TKSHPPIPE 297 (536)
Q Consensus 223 ~~~~~~~~~~~~Gt~~Y~APEvl---~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~--~~~~~~~~~ 297 (536)
. +....+.+.|||+|||||+- +.++|+..||||++|+...|+---.+|-.+-.......+.... ......-+.
T Consensus 164 a--ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~ 241 (829)
T KOG0576|consen 164 A--TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKT 241 (829)
T ss_pred h--hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCc
Confidence 3 44456789999999999985 4678999999999999999998888885443322222221111 111222334
Q ss_pred cCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 298 NLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 298 ~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
..++.+-+|++.+|.++|++||+++.+|.|||+...
T Consensus 242 kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 678899999999999999999999999999999765
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=277.43 Aligned_cols=255 Identities=27% Similarity=0.479 Sum_probs=203.5
Q ss_pred CCCCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCC-CCceeeEeee
Q 009364 61 KMSPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS-HPNIVRYLGT 139 (536)
Q Consensus 61 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~ 139 (536)
......+|++.+.+|+|.|+.||.|.+..+++.++||++. + -..+.+.+|+++|..|. ||||++++++
T Consensus 33 ~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLK--------P---VkkkKIkREikIL~nL~gg~NIi~L~Di 101 (338)
T KOG0668|consen 33 DWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILK--------P---VKKKKIKREIKILQNLRGGPNIIKLLDI 101 (338)
T ss_pred eccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeec--------h---HHHHHHHHHHHHHHhccCCCCeeehhhh
Confidence 3345678999999999999999999999999999999882 1 12356789999999996 9999999999
Q ss_pred eecCC--ceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCC-cEEEEecC
Q 009364 140 VREEE--SLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKG-CIKLADFG 216 (536)
Q Consensus 140 ~~~~~--~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~-~vkL~DFG 216 (536)
..+.. ...+|+||+.+.+...+- ..++...++.++.|++.||.|||+.||+|||+||.|++|+... .++|+|+|
T Consensus 102 V~Dp~SktpaLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWG 178 (338)
T KOG0668|consen 102 VKDPESKTPSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWG 178 (338)
T ss_pred hcCccccCchhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecc
Confidence 98654 578999999887766553 4578889999999999999999999999999999999998754 79999999
Q ss_pred cchhhhhhhcccCCcccCCCCCCCChhhhhh-cCCCccceEechhHHHHHHhhCCCCCchh---hHHH---HHH------
Q 009364 217 ASKQVAELATVSGAKSMKGTPYWMAPEVIRQ-TGHSYSADIWSVGCTVIEMATGKPPWSQQ---YQEV---AAL------ 283 (536)
Q Consensus 217 la~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~-~~~s~k~DIwSlGvil~eLltG~~Pf~~~---~~~~---~~~------ 283 (536)
+|....+... ....+.+.+|.-||.+-. ..|+.+-|+|||||+|..|+..+.||-.. .... ...
T Consensus 179 LAEFYHp~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el 255 (338)
T KOG0668|consen 179 LAEFYHPGKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDEL 255 (338)
T ss_pred hHhhcCCCce---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHH
Confidence 9998766433 334567889999998864 46899999999999999999999998421 1111 111
Q ss_pred ---HhhCCC------------CCCCCC--------CCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcC
Q 009364 284 ---FHIGTT------------KSHPPI--------PENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTG 332 (536)
Q Consensus 284 ---~~~~~~------------~~~~~~--------~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~ 332 (536)
...... ....+| ..-+++++.||+.++|..|-.+|+||.|++.||||..
T Consensus 256 ~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 256 YAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP 327 (338)
T ss_pred HHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence 100000 000011 1135799999999999999999999999999999964
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=288.76 Aligned_cols=256 Identities=26% Similarity=0.402 Sum_probs=203.6
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE 142 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 142 (536)
..+.||.-.+.+|.|+- .|..|.|...+++||+|.+... .......++..+|..++..+.|+||++++.+|.-
T Consensus 14 tv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p------f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP 86 (369)
T KOG0665|consen 14 TVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP------FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTP 86 (369)
T ss_pred eeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc------cccCccchhhhhhhhhhhhhcccceeeeeeccCc
Confidence 44568999999999999 8889999999999999987432 1123445677899999999999999999999864
Q ss_pred C------CceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecC
Q 009364 143 E------ESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFG 216 (536)
Q Consensus 143 ~------~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFG 216 (536)
. ...|+|||++ ..+|...+. -.+.-..+..++.|++.|++|||+.||+||||||+||++..++.+||.|||
T Consensus 87 ~~~l~~~~e~y~v~e~m-~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg 163 (369)
T KOG0665|consen 87 QKTLEEFQEVYLVMELM-DANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFG 163 (369)
T ss_pred cccHHHHHhHHHHHHhh-hhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccch
Confidence 3 3589999999 567777765 346778899999999999999999999999999999999999999999999
Q ss_pred cchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH-----------------
Q 009364 217 ASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE----------------- 279 (536)
Q Consensus 217 la~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~----------------- 279 (536)
+|+.-... -..+.++.|..|+|||++.+.+|.+.+||||+|||+.||++|...|.+...-
T Consensus 164 ~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F 240 (369)
T KOG0665|consen 164 LARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSF 240 (369)
T ss_pred hhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHH
Confidence 99864432 2456788999999999999999999999999999999999999888542210
Q ss_pred ------HHHHHhhCC-----CCCCC-----CC------CCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCc
Q 009364 280 ------VAALFHIGT-----TKSHP-----PI------PENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVT 331 (536)
Q Consensus 280 ------~~~~~~~~~-----~~~~~-----~~------~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~ 331 (536)
....+.... ..... .+ ++.-+..+++|+.+||..||++|.++.++|+|||+.
T Consensus 241 ~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 241 MKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 000000000 00000 01 112345688999999999999999999999999996
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=304.70 Aligned_cols=257 Identities=29% Similarity=0.465 Sum_probs=204.8
Q ss_pred CCCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCC------CCceee
Q 009364 62 MSPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS------HPNIVR 135 (536)
Q Consensus 62 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~------HpnIv~ 135 (536)
.-...+|.+....|+|-||+|.+|.+...|..||||+|. ..+-..+.=..|+++|++|+ --|+++
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIR---------nNE~M~KtGl~EleiLkKL~~AD~Edk~Hclr 498 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIR---------NNEVMHKTGLKELEILKKLNDADPEDKFHCLR 498 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEee---------cchHHhhhhhHHHHHHHHhhccCchhhhHHHH
Confidence 344568999999999999999999999999999999983 22223344568999999995 258999
Q ss_pred EeeeeecCCceeEEEEecCCCCcccccccCC---CCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCC-cEE
Q 009364 136 YLGTVREEESLNILLEFVPGGSISSLLGKFG---PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKG-CIK 211 (536)
Q Consensus 136 l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~---~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~-~vk 211 (536)
++-.|...+++|||+|-+ ..+|.+++++.+ .+....++.++.|++.||..|...||+|.||||.||||++.. .+|
T Consensus 499 l~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLK 577 (752)
T KOG0670|consen 499 LFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILK 577 (752)
T ss_pred HHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceee
Confidence 999999999999999988 688999998765 478889999999999999999999999999999999998754 789
Q ss_pred EEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH-HHHHHhhCCCC
Q 009364 212 LADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE-VAALFHIGTTK 290 (536)
Q Consensus 212 L~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~ 290 (536)
|||||.|....+.. .+.+.-+..|+|||++.|.+|++..|+||+||+||||.||+..|.+.... +..++......
T Consensus 578 LCDfGSA~~~~ene----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk 653 (752)
T KOG0670|consen 578 LCDFGSASFASENE----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGK 653 (752)
T ss_pred eccCcccccccccc----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCC
Confidence 99999998765432 23334566799999999999999999999999999999999998754322 11111100000
Q ss_pred C-----------------------------------------CC------------CCC---CcCcHHHHHHHHHhcccC
Q 009364 291 S-----------------------------------------HP------------PIP---ENLSVKAKDFLLKCLEKE 314 (536)
Q Consensus 291 ~-----------------------------------------~~------------~~~---~~~s~~~~dLi~~cL~~d 314 (536)
. .| .++ ..+-.++++|+.+||..|
T Consensus 654 ~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~Ld 733 (752)
T KOG0670|consen 654 FPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILD 733 (752)
T ss_pred CcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccC
Confidence 0 00 000 112346779999999999
Q ss_pred CCCCCCHHHHHhCCCCcC
Q 009364 315 PDLRPTASELLKHPFVTG 332 (536)
Q Consensus 315 P~~Rps~~eiL~hp~~~~ 332 (536)
|++|.|..|+|+||||+.
T Consensus 734 P~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 734 PEKRITVNQALKHPFITE 751 (752)
T ss_pred hhhcCCHHHHhcCCcccC
Confidence 999999999999999974
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=339.96 Aligned_cols=239 Identities=22% Similarity=0.387 Sum_probs=187.7
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCce
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESL 146 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 146 (536)
.|...+.||+|+||.||+|.+..+|..||+|.+.... .....|++++++++|||||++++++.+....
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~------------~~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~ 758 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVN------------SIPSSEIADMGKLQHPNIVKLIGLCRSEKGA 758 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCc------------cccHHHHHHHhhCCCCCcceEEEEEEcCCCC
Confidence 3556678999999999999999999999999873110 0112457889999999999999999999999
Q ss_pred eEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCCccccCCCCCcccCCCCcEEEEecCcchhhhh
Q 009364 147 NILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLH---NHGIMHRDIKGANILVDNKGCIKLADFGASKQVAE 223 (536)
Q Consensus 147 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH---~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 223 (536)
++||||+++|+|.+++.. +++..+..++.|++.||+||| +.+|+||||||+||+++.++..++. ||.......
T Consensus 759 ~lv~Ey~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~ 834 (968)
T PLN00113 759 YLIHEYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT 834 (968)
T ss_pred EEEEeCCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc
Confidence 999999999999999853 789999999999999999999 6699999999999999998888776 665433211
Q ss_pred hhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhh---HHHHHHHhhCC----------C-
Q 009364 224 LATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQY---QEVAALFHIGT----------T- 289 (536)
Q Consensus 224 ~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~---~~~~~~~~~~~----------~- 289 (536)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||.... ........... .
T Consensus 835 ------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (968)
T PLN00113 835 ------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPS 908 (968)
T ss_pred ------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCcc
Confidence 223468999999999999899999999999999999999999985321 11111110000 0
Q ss_pred -CCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 290 -KSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 290 -~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
......+.....++.+++.+||+.||++|||+.|+++.
T Consensus 909 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 909 IRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred ccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 00011112233467789999999999999999999875
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=307.83 Aligned_cols=249 Identities=29% Similarity=0.496 Sum_probs=204.3
Q ss_pred CceeeeEEcccCceEEEEEEEcC-------CCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeEee
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLD-------SGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRYLG 138 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~-------~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~ 138 (536)
+..+.+.||+|.||+|++|.-.. ....||||.+.. .......+.+..|+++|+.+ .|+||+.++|
T Consensus 297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~-------~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKE-------NASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred hccccceeecccccceEeEEEeecccccccceEEEEEEeccc-------ccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 34677799999999999996431 145789998732 22224567889999999999 5999999999
Q ss_pred eeecCCceeEEEEecCCCCcccccccCC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCc
Q 009364 139 TVREEESLNILLEFVPGGSISSLLGKFG----------------PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANI 202 (536)
Q Consensus 139 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~----------------~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NI 202 (536)
++...+.+++|+||+..|+|..++...+ .++......++.||+.|++||++.++|||||-..||
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNV 449 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNV 449 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhE
Confidence 9999999999999999999999987655 388899999999999999999999999999999999
Q ss_pred ccCCCCcEEEEecCcchhhhhhhcccCCcccCC--CCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchh--h
Q 009364 203 LVDNKGCIKLADFGASKQVAELATVSGAKSMKG--TPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQ--Y 277 (536)
Q Consensus 203 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~G--t~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~--~ 277 (536)
|+..+..+||+|||+|+......... .+...| ...|||||.+....|+.++||||+||+|||++| |..||.+. .
T Consensus 450 Li~~~~~~kIaDFGlar~~~~~~~y~-~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~ 528 (609)
T KOG0200|consen 450 LITKNKVIKIADFGLARDHYNKDYYR-TKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT 528 (609)
T ss_pred EecCCCEEEEccccceeccCCCCceE-ecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence 99999999999999998654432221 122222 344999999999999999999999999999998 88999762 3
Q ss_pred HHHHHHHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHh
Q 009364 278 QEVAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~ 326 (536)
.++...+ ........|..++.++.++++.||+.+|++||++.++.+
T Consensus 529 ~~l~~~l---~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 529 EELLEFL---KEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHHHHHH---hcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 3333323 333455667789999999999999999999999999976
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=298.72 Aligned_cols=248 Identities=29% Similarity=0.489 Sum_probs=208.7
Q ss_pred ceeeeEEcccCceEEEEEEEcCCCc----EEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC
Q 009364 68 WRKGELIGCGAFGRVYMGMNLDSGE----LLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE 143 (536)
Q Consensus 68 y~~~~~LG~G~fg~Vy~a~~~~~g~----~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 143 (536)
.+..++||+|+||+||+|.+...|+ +||+|++.. ....+...++.+|+-+|.+++|||++++++++...
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~-------~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s 770 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIE-------FTSPKASIELLDEALRMASLDHPNLLRLLGVCMLS 770 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeec-------cCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccc
Confidence 4557799999999999999987665 577777632 22223346678899999999999999999999877
Q ss_pred CceeEEEEecCCCCcccccccC-CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhh
Q 009364 144 ESLNILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVA 222 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~ 222 (536)
. +-||++|+++|.|.++++.+ ..+..+....|..||++||.|||.++++||||-..||||..-..+||+|||+++...
T Consensus 771 ~-~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~ 849 (1177)
T KOG1025|consen 771 T-LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLA 849 (1177)
T ss_pred h-HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence 6 88999999999999998754 578899999999999999999999999999999999999999999999999999887
Q ss_pred hhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchh-hHHHHHHHhhCCCCCCCCCCCcCc
Q 009364 223 ELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQ-YQEVAALFHIGTTKSHPPIPENLS 300 (536)
Q Consensus 223 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~-~~~~~~~~~~~~~~~~~~~~~~~s 300 (536)
............-.+-|||=|.+....|+.++|||||||.+||++| |..|+.+. ..++..++..+.. .+.|+.++
T Consensus 850 ~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR---LsqPpiCt 926 (1177)
T KOG1025|consen 850 PDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER---LSQPPICT 926 (1177)
T ss_pred cccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc---CCCCCCcc
Confidence 7655444444444567999999999999999999999999999998 88888654 3455556555433 45667899
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHh
Q 009364 301 VKAKDFLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 301 ~~~~dLi~~cL~~dP~~Rps~~eiL~ 326 (536)
-++.-++.+||..|+..||+++++..
T Consensus 927 iDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 927 IDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHHHHHHHHHhccCcccCccHHHHHH
Confidence 99999999999999999999998764
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=294.14 Aligned_cols=206 Identities=23% Similarity=0.419 Sum_probs=178.2
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCC---CCceeeEeeeeec
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS---HPNIVRYLGTVRE 142 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~---HpnIv~l~~~~~~ 142 (536)
..|...+.+|.|+||.|++|.++.+...|+||.|.+.+.....-......-.+-.||+||..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 4699999999999999999999999999999988533322111111111223568999999997 9999999999999
Q ss_pred CCceeEEEEec-CCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhh
Q 009364 143 EESLNILLEFV-PGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQV 221 (536)
Q Consensus 143 ~~~~~lV~E~~-~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~ 221 (536)
++.+||+||-. +|-+|+++|..+..++|.++..|++|++.|+++||+.||||||||-+||.++.+|.+||+|||.|...
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~~ 720 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYT 720 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhhh
Confidence 99999999976 45689999999999999999999999999999999999999999999999999999999999998766
Q ss_pred hhhhcccCCcccCCCCCCCChhhhhhcCC-CccceEechhHHHHHHhhCCCCCch
Q 009364 222 AELATVSGAKSMKGTPYWMAPEVIRQTGH-SYSADIWSVGCTVIEMATGKPPWSQ 275 (536)
Q Consensus 222 ~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~-s~k~DIwSlGvil~eLltG~~Pf~~ 275 (536)
.. .....++||..|.|||++.|..| +..-|||++|++||.++....||+.
T Consensus 721 ks----gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 721 KS----GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred cC----CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 54 23678899999999999999888 6778999999999999999999853
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=281.59 Aligned_cols=255 Identities=28% Similarity=0.463 Sum_probs=199.5
Q ss_pred CCceeeeEEcccCceEEEEEEEcC---CCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeEeeeee
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLD---SGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRYLGTVR 141 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~---~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~ 141 (536)
..|+++++||.|+|++||+|.+.. ..+.||+|.+.... ....+.+|+++|..+ .+.||+++.+.+.
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts----------~p~ri~~El~~L~~~gG~~ni~~~~~~~r 105 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS----------SPSRILNELEMLYRLGGSDNIIKLNGCFR 105 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc----------CchHHHHHHHHHHHhccchhhhcchhhhc
Confidence 468999999999999999999887 78999999884322 224578999999999 5999999999999
Q ss_pred cCCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCC-CCcEEEEecCcchh
Q 009364 142 EEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDN-KGCIKLADFGASKQ 220 (536)
Q Consensus 142 ~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~-~~~vkL~DFGla~~ 220 (536)
..+...+|+||+++....++... ++...++.+++.++.||+++|.+|||||||||.|+|.+. .+.-.|+|||+|..
T Consensus 106 nnd~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~ 182 (418)
T KOG1167|consen 106 NNDQVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQR 182 (418)
T ss_pred cCCeeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHH
Confidence 99999999999999888887654 678999999999999999999999999999999999975 46889999999973
Q ss_pred hhhhh-------------cc-----------------------------cCCcccCCCCCCCChhhhhhc-CCCccceEe
Q 009364 221 VAELA-------------TV-----------------------------SGAKSMKGTPYWMAPEVIRQT-GHSYSADIW 257 (536)
Q Consensus 221 ~~~~~-------------~~-----------------------------~~~~~~~Gt~~Y~APEvl~~~-~~s~k~DIw 257 (536)
..... .. .......||++|+|||++... ..++++|||
T Consensus 183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiw 262 (418)
T KOG1167|consen 183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIW 262 (418)
T ss_pred HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcccee
Confidence 22110 00 001134599999999998764 458899999
Q ss_pred chhHHHHHHhhCCCCCchhhHHH------HHHHh----------hCC---------------------C-----------
Q 009364 258 SVGCTVIEMATGKPPWSQQYQEV------AALFH----------IGT---------------------T----------- 289 (536)
Q Consensus 258 SlGvil~eLltG~~Pf~~~~~~~------~~~~~----------~~~---------------------~----------- 289 (536)
|.|||+..++++..||-....+. ..++. .+. .
T Consensus 263 s~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~ 342 (418)
T KOG1167|consen 263 SAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQP 342 (418)
T ss_pred eccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccc
Confidence 99999999999999984221110 00000 000 0
Q ss_pred -CCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 290 -KSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 290 -~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
.....+....+..+.+|+.+||..||.+|.|++++|+||||...
T Consensus 343 n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~ 387 (418)
T KOG1167|consen 343 NTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEA 387 (418)
T ss_pred ceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcch
Confidence 00001122345688899999999999999999999999999743
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.1e-33 Score=281.10 Aligned_cols=242 Identities=26% Similarity=0.395 Sum_probs=188.1
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHh--CCCCceeeEeeeeecCC
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKD--LSHPNIVRYLGTVREEE 144 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~--l~HpnIv~l~~~~~~~~ 144 (536)
...+.++||+|.||.||+|.. +++.||||++.. +....+.+|-+|.+. ++|+||+++++.-....
T Consensus 211 pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~-----------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t 277 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPE-----------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGT 277 (534)
T ss_pred chhhHHHhhcCccceeehhhc--cCceeEEEecCH-----------HHHHHHHhHHHHHhccCccchhHHHhhchhccCC
Confidence 456788999999999999975 569999999831 223455666666654 57999999998765444
Q ss_pred ----ceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---------CCccccCCCCCcccCCCCcEE
Q 009364 145 ----SLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNH---------GIMHRDIKGANILVDNKGCIK 211 (536)
Q Consensus 145 ----~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~---------~ivHrDLKp~NILl~~~~~vk 211 (536)
.++||++|.+.|+|.+++.. ..+++....+++..+++||+|||+. .|+|||||..||||.+|++..
T Consensus 278 ~~~~eywLVt~fh~kGsL~dyL~~-ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTcc 356 (534)
T KOG3653|consen 278 ADRMEYWLVTEFHPKGSLCDYLKA-NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCC 356 (534)
T ss_pred ccccceeEEeeeccCCcHHHHHHh-ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEE
Confidence 89999999999999999987 5689999999999999999999963 499999999999999999999
Q ss_pred EEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCC------ccceEechhHHHHHHhhCC------------CCC
Q 009364 212 LADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHS------YSADIWSVGCTVIEMATGK------------PPW 273 (536)
Q Consensus 212 L~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s------~k~DIwSlGvil~eLltG~------------~Pf 273 (536)
|+|||+|..+...........-+||.+|||||+|.+...- .+.||||+|.|||||+++- +||
T Consensus 357 IaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpf 436 (534)
T KOG3653|consen 357 IADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPF 436 (534)
T ss_pred eeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCch
Confidence 9999999988765554455567899999999999865321 2579999999999999853 234
Q ss_pred ch------hhHHHHHHHhhCCCCCCCCCCC-----cCcHHHHHHHHHhcccCCCCCCCHHHH
Q 009364 274 SQ------QYQEVAALFHIGTTKSHPPIPE-----NLSVKAKDFLLKCLEKEPDLRPTASEL 324 (536)
Q Consensus 274 ~~------~~~~~~~~~~~~~~~~~~~~~~-----~~s~~~~dLi~~cL~~dP~~Rps~~ei 324 (536)
.. ..+++...... .+.+|.++. ....-+++.+..||..||+.|.|+.=+
T Consensus 437 e~evG~hPt~e~mq~~VV~--kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv 496 (534)
T KOG3653|consen 437 EAEVGNHPTLEEMQELVVR--KKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV 496 (534)
T ss_pred hHHhcCCCCHHHHHHHHHh--hccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence 31 11233332222 222333332 233457899999999999999998644
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=248.78 Aligned_cols=212 Identities=41% Similarity=0.698 Sum_probs=185.9
Q ss_pred EcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCceeEEEEec
Q 009364 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESLNILLEFV 153 (536)
Q Consensus 74 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 153 (536)
||+|++|.||++.+..+|+.+++|++.... .......+.+|+..++.++|++|+++++++......++++||+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~-------~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~ 73 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKED-------SSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYC 73 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEecccc-------chhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecC
Confidence 689999999999998889999999884211 1113466889999999999999999999999999999999999
Q ss_pred CCCCcccccccC-CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCC-CCcEEEEecCcchhhhhhhcccCCc
Q 009364 154 PGGSISSLLGKF-GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDN-KGCIKLADFGASKQVAELATVSGAK 231 (536)
Q Consensus 154 ~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~-~~~vkL~DFGla~~~~~~~~~~~~~ 231 (536)
.|++|.+++... ..++...++.++.+++.++++||+.|++|+||+|.||+++. ++.++|+|||.+........ ...
T Consensus 74 ~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~ 151 (215)
T cd00180 74 EGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLK 151 (215)
T ss_pred CCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhh
Confidence 999999998765 57899999999999999999999999999999999999999 89999999999876543211 123
Q ss_pred ccCCCCCCCChhhhhhc-CCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcHHHHHHHHHh
Q 009364 232 SMKGTPYWMAPEVIRQT-GHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKDFLLKC 310 (536)
Q Consensus 232 ~~~Gt~~Y~APEvl~~~-~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~c 310 (536)
...+...|++||.+... .++.+.|+|++|+++++| ..+.+++.+|
T Consensus 152 ~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------~~~~~~l~~~ 197 (215)
T cd00180 152 TIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------PELKDLIRKM 197 (215)
T ss_pred cccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------HHHHHHHHHH
Confidence 45678899999999887 788999999999999999 6788999999
Q ss_pred cccCCCCCCCHHHHHhCC
Q 009364 311 LEKEPDLRPTASELLKHP 328 (536)
Q Consensus 311 L~~dP~~Rps~~eiL~hp 328 (536)
|..+|.+||++.++++|+
T Consensus 198 l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 198 LQKDPEKRPSAKEILEHL 215 (215)
T ss_pred hhCCcccCcCHHHHhhCC
Confidence 999999999999999885
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-32 Score=248.79 Aligned_cols=202 Identities=31% Similarity=0.491 Sum_probs=166.8
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeEeeeeecCC
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRYLGTVREEE 144 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~ 144 (536)
+....+..||+|+||.|-+-++..+|...|+|.+....+ .+..+++.+|+.+..+. .+|.+|.+||.+..+.
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn-------~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg 118 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN-------SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG 118 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC-------hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc
Confidence 445567789999999999999999999999998843221 23445667788776554 7999999999999999
Q ss_pred ceeEEEEecCCCCccc----ccccCCCCCHHHHHHHHHHHHHHHHHHHHc-CCccccCCCCCcccCCCCcEEEEecCcch
Q 009364 145 SLNILLEFVPGGSISS----LLGKFGPFPEAVMRTYTKQLLLGLEYLHNH-GIMHRDIKGANILVDNKGCIKLADFGASK 219 (536)
Q Consensus 145 ~~~lV~E~~~gg~L~~----~l~~~~~l~~~~~~~i~~qil~aL~yLH~~-~ivHrDLKp~NILl~~~~~vkL~DFGla~ 219 (536)
..++.||.|. .+|.. .+.+.+.++|..+-+|+..++.||.|||++ .++|||+||+|||++.+|+||+||||.+-
T Consensus 119 dvwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 119 DVWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred cEEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccce
Confidence 9999999984 55543 356667899999999999999999999987 89999999999999999999999999987
Q ss_pred hhhhhhcccCCcccCCCCCCCChhhhh----hcCCCccceEechhHHHHHHhhCCCCCchhhH
Q 009364 220 QVAELATVSGAKSMKGTPYWMAPEVIR----QTGHSYSADIWSVGCTVIEMATGKPPWSQQYQ 278 (536)
Q Consensus 220 ~~~~~~~~~~~~~~~Gt~~Y~APEvl~----~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~ 278 (536)
.+.+... .+-..|--.|||||.+. ..+|+-++||||||+.++||.+++.||.....
T Consensus 198 ~L~dSiA---kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t 257 (282)
T KOG0984|consen 198 YLVDSIA---KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT 257 (282)
T ss_pred eehhhhH---HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence 6543211 12245788899999875 44789999999999999999999999875543
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=268.02 Aligned_cols=249 Identities=27% Similarity=0.402 Sum_probs=190.2
Q ss_pred CCCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHh--CCCCceeeEeee
Q 009364 62 MSPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKD--LSHPNIVRYLGT 139 (536)
Q Consensus 62 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~--l~HpnIv~l~~~ 139 (536)
.....+..+.+.||+|.||.||+|.+ .|+.||||++. .. ....+.+|.+|.+. |+|+||+.+++.
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~------sr-----dE~SWfrEtEIYqTvmLRHENILgFIaa 273 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFS------SR-----DERSWFRETEIYQTVMLRHENILGFIAA 273 (513)
T ss_pred HhhhheeEEEEEecCccccceeeccc--cCCceEEEEec------cc-----chhhhhhHHHHHHHHHhccchhhhhhhc
Confidence 34445678999999999999999987 68999999983 11 12346677777775 489999999876
Q ss_pred eecC----CceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHc--------CCccccCCCCCcccCCC
Q 009364 140 VREE----ESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNH--------GIMHRDIKGANILVDNK 207 (536)
Q Consensus 140 ~~~~----~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~--------~ivHrDLKp~NILl~~~ 207 (536)
=..+ .+++||++|.+.|+|+|+|.+ ..++-+...+++..++.||++||.. .|.|||||..||||..+
T Consensus 274 D~~~~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn 352 (513)
T KOG2052|consen 274 DNKDNGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN 352 (513)
T ss_pred cccCCCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccC
Confidence 4432 368999999999999999988 7889999999999999999999953 49999999999999999
Q ss_pred CcEEEEecCcchhhhhhhc--ccCCcccCCCCCCCChhhhhhcCC-----C-ccceEechhHHHHHHhhC----------
Q 009364 208 GCIKLADFGASKQVAELAT--VSGAKSMKGTPYWMAPEVIRQTGH-----S-YSADIWSVGCTVIEMATG---------- 269 (536)
Q Consensus 208 ~~vkL~DFGla~~~~~~~~--~~~~~~~~Gt~~Y~APEvl~~~~~-----s-~k~DIwSlGvil~eLltG---------- 269 (536)
|.+.|+|+|+|........ .......+||-.|||||+|...-. + ..+||||||.|+||+..+
T Consensus 353 ~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey 432 (513)
T KOG2052|consen 353 GTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEY 432 (513)
T ss_pred CcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhh
Confidence 9999999999977654321 122456789999999999975422 2 248999999999999863
Q ss_pred CCCCchh------hHHHHHHHhhCCCCCCCCCCCcC-----cHHHHHHHHHhcccCCCCCCCHHHHHh
Q 009364 270 KPPWSQQ------YQEVAALFHIGTTKSHPPIPENL-----SVKAKDFLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 270 ~~Pf~~~------~~~~~~~~~~~~~~~~~~~~~~~-----s~~~~dLi~~cL~~dP~~Rps~~eiL~ 326 (536)
.+||.+. .+++....-.. +..|.+|... -..+..|++.||..||.-|.|+--|.+
T Consensus 433 ~~Pyyd~Vp~DPs~eeMrkVVCv~--~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 433 QLPYYDVVPSDPSFEEMRKVVCVQ--KLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred cCCcccCCCCCCCHHHHhcceeec--ccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 3677532 23333333222 2333333322 124557899999999999999877754
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=252.33 Aligned_cols=254 Identities=24% Similarity=0.343 Sum_probs=197.3
Q ss_pred CCCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeEeee-
Q 009364 62 MSPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRYLGT- 139 (536)
Q Consensus 62 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~- 139 (536)
+...+.|.+.+.||+|.||.+-+|.++.++..+++|.+. ......+++.+|...--.| .|.||+.-|++
T Consensus 20 v~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp---------~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~va 90 (378)
T KOG1345|consen 20 VDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVP---------RPQTTQADFVREFHYSFFLSPHQHIIDTYEVA 90 (378)
T ss_pred cchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccC---------cchhhHHHHHHHhccceeeccchhhhHHHHHH
Confidence 455568999999999999999999999999999999872 2234457788888765556 48999988764
Q ss_pred eecCCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCC--CCcEEEEecCc
Q 009364 140 VREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDN--KGCIKLADFGA 217 (536)
Q Consensus 140 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~--~~~vkL~DFGl 217 (536)
|+..+.+++++||++.|+|.+-+.. ..+.|...+.++.|+++||.|||++++||||||.+||||-. .-+|||||||+
T Consensus 91 Fqt~d~YvF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~ 169 (378)
T KOG1345|consen 91 FQTSDAYVFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGL 169 (378)
T ss_pred hhcCceEEEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeeccc
Confidence 7788889999999999999988876 55889999999999999999999999999999999999943 23899999999
Q ss_pred chhhhhhhcccCCcccCCCCCCCChhhhhhc-----CCCccceEechhHHHHHHhhCCCCCchhh------HHHHHHHhh
Q 009364 218 SKQVAELATVSGAKSMKGTPYWMAPEVIRQT-----GHSYSADIWSVGCTVIEMATGKPPWSQQY------QEVAALFHI 286 (536)
Q Consensus 218 a~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~-----~~s~k~DIwSlGvil~eLltG~~Pf~~~~------~~~~~~~~~ 286 (536)
.+..+... ...--+..|.|||+.... ...+.+|+|.||+|+|..+||.+||+... .+...+..
T Consensus 170 t~k~g~tV-----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~- 243 (378)
T KOG1345|consen 170 TRKVGTTV-----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLK- 243 (378)
T ss_pred ccccCcee-----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhc-
Confidence 87654311 122235679999987532 23678999999999999999999997432 12222222
Q ss_pred CCCCCCCCCCCcCcHHHHHHHHHhcccCCCCC---CCHHHHHhCCCCc
Q 009364 287 GTTKSHPPIPENLSVKAKDFLLKCLEKEPDLR---PTASELLKHPFVT 331 (536)
Q Consensus 287 ~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~R---ps~~eiL~hp~~~ 331 (536)
+.....|.....+++.+..+.++-|.++|+.| -+++...+..|..
T Consensus 244 rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E 291 (378)
T KOG1345|consen 244 RKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE 291 (378)
T ss_pred ccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence 22222333345689999999999999999999 4555555666653
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-30 Score=245.27 Aligned_cols=200 Identities=39% Similarity=0.699 Sum_probs=174.7
Q ss_pred ceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCcee
Q 009364 68 WRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESLN 147 (536)
Q Consensus 68 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 147 (536)
|++.+.||.|++|+||+|.+..+++.+|+|.+..... ....+.+.+|++.++.++|+|++++++.+......+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-------~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~ 73 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKT-------EKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLY 73 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccc-------hHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceE
Confidence 5778999999999999999988899999998843211 024567888999999999999999999999999999
Q ss_pred EEEEecCCCCcccccccCCC-CCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhc
Q 009364 148 ILLEFVPGGSISSLLGKFGP-FPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELAT 226 (536)
Q Consensus 148 lV~E~~~gg~L~~~l~~~~~-l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 226 (536)
+++||+++++|.+++..... +++..+..++.|++.++.+||+.+++|+||+|.||+++.++.++|+|||.+........
T Consensus 74 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~ 153 (225)
T smart00221 74 LVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA 153 (225)
T ss_pred EEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc
Confidence 99999999999999987666 89999999999999999999999999999999999999999999999999877654320
Q ss_pred ccCCcccCCCCCCCChhhh-hhcCCCccceEechhHHHHHHhhCCCCCch
Q 009364 227 VSGAKSMKGTPYWMAPEVI-RQTGHSYSADIWSVGCTVIEMATGKPPWSQ 275 (536)
Q Consensus 227 ~~~~~~~~Gt~~Y~APEvl-~~~~~s~k~DIwSlGvil~eLltG~~Pf~~ 275 (536)
.......++..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus 154 -~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 154 -ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred -ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 123456788999999998 666778899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=303.34 Aligned_cols=202 Identities=20% Similarity=0.265 Sum_probs=150.4
Q ss_pred HhCCC-CceeeEeeee-------ecCCceeEEEEecCCCCccccccc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCcccc
Q 009364 126 KDLSH-PNIVRYLGTV-------REEESLNILLEFVPGGSISSLLGK-FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRD 196 (536)
Q Consensus 126 ~~l~H-pnIv~l~~~~-------~~~~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrD 196 (536)
+.+.| +||++++++| .....++.++||+ +++|.+++.. ...+++..++.+++||+.||.|||++||+|||
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrD 105 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHN 105 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 34455 5777777776 2334677889987 6799999965 35699999999999999999999999999999
Q ss_pred CCCCCcccCCC-------------------CcEEEEecCcchhhhhhh--------c------ccCCcccCCCCCCCChh
Q 009364 197 IKGANILVDNK-------------------GCIKLADFGASKQVAELA--------T------VSGAKSMKGTPYWMAPE 243 (536)
Q Consensus 197 LKp~NILl~~~-------------------~~vkL~DFGla~~~~~~~--------~------~~~~~~~~Gt~~Y~APE 243 (536)
|||+||||+.. +.+||+|||+++...... . .......+||++|||||
T Consensus 106 lKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 185 (793)
T PLN00181 106 VRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPE 185 (793)
T ss_pred CCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChh
Confidence 99999999653 456666666665321100 0 00011246899999999
Q ss_pred hhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHH
Q 009364 244 VIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASE 323 (536)
Q Consensus 244 vl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~e 323 (536)
++.+..|+.++|||||||+||||++|.+|+.............. .++......+...+++.+||+++|.+||++.|
T Consensus 186 ~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~e 261 (793)
T PLN00181 186 EDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLRHRV----LPPQILLNWPKEASFCLWLLHPEPSCRPSMSE 261 (793)
T ss_pred hhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHHHHhh----cChhhhhcCHHHHHHHHHhCCCChhhCcChHH
Confidence 99999999999999999999999999999865432222221111 11111122456679999999999999999999
Q ss_pred HHhCCCCcC
Q 009364 324 LLKHPFVTG 332 (536)
Q Consensus 324 iL~hp~~~~ 332 (536)
+++||||..
T Consensus 262 il~h~~~~~ 270 (793)
T PLN00181 262 LLQSEFINE 270 (793)
T ss_pred Hhhchhhhh
Confidence 999999975
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=250.63 Aligned_cols=252 Identities=27% Similarity=0.392 Sum_probs=197.0
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcE-----EEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeee
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGEL-----LAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGT 139 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~-----vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~ 139 (536)
..|++...++-+|.||.||.|.++....+ |-+|.+ .....+-+...+..|.-++..+.|||+..+.++
T Consensus 283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTv-------k~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTV-------KQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHH-------HhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 34788888999999999999988754432 334433 111223345667788888899999999999998
Q ss_pred eecC-CceeEEEEecCCCCcccccccC--------CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcE
Q 009364 140 VREE-ESLNILLEFVPGGSISSLLGKF--------GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCI 210 (536)
Q Consensus 140 ~~~~-~~~~lV~E~~~gg~L~~~l~~~--------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~v 210 (536)
+..+ ...+.++.+..-|+|..++... ..++..+...++.|++.|++|||+.||||.||-..|.+|++.-+|
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqV 435 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQV 435 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeE
Confidence 7654 5677788888889999988622 246677788899999999999999999999999999999999999
Q ss_pred EEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhH-HHHHHHhhCC
Q 009364 211 KLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQ-EVAALFHIGT 288 (536)
Q Consensus 211 kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~-~~~~~~~~~~ 288 (536)
||+|=.+++.+-+.....-...--.+..||+||.+.+..|+.++|+|||||+||||+| |+.|+.+-.. ++...+.
T Consensus 436 kltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylk--- 512 (563)
T KOG1024|consen 436 KLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLK--- 512 (563)
T ss_pred EeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHh---
Confidence 9999999886543221111122224667999999999999999999999999999998 8999976543 3333333
Q ss_pred CCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHh
Q 009364 289 TKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 289 ~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~ 326 (536)
...+...|-+++.++..++..||...|++||+++|+..
T Consensus 513 dGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 513 DGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred ccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 33444566799999999999999999999999999864
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.2e-29 Score=231.98 Aligned_cols=161 Identities=27% Similarity=0.358 Sum_probs=128.3
Q ss_pred CCcccccccC-CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhcccCCcccC
Q 009364 156 GSISSLLGKF-GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMK 234 (536)
Q Consensus 156 g~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~ 234 (536)
|+|.+++... .++++..++.++.||+.||.|||+++ ||+|||++.++.+|+ ||+++..... ...
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~-------~~~ 65 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE-------QSR 65 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc-------cCC
Confidence 6888888763 56999999999999999999999999 999999999999999 9998765431 236
Q ss_pred CCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhH---HHHHHHhhCCCCC--CCCCCCcCcH--HHHHHH
Q 009364 235 GTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQ---EVAALFHIGTTKS--HPPIPENLSV--KAKDFL 307 (536)
Q Consensus 235 Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~---~~~~~~~~~~~~~--~~~~~~~~s~--~~~dLi 307 (536)
||+.|+|||++.+..++.++|||||||++|+|++|.+||..... ............. ....+..++. +++++|
T Consensus 66 g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 145 (176)
T smart00750 66 VDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM 145 (176)
T ss_pred CcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence 89999999999999999999999999999999999999964321 1111111111110 0112223444 699999
Q ss_pred HHhcccCCCCCCCHHHHHhCCCCc
Q 009364 308 LKCLEKEPDLRPTASELLKHPFVT 331 (536)
Q Consensus 308 ~~cL~~dP~~Rps~~eiL~hp~~~ 331 (536)
.+||..+|.+||++.++++|+|+.
T Consensus 146 ~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 146 RVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHHhcccccccCHHHHHHHHHHH
Confidence 999999999999999999999874
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-29 Score=274.37 Aligned_cols=262 Identities=25% Similarity=0.394 Sum_probs=207.8
Q ss_pred eeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCceeE
Q 009364 69 RKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESLNI 148 (536)
Q Consensus 69 ~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 148 (536)
....++|.|++|.|+.+......+.++.|...+. .. ...........+..|+-+-..+.|||++..+..+.+.....-
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~-~~-~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~ 398 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVR-VK-PTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQ 398 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcc-cC-CcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchh
Confidence 4577899999999999888877777777765321 10 122222333337788888889999999988888877776667
Q ss_pred EEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhcc-
Q 009364 149 LLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATV- 227 (536)
Q Consensus 149 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~- 227 (536)
+||||++ +|+.++...+.+....+..++.|++.|++|||+.||.||||||+|+++..+|.+||+|||.+..+......
T Consensus 399 ~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~ 477 (601)
T KOG0590|consen 399 SMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKN 477 (601)
T ss_pred hhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchh
Confidence 7999999 99999988778999999999999999999999999999999999999999999999999998765432222
Q ss_pred -cCCcccCCCCCCCChhhhhhcCCCc-cceEechhHHHHHHhhCCCCCchhhHHHHH------HHhhCCCCCCCCCCCcC
Q 009364 228 -SGAKSMKGTPYWMAPEVIRQTGHSY-SADIWSVGCTVIEMATGKPPWSQQYQEVAA------LFHIGTTKSHPPIPENL 299 (536)
Q Consensus 228 -~~~~~~~Gt~~Y~APEvl~~~~~s~-k~DIwSlGvil~eLltG~~Pf~~~~~~~~~------~~~~~~~~~~~~~~~~~ 299 (536)
......+|+..|+|||++.+..|.+ ..||||.|++++.|.+|+.||......... ............+...+
T Consensus 478 ~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 557 (601)
T KOG0590|consen 478 IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLL 557 (601)
T ss_pred hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhc
Confidence 3456788999999999999988865 589999999999999999999644322111 00011111222344567
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 300 SVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 300 s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
+.+.+.+|.+||+.||.+|.|+++|++.+||+..
T Consensus 558 p~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i 591 (601)
T KOG0590|consen 558 PRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI 591 (601)
T ss_pred hhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence 8899999999999999999999999999999864
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.8e-26 Score=225.97 Aligned_cols=257 Identities=36% Similarity=0.581 Sum_probs=205.6
Q ss_pred ceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCC-ceeeEeeeeecCCce
Q 009364 68 WRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHP-NIVRYLGTVREEESL 146 (536)
Q Consensus 68 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hp-nIv~l~~~~~~~~~~ 146 (536)
|.+.+.||.|+||.||++.+. ..+++|.+....... ......+.+|+.++..+.|+ +|+++++.+......
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~-----~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESK-----SKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccc-----hhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEE
Confidence 788899999999999999986 788999884322111 12456788899999999988 799999999877778
Q ss_pred eEEEEecCCCCcccccccCC---CCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCC-cEEEEecCcchhhh
Q 009364 147 NILLEFVPGGSISSLLGKFG---PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKG-CIKLADFGASKQVA 222 (536)
Q Consensus 147 ~lV~E~~~gg~L~~~l~~~~---~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~-~vkL~DFGla~~~~ 222 (536)
+++++++.++++.+++.... .++......++.|++.++.|+|+.+++|||+||+||+++..+ .++++|||.++...
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~ 153 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLP 153 (384)
T ss_pred EEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecC
Confidence 99999999999997776654 799999999999999999999999999999999999999988 79999999987554
Q ss_pred hhhccc----CCcccCCCCCCCChhhhhh---cCCCccceEechhHHHHHHhhCCCCCchhhH-----HHHHHHhhCCCC
Q 009364 223 ELATVS----GAKSMKGTPYWMAPEVIRQ---TGHSYSADIWSVGCTVIEMATGKPPWSQQYQ-----EVAALFHIGTTK 290 (536)
Q Consensus 223 ~~~~~~----~~~~~~Gt~~Y~APEvl~~---~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~-----~~~~~~~~~~~~ 290 (536)
...... ......||+.|+|||.+.+ ..++...|+||+|++++++++|..||..... ............
T Consensus 154 ~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 233 (384)
T COG0515 154 DPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP 233 (384)
T ss_pred CCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc
Confidence 432211 2467789999999999987 5788999999999999999999999865532 222222222222
Q ss_pred -CCCCCCCcC----cHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcC
Q 009364 291 -SHPPIPENL----SVKAKDFLLKCLEKEPDLRPTASELLKHPFVTG 332 (536)
Q Consensus 291 -~~~~~~~~~----s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~ 332 (536)
......... ...+.+++.+|+..+|..|.+..+...++|...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~ 280 (384)
T COG0515 234 SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH 280 (384)
T ss_pred ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence 122222222 257889999999999999999999999866543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.8e-26 Score=234.19 Aligned_cols=172 Identities=17% Similarity=0.196 Sum_probs=132.3
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcC-CCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceee-Eeeee
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLD-SGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVR-YLGTV 140 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~-~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~-l~~~~ 140 (536)
....+|++.+.||+|+||+||+|++.. +++.+|||++...... .......+.+.+|+++|+.++|+||++ +++.
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~---~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPW---WSKPLARHLAAREIRALKTVRGIGVVPQLLAT- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccc---cccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-
Confidence 445689999999999999999998876 6788899986311000 001123456889999999999999985 4432
Q ss_pred ecCCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccC-CCCCcccCCCCcEEEEecCcch
Q 009364 141 REEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDI-KGANILVDNKGCIKLADFGASK 219 (536)
Q Consensus 141 ~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDL-Kp~NILl~~~~~vkL~DFGla~ 219 (536)
+..|+||||++|++|... .. .. ...++.|++.||.|||++||+|||| ||+|||++.++.+||+|||+|+
T Consensus 91 ---~~~~LVmE~~~G~~L~~~-~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~ 160 (365)
T PRK09188 91 ---GKDGLVRGWTEGVPLHLA-RP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLAS 160 (365)
T ss_pred ---CCcEEEEEccCCCCHHHh-Cc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccce
Confidence 458999999999999732 11 11 1468899999999999999999999 9999999999999999999998
Q ss_pred hhhhhhcccC------CcccCCCCCCCChhhhhhc
Q 009364 220 QVAELATVSG------AKSMKGTPYWMAPEVIRQT 248 (536)
Q Consensus 220 ~~~~~~~~~~------~~~~~Gt~~Y~APEvl~~~ 248 (536)
.+........ ..+..|++.|+|||.+...
T Consensus 161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 7654332211 2466789999999998643
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.6e-25 Score=226.77 Aligned_cols=252 Identities=21% Similarity=0.254 Sum_probs=191.9
Q ss_pred CceeeeEEcccCceEEEEEEEcCCC-cEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCC----CceeeEeeee-
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSG-ELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH----PNIVRYLGTV- 140 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g-~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~H----pnIv~l~~~~- 140 (536)
+|++.+.||+|+||.||.|.+..++ ..+|+|+........ ...+..|+.++..+.. +++..+++..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~--------~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~ 90 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK--------PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR 90 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC--------CccchhHHHHHHHHhhhcCCCCCCEEEEecc
Confidence 8999999999999999999988775 688999764221110 1145678888888762 6888999888
Q ss_pred ecCCceeEEEEecCCCCcccccccC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCC-----CcEEEE
Q 009364 141 REEESLNILLEFVPGGSISSLLGKF--GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNK-----GCIKLA 213 (536)
Q Consensus 141 ~~~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~-----~~vkL~ 213 (536)
......++||+.+ |.+|.++.... +.|+..++..++.|++.+|.+||+.|++||||||.|+++... ..+.|.
T Consensus 91 ~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~ll 169 (322)
T KOG1164|consen 91 STEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLL 169 (322)
T ss_pred CCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEE
Confidence 5777899999988 89999987443 579999999999999999999999999999999999999765 369999
Q ss_pred ecCcchhhh--hhhc----cc-C-CcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhH--HHHHH
Q 009364 214 DFGASKQVA--ELAT----VS-G-AKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQ--EVAAL 283 (536)
Q Consensus 214 DFGla~~~~--~~~~----~~-~-~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~--~~~~~ 283 (536)
|||+++... .... .. . .....||..|+++.+..+...+.+.|+||++.++.+|+.|..||..... .....
T Consensus 170 DfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~ 249 (322)
T KOG1164|consen 170 DFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKF 249 (322)
T ss_pred ecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHH
Confidence 999998322 1111 11 1 2245699999999999999999999999999999999999999964321 11111
Q ss_pred HhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 284 FHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 284 ~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
................+..+.++...+-..+...+|....+...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 250 EKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred HHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 11111111111333456777787777777899999998888664
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-26 Score=243.67 Aligned_cols=242 Identities=30% Similarity=0.490 Sum_probs=202.7
Q ss_pred EcccCceEEEEEEE---cCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCC-CCceeeEeeeeecCCceeEE
Q 009364 74 IGCGAFGRVYMGMN---LDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS-HPNIVRYLGTVREEESLNIL 149 (536)
Q Consensus 74 LG~G~fg~Vy~a~~---~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV 149 (536)
+|+|+||.|++++. ...|.-+|+|+..++.... +.+. .-..|..++..++ ||.++++...++.+...+++
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~-~~~~-----~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ 75 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKV-RDRT-----HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLI 75 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhccccccccc-cccc-----ccccHHHHHhhccCCCceeeeeeeeccccchhHh
Confidence 79999999998643 2457789999875432211 1111 3345667788886 99999999999999999999
Q ss_pred EEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhcccC
Q 009364 150 LEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSG 229 (536)
Q Consensus 150 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 229 (536)
+++..||.|...+.+...+.+...+.+...++-+++++|+.+|+|||+|++||+++.+|++++.|||+++..-...
T Consensus 76 ld~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~---- 151 (612)
T KOG0603|consen 76 LDFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK---- 151 (612)
T ss_pred hhhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhh----
Confidence 9999999999999998999999999999999999999999999999999999999999999999999998765422
Q ss_pred CcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcHHHHHHHHH
Q 009364 230 AKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKDFLLK 309 (536)
Q Consensus 230 ~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~ 309 (536)
..|||..|||||+++ ++..++|.||+|+++++|+||..||.. .....+. +....+|...+..+++++.+
T Consensus 152 --~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~--~~~~~Il-----~~~~~~p~~l~~~a~~~~~~ 220 (612)
T KOG0603|consen 152 --IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG--DTMKRIL-----KAELEMPRELSAEARSLFRQ 220 (612)
T ss_pred --hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch--HHHHHHh-----hhccCCchhhhHHHHHHHHH
Confidence 229999999999998 688999999999999999999999977 1222222 23456788999999999999
Q ss_pred hcccCCCCCCC-----HHHHHhCCCCcCCCCC
Q 009364 310 CLEKEPDLRPT-----ASELLKHPFVTGDDED 336 (536)
Q Consensus 310 cL~~dP~~Rps-----~~eiL~hp~~~~~~~~ 336 (536)
++..+|..|.. +.++++|++|+...+.
T Consensus 221 l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~ 252 (612)
T KOG0603|consen 221 LFKRNPENRLGAGPDGVDEIKQHEFFQSIDWN 252 (612)
T ss_pred HHhhCHHHHhccCcchhHHHhccchheeeeHh
Confidence 99999999975 5799999999877654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.4e-25 Score=207.38 Aligned_cols=251 Identities=22% Similarity=0.312 Sum_probs=199.3
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCC-CceeeEeeeee
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH-PNIVRYLGTVR 141 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~H-pnIv~l~~~~~ 141 (536)
....+|++++.||.|+||.+|+|....+|+.||||+-... ....++..|.++.+.|++ ..|..+..+..
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~----------a~hpqL~yEskvY~iL~~g~GiP~i~~y~~ 81 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK----------AKHPQLLYESKVYRILQGGVGIPHIRHYGT 81 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc----------CCCcchhHHHHHHHHhccCCCCchhhhhcc
Confidence 3456899999999999999999999999999999975211 112345678888888864 67888888888
Q ss_pred cCCceeEEEEecCCCCccccccc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCC---CcEEEEecCc
Q 009364 142 EEESLNILLEFVPGGSISSLLGK-FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNK---GCIKLADFGA 217 (536)
Q Consensus 142 ~~~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~---~~vkL~DFGl 217 (536)
+...-.+||+.+ |.+|.++..- .+.|+..++.-++-|++.-++|+|.+++|||||||+|+|+.-+ ..+.|+|||+
T Consensus 82 e~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGL 160 (341)
T KOG1163|consen 82 EKDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGL 160 (341)
T ss_pred ccccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccc
Confidence 888999999998 8999998864 3579999999999999999999999999999999999999533 4799999999
Q ss_pred chhhhhhhcc-----cCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhh-----HHHHHHHhhC
Q 009364 218 SKQVAELATV-----SGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQY-----QEVAALFHIG 287 (536)
Q Consensus 218 a~~~~~~~~~-----~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~-----~~~~~~~~~~ 287 (536)
|+.+.+..+. .......||..|.+--...+...+...|+-|+|.+|.++.-|..||++-. +....+....
T Consensus 161 aKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK 240 (341)
T KOG1163|consen 161 AKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKK 240 (341)
T ss_pred hhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhh
Confidence 9987653321 22356789999999888887788899999999999999999999997532 2223333333
Q ss_pred CCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHH
Q 009364 288 TTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASEL 324 (536)
Q Consensus 288 ~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~ei 324 (536)
.......+..+.|.++.-.+..|-..--++-|...-+
T Consensus 241 ~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~yl 277 (341)
T KOG1163|consen 241 MSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYL 277 (341)
T ss_pred cCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHH
Confidence 3333334557889999999999988777777876543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.8e-25 Score=213.39 Aligned_cols=248 Identities=24% Similarity=0.347 Sum_probs=195.1
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCC-CCceeeEeeeeecC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS-HPNIVRYLGTVREE 143 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~ 143 (536)
...|+++++||+|+||..+.|.+.-++++||||.-.. + ...-++..|....+.|. .++|..+|.+..+.
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr------k----S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG 96 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR------K----SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEG 96 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccc------c----CCcchHHHHHHHHHHHcCCCCCCceeeecccc
Confidence 3479999999999999999999999999999996421 1 12235667888888774 79999999888888
Q ss_pred CceeEEEEecCCCCcccccccC-CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCC-----cEEEEecCc
Q 009364 144 ESLNILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKG-----CIKLADFGA 217 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~-----~vkL~DFGl 217 (536)
.+-.||+|.+ |.+|.|+..-. +.|+...+..++.|++.-++|+|++.+|+|||||+|+||...+ .|.|+|||+
T Consensus 97 ~~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGm 175 (449)
T KOG1165|consen 97 KYNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGM 175 (449)
T ss_pred chhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccc
Confidence 8889999998 88998888654 4699999999999999999999999999999999999997544 599999999
Q ss_pred chhhhhhhc-----ccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhH--HHHHHHhhCCCC
Q 009364 218 SKQVAELAT-----VSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQ--EVAALFHIGTTK 290 (536)
Q Consensus 218 a~~~~~~~~-----~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~--~~~~~~~~~~~~ 290 (536)
|+.+.+..+ ....++..||..||+--...|...+...|+-|||-++++.|-|..||.+-.. .-.....++..+
T Consensus 176 AK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~K 255 (449)
T KOG1165|consen 176 AKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETK 255 (449)
T ss_pred hhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccc
Confidence 998765433 2234578899999999988898999999999999999999999999974321 111222222222
Q ss_pred CCC---CCCCcCcHHHHHHHHHhcccCCCCCCCHHH
Q 009364 291 SHP---PIPENLSVKAKDFLLKCLEKEPDLRPTASE 323 (536)
Q Consensus 291 ~~~---~~~~~~s~~~~dLi~~cL~~dP~~Rps~~e 323 (536)
... .+..+++.++...++..-..+-.+-|..+-
T Consensus 256 r~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdy 291 (449)
T KOG1165|consen 256 RSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDY 291 (449)
T ss_pred ccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHH
Confidence 222 234567777777777666666666776554
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.2e-24 Score=232.60 Aligned_cols=231 Identities=32% Similarity=0.462 Sum_probs=175.5
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE 142 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 142 (536)
.....|..++.|-.|+||-||.++|+.+.+++|+|+= +.. --+++ ++.....|.+|
T Consensus 80 p~e~df~~IklisngAygavylvrh~~trqrfa~kiN--------kq~-----lilRn---ilt~a~npfvv-------- 135 (1205)
T KOG0606|consen 80 PSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKIN--------KQN-----LILRN---ILTFAGNPFVV-------- 135 (1205)
T ss_pred CCccccceeEeeccCCCCceeeeeccccccchhhccc--------ccc-----hhhhc---cccccCCccee--------
Confidence 4456899999999999999999999999999999632 100 00111 33333344443
Q ss_pred CCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhh
Q 009364 143 EESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVA 222 (536)
Q Consensus 143 ~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~ 222 (536)
|+=..+++..++++... +.+++|||+.||+|||+||+|.+|+.-|++|++|||+++...
T Consensus 136 -------------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GL 194 (1205)
T KOG0606|consen 136 -------------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGL 194 (1205)
T ss_pred -------------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhh
Confidence 55556666666666543 889999999999999999999999999999999999986532
Q ss_pred hhhc-------------ccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCC
Q 009364 223 ELAT-------------VSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTT 289 (536)
Q Consensus 223 ~~~~-------------~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~ 289 (536)
.... .-..+..||||.|+||||+...+|+..+|+|++|+|+|+.+-|..||.+...+...-..+...
T Consensus 195 ms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~ 274 (1205)
T KOG0606|consen 195 MSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD 274 (1205)
T ss_pred hhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhh
Confidence 1111 011346799999999999999999999999999999999999999998775443222222333
Q ss_pred CCCCCCCCcCcHHHHHHHHHhcccCCCCC---CCHHHHHhCCCCcCCCCCcc
Q 009364 290 KSHPPIPENLSVKAKDFLLKCLEKEPDLR---PTASELLKHPFVTGDDEDPV 338 (536)
Q Consensus 290 ~~~~~~~~~~s~~~~dLi~~cL~~dP~~R---ps~~eiL~hp~~~~~~~~~~ 338 (536)
..++.-...++++++++|.++|+.+|..| +.+-++.+|+||+..++...
T Consensus 275 i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~~l 326 (1205)
T KOG0606|consen 275 IEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWKSL 326 (1205)
T ss_pred ccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccchh
Confidence 34444456789999999999999999999 46888999999998776643
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.9e-23 Score=199.09 Aligned_cols=174 Identities=11% Similarity=0.157 Sum_probs=133.3
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHH------HHHHHHHHHHHhCCCCceeeEe
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHI------KELEEEVKLLKDLSHPNIVRYL 137 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~------~~~~~Ei~iL~~l~HpnIv~l~ 137 (536)
...+|++.++||.|+||.||++.+ ++..+|+|++.... . ..+... ..+.+|+..+.++.|++|..+.
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~--~---~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~ 101 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKV--K---RTERFLKSFVKGDYYENLIVQTDRVRSEGLASLN 101 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhc--C---chHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcce
Confidence 346899999999999999999755 46689999873211 1 111222 2267899999999999999998
Q ss_pred eeeecC--------CceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCc
Q 009364 138 GTVREE--------ESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGC 209 (536)
Q Consensus 138 ~~~~~~--------~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~ 209 (536)
+++... ...++||||++|.+|.++.. +++ ....+++.+|..||+.|++|||+||+||+++.+|
T Consensus 102 d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 102 DFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred EeeeecccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-
Confidence 886533 35889999999999987732 333 3466999999999999999999999999999988
Q ss_pred EEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHh
Q 009364 210 IKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMA 267 (536)
Q Consensus 210 vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLl 267 (536)
++|+|||.++........ ..++....|+.++|+||||+.+..+.
T Consensus 173 i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999987654321110 11445556778999999999987765
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=1e-22 Score=193.33 Aligned_cols=147 Identities=20% Similarity=0.198 Sum_probs=111.0
Q ss_pred eeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchh------------------HHHHHHHHHHHHHHHHHhCCCCc
Q 009364 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKE------------------KAQDHIKELEEEVKLLKDLSHPN 132 (536)
Q Consensus 71 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~------------------~~~~~~~~~~~Ei~iL~~l~Hpn 132 (536)
...||+|+||.||+|.+. +|+.||+|++.......... ...........|++++..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 457999999999999986 89999999985432110000 00001123356999999998777
Q ss_pred eeeEeeeeecCCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHH-HHcCCccccCCCCCcccCCCCcEE
Q 009364 133 IVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYL-HNHGIMHRDIKGANILVDNKGCIK 211 (536)
Q Consensus 133 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yL-H~~~ivHrDLKp~NILl~~~~~vk 211 (536)
+.....+.. ...++||||++|+++...+....++++..+..++.|++.+|.++ |+.||+||||||+|||++ ++.++
T Consensus 81 v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 81 IPCPEPILL--KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred CCCCcEEEe--cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence 644332222 23489999999887766544457899999999999999999999 799999999999999998 47899
Q ss_pred EEecCcchhh
Q 009364 212 LADFGASKQV 221 (536)
Q Consensus 212 L~DFGla~~~ 221 (536)
|+|||+|...
T Consensus 158 LiDFG~a~~~ 167 (190)
T cd05147 158 IIDVSQSVEH 167 (190)
T ss_pred EEEccccccC
Confidence 9999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.9e-23 Score=204.46 Aligned_cols=195 Identities=24% Similarity=0.379 Sum_probs=144.6
Q ss_pred CCCceeeEeeeeec---------------------------CCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHH
Q 009364 129 SHPNIVRYLGTVRE---------------------------EESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLL 181 (536)
Q Consensus 129 ~HpnIv~l~~~~~~---------------------------~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil 181 (536)
+|||||++.++|.+ ...+|+||... ..+|..++-. ...+.....-++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~-~~~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWT-RHRSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhc-CCCchHHHHHHHHHHH
Confidence 69999999887632 23578888776 3577777754 3456677888999999
Q ss_pred HHHHHHHHcCCccccCCCCCcccC--CCC--cEEEEecCcchhhhhhh----cccCCcccCCCCCCCChhhhhhcC----
Q 009364 182 LGLEYLHNHGIMHRDIKGANILVD--NKG--CIKLADFGASKQVAELA----TVSGAKSMKGTPYWMAPEVIRQTG---- 249 (536)
Q Consensus 182 ~aL~yLH~~~ivHrDLKp~NILl~--~~~--~vkL~DFGla~~~~~~~----~~~~~~~~~Gt~~Y~APEvl~~~~---- 249 (536)
+|+.|||.+||.|||||.+|||+. +++ .+.|+|||++---.... .....-...|...-||||+....+
T Consensus 352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a 431 (598)
T KOG4158|consen 352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA 431 (598)
T ss_pred HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence 999999999999999999999994 443 68999999874322200 001112345888899999987432
Q ss_pred --CCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCH---HHH
Q 009364 250 --HSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTA---SEL 324 (536)
Q Consensus 250 --~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~---~ei 324 (536)
.-.++|.|+.|.+.||+++...||+...+....... ......+.+|..+++.+++|+..+|+.||.+|+++ +.+
T Consensus 432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~-Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANv 510 (598)
T KOG4158|consen 432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT-YQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANV 510 (598)
T ss_pred eeccchhhhhhhhhhHHHHhccCCcccccchheechhh-hhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhH
Confidence 135899999999999999999999874332221111 22344567888999999999999999999999985 445
Q ss_pred Hh
Q 009364 325 LK 326 (536)
Q Consensus 325 L~ 326 (536)
|+
T Consensus 511 l~ 512 (598)
T KOG4158|consen 511 LN 512 (598)
T ss_pred HH
Confidence 54
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-23 Score=230.30 Aligned_cols=251 Identities=21% Similarity=0.292 Sum_probs=182.3
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCce
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESL 146 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 146 (536)
.|...+.||.+.|=+|.+|++.+ | .|+||++.+.....+-. . ..+...|++ ...++|||++++.-+...+...
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G-~vVvKVFvk~~p~~sL~---~-~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAA 96 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-G-LVVVKVFVKQDPTISLR---P-FKQRLEEIK-FALMKAPNCLPFQKVLVTDKAA 96 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-c-eEEEEEEeccCCCCCch---H-HHHHHHHHH-HHhhcCCcccchHHHHHhhHHH
Confidence 67788999999999999998753 4 49999986544222221 2 222334455 5667899999999988888899
Q ss_pred eEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhh--hh
Q 009364 147 NILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVA--EL 224 (536)
Q Consensus 147 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~--~~ 224 (536)
|+|-+|. --+|+|.+..+.-+..-+.+.|+.||+.||..+|..||+|||||.+||||+.-+-+.|+||..-+..- ++
T Consensus 97 ylvRqyv-khnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 97 YLVRQYV-KHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred HHHHHHH-hhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 9999998 46899999887778888899999999999999999999999999999999999999999998654321 11
Q ss_pred hccc---CCcccCCCCCCCChhhhhhcC-----------CCccceEechhHHHHHHhh-CCCCCchhhHHHHHHHhhCCC
Q 009364 225 ATVS---GAKSMKGTPYWMAPEVIRQTG-----------HSYSADIWSVGCTVIEMAT-GKPPWSQQYQEVAALFHIGTT 289 (536)
Q Consensus 225 ~~~~---~~~~~~Gt~~Y~APEvl~~~~-----------~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~ 289 (536)
.+.. ...+...-..|.|||.+.... .+++-||||+||+++||++ |+|||.-. ....+......
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS--QL~aYr~~~~~ 253 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS--QLLAYRSGNAD 253 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH--HHHhHhccCcc
Confidence 1100 012223345699999875321 4678899999999999998 68998421 11111110000
Q ss_pred CCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 290 KSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 290 ~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
.....+..--+..+++||..|++.||.+|.+|++.|+.
T Consensus 254 ~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 254 DPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred CHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 00000111224468999999999999999999999985
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-22 Score=202.24 Aligned_cols=234 Identities=21% Similarity=0.345 Sum_probs=149.2
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCC----------CceeeE
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH----------PNIVRY 136 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~H----------pnIv~l 136 (536)
.+..++.||.|+++.||.+++..+|+.+|+|+...... .....++.+++|.-....+.+ -.++-.
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~-----~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P 87 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPAD-----ASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVP 87 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESST-----THTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccc-----cchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEee
Confidence 46678999999999999999999999999999876542 122334555555544333222 122222
Q ss_pred eeeee---------cC---C-----ceeEEEEecCCCCcccccc---cCCC----CCHHHHHHHHHHHHHHHHHHHHcCC
Q 009364 137 LGTVR---------EE---E-----SLNILLEFVPGGSISSLLG---KFGP----FPEAVMRTYTKQLLLGLEYLHNHGI 192 (536)
Q Consensus 137 ~~~~~---------~~---~-----~~~lV~E~~~gg~L~~~l~---~~~~----l~~~~~~~i~~qil~aL~yLH~~~i 192 (536)
++... .. . ..+++|+-+ .++|.+++. .... +.......+..|+++.+++||+.|+
T Consensus 88 ~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~Gl 166 (288)
T PF14531_consen 88 LDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGL 166 (288)
T ss_dssp SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred eEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcce
Confidence 22211 11 1 346677776 567776642 1111 1222234566899999999999999
Q ss_pred ccccCCCCCcccCCCCcEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhc--------CCCccceEechhHHHH
Q 009364 193 MHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQT--------GHSYSADIWSVGCTVI 264 (536)
Q Consensus 193 vHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~--------~~s~k~DIwSlGvil~ 264 (536)
+|+||+|+|++++.+|.++|+||+.....+..... ...+..|.|||..... .++.+.|.|+||+++|
T Consensus 167 VHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly 241 (288)
T PF14531_consen 167 VHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLY 241 (288)
T ss_dssp EEST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHH
T ss_pred EecccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHH
Confidence 99999999999999999999999987665442211 2345889999987543 4688999999999999
Q ss_pred HHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCC
Q 009364 265 EMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLR 318 (536)
Q Consensus 265 eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~R 318 (536)
.|+||..||........... ...... +++..++.||.++|++||.+|
T Consensus 242 ~lWC~~lPf~~~~~~~~~~~------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 242 SLWCGRLPFGLSSPEADPEW------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHSS-STCCCGGGSTSGG------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHccCCCCCCCccccccc------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999999975432211110 112233 889999999999999999987
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.9e-22 Score=187.36 Aligned_cols=148 Identities=20% Similarity=0.176 Sum_probs=112.7
Q ss_pred eeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccch------------------hHHHHHHHHHHHHHHHHHhCCCCc
Q 009364 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASK------------------EKAQDHIKELEEEVKLLKDLSHPN 132 (536)
Q Consensus 71 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~------------------~~~~~~~~~~~~Ei~iL~~l~Hpn 132 (536)
...||+|+||+||+|.+. +|+.||||++......... ............|...+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 468999999999999987 8999999998543211000 000111223467899999999998
Q ss_pred eeeEeeeeecCCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHH-cCCccccCCCCCcccCCCCcEE
Q 009364 133 IVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHN-HGIMHRDIKGANILVDNKGCIK 211 (536)
Q Consensus 133 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~-~~ivHrDLKp~NILl~~~~~vk 211 (536)
|.....+... ..++||||++|+++.........++...+..++.|++.++.+||+ .||+||||||+|||++ ++.++
T Consensus 81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~ 157 (190)
T cd05145 81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPY 157 (190)
T ss_pred CCCceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEE
Confidence 7544433332 248999999988654433334678889999999999999999999 9999999999999998 78999
Q ss_pred EEecCcchhhh
Q 009364 212 LADFGASKQVA 222 (536)
Q Consensus 212 L~DFGla~~~~ 222 (536)
|+|||+++...
T Consensus 158 liDFG~a~~~~ 168 (190)
T cd05145 158 IIDVSQAVELD 168 (190)
T ss_pred EEEcccceecC
Confidence 99999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2e-22 Score=192.34 Aligned_cols=238 Identities=20% Similarity=0.358 Sum_probs=185.3
Q ss_pred eeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCceeEE
Q 009364 70 KGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESLNIL 149 (536)
Q Consensus 70 ~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 149 (536)
+.-+|.+...|..|+|++ .|..++.|++.+. +-....-+.+..|.-.|+-..||||+.+++.|.....+.++
T Consensus 194 l~tkl~e~hsgelwrgrw--qgndivakil~vr------~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~i 265 (448)
T KOG0195|consen 194 LITKLAESHSGELWRGRW--QGNDIVAKILNVR------EVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVII 265 (448)
T ss_pred hhhhhccCCCcccccccc--cCcchhhhhhhhh------hcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEe
Confidence 455688889999999987 4556777876432 12223345677888889999999999999999999999999
Q ss_pred EEecCCCCcccccccCCC--CCHHHHHHHHHHHHHHHHHHHHcC-Ccc-ccCCCCCcccCCCCcEEEE--ecCcchhhhh
Q 009364 150 LEFVPGGSISSLLGKFGP--FPEAVMRTYTKQLLLGLEYLHNHG-IMH-RDIKGANILVDNKGCIKLA--DFGASKQVAE 223 (536)
Q Consensus 150 ~E~~~gg~L~~~l~~~~~--l~~~~~~~i~~qil~aL~yLH~~~-ivH-rDLKp~NILl~~~~~vkL~--DFGla~~~~~ 223 (536)
..|++-|+|+.++..... ....++.+++..+++|++|||+.. ++- --|....++++++-+.+|. |--++.+
T Consensus 266 sq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq--- 342 (448)
T KOG0195|consen 266 SQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ--- 342 (448)
T ss_pred eeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee---
Confidence 999999999999976543 567789999999999999999985 443 3688899999998866653 4332211
Q ss_pred hhcccCCcccCCCCCCCChhhhhhcCC---CccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCc
Q 009364 224 LATVSGAKSMKGTPYWMAPEVIRQTGH---SYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLS 300 (536)
Q Consensus 224 ~~~~~~~~~~~Gt~~Y~APEvl~~~~~---s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s 300 (536)
.....-.|.||+||.+...+- -.++|+|||++++|||.|...||.+-..- ..-.++........+|++++
T Consensus 343 ------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspm-ecgmkialeglrv~ippgis 415 (448)
T KOG0195|consen 343 ------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPM-ECGMKIALEGLRVHIPPGIS 415 (448)
T ss_pred ------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCch-hhhhhhhhccccccCCCCcc
Confidence 112334788999999987654 35799999999999999999999764321 12223334556677899999
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHH
Q 009364 301 VKAKDFLLKCLEKEPDLRPTASELL 325 (536)
Q Consensus 301 ~~~~dLi~~cL~~dP~~Rps~~eiL 325 (536)
..+..|+.-|++.||.+||.+..|+
T Consensus 416 ~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 416 RHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred HHHHHHHHHHhcCCCCcCCCcceeh
Confidence 9999999999999999999998764
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.2e-21 Score=181.55 Aligned_cols=191 Identities=18% Similarity=0.181 Sum_probs=139.4
Q ss_pred eeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCC-CCceeeEeeeeecCCcee
Q 009364 69 RKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS-HPNIVRYLGTVREEESLN 147 (536)
Q Consensus 69 ~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~ 147 (536)
.++..|++|+||+||.+.. .+.+++.+.+...+-. ...-....+.+|+++|++|. |++|++++++ ...+
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~----~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~ 74 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWW----LRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRH 74 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhh----hhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEE
Confidence 3567899999999998754 6777877665221111 00111225789999999995 5889998886 3468
Q ss_pred EEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccC-CCCCcccCCCCcEEEEecCcchhhhhhhc
Q 009364 148 ILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDI-KGANILVDNKGCIKLADFGASKQVAELAT 226 (536)
Q Consensus 148 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDL-Kp~NILl~~~~~vkL~DFGla~~~~~~~~ 226 (536)
++|||+.|.+|...+.. . ...++.|++.+|.++|++||+|||| ||+|||++.+|.++|+|||+|........
T Consensus 75 lvmeyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 75 LDRSYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred EEEeeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 99999999998754321 1 2357889999999999999999999 79999999999999999999985443221
Q ss_pred c----cC-------CcccCCCCCCCChhhhhhc-CCC-ccceEechhHHHHHHhhCCCCCchh
Q 009364 227 V----SG-------AKSMKGTPYWMAPEVIRQT-GHS-YSADIWSVGCTVIEMATGKPPWSQQ 276 (536)
Q Consensus 227 ~----~~-------~~~~~Gt~~Y~APEvl~~~-~~s-~k~DIwSlGvil~eLltG~~Pf~~~ 276 (536)
. .. ..-...++.|++|+.-.-- ..+ ...++++.|+-+|.++||..|+..+
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 0 00 0112368889999864322 223 5678999999999999999987543
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.9e-21 Score=201.64 Aligned_cols=180 Identities=26% Similarity=0.408 Sum_probs=140.7
Q ss_pred CceeEEEEecCCCCcccccccCC---CCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchh
Q 009364 144 ESLNILLEFVPGGSISSLLGKFG---PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQ 220 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~~~~---~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~ 220 (536)
..+||.|++|.-.+|.+++.... ..+......++.|++.|+.| +|.+|||+||.||++..+..+||.|||+...
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence 35889999999999999997543 35677888999999999999 9999999999999999999999999999887
Q ss_pred hhhhh----cccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCC
Q 009364 221 VAELA----TVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIP 296 (536)
Q Consensus 221 ~~~~~----~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 296 (536)
..... .....+...||.+||+||.+.+..|+.++||||||+||+||+. +|..........-........+.+.
T Consensus 406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~---~f~T~~er~~t~~d~r~g~ip~~~~ 482 (516)
T KOG1033|consen 406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI---QFSTQFERIATLTDIRDGIIPPEFL 482 (516)
T ss_pred cccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH---HhccHHHHHHhhhhhhcCCCChHHh
Confidence 66543 1223456789999999999999999999999999999999997 4443333333222222222222222
Q ss_pred CcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCC
Q 009364 297 ENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFV 330 (536)
Q Consensus 297 ~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~ 330 (536)
.+. ++-..|+.+||.+.|.+||++.+.--|+|.
T Consensus 483 ~d~-p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 483 QDY-PEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred hcC-cHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 233 334689999999999999988888888775
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.4e-20 Score=179.33 Aligned_cols=135 Identities=23% Similarity=0.349 Sum_probs=106.2
Q ss_pred eeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-----CCCceeeEeeeeecCC
Q 009364 70 KGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-----SHPNIVRYLGTVREEE 144 (536)
Q Consensus 70 ~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-----~HpnIv~l~~~~~~~~ 144 (536)
-.++||+|+||.||. +..++.. +||++.... ....+.+.+|+.+++.+ .||||++++|++.++.
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~--------~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~ 74 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG--------DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC 74 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCe-EEEEEeccc--------cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC
Confidence 356899999999995 6767665 699874311 11235678999999999 5799999999998874
Q ss_pred ---c-eeEEEEe--cCCCCcccccccCCCCCHHHHHHHHHHHHHHH-HHHHHcCCccccCCCCCcccCCC----CcEEEE
Q 009364 145 ---S-LNILLEF--VPGGSISSLLGKFGPFPEAVMRTYTKQLLLGL-EYLHNHGIMHRDIKGANILVDNK----GCIKLA 213 (536)
Q Consensus 145 ---~-~~lV~E~--~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL-~yLH~~~ivHrDLKp~NILl~~~----~~vkL~ 213 (536)
. +.+|+|| +.+|+|.+++.+ +.+++. ..++.|++.++ +|||+++|+||||||+|||++.. +.++|+
T Consensus 75 g~g~v~~~I~e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~Li 151 (210)
T PRK10345 75 GTGYVYDVIADFDGKPSITLTEFAEQ-CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVC 151 (210)
T ss_pred CCeEEEEEEecCCCCcchhHHHHHHc-ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEE
Confidence 3 3378999 557999999976 456666 36688888888 99999999999999999999743 379999
Q ss_pred ecCcc
Q 009364 214 DFGAS 218 (536)
Q Consensus 214 DFGla 218 (536)
||+.+
T Consensus 152 Dg~G~ 156 (210)
T PRK10345 152 DNIGE 156 (210)
T ss_pred ECCCC
Confidence 95433
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.1e-22 Score=217.50 Aligned_cols=262 Identities=27% Similarity=0.407 Sum_probs=211.2
Q ss_pred CCCceeeeEEcccCceEEEEEEEcC-CCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCC-CCceeeEeeeeec
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLD-SGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS-HPNIVRYLGTVRE 142 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~-~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~ 142 (536)
...|++.+.||+|+|+.|-.+.... ....+|.|.+.... ........+..|..+-+.+. |.|++.+++....
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~------~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~ 92 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP------KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS 92 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC------CccchhhhcCccccccccccccccccccCCccCC
Confidence 3457788889999999999987643 34456666553221 22234455667788877776 9999999999999
Q ss_pred CCceeEEEEecCCCCccccc-ccCC-CCCHHHHHHHHHHHHHHHHHHH-HcCCccccCCCCCcccCCCC-cEEEEecCcc
Q 009364 143 EESLNILLEFVPGGSISSLL-GKFG-PFPEAVMRTYTKQLLLGLEYLH-NHGIMHRDIKGANILVDNKG-CIKLADFGAS 218 (536)
Q Consensus 143 ~~~~~lV~E~~~gg~L~~~l-~~~~-~l~~~~~~~i~~qil~aL~yLH-~~~ivHrDLKp~NILl~~~~-~vkL~DFGla 218 (536)
.+..+++++|..|+++.+-+ .... ..+...+..++.|+..++.|+| ..++.||||||+|.+++..+ .+|+.|||+|
T Consensus 93 ~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~A 172 (601)
T KOG0590|consen 93 PRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLA 172 (601)
T ss_pred CcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhh
Confidence 99999999999999999998 5554 6788889999999999999999 99999999999999999999 9999999999
Q ss_pred hhhhh-hhcccCCcccCC-CCCCCChhhhhhc-CCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCC--CCCC
Q 009364 219 KQVAE-LATVSGAKSMKG-TPYWMAPEVIRQT-GHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTT--KSHP 293 (536)
Q Consensus 219 ~~~~~-~~~~~~~~~~~G-t~~Y~APEvl~~~-~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~--~~~~ 293 (536)
..+.. ..........+| ++.|+|||...+. ......|+||.|+++.-+++|..||................ ....
T Consensus 173 t~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 252 (601)
T KOG0590|consen 173 TAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQ 252 (601)
T ss_pred ccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeeccccccccc
Confidence 88776 444444566788 9999999999884 55788999999999999999999997554332222111111 2123
Q ss_pred CCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcC
Q 009364 294 PIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTG 332 (536)
Q Consensus 294 ~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~ 332 (536)
..+..++....+++.+++..+|..|.+.+++..+||+..
T Consensus 253 ~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 253 LPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred CccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 445688999999999999999999999999999999987
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.2e-20 Score=179.41 Aligned_cols=151 Identities=21% Similarity=0.181 Sum_probs=115.7
Q ss_pred CCceeeeEEcccCceEEEEEE-EcCCCcEEEEEEEeehhhccch----------------hHHHHHHHHHHHHHHHHHhC
Q 009364 66 IRWRKGELIGCGAFGRVYMGM-NLDSGELLAVKQVLIAANFASK----------------EKAQDHIKELEEEVKLLKDL 128 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~-~~~~g~~vAiK~i~~~~~~~~~----------------~~~~~~~~~~~~Ei~iL~~l 128 (536)
.-|++.+.||+|+||.||+|. +..+|+.||+|++......... .........+..|+.+++++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 358899999999999999998 6678999999988532210000 00011123467899999999
Q ss_pred CCC--ceeeEeeeeecCCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC-CccccCCCCCcccC
Q 009364 129 SHP--NIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHG-IMHRDIKGANILVD 205 (536)
Q Consensus 129 ~Hp--nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~-ivHrDLKp~NILl~ 205 (536)
.+. .+.++++. ...++||||++|++|.........+....+..++.||+.+|.+||+.| |+||||||+||+++
T Consensus 108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~ 183 (237)
T smart00090 108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH 183 (237)
T ss_pred HhcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE
Confidence 753 33444432 235899999999888776644456777778899999999999999999 99999999999999
Q ss_pred CCCcEEEEecCcchhh
Q 009364 206 NKGCIKLADFGASKQV 221 (536)
Q Consensus 206 ~~~~vkL~DFGla~~~ 221 (536)
++.++|+|||.+...
T Consensus 184 -~~~i~LiDFg~a~~~ 198 (237)
T smart00090 184 -DGKVVIIDVSQSVEL 198 (237)
T ss_pred -CCCEEEEEChhhhcc
Confidence 789999999987643
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.1e-20 Score=205.98 Aligned_cols=194 Identities=24% Similarity=0.332 Sum_probs=156.7
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCC---CCceeeEeeeeec
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS---HPNIVRYLGTVRE 142 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~---HpnIv~l~~~~~~ 142 (536)
..|.|.+.||+|+||+||.|.+.+ |+.||+|+-..+..+. +.--.+++.+|+ -+.|..+...+.-
T Consensus 698 ~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE-----------fYI~~q~~~RLk~~~~~~~~~~~~a~~~ 765 (974)
T KOG1166|consen 698 EKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE-----------FYICLQVMERLKPQMLPSIMHISSAHVF 765 (974)
T ss_pred eeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee-----------eeehHHHHHhhchhhhcchHHHHHHHcc
Confidence 479999999999999999999877 9999999752211110 111122333343 2455566666666
Q ss_pred CCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCC-------CcEEEEec
Q 009364 143 EESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNK-------GCIKLADF 215 (536)
Q Consensus 143 ~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~-------~~vkL~DF 215 (536)
.+.-++|+||.+.|+|.++++..+.+++..+..+..|++.-|+.||..+||||||||+|+||... --++|+||
T Consensus 766 ~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 766 QNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred CCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEec
Confidence 77788999999999999999988899999999999999999999999999999999999999422 25999999
Q ss_pred CcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCC
Q 009364 216 GASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKP 271 (536)
Q Consensus 216 Gla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~ 271 (536)
|.+.-+............++|-.+--+|...|..+++.+|.|.|+.+++.||.|+.
T Consensus 846 G~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 846 GRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 98865543333334567789999999999999999999999999999999999863
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.9e-19 Score=171.04 Aligned_cols=142 Identities=20% Similarity=0.287 Sum_probs=114.4
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCceeEEEE
Q 009364 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESLNILLE 151 (536)
Q Consensus 72 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 151 (536)
+.||+|++|.||+|.+ .|..+++|+...................+.+|+.++..+.|++|.....++......++|||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5799999999999986 77889999753211111111112233567889999999999998877777777788899999
Q ss_pred ecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchh
Q 009364 152 FVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQ 220 (536)
Q Consensus 152 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~ 220 (536)
|++|++|.+++..... ....++.+++.+|.+||+.|++|||++|.|||++ ++.++|+|||.+..
T Consensus 80 ~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999998865332 7789999999999999999999999999999999 78999999998764
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.78 E-value=1e-18 Score=166.70 Aligned_cols=138 Identities=20% Similarity=0.287 Sum_probs=107.9
Q ss_pred EEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCceeEEEEe
Q 009364 73 LIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESLNILLEF 152 (536)
Q Consensus 73 ~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 152 (536)
.||+|+||.||+|.. +|..+++|+..................++.+|+++++.+.|+++.....++......++||||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 389999999999984 678899998632111111111222346678999999999888765555455566678999999
Q ss_pred cCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchh
Q 009364 153 VPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQ 220 (536)
Q Consensus 153 ~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~ 220 (536)
++|++|.+++..... .++.|++.+|.+||+.|++|||++|.||+++ ++.++++|||++..
T Consensus 79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999988754321 7899999999999999999999999999999 78999999998765
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=6.5e-19 Score=185.91 Aligned_cols=202 Identities=25% Similarity=0.460 Sum_probs=156.0
Q ss_pred HHhCCCCceeeEeeeeecCCceeEEEEecCCCCccccccc-CCCCCHHHHHHHHHHHHHHHHHHHHcCC-ccccCCCCCc
Q 009364 125 LKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGK-FGPFPEAVMRTYTKQLLLGLEYLHNHGI-MHRDIKGANI 202 (536)
Q Consensus 125 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~i-vHrDLKp~NI 202 (536)
|+.+.|.|+.+++|.+.+....++|.+||..|+|.+.+.. .-.++.--...+++.|+.||+|||...| .|+.|+..|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 4568899999999999999999999999999999999976 3457777778899999999999999877 9999999999
Q ss_pred ccCCCCcEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcC-------CCccceEechhHHHHHHhhCCCCCch
Q 009364 203 LVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTG-------HSYSADIWSVGCTVIEMATGKPPWSQ 275 (536)
Q Consensus 203 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~-------~s~k~DIwSlGvil~eLltG~~Pf~~ 275 (536)
+++....+||+|||+.................-..-|.|||.+.+.. .+.+.||||+|+|++|+++...||..
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~ 160 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL 160 (484)
T ss_pred eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence 99999999999999977653211111111222345699999997642 35679999999999999999999964
Q ss_pred hh-----HHHHHHHhh-CCCCCCCCCCC--cCcHHHHHHHHHhcccCCCCCCCHHHHHh
Q 009364 276 QY-----QEVAALFHI-GTTKSHPPIPE--NLSVKAKDFLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 276 ~~-----~~~~~~~~~-~~~~~~~~~~~--~~s~~~~dLi~~cL~~dP~~Rps~~eiL~ 326 (536)
.. .++...... ......|.+.. ...+++..++.+||..+|..||+++++-.
T Consensus 161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 22 122222222 22223333321 45567899999999999999999999865
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.3e-18 Score=163.41 Aligned_cols=145 Identities=20% Similarity=0.225 Sum_probs=109.6
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchh--------------HHHHHHHHHHHHHHHHHhCCCCc
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKE--------------KAQDHIKELEEEVKLLKDLSHPN 132 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~--------------~~~~~~~~~~~Ei~iL~~l~Hpn 132 (536)
.|.+.+.||+|+||.||+|.+. +|+.||||++.......... ...........|+.++..+.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 4788899999999999999864 79999999874322100000 00011223667888999887774
Q ss_pred --eeeEeeeeecCCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcE
Q 009364 133 --IVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCI 210 (536)
Q Consensus 133 --Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~v 210 (536)
++..++ ....++||||++|++|..+... .....++.+++.++.++|+.||+||||||+||+++.++.+
T Consensus 95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~ 164 (198)
T cd05144 95 FPVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKI 164 (198)
T ss_pred CCCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcE
Confidence 444443 2356899999999998776431 3456789999999999999999999999999999999999
Q ss_pred EEEecCcchhhh
Q 009364 211 KLADFGASKQVA 222 (536)
Q Consensus 211 kL~DFGla~~~~ 222 (536)
+|+|||.+....
T Consensus 165 ~liDfg~~~~~~ 176 (198)
T cd05144 165 YIIDWPQMVSTD 176 (198)
T ss_pred EEEECCccccCC
Confidence 999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.8e-18 Score=187.25 Aligned_cols=145 Identities=21% Similarity=0.270 Sum_probs=113.8
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
..|...+.||+|+||+||+|.+. +..+++|+.................+.+.+|+++++.++|++++..+.++.....
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred cccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 45567899999999999999764 4445555442211111111112234568899999999999999887777777778
Q ss_pred eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhh
Q 009364 146 LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQV 221 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~ 221 (536)
.++||||++|++|.+++. ....++.|++.+|.+||+.|++||||||+|||+ .++.++|+|||+++..
T Consensus 411 ~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred CEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 899999999999988775 356799999999999999999999999999999 6789999999998653
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=7e-17 Score=152.34 Aligned_cols=144 Identities=25% Similarity=0.308 Sum_probs=98.8
Q ss_pred eeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHH----------------HHHHHHHHHHHHHHHhCCCCc--
Q 009364 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKA----------------QDHIKELEEEVKLLKDLSHPN-- 132 (536)
Q Consensus 71 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~----------------~~~~~~~~~Ei~iL~~l~Hpn-- 132 (536)
++.||+|+||+||+|.+. +|+.||||++............ .........|...+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 567999999999999876 7999999987432111000000 000011235666666664432
Q ss_pred eeeEeeeeecCCceeEEEEecCCCCcccc-cccCCCCCHHHHHHHHHHHHHHHHHHHH-cCCccccCCCCCcccCCCCcE
Q 009364 133 IVRYLGTVREEESLNILLEFVPGGSISSL-LGKFGPFPEAVMRTYTKQLLLGLEYLHN-HGIMHRDIKGANILVDNKGCI 210 (536)
Q Consensus 133 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~-l~~~~~l~~~~~~~i~~qil~aL~yLH~-~~ivHrDLKp~NILl~~~~~v 210 (536)
+.+.++. ...++||||++|+.+... +.... . ...+..++.+++.++.++|. .||+||||||+||+++ ++.+
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~ 153 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKV 153 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhh-h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcE
Confidence 4444433 246899999998654321 21111 1 16678999999999999999 9999999999999999 8899
Q ss_pred EEEecCcchhhh
Q 009364 211 KLADFGASKQVA 222 (536)
Q Consensus 211 kL~DFGla~~~~ 222 (536)
+|+|||.+....
T Consensus 154 ~liDfg~a~~~~ 165 (187)
T cd05119 154 YIIDVPQAVEID 165 (187)
T ss_pred EEEECccccccc
Confidence 999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.66 E-value=6.6e-16 Score=152.00 Aligned_cols=143 Identities=20% Similarity=0.292 Sum_probs=105.1
Q ss_pred eeEEc-ccCceEEEEEEEcCCCcEEEEEEEeehhh---ccchh--HHHHHHHHHHHHHHHHHhCCCCce--eeEeeeeec
Q 009364 71 GELIG-CGAFGRVYMGMNLDSGELLAVKQVLIAAN---FASKE--KAQDHIKELEEEVKLLKDLSHPNI--VRYLGTVRE 142 (536)
Q Consensus 71 ~~~LG-~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~---~~~~~--~~~~~~~~~~~Ei~iL~~l~HpnI--v~l~~~~~~ 142 (536)
+..|| .|+.|+||.+.. .+..++||.+..... ..... ........+.+|+.++..+.|++| +..+++...
T Consensus 36 ~~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred CceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 34688 899999998865 478899998742111 00000 001223567889999999998775 666665433
Q ss_pred C-Cc---eeEEEEecCC-CCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCc
Q 009364 143 E-ES---LNILLEFVPG-GSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGA 217 (536)
Q Consensus 143 ~-~~---~~lV~E~~~g-g~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGl 217 (536)
. .. .++|||+++| .+|.+++.. .++++. .+.||+.+|.+||++||+||||||+|||++.++.++|+|||.
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~ 188 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQE-APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDR 188 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhc-CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCC
Confidence 2 22 2599999997 688888765 455554 367899999999999999999999999999989999999998
Q ss_pred chh
Q 009364 218 SKQ 220 (536)
Q Consensus 218 a~~ 220 (536)
++.
T Consensus 189 ~~~ 191 (239)
T PRK01723 189 GEL 191 (239)
T ss_pred ccc
Confidence 754
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.64 E-value=4.2e-16 Score=139.90 Aligned_cols=132 Identities=23% Similarity=0.262 Sum_probs=110.0
Q ss_pred eeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCC--CceeeEeeeeecCCcee
Q 009364 70 KGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH--PNIVRYLGTVREEESLN 147 (536)
Q Consensus 70 ~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~H--pnIv~l~~~~~~~~~~~ 147 (536)
+.+.||+|.++.||++... +..+++|...... . ...+.+|+.+++.+.| .++++++.++...+..+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~-------~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~ 69 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSRE-------K---GADREREVAILQLLARKGLPVPKVLASGESDGWSY 69 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCC-------c---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccE
Confidence 4578999999999999873 4789999873211 0 2457788899999976 58899998888888899
Q ss_pred EEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccccCCCCCcccCCCCcEEEEecCcchh
Q 009364 148 ILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNH---GIMHRDIKGANILVDNKGCIKLADFGASKQ 220 (536)
Q Consensus 148 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~---~ivHrDLKp~NILl~~~~~vkL~DFGla~~ 220 (536)
++|||+.|+.+..+ +......++.+++.++++||.. +++|+||+|+||+++..+.++++|||.++.
T Consensus 70 ~v~e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 70 LLMEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred EEEEecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 99999998887655 5566778899999999999985 799999999999999989999999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.2e-16 Score=176.79 Aligned_cols=272 Identities=24% Similarity=0.363 Sum_probs=208.2
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE 142 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 142 (536)
..+..+.+.+.+-+|++|.++.+.-..+|...++|+...+..... ...+.+..+-.++-...+|-++...-.+..
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~-----~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~ 875 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRT-----NDYESIRSKSNILITPRSPAVVRSFPSFPC 875 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhcc-----ccccccCCccCccccCCCCceecccCCCCC
Confidence 345567778889999999999998878887777776643322211 112333334444444456777766666666
Q ss_pred CCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhh
Q 009364 143 EESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVA 222 (536)
Q Consensus 143 ~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~ 222 (536)
....++|++|..|++|...+++.+..+.+-++..+..+.++++|||+..+.|||++|.|+|+..+|+.+++|||......
T Consensus 876 rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 876 RSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred CCCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccc
Confidence 77899999999999999999998888888899999999999999999999999999999999999999999998443322
Q ss_pred hhh------------------------cc-----cCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCC
Q 009364 223 ELA------------------------TV-----SGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPW 273 (536)
Q Consensus 223 ~~~------------------------~~-----~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf 273 (536)
... .. .......||+.|.+||.+.+......+|+|++|+++++.++|.+||
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 110 00 0122456999999999999999999999999999999999999999
Q ss_pred chhhHHHHHHHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHH---HHHhCCCCcCCCCCcch
Q 009364 274 SQQYQEVAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTAS---ELLKHPFVTGDDEDPVL 339 (536)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~---eiL~hp~~~~~~~~~~~ 339 (536)
........-.........++..+...+.++++++.++|..+|.+|..+. ++-.|++|+...++...
T Consensus 1036 na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~l~ 1104 (1205)
T KOG0606|consen 1036 NAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWENLA 1104 (1205)
T ss_pred CCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCccccc
Confidence 7654332221112223344555667899999999999999999999887 89999999987776543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.7e-15 Score=160.22 Aligned_cols=256 Identities=24% Similarity=0.253 Sum_probs=194.2
Q ss_pred CCceeeeEEcc--cCceEEEEEEE--cCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeEeeee
Q 009364 66 IRWRKGELIGC--GAFGRVYMGMN--LDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRYLGTV 140 (536)
Q Consensus 66 ~~y~~~~~LG~--G~fg~Vy~a~~--~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~ 140 (536)
..+.+.+.+|. |.+|.||.+.. ..++..+|+|.-.+..... ..-..=.+|+...+.+ .|+|.++.+..+
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p------~~~~~k~~~~~s~~~i~~~~~~v~~~~~~ 187 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPP------LDSKRKLREFLSHHKIDSHENPVRDSPAW 187 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCc------cccccccchhhcccccCccccccccCccc
Confidence 35677889999 99999999988 8889999999732211100 0011113455555666 499999999999
Q ss_pred ecCCceeEEEEecCCCCcccccccCCC-CCHHHHHHHHHHHHH----HHHHHHHcCCccccCCCCCcccCCC-CcEEEEe
Q 009364 141 REEESLNILLEFVPGGSISSLLGKFGP-FPEAVMRTYTKQLLL----GLEYLHNHGIMHRDIKGANILVDNK-GCIKLAD 214 (536)
Q Consensus 141 ~~~~~~~lV~E~~~gg~L~~~l~~~~~-l~~~~~~~i~~qil~----aL~yLH~~~ivHrDLKp~NILl~~~-~~vkL~D 214 (536)
...+..++-+|+| +.+|..+...... ++...++..+.+..+ ||.++|+.+++|-|+||.||+...+ ...+++|
T Consensus 188 e~~~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~d 266 (524)
T KOG0601|consen 188 EGSGILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTD 266 (524)
T ss_pred ccCCcceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCC
Confidence 9999999999999 5777777665444 899999999999999 9999999999999999999999999 7899999
Q ss_pred cCcchhhhhhhcccC---CcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCC
Q 009364 215 FGASKQVAELATVSG---AKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKS 291 (536)
Q Consensus 215 FGla~~~~~~~~~~~---~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~ 291 (536)
||+...+....-... .....|...|++||++++ -++.+.|+|++|.++.+-.+|..+........ +........
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~--W~~~r~~~i 343 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSS--WSQLRQGYI 343 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCC--ccccccccC
Confidence 999888765432111 123357888999999876 68999999999999999998876653221111 111111112
Q ss_pred CCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCc
Q 009364 292 HPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVT 331 (536)
Q Consensus 292 ~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~ 331 (536)
...+....+.++...+..|++.+|..|+++..++.|+++.
T Consensus 344 p~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~ 383 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIH 383 (524)
T ss_pred chhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcccccc
Confidence 2334456677788899999999999999999999999986
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.48 E-value=3.2e-14 Score=153.91 Aligned_cols=148 Identities=18% Similarity=0.236 Sum_probs=95.5
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhc--------------------------cchhHHHHHHHHHHH
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANF--------------------------ASKEKAQDHIKELEE 120 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~--------------------------~~~~~~~~~~~~~~~ 120 (536)
.|+. +.||+|++|+||+|+.+.+|+.||||++...... .......+..+.+.+
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 3555 7899999999999999888999999998432100 000111122223333
Q ss_pred HHH------HHHhC----CCCceeeEeeeeec-CCceeEEEEecCCCCcccc--cccCC----CCCHHHHHHHHHHHHHH
Q 009364 121 EVK------LLKDL----SHPNIVRYLGTVRE-EESLNILLEFVPGGSISSL--LGKFG----PFPEAVMRTYTKQLLLG 183 (536)
Q Consensus 121 Ei~------iL~~l----~HpnIv~l~~~~~~-~~~~~lV~E~~~gg~L~~~--l~~~~----~l~~~~~~~i~~qil~a 183 (536)
|+. .+.++ .+.+.+.+-.++.+ ....++||||+.|+.+.++ +...+ .+.+..+..++.|++
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-- 277 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-- 277 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH--
Confidence 333 33333 23333333333322 3456799999999999774 33322 244444445555554
Q ss_pred HHHHHHcCCccccCCCCCcccCCCC----cEEEEecCcchhhh
Q 009364 184 LEYLHNHGIMHRDIKGANILVDNKG----CIKLADFGASKQVA 222 (536)
Q Consensus 184 L~yLH~~~ivHrDLKp~NILl~~~~----~vkL~DFGla~~~~ 222 (536)
..|++|+|+||.||+++.+| .++++|||++..+.
T Consensus 278 -----~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 278 -----RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred -----hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 59999999999999999888 99999999976554
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.45 E-value=2.9e-13 Score=144.47 Aligned_cols=148 Identities=18% Similarity=0.198 Sum_probs=97.0
Q ss_pred eeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccc--------------------------hhHHHHHHH------HH
Q 009364 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFAS--------------------------KEKAQDHIK------EL 118 (536)
Q Consensus 71 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~--------------------------~~~~~~~~~------~~ 118 (536)
.+.||.|++|+||+|+. .+|+.||||+........- .....+... .+
T Consensus 122 ~~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 122 EKPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred CcceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 35799999999999985 4799999998742210000 000011111 13
Q ss_pred HHHHHHHHhC----CCCceeeEeeeee-cCCceeEEEEecCCCCcccccccC-CCCCHHHHHHHHHHHHH-HHHHHHHcC
Q 009364 119 EEEVKLLKDL----SHPNIVRYLGTVR-EEESLNILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLL-GLEYLHNHG 191 (536)
Q Consensus 119 ~~Ei~iL~~l----~HpnIv~l~~~~~-~~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~-aL~yLH~~~ 191 (536)
.+|...+.++ +|.+-+.+-.++. .....++||||++|++|.++.... ... ....++.+++. .+..+|..|
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhCC
Confidence 4455544444 2332233333332 234578999999999998876421 112 23456666665 478899999
Q ss_pred CccccCCCCCcccCCCCcEEEEecCcchhhh
Q 009364 192 IMHRDIKGANILVDNKGCIKLADFGASKQVA 222 (536)
Q Consensus 192 ivHrDLKp~NILl~~~~~vkL~DFGla~~~~ 222 (536)
++|+|+||.||+++.+|.++++|||++..+.
T Consensus 278 ~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 9999999999999999999999999986654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.2e-12 Score=124.11 Aligned_cols=145 Identities=17% Similarity=0.134 Sum_probs=102.2
Q ss_pred eEEcccCceEEEEEEEcC------CCcEEEEEEEeehhh-ccchh-----------------HHHHHHHHHHHHHHHHHh
Q 009364 72 ELIGCGAFGRVYMGMNLD------SGELLAVKQVLIAAN-FASKE-----------------KAQDHIKELEEEVKLLKD 127 (536)
Q Consensus 72 ~~LG~G~fg~Vy~a~~~~------~g~~vAiK~i~~~~~-~~~~~-----------------~~~~~~~~~~~Ei~iL~~ 127 (536)
..||.|--+.||.|.... .+..+|||+...... +.... ..........+|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 469999999999997653 357999998754321 11000 001111223489999998
Q ss_pred CC--CCceeeEeeeeecCCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHH-HHcCCccccCCCCCccc
Q 009364 128 LS--HPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYL-HNHGIMHRDIKGANILV 204 (536)
Q Consensus 128 l~--HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yL-H~~~ivHrDLKp~NILl 204 (536)
+. .-++..++++ ...++||||+.++.+..-.-+...+++..+..+..|++.+|..| |..|||||||++.|||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~ 158 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLW 158 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 85 3466666654 45789999997654432211223456667778899999999999 89999999999999999
Q ss_pred CCCCcEEEEecCcchhh
Q 009364 205 DNKGCIKLADFGASKQV 221 (536)
Q Consensus 205 ~~~~~vkL~DFGla~~~ 221 (536)
. ++.+.|+|||.+...
T Consensus 159 ~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 159 H-DGKVWFIDVSQSVEP 174 (197)
T ss_pred E-CCcEEEEECCCceeC
Confidence 6 468999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.42 E-value=6.3e-13 Score=142.23 Aligned_cols=169 Identities=25% Similarity=0.389 Sum_probs=127.4
Q ss_pred EEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCceeEEEEecCCCCcccccc
Q 009364 84 MGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLG 163 (536)
Q Consensus 84 ~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~ 163 (536)
.|..+.++.+|.|..+.... ......+.+-++.|+.++||||+++++.++.++.+|||+|.+ ..|..+++
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~--------~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk 99 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSN--------GEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLK 99 (690)
T ss_pred ccceeccCCceEEEEEeCCC--------chhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHH
Confidence 45667788899998874221 134455677888999999999999999999999999999988 35555665
Q ss_pred cCCCCCHHHHHHHHHHHHHHHHHHH-HcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhcccCCcccCCCCCCCCh
Q 009364 164 KFGPFPEAVMRTYTKQLLLGLEYLH-NHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAP 242 (536)
Q Consensus 164 ~~~~l~~~~~~~i~~qil~aL~yLH-~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~AP 242 (536)
+. ........+.||+.||.+|| ..+++|++|.-..|+|+..|..||++|.++........ ......---.|..|
T Consensus 100 ~l---~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P 174 (690)
T KOG1243|consen 100 EL---GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDP 174 (690)
T ss_pred Hh---HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccCh
Confidence 53 36667788999999999998 56899999999999999999999999988754432111 11111222236666
Q ss_pred hhhhhcCCCccceEechhHHHHHHhhC
Q 009364 243 EVIRQTGHSYSADIWSVGCTVIEMATG 269 (536)
Q Consensus 243 Evl~~~~~s~k~DIwSlGvil~eLltG 269 (536)
+.+.... ...|.|.|||++++++.|
T Consensus 175 ~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 175 EEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred hhcCccc--cchhhhhHHHHHHHHhCc
Confidence 6543222 457999999999999999
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.3e-14 Score=142.70 Aligned_cols=244 Identities=21% Similarity=0.344 Sum_probs=159.5
Q ss_pred CceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC-----CceeEEEEe
Q 009364 78 AFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE-----ESLNILLEF 152 (536)
Q Consensus 78 ~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~-----~~~~lV~E~ 152 (536)
+.-.||++.++..|..|+.-.+... .........+....-..-|-.+-|.|||+++.++.+. ....++.||
T Consensus 78 gid~v~lamd~e~g~evvwneVq~~----~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFitey 153 (458)
T KOG1266|consen 78 GIDDVYLAMDTEEGVEVVWNEVQFS----ERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEY 153 (458)
T ss_pred chHHHHHHhhhccCchhhHHHHHHH----HhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEec
Confidence 3456888888887776654433111 1111111111122222334456799999999887643 357889999
Q ss_pred cCCCCcccccccC----CCCCHHHHHHHHHHHHHHHHHHHHcC--CccccCCCCCcccCCCCcEEEEecCcchhhhhh--
Q 009364 153 VPGGSISSLLGKF----GPFPEAVMRTYTKQLLLGLEYLHNHG--IMHRDIKGANILVDNKGCIKLADFGASKQVAEL-- 224 (536)
Q Consensus 153 ~~gg~L~~~l~~~----~~l~~~~~~~i~~qil~aL~yLH~~~--ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~-- 224 (536)
+..|++..+|++. ..+......+|+-||+.||.|||+.. |+|+++...-|++..+|-+|+.---........
T Consensus 154 mssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~ 233 (458)
T KOG1266|consen 154 MSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNS 233 (458)
T ss_pred ccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccccchhhhh
Confidence 9999999998653 45788888999999999999999985 999999999999999998887521111100000
Q ss_pred hcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH--HHHHHhhCCCCCCCCCCCcCcHH
Q 009364 225 ATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE--VAALFHIGTTKSHPPIPENLSVK 302 (536)
Q Consensus 225 ~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~--~~~~~~~~~~~~~~~~~~~~s~~ 302 (536)
..........|-++|.|||.=.....+.++|||++|+...+|..|..--...... ............. ...
T Consensus 234 ~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~le-------n~l 306 (458)
T KOG1266|consen 234 TREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGLE-------NGL 306 (458)
T ss_pred hhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeecc-------Ccc
Confidence 0000112234678999999766666778899999999999998876532111111 0111111111111 112
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHhCCCCcC
Q 009364 303 AKDFLLKCLEKEPDLRPTASELLKHPFVTG 332 (536)
Q Consensus 303 ~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~ 332 (536)
-+++|.+||+..|..||++.+++.||.+-+
T Consensus 307 qr~~i~kcl~~eP~~rp~ar~llfHpllfe 336 (458)
T KOG1266|consen 307 QRGSITKCLEGEPNGRPDARLLLFHPLLFE 336 (458)
T ss_pred ccCcCcccccCCCCCCcchhhhhcCceeee
Confidence 247899999999999999999999998754
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.39 E-value=7.3e-13 Score=122.57 Aligned_cols=127 Identities=17% Similarity=0.136 Sum_probs=93.7
Q ss_pred eeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCcee-eEeeeeecCCceeEE
Q 009364 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIV-RYLGTVREEESLNIL 149 (536)
Q Consensus 71 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv-~l~~~~~~~~~~~lV 149 (536)
.+.|+.|.++.||++.. .|..|++|+..... ........|+.+++.+.+.+++ +++... ....++|
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~---------~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv 69 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGT---------ELLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLI 69 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCc---------ccccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEE
Confidence 45789999999999976 47889999762110 0112346788888888654443 444443 2345799
Q ss_pred EEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCC-----ccccCCCCCcccCCCCcEEEEecCcch
Q 009364 150 LEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGI-----MHRDIKGANILVDNKGCIKLADFGASK 219 (536)
Q Consensus 150 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~i-----vHrDLKp~NILl~~~~~vkL~DFGla~ 219 (536)
|||++|.++.... .....++.+++.+|+.||+.++ +|||++|.||+++ ++.++++|||.+.
T Consensus 70 ~e~i~G~~l~~~~--------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 70 TEFIEGSELLTED--------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred EEecCCCcccccc--------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 9999998876531 1123467899999999999985 9999999999998 6789999999865
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.35 E-value=6.3e-13 Score=140.93 Aligned_cols=251 Identities=25% Similarity=0.241 Sum_probs=181.6
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEc-CCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeEeeee
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNL-DSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRYLGTV 140 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~-~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~ 140 (536)
....+|..+..||.|.|+.|+..... .++..|++|.+..... .....+. -..|+.+...+ .|.+++.++..+
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~-----~~~~di~-sl~ev~l~~~l~~~~~~~g~~~~W 335 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLA-----TFASDIF-SLGEVILEAILGSHLPSVGKNSSW 335 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcccc-----chHhhhc-chhhhhHhhHhhcccccCCCCCCc
Confidence 34457888999999999999987755 6788899997632111 0111111 12455555555 589999988888
Q ss_pred ecCCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCC-CcEEEEecCcch
Q 009364 141 REEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNK-GCIKLADFGASK 219 (536)
Q Consensus 141 ~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~-~~vkL~DFGla~ 219 (536)
...+..|+-.|||.++++...+.-...+.+...+++..|++.++.++|+..++|+|+||+||++.++ +..++.|||+..
T Consensus 336 ~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 336 SQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred cccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccc
Confidence 8888888999999999887766444567888899999999999999999999999999999999886 788999999876
Q ss_pred hhhhhhcccCCcccCCCCCCC--ChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCC
Q 009364 220 QVAELATVSGAKSMKGTPYWM--APEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPE 297 (536)
Q Consensus 220 ~~~~~~~~~~~~~~~Gt~~Y~--APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 297 (536)
.+.- ... ...+.-++. +|.......+..++|++|||.-+.+.++|.+.=.. ......+ .....+.. .
T Consensus 416 ~~~~----~~~-~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~-~~~~~~i----~~~~~p~~-~ 484 (524)
T KOG0601|consen 416 RLAF----SSG-VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES-GVQSLTI----RSGDTPNL-P 484 (524)
T ss_pred ccce----ecc-cccccccccccchhhccccccccccccccccccccccccCcccCcc-cccceee----ecccccCC-C
Confidence 4321 111 222333444 55555667789999999999999999998753211 1111111 11112222 3
Q ss_pred cCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCC
Q 009364 298 NLSVKAKDFLLKCLEKEPDLRPTASELLKHPFV 330 (536)
Q Consensus 298 ~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~ 330 (536)
....++..+.+.++.+++..||.+.++..|.-|
T Consensus 485 ~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 485 GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred chHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 445888899999999999999999999988655
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.28 E-value=2.6e-11 Score=111.81 Aligned_cols=138 Identities=20% Similarity=0.281 Sum_probs=102.8
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHH-HHHHHHHHHHHHHhCCCCceeeEeeeeecCCceeEEE
Q 009364 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQD-HIKELEEEVKLLKDLSHPNIVRYLGTVREEESLNILL 150 (536)
Q Consensus 72 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 150 (536)
..+++|+-+.+|.+.. -|..+++|. .+++.+..+...+. ...+-.+|..++..+.--.|...+=+..+.....|+|
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~-Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~m 78 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKE-RIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVM 78 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEe-ecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEE
Confidence 4588999999999865 344566664 34443333333322 2455678999999886555544444556677788999
Q ss_pred EecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchh
Q 009364 151 EFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQ 220 (536)
Q Consensus 151 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~ 220 (536)
||++|..|.+.+... ...+++.+-.-+.-||.+||+|+||.++||++...+ +.++|||++..
T Consensus 79 e~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 79 EYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 999999999888764 256777888888999999999999999999997764 99999999864
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.23 E-value=5.3e-11 Score=109.27 Aligned_cols=148 Identities=24% Similarity=0.255 Sum_probs=107.8
Q ss_pred eeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCceeEE
Q 009364 70 KGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESLNIL 149 (536)
Q Consensus 70 ~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 149 (536)
...+|-+|+-+.|+++.+ .|+...||.-....-..+.-..+-...+..+|+++|.++.--.|.-..=++.+...-.|+
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 467899999999999965 788888886422221222222233456678899999888654554444456677777899
Q ss_pred EEecCC-CCcccccccC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCC---cEEEEecCcch
Q 009364 150 LEFVPG-GSISSLLGKF--GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKG---CIKLADFGASK 219 (536)
Q Consensus 150 ~E~~~g-g~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~---~vkL~DFGla~ 219 (536)
|||++| .++.+++... ..........++++|-+.+.-||.++|||+||..+||++..+| .+.++|||++.
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchh
Confidence 999977 3677766432 2233333478999999999999999999999999999997766 46899999875
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.1e-10 Score=112.45 Aligned_cols=140 Identities=17% Similarity=0.242 Sum_probs=105.8
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCC--CceeeEeeeeecC---Cce
Q 009364 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH--PNIVRYLGTVREE---ESL 146 (536)
Q Consensus 72 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~H--pnIv~l~~~~~~~---~~~ 146 (536)
+.||.|..+.||++... +|+.+++|........ .....+..|+++++.+.+ .++.+++.+.... +..
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~-------~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~ 75 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL-------PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTP 75 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccC-------cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCc
Confidence 57899999999999764 3688999986321110 123456788999998865 3456677666553 367
Q ss_pred eEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------
Q 009364 147 NILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHN------------------------------------- 189 (536)
Q Consensus 147 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~------------------------------------- 189 (536)
++||||++|.++.+.+.. ..+++.....++.+++.+|..||+
T Consensus 76 ~~v~e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (223)
T cd05154 76 FYVMERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEP 154 (223)
T ss_pred eEEEEEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhccccc
Confidence 899999999998886643 457777888888888888888884
Q ss_pred -------------------cCCccccCCCCCcccCC--CCcEEEEecCcchh
Q 009364 190 -------------------HGIMHRDIKGANILVDN--KGCIKLADFGASKQ 220 (536)
Q Consensus 190 -------------------~~ivHrDLKp~NILl~~--~~~vkL~DFGla~~ 220 (536)
..++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 155 PAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23699999999999988 56789999997653
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.99 E-value=4.5e-09 Score=104.98 Aligned_cols=145 Identities=14% Similarity=0.038 Sum_probs=94.3
Q ss_pred EEcccCceEEEEEEEcCCCcEEEEEEEeehhhcc-chhH--HHHHHHHHHHHHHHHHhCCCCc--eeeEeeeeec-----
Q 009364 73 LIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFA-SKEK--AQDHIKELEEEVKLLKDLSHPN--IVRYLGTVRE----- 142 (536)
Q Consensus 73 ~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~-~~~~--~~~~~~~~~~Ei~iL~~l~Hpn--Iv~l~~~~~~----- 142 (536)
.+-......|+++.. .|+.|.||......-.. .+.- ...-...+.+|...+..|...+ ++.++.+...
T Consensus 29 ~v~~~~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 29 VFRELEGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred EEecCCCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 343334444666543 67789999662111000 0000 0000113567888877774322 2333334332
Q ss_pred CCceeEEEEecCCC-Cccccccc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCC-------CCcEEE
Q 009364 143 EESLNILLEFVPGG-SISSLLGK--FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDN-------KGCIKL 212 (536)
Q Consensus 143 ~~~~~lV~E~~~gg-~L~~~l~~--~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~-------~~~vkL 212 (536)
....++|||++++. +|.+++.. ..+.+......++.+++..+.-||.+||+|+||++.|||++. ++.+.|
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~L 186 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSV 186 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEE
Confidence 23578999999876 78888753 245567778899999999999999999999999999999975 458999
Q ss_pred EecCcch
Q 009364 213 ADFGASK 219 (536)
Q Consensus 213 ~DFGla~ 219 (536)
+||+.+.
T Consensus 187 IDl~r~~ 193 (268)
T PRK15123 187 IDLHRAQ 193 (268)
T ss_pred EECCccc
Confidence 9999774
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.8e-09 Score=101.98 Aligned_cols=133 Identities=23% Similarity=0.274 Sum_probs=84.4
Q ss_pred EEEEEEEcCCCcEEEEEEEeehhhcc------------------chhHHHHHHHHHHHHHHHHHhCCCC--ceeeEeeee
Q 009364 81 RVYMGMNLDSGELLAVKQVLIAANFA------------------SKEKAQDHIKELEEEVKLLKDLSHP--NIVRYLGTV 140 (536)
Q Consensus 81 ~Vy~a~~~~~g~~vAiK~i~~~~~~~------------------~~~~~~~~~~~~~~Ei~iL~~l~Hp--nIv~l~~~~ 140 (536)
.||.|.. .+|..+|+|+........ .............+|.+.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 4899986 467899999875432100 0111122345678899999999755 566666443
Q ss_pred ecCCceeEEEEecC--CCCcccccccCCCCCHHHHHHHHHHHHHHHHH-HHHcCCccccCCCCCcccCCCCcEEEEecCc
Q 009364 141 REEESLNILLEFVP--GGSISSLLGKFGPFPEAVMRTYTKQLLLGLEY-LHNHGIMHRDIKGANILVDNKGCIKLADFGA 217 (536)
Q Consensus 141 ~~~~~~~lV~E~~~--gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~y-LH~~~ivHrDLKp~NILl~~~~~vkL~DFGl 217 (536)
..+|||||++ |..+..+... .++......++.+++..+.. +|..||+||||.+.|||++.+ .+.|+|||.
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q 152 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ 152 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred ----CCEEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence 3579999998 5555443322 12244567788888886655 579999999999999999877 899999998
Q ss_pred chhh
Q 009364 218 SKQV 221 (536)
Q Consensus 218 a~~~ 221 (536)
+...
T Consensus 153 av~~ 156 (188)
T PF01163_consen 153 AVDS 156 (188)
T ss_dssp EEET
T ss_pred ceec
Confidence 7543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.94 E-value=3.8e-10 Score=121.63 Aligned_cols=153 Identities=22% Similarity=0.306 Sum_probs=113.1
Q ss_pred HHHHHHHHHHHc-CCccccCCCCCcccCCCCcEEEEecCcchhhhhhhcccCC--------cccCCCCCCCChhhhhhcC
Q 009364 179 QLLLGLEYLHNH-GIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGA--------KSMKGTPYWMAPEVIRQTG 249 (536)
Q Consensus 179 qil~aL~yLH~~-~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~--------~~~~Gt~~Y~APEvl~~~~ 249 (536)
+.+.|+.|+|.. ++||+.|.|++|.++..|.+||+.|+.+........ ... ....-...|.|||++.+..
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~-~p~~~yd~~lp~~~~~~~~f~apE~~~~~~ 185 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTE-YPFSEYDPPLPLLLQPHLNFLAPEYLLGTT 185 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCc-cccccCCCCCChhhccCcccccchhhcccc
Confidence 344899999965 899999999999999999999999998765443111 111 1112356799999999988
Q ss_pred CCccceEechhHHHHHHh-hCCCCCchhhHHHH-HHHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 250 HSYSADIWSVGCTVIEMA-TGKPPWSQQYQEVA-ALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 250 ~s~k~DIwSlGvil~eLl-tG~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
.+.++|+||+||++|.+. .|+..+........ .............+..+++.++++-+.++|..++..||++.+++..
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~ 265 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSI 265 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhcc
Confidence 899999999999999999 55555543321111 1111111112223446899999999999999999999999999999
Q ss_pred CCCcC
Q 009364 328 PFVTG 332 (536)
Q Consensus 328 p~~~~ 332 (536)
|||..
T Consensus 266 ~ff~D 270 (700)
T KOG2137|consen 266 PFFSD 270 (700)
T ss_pred cccCC
Confidence 99975
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.93 E-value=5.6e-09 Score=109.17 Aligned_cols=212 Identities=19% Similarity=0.240 Sum_probs=152.9
Q ss_pred CceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeee----cCCceeEEEEec
Q 009364 78 AFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVR----EEESLNILLEFV 153 (536)
Q Consensus 78 ~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~----~~~~~~lV~E~~ 153 (536)
--.+.|++....+|..|++|.+........ .....-+++++++.|+|||++.++|. .+..+++|++|.
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~--------nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYy 359 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQST--------NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYY 359 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCc--------ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecC
Confidence 446889999999999999998832221111 11123467899999999999999987 345789999998
Q ss_pred CCC-Cccccc---------------ccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCc
Q 009364 154 PGG-SISSLL---------------GKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGA 217 (536)
Q Consensus 154 ~gg-~L~~~l---------------~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGl 217 (536)
++. +|.++- ......+|..+|.++.||..||.++|+.|+.-+-|.|.+||++.+.+++|...|.
T Consensus 360 P~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i 439 (655)
T KOG3741|consen 360 PSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGI 439 (655)
T ss_pred CCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccc
Confidence 864 565543 1123478999999999999999999999999999999999999988999988887
Q ss_pred chhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCC-Cch-hhHHHHHHHhhCCCCCCCCC
Q 009364 218 SKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPP-WSQ-QYQEVAALFHIGTTKSHPPI 295 (536)
Q Consensus 218 a~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~P-f~~-~~~~~~~~~~~~~~~~~~~~ 295 (536)
...+.... + |-+.+ -.+-|.=.||.++..|.||..- +.. ..+.. .+ ..+
T Consensus 440 ~Dvl~~d~---------~-------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s-~~---------~~I 490 (655)
T KOG3741|consen 440 MDVLQEDP---------T-------EPLES---QQQNDLRDLGLLLLALATGTENSNRTDSTQSS-HL---------TRI 490 (655)
T ss_pred eeeecCCC---------C-------cchhH---HhhhhHHHHHHHHHHHhhcccccccccchHHH-HH---------HHh
Confidence 65443321 0 11111 1245777899999999999543 111 11111 00 113
Q ss_pred CCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 296 PENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 296 ~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
...++.+++++|..+...++++ -+..+++.|
T Consensus 491 ~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 491 TTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred hhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 3578999999999999999986 778888765
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.89 E-value=7.4e-09 Score=101.05 Aligned_cols=142 Identities=22% Similarity=0.246 Sum_probs=103.4
Q ss_pred ceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhH--------------HHHHHHHHHHHHHHHHhCCCC--
Q 009364 68 WRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEK--------------AQDHIKELEEEVKLLKDLSHP-- 131 (536)
Q Consensus 68 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~--------------~~~~~~~~~~Ei~iL~~l~Hp-- 131 (536)
+.++..||-|--|.||.|.+. .|.++|+|.-........+.+ ..-.....++|.++|..|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 567899999999999999865 689999997533222111100 011234567899999998644
Q ss_pred ceeeEeeeeecCCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEE
Q 009364 132 NIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIK 211 (536)
Q Consensus 132 nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vk 211 (536)
.|.+.+++ +...+||||++|-.|...-- ..+....++..|+.-+.-+-..||||+|+.+-||+++++|.+.
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r~-----~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~ 242 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLRL-----DVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIV 242 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeecccC-----cccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEE
Confidence 66665543 45679999999977765431 3444556667777777766789999999999999999999999
Q ss_pred EEecCcch
Q 009364 212 LADFGASK 219 (536)
Q Consensus 212 L~DFGla~ 219 (536)
++||--+.
T Consensus 243 vIDwPQ~v 250 (304)
T COG0478 243 VIDWPQAV 250 (304)
T ss_pred EEeCcccc
Confidence 99997543
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.82 E-value=5.5e-08 Score=99.54 Aligned_cols=237 Identities=17% Similarity=0.204 Sum_probs=147.8
Q ss_pred eeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeEeee------ee-
Q 009364 70 KGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRYLGT------VR- 141 (536)
Q Consensus 70 ~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~------~~- 141 (536)
.++.||+|+-+.+|-.-.. + ..+.|++....... +. .-+..|... .||-+-.=+-| .-
T Consensus 15 ~gr~LgqGgea~ly~l~e~--~-d~VAKIYh~Pppa~-----~a------qk~a~la~~p~~p~~~~rvaWPqa~L~G~~ 80 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV--R-DQVAKIYHAPPPAA-----QA------QKVAELAATPDAPLLNYRVAWPQATLHGGR 80 (637)
T ss_pred CCccccCCccceeeecchh--h-chhheeecCCCchH-----HH------HHHHHhccCCCCcchhhhhcccHHHhhCCC
Confidence 3567999999999964321 2 23457764322111 10 112223333 45543321111 11
Q ss_pred cCCceeEEEEecCCCC-ccccc------ccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEe
Q 009364 142 EEESLNILLEFVPGGS-ISSLL------GKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLAD 214 (536)
Q Consensus 142 ~~~~~~lV~E~~~gg~-L~~~l------~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~D 214 (536)
....+.+.|..++|.. +..+. +....+.+.-+.+.++.|+.+.+.||..|.+-+|+.++|+|+++++.|.|+|
T Consensus 81 ~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVd 160 (637)
T COG4248 81 RGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVD 160 (637)
T ss_pred ccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEc
Confidence 1223678888887652 22222 1223467788899999999999999999999999999999999999999998
Q ss_pred cCcchhhhhhhcccCCcccCCCCCCCChhhhh-----hcCCCccceEechhHHHHHHhhC-CCCCchhh---------H-
Q 009364 215 FGASKQVAELATVSGAKSMKGTPYWMAPEVIR-----QTGHSYSADIWSVGCTVIEMATG-KPPWSQQY---------Q- 278 (536)
Q Consensus 215 FGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~-----~~~~s~k~DIwSlGvil~eLltG-~~Pf~~~~---------~- 278 (536)
=..-.... ........+|.+.|.+||... +..-+...|.|.|||++++|+.| +.||.+.. +
T Consensus 161 sDsfqi~~---ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~ 237 (637)
T COG4248 161 SDSFQINA---NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET 237 (637)
T ss_pred ccceeecc---CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh
Confidence 55332221 112234567999999999764 44457789999999999999887 89996422 1
Q ss_pred HHHHHH-h------hCCCCCCCCCC-CcCcHHHHHHHHHhccc--CCCCCCCHHH
Q 009364 279 EVAALF-H------IGTTKSHPPIP-ENLSVKAKDFLLKCLEK--EPDLRPTASE 323 (536)
Q Consensus 279 ~~~~~~-~------~~~~~~~~~~~-~~~s~~~~dLi~~cL~~--dP~~Rps~~e 323 (536)
.+..-. . .+.......+| .-++++++.|..+|+.. ++.-|||++.
T Consensus 238 ~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 238 DIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred hhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 111100 0 00001111111 35788999999999875 3678999864
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.79 E-value=3.3e-08 Score=95.13 Aligned_cols=104 Identities=22% Similarity=0.294 Sum_probs=80.6
Q ss_pred HHHHHHHHHHhCCC--CceeeEeeeeecC----CceeEEEEecCCC-CcccccccCCCCCHHHHHHHHHHHHHHHHHHHH
Q 009364 117 ELEEEVKLLKDLSH--PNIVRYLGTVREE----ESLNILLEFVPGG-SISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHN 189 (536)
Q Consensus 117 ~~~~Ei~iL~~l~H--pnIv~l~~~~~~~----~~~~lV~E~~~gg-~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~ 189 (536)
...+|...+..|.. -.+++.+.+.... ...++|+|++++. +|.+++......+......++.+++..++-||.
T Consensus 57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH~ 136 (206)
T PF06293_consen 57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLHD 136 (206)
T ss_pred HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHHH
Confidence 45667777666642 2234444444332 2458999999885 788888765557778888999999999999999
Q ss_pred cCCccccCCCCCcccCCCC---cEEEEecCcchh
Q 009364 190 HGIMHRDIKGANILVDNKG---CIKLADFGASKQ 220 (536)
Q Consensus 190 ~~ivHrDLKp~NILl~~~~---~vkL~DFGla~~ 220 (536)
+||+|+|+++.|||++.++ .+.++||+-++.
T Consensus 137 ~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 137 AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred CcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999999999999999887 899999997654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.79 E-value=1.1e-09 Score=116.95 Aligned_cols=247 Identities=24% Similarity=0.232 Sum_probs=174.3
Q ss_pred CCCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCc-eeeEeeee
Q 009364 62 MSPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPN-IVRYLGTV 140 (536)
Q Consensus 62 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hpn-Iv~l~~~~ 140 (536)
...+..|...+-+++|+++++++.+...+...+ .+.+. .. ....-++++|.+++||| .+..++-+
T Consensus 238 kDk~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs-------~~------l~~rl~~eLLdK~n~P~~~v~~~~d~ 303 (829)
T KOG0576|consen 238 KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVS-------QT------LSRRLAIELLDKVNNPNPVVRYLEDY 303 (829)
T ss_pred cCCccchHHHHHHHHHHhcCCCccCCChhhhee-ceeec-------cc------hhhHHHHHHHHHccCCCCcccccccC
Confidence 355566777888999999999998776554444 55552 11 23456788999999999 78888888
Q ss_pred ecCCceeEEEEecCCC-Cccccccc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcc
Q 009364 141 REEESLNILLEFVPGG-SISSLLGK-FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGAS 218 (536)
Q Consensus 141 ~~~~~~~lV~E~~~gg-~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla 218 (536)
..+...+++++++.++ +....+.. .-.+.+-+...+.+.-+++++++|+.-=+||| ||+..+ +..|..||+..
T Consensus 304 ~~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~ 378 (829)
T KOG0576|consen 304 DGEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVP 378 (829)
T ss_pred CcccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCC
Confidence 8888999999999887 33222211 11233444556677778899999998888999 887765 68999999988
Q ss_pred hhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCC-
Q 009364 219 KQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPE- 297 (536)
Q Consensus 219 ~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~- 297 (536)
..+.... ...+..+|+.++|||+.....+....|.|++|+-..+|--|.+|-..... .....+.....+....
T Consensus 379 ~~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~---~~~~~g~~p~s~~L~~~ 452 (829)
T KOG0576|consen 379 PQLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSPPA---VLPMIGNGPNSPMLTDK 452 (829)
T ss_pred cccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCCcc---ccCCCCCCCCccccchh
Confidence 7766533 35678899999999999999999999999999988888888887543110 0111111110000000
Q ss_pred -cCc-HHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 298 -NLS-VKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 298 -~~s-~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
..+ ..-.++...|+..-|..|+....++.|.+|...
T Consensus 453 ~aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngC 490 (829)
T KOG0576|consen 453 SAWSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGC 490 (829)
T ss_pred hhcCcccccCCcccccCCCCCCCcchhhHHHHHHhccC
Confidence 000 111247788999999999999999999988754
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.55 E-value=1.3e-06 Score=84.61 Aligned_cols=144 Identities=17% Similarity=0.202 Sum_probs=97.2
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchh---------------HHHH-HHHHHHHHHHHHHhCC--CCce
Q 009364 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKE---------------KAQD-HIKELEEEVKLLKDLS--HPNI 133 (536)
Q Consensus 72 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~---------------~~~~-~~~~~~~Ei~iL~~l~--HpnI 133 (536)
-.|..|--+.||+|.. .++..+|+|++........+. .... ...-..+|+.-|+++. +-.+
T Consensus 54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 3677888889999974 568999999985443221110 0001 1122457788888774 4445
Q ss_pred eeEeeeeecCCceeEEEEecCCCC-cccccccCCCCCHHHHHHHHHHHHHHHHHHHH-cCCccccCCCCCcccCCCCcEE
Q 009364 134 VRYLGTVREEESLNILLEFVPGGS-ISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHN-HGIMHRDIKGANILVDNKGCIK 211 (536)
Q Consensus 134 v~l~~~~~~~~~~~lV~E~~~gg~-L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~-~~ivHrDLKp~NILl~~~~~vk 211 (536)
.+.+.+. ...|||||+...- -.-.|+. -++....+..+..++++.+.-|-. .++||+||..-|||+. ++.+.
T Consensus 133 P~Pi~~~----~nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~ 206 (268)
T COG1718 133 PEPIAFR----NNVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPY 206 (268)
T ss_pred CCceeec----CCeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEE
Confidence 5555544 3469999995431 1112222 223344788899999999999877 8999999999999998 78999
Q ss_pred EEecCcchhhh
Q 009364 212 LADFGASKQVA 222 (536)
Q Consensus 212 L~DFGla~~~~ 222 (536)
|+|||-|....
T Consensus 207 iID~~QaV~~~ 217 (268)
T COG1718 207 IIDVSQAVTID 217 (268)
T ss_pred EEECccccccC
Confidence 99999876443
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.54 E-value=1.8e-06 Score=82.78 Aligned_cols=139 Identities=17% Similarity=0.238 Sum_probs=88.7
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHH------HHHHHHHHHHhCC---CCceee
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIK------ELEEEVKLLKDLS---HPNIVR 135 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~------~~~~Ei~iL~~l~---HpnIv~ 135 (536)
..+|.+.+++-......|.+.. .+|+.+++|...... ...+.... ...+++..+.++. -..+..
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~-----~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~ 102 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREEN-----RRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPAD 102 (229)
T ss_pred hCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhh-----hhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccc
Confidence 3578888888888888887764 367889999752111 01111111 1223333333332 222222
Q ss_pred Eeee-----eecCCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcE
Q 009364 136 YLGT-----VREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCI 210 (536)
Q Consensus 136 l~~~-----~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~v 210 (536)
++-+ +.-....+++|||++|..|.+... +++ .+...+.+++.-||..|++|+|.+|.|++++++ .+
T Consensus 103 ~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i 173 (229)
T PF06176_consen 103 PYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GI 173 (229)
T ss_pred ceeeeeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cE
Confidence 2222 222345678999999988877632 233 345677788999999999999999999999865 49
Q ss_pred EEEecCcch
Q 009364 211 KLADFGASK 219 (536)
Q Consensus 211 kL~DFGla~ 219 (536)
+++||+..+
T Consensus 174 ~iID~~~k~ 182 (229)
T PF06176_consen 174 RIIDTQGKR 182 (229)
T ss_pred EEEECcccc
Confidence 999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.49 E-value=5.4e-07 Score=97.47 Aligned_cols=147 Identities=22% Similarity=0.251 Sum_probs=90.2
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEEeehhh--------------------------ccchhHHHHHHHHH------H
Q 009364 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAAN--------------------------FASKEKAQDHIKEL------E 119 (536)
Q Consensus 72 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~--------------------------~~~~~~~~~~~~~~------~ 119 (536)
+.|+.++-|+||+|+.. +|+.||||+...... ........+..+.+ .
T Consensus 131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 56999999999999864 599999998622110 01111111222222 3
Q ss_pred HHHHHHHhC----C-CCceeeEeeee-ecCCceeEEEEecCCCCccccc--ccCCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 009364 120 EEVKLLKDL----S-HPNIVRYLGTV-REEESLNILLEFVPGGSISSLL--GKFGPFPEAVMRTYTKQLLLGLEYLHNHG 191 (536)
Q Consensus 120 ~Ei~iL~~l----~-HpnIv~l~~~~-~~~~~~~lV~E~~~gg~L~~~l--~~~~~l~~~~~~~i~~qil~aL~yLH~~~ 191 (536)
+|...+.++ + .++| .+=.+| +-...-.++|||++|-.+.+.. .. ..++...+.....++ -+..+-..|
T Consensus 210 ~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~--f~~q~~~dg 285 (517)
T COG0661 210 REAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRA--FLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHH--HHHHHHhcC
Confidence 333333333 2 2333 222222 2345568999999999988874 33 344533332222221 122333589
Q ss_pred CccccCCCCCcccCCCCcEEEEecCcchhhhh
Q 009364 192 IMHRDIKGANILVDNKGCIKLADFGASKQVAE 223 (536)
Q Consensus 192 ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 223 (536)
+.|.|.+|.||+++.+|.+.+.|||+...+.+
T Consensus 286 ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 286 FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 99999999999999999999999999866544
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.46 E-value=9.9e-07 Score=84.25 Aligned_cols=142 Identities=18% Similarity=0.186 Sum_probs=97.0
Q ss_pred EcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCc--eeeEeeeee---c--CCce
Q 009364 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPN--IVRYLGTVR---E--EESL 146 (536)
Q Consensus 74 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hpn--Iv~l~~~~~---~--~~~~ 146 (536)
-|+||-|.|+.... .|+.+=+|.-......... ..--...+.+|+..|..|...+ +.++. ++. . ....
T Consensus 26 ~~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r--~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA 100 (216)
T PRK09902 26 YRRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVR--YPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRA 100 (216)
T ss_pred cCCCCcceEEEEEe--CCcEEEEEeccCccccccc--CCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEE
Confidence 36789999998754 4456777764200000000 0011345778888888885322 44444 222 1 2246
Q ss_pred eEEEEecCC-CCcccccccC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCc--EEEEecCcchh
Q 009364 147 NILLEFVPG-GSISSLLGKF--GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGC--IKLADFGASKQ 220 (536)
Q Consensus 147 ~lV~E~~~g-g~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~--vkL~DFGla~~ 220 (536)
+||+|-+.| -+|.+++.+. .+.+......++.+++.++.-||..|+.|+|+-+.||+++.+|. ++++||--++.
T Consensus 101 ~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 101 LLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 799998854 4777777552 35677778899999999999999999999999999999987776 99999986653
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.42 E-value=7.3e-07 Score=101.39 Aligned_cols=205 Identities=26% Similarity=0.386 Sum_probs=149.4
Q ss_pred HHHHHHHHHHHHHhCCCCceeeEeeeeecCCc----eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHH
Q 009364 114 HIKELEEEVKLLKDLSHPNIVRYLGTVREEES----LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHN 189 (536)
Q Consensus 114 ~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~----~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~ 189 (536)
.+....-|...+..+.|+|++.++.+...... ..+..++|...++...+...+..+....+.+..+++.|+.|+|+
T Consensus 225 ~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 225 EIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHH
Confidence 34455567778888899999999988765433 33456889999999999988999999999999999999999999
Q ss_pred cCCccccCCCC---CcccCCCCcEEEE--ecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCcc--ceEechhHH
Q 009364 190 HGIMHRDIKGA---NILVDNKGCIKLA--DFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYS--ADIWSVGCT 262 (536)
Q Consensus 190 ~~ivHrDLKp~---NILl~~~~~vkL~--DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k--~DIwSlGvi 262 (536)
....|.-|... +.-++..+.+.++ ||+.+........ .....-+..|.|||.........+ .|+|.+|..
T Consensus 305 ~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~---~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll 381 (1351)
T KOG1035|consen 305 LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK---SFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLL 381 (1351)
T ss_pred hccceeEEecccccccccCccceeecchhhhcccccCCCccc---chhhcCccccccccccccccchhhhhhHHHHHHHH
Confidence 97777666555 5555666677777 8888776553221 222334566888888876665544 699999999
Q ss_pred HHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 263 VIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 263 l~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
+..+..|..+-... ..... ..+........+++.+|+.-++++|+++.+++.|+|.+..
T Consensus 382 ~~~~~~~~~i~~~~-~~~~~-----------~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 382 LLQLSQGEDISEKS-AVPVS-----------LLDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFP 440 (1351)
T ss_pred HhhhhhcCcccccc-cchhh-----------hhccccchhhhhhhhhhcchhhhhccchhhhhhchhcccc
Confidence 99999887552111 00000 0111222267788999999999999999999999998754
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.41 E-value=1.1e-06 Score=85.90 Aligned_cols=133 Identities=14% Similarity=0.177 Sum_probs=80.7
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCc--eeeEeeeeecCCceeEE
Q 009364 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPN--IVRYLGTVREEESLNIL 149 (536)
Q Consensus 72 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hpn--Iv~l~~~~~~~~~~~lV 149 (536)
.+||+|..+.||+. .|..+++|..... . ....+.+|.++++.+..-. +.+.+++....+...+|
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~-------~---~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv 72 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPG-------F---DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLI 72 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCC-------C---CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeee
Confidence 57899999999984 2556788876210 0 1233577888888885433 46677777777778899
Q ss_pred EEecCCCC-ccccc---------------------ccC--CCCCHHHH-HHHHHHH----------HH-HHHHHHH----
Q 009364 150 LEFVPGGS-ISSLL---------------------GKF--GPFPEAVM-RTYTKQL----------LL-GLEYLHN---- 189 (536)
Q Consensus 150 ~E~~~gg~-L~~~l---------------------~~~--~~l~~~~~-~~i~~qi----------l~-aL~yLH~---- 189 (536)
||+++|.+ +...+ +.. ...+.... ..+..++ .. ...+|..
T Consensus 73 ~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~ 152 (226)
T TIGR02172 73 YELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDT 152 (226)
T ss_pred eeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCC
Confidence 99999863 11111 110 01111110 0111111 11 1122221
Q ss_pred cCCccccCCCCCcccCCCCcEEEEecCcch
Q 009364 190 HGIMHRDIKGANILVDNKGCIKLADFGASK 219 (536)
Q Consensus 190 ~~ivHrDLKp~NILl~~~~~vkL~DFGla~ 219 (536)
..++|+|++|.||+++.++ +.|+||+.+.
T Consensus 153 ~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 153 STCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 2468999999999999888 9999999764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.36 E-value=3e-06 Score=81.87 Aligned_cols=137 Identities=26% Similarity=0.357 Sum_probs=78.5
Q ss_pred eeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCC--ceeeEeeee---ecCCc
Q 009364 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHP--NIVRYLGTV---REEES 145 (536)
Q Consensus 71 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hp--nIv~l~~~~---~~~~~ 145 (536)
++.|+.|..+.||++.... ..+++|... .. .....+.+|..+++.+... .+.+++... .....
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~-------~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~ 69 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYR-------PP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGF 69 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEES-------SH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeC-------CC---CCHHHHHHHHHHHHHHHhcCCCCceEEeeccccccccc
Confidence 4679999999999998644 589999862 11 2345566788888777432 345555533 22335
Q ss_pred eeEEEEecCCCCccc----------------cc---ccC----CCCCHHH---H---HH---H------------HHHHH
Q 009364 146 LNILLEFVPGGSISS----------------LL---GKF----GPFPEAV---M---RT---Y------------TKQLL 181 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~----------------~l---~~~----~~l~~~~---~---~~---i------------~~qil 181 (536)
.+++|++++|..+.. .+ +.. .++.... . .. . ...+.
T Consensus 70 ~~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (239)
T PF01636_consen 70 PYLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELE 149 (239)
T ss_dssp EEEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHH
T ss_pred ceEEEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHH
Confidence 789999999887766 11 011 1111000 0 00 0 11122
Q ss_pred H-HHHHHHH-------cCCccccCCCCCcccC-CCCcEEEEecCcch
Q 009364 182 L-GLEYLHN-------HGIMHRDIKGANILVD-NKGCIKLADFGASK 219 (536)
Q Consensus 182 ~-aL~yLH~-------~~ivHrDLKp~NILl~-~~~~vkL~DFGla~ 219 (536)
. .+..++. ..++|+|+.|.|||++ .++.+-|+||+.+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 150 ERLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 2 3333332 3599999999999999 66677899998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.13 E-value=9.9e-06 Score=87.58 Aligned_cols=146 Identities=20% Similarity=0.193 Sum_probs=88.1
Q ss_pred eeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhc-----------------------cchhHHHHHHHHHHHH------
Q 009364 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANF-----------------------ASKEKAQDHIKELEEE------ 121 (536)
Q Consensus 71 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~-----------------------~~~~~~~~~~~~~~~E------ 121 (536)
.+.||.-+.|+||+|+.+. |+.||||+-...-.. .-.-...+..+.+..|
T Consensus 166 ~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E 244 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE 244 (538)
T ss_pred cchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence 3679999999999999655 999999985211100 0000000111112222
Q ss_pred H----HHHHhCCCCc------eeeEeeeeecCCceeEEEEecCCCCccccc--ccCCCCCHHHHHHHHHHHHHHHH-HHH
Q 009364 122 V----KLLKDLSHPN------IVRYLGTVREEESLNILLEFVPGGSISSLL--GKFGPFPEAVMRTYTKQLLLGLE-YLH 188 (536)
Q Consensus 122 i----~iL~~l~Hpn------Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l--~~~~~l~~~~~~~i~~qil~aL~-yLH 188 (536)
. ++.+.+.|-+ |.++|..+ ...-.|+||||+|..+.++- .+ ..++... +...+.++.. -|=
T Consensus 245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~-~gi~~~~---i~~~l~~~~~~qIf 318 (538)
T KOG1235|consen 245 AKNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDK-RGISPHD---ILNKLVEAYLEQIF 318 (538)
T ss_pred HHhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHH-cCCCHHH---HHHHHHHHHHHHHH
Confidence 2 2333344545 44444333 23567999999999887763 33 3345443 3333333322 233
Q ss_pred HcCCccccCCCCCcccCC----CCcEEEEecCcchhhhh
Q 009364 189 NHGIMHRDIKGANILVDN----KGCIKLADFGASKQVAE 223 (536)
Q Consensus 189 ~~~ivHrDLKp~NILl~~----~~~vkL~DFGla~~~~~ 223 (536)
..|++|+|=+|.||++.. ++.+.+-|||+...+..
T Consensus 319 ~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 319 KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred hcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 578999999999999983 56899999999765543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.12 E-value=1.5e-05 Score=78.53 Aligned_cols=75 Identities=20% Similarity=0.140 Sum_probs=50.2
Q ss_pred EEcccCc-eEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCC-CCceeeEeeeeecCCceeEEE
Q 009364 73 LIGCGAF-GRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS-HPNIVRYLGTVREEESLNILL 150 (536)
Q Consensus 73 ~LG~G~f-g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV~ 150 (536)
.|-.|.. ..||+... .+..+.+|.... .. ...+.+|+.+++.+. +--+.+++++....+..++||
T Consensus 5 ~~~~g~~~~~v~~~~~--~~~~~~vk~~~~-------~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 71 (244)
T cd05150 5 RVTEGQSGATVYRLDG--KNPGLYLKIAPS-------GP----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLT 71 (244)
T ss_pred ecCCCCCcCeEEEEcC--CCCcEEEEecCC-------Cc----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEE
Confidence 3445555 88999864 346788886521 00 224567888887774 344567777777667789999
Q ss_pred EecCCCCccc
Q 009364 151 EFVPGGSISS 160 (536)
Q Consensus 151 E~~~gg~L~~ 160 (536)
|+++|.++..
T Consensus 72 e~i~G~~l~~ 81 (244)
T cd05150 72 SAVPGVPAAA 81 (244)
T ss_pred EeeCCccHhH
Confidence 9999887654
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.07 E-value=3e-05 Score=89.71 Aligned_cols=81 Identities=12% Similarity=0.224 Sum_probs=55.2
Q ss_pred eeEEcccCceEEEEEEEcCCC--cEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCC-CCce--eeEeeeeecC--
Q 009364 71 GELIGCGAFGRVYMGMNLDSG--ELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS-HPNI--VRYLGTVREE-- 143 (536)
Q Consensus 71 ~~~LG~G~fg~Vy~a~~~~~g--~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnI--v~l~~~~~~~-- 143 (536)
.+.|+.|.+..+|+......+ ..+++|+..... .......+.+|+.+|+.+. |.++ .+++.++.+.
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~-------~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v 115 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGK-------LLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASV 115 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCc-------cCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCc
Confidence 577899999999998764432 467777642111 0011235678999999985 6664 6777777654
Q ss_pred -CceeEEEEecCCCCc
Q 009364 144 -ESLNILLEFVPGGSI 158 (536)
Q Consensus 144 -~~~~lV~E~~~gg~L 158 (536)
+..|+||||++|..+
T Consensus 116 ~G~~flVME~v~G~~~ 131 (822)
T PLN02876 116 IGTAFYIMEYLEGRIF 131 (822)
T ss_pred CCCceEEEEecCCccc
Confidence 467899999988654
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.07 E-value=1.2e-05 Score=74.18 Aligned_cols=131 Identities=21% Similarity=0.183 Sum_probs=91.0
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceee-EeeeeecCCc
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVR-YLGTVREEES 145 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~-l~~~~~~~~~ 145 (536)
.-++.+.||+|++|.||++.+ .|..+|+|+-.- ......+..|.++|..++-.++.+ +|.+-.
T Consensus 23 ~~~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~----------ds~r~~l~kEakiLeil~g~~~~p~vy~yg~---- 86 (201)
T COG2112 23 ELRVEKELAKGTTSVVYLGEW--RGGEVALKVRRR----------DSPRRNLEKEAKILEILAGEGVTPEVYFYGE---- 86 (201)
T ss_pred hhhhhhhhhcccccEEEEeec--cCceEEEEEecC----------CcchhhHHHHHHHHHHhhhcCCCceEEEech----
Confidence 345678899999999999987 566899997521 122356788999999888766654 333322
Q ss_pred eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCC-CCCcccCCCCcEEEEecCcchh
Q 009364 146 LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIK-GANILVDNKGCIKLADFGASKQ 220 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLK-p~NILl~~~~~vkL~DFGla~~ 220 (536)
.++.|||+.|-.|.++-... -++-...++.+-.-|-..||-|+.|. |...++..++.+.|+||..|+.
T Consensus 87 ~~i~me~i~G~~L~~~~~~~-------~rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 87 DFIRMEYIDGRPLGKLEIGG-------DRKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhhhhcCcchhhhhhcc-------cHHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 23559999987877654321 13344556666666778899999996 4444444555999999998873
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.05 E-value=4.4e-05 Score=72.49 Aligned_cols=133 Identities=26% Similarity=0.337 Sum_probs=89.9
Q ss_pred CCceeeeEEcccCc-eEEEEEEEcCCCcEEEEEEEee---hhh------ccchh----HHHHHHHHHHHHHHHHHhC---
Q 009364 66 IRWRKGELIGCGAF-GRVYMGMNLDSGELLAVKQVLI---AAN------FASKE----KAQDHIKELEEEVKLLKDL--- 128 (536)
Q Consensus 66 ~~y~~~~~LG~G~f-g~Vy~a~~~~~g~~vAiK~i~~---~~~------~~~~~----~~~~~~~~~~~Ei~iL~~l--- 128 (536)
..++..+.||.|.- |.||++.. .|+.||+|+..- ... ..... ........+..|.+...+|
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 46788999999999 99999975 788999998311 100 00000 0012334567777766666
Q ss_pred CCCce--eeEeeeeecC------------------CceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHH
Q 009364 129 SHPNI--VRYLGTVREE------------------ESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLH 188 (536)
Q Consensus 129 ~HpnI--v~l~~~~~~~------------------~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH 188 (536)
.+.++ |+.+|+..-. ....||.||++... .....-+.+|.+-|..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~~~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQIRDIPQMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccchhHHHHHHHHHHHHH
Confidence 45566 8999987322 12356777665433 122345678888899999
Q ss_pred HcCCccccCCCCCcccCCCCcEEEEecCcc
Q 009364 189 NHGIMHRDIKGANILVDNKGCIKLADFGAS 218 (536)
Q Consensus 189 ~~~ivHrDLKp~NILl~~~~~vkL~DFGla 218 (536)
..||+-+|+++.|.. .-||+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HCCeeeccCcccccc-----CCEEEecccC
Confidence 999999999999976 3589999964
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.03 E-value=3.6e-05 Score=72.95 Aligned_cols=100 Identities=26% Similarity=0.249 Sum_probs=80.1
Q ss_pred HHHHHHHHhCCC-CceeeEeeeeecCCceeEEEEecCCCCccc---ccccCCCCCHHHHHHHHHHHHHHHHHHHH---cC
Q 009364 119 EEEVKLLKDLSH-PNIVRYLGTVREEESLNILLEFVPGGSISS---LLGKFGPFPEAVMRTYTKQLLLGLEYLHN---HG 191 (536)
Q Consensus 119 ~~Ei~iL~~l~H-pnIv~l~~~~~~~~~~~lV~E~~~gg~L~~---~l~~~~~l~~~~~~~i~~qil~aL~yLH~---~~ 191 (536)
..|.-+|+.+.+ +++++++|+|-. ++|.||...+++.. .+.+....++..+.+|+.++++.+.+++. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 357778888875 699999999943 57899998776642 12222345899999999999999999997 35
Q ss_pred CccccCCCCCcccCCCCcEEEEecCcchhhh
Q 009364 192 IMHRDIKGANILVDNKGCIKLADFGASKQVA 222 (536)
Q Consensus 192 ivHrDLKp~NILl~~~~~vkL~DFGla~~~~ 222 (536)
+.-.|++++|+-++++|++|++|...+....
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVED 113 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence 7789999999999999999999998765443
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.99 E-value=5.8e-05 Score=72.00 Aligned_cols=136 Identities=24% Similarity=0.367 Sum_probs=90.2
Q ss_pred eeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhc--------cchhHHHHHHHHHHHHHHHHHhCC------CCceeeE
Q 009364 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANF--------ASKEKAQDHIKELEEEVKLLKDLS------HPNIVRY 136 (536)
Q Consensus 71 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~--------~~~~~~~~~~~~~~~Ei~iL~~l~------HpnIv~l 136 (536)
...||+|+.-.||.- .......||+....... ..+-......++..+|+.....+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 357999999999963 34556778987543300 000000111334445555444444 8899999
Q ss_pred eeeeecCCceeEEEEecCC--C----CcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCC--
Q 009364 137 LGTVREEESLNILLEFVPG--G----SISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKG-- 208 (536)
Q Consensus 137 ~~~~~~~~~~~lV~E~~~g--g----~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~-- 208 (536)
+|+.+++.-..+|+|.+.+ | +|.+++.+ +.+++ .+...+-.-..||-.++|+.+||+|.||++....
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~----~~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~ 157 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE----ELRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG 157 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH----HHHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence 9999999999999998743 2 56667644 44555 3344445566788899999999999999995432
Q ss_pred --cEEEEe
Q 009364 209 --CIKLAD 214 (536)
Q Consensus 209 --~vkL~D 214 (536)
.+.|+|
T Consensus 158 ~~~lvlID 165 (199)
T PF10707_consen 158 EFRLVLID 165 (199)
T ss_pred ceEEEEEe
Confidence 588888
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.89 E-value=5.4e-05 Score=74.20 Aligned_cols=30 Identities=27% Similarity=0.378 Sum_probs=25.2
Q ss_pred CCccccCCCCCcccCCCCcEEEEecCcchh
Q 009364 191 GIMHRDIKGANILVDNKGCIKLADFGASKQ 220 (536)
Q Consensus 191 ~ivHrDLKp~NILl~~~~~vkL~DFGla~~ 220 (536)
+++|+|+++.||+++.++..-|+||+.+..
T Consensus 165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred eEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 489999999999998765567999997643
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.82 E-value=4.4e-06 Score=97.04 Aligned_cols=210 Identities=15% Similarity=0.015 Sum_probs=147.4
Q ss_pred HHHHHHHHHhCCCCceeeEeeeee--cCCceeEEEEecCCCCcccccccC----CCCCHHHHHHHHHHHHHHHHHHHHcC
Q 009364 118 LEEEVKLLKDLSHPNIVRYLGTVR--EEESLNILLEFVPGGSISSLLGKF----GPFPEAVMRTYTKQLLLGLEYLHNHG 191 (536)
Q Consensus 118 ~~~Ei~iL~~l~HpnIv~l~~~~~--~~~~~~lV~E~~~gg~L~~~l~~~----~~l~~~~~~~i~~qil~aL~yLH~~~ 191 (536)
+..|...++...|+++...+.-.. ....-+.+++|+.+|.+.+.|.+. ....+.-+.....+.+.+..-+|+..
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 445555666678999887665443 234568899999999999988543 23444444455555577888877642
Q ss_pred -----CccccCCCCCcccCCCCcEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHH
Q 009364 192 -----IMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEM 266 (536)
Q Consensus 192 -----ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eL 266 (536)
.+|++||+-|.+|..+.++|+.++|+.+...+. ........+++.|++|++.+.-.++.++|+|..|+-+|.+
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~--~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV--LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCch--HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence 799999999999999999999999999833321 1224567789999999999988899999999999999999
Q ss_pred hhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCc
Q 009364 267 ATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVT 331 (536)
Q Consensus 267 ltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~ 331 (536)
..|..+|....+.... ..........++.-.|.++-.....+|-..-..||.-..++.-+.|.
T Consensus 1434 s~~n~~fi~flq~~Lk--giidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1434 SDGNAYFIFFLQPALK--GIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred hcccHHHHHHHHHHHc--CcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence 9999998655433221 11122222233333344444455555556667889888888877764
|
|
| >KOG0027 consensus Calmodulin and related proteins (EF-Hand superfamily) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.80 E-value=3.4e-06 Score=77.02 Aligned_cols=73 Identities=12% Similarity=-0.012 Sum_probs=60.2
Q ss_pred cCCCCCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhccccccc-C----Chhhh
Q 009364 365 TSPGSPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSSI-L----APNDL 431 (536)
Q Consensus 365 t~~~sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~~-~----~~e~l 431 (536)
....+|..||.+++|.|+..||+. ++++++..+++++| .||+|.|+|+||+..+...... . ..+++
T Consensus 9 el~~~F~~fD~d~~G~i~~~el~~~lr~lg~~~t~~el~~~~~~~D-~dg~g~I~~~eF~~l~~~~~~~~~~~~~~~~el 87 (151)
T KOG0027|consen 9 ELKEAFQLFDKDGDGKISVEELGAVLRSLGQNPTEEELRDLIKEID-LDGDGTIDFEEFLDLMEKLGEEKTDEEASSEEL 87 (151)
T ss_pred HHHHHHHHHCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhC-CCCCCeEcHHHHHHHHHhhhcccccccccHHHH
Confidence 344569999999999999999987 68999999999999 8999999999999776654321 1 34589
Q ss_pred hhccCCC
Q 009364 432 EKSRNPM 438 (536)
Q Consensus 432 ~~aF~~~ 438 (536)
++||+-.
T Consensus 88 ~eaF~~f 94 (151)
T KOG0027|consen 88 KEAFRVF 94 (151)
T ss_pred HHHHHHH
Confidence 9999854
|
|
| >COG5126 FRQ1 Ca2+-binding protein (EF-Hand superfamily) [Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only] | Back alignment and domain information |
|---|
Probab=97.73 E-value=6.2e-06 Score=74.99 Aligned_cols=79 Identities=8% Similarity=-0.109 Sum_probs=65.3
Q ss_pred hhhhhcccCCCCCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhccccc-ccCCh
Q 009364 358 LESLQMLTSPGSPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLS-SILAP 428 (536)
Q Consensus 358 l~s~q~~t~~~sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~-~~~~~ 428 (536)
+...++....++|.++|.+++|.|+..+|.. ++++++..|+..+| . |.|.|+|.+|+.++.... .....
T Consensus 14 ~t~~qi~~lkeaF~l~D~d~~G~I~~~el~~ilr~lg~~~s~~ei~~l~~~~d-~-~~~~idf~~Fl~~ms~~~~~~~~~ 91 (160)
T COG5126 14 LTEEQIQELKEAFQLFDRDSDGLIDRNELGKILRSLGFNPSEAEINKLFEEID-A-GNETVDFPEFLTVMSVKLKRGDKE 91 (160)
T ss_pred CCHHHHHHHHHHHHHhCcCCCCCCcHHHHHHHHHHcCCCCcHHHHHHHHHhcc-C-CCCccCHHHHHHHHHHHhccCCcH
Confidence 3344445566679999999999999999987 68999999999999 5 888999999997766544 56678
Q ss_pred hhhhhccCCC
Q 009364 429 NDLEKSRNPM 438 (536)
Q Consensus 429 e~l~~aF~~~ 438 (536)
|+|++||+-.
T Consensus 92 Eel~~aF~~f 101 (160)
T COG5126 92 EELREAFKLF 101 (160)
T ss_pred HHHHHHHHHh
Confidence 8999999854
|
|
| >cd05022 S-100A13 S-100A13: S-100A13 domain found in proteins similar to S100A13 | Back alignment and domain information |
|---|
Probab=97.67 E-value=1.7e-05 Score=65.44 Aligned_cols=56 Identities=16% Similarity=0.026 Sum_probs=47.5
Q ss_pred cCCCCCCCccc-cCCCccchhhhhh---------hhh-hhhhhhhhccCCCCCCCccchhhhhhhccc
Q 009364 365 TSPGSPGSVDI-CNLDSLSCSRVIV---------EKL-SGSMHGWVTSNSNDDLCQLDQEDFVAGDRK 421 (536)
Q Consensus 365 t~~~sf~~~D~-~~~g~ls~~el~~---------~~~-~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~ 421 (536)
+....|..||. ++.|.|+.+||+. .+. ++++.|++.+| .|+||.|+|+||+.++..
T Consensus 9 ~l~~~F~~fd~~~~~g~i~~~ELk~ll~~elg~~ls~~~~v~~mi~~~D-~d~DG~I~F~EF~~l~~~ 75 (89)
T cd05022 9 TLVSNFHKASVKGGKESLTASEFQELLTQQLPHLLKDVEGLEEKMKNLD-VNQDSKLSFEEFWELIGE 75 (89)
T ss_pred HHHHHHHHHhCCCCCCeECHHHHHHHHHHHhhhhccCHHHHHHHHHHhC-CCCCCCCcHHHHHHHHHH
Confidence 34456999999 9999999999986 234 78999999999 899999999999966543
|
S100A13 is a calcium-binding protein belonging to a large S100 vertebrate-specific protein family within the EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100A13 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100A13 is involved in the cellular export of interleukin-1 (IL-1) and of fibroblast growth factor-1 (FGF-1), which plays an important role in angiogenesis and tissue regeneration. Export is based on the CuII-dependent formation of multiprotein complexes containing the S100A13 protein. Assembly of these complexes occurs near the inner surface of the plasma membrane. Binding of two Ca(II) ions per monomer triggers key conformational changes leading to the creation of two identical and symmetrical Cu(II)-binding sites on the surface of the protein, close to the interface between the two monomers. These Cu |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00043 Score=70.48 Aligned_cols=77 Identities=16% Similarity=0.071 Sum_probs=52.6
Q ss_pred eeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCC---CceeeEeeeeec---C
Q 009364 70 KGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH---PNIVRYLGTVRE---E 143 (536)
Q Consensus 70 ~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~H---pnIv~l~~~~~~---~ 143 (536)
-.+.||.|..+.||.... ++..+.+|... .. .....+..|...|+.+.. -.+.++++++.. .
T Consensus 18 ~~~~i~~G~~~~vy~~~~--~~~~~~~k~~~--------~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~ 85 (297)
T PRK10593 18 RVECISEQPYAALWALYD--SQGNPMPLMAR--------SF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSP 85 (297)
T ss_pred eeeecCCccceeEEEEEc--CCCCEEEEEec--------cc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcC
Confidence 356799999999999853 22356677641 10 011356778888888743 357778877654 3
Q ss_pred CceeEEEEecCCCCc
Q 009364 144 ESLNILLEFVPGGSI 158 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L 158 (536)
+..++|||+++|+++
T Consensus 86 g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 86 GPDVLLLERLRGVSV 100 (297)
T ss_pred CCeEEEEeccCCEec
Confidence 668999999998765
|
|
| >KOG0028 consensus Ca2+-binding protein (centrin/caltractin), EF-Hand superfamily protein [Cytoskeleton; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.65 E-value=1.3e-05 Score=71.60 Aligned_cols=76 Identities=13% Similarity=0.032 Sum_probs=63.5
Q ss_pred hcccCCCCCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhc-ccccccCChhhhh
Q 009364 362 QMLTSPGSPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGD-RKLSSILAPNDLE 432 (536)
Q Consensus 362 q~~t~~~sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~-~~~~~~~~~e~l~ 432 (536)
+.......|..||.+..|.|+..||.. +.++|+.+|+..+| .+|.|.|+|++|..++ .......+.++++
T Consensus 31 q~q~i~e~f~lfd~~~~g~iD~~EL~vAmralGFE~~k~ei~kll~d~d-k~~~g~i~fe~f~~~mt~k~~e~dt~eEi~ 109 (172)
T KOG0028|consen 31 QKQEIKEAFELFDPDMAGKIDVEELKVAMRALGFEPKKEEILKLLADVD-KEGSGKITFEDFRRVMTVKLGERDTKEEIK 109 (172)
T ss_pred HHhhHHHHHHhhccCCCCcccHHHHHHHHHHcCCCcchHHHHHHHHhhh-hccCceechHHHHHHHHHHHhccCcHHHHH
Confidence 334556679999999999999999965 67899999999999 8999999999999654 4444556899999
Q ss_pred hccCCC
Q 009364 433 KSRNPM 438 (536)
Q Consensus 433 ~aF~~~ 438 (536)
+||+--
T Consensus 110 ~afrl~ 115 (172)
T KOG0028|consen 110 KAFRLF 115 (172)
T ss_pred HHHHcc
Confidence 999853
|
|
| >PF13499 EF-hand_7: EF-hand domain pair; PDB: 1TCF_A 2TN4_A 1TN4_A 1A2X_A 2CT9_B 2OTG_B 2OS8_B 1SNL_A 3O4Y_A 3J04_E | Back alignment and domain information |
|---|
Probab=97.64 E-value=1.7e-05 Score=61.45 Aligned_cols=49 Identities=10% Similarity=-0.065 Sum_probs=42.2
Q ss_pred CCCCccccCCCccchhhhhh------------hhhhhhhhhhhccCCCCCCCccchhhhhhh
Q 009364 369 SPGSVDICNLDSLSCSRVIV------------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAG 418 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~------------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~ 418 (536)
.|..+|.+++|.|+.+||.. ...+.++.+++.+| .|++|.|+|+||+.+
T Consensus 5 ~F~~~D~d~~G~i~~~el~~~~~~~~~~~~~~~~~~~~~~~~~~~D-~d~dG~i~~~Ef~~~ 65 (66)
T PF13499_consen 5 AFKKFDKDGDGYISKEELRRALKHLGRDMSDEESDEMIDQIFREFD-TDGDGRISFDEFLNF 65 (66)
T ss_dssp HHHHHSTTSSSEEEHHHHHHHHHHTTSHSTHHHHHHHHHHHHHHHT-TTSSSSEEHHHHHHH
T ss_pred HHHHHcCCccCCCCHHHHHHHHHHhcccccHHHHHHHHHHHHHHhC-CCCcCCCcHHHHhcc
Confidence 48889999999999999976 23467777799999 899999999999865
|
... |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.62 E-value=5.8e-05 Score=75.84 Aligned_cols=141 Identities=21% Similarity=0.236 Sum_probs=97.6
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHH------------HHH--HHHHHHHHHHHHhCC-CC
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKA------------QDH--IKELEEEVKLLKDLS-HP 131 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~------------~~~--~~~~~~Ei~iL~~l~-Hp 131 (536)
-|.+++.||-|.-+.||.+.+ ..|.+.++|.-.........-+. ... .-...+|+..|+.|. |-
T Consensus 93 v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 467899999999999999986 45888999964332211111110 111 123457888888884 32
Q ss_pred c-eeeEeeeeecCCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcE
Q 009364 132 N-IVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCI 210 (536)
Q Consensus 132 n-Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~v 210 (536)
. |.+.++ .+..++|||++.|..|..+-+- ..+..+...+..-+.-|-.+|+||+|..--||++.+++.+
T Consensus 172 fpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i 241 (465)
T KOG2268|consen 172 FPVPKPID----HNRHCVVMELVDGYPLRQVRHV------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKI 241 (465)
T ss_pred CCCCCccc----ccceeeHHHhhcccceeeeeec------CChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCE
Confidence 2 333333 3456799999999888766432 1234556666677778889999999999999999999999
Q ss_pred EEEecCcc
Q 009364 211 KLADFGAS 218 (536)
Q Consensus 211 kL~DFGla 218 (536)
+++||--.
T Consensus 242 ~vIDFPQm 249 (465)
T KOG2268|consen 242 VVIDFPQM 249 (465)
T ss_pred EEeechHh
Confidence 99999643
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00017 Score=71.53 Aligned_cols=133 Identities=19% Similarity=0.215 Sum_probs=74.5
Q ss_pred EEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCce-eeEeeeeecCCceeEEEE
Q 009364 73 LIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNI-VRYLGTVREEESLNILLE 151 (536)
Q Consensus 73 ~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnI-v~l~~~~~~~~~~~lV~E 151 (536)
.+..|-.+.+|+.. .+|+.+++|...... ...--...+|..+++.+....+ .+++.... -++|||
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~--------~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e 68 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVC--------KALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVE 68 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCccc--------ccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEE
Confidence 35678888999886 456788888642110 0000123567788887754323 33333322 368999
Q ss_pred ecCCCCcccc-----------------cccC----CCCCH-HHHHHHHHHH---------HHHHHHHHH--------cCC
Q 009364 152 FVPGGSISSL-----------------LGKF----GPFPE-AVMRTYTKQL---------LLGLEYLHN--------HGI 192 (536)
Q Consensus 152 ~~~gg~L~~~-----------------l~~~----~~l~~-~~~~~i~~qi---------l~aL~yLH~--------~~i 192 (536)
|++|..+... ++.. .+++. ..+..+..++ ...+..+-. ..+
T Consensus 69 ~i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 148 (256)
T TIGR02721 69 WLEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAP 148 (256)
T ss_pred eccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCee
Confidence 9998765431 0110 11111 1112222111 111222221 248
Q ss_pred ccccCCCCCcccCCCCcEEEEecCcchh
Q 009364 193 MHRDIKGANILVDNKGCIKLADFGASKQ 220 (536)
Q Consensus 193 vHrDLKp~NILl~~~~~vkL~DFGla~~ 220 (536)
+|+|+.|.||+++.++ +.|+||..+..
T Consensus 149 ~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 149 LHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred ecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 9999999999999877 78999987653
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00035 Score=68.20 Aligned_cols=75 Identities=19% Similarity=0.252 Sum_probs=45.9
Q ss_pred eeEEcccCceEEEEEEEcC-CCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCc-eeeEeeeeecCCceeE
Q 009364 71 GELIGCGAFGRVYMGMNLD-SGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPN-IVRYLGTVREEESLNI 148 (536)
Q Consensus 71 ~~~LG~G~fg~Vy~a~~~~-~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hpn-Iv~l~~~~~~~~~~~l 148 (536)
.+.|..|-...||++.... .++.|++|+.... . .......+|+.+++.+...+ .+++++.+. -.+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~--------~-~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~ 69 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNK--------T-ELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGL 69 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCC--------c-cceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcE
Confidence 4568888899999986433 3568889965211 0 00112246788888774333 344444332 248
Q ss_pred EEEecCCCCc
Q 009364 149 LLEFVPGGSI 158 (536)
Q Consensus 149 V~E~~~gg~L 158 (536)
||||++|.++
T Consensus 70 l~e~i~G~~l 79 (235)
T cd05157 70 IYEFIPGRTL 79 (235)
T ss_pred EEEeeCCCcC
Confidence 9999998765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00065 Score=71.63 Aligned_cols=83 Identities=19% Similarity=0.157 Sum_probs=51.8
Q ss_pred eeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCC---CCceeeEeeeeecCCcee
Q 009364 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS---HPNIVRYLGTVREEESLN 147 (536)
Q Consensus 71 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~---HpnIv~l~~~~~~~~~~~ 147 (536)
.+.||.|.+..||++.....++.++||.-....... .....-..++...|.+.|+.+. ..++++++.+ +....+
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~-g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~ 107 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVV-GESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAV 107 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccc-cccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCE
Confidence 467999999999999876444689999742110000 0000112344556777777652 3456677665 445678
Q ss_pred EEEEecCCC
Q 009364 148 ILLEFVPGG 156 (536)
Q Consensus 148 lV~E~~~gg 156 (536)
+||||+++.
T Consensus 108 lVME~L~~~ 116 (401)
T PRK09550 108 TVMEDLSDH 116 (401)
T ss_pred EEEecCCCc
Confidence 999999864
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.00081 Score=68.09 Aligned_cols=136 Identities=20% Similarity=0.176 Sum_probs=80.1
Q ss_pred eeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCC--ceeeEeee------eec
Q 009364 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHP--NIVRYLGT------VRE 142 (536)
Q Consensus 71 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hp--nIv~l~~~------~~~ 142 (536)
.+.|..|....+|+... ++..+++|+... . ....+..|+.++..+.+. .+.+++.. ...
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~--------~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~ 85 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEK--------V---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSEL 85 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCC--------C---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeee
Confidence 55688888899999854 345788897621 1 113455677777776432 24444432 233
Q ss_pred CCceeEEEEecCCCCcccc----c----------ccC-CCCCH--------H--H--HH--------HHHHHHHHHHHHH
Q 009364 143 EESLNILLEFVPGGSISSL----L----------GKF-GPFPE--------A--V--MR--------TYTKQLLLGLEYL 187 (536)
Q Consensus 143 ~~~~~lV~E~~~gg~L~~~----l----------~~~-~~l~~--------~--~--~~--------~i~~qil~aL~yL 187 (536)
.+..++|++|++|..+... . +.. ..+.. . . .. .....+..++.++
T Consensus 86 ~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l 165 (296)
T cd05153 86 AGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQ 165 (296)
T ss_pred CCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHH
Confidence 4567899999998765331 0 000 00000 0 0 00 0111223344444
Q ss_pred HH-------cCCccccCCCCCcccCCCCcEEEEecCcch
Q 009364 188 HN-------HGIMHRDIKGANILVDNKGCIKLADFGASK 219 (536)
Q Consensus 188 H~-------~~ivHrDLKp~NILl~~~~~vkL~DFGla~ 219 (536)
.. .+++|+|+.|.||+++.++.+.|+||+.+.
T Consensus 166 ~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 166 DAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred HhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 43 369999999999999988777899998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05026 S-100Z S-100Z: S-100Z domain found in proteins similar to S100Z | Back alignment and domain information |
|---|
Probab=97.45 E-value=3.9e-05 Score=63.99 Aligned_cols=56 Identities=11% Similarity=-0.169 Sum_probs=45.9
Q ss_pred cCCCCCCCcc-ccCCC-ccchhhhhh-h------------hhhhhhhhhhccCCCCCCCccchhhhhhhccc
Q 009364 365 TSPGSPGSVD-ICNLD-SLSCSRVIV-E------------KLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRK 421 (536)
Q Consensus 365 t~~~sf~~~D-~~~~g-~ls~~el~~-~------------~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~ 421 (536)
+....|..|| .+++| .|+..||+. . +..+++++++.+| .|++|.|+|+||+.++..
T Consensus 11 ~~~~~F~~~dd~dgdg~~Is~~EL~~ll~~~~~~~~~~~~~~~~v~~i~~elD-~n~dG~Idf~EF~~l~~~ 81 (93)
T cd05026 11 TLIRIFHNYSGKEGDRYKLSKGELKELLQRELTDFLSSQKDPMLVDKIMNDLD-SNKDNEVDFNEFVVLVAA 81 (93)
T ss_pred HHHHHHHHHHccCCCCCEECHHHHHHHHHHHhHHhcccccCHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHH
Confidence 3445699999 78998 599999986 1 3457999999999 899999999999976554
|
S100Z is a member of the S100 domain family within the EF-hand Ca2+-binding proteins superfamily. Note that the S-100 hierarchy, to which this S-100Z group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately.S100 proteins exhibit unique patterns of tissue- and cell type-specific expression and have been implicated in the Ca2+-dependent regulation of diverse physiological processes, including cell cycle regulation, differentiation, growth, and metabolic control. S100Z is normally expressed in various tissues, with its highest level of expression being in spleen and leukocytes. The function of S100Z remains unclear. Preliminary structural data suggests that S100Z is homodimer, however a heterodimer with S100P has been reported. S100Z is capable of binding calcium ions. When calcium binds to S110Z, the protein experiences a conformational change, which exposes hydrophobic surfac |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.002 Score=65.96 Aligned_cols=30 Identities=23% Similarity=0.392 Sum_probs=25.7
Q ss_pred cCCccccCCCCCcccCCCCcEEEEecCcch
Q 009364 190 HGIMHRDIKGANILVDNKGCIKLADFGASK 219 (536)
Q Consensus 190 ~~ivHrDLKp~NILl~~~~~vkL~DFGla~ 219 (536)
.++||+|++|.||+++.+...-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 379999999999999866556899999764
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.0026 Score=65.27 Aligned_cols=145 Identities=19% Similarity=0.218 Sum_probs=93.1
Q ss_pred eeEEcccCceEEEEEEEcCCCcEEEEEEEeehhh------------------ccchhHHHHHHH-HHHHHHHHHHhCCCC
Q 009364 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAAN------------------FASKEKAQDHIK-ELEEEVKLLKDLSHP 131 (536)
Q Consensus 71 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~------------------~~~~~~~~~~~~-~~~~Ei~iL~~l~Hp 131 (536)
-..|..|--+-||.|. ..+|..+|||++.-..- +... ..+..++ -...|+.-|+++...
T Consensus 149 nGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~-NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 149 NGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKH-NPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred ccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccC-CcHHHHHHHHHHHHHHHHHHHhc
Confidence 3446677788899987 46788899998632110 1111 1111122 245688888888655
Q ss_pred ceeeEeeeeecCCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHH-HcCCccccCCCCCcccCCCCcE
Q 009364 132 NIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLH-NHGIMHRDIKGANILVDNKGCI 210 (536)
Q Consensus 132 nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH-~~~ivHrDLKp~NILl~~~~~v 210 (536)
.|.-.--+.. ....|||+++.+.....-.-+.-.++...+..+-.|++.-+.-|- ..++||.||.--|+|+. +|.+
T Consensus 227 GIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-dG~l 303 (520)
T KOG2270|consen 227 GIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-DGKL 303 (520)
T ss_pred CCCCCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-CCEE
Confidence 5432111111 234699999953322222223346777888888888888888774 56999999999999994 5789
Q ss_pred EEEecCcchh
Q 009364 211 KLADFGASKQ 220 (536)
Q Consensus 211 kL~DFGla~~ 220 (536)
.|+|.+-+..
T Consensus 304 yiIDVSQSVE 313 (520)
T KOG2270|consen 304 YIIDVSQSVE 313 (520)
T ss_pred EEEEcccccc
Confidence 9999987643
|
|
| >cd05027 S-100B S-100B: S-100B domain found in proteins similar to S100B | Back alignment and domain information |
|---|
Probab=97.26 E-value=5.7e-05 Score=62.28 Aligned_cols=56 Identities=13% Similarity=-0.093 Sum_probs=46.6
Q ss_pred ccCCCCCCCcc-ccCCC-ccchhhhhh-------------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 364 LTSPGSPGSVD-ICNLD-SLSCSRVIV-------------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 364 ~t~~~sf~~~D-~~~~g-~ls~~el~~-------------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
.+...+|..|| .+++| .|+.+||+. .++++++.+++.+| .|++|.|+|+||+....
T Consensus 8 ~~l~~aF~~fD~~dgdG~~I~~~eL~~ll~~~~~~~lg~~~~~~~v~~~i~~~D-~n~dG~v~f~eF~~li~ 78 (88)
T cd05027 8 VALIDVFHQYSGREGDKHKLKKSELKELINNELSHFLEEIKEQEVVDKVMETLD-SDGDGECDFQEFMAFVA 78 (88)
T ss_pred HHHHHHHHHhcccCCCcCEECHHHHHHHHHHHhHHHhcCCCCHHHHHHHHHHhC-CCCCCcCcHHHHHHHHH
Confidence 34455699998 89999 699999975 35678999999999 89999999999986543
|
S100B is a calcium-binding protein belonging to a large S100 vertebrate-specific protein family within the EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100B group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100B is most abundant in glial cells of the central nervous system, predominately in astrocytes. S100B is involved in signal transduction via the inhibition of protein phoshorylation, regulation of enzyme activity and by affecting the calcium homeostasis. Upon calcium binding the S100B homodimer changes conformation to expose a hydrophobic cleft, which represents the interaction site of S100B with its more than 20 known target proteins. These target proteins include several cellular architecture proteins such as tubulin and GFAP; S100B can inhibit polymerization of these oligomeric molecules. Furthermore, S100B i |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0025 Score=65.07 Aligned_cols=137 Identities=20% Similarity=0.194 Sum_probs=77.6
Q ss_pred eeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCC--ceeeEeeee------ec
Q 009364 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHP--NIVRYLGTV------RE 142 (536)
Q Consensus 71 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hp--nIv~l~~~~------~~ 142 (536)
.+.++.|....||++.. .+| .+++|+... ... ...+..|++++..|... .+.+++... ..
T Consensus 27 i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~-------~~~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~ 94 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTT-DVG-RYILTLYEK-------RVK---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTL 94 (307)
T ss_pred ccccCCccccceEEEEe-CCC-cEEEEEecC-------CCC---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhc
Confidence 45678888899999863 334 577887521 000 12234556666666322 234443321 22
Q ss_pred CCceeEEEEecCCCCcccc-----------c---cc-CCCC--------CHHH-----HH----------HHHHHHHHHH
Q 009364 143 EESLNILLEFVPGGSISSL-----------L---GK-FGPF--------PEAV-----MR----------TYTKQLLLGL 184 (536)
Q Consensus 143 ~~~~~lV~E~~~gg~L~~~-----------l---~~-~~~l--------~~~~-----~~----------~i~~qil~aL 184 (536)
.+..+++++|++|..+... + +. ...+ .... .. .....+...+
T Consensus 95 ~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~ 174 (307)
T TIGR00938 95 AGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKEL 174 (307)
T ss_pred CCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHH
Confidence 4567899999998654211 0 00 0001 0000 00 0111233445
Q ss_pred HHHHH-------cCCccccCCCCCcccCCCCcEEEEecCcch
Q 009364 185 EYLHN-------HGIMHRDIKGANILVDNKGCIKLADFGASK 219 (536)
Q Consensus 185 ~yLH~-------~~ivHrDLKp~NILl~~~~~vkL~DFGla~ 219 (536)
+++.. .+++|+|+++.||+++.++.+.|+||+.+.
T Consensus 175 ~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 175 DYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 55542 579999999999999988777899999763
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PF00036 EF-hand_1: EF hand; InterPro: IPR018248 Many calcium-binding proteins belong to the same evolutionary family and share a type of calcium-binding domain known as the EF-hand | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.00011 Score=47.20 Aligned_cols=27 Identities=15% Similarity=0.142 Sum_probs=24.1
Q ss_pred hhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 393 GSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 393 ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
|++.+|+..| .|++|.|+++||+.++.
T Consensus 1 E~~~~F~~~D-~d~dG~I~~~Ef~~~~~ 27 (29)
T PF00036_consen 1 ELKEAFREFD-KDGDGKIDFEEFKEMMK 27 (29)
T ss_dssp HHHHHHHHHS-TTSSSEEEHHHHHHHHH
T ss_pred CHHHHHHHHC-CCCCCcCCHHHHHHHHH
Confidence 6789999999 99999999999997654
|
This type of domain consists of a twelve residue loop flanked on both sides by a twelve residue alpha-helical domain. In an EF-hand loop the calcium ion is coordinated in a pentagonal bipyramidal configuration. The six residues involved in the binding are in positions 1, 3, 5, 7, 9 and 12; these residues are denoted by X, Y, Z, -Y, -X and -Z. The invariant Glu or Asp at position 12 provides two oxygens for liganding Ca (bidentate ligand).; PDB: 1BJF_A 1XFW_R 1XFV_O 2K0J_A 2F3Z_A 3BYA_A 1XFU_Q 2R28_B 1ZOT_B 3G43_D .... |
| >COG5126 FRQ1 Ca2+-binding protein (EF-Hand superfamily) [Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only] | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.00011 Score=66.81 Aligned_cols=54 Identities=11% Similarity=-0.096 Sum_probs=48.0
Q ss_pred CCCCCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 366 SPGSPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 366 ~~~sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
...+|..||.+++|.|+..||.. .+.+|++.|++.+| .|++|.|+|+||+..+.
T Consensus 94 l~~aF~~fD~d~dG~Is~~eL~~vl~~lge~~~deev~~ll~~~d-~d~dG~i~~~eF~~~~~ 155 (160)
T COG5126 94 LREAFKLFDKDHDGYISIGELRRVLKSLGERLSDEEVEKLLKEYD-EDGDGEIDYEEFKKLIK 155 (160)
T ss_pred HHHHHHHhCCCCCceecHHHHHHHHHhhcccCCHHHHHHHHHhcC-CCCCceEeHHHHHHHHh
Confidence 34469999999999999999976 57899999999999 89999999999997554
|
|
| >smart00027 EH Eps15 homology domain | Back alignment and domain information |
|---|
Probab=97.20 E-value=7.2e-05 Score=62.71 Aligned_cols=55 Identities=13% Similarity=0.062 Sum_probs=47.7
Q ss_pred CCCCCCCccccCCCccchhhhhh------hhhhhhhhhhhccCCCCCCCccchhhhhhhccc
Q 009364 366 SPGSPGSVDICNLDSLSCSRVIV------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRK 421 (536)
Q Consensus 366 ~~~sf~~~D~~~~g~ls~~el~~------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~ 421 (536)
....|..+|.+++|.|+.+||.. .+.++++.++..+| .+++|.|+|+||+.++..
T Consensus 12 l~~~F~~~D~d~~G~Is~~el~~~l~~~~~~~~ev~~i~~~~d-~~~~g~I~~~eF~~~~~~ 72 (96)
T smart00027 12 YEQIFRSLDKNQDGTVTGAQAKPILLKSGLPQTLLAKIWNLAD-IDNDGELDKDEFALAMHL 72 (96)
T ss_pred HHHHHHHhCCCCCCeEeHHHHHHHHHHcCCCHHHHHHHHHHhc-CCCCCCcCHHHHHHHHHH
Confidence 34459999999999999999976 56789999999999 899999999999976543
|
Pair of EF hand motifs that recognise proteins containing Asn-Pro-Phe (NPF) sequences. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0013 Score=66.88 Aligned_cols=76 Identities=18% Similarity=0.246 Sum_probs=45.7
Q ss_pred eeEEcccCceEEEEEEEcC------CCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCce-eeEeeeeecC
Q 009364 71 GELIGCGAFGRVYMGMNLD------SGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNI-VRYLGTVREE 143 (536)
Q Consensus 71 ~~~LG~G~fg~Vy~a~~~~------~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnI-v~l~~~~~~~ 143 (536)
.+.|..|-...||++.... .++.+++|+..... .......+|..+++.+...++ .++++.+..
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~---------~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~- 72 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV---------ELLIDRERELVVFARLSERNLGPKLYGIFPN- 72 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC---------cceechHHHHHHHHHHHhCCCCCceEEEeCC-
Confidence 3456777778999886432 25789999862111 111234567777777743333 345555432
Q ss_pred CceeEEEEecCCCCcc
Q 009364 144 ESLNILLEFVPGGSIS 159 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~ 159 (536)
.+|+||++|..+.
T Consensus 73 ---~~v~e~i~G~~l~ 85 (302)
T cd05156 73 ---GRIEEFIPSRTLT 85 (302)
T ss_pred ---CchhheeCCCcCC
Confidence 3689999887664
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG0027 consensus Calmodulin and related proteins (EF-Hand superfamily) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.00016 Score=65.88 Aligned_cols=55 Identities=13% Similarity=-0.084 Sum_probs=48.9
Q ss_pred cCCCCCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 365 TSPGSPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 365 t~~~sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
....+|..||.+++|.|+.+||+. .+.++++.+++.+| .|++|.|+|+||+.++.
T Consensus 86 el~eaF~~fD~d~~G~Is~~el~~~l~~lg~~~~~~e~~~mi~~~d-~d~dg~i~f~ef~~~m~ 148 (151)
T KOG0027|consen 86 ELKEAFRVFDKDGDGFISASELKKVLTSLGEKLTDEECKEMIREVD-VDGDGKVNFEEFVKMMS 148 (151)
T ss_pred HHHHHHHHHccCCCCcCcHHHHHHHHHHhCCcCCHHHHHHHHHhcC-CCCCCeEeHHHHHHHHh
Confidence 345569999999999999999987 46889999999999 89999999999997664
|
|
| >cd00052 EH Eps15 homology domain; found in proteins implicated in endocytosis, vesicle transport, and signal transduction | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.00023 Score=54.86 Aligned_cols=50 Identities=20% Similarity=0.086 Sum_probs=44.4
Q ss_pred CCCCccccCCCccchhhhhh------hhhhhhhhhhhccCCCCCCCccchhhhhhhc
Q 009364 369 SPGSVDICNLDSLSCSRVIV------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGD 419 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~ 419 (536)
.|..+|.+++|.|+.+|+.. .+.++++.+++..| .+++|.|+|+||+.++
T Consensus 4 ~F~~~D~~~~G~i~~~el~~~l~~~g~~~~~~~~i~~~~d-~~~~g~i~~~ef~~~~ 59 (67)
T cd00052 4 IFRSLDPDGDGLISGDEARPFLGKSGLPRSVLAQIWDLAD-TDKDGKLDKEEFAIAM 59 (67)
T ss_pred HHHHhCCCCCCcCcHHHHHHHHHHcCCCHHHHHHHHHHhc-CCCCCcCCHHHHHHHH
Confidence 58889999999999999976 46788999999999 8999999999998654
|
The alignment contains a pair of EF-hand motifs, typically one of them is canonical and binds to Ca2+, while the other may not bind to Ca2+. A hydrophobic binding pocket is formed by residues from both EF-hand motifs. The EH domain binds to proteins containing NPF (class I), [WF]W or SWG (class II), or H[TS]F (class III) sequence motifs. |
| >cd05029 S-100A6 S-100A6: S-100A6 domain found in proteins similar to S100A6 | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.0002 Score=59.00 Aligned_cols=51 Identities=6% Similarity=-0.143 Sum_probs=43.2
Q ss_pred CCCCccc-cC-CCccchhhhhh-----------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 369 SPGSVDI-CN-LDSLSCSRVIV-----------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 369 sf~~~D~-~~-~g~ls~~el~~-----------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
.|..+|. ++ .|.|+.+||+. .+.+|+.++++.+| .|++|.|+|+||+..+.
T Consensus 15 ~F~~y~~~~~~~g~Is~~EL~~~l~~~~~lg~k~t~~ev~~m~~~~D-~d~dG~Idf~EFv~lm~ 78 (88)
T cd05029 15 IFHKYSGREGDKNTLSKKELKELIQKELTIGSKLQDAEIAKLMEDLD-RNKDQEVNFQEYVTFLG 78 (88)
T ss_pred HHHHHHccCCCCCEECHHHHHHHHHHHHhcCCCCCHHHHHHHHHHhc-CCCCCCCcHHHHHHHHH
Confidence 4788887 55 88999999875 36789999999999 89999999999986554
|
S100A6 is a member of the S100 domain family within EF-hand Ca2+-binding proteins superfamily. Note that the S-100 hierarchy, to which this S-100A6 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins exhibit unique patterns of tissue- and cell type-specific expression and have been implicated in the Ca2+-dependent regulation of diverse physiological processes, including cell cycle regulation, differentiation, growth, and metabolic control . S100A6 is normally expressed in the G1 phase of the cell cycle in neuronal cells. The function of S100A6 remains unclear, but evidence suggests that it is involved in cell cycle regulation and exocytosis. S100A6 may also be involved in tumorigenesis; the protein is overexpressed in several tumors. Ca2+ binding to S100A6 leads to a conformational change in the protein, which exposes a hydrophobic surface for interact |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.004 Score=62.69 Aligned_cols=30 Identities=27% Similarity=0.460 Sum_probs=25.0
Q ss_pred CCccccCCCCCcccCCCCc-EEEEecCcchh
Q 009364 191 GIMHRDIKGANILVDNKGC-IKLADFGASKQ 220 (536)
Q Consensus 191 ~ivHrDLKp~NILl~~~~~-vkL~DFGla~~ 220 (536)
.++|+|++|.|||++.++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 3799999999999987565 56999998754
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >cd05023 S-100A11 S-100A11: S-100A11 domain found in proteins similar to S100A11 | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.00036 Score=57.66 Aligned_cols=52 Identities=12% Similarity=-0.086 Sum_probs=42.6
Q ss_pred CCCCC-ccccCCC-ccchhhhhh-------------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 368 GSPGS-VDICNLD-SLSCSRVIV-------------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 368 ~sf~~-~D~~~~g-~ls~~el~~-------------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
..|.. +|.++++ .|+.+||+. ....+++.+++..| .|+||.|+|+||+.++.
T Consensus 13 ~~F~~y~~~dg~~~~Ls~~Elk~ll~~e~~~~~~~~~~~~~~~~ll~~~D-~d~DG~I~f~EF~~l~~ 79 (89)
T cd05023 13 AVFQKYAGKDGDSYQLSKTEFLSFMNTELASFTKNQKDPGVLDRMMKKLD-LNSDGQLDFQEFLNLIG 79 (89)
T ss_pred HHHHHHhccCCCcCeECHHHHHHHHHHhhhHhhcCCCCHHHHHHHHHHcC-CCCCCcCcHHHHHHHHH
Confidence 34777 6787876 999999987 12468999999999 89999999999996554
|
S100A11 is a member of the S-100 domain family within EF-hand Ca2+-binding proteins superfamily. Note that the S-100 hierarchy, to which this S-100A11 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins exhibit unique patterns of tissue- and cell type-specific expression and have been implicated in the Ca2+-dependent regulation of diverse physiological processes, including cell cycle regulation, differentiation, growth, and metabolic control . S100 proteins have also been associated with a variety of pathological events, including neoplastic transformation and neurodegenerative diseases such as Alzheimer's, usually via over expression of the protein. S100A11 is expressed in smooth muscle and other tissues and involves in calcium-dependent membrane aggregation, which is important for cell vesiculation . As is the case for many other S100 proteins, S |
| >PF14658 EF-hand_9: EF-hand domain | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.00074 Score=51.90 Aligned_cols=51 Identities=14% Similarity=0.056 Sum_probs=45.3
Q ss_pred CCCCccccCCCccchhhhhh---------hhhhhhhhhhhccCCCCCC-Cccchhhhhhhcc
Q 009364 369 SPGSVDICNLDSLSCSRVIV---------EKLSGSMHGWVTSNSNDDL-CQLDQEDFVAGDR 420 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~---------~~~~ei~~l~~~~d~~d~~-g~Id~~EF~~~~~ 420 (536)
.|..||..+.|.+..++|.. +++++++.+.+++| -+|. |.|+|+.|+.+|.
T Consensus 3 ~F~~fD~~~tG~V~v~~l~~~Lra~~~~~p~e~~Lq~l~~elD-P~g~~~~v~~d~F~~iM~ 63 (66)
T PF14658_consen 3 AFDAFDTQKTGRVPVSDLITYLRAVTGRSPEESELQDLINELD-PEGRDGSVNFDTFLAIMR 63 (66)
T ss_pred chhhcCCcCCceEeHHHHHHHHHHHcCCCCcHHHHHHHHHHhC-CCCCCceEeHHHHHHHHH
Confidence 59999999999999999976 67899999999999 5555 9999999997664
|
|
| >cd05025 S-100A1 S-100A1: S-100A1 domain found in proteins similar to S100A1 | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.00046 Score=57.31 Aligned_cols=54 Identities=9% Similarity=-0.106 Sum_probs=45.6
Q ss_pred CCCCCCCcc-ccCCC-ccchhhhhh-------------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 366 SPGSPGSVD-ICNLD-SLSCSRVIV-------------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 366 ~~~sf~~~D-~~~~g-~ls~~el~~-------------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
....|..|| .+++| .|+..||+. ++.++++.+++.+| .|++|.|+|+||+.++.
T Consensus 11 l~~~F~~fDd~dg~G~~Is~~El~~~l~~~lg~~~~~~~s~~~v~~i~~~~D-~d~~G~I~f~eF~~l~~ 79 (92)
T cd05025 11 LINVFHAHSGKEGDKYKLSKKELKDLLQTELSDFLDAQKDADAVDKIMKELD-ENGDGEVDFQEFVVLVA 79 (92)
T ss_pred HHHHHHHHhcccCCCCeECHHHHHHHHHHHHHHHccCCCCHHHHHHHHHHHC-CCCCCcCcHHHHHHHHH
Confidence 344699997 99999 599999976 14678999999999 89999999999996554
|
S100A1 is a calcium-binding protein belonging to a large S100 vertebrate-specific protein family within the EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100A1 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. As is the case with many other members of S100 protein family, S100A1 is implicated in intracellular and extracellular regulatory activities, including interaction with myosin-associated twitchin kinase, actin-capping protein CapZ, sinapsin I, and tubulin. Structural data suggests that S100A1 proteins exist within cells as antiparallel homodimers, while heterodimers with S100A4 and S100B also has been reported. Upon binding calcium S100A1 changes conformation to expose a hydrophobic cleft which is the interaction site of S100A1 with its more that 20 known target proteins. |
| >cd05031 S-100A10_like S-100A10_like: S-100A10 domain found in proteins similar to S100A10 | Back alignment and domain information |
|---|
Probab=96.72 E-value=0.00057 Score=57.01 Aligned_cols=54 Identities=9% Similarity=-0.116 Sum_probs=45.3
Q ss_pred CCCCCCccc-cC-CCccchhhhhh-------------hhhhhhhhhhhccCCCCCCCccchhhhhhhccc
Q 009364 367 PGSPGSVDI-CN-LDSLSCSRVIV-------------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRK 421 (536)
Q Consensus 367 ~~sf~~~D~-~~-~g~ls~~el~~-------------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~ 421 (536)
...|..||. ++ +|.|+..||.. ++.++++.+++.+| .+++|.|+|+||+.++..
T Consensus 11 ~~~F~~~D~~dg~dG~Is~~El~~~l~~~~g~~lg~~~s~~ei~~~~~~~D-~~~dg~I~f~eF~~l~~~ 79 (94)
T cd05031 11 ILTFHRYAGKDGDKNTLSRKELKKLMEKELSEFLKNQKDPMAVDKIMKDLD-QNRDGKVNFEEFVSLVAG 79 (94)
T ss_pred HHHHHHHhccCCCCCeECHHHHHHHHHHHhHHHhhccccHHHHHHHHHHhC-CCCCCcCcHHHHHHHHHH
Confidence 345999997 86 69999999975 25678999999999 899999999999976543
|
S100A10 is a member of the S100 family of EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100A1_like group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins are expressed exclusively in vertebrates, and are implicated in intracellular and extracellular regulatory activities. A unique feature of S100A10 is that it contains mutation in both of the calcium binding sites, making it calcium insensitive. S100A10 has been detected in brain, heart, gastrointestinal tract, kidney, liver, lung, spleen, testes, epidermis, aorta, and thymus. Structural data supports the homo- and hetero-dimeric as well as hetero-tetrameric nature of the protein. S100A10 has multiple binding partners in its calcium free state and is therefore involved in many diverse biological functions. |
| >PF13833 EF-hand_8: EF-hand domain pair; PDB: 3KF9_A 1TTX_A 1WLZ_A 1ALV_A 1NX3_A 1ALW_A 1NX2_A 1NX1_A 1NX0_A 1DF0_A | Back alignment and domain information |
|---|
Probab=96.66 E-value=0.0008 Score=49.75 Aligned_cols=42 Identities=5% Similarity=-0.065 Sum_probs=35.6
Q ss_pred CCccchhhhhh---------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 378 LDSLSCSRVIV---------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 378 ~g~ls~~el~~---------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
.|.|+.+++.. .+++++..|+..+| .|++|.|+|+||+.++.
T Consensus 2 ~G~i~~~~~~~~l~~~g~~~~s~~e~~~l~~~~D-~~~~G~I~~~EF~~~~~ 52 (54)
T PF13833_consen 2 DGKITREEFRRALSKLGIKDLSEEEVDRLFREFD-TDGDGYISFDEFISMMQ 52 (54)
T ss_dssp SSEEEHHHHHHHHHHTTSSSSCHHHHHHHHHHHT-TSSSSSEEHHHHHHHHH
T ss_pred cCEECHHHHHHHHHHhCCCCCCHHHHHHHHHhcc-cCCCCCCCHHHHHHHHH
Confidence 57788888765 46789999999999 99999999999997553
|
... |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.027 Score=59.45 Aligned_cols=80 Identities=16% Similarity=0.111 Sum_probs=48.7
Q ss_pred eeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCC---CCceeeEeeeeecCCcee
Q 009364 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS---HPNIVRYLGTVREEESLN 147 (536)
Q Consensus 71 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~---HpnIv~l~~~~~~~~~~~ 147 (536)
.+.||-|....||+..+ .+..++||.-........ ........+...|...|+.+. ..++.+++.++. +..+
T Consensus 37 ~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vg-a~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v 111 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIG-ESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL 111 (418)
T ss_pred EEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCC-ccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence 67799999999999876 345788997531111000 000001223334556665553 347777887776 4467
Q ss_pred EEEEecCC
Q 009364 148 ILLEFVPG 155 (536)
Q Consensus 148 lV~E~~~g 155 (536)
++|||+++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 89999977
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 536 | ||||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 6e-51 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-50 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-45 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-45 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 6e-45 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 8e-45 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-44 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-44 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-44 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-44 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-44 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-43 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-43 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-43 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-41 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-37 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-37 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-37 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-37 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-37 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-36 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-36 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-36 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-35 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-35 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-33 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-32 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-31 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-30 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-30 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-30 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-30 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-30 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-30 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-30 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-30 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-30 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-30 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-30 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-30 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-30 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-30 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-30 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-30 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-30 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-30 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-30 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-30 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-30 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-30 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 6e-30 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 7e-30 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 7e-30 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 7e-30 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 8e-30 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 8e-30 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 9e-30 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-29 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-29 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-29 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-29 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-29 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-29 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-29 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-29 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-29 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-29 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-29 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-29 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-29 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-29 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-29 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-29 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-29 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-29 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 6e-29 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-28 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-28 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-28 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-28 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-27 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-27 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-27 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-27 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-27 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-27 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-27 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-27 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-27 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-27 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-27 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-27 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-27 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-27 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-27 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-27 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-27 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-27 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-27 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-27 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-27 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-27 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-27 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-27 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-27 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 6e-27 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 6e-27 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 6e-27 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-27 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 7e-27 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 7e-27 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 7e-27 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 7e-27 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 8e-27 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 8e-27 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 9e-27 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-26 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-26 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-26 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-26 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-26 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-26 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-26 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-26 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-26 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-26 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-26 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-26 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-26 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-26 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-26 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-26 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-26 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-26 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-26 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-26 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-26 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-26 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-26 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-26 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-26 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-26 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-26 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-26 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-26 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-26 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-26 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-26 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-26 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-26 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-26 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-26 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 6e-26 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-26 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-26 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-26 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 6e-26 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-26 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-26 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 8e-26 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-26 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-26 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-25 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-25 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-25 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-25 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-25 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-25 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-25 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-25 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-25 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-25 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-25 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-25 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-25 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-25 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-25 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-25 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 5e-25 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-25 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-25 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-25 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 6e-25 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-25 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 6e-25 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 6e-25 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-25 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 7e-25 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 7e-25 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 7e-25 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 8e-25 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 9e-25 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 9e-25 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-24 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-24 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-24 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-24 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-24 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-24 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-24 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-24 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-24 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-24 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-24 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-24 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-24 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-24 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-24 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-24 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-24 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 7e-24 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 7e-24 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 7e-24 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 9e-24 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 9e-24 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-23 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-23 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-23 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-23 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-23 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-23 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-23 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-23 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-23 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-23 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-23 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-23 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-23 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-23 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-23 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-23 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-23 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-23 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-23 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-23 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-23 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-23 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-23 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-23 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-23 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-23 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-23 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-23 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-23 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-23 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-23 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-23 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-23 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-23 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-23 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-23 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-23 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-23 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-23 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-23 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-23 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 6e-23 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 6e-23 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 6e-23 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-23 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-23 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-23 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-23 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-23 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-23 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-23 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-23 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-23 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-23 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 7e-23 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-23 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 7e-23 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 7e-23 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 7e-23 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 7e-23 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 8e-23 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-22 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-22 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-22 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-22 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-22 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-22 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-22 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-22 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-22 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-22 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-22 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-22 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-22 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-22 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-22 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-22 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-22 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-22 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-22 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-22 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-22 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-22 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-22 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 6e-22 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 6e-22 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-22 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 7e-22 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 9e-22 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-22 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 9e-22 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 9e-22 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-21 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-21 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-21 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-21 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-21 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-21 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-21 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-21 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-21 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-21 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-21 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-21 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-21 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-21 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-21 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-21 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-21 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-21 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-21 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-21 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-21 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-21 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-21 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-21 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-21 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-21 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-21 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-21 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-21 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-21 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-21 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-21 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-21 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-21 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-21 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-21 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-21 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-21 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-21 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-21 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-21 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-21 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-21 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 5e-21 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-21 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-21 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-21 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 6e-21 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-21 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-21 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-21 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 7e-21 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 8e-21 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 8e-21 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 9e-21 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 9e-21 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-20 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-20 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-20 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-20 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-20 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-20 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-20 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-20 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-20 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-20 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 3e-20 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-20 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-20 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-20 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-20 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-20 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-20 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-20 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-20 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 5e-20 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-20 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 6e-20 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 6e-20 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-20 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 7e-20 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 7e-20 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 8e-20 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 8e-20 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 8e-20 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 9e-20 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 9e-20 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-20 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 9e-20 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-19 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-19 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-19 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-19 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-19 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-19 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-19 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-19 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-19 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-19 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-19 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-19 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-19 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-19 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-19 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-19 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-19 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-19 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-19 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-19 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-19 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-19 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-19 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-19 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-19 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-19 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-19 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-19 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-19 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-19 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-19 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 3e-19 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-19 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-19 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-19 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-19 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-19 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-19 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-19 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-19 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-19 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-19 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 4e-19 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-19 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-19 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-19 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-19 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-19 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-19 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-19 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-19 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-19 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-19 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 5e-19 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 6e-19 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-19 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 6e-19 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-19 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 6e-19 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-19 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-19 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 7e-19 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 7e-19 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 7e-19 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 7e-19 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 7e-19 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 7e-19 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 7e-19 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 7e-19 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 7e-19 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 7e-19 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 7e-19 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 7e-19 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 7e-19 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-19 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 8e-19 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 8e-19 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-19 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 8e-19 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 8e-19 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-19 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 8e-19 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 9e-19 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 9e-19 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 9e-19 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 9e-19 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 9e-19 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-18 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-18 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-18 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-18 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-18 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-18 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-18 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-18 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-18 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-18 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-18 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-18 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-18 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-18 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-18 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-18 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-18 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-18 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-18 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-18 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-18 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-18 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-18 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-18 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-18 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-18 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-18 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-18 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-18 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-18 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-18 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-18 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-18 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 5e-18 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-18 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 6e-18 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 6e-18 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-18 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 6e-18 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 6e-18 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 7e-18 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 7e-18 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 7e-18 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-18 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 7e-18 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 8e-18 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 8e-18 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 8e-18 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 8e-18 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 9e-18 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 9e-18 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 9e-18 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 9e-18 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-17 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-17 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-17 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-17 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-17 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-17 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-17 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-17 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-17 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-17 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-17 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-17 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-17 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-17 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-17 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-17 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-17 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-17 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-17 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-17 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-17 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-17 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-17 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-17 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-17 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-17 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-17 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-17 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-17 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-17 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-17 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-17 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 5e-17 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-17 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 5e-17 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 5e-17 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-17 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-17 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-17 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 6e-17 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-17 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 7e-17 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 7e-17 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 7e-17 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 7e-17 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 8e-17 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 8e-17 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-17 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 8e-17 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 8e-17 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-17 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 9e-17 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-16 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-16 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-16 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-16 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-16 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-16 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-16 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-16 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-16 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-16 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-16 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-16 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-16 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-16 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-16 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-16 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-16 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-16 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-16 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-16 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-16 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-16 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-16 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-16 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-16 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-16 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-16 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-16 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-16 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-16 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-16 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-16 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-16 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 5e-16 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 6e-16 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 6e-16 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-16 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 6e-16 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-16 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 7e-16 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 7e-16 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 7e-16 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 7e-16 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 8e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 8e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 8e-16 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 8e-16 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 9e-16 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-15 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-15 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-15 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-15 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-15 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-15 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-15 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-15 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-15 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-15 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-15 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-15 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-15 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-15 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-15 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-15 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-15 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-15 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-15 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-15 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-15 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-15 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-15 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-15 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-15 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-15 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-15 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-15 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-15 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-15 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-15 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-15 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-15 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-15 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-15 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-15 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-15 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-15 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-15 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-15 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-15 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-15 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-15 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-15 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-15 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-15 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-15 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-15 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-15 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-15 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-15 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-15 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-15 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-15 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-15 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-15 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-15 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-15 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-15 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-15 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-15 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-15 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-15 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-15 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-15 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 5e-15 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 5e-15 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 6e-15 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-15 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-15 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 6e-15 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 6e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 7e-15 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 7e-15 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 7e-15 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 7e-15 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 7e-15 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 7e-15 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 7e-15 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 7e-15 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 8e-15 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 8e-15 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-15 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 8e-15 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 8e-15 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 8e-15 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 8e-15 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 8e-15 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 8e-15 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-15 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 8e-15 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 9e-15 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 9e-15 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-14 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-14 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-14 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-14 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-14 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-14 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-14 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-14 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-14 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-14 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-14 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-14 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-14 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-14 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-14 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-14 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-14 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-14 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-14 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-14 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-14 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-14 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-14 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-14 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-14 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-14 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-14 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-14 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-14 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-14 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-14 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-14 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-14 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-14 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-14 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-14 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-14 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-14 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-14 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-14 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-14 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-14 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-14 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-14 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 4e-14 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-14 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-14 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 4e-14 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-14 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-14 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-14 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-14 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-14 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-14 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 4e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-14 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-14 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 4e-14 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 4e-14 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-14 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 4e-14 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 4e-14 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-14 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-14 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-14 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-14 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-14 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 5e-14 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 5e-14 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 5e-14 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 5e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-14 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 5e-14 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 5e-14 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-14 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 6e-14 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 6e-14 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 6e-14 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-14 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 6e-14 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 6e-14 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 7e-14 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 7e-14 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 8e-14 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 8e-14 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 8e-14 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 8e-14 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 8e-14 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 8e-14 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 9e-14 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 9e-14 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 9e-14 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-14 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 9e-14 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-13 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-13 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-13 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-13 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-13 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-13 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-13 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-13 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-13 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-13 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-13 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 1e-13 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-13 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-13 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-13 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-13 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-13 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-13 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-13 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-13 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-13 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-13 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-13 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-13 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-13 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-13 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-13 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-13 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-13 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-13 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-13 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-13 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-13 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-13 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-13 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-13 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-13 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-13 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-13 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-13 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-13 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-13 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-13 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-13 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-13 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-13 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-13 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-13 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-13 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-13 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-13 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-13 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-13 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-13 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-13 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 3e-13 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-13 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-13 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-13 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-13 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-13 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-13 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-13 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-13 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-13 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-13 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-13 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-13 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-13 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-13 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-13 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-13 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-13 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-13 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-13 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-13 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-13 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-13 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 4e-13 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-13 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-13 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-13 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-13 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-13 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 5e-13 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 5e-13 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-13 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-13 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-13 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-13 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-13 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-13 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-13 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-13 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 5e-13 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 5e-13 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 6e-13 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 6e-13 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 6e-13 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-13 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-13 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 6e-13 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 7e-13 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 7e-13 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 7e-13 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-13 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 8e-13 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 8e-13 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 8e-13 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-13 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-13 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 9e-13 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 9e-13 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-12 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-12 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-12 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-12 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-12 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-12 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-12 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-12 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-12 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-12 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-12 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-12 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-12 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-12 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-12 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-12 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-12 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-12 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-12 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 5e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 6e-12 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 6e-12 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 7e-12 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-12 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 9e-12 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 9e-12 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 9e-12 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-11 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-11 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-11 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-11 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 1e-11 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-11 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-11 |
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 449 bits (1156), Expect = e-157
Identities = 115/280 (41%), Positives = 173/280 (61%), Gaps = 16/280 (5%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLK 126
++G G +G VY G +L + +A+K++ E+ + + L EE+ L K
Sbjct: 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEI--------PERDSRYSQPLHEEIALHK 74
Query: 127 DLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLL-GKFGPFP--EAVMRTYTKQLLLG 183
L H NIV+YLG+ E + I +E VPGGS+S+LL K+GP E + YTKQ+L G
Sbjct: 75 HLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEG 134
Query: 184 LEYLHNHGIMHRDIKGANILVDNK-GCIKLADFGASKQVAELATVSGAKSMKGTPYWMAP 242
L+YLH++ I+HRDIKG N+L++ G +K++DFG SK++A + ++ GT +MAP
Sbjct: 135 LKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN--PCTETFTGTLQYMAP 192
Query: 243 EVIRQ--TGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLS 300
E+I + G+ +ADIWS+GCT+IEMATGKPP+ + + AA+F +G K HP IPE++S
Sbjct: 193 EIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMS 252
Query: 301 VKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDPVLH 340
+AK F+LKC E +PD R A++LL F+ +
Sbjct: 253 AEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQ 292
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 425 bits (1095), Expect = e-147
Identities = 88/345 (25%), Positives = 140/345 (40%), Gaps = 21/345 (6%)
Query: 16 TTAESTTDAQTANSPTPFSGGNLVERFNSCIRNSRVLSKHISP-SVKMSPPIRWRKG-EL 73
++ ++ + A A + + S + +L++ + P + + W
Sbjct: 6 SSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPR 65
Query: 74 IGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNI 133
+G G+FG V+ + +G AVK+V + EE+ LS P I
Sbjct: 66 VGRGSFGEVHRMKDKQTGFQCAVKKVRLE-------------VFRVEELVACAGLSSPRI 112
Query: 134 VRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIM 193
V G VRE +NI +E + GGS+ L+ + G PE Y Q L GLEYLH I+
Sbjct: 113 VPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRIL 172
Query: 194 HRDIKGANILVDNKGC-IKLADFGASKQVAEL---ATVSGAKSMKGTPYWMAPEVIRQTG 249
H D+K N+L+ + G L DFG + + ++ + GT MAPEV+
Sbjct: 173 HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP 232
Query: 250 HSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGT-TKSHPPIPENLSVKAKDFLL 308
DIWS C ++ M G PW+ QY I + IP + + +
Sbjct: 233 CDAKVDIWSSCCMMLHMLNGCHPWT-QYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQ 291
Query: 309 KCLEKEPDLRPTASELLKHPFVTGDDEDPVLHASVMKSSEILSPS 353
+ L KEP R +A EL + + + + E S
Sbjct: 292 EGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEPRGNS 336
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 377 bits (970), Expect = e-129
Identities = 80/296 (27%), Positives = 152/296 (51%), Gaps = 21/296 (7%)
Query: 47 RNSRVLSKHISPSVKMSPPIRWRK-GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANF 105
+ + + + +V MS R+ K IG G+F VY G++ ++ +A ++
Sbjct: 6 QQQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQD---- 61
Query: 106 ASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLG----TVREEESLNILLEFVPGGSISSL 161
++ + + +EE ++LK L HPNIVR+ TV+ ++ + ++ E + G++ +
Sbjct: 62 --RKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTY 119
Query: 162 LGKFGPFPEAVMRTYTKQLLLGLEYLHNHG--IMHRDIKGANILVDNK-GCIKLADFGAS 218
L +F V+R++ +Q+L GL++LH I+HRD+K NI + G +K+ D G +
Sbjct: 120 LKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179
Query: 219 KQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQ 278
S AK++ GTP +MAPE+ + + S D+++ G ++EMAT + P+S + Q
Sbjct: 180 TLK----RASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYS-ECQ 233
Query: 279 EVAALFHIGTTKSHPP-IPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333
A ++ T+ P + + K+ + C+ + D R + +LL H F +
Sbjct: 234 NAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 340 bits (874), Expect = e-114
Identities = 90/307 (29%), Positives = 152/307 (49%), Gaps = 20/307 (6%)
Query: 53 SKHISPSVKMSPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQ 112
K + P + + +R + IG G F VY L G +A+K+V I +K +
Sbjct: 19 QKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKAR-- 76
Query: 113 DHIKELEEEVKLLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFG----PF 168
+ +E+ LLK L+HPN+++Y + E+ LNI+LE G +S ++ F
Sbjct: 77 ---ADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLI 133
Query: 169 PEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVS 228
PE + Y QL LE++H+ +MHRDIK AN+ + G +KL D G + + + +
Sbjct: 134 PERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS--SKTT 191
Query: 229 GAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGT 288
A S+ GTPY+M+PE I + G+++ +DIWS+GC + EMA + P+ + +L
Sbjct: 192 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE 251
Query: 289 TKSHPPIP-ENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDPVLHASVMKSS 347
+PP+P ++ S + + + C+ +P+ RP + + +HA S
Sbjct: 252 QCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAK--------RMHACTASSL 303
Query: 348 EILSPSH 354
E H
Sbjct: 304 EHHHHHH 310
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 322 bits (827), Expect = e-107
Identities = 67/288 (23%), Positives = 118/288 (40%), Gaps = 40/288 (13%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLK 126
+ + E IG G FG V+ + G + A+K+ + D L E
Sbjct: 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKK-----PLAGSVDEQNALREVYAHAV 66
Query: 127 DLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLL----GKFGPFPEAVMRTYTKQLLL 182
H ++VRY E++ + I E+ GGS++ + F EA ++ Q+
Sbjct: 67 LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126
Query: 183 GLEYLHNHGIMHRDIKGANILVDNKGCI-------------------KLADFGASKQVAE 223
GL Y+H+ ++H DIK +NI + K+ D G +
Sbjct: 127 GLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR--- 183
Query: 224 LATVSGAKSMKGTPYWMAPEVIRQT-GHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAA 282
+S + +G ++A EV+++ H ADI+++ TV+ A +P
Sbjct: 184 ---ISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN-----GD 235
Query: 283 LFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFV 330
+H P IP+ LS + + L + +P+ RP+A L+KH +
Sbjct: 236 QWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVL 283
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 322 bits (826), Expect = e-106
Identities = 80/317 (25%), Positives = 136/317 (42%), Gaps = 30/317 (9%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKA-QDHIKELEEEVKLL 125
+ + IG G +V+ +N + ++ A+K V + E+A + E+ L
Sbjct: 10 IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYV-------NLEEADNQTLDSYRNEIAYL 61
Query: 126 KDLSHPN--IVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLG 183
L + I+R ++ + +++E ++S L K ++Y K +L
Sbjct: 62 NKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEA 120
Query: 184 LEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPE 243
+ +H HGI+H D+K AN L+ + G +KL DFG + Q+ T S GT +M PE
Sbjct: 121 VHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 179
Query: 244 VIRQTG-----------HSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSH 292
I+ S +D+WS+GC + M GK P+ Q +++ L I
Sbjct: 180 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 239
Query: 293 PPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDPVLHASVMKSSEILSP 352
P+ +D L CL+++P R + ELL HP+V V + ++ +
Sbjct: 240 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ------THPVNQMAKGTTE 293
Query: 353 SHVANLESLQMLTSPGS 369
L L L SP S
Sbjct: 294 EMKYVLGQLVGLNSPNS 310
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 320 bits (821), Expect = e-106
Identities = 82/314 (26%), Positives = 133/314 (42%), Gaps = 26/314 (8%)
Query: 29 SPTPFSGGNLVERFNSCIRNSRVLSKHISPSVKMSPPI-----------RWRKGELIGCG 77
S NL + ++ RV + + SP +++ +G G
Sbjct: 9 SGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHG 68
Query: 78 AFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYL 137
++G V+ + + G L AVK+ + +D ++L E K HP VR
Sbjct: 69 SYGEVFKVRSKEDGRLYAVKRSMSP-----FRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123
Query: 138 GTVREEESLNILLEFVPGGSISSLLGKFG-PFPEAVMRTYTKQLLLGLEYLHNHGIMHRD 196
E L + E G S+ +G PEA + Y + LL L +LH+ G++H D
Sbjct: 124 QAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLD 182
Query: 197 IKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADI 256
+K ANI + +G KL DFG + L T + +G P +MAPE++ Q + +AD+
Sbjct: 183 VKPANIFLGPRGRCKLGDFGLLVE---LGTAGAGEVQEGDPRYMAPELL-QGSYGTAADV 238
Query: 257 WSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPD 316
+S+G T++E+A + P LS + + L+ LE +P
Sbjct: 239 FSLGLTILEVACNMELPHGG----EGWQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPK 294
Query: 317 LRPTASELLKHPFV 330
LR TA LL P +
Sbjct: 295 LRATAEALLALPVL 308
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 319 bits (819), Expect = e-105
Identities = 79/317 (24%), Positives = 135/317 (42%), Gaps = 30/317 (9%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKA-QDHIKELEEEVKLL 125
+ + IG G +V+ +N + ++ A+K V + E+A + E+ L
Sbjct: 57 IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYV-------NLEEADNQTLDSYRNEIAYL 108
Query: 126 KDLSHPN--IVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLG 183
L + I+R ++ + +++E ++S L K ++Y K +L
Sbjct: 109 NKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEA 167
Query: 184 LEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPE 243
+ +H HGI+H D+K AN L+ + G +KL DFG + Q+ T S G +M PE
Sbjct: 168 VHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE 226
Query: 244 VIRQTG-----------HSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSH 292
I+ S +D+WS+GC + M GK P+ Q +++ L I
Sbjct: 227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 286
Query: 293 PPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDPVLHASVMKSSEILSP 352
P+ +D L CL+++P R + ELL HP+V V + ++ +
Sbjct: 287 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ------THPVNQMAKGTTE 340
Query: 353 SHVANLESLQMLTSPGS 369
L L L SP S
Sbjct: 341 EMKYVLGQLVGLNSPNS 357
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 313 bits (804), Expect = e-104
Identities = 76/296 (25%), Positives = 130/296 (43%), Gaps = 25/296 (8%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKA-QDHIKELEEEVKLL 125
+ + IG G +V+ +N + ++ A+K V + E+A + E+ L
Sbjct: 29 IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYV-------NLEEADNQTLDSYRNEIAYL 80
Query: 126 KDLSHPN--IVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLG 183
L + I+R ++ + +++E ++S L K ++Y K +L
Sbjct: 81 NKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEA 139
Query: 184 LEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPE 243
+ +H HGI+H D+K AN L+ + G +KL DFG + Q+ T S GT +M PE
Sbjct: 140 VHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 198
Query: 244 VIRQTG-----------HSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSH 292
I+ S +D+WS+GC + M GK P+ Q +++ L I
Sbjct: 199 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 258
Query: 293 PPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDPVLHASVMKSSE 348
P+ +D L CL+++P R + ELL HP+V PV + + E
Sbjct: 259 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ-IQTHPVNQMAKGTTEE 313
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 305 bits (784), Expect = e-101
Identities = 107/275 (38%), Positives = 168/275 (61%), Gaps = 14/275 (5%)
Query: 58 PSVKMSPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKE 117
++K P + K E IG G+FG V+ G++ + +++A+K + + E+A+D I++
Sbjct: 14 QNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDL-------EEAEDEIED 66
Query: 118 LEEEVKLLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYT 177
+++E+ +L P + +Y G+ ++ L I++E++ GGS LL + GP E + T
Sbjct: 67 IQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-EPGPLDETQIATIL 125
Query: 178 KQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTP 237
+++L GL+YLH+ +HRDIK AN+L+ G +KLADFG + Q+ T + GTP
Sbjct: 126 REILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTP 183
Query: 238 YWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPP-IP 296
+WMAPEVI+Q+ + ADIWS+G T IE+A G+PP S + + LF I K++PP +
Sbjct: 184 FWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHS-ELHPMKVLFLI--PKNNPPTLE 240
Query: 297 ENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVT 331
N S K+F+ CL KEP RPTA ELLKH F+
Sbjct: 241 GNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIL 275
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 294 bits (754), Expect = 3e-96
Identities = 103/286 (36%), Positives = 167/286 (58%), Gaps = 19/286 (6%)
Query: 50 RVLSKHISPSVKMSPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKE 109
R L K S+ P + E +G G++G VY ++ ++G+++A+KQV +
Sbjct: 13 RQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV-------- 64
Query: 110 KAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKF-GPF 168
+ ++E+ +E+ +++ P++V+Y G+ + L I++E+ GS+S ++
Sbjct: 65 --ESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTL 122
Query: 169 PEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVS 228
E + T + L GLEYLH +HRDIK NIL++ +G KLADFG + Q+ + T++
Sbjct: 123 TEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD--TMA 180
Query: 229 GAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGT 288
++ GTP+WMAPEVI++ G++ ADIWS+G T IEMA GKPP++ + A+F I
Sbjct: 181 KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYA-DIHPMRAIFMI-- 237
Query: 289 TKSHPPI---PENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVT 331
+ PP PE S DF+ +CL K P+ R TA++LL+HPFV
Sbjct: 238 PTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVR 283
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 290 bits (745), Expect = 4e-95
Identities = 103/285 (36%), Positives = 160/285 (56%), Gaps = 22/285 (7%)
Query: 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVK 123
P W +G GAFG+VY N ++G L A K + K+++ +++ E++
Sbjct: 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIET--------KSEEELEDYIVEIE 68
Query: 124 LLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLL 182
+L HP IV+ LG + L I++EF PGG++ +++ + E ++ +Q+L
Sbjct: 69 ILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLE 128
Query: 183 GLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAP 242
L +LH+ I+HRD+K N+L+ +G I+LADFG S + + T+ S GTPYWMAP
Sbjct: 129 ALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK--TLQKRDSFIGTPYWMAP 186
Query: 243 EVI-----RQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPI-- 295
EV+ + T + Y ADIWS+G T+IEMA +PP + + L I KS PP
Sbjct: 187 EVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHH-ELNPMRVLLKI--AKSDPPTLL 243
Query: 296 -PENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDPVL 339
P SV+ +DFL L+K P+ RP+A++LL+HPFV+ + L
Sbjct: 244 TPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKAL 288
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 288 bits (738), Expect = 4e-94
Identities = 91/271 (33%), Positives = 151/271 (55%), Gaps = 17/271 (6%)
Query: 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVK 123
P ++ + E IG GA G VY M++ +G+ +A++Q+ + + Q + + E+
Sbjct: 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNL--------QQQPKKELIINEIL 69
Query: 124 LLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLG 183
++++ +PNIV YL + + L +++E++ GGS++ ++ E + ++ L
Sbjct: 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQA 128
Query: 184 LEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPE 243
LE+LH++ ++HRDIK NIL+ G +KL DFG Q+ S +M GTPYWMAPE
Sbjct: 129 LEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMVGTPYWMAPE 186
Query: 244 VIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPI---PENLS 300
V+ + + DIWS+G IEM G+PP+ + AL+ I + P PE LS
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL-NENPLRALYLI--ATNGTPELQNPEKLS 243
Query: 301 VKAKDFLLKCLEKEPDLRPTASELLKHPFVT 331
+DFL +CLE + + R +A ELL+H F+
Sbjct: 244 AIFRDFLNRCLEMDVEKRGSAKELLQHQFLK 274
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 288 bits (740), Expect = 9e-94
Identities = 77/285 (27%), Positives = 148/285 (51%), Gaps = 19/285 (6%)
Query: 55 HISPSVKMSPPI-------RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFAS 107
H S V + ++ + + IG G+FG+ + + + G +K++ I+ +S
Sbjct: 6 HHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINIS-RMSS 64
Query: 108 KEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLL--GKF 165
KE+ +E EV +L ++ HPNIV+Y + E SL I++++ GG + + K
Sbjct: 65 KER-----EESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKG 119
Query: 166 GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA 225
F E + + Q+ L L+++H+ I+HRDIK NI + G ++L DFG ++ +
Sbjct: 120 VLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS-- 177
Query: 226 TVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFH 285
TV A++ GTPY+++PE+ ++ +DIW++GC + E+ T K + + +
Sbjct: 178 TVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAF-EAGSMKNLVLK 236
Query: 286 IGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFV 330
I + S PP+ + S + + + ++ P RP+ + +L+ F+
Sbjct: 237 I-ISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFI 280
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 287 bits (737), Expect = 1e-93
Identities = 94/271 (34%), Positives = 143/271 (52%), Gaps = 17/271 (6%)
Query: 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVK 123
P + IG G+ G V + SG +AVK + + + Q + L EV
Sbjct: 43 PRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDL--------RKQQRRELLFNEVV 94
Query: 124 LLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLG 183
+++D H N+V + E L +L+EF+ GG+++ ++ E + T + +L
Sbjct: 95 IMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIV-SQVRLNEEQIATVCEAVLQA 153
Query: 184 LEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPE 243
L YLH G++HRDIK +IL+ G +KL+DFG Q+++ V KS+ GTPYWMAPE
Sbjct: 154 LAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK--DVPKRKSLVGTPYWMAPE 211
Query: 244 VIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPI---PENLS 300
VI ++ ++ DIWS+G VIEM G+PP+ V A+ + S PP +S
Sbjct: 212 VISRSLYATEVDIWSLGIMVIEMVDGEPPYF-SDSPVQAMKRL--RDSPPPKLKNSHKVS 268
Query: 301 VKAKDFLLKCLEKEPDLRPTASELLKHPFVT 331
+DFL + L ++P R TA ELL HPF+
Sbjct: 269 PVLRDFLERMLVRDPQERATAQELLDHPFLL 299
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 285 bits (731), Expect = 5e-93
Identities = 95/302 (31%), Positives = 154/302 (50%), Gaps = 32/302 (10%)
Query: 52 LSKHISPSVKMSPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKA 111
+S+ S + E+IG GA V E +A+K++ + EK
Sbjct: 1 MSEDSSALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINL-------EKC 53
Query: 112 QDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLL--------G 163
Q + EL +E++ + HPNIV Y + ++ L ++++ + GGS+ ++
Sbjct: 54 QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEH 113
Query: 164 KFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAE 223
K G E+ + T +++L GLEYLH +G +HRD+K NIL+ G +++ADFG S +A
Sbjct: 114 KSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLAT 173
Query: 224 LATVSGA---KSMKGTPYWMAPEVIRQT-GHSYSADIWSVGCTVIEMATGKPPWSQQYQE 279
++ K+ GTP WMAPEV+ Q G+ + ADIWS G T IE+ATG P+ +Y
Sbjct: 174 GGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYH-KYPP 232
Query: 280 VAALFHIGTTKSHPP----------IPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPF 329
+ L ++ PP + + + + CL+K+P+ RPTA+ELL+H F
Sbjct: 233 MKVLMLT--LQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKF 290
Query: 330 VT 331
Sbjct: 291 FQ 292
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 286 bits (734), Expect = 7e-93
Identities = 93/281 (33%), Positives = 151/281 (53%), Gaps = 19/281 (6%)
Query: 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVK 123
P + IG G+FG VY ++ + E++A+K++ S +++ + +++ +EV+
Sbjct: 52 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSY-----SGKQSNEKWQDIIKEVR 106
Query: 124 LLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLG 183
L+ L HPN ++Y G E + +++E+ G + L P E + T L G
Sbjct: 107 FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQG 166
Query: 184 LEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPE 243
L YLH+H ++HRD+K NIL+ G +KL DFG++ + ++ A S GTPYWMAPE
Sbjct: 167 LAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSA------SIMAPANSFVGTPYWMAPE 220
Query: 244 VI---RQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPI--PEN 298
VI + + D+WS+G T IE+A KPP ++AL+HI ++ P +
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLF-NMNAMSALYHI--AQNESPALQSGH 277
Query: 299 LSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDPVL 339
S ++F+ CL+K P RPT+ LLKH FV + V+
Sbjct: 278 WSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVI 318
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 282 bits (723), Expect = 1e-91
Identities = 98/308 (31%), Positives = 152/308 (49%), Gaps = 30/308 (9%)
Query: 54 KHISPSVKMSPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQD 113
I S P + EL+G G +G+VY G ++ +G+L A+K + + D
Sbjct: 12 DEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---------GD 62
Query: 114 HIKELEEEVKLLKDLS-HPNIVRYLG------TVREEESLNILLEFVPGGSISSLL--GK 164
+E+++E+ +LK S H NI Y G ++ L +++EF GS++ L+ K
Sbjct: 63 EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK 122
Query: 165 FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAEL 224
E + +++L GL +LH H ++HRDIKG N+L+ +KL DFG S Q+
Sbjct: 123 GNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD-- 180
Query: 225 ATVSGAKSMKGTPYWMAPEVIR-----QTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE 279
TV + GTPYWMAPEVI + + +D+WS+G T IEMA G PP
Sbjct: 181 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC-DMHP 239
Query: 280 VAALFHIGTTKSHPPI--PENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDP 337
+ ALF I ++ P + S K + F+ CL K RP +L+KHPF+ +
Sbjct: 240 MRALFLI--PRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNER 297
Query: 338 VLHASVMK 345
+ +
Sbjct: 298 QVRIQLKD 305
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 266 bits (681), Expect = 2e-84
Identities = 67/326 (20%), Positives = 121/326 (37%), Gaps = 66/326 (20%)
Query: 62 MSPPIRWRKGELIGCGA--FGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELE 119
+ + +IG G V + +GE + V+++ + + + + + L+
Sbjct: 21 LPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINL------EACSNEMVTFLQ 74
Query: 120 EEVKLLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLL--GKFGPFPEAVMRTYT 177
E+ + K +HPNIV Y T + L ++ F+ GS L+ E +
Sbjct: 75 GELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYIL 134
Query: 178 KQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMK--- 234
+ +L L+Y+H+ G +HR +K ++IL+ G + L+ ++ + + +
Sbjct: 135 QGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS--HGQRQRVVHDFP 192
Query: 235 ----GTPYWMAPEVIRQTGHSYS--ADIWSVGCTVIEMATGKPPWSQQYQEVAALFHI-- 286
W++PEV++Q Y +DI+SVG T E+A G P+ L
Sbjct: 193 KYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK-DMPATQMLLEKLN 251
Query: 287 ------------------------------------------GTTKSHPPIPENLSVKAK 304
P S
Sbjct: 252 GTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFH 311
Query: 305 DFLLKCLEKEPDLRPTASELLKHPFV 330
F+ +CL++ PD RP+AS LL H F
Sbjct: 312 HFVEQCLQRNPDARPSASTLLNHSFF 337
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 261 bits (668), Expect = 7e-84
Identities = 69/280 (24%), Positives = 118/280 (42%), Gaps = 40/280 (14%)
Query: 69 RKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL 128
++ ELIG G FG+V+ + G+ +K+V ++ E EVK L L
Sbjct: 14 KEIELIGSGGFGQVFKAKHRIDGKTYVIKRV-------KYNN-----EKAEREVKALAKL 61
Query: 129 SHPNIVRYLG----------------TVREEESLNILLEFVPGGSISSLLGK--FGPFPE 170
H NIV Y G + + + L I +EF G++ + K +
Sbjct: 62 DHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDK 121
Query: 171 AVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGA 230
+ +Q+ G++Y+H+ +++RD+K +NI + + +K+ DFG L
Sbjct: 122 VLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTS---LKNDGKR 178
Query: 231 KSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTK 290
KGT +M+PE I + D++++G + E+ E + F
Sbjct: 179 TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT----AFETSKFFTDLR-- 232
Query: 291 SHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFV 330
I + K K L K L K+P+ RP SE+L+ V
Sbjct: 233 -DGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTV 271
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 253 bits (648), Expect = 2e-80
Identities = 78/278 (28%), Positives = 132/278 (47%), Gaps = 24/278 (8%)
Query: 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVK-LLKDLSH 130
+G G G+V+ +G ++AVKQ+ ++ K + ++ +LK
Sbjct: 31 GEMGSGTCGQVWKMRFRKTGHVIAVKQMRR-------SGNKEENKRILMDLDVVLKSHDC 83
Query: 131 PNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLH-N 189
P IV+ GT + I +E + + GP PE ++ T ++ L YL
Sbjct: 84 PYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK 143
Query: 190 HGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMK-GTPYWMAPEVI--- 245
HG++HRD+K +NIL+D +G IKL DFG S ++ + AK G +MAPE I
Sbjct: 144 HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD----DKAKDRSAGCAAYMAPERIDPP 199
Query: 246 --RQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPI---PENLS 300
+ + AD+WS+G +++E+ATG+ P+ + L + + PP+ S
Sbjct: 200 DPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKV--LQEEPPLLPGHMGFS 257
Query: 301 VKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDPV 338
+ F+ CL K+ RP ++LL+H F+ + V
Sbjct: 258 GDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEV 295
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 251 bits (644), Expect = 2e-80
Identities = 79/273 (28%), Positives = 132/273 (48%), Gaps = 21/273 (7%)
Query: 69 RKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL 128
IG G++GR G++L K++ + EK + L EV LL++L
Sbjct: 9 EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYG-SMTEAEK-----QMLVSEVNLLREL 62
Query: 129 SHPNIVRYLGTVREEES--LNILLEFVPGGSISSLLGKFG----PFPEAVMRTYTKQLLL 182
HPNIVRY + + + L I++E+ GG ++S++ K E + QL L
Sbjct: 63 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 183 GLEYLH-----NHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTP 237
L+ H H ++HRD+K AN+ +D K +KL DFG ++ + S AK+ GTP
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN--HDTSFAKTFVGTP 180
Query: 238 YWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPE 297
Y+M+PE + + ++ +DIWS+GC + E+ PP+ L IP
Sbjct: 181 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF--TAFSQKELAGKIREGKFRRIPY 238
Query: 298 NLSVKAKDFLLKCLEKEPDLRPTASELLKHPFV 330
S + + + + L + RP+ E+L++P +
Sbjct: 239 RYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 251 bits (644), Expect = 4e-80
Identities = 75/280 (26%), Positives = 130/280 (46%), Gaps = 27/280 (9%)
Query: 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVK-LLKDLSH 130
+G GA+G V ++ SG+++AVK++ K L ++ ++ +
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQIMAVKRIRA-------TVNSQEQKRLLMDLDISMRTVDC 65
Query: 131 PNIVRYLGTVREEESLNILLEFVPGGSISSLLGKF----GPFPEAVMRTYTKQLLLGLEY 186
P V + G + E + I +E + S+ + PE ++ ++ LE+
Sbjct: 66 PFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124
Query: 187 LH-NHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMK-GTPYWMAPEV 244
LH ++HRD+K +N+L++ G +K+ DFG S + + AK + G +MAPE
Sbjct: 125 LHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD----DVAKDIDAGCKPYMAPER 180
Query: 245 I----RQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPI--PEN 298
I Q G+S +DIWS+G T+IE+A + P+ L + + P +
Sbjct: 181 INPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV--VEEPSPQLPADK 238
Query: 299 LSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDPV 338
S + DF +CL+K RPT EL++HPF T +
Sbjct: 239 FSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKGT 278
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 254 bits (649), Expect = 4e-80
Identities = 90/333 (27%), Positives = 150/333 (45%), Gaps = 57/333 (17%)
Query: 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHP 131
+G G G V+ + SG ++A K + + E ++ E+++L + + P
Sbjct: 39 SELGAGNGGVVFKVSHKPSGLVMARKLIHL-------EIKPAIRNQIIRELQVLHECNSP 91
Query: 132 NIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLH-NH 190
IV + G + ++I +E + GGS+ +L K G PE ++ + ++ GL YL H
Sbjct: 92 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 151
Query: 191 GIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGH 250
IMHRD+K +NILV+++G IKL DFG S Q+ + S A S GT +M+PE ++ T +
Sbjct: 152 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPERLQGTHY 207
Query: 251 SYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTT--------------------- 289
S +DIWS+G +++EMA G+ P + L
Sbjct: 208 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKF 267
Query: 290 ------------------KSHPPI--PENLSVKAKDFLLKCLEKEPDLRPTASELLKHPF 329
PP S++ +DF+ KCL K P R +L+ H F
Sbjct: 268 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 327
Query: 330 VTGDDEDPVLHAS----VMKSSEILSPSHVANL 358
+ D + V A + ++ +P+H A +
Sbjct: 328 IKRSDAEEVDFAGWLCSTIGLNQPSTPTHAAGV 360
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 252 bits (646), Expect = 5e-80
Identities = 86/284 (30%), Positives = 132/284 (46%), Gaps = 31/284 (10%)
Query: 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVK-LLKDLSH 130
IG GA+G V ++ SG+++AVK++ + K+L ++ +++
Sbjct: 28 GEIGRGAYGSVNKMVHKPSGQIMAVKRIRS-------TVDEKEQKQLLMDLDVVMRSSDC 80
Query: 131 PNIVRYLGTVREEESLNILLEFVPGGSISSLLGKF-----GPFPEAVMRTYTKQLLLGLE 185
P IV++ G + E I +E + S PE ++ T + L
Sbjct: 81 PYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALN 139
Query: 186 YLH-NHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMK-GTPYWMAPE 243
+L N I+HRDIK +NIL+D G IKL DFG S Q+ S AK+ G +MAPE
Sbjct: 140 HLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL----VDSIAKTRDAGCRPYMAPE 195
Query: 244 VI----RQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPI---- 295
I + G+ +D+WS+G T+ E+ATG+ P+ + L + K PP
Sbjct: 196 RIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV--VKGDPPQLSNS 253
Query: 296 -PENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDPV 338
S +F+ CL K+ RP ELLKHPF+ +E V
Sbjct: 254 EEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAV 297
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 249 bits (638), Expect = 4e-79
Identities = 70/302 (23%), Positives = 124/302 (41%), Gaps = 37/302 (12%)
Query: 70 KGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS 129
+ ++G GAFG+V N A+K++ ++ + + EV LL L+
Sbjct: 10 EIAVLGQGAFGQVVKARNALDSRYYAIKKI---------RHTEEKLSTILSEVMLLASLN 60
Query: 130 HPNIVRYLGTVREEES-------------LNILLEFVPGGSISSLLGKFG-PFPEAVMRT 175
H +VRY E + L I +E+ G++ L+
Sbjct: 61 HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR 120
Query: 176 YTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSG------ 229
+Q+L L Y+H+ GI+HRD+K NI +D +K+ DFG +K V +
Sbjct: 121 LFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 230 ------AKSMKGTPYWMAPEVIRQTGH-SYSADIWSVGCTVIEMATGKPPWSQQYQEVAA 282
S GT ++A EV+ TGH + D++S+G EM ++ +
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKK 240
Query: 283 LFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDPVLHAS 342
L + + P +N K + ++ +P+ RP A LL ++ +D V+ +
Sbjct: 241 LRS-VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDEVIKEA 299
Query: 343 VM 344
+
Sbjct: 300 LK 301
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 249 bits (638), Expect = 2e-77
Identities = 73/308 (23%), Positives = 132/308 (42%), Gaps = 24/308 (7%)
Query: 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLL 125
I + +++G GA G + D +AVK++L + + EV+LL
Sbjct: 24 ISFCPKDVLGHGAEGTIVYRGMFD-NRDVAVKRIL-----------PECFSFADREVQLL 71
Query: 126 KDLS-HPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGL 184
++ HPN++RY T ++ + I +E + K T +Q GL
Sbjct: 72 RESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGL 131
Query: 185 EYLHNHGIMHRDIKGANILVDNKG-----CIKLADFGASKQV-AELATVSGAKSMKGTPY 238
+LH+ I+HRD+K NIL+ ++DFG K++ + S + GT
Sbjct: 132 AHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191
Query: 239 WMAPEVIRQT---GHSYSADIWSVGCTVIEMAT-GKPPWSQQYQEVAALFHIGTTKSHPP 294
W+APE++ + +Y+ DI+S GC + + G P+ + Q A + +
Sbjct: 192 WIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLH 251
Query: 295 IPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDPVLHASVMKSSEILSPSH 354
++ V A++ + K + +P RP+A +LKHPF ++ V E
Sbjct: 252 PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQFFQDVSDRIEK-ESLD 310
Query: 355 VANLESLQ 362
++ L+
Sbjct: 311 GPIVKQLE 318
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 240 bits (614), Expect = 1e-75
Identities = 63/288 (21%), Positives = 107/288 (37%), Gaps = 36/288 (12%)
Query: 69 RKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL 128
+ +G G FG V+ N A+K++ + ++EK EVK L L
Sbjct: 8 EPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVM-------REVKALAKL 60
Query: 129 SHPNIVRYLGTVREEES------------LNILLEFVPGGSISSLL---GKFGPFPEAVM 173
HP IVRY E+ + L I ++ ++ + +V
Sbjct: 61 EHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVC 120
Query: 174 RTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQV----------AE 223
Q+ +E+LH+ G+MHRD+K +NI +K+ DFG +
Sbjct: 121 LHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 224 LATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAAL 283
+ + GT +M+PE I +S+ DI+S+G + E+ P +Q E
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY--PFSTQ--MERVRT 236
Query: 284 FHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVT 331
PP+ + L P RP A ++++
Sbjct: 237 LTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFE 284
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 4e-69
Identities = 83/281 (29%), Positives = 135/281 (48%), Gaps = 18/281 (6%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDH--IKELEEEVKLLKDL 128
G +G G FG VY+ S +LA+K VL K + + +L EV++ L
Sbjct: 14 GRPLGKGKFGNVYLAREKQSKFILALK-VL------FKAQLEKAGVEHQLRREVEIQSHL 66
Query: 129 SHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLH 188
HPNI+R G + + ++LE+ P G++ L K F E TY +L L Y H
Sbjct: 67 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 126
Query: 189 NHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQT 248
+ ++HRDIK N+L+ + G +K+ADFG S S + GT ++ PE+I
Sbjct: 127 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS----SRRTDLCGTLDYLPPEMIEGR 182
Query: 249 GHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFH-IGTTKSHPPIPENLSVKAKDFL 307
H D+WS+G E GKPP+ + + I ++ P+ ++ A+D +
Sbjct: 183 MHDEKVDLWSLGVLCYEFLVGKPPF--EANTYQETYKRI--SRVEFTFPDFVTEGARDLI 238
Query: 308 LKCLEKEPDLRPTASELLKHPFVTGDDEDPVLHASVMKSSE 348
+ L+ P RP E+L+HP++T + P + +S+
Sbjct: 239 SRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASK 279
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 2e-68
Identities = 77/288 (26%), Positives = 140/288 (48%), Gaps = 26/288 (9%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDH--IKELEEEVKL 124
R+ +G +G G F + + + D+ E+ A K V K +++ E+ +
Sbjct: 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIV-------PKSLLLKPHQREKMSMEISI 68
Query: 125 LKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGL 184
+ L+H ++V + G + + + ++LE S+ L + E R Y +Q++LG
Sbjct: 69 HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC 128
Query: 185 EYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMK-----GTPYW 239
+YLH + ++HRD+K N+ ++ +K+ DFG LAT + GTP +
Sbjct: 129 QYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFG-------LATKVEYDGERKKVLCGTPNY 181
Query: 240 MAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFH-IGTTKSHPPIPEN 298
+APEV+ + GHS+ D+WS+GC + + GKPP+ + + + I K+ IP++
Sbjct: 182 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF--ETSCLKETYLRI--KKNEYSIPKH 237
Query: 299 LSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDPVLHASVMKS 346
++ A + K L+ +P RPT +ELL F T L + +
Sbjct: 238 INPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTI 285
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 1e-67
Identities = 76/286 (26%), Positives = 142/286 (49%), Gaps = 22/286 (7%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLK 126
R+ +G +G G F + + + D+ E+ A K ++ + K ++ + E+ + +
Sbjct: 42 RYVRGRFLGKGGFAKCFEISDADTKEVFAGK--IVPKSLLLKPHQREKMSM---EISIHR 96
Query: 127 DLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEY 186
L+H ++V + G + + + ++LE S+ L + E R Y +Q++LG +Y
Sbjct: 97 SLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQY 156
Query: 187 LHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMK-----GTPYWMA 241
LH + ++HRD+K N+ ++ +K+ DFG LAT + GTP ++A
Sbjct: 157 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFG-------LATKVEYDGERKKVLCGTPNYIA 209
Query: 242 PEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFH-IGTTKSHPPIPENLS 300
PEV+ + GHS+ D+WS+GC + + GKPP+ + + + I K+ IP++++
Sbjct: 210 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF--ETSCLKETYLRI--KKNEYSIPKHIN 265
Query: 301 VKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDPVLHASVMKS 346
A + K L+ +P RPT +ELL F T L + +
Sbjct: 266 PVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTI 311
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 3e-66
Identities = 66/280 (23%), Positives = 108/280 (38%), Gaps = 26/280 (9%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLK 126
+ + +G G F V + L G A+K++L Q +E + E + +
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILC--------HEQQDREEAQREADMHR 81
Query: 127 DLSHPNIVRYLGTVREEES----LNILLEFVPGGS----ISSLLGKFGPFPEAVMRTYTK 178
+HPNI+R + E +LL F G+ I L K E +
Sbjct: 82 LFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLL 141
Query: 179 QLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQV-------AELATVSGAK 231
+ GLE +H G HRD+K NIL+ ++G L D G+ Q + T+
Sbjct: 142 GICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWA 201
Query: 232 SMKGTPYWMAPEVIRQTGH---SYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGT 288
+ + T + APE+ H D+WS+GC + M G+ P+ +Q+ ++
Sbjct: 202 AQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ 261
Query: 289 TKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHP 328
+ P S L + +P RP LL
Sbjct: 262 NQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 4e-66
Identities = 78/274 (28%), Positives = 139/274 (50%), Gaps = 27/274 (9%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDH--IKELEEEVKL 124
++ G L+G G+F VY ++ +G +A+K + K+ ++ ++ EVK+
Sbjct: 12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMI-------DKKAMYKAGMVQRVQNEVKI 64
Query: 125 LKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLL-GKFGPFPEAVMRTYTKQLLLG 183
L HP+I+ + + ++LE G ++ L + PF E R + Q++ G
Sbjct: 65 HCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITG 124
Query: 184 LEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMK-----GTPY 238
+ YLH+HGI+HRD+ +N+L+ IK+ADFG LAT K GTP
Sbjct: 125 MLYLHSHGILHRDLTLSNLLLTRNMNIKIADFG-------LATQLKMPHEKHYTLCGTPN 177
Query: 239 WMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFH-IGTTKSHPPIPE 297
+++PE+ ++ H +D+WS+GC + G+PP+ V + + + +P
Sbjct: 178 YISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPF--DTDTVKNTLNKV--VLADYEMPS 233
Query: 298 NLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVT 331
LS++AKD + + L + P R + S +L HPF++
Sbjct: 234 FLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMS 267
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 2e-65
Identities = 71/307 (23%), Positives = 123/307 (40%), Gaps = 57/307 (18%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLK 126
W +++G GA V+ G + +G+L A+K + + E ++LK
Sbjct: 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVF-------NNISFLRPVDVQMREFEVLK 62
Query: 127 DLSHPNIVRYLGTVREEESLNILL--EFVPGGSISSLL---GKFGPFPEAVMRTYTKQLL 181
L+H NIV+ E + + +L EF P GS+ ++L PE+ + ++
Sbjct: 63 KLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 122
Query: 182 LGLEYLHNHGIMHRDIKGANILV----DNKGCIKLADFGASKQVAELATVSGAKSMKGTP 237
G+ +L +GI+HR+IK NI+ D + KL DFGA++ EL S+ GT
Sbjct: 123 GGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR---ELEDDEQFVSLYGTE 179
Query: 238 YWMAPEVIR--------QTGHSYSADIWSVGCTVIEMATGKPPW-----SQQYQEVAALF 284
++ P++ Q + + D+WS+G T ATG P+ ++ +EV ++
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV--MY 237
Query: 285 HIGTTKSH-----------------------PPIPENLSVKAKDFLLKCLEKEPDLRPTA 321
I T K + L V L LE + +
Sbjct: 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF 297
Query: 322 SELLKHP 328
+
Sbjct: 298 DQFFAET 304
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 8e-65
Identities = 78/264 (29%), Positives = 119/264 (45%), Gaps = 18/264 (6%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDH--IKELEEEVKLLKDL 128
G +G G FG VY+ + ++A+K VL K + + +L E+++ L
Sbjct: 19 GRPLGKGKFGNVYLAREKQNKFIMALK-VL------FKSQLEKEGVEHQLRREIEIQSHL 71
Query: 129 SHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLH 188
HPNI+R + + + ++LEF P G + L K G F E T+ ++L L Y H
Sbjct: 72 RHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCH 131
Query: 189 NHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQT 248
++HRDIK N+L+ KG +K+ADFG S L ++M GT ++ PE+I
Sbjct: 132 ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR----RTMCGTLDYLPPEMIEGK 187
Query: 249 GHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFH-IGTTKSHPPIPENLSVKAKDFL 307
H D+W G E G PP+ I P LS +KD +
Sbjct: 188 THDEKVDLWCAGVLCYEFLVGMPPF--DSPSHTETHRRI--VNVDLKFPPFLSDGSKDLI 243
Query: 308 LKCLEKEPDLRPTASELLKHPFVT 331
K L P R +++HP+V
Sbjct: 244 SKLLRYHPPQRLPLKGVMEHPWVK 267
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 5e-64
Identities = 76/268 (28%), Positives = 129/268 (48%), Gaps = 19/268 (7%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH 130
+ IG G FG V+ G + ++A+K LI + + + + +E + EV ++ +L+H
Sbjct: 24 EKQIGKGGFGLVHKGRLVKDKSVVAIK-SLILGDSEGETEMIEKFQEFQREVFIMSNLNH 82
Query: 131 PNIVRYLGTVREEESLNILLEFVPGGSISSLL-GKFGPFPEAVMRTYTKQLLLGLEYLHN 189
PNIV+ G + +++EFVP G + L K P +V + LG+EY+ N
Sbjct: 83 PNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN 140
Query: 190 HG--IMHRDIKGANILVDNKG-----CIKLADFGASKQVAELATVSGAKSMKGTPYWMAP 242
I+HRD++ NI + + C K+ADFG S+Q + + G WMAP
Sbjct: 141 QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVS-----GLLGNFQWMAP 195
Query: 243 EVIRQTGHSYS--ADIWSVGCTVIEMATGKPPWSQ-QYQEVAALFHIGTTKSHPPIPENL 299
E I SY+ AD +S + + TG+ P+ + Y ++ + I P IPE+
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDC 255
Query: 300 SVKAKDFLLKCLEKEPDLRPTASELLKH 327
+ ++ + C +P RP S ++K
Sbjct: 256 PPRLRNVIELCWSGDPKKRPHFSYIVKE 283
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 2e-63
Identities = 75/274 (27%), Positives = 129/274 (47%), Gaps = 32/274 (11%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELLAVK----QVLIAANFASKEKAQDHIKELEEEVKLLK 126
G+++G G+F V + L + A+K + +I KE ++ E ++
Sbjct: 35 GKILGEGSFSTVVLARELATSREYAIKILEKRHII------KENKVPYVTR---ERDVMS 85
Query: 127 DLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEY 186
L HP V+ T +++E L L + G + + K G F E R YT +++ LEY
Sbjct: 86 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 145
Query: 187 LHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIR 246
LH GI+HRD+K NIL++ I++ DFG +K ++ + + A S GT +++PE++
Sbjct: 146 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 205
Query: 247 QTGHSYSADIWSVGCTVIEMATGKPPW-----SQQYQEVAALFHIGTTKSHPPIPENLSV 301
+ S+D+W++GC + ++ G PP+ +Q++ K PE
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI--------IKLEYDFPEKFFP 257
Query: 302 KAKDFLLKCLEKEPDLRPT------ASELLKHPF 329
KA+D + K L + R L HPF
Sbjct: 258 KARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 291
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 8e-63
Identities = 73/310 (23%), Positives = 132/310 (42%), Gaps = 44/310 (14%)
Query: 58 PSVKMSPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKE 117
P+ + S +++G G+ G V + G +AVK++LI D
Sbjct: 7 PNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQ-GRPVAVKRMLI-----------DFCDI 54
Query: 118 LEEEVKLLKDLS-HPNIVRYLGTVREEESLNILLEFVPGG------SISSLLGKFGPFPE 170
E+KLL + HPN++RY + + L I LE S + E
Sbjct: 55 ALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKE 114
Query: 171 AVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGC-------------IKLADFGA 217
+ +Q+ G+ +LH+ I+HRD+K NILV I ++DFG
Sbjct: 115 YNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 174
Query: 218 SKQVA--ELATVSGAKSMKGTPYWMAPEVIRQTGH-------SYSADIWSVGCTVIEMAT 268
K++ + + + + GT W APE++ ++ + + S DI+S+GC + +
Sbjct: 175 CKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234
Query: 269 -GKPPWSQQYQEVAALF--HIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELL 325
GK P+ +Y + + + +L +A D + + ++ +P RPTA ++L
Sbjct: 235 KGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVL 294
Query: 326 KHPFVTGDDE 335
+HP +
Sbjct: 295 RHPLFWPKSK 304
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 1e-62
Identities = 76/277 (27%), Positives = 127/277 (45%), Gaps = 13/277 (4%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELLAVK-----QVLIAANFASKEKAQDHIKELEEEVKLL 125
+G GA+G V + + A+K Q + + +E+ E+ LL
Sbjct: 41 VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLL 100
Query: 126 KDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLE 185
K L HPNI++ +++ ++ EF GG + + F E KQ+L G+
Sbjct: 101 KSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGIC 160
Query: 186 YLHNHGIMHRDIKGANILVDNKG---CIKLADFGASKQVAELATVSGAKSMKGTPYWMAP 242
YLH H I+HRDIK NIL++NK IK+ DFG S ++ + + GT Y++AP
Sbjct: 161 YLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL---RDRLGTAYYIAP 217
Query: 243 EVIRQTGHSYSADIWSVGCTVIEMATGKPP-WSQQYQEVAALFHIGTTKSHPPIPENLSV 301
EV+++ ++ D+WS G + + G PP Q Q++ G +N+S
Sbjct: 218 EVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISD 276
Query: 302 KAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDPV 338
+AK+ + L + + R TA E L ++ +
Sbjct: 277 EAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNIN 313
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 205 bits (525), Expect = 1e-62
Identities = 73/271 (26%), Positives = 129/271 (47%), Gaps = 30/271 (11%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH 130
+G GAFG V++ SG +K + +K+++Q ++++E E+++LK L H
Sbjct: 27 KRKLGSGAFGDVHLVEERSSGLERVIKTI-------NKDRSQVPMEQIEAEIEVLKSLDH 79
Query: 131 PNIVRYLGTVREEESLNILLEFVPGG----SISSLLGKFGPFPEAVMRTYTKQLLLGLEY 186
PNI++ + ++ I++E GG I S + E + KQ++ L Y
Sbjct: 80 PNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAY 139
Query: 187 LHNHGIMHRDIKGANILVDNK---GCIKLADFGASKQVAELATVSGAKSMK---GTPYWM 240
H+ ++H+D+K NIL + IK+ DFG ++ + GT +M
Sbjct: 140 FHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS------DEHSTNAAGTALYM 193
Query: 241 APEVIRQTGHSYSADIWSVGCTVIE--MATGKPP-WSQQYQEVAALFHIGTTKSHPPIPE 297
APEV ++ ++ DIWS G V+ + TG P +EV ++
Sbjct: 194 APEVFKR-DVTFKCDIWSAG--VVMYFLLTGCLPFTGTSLEEVQQKATYKEP-NYAVECR 249
Query: 298 NLSVKAKDFLLKCLEKEPDLRPTASELLKHP 328
L+ +A D L + L K+P+ RP+A+++L H
Sbjct: 250 PLTPQAVDLLKQMLTKDPERRPSAAQVLHHE 280
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 3e-62
Identities = 82/283 (28%), Positives = 141/283 (49%), Gaps = 12/283 (4%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH 130
+ +G GA G V + + + +A++ + + D +E E+++LK L+H
Sbjct: 140 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNH 199
Query: 131 PNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNH 190
P I++ + E I+LE + GG + + EA + Y Q+LL ++YLH +
Sbjct: 200 PCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN 258
Query: 191 GIMHRDIKGANILVDNKG---CIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQ 247
GI+HRD+K N+L+ ++ IK+ DFG SK + E S +++ GTP ++APEV+
Sbjct: 259 GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE---TSLMRTLCGTPTYLAPEVLVS 315
Query: 248 TGH-SYS--ADIWSVGCTVIEMATGKPPWSQQYQEVAALFHI--GTTKSHPPIPENLSVK 302
G Y+ D WS+G + +G PP+S+ +V+ I G P + +S K
Sbjct: 316 VGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEK 375
Query: 303 AKDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDPVLHASVMK 345
A D + K L +P R T E L+HP++ +D + +
Sbjct: 376 ALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSE 418
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 2e-61
Identities = 73/272 (26%), Positives = 128/272 (47%), Gaps = 13/272 (4%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH 130
++G G+FG V + + +G+ AVK + + K + + L EV+LLK L H
Sbjct: 31 QRVLGKGSFGEVILCKDKITGQECAVKVISK-----RQVKQKTDKESLLREVQLLKQLDH 85
Query: 131 PNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNH 190
PNI++ ++ ++ E GG + + F E +Q+L G+ Y+H +
Sbjct: 86 PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN 145
Query: 191 GIMHRDIKGANILVDNKG---CIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQ 247
I+HRD+K N+L+++K I++ DFG S + K GT Y++APEV+
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM---KDKIGTAYYIAPEVLHG 202
Query: 248 TGHSYSADIWSVGCTVIEMATGKPP-WSQQYQEVAALFHIGTTKSHPPIPENLSVKAKDF 306
T + D+WS G + + +G PP ++ G P + +S AKD
Sbjct: 203 T-YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDL 261
Query: 307 LLKCLEKEPDLRPTASELLKHPFVTGDDEDPV 338
+ K L P +R +A + L H ++ ++ +
Sbjct: 262 IRKMLTYVPSMRISARDALDHEWIQTYTKEQI 293
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 2e-61
Identities = 78/286 (27%), Positives = 133/286 (46%), Gaps = 16/286 (5%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEK-AQDHIKELEEEVKLLKDLS 129
+ +G GA+G V + + + A+K + K + +L EEV +LK L
Sbjct: 42 VKKLGSGAYGEVLLCRDKVTHVERAIKII-------RKTSVSTSSNSKLLEEVAVLKLLD 94
Query: 130 HPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHN 189
HPNI++ ++ + +++E GG + + F E KQ+L G+ YLH
Sbjct: 95 HPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHK 154
Query: 190 HGIMHRDIKGANILVDNKG---CIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIR 246
H I+HRD+K N+L+++K IK+ DFG S + K GT Y++APEV+R
Sbjct: 155 HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM---KERLGTAYYIAPEVLR 211
Query: 247 QTGHSYSADIWSVGCTVIEMATGKPP-WSQQYQEVAALFHIGTTKSHPPIPENLSVKAKD 305
+ + D+WS+G + + G PP Q QE+ G P +N+S AKD
Sbjct: 212 K-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKD 270
Query: 306 FLLKCLEKEPDLRPTASELLKHPFVTGDDEDPVLHASVMKSSEILS 351
+ + L+ + R +A + L+HP++ + + +
Sbjct: 271 LIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIE 316
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 2e-61
Identities = 81/286 (28%), Positives = 133/286 (46%), Gaps = 16/286 (5%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEK-AQDHIKELEEEVKLLKDLS 129
++G G+FG V + + + AVK + +K + EV+LLK L
Sbjct: 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVI-------NKASAKNKDTSTILREVELLKKLD 79
Query: 130 HPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHN 189
HPNI++ + + S I+ E GG + + K F E KQ+ G+ Y+H
Sbjct: 80 HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK 139
Query: 190 HGIMHRDIKGANILVDNKG---CIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIR 246
H I+HRD+K NIL+++K IK+ DFG S + + K GT Y++APEV+R
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---KDRIGTAYYIAPEVLR 196
Query: 247 QTGHSYSADIWSVGCTVIEMATGKPP-WSQQYQEVAALFHIGTTKSHPPIPENLSVKAKD 305
T + D+WS G + + +G PP + + ++ G P +S AKD
Sbjct: 197 GT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKD 255
Query: 306 FLLKCLEKEPDLRPTASELLKHPFVTGDDEDPVLHASVMKSSEILS 351
+ K L P LR TA++ L+HP++ + + + ++
Sbjct: 256 LIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMT 301
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 206 bits (525), Expect = 2e-61
Identities = 72/306 (23%), Positives = 126/306 (41%), Gaps = 57/306 (18%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLK 126
W +++G GA V+ G + +G+L A+K + + E ++LK
Sbjct: 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVF-------NNISFLRPVDVQMREFEVLK 62
Query: 127 DLSHPNIVRYLGTVREEESLNILL--EFVPGGSISSLL---GKFGPFPEAVMRTYTKQLL 181
L+H NIV+ E + + +L EF P GS+ ++L PE+ + ++
Sbjct: 63 KLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 122
Query: 182 LGLEYLHNHGIMHRDIKGANILV----DNKGCIKLADFGASKQVAELATVSGAKSMKGTP 237
G+ +L +GI+HR+IK NI+ D + KL DFGA++ EL S+ GT
Sbjct: 123 GGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR---ELEDDEQFVSLYGTE 179
Query: 238 YWMAPEVIR--------QTGHSYSADIWSVGCTVIEMATGKPPW-----SQQYQEVAALF 284
++ P++ Q + + D+WS+G T ATG P+ ++ +EV ++
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV--MY 237
Query: 285 HIGTTK-------------------SHPPIPENLSVKAKD----FLLKCLEKEPDLRPTA 321
I T K P+ +LS + L LE + +
Sbjct: 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF 297
Query: 322 SELLKH 327
+
Sbjct: 298 DQFFAE 303
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 205 bits (522), Expect = 3e-61
Identities = 48/319 (15%), Positives = 103/319 (32%), Gaps = 54/319 (16%)
Query: 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQV----LIAANFASKEKAQDHIKELE 119
P +G ++G + ++GE V +N + K + L
Sbjct: 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL 130
Query: 120 EEVK----------------LLKDLSHPNIVRYLGTVREEESLNILLEF--------VPG 155
+K L+KD ++R R+ L+ + G
Sbjct: 131 RGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFG 190
Query: 156 GSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADF 215
+ S T Q++ L LH++G++H ++ +I++D +G + L F
Sbjct: 191 EVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGF 250
Query: 216 GASKQVAELATVSGAKSMKGTPYWMAPEVI-----------RQTGHSYSADIWSVGCTVI 264
+ S + + PE+ R+T ++S D W++G +
Sbjct: 251 EHLVRDGARVVSS------VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304
Query: 265 EMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASEL 324
+ P ++ +G ++ +N+ + L L + R +
Sbjct: 305 WIWCADLPITKDAA-------LGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQA 357
Query: 325 LKHPFVTGDDEDPVLHASV 343
++ P L A++
Sbjct: 358 METPEYE--QLRTELSAAL 374
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 9e-61
Identities = 83/277 (29%), Positives = 133/277 (48%), Gaps = 18/277 (6%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH 130
E+IG G F V +N ++G+ AVK V +A F S ++L+ E + L H
Sbjct: 29 CEVIGKGPFSVVRRCINRETGQQFAVKIVDVA-KFTSSPGLS--TEDLKREASICHMLKH 85
Query: 131 PNIVRYLGTVREEESLNILLEFVPGG----SISSLLGKFGPFPEAVMRTYTKQLLLGLEY 186
P+IV L T + L ++ EF+ G I + EAV Y +Q+L L Y
Sbjct: 86 PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 187 LHNHGIMHRDIKGANILVDNKGC---IKLADFGASKQVAELATVSGAKSMKGTPYWMAPE 243
H++ I+HRD+K +L+ +K +KL FG + Q+ E V+ GTP++MAPE
Sbjct: 146 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVA--GGRVGTPHFMAPE 203
Query: 244 VIRQTGHSYSADIWSVGCTVIE--MATGKPP-WSQQYQEVAALFHIGTTKSHPPIPENLS 300
V+++ + D+W G VI + +G P + + + + G K +P ++S
Sbjct: 204 VVKREPYGKPVDVWGCG--VILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHIS 260
Query: 301 VKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDP 337
AKD + + L +P R T E L HP++ D
Sbjct: 261 ESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYA 297
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 4e-60
Identities = 86/264 (32%), Positives = 133/264 (50%), Gaps = 20/264 (7%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH 130
E IG G+FG V+ G +AVK ++ ++ + + E EV ++K L H
Sbjct: 42 KEKIGAGSFGTVHRAEW--HGSDVAVKILM------EQDFHAERVNEFLREVAIMKRLRH 93
Query: 131 PNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFG---PFPEAVMRTYTKQLLLGLEYL 187
PNIV ++G V + +L+I+ E++ GS+ LL K G E + + G+ YL
Sbjct: 94 PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYL 153
Query: 188 HNHG--IMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVI 245
HN I+HR++K N+LVD K +K+ DFG S+ A T +KS GTP WMAPEV+
Sbjct: 154 HNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS--TFLSSKSAAGTPEWMAPEVL 211
Query: 246 RQTGHSYSADIWSVGCTVI--EMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKA 303
R + +D++S G VI E+AT + PW + +G IP NL+ +
Sbjct: 212 RDEPSNEKSDVYSFG--VILWELATLQQPWG-NLNPAQVVAAVGFKCKRLEIPRNLNPQV 268
Query: 304 KDFLLKCLEKEPDLRPTASELLKH 327
+ C EP RP+ + ++
Sbjct: 269 AAIIEGCWTNEPWKRPSFATIMDL 292
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 202 bits (514), Expect = 4e-60
Identities = 42/314 (13%), Positives = 88/314 (28%), Gaps = 50/314 (15%)
Query: 58 PSVKMSPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKE 117
S+ + + E + G V++ +++ E A+K + E ++ ++
Sbjct: 54 DSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTM-----GAENSRSELER 108
Query: 118 LEEEVKLLKDLSHPNIVRYLGTVREEESLNI-------------------------LLEF 152
L E L + R + LL
Sbjct: 109 LHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMP 168
Query: 153 VPGGSISSLLGKF-------GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVD 205
+ L G + T QL+ L + G++H N+ +
Sbjct: 169 AASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIM 228
Query: 206 NKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVI--RQTGHSYSADIWSVGCTV 263
G + L D A +V S + E + +++ + W +G ++
Sbjct: 229 PDGRLMLGDVSALWKVGTRGPASS-----VPVTYAPREFLNASTATFTHALNAWQLGLSI 283
Query: 264 IEMATGKPPW------SQQYQEVAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDL 317
+ P+ + + +L GT L K + + L +
Sbjct: 284 YRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRR 343
Query: 318 RPTASELLKHPFVT 331
R E ++ P
Sbjct: 344 RLLPLEAMETPEFL 357
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 201 bits (512), Expect = 4e-60
Identities = 78/314 (24%), Positives = 121/314 (38%), Gaps = 50/314 (15%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH 130
IG G++G V + + + + A+K + ++ ++ ++ EV+L+K L H
Sbjct: 31 KGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNK---IRQINPKDVERIKTEVRLMKKLHH 87
Query: 131 PNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFG------------------------ 166
PNI R +E+ + +++E GG + L F
Sbjct: 88 PNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNE 147
Query: 167 ----------------PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKG-- 208
E ++ +Q+ L YLHN GI HRDIK N L
Sbjct: 148 EAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSF 207
Query: 209 CIKLADFGASKQVAELATVSGAKSMK--GTPYWMAPEVIRQTGHSYS--ADIWSVGCTVI 264
IKL DFG SK+ +L GTPY++APEV+ T SY D WS G +
Sbjct: 208 EIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLH 267
Query: 265 EMATGKPP-WSQQYQEVAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASE 323
+ G P + + P LS A+D L L + D R A
Sbjct: 268 LLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMR 327
Query: 324 LLKHPFVTGDDEDP 337
L+HP+++ +
Sbjct: 328 ALQHPWISQFSDKI 341
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 5e-60
Identities = 80/280 (28%), Positives = 133/280 (47%), Gaps = 17/280 (6%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH 130
E++G GAF V++ +G+L A+K + K A LE E+ +LK + H
Sbjct: 14 MEVLGSGAFSEVFLVKQRLTGKLFALKCI-------KKSPAFRD-SSLENEIAVLKKIKH 65
Query: 131 PNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNH 190
NIV ++++ V GG + + + G + E +Q+L ++YLH +
Sbjct: 66 ENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN 125
Query: 191 GIMHRDIKGANILVDNKG---CIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQ 247
GI+HRD+K N+L I + DFG SK + GTP ++APEV+ Q
Sbjct: 126 GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN----GIMSTACGTPGYVAPEVLAQ 181
Query: 248 TGHSYSADIWSVGCTVIEMATGKPP-WSQQYQEVAALFHIGTTKSHPPIPENLSVKAKDF 306
+S + D WS+G + G PP + + ++ G + P +++S AKDF
Sbjct: 182 KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDF 241
Query: 307 LLKCLEKEPDLRPTASELLKHPFVTGDD-EDPVLHASVMK 345
+ LEK+P+ R T + L HP++ G+ ++ SV
Sbjct: 242 ICHLLEKDPNERYTCEKALSHPWIDGNTALHRDIYPSVSL 281
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 2e-59
Identities = 85/291 (29%), Positives = 143/291 (49%), Gaps = 22/291 (7%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH 130
+ +G GA G V + + + +A+K + + D +E E+++LK L+H
Sbjct: 15 SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74
Query: 131 PNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNH 190
P I++ + E I+LE + GG + + EA + Y Q+LL ++YLH +
Sbjct: 75 PCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN 133
Query: 191 GIMHRDIKGANILVDNKG---CIKLADFGASKQVAELATVSGAKSMK---GTPYWMAPEV 244
GI+HRD+K N+L+ ++ IK+ DFG SK + E M+ GTP ++APEV
Sbjct: 134 GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE------TSLMRTLCGTPTYLAPEV 187
Query: 245 IRQT---GHSYSADIWSVGCTVIE--MATGKPPWSQQYQEVAALFHI--GTTKSHPPIPE 297
+ G++ + D WS+G VI +G PP+S+ +V+ I G P +
Sbjct: 188 LVSVGTAGYNRAVDCWSLG--VILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 245
Query: 298 NLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDPVLHASVMKSSE 348
+S KA D + K L +P R T E L+HP++ +D + + +E
Sbjct: 246 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENE 296
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 4e-59
Identities = 76/275 (27%), Positives = 136/275 (49%), Gaps = 25/275 (9%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEK-AQDHIKELEEEVKLLKDLS 129
E +G GAF V ++ +G A K + + +K + ++LE E ++ + L
Sbjct: 11 KEELGKGAFSVVRRCVHKTTGLEFAAKII-------NTKKLSARDFQKLEREARICRKLQ 63
Query: 130 HPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHN 189
HPNIVR +++EE ++ + V GG + + + EA +Q+L + Y H+
Sbjct: 64 HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS 123
Query: 190 HGIMHRDIKGANILVDNKG---CIKLADFGASKQVAELATVSGAKSMK---GTPYWMAPE 243
+GI+HR++K N+L+ +K +KLADFG + +V + +++ GTP +++PE
Sbjct: 124 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND------SEAWHGFAGTPGYLSPE 177
Query: 244 VIRQTGHSYSADIWSVGCTVIE--MATGKPP-WSQQYQEVAALFHIGTTKSHPPIPENLS 300
V+++ +S DIW+ G VI + G PP W + + A G P + ++
Sbjct: 178 VLKKDPYSKPVDIWACG--VILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVT 235
Query: 301 VKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDE 335
+AK + L P R TA + LK P++ +
Sbjct: 236 PEAKSLIDSMLTVNPKKRITADQALKVPWICNRER 270
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 5e-59
Identities = 69/264 (26%), Positives = 124/264 (46%), Gaps = 26/264 (9%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH 130
E++G GAFG V + +A+KQ+ +++ K E++ L ++H
Sbjct: 13 EEVVGRGAFGVVCKAKW--RAKDVAIKQI----------ESESERKAFIVELRQLSRVNH 60
Query: 131 PNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLL---LGLEYL 187
PNIV+ G + +++E+ GGS+ ++L P P L G+ YL
Sbjct: 61 PNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 118
Query: 188 HNH---GIMHRDIKGANILVDNKG-CIKLADFGASKQVAELATVSGAKSMKGTPYWMAPE 243
H+ ++HRD+K N+L+ G +K+ DFG + + T + KG+ WMAPE
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMT-----NNKGSAAWMAPE 173
Query: 244 VIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKA 303
V + +S D++S G + E+ T + P+ + + + PP+ +NL
Sbjct: 174 VFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPI 233
Query: 304 KDFLLKCLEKEPDLRPTASELLKH 327
+ + +C K+P RP+ E++K
Sbjct: 234 ESLMTRCWSKDPSQRPSMEEIVKI 257
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 5e-59
Identities = 83/321 (25%), Positives = 142/321 (44%), Gaps = 19/321 (5%)
Query: 62 MSPPI--RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELE 119
M+ P W + +G GA+G V + +N + E +AVK V ++A D + ++
Sbjct: 1 MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV-------DMKRAVDCPENIK 53
Query: 120 EEVKLLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQ 179
+E+ + K L+H N+V++ G RE + LE+ GG + + PE + + Q
Sbjct: 54 KEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ 113
Query: 180 LLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYW 239
L+ G+ YLH GI HRDIK N+L+D + +K++DFG + M GT +
Sbjct: 114 LMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 240 MAPEVIRQTGHSY---SADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIP 296
+APE+++ + D+WS G + M G+ PW Q K++
Sbjct: 174 VAPELLK--RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 231
Query: 297 ENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDPVLHASVMKSSEILSPSHV- 355
+ + L K L + P R T ++ K + + V SPS
Sbjct: 232 KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFS 291
Query: 356 ----ANLESLQMLTSPGSPGS 372
+NL+ + ++ +PGS
Sbjct: 292 KHIQSNLDFSPVNSASRTPGS 312
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 6e-59
Identities = 78/276 (28%), Positives = 136/276 (49%), Gaps = 23/276 (8%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH 130
E +G GAF V ++ +G A K + K A+D ++LE E ++ + L H
Sbjct: 34 KEELGKGAFSVVRRCVHKTTGLEFAAKIINT-----KKLSARDF-QKLEREARICRKLQH 87
Query: 131 PNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNH 190
PNIVR +++EE ++ + V GG + + + EA +Q+L + Y H++
Sbjct: 88 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 147
Query: 191 GIMHRDIKGANILVDNKG---CIKLADFGASKQVAELATVSGAKSMK---GTPYWMAPEV 244
GI+HR++K N+L+ +K +KLADFG + +V + +++ GTP +++PEV
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND------SEAWHGFAGTPGYLSPEV 201
Query: 245 IRQTGHSYSADIWSVGCTVIE--MATGKPP-WSQQYQEVAALFHIGTTKSHPPIPENLSV 301
+++ +S DIW+ G VI + G PP W + + A G P + ++
Sbjct: 202 LKKDPYSKPVDIWACG--VILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTP 259
Query: 302 KAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDP 337
+AK + L P R TA + LK P++ +
Sbjct: 260 EAKSLIDSMLTVNPKKRITADQALKVPWICNRERVA 295
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 8e-59
Identities = 74/273 (27%), Positives = 126/273 (46%), Gaps = 14/273 (5%)
Query: 62 MSPPI--RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELE 119
M+ P W + +G GA+G V + +N + E +AVK V ++A D + ++
Sbjct: 1 MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV-------DMKRAVDCPENIK 53
Query: 120 EEVKLLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQ 179
+E+ + K L+H N+V++ G RE + LE+ GG + + PE + + Q
Sbjct: 54 KEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ 113
Query: 180 LLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYW 239
L+ G+ YLH GI HRDIK N+L+D + +K++DFG + M GT +
Sbjct: 114 LMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 240 MAPEVIRQTGHSY---SADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIP 296
+APE+++ + D+WS G + M G+ PW Q K++
Sbjct: 174 VAPELLK--RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 231
Query: 297 ENLSVKAKDFLLKCLEKEPDLRPTASELLKHPF 329
+ + L K L + P R T ++ K +
Sbjct: 232 KKIDSAPLALLHKILVENPSARITIPDIKKDRW 264
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 1e-58
Identities = 84/273 (30%), Positives = 129/273 (47%), Gaps = 26/273 (9%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEK-AQDHIKELEEEVKLLKDLS 129
++G G+FG V + + + AVK + +K + EV+LLK L
Sbjct: 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVI-------NKASAKNKDTSTILREVELLKKLD 79
Query: 130 HPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHN 189
HPNI++ + + S I+ E GG + + K F E KQ+ G+ Y+H
Sbjct: 80 HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK 139
Query: 190 HGIMHRDIKGANILVDNKG---CIKLADFGASKQVAELATVSGAKSMK---GTPYWMAPE 243
H I+HRD+K NIL+++K IK+ DFG S + MK GT Y++APE
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ------NTKMKDRIGTAYYIAPE 193
Query: 244 VIRQTGHSYSADIWSVGCTVIE--MATGKPP-WSQQYQEVAALFHIGTTKSHPPIPENLS 300
V+R T + D+WS G VI + +G PP + + ++ G P +S
Sbjct: 194 VLRGT-YDEKCDVWSAG--VILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTIS 250
Query: 301 VKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333
AKD + K L P LR TA++ L+HP++
Sbjct: 251 DDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 1e-58
Identities = 68/276 (24%), Positives = 118/276 (42%), Gaps = 26/276 (9%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH 130
IG G++G V + + + A K++ K +D + ++E++++K L H
Sbjct: 14 ENTIGRGSWGEVKIAVQKGTRIRRAAKKI-------PKYFVED-VDRFKQEIEIMKSLDH 65
Query: 131 PNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNH 190
PNI+R T + + +++E GG + + F E+ K +L + Y H
Sbjct: 66 PNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL 125
Query: 191 GIMHRDIKGANILVDNKG---CIKLADFGASKQVAELATVSGAKSMK---GTPYWMAPEV 244
+ HRD+K N L +KL DFG + + K M+ GTPY+++P+V
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP------GKMMRTKVGTPYYVSPQV 179
Query: 245 IRQTGHSYSADIWSVGCTVIE--MATGKPP-WSQQYQEVAALFHIGTTKSHPPIPENLSV 301
+ + D WS G V+ + G PP + EV GT N+S
Sbjct: 180 LEG-LYGPECDEWSAG--VMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSP 236
Query: 302 KAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDP 337
+A+ + + L K P R T+ + L+H +
Sbjct: 237 QAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSS 272
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 1e-58
Identities = 78/276 (28%), Positives = 134/276 (48%), Gaps = 22/276 (7%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH 130
E +G GAF V + + +G+ A + K A+DH ++LE E ++ + L H
Sbjct: 16 FEELGKGAFSVVRRCVKVLAGQEYAAMIINT-----KKLSARDH-QKLEREARICRLLKH 69
Query: 131 PNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNH 190
PNIVR ++ EE ++ + V GG + + + EA +Q+L + + H
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 129
Query: 191 GIMHRDIKGANILVDNKG---CIKLADFGASKQVAELATVSGAKSMK---GTPYWMAPEV 244
G++HR++K N+L+ +K +KLADFG + +V ++ GTP +++PEV
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE-----GEQQAWFGFAGTPGYLSPEV 184
Query: 245 IRQTGHSYSADIWSVGCTVIE--MATGKPP-WSQQYQEVAALFHIGTTKSHPPIPENLSV 301
+R+ + D+W+ G VI + G PP W + + G P + ++
Sbjct: 185 LRKDPYGKPVDLWACG--VILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTP 242
Query: 302 KAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDP 337
+AKD + K L P R TA+E LKHP+++
Sbjct: 243 EAKDLINKMLTINPSKRITAAEALKHPWISHRSTVA 278
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 1e-58
Identities = 65/309 (21%), Positives = 121/309 (39%), Gaps = 43/309 (13%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVK---------QVLIAANFASKEKAQDHIKE 117
+R + G F ++ + + A+K + + K + +
Sbjct: 32 DYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 118 LEEEVKLLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFG--------PFP 169
+ E++++ D+ + + G + + + I+ E++ SI F P
Sbjct: 90 FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 170 EAVMRTYTKQLLLGLEYLHNH-GIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVS 228
V++ K +L Y+HN I HRD+K +NIL+D G +KL+DFG S+ + +
Sbjct: 150 IQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVD----K 205
Query: 229 GAKSMKGTPYWMAPEVI--RQTGHSYSADIWSVGCTVIEMATGKPP-------------- 272
K +GT +M PE + + DIWS+G + M P
Sbjct: 206 KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNI 265
Query: 273 WSQQYQ---EVAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPF 329
++ + + + T K LS + DFL L K P R T+ + LKH +
Sbjct: 266 RTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEW 325
Query: 330 VTGDDEDPV 338
+ + + +
Sbjct: 326 LADTNIEDL 334
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 2e-58
Identities = 63/279 (22%), Positives = 127/279 (45%), Gaps = 28/279 (10%)
Query: 66 IRWRK---GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEV 122
R GE++G G FG+ + ++GE++ +K++ ++ + +EV
Sbjct: 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKEL--------IRFDEETQRTFLKEV 58
Query: 123 KLLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLL-GKFGPFPEAVMRTYTKQLL 181
K+++ L HPN+++++G + +++ LN + E++ GG++ ++ +P + ++ K +
Sbjct: 59 KVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIA 118
Query: 182 LGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGA----------- 230
G+ YLH+ I+HRD+ N LV + +ADFG ++ + + T
Sbjct: 119 SGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKK 178
Query: 231 -KSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWS--QQYQEVAALFHIG 287
++ G PYWMAPE+I + D++S G + E+ L G
Sbjct: 179 RYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRG 238
Query: 288 TTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLK 326
P N ++C + +P+ RP+ +L
Sbjct: 239 --FLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 2e-58
Identities = 68/266 (25%), Positives = 128/266 (48%), Gaps = 22/266 (8%)
Query: 73 LIGCGAFGRVYMGMNLDSGELLAVK----QVLIAANFASKEKAQDHIKELEEEVKLLKDL 128
IG G+FG+V + D+ ++ A+K Q + + ++ + E+++++ L
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCV------ERNEVRNVFK---ELQIMQGL 72
Query: 129 SHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLH 188
HP +V + ++EE + ++++ + GG + L + F E ++ + +L++ L+YL
Sbjct: 73 EHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQ 132
Query: 189 NHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVI--- 245
N I+HRD+K NIL+D G + + DF + + +M GT +MAPE+
Sbjct: 133 NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMAGTKPYMAPEMFSSR 189
Query: 246 RQTGHSYSADIWSVGCTVIEMATGKPP-WSQQYQEVAALFHIGTTKSHPPIPENLSVKAK 304
+ G+S++ D WS+G T E+ G+ P + + H + P S +
Sbjct: 190 KGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT-FETTVVTYPSAWSQEMV 248
Query: 305 DFLLKCLEKEPDLR-PTASELLKHPF 329
L K LE PD R S++ P+
Sbjct: 249 SLLKKLLEPNPDQRFSQLSDVQNFPY 274
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 3e-58
Identities = 78/268 (29%), Positives = 128/268 (47%), Gaps = 23/268 (8%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH 130
E+IG G FG+VY + G+ +AVK + E I+ + +E KL L H
Sbjct: 12 EEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPD----EDISQTIENVRQEAKLFAMLKH 65
Query: 131 PNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNH 190
PNI+ G +E +L +++EF GG ++ +L P ++ + Q+ G+ YLH+
Sbjct: 66 PNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDE 124
Query: 191 G---IMHRDIKGANILVDNKG--------CIKLADFGASKQVAELATVSGAKSMKGTPYW 239
I+HRD+K +NIL+ K +K+ DFG +++ + S G W
Sbjct: 125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR----TTKMSAAGAYAW 180
Query: 240 MAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENL 299
MAPEVIR + S +D+WS G + E+ TG+ P+ + +A + + K PIP
Sbjct: 181 MAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF-RGIDGLAVAYGVAMNKLALPIPSTC 239
Query: 300 SVKAKDFLLKCLEKEPDLRPTASELLKH 327
+ C +P RP+ + +L
Sbjct: 240 PEPFAKLMEDCWNPDPHSRPSFTNILDQ 267
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 5e-58
Identities = 82/294 (27%), Positives = 136/294 (46%), Gaps = 39/294 (13%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVK------------------QVLIAANFASK 108
++ + IG G++G V + N + A+K
Sbjct: 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 109 EKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE---EESLNILLEFVPGGSISSLLGKF 165
+ + I+++ +E+ +LK L HPN+V+ L V + E+ L ++ E V G + +
Sbjct: 74 IQPRGPIEQVYQEIAILKKLDHPNVVK-LVEVLDDPNEDHLYMVFELVNQGPVMEVPTL- 131
Query: 166 GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGAS----KQV 221
P E R Y + L+ G+EYLH I+HRDIK +N+LV G IK+ADFG S
Sbjct: 132 KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD 191
Query: 222 AELATVSGAKSMKGTPYWMAPEVIRQTGHSYS---ADIWSVGCTVIEMATGKPPWSQQYQ 278
A L+ GTP +MAPE + +T +S D+W++G T+ G+ P+ +
Sbjct: 192 ALLSNTV------GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER- 244
Query: 279 EVAALFH-IGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVT 331
+ L I + P +++ KD + + L+K P+ R E+ HP+VT
Sbjct: 245 -IMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 1e-57
Identities = 80/274 (29%), Positives = 124/274 (45%), Gaps = 14/274 (5%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH 130
GE +G G F V +G A K I + + +E+E EV +L+ + H
Sbjct: 17 GEELGSGQFAIVKKCREKSTGLEYAAKF--IKKRQSRASRRGVSREEIEREVSILRQVLH 74
Query: 131 PNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNH 190
N++ + ++LE V GG + L + E ++ KQ+L G+ YLH
Sbjct: 75 HNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK 134
Query: 191 GIMHRDIKGANILVDNK----GCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIR 246
I H D+K NI++ +K IKL DFG + ++ + K++ GTP ++APE++
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFGTPEFVAPEIVN 191
Query: 247 QTGHSYSADIWSVGCTVIE--MATGKPP-WSQQYQEVAALFHIGTTKSHPPIPENLSVKA 303
AD+WS+G VI + +G P QE A + + S A
Sbjct: 192 YEPLGLEADMWSIG--VITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELA 249
Query: 304 KDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDP 337
KDF+ K L KE R T E L+HP++T D
Sbjct: 250 KDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQ 283
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 2e-57
Identities = 52/325 (16%), Positives = 104/325 (32%), Gaps = 67/325 (20%)
Query: 68 WRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKA---------------- 111
+ + +G G FG V+ N A+K++ + ++EK
Sbjct: 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67
Query: 112 ----------------------------------QDHIKELEEEVKLLKDLSHPNIVRYL 137
+ +++ + S N V L
Sbjct: 68 RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127
Query: 138 GTVREEESLNILLEFVPGGSISSLLGK---FGPFPEAVMRTYTKQLLLGLEYLHNHGIMH 194
+ L I ++ ++ + + V Q+ +E+LH+ G+MH
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMH 187
Query: 195 RDIKGANILVDNKGCIKLADFG----------ASKQVAELATVSGAKSMKGTPYWMAPEV 244
RD+K +NI +K+ DFG + + + GT +M+PE
Sbjct: 188 RDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQ 247
Query: 245 IRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAK 304
I +S+ DI+S+G + E+ E + P + +
Sbjct: 248 IHGNNYSHKVDIFSLGLILFELLYSFSTQM----ERVRIITDVRNLKFPLLFTQKYPQEH 303
Query: 305 DFLLKCLEKEPDLRPTASELLKHPF 329
+ L P RP A++++++
Sbjct: 304 MMVQDMLSPSPTERPEATDIIENAI 328
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 2e-57
Identities = 78/277 (28%), Positives = 126/277 (45%), Gaps = 14/277 (5%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH 130
GE +G G F V +G A K I + +++E EV +LK++ H
Sbjct: 16 GEELGSGQFAVVKKCREKSTGLQYAAKF--IKKRRTKSSRRGVSREDIEREVSILKEIQH 73
Query: 131 PNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNH 190
PN++ + + ++LE V GG + L + E + KQ+L G+ YLH+
Sbjct: 74 PNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL 133
Query: 191 GIMHRDIKGANILVDNKGC----IKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIR 246
I H D+K NI++ ++ IK+ DFG + ++ K++ GTP ++APE++
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPEIVN 190
Query: 247 QTGHSYSADIWSVGCTVIE--MATGKPP-WSQQYQEVAALFHIGTTKSHPPIPENLSVKA 303
AD+WS+G VI + +G P QE A + N S A
Sbjct: 191 YEPLGLEADMWSIG--VITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALA 248
Query: 304 KDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDPVLH 340
KDF+ + L K+P R T + L+HP++ D L
Sbjct: 249 KDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALS 285
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 4e-57
Identities = 79/284 (27%), Positives = 129/284 (45%), Gaps = 22/284 (7%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAA-NFASKEKAQDHIKELEEEVKLLKDLS 129
E++G G V ++ + + AVK + + S E+ Q+ + +EV +L+ +S
Sbjct: 22 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 81
Query: 130 -HPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLH 188
HPNI++ T ++ + + G + L + E R + LL + LH
Sbjct: 82 GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH 141
Query: 189 NHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMK---GTPYWMAPEVI 245
I+HRD+K NIL+D+ IKL DFG S Q+ + ++ GTP ++APE+I
Sbjct: 142 KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP------GEKLREVCGTPSYLAPEII 195
Query: 246 R------QTGHSYSADIWSVGCTVIE--MATGKPP-WSQQYQEVAALFHIGTTKSHPPIP 296
G+ D+WS G VI + G PP W ++ + + G + P
Sbjct: 196 ECSMNDNHPGYGKEVDMWSTG--VIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW 253
Query: 297 ENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDPVLH 340
++ S KD + + L +P R TA E L HPF + V H
Sbjct: 254 DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEVRH 297
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 4e-57
Identities = 79/275 (28%), Positives = 126/275 (45%), Gaps = 14/275 (5%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH 130
GE +G G F V +G+ A K I S + +E+E EV +L+++ H
Sbjct: 10 GEELGSGQFAIVRKCRQKGTGKEYAAKF--IKKRRLSSSRRGVSREEIEREVNILREIRH 67
Query: 131 PNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNH 190
PNI+ + + ++LE V GG + L + E + KQ+L G+ YLH+
Sbjct: 68 PNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSK 127
Query: 191 GIMHRDIKGANILVDNKGC----IKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIR 246
I H D+K NI++ +K IKL DFG + ++ K++ GTP ++APE++
Sbjct: 128 RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFGTPEFVAPEIVN 184
Query: 247 QTGHSYSADIWSVGCTVIE--MATGKPP-WSQQYQEVAALFHIGTTKSHPPIPENLSVKA 303
AD+WS+G VI + +G P + QE N S A
Sbjct: 185 YEPLGLEADMWSIG--VITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELA 242
Query: 304 KDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDPV 338
KDF+ + L K+P R T ++ L+H ++ V
Sbjct: 243 KDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNV 277
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 7e-57
Identities = 81/282 (28%), Positives = 132/282 (46%), Gaps = 22/282 (7%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH 130
+G GA VY + + A+K + K D K + E+ +L LSH
Sbjct: 58 ESELGRGATSIVYRCKQKGTQKPYALKVLK---------KTVD-KKIVRTEIGVLLRLSH 107
Query: 131 PNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNH 190
PNI++ ++++LE V GG + + + G + E KQ+L + YLH +
Sbjct: 108 PNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHEN 167
Query: 191 GIMHRDIKGANILVDNKG---CIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQ 247
GI+HRD+K N+L +K+ADFG SK V + K++ GTP + APE++R
Sbjct: 168 GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM---KTVCGTPGYCAPEILRG 224
Query: 248 TGHSYSADIWSVGCTVIE--MATGKPP-WSQQY-QEVAALFHIGTTKSHPPIPENLSVKA 303
+ D+WSVG +I + G P + ++ Q + P + +S+ A
Sbjct: 225 CAYGPEVDMWSVG--IITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNA 282
Query: 304 KDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDPVLHASVMK 345
KD + K + +P R T + L+HP+VTG + V + K
Sbjct: 283 KDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANFVHMDTAQK 324
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 3e-56
Identities = 69/287 (24%), Positives = 131/287 (45%), Gaps = 19/287 (6%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH 130
E +G GAFG V+ + +G + K + + D ++ E+ ++ L H
Sbjct: 56 LEELGSGAFGVVHRCVEKATGRVFVAKFI-------NTPYPLD-KYTVKNEISIMNQLHH 107
Query: 131 PNIVRYLGTVREEESLNILLEFVPGGSI-SSLLGKFGPFPEAVMRTYTKQLLLGLEYLHN 189
P ++ ++ + ++LEF+ GG + + + EA + Y +Q GL+++H
Sbjct: 108 PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE 167
Query: 190 HGIMHRDIKGANILVDNKG--CIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQ 247
H I+H DIK NI+ + K +K+ DFG + ++ V K T + APE++ +
Sbjct: 168 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV---KVTTATAEFAAPEIVDR 224
Query: 248 TGHSYSADIWSVGCTVIE--MATGKPP-WSQQYQEVAALFHIGTTKSHPPIPENLSVKAK 304
+ D+W++G V+ + +G P + E + ++S +AK
Sbjct: 225 EPVGFYTDMWAIG--VLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK 282
Query: 305 DFLLKCLEKEPDLRPTASELLKHPFVTGDDEDPVLHASVMKSSEILS 351
DF+ L+KEP R T + L+HP++ GD + + ++I
Sbjct: 283 DFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQ 329
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 3e-56
Identities = 82/276 (29%), Positives = 125/276 (45%), Gaps = 14/276 (5%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH 130
GE +G G F V +G A K I + + +E+E EV +L+ + H
Sbjct: 17 GEELGSGQFAIVKKCREKSTGLEYAAKF--IKKRQSRASRRGVCREEIEREVSILRQVLH 74
Query: 131 PNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNH 190
PNI+ + ++LE V GG + L + E ++ KQ+L G+ YLH
Sbjct: 75 PNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK 134
Query: 191 GIMHRDIKGANILVDNKGC----IKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIR 246
I H D+K NI++ +K IKL DFG + ++ + K++ GTP ++APE++
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFGTPEFVAPEIVN 191
Query: 247 QTGHSYSADIWSVGCTVIE--MATGKPP-WSQQYQEVAALFHIGTTKSHPPIPENLSVKA 303
AD+WS+G VI + +G P QE A + S A
Sbjct: 192 YEPLGLEADMWSIG--VITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELA 249
Query: 304 KDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDPVL 339
KDF+ K L KE R T E L+HP++T D +
Sbjct: 250 KDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAM 285
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 5e-56
Identities = 70/265 (26%), Positives = 127/265 (47%), Gaps = 19/265 (7%)
Query: 71 GELIGCGAFGRVYMGM-NLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS 129
G+ IG G+FG VY G + G++ AVK + + ++ + EV +L+
Sbjct: 29 GQRIGSGSFGTVYKGKWH---GDV-AVKMLNV------TAPTPQQLQAFKNEVGVLRKTR 78
Query: 130 HPNIVRYLGTVREEESLNILLEFVPGGSISSLL-GKFGPFPEAVMRTYTKQLLLGLEYLH 188
H NI+ ++G + L I+ ++ G S+ L F + +Q G++YLH
Sbjct: 79 HVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH 137
Query: 189 NHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQT 248
I+HRD+K NI + +K+ DFG + + + + + + G+ WMAPEVIR
Sbjct: 138 AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 249 GHS-YS--ADIWSVGCTVIEMATGKPPWS--QQYQEVAALFHIGTTK-SHPPIPENLSVK 302
+ YS +D+++ G + E+ TG+ P+S ++ + G+ + N +
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKR 257
Query: 303 AKDFLLKCLEKEPDLRPTASELLKH 327
K + +CL+K+ D RP+ +L
Sbjct: 258 MKRLMAECLKKKRDERPSFPRILAE 282
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 6e-56
Identities = 75/268 (27%), Positives = 135/268 (50%), Gaps = 30/268 (11%)
Query: 73 LIGCGAFGRVYMGMNLDSGELLAVK----QVLIAANFASKEKAQDHIKELEEEVKLLKDL 128
+G G+FGRV++ + +G A+K ++++ + K +H + E +L +
Sbjct: 13 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV------RLKQVEHTND---ERLMLSIV 63
Query: 129 SHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLH 188
+HP I+R GT ++ + + ++++++ GG + SLL K FP V + Y ++ L LEYLH
Sbjct: 64 THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH 123
Query: 189 NHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQT 248
+ I++RD+K NIL+D G IK+ DFG +K V + ++ GTP ++APEV+
Sbjct: 124 SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGTPDYIAPEVVSTK 178
Query: 249 GHSYSADIWSVGCTVIEMATGKPP-WSQQYQEVAALFH-IGTTKSHPPIPENLSVKAKDF 306
++ S D WS G + EM G P + + + I + P + KD
Sbjct: 179 PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK---TYEKI--LNAELRFPPFFNEDVKDL 233
Query: 307 LLKCLEKEPDLR-----PTASELLKHPF 329
L + + ++ R ++ HP+
Sbjct: 234 LSRLITRDLSQRLGNLQNGTEDVKNHPW 261
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 188 bits (481), Expect = 8e-56
Identities = 79/302 (26%), Positives = 129/302 (42%), Gaps = 57/302 (18%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLK 126
++ K IG G++G V+ N D+G+++A+K+ L S++ L E +++LK
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLE-----SEDDPVIKKIALRE-IRMLK 57
Query: 127 DLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLG----KFGPFPEAVMRTYTKQLLL 182
L HPN+V L R + L+++ E+ ++L PE ++++ T Q L
Sbjct: 58 QLKHPNLVNLLEVFRRKRRLHLVFEYCD----HTVLHELDRYQRGVPEHLVKSITWQTLQ 113
Query: 183 GLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPY---- 238
+ + H H +HRD+K NIL+ IKL DFG A + S
Sbjct: 114 AVNFCHKHNCIHRDVKPENILITKHSVIKLCDFG-------FARLLTGPSDYYDDEVATR 166
Query: 239 WM-APEVI-RQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHI----GT-TKS 291
W +PE++ T + D+W++GC E+ +G P W +V L+ I G
Sbjct: 167 WYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLW-PGKSDVDQLYLIRKTLGDLIPR 225
Query: 292 HPPIPE------------------------NLSVKAKDFLLKCLEKEPDLRPTASELLKH 327
H + N+S A L CL +P R T +LL H
Sbjct: 226 HQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285
Query: 328 PF 329
P+
Sbjct: 286 PY 287
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 8e-56
Identities = 85/312 (27%), Positives = 130/312 (41%), Gaps = 77/312 (24%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEE------ 120
++ L+G G++G V N D+G ++A+K+ E ++
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKK----------------FLESDDDKMVKK 69
Query: 121 ----EVKLLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLG----KFGPFPEAV 172
E+KLLK L H N+V L ++++ ++ EFV ++L V
Sbjct: 70 IAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVD----HTILDDLELFPNGLDYQV 125
Query: 173 MRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKS 232
++ Y Q++ G+ + H+H I+HRDIK NILV G +KL DFG A A
Sbjct: 126 VQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFG-------FARTLAAPG 178
Query: 233 MKGTPY----WM-APEVI-RQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHI 286
W APE++ + + D+W++GC V EM G+P + ++ L+HI
Sbjct: 179 EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLF-PGDSDIDQLYHI 237
Query: 287 ----GT-TKSH---------------PPIPE---------NLSVKAKDFLLKCLEKEPDL 317
G H P I E LS D KCL +PD
Sbjct: 238 MMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDK 297
Query: 318 RPTASELLKHPF 329
RP +ELL H F
Sbjct: 298 RPFCAELLHHDF 309
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 8e-56
Identities = 75/267 (28%), Positives = 135/267 (50%), Gaps = 28/267 (10%)
Query: 73 LIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPN 132
+G G+FGRV + + +SG A+K +L K K +H E ++L+ ++ P
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMK-ILDKQKVV-KLKQIEHTLN---EKRILQAVNFPF 102
Query: 133 IVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGI 192
+V+ + ++ +L +++E+V GG + S L + G F E R Y Q++L EYLH+ +
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDL 162
Query: 193 MHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSY 252
++RD+K N+L+D +G I++ DFG +K+V ++ GTP +APE+I G++
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEALAPEIILSKGYNK 217
Query: 253 SADIWSVGCTVIEMATGKPPWSQQ-----YQEVAALFHIGTTKSHPPIPENLSVKAKDFL 307
+ D W++G + EMA G PP+ Y+++ P + S KD L
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV--------SGKVRFPSHFSSDLKDLL 269
Query: 308 LKCLEKEPDLR-----PTASELLKHPF 329
L+ + R +++ H +
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKW 296
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 197 bits (501), Expect = 1e-55
Identities = 84/334 (25%), Positives = 133/334 (39%), Gaps = 47/334 (14%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLK 126
W E +G G FG V ++ D+GE +A+KQ +E + + + E++++K
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQC-------RQELSPKNRERWCLEIQIMK 67
Query: 127 DLSHPNIVRYLGTVREEESLN------ILLEFVPGGSISSLL---GKFGPFPEAVMRTYT 177
L+HPN+V + L + +E+ GG + L E +RT
Sbjct: 68 KLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLL 127
Query: 178 KQLLLGLEYLHNHGIMHRDIKGANILVD---NKGCIKLADFGASKQVAELATVSGAKSMK 234
+ L YLH + I+HRD+K NI++ + K+ D G +K EL
Sbjct: 128 SDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK---ELDQGELCTEFV 184
Query: 235 GTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEV--------AALFHI 286
GT ++APE++ Q ++ + D WS G E TG P+ +Q V + HI
Sbjct: 185 GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHI 244
Query: 287 GTTK---------SHPPIPENLS----VKAKDFLLKCLEKEPDLRPTASELLKHP-FVTG 332
S P P +LS K + +L L R T + F
Sbjct: 245 VVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQAL 304
Query: 333 DDEDP--VLHASVMKSSEILSPSHVANLESLQML 364
D +L M S + + V E+LQ L
Sbjct: 305 DSILSLKLLSVMNMVSGRVHT-YPVTENENLQNL 337
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 1e-55
Identities = 77/284 (27%), Positives = 134/284 (47%), Gaps = 19/284 (6%)
Query: 70 KGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS 129
K E++G G FG+V+ +G LA K + +D +E++ E+ ++ L
Sbjct: 93 KTEILGGGRFGQVHKCEETATGLKLAAKII-------KTRGMKD-KEEVKNEISVMNQLD 144
Query: 130 HPNIVRYLGTVREEESLNILLEFVPGGSI-SSLLGKFGPFPEAVMRTYTKQLLLGLEYLH 188
H N+++ + + +++E+V GG + ++ + E + KQ+ G+ ++H
Sbjct: 145 HANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMH 204
Query: 189 NHGIMHRDIKGANILVDNKG--CIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIR 246
I+H D+K NIL N+ IK+ DFG +++ + K GTP ++APEV+
Sbjct: 205 QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL---KVNFGTPEFLAPEVVN 261
Query: 247 QTGHSYSADIWSVGCTVIE--MATGKPP-WSQQYQEVAALFHIGTTKSHPPIPENLSVKA 303
S+ D+WSVG VI + +G P E +++S +A
Sbjct: 262 YDFVSFPTDMWSVG--VIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEA 319
Query: 304 KDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDPVLHASVMKSS 347
K+F+ K L KE R +ASE LKHP+++ L A K+
Sbjct: 320 KEFISKLLIKEKSWRISASEALKHPWLSDHKLHSRLSAQKKKNR 363
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 2e-55
Identities = 67/285 (23%), Positives = 124/285 (43%), Gaps = 35/285 (12%)
Query: 70 KGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS 129
K + +G G+F ++ S + AVK + SK + ++E+ LK
Sbjct: 15 KDKPLGEGSFSICRKCVHKKSNQAFAVKII-------SKRMEAN----TQKEITALKLCE 63
Query: 130 -HPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLH 188
HPNIV+ ++ +++E + GG + + K F E ++L+ + ++H
Sbjct: 64 GHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMH 123
Query: 189 NHGIMHRDIKGANILVDNKG---CIKLADFGASKQVAELATVSGAKSMK---GTPYWMAP 242
+ G++HRD+K N+L ++ IK+ DFG ++ + +K T ++ AP
Sbjct: 124 DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP-----DNQPLKTPCFTLHYAAP 178
Query: 243 EVIRQTGHSYSADIWSVGCTVIE--MATGKPP-WSQQYQEVAA----LFH-IGTTKSHPP 294
E++ Q G+ S D+WS+G VI M +G+ P S + I
Sbjct: 179 ELLNQNGYDESCDLWSLG--VILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFE 236
Query: 295 IPE--NLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDP 337
N+S +AKD + L +P+ R S L + ++ +
Sbjct: 237 GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLS 281
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 2e-55
Identities = 70/273 (25%), Positives = 122/273 (44%), Gaps = 20/273 (7%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH 130
E +G G FG V+ + S + K V K K D +++E+ +L H
Sbjct: 10 AEDLGRGEFGIVHRCVETSSKKTYMAKFV--------KVKGTD-QVLVKKEISILNIARH 60
Query: 131 PNIVRYLGTVREEESLNILLEFVPGGSI-SSLLGKFGPFPEAVMRTYTKQLLLGLEYLHN 189
NI+ + E L ++ EF+ G I + E + +Y Q+ L++LH+
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120
Query: 190 HGIMHRDIKGANILVDNK--GCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQ 247
H I H DI+ NI+ + IK+ +FG ++Q+ + + P + APEV +
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFTAPEYYAPEVHQH 177
Query: 248 TGHSYSADIWSVGCTVIE--MATGKPP-WSQQYQEVAALFHIGTTKSHPPIPENLSVKAK 304
S + D+WS+G + + +G P ++ Q++ + +S++A
Sbjct: 178 DVVSTATDMWSLG--TLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM 235
Query: 305 DFLLKCLEKEPDLRPTASELLKHPFVTGDDEDP 337
DF+ + L KE R TASE L+HP++ E
Sbjct: 236 DFVDRLLVKERKSRMTASEALQHPWLKQKIERV 268
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 4e-55
Identities = 74/281 (26%), Positives = 128/281 (45%), Gaps = 33/281 (11%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS- 129
E IG G++ ++ + AVK + K K ++ EE+++L
Sbjct: 27 KEDIGVGSYSVCKRCIHKATNMEFAVKII-------DKSK-----RDPTEEIEILLRYGQ 74
Query: 130 HPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHN 189
HPNI+ + + + ++ E + GG + + + F E + +EYLH
Sbjct: 75 HPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHA 134
Query: 190 HGIMHRDIKGANILV----DNKGCIKLADFGASKQVAELATVSGAKSMK---GTPYWMAP 242
G++HRD+K +NIL N I++ DFG +KQ+ + + T ++AP
Sbjct: 135 QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR-----AENGLLMTPCYTANFVAP 189
Query: 243 EVIRQTGHSYSADIWSVGCTVIE--MATGKPP-WSQQYQEVAALFH-IGTTKSHPPIPE- 297
EV+ + G+ + DIWS+G V+ M TG P + + IG+ K
Sbjct: 190 EVLERQGYDAACDIWSLG--VLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYW 247
Query: 298 -NLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDP 337
++S AKD + K L +P R TA+ +L+HP++ D+ P
Sbjct: 248 NSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLP 288
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 9e-55
Identities = 70/270 (25%), Positives = 122/270 (45%), Gaps = 24/270 (8%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH 130
GELIG G FG+VY G GE+ A++ + I + +D +K + EV + H
Sbjct: 38 GELIGKGRFGQVYHGRW--HGEV-AIRLIDI------ERDNEDQLKAFKREVMAYRQTRH 88
Query: 131 PNIVRYLGTVREEESLNILLEFVPGGSISSLL-GKFGPFPEAVMRTYTKQLLLGLEYLHN 189
N+V ++G L I+ G ++ S++ R ++++ G+ YLH
Sbjct: 89 ENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHA 148
Query: 190 HGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMK---GTPYWMAPEVIR 246
GI+H+D+K N+ DN G + + DFG L ++ G +APE+IR
Sbjct: 149 KGILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIR 207
Query: 247 -------QTGHSYS--ADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPE 297
+ +S +D++++G E+ + P+ Q E A ++ +GT
Sbjct: 208 QLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE-AIIWQMGTGMKPNLSQI 266
Query: 298 NLSVKAKDFLLKCLEKEPDLRPTASELLKH 327
+ + D LL C E + RPT ++L+
Sbjct: 267 GMGKEISDILLFCWAFEQEERPTFTKLMDM 296
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 1e-54
Identities = 70/292 (23%), Positives = 124/292 (42%), Gaps = 24/292 (8%)
Query: 70 KGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS 129
+ +G G F V ++ +G+ A K + + + QD E+ E+ +L+
Sbjct: 33 TSKELGRGKFAVVRQCISKSTGQEYAAKFL------KKRRRGQDCRAEILHEIAVLELAK 86
Query: 130 H-PNIVRYLGTVREEESLNILLEFVPGG----SISSLLGKFGPFPEAVMRTYTKQLLLGL 184
P ++ + ++LE+ GG E + KQ+L G+
Sbjct: 87 SCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLP--ELAEMVSENDVIRLIKQILEGV 144
Query: 185 EYLHNHGIMHRDIKGANILVDNK---GCIKLADFGASKQVAELATVSGAKSMKGTPYWMA 241
YLH + I+H D+K NIL+ + G IK+ DFG S+++ + + + GTP ++A
Sbjct: 145 YYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL---REIMGTPEYLA 201
Query: 242 PEVIRQTGHSYSADIWSVGCTVIE--MATGKPP-WSQQYQEVAALFHIGTTKSHPPIPEN 298
PE++ + + D+W++G +I + T P + QE +
Sbjct: 202 PEILNYDPITTATDMWNIG--IIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSS 259
Query: 299 LSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDPVLHASVMKSSEIL 350
+S A DF+ L K P+ RPTA L H ++ D + + H SS
Sbjct: 260 VSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEETSSSSQT 311
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 3e-54
Identities = 69/274 (25%), Positives = 133/274 (48%), Gaps = 21/274 (7%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS- 129
++IG G V ++ +G AVK + + A S E+ ++ + E +L+ ++
Sbjct: 99 KDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAG 158
Query: 130 HPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHN 189
HP+I+ + + + ++ + + G + L + E R+ + LL + +LH
Sbjct: 159 HPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHA 218
Query: 190 HGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMK---GTPYWMAPEVIR 246
+ I+HRD+K NIL+D+ I+L+DFG S + + ++ GTP ++APE+++
Sbjct: 219 NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP------GEKLRELCGTPGYLAPEILK 272
Query: 247 ------QTGHSYSADIWSVGCTVIE--MATGKPP-WSQQYQEVAALFHIGTTKSHPPIPE 297
G+ D+W+ G VI + G PP W ++ + + G + P +
Sbjct: 273 CSMDETHPGYGKEVDLWACG--VILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWD 330
Query: 298 NLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVT 331
+ S KD + + L+ +P+ R TA + L+HPF
Sbjct: 331 DRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 7e-54
Identities = 46/268 (17%), Positives = 102/268 (38%), Gaps = 29/268 (10%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH 130
+ G ++ G G + VK ++ + ++ EE L+ SH
Sbjct: 15 LTKLNENHSGELWKGRW--QGNDIVVKV------LKVRDWSTRKSRDFNEECPRLRIFSH 66
Query: 131 PNIVRYLGTVREEESLN--ILLEFVPGGSISSLL--GKFGPFPEAVMRTYTKQLLLGLEY 186
PN++ LG + + + ++ ++P GS+ ++L G ++ + + G+ +
Sbjct: 67 PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAF 126
Query: 187 LHNHG--IMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEV 244
LH I + ++++D +++ P W+APE
Sbjct: 127 LHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-------PGRMYAPAWVAPEA 179
Query: 245 IRQ---TGHSYSADIWSVGCTVI--EMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENL 299
+++ + SAD+WS V+ E+ T + P++ + + P IP +
Sbjct: 180 LQKKPEDTNRRSADMWSFA--VLLWELVTREVPFA-DLSNMEIGMKVALEGLRPTIPPGI 236
Query: 300 SVKAKDFLLKCLEKEPDLRPTASELLKH 327
S + C+ ++P RP ++
Sbjct: 237 SPHVSKLMKICMNEDPAKRPKFDMIVPI 264
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 183 bits (468), Expect = 8e-54
Identities = 79/266 (29%), Positives = 140/266 (52%), Gaps = 19/266 (7%)
Query: 73 LIGCGAFGRVYM---GMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS 129
++G G +G+V+ ++G++ A+K VL A K H K E +L+++
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMK-VLKKAMIVRNAKDTAHTKA---ERNILEEVK 79
Query: 130 HPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHN 189
HP IV + + L ++LE++ GG + L + G F E Y ++ + L +LH
Sbjct: 80 HPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQ 139
Query: 190 HGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTG 249
GI++RD+K NI+++++G +KL DFG K+ + + + GT +MAPE++ ++G
Sbjct: 140 KGIIYRDLKPENIMLNHQGHVKLTDFGLCKE--SIHDGTVTHTFCGTIEYMAPEILMRSG 197
Query: 250 HSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFH-IGTTKSHPPIPENLSVKAKDFLL 308
H+ + D WS+G + +M TG PP++ + ++ I K +P L+ +A+D L
Sbjct: 198 HNRAVDWWSLGALMYDMLTGAPPFTGENRKK--TIDKI--LKCKLNLPPYLTQEARDLLK 253
Query: 309 KCLEKEPDLR----PT-ASELLKHPF 329
K L++ R P A E+ HPF
Sbjct: 254 KLLKRNAASRLGAGPGDAGEVQAHPF 279
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 190 bits (483), Expect = 9e-54
Identities = 77/344 (22%), Positives = 131/344 (38%), Gaps = 37/344 (10%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH 130
E +G GAFG V+ +G A K V D + + +E++ + L H
Sbjct: 162 HEELGTGAFGVVHRVTERATGNNFAAKFV-------MTPHESD-KETVRKEIQTMSVLRH 213
Query: 131 PNIVRYLGTVREEESLNILLEFVPGGSI-SSLLGKFGPFPEAVMRTYTKQLLLGLEYLHN 189
P +V ++ + ++ EF+ GG + + + E Y +Q+ GL ++H
Sbjct: 214 PTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE 273
Query: 190 HGIMHRDIKGANILVDNKG--CIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQ 247
+ +H D+K NI+ K +KL DFG + + +V K GT + APEV
Sbjct: 274 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV---KVTTGTAEFAAPEVAEG 330
Query: 248 TGHSYSADIWSVGCTVIE--MATGKPP-WSQQYQEVAALFHIGTTKSHPPIPENLSVKAK 304
Y D+WSVG V+ + +G P + E +S K
Sbjct: 331 KPVGYYTDMWSVG--VLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK 388
Query: 305 DFLLKCLEKEPDLRPTASELLKHPFVTGDDE---DPVLHASVMK-------------SSE 348
DF+ K L +P+ R T + L+HP++T + D + +S
Sbjct: 389 DFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAWPEP 448
Query: 349 ILSPSHVANLESLQMLTSPGSPGSVDICNLDSLSCSRVIVEKLS 392
+ ++N SL+ S+ D + K
Sbjct: 449 LPPLGRISNYSSLRKHRP--QEYSIRDAFWDRSEAQPRFIVKPY 490
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 1e-53
Identities = 77/310 (24%), Positives = 136/310 (43%), Gaps = 45/310 (14%)
Query: 70 KGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKE-LEEEVKLLKDL 128
+ +++G GA RV +NL + + AVK + EK HI+ + EV++L
Sbjct: 17 QEDVLGEGAHARVQTCINLITSQEYAVKII---------EKQPGHIRSRVFREVEMLYQC 67
Query: 129 S-HPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYL 187
H N++ + EE+ ++ E + GGSI S + K F E + + L++L
Sbjct: 68 QGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFL 127
Query: 188 HNHGIMHRDIKGANILVDNKG---CIKLADFGASKQVAELATVSGAKSMK-----GTPYW 239
HN GI HRD+K NIL ++ +K+ DF + S + + G+ +
Sbjct: 128 HNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEY 187
Query: 240 MAPEVIR-----QTGHSYSADIWSVGCTVIE--MATGKPP-WSQQYQEVAALFHIGTTKS 291
MAPEV+ + + D+WS+G VI + +G PP + +
Sbjct: 188 MAPEVVEAFSEEASIYDKRCDLWSLG--VILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245
Query: 292 HPPI-------------PE--NLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDED 336
+ + ++S AKD + K L ++ R +A+++L+HP+V G +
Sbjct: 246 QNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPE 305
Query: 337 PVLH-ASVMK 345
L V++
Sbjct: 306 NTLPTPMVLQ 315
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 2e-53
Identities = 75/303 (24%), Positives = 141/303 (46%), Gaps = 27/303 (8%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQD-HIKELEEEVKLL 125
+R + IG G F +V + ++ +G +A+K + K + +++L EV+++
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKII-------DKTQLNPTSLQKLFREVRIM 68
Query: 126 KDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLE 185
K L+HPNIV+ + E++L +++E+ GG + L G E R+ +Q++ ++
Sbjct: 69 KILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ 128
Query: 186 YLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMK---GTPYWMAP 242
Y H I+HRD+K N+L+D IK+ADFG S + + G P + AP
Sbjct: 129 YCHQKRIVHRDLKAENLLLDADMNIKIADFGFS------NEFTVGGKLDAFCGAPPYAAP 182
Query: 243 EVIRQTGHSYS---ADIWSVGCTVIEMATGKPPWSQQYQEVAALF-HIGTTKSHPPIPEN 298
E+ + G Y D+WS+G + + +G P+ Q + L + + IP
Sbjct: 183 ELFQ--GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN--LKELRERV--LRGKYRIPFY 236
Query: 299 LSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDPVLHASVMKSSEILSPSHVANL 358
+S ++ L + L P R T +++K ++ E+ L V +I + +
Sbjct: 237 MSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDISDQKRIDIM 296
Query: 359 ESL 361
+
Sbjct: 297 VGM 299
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 2e-52
Identities = 79/305 (25%), Positives = 134/305 (43%), Gaps = 63/305 (20%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEE------ 120
R+ K + +G G F VY + ++ +++A+K++ + H E ++
Sbjct: 11 RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKL-----------GHRSEAKDGINRTA 59
Query: 121 --EVKLLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLL-GKFGPFPEAVMRTYT 177
E+KLL++LSHPNI+ L + +++++ +F+ + ++ + ++ Y
Sbjct: 60 LREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYM 118
Query: 178 KQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTP 237
L GLEYLH H I+HRD+K N+L+D G +KLADFG LA G+ + T
Sbjct: 119 LMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFG-------LAKSFGSPNRAYTH 171
Query: 238 ------YWMAPEVIRQTGHSYSA--DIWSVGCTVIEMATGKP------------------ 271
Y APE++ Y D+W+VGC + E+ P
Sbjct: 172 QVVTRWYR-APELLFGARM-YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETL 229
Query: 272 --PWSQQYQEVAALFHIGTTKSHPPIP-----ENLSVKAKDFLLKCLEKEPDLRPTASEL 324
P +Q+ ++ +L T KS P IP D + P R TA++
Sbjct: 230 GTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 289
Query: 325 LKHPF 329
LK +
Sbjct: 290 LKMKY 294
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 3e-52
Identities = 88/266 (33%), Positives = 142/266 (53%), Gaps = 21/266 (7%)
Query: 73 LIGCGAFGRVYM---GMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS 129
++G G+FG+V++ D+ +L A+K VL A +++ K E +L +++
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMK-VLKKATLKVRDRV--RTKM---ERDILVEVN 84
Query: 130 HPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHN 189
HP IV+ + E L ++L+F+ GG + + L K F E ++ Y +L L L++LH+
Sbjct: 85 HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS 144
Query: 190 HGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTG 249
GI++RD+K NIL+D +G IKL DFG SK+ + A S GT +MAPEV+ + G
Sbjct: 145 LGIIYRDLKPENILLDEEGHIKLTDFGLSKE--SIDHEKKAYSFCGTVEYMAPEVVNRRG 202
Query: 250 HSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFH-IGTTKSHPPIPENLSVKAKDFLL 308
H+ SAD WS G + EM TG P+ ++ I K+ +P+ LS +A+ L
Sbjct: 203 HTQSADWWSFGVLMFEMLTGTLPFQG--KDRKETMTMI--LKAKLGMPQFLSPEAQSLLR 258
Query: 309 KCLEKEPDLR----PT-ASELLKHPF 329
++ P R P E+ +H F
Sbjct: 259 MLFKRNPANRLGAGPDGVEEIKRHSF 284
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 3e-52
Identities = 80/311 (25%), Positives = 130/311 (41%), Gaps = 76/311 (24%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEE------ 120
++ K E IG G +G V+ N ++ E++A+K+V + + ++
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRL---------------DDDDEGVPSS 47
Query: 121 ---EVKLLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKF-----GPFPEAV 172
E+ LLK+L H NIVR + ++ L ++ EF L K+ G +
Sbjct: 48 ALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC-----DQDLKKYFDSCNGDLDPEI 102
Query: 173 MRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKS 232
++++ QLL GL + H+ ++HRD+K N+L++ G +KLA+FG LA G
Sbjct: 103 VKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFG-------LARAFGIPV 155
Query: 233 MKGTP------YWMAPEVI-RQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFH 285
+ Y P+V+ +S S D+WS GC E+A P L
Sbjct: 156 RCYSAEVVTLWYR-PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKR 214
Query: 286 I----GT--------------TKSHPPIPE---------NLSVKAKDFLLKCLEKEPDLR 318
I GT K +P P L+ +D L L+ P R
Sbjct: 215 IFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQR 274
Query: 319 PTASELLKHPF 329
+A E L+HP+
Sbjct: 275 ISAEEALQHPY 285
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 4e-52
Identities = 83/312 (26%), Positives = 129/312 (41%), Gaps = 79/312 (25%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEE------ 120
+ K + +G G + VY G + + L+A+K++ + E EE
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRL---------------EHEEGAPCTA 47
Query: 121 --EVKLLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKF-----GPFPEAVM 173
EV LLKDL H NIV + E+SL ++ E++ L ++ +
Sbjct: 48 IREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL-----DKDLKQYLDDCGNIINMHNV 102
Query: 174 RTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSM 233
+ + QLL GL Y H ++HRD+K N+L++ +G +KLADFG LA AKS+
Sbjct: 103 KLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFG-------LAR---AKSI 152
Query: 234 KGTPY-------WM-APEVI-RQTGHSYSADIWSVGCTVIEMATGKP------------- 271
Y W P+++ T +S D+W VGC EMATG+P
Sbjct: 153 PTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHF 212
Query: 272 -------PWSQQYQEVAAL--FHIGTTKSHPPIP-----ENLSVKAKDFLLKCLEKEPDL 317
P + + + + F + L D L K L+ E
Sbjct: 213 IFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRN 272
Query: 318 RPTASELLKHPF 329
R +A + +KHPF
Sbjct: 273 RISAEDAMKHPF 284
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 8e-52
Identities = 90/270 (33%), Positives = 146/270 (54%), Gaps = 19/270 (7%)
Query: 73 LIGCGAFGRVYM---GMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS 129
++G GA+G+V++ D+G+L A+K VL A K K +H + E +V L
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMK-VLKKATIVQKAKTTEHTR-TERQV-LEHIRQ 117
Query: 130 HPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHN 189
P +V + E L+++L+++ GG + + L + F E ++ Y +++L LE+LH
Sbjct: 118 SPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHK 177
Query: 190 HGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIR--Q 247
GI++RDIK NIL+D+ G + L DFG SK+ T A GT +MAP+++R
Sbjct: 178 LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET-ERAYDFCGTIEYMAPDIVRGGD 236
Query: 248 TGHSYSADIWSVGCTVIEMATGKPPWSQQYQE--VAALFH-IGTTKSHPPIPENLSVKAK 304
+GH + D WS+G + E+ TG P++ ++ A + I KS PP P+ +S AK
Sbjct: 237 SGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI--LKSEPPYPQEMSALAK 294
Query: 305 DFLLKCLEKEPDLR----PT-ASELLKHPF 329
D + + L K+P R P A E+ +H F
Sbjct: 295 DLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 178 bits (455), Expect = 8e-52
Identities = 80/265 (30%), Positives = 132/265 (49%), Gaps = 21/265 (7%)
Query: 73 LIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEK--AQDHIKELEEEVKLLKDLSH 130
L+G G FG+V + +G A+K +L KE A+D + E ++L++ H
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMK-IL------RKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 131 PNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNH 190
P + + + L ++E+ GG + L + F E R Y +++ LEYLH+
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124
Query: 191 GIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGH 250
+++RDIK N+++D G IK+ DFG K+ ++ + K+ GTP ++APEV+ +
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTFCGTPEYLAPEVLEDNDY 182
Query: 251 SYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFH-IGTTKSHPPIPENLSVKAKDFLLK 309
+ D W +G + EM G+ P+ Q E LF I P LS +AK L
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFYNQDHER--LFELI--LMEEIRFPRTLSPEAKSLLAG 238
Query: 310 CLEKEPDLR----PT-ASELLKHPF 329
L+K+P R P+ A E+++H F
Sbjct: 239 LLKKDPKQRLGGGPSDAKEVMEHRF 263
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 1e-51
Identities = 75/285 (26%), Positives = 128/285 (44%), Gaps = 40/285 (14%)
Query: 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS-H 130
+++G G G+V + +G+ A+K + + +EV S
Sbjct: 35 QVLGLGVNGKVLECFHRRTGQKCALKLL---------YDSPK----ARQEVDHHWQASGG 81
Query: 131 PNIVR----YLGTVREEESLNILLEFVPGGSISSLLGKFG--PFPEAVMRTYTKQLLLGL 184
P+IV Y + L I++E + GG + S + + G F E + + +
Sbjct: 82 PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAI 141
Query: 185 EYLHNHGIMHRDIKGANILVDNKG---CIKLADFGASKQVAE--LATVSGAKSMKGTPYW 239
++LH+H I HRD+K N+L +K +KL DFG +K+ + L T TPY+
Sbjct: 142 QFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPC------YTPYY 195
Query: 240 MAPEVIRQTGHSYSADIWSVGCTVIE--MATGKPP-WSQQYQEVA-ALFH-IGTTKSHPP 294
+APEV+ + S D+WS+G VI + G PP +S Q ++ + I + P
Sbjct: 196 VAPEVLGPEKYDKSCDMWSLG--VIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFP 253
Query: 295 IPE--NLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDP 337
PE +S AK + L+ +P R T ++ + HP++ P
Sbjct: 254 NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVP 298
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 2e-51
Identities = 71/270 (26%), Positives = 126/270 (46%), Gaps = 23/270 (8%)
Query: 73 LIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKE--KAQDHIKELEEEVKLLKDLSH 130
++G G FG V+ +G+L A K L +K+ K + + E K+L +
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACK-KL------NKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 131 PNIVRYLGTVREEESLNILLEFVPGGS----ISSLLGKFGPFPEAVMRTYTKQLLLGLEY 186
IV + L +++ + GG I ++ F E YT Q++ GLE+
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 187 LHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIR 246
LH I++RD+K N+L+D+ G ++++D G + ++ T K GTP +MAPE++
Sbjct: 305 LHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPELLL 362
Query: 247 QTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAA--LFHIGTTKSHPPIPENLSVKAK 304
+ +S D +++G T+ EM + P+ + ++V L + P+ S +K
Sbjct: 363 GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQR-VLEQAVTYPDKFSPASK 421
Query: 305 DFLLKCLEKEPDLR-----PTASELLKHPF 329
DF L+K+P+ R + L HP
Sbjct: 422 DFCEALLQKDPEKRLGFRDGSCDGLRTHPL 451
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 3e-51
Identities = 70/289 (24%), Positives = 118/289 (40%), Gaps = 39/289 (13%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLK 126
R R ++ G F VY ++ SG A+K++L ++ + + +EV +K
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLS--------NEEEKNRAIIQEVCFMK 80
Query: 127 DLS-HPNIVRYLG--TVREEESLN------ILLEFVPGGSISSLL--GKFGPFPEAVMRT 175
LS HPNIV++ ++ +EES +L E G + L GP +
Sbjct: 81 KLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLK 140
Query: 176 YTKQLLLGLEYLHNHG--IMHRDIKGANILVDNKGCIKLADFG----------ASKQVAE 223
Q ++++H I+HRD+K N+L+ N+G IKL DFG S
Sbjct: 141 IFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQR 200
Query: 224 LATVSGAKSMKGTPYWMAPEVIRQTGHSY---SADIWSVGCTVIEMATGKPPWSQQYQEV 280
A V + TP + PE+I + DIW++GC + + + P+ E
Sbjct: 201 RALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF-----ED 255
Query: 281 AALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPF 329
A I K P + + L+ P+ R + +E++
Sbjct: 256 GAKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 5e-51
Identities = 75/319 (23%), Positives = 125/319 (39%), Gaps = 72/319 (22%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEE------ 120
R+R+ +G G +G VY ++ + E +A+K++ + E EE
Sbjct: 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRL---------------EHEEEGVPGT 79
Query: 121 ---EVKLLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYT 177
EV LLK+L H NI+ + L+++ E+ + + K V++++
Sbjct: 80 AIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFL 138
Query: 178 KQLLLGLEYLHNHGIMHRDIKGANILVD-----NKGCIKLADFGASKQVAELATVSGAKS 232
QL+ G+ + H+ +HRD+K N+L+ +K+ DFG LA G
Sbjct: 139 YQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFG-------LARAFGIPI 191
Query: 233 MKGTP------YWMAPEVI-RQTGHSYSADIWSVGCTVIEMATGKP-------------- 271
+ T Y PE++ +S S DIWS+ C EM P
Sbjct: 192 RQFTHEIITLWYR-PPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKI 250
Query: 272 ------PWSQQYQEVAALFHIGTTKSHPP-------IPENLSVKAKDFLLKCLEKEPDLR 318
P + V AL + + L + D L LE +P R
Sbjct: 251 FEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKR 310
Query: 319 PTASELLKHPFVTGDDEDP 337
+A L+HP+ + +D DP
Sbjct: 311 ISAKNALEHPYFSHNDFDP 329
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 5e-51
Identities = 88/322 (27%), Positives = 136/322 (42%), Gaps = 80/322 (24%)
Query: 62 MSPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEE- 120
MS ++++ E +G G + VY G+N +G +A+K+V + + EE
Sbjct: 1 MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKL---------------DSEEG 45
Query: 121 -------EVKLLKDLSHPNIVRYLGTVREEESLNILLEFVP---GGSISSLLGKF--GPF 168
E+ L+K+L H NIVR + E L ++ EF+ + S
Sbjct: 46 TPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGL 105
Query: 169 PEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVS 228
+++ + QLL GL + H + I+HRD+K N+L++ +G +KL DFG LA
Sbjct: 106 ELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFG-------LA--- 155
Query: 229 GAKSMKGTPY-------WM-APEVI-RQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE 279
A + + W AP+V+ +S S DIWS GC + EM TGKP + +
Sbjct: 156 RAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLF-PGTND 214
Query: 280 VAALFHI----GT------------------TKSHPPIP----------ENLSVKAKDFL 307
L I GT + PP E L DFL
Sbjct: 215 EEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFL 274
Query: 308 LKCLEKEPDLRPTASELLKHPF 329
L+ PD+R +A + L HP+
Sbjct: 275 HGLLQLNPDMRLSAKQALHHPW 296
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 5e-51
Identities = 75/297 (25%), Positives = 136/297 (45%), Gaps = 20/297 (6%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLK 126
++ G+L+G G++G+V ++ ++ AVK +L + ++K+ E++LL+
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVK-ILKKKKLRRIPNGEANVKK---EIQLLR 61
Query: 127 DLSHPNIVRYLGTVREEES---LNILLEFVPGGSISSLLGKF--GPFPEAVMRTYTKQLL 181
L H N+++ L V E + +++E+ G +L FP Y QL+
Sbjct: 62 RLRHKNVIQ-LVDVLYNEEKQKMYMVMEYCVCGM-QEMLDSVPEKRFPVCQAHGYFCQLI 119
Query: 182 LGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMA 241
GLEYLH+ GI+H+DIK N+L+ G +K++ G ++ + A ++ +G+P +
Sbjct: 120 DGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQP 179
Query: 242 PEVIRQTGHSYS---ADIWSVGCTVIEMATGKPPWSQQYQEVAALFH-IGTTKSHPPIPE 297
PE+ ++S DIWS G T+ + TG P+ + + LF IG IP
Sbjct: 180 PEIA-NGLDTFSGFKVDIWSAGVTLYNITTGLYPF--EGDNIYKLFENIGKGSYA--IPG 234
Query: 298 NLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDPVLHASVMKSSEILSPSH 354
+ D L LE EP R + ++ +H + + S +
Sbjct: 235 DCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPDTKDRWR 291
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 6e-51
Identities = 73/268 (27%), Positives = 129/268 (48%), Gaps = 22/268 (8%)
Query: 73 LIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKE--KAQDHIKELEEEVKLLKDLSH 130
++G G FG V +G++ A K L K+ K + E ++L+ ++
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACK-KL------EKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 131 PNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFG--PFPEAVMRTYTKQLLLGLEYLH 188
+V +++L ++L + GG + + G FPEA Y ++ GLE LH
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH 303
Query: 189 NHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQT 248
I++RD+K NIL+D+ G I+++D G + V E T K GT +MAPEV++
Sbjct: 304 RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNE 360
Query: 249 GHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAA--LFHIGTTKSHPPIPENLSVKAKDF 306
+++S D W++GC + EM G+ P+ Q+ +++ + + E S +A+
Sbjct: 361 RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER-LVKEVPEEYSERFSPQARSL 419
Query: 307 LLKCLEKEPDLR-----PTASELLKHPF 329
+ L K+P R +A E+ +HP
Sbjct: 420 CSQLLCKDPAERLGCRGGSAREVKEHPL 447
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 7e-51
Identities = 79/263 (30%), Positives = 128/263 (48%), Gaps = 17/263 (6%)
Query: 73 LIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPN 132
+IG G+FG+V + + AVK VL K K + HI E V LLK++ HP
Sbjct: 45 VIGKGSFGKVLLARHKAEEVFYAVK-VLQKKAILKK-KEEKHIM-SERNV-LLKNVKHPF 100
Query: 133 IVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGI 192
+V + + + L +L+++ GG + L + F E R Y ++ L YLH+ I
Sbjct: 101 LVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNI 160
Query: 193 MHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSY 252
++RD+K NIL+D++G I L DFG K+ + S + GTP ++APEV+ + +
Sbjct: 161 VYRDLKPENILLDSQGHIVLTDFGLCKE--NIEHNSTTSTFCGTPEYLAPEVLHKQPYDR 218
Query: 253 SADIWSVGCTVIEMATGKPPW-SQQYQEVAALFH-IGTTKSHPPIPENLSVKAKDFLLKC 310
+ D W +G + EM G PP+ S+ E ++ I + N++ A+ L
Sbjct: 219 TVDWWCLGAVLYEMLYGLPPFYSRNTAE---MYDNI--LNKPLQLKPNITNSARHLLEGL 273
Query: 311 LEKEPDLR----PTASELLKHPF 329
L+K+ R E+ H F
Sbjct: 274 LQKDRTKRLGAKDDFMEIKSHVF 296
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 1e-50
Identities = 77/289 (26%), Positives = 124/289 (42%), Gaps = 45/289 (15%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS- 129
+++G G G+V N + E A+K + + EV+L S
Sbjct: 67 SQVLGLGINGKVLQIFNKRTQEKFALKML---------QDCPK----ARREVELHWRASQ 113
Query: 130 HPNIVR----YLGTVREEESLNILLEFVPGG----SISSLLGKFGPFPEAVMRTYTKQLL 181
P+IVR Y + L I++E + GG I + F E K +
Sbjct: 114 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA--FTEREASEIMKSIG 171
Query: 182 LGLEYLHNHGIMHRDIKGANILVDNKG---CIKLADFGASKQVAELATVSGAKSMK---G 235
++YLH+ I HRD+K N+L +K +KL DFG +K+ + S+
Sbjct: 172 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE------TTSHNSLTTPCY 225
Query: 236 TPYWMAPEVIRQTGHSYSADIWSVGCTVIE--MATGKPP-WSQQYQEV-AALFH-IGTTK 290
TPY++APEV+ + S D+WS+G VI + G PP +S + + I +
Sbjct: 226 TPYYVAPEVLGPEKYDKSCDMWSLG--VIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 283
Query: 291 SHPPIPE--NLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDP 337
P PE +S + K + L+ EP R T +E + HP++ + P
Sbjct: 284 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP 332
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 183 bits (465), Expect = 2e-50
Identities = 75/272 (27%), Positives = 131/272 (48%), Gaps = 30/272 (11%)
Query: 73 LIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEE---------VK 123
+IG G FG VY D+G++ A+K L +K IK + E +
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMK-CL--------DK--KRIKMKQGETLALNERIMLS 244
Query: 124 LLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLG 183
L+ P IV + L+ +L+ + GG + L + G F EA MR Y +++LG
Sbjct: 245 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG 304
Query: 184 LEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPE 243
LE++HN +++RD+K ANIL+D G ++++D G + ++ + GT +MAPE
Sbjct: 305 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK----KKPHASVGTHGYMAPE 360
Query: 244 VI-RQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVK 302
V+ + + SAD +S+GC + ++ G P+ Q + T +P++ S +
Sbjct: 361 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPE 420
Query: 303 AKDFLLKCLEKEPDLR-----PTASELLKHPF 329
+ L L+++ + R A E+ + PF
Sbjct: 421 LRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF 452
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 3e-50
Identities = 77/271 (28%), Positives = 130/271 (47%), Gaps = 22/271 (8%)
Query: 73 LIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPN 132
+IG G++ +V + + + A+K V+ + D ++ E+ V + +HP
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMK-VVKKELVNDD-EDIDWVQ-TEKHV-FEQASNHPF 71
Query: 133 IVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGI 192
+V + E L ++E+V GG + + + PE R Y+ ++ L L YLH GI
Sbjct: 72 LVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGI 131
Query: 193 MHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSY 252
++RD+K N+L+D++G IKL D+G K+ L + GTP ++APE++R + +
Sbjct: 132 IYRDLKLDNVLLDSEGHIKLTDYGMCKE--GLRPGDTTSTFCGTPNYIAPEILRGEDYGF 189
Query: 253 SADIWSVGCTVIEMATGKPPWSQQYQEVAA-------LFH-IGTTKSHPPIPENLSVKAK 304
S D W++G + EM G+ P+ LF I + IP +LSVKA
Sbjct: 190 SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI--LEKQIRIPRSLSVKAA 247
Query: 305 DFLLKCLEKEPDLR------PTASELLKHPF 329
L L K+P R +++ HPF
Sbjct: 248 SVLKSFLNKDPKERLGCHPQTGFADIQGHPF 278
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 3e-50
Identities = 42/299 (14%), Positives = 92/299 (30%), Gaps = 41/299 (13%)
Query: 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQV-----------------LIAANFA 106
P +G ++G + ++GE V ++
Sbjct: 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL 135
Query: 107 SKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESLNILLEFVP-----------G 155
K Q K + + P + + +E + +L F G
Sbjct: 136 RGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFG 195
Query: 156 GSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADF 215
+ S T Q++ L LH++G++H ++ +I++D +G + L F
Sbjct: 196 EVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGF 255
Query: 216 GASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGH-----SYSADIWSVGCTVIEMATGK 270
+ A + P A ++ H +++ D W++G + +
Sbjct: 256 EHLVRDGASAVSPIGRGF-APPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
Query: 271 PPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPF 329
P + + + +S IP+ + L L + R + ++ P
Sbjct: 315 LPNTDDAALGGSEWIF---RSCKNIPQP----VRALLEGFLRYPKEDRLLPLQAMETPE 366
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 5e-50
Identities = 82/306 (26%), Positives = 133/306 (43%), Gaps = 67/306 (21%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEE------ 120
+++K E +G G +G VY + G ++A+K++ + + E+
Sbjct: 22 KYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRL---------------DAEDEGIPST 65
Query: 121 ---EVKLLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYT 177
E+ LLK+L HPNIV + + E L ++ EF+ L ++ ++ Y
Sbjct: 66 AIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYL 125
Query: 178 KQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTP 237
QLL G+ + H H I+HRD+K N+L+++ G +KLADFG LA G T
Sbjct: 126 YQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFG-------LARAFGIPVRSYTH 178
Query: 238 ------YWMAPEVI-RQTGHSYSADIWSVGCTVIEMATGKP------------------- 271
Y AP+V+ +S S DIWS+GC EM TGKP
Sbjct: 179 EVVTLWYR-APDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILG 237
Query: 272 -PWSQQYQEVAAL--FHIGTTKSHPPIP-----ENLSVKAKDFLLKCLEKEPDLRPTASE 323
P +++ +V L + T + P + D L L +P+ R +A +
Sbjct: 238 TPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARD 297
Query: 324 LLKHPF 329
+ HP+
Sbjct: 298 AMNHPY 303
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 1e-49
Identities = 75/275 (27%), Positives = 140/275 (50%), Gaps = 26/275 (9%)
Query: 73 LIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEK--AQDHIKELEEEVKLLKDLSH 130
+IG GAFG V + + + ++ A+K +L SK + + EE ++ +
Sbjct: 76 VIGRGAFGEVQLVRHKSTRKVYAMK-LL------SKFEMIKRSDSAFFWEERDIMAFANS 128
Query: 131 PNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNH 190
P +V+ +++ L +++E++PGG + +L+ + PE R YT +++L L+ +H+
Sbjct: 129 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIHSM 187
Query: 191 GIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTG- 249
G +HRD+K N+L+D G +KLADFG ++ + V + GTP +++PEV++ G
Sbjct: 188 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR-CDTAVGTPDYISPEVLKSQGG 246
Query: 250 ---HSYSADIWSVGCTVIEMATGKPPWSQQYQE-VAALFH-IGTTKSHPPIPEN--LSVK 302
+ D WSVG + EM G P+ Y + + + I K+ P++ +S +
Sbjct: 247 DGYYGRECDWWSVGVFLYEMLVGDTPF---YADSLVGTYSKIMNHKNSLTFPDDNDISKE 303
Query: 303 AKDFLLKCLEKEPDLR---PTASELLKHPFVTGDD 334
AK+ L+ + ++R E+ +H F D
Sbjct: 304 AKN-LICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 337
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 1e-49
Identities = 78/277 (28%), Positives = 137/277 (49%), Gaps = 30/277 (10%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDH--IKELEEEVKL 124
+ G+ +G G FG+V +G + +G +AVK + +++K + + +++ E++
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKIL-------NRQKIRSLDVVGKIKREIQN 64
Query: 125 LKDLSHPNIVRYLGTVREEES-LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLG 183
LK HP+I++ L V + +++E+V GG + + K G E R +Q+L
Sbjct: 65 LKLFRHPHIIK-LYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSA 123
Query: 184 LEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMK---GTPYWM 240
++Y H H ++HRD+K N+L+D K+ADFG S +S + ++ G+P +
Sbjct: 124 VDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS------NMMSDGEFLRTSCGSPNYA 177
Query: 241 APEVIRQTGHSYS---ADIWSVGCTVIEMATGKPPWSQQYQEVAALFH-IGTTKSHPPIP 296
APEVI G Y+ DIWS G + + G P+ ++ V LF I IP
Sbjct: 178 APEVIS--GRLYAGPEVDIWSCGVILYALLCGTLPFDDEH--VPTLFKKI--RGGVFYIP 231
Query: 297 ENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333
E L+ L+ L+ +P R T ++ +H + D
Sbjct: 232 EYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 2e-49
Identities = 74/264 (28%), Positives = 128/264 (48%), Gaps = 17/264 (6%)
Query: 73 LIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPN 132
++G G+FG+V + ++G+L AVK VL + E+ + L +HP
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYAVK-VLKKDVILQD-DDVECTM-TEKRI-LSLARNHPF 85
Query: 133 IVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGI 192
+ + + + L ++EFV GG + + K F EA R Y +++ L +LH+ GI
Sbjct: 86 LTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGI 145
Query: 193 MHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSY 252
++RD+K N+L+D++G KLADFG K+ + + GTP ++APE++++ +
Sbjct: 146 IYRDLKLDNVLLDHEGHCKLADFGMCKE--GICNGVTTATFCGTPDYIAPEILQEMLYGP 203
Query: 253 SADIWSVGCTVIEMATGKPPWSQQYQEVAALFH-IGTTKSHPPIPENLSVKAKDFLLKCL 311
+ D W++G + EM G P+ + ++ LF I P L A L +
Sbjct: 204 AVDWWAMGVLLYEMLCGHAPFEAENEDD--LFEAI--LNDEVVYPTWLHEDATGILKSFM 259
Query: 312 EKEPDLR------PTASELLKHPF 329
K P +R +L+HPF
Sbjct: 260 TKNPTMRLGSLTQGGEHAILRHPF 283
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 2e-49
Identities = 84/311 (27%), Positives = 131/311 (42%), Gaps = 78/311 (25%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEE------ 120
++ E IG G +G VY N + GE A+K++ + E E+
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRL---------------EKEDEGIPST 46
Query: 121 ---EVKLLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKF-----GPFPEAV 172
E+ +LK+L H NIV+ + ++ L ++ E + L K G
Sbjct: 47 TIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL-----DQDLKKLLDVCEGGLESVT 101
Query: 173 MRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKS 232
+++ QLL G+ Y H+ ++HRD+K N+L++ +G +K+ADFG LA G
Sbjct: 102 AKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFG-------LARAFGIPV 154
Query: 233 MKGTP------YWMAPEVI-RQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFH 285
K T Y AP+V+ +S + DIWSVGC EM G P + E L
Sbjct: 155 RKYTHEIVTLWYR-APDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLF-PGVSEADQLMR 212
Query: 286 I----GT------------------TKSHPPIP-----ENLSVKAKDFLLKCLEKEPDLR 318
I GT + P+P + L D L K L+ +P+ R
Sbjct: 213 IFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQR 272
Query: 319 PTASELLKHPF 329
TA + L+H +
Sbjct: 273 ITAKQALEHAY 283
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 3e-49
Identities = 77/259 (29%), Positives = 134/259 (51%), Gaps = 12/259 (4%)
Query: 73 LIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPN 132
++G G+FG+V++ + + A+K L + +E+ V L HP
Sbjct: 24 MLGKGSFGKVFLAEFKKTNQFFAIK-ALKKDVVLMD-DDVECTM-VEKRV-LSLAWEHPF 79
Query: 133 IVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGI 192
+ T + +E+L ++E++ GG + + F + Y +++LGL++LH+ GI
Sbjct: 80 LTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGI 139
Query: 193 MHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSY 252
++RD+K NIL+D G IK+ADFG K+ + + + GTP ++APE++ +++
Sbjct: 140 VYRDLKLDNILLDKDGHIKIADFGMCKE--NMLGDAKTNTFCGTPDYIAPEILLGQKYNH 197
Query: 253 SADIWSVGCTVIEMATGKPPWSQQYQEVAALFH-IGTTKSHPPIPENLSVKAKDFLLKCL 311
S D WS G + EM G+ P+ Q +E LFH I +P P L +AKD L+K
Sbjct: 198 SVDWWSFGVLLYEMLIGQSPFHGQDEEE--LFHSI--RMDNPFYPRWLEKEAKDLLVKLF 253
Query: 312 EKEPDLR-PTASELLKHPF 329
+EP+ R ++ +HP
Sbjct: 254 VREPEKRLGVRGDIRQHPL 272
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 6e-49
Identities = 76/271 (28%), Positives = 130/271 (47%), Gaps = 22/271 (8%)
Query: 73 LIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPN 132
+IG G++ +V + + + A++ V+ + D ++ E+ V + +HP
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMR-VVKKELVNDD-EDIDWVQ-TEKHV-FEQASNHPF 114
Query: 133 IVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGI 192
+V + E L ++E+V GG + + + PE R Y+ ++ L L YLH GI
Sbjct: 115 LVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGI 174
Query: 193 MHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSY 252
++RD+K N+L+D++G IKL D+G K+ L + GTP ++APE++R + +
Sbjct: 175 IYRDLKLDNVLLDSEGHIKLTDYGMCKE--GLRPGDTTSTFCGTPNYIAPEILRGEDYGF 232
Query: 253 SADIWSVGCTVIEMATGKPPWSQQYQEVAA-------LFH-IGTTKSHPPIPENLSVKAK 304
S D W++G + EM G+ P+ LF I + IP +LSVKA
Sbjct: 233 SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI--LEKQIRIPRSLSVKAA 290
Query: 305 DFLLKCLEKEPDLR------PTASELLKHPF 329
L L K+P R +++ HPF
Sbjct: 291 SVLKSFLNKDPKERLGCHPQTGFADIQGHPF 321
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 8e-49
Identities = 70/263 (26%), Positives = 128/263 (48%), Gaps = 16/263 (6%)
Query: 73 LIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPN 132
++G G+FG+V + + EL AVK +L + +E+ V L P
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYAVK-ILKKDVVIQD-DDVECTM-VEKRV-LALPGKPPF 82
Query: 133 IVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGI 192
+ + + + L ++E+V GG + + + G F E Y ++ +GL +L + GI
Sbjct: 83 LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGI 142
Query: 193 MHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSY 252
++RD+K N+++D++G IK+ADFG K+ + K+ GTP ++APE+I +
Sbjct: 143 IYRDLKLDNVMLDSEGHIKIADFGMCKE--NIWDGVTTKTFCGTPDYIAPEIIAYQPYGK 200
Query: 253 SADIWSVGCTVIEMATGKPPWSQQYQEVAALFH-IGTTKSHPPIPENLSVKAKDFLLKCL 311
S D W+ G + EM G+ P+ + ++ LF I + + P+++S +A +
Sbjct: 201 SVDWWAFGVLLYEMLAGQAPFEGEDEDE--LFQSI--MEHNVAYPKSMSKEAVAICKGLM 256
Query: 312 EKEPDLR----PT-ASELLKHPF 329
K P R P ++ +H F
Sbjct: 257 TKHPGKRLGCGPEGERDIKEHAF 279
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 8e-49
Identities = 86/321 (26%), Positives = 125/321 (38%), Gaps = 73/321 (22%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEE------ 120
R+ IG GA+G VY + SG +A+K V + +
Sbjct: 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRV-----------PNGGGGGGGLPIST 58
Query: 121 --EVKLLKDLS---HPNIVRYL-----GTVREEESLNILLEFVP---GGSISSLLGKFGP 167
EV LL+ L HPN+VR + E + ++ E V +
Sbjct: 59 VREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-- 116
Query: 168 FPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATV 227
P ++ +Q L GL++LH + I+HRD+K NILV + G +KLADFG LA +
Sbjct: 117 LPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFG-------LARI 169
Query: 228 SGAKSMKGTP------YWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVA 281
M TP Y APEV+ Q+ ++ D+WSVGC EM KP + E
Sbjct: 170 YS-YQMALTPVVVTLWYR-APEVLLQSTYATPVDMWSVGCIFAEMFRRKPLF-CGNSEAD 226
Query: 282 ALFHI----GT----------------TKSHPPIP-----ENLSVKAKDFLLKCLEKEPD 316
L I G P P + LL+ L P
Sbjct: 227 QLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPH 286
Query: 317 LRPTASELLKHPFVTGDDEDP 337
R +A L+H ++ D+ +P
Sbjct: 287 KRISAFRALQHSYLHKDEGNP 307
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 8e-49
Identities = 76/266 (28%), Positives = 129/266 (48%), Gaps = 22/266 (8%)
Query: 73 LIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKE--KAQDHIKELEEEVKLLKDLSH 130
L+G G FG+V + +G A+K +L KE A+D + E ++L++ H
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMK-IL------KKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 131 PNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHN- 189
P + + + + L ++E+ GG + L + F E R Y +++ L+YLH+
Sbjct: 208 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE 267
Query: 190 HGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTG 249
+++RD+K N+++D G IK+ DFG K+ + + K+ GTP ++APEV+
Sbjct: 268 KNVVYRDLKLENLMLDKDGHIKITDFGLCKE--GIKDGATMKTFCGTPEYLAPEVLEDND 325
Query: 250 HSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFH-IGTTKSHPPIPENLSVKAKDFLL 308
+ + D W +G + EM G+ P+ Q E LF I P L +AK L
Sbjct: 326 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--LFELI--LMEEIRFPRTLGPEAKSLLS 381
Query: 309 KCLEKEPDLR----PT-ASELLKHPF 329
L+K+P R A E+++H F
Sbjct: 382 GLLKKDPKQRLGGGSEDAKEIMQHRF 407
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 1e-48
Identities = 76/292 (26%), Positives = 126/292 (43%), Gaps = 44/292 (15%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKE-----LEEE 121
+R G L+G G FG V+ G L +A+K + + + E
Sbjct: 32 EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVI-------PRNRVLGWSPLSDSVTCPLE 84
Query: 122 VKLLKDLS----HPNIVRYLGTVREEESLNILLEF-VPGGSISSLLGKFGPFPEAVMRTY 176
V LL + HP ++R L +E ++LE +P + + + GP E R +
Sbjct: 85 VALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCF 144
Query: 177 TKQLLLGLEYLHNHGIMHRDIKGANILVD-NKGCIKLADFGAS--KQVAELATVSGAKSM 233
Q++ +++ H+ G++HRDIK NIL+D +GC KL DFG+
Sbjct: 145 FGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD----- 199
Query: 234 KGTPYWMAPEVIRQTGHSY---SADIWSVGCTVI--EMATGKPPWSQQYQEVAALFHIGT 288
GT + PE I H Y A +WS+G ++ +M G P+ + + + A H
Sbjct: 200 -GTRVYSPPEWIS--RHQYHALPATVWSLG--ILLYDMVCGDIPFERDQEILEAELH--- 251
Query: 289 TKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDPVLH 340
P ++S + +CL +P RP+ E+L P++ ED L+
Sbjct: 252 ------FPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLN 297
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 173 bits (439), Expect = 2e-48
Identities = 77/278 (27%), Positives = 137/278 (49%), Gaps = 28/278 (10%)
Query: 73 LIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEK--AQDHIKELEEEVKLLKDLSH 130
+IG GAFG V + ++ ++ A+K +L +K + + EE +L +
Sbjct: 81 VIGRGAFGEVAVVKLKNADKVFAMK-IL------NKWEMLKRAETACFREERDVLVNGDS 133
Query: 131 PNIVRYLGTVREEESLNILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLLGLEYLHN 189
I +++ +L +++++ GG + +LL KF PE + R Y ++++ ++ +H
Sbjct: 134 KWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ 193
Query: 190 HGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIR--- 246
+HRDIK NIL+D G I+LADFG+ ++ E TV + GTP +++PE+++
Sbjct: 194 LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ-SSVAVGTPDYISPEILQAME 252
Query: 247 --QTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE-VAALFH-IGTTKSH---PPIPENL 299
+ + D WS+G + EM G+ P+ Y E + + I K P ++
Sbjct: 253 GGKGRYGPECDWWSLGVCMYEMLYGETPF---YAESLVETYGKIMNHKERFQFPTQVTDV 309
Query: 300 SVKAKDFLLKCLEKEPDLR---PTASELLKHPFVTGDD 334
S AKD L++ L + R + KHPF +G D
Sbjct: 310 SENAKD-LIRRLICSREHRLGQNGIEDFKKHPFFSGID 346
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 2e-48
Identities = 42/280 (15%), Positives = 91/280 (32%), Gaps = 36/280 (12%)
Query: 71 GELIGCGAFGRVYMGMNLD-----SGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLL 125
L+G GAF +VY D + + +K + + ++ L
Sbjct: 70 HHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQ-------KPANPWE-FYIGTQLMERL 121
Query: 126 KDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFG-----PFPEAVMRTYTKQL 180
K +++ + ++ E G++ + + + P+ ++ ++ ++
Sbjct: 122 KPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRM 181
Query: 181 LLGLEYLHNHGIMHRDIKGANILV-----------DNKGCIKLADFGASKQVAELATVSG 229
L +E +H+ I+H DIK N ++ D + L D G S + +
Sbjct: 182 LYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTI 241
Query: 230 AKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTT 289
+ T + E++ +Y D + V TV M G + +
Sbjct: 242 FTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRR 301
Query: 290 KSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPF 329
H + +F L + +LL+
Sbjct: 302 LPHLDM-------WNEFFHVMLNIPDCHHLPSLDLLRQKL 334
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 2e-48
Identities = 79/321 (24%), Positives = 138/321 (42%), Gaps = 43/321 (13%)
Query: 43 NSCIRNSRVLSKHISPSVKMSPPI-RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLI 101
+ + + + ++P + P +++ G L+G G FG VY G+ + +A+K V
Sbjct: 19 SHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHV-- 76
Query: 102 AANFASKEKAQDHIKE-----LEEEVKLLKDLSH--PNIVRYLGTVREEESLNILLEFV- 153
K++ D + + EV LLK +S ++R L +S ++LE
Sbjct: 77 -----EKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPE 131
Query: 154 PGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVD-NKGCIKL 212
P + + + G E + R++ Q+L + + HN G++HRDIK NIL+D N+G +KL
Sbjct: 132 PVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKL 191
Query: 213 ADFGAS--KQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSY---SADIWSVGCTVI--E 265
DFG+ + GT + PE IR H Y SA +WS+G ++ +
Sbjct: 192 IDFGSGALLKDTVYTDFD------GTRVYSPPEWIR--YHRYHGRSAAVWSLG--ILLYD 241
Query: 266 MATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELL 325
M G P+ + + + +S + + + CL P RPT E+
Sbjct: 242 MVCGDIPFEHDEEIIRGQVF---------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQ 292
Query: 326 KHPFVTGDDEDPVLHASVMKS 346
HP++ + S
Sbjct: 293 NHPWMQDVLLPQETAEIHLHS 313
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 2e-48
Identities = 93/355 (26%), Positives = 150/355 (42%), Gaps = 61/355 (17%)
Query: 15 RTTAESTTDAQTANSPTPFSGGNLVERFNSCIRNSRVLSKHISPSVKMSPPIRWRKGELI 74
RTT+ + + + P+ F + + + V + P + + ++I
Sbjct: 6 RTTSFAES-CKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQ--EVSYTDTKVI 62
Query: 75 GCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIV 134
G G+FG VY DSGEL+A+K+VL F ++E +++++ L H NIV
Sbjct: 63 GNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE------------LQIMRKLDHCNIV 110
Query: 135 RYL------GTVREEESLNILLEFVPG---GSISSLLGKFGPFPEAVMRTYTKQLLLGLE 185
R G ++E LN++L++VP P ++ Y QL L
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 170
Query: 186 YLHNHGIMHRDIKGANILVD-NKGCIKLADFGASKQVAELATVSGAKSMKG---TPYWMA 241
Y+H+ GI HRDIK N+L+D + +KL DFG++KQ+ + + Y+ A
Sbjct: 171 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR------GEPNVSYICSRYYRA 224
Query: 242 PEVI-RQTGHSYSADIWSVGCTVIEMATGKP--------------------PWSQQYQEV 280
PE+I T ++ S D+WS GC + E+ G+P P +Q +E+
Sbjct: 225 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 284
Query: 281 ---AALFHIGTTKSHPP---IPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPF 329
F K+HP +A + LE P R T E H F
Sbjct: 285 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 339
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 5e-48
Identities = 63/279 (22%), Positives = 119/279 (42%), Gaps = 26/279 (9%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLK 126
++ +G GAFG V+ ++ + + + VK + + ++ E+ +L
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 127 DLSHPNIVRYLGTVREEESLNILLEF-VPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLE 185
+ H NI++ L + +++E G + + + + E + +QL+ +
Sbjct: 85 RVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVG 144
Query: 186 YLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMK---GTPYWMAP 242
YL I+HRDIK NI++ IKL DFG++ A + K GT + AP
Sbjct: 145 YLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSA------AYLERGKLFYTFCGTIEYCAP 198
Query: 243 EVIRQTGHSYS---ADIWSVGCTVIEMATGKPPWSQQYQEV-AALFHIGTTKSHPPIPEN 298
EV+ G+ Y ++WS+G T+ + + P+ + +E A H P
Sbjct: 199 EVLM--GNPYRGPELEMWSLGVTLYTLVFEENPF-CELEETVEAAIH---------PPYL 246
Query: 299 LSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDP 337
+S + + L+ P+ R T +L+ P+VT
Sbjct: 247 VSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLA 285
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 5e-48
Identities = 73/293 (24%), Positives = 140/293 (47%), Gaps = 31/293 (10%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDH--IKELEEEVKL 124
+ E +G G+FG+V + + + + +A+K + S++ + +E E+
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFI-------SRQLLKKSDMHMRVEREISY 62
Query: 125 LKDLSHPNIVRYLGTVREEES-LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLG 183
LK L HP+I++ L V + + +++E+ GG + + + E R + +Q++
Sbjct: 63 LKLLRHPHIIK-LYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICA 120
Query: 184 LEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMK---GTPYWM 240
+EY H H I+HRD+K N+L+D+ +K+ADFG S ++ +K G+P +
Sbjct: 121 IEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLS------NIMTDGNFLKTSCGSPNYA 174
Query: 241 APEVIRQTGHSYS---ADIWSVGCTVIEMATGKPPWSQQYQEVAALFH-IGTTKSHPPIP 296
APEVI G Y+ D+WS G + M G+ P+ + + LF + +P
Sbjct: 175 APEVIN--GKLYAGPEVDVWSCGIVLYVMLVGRLPF--DDEFIPNLFKKV--NSCVYVMP 228
Query: 297 ENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDPVLHASVMKSSEI 349
+ LS A+ + + + +P R T E+ + P+ + D + ++ S
Sbjct: 229 DFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSYA 281
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 6e-48
Identities = 76/277 (27%), Positives = 134/277 (48%), Gaps = 24/277 (8%)
Query: 73 LIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEK--AQDHIKELEEEVKLLKDLSH 130
+IG GAF V + +G++ A+K ++ +K + + EE +L +
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMK-IM------NKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 131 PNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGP-FPEAVMRTYTKQLLLGLEYLHN 189
I + ++E L +++E+ GG + +LL KFG P + R Y ++++ ++ +H
Sbjct: 121 RWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHR 180
Query: 190 HGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTG 249
G +HRDIK NIL+D G I+LADFG+ ++ TV + GTP +++PE+++ G
Sbjct: 181 LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV-RSLVAVGTPDYLSPEILQAVG 239
Query: 250 -------HSYSADIWSVGCTVIEMATGKPPW-SQQYQEV-AALFHIGTTKSHPPIPENLS 300
+ D W++G EM G+ P+ + E + H S P + E +
Sbjct: 240 GGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVP 299
Query: 301 VKAKDFLLKCLEKEPDLR---PTASELLKHPFVTGDD 334
+A+D ++ L P+ R A + HPF G D
Sbjct: 300 EEARD-FIQRLLCPPETRLGRGGAGDFRTHPFFFGLD 335
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 7e-48
Identities = 82/319 (25%), Positives = 148/319 (46%), Gaps = 33/319 (10%)
Query: 56 ISPSVKMSPPIR---WRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEK-- 110
++ K ++ + G+ +G G FG+V +G + +G +AVK + +++K
Sbjct: 3 MAEKQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKIL-------NRQKIR 55
Query: 111 AQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES-LNILLEFVPGGSISSLLGKFGPFP 169
+ D + ++ E++ LK HP+I++ L V S + +++E+V GG + + K G
Sbjct: 56 SLDVVGKIRREIQNLKLFRHPHIIK-LYQVISTPSDIFMVMEYVSGGELFDYICKNGRLD 114
Query: 170 EAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSG 229
E R +Q+L G++Y H H ++HRD+K N+L+D K+ADFG S +S
Sbjct: 115 EKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS------NMMSD 168
Query: 230 AKSMK---GTPYWMAPEVIRQTGHSYS---ADIWSVGCTVIEMATGKPPWSQQYQEVAAL 283
+ ++ G+P + APEVI G Y+ DIWS G + + G P+ + V L
Sbjct: 169 GEFLRTSCGSPNYAAPEVIS--GRLYAGPEVDIWSSGVILYALLCGTLPFDDDH--VPTL 224
Query: 284 FH-IGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDPVLHAS 342
F I P+ L+ L L+ +P R T ++ +H + D +
Sbjct: 225 FKKI--CDGIFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPED 282
Query: 343 VMKSSEILSPSHVANLESL 361
SS ++ + +
Sbjct: 283 PSYSSTMIDDEALKEVCEK 301
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 8e-48
Identities = 84/306 (27%), Positives = 136/306 (44%), Gaps = 61/306 (19%)
Query: 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKL 124
I + ++IG G+FG V+ ++S E+ A+K+VL F ++E +++
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEV-AIKKVLQDKRFKNRE------------LQI 85
Query: 125 LKDLSHPNIVRYL------GTVREEESLNILLEFVPG---GSISSLLGKFGPFPEAVMRT 175
++ + HPN+V G ++E LN++LE+VP + P +++
Sbjct: 86 MRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKL 145
Query: 176 YTKQLLLGLEYLHNHGIMHRDIKGANILVD-NKGCIKLADFGASKQVAELAT----VSGA 230
Y QLL L Y+H+ GI HRDIK N+L+D G +KL DFG++K + +
Sbjct: 146 YMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYIC-- 203
Query: 231 KSMKGTPYWMAPEVI-RQTGHSYSADIWSVGCTVIEMATGKP------------------ 271
+ Y+ APE+I T ++ + DIWS GC + E+ G+P
Sbjct: 204 -----SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVL 258
Query: 272 --PWSQQYQEVAALFHIGTTKSHPPIP------ENLSVKAKDFLLKCLEKEPDLRPTASE 323
P +Q + + + P P A D + + LE P R TA E
Sbjct: 259 GTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIE 318
Query: 324 LLKHPF 329
L HPF
Sbjct: 319 ALCHPF 324
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 9e-47
Identities = 75/324 (23%), Positives = 122/324 (37%), Gaps = 88/324 (27%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEE------ 120
++ K IG G FG V+ + +G+ +A+K+VL+ E E+
Sbjct: 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLM---------------ENEKEGFPIT 62
Query: 121 ---EVKLLKDLSHPNIVRYLGTVREEE--------SLNILLEFVP---GGSISSLLGKFG 166
E+K+L+ L H N+V + R + S+ ++ +F G +S+
Sbjct: 63 ALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN---VLV 119
Query: 167 PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELAT 226
F + ++ + LL GL Y+H + I+HRD+K AN+L+ G +KLADFG LA
Sbjct: 120 KFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFG-------LAR 172
Query: 227 VSGAKSMKGTPYWMAPEVI----R-------QTGHSYSADIWSVGCTVIEMATGKPPWSQ 275
+ P V+ R + + D+W GC + EM T P Q
Sbjct: 173 AFSL-AKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM-Q 230
Query: 276 QYQEVAALFHI----GT-----------------TKSHPPIPENL---------SVKAKD 305
E L I G+ + + A D
Sbjct: 231 GNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALD 290
Query: 306 FLLKCLEKEPDLRPTASELLKHPF 329
+ K L +P R + + L H F
Sbjct: 291 LIDKLLVLDPAQRIDSDDALNHDF 314
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 1e-46
Identities = 89/315 (28%), Positives = 131/315 (41%), Gaps = 79/315 (25%)
Query: 67 RWRKGELIGCGAFGRVYMGMNL-DSGELLAVKQVLIAANFASKEKAQDHIKELEE----- 120
++ IG GA+G+V+ +L + G +A+K+V + + E
Sbjct: 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRV---------------QTGEEGMPL 56
Query: 121 ----EVKLLKDLS---HPNIVR-----YLGTVREEESLNILLEFVP---GGSISSLLGKF 165
EV +L+ L HPN+VR + E L ++ E V + +
Sbjct: 57 STIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG 116
Query: 166 GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA 225
P ++ QLL GL++LH+H ++HRD+K NILV + G IKLADFG LA
Sbjct: 117 --VPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG-------LA 167
Query: 226 TVSGAKSMKGTP------YWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE 279
+ M T Y APEV+ Q+ ++ D+WSVGC EM KP + + +
Sbjct: 168 RIYS-FQMALTSVVVTLWYR-APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF-RGSSD 224
Query: 280 VAALFHI----GT----------------TKSHPPIP-----ENLSVKAKDFLLKCLEKE 314
V L I G S P ++ KD LLKCL
Sbjct: 225 VDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFN 284
Query: 315 PDLRPTASELLKHPF 329
P R +A L HP+
Sbjct: 285 PAKRISAYSALSHPY 299
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 171 bits (434), Expect = 2e-46
Identities = 69/263 (26%), Positives = 128/263 (48%), Gaps = 16/263 (6%)
Query: 73 LIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPN 132
++G G+FG+V + + EL AVK +L + + +E+ V L P
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVK-ILKKDVVIQDDDV-ECTM-VEKRV-LALPGKPPF 403
Query: 133 IVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGI 192
+ + + + L ++E+V GG + + + G F E Y ++ +GL +L + GI
Sbjct: 404 LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGI 463
Query: 193 MHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSY 252
++RD+K N+++D++G IK+ADFG K+ + K+ GTP ++APE+I +
Sbjct: 464 IYRDLKLDNVMLDSEGHIKIADFGMCKE--NIWDGVTTKTFCGTPDYIAPEIIAYQPYGK 521
Query: 253 SADIWSVGCTVIEMATGKPPWSQQYQEVAALFH-IGTTKSHPPIPENLSVKAKDFLLKCL 311
S D W+ G + EM G+ P+ + ++ LF I + + P+++S +A +
Sbjct: 522 SVDWWAFGVLLYEMLAGQAPFEGEDEDE--LFQSI--MEHNVAYPKSMSKEAVAICKGLM 577
Query: 312 EKEPDLR-----PTASELLKHPF 329
K P R ++ +H F
Sbjct: 578 TKHPGKRLGCGPEGERDIKEHAF 600
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 6e-46
Identities = 81/327 (24%), Positives = 137/327 (41%), Gaps = 39/327 (11%)
Query: 52 LSKHISPSVKMSPPI-----RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFA 106
+ + + + PI R+ + IG G FG + + + EL+AVK +
Sbjct: 1 MDRAPVTTGPLDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYI------- 53
Query: 107 SKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES-LNILLEFVPGGSISSLLGKF 165
E+ + ++ E+ + L HPNIVR V + L I++E+ GG + +
Sbjct: 54 --ERGAAIDENVQREIINHRSLRHPNIVR-FKEVILTPTHLAIIMEYASGGELYERICNA 110
Query: 166 GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGC--IKLADFGASKQVAE 223
G F E R + +QLL G+ Y H+ I HRD+K N L+D +K+ DFG SK
Sbjct: 111 GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170
Query: 224 ---LATVSGAKSMKGTPYWMAPEVIRQTGHSY---SADIWSVGCTVIEMATGKPPWSQQY 277
+ GTP ++APEV+ Y AD+WS G T+ M G P+ +
Sbjct: 171 HSQPKSTV------GTPAYIAPEVLL--RQEYDGKIADVWSCGVTLYVMLVGAYPF--ED 220
Query: 278 QEVAALFH-----IGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTG 332
E + I + K P +S + + + +P R + E+ H +
Sbjct: 221 PEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLK 280
Query: 333 DDEDPVLHASVMKSSEILSPSHVANLE 359
+ +++ S S + +L+
Sbjct: 281 NLPADLMNESNTGSQFQEPEQPMQSLD 307
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 1e-44
Identities = 65/295 (22%), Positives = 105/295 (35%), Gaps = 51/295 (17%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH 130
E +G G +G V+ G GE +AVK F+S+++ E E+ L H
Sbjct: 13 LECVGKGRYGEVWRGSW--QGENVAVKI------FSSRDEKSW---FRETELYNTVMLRH 61
Query: 131 PNIVRYLGTVREEESLN----ILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEY 186
NI+ ++ + + ++ + GS+ L + GL +
Sbjct: 62 ENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAH 120
Query: 187 LH--------NHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSM--KGT 236
LH I HRD+K NILV G +AD G + ++ + GT
Sbjct: 121 LHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGT 180
Query: 237 PYWMAPEVIRQTGHSYS------ADIWSVGCTVIEMATG----------KPPWSQQYQEV 280
+MAPEV+ +T DIW+ G + E+A KPP+
Sbjct: 181 KRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND 240
Query: 281 AALFHI----GTTKSHPPIPENLSVKA-----KDFLLKCLEKEPDLRPTASELLK 326
+ + + P IP + +C + P R TA + K
Sbjct: 241 PSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 2e-44
Identities = 69/262 (26%), Positives = 130/262 (49%), Gaps = 9/262 (3%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLK 126
R++ + +G G VY+ + +A+K I KE+ +K E EV
Sbjct: 12 RYKIVDKLGGGGMSTVYLAEDTILNIKVAIK--AIFIPPREKEET---LKRFEREVHNSS 66
Query: 127 DLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEY 186
LSH NIV + E++ +++E++ G ++S + GP +T Q+L G+++
Sbjct: 67 QLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKH 126
Query: 187 LHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIR 246
H+ I+HRDIK NIL+D+ +K+ DFG +K ++E +++ + GT + +PE +
Sbjct: 127 AHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE-TSLTQTNHVLGTVQYFSPEQAK 185
Query: 247 QTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPP--IPENLSVKAK 304
DI+S+G + EM G+PP++ + A+ HI + + + +++
Sbjct: 186 GEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLS 245
Query: 305 DFLLKCLEKEPDLRP-TASELL 325
+ +L+ EK+ R T E+
Sbjct: 246 NVILRATEKDKANRYKTIQEMK 267
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 8e-44
Identities = 70/309 (22%), Positives = 122/309 (39%), Gaps = 65/309 (21%)
Query: 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKL 124
++ +G G + V+ +N+ + E + VK + K K+++ E+K+
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL-------KPVKK----KKIKREIKI 83
Query: 125 LKDLS-HPNIVRYLGTVREEESLNILL--EFVPGGSISSLLGKFGPFPEAVMRTYTKQLL 181
L++L PNI+ V++ S L E V L + + +R Y ++L
Sbjct: 84 LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEIL 140
Query: 182 LGLEYLHNHGIMHRDIKGANILVDNKGC-IKLADFGASKQVAELA-TVSGAKSMKG---T 236
L+Y H+ GIMHRD+K N+++D++ ++L D+G LA + +
Sbjct: 141 KALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWG-------LAEFYHPGQEYNVRVAS 193
Query: 237 PYWMAPEVIRQTGH-SYSADIWSVGCTVIEMATGKPP----------------------- 272
Y+ PE++ YS D+WS+GC + M K P
Sbjct: 194 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDL 253
Query: 273 --WSQQYQEVAALFHIGTTKSHPPIP----------ENLSVKAKDFLLKCLEKEPDLRPT 320
+ +Y H +S +A DFL K L + R T
Sbjct: 254 YDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT 313
Query: 321 ASELLKHPF 329
A E ++HP+
Sbjct: 314 AREAMEHPY 322
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 1e-43
Identities = 65/319 (20%), Positives = 114/319 (35%), Gaps = 57/319 (17%)
Query: 53 SKHISPSVKMSPP---IRWRK---GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFA 106
H S V + + E+ G FG V+ E +AVK + +
Sbjct: 5 HHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL--LNEYVAVK-IFPIQDKQ 61
Query: 107 SKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESLN----ILLEFVPGGSISSLL 162
S + E EV L + H NI++++G + S++ ++ F GS+S L
Sbjct: 62 SWQN--------EYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL 113
Query: 163 GKFGPFPEAVMRTYTKQLLLGLEYLHNH----------GIMHRDIKGANILVDNKGCIKL 212
K + + + GL YLH I HRDIK N+L+ N +
Sbjct: 114 -KANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACI 172
Query: 213 ADFGASKQVAELATVSGAKSMKGTPYWMAPEVIR---QTGHSYS--ADIWSVGCTVIEMA 267
ADFG + + + GT +MAPEV+ D++++G + E+A
Sbjct: 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELA 232
Query: 268 TGKPPWSQQYQEVAALFH---------------IGTTKSHPPIPENLSVKA-----KDFL 307
+ E F + K P + + A + +
Sbjct: 233 SRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETI 292
Query: 308 LKCLEKEPDLRPTASELLK 326
+C + + + R +A + +
Sbjct: 293 EECWDHDAEARLSAGCVGE 311
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 3e-43
Identities = 63/267 (23%), Positives = 120/267 (44%), Gaps = 35/267 (13%)
Query: 67 RWRKGELIGCGAFGRVYMG--MNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKL 124
++ I G G +Y+ N++ G + +K L+ + + E +
Sbjct: 81 QYEVKGCIAHGGLGWIYLALDRNVN-GRPVVLK-GLVHSG------DAEAQAMAMAERQF 132
Query: 125 LKDLSHPNIVRYLGTVREEESLN-----ILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQ 179
L ++ HP+IV+ V + I++E+V G S+ G+ P EA+ Y +
Sbjct: 133 LAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAI--AYLLE 190
Query: 180 LLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYW 239
+L L YLH+ G+++ D+K NI++ + +KL D GA ++ G + GTP +
Sbjct: 191 ILPALSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRI----NSFGY--LYGTPGF 243
Query: 240 MAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENL 299
APE++R TG + + DI++VG T+ + P + +Y + + ++
Sbjct: 244 QAPEIVR-TGPTVATDIYTVGRTLAALTLDLPTRNGRY-----VDGLPEDDPVLKTYDSY 297
Query: 300 SVKAKDFLLKCLEKEPDLRP-TASELL 325
L + ++ +P R TA E+
Sbjct: 298 G----RLLRRAIDPDPRQRFTTAEEMS 320
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 3e-43
Identities = 64/303 (21%), Positives = 104/303 (34%), Gaps = 54/303 (17%)
Query: 66 IRWRK---GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEV 122
++ + IG G +G V+MG GE +AVK V AS + E E+
Sbjct: 34 TIAKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVK-VFFTTEEASWFR--------ETEI 82
Query: 123 KLLKDLSHPNIVRYLGTVREEESLN----ILLEFVPGGSISSLLGKFGPFPEAVMRTYTK 178
+ H NI+ ++ + ++ ++ GS+ L K M
Sbjct: 83 YQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL-KSTTLDAKSMLKLAY 141
Query: 179 QLLLGLEYLH--------NHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVS-- 228
+ GL +LH I HRD+K NILV G +AD G + +
Sbjct: 142 SSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDI 201
Query: 229 GAKSMKGTPYWMAPEVIRQTGHSYS------ADIWSVGCTVIEMATG----------KPP 272
+ GT +M PEV+ ++ + AD++S G + E+A + P
Sbjct: 202 PPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP 261
Query: 273 WSQQYQEVAALFHIGTTKSH----PPIPENLSVKAKDFLLK-----CLEKEPDLRPTASE 323
+ + + P P S + C P R TA
Sbjct: 262 YHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALR 321
Query: 324 LLK 326
+ K
Sbjct: 322 VKK 324
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 3e-43
Identities = 70/286 (24%), Positives = 111/286 (38%), Gaps = 60/286 (20%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS- 129
+++G G G+V N + E A+K + + EV+L S
Sbjct: 23 SQVLGLGINGKVLQIFNKRTQEKFALKML---------QDCPK----ARREVELHWRASQ 69
Query: 130 HPNIVR----YLGTVREEESLNILLEFVPGG----SISSLLGKFGPFPEAVMRTYTKQLL 181
P+IVR Y + L I++E + GG I + F E K +
Sbjct: 70 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA--FTEREASEIMKSIG 127
Query: 182 LGLEYLHNHGIMHRDIKGANILVDNKG---CIKLADFGASKQVAELATVSGAKSMKGTPY 238
++YLH+ I HRD+K N+L +K +KL DFG
Sbjct: 128 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG---------------------- 165
Query: 239 WMAPEVIRQTGHSYSADIWSVGCTVIE--MATGKPP-WSQQYQEV-AALFH-IGTTKSHP 293
A E + + S D+WS+G VI + G PP +S + + I +
Sbjct: 166 -FAKETTGE-KYDKSCDMWSLG--VIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 221
Query: 294 PIPE--NLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDP 337
P PE +S + K + L+ EP R T +E + HP++ + P
Sbjct: 222 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP 267
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 7e-42
Identities = 66/267 (24%), Positives = 114/267 (42%), Gaps = 21/267 (7%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLK 126
+R L+G G G VY + ++A+K L++ +S + ++ E +
Sbjct: 35 PYRLRRLVGRGGMGDVYEAEDTVRERIVALK--LMSETLSSDPVFRTR---MQREARTAG 89
Query: 127 DLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFP--EAVMRTYTKQLLLGL 184
L P++V + L + + + G ++++L + GP AV +Q+ L
Sbjct: 90 RLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAV--AIVRQIGSAL 147
Query: 185 EYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEV 244
+ H G HRD+K NILV L DFG + + ++ + GT Y+MAPE
Sbjct: 148 DAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTD-EKLTQLGNTVGTLYYMAPER 206
Query: 245 IRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGT-----TKSHPPIPENL 299
++ +Y ADI+++ C + E TG PP+ V HI + P IP
Sbjct: 207 FSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV-MGAHINQAIPRPSTVRPGIPVAF 265
Query: 300 SVKAKDFLLKCLEKEPDLR-PTASELL 325
+ + + K P+ R T +L
Sbjct: 266 D----AVIARGMAKNPEDRYVTCGDLS 288
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 7e-42
Identities = 66/277 (23%), Positives = 120/277 (43%), Gaps = 29/277 (10%)
Query: 69 RKGELIGCGAFGRVYMG----MNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKL 124
+ +G G FG V + + ++G L+AVKQ+ + D ++ + E+++
Sbjct: 26 KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL--------QHSGPDQQRDFQREIQI 77
Query: 125 LKDLSHPNIVRYLG--TVREEESLNILLEFVPGGSISSLLGKFGP-FPEAVMRTYTKQLL 181
LK L IV+Y G +SL +++E++P G + L + + + Y+ Q+
Sbjct: 78 LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQIC 137
Query: 182 LGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPY-WM 240
G+EYL + +HRD+ NILV+++ +K+ADFG +K + + +P W
Sbjct: 138 KGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY 197
Query: 241 APEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQEVAALFHIGTTKSHP------ 293
APE + S +D+WS G + E+ T S + + + +
Sbjct: 198 APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257
Query: 294 ------PIPENLSVKAKDFLLKCLEKEPDLRPTASEL 324
P P + + + C P RP+ S L
Sbjct: 258 EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSAL 294
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 1e-41
Identities = 74/356 (20%), Positives = 124/356 (34%), Gaps = 91/356 (25%)
Query: 69 RKGELIGCGAFGRVYMGMNLD--SGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLK 126
+G +G G +G VY D + A+KQ+ + E+ LL+
Sbjct: 24 YEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQI----------EGTGISMSACREIALLR 73
Query: 127 DLSHPNIVRYLGTVRE--EESLNILLEFVP--------GGSISSLLGKFGPFPEAVMRTY 176
+L HPN++ + + +L ++ S K P ++++
Sbjct: 74 ELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSL 133
Query: 177 TKQLLLGLEYLHNHGIMHRDIKGANILV----DNKGCIKLADFGASKQVAELATVSGAKS 232
Q+L G+ YLH + ++HRD+K ANILV +G +K+AD G A + +
Sbjct: 134 LYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG-------FARLFNSPL 186
Query: 233 MKGTPYWM--------APEVIRQTGHSYSA--DIWSVGCTVIEMATGKP--------PWS 274
APE++ H Y+ DIW++GC E+ T +P +
Sbjct: 187 KPLADLDPVVVTFWYRAPELLLGARH-YTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKT 245
Query: 275 QQYQEVAALFHI----GT---------------TKSHPPIPEN----------------- 298
L I G + N
Sbjct: 246 SNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVK 305
Query: 299 LSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDPVLHASVMKSSEILSPSH 354
KA L K L +P R T+ + ++ P+ EDP+ + V +I P
Sbjct: 306 PDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFL---EDPLPTSDVFAGCQIPYPKR 358
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 1e-41
Identities = 77/313 (24%), Positives = 132/313 (42%), Gaps = 65/313 (20%)
Query: 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLL 125
R++ + G G FG V +G +G +A+K+V+ + + +EL + ++ L
Sbjct: 23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVI--------QDPRFRNREL-QIMQDL 73
Query: 126 KDLSHPNIVR---YLGTVREEES----LNILLEFVPG---GSISSLLGKFGPFPEAVMRT 175
L HPNIV+ Y T+ E + LN+++E+VP + + P +++
Sbjct: 74 AVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKV 133
Query: 176 YTKQLLLGLEYLHN--HGIMHRDIKGANILVDNKGC-IKLADFGASKQVAELATVSGAKS 232
+ QL+ + LH + HRDIK N+LV+ +KL DFG++K++ + S
Sbjct: 134 FLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL--------SPS 185
Query: 233 MKGTPYWM-----APEVI-RQTGHSYSADIWSVGCTVIEMATGKP--------------- 271
Y APE+I ++ + DIWSVGC EM G+P
Sbjct: 186 EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIV 245
Query: 272 -----PWSQQYQEVA---ALFHIGTTKSHP------PIPENLSVKAKDFLLKCLEKEPDL 317
P + +++ + +K P + +A D L L+ P+
Sbjct: 246 RVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEE 305
Query: 318 RPTASELLKHPFV 330
R E L HP+
Sbjct: 306 RMKPYEALCHPYF 318
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 2e-41
Identities = 66/295 (22%), Positives = 104/295 (35%), Gaps = 51/295 (17%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH 130
E IG G FG V+ G GE +AVK F+S+E+ E E+ L H
Sbjct: 47 QESIGKGRFGEVWRGKW--RGEEVAVKI------FSSREERSW---FREAEIYQTVMLRH 95
Query: 131 PNIVRYLGTVREEESLN----ILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEY 186
NI+ ++ ++ ++ ++ GS+ L + M GL +
Sbjct: 96 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAH 154
Query: 187 LH--------NHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVS--GAKSMKGT 236
LH I HRD+K NILV G +AD G + + GT
Sbjct: 155 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 214
Query: 237 PYWMAPEVIRQTGHSYS------ADIWSVGCTVIEMATG----------KPPWSQQYQEV 280
+MAPEV+ + + ADI+++G E+A + P+
Sbjct: 215 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 274
Query: 281 AAL----FHIGTTKSHPPIPENLSVKAKDFLLK-----CLEKEPDLRPTASELLK 326
++ + K P IP ++ C R TA + K
Sbjct: 275 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 2e-41
Identities = 79/338 (23%), Positives = 138/338 (40%), Gaps = 90/338 (26%)
Query: 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKL 124
++ G+ +G G+FG V +++SG+ A+K+VL + ++E + +
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRE------------LDI 53
Query: 125 LKDLSHPNIVR--------------------------------------YLGTVREEESL 146
+K L H NI++ + + + L
Sbjct: 54 MKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYL 113
Query: 147 NILLEFVPG---GSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANIL 203
N+++E+VP + S + P ++ Y QL + ++H+ GI HRDIK N+L
Sbjct: 114 NVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLL 173
Query: 204 VDNKGCI-KLADFGASKQVAELATVSGAKSMKG---TPYWMAPEVI-RQTGHSYSADIWS 258
V++K KL DFG++K++ ++ + ++ APE++ T ++ S D+WS
Sbjct: 174 VNSKDNTLKLCDFGSAKKLIP------SEPSVAYICSRFYRAPELMLGATEYTPSIDLWS 227
Query: 259 VGCTVIEMATGKP--------------------PWSQQYQEV---AALFHIGTTKSHP-- 293
+GC E+ GKP P +Q + T K+
Sbjct: 228 IGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWR 287
Query: 294 -PIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFV 330
+PE A D L + L EPDLR E + HPF
Sbjct: 288 KILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFF 325
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-40
Identities = 76/287 (26%), Positives = 124/287 (43%), Gaps = 17/287 (5%)
Query: 45 CIRNSRVLSKHISPSVKMSPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAAN 104
++ VL + + + GE IG G FG V+ G L+AVK
Sbjct: 93 TKKSGVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSC----- 147
Query: 105 FASKEKA-QDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLG 163
+E D + +E ++LK SHPNIVR +G +++ + I++E V GG + L
Sbjct: 148 ---RETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLR 204
Query: 164 KFGP-FPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVA 222
G + G+EYL + +HRD+ N LV K +K++DFG S++ A
Sbjct: 205 TEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEA 264
Query: 223 ELATVSGAKSMKGTPY-WMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPP-WSQQYQE 279
+ + + ++ P W APE + +S +D+WS G + E + G P + Q+
Sbjct: 265 D-GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ 323
Query: 280 VAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLK 326
G P PE + +C EP RP+ S + +
Sbjct: 324 TREFVEKG---GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 3e-40
Identities = 72/270 (26%), Positives = 124/270 (45%), Gaps = 20/270 (7%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLK 126
R+ GE++G G V++ +L +AVK VL A+ A E +
Sbjct: 13 RYELGEILGFGGMSEVHLARDLRDHRDVAVK-VL-RADLARDPSF---YLRFRREAQNAA 67
Query: 127 DLSHPNIVRYLGTVREEESLN----ILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLL 182
L+HP IV T E I++E+V G ++ ++ GP
Sbjct: 68 ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQ 127
Query: 183 GLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAE-LATVSGAKSMKGTPYWMA 241
L + H +GI+HRD+K ANI++ +K+ DFG ++ +A+ +V+ ++ GT +++
Sbjct: 128 ALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187
Query: 242 PEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTT-----KSHPPIP 296
PE R +D++S+GC + E+ TG+PP++ A H+ H +
Sbjct: 188 PEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS 247
Query: 297 ENLSVKAKDFLLKCLEKEPDLRP-TASELL 325
+L +LK L K P+ R TA+E+
Sbjct: 248 ADL----DAVVLKALAKNPENRYQTAAEMR 273
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 6e-40
Identities = 72/281 (25%), Positives = 129/281 (45%), Gaps = 36/281 (12%)
Query: 69 RKGELIGCGAFGRVYMG----MNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKL 124
+ + +G G FG V M + ++GE++AVK++ + ++H+++ E E+++
Sbjct: 13 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--------QHSTEEHLRDFEREIEI 64
Query: 125 LKDLSHPNIVRYLG--TVREEESLNILLEFVPGGSISSLLGKFGP-FPEAVMRTYTKQLL 181
LK L H NIV+Y G +L +++E++P GS+ L K + YT Q+
Sbjct: 65 LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 124
Query: 182 LGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTP-YWM 240
G+EYL +HRD+ NILV+N+ +K+ DFG +K + + K +P +W
Sbjct: 125 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY 184
Query: 241 APEVIRQTGHSYSADIWSVGCTVIEMAT----------------GKPPWSQQY-QEVAAL 283
APE + ++ S ++D+WS G + E+ T G Q + L
Sbjct: 185 APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 244
Query: 284 FHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASEL 324
P P+ + + +C + RP+ +L
Sbjct: 245 LKNN---GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 282
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-39
Identities = 72/281 (25%), Positives = 129/281 (45%), Gaps = 36/281 (12%)
Query: 69 RKGELIGCGAFGRVYMG----MNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKL 124
+ + +G G FG V M + ++GE++AVK++ + ++H+++ E E+++
Sbjct: 44 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--------QHSTEEHLRDFEREIEI 95
Query: 125 LKDLSHPNIVRYLG--TVREEESLNILLEFVPGGSISSLLGKFGP-FPEAVMRTYTKQLL 181
LK L H NIV+Y G +L +++E++P GS+ L K + YT Q+
Sbjct: 96 LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 155
Query: 182 LGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTP-YWM 240
G+EYL +HRD+ NILV+N+ +K+ DFG +K + + K +P +W
Sbjct: 156 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY 215
Query: 241 APEVIRQTGHSYSADIWSVGCTVIEMAT----------------GKPPWSQQY-QEVAAL 283
APE + ++ S ++D+WS G + E+ T G Q + L
Sbjct: 216 APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 275
Query: 284 FHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASEL 324
P P+ + + +C + RP+ +L
Sbjct: 276 LKNN---GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 313
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-38
Identities = 73/279 (26%), Positives = 126/279 (45%), Gaps = 30/279 (10%)
Query: 69 RKGELIGCGAFGRVYMGM----NLDSGELLAVKQVLIAANFASKEKAQD-HIKELEEEVK 123
+K +G G FG+V + N +GE++AVK + K A H ++E+
Sbjct: 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL--------KADAGPQHRSGWKQEID 85
Query: 124 LLKDLSHPNIVRYLG--TVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLL 181
+L+ L H +I++Y G SL +++E+VP GS+ L + A + + +Q+
Sbjct: 86 ILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR-HSIGLAQLLLFAQQIC 144
Query: 182 LGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTP-YWM 240
G+ YLH +HRD+ N+L+DN +K+ DFG +K V E + +P +W
Sbjct: 145 EGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY 204
Query: 241 APEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQEVAALFHIGTTKSHP------ 293
APE +++ Y++D+WS G T+ E+ T S + + + +
Sbjct: 205 APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL 264
Query: 294 ------PIPENLSVKAKDFLLKCLEKEPDLRPTASELLK 326
P P+ + + C E E RPT L+
Sbjct: 265 ERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 9e-38
Identities = 69/277 (24%), Positives = 123/277 (44%), Gaps = 30/277 (10%)
Query: 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELL----AVKQVLIAANFASKEKAQDH-IKEL 118
++K +++G GAFG VY G+ + GE + A+K L +E KE+
Sbjct: 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIK-EL-------REATSPKANKEI 64
Query: 119 EEEVKLLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISS-LLGKFGPFPEAVMRTYT 177
+E ++ + +P++ R LG ++ ++ + +P G + + + +
Sbjct: 65 LDEAYVMASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC 123
Query: 178 KQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAE---LATVSGAKSMK 234
Q+ G+ YL + ++HRD+ N+LV +K+ DFG +K + G K
Sbjct: 124 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK--- 180
Query: 235 GTPY-WMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPP-WSQQYQEVAALFHIGTTKS 291
P WMA E I +++ +D+WS G TV E+ T G P E++++ G
Sbjct: 181 -VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 239
Query: 292 HPPI-PENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327
PPI ++ + KC + D RP EL+
Sbjct: 240 QPPICTIDVY----MIMRKCWMIDADSRPKFRELIIE 272
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-37
Identities = 70/278 (25%), Positives = 127/278 (45%), Gaps = 30/278 (10%)
Query: 69 RKGELIGCGAFGRVYMGM----NLDSGELLAVKQVLIAANFASKEKAQD-HIKELEEEVK 123
++ +G G FG+V + ++GE +AVK + K ++ HI +L++E++
Sbjct: 24 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL--------KPESGGNHIADLKKEIE 75
Query: 124 LLKDLSHPNIVRYLG--TVREEESLNILLEFVPGGSISS-LLGKFGPFPEAVMRTYTKQL 180
+L++L H NIV+Y G T + +++EF+P GS+ L Y Q+
Sbjct: 76 ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQI 135
Query: 181 LLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTP-YW 239
G++YL + +HRD+ N+LV+++ +K+ DFG +K + K + +P +W
Sbjct: 136 CKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFW 195
Query: 240 MAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQEVAALFHIGTTKSHP----- 293
APE + Q+ ++D+WS G T+ E+ T S + + +
Sbjct: 196 YAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT 255
Query: 294 -------PIPENLSVKAKDFLLKCLEKEPDLRPTASEL 324
P P N + + KC E +P R + L
Sbjct: 256 LKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNL 293
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 7e-37
Identities = 74/329 (22%), Positives = 133/329 (40%), Gaps = 82/329 (24%)
Query: 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS-- 129
+G G F V++ ++ + +A+K ++ + E A+D E+KLL+ ++
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMK--IVRGDKVYTEAAED-------EIKLLQRVNDA 75
Query: 130 ---------HPNIVRYLG--TVREEESLNILLEF-VPGGSISSLLGK--FGPFPEAVMRT 175
+I++ L + +++++ F V G ++ +L+ K P ++
Sbjct: 76 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ 135
Query: 176 YTKQLLLGLEYLH-NHGIMHRDIKGANILVD------NKGCIKLADFGASKQVAELATVS 228
+KQLLLGL+Y+H GI+H DIK N+L++ N IK+AD G + E T
Sbjct: 136 ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT-- 193
Query: 229 GAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKP----------------- 271
+ T + +PEV+ ADIWS C + E+ TG
Sbjct: 194 ---NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 250
Query: 272 ------------------PWSQQYQEVAALFHIGTTKSHPPIPENLSVKAK--------- 304
+++ + L + P+ + L+ K K
Sbjct: 251 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEI 310
Query: 305 -DFLLKCLEKEPDLRPTASELLKHPFVTG 332
DFL L+ +P R A L+ HP++
Sbjct: 311 SDFLSPMLQLDPRKRADAGGLVNHPWLKD 339
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-36
Identities = 65/264 (24%), Positives = 111/264 (42%), Gaps = 19/264 (7%)
Query: 70 KGELIGCGAFGRVYMGM-NLDSGELL-AVKQVLIAANFASKEKA--QDHIKELEEEVKLL 125
+ + +G G FG V G + AVK + K +A EL E ++
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL--------KNEANDPALKDELLAEANVM 72
Query: 126 KDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLE 185
+ L +P IVR +G E ES +++E G ++ L + + + Q+ +G++
Sbjct: 73 QQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMK 131
Query: 186 YLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPY-WMAPEV 244
YL +HRD+ N+L+ + K++DFG SK + A++ P W APE
Sbjct: 132 YLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 191
Query: 245 IRQTGHSYSADIWSVGCTVIEMAT-GKPP-WSQQYQEVAALFHIGTTKSHPPIPENLSVK 302
I S +D+WS G + E + G+ P + EV A+ G P +
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG---ERMGCPAGCPRE 248
Query: 303 AKDFLLKCLEKEPDLRPTASELLK 326
D + C + + RP + +
Sbjct: 249 MYDLMNLCWTYDVENRPGFAAVEL 272
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-36
Identities = 72/318 (22%), Positives = 113/318 (35%), Gaps = 65/318 (20%)
Query: 62 MSPPIRWRK---GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKEL 118
P + ELIG G +G VY G LD +AVK V AN +
Sbjct: 6 SEPSLDLDNLKLLELIGRGRYGAVYKGS-LD-ERPVAVK-VFSFANRQNFIN-------- 54
Query: 119 EEEVKLLKDLSHPNIVRYLG-----TVREEESLNILLEFVPGGSISSLLGKFGPFPEAVM 173
E+ + + + H NI R++ T +++E+ P GS+ L +
Sbjct: 55 EKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSC 114
Query: 174 RTYTKQLLLGLEYLH---------NHGIMHRDIKGANILVDNKGCIKLADFGASKQVAEL 224
R + GL YLH I HRD+ N+LV N G ++DFG S ++
Sbjct: 115 R-LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173
Query: 225 ATVSGA------KSMKGTPYWMAPEVIRQT-------GHSYSADIWSVG---------CT 262
V S GT +MAPEV+ D++++G CT
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233
Query: 263 VIEMATGKPPWSQQYQEVAALF--------HIGTTKSHPPIPENLSVKA------KDFLL 308
+ P + +Q + K P PE + K+ +
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293
Query: 309 KCLEKEPDLRPTASELLK 326
C +++ + R TA +
Sbjct: 294 DCWDQDAEARLTAQXAEE 311
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-36
Identities = 74/273 (27%), Positives = 117/273 (42%), Gaps = 23/273 (8%)
Query: 64 PPIRWRKGELIGCGAFGRVYMGM-NLDSGELL--AVKQVLIAANFASKEKAQDHIKELEE 120
R E +G G+FG V G + SG+ + AVK L + E D I
Sbjct: 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVK-CLKPDVLSQPEAMDDFI----R 70
Query: 121 EVKLLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGP-FPEAVMRTYTKQ 179
EV + L H N++R G V + ++ E P GS+ L K F + Y Q
Sbjct: 71 EVNAMHSLDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 129
Query: 180 LLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVA----ELATVSGAKSMKG 235
+ G+ YL + +HRD+ N+L+ + +K+ DFG + + K
Sbjct: 130 VAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK---- 185
Query: 236 TPY-WMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPW-SQQYQEVAALFHIGTTKSH 292
P+ W APE ++ S+++D W G T+ EM T G+ PW ++ L I
Sbjct: 186 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI--LHKIDKEGER 243
Query: 293 PPIPENLSVKAKDFLLKCLEKEPDLRPTASELL 325
P PE+ + +++C +P+ RPT L
Sbjct: 244 LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALR 276
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 5e-36
Identities = 66/260 (25%), Positives = 115/260 (44%), Gaps = 19/260 (7%)
Query: 74 IGCGAFGRVYMGM-NLDSGELL-AVKQVLIAANFASKEKAQDHIK-ELEEEVKLLKDLSH 130
+GCG FG V G+ + ++ A+K + K+ + E+ E +++ L +
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVL--------KQGTEKADTEEMMREAQIMHQLDN 69
Query: 131 PNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGP-FPEAVMRTYTKQLLLGLEYLHN 189
P IVR +G + E+L +++E GG + L P + + Q+ +G++YL
Sbjct: 70 PYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE 128
Query: 190 HGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPY-WMAPEVIRQT 248
+HRD+ N+L+ N+ K++DFG SK + + A+S P W APE I
Sbjct: 129 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 188
Query: 249 GHSYSADIWSVGCTVIEMAT-GKPP-WSQQYQEVAALFHIGTTKSHPPIPENLSVKAKDF 306
S +D+WS G T+ E + G+ P + EV A G P +
Sbjct: 189 KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG---KRMECPPECPPELYAL 245
Query: 307 LLKCLEKEPDLRPTASELLK 326
+ C + + RP + +
Sbjct: 246 MSDCWIYKWEDRPDFLTVEQ 265
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-35
Identities = 67/276 (24%), Positives = 124/276 (44%), Gaps = 28/276 (10%)
Query: 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELL----AVKQVLIAANFASKEKAQDH-IKEL 118
++K +++G GAFG VY G+ + GE + A+K++ +E KE+
Sbjct: 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--------REATSPKANKEI 64
Query: 119 EEEVKLLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISS-LLGKFGPFPEAVMRTYT 177
+E ++ + +P++ R LG ++ ++ + +P G + + + +
Sbjct: 65 LDEAYVMASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC 123
Query: 178 KQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAE---LATVSGAKSMK 234
Q+ G+ YL + ++HRD+ N+LV +K+ DFG +K + G K
Sbjct: 124 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK--- 180
Query: 235 GTPY-WMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPP-WSQQYQEVAALFHIGTTKS 291
P WMA E I +++ +D+WS G TV E+ T G P E++++ G
Sbjct: 181 -VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG---E 236
Query: 292 HPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327
P P ++ ++KC + D RP EL+
Sbjct: 237 RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-35
Identities = 68/267 (25%), Positives = 118/267 (44%), Gaps = 25/267 (9%)
Query: 71 GELIGCGAFGRVYMGM--NLDSGELL-AVKQVLIAANFASKEKAQDHIKELEEEVKLLKD 127
++IG G G V G ++ A+K + A + +++ ++ E ++
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKA--LKAGYTERQR-----RDFLSEASIMGQ 106
Query: 128 LSHPNIVRYLGTVREEESLNILLEFVPGGSISSLL-GKFGPFPEAVMRTYTKQLLLGLEY 186
HPNI+R G V I+ E++ GS+ + L G F + + + G+ Y
Sbjct: 107 FDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRY 166
Query: 187 LHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA----TVSGAKSMKGTPY-WMA 241
L + G +HRD+ N+LVD+ K++DFG S+ + + T +G K P W A
Sbjct: 167 LSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKI----PIRWTA 222
Query: 242 PEVIRQTGHSYSADIWSVGCTVIEMAT-GKPP-WSQQYQEVAALFHIGTTKSHPPIPENL 299
PE I S ++D+WS G + E+ G+ P W+ ++V + G P P
Sbjct: 223 PEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGY---RLPAPMGC 279
Query: 300 SVKAKDFLLKCLEKEPDLRPTASELLK 326
+L C K+ RP S+++
Sbjct: 280 PHALHQLMLDCWHKDRAQRPRFSQIVS 306
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 6e-35
Identities = 70/264 (26%), Positives = 113/264 (42%), Gaps = 23/264 (8%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH 130
+G G +G VY G+ +AVK + KE + +E +E ++K++ H
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTL--------KEDTMEV-EEFLKEAAVMKEIKH 68
Query: 131 PNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGP--FPEAVMRTYTKQLLLGLEYLH 188
PN+V+ LG E I+ EF+ G++ L + V+ Q+ +EYL
Sbjct: 69 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 128
Query: 189 NHGIMHRDIKGANILVDNKGCIKLADFGASKQVA--ELATVSGAKSMKGTPY-WMAPEVI 245
+HRD+ N LV +K+ADFG S+ + +GAK P W APE +
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK----FPIKWTAPESL 184
Query: 246 RQTGHSYSADIWSVGCTVIEMAT-GKPP-WSQQYQEVAALFHIGTTKSHPPIPENLSVKA 303
S +D+W+ G + E+AT G P +V L PE K
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY---RMERPEGCPEKV 241
Query: 304 KDFLLKCLEKEPDLRPTASELLKH 327
+ + C + P RP+ +E+ +
Sbjct: 242 YELMRACWQWNPSDRPSFAEIHQA 265
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 7e-35
Identities = 72/264 (27%), Positives = 115/264 (43%), Gaps = 26/264 (9%)
Query: 71 GELIGCGAFGRVYMGM--NLDSGELL-AVKQVLIAANFASKEKAQDHIK-ELEEEVKLLK 126
G IG G FG V+ G+ + ++ L A+K K D ++ + +E ++
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTC--------KNCTSDSVREKFLQEALTMR 71
Query: 127 DLSHPNIVRYLGTVREEESLNILLEFVPGGSISS-LLGKFGPFPEAVMRTYTKQLLLGLE 185
HP+IV+ +G + E + I++E G + S L + A + Y QL L
Sbjct: 72 QFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA 130
Query: 186 YLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSM---KGTPYWMAP 242
YL + +HRDI N+LV + C+KL DFG S+ + + +K K WMAP
Sbjct: 131 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK----WMAP 186
Query: 243 EVIRQTGHSYSADIWSVGCTVIEMAT-GKPP-WSQQYQEVAALFHIGTTKSHPPIPENLS 300
E I + ++D+W G + E+ G P + +V G P+P N
Sbjct: 187 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG---ERLPMPPNCP 243
Query: 301 VKAKDFLLKCLEKEPDLRPTASEL 324
+ KC +P RP +EL
Sbjct: 244 PTLYSLMTKCWAYDPSRRPRFTEL 267
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 8e-35
Identities = 73/323 (22%), Positives = 138/323 (42%), Gaps = 61/323 (18%)
Query: 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKL 124
R+ + +GCG G V+ ++ D + +A+K+++ + + ++E+ K+
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV----LTDPQSVKHALREI----KI 61
Query: 125 LKDLSHPNIVRYLGTVREEESLNILLEFVPGGS-----ISSLLG-------KFGPFPEAV 172
++ L H NIV+ + S + + + GP E
Sbjct: 62 IRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEH 121
Query: 173 MRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGC-IKLADFGASKQVAELATVSGAK 231
R + QLL GL+Y+H+ ++HRD+K AN+ ++ + +K+ DFG ++ + + G
Sbjct: 122 ARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGH- 180
Query: 232 SMKG---TPYWMAPEVIRQTGHSYSA--DIWSVGCTVIEMATGKP--------------- 271
+ T ++ +P ++ + ++Y+ D+W+ GC EM TGK
Sbjct: 181 -LSEGLVTKWYRSPRLL-LSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLIL 238
Query: 272 -----PWSQQYQEVA--ALFHIGTTKSHPPIP-----ENLSVKAKDFLLKCLEKEPDLRP 319
+ QE+ +I + P P +S +A DFL + L P R
Sbjct: 239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRL 298
Query: 320 TASELLKHPFVTG----DDEDPV 338
TA E L HP+++ DE P+
Sbjct: 299 TAEEALSHPYMSIYSFPMDE-PI 320
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 8e-35
Identities = 71/262 (27%), Positives = 120/262 (45%), Gaps = 23/262 (8%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH 130
+ IG G FG V++G L+ ++ A+K + +E A ++ EE +++ LSH
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDKV-AIKTI--------REGAMSE-EDFIEEAEVMMKLSH 62
Query: 131 PNIVRYLGTVREEESLNILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLLGLEYLHN 189
P +V+ G E+ + ++ EF+ G +S L G F + + G+ YL
Sbjct: 63 PKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 122
Query: 190 HGIMHRDIKGANILVDNKGCIKLADFGASKQVA--ELATVSGAKSMKGTPY-WMAPEVIR 246
++HRD+ N LV IK++DFG ++ V + + +G K P W +PEV
Sbjct: 123 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK----FPVKWASPEVFS 178
Query: 247 QTGHSYSADIWSVGCTVIEMAT-GKPP-WSQQYQEVAALFHIGTTKSHPPIPENLSVKAK 304
+ +S +D+WS G + E+ + GK P ++ EV G P S
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG---FRLYKPRLASTHVY 235
Query: 305 DFLLKCLEKEPDLRPTASELLK 326
+ C + P+ RP S LL+
Sbjct: 236 QIMNHCWRERPEDRPAFSRLLR 257
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 8e-35
Identities = 67/262 (25%), Positives = 112/262 (42%), Gaps = 19/262 (7%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH 130
+G G +G VY G+ +AVK + KE + +E +E ++K++ H
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTL--------KEDTMEV-EEFLKEAAVMKEIKH 275
Query: 131 PNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGP--FPEAVMRTYTKQLLLGLEYLH 188
PN+V+ LG E I+ EF+ G++ L + V+ Q+ +EYL
Sbjct: 276 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 335
Query: 189 NHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPY-WMAPEVIRQ 247
+HR++ N LV +K+ADFG S+ + + A + P W APE +
Sbjct: 336 KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK--FPIKWTAPESLAY 393
Query: 248 TGHSYSADIWSVGCTVIEMAT-GKPP-WSQQYQEVAALFHIGTTKSHPPIPENLSVKAKD 305
S +D+W+ G + E+AT G P +V L PE K +
Sbjct: 394 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY---RMERPEGCPEKVYE 450
Query: 306 FLLKCLEKEPDLRPTASELLKH 327
+ C + P RP+ +E+ +
Sbjct: 451 LMRACWQWNPSDRPSFAEIHQA 472
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-34
Identities = 65/263 (24%), Positives = 112/263 (42%), Gaps = 27/263 (10%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH 130
+ IG G FG V +G G +AVK + K A + E ++ L H
Sbjct: 26 LQTIGKGEFGDVMLGD--YRGNKVAVKCI--------KNDATA--QAFLAEASVMTQLRH 73
Query: 131 PNIVRYLGTV-REEESLNILLEFVPGGSISSLLGKFGP--FPEAVMRTYTKQLLLGLEYL 187
N+V+ LG + E+ L I+ E++ GS+ L G + ++ + +EYL
Sbjct: 74 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 133
Query: 188 HNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPY-WMAPEVIR 246
+ +HRD+ N+LV K++DFG +K+ + T K P W APE +R
Sbjct: 134 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS--TQDTGK----LPVKWTAPEALR 187
Query: 247 QTGHSYSADIWSVGCTVIEMAT-GKPP-WSQQYQEVAALFHIGTTKSHPPIPENLSVKAK 304
+ S +D+WS G + E+ + G+ P ++V G P+
Sbjct: 188 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY---KMDAPDGCPPAVY 244
Query: 305 DFLLKCLEKEPDLRPTASELLKH 327
+ + C + +RP+ +L +
Sbjct: 245 EVMKNCWHLDAAMRPSFLQLREQ 267
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-34
Identities = 71/268 (26%), Positives = 129/268 (48%), Gaps = 28/268 (10%)
Query: 69 RKGELIGCGAFGRVYMGMNLDSGELL----AVKQVLIAANFASKEKAQDH-IKELEEEVK 123
RK +++G G FG V+ G+ + GE + +K + ++K+ + + + +
Sbjct: 16 RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI--------EDKSGRQSFQAVTDHML 67
Query: 124 LLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISS-LLGKFGPFPEAVMRTYTKQLLL 182
+ L H +IVR LG SL ++ +++P GS+ + G ++ + Q+
Sbjct: 68 AIGSLDHAHIVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAK 126
Query: 183 GLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVA---ELATVSGAKSMKGTPY- 238
G+ YL HG++HR++ N+L+ + +++ADFG + + + S AK TP
Sbjct: 127 GMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAK----TPIK 182
Query: 239 WMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPP-WSQQYQEVAALFHIGTTKSHPPIP 296
WMA E I +++ +D+WS G TV E+ T G P + EV L G P
Sbjct: 183 WMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG---ERLAQP 239
Query: 297 ENLSVKAKDFLLKCLEKEPDLRPTASEL 324
+ ++ ++KC + ++RPT EL
Sbjct: 240 QICTIDVYMVMVKCWMIDENIRPTFKEL 267
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-34
Identities = 70/270 (25%), Positives = 124/270 (45%), Gaps = 28/270 (10%)
Query: 69 RKGELIGCGAFGRVYMGM-NLDSGELL---AVKQVLIAANFASKEKAQDHIK-ELEEEVK 123
+ ++IG G FG VY GM SG+ A+K + K + + + E
Sbjct: 47 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL--------KAGYTEKQRVDFLGEAG 98
Query: 124 LLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGP-FPEAVMRTYTKQLLL 182
++ SH NI+R G + + + + I+ E++ G++ L + F + + +
Sbjct: 99 IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAA 158
Query: 183 GLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA----TVSGAKSMKGTPY 238
G++YL N +HRD+ NILV++ K++DFG S+ + + T SG K P
Sbjct: 159 GMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI----PI 214
Query: 239 -WMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPP-WSQQYQEVAALFHIGTTKSHPPI 295
W APE I + ++D+WS G + E+ T G+ P W EV + G P
Sbjct: 215 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG---FRLPT 271
Query: 296 PENLSVKAKDFLLKCLEKEPDLRPTASELL 325
P + +++C ++E RP ++++
Sbjct: 272 PMDCPSAIYQLMMQCWQQERARRPKFADIV 301
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-34
Identities = 71/264 (26%), Positives = 115/264 (43%), Gaps = 22/264 (8%)
Query: 69 RKGELIGCGAFGRVYMGM--NLDSGELL-AVKQVLIAANFASKEKAQDHIK-ELEEEVKL 124
G IG G FG V+ G+ + ++ + A+K K D ++ + +E
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC--------KNCTSDSVREKFLQEALT 444
Query: 125 LKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISS-LLGKFGPFPEAVMRTYTKQLLLG 183
++ HP+IV+ +G + E + I++E G + S L + A + Y QL
Sbjct: 445 MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTA 503
Query: 184 LEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPY-WMAP 242
L YL + +HRDI N+LV + C+KL DFG S+ + + +K P WMAP
Sbjct: 504 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK--LPIKWMAP 561
Query: 243 EVIRQTGHSYSADIWSVGCTVIEMAT--GKPPWSQQYQEVAALFHIGTTKSHPPIPENLS 300
E I + ++D+W G + E+ KP + +V G P+P N
Sbjct: 562 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG---ERLPMPPNCP 618
Query: 301 VKAKDFLLKCLEKEPDLRPTASEL 324
+ KC +P RP +EL
Sbjct: 619 PTLYSLMTKCWAYDPSRRPRFTEL 642
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-34
Identities = 69/262 (26%), Positives = 114/262 (43%), Gaps = 23/262 (8%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH 130
+ +G G FG V +G +AVK + KE + E +E + + LSH
Sbjct: 13 LKELGSGQFGVVKLGK-WKGQYDVAVKMI--------KEGSMSE-DEFFQEAQTMMKLSH 62
Query: 131 PNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGP-FPEAVMRTYTKQLLLGLEYLHN 189
P +V++ G +E + I+ E++ G + + L G + + + G+ +L +
Sbjct: 63 PKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLES 122
Query: 190 HGIMHRDIKGANILVDNKGCIKLADFGASKQVAE--LATVSGAKSMKGTPY-WMAPEVIR 246
H +HRD+ N LVD C+K++DFG ++ V + + G K P W APEV
Sbjct: 123 HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTK----FPVKWSAPEVFH 178
Query: 247 QTGHSYSADIWSVGCTVIEMAT-GKPP-WSQQYQEVAALFHIGTTKSHPPIPENLSVKAK 304
+S +D+W+ G + E+ + GK P EV G P S
Sbjct: 179 YFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQG---HRLYRPHLASDTIY 235
Query: 305 DFLLKCLEKEPDLRPTASELLK 326
+ C + P+ RPT +LL
Sbjct: 236 QIMYSCWHELPEKRPTFQQLLS 257
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-34
Identities = 72/317 (22%), Positives = 134/317 (42%), Gaps = 39/317 (12%)
Query: 71 GELIGCGAFGRVYMGM-NLDSGELL--AVKQVLIAANFASKEKAQDHIK-ELEEEVKLLK 126
+++G G FG V G L S + + A+K + K + + + E ++
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL--------KVGYTEKQRRDFLGEASIMG 101
Query: 127 DLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGP-FPEAVMRTYTKQLLLGLE 185
HPNI+R G V + + + I+ E++ GS+ S L K F + + + G++
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMK 161
Query: 186 YLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA----TVSGAKSMKGTPY-WM 240
YL + G +HRD+ NIL+++ K++DFG + + + T G K P W
Sbjct: 162 YLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKI----PIRWT 217
Query: 241 APEVIRQTGHSYSADIWSVGCTVIEMAT-GKPP-WSQQYQEVAALFHIGTTKSHPPIPEN 298
+PE I + ++D+WS G + E+ + G+ P W Q+V G P P +
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY---RLPPPMD 274
Query: 299 LSVKAKDFLLKCLEKEPDLRPTASEL-------LKHP----FVTGDDEDPVLHASVMKSS 347
+L C +K+ + RP ++ +++P +T P +
Sbjct: 275 CPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNLLLDQSNV 334
Query: 348 EILSPSHVAN-LESLQM 363
+I + + L +
Sbjct: 335 DITTFRTTGDWLNGVWT 351
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-34
Identities = 72/266 (27%), Positives = 122/266 (45%), Gaps = 28/266 (10%)
Query: 71 GELIGCGAFGRVYMGM-NLDSGELL--AVKQVLIAANFASKEKAQDHIK-ELEEEVKLLK 126
++G G FG VY G+ GE + AVK K+ K + E ++K
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTC--------KKDCTLDNKEKFMSEAVIMK 68
Query: 127 DLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGP-FPEAVMRTYTKQLLLGLE 185
+L HP+IV+ +G + EEE I++E P G + L + + Y+ Q+ +
Sbjct: 69 NLDHPHIVKLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMA 127
Query: 186 YLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSM---KGTPYWMAP 242
YL + +HRDI NILV + C+KL DFG S+ + + + + K WM+P
Sbjct: 128 YLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK----WMSP 183
Query: 243 EVIRQTGHSYSADIWSVGCTVIEMAT-GKPP-WSQQYQEVAALFHIGTTKSHPPI-PENL 299
E I + ++D+W + E+ + GK P + + ++V + G P + P L
Sbjct: 184 ESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVL 243
Query: 300 SVKAKDFLLKCLEKEPDLRPTASELL 325
+ +C + +P RP +EL+
Sbjct: 244 Y----TLMTRCWDYDPSDRPRFTELV 265
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 5e-34
Identities = 71/290 (24%), Positives = 123/290 (42%), Gaps = 25/290 (8%)
Query: 52 LSKHISPSVKMSPPIRWRK----GELIGCGAFGRVYMGMNLDSGE---LLAVKQVLIAAN 104
L+ + +V+ E+IG G FG VY G LD+ AVK +
Sbjct: 7 LNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL----- 61
Query: 105 FASKEKAQDH-IKELEEEVKLLKDLSHPNIVRYLGTV-REEESLNILLEFVPGGSISSLL 162
+ + E ++KD SHPN++ LG R E S ++L ++ G + + +
Sbjct: 62 ---NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 118
Query: 163 GKFGP-FPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQV 221
+ + Q+ G++YL + +HRD+ N ++D K +K+ADFG ++ +
Sbjct: 119 RNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 178
Query: 222 AELATVSGAKSMKGT-PY-WMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPP-WSQQY 277
+ S P WMA E ++ + +D+WS G + E+ T G PP
Sbjct: 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 238
Query: 278 QEVAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327
++ G PE + +LKC + ++RP+ SEL+
Sbjct: 239 FDITVYLLQG---RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 285
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 5e-34
Identities = 72/263 (27%), Positives = 113/263 (42%), Gaps = 25/263 (9%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH 130
+G G FG V+MG + + A+K + K L+E +++K L H
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRV-AIKTL--------KPGTMSPEAFLQEA-QVMKKLRH 238
Query: 131 PNIVRYLGTVREEESLNILLEFVPGGSISSLL----GKFGPFPEAVMRTYTKQLLLGLEY 186
+V+ V EE + I+ E++ GS+ L GK+ P+ V Q+ G+ Y
Sbjct: 239 EKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD--MAAQIASGMAY 295
Query: 187 LHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPY-WMAPEVI 245
+ +HRD++ ANILV K+ADFG ++ + + A+ P W APE
Sbjct: 296 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT--ARQGAKFPIKWTAPEAA 353
Query: 246 RQTGHSYSADIWSVGCTVIEMAT-GKPP-WSQQYQEVAALFHIGTTKSHPPIPENLSVKA 303
+ +D+WS G + E+ T G+ P +EV G P P
Sbjct: 354 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPESL 410
Query: 304 KDFLLKCLEKEPDLRPTASELLK 326
D + +C KEP+ RPT L
Sbjct: 411 HDLMCQCWRKEPEERPTFEYLQA 433
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-33
Identities = 72/283 (25%), Positives = 117/283 (41%), Gaps = 41/283 (14%)
Query: 71 GELIGCGAFGRVYMGM--NLDSGE---LLAVKQVLIAANFASKEKAQDHIKELEEEVKLL 125
+G GAFG+V++ NL + L+AVK + KE ++ ++ + E +LL
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL--------KEASESARQDFQREAELL 97
Query: 126 KDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYT-------- 177
L H +IVR+ G E L ++ E++ G ++ L GP + +
Sbjct: 98 TMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGL 157
Query: 178 KQLL-------LGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA-TVSG 229
QLL G+ YL +HRD+ N LV +K+ DFG S+ + G
Sbjct: 158 GQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 217
Query: 230 AKSM---KGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQY-QEVAALF 284
++M + WM PE I + +D+WS G + E+ T GK PW Q E
Sbjct: 218 GRTMLPIR----WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI 273
Query: 285 HIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327
G P + + C ++EP R + ++
Sbjct: 274 TQG---RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 76/334 (22%), Positives = 134/334 (40%), Gaps = 25/334 (7%)
Query: 8 VRRSIVFRTTAESTTDAQTANSPTPFSGGNLVERFNSCIRNSRVLSKHISPSVKMSPPIR 67
V R S + T+ S + N+ + L+ + +V+
Sbjct: 27 VPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGP 86
Query: 68 WRK----GELIGCGAFGRVYMGMNLDSGE---LLAVKQVLIAANFASKEKAQDH-IKELE 119
E+IG G FG VY G LD+ AVK + + +
Sbjct: 87 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--------NRITDIGEVSQFL 138
Query: 120 EEVKLLKDLSHPNIVRYLGTV-REEESLNILLEFVPGGSISSLLGKFGP-FPEAVMRTYT 177
E ++KD SHPN++ LG R E S ++L ++ G + + + + +
Sbjct: 139 TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG 198
Query: 178 KQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGT- 236
Q+ G+++L + +HRD+ N ++D K +K+ADFG ++ + + S
Sbjct: 199 LQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 258
Query: 237 PY-WMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPP-WSQQYQEVAALFHIGTTKSHP 293
P WMA E ++ + +D+WS G + E+ T G PP ++ G
Sbjct: 259 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG---RRL 315
Query: 294 PIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327
PE + +LKC + ++RP+ SEL+
Sbjct: 316 LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-33
Identities = 66/262 (25%), Positives = 110/262 (41%), Gaps = 27/262 (10%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH 130
+ IG G FG V +G G +AVK + K + E ++ L H
Sbjct: 198 LQTIGKGEFGDVMLGD--YRGNKVAVKCI----------KNDATAQAFLAEASVMTQLRH 245
Query: 131 PNIVRYLGTV-REEESLNILLEFVPGGSISSLLGKFGP--FPEAVMRTYTKQLLLGLEYL 187
N+V+ LG + E+ L I+ E++ GS+ L G + ++ + +EYL
Sbjct: 246 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 305
Query: 188 HNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPY-WMAPEVIR 246
+ +HRD+ N+LV K++DFG +K+ + T K P W APE +R
Sbjct: 306 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS--TQDTGK----LPVKWTAPEALR 359
Query: 247 QTGHSYSADIWSVGCTVIEMAT-GKPP-WSQQYQEVAALFHIGTTKSHPPIPENLSVKAK 304
+ S +D+WS G + E+ + G+ P ++V G P+
Sbjct: 360 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY---KMDAPDGCPPAVY 416
Query: 305 DFLLKCLEKEPDLRPTASELLK 326
D + C + RPT +L +
Sbjct: 417 DVMKNCWHLDAATRPTFLQLRE 438
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-33
Identities = 62/269 (23%), Positives = 113/269 (42%), Gaps = 21/269 (7%)
Query: 69 RKGELIGCGAFGRVYMGMNLDSGE---LLAVKQVLIAANFASKEKAQDH-IKELEEEVKL 124
+IG G FG VY G +D + A+K + + ++ E L
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL--------SRITEMQQVEAFLREGLL 75
Query: 125 LKDLSHPNIVRYLGTV-REEESLNILLEFVPGGSISSLLGKFGP-FPEAVMRTYTKQLLL 182
++ L+HPN++ +G + E ++LL ++ G + + + ++ Q+
Sbjct: 76 MRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVAR 135
Query: 183 GLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGT-PY-WM 240
G+EYL +HRD+ N ++D +K+ADFG ++ + + S + P W
Sbjct: 136 GMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT 195
Query: 241 APEVIRQTGHSYSADIWSVGCTVIEMAT-GKPP-WSQQYQEVAALFHIGTTKSHPPIPEN 298
A E ++ + +D+WS G + E+ T G PP ++ G P PE
Sbjct: 196 ALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQG---RRLPQPEY 252
Query: 299 LSVKAKDFLLKCLEKEPDLRPTASELLKH 327
+ +C E +P +RPT L+
Sbjct: 253 CPDSLYQVMQQCWEADPAVRPTFRVLVGE 281
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 3e-33
Identities = 77/324 (23%), Positives = 132/324 (40%), Gaps = 69/324 (21%)
Query: 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKL 124
R++ + IG GA G V + +A+K++ F ++ A+ +EL L
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP--FQNQTHAKRAYREL----VL 77
Query: 125 LKDLSHPNIVRYLGTVREEESLN------ILLEFVPGGSISSLLGKFGPFPEAVMRTYTK 178
+K ++H NI+ L ++SL I++E + ++ ++ M
Sbjct: 78 MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQM--ELDHERMSYLLY 134
Query: 179 QLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPY 238
Q+L G+++LH+ GI+HRD+K +NI+V + +K+ DFG ++ S TPY
Sbjct: 135 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--------SFMMTPY 186
Query: 239 WM-----APEVIRQTGHSYSADIWSVGCTVIEMATGKP---------------------- 271
+ APEVI G+ + DIWSVGC + EM G
Sbjct: 187 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 246
Query: 272 --------PWSQQY---------QEVAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKE 314
P + Y LF + + + +A+D L K L +
Sbjct: 247 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVID 306
Query: 315 PDLRPTASELLKHPFVTG--DDED 336
R + E L+HP++ D +
Sbjct: 307 ASKRISVDEALQHPYINVWYDPSE 330
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-33
Identities = 87/314 (27%), Positives = 140/314 (44%), Gaps = 61/314 (19%)
Query: 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKL 124
P + +G GA+G V ++ SGE +A+K++ F S+ A+ +EL L
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP--FQSEIFAKRAYREL----LL 76
Query: 125 LKDLSHPNIVRYLGTVREEESLN------ILLEFVPGGSISSLLGKFGPFPEAVMRTYTK 178
LK + H N++ L SL +++ F+ + ++G F E ++
Sbjct: 77 LKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIMGL--KFSEEKIQYLVY 133
Query: 179 QLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELAT--VSGAKSMKGT 236
Q+L GL+Y+H+ G++HRD+K N+ V+ +K+ DFG ++ T V T
Sbjct: 134 QMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV-------T 186
Query: 237 PYWMAPEVIRQTGH-SYSADIWSVGCTVIEMATGKP--P---WSQQYQEVAALFHIGT-- 288
++ APEVI H + + DIWSVGC + EM TGK + Q ++ + G
Sbjct: 187 RWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKV--TGVPG 244
Query: 289 ---------------TKSHPPIPE--------NLSVKAKDFLLKCLEKEPDLRPTASELL 325
+S P P S +A D L K LE + D R TA++ L
Sbjct: 245 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQAL 304
Query: 326 KHPFVTG----DDE 335
HPF ++E
Sbjct: 305 THPFFEPFRDPEEE 318
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-33
Identities = 67/260 (25%), Positives = 116/260 (44%), Gaps = 19/260 (7%)
Query: 74 IGCGAFGRVYMGM-NLDSGELL-AVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHP 131
+GCG FG V G+ + ++ A+K + + +E+ E +++ L +P
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKV--LKQGTEKADT-----EEMMREAQIMHQLDNP 396
Query: 132 NIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGP-FPEAVMRTYTKQLLLGLEYLHNH 190
IVR +G + E+L +++E GG + L P + + Q+ +G++YL
Sbjct: 397 YIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK 455
Query: 191 GIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPY-WMAPEVIRQTG 249
+HR++ N+L+ N+ K++DFG SK + + A+S P W APE I
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 515
Query: 250 HSYSADIWSVGCTVIEMAT-GKPP-WSQQYQEVAALFHIGTTKSHPPI-PENLSVKAKDF 306
S +D+WS G T+ E + G+ P + EV A G PP P L
Sbjct: 516 FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELY----AL 571
Query: 307 LLKCLEKEPDLRPTASELLK 326
+ C + + RP + +
Sbjct: 572 MSDCWIYKWEDRPDFLTVEQ 591
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 5e-33
Identities = 70/263 (26%), Positives = 117/263 (44%), Gaps = 23/263 (8%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH 130
+ +G G FG V G +A+K + KE + E EE K++ +LSH
Sbjct: 29 LKELGTGQFGVVKYGK-WRGQYDVAIKMI--------KEGSMSE-DEFIEEAKVMMNLSH 78
Query: 131 PNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGP-FPEAVMRTYTKQLLLGLEYLHN 189
+V+ G ++ + I+ E++ G + + L + F + K + +EYL +
Sbjct: 79 EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 138
Query: 190 HGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA--TVSGAKSMKGTPY-WMAPEVIR 246
+HRD+ N LV+++G +K++DFG S+ V + + G+K P W PEV+
Sbjct: 139 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK----FPVRWSPPEVLM 194
Query: 247 QTGHSYSADIWSVGCTVIEMAT-GKPP-WSQQYQEVAALFHIGTTKSHPPIPENLSVKAK 304
+ S +DIW+ G + E+ + GK P E A G P S K
Sbjct: 195 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG---LRLYRPHLASEKVY 251
Query: 305 DFLLKCLEKEPDLRPTASELLKH 327
+ C ++ D RPT LL +
Sbjct: 252 TIMYSCWHEKADERPTFKILLSN 274
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 6e-33
Identities = 59/278 (21%), Positives = 109/278 (39%), Gaps = 44/278 (15%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELL-------AVKQVLIAANFASKEKAQDHIKELEEEVK 123
E +G G F +++ G+ + G+ +K + + +++ + E
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVL--------DKAHRNYSESFFEAAS 64
Query: 124 LLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGP-FPEAVMRTYTKQLLL 182
++ LSH ++V G + ++ EFV GS+ + L K KQL
Sbjct: 65 MMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAA 124
Query: 183 GLEYLHNHGIMHRDIKGANILVDNKG--------CIKLADFGASKQVAELATVSGAKSMK 234
+ +L + ++H ++ NIL+ + IKL+D G S V K +
Sbjct: 125 AMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP-------KDIL 177
Query: 235 GTPY-WMAPEVIRQTGH-SYSADIWSVGCTVIEMAT-GKPP-WSQQYQEVAALFHIGTTK 290
W+ PE I + + + D WS G T+ E+ + G P + Q +
Sbjct: 178 QERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQL 237
Query: 291 SHPPIPE--NLSVKAKDFLLKCLEKEPDLRPTASELLK 326
P E NL + C++ EPD RP+ +++
Sbjct: 238 PAPKAAELANL-------INNCMDYEPDHRPSFRAIIR 268
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 6e-33
Identities = 75/278 (26%), Positives = 125/278 (44%), Gaps = 39/278 (14%)
Query: 73 LIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPN 132
LIG G FG+VY G+ L G +A+K+ + E +Q +E E E++ L HP+
Sbjct: 46 LIGHGVFGKVYKGV-LRDGAKVALKR-------RTPESSQGI-EEFETEIETLSFCRHPH 96
Query: 133 IVRYLGTVREEESLNILL-EFVPGGSISSLLGKFGPFPEAVMRTYTKQLLL------GLE 185
+V +G E + IL+ +++ G++ L +G + ++ ++L + GL
Sbjct: 97 LVSLIGFCDERNEM-ILIYKYMENGNLKRHL--YGSDLPTMSMSWEQRLEICIGAARGLH 153
Query: 186 YLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELAT--VSGAKSMKGTPYWMAPE 243
YLH I+HRD+K NIL+D K+ DFG SK+ EL +S +KGT ++ PE
Sbjct: 154 YLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTV--VKGTLGYIDPE 211
Query: 244 VIRQTGH-SYSADIWSVGCTVIEMATGKPP--------------WSQQYQEVAALFHIGT 288
G + +D++S G + E+ + W+ + L I
Sbjct: 212 YFI-KGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVD 270
Query: 289 TKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLK 326
I K D +KCL + RP+ ++L
Sbjct: 271 PNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLW 308
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 7e-33
Identities = 72/263 (27%), Positives = 113/263 (42%), Gaps = 25/263 (9%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH 130
+G G FG V+MG + + A+K + K L+E +++K L H
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRV-AIKTL--------KPGTMSPEAFLQEA-QVMKKLRH 321
Query: 131 PNIVRYLGTVREEESLNILLEFVPGGSISSLL----GKFGPFPEAVMRTYTKQLLLGLEY 186
+V+ V EE + I+ E++ GS+ L GK+ P+ V Q+ G+ Y
Sbjct: 322 EKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD--MAAQIASGMAY 378
Query: 187 LHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPY-WMAPEVI 245
+ +HRD++ ANILV K+ADFG ++ + + A+ P W APE
Sbjct: 379 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT--ARQGAKFPIKWTAPEAA 436
Query: 246 RQTGHSYSADIWSVGCTVIEMAT-GKPP-WSQQYQEVAALFHIGTTKSHPPIPENLSVKA 303
+ +D+WS G + E+ T G+ P +EV G P P
Sbjct: 437 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPESL 493
Query: 304 KDFLLKCLEKEPDLRPTASELLK 326
D + +C KEP+ RPT L
Sbjct: 494 HDLMCQCWRKEPEERPTFEYLQA 516
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 7e-33
Identities = 73/279 (26%), Positives = 111/279 (39%), Gaps = 37/279 (13%)
Query: 71 GELIGCGAFGRVYMG----MNLDSGELL-AVKQVLIAANFASKEKAQDH-IKELEEEVKL 124
+G GAFG VY G M D L AVK + E + + E +
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--------PEVCSEQDELDFLMEALI 86
Query: 125 LKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLL-- 182
+ +H NIVR +G + IL+E + GG + S L + P P LL
Sbjct: 87 ISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 146
Query: 183 -----GLEYLHNHGIMHRDIKGANILVDNKG---CIKLADFGASKQVAELA-TVSGAKSM 233
G +YL + +HRDI N L+ G K+ DFG ++ + + G +M
Sbjct: 147 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 206
Query: 234 ---KGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPP-WSQQYQEVAALFHIGT 288
K WM PE + + D WS G + E+ + G P S+ QEV G
Sbjct: 207 LPVK----WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG- 261
Query: 289 TKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327
P+N + +C + +P+ RP + +L+
Sbjct: 262 --GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILER 298
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 8e-33
Identities = 75/282 (26%), Positives = 111/282 (39%), Gaps = 43/282 (15%)
Query: 71 GELIGCGAFGRVYMG----MNLDSGELL-AVKQVLIAANFASKEKAQDH-IKELEEEVKL 124
+G GAFG VY G M D L AVK + E + + E +
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--------PEVCSEQDELDFLMEALI 127
Query: 125 LKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLL--- 181
+ +H NIVR +G + ILLE + GG + S L + P P LL
Sbjct: 128 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 187
Query: 182 ----LGLEYLHNHGIMHRDIKGANILVDNKG---CIKLADFGASKQVAELA-TVSGAKSM 233
G +YL + +HRDI N L+ G K+ DFG ++ + G +M
Sbjct: 188 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAM 247
Query: 234 ---KGTPYWMAPEVIRQ---TGHSYSADIWSVGCTVIEMAT-GKPP-WSQQYQEVAALFH 285
K WM PE + T + D WS G + E+ + G P S+ QEV
Sbjct: 248 LPVK----WMPPEAFMEGIFTSKT---DTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 300
Query: 286 IGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327
G P+N + +C + +P+ RP + +L+
Sbjct: 301 SGGR---MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILER 339
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 8e-33
Identities = 65/282 (23%), Positives = 118/282 (41%), Gaps = 43/282 (15%)
Query: 71 GELIGCGAFGRVYMG----MNLDSGELL-AVKQVLIAANFASKEKAQDH-IKELEEEVKL 124
+G G+FG VY G + D E A+K V E A E E +
Sbjct: 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV--------NEAASMRERIEFLNEASV 81
Query: 125 LKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGP---FPEAVMRTYTKQLL 181
+K+ + ++VR LG V + + +++E + G + S L P + +++
Sbjct: 82 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 141
Query: 182 L-------GLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAEL-ATVSGAKSM 233
G+ YL+ + +HRD+ N +V +K+ DFG ++ + E G K +
Sbjct: 142 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 201
Query: 234 ---KGTPYWMAPEVIRQ---TGHSYSADIWSVGCTVIEMAT-GKPPWSQ-QYQEVAALFH 285
+ WM+PE ++ T +S D+WS G + E+AT + P+ ++V
Sbjct: 202 LPVR----WMSPESLKDGVFTTYS---DVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 254
Query: 286 IGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327
G P+N + + C + P +RP+ E++
Sbjct: 255 EG---GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 9e-33
Identities = 75/283 (26%), Positives = 120/283 (42%), Gaps = 42/283 (14%)
Query: 71 GELIGCGAFGRVYMGM--NLDSGE---LLAVKQVLIAANFASKEKAQDHIKELEEEVKLL 125
+G GAFG+V++ NL + L+AVK + K+ K+ + E +LL
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL--------KDPTLAARKDFQREAELL 71
Query: 126 KDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYT-------- 177
+L H +IV++ G + + L ++ E++ G ++ L GP ++
Sbjct: 72 TNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 131
Query: 178 -KQLL-------LGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAEL-ATVS 228
Q+L G+ YL + +HRD+ N LV +K+ DFG S+ V
Sbjct: 132 LSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV 191
Query: 229 GAKSM---KGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQY-QEVAAL 283
G +M + WM PE I + +D+WS G + E+ T GK PW Q EV
Sbjct: 192 GGHTMLPIR----WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC 247
Query: 284 FHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLK 326
G P + D +L C ++EP R E+ K
Sbjct: 248 ITQG---RVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYK 287
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 1e-32
Identities = 77/328 (23%), Positives = 135/328 (41%), Gaps = 71/328 (21%)
Query: 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKL 124
R++ + IG GA G V + +A+K++ F ++ A+ +EL L
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP--FQNQTHAKRAYREL----VL 114
Query: 125 LKDLSHPNIVRYLGTVREEESLN------ILLEFVPGGSISSLLGKFGPFPEAVMRTYTK 178
+K ++H NI+ L +++L +++E + ++ ++ M
Sbjct: 115 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQM--ELDHERMSYLLY 171
Query: 179 QLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPY 238
Q+L G+++LH+ GI+HRD+K +NI+V + +K+ DFG LA +G M TPY
Sbjct: 172 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-------LARTAGTSFMM-TPY 223
Query: 239 WM-----APEVIRQTGHSYSADIWSVGCTVIEMATGKP---------------------- 271
+ APEVI G+ + DIWSVGC + EM K
Sbjct: 224 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 283
Query: 272 --------PWSQQY---------QEVAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKE 314
P + Y LF + + + +A+D L K L +
Sbjct: 284 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID 343
Query: 315 PDLRPTASELLKHPFVTG----DDEDPV 338
P R + + L+HP++ + +
Sbjct: 344 PAKRISVDDALQHPYINVWYDPAEVEAP 371
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-32
Identities = 72/333 (21%), Positives = 122/333 (36%), Gaps = 93/333 (27%)
Query: 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHP 131
++IG G+FG+V + + +A+K ++ +A + I+ LE K KD +
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALK--MVRNEKRFHRQAAEEIRILEHLRKQDKDNTM- 159
Query: 132 NIVRYLGT---------VREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLL 182
N++ L E S+N L E + KF F ++R + +L
Sbjct: 160 NVIHMLENFTFRNHICMTFELLSMN-LYELIKKN-------KFQGFSLPLVRKFAHSILQ 211
Query: 183 GLEYLHNHGIMHRDIKGANILV--DNKGCIKLADFGASKQVAELATVSGAKSMKGTPY-- 238
L+ LH + I+H D+K NIL+ + IK+ DFG+S + + Y
Sbjct: 212 CLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ----------RVYTYIQ 261
Query: 239 ---WMAPEVIRQTGHSYSADIWSVGCTVIEMAT---------------------GKPPW- 273
+ APEVI + D+WS+GC + E+ T G P
Sbjct: 262 SRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQK 321
Query: 274 -------SQQYQEVAALFHIGTTKSHPPIPENLSVKA----------------------- 303
++ + T + L+
Sbjct: 322 LLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCD 381
Query: 304 ----KDFLLKCLEKEPDLRPTASELLKHPFVTG 332
DFL +CLE +P +R T + L+HP++
Sbjct: 382 DPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRR 414
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 87/314 (27%), Positives = 142/314 (45%), Gaps = 60/314 (19%)
Query: 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKL 124
+R + +G GA+G V ++ +G +A+K++ F S+ A+ +EL +L
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP--FQSELFAKRAYREL----RL 77
Query: 125 LKDLSHPNIVRYLGTVREEESLN------ILLEFVPGGSISSLLGKFGPFPEAVMRTYTK 178
LK + H N++ L +E+L+ +++ F+ G + L+ K E ++
Sbjct: 78 LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLM-KHEKLGEDRIQFLVY 135
Query: 179 QLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELAT--VSGAKSMKGT 236
Q+L GL Y+H GI+HRD+K N+ V+ +K+ DFG ++Q T V T
Sbjct: 136 QMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVV-------T 188
Query: 237 PYWMAPEVI-RQTGHSYSADIWSVGCTVIEMATGKP--P---WSQQYQEVAALFHIGT-- 288
++ APEVI ++ + DIWSVGC + EM TGK Q +E+ + GT
Sbjct: 189 RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKV--TGTPP 246
Query: 289 ---------------TKSHPPIPE--------NLSVKAKDFLLKCLEKEPDLRPTASELL 325
K P + + N S A + L K L + + R TA E L
Sbjct: 247 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEAL 306
Query: 326 KHPFVTG----DDE 335
HP+ +DE
Sbjct: 307 AHPYFESLHDTEDE 320
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 6e-32
Identities = 67/285 (23%), Positives = 117/285 (41%), Gaps = 43/285 (15%)
Query: 71 GELIGCGAFGRVYMGM--NLDSGE---LLAVKQVLIAANFASKEKAQDHIK-ELEEEVKL 124
E +G FG+VY G GE +A+K + K+KA+ ++ E E L
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL--------KDKAEGPLREEFRHEAML 65
Query: 125 LKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYT------- 177
L HPN+V LG V +++ L+++ + G + L P +
Sbjct: 66 RARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSAL 125
Query: 178 --KQLLL-------GLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELAT-V 227
+ G+EYL +H ++H+D+ N+LV +K +K++D G ++V
Sbjct: 126 EPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYK 185
Query: 228 SGAKSM---KGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT--GKPPWSQQYQEVAA 282
S+ + WMAPE I S +DIWS G + E+ + +P Q+V
Sbjct: 186 LLGNSLLPIR----WMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE 241
Query: 283 LFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327
+ P P++ +++C + P RP ++
Sbjct: 242 MIRNR---QVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 283
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 9e-32
Identities = 82/314 (26%), Positives = 144/314 (45%), Gaps = 60/314 (19%)
Query: 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKL 124
P R++ +G GA+G V + +G +AVK+ ++ F S A+ +EL +L
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKK--LSRPFQSIIHAKRTYREL----RL 81
Query: 125 LKDLSHPNIVRYLGTVREEESLN------ILLEFVPGGSISSLLGKFGPFPEAVMRTYTK 178
LK + H N++ L SL ++ + G +++++ K + ++
Sbjct: 82 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIV-KCQKLTDDHVQFLIY 139
Query: 179 QLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELAT--VSGAKSMKGT 236
Q+L GL+Y+H+ I+HRD+K +N+ V+ +K+ DFG ++ A+ T V+ T
Sbjct: 140 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVA-------T 192
Query: 237 PYWMAPEVIRQTGH-SYSADIWSVGCTVIEMATGKP--P---WSQQYQEVAALFHIGT-- 288
++ APE++ H + + DIWSVGC + E+ TG+ P Q + + L +GT
Sbjct: 193 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL--VGTPG 250
Query: 289 ---------------TKSHPPIPE--------NLSVKAKDFLLKCLEKEPDLRPTASELL 325
+S +P+ + A D L K L + D R TA++ L
Sbjct: 251 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 310
Query: 326 KHPFVTG----DDE 335
H + DDE
Sbjct: 311 AHAYFAQYHDPDDE 324
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-31
Identities = 69/264 (26%), Positives = 110/264 (41%), Gaps = 25/264 (9%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH 130
E +G G FG V+MG ++ AVK + K+ + E L+K L H
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTKV-AVKSL--------KQGSMSP-DAFLAEANLMKQLQH 67
Query: 131 PNIVRYLGTVREEESLNILLEFVPGGSISSLL--GKFGPFPEAVMRTYTKQLLLGLEYLH 188
+VR V +E + I+ E++ GS+ L + Q+ G+ ++
Sbjct: 68 QRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 189 NHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA--TVSGAKSMKGTPY-WMAPEVI 245
+HRD++ ANILV + K+ADFG ++ + + GAK P W APE I
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK----FPIKWTAPEAI 182
Query: 246 RQTGHSYSADIWSVGCTVIEMAT-GKPP-WSQQYQEVAALFHIGTTKSHPPIPENLSVKA 303
+ +D+WS G + E+ T G+ P EV G P+N +
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG---YRMVRPDNCPEEL 239
Query: 304 KDFLLKCLEKEPDLRPTASELLKH 327
+ C ++ P+ RPT L
Sbjct: 240 YQLMRLCWKERPEDRPTFDYLRSV 263
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 59/281 (20%), Positives = 108/281 (38%), Gaps = 40/281 (14%)
Query: 71 GELIGCGAFGRVYMGM--NLDSGELL-AVKQVLIAANFASKEKA--QDHIKELEEEVKLL 125
G ++G G FG V D + AVK + K I+E E +
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKML--------KADIIASSDIEEFLREAACM 79
Query: 126 KDLSHPNIVRYLGTVREEESLN------ILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQ 179
K+ HP++ + +G + ++L F+ G + + L +
Sbjct: 80 KEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLP-LQT 138
Query: 180 LLL-------GLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELAT-VSGAK 231
L+ G+EYL + +HRD+ N ++ + +ADFG S+++ G
Sbjct: 139 LVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCA 198
Query: 232 SM---KGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPW-SQQYQEVAALFHI 286
S K W+A E + ++ +D+W+ G T+ E+ T G+ P+ + E+
Sbjct: 199 SKLPVK----WLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG 254
Query: 287 GTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327
G P + D + +C +P RP+ + L
Sbjct: 255 GN---RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRME 292
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 69/350 (19%), Positives = 121/350 (34%), Gaps = 102/350 (29%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLK 126
R+ LIG G+FG+V + E +A+K +I A +AQ ++ LE K
Sbjct: 55 RYEIDSLIGKGSFGQVVKAYDRVEQEWVAIK--IIKNKKAFLNQAQIEVRLLELMNKHDT 112
Query: 127 DLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLG----------KFGPFPEAVMRTY 176
++ + IV L ++ E +L F + R +
Sbjct: 113 EMKY-YIVHLKRHFMFRNHLCLVFE---------MLSYNLYDLLRNTNFRGVSLNLTRKF 162
Query: 177 TKQLLLGLEYLHNH--GIMHRDIKGANILVDN--KGCIKLADFGASKQVAELATVSGAKS 232
+Q+ L +L I+H D+K NIL+ N + IK+ DFG+S Q+ +
Sbjct: 163 AQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ--------- 213
Query: 233 MKGTPY-----WMAPEVIRQTGHSYSADIWSVGCTVIEMAT------------------- 268
+ Y + +PEV+ + + D+WS+GC ++EM T
Sbjct: 214 -RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVE 272
Query: 269 --GKPP-------------------------WSQQYQEV------AALFHIGTTKSHPPI 295
G PP ++ + L +I ++ P
Sbjct: 273 VLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPG 332
Query: 296 PENLSVKAK---------DFLLKCLEKEPDLRPTASELLKHPFVTGDDED 336
D +L+ L+ +P R L+H F ++
Sbjct: 333 GRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADE 382
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-31
Identities = 73/314 (23%), Positives = 131/314 (41%), Gaps = 56/314 (17%)
Query: 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKL 124
R+ IG GA+G V + + +A+K++ + F + Q ++E+ K+
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI---SPFEHQTYCQRTLREI----KI 78
Query: 125 LKDLSHPNIVRYLGTVR--EEESLN---ILLEFVPGGSISSL--LGKFGPFPEAVMRTYT 177
L H NI+ +R E + I+ + + + L L K + +
Sbjct: 79 LLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME----TDLYKLLKTQHLSNDHICYFL 134
Query: 178 KQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKG-- 235
Q+L GL+Y+H+ ++HRD+K +N+L++ +K+ DFG ++ +G +
Sbjct: 135 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF--LTEYV 192
Query: 236 -TPYWMAPEVI-RQTGHSYSADIWSVGCTVIEMATGKP--------------------PW 273
T ++ APE++ G++ S DIWSVGC + EM + +P P
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 252
Query: 274 SQQYQEVA---ALFHIGTTKSHPPIP-----ENLSVKAKDFLLKCLEKEPDLRPTASELL 325
+ + A ++ + +P N KA D L K L P R + L
Sbjct: 253 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 312
Query: 326 KHPFVTG----DDE 335
HP++ DE
Sbjct: 313 AHPYLEQYYDPSDE 326
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 5e-31
Identities = 40/282 (14%), Positives = 81/282 (28%), Gaps = 50/282 (17%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLK 126
R+R G + + ++ +A+ V D ++E L
Sbjct: 32 RYRLLIFHGGVPPLQFWQALDTALDRQVALTFVD-----PQGVLPDDVLQETLSRTLRLS 86
Query: 127 DLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEY 186
+ P + R L V ++ E++ GGS+ + P P +R + L +
Sbjct: 87 RIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADT-SPSPVGAIR-AMQSLAAAADA 144
Query: 187 LHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIR 246
H G+ + + V G + LA M
Sbjct: 145 AHRAGVALSIDHPSRVRVSIDGDVVLAYPAT----------------------MPDA--- 179
Query: 247 QTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPP--------IPEN 298
+ DI +G ++ + + P + T P IP
Sbjct: 180 ----NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQ 235
Query: 299 LSVKAKDFLLKCLEKEPDLRP--TASELLKHPFVTGDDEDPV 338
+S + ++ + +R T L++ D + +
Sbjct: 236 IS----AVAARSVQGDGGIRSASTLLNLMQQATAVADRTEVL 273
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 5e-31
Identities = 72/277 (25%), Positives = 116/277 (41%), Gaps = 33/277 (11%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELL---AVKQVLIAANFASKEKAQDHIKELEEEVKLLKD 127
G+++G G FG V G AVK + N + +E +E E +KD
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKT-MKLDNSSQREI-----EEFLSEAACMKD 92
Query: 128 LSHPNIVRYLGTVREEESLN-----ILLEFVPGGSISSLL------GKFGPFPEAVMRTY 176
SHPN++R LG E S ++L F+ G + + L P + +
Sbjct: 93 FSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKF 152
Query: 177 TKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELAT-VSGAKSM-- 233
+ LG+EYL N +HRD+ N ++ + + +ADFG SK++ G +
Sbjct: 153 MVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMP 212
Query: 234 -KGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPP-WSQQYQEVAALFHIGTTK 290
K W+A E + ++ +D+W+ G T+ E+AT G P Q E+ G
Sbjct: 213 VK----WIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHG--- 265
Query: 291 SHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327
PE+ + + + C +P RPT S L
Sbjct: 266 HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 6e-31
Identities = 76/322 (23%), Positives = 135/322 (41%), Gaps = 64/322 (19%)
Query: 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKL 124
++ L+G GA+G V + +GE++A+K++ F A ++E+ K+
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI---EPFDKPLFALRTLREI----KI 62
Query: 125 LKDLSHPNIVRYLGTVREEESLN-----ILLEFVP---GGSISSLLGKFGPFPEAVMRTY 176
LK H NI+ R + N I+ E + IS+ + ++ +
Sbjct: 63 LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIST-----QMLSDDHIQYF 117
Query: 177 TKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKG- 235
Q L ++ LH ++HRD+K +N+L+++ +K+ DFG ++ + E A + + +
Sbjct: 118 IYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 236 --TPY----WM-APEVIRQTGHSYSA--DIWSVGCTVIEMATGKP--------------- 271
+ W APEV+ T YS D+WS GC + E+ +P
Sbjct: 178 GMVEFVATRWYRAPEVM-LTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIF 236
Query: 272 -----PWSQQYQEV----AALFHIGTTKSHPPIP-----ENLSVKAKDFLLKCLEKEPDL 317
P S A +I + +P P ++ K D L + L +P
Sbjct: 237 GIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAK 296
Query: 318 RPTASELLKHPFVTG----DDE 335
R TA E L+HP++ +DE
Sbjct: 297 RITAKEALEHPYLQTYHDPNDE 318
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 7e-31
Identities = 66/293 (22%), Positives = 112/293 (38%), Gaps = 51/293 (17%)
Query: 71 GELIGCGAFGRVYMGM--NLDSGE---LLAVKQVLIAANFASKEKAQDH-IKELEEEVKL 124
IG GAFGRV+ L E ++AVK + KE+A + + E L
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML--------KEEASADMQADFQREAAL 103
Query: 125 LKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLL----------------GKFGPF 168
+ + +PNIV+ LG + + +L E++ G ++ L
Sbjct: 104 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 163
Query: 169 PEAVMRTYTKQLLL--------GLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQ 220
+ L G+ YL +HRD+ N LV +K+ADFG S+
Sbjct: 164 SSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRN 223
Query: 221 VAELAT-VSGAKSM---KGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQ 275
+ + + WM PE I ++ +D+W+ G + E+ + G P+
Sbjct: 224 IYSADYYKADGNDAIPIR----WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279
Query: 276 -QYQEVAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327
++EV G PEN ++ + + C K P RP+ + +
Sbjct: 280 MAHEEVIYYVRDGN---ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 66/293 (22%), Positives = 119/293 (40%), Gaps = 55/293 (18%)
Query: 71 GELIGCGAFGRVYMG--MNLDSGE---LLAVKQVLIAANFASKEKA-QDHIKELEEEVKL 124
G+ +G GAFG+V L + +AVK + K A + L E+K+
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML--------KPSAHLTEREALMSELKV 79
Query: 125 LKDL-SHPNIVRYLGTVREEESLNILLEFVPGGSISSLL-----------GKFGPFPEAV 172
L L +H NIV LG ++ E+ G + + L +
Sbjct: 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 173 MRTYTKQLLL-------GLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAE-- 223
+ + LL G+ +L + +HRD+ NIL+ + K+ DFG ++ +
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 224 --LATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-------GKPPWS 274
+ + +K WMAPE I +++ +D+WS G + E+ + G P S
Sbjct: 200 NYVVKGNARLPVK----WMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255
Query: 275 QQYQEVAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327
+ Y+ + F + PE+ + D + C + +P RPT ++++
Sbjct: 256 KFYKMIKEGFRM-------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 76/343 (22%), Positives = 122/343 (35%), Gaps = 108/343 (31%)
Query: 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH- 130
+G G FGRV + ++D+ + AVK ++ A+ E +LK + +
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKYYAVK--VVRNIKKYTRSAKI-------EADILKKIQND 91
Query: 131 ----PNIVRYLGT---------VREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYT 177
NIV+Y G + E + L E + + F ++ Y
Sbjct: 92 DINNNNIVKYHGKFMYYDHMCLIFEPLGPS-LYEIITRN-------NYNGFHIEDIKLYC 143
Query: 178 KQLLLGLEYLHNHGIMHRDIKGANILVDNKGC-------------------------IKL 212
++L L YL + H D+K NIL+D+ IKL
Sbjct: 144 IEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKL 203
Query: 213 ADFGASKQVAELAT--VSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGK 270
DFG + ++ ++ T + APEVI G S+D+WS GC + E+ TG
Sbjct: 204 IDFGCATFKSDYHGSIIN-------TRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS 256
Query: 271 P---------------------PWS--QQYQEVAALFHIGTTKSHPPIPENLSVKA---- 303
P + + + ++ + PEN S
Sbjct: 257 LLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKH 316
Query: 304 ----------------KDFLLKCLEKEPDLRPTASELLKHPFV 330
DFL L+ +P LRP+ +ELLKH F+
Sbjct: 317 VKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 119 bits (302), Expect = 2e-30
Identities = 63/286 (22%), Positives = 115/286 (40%), Gaps = 42/286 (14%)
Query: 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEV 122
G +G G FG VY G ++ +AVK++ + ++ + ++ ++E+
Sbjct: 28 DERPISVGGNKMGEGGFGVVYKGY-VN-NTTVAVKKLAAMVDITTE---ELK-QQFDQEI 81
Query: 123 KLLKDLSHPNIVRYLGTVREEESLNILL--EFVPGGSISSLLGKFGPFPEAVM--RTYTK 178
K++ H N+V LG + + L L ++P GS+ L + K
Sbjct: 82 KVMAKCQHENLVELLGFSSDGDDL--CLVYVYMPNGSLLDRL--SCLDGTPPLSWHMRCK 137
Query: 179 QLL---LGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSM-- 233
G+ +LH + +HRDIK ANIL+D K++DFG ++ + A+++
Sbjct: 138 IAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEK-----FAQTVMT 192
Query: 234 ---KGTPYWMAPEVIRQTGHSYS-ADIWSVGCTVIEMATGKPPWSQQYQEVA----ALFH 285
GT +MAPE + G +DI+S G ++E+ TG P + +
Sbjct: 193 SRIVGTTAYMAPEAL--RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEI 250
Query: 286 IGTTKSHPPI--------PENLSVKAKDFLLKCLEKEPDLRPTASE 323
K+ +CL ++ + RP +
Sbjct: 251 EDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKK 296
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-30
Identities = 74/290 (25%), Positives = 123/290 (42%), Gaps = 41/290 (14%)
Query: 58 PSVKMSPPIRWRK------------GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANF 105
P + P W K + +G G FG V+M ++ AVK +
Sbjct: 168 PCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTM------ 220
Query: 106 ASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLL--- 162
K + + E ++K L H +V+ V +E + I+ EF+ GS+ L
Sbjct: 221 --KPGSMSV-EAFLAEANVMKTLQHDKLVKLHAVV-TKEPIYIITEFMAKGSLLDFLKSD 276
Query: 163 -GKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQV 221
G P P+ + ++ Q+ G+ ++ +HRD++ ANILV K+ADFG ++ +
Sbjct: 277 EGSKQPLPKLID--FSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVI 334
Query: 222 AELA--TVSGAKSMKGTPY-WMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPP-WSQQ 276
+ GAK P W APE I + +D+WS G ++E+ T G+ P
Sbjct: 335 EDNEYTAREGAK----FPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS 390
Query: 277 YQEVAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLK 326
EV G P PEN + + +++C + P+ RPT +
Sbjct: 391 NPEVIRALERG---YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 437
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-30
Identities = 78/288 (27%), Positives = 127/288 (44%), Gaps = 46/288 (15%)
Query: 71 GELIGCGAFGRVYMG--MNLDSGELL---AVKQVLIAANFASKEKAQDH-IKELEEEVKL 124
G+ +G GAFG+V +D AVK + KE A + L E+K+
Sbjct: 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--------KEGATHSEHRALMSELKI 83
Query: 125 LKDL-SHPNIVRYLGTV-REEESLNILLEFVPGGSISSLL----GKFGPFPEAVMRTYTK 178
L + H N+V LG + L +++EF G++S+ L +F P+ A Y
Sbjct: 84 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 143
Query: 179 QLLL------------GLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAE--- 223
L L G+E+L + +HRD+ NIL+ K +K+ DFG ++ + +
Sbjct: 144 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 203
Query: 224 -LATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWS--QQYQE 279
+ +K WMAPE I ++ +D+WS G + E+ + G P+ + +E
Sbjct: 204 YVRKGDARLPLK----WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 259
Query: 280 VAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327
GT P+ + + +L C EP RPT SEL++H
Sbjct: 260 FCRRLKEGT---RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-30
Identities = 68/318 (21%), Positives = 119/318 (37%), Gaps = 56/318 (17%)
Query: 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHI---KELEEE 121
+ I G++G V G++ G +A+K+V + K + E
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLRE 79
Query: 122 VKLLKDLSHPNIVRYLGTVR--EEESLN---ILLEFVPGGSISSLLGKFGPFPEAVMRTY 176
++LL HPNI+ EE +++ ++ E + + + ++ +
Sbjct: 80 IRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYF 139
Query: 177 TKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA-TVSGAKSMKG 235
+LLGL LH G++HRD+ NIL+ + I + DF LA + +
Sbjct: 140 MYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFN-------LAREDTADANKTH 192
Query: 236 ---TPYWMAPEVI-RQTGHSYSADIWSVGCTVIEMATGKP--PWS---QQYQEVAALFHI 286
++ APE++ + G + D+WS GC + EM K S Q ++ + +
Sbjct: 193 YVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEV--V 250
Query: 287 GT------------------TKSHPPIPE--------NLSVKAKDFLLKCLEKEPDLRPT 320
GT S +P A D + K LE P R +
Sbjct: 251 GTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRIS 310
Query: 321 ASELLKHPFVTG--DDED 336
+ L+HP+ D D
Sbjct: 311 TEQALRHPYFESLFDPLD 328
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 7e-30
Identities = 72/294 (24%), Positives = 130/294 (44%), Gaps = 53/294 (18%)
Query: 71 GELIGCGAFGRVYMG--MNLDSGE---LLAVKQVLIAANFASKEKAQDH-IKELEEEVKL 124
G+ +G G FG+V +L +AVK + KE A +++L E +
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML--------KENASPSELRDLLSEFNV 79
Query: 125 LKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYT------- 177
LK ++HP++++ G ++ L +++E+ GS+ L + + +
Sbjct: 80 LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139
Query: 178 ----------KQLLL-------GLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQ 220
L+ G++YL ++HRD+ NILV +K++DFG S+
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRD 199
Query: 221 VAELAT-VSGAKSM---KGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQ 275
V E + V ++ K WMA E + ++ +D+WS G + E+ T G P
Sbjct: 200 VYEEDSYVKRSQGRIPVK----WMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP--- 252
Query: 276 QYQEVAA--LFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327
Y + LF++ T P+N S + +L+C ++EPD RP +++ K
Sbjct: 253 -YPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 8e-30
Identities = 62/285 (21%), Positives = 105/285 (36%), Gaps = 43/285 (15%)
Query: 71 GELIGCGAFGRVYMG----MNLDSGELL-AVKQVLIAANFASKEKAQDH-IKELEEEVKL 124
G+ +G GAFG+V + + L AVK + K A + L E+K+
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML--------KSTAHADEKEALMSELKI 102
Query: 125 LKDL-SHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLL- 182
+ L H NIV LG + ++ E+ G + + L + E
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAS 162
Query: 183 -------------GLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAE----LA 225
G+ +L + +HRD+ N+L+ N K+ DFG ++ + +
Sbjct: 163 TRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222
Query: 226 TVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPW--SQQYQEVAA 282
+ +K WMAPE I ++ +D+WS G + E+ + G P+ +
Sbjct: 223 KGNARLPVK----WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK 278
Query: 283 LFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327
L G P + C EP RPT ++
Sbjct: 279 LVKDGY---QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 9e-30
Identities = 76/365 (20%), Positives = 126/365 (34%), Gaps = 101/365 (27%)
Query: 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKL 124
P R+ LIG G++G V + ++A+K++L F + ++E+ +
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV--FEDLIDCKRILREI----AI 105
Query: 125 LKDLSHPNIVRYLGTVREEESLN-----ILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQ 179
L L+H ++V+ L V ++ ++LE L E ++T
Sbjct: 106 LNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYN 164
Query: 180 LLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYW 239
LL+G++Y+H+ GI+HRD+K AN LV+ +K+ DFG ++ V + +
Sbjct: 165 LLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDD 224
Query: 240 M-------------------------APEVI-RQTGHSYSADIWSVGCTVIEM------- 266
M APE+I Q ++ + D+WS+GC E+
Sbjct: 225 MNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284
Query: 267 ----ATGKP-------------------PWSQQYQEVAALFHI----GT----------- 288
A P L I GT
Sbjct: 285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEK 344
Query: 289 ------TKSHPPIPE--------NLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTG-- 332
+ P S A L + L P+ R T +E L HPF
Sbjct: 345 EDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR 404
Query: 333 --DDE 335
+ E
Sbjct: 405 IAEVE 409
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 71/344 (20%), Positives = 117/344 (34%), Gaps = 91/344 (26%)
Query: 72 ELIGCGAFGRVYMGM-NLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH 130
+G G FG+V + + +A+K +I +E A+ I L++ + K+
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALK--IIRNVGKYREAARLEINVLKKIKEKDKENKF 82
Query: 131 PNIVRYLGT---------VREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLL 181
V E N EF+ F P+P +R QL
Sbjct: 83 -LCVLMSDWFNFHGHMCIAFELLGKN-TFEFLKEN-------NFQPYPLPHVRHMAYQLC 133
Query: 182 LGLEYLHNHGIMHRDIKGANILVDNKGC-------------------IKLADFGASKQVA 222
L +LH + + H D+K NIL N I++ADFG++
Sbjct: 134 HALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDH 193
Query: 223 ELAT--VSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKP--------- 271
E T V+ T ++ PEVI + G + D+WS+GC + E G
Sbjct: 194 EHHTTIVA-------TRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246
Query: 272 --------------------PWSQQYQEVAALFHIGTTKSHPPIPENLSVKA-------- 303
+ + + ++ ++ +K+
Sbjct: 247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLE 306
Query: 304 ----KDFLLKCLEKEPDLRPTASELLKHPFVTGD-DEDPVLHAS 342
D + + LE +P R T +E L HPF G E+ H S
Sbjct: 307 HVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTS 350
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 5e-29
Identities = 72/291 (24%), Positives = 122/291 (41%), Gaps = 52/291 (17%)
Query: 71 GELIGCGAFGRVYMGM--NLDSGELL-----AVKQVLIAANFASKEKAQDH-IKELEEEV 122
G+ +G GAFG+V M +D + AVK + K+ A + + +L E+
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML--------KDDATEKDLSDLVSEM 91
Query: 123 KLLKDL-SHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYT---- 177
+++K + H NI+ LG ++ L +++E+ G++ L P
Sbjct: 92 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 178 -----KQLLL-------GLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAE-- 223
K L+ G+EYL + +HRD+ N+LV +K+ADFG ++ +
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 224 --LATVSGAKSMKGTPYWMAPEVIRQTGHSYSA--DIWSVGCTVIEMAT-GKPPWSQQYQ 278
T +G +K WMAPE + Y+ D+WS G + E+ T G P Y
Sbjct: 212 YYKKTTNGRLPVK----WMAPEALFD--RVYTHQSDVWSFGVLMWEIFTLGGSP----YP 261
Query: 279 EVAA--LFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327
+ LF + P N + + + C P RPT +L++
Sbjct: 262 GIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 7e-29
Identities = 64/295 (21%), Positives = 114/295 (38%), Gaps = 54/295 (18%)
Query: 71 GELIGCGAFGRVYMGM--NLDSGE---LLAVKQVLIAANFASKEKA-QDHIKELEEEVKL 124
G+++G GAFG+V + +AVK + KEKA + L E+K+
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML--------KEKADSSEREALMSELKM 101
Query: 125 LKDL-SHPNIVRYLGTVREEESLNILLEFVPGGSISSLL----------------GKFGP 167
+ L SH NIV LG + ++ E+ G + + L K
Sbjct: 102 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 161
Query: 168 FPEAVMRTYTKQLLL-------GLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQ 220
E + + LL G+E+L +HRD+ N+LV + +K+ DFG ++
Sbjct: 162 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARD 221
Query: 221 VAE----LATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQ 275
+ + + +K WMAPE + + ++ +D+WS G + E+ + G P
Sbjct: 222 IMSDSNYVVRGNARLPVK----WMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP--- 274
Query: 276 QYQEVAA---LFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327
Y + + + P + + + C + RP+ L
Sbjct: 275 -YPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 328
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 7e-29
Identities = 70/291 (24%), Positives = 121/291 (41%), Gaps = 52/291 (17%)
Query: 71 GELIGCGAFGRVYMGM--NLDSGELL-----AVKQVLIAANFASKEKAQDH-IKELEEEV 122
G+ +G G FG+V M +D + AVK + K+ A + + +L E+
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML--------KDDATEKDLSDLVSEM 137
Query: 123 KLLKDL-SHPNIVRYLGTVREEESLNILLEFVPGGSISSLL--------GKFGPFPEAVM 173
+++K + H NI+ LG ++ L +++E+ G++ L
Sbjct: 138 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 197
Query: 174 RTYTKQLLL--------GLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAE-- 223
T + L+ G+EYL + +HRD+ N+LV +K+ADFG ++ +
Sbjct: 198 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 257
Query: 224 --LATVSGAKSMKGTPYWMAPEVIRQTGHSYSA--DIWSVGCTVIEMAT-GKPPWSQQYQ 278
T +G +K WMAPE + Y+ D+WS G + E+ T G P Y
Sbjct: 258 YYKKTTNGRLPVK----WMAPEALFD--RVYTHQSDVWSFGVLMWEIFTLGGSP----YP 307
Query: 279 EVAA--LFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327
+ LF + P N + + + C P RPT +L++
Sbjct: 308 GIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 72/305 (23%), Positives = 122/305 (40%), Gaps = 47/305 (15%)
Query: 55 HISPSVKMSPPIRWRK---------GELIGCGAFGRVYMGM-NLDSGELL-AVKQVLIAA 103
H K +P ++IG G FG+V D + A+K++
Sbjct: 5 HHHHHGKNNPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM---- 60
Query: 104 NFASKEKA-QDHIKELEEEVKLLKDL-SHPNIVRYLGTVREEESLNILLEFVPGGSISSL 161
KE A +D ++ E+++L L HPNI+ LG L + +E+ P G++
Sbjct: 61 ----KEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDF 116
Query: 162 L---------GKFGPFPEAVMRTYTKQLLL-------GLEYLHNHGIMHRDIKGANILVD 205
L F ++QLL G++YL +HRD+ NILV
Sbjct: 117 LRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG 176
Query: 206 NKGCIKLADFGASKQVAELATVSGAKSMKGTPY-WMAPEVIRQTGHSYSADIWSVGCTVI 264
K+ADFG S+ + + P WMA E + + ++ ++D+WS G +
Sbjct: 177 ENYVAKIADFGLSRGQEVYVKKTMGR----LPVRWMAIESLNYSVYTTNSDVWSYGVLLW 232
Query: 265 EMAT--GKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTAS 322
E+ + G P E+ G P N + D + +C ++P RP+ +
Sbjct: 233 EIVSLGGTPYCGMTCAELYEKLPQGYRL---EKPLNCDDEVYDLMRQCWREKPYERPSFA 289
Query: 323 ELLKH 327
++L
Sbjct: 290 QILVS 294
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 74/334 (22%), Positives = 119/334 (35%), Gaps = 92/334 (27%)
Query: 72 ELIGCGAFGRVYMGMNLDSG-ELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH 130
+ +G GAFG+V ++ +G +AVK ++ E A+ I+ LE + +
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVAVK--IVKNVDRYCEAARSEIQVLEHLNTTDPNSTF 77
Query: 131 PNIVRYLGTVREEESLNILLEFVPGGSISSLLG----------KFGPFPEAVMRTYTKQL 180
V+ L + I+ E LLG F PF +R Q+
Sbjct: 78 -RCVQMLEWFEHHGHICIVFE---------LLGLSTYDFIKENGFLPFRLDHIRKMAYQI 127
Query: 181 LLGLEYLHNHGIMHRDIKGANILVDNKGC-------------------IKLADFGASKQV 221
+ +LH++ + H D+K NIL IK+ DFG++
Sbjct: 128 CKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYD 187
Query: 222 AELAT--VSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKP-------- 271
E + VS T ++ APEVI G S D+WS+GC +IE G
Sbjct: 188 DEHHSTLVS-------TRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240
Query: 272 ---------------------PWSQQYQEVAALFHIGTT------KSHPPIPENLSVKAK 304
+ + + ++ ++ P+ E + +
Sbjct: 241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDV 300
Query: 305 ------DFLLKCLEKEPDLRPTASELLKHPFVTG 332
D + K LE +P R T E LKHPF
Sbjct: 301 EHERLFDLIQKMLEYDPAKRITLREALKHPFFDL 334
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-28
Identities = 75/323 (23%), Positives = 132/323 (40%), Gaps = 56/323 (17%)
Query: 45 CIRNSRVLSKHISPS-VKMSPPIRW---RK----GELIGCGAFGRVYMG--MNLDSGE-- 92
N S ++ RW R G+ +G GAFG+V + + LD +
Sbjct: 40 TTENLYFQGMLAGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPN 99
Query: 93 ---LLAVKQVLIAANFASKEKAQDH-IKELEEEVKLLKDL-SHPNIVRYLGTVREEESLN 147
+AVK + K A + + +L E++++K + H NI+ LG ++ L
Sbjct: 100 RVTKVAVKML--------KSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLY 151
Query: 148 ILLEFVPGGSISSLL---------GKFGPFPEAVMRTYTKQLLL-------GLEYLHNHG 191
+++E+ G++ L + P + +K L+ G+EYL +
Sbjct: 152 VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK 211
Query: 192 IMHRDIKGANILVDNKGCIKLADFGASKQVAELAT-VSGAKSM---KGTPYWMAPEVIRQ 247
+HRD+ N+LV +K+ADFG ++ + + K WMAPE +
Sbjct: 212 CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK----WMAPEALFD 267
Query: 248 TGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQEVAA--LFHIGTTKSHPPIPENLSVKAK 304
+++ +D+WS G + E+ T G P Y V LF + P N + +
Sbjct: 268 RIYTHQSDVWSFGVLLWEIFTLGGSP----YPGVPVEELFKLLKEGHRMDKPSNCTNELY 323
Query: 305 DFLLKCLEKEPDLRPTASELLKH 327
+ C P RPT +L++
Sbjct: 324 MMMRDCWHAVPSQRPTFKQLVED 346
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 7e-28
Identities = 74/357 (20%), Positives = 125/357 (35%), Gaps = 93/357 (26%)
Query: 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKL 124
P + LIG G++G VY+ + ++ + +A+K+V F + ++E+ +
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM--FEDLIDCKRILREI----TI 78
Query: 125 LKDLSHPNIVRYLGTVREEESLN-----ILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQ 179
L L I+R + ++ L I+LE + L E ++T
Sbjct: 79 LNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYN 137
Query: 180 LLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKG---- 235
LLLG ++H GI+HRD+K AN L++ +K+ DFG ++ + + ++
Sbjct: 138 LLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEP 197
Query: 236 -----------TPY----WM-APEVI-RQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQ 278
T + W APE+I Q ++ S DIWS GC E+
Sbjct: 198 GPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPT 257
Query: 279 EVAALF-------------------------------HIGT-----------------TK 290
LF IGT K
Sbjct: 258 NRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIK 317
Query: 291 SHPPIPE--------NLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTG----DDE 335
P ++S + L L+ P+ R T + L HP++ E
Sbjct: 318 LFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLE 374
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 63/214 (29%), Positives = 106/214 (49%), Gaps = 30/214 (14%)
Query: 73 LIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPN 132
++G G FG+VY G L G L+AVK++ +E+ Q + + EV+++ H N
Sbjct: 37 ILGRGGFGKVYKGR-LADGTLVAVKRL-------KEERTQGGELQFQTEVEMISMAVHRN 88
Query: 133 IVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAV-----MRTYTKQLLLG---- 183
++R G ++ ++ GS++S L R +++ LG
Sbjct: 89 LLRLRGFCMTPTERLLVYPYMANGSVASCL--RERPESQPPLDWPKR---QRIALGSARG 143
Query: 184 LEYLHNHG---IMHRDIKGANILVDNKGCIKLADFGASKQVAELAT-VSGAKSMKGTPYW 239
L YLH+H I+HRD+K ANIL+D + + DFG +K + T V+ A ++GT
Sbjct: 144 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA--VRGTIGH 201
Query: 240 MAPEVIRQTGH-SYSADIWSVGCTVIEMATGKPP 272
+APE + TG S D++ G ++E+ TG+
Sbjct: 202 IAPEYL-STGKSSEKTDVFGYGVMLLELITGQRA 234
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 5e-27
Identities = 80/339 (23%), Positives = 143/339 (42%), Gaps = 87/339 (25%)
Query: 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKL 124
++ + +G GA+G V+ ++ +GE++AVK++ A F + AQ +E+ +
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA--FQNSTDAQRTFREI----MI 61
Query: 125 LKDLS-HPNIVRYLGTVREEESLNILLEFVPGGSISSLLG-------KFGPFPEAVMRTY 176
L +LS H NIV L +R + ++ L + + + +
Sbjct: 62 LTELSGHENIVNLLNVLRADNDRDVYL-------VFDYMETDLHAVIRANILEPVHKQYV 114
Query: 177 TKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKG- 235
QL+ ++YLH+ G++HRD+K +NIL++ + +K+ADFG S+ + V+ +
Sbjct: 115 VYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSIN 174
Query: 236 -------------TPY----WM-APEVIRQTGHSYSA--DIWSVGCTVIEMATGKP---- 271
T Y W APE++ Y+ D+WS+GC + E+ GKP
Sbjct: 175 ENTENFDDDQPILTDYVATRWYRAPEIL-LGSTKYTKGIDMWSLGCILGEILCGKPIFPG 233
Query: 272 ----------------PWSQQYQEVA---ALFHIGTTKSHPPIP---------------- 296
P ++ + + A I + K I
Sbjct: 234 SSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLL 293
Query: 297 -----ENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFV 330
+ + +A D L K L+ P+ R +A++ LKHPFV
Sbjct: 294 KINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFV 332
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 80/371 (21%), Positives = 130/371 (35%), Gaps = 122/371 (32%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLK 126
R+ +G G F V++ ++ + +A+K V+ +A + + + +E++LLK
Sbjct: 38 RYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK-VVKSA--------EHYTETALDEIRLLK 88
Query: 127 -----DLSHPN---IVRYLG--TVREEESLNILLEFVP-GGSISSLLGKF--GPFPEAVM 173
D + PN +V+ L + +I + F G + + K P +
Sbjct: 89 SVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCV 148
Query: 174 RTYTKQLLLGLEYLHNH-GIMHRDIKGANILV---------------------------- 204
+ +Q+L GL+YLH I+H DIK NIL+
Sbjct: 149 KKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGS 208
Query: 205 ---------------------DNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPE 243
K +K+AD G + V + T T + + E
Sbjct: 209 AVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFT-----EDIQTRQYRSLE 263
Query: 244 VIRQTGHSYSADIWSVGCTVIEMAT---------------------------GKPP--WS 274
V+ +G++ ADIWS C E+AT GK P
Sbjct: 264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLI 323
Query: 275 QQYQEVAALFH-----IGTTKSHPPIPENLSVK-----------AKDFLLKCLEKEPDLR 318
+ F TK P + V+ DFLL LE P+ R
Sbjct: 324 VAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKR 383
Query: 319 PTASELLKHPF 329
TA+E L+HP+
Sbjct: 384 ATAAECLRHPW 394
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 5e-23
Identities = 51/234 (21%), Positives = 92/234 (39%), Gaps = 34/234 (14%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLK 126
+W G+ IG G FG +Y+ + E A K + Q++ L E+K +
Sbjct: 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARH--------VVKVEYQEN-GPLFSELKFYQ 88
Query: 127 DLSH------------------PNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPF 168
++ P T + S ++ G + + G+ G F
Sbjct: 89 RVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTF 148
Query: 169 PEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGC--IKLADFGASKQVAELAT 226
++ + ++L LEY+H + +H DIK AN+L+ K + LAD+G S +
Sbjct: 149 KKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGN 208
Query: 227 -----VSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQ 275
+ K GT + + + + S +D+ +G ++ GK PW Q
Sbjct: 209 HKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ 262
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 7e-23
Identities = 53/219 (24%), Positives = 95/219 (43%), Gaps = 25/219 (11%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLK 126
R+R G IG G+FG +Y+G ++ +GE +A+K E + +L E K+ K
Sbjct: 10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL----------ECVKTKHPQLHIESKIYK 59
Query: 127 DLSH-PNI--VRYLGTVREEESLNILLEFVPGGSISSLLGKFG-PFPEAVMRTYTKQLLL 182
+ I +R+ G E N+++ + G S+ L F + Q++
Sbjct: 60 MMQGGVGIPTIRWCGA---EGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMIS 116
Query: 183 GLEYLHNHGIMHRDIKGANILV---DNKGCIKLADFGASKQVAELAT-----VSGAKSMK 234
+EY+H+ +HRD+K N L+ + + DFG +K+ + T K++
Sbjct: 117 RIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT 176
Query: 235 GTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPW 273
GT + + S D+ S+G ++ G PW
Sbjct: 177 GTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPW 215
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 4e-22
Identities = 56/221 (25%), Positives = 93/221 (42%), Gaps = 27/221 (12%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLK 126
++ G IG G+FG ++ G NL + + +A+K E + +L +E + K
Sbjct: 11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF----------EPRRSDAPQLRDEYRTYK 60
Query: 127 DLSH-PNI--VRYLGTVREEESLNILLEFVPGGSISSLLGKFG-PFPEAVMRTYTKQLLL 182
L+ I V Y G E N+L+ + G S+ LL G F + KQ+L
Sbjct: 61 LLAGCTGIPNVYYFGQ---EGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLA 117
Query: 183 GLEYLHNHGIMHRDIKGANILV-----DNKGCIKLADFGASKQVAELATVS-----GAKS 232
++ +H +++RDIK N L+ N I + DFG K + T K+
Sbjct: 118 RVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKN 177
Query: 233 MKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPW 273
+ GT +M+ S D+ ++G + G PW
Sbjct: 178 LSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPW 218
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 98.5 bits (245), Expect = 4e-22
Identities = 53/219 (24%), Positives = 94/219 (42%), Gaps = 25/219 (11%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLK 126
++R G IG G+FG +Y+G N+ + E +A+K E + +L E K+ +
Sbjct: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL----------ENVKTKHPQLLYESKIYR 57
Query: 127 DLS-HPNI--VRYLGTVREEESLNILLEFVPGGSISSLLGKFG-PFPEAVMRTYTKQLLL 182
L I VR+ G E N+L+ + G S+ L + Q++
Sbjct: 58 ILQGGTGIPNVRWFGV---EGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
Query: 183 GLEYLHNHGIMHRDIKGANILV---DNKGCIKLADFGASKQVAELAT-----VSGAKSMK 234
+E++H+ +HRDIK N L+ + + DFG +K+ + +T K++
Sbjct: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT 174
Query: 235 GTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPW 273
GT + + S D+ S+G ++ G PW
Sbjct: 175 GTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 5e-20
Identities = 54/221 (24%), Positives = 90/221 (40%), Gaps = 27/221 (12%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLK 126
+R G+ IGCG FG + +G NL + E +A+K E + +L E + K
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKL----------EPMKSRAPQLHLEYRFYK 59
Query: 127 DLSH-PNI--VRYLGTVREEESLNILLEFVPGGSISSLLGKFG-PFPEAVMRTYTKQLLL 182
L I V Y G N ++ + G S+ L F + QL+
Sbjct: 60 QLGSGDGIPQVYYFGP---CGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLIS 116
Query: 183 GLEYLHNHGIMHRDIKGANILV-----DNKGCIKLADFGASKQVAELATVS-----GAKS 232
+EY+H+ +++RD+K N L+ + I + DF +K+ + T KS
Sbjct: 117 RMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKS 176
Query: 233 MKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPW 273
+ GT +M+ S D+ ++G + G PW
Sbjct: 177 LTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPW 217
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 1e-19
Identities = 48/278 (17%), Positives = 96/278 (34%), Gaps = 56/278 (20%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLK 126
W+ G IG G FG +Y+ +++S E + K + D+ L E+K +
Sbjct: 36 AWKVGLPIGQGGFGCIYLA-DMNSSESVGSDA-----PCVVKVEPSDN-GPLFTELKFYQ 88
Query: 127 DLSHPNIVRYLGTVREEESLNI----------------------LLEFVPGGSISSLLGK 164
+ P ++ R+ + L + G + +
Sbjct: 89 RAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF----GSDLQKIYEA 144
Query: 165 FG-PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGC--IKLADFGASKQV 221
F + + ++L LEY+H H +H DIK +N+L++ K + L D+G + +
Sbjct: 145 NAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRY 204
Query: 222 AELATV-----SGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPW--- 273
+ GT + + + S D+ +G +I+ TG PW
Sbjct: 205 CPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDN 264
Query: 274 -----SQQYQEVAALFHIGTTKSHPPIPENLSVKAKDF 306
+ + I ++ + + A +
Sbjct: 265 LKDPKYVRDSK------IRYRENIASL-MDKCFPAANA 295
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 7e-19
Identities = 39/231 (16%), Positives = 83/231 (35%), Gaps = 29/231 (12%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSG--------ELLAVK------QVLIAANFASKEKAQ 112
+W+ G +Y + + ++K ++ NF +
Sbjct: 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKP 102
Query: 113 DHIKELEEEVKLLKDLSHPNIVRYLGTVREEESLNIL-LEFVPGGSISSLLGKFG--PFP 169
+ + K L I +G ++ L L + G S+ S L
Sbjct: 103 LQVNKW----KKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLS 157
Query: 170 EAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILV--DNKGCIKLADFGASKQVAELAT- 226
E + +LL LE+LH + +H ++ NI V +++ + LA +G + +
Sbjct: 158 ERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKH 217
Query: 227 ----VSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPW 273
+G +++ ++ + G S +D+ S+G +++ G PW
Sbjct: 218 VAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPW 268
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 73.4 bits (180), Expect = 2e-14
Identities = 43/152 (28%), Positives = 73/152 (48%), Gaps = 6/152 (3%)
Query: 179 QLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPY 238
Q+ G+E+L + +HRD+ NIL+ K +K+ DFG ++ + + +
Sbjct: 201 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 260
Query: 239 WMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWS--QQYQEVAALFHIGTTKSHPPI 295
WMAPE I ++ +D+WS G + E+ + G P+ + +E GT
Sbjct: 261 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT---RMRA 317
Query: 296 PENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327
P+ + + +L C EP RPT SEL++H
Sbjct: 318 PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 28/100 (28%), Positives = 46/100 (46%), Gaps = 16/100 (16%)
Query: 71 GELIGCGAFGRVYMG-----MNLDSGELLAVKQVLIAANFASKEKA-QDHIKELEEEVKL 124
G+ +G GAFG+V + +AVK + KE A + L E+K+
Sbjct: 27 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--------KEGATHSEHRALMSELKI 78
Query: 125 LKDL-SHPNIVRYLGTV-REEESLNILLEFVPGGSISSLL 162
L + H N+V LG + L +++EF G++S+ L
Sbjct: 79 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 118
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 73.4 bits (179), Expect = 3e-14
Identities = 36/199 (18%), Positives = 61/199 (30%), Gaps = 45/199 (22%)
Query: 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVK 123
P + ++ E IG G FG V+ + +A+K + I Q +E+ E+
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75
Query: 124 LLKDL---------SHPNIVRYLG------------------------------TVREEE 144
+ K+L + +++
Sbjct: 76 ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135
Query: 145 SLNILLEFVPGG-SISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHN-HGIMHRDIKGANI 202
L I+LEF GG + + K A ++ QL L HRD+ N+
Sbjct: 136 QLFIVLEFEFGGIDLEQMRTKLSSLATA--KSILHQLTASLAVAEASLRFEHRDLHWGNV 193
Query: 203 LVDNKGCIKLADFGASKQV 221
L+ KL K
Sbjct: 194 LLKKTSLKKLHYTLNGKSS 212
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 62.9 bits (152), Expect = 2e-10
Identities = 95/615 (15%), Positives = 180/615 (29%), Gaps = 214/615 (34%)
Query: 86 MNLDSGE-------LLAVKQVLIAANFASKEKAQDHIKEL--EEEVK-LLKDLSHPNIVR 135
M+ ++GE +L+V + NF K+ QD K + +EE+ ++ +
Sbjct: 7 MDFETGEHQYQYKDILSVFEDAFVDNFDCKD-VQDMPKSILSKEEIDHIIMSKDAVSGTL 65
Query: 136 YLGTVREEESLNILLEFVPGGSISSLLGKFGPF-----------PEAVMRTYTKQLLLGL 184
L + ++ +FV +L F P + R Y +Q
Sbjct: 66 RLFWTLLSKQEEMVQKFV-----EEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQR---- 116
Query: 185 EYLHNHGI-----------MHRDIKGA--------NILVDNKGCIKLADFGASKQVAELA 225
+ L+N + ++ A N+L+D G+ K L
Sbjct: 117 DRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVL-------GSGKTWVALD 169
Query: 226 TVSGAK---SMKGTPYWM------APEVI--------RQTGHSYSA-------------- 254
K M +W+ +PE + Q ++++
Sbjct: 170 VCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHS 229
Query: 255 ----------------------DIWS--------VGCTVIEMATGKPPWSQQYQEVAALF 284
++ + + C ++ + T ++++V F
Sbjct: 230 IQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKIL-LTT-------RFKQVTD-F 280
Query: 285 HIGTTKSHPPIPENLSV----KAKDFLLKCLEKEP-DLRPTASELLKHPFVTG------D 333
T +H + + + K LLK L+ P DL +P
Sbjct: 281 LSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTT--NPRRLSIIAESIR 338
Query: 334 DE----DPVLH------ASVMKSS-EILSPSHV-ANLESLQMLTSPGSPGSVDI------ 375
D D H ++++SS +L P+ + L + P S I
Sbjct: 339 DGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVF-----PPSAHIPTILLS 393
Query: 376 ---CNLDSLSCSRVIVEKL-SGSMHGWVTSNSNDDLC-----QLDQEDFVAGDRKLSSIL 426
++ S V+V KL S+ V + L+ + + + L +
Sbjct: 394 LIWFDVIK-SDVMVVVNKLHKYSL---VEKQPKESTISIPSIYLELKVKLENEYALHRSI 449
Query: 427 APNDLEKSRNPMCEPSDD---------WRWKF----DGSPEPEKNELKPDSDESLKVPAS 473
++ P SDD + PE+ L +
Sbjct: 450 ----VDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQ 505
Query: 474 RINASGEEDNGFSFPRGTPLSE---------DDDELTESKIKAFLD-----AKVLVCIRI 519
+I N T L + D+D E + A LD + L+C +
Sbjct: 506 KIRHDSTAWNASGSILNT-LQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSK- 563
Query: 520 GLFVVMLNLIYITLM 534
+L+ I LM
Sbjct: 564 -----YTDLLRIALM 573
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 41.8 bits (97), Expect = 6e-04
Identities = 70/525 (13%), Positives = 138/525 (26%), Gaps = 223/525 (42%)
Query: 40 ERFNSCI----RNSRVLSKHISPSVKMSPPIR-----WRKGELI------GCG------- 77
+ +++V +K+ ++ +R R + + G G
Sbjct: 110 RMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALD 169
Query: 78 ----------AFGRVY---MGMNLDSGELLAVKQVL---IAANFASKEKAQDHIKELEEE 121
+++ + +L + Q L I N+ S+ +IK
Sbjct: 170 VCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHS 229
Query: 122 VK-----------------LLKDLSHPNIVRY-------LGTVR---------------- 141
++ +L ++ + L T R
Sbjct: 230 IQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHI 289
Query: 142 ----------EEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHG 191
+E ++LL+++ L P E + T L +
Sbjct: 290 SLDHHSMTLTPDEVKSLLLKYL-DCRPQDL-----P-REVLT---TNPRRLSI------- 332
Query: 192 IMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTP-YWMAPEVIRQTGH 250
S + T W + T
Sbjct: 333 -----------------------IAESI-----------RDGLATWDNWKHVNCDKLT-- 356
Query: 251 SYSADIWSVGCTVIEMATG--KPPWSQQYQEVAALFHIGTTKSHPPIPEN-LSV------ 301
T+IE + +P ++ + ++F IP LS+
Sbjct: 357 -----------TIIESSLNVLEPAEYRKMFDRLSVFPPSA-----HIPTILLSLIWFDVI 400
Query: 302 --KAKDFLLKC-----LEKEPDLRPTAS------ELLKHPFVTGDDEDPVLHASVMKSSE 348
+ K +EK+P T S EL + + LH S++
Sbjct: 401 KSDVMVVVNKLHKYSLVEKQPK-ESTISIPSIYLELKVKL-----ENEYALHRSIVDHYN 454
Query: 349 I--------LSPS------------HVANLESLQMLTSPGSPGSVDICNLDSLSCSRVIV 388
I L P H+ N+E + +T + LD R +
Sbjct: 455 IPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMT------LFRMVFLD----FRFLE 504
Query: 389 EKLSGSMHGWVTSNS-NDDLCQLDQ-EDFVAG-----DRKLSSIL 426
+K+ W S S + L QL + ++ +R +++IL
Sbjct: 505 QKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAIL 549
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 536 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.92 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.83 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.73 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.32 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.17 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.16 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.01 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.78 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.51 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.51 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.36 | |
| 2lv7_A | 100 | Calcium-binding protein 7; metal binding protein; | 98.28 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.25 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.16 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.08 | |
| 4drw_A | 121 | Protein S100-A10/annexin A2 chimeric protein; atyp | 97.95 | |
| 3pm8_A | 197 | PFCDPK2, calcium-dependent protein kinase 2; malar | 97.93 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.93 | |
| 2kn2_A | 92 | Calmodulin; S MAPK phosphatase 1, NTMKP1, tobacco | 97.92 | |
| 1fi6_A | 92 | EH domain protein REPS1; EPS15 homology domain, EF | 97.89 | |
| 1eh2_A | 106 | EPS15; calcium binding, signaling domain, NPF bind | 97.88 | |
| 1qjt_A | 99 | EH1, epidermal growth factor receptor substrate su | 97.85 | |
| 1c07_A | 95 | Protein (epidermal growth factor receptor pathway | 97.81 | |
| 2opo_A | 86 | Polcalcin CHE A 3; calcium-binding protein, dimer, | 97.8 | |
| 2h2k_A | 106 | Protein S100-A13; calcium binding protein, metal b | 97.79 | |
| 1iq3_A | 110 | Ralbp1-interacting protein (partner of ralbp1); EF | 97.78 | |
| 2lhi_A | 176 | Calmodulin, serine/threonine-protein phosphatase c | 97.77 | |
| 3nso_A | 101 | Protein S100-A3; EF-hand, Ca2+, Zn2+ binding, meta | 97.77 | |
| 3u0k_A | 440 | Rcamp; fluorescent protein, calcium binding, EF-ha | 97.73 | |
| 3n22_A | 98 | Protein S100-A2; EF-hand, calcium-binding, zinc-bi | 97.72 | |
| 3nxa_A | 100 | Protein S100-A16; S100 family, calcium binding pro | 97.72 | |
| 3li6_A | 66 | Calcium-binding protein; calcium signaling protein | 97.72 | |
| 1k9u_A | 78 | Polcalcin PHL P 7; pollen allergen, calcium-bindin | 97.72 | |
| 2lmt_A | 148 | Calmodulin-related protein 97A; spermatogenesis, m | 97.7 | |
| 2jq6_A | 139 | EH domain-containing protein 1; metal binding prot | 97.68 | |
| 2b1u_A | 71 | Calmodulin-like protein 5; CLSP, calmodulin-like S | 97.67 | |
| 3zwh_A | 104 | Protein S100-A4; Ca-binding protein-motor protein | 97.66 | |
| 1wy9_A | 147 | Allograft inflammatory factor 1; EF-hand, calucium | 97.65 | |
| 4eto_A | 93 | Protein S100-A4; calcium-binding protein, EF-hand, | 97.65 | |
| 2kgr_A | 111 | Intersectin-1; structure, alternative splicing, ca | 97.65 | |
| 1m45_A | 148 | MLC1P, myosin light chain; protein-peptide complex | 97.64 | |
| 2lnk_A | 113 | Protein S100-A4; EF-hand, calcium binding, all alp | 97.61 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.59 | |
| 1s6j_A | 87 | CDPK, calcium-dependent protein kinase SK5; EF-han | 97.59 | |
| 3k21_A | 191 | PFCDPK3, calcium-dependent protein kinase 3; calci | 97.59 | |
| 1tiz_A | 67 | Calmodulin-related protein, putative; helix-turn-h | 97.59 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.55 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.53 | |
| 2jjz_A | 150 | Ionized calcium-binding adapter molecule 2; EF-han | 97.51 | |
| 2lmt_A | 148 | Calmodulin-related protein 97A; spermatogenesis, m | 97.51 | |
| 2kz2_A | 94 | Calmodulin, CAM; TR2C, metal binding protein; NMR | 97.51 | |
| 2joj_A | 77 | Centrin protein; N-terminal domain, centrin soluti | 97.5 | |
| 1s6i_A | 188 | CDPK, calcium-dependent protein kinase SK5; EF-han | 97.5 | |
| 2obh_A | 143 | Centrin-2; DNA repair complex EF hand superfamily | 97.49 | |
| 2ktg_A | 85 | Calmodulin, putative; ehcam, Ca-binding protein, p | 97.48 | |
| 3i5g_B | 153 | Myosin regulatory light chain LC-2, mantle muscle; | 97.47 | |
| 3i5g_C | 159 | Myosin catalytic light chain LC-1, mantle muscle; | 97.46 | |
| 2lhi_A | 176 | Calmodulin, serine/threonine-protein phosphatase c | 97.44 | |
| 2wcb_A | 95 | Protein S100-A12; calcium signalling, HOST-parasit | 97.43 | |
| 1h8b_A | 75 | ACT-EF34, alpha-actinin 2, skeletal muscle isoform | 97.42 | |
| 3fia_A | 121 | Intersectin-1; EH 1 domain, NESG, structural genom | 97.41 | |
| 1avs_A | 90 | Troponin C; muscle contraction, calcium-activated, | 97.4 | |
| 2d58_A | 107 | Allograft inflammatory factor 1; EF-hand, metal bi | 97.39 | |
| 2pmy_A | 91 | RAS and EF-hand domain-containing protein; rasef, | 97.39 | |
| 3i5g_C | 159 | Myosin catalytic light chain LC-1, mantle muscle; | 97.39 | |
| 1qx2_A | 76 | Vitamin D-dependent calcium-binding protein, INTE; | 97.36 | |
| 2y5i_A | 99 | S100Z, S100 calcium binding protein Z; metal-bindi | 97.35 | |
| 3rm1_A | 92 | Protein S100-B; alpha-helical, EF hand, metal bind | 97.33 | |
| 1j55_A | 95 | S-100P protein; metal binding protein; 2.00A {Homo | 97.32 | |
| 1xk4_A | 93 | Calgranulin A; S100 family, heterotetramer, metal | 97.32 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.32 | |
| 1wlz_A | 105 | DJBP, CAP-binding protein complex interacting prot | 97.31 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.3 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.3 | |
| 2obh_A | 143 | Centrin-2; DNA repair complex EF hand superfamily | 97.29 | |
| 3e3r_A | 204 | Calcyphosin, calcyphosine; human calcyphosine, EF- | 97.28 | |
| 1j7q_A | 86 | CAVP, calcium vector protein; EF-hand family, calc | 97.27 | |
| 2bl0_C | 142 | Myosin regulatory light chain; muscle protein, sli | 97.25 | |
| 3j04_B | 143 | Myosin regulatory light chain 2, smooth muscle MA | 97.24 | |
| 2jnf_A | 158 | Troponin C; stretch activated muscle contraction, | 97.23 | |
| 2kax_A | 92 | Protein S100-A5; EF-hand, calcium binding protien, | 97.21 | |
| 2kyc_A | 108 | Parvalbumin-3, parvalbumin, thymic CPV3; EF-hand p | 97.2 | |
| 1yx7_A | 83 | Calsensin, LAN3-6 antigen; calcium-binding protein | 97.18 | |
| 1psr_A | 100 | Psoriasin, S100A7; EF-hand protein, MAD phasing, p | 97.18 | |
| 2mys_B | 166 | Myosin; muscle protein, motor protein; HET: MLY; 2 | 97.16 | |
| 2kld_A | 123 | Polycystin-2; PC2, PKD2, calcium binding domain, E | 97.16 | |
| 1c7v_A | 81 | CAVP, calcium vector protein; EF-hand family, calc | 97.14 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.13 | |
| 1dtl_A | 161 | Cardiac troponin C; helix-turn-helix, structural p | 97.13 | |
| 1wdc_C | 156 | Scallop myosin; calcium binding protein, muscle pr | 97.13 | |
| 3i5g_B | 153 | Myosin regulatory light chain LC-2, mantle muscle; | 97.12 | |
| 1exr_A | 148 | Calmodulin; high resolution, disorder, metal trans | 97.1 | |
| 1exr_A | 148 | Calmodulin; high resolution, disorder, metal trans | 97.09 | |
| 2aao_A | 166 | CDPK, calcium-dependent protein kinase, isoform AK | 97.09 | |
| 3fs7_A | 109 | Parvalbumin, thymic; calcium-binding protein, EF-h | 97.08 | |
| 1m45_A | 148 | MLC1P, myosin light chain; protein-peptide complex | 97.07 | |
| 1cb1_A | 78 | Calbindin D9K; calcium-binding protein; NMR {Sus s | 97.07 | |
| 3mse_B | 180 | Calcium-dependent protein kinase, putative; CDPKS, | 97.05 | |
| 1a4p_A | 96 | S100A10; S100 family, EF-hand protein, ligand of a | 97.05 | |
| 3h4s_E | 135 | KCBP interacting Ca2+-binding protein; kinesin, mo | 97.05 | |
| 2ovk_C | 159 | Myosin catalytic light chain LC-1, mantle muscle, | 97.05 | |
| 1jfj_A | 134 | Ehcabp, calcium-binding protein; EF-hand, helix-lo | 97.0 | |
| 5pal_A | 109 | Parvalbumin; calcium-binding protein; 1.54A {Triak | 97.0 | |
| 3khe_A | 191 | Calmodulin-like domain protein kinase isoform 3; c | 97.0 | |
| 1pva_A | 110 | Parvalbumin; calcium binding; 1.65A {Esox lucius} | 96.99 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.98 | |
| 1s6i_A | 188 | CDPK, calcium-dependent protein kinase SK5; EF-han | 96.98 | |
| 2pvb_A | 108 | Protein (parvalbumin); calcium binding protein, me | 96.96 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.95 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.94 | |
| 2mys_C | 149 | Myosin; muscle protein, motor protein; HET: MLY; 2 | 96.94 | |
| 1rro_A | 108 | RAT oncomodulin; calcium-binding protein; 1.30A {R | 96.92 | |
| 1xk4_C | 113 | Calgranulin B; S100 family, heterotetramer, metal | 96.92 | |
| 1rwy_A | 109 | Parvalbumin alpha; EF-hand, calcium-binding, calci | 96.91 | |
| 1bu3_A | 109 | Calcium-binding protein; 1.65A {Merluccius bilinea | 96.9 | |
| 2ggz_A | 211 | Guanylyl cyclase-activating protein 3; EF hand, gu | 96.88 | |
| 1jba_A | 204 | GCAP-2, protein (guanylate cyclase activating prot | 96.88 | |
| 3u0k_A | 440 | Rcamp; fluorescent protein, calcium binding, EF-ha | 96.88 | |
| 3ox6_A | 153 | Calcium-binding protein 1; EF-hand, calcium-sensor | 96.86 | |
| 2bl0_B | 145 | Myosin regulatory light chain; muscle protein, sli | 96.85 | |
| 1w7j_B | 151 | Myosin light chain 1; motor protein, unconventiona | 96.83 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.83 | |
| 3sjs_A | 220 | URE3-BP sequence specific DNA binding protein; EF- | 96.82 | |
| 3qrx_A | 169 | Centrin; calcium-binding, EF-hand, cell division, | 96.82 | |
| 3a8r_A | 179 | Putative uncharacterized protein; EF-hand, membran | 96.81 | |
| 3fwb_A | 161 | Cell division control protein 31; gene gating, com | 96.81 | |
| 2mys_C | 149 | Myosin; muscle protein, motor protein; HET: MLY; 2 | 96.8 | |
| 3ll8_B | 155 | Calcineurin subunit B type 1; protein-peptide dock | 96.79 | |
| 3qrx_A | 169 | Centrin; calcium-binding, EF-hand, cell division, | 96.79 | |
| 2jnf_A | 158 | Troponin C; stretch activated muscle contraction, | 96.79 | |
| 3fwb_A | 161 | Cell division control protein 31; gene gating, com | 96.77 | |
| 1k2h_A | 93 | S100A1, S-100 protein, alpha chain; non-covalent h | 96.76 | |
| 2ovk_C | 159 | Myosin catalytic light chain LC-1, mantle muscle, | 96.76 | |
| 3ox6_A | 153 | Calcium-binding protein 1; EF-hand, calcium-sensor | 96.76 | |
| 1qls_A | 99 | S100C protein, calgizzarin; metal-binding protein/ | 96.75 | |
| 1djx_A | 624 | PLC-D1, phosphoinositide-specific phospholipase C, | 96.75 | |
| 1wdc_C | 156 | Scallop myosin; calcium binding protein, muscle pr | 96.75 | |
| 1y1x_A | 191 | Leishmania major homolog of programmed cell death | 96.73 | |
| 3pm8_A | 197 | PFCDPK2, calcium-dependent protein kinase 2; malar | 96.73 | |
| 1qv0_A | 195 | Obelin, OBL; photoprotein, bioluminescence, atomic | 96.72 | |
| 2f2o_A | 179 | Calmodulin fused with calmodulin-binding domain of | 96.71 | |
| 1q80_A | 174 | SCP, sarcoplasmic calcium-binding protein; all-alp | 96.71 | |
| 2ovk_B | 153 | RLC, myosin regulatory light chain LC-2, mantle mu | 96.7 | |
| 1ggw_A | 140 | Protein (CDC4P); light chain, cytokinesis, cell cy | 96.7 | |
| 3j04_B | 143 | Myosin regulatory light chain 2, smooth muscle MA | 96.7 | |
| 1ggw_A | 140 | Protein (CDC4P); light chain, cytokinesis, cell cy | 96.69 | |
| 1w7j_B | 151 | Myosin light chain 1; motor protein, unconventiona | 96.68 | |
| 1uhk_A | 191 | Aequorin 2, aequorin; EF-hand motif, complex, lumi | 96.67 | |
| 1dtl_A | 161 | Cardiac troponin C; helix-turn-helix, structural p | 96.67 | |
| 2f2o_A | 179 | Calmodulin fused with calmodulin-binding domain of | 96.66 | |
| 2znd_A | 172 | Programmed cell death protein 6; penta-EF-hand pro | 96.65 | |
| 2l2e_A | 190 | Calcium-binding protein NCS-1; NCS1P, myristoylate | 96.65 | |
| 2bec_A | 202 | Calcineurin B homologous protein 2; calcineurin-ho | 96.64 | |
| 1y1x_A | 191 | Leishmania major homolog of programmed cell death | 96.64 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.63 | |
| 4ds7_A | 147 | Calmodulin, CAM; protein binding, metal binding, s | 96.63 | |
| 1top_A | 162 | Troponin C; contractIle system protein; 1.78A {Gal | 96.63 | |
| 2f33_A | 263 | Calbindin; EF-hand, Ca2+-binding, metal binding pr | 96.61 | |
| 2lvv_A | 226 | Flagellar calcium-binding protein TB-24; EF-hand, | 96.56 | |
| 2bl0_C | 142 | Myosin regulatory light chain; muscle protein, sli | 96.56 | |
| 1snl_A | 103 | Nucleobindin 1, calnuc; EF-hand, calcium-binding, | 96.54 | |
| 1k8u_A | 90 | S100A6, calcyclin, CACY; calcium regulatory protei | 96.53 | |
| 3dtp_E | 196 | RLC, myosin regulatory light chain; muscle protein | 96.52 | |
| 1nya_A | 176 | Calerythrin; EF-hand, metal binding protein; NMR { | 96.52 | |
| 2hpk_A | 208 | Photoprotein berovin; structural genomics, PSI, pr | 96.5 | |
| 1wdc_B | 156 | Scallop myosin; calcium binding protein, muscle pr | 96.5 | |
| 3akb_A | 166 | Putative calcium binding protein; EF-hand, metal b | 96.5 | |
| 2ct9_A | 208 | Calcium-binding protein P22; EF-hand, metal bindin | 96.47 | |
| 2ccm_A | 191 | Calexcitin; EF hand, calcium, signaling protein; 1 | 96.47 | |
| 3ll8_B | 155 | Calcineurin subunit B type 1; protein-peptide dock | 96.46 | |
| 3k21_A | 191 | PFCDPK3, calcium-dependent protein kinase 3; calci | 96.46 | |
| 1gjy_A | 167 | Sorcin, CP-22, V19; calcium binding, calcium-bindi | 96.45 | |
| 1k94_A | 165 | Grancalcin; penta-EF-hand protein, calcium binding | 96.44 | |
| 2i7a_A | 174 | Calpain 13; calcium-dependent cytoplasmic cysteine | 96.43 | |
| 1s6c_A | 183 | KV4 potassium channel-interacting protein kchip1B; | 96.43 | |
| 2hpk_A | 208 | Photoprotein berovin; structural genomics, PSI, pr | 96.42 | |
| 2bl0_B | 145 | Myosin regulatory light chain; muscle protein, sli | 96.4 | |
| 3khe_A | 191 | Calmodulin-like domain protein kinase isoform 3; c | 96.4 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.4 | |
| 1juo_A | 198 | Sorcin; calcium-binding proteins, penta-EF-hand, P | 96.37 | |
| 3cs1_A | 219 | Flagellar calcium-binding protein; myristoylated, | 96.37 | |
| 1top_A | 162 | Troponin C; contractIle system protein; 1.78A {Gal | 96.37 | |
| 1uhk_A | 191 | Aequorin 2, aequorin; EF-hand motif, complex, lumi | 96.37 | |
| 3h4s_E | 135 | KCBP interacting Ca2+-binding protein; kinesin, mo | 96.36 | |
| 2znd_A | 172 | Programmed cell death protein 6; penta-EF-hand pro | 96.36 | |
| 1nya_A | 176 | Calerythrin; EF-hand, metal binding protein; NMR { | 96.35 | |
| 2bec_A | 202 | Calcineurin B homologous protein 2; calcineurin-ho | 96.35 | |
| 2r2i_A | 198 | Guanylyl cyclase-activating protein 1; EF hand, GC | 96.34 | |
| 4ds7_A | 147 | Calmodulin, CAM; protein binding, metal binding, s | 96.34 | |
| 2sas_A | 185 | Sarcoplasmic calcium-binding protein; 2.40A {Branc | 96.33 | |
| 2qac_A | 146 | Myosin A tail domain interacting protein MTIP; mal | 96.3 | |
| 3mse_B | 180 | Calcium-dependent protein kinase, putative; CDPKS, | 96.28 | |
| 3a4u_B | 143 | Multiple coagulation factor deficiency protein 2; | 96.27 | |
| 1qv0_A | 195 | Obelin, OBL; photoprotein, bioluminescence, atomic | 96.27 | |
| 2aao_A | 166 | CDPK, calcium-dependent protein kinase, isoform AK | 96.25 | |
| 2lvv_A | 226 | Flagellar calcium-binding protein TB-24; EF-hand, | 96.25 | |
| 3sg6_A | 450 | Gcamp2, myosin light chain kinase, green fluoresce | 96.24 | |
| 1sjj_A | 863 | Actinin; 3-helix bundle, calponin homology domain, | 96.2 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 96.19 | |
| 2d8n_A | 207 | Recoverin; structural genomics, NPPSFA, national p | 96.19 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 96.15 | |
| 2ct9_A | 208 | Calcium-binding protein P22; EF-hand, metal bindin | 96.14 | |
| 1alv_A | 173 | Calpain, S-camld; calcium binding, calmodulin like | 96.14 | |
| 1bjf_A | 193 | Neurocalcin delta; calcium-binding, myristoylation | 96.13 | |
| 1fpw_A | 190 | Yeast frequenin, calcium-binding protein NCS-1; EF | 96.12 | |
| 2i7a_A | 174 | Calpain 13; calcium-dependent cytoplasmic cysteine | 96.1 | |
| 2ehb_A | 207 | Calcineurin B-like protein 4; protein complex, Ca( | 96.03 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 96.02 | |
| 1fpw_A | 190 | Yeast frequenin, calcium-binding protein NCS-1; EF | 96.02 | |
| 1ij5_A | 323 | Plasmodial specific LAV1-2 protein; fourty kDa cal | 96.02 | |
| 3sjs_A | 220 | URE3-BP sequence specific DNA binding protein; EF- | 96.01 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 96.01 | |
| 3a4u_B | 143 | Multiple coagulation factor deficiency protein 2; | 95.99 | |
| 2zfd_A | 226 | Calcineurin B-like protein 2; calcium binding prot | 95.97 | |
| 1s1e_A | 224 | KV channel interacting protein 1; kchip, calcium-b | 95.96 | |
| 1g8i_A | 190 | Frequenin, neuronal calcium sensor 1; calcium bind | 95.96 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.95 | |
| 3e3r_A | 204 | Calcyphosin, calcyphosine; human calcyphosine, EF- | 95.92 | |
| 1s6c_A | 183 | KV4 potassium channel-interacting protein kchip1B; | 95.85 | |
| 2hps_A | 186 | Coelenterazine-binding protein with bound coelent; | 95.85 | |
| 1jba_A | 204 | GCAP-2, protein (guanylate cyclase activating prot | 95.84 | |
| 2r2i_A | 198 | Guanylyl cyclase-activating protein 1; EF hand, GC | 95.84 | |
| 2ovk_B | 153 | RLC, myosin regulatory light chain LC-2, mantle mu | 95.81 | |
| 1wdc_B | 156 | Scallop myosin; calcium binding protein, muscle pr | 95.79 | |
| 2f33_A | 263 | Calbindin; EF-hand, Ca2+-binding, metal binding pr | 95.78 | |
| 1dgu_A | 183 | Calcium-saturated CIB; helical, EF-hands, blood cl | 95.77 | |
| 1g8i_A | 190 | Frequenin, neuronal calcium sensor 1; calcium bind | 95.74 | |
| 2l4h_A | 214 | Calcium and integrin-binding protein 1; metal bind | 95.72 | |
| 2ccm_A | 191 | Calexcitin; EF hand, calcium, signaling protein; 1 | 95.68 | |
| 2l2e_A | 190 | Calcium-binding protein NCS-1; NCS1P, myristoylate | 95.67 | |
| 1sra_A | 151 | Sparc; extracellular matrix protein, calcium-bindi | 95.64 | |
| 3sg6_A | 450 | Gcamp2, myosin light chain kinase, green fluoresce | 95.54 | |
| 3dd4_A | 229 | KV channel-interacting protein 4; EF-hands protein | 95.5 | |
| 3dd4_A | 229 | KV channel-interacting protein 4; EF-hands protein | 95.49 | |
| 2ggz_A | 211 | Guanylyl cyclase-activating protein 3; EF hand, gu | 95.48 | |
| 2jul_A | 256 | Calsenilin; EF-hand, calcium, LXXLL, DNA binding p | 95.45 | |
| 3cs1_A | 219 | Flagellar calcium-binding protein; myristoylated, | 95.43 | |
| 1s1e_A | 224 | KV channel interacting protein 1; kchip, calcium-b | 95.42 | |
| 2sas_A | 185 | Sarcoplasmic calcium-binding protein; 2.40A {Branc | 95.38 | |
| 3akb_A | 166 | Putative calcium binding protein; EF-hand, metal b | 95.36 | |
| 2mys_B | 166 | Myosin; muscle protein, motor protein; HET: MLY; 2 | 95.23 | |
| 2jul_A | 256 | Calsenilin; EF-hand, calcium, LXXLL, DNA binding p | 95.22 | |
| 2be4_A | 272 | Hypothetical protein LOC449832; DR.36843, BC083168 | 95.2 | |
| 1jfj_A | 134 | Ehcabp, calcium-binding protein; EF-hand, helix-lo | 95.19 | |
| 1ij5_A | 323 | Plasmodial specific LAV1-2 protein; fourty kDa cal | 95.18 | |
| 3dtp_E | 196 | RLC, myosin regulatory light chain; muscle protein | 95.16 | |
| 3fs7_A | 109 | Parvalbumin, thymic; calcium-binding protein, EF-h | 95.12 | |
| 2zkm_X | 799 | 1-phosphatidylinositol-4,5-bisphosphate phosphodie | 95.07 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-63 Score=502.78 Aligned_cols=265 Identities=28% Similarity=0.496 Sum_probs=231.3
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEE 144 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 144 (536)
+.+|++++.||+|+||+||+|+++.+|+.||||++.+... ......+.+.+|+++|+.++|||||+++++|.+++
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~-----~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 105 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI-----IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE 105 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHC-----CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC
Confidence 4579999999999999999999999999999999843211 11223567889999999999999999999999999
Q ss_pred ceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhh
Q 009364 145 SLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAEL 224 (536)
Q Consensus 145 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 224 (536)
.+|+|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.+...
T Consensus 106 ~~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 106 KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 99999999999999999998899999999999999999999999999999999999999999999999999999987654
Q ss_pred hcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhH-HHHHHHhhCCCCCCCCCCCcCcHHH
Q 009364 225 ATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQ-EVAALFHIGTTKSHPPIPENLSVKA 303 (536)
Q Consensus 225 ~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~s~~~ 303 (536)
.......+.+||+.|||||++.+..|+.++|||||||++|+|+||.+||.+... +....+... ...+|..+++++
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~----~~~~p~~~s~~~ 261 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKL----EYDFPEKFFPKA 261 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT----CCCCCTTCCHHH
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC----CCCCCcccCHHH
Confidence 444445678999999999999999999999999999999999999999976432 222222222 234677899999
Q ss_pred HHHHHHhcccCCCCCCCHHH------HHhCCCCcCCCCCcc
Q 009364 304 KDFLLKCLEKEPDLRPTASE------LLKHPFVTGDDEDPV 338 (536)
Q Consensus 304 ~dLi~~cL~~dP~~Rps~~e------iL~hp~~~~~~~~~~ 338 (536)
++||.+||++||++|||+.| |++||||++.+++..
T Consensus 262 ~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l 302 (311)
T 4aw0_A 262 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 302 (311)
T ss_dssp HHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTG
T ss_pred HHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHh
Confidence 99999999999999999987 689999998776644
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-62 Score=505.17 Aligned_cols=258 Identities=33% Similarity=0.521 Sum_probs=223.2
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEE 144 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 144 (536)
..+|++.+.||+|+||+||+|+++.+|+.||||++..... ...+.+.+|+.+|+.++|||||+++++|.+++
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~--------~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~ 144 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ--------QRRELLFNEVVIMRDYQHENVVEMYNSYLVGD 144 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--------SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch--------hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 3579999999999999999999999999999999853221 11245678999999999999999999999999
Q ss_pred ceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhh
Q 009364 145 SLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAEL 224 (536)
Q Consensus 145 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 224 (536)
.+|||||||+||+|.+++.+ +++++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+.+...
T Consensus 145 ~~~ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 223 (346)
T 4fih_A 145 ELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 223 (346)
T ss_dssp EEEEEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred EEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCC
Confidence 99999999999999999876 67999999999999999999999999999999999999999999999999999876542
Q ss_pred hcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH-HHHHHhhCCCCCCCCCCCcCcHHH
Q 009364 225 ATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE-VAALFHIGTTKSHPPIPENLSVKA 303 (536)
Q Consensus 225 ~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~ 303 (536)
. ....+.+||+.|||||++.+..|+.++||||||||+|||++|.+||.+.... ....+.. ........+..+|+++
T Consensus 224 ~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~-~~~~~~~~~~~~s~~~ 300 (346)
T 4fih_A 224 V--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD-NLPPRLKNLHKVSPSL 300 (346)
T ss_dssp S--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-SSCCCCSCGGGSCHHH
T ss_pred C--CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc-CCCCCCCccccCCHHH
Confidence 2 2346789999999999999999999999999999999999999999765322 2222222 2222334456899999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHhCCCCcCCC
Q 009364 304 KDFLLKCLEKEPDLRPTASELLKHPFVTGDD 334 (536)
Q Consensus 304 ~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~ 334 (536)
++||.+||++||++|||+.|+|+||||++..
T Consensus 301 ~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 301 KGFLDRLLVRDPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence 9999999999999999999999999998654
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-62 Score=501.06 Aligned_cols=257 Identities=26% Similarity=0.516 Sum_probs=217.6
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
++|++++.||+|+||+||+|+++.+|+.||||++.... ......+.+.+|+.+|+.++|||||++++++.+++.
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~ 97 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISR------MSSKEREESRREVAVLANMKHPNIVQYRESFEENGS 97 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTT------SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHH------CCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCE
Confidence 58999999999999999999999999999999985322 112345678899999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhh
Q 009364 146 LNILLEFVPGGSISSLLGKF--GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAE 223 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 223 (536)
+|||||||+||+|.+++... ..+++..++.|+.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+.+..
T Consensus 98 ~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 177 (350)
T 4b9d_A 98 LYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS 177 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence 99999999999999999643 4579999999999999999999999999999999999999999999999999987654
Q ss_pred hhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH-HHHHHhhCCCCCCCCCCCcCcHH
Q 009364 224 LATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE-VAALFHIGTTKSHPPIPENLSVK 302 (536)
Q Consensus 224 ~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~ 302 (536)
... ...+.+||+.|||||++.+..|+.++||||||||+|||+||++||...... ....+.. ...++++..+|.+
T Consensus 178 ~~~--~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~---~~~~~~~~~~s~~ 252 (350)
T 4b9d_A 178 TVE--LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIIS---GSFPPVSLHYSYD 252 (350)
T ss_dssp HHH--HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH---TCCCCCCTTSCHH
T ss_pred Ccc--cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc---CCCCCCCccCCHH
Confidence 322 234678999999999999999999999999999999999999999765322 2222222 2234567789999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 303 AKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 303 ~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
+++||.+||++||++|||+.|+|+||||+..
T Consensus 253 ~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 253 LRSLVSQLFKRNPRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence 9999999999999999999999999999753
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-61 Score=484.94 Aligned_cols=258 Identities=27% Similarity=0.486 Sum_probs=217.1
Q ss_pred CCCCc-eeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec
Q 009364 64 PPIRW-RKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE 142 (536)
Q Consensus 64 ~~~~y-~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 142 (536)
...|| ++.+.||+|+||+||+|.++.++..||+|++... .......+.+.+|+++|+.++|||||+++++|.+
T Consensus 23 ~~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~------~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~ 96 (290)
T 3fpq_A 23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDR------KLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWES 96 (290)
T ss_dssp TTSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGG------GSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred CCCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchh------hCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEee
Confidence 34455 7888999999999999999999999999998432 1122345678999999999999999999999865
Q ss_pred ----CCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--CccccCCCCCcccCC-CCcEEEEec
Q 009364 143 ----EESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHG--IMHRDIKGANILVDN-KGCIKLADF 215 (536)
Q Consensus 143 ----~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~--ivHrDLKp~NILl~~-~~~vkL~DF 215 (536)
...+|||||||+||+|.+++.+.+.+++..++.++.||+.||+|||++| ||||||||+|||++. +|.+||+||
T Consensus 97 ~~~~~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DF 176 (290)
T 3fpq_A 97 TVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDL 176 (290)
T ss_dssp EETTEEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCT
T ss_pred ccCCCcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeC
Confidence 3568999999999999999998899999999999999999999999998 999999999999974 789999999
Q ss_pred CcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCC
Q 009364 216 GASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPI 295 (536)
Q Consensus 216 Gla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 295 (536)
|+|+.... ....+.+||+.|||||++.+ .|+.++|||||||++|||+||++||.+...................+
T Consensus 177 Gla~~~~~----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~ 251 (290)
T 3fpq_A 177 GLATLKRA----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASF 251 (290)
T ss_dssp TGGGGCCT----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGG
T ss_pred cCCEeCCC----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCC
Confidence 99975432 23457899999999999876 69999999999999999999999996543222222222222233345
Q ss_pred CCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcC
Q 009364 296 PENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTG 332 (536)
Q Consensus 296 ~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~ 332 (536)
+..+++++++||.+||++||++|||+.|+|+||||++
T Consensus 252 ~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 252 DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred CccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 6678899999999999999999999999999999975
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-61 Score=480.57 Aligned_cols=255 Identities=25% Similarity=0.423 Sum_probs=207.8
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
++|++++.||+|+||+||+|+++.+|+.||||++.... .........+.+|+++|+.++|||||++++++.+++.
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~ 87 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKV-----LAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDE 87 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC-----------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHH-----cCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence 47999999999999999999999999999999984321 1112334568899999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhh
Q 009364 146 LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA 225 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 225 (536)
+|+||||| +|+|.+++.+.+++++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+......
T Consensus 88 ~~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 88 IIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN 166 (275)
T ss_dssp EEEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred EEEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence 99999999 78999999888999999999999999999999999999999999999999999999999999998765422
Q ss_pred cccCCcccCCCCCCCChhhhhhcCC-CccceEechhHHHHHHhhCCCCCchhhHH-HHHHHhhCCCCCCCCCCCcCcHHH
Q 009364 226 TVSGAKSMKGTPYWMAPEVIRQTGH-SYSADIWSVGCTVIEMATGKPPWSQQYQE-VAALFHIGTTKSHPPIPENLSVKA 303 (536)
Q Consensus 226 ~~~~~~~~~Gt~~Y~APEvl~~~~~-s~k~DIwSlGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~ 303 (536)
...+.+||+.|||||++.+..| +.++||||+||++|+|+||++||.+.... ....+... ...+|..+|+++
T Consensus 167 ---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~----~~~~p~~~s~~~ 239 (275)
T 3hyh_A 167 ---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNG----VYTLPKFLSPGA 239 (275)
T ss_dssp -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT----CCCCCTTSCHHH
T ss_pred ---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC----CCCCCCCCCHHH
Confidence 2456889999999999998876 68999999999999999999999765332 22222222 234667899999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 304 KDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 304 ~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
++||.+||++||++|||+.|+++||||+..
T Consensus 240 ~~li~~~L~~dP~~R~s~~eil~hpw~k~~ 269 (275)
T 3hyh_A 240 AGLIKRMLIVNPLNRISIHEIMQDDWFKVD 269 (275)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHHCHHHHTT
T ss_pred HHHHHHHccCChhHCcCHHHHHcCcccccC
Confidence 999999999999999999999999999753
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-61 Score=504.91 Aligned_cols=258 Identities=33% Similarity=0.527 Sum_probs=223.4
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEE 144 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 144 (536)
..+|++.+.||+|+||+||+|+++.+|+.||||++..... ...+.+.+|+.+|+.++|||||+++++|.+.+
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~--------~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~ 221 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ--------QRRELLFNEVVIMRDYQHENVVEMYNSYLVGD 221 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC--------SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch--------hHHHHHHHHHHHHHhCCCCCCCceEEEEEECC
Confidence 3579999999999999999999999999999999854321 11245778999999999999999999999999
Q ss_pred ceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhh
Q 009364 145 SLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAEL 224 (536)
Q Consensus 145 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 224 (536)
.+|||||||+||+|.+++.. +.+++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+...
T Consensus 222 ~~~iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~ 300 (423)
T 4fie_A 222 ELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 300 (423)
T ss_dssp EEEEEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSS
T ss_pred EEEEEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCC
Confidence 99999999999999999865 67999999999999999999999999999999999999999999999999999876542
Q ss_pred hcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhH-HHHHHHhhCCCCCCCCCCCcCcHHH
Q 009364 225 ATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQ-EVAALFHIGTTKSHPPIPENLSVKA 303 (536)
Q Consensus 225 ~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~s~~~ 303 (536)
. ....+.+||+.|||||++.+..|+.++||||||||+|||++|.+||.+... +....+.. ........+..+|+++
T Consensus 301 ~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~-~~~~~~~~~~~~s~~~ 377 (423)
T 4fie_A 301 V--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD-NLPPRLKNLHKVSPSL 377 (423)
T ss_dssp C--CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-SCCCCCSCTTSSCHHH
T ss_pred C--ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc-CCCCCCcccccCCHHH
Confidence 2 235678999999999999999999999999999999999999999976432 22222222 2222334456899999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHhCCCCcCCC
Q 009364 304 KDFLLKCLEKEPDLRPTASELLKHPFVTGDD 334 (536)
Q Consensus 304 ~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~ 334 (536)
++||.+||++||++|||+.|+|+||||+...
T Consensus 378 ~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~ 408 (423)
T 4fie_A 378 KGFLDRLLVRDPAQRATAAELLKHPFLAKAG 408 (423)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HHHHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence 9999999999999999999999999998654
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-61 Score=488.81 Aligned_cols=262 Identities=32% Similarity=0.511 Sum_probs=217.9
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEc---CCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeee
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNL---DSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGT 139 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~ 139 (536)
..+.+|++++.||+|+||+||+|++. .+++.||+|++........ ....+.+|+.+|++++|||||+++++
T Consensus 21 ~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~------~~~~~~~E~~il~~l~HpnIv~l~~~ 94 (304)
T 3ubd_A 21 ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR------DRVRTKMERDILVEVNHPFIVKLHYA 94 (304)
T ss_dssp CCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE------ECC------CCCCCCCCTTEECEEEE
T ss_pred CCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH------HHHHHHHHHHHHHHCCCCCCCeEEEE
Confidence 44578999999999999999999984 4688999999853221111 11246789999999999999999999
Q ss_pred eecCCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcch
Q 009364 140 VREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASK 219 (536)
Q Consensus 140 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~ 219 (536)
+.+++.+|+|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+
T Consensus 95 ~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~ 174 (304)
T 3ubd_A 95 FQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK 174 (304)
T ss_dssp EEETTEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEE
T ss_pred EEECCEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccce
Confidence 99999999999999999999999998999999999999999999999999999999999999999999999999999998
Q ss_pred hhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhH-HHHHHHhhCCCCCCCCCCCc
Q 009364 220 QVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQ-EVAALFHIGTTKSHPPIPEN 298 (536)
Q Consensus 220 ~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~ 298 (536)
...... ....+.+||+.|||||++.+..|+.++|||||||++|||+||++||.+... +....+.. ....+|..
T Consensus 175 ~~~~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~----~~~~~p~~ 248 (304)
T 3ubd_A 175 ESIDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK----AKLGMPQF 248 (304)
T ss_dssp C-------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----CCCCCCTT
T ss_pred eccCCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHc----CCCCCCCc
Confidence 654322 234578999999999999999999999999999999999999999976533 22222222 23356778
Q ss_pred CcHHHHHHHHHhcccCCCCCCC-----HHHHHhCCCCcCCCCC
Q 009364 299 LSVKAKDFLLKCLEKEPDLRPT-----ASELLKHPFVTGDDED 336 (536)
Q Consensus 299 ~s~~~~dLi~~cL~~dP~~Rps-----~~eiL~hp~~~~~~~~ 336 (536)
+|+++++||++||++||++||| ++|+++||||+..+++
T Consensus 249 ~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~ 291 (304)
T 3ubd_A 249 LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWN 291 (304)
T ss_dssp SCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred CCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHH
Confidence 9999999999999999999998 5899999999876543
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-60 Score=483.68 Aligned_cols=254 Identities=32% Similarity=0.462 Sum_probs=214.9
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
..|++.+.||+|+||+||+|+++.+|+.||||++.... ...+|+.+|+.++|||||++++++.+.+.
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-------------~~~~E~~il~~l~HpnIV~l~~~~~~~~~ 124 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-------------FRVEELVACAGLSSPRIVPLYGAVREGPW 124 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-------------CCTHHHHTTTTCCCTTBCCEEEEEEETTE
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-------------hHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 46899999999999999999999999999999984321 11369999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCC-cEEEEecCcchhhhhh
Q 009364 146 LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKG-CIKLADFGASKQVAEL 224 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~-~vkL~DFGla~~~~~~ 224 (536)
+|||||||+||+|.+++.+.+++++..++.++.||+.||+|||++|||||||||+|||++.+| .+||+|||+|+.+...
T Consensus 125 ~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 125 VNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred EEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 999999999999999999889999999999999999999999999999999999999999988 6999999999876543
Q ss_pred hcc---cCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH-HHHHHhhCCCCCCCCCCCcCc
Q 009364 225 ATV---SGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE-VAALFHIGTTKSHPPIPENLS 300 (536)
Q Consensus 225 ~~~---~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~s 300 (536)
... ......+||+.|||||++.+..|+.++|||||||++|||+||++||.+.... ....+.. .......+++.++
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~-~~~~~~~~~~~~s 283 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS-EPPPIREIPPSCA 283 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHH-SCCGGGGSCTTSC
T ss_pred CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHc-CCCCchhcCccCC
Confidence 211 1234578999999999999999999999999999999999999999754321 1111111 1122234677899
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHH-------------HhCCCCcCC
Q 009364 301 VKAKDFLLKCLEKEPDLRPTASEL-------------LKHPFVTGD 333 (536)
Q Consensus 301 ~~~~dLi~~cL~~dP~~Rps~~ei-------------L~hp~~~~~ 333 (536)
+++++||.+||++||.+|||+.|+ |+|||+...
T Consensus 284 ~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~ 329 (336)
T 4g3f_A 284 PLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEY 329 (336)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCC
Confidence 999999999999999999999998 579998754
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-57 Score=477.51 Aligned_cols=263 Identities=25% Similarity=0.404 Sum_probs=215.6
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec-
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE- 142 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~- 142 (536)
..++|++++.||+|+||+||+|+++.+|+.||||++... .......+.+.+|+++|+.++|||||++++++..
T Consensus 52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~------~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 125 (398)
T 4b99_A 52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNA------FDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPT 125 (398)
T ss_dssp CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTT------TSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCS
T ss_pred CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcc------ccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecc
Confidence 456899999999999999999999999999999998321 1122334667899999999999999999998764
Q ss_pred -----CCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCc
Q 009364 143 -----EESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGA 217 (536)
Q Consensus 143 -----~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGl 217 (536)
.+.+|||||||. |+|.+++.+.+++++..++.+++||+.||+|||++|||||||||+|||++.+|.+||+|||+
T Consensus 126 ~~~~~~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGl 204 (398)
T 4b99_A 126 VPYGEFKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGM 204 (398)
T ss_dssp SCTTTCCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred cccccCCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecce
Confidence 367899999995 67999999889999999999999999999999999999999999999999999999999999
Q ss_pred chhhhhhh--cccCCcccCCCCCCCChhhhhhc-CCCccceEechhHHHHHHhhCCCCCchhhHH--HHHHHhhCCC---
Q 009364 218 SKQVAELA--TVSGAKSMKGTPYWMAPEVIRQT-GHSYSADIWSVGCTVIEMATGKPPWSQQYQE--VAALFHIGTT--- 289 (536)
Q Consensus 218 a~~~~~~~--~~~~~~~~~Gt~~Y~APEvl~~~-~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~--~~~~~~~~~~--- 289 (536)
|+.+.... ......+.+||+.|||||++.+. .|+.++||||+|||+|||++|++||.+.... ...+......
T Consensus 205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~ 284 (398)
T 4b99_A 205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSP 284 (398)
T ss_dssp CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCG
T ss_pred eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 98764321 12234578999999999998875 5699999999999999999999999754321 1111111000
Q ss_pred ------------------CCCCC-----CCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 290 ------------------KSHPP-----IPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 290 ------------------~~~~~-----~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
....+ +.+.+++++++||.+||++||.+|||+.|+|+||||+..
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 351 (398)
T 4b99_A 285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY 351 (398)
T ss_dssp GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence 00011 123678999999999999999999999999999999864
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-58 Score=464.43 Aligned_cols=257 Identities=25% Similarity=0.380 Sum_probs=202.9
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCC--
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEE-- 144 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~-- 144 (536)
+|++.+.||+|+||+||+|+++.+|+.||||++.... .....+.+.+|+++|+.++|||||+++++|.+.+
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-------~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~ 78 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-------RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTT 78 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-------SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-------CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcc
Confidence 5899999999999999999999999999999985321 2233457889999999999999999999987554
Q ss_pred ----------ceeEEEEecCCCCcccccccCCCC---CHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEE
Q 009364 145 ----------SLNILLEFVPGGSISSLLGKFGPF---PEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIK 211 (536)
Q Consensus 145 ----------~~~lV~E~~~gg~L~~~l~~~~~l---~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vk 211 (536)
.+|+|||||+||+|.+++.....+ ++..++.++.||+.||+|||++||+||||||+|||++.+|.+|
T Consensus 79 ~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vK 158 (299)
T 4g31_A 79 EKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVK 158 (299)
T ss_dssp --------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEE
T ss_pred ccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEE
Confidence 379999999999999999876543 4566889999999999999999999999999999999999999
Q ss_pred EEecCcchhhhhhhcc----------cCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHH
Q 009364 212 LADFGASKQVAELATV----------SGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVA 281 (536)
Q Consensus 212 L~DFGla~~~~~~~~~----------~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~ 281 (536)
|+|||+|+.+...... ....+.+||+.|||||++.+..|+.++|||||||++|||++ ||........
T Consensus 159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~ 235 (299)
T 4g31_A 159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVR 235 (299)
T ss_dssp ECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred EccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHH
Confidence 9999999876543211 12345689999999999999999999999999999999996 8866544333
Q ss_pred HHHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCC
Q 009364 282 ALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDD 334 (536)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~ 334 (536)
.+...... ..++.+...++.+++||++||++||.+|||+.|+|+||||....
T Consensus 236 ~~~~~~~~-~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~ 287 (299)
T 4g31_A 236 TLTDVRNL-KFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD 287 (299)
T ss_dssp HHHHHHTT-CCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred HHHHHhcC-CCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence 33222222 22333345677889999999999999999999999999998654
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-57 Score=456.31 Aligned_cols=254 Identities=26% Similarity=0.458 Sum_probs=214.0
Q ss_pred CCCceeeeEEcccCceEEEEEEEc-----CCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeee
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNL-----DSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGT 139 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~ 139 (536)
..+|.+.+.||+|+||+||+|++. .+|..||||++.. ......+.+.+|+++|++++|||||+++|+
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~--------~~~~~~~~f~~E~~il~~l~HpnIV~l~g~ 83 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD--------ASDNARKDFHREAELLTNLQHEHIVKFYGV 83 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECS--------CCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCC--------CChHHHHHHHHHHHHHHhCCCCCCccEEEE
Confidence 357999999999999999999875 3588999999832 122345678999999999999999999999
Q ss_pred eecCCceeEEEEecCCCCcccccccC-------------CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCC
Q 009364 140 VREEESLNILLEFVPGGSISSLLGKF-------------GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDN 206 (536)
Q Consensus 140 ~~~~~~~~lV~E~~~gg~L~~~l~~~-------------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~ 206 (536)
+.+.+.++||||||+||+|.+++.+. ..+++..+..++.||+.||+|||+++||||||||+|||++.
T Consensus 84 ~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~ 163 (299)
T 4asz_A 84 CVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGE 163 (299)
T ss_dssp ECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred EeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECC
Confidence 99999999999999999999999653 36999999999999999999999999999999999999999
Q ss_pred CCcEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhH-HHHHHH
Q 009364 207 KGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQ-EVAALF 284 (536)
Q Consensus 207 ~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~-~~~~~~ 284 (536)
++.+||+|||+|+..............+||+.|||||++.+..|+.++|||||||++|||+| |++||.+... ++...+
T Consensus 164 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i 243 (299)
T 4asz_A 164 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI 243 (299)
T ss_dssp GGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred CCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 99999999999987765433333445679999999999999999999999999999999998 8999976432 333333
Q ss_pred hhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCc
Q 009364 285 HIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVT 331 (536)
Q Consensus 285 ~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~ 331 (536)
..+ ..++.|..+++++.+||.+||+.||++|||+.+|+ +|+.
T Consensus 244 ~~~---~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~ 285 (299)
T 4asz_A 244 TQG---RVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQ 285 (299)
T ss_dssp HHT---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHH
T ss_pred HcC---CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHH
Confidence 222 23456778999999999999999999999999994 4553
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-57 Score=489.05 Aligned_cols=362 Identities=25% Similarity=0.351 Sum_probs=283.9
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
.+|++.+.||+|+||+||+|.+..+|+.||+|++...... ......+.+|+.+|+.++||||+++++++.+...
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 95 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK------NKDTSTILREVELLKKLDHPNIMKLFEILEDSSS 95 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHB------CSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEeccccc------chHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCE
Confidence 3799999999999999999999999999999998432211 1123567899999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccC---CCCcEEEEecCcchhhh
Q 009364 146 LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVD---NKGCIKLADFGASKQVA 222 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~---~~~~vkL~DFGla~~~~ 222 (536)
+++|||||.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++...
T Consensus 96 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 999999999999999998888999999999999999999999999999999999999995 45679999999998664
Q ss_pred hhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhH-HHHHHHhhCCCCCCCCCCCcCcH
Q 009364 223 ELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQ-EVAALFHIGTTKSHPPIPENLSV 301 (536)
Q Consensus 223 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~s~ 301 (536)
... .....+||+.|+|||++.+ .++.++|||||||++|+|++|.+||..... +....+.........+.+..+++
T Consensus 176 ~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 251 (486)
T 3mwu_A 176 QNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISD 251 (486)
T ss_dssp CC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCH
T ss_pred CCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCH
Confidence 322 2345689999999999986 599999999999999999999999976432 23333333333333334457899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCCCCcchhhc------c---ccccccCCh-------hHHhhh-hhhhcc
Q 009364 302 KAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDPVLHAS------V---MKSSEILSP-------SHVANL-ESLQML 364 (536)
Q Consensus 302 ~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~~~~~~~~~------~---~~~~~~~~~-------~~~~~l-~s~q~~ 364 (536)
++++||.+||+.||.+|||+.|+|+||||+........... . ++.+..... .....+ ...+..
T Consensus 252 ~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ia~~l~~~~~~~ 331 (486)
T 3mwu_A 252 DAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTNIRQFQAEKKLAQAALLYMASKLTTLDETK 331 (486)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCCCCCCGGGHHHHHHHHHHHHHHHHSCHHHHHHHHHHHHHHCCHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcccCccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccHHHHH
Confidence 99999999999999999999999999999865432211000 0 011110000 001111 122223
Q ss_pred cCCCCCCCccccCCCccchhhhhh------------hh----------hhhhhhhhhccCCCCCCCccchhhhhhhcccc
Q 009364 365 TSPGSPGSVDICNLDSLSCSRVIV------------EK----------LSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKL 422 (536)
Q Consensus 365 t~~~sf~~~D~~~~g~ls~~el~~------------~~----------~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~ 422 (536)
.....|..+|.+++|.|+.+|+.. ++ .++++.+++.+| .|++|.|+|+||+.++...
T Consensus 332 ~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~D-~d~dG~I~~~Ef~~~~~~~ 410 (486)
T 3mwu_A 332 QLTEIFRKLDTNNDGMLDRDELVRGYHEFMRLKGVDSNSLIQNEGSTIEDQIDSLMPLLD-MDGSGSIEYSEFIASAIDR 410 (486)
T ss_dssp HHHHHHHHHCTTCSSSBCHHHHHHHHHHHHHHHTCCGGGHHHHTSSCHHHHHHHHHHHHC-TTCCSSBCHHHHHHHHSCT
T ss_pred HHHHHHHHhCCCCCceeeHHHHHHHHHHhhhhhcccchhcccccchhhHHHHHHHHHHhc-CCCCCcCcHHHHHHHHHhh
Confidence 345579999999999999999943 12 778999999999 8999999999999877766
Q ss_pred cccCChhhhhhccCCC
Q 009364 423 SSILAPNDLEKSRNPM 438 (536)
Q Consensus 423 ~~~~~~e~l~~aF~~~ 438 (536)
.....+++++++|+-.
T Consensus 411 ~~~~~~~~~~~~F~~~ 426 (486)
T 3mwu_A 411 TILLSRERMERAFKMF 426 (486)
T ss_dssp TTTCCHHHHHHHHHHH
T ss_pred hccchHHHHHHHHHHh
Confidence 6566777888888754
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-57 Score=487.90 Aligned_cols=362 Identities=26% Similarity=0.357 Sum_probs=281.1
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
.+|++++.||+|+||+||+|++..++..||+|++..... .......+.+|+.+|+.++||||+++++++.+...
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 110 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSV------STSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRN 110 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEecccc------CchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence 479999999999999999999999999999999853221 11123567889999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCC---CcEEEEecCcchhhh
Q 009364 146 LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNK---GCIKLADFGASKQVA 222 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~---~~vkL~DFGla~~~~ 222 (536)
+++|||||+||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.. +.+||+|||+++...
T Consensus 111 ~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 111 YYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 99999999999999999888889999999999999999999999999999999999999764 459999999998765
Q ss_pred hhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhH-HHHHHHhhCCCCCCCCCCCcCcH
Q 009364 223 ELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQ-EVAALFHIGTTKSHPPIPENLSV 301 (536)
Q Consensus 223 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~s~ 301 (536)
.. ......+||+.|+|||++.+ .++.++|||||||++|+|++|.+||..... +..............+.+..++.
T Consensus 191 ~~---~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 266 (494)
T 3lij_A 191 NQ---KKMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSE 266 (494)
T ss_dssp TT---BCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCH
T ss_pred CC---ccccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCH
Confidence 42 22456789999999999875 699999999999999999999999976543 33333333333333344457899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCC-------CCcchhhc--cccccccCC---hhHHh----hh-hhhhcc
Q 009364 302 KAKDFLLKCLEKEPDLRPTASELLKHPFVTGDD-------EDPVLHAS--VMKSSEILS---PSHVA----NL-ESLQML 364 (536)
Q Consensus 302 ~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~-------~~~~~~~~--~~~~~~~~~---~~~~~----~l-~s~q~~ 364 (536)
.+++||++||+.||.+|||+.|+|+||||.... ..+..... .++.+.... ..... .+ ...+..
T Consensus 267 ~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~qa~l~~ia~~~~~~~~~~ 346 (494)
T 3lij_A 267 GAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRKFQNSQKLAQAALLYMASKLTSQEETK 346 (494)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHHHHHHC---CCCCSSHHHHHHTTTTCCHHHHHHHHHHHHHSCCHHHHH
T ss_pred HHHHHHHHHCCCChhhCccHHHHhcCcccccCcccccccccccccHHHHHHHHHHHHhHHHHHHHHHHHHHhcccHHHHH
Confidence 999999999999999999999999999997421 01110000 011111111 00000 01 122223
Q ss_pred cCCCCCCCccccCCCccchhhhhh----------------hhhhhhhhhhhccCCCCCCCccchhhhhhhcccccccCCh
Q 009364 365 TSPGSPGSVDICNLDSLSCSRVIV----------------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSSILAP 428 (536)
Q Consensus 365 t~~~sf~~~D~~~~g~ls~~el~~----------------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~~~~~ 428 (536)
.....|..+|.+++|.|+.+|+.. .+.++++.+++.+| .|++|.|+|+||+.++........+
T Consensus 347 ~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~D-~d~~G~I~~~EF~~~~~~~~~~~~~ 425 (494)
T 3lij_A 347 ELTDIFRHIDKNGDGQLDRQELIDGYSKLSGEEVAVFDLPQIESEVDAILGAAD-FDRNGYIDYSEFVTVAMDRKSLLSK 425 (494)
T ss_dssp HHHHHHHHHCTTCSSEECHHHHHHTTHHHHSSCCCCC--CHHHHHHHHHHHHHC-TTCSSSEEHHHHHHHHSCHHHHTCH
T ss_pred HHHHHHHHhCcCCCCeEcHHHHHHHHHHhcccccccccccccHHHHHHHHHHhC-CCCCCcCcHHHHHHHHHhhhccccH
Confidence 344569999999999999999964 23789999999999 8999999999999887766556677
Q ss_pred hhhhhccCCC
Q 009364 429 NDLEKSRNPM 438 (536)
Q Consensus 429 e~l~~aF~~~ 438 (536)
++++++|+-.
T Consensus 426 ~~~~~~F~~~ 435 (494)
T 3lij_A 426 DKLESAFQKF 435 (494)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 8888888754
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-56 Score=486.11 Aligned_cols=370 Identities=23% Similarity=0.300 Sum_probs=285.5
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccc-----hhHHHHHHHHHHHHHHHHHhCCCCceeeEee
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFAS-----KEKAQDHIKELEEEVKLLKDLSHPNIVRYLG 138 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~-----~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~ 138 (536)
...+|++++.||+|+||+||+|.+..+++.||+|++........ ........+.+.+|+.+|+.++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 34689999999999999999999999999999999853221100 0001123467889999999999999999999
Q ss_pred eeecCCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCC---cEEEEec
Q 009364 139 TVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKG---CIKLADF 215 (536)
Q Consensus 139 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~---~vkL~DF 215 (536)
++.+...+++|||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+||
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df 193 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDF 193 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEEC
Confidence 9999999999999999999999998888999999999999999999999999999999999999998776 6999999
Q ss_pred CcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhH-HHHHHHhhCCCCCCCC
Q 009364 216 GASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQ-EVAALFHIGTTKSHPP 294 (536)
Q Consensus 216 Gla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~-~~~~~~~~~~~~~~~~ 294 (536)
|+++..... ......+||+.|+|||++.+ .++.++|||||||++|+|++|.+||..... .....+.........+
T Consensus 194 g~a~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 269 (504)
T 3q5i_A 194 GLSSFFSKD---YKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFN 269 (504)
T ss_dssp TTCEECCTT---SCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHH
T ss_pred CCCEEcCCC---CccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcc
Confidence 999876542 22456789999999999875 699999999999999999999999976543 2333333332222222
Q ss_pred CCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCCCCcchh-----hcc---ccccccCChh--HH-----hhh-
Q 009364 295 IPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDPVLH-----ASV---MKSSEILSPS--HV-----ANL- 358 (536)
Q Consensus 295 ~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~~~~~~~-----~~~---~~~~~~~~~~--~~-----~~l- 358 (536)
.+..++.++++||++||++||.+|||+.|+|+||||+......... ... ++.+...... .. ..+
T Consensus 270 ~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~~a~l~~i~~~~~ 349 (504)
T 3q5i_A 270 DWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNMRKFEGSQKLAQAAILFIGSKLT 349 (504)
T ss_dssp HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCCCCGGGHHHHHHHHHHHHHCCCCSHHHHHHHHHHHHHTS
T ss_pred ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhcccccchhhHHHHHHHHHHHHHHHHHHHHHHHHhhccCC
Confidence 3357899999999999999999999999999999997654332100 000 1111111100 00 011
Q ss_pred hhhhcccCCCCCCCccccCCCccchhhhhh----------------hhhhhhhhhhhccCCCCCCCccchhhhhhhcccc
Q 009364 359 ESLQMLTSPGSPGSVDICNLDSLSCSRVIV----------------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKL 422 (536)
Q Consensus 359 ~s~q~~t~~~sf~~~D~~~~g~ls~~el~~----------------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~ 422 (536)
...+.......|..+|.+++|.|+.+|+.. .+.++++.+++.+| .|++|.|+|+||+.++...
T Consensus 350 ~~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~D-~d~dG~I~~~EF~~~~~~~ 428 (504)
T 3q5i_A 350 TLEERKELTDIFKKLDKNGDGQLDKKELIEGYNVLRNFKNELGELKNVEEEVDNILKEVD-FDKNGYIEYSEFISVCMDK 428 (504)
T ss_dssp CHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHHHC--CCSCCCHHHHHHHHHHHHC-TTCSSSEEHHHHHHHHSCH
T ss_pred cHHHHHHHHHHHHeeCCCCCCeEcHHHHHHHHHHhhhcccccccccccHHHHHHHHHHhC-CCCCCcEeHHHHHHHHHhh
Confidence 122233345579999999999999999864 24689999999999 8999999999999877766
Q ss_pred cccCChhhhhhccCCC
Q 009364 423 SSILAPNDLEKSRNPM 438 (536)
Q Consensus 423 ~~~~~~e~l~~aF~~~ 438 (536)
.....+++++++|+-.
T Consensus 429 ~~~~~~~~~~~~F~~~ 444 (504)
T 3q5i_A 429 QILFSEERLRRAFNLF 444 (504)
T ss_dssp HHHTCHHHHHHHHHHH
T ss_pred hcccCHHHHHHHHHHh
Confidence 5566777888888754
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-56 Score=451.38 Aligned_cols=255 Identities=26% Similarity=0.455 Sum_probs=204.9
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE 142 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 142 (536)
.+..++++++.||+|+||+||+|++. ..||||++... .......+.+.+|+.+|++++|||||++++++.+
T Consensus 33 i~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~------~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~ 103 (307)
T 3omv_A 33 IEASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVV------DPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK 103 (307)
T ss_dssp CCTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCS------SCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred EcHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEec------CCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC
Confidence 34567889999999999999999753 35999987421 1123445778999999999999999999998864
Q ss_pred CCceeEEEEecCCCCccccccc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhh
Q 009364 143 EESLNILLEFVPGGSISSLLGK-FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQV 221 (536)
Q Consensus 143 ~~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~ 221 (536)
+.++||||||+||+|.+++.. .+++++..+..|+.||+.||+|||+++||||||||+|||++.++.+||+|||+|+..
T Consensus 104 -~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 182 (307)
T 3omv_A 104 -DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVK 182 (307)
T ss_dssp -SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-
T ss_pred -CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceec
Confidence 568999999999999999865 467999999999999999999999999999999999999999999999999999876
Q ss_pred hhhhcccCCcccCCCCCCCChhhhhh---cCCCccceEechhHHHHHHhhCCCCCchhh--HHHHHHHhhCC-CCCCCCC
Q 009364 222 AELATVSGAKSMKGTPYWMAPEVIRQ---TGHSYSADIWSVGCTVIEMATGKPPWSQQY--QEVAALFHIGT-TKSHPPI 295 (536)
Q Consensus 222 ~~~~~~~~~~~~~Gt~~Y~APEvl~~---~~~s~k~DIwSlGvil~eLltG~~Pf~~~~--~~~~~~~~~~~-~~~~~~~ 295 (536)
............+||+.|||||++.+ ..|+.++|||||||++|||+||++||.+.. ........... ....+..
T Consensus 183 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~ 262 (307)
T 3omv_A 183 SRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKL 262 (307)
T ss_dssp -----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTS
T ss_pred ccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccc
Confidence 55443344567789999999999974 358999999999999999999999997533 22222222221 2223456
Q ss_pred CCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 296 PENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 296 ~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
+..++.++++||.+||+.||++|||+.||+++
T Consensus 263 ~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 263 YKNCPKAMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp CTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred cccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 67899999999999999999999999988654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-56 Score=456.23 Aligned_cols=252 Identities=25% Similarity=0.426 Sum_probs=206.3
Q ss_pred CCCceeeeEEcccCceEEEEEEEc-----CCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeee
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNL-----DSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGT 139 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~ 139 (536)
..+|.+.+.||+|+||+||+|++. .+++.||||++.. ......+.+.+|+++|++++|||||+++|+
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~--------~~~~~~~~f~~E~~il~~l~HpnIV~l~g~ 111 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE--------ASESARQDFQREAELLTMLQHQHIVRFFGV 111 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESC--------CSHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECc--------CCHHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 356889999999999999999865 3688999999832 122345678999999999999999999999
Q ss_pred eecCCceeEEEEecCCCCcccccccC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCccc
Q 009364 140 VREEESLNILLEFVPGGSISSLLGKF---------------GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILV 204 (536)
Q Consensus 140 ~~~~~~~~lV~E~~~gg~L~~~l~~~---------------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl 204 (536)
|.+.+.++||||||++|+|.+++.+. +++++..+..|+.||+.||+|||+++||||||||+|||+
T Consensus 112 ~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl 191 (329)
T 4aoj_A 112 CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV 191 (329)
T ss_dssp ECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred EEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEE
Confidence 99999999999999999999998653 358999999999999999999999999999999999999
Q ss_pred CCCCcEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhH-HHHH
Q 009364 205 DNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQ-EVAA 282 (536)
Q Consensus 205 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~-~~~~ 282 (536)
+.++.+||+|||+|+.+............+||+.|||||++.+..|+.++|||||||++|||+| |++||.+... +...
T Consensus 192 ~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~ 271 (329)
T 4aoj_A 192 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID 271 (329)
T ss_dssp ETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHH
T ss_pred CCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999999999987655433333456789999999999999999999999999999999999 8999976432 2222
Q ss_pred HHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 283 LFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 283 ~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
.+..+ ..++.|..+++++.+||.+||+.||++|||+.||+++
T Consensus 272 ~i~~g---~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 272 CITQG---RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHHHT---CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred HHHcC---CCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 22222 3456678899999999999999999999999999875
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-56 Score=453.09 Aligned_cols=254 Identities=25% Similarity=0.418 Sum_probs=215.6
Q ss_pred CCCCceeeeEEcccCceEEEEEEEc-----CCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEee
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNL-----DSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLG 138 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~ 138 (536)
+...+++.+.||+|+||+||+|... .+++.||||++.... .....+.+.+|+.+|++++|||||+++|
T Consensus 24 ~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-------~~~~~~~f~~E~~il~~l~HpNIV~l~g 96 (308)
T 4gt4_A 24 SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-------EGPLREEFRHEAMLRARLQHPNVVCLLG 96 (308)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-------CC-CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-------ChHHHHHHHHHHHHHHhCCCCCCCCcce
Confidence 3456888999999999999999863 467899999884211 1123457889999999999999999999
Q ss_pred eeecCCceeEEEEecCCCCcccccccC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCc
Q 009364 139 TVREEESLNILLEFVPGGSISSLLGKF----------------GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANI 202 (536)
Q Consensus 139 ~~~~~~~~~lV~E~~~gg~L~~~l~~~----------------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NI 202 (536)
++.+++.+++|||||++|+|.++|... ..+++..+..++.||+.||+|||+++||||||||+||
T Consensus 97 ~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NI 176 (308)
T 4gt4_A 97 VVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNV 176 (308)
T ss_dssp EECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccce
Confidence 999999999999999999999998542 3589999999999999999999999999999999999
Q ss_pred ccCCCCcEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhH-HH
Q 009364 203 LVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQ-EV 280 (536)
Q Consensus 203 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~-~~ 280 (536)
||++++.+||+|||+|+.+............+||+.|||||++.+..|+.++|||||||++|||+| |.+||.+... ++
T Consensus 177 Ll~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~ 256 (308)
T 4gt4_A 177 LVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV 256 (308)
T ss_dssp EECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHH
T ss_pred EECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999999988765444444566789999999999999999999999999999999998 8999976543 33
Q ss_pred HHHHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 281 AALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
...+. .....+.|..++.++.+||.+||+.||.+|||+.||+++
T Consensus 257 ~~~i~---~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 257 VEMIR---NRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHHH---TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHH---cCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 33222 233456778999999999999999999999999999876
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-56 Score=493.24 Aligned_cols=266 Identities=27% Similarity=0.433 Sum_probs=223.0
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
++|++++.||+|+||+||+|+++.+|+.||||++.+..... ............++.+++.++|||||+++++|.+.+.
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~--~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ 266 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM--KQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 266 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH--TTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcch--hhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCE
Confidence 57999999999999999999999999999999985322111 1111223333456778888899999999999999999
Q ss_pred eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhh
Q 009364 146 LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA 225 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 225 (536)
+|+|||||+||+|.++|.+.+.+++..++.++.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+...
T Consensus 267 lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~- 345 (689)
T 3v5w_A 267 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK- 345 (689)
T ss_dssp EEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCC-
Confidence 9999999999999999999899999999999999999999999999999999999999999999999999999876432
Q ss_pred cccCCcccCCCCCCCChhhhh-hcCCCccceEechhHHHHHHhhCCCCCchhhH-HHHHHHhhCCCCCCCCCCCcCcHHH
Q 009364 226 TVSGAKSMKGTPYWMAPEVIR-QTGHSYSADIWSVGCTVIEMATGKPPWSQQYQ-EVAALFHIGTTKSHPPIPENLSVKA 303 (536)
Q Consensus 226 ~~~~~~~~~Gt~~Y~APEvl~-~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~s~~~ 303 (536)
...+.+||+.|||||++. +..|+.++||||||||+|||++|.+||.+... ....+... .......+|..+|+++
T Consensus 346 ---~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~-i~~~~~~~p~~~S~~a 421 (689)
T 3v5w_A 346 ---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM-TLTMAVELPDSFSPEL 421 (689)
T ss_dssp ---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHH-HHHCCCCCCTTSCHHH
T ss_pred ---CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh-hcCCCCCCCccCCHHH
Confidence 345789999999999996 46899999999999999999999999975321 11111111 1112345677899999
Q ss_pred HHHHHHhcccCCCCCCC-----HHHHHhCCCCcCCCCCcc
Q 009364 304 KDFLLKCLEKEPDLRPT-----ASELLKHPFVTGDDEDPV 338 (536)
Q Consensus 304 ~dLi~~cL~~dP~~Rps-----~~eiL~hp~~~~~~~~~~ 338 (536)
++||.+||++||.+|++ ++||++||||++.+++..
T Consensus 422 ~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l 461 (689)
T 3v5w_A 422 RSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMV 461 (689)
T ss_dssp HHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHH
T ss_pred HHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHH
Confidence 99999999999999998 899999999998766543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-57 Score=488.77 Aligned_cols=363 Identities=23% Similarity=0.340 Sum_probs=284.0
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
.+|++.+.||+|+||+||+|.+..+|+.||||++....... ......+.+|+.+++.++||||+++++++.+.+.
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 100 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQ-----KTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGY 100 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCB-----SSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhccc-----chHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 57999999999999999999999999999999984322111 1223567899999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCccc---CCCCcEEEEecCcchhhh
Q 009364 146 LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILV---DNKGCIKLADFGASKQVA 222 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl---~~~~~vkL~DFGla~~~~ 222 (536)
+++|||||.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.+.
T Consensus 101 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 180 (484)
T 3nyv_A 101 FYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180 (484)
T ss_dssp EEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence 99999999999999999888899999999999999999999999999999999999999 467899999999998664
Q ss_pred hhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhH-HHHHHHhhCCCCCCCCCCCcCcH
Q 009364 223 ELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQ-EVAALFHIGTTKSHPPIPENLSV 301 (536)
Q Consensus 223 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~s~ 301 (536)
.. ......+||+.|+|||++.+ .++.++|||||||++|+|++|.+||..... +....+.........+.+..+++
T Consensus 181 ~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 256 (484)
T 3nyv_A 181 AS---KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSE 256 (484)
T ss_dssp CC---CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCH
T ss_pred cc---cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCH
Confidence 32 12345679999999999977 699999999999999999999999976432 22333333333333334457899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCCCCc------chhhcc--cccccc---CCh---hH-Hhhh-hhhhccc
Q 009364 302 KAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDP------VLHASV--MKSSEI---LSP---SH-VANL-ESLQMLT 365 (536)
Q Consensus 302 ~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~~~~------~~~~~~--~~~~~~---~~~---~~-~~~l-~s~q~~t 365 (536)
++++||++||++||.+|||+.|+|+||||+...... ...... ++.+.. +.. .. ...+ ...+...
T Consensus 257 ~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~qa~l~~i~~~~~~~~~~~~ 336 (484)
T 3nyv_A 257 SAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGTQKLAQAALLYMGSKLTSQDETKE 336 (484)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC-----CCCBCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhhChhhcccccccccccccchHHHHHHHHHHhhhhHHHHHHHHHHHhccCcHHHHHH
Confidence 999999999999999999999999999997543211 111100 000000 000 00 0011 2222334
Q ss_pred CCCCCCCccccCCCccchhhhhh------------hh-------hhhhhhhhhccCCCCCCCccchhhhhhhcccccccC
Q 009364 366 SPGSPGSVDICNLDSLSCSRVIV------------EK-------LSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSSIL 426 (536)
Q Consensus 366 ~~~sf~~~D~~~~g~ls~~el~~------------~~-------~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~~~ 426 (536)
....|..+|.+++|.|+.+|+.. ++ .++++.+|+.+| .|++|.|+|+||+.++.......
T Consensus 337 l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~D-~d~~g~i~~~Ef~~~~~~~~~~~ 415 (484)
T 3nyv_A 337 LTAIFHKMDKNGDGQLDRAELIEGYKELMRMKGQDASMLDASAVEHEVDQVLDAVD-FDKNGYIEYSEFVTVAMDRKTLL 415 (484)
T ss_dssp HHHHHHHHCTTCSSEEEHHHHHHHHHHHHC----CGGGCSHHHHHHHHHHHHHHHT-CCTTSEEEHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhCcCCCceEeHHHHHHHHHHHhhhcccccccccccccHHHHHHHHHHhC-CCCCCeEeHHHHHHHHHhccccC
Confidence 45569999999999999999942 22 689999999999 89999999999998766554445
Q ss_pred ChhhhhhccCCC
Q 009364 427 APNDLEKSRNPM 438 (536)
Q Consensus 427 ~~e~l~~aF~~~ 438 (536)
.+++++++|+-.
T Consensus 416 ~~~~~~~~F~~~ 427 (484)
T 3nyv_A 416 SRERLERAFRMF 427 (484)
T ss_dssp HHHHHHHHHHHH
T ss_pred cHHHHHHHHHHH
Confidence 567788888754
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-56 Score=459.99 Aligned_cols=255 Identities=25% Similarity=0.415 Sum_probs=204.6
Q ss_pred CCCceeeeEEcccCceEEEEEEEc---CCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeEeeee
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNL---DSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRYLGTV 140 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~ 140 (536)
.++|++.+.||+|+||+||+|+++ .+++.||+|++... . ....+.+|+++|+.+ +||||++++++|
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~-------~---~~~~~~~E~~~l~~~~~h~nIv~l~~~~ 89 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT-------S---HPIRIAAELQCLTVAGGQDNVMGVKYCF 89 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT-------S---CHHHHHHHHHHHHHTCSBTTBCCCSEEE
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc-------c---CHHHHHHHHHHHHHhcCCCCCceEEEEE
Confidence 358999999999999999999875 46789999987321 1 123467899999998 699999999999
Q ss_pred ecCCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCC-CcEEEEecCcch
Q 009364 141 REEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNK-GCIKLADFGASK 219 (536)
Q Consensus 141 ~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~-~~vkL~DFGla~ 219 (536)
.+.+.+|+|||||+||+|.+++. .+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+
T Consensus 90 ~~~~~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 90 RKNDHVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp EETTEEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EECCEEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 99999999999999999999984 58999999999999999999999999999999999999876 799999999997
Q ss_pred hhhhhhc--------------------------ccCCcccCCCCCCCChhhhhhc-CCCccceEechhHHHHHHhhCCCC
Q 009364 220 QVAELAT--------------------------VSGAKSMKGTPYWMAPEVIRQT-GHSYSADIWSVGCTVIEMATGKPP 272 (536)
Q Consensus 220 ~~~~~~~--------------------------~~~~~~~~Gt~~Y~APEvl~~~-~~s~k~DIwSlGvil~eLltG~~P 272 (536)
....... .....+.+||++|||||++.+. .|+.++||||+|||+|+|++|++|
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence 5432110 1123456899999999999875 589999999999999999999999
Q ss_pred CchhhHHH---HHHHhh-----------------------------------C--------------CCCCCCCCCCcCc
Q 009364 273 WSQQYQEV---AALFHI-----------------------------------G--------------TTKSHPPIPENLS 300 (536)
Q Consensus 273 f~~~~~~~---~~~~~~-----------------------------------~--------------~~~~~~~~~~~~s 300 (536)
|.....+. ..+... . ........+..+|
T Consensus 247 f~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is 326 (361)
T 4f9c_A 247 FYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVP 326 (361)
T ss_dssp SSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCC
T ss_pred CCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCC
Confidence 95322111 111000 0 0000111234689
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhCCCCcC
Q 009364 301 VKAKDFLLKCLEKEPDLRPTASELLKHPFVTG 332 (536)
Q Consensus 301 ~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~ 332 (536)
++++|||++||++||++|||++|+|+||||++
T Consensus 327 ~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~ 358 (361)
T 4f9c_A 327 DEAYDLLDKLLDLNPASRITAEEALLHPFFKD 358 (361)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred HHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 99999999999999999999999999999975
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-55 Score=478.84 Aligned_cols=259 Identities=25% Similarity=0.420 Sum_probs=223.6
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
++|++++.||+|+||+||+|+++.+|+.||+|++... .....+.+.+|+.+|+.++|||||+++++|.+...
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~--------~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~ 228 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--------HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE 228 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSE
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc--------chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence 5899999999999999999999999999999988431 11224567899999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccc-cCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCC--CcEEEEecCcchhhh
Q 009364 146 LNILLEFVPGGSISSLLG-KFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNK--GCIKLADFGASKQVA 222 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~-~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~--~~vkL~DFGla~~~~ 222 (536)
+|+|||||+||+|.+++. +.+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.+.
T Consensus 229 ~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~ 308 (573)
T 3uto_A 229 MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308 (573)
T ss_dssp EEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred EEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence 999999999999999885 44689999999999999999999999999999999999999854 799999999998775
Q ss_pred hhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhH-HHHHHHhhCCCCCCCCCCCcCcH
Q 009364 223 ELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQ-EVAALFHIGTTKSHPPIPENLSV 301 (536)
Q Consensus 223 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~s~ 301 (536)
... .....+||+.|||||++.+..|+.++|||||||++|+|++|.+||.+... +....+...........+..+|.
T Consensus 309 ~~~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 385 (573)
T 3uto_A 309 PKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE 385 (573)
T ss_dssp TTS---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCH
T ss_pred CCC---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCH
Confidence 432 24567899999999999999999999999999999999999999976543 22233333333333444568999
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCCC
Q 009364 302 KAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDE 335 (536)
Q Consensus 302 ~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~~ 335 (536)
++++||++||++||.+|||+.|+|+||||+....
T Consensus 386 ~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~ 419 (573)
T 3uto_A 386 DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 419 (573)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCC
Confidence 9999999999999999999999999999986543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-55 Score=451.74 Aligned_cols=255 Identities=27% Similarity=0.455 Sum_probs=214.9
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCC-----CcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCC-CceeeE
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDS-----GELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH-PNIVRY 136 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~-----g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~H-pnIv~l 136 (536)
.+..+|++++.||+|+||+||+|.+..+ ++.||||.+.. .......+.+.+|+++|++++| ||||++
T Consensus 61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~-------~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKE-------GATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECT-------TCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcc-------ccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 4556899999999999999999998654 36799998732 1222345678899999999965 899999
Q ss_pred eeeeecC-CceeEEEEecCCCCcccccccC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCC
Q 009364 137 LGTVREE-ESLNILLEFVPGGSISSLLGKF----------------GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKG 199 (536)
Q Consensus 137 ~~~~~~~-~~~~lV~E~~~gg~L~~~l~~~----------------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp 199 (536)
+|+|... +.+++|||||++|+|.++|.+. ..+++..+..++.||+.||+|||+++||||||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~ 213 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAA 213 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCc
Confidence 9998764 5689999999999999998642 3489999999999999999999999999999999
Q ss_pred CCcccCCCCcEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhh-
Q 009364 200 ANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQY- 277 (536)
Q Consensus 200 ~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~- 277 (536)
+|||++.++.+||+|||+|+.+............+||+.|||||++.+..|+.++|||||||++|||+| |.+||.+..
T Consensus 214 ~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~ 293 (353)
T 4ase_A 214 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 293 (353)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred cceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987654433333456789999999999999999999999999999999998 999997532
Q ss_pred -HHHHHHHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 278 -QEVAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 278 -~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
.........+ ..++.|..+++++++||.+||+.||.+|||+.||++|
T Consensus 294 ~~~~~~~i~~g---~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 294 DEEFCRRLKEG---TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp SHHHHHHHHHT---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcC---CCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 3333333322 3456677899999999999999999999999999998
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-51 Score=420.46 Aligned_cols=256 Identities=27% Similarity=0.469 Sum_probs=222.9
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
.+|++.+.||+|+||+||+|.+..+|+.||||++.... ......+.+.+|+++|+.++||||+++++++...+.
T Consensus 15 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 88 (328)
T 3fe3_A 15 GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQ------LNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKT 88 (328)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG------SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred CCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhc------CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCE
Confidence 58999999999999999999999999999999984321 122345678899999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhh
Q 009364 146 LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA 225 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 225 (536)
+++||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 168 (328)
T 3fe3_A 89 LYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG 168 (328)
T ss_dssp EEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred EEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence 99999999999999999888899999999999999999999999999999999999999999999999999998665322
Q ss_pred cccCCcccCCCCCCCChhhhhhcCCC-ccceEechhHHHHHHhhCCCCCchhhH-HHHHHHhhCCCCCCCCCCCcCcHHH
Q 009364 226 TVSGAKSMKGTPYWMAPEVIRQTGHS-YSADIWSVGCTVIEMATGKPPWSQQYQ-EVAALFHIGTTKSHPPIPENLSVKA 303 (536)
Q Consensus 226 ~~~~~~~~~Gt~~Y~APEvl~~~~~s-~k~DIwSlGvil~eLltG~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~s~~~ 303 (536)
.....+||+.|+|||++.+..+. .++|||||||++|+|++|.+||..... ......... ...+|..+++++
T Consensus 169 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~----~~~~p~~~s~~~ 241 (328)
T 3fe3_A 169 ---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG----KYRIPFYMSTDC 241 (328)
T ss_dssp ---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC----CCCCCTTSCHHH
T ss_pred ---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC----CCCCCCCCCHHH
Confidence 24567899999999999988774 899999999999999999999976542 222222222 234566789999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHhCCCCcCCC
Q 009364 304 KDFLLKCLEKEPDLRPTASELLKHPFVTGDD 334 (536)
Q Consensus 304 ~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~ 334 (536)
.+||++||+.||.+|||+.|+++||||....
T Consensus 242 ~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 242 ENLLKRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp HHHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred HHHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 9999999999999999999999999998654
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-51 Score=418.20 Aligned_cols=263 Identities=27% Similarity=0.431 Sum_probs=220.6
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEE 144 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 144 (536)
..+|++++.||+|+||+||+|.+..+|+.||+|++... ......+.+.+|+.+++.++||||+++++++.+.+
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 78 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-------RAVDCPENIKKEICINKMLNHENVVKFYGHRREGN 78 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------------CHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcc-------cccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 46899999999999999999999999999999998422 11223356788999999999999999999999999
Q ss_pred ceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhh
Q 009364 145 SLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAEL 224 (536)
Q Consensus 145 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 224 (536)
..++||||++||+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+...
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 79 IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp EEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred eEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 99999999999999999998888999999999999999999999999999999999999999999999999999876543
Q ss_pred hcccCCcccCCCCCCCChhhhhhcCC-CccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcHHH
Q 009364 225 ATVSGAKSMKGTPYWMAPEVIRQTGH-SYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKA 303 (536)
Q Consensus 225 ~~~~~~~~~~Gt~~Y~APEvl~~~~~-s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 303 (536)
.........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.........................++..+
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 238 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHH
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHH
Confidence 33333456789999999999987765 78999999999999999999999654322111111111122222345789999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHhCCCCcCCC
Q 009364 304 KDFLLKCLEKEPDLRPTASELLKHPFVTGDD 334 (536)
Q Consensus 304 ~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~ 334 (536)
.+||.+||+.||.+|||+.|+++||||....
T Consensus 239 ~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 239 LALLHKILVENPSARITIPDIKKDRWYNKPL 269 (323)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence 9999999999999999999999999998653
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-51 Score=412.88 Aligned_cols=259 Identities=34% Similarity=0.599 Sum_probs=221.1
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE 143 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 143 (536)
...+|++.+.||+|+||+||+|.+..+|+.||+|++..... ...+.+.+|+.+++.++||||+++++++...
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--------PKKELIINEILVMRENKNPNIVNYLDSYLVG 89 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC--------SCHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc--------cHHHHHHHHHHHHhcCCCCCCCeEeEEEEEC
Confidence 44689999999999999999999999999999998843221 1134577899999999999999999999999
Q ss_pred CceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhh
Q 009364 144 ESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAE 223 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 223 (536)
+.+++||||++||+|.+++.+ ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 90 ~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (297)
T 3fxz_A 90 DELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (297)
T ss_dssp TEEEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred CEEEEEEECCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 999999999999999999876 4699999999999999999999999999999999999999999999999999876654
Q ss_pred hhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcHHH
Q 009364 224 LATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKA 303 (536)
Q Consensus 224 ~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 303 (536)
.. ......+||+.|+|||++.+..++.++|||||||++|+|++|..||......................+..++..+
T Consensus 169 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (297)
T 3fxz_A 169 EQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF 246 (297)
T ss_dssp TT--CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHH
T ss_pred cc--cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHH
Confidence 22 2244678999999999999999999999999999999999999999765432221111111222334466899999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 304 KDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 304 ~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
++||.+||+.||.+|||+.|+++||||...
T Consensus 247 ~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 247 RDFLNRCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence 999999999999999999999999999754
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=419.38 Aligned_cols=248 Identities=26% Similarity=0.311 Sum_probs=193.7
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCC-
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEE- 144 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~- 144 (536)
.+|.+.+.||+|+||+||+|++ +|+.||||++.. .... ......|+..+..++|||||++++++..++
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~-------~~~~--~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~ 71 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSS-------REER--SWFREAEIYQTVMLRHENILGFIAADNKDNG 71 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECG-------GGHH--HHHHHHHHHTSTTCCCTTBCCEEEEEEEECS
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECc-------cchh--hHHHHHHHHHHhcCCCCCCCcEEEEEEecCC
Confidence 3588999999999999999987 689999998831 1111 122345777778899999999999998654
Q ss_pred ---ceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHc--------CCccccCCCCCcccCCCCcEEEE
Q 009364 145 ---SLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNH--------GIMHRDIKGANILVDNKGCIKLA 213 (536)
Q Consensus 145 ---~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~--------~ivHrDLKp~NILl~~~~~vkL~ 213 (536)
.+|||||||+||+|.+++.+ .+++++.+..++.|++.||+|||++ +||||||||+|||++.++++||+
T Consensus 72 ~~~~~~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~ 150 (303)
T 3hmm_A 72 TWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 150 (303)
T ss_dssp SSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred CceEEEEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEE
Confidence 57999999999999999976 5689999999999999999999987 99999999999999999999999
Q ss_pred ecCcchhhhhhhcc--cCCcccCCCCCCCChhhhhhc------CCCccceEechhHHHHHHhhCCCCCchh---------
Q 009364 214 DFGASKQVAELATV--SGAKSMKGTPYWMAPEVIRQT------GHSYSADIWSVGCTVIEMATGKPPWSQQ--------- 276 (536)
Q Consensus 214 DFGla~~~~~~~~~--~~~~~~~Gt~~Y~APEvl~~~------~~s~k~DIwSlGvil~eLltG~~Pf~~~--------- 276 (536)
|||+|+........ ......+||+.|||||++.+. .++.++|||||||++|||+||.+||...
T Consensus 151 DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~ 230 (303)
T 3hmm_A 151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 230 (303)
T ss_dssp CCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT
T ss_pred eCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchh
Confidence 99999876543221 123356899999999999764 3678999999999999999998766321
Q ss_pred -------hHHHHHHHhhCCCCCCCCCCCc-----CcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 277 -------YQEVAALFHIGTTKSHPPIPEN-----LSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 277 -------~~~~~~~~~~~~~~~~~~~~~~-----~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
........ ......+.+|.. ++..+.+|+.+||+.||++|||+.||++.
T Consensus 231 ~~~~~~~~~~~~~~~--~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 231 LVPSDPSVEEMRKVV--CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp TSCSSCCHHHHHHHH--TTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred cccccchHHHHHHHH--hcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 11222221 122233344432 34578899999999999999999999874
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-51 Score=426.22 Aligned_cols=260 Identities=29% Similarity=0.431 Sum_probs=207.8
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE 142 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 142 (536)
....+|++.+.||+|+||+||+|++..+|+.||+|++..... ..+.+.+|+.+++.++||||+++++++.+
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 87 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA---------IDENVQREIINHRSLRHPNIVRFKEVILT 87 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT---------SCHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc---------ccHHHHHHHHHHHhCCCCCCCcEEEEEee
Confidence 445789999999999999999999999999999999843211 11346789999999999999999999999
Q ss_pred CCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCc--EEEEecCcchh
Q 009364 143 EESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGC--IKLADFGASKQ 220 (536)
Q Consensus 143 ~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~--vkL~DFGla~~ 220 (536)
...+++||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++.
T Consensus 88 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~ 167 (361)
T 3uc3_A 88 PTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS 167 (361)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred CCEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence 9999999999999999999988888999999999999999999999999999999999999987765 99999999875
Q ss_pred hhhhhcccCCcccCCCCCCCChhhhhhcCCCcc-ceEechhHHHHHHhhCCCCCchhhH--HH-HHHHhhCCCCCCCCCC
Q 009364 221 VAELATVSGAKSMKGTPYWMAPEVIRQTGHSYS-ADIWSVGCTVIEMATGKPPWSQQYQ--EV-AALFHIGTTKSHPPIP 296 (536)
Q Consensus 221 ~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k-~DIwSlGvil~eLltG~~Pf~~~~~--~~-~~~~~~~~~~~~~~~~ 296 (536)
.... ......+||+.|+|||++.+..++.+ +|||||||++|+|++|.+||..... .. .............+..
T Consensus 168 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (361)
T 3uc3_A 168 SVLH---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDD 244 (361)
T ss_dssp ----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTT
T ss_pred cccc---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCc
Confidence 4322 22345679999999999988887655 8999999999999999999975321 01 1111111122222333
Q ss_pred CcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCC
Q 009364 297 ENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDD 334 (536)
Q Consensus 297 ~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~ 334 (536)
..+++++++||.+||+.||.+|||+.|+++||||....
T Consensus 245 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~ 282 (361)
T 3uc3_A 245 IRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNL 282 (361)
T ss_dssp SCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTC
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcCC
Confidence 46899999999999999999999999999999997643
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=418.17 Aligned_cols=260 Identities=28% Similarity=0.464 Sum_probs=223.9
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
.+|++.+.||+|+||+||+|++..+|+.||+|++..... ........+.+|+.+|+.++||||+++++++.+.+.
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~ 79 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVI-----IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDR 79 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHh-----hhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCE
Confidence 579999999999999999999999999999999842211 112234567889999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhh
Q 009364 146 LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA 225 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 225 (536)
+++||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 80 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~- 158 (337)
T 1o6l_A 80 LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD- 158 (337)
T ss_dssp EEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccC-
Confidence 9999999999999999988889999999999999999999999999999999999999999999999999998754321
Q ss_pred cccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH-HHHHHhhCCCCCCCCCCCcCcHHHH
Q 009364 226 TVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE-VAALFHIGTTKSHPPIPENLSVKAK 304 (536)
Q Consensus 226 ~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~~ 304 (536)
.......+||+.|+|||++.+..++.++|||||||++|+|++|.+||...... ....+... ...+|..++++++
T Consensus 159 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~----~~~~p~~~s~~~~ 233 (337)
T 1o6l_A 159 -GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME----EIRFPRTLSPEAK 233 (337)
T ss_dssp -TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC----CCCCCTTSCHHHH
T ss_pred -CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcC----CCCCCCCCCHHHH
Confidence 12345678999999999999999999999999999999999999999754322 22222221 2346678999999
Q ss_pred HHHHHhcccCCCCCC-----CHHHHHhCCCCcCCCCC
Q 009364 305 DFLLKCLEKEPDLRP-----TASELLKHPFVTGDDED 336 (536)
Q Consensus 305 dLi~~cL~~dP~~Rp-----s~~eiL~hp~~~~~~~~ 336 (536)
+||.+||++||.+|| ++.++++||||....+.
T Consensus 234 ~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~ 270 (337)
T 1o6l_A 234 SLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ 270 (337)
T ss_dssp HHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred HHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHH
Confidence 999999999999999 99999999999876544
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=421.62 Aligned_cols=265 Identities=30% Similarity=0.434 Sum_probs=223.8
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE 143 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 143 (536)
...+|++++.||+|+||+||+|.+..+|+.||+|++.......... ....+.+.+|+.+|+.++||||+++++++.+.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 87 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRR--GVCREEIEREVSILRQVLHPNIITLHDVYENR 87 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSS--SBCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccc--hhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeC
Confidence 3458999999999999999999999999999999985432211100 01235678999999999999999999999999
Q ss_pred CceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCC----cEEEEecCcch
Q 009364 144 ESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKG----CIKLADFGASK 219 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~----~vkL~DFGla~ 219 (536)
..+++||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++
T Consensus 88 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~ 167 (361)
T 2yab_A 88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (361)
T ss_dssp SEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence 99999999999999999998888999999999999999999999999999999999999998877 79999999998
Q ss_pred hhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhH-HHHHHHhhCCCCCCCCCCCc
Q 009364 220 QVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQ-EVAALFHIGTTKSHPPIPEN 298 (536)
Q Consensus 220 ~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~ 298 (536)
..... ......+||+.|+|||++.+..++.++|||||||++|+|++|.+||..... +....+...........+..
T Consensus 168 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (361)
T 2yab_A 168 EIEDG---VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQ 244 (361)
T ss_dssp ECCTT---CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred EcCCC---CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccC
Confidence 76542 224567899999999999999999999999999999999999999975432 22222222222222233457
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 299 LSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 299 ~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
++..+++||.+||.+||.+|||+.|+++||||...
T Consensus 245 ~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 279 (361)
T 2yab_A 245 TSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (361)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence 89999999999999999999999999999999754
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-51 Score=421.43 Aligned_cols=261 Identities=27% Similarity=0.443 Sum_probs=219.5
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeEeeeeecC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRYLGTVREE 143 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~ 143 (536)
..+|++.+.||+|+||+||+|+++.+|+.||+|++.... .......+.+.+|..+++.+ +||||+++++++.+.
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~-----~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~ 96 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDV-----ILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP 96 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHH-----HHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHH-----hcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC
Confidence 358999999999999999999999999999999984221 11223355677899999988 699999999999999
Q ss_pred CceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhh
Q 009364 144 ESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAE 223 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 223 (536)
+.+|+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 97 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 97 DRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 99999999999999999998888999999999999999999999999999999999999999999999999999875332
Q ss_pred hhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH-HHHHHhhCCCCCCCCCCCcCcHH
Q 009364 224 LATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE-VAALFHIGTTKSHPPIPENLSVK 302 (536)
Q Consensus 224 ~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~ 302 (536)
. .......+||+.|+|||++.+..++.++|||||||++|+|++|.+||...... ....+... ...++..++.+
T Consensus 177 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~----~~~~p~~~~~~ 250 (353)
T 3txo_A 177 N--GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND----EVVYPTWLHED 250 (353)
T ss_dssp -----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC----CCCCCTTSCHH
T ss_pred C--CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcC----CCCCCCCCCHH
Confidence 1 12345678999999999999999999999999999999999999999765432 22222221 23456679999
Q ss_pred HHHHHHHhcccCCCCCCCH------HHHHhCCCCcCCCCC
Q 009364 303 AKDFLLKCLEKEPDLRPTA------SELLKHPFVTGDDED 336 (536)
Q Consensus 303 ~~dLi~~cL~~dP~~Rps~------~eiL~hp~~~~~~~~ 336 (536)
+++||++||++||.+||++ .++++||||....+.
T Consensus 251 ~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~ 290 (353)
T 3txo_A 251 ATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWA 290 (353)
T ss_dssp HHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHH
T ss_pred HHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHH
Confidence 9999999999999999999 999999999876544
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=426.80 Aligned_cols=262 Identities=28% Similarity=0.476 Sum_probs=221.4
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeEeeeeecC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRYLGTVREE 143 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~ 143 (536)
..+|++.+.||+|+||+||+|+++.+++.||+|++..... ........+.+|..+|..+ +||||+++++++.+.
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~-----~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~ 125 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELV-----NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE 125 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGT-----C----CCHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhc-----cCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEEC
Confidence 3579999999999999999999999999999999853221 1123345577889999877 899999999999999
Q ss_pred CceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhh
Q 009364 144 ESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAE 223 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 223 (536)
..+++||||++||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 126 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 126 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred CEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 99999999999999999998888999999999999999999999999999999999999999999999999999975322
Q ss_pred hhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhh----------HHHHHHHhhCCCCCCC
Q 009364 224 LATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQY----------QEVAALFHIGTTKSHP 293 (536)
Q Consensus 224 ~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~----------~~~~~~~~~~~~~~~~ 293 (536)
. .......+||+.|+|||++.+..++.++|||||||++|+|++|.+||.... ......+.. ...
T Consensus 206 ~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~----~~~ 279 (396)
T 4dc2_A 206 P--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE----KQI 279 (396)
T ss_dssp T--TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH----CCC
T ss_pred C--CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc----ccc
Confidence 1 123457889999999999999999999999999999999999999995321 111122211 234
Q ss_pred CCCCcCcHHHHHHHHHhcccCCCCCCCH------HHHHhCCCCcCCCCCc
Q 009364 294 PIPENLSVKAKDFLLKCLEKEPDLRPTA------SELLKHPFVTGDDEDP 337 (536)
Q Consensus 294 ~~~~~~s~~~~dLi~~cL~~dP~~Rps~------~eiL~hp~~~~~~~~~ 337 (536)
.+|..++.++++||++||++||.+||++ .||++||||....++.
T Consensus 280 ~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~ 329 (396)
T 4dc2_A 280 RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDM 329 (396)
T ss_dssp CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHH
T ss_pred CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHH
Confidence 5677899999999999999999999985 8999999998765543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-50 Score=410.51 Aligned_cols=257 Identities=28% Similarity=0.479 Sum_probs=222.6
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
.+|++.+.||+|+||+||+|++..+|+.||+|++..... ......+.+.+|+.+++.++||||+++++++.+...
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~ 80 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV-----VRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQ 80 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-----hhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCE
Confidence 579999999999999999999999999999999842211 111234567789999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhh
Q 009364 146 LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA 225 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 225 (536)
+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 81 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~-- 158 (318)
T 1fot_A 81 IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-- 158 (318)
T ss_dssp EEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--
T ss_pred EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC--
Confidence 999999999999999999888999999999999999999999999999999999999999999999999999976543
Q ss_pred cccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH-HHHHHhhCCCCCCCCCCCcCcHHHH
Q 009364 226 TVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE-VAALFHIGTTKSHPPIPENLSVKAK 304 (536)
Q Consensus 226 ~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~~ 304 (536)
.....+||+.|+|||++.+..++.++|||||||++|+|++|.+||...... ....+... ...++..++.+++
T Consensus 159 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~----~~~~p~~~~~~~~ 231 (318)
T 1fot_A 159 ---VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA----ELRFPPFFNEDVK 231 (318)
T ss_dssp ---CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC----CCCCCTTSCHHHH
T ss_pred ---ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC----CCCCCCCCCHHHH
Confidence 234678999999999999999999999999999999999999999654322 22222111 2345678999999
Q ss_pred HHHHHhcccCCCCCC-----CHHHHHhCCCCcCCCCC
Q 009364 305 DFLLKCLEKEPDLRP-----TASELLKHPFVTGDDED 336 (536)
Q Consensus 305 dLi~~cL~~dP~~Rp-----s~~eiL~hp~~~~~~~~ 336 (536)
+||.+||+.||.+|| +++++++||||....+.
T Consensus 232 ~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~ 268 (318)
T 1fot_A 232 DLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE 268 (318)
T ss_dssp HHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred HHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHH
Confidence 999999999999999 99999999999876543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=425.37 Aligned_cols=259 Identities=27% Similarity=0.431 Sum_probs=221.6
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
.+|++.+.||+|+||+||+|.+..+|+.||+|++... .......+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~------~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 84 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTK------KLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGH 84 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESC------SCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSE
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcc------cCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCE
Confidence 4799999999999999999999999999999998432 1122345678899999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccC---CCCcEEEEecCcchhhh
Q 009364 146 LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVD---NKGCIKLADFGASKQVA 222 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~---~~~~vkL~DFGla~~~~ 222 (536)
.++|||||.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++...
T Consensus 85 ~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 85 HYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp EEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 999999999999999998888999999999999999999999999999999999999998 45789999999997665
Q ss_pred hhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhH-HHHHHHhhCCCCCCCCCCCcCcH
Q 009364 223 ELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQ-EVAALFHIGTTKSHPPIPENLSV 301 (536)
Q Consensus 223 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~s~ 301 (536)
... ......+||+.|+|||++.+..++.++|||||||++|+|++|.+||..... .....+.........+....+++
T Consensus 165 ~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 242 (444)
T 3soa_A 165 GEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTP 242 (444)
T ss_dssp TTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCH
T ss_pred CCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCH
Confidence 422 223457899999999999999999999999999999999999999965432 33333333333333444468999
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhCCCCcC
Q 009364 302 KAKDFLLKCLEKEPDLRPTASELLKHPFVTG 332 (536)
Q Consensus 302 ~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~ 332 (536)
++++||.+||+.||.+|||+.|+|+||||..
T Consensus 243 ~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 243 EAKDLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred HHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 9999999999999999999999999999964
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-50 Score=415.69 Aligned_cols=258 Identities=28% Similarity=0.464 Sum_probs=221.3
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
.+|++.+.||+|+||.||+|.+..+|+.||+|++.... ......+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~ 102 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK------LSARDFQKLEREARICRKLQHPNIVRLHDSIQEESF 102 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT------CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEccc------CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence 47999999999999999999999999999999984321 122345678899999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCC---cEEEEecCcchhhh
Q 009364 146 LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKG---CIKLADFGASKQVA 222 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~---~vkL~DFGla~~~~ 222 (536)
.++||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~ 182 (362)
T 2bdw_A 103 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182 (362)
T ss_dssp EEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence 999999999999999998888899999999999999999999999999999999999998654 59999999998765
Q ss_pred hhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhH-HHHHHHhhCCCCCCCCCCCcCcH
Q 009364 223 ELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQ-EVAALFHIGTTKSHPPIPENLSV 301 (536)
Q Consensus 223 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~s~ 301 (536)
.. ......+||+.|+|||++.+..++.++|||||||++|+|++|.+||..... .....+.........+....+++
T Consensus 183 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 259 (362)
T 2bdw_A 183 DS---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTP 259 (362)
T ss_dssp TC---CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCH
T ss_pred CC---cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCH
Confidence 32 223457899999999999999999999999999999999999999975432 22333333333333333457899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhCCCCcC
Q 009364 302 KAKDFLLKCLEKEPDLRPTASELLKHPFVTG 332 (536)
Q Consensus 302 ~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~ 332 (536)
++++||.+||+.||.+|||+.++|+||||..
T Consensus 260 ~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 260 EAKSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 9999999999999999999999999999964
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-50 Score=414.81 Aligned_cols=261 Identities=28% Similarity=0.483 Sum_probs=222.4
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeEeeeeecC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRYLGTVREE 143 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~ 143 (536)
..+|++.+.||+|+||+||+|++..+|+.||+|++..... ......+.+.+|..+++.+ +||||+++++++.+.
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~ 82 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELV-----NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE 82 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGS-----CSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHh-----cchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeC
Confidence 3579999999999999999999999999999999853211 1223456678899999988 899999999999999
Q ss_pred CceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhh
Q 009364 144 ESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAE 223 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 223 (536)
..+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 83 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 83 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 99999999999999999998888899999999999999999999999999999999999999999999999999875332
Q ss_pred hhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchh----------hHHHHHHHhhCCCCCCC
Q 009364 224 LATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQ----------YQEVAALFHIGTTKSHP 293 (536)
Q Consensus 224 ~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~----------~~~~~~~~~~~~~~~~~ 293 (536)
. .......+||+.|+|||++.+..++.++|||||||++|+|++|.+||... .......... ...
T Consensus 163 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~----~~~ 236 (345)
T 3a8x_A 163 P--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE----KQI 236 (345)
T ss_dssp T--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHH----CCC
T ss_pred C--CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHc----CCC
Confidence 1 12345678999999999999999999999999999999999999999531 1111112211 223
Q ss_pred CCCCcCcHHHHHHHHHhcccCCCCCCCH------HHHHhCCCCcCCCCC
Q 009364 294 PIPENLSVKAKDFLLKCLEKEPDLRPTA------SELLKHPFVTGDDED 336 (536)
Q Consensus 294 ~~~~~~s~~~~dLi~~cL~~dP~~Rps~------~eiL~hp~~~~~~~~ 336 (536)
.+|..++.++++||++||++||.+||++ .++++||||....++
T Consensus 237 ~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~ 285 (345)
T 3a8x_A 237 RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD 285 (345)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHH
T ss_pred CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHH
Confidence 4667899999999999999999999995 899999999876543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-50 Score=415.65 Aligned_cols=262 Identities=27% Similarity=0.474 Sum_probs=223.1
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeEeeeeec
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRYLGTVRE 142 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~ 142 (536)
...+|++.+.||+|+||+||+|+++.+|+.||+|++..... ........+..|..++..+ +||||+++++++.+
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~ 89 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV-----LMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT 89 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHh-----hhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe
Confidence 34689999999999999999999999999999999843211 1112345567888888876 89999999999999
Q ss_pred CCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhh
Q 009364 143 EESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVA 222 (536)
Q Consensus 143 ~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~ 222 (536)
.+.+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 90 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 169 (345)
T 1xjd_A 90 KENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM 169 (345)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence 99999999999999999999888889999999999999999999999999999999999999999999999999997543
Q ss_pred hhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH-HHHHHhhCCCCCCCCCCCcCcH
Q 009364 223 ELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE-VAALFHIGTTKSHPPIPENLSV 301 (536)
Q Consensus 223 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~s~ 301 (536)
... ......+||+.|+|||++.+..++.++|||||||++|+|++|.+||...... ....+... ...++..++.
T Consensus 170 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~----~~~~p~~~s~ 243 (345)
T 1xjd_A 170 LGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD----NPFYPRWLEK 243 (345)
T ss_dssp CTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC----CCCCCTTSCH
T ss_pred cCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhC----CCCCCcccCH
Confidence 211 2245678999999999999999999999999999999999999999754332 22222222 2345678999
Q ss_pred HHHHHHHHhcccCCCCCCCHH-HHHhCCCCcCCCCC
Q 009364 302 KAKDFLLKCLEKEPDLRPTAS-ELLKHPFVTGDDED 336 (536)
Q Consensus 302 ~~~dLi~~cL~~dP~~Rps~~-eiL~hp~~~~~~~~ 336 (536)
++++||.+||+.||.+||++. ++++||||....++
T Consensus 244 ~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~ 279 (345)
T 1xjd_A 244 EAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWE 279 (345)
T ss_dssp HHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHH
T ss_pred HHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCHH
Confidence 999999999999999999998 99999999876543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-50 Score=411.07 Aligned_cols=257 Identities=26% Similarity=0.371 Sum_probs=218.9
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEE 144 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 144 (536)
..+|++++.||+|+||+||+|.+..+|+.||+|++... . .....+.+|+.+++.++||||+++++++.+.+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~------~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 74 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK------G---TDQVLVKKEISILNIARHRNILHLHESFESME 74 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC------T---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETT
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC------c---ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCC
Confidence 46899999999999999999999999999999988421 1 22345789999999999999999999999999
Q ss_pred ceeEEEEecCCCCcccccccC-CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCC--CCcEEEEecCcchhh
Q 009364 145 SLNILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDN--KGCIKLADFGASKQV 221 (536)
Q Consensus 145 ~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~--~~~vkL~DFGla~~~ 221 (536)
.+++|||||+||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++..
T Consensus 75 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~ 154 (321)
T 1tki_A 75 ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp EEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence 999999999999999999765 47999999999999999999999999999999999999987 789999999999876
Q ss_pred hhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhH-HHHHHHhhCCCCCCCCCCCcCc
Q 009364 222 AELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQ-EVAALFHIGTTKSHPPIPENLS 300 (536)
Q Consensus 222 ~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~s 300 (536)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||..... .....+...........+..++
T Consensus 155 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 231 (321)
T 1tki_A 155 KPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEIS 231 (321)
T ss_dssp CTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSC
T ss_pred CCCC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCC
Confidence 5422 23456799999999999998899999999999999999999999975432 2222222222222222234789
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 301 VKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 301 ~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
.++++||.+||..||.+|||+.|+|+||||...
T Consensus 232 ~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 232 IEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 999999999999999999999999999999754
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-50 Score=413.47 Aligned_cols=260 Identities=28% Similarity=0.484 Sum_probs=225.1
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE 142 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 142 (536)
....+|++.+.||+|+||+||+|++..+|+.||+|++..... ......+.+.+|+.+|+.++||||+++++++.+
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 112 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV-----VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD 112 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHh-----ccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 445689999999999999999999999999999999842211 111234567889999999999999999999999
Q ss_pred CCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhh
Q 009364 143 EESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVA 222 (536)
Q Consensus 143 ~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~ 222 (536)
...+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 113 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 113 NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceecc
Confidence 99999999999999999999888899999999999999999999999999999999999999999999999999998654
Q ss_pred hhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhH-HHHHHHhhCCCCCCCCCCCcCcH
Q 009364 223 ELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQ-EVAALFHIGTTKSHPPIPENLSV 301 (536)
Q Consensus 223 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~s~ 301 (536)
. .....+||+.|+|||++.+..++.++|||||||++|+|++|.+||..... .....+... ...++..++.
T Consensus 193 ~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~----~~~~p~~~~~ 263 (350)
T 1rdq_E 193 G-----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPSHFSS 263 (350)
T ss_dssp S-----CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC----CCCCCTTCCH
T ss_pred C-----CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcC----CCCCCCCCCH
Confidence 3 23467899999999999999999999999999999999999999975432 222222222 2345678999
Q ss_pred HHHHHHHHhcccCCCCCCC-----HHHHHhCCCCcCCCCC
Q 009364 302 KAKDFLLKCLEKEPDLRPT-----ASELLKHPFVTGDDED 336 (536)
Q Consensus 302 ~~~dLi~~cL~~dP~~Rps-----~~eiL~hp~~~~~~~~ 336 (536)
++++||.+||+.||.+||+ +.+|++||||....+.
T Consensus 264 ~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~ 303 (350)
T 1rdq_E 264 DLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWI 303 (350)
T ss_dssp HHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHH
T ss_pred HHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHH
Confidence 9999999999999999998 9999999999876543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-50 Score=422.31 Aligned_cols=261 Identities=27% Similarity=0.496 Sum_probs=223.4
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
.+|++.+.||+|+||+||+|.+..+|+.||+|++.... .......+.+.+|+.+|+.++||||+++++++.+...
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~-----~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 89 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQK-----CVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEED 89 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHH-----HHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhh-----cccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 57999999999999999999999999999999984221 1112234667899999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhh
Q 009364 146 LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA 225 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 225 (536)
+|+||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.+...
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~- 168 (384)
T 4fr4_A 90 MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE- 168 (384)
T ss_dssp EEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC-
Confidence 9999999999999999998889999999999999999999999999999999999999999999999999999866432
Q ss_pred cccCCcccCCCCCCCChhhhhh---cCCCccceEechhHHHHHHhhCCCCCchhh----HHHHHHHhhCCCCCCCCCCCc
Q 009364 226 TVSGAKSMKGTPYWMAPEVIRQ---TGHSYSADIWSVGCTVIEMATGKPPWSQQY----QEVAALFHIGTTKSHPPIPEN 298 (536)
Q Consensus 226 ~~~~~~~~~Gt~~Y~APEvl~~---~~~s~k~DIwSlGvil~eLltG~~Pf~~~~----~~~~~~~~~~~~~~~~~~~~~ 298 (536)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.... ......... ....++..
T Consensus 169 --~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~----~~~~~p~~ 242 (384)
T 4fr4_A 169 --TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET----TVVTYPSA 242 (384)
T ss_dssp --CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH----CCCCCCTT
T ss_pred --CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh----cccCCCCc
Confidence 23456789999999999963 458999999999999999999999996321 222222221 23345678
Q ss_pred CcHHHHHHHHHhcccCCCCCCC-HHHHHhCCCCcCCCCCcc
Q 009364 299 LSVKAKDFLLKCLEKEPDLRPT-ASELLKHPFVTGDDEDPV 338 (536)
Q Consensus 299 ~s~~~~dLi~~cL~~dP~~Rps-~~eiL~hp~~~~~~~~~~ 338 (536)
++.++++||.+||+.||.+||+ +.++++||||....++..
T Consensus 243 ~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~~~ 283 (384)
T 4fr4_A 243 WSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWDAV 283 (384)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCHHHH
T ss_pred CCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCHHHH
Confidence 9999999999999999999998 999999999987665433
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-50 Score=414.39 Aligned_cols=262 Identities=30% Similarity=0.440 Sum_probs=219.2
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
.+|++.+.||+|+||+||+|.+..+|+.||+|++......... ....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 100 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSP---GLSTEDLKREASICHMLKHPHIVELLETYSSDGM 100 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSS---SCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccc---cchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 4799999999999999999999999999999998432111000 0123567899999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccC----CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCc---EEEEecCcc
Q 009364 146 LNILLEFVPGGSISSLLGKF----GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGC---IKLADFGAS 218 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~----~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~---vkL~DFGla 218 (536)
+++|||||+||+|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++
T Consensus 101 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 99999999999998877532 35899999999999999999999999999999999999987654 999999999
Q ss_pred hhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCc
Q 009364 219 KQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPEN 298 (536)
Q Consensus 219 ~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (536)
+...... ......+||+.|+|||++.+..++.++|||||||++|+|++|.+||...................+..+..
T Consensus 181 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~i~~~~~~~~~~~~~~ 258 (351)
T 3c0i_A 181 IQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWSH 258 (351)
T ss_dssp EECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHHHHHTCCCCCHHHHTT
T ss_pred eEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHHHHcCCCCCCcccccc
Confidence 8765422 12345689999999999999999999999999999999999999998765544443333332222223357
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcC
Q 009364 299 LSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTG 332 (536)
Q Consensus 299 ~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~ 332 (536)
++.++++||.+||+.||.+|||+.++|+||||..
T Consensus 259 ~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 292 (351)
T 3c0i_A 259 ISESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292 (351)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence 8999999999999999999999999999999974
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=406.79 Aligned_cols=264 Identities=28% Similarity=0.441 Sum_probs=222.0
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
.+|++.+.||+|+||+||+|.+..+|+.||+|++.......... ....+.+.+|+.+|+.++||||+++++++.+...
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRR--GVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSS--SBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 47999999999999999999999999999999985432111100 0123567899999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCC----cEEEEecCcchhh
Q 009364 146 LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKG----CIKLADFGASKQV 221 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~----~vkL~DFGla~~~ 221 (536)
+++||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~ 168 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168 (326)
T ss_dssp EEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence 999999999999999998888999999999999999999999999999999999999999887 8999999999876
Q ss_pred hhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhH-HHHHHHhhCCCCCCCCCCCcCc
Q 009364 222 AELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQ-EVAALFHIGTTKSHPPIPENLS 300 (536)
Q Consensus 222 ~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~s 300 (536)
.... .....+||+.|+|||++.+..++.++|||||||++|+|++|.+||..... +................+..++
T Consensus 169 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (326)
T 2y0a_A 169 DFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 245 (326)
T ss_dssp CTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSC
T ss_pred CCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCC
Confidence 4322 23456899999999999999999999999999999999999999965432 2222222222222222335789
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCC
Q 009364 301 VKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDD 334 (536)
Q Consensus 301 ~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~ 334 (536)
..+++||.+||+.||.+|||+.|+|+||||....
T Consensus 246 ~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 279 (326)
T 2y0a_A 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 279 (326)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence 9999999999999999999999999999997543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=400.38 Aligned_cols=260 Identities=28% Similarity=0.461 Sum_probs=211.6
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
.+|++.+.||+|+||+||+|.+..+|+.||+|++..... .......+.+|+.+++.++||||+++++++.+.+.
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 75 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD------DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK 75 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS------STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC------cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCE
Confidence 479999999999999999999999999999999853221 11234567789999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhh
Q 009364 146 LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA 225 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 225 (536)
+++||||+.++.+..+....+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 76 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~- 154 (292)
T 3o0g_A 76 LTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP- 154 (292)
T ss_dssp EEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC-
T ss_pred EEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCc-
Confidence 9999999986555555555678999999999999999999999999999999999999999999999999999765432
Q ss_pred cccCCcccCCCCCCCChhhhhhcC-CCccceEechhHHHHHHhhCCCCCc-hhh--HHHHHHHhhCCC------------
Q 009364 226 TVSGAKSMKGTPYWMAPEVIRQTG-HSYSADIWSVGCTVIEMATGKPPWS-QQY--QEVAALFHIGTT------------ 289 (536)
Q Consensus 226 ~~~~~~~~~Gt~~Y~APEvl~~~~-~s~k~DIwSlGvil~eLltG~~Pf~-~~~--~~~~~~~~~~~~------------ 289 (536)
........||+.|+|||++.+.. ++.++|||||||++|+|++|..||. ... .....+......
T Consensus 155 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 233 (292)
T 3o0g_A 155 -VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp -CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred -cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccc
Confidence 22344567999999999998765 7999999999999999999888753 221 111111111000
Q ss_pred ------------CCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 290 ------------KSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 290 ------------~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
.......+.++.++++||++||+.||.+|||++|+|+||||+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred ccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 00111234688999999999999999999999999999999753
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=412.28 Aligned_cols=261 Identities=25% Similarity=0.396 Sum_probs=222.8
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeEeeeeecC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRYLGTVREE 143 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~ 143 (536)
..+|++.+.||+|+||+||+|++..+|+.||+|++..... ......+.+..|..+|..+ +||||+++++++.+.
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~-----~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~ 93 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVV-----IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM 93 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECS
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-----hcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcC
Confidence 4589999999999999999999999999999999843211 1112345677899999888 799999999999999
Q ss_pred CceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhh
Q 009364 144 ESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAE 223 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 223 (536)
+.+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 94 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 94 DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 99999999999999999998888899999999999999999999999999999999999999999999999999975332
Q ss_pred hhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH-HHHHHhhCCCCCCCCCCCcCcHH
Q 009364 224 LATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE-VAALFHIGTTKSHPPIPENLSVK 302 (536)
Q Consensus 224 ~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~ 302 (536)
. .......+||+.|+|||++.+..++.++|||||||++|+|++|.+||...... ....+... ...+|..++.+
T Consensus 174 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~----~~~~p~~~s~~ 247 (353)
T 2i0e_A 174 D--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH----NVAYPKSMSKE 247 (353)
T ss_dssp T--TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC----CCCCCTTSCHH
T ss_pred C--CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhC----CCCCCCCCCHH
Confidence 1 12345678999999999999999999999999999999999999999754332 22222221 23456789999
Q ss_pred HHHHHHHhcccCCCCCC-----CHHHHHhCCCCcCCCCC
Q 009364 303 AKDFLLKCLEKEPDLRP-----TASELLKHPFVTGDDED 336 (536)
Q Consensus 303 ~~dLi~~cL~~dP~~Rp-----s~~eiL~hp~~~~~~~~ 336 (536)
+++||++||++||.+|| ++.++++||||....++
T Consensus 248 ~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~ 286 (353)
T 2i0e_A 248 AVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE 286 (353)
T ss_dssp HHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHH
T ss_pred HHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHH
Confidence 99999999999999999 47999999999876543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-50 Score=412.78 Aligned_cols=256 Identities=26% Similarity=0.444 Sum_probs=218.7
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
.+|++.+.||+|+||+||+|.+..+|+.||+|++.... .........+.+|+.+++.++||||+++++++.....
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 83 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQL-----LKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTD 83 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHH-----HHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHH-----ccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence 58999999999999999999999999999999984211 0111123467899999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhh
Q 009364 146 LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA 225 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 225 (536)
+++||||+ +|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~- 161 (336)
T 3h4j_B 84 IVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG- 161 (336)
T ss_dssp EEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS-
T ss_pred EEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC-
Confidence 99999999 7899999888889999999999999999999999999999999999999999999999999999876542
Q ss_pred cccCCcccCCCCCCCChhhhhhcCC-CccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcHHHH
Q 009364 226 TVSGAKSMKGTPYWMAPEVIRQTGH-SYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAK 304 (536)
Q Consensus 226 ~~~~~~~~~Gt~~Y~APEvl~~~~~-s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 304 (536)
......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||....... . ..........++..++++++
T Consensus 162 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~--~-~~~i~~~~~~~p~~~s~~~~ 236 (336)
T 3h4j_B 162 --NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN--L-FKKVNSCVYVMPDFLSPGAQ 236 (336)
T ss_dssp --BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT--C-BCCCCSSCCCCCTTSCHHHH
T ss_pred --cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH--H-HHHHHcCCCCCcccCCHHHH
Confidence 22456789999999999988776 789999999999999999999997542110 1 11112223446678999999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 305 DFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 305 dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
+||++||+.||.+|||+.|+++||||+..
T Consensus 237 ~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 237 SLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp HHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred HHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 99999999999999999999999999754
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=408.62 Aligned_cols=259 Identities=29% Similarity=0.412 Sum_probs=208.2
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE 143 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 143 (536)
...+|++.+.||+|+||+||+|.+..+++.||+|++... ...+.+.+|+.+|+.++||||+++++++...
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~----------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 120 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT----------VDKKIVRTEIGVLLRLSHPNIIKLKEIFETP 120 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------------CHHHHHCCCTTBCCEEEEEECS
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc----------hhHHHHHHHHHHHHhCCCCCCcceeeeEecC
Confidence 346899999999999999999999999999999988421 1234577899999999999999999999999
Q ss_pred CceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCC---CCcEEEEecCcchh
Q 009364 144 ESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDN---KGCIKLADFGASKQ 220 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~---~~~vkL~DFGla~~ 220 (536)
..+++||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++.
T Consensus 121 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~ 200 (349)
T 2w4o_A 121 TEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKI 200 (349)
T ss_dssp SEEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred CeEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence 999999999999999999988888999999999999999999999999999999999999975 78999999999986
Q ss_pred hhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH--HHHHHhhCCCCCCCCCCCc
Q 009364 221 VAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE--VAALFHIGTTKSHPPIPEN 298 (536)
Q Consensus 221 ~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~--~~~~~~~~~~~~~~~~~~~ 298 (536)
..... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||...... ....+.........++...
T Consensus 201 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~ 277 (349)
T 2w4o_A 201 VEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDE 277 (349)
T ss_dssp ---------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTT
T ss_pred cCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhh
Confidence 64321 234567999999999999999999999999999999999999999654322 2222222223333345568
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCCC
Q 009364 299 LSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDE 335 (536)
Q Consensus 299 ~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~~ 335 (536)
++.++++||++||+.||++|||+.|+|+||||.....
T Consensus 278 ~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 314 (349)
T 2w4o_A 278 VSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAA 314 (349)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTC
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCcc
Confidence 9999999999999999999999999999999986543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=423.99 Aligned_cols=265 Identities=27% Similarity=0.422 Sum_probs=200.7
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE 142 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 142 (536)
..+.+|++++.||+|+||+||+|++..+|+.||||++... .......+.+.+|+.+|+.++||||+++++++..
T Consensus 50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~------~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 123 (458)
T 3rp9_A 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV------FEDLIDCKRILREIAILNRLNHDHVVKVLDIVIP 123 (458)
T ss_dssp CSCTTEEECCC-------CEEEEEECC--CEEEEEEECST------TSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCC
T ss_pred ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechh------hcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEec
Confidence 4457999999999999999999999999999999988421 1122345678899999999999999999999843
Q ss_pred -----CCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCc
Q 009364 143 -----EESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGA 217 (536)
Q Consensus 143 -----~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGl 217 (536)
...+|+||||+ +|+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 124 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGl 202 (458)
T 3rp9_A 124 KDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGL 202 (458)
T ss_dssp SCTTTCCCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred CCcccCceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeeccccc
Confidence 35789999998 679999998888899999999999999999999999999999999999999999999999999
Q ss_pred chhhhhhhcc-------------------------cCCcccCCCCCCCChhhh-hhcCCCccceEechhHHHHHHhh---
Q 009364 218 SKQVAELATV-------------------------SGAKSMKGTPYWMAPEVI-RQTGHSYSADIWSVGCTVIEMAT--- 268 (536)
Q Consensus 218 a~~~~~~~~~-------------------------~~~~~~~Gt~~Y~APEvl-~~~~~s~k~DIwSlGvil~eLlt--- 268 (536)
++........ ......+||++|+|||++ .+..|+.++||||||||+|||++
T Consensus 203 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~ 282 (458)
T 3rp9_A 203 ARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIK 282 (458)
T ss_dssp CBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTST
T ss_pred chhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcc
Confidence 9876422110 123456899999999986 46679999999999999999999
Q ss_pred --------CCCCCchhh----------------------HHHHHHHhh-----------------------CCC---CCC
Q 009364 269 --------GKPPWSQQY----------------------QEVAALFHI-----------------------GTT---KSH 292 (536)
Q Consensus 269 --------G~~Pf~~~~----------------------~~~~~~~~~-----------------------~~~---~~~ 292 (536)
|.++|.+.. .....+... ... ...
T Consensus 283 ~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (458)
T 3rp9_A 283 ENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDL 362 (458)
T ss_dssp TTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCG
T ss_pred ccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCH
Confidence 677774421 001111100 000 001
Q ss_pred CCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCC
Q 009364 293 PPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDD 334 (536)
Q Consensus 293 ~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~ 334 (536)
....+.+++++++||++||+.||.+|||++|+|+||||....
T Consensus 363 ~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~ 404 (458)
T 3rp9_A 363 AERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR 404 (458)
T ss_dssp GGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcC
Confidence 112246799999999999999999999999999999998654
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-50 Score=421.94 Aligned_cols=269 Identities=25% Similarity=0.411 Sum_probs=221.9
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE 142 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 142 (536)
....+|++.+.||+|+||+||+|+++.+|+.||+|++..... ........+.+|+.+++.++||||+++++++.+
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~-----~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM-----IKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-----HHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhh-----hhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 345689999999999999999999999999999999842111 011112346789999999999999999999999
Q ss_pred CCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhh
Q 009364 143 EESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVA 222 (536)
Q Consensus 143 ~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~ 222 (536)
...+|+|||||+||+|.+++.+ ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~ 219 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 219 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred CCEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeec
Confidence 9999999999999999999876 579999999999999999999999999999999999999999999999999998765
Q ss_pred hhhcccCCcccCCCCCCCChhhhhhcC----CCccceEechhHHHHHHhhCCCCCchhhHH-HHHHHhhCCCCCCCCCCC
Q 009364 223 ELATVSGAKSMKGTPYWMAPEVIRQTG----HSYSADIWSVGCTVIEMATGKPPWSQQYQE-VAALFHIGTTKSHPPIPE 297 (536)
Q Consensus 223 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~----~s~k~DIwSlGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~ 297 (536)
.... ....+.+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||...... ....+.........+.+.
T Consensus 220 ~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 298 (410)
T 3v8s_A 220 KEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDN 298 (410)
T ss_dssp TTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTC
T ss_pred cCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcc
Confidence 4221 2244678999999999998765 789999999999999999999999754322 211111111111222334
Q ss_pred cCcHHHHHHHHHhcccCCCC--CCCHHHHHhCCCCcCCCCCcc
Q 009364 298 NLSVKAKDFLLKCLEKEPDL--RPTASELLKHPFVTGDDEDPV 338 (536)
Q Consensus 298 ~~s~~~~dLi~~cL~~dP~~--Rps~~eiL~hp~~~~~~~~~~ 338 (536)
.++.++++||++||+.+|.+ ||++.||++||||+...++..
T Consensus 299 ~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~~ 341 (410)
T 3v8s_A 299 DISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWE 341 (410)
T ss_dssp CCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCST
T ss_pred cccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHHH
Confidence 78999999999999999998 999999999999998766543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-49 Score=396.57 Aligned_cols=261 Identities=29% Similarity=0.501 Sum_probs=209.9
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccch------------------hHHHHHHHHHHHHHHHHHh
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASK------------------EKAQDHIKELEEEVKLLKD 127 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~------------------~~~~~~~~~~~~Ei~iL~~ 127 (536)
.+|++.+.||+|+||+||+|.+..+|+.||+|++......... .......+.+.+|+.+|+.
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 5899999999999999999999999999999998532211000 0011234568899999999
Q ss_pred CCCCceeeEeeeeec--CCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccC
Q 009364 128 LSHPNIVRYLGTVRE--EESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVD 205 (536)
Q Consensus 128 l~HpnIv~l~~~~~~--~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~ 205 (536)
++||||+++++++.+ ...+++||||+++++|.+++.. +++++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~ 171 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVG 171 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEC
Confidence 999999999999986 5679999999999999987654 6799999999999999999999999999999999999999
Q ss_pred CCCcEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcC---CCccceEechhHHHHHHhhCCCCCchhhHH-HH
Q 009364 206 NKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTG---HSYSADIWSVGCTVIEMATGKPPWSQQYQE-VA 281 (536)
Q Consensus 206 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~---~s~k~DIwSlGvil~eLltG~~Pf~~~~~~-~~ 281 (536)
.++.+||+|||+++....... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||...... ..
T Consensus 172 ~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 249 (298)
T 2zv2_A 172 EDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLH 249 (298)
T ss_dssp TTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred CCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHH
Confidence 999999999999986543221 134567999999999998765 378899999999999999999999754322 11
Q ss_pred HHHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCc
Q 009364 282 ALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVT 331 (536)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~ 331 (536)
...... ....+....++.++++||.+||+.||.+|||+.|+++||||+
T Consensus 250 ~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 250 SKIKSQ--ALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp HHHHHC--CCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred HHHhcc--cCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 222111 112223457899999999999999999999999999999985
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-49 Score=398.48 Aligned_cols=262 Identities=30% Similarity=0.516 Sum_probs=209.4
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE 142 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 142 (536)
....+|++.+.||+|+||+||+|.+. +|+.||+|++... .........+.+|+.+++.++||||+++++++.+
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~------~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 90 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLD------AEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS 90 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------------CHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred chHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecc------cccchhhHHHHHHHHHHHHcCCCCEeeeeeEEcc
Confidence 34468999999999999999999985 5899999988422 1122234567899999999999999999999999
Q ss_pred CCceeEEEEecCCCCccccccc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhh
Q 009364 143 EESLNILLEFVPGGSISSLLGK-FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQV 221 (536)
Q Consensus 143 ~~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~ 221 (536)
...+++||||+++ +|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 91 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 169 (311)
T 3niz_A 91 ERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAF 169 (311)
T ss_dssp SSCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEET
T ss_pred CCEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceec
Confidence 9999999999975 66666644 456999999999999999999999999999999999999999999999999999865
Q ss_pred hhhhcccCCcccCCCCCCCChhhhhh-cCCCccceEechhHHHHHHhhCCCCCchhh--HHHHHHHhhCCCCCCC-----
Q 009364 222 AELATVSGAKSMKGTPYWMAPEVIRQ-TGHSYSADIWSVGCTVIEMATGKPPWSQQY--QEVAALFHIGTTKSHP----- 293 (536)
Q Consensus 222 ~~~~~~~~~~~~~Gt~~Y~APEvl~~-~~~s~k~DIwSlGvil~eLltG~~Pf~~~~--~~~~~~~~~~~~~~~~----- 293 (536)
... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.... .....+..........
T Consensus 170 ~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 247 (311)
T 3niz_A 170 GIP--VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQV 247 (311)
T ss_dssp TSC--CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGG
T ss_pred CCC--cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhh
Confidence 432 122345679999999999976 568999999999999999999999996432 1111211111100000
Q ss_pred --------------------CCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCC
Q 009364 294 --------------------PIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDD 334 (536)
Q Consensus 294 --------------------~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~ 334 (536)
.+.+.++.++++||.+||++||.+|||+.|+|+||||+...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308 (311)
T ss_dssp TTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred hccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence 11235788999999999999999999999999999998654
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=422.79 Aligned_cols=270 Identities=25% Similarity=0.400 Sum_probs=223.4
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE 142 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 142 (536)
....+|++.+.||+|+||+||+|++..+|+.||+|++..... ........+.+|+.++..++||||+++++++.+
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~-----~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEM-----LKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHH-----HHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHh-----hhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 345689999999999999999999999999999999842111 111122347789999999999999999999999
Q ss_pred CCceeEEEEecCCCCccccccc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhh
Q 009364 143 EESLNILLEFVPGGSISSLLGK-FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQV 221 (536)
Q Consensus 143 ~~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~ 221 (536)
.+.+|+|||||+||+|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~ 225 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKL 225 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhc
Confidence 9999999999999999999977 578999999999999999999999999999999999999999999999999999765
Q ss_pred hhhhcccCCcccCCCCCCCChhhhh-----hcCCCccceEechhHHHHHHhhCCCCCchhhHH-H-HHHHhhCCCCCCCC
Q 009364 222 AELATVSGAKSMKGTPYWMAPEVIR-----QTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE-V-AALFHIGTTKSHPP 294 (536)
Q Consensus 222 ~~~~~~~~~~~~~Gt~~Y~APEvl~-----~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~-~-~~~~~~~~~~~~~~ 294 (536)
..... ......+||+.|+|||++. +..|+.++|||||||++|||++|.+||...... . ..+.........+.
T Consensus 226 ~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 304 (437)
T 4aw2_A 226 MEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPT 304 (437)
T ss_dssp CTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCS
T ss_pred ccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCc
Confidence 44222 1234578999999999997 456899999999999999999999999754322 1 22221111122333
Q ss_pred CCCcCcHHHHHHHHHhcccCCCC--CCCHHHHHhCCCCcCCCCCcc
Q 009364 295 IPENLSVKAKDFLLKCLEKEPDL--RPTASELLKHPFVTGDDEDPV 338 (536)
Q Consensus 295 ~~~~~s~~~~dLi~~cL~~dP~~--Rps~~eiL~hp~~~~~~~~~~ 338 (536)
....+++++++||++||+.+|++ ||+++|+++||||.+..++..
T Consensus 305 ~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l 350 (437)
T 4aw2_A 305 QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNI 350 (437)
T ss_dssp SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTG
T ss_pred ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHH
Confidence 34568999999999999988888 999999999999998877654
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-49 Score=412.82 Aligned_cols=263 Identities=29% Similarity=0.427 Sum_probs=215.9
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHH-HHhCCCCceeeEeeeeec
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKL-LKDLSHPNIVRYLGTVRE 142 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~i-L~~l~HpnIv~l~~~~~~ 142 (536)
...+|++.+.||+|+||+||+|+++.+++.||+|++...... .......+.+|..+ ++.++||||+++++++.+
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~-----~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~ 110 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAIL-----KKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT 110 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC------------------CCBCCCCCTTBCCEEEEEEC
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhh-----hhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe
Confidence 345899999999999999999999999999999998532211 11233445666666 567899999999999999
Q ss_pred CCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhh
Q 009364 143 EESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVA 222 (536)
Q Consensus 143 ~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~ 222 (536)
.+.+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 111 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 111 ADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 99999999999999999999888889999999999999999999999999999999999999999999999999997643
Q ss_pred hhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhH-HHHHHHhhCCCCCCCCCCCcCcH
Q 009364 223 ELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQ-EVAALFHIGTTKSHPPIPENLSV 301 (536)
Q Consensus 223 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~s~ 301 (536)
.. .......+||+.|+|||++.+..++.++|||||||++|+|++|.+||..... +....+... ...++..++.
T Consensus 191 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~----~~~~~~~~~~ 264 (373)
T 2r5t_A 191 EH--NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK----PLQLKPNITN 264 (373)
T ss_dssp CC--CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHS----CCCCCSSSCH
T ss_pred cC--CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc----ccCCCCCCCH
Confidence 21 2234577899999999999999999999999999999999999999975432 222222221 2345678999
Q ss_pred HHHHHHHHhcccCCCCCCCH----HHHHhCCCCcCCCCCc
Q 009364 302 KAKDFLLKCLEKEPDLRPTA----SELLKHPFVTGDDEDP 337 (536)
Q Consensus 302 ~~~dLi~~cL~~dP~~Rps~----~eiL~hp~~~~~~~~~ 337 (536)
++++||++||++||.+||++ .++++||||....++.
T Consensus 265 ~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~ 304 (373)
T 2r5t_A 265 SARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDD 304 (373)
T ss_dssp HHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHH
T ss_pred HHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHHH
Confidence 99999999999999999986 6999999998766543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-49 Score=390.56 Aligned_cols=262 Identities=27% Similarity=0.431 Sum_probs=220.0
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
.+|++.+.||+|+||+||+|.+..+|+.||+|++.... .....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-------AVDCPENIKKEICINKMLNHENVVKFYGHRREGNI 79 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGG-------CTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeecc-------chhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCE
Confidence 47999999999999999999999999999999884321 11234567899999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhh
Q 009364 146 LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA 225 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 225 (536)
.++||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 80 QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp EEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred EEEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 99999999999999999888889999999999999999999999999999999999999999999999999997665433
Q ss_pred cccCCcccCCCCCCCChhhhhhcCC-CccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcHHHH
Q 009364 226 TVSGAKSMKGTPYWMAPEVIRQTGH-SYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAK 304 (536)
Q Consensus 226 ~~~~~~~~~Gt~~Y~APEvl~~~~~-s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 304 (536)
........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.........................++..++
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHH
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHH
Confidence 3333456789999999999987665 789999999999999999999996543211111111111112223357899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhCCCCcCCC
Q 009364 305 DFLLKCLEKEPDLRPTASELLKHPFVTGDD 334 (536)
Q Consensus 305 dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~ 334 (536)
+||.+||+.||.+|||+.|+++||||+...
T Consensus 240 ~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (276)
T 2yex_A 240 ALLHKILVENPSARITIPDIKKDRWYNKPL 269 (276)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HHHHHHCCCCchhCCCHHHHhcCccccChh
Confidence 999999999999999999999999997653
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=389.83 Aligned_cols=262 Identities=28% Similarity=0.453 Sum_probs=223.8
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE 143 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 143 (536)
...+|++.+.||+|+||+||+|.+..+|+.||+|++... .......+.+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 77 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTK------KLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE 77 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGG------GCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecc------cCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcC
Confidence 356899999999999999999999999999999998432 11233456788999999999999999999999999
Q ss_pred CceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCc---EEEEecCcchh
Q 009364 144 ESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGC---IKLADFGASKQ 220 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~---vkL~DFGla~~ 220 (536)
...++||||+++++|.+.+.....+++..++.++.|++.||.|||++||+||||||+||+++.++. +||+|||++..
T Consensus 78 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 78 SFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 999999999999999999888888999999999999999999999999999999999999986654 99999999976
Q ss_pred hhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhH-HHHHHHhhCCCCCCCCCCCcC
Q 009364 221 VAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQ-EVAALFHIGTTKSHPPIPENL 299 (536)
Q Consensus 221 ~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~ 299 (536)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ...............+....+
T Consensus 158 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T 3kk8_A 158 VNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTV 234 (284)
T ss_dssp CCSSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTS
T ss_pred cccCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhccc
Confidence 54322 23456799999999999999999999999999999999999999965433 222333333333333444688
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCC
Q 009364 300 SVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDD 334 (536)
Q Consensus 300 s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~ 334 (536)
++++++||.+||+.||.+|||+.|+++||||....
T Consensus 235 ~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (284)
T 3kk8_A 235 TPEAKSLIDSMLTVNPKKRITADQALKVPWICNRE 269 (284)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred CHHHHHHHHHHcccChhhCCCHHHHhcCccccCCh
Confidence 99999999999999999999999999999997653
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-49 Score=412.16 Aligned_cols=267 Identities=25% Similarity=0.414 Sum_probs=216.1
Q ss_pred CCCCCCceeeeEEccc--CceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeee
Q 009364 62 MSPPIRWRKGELIGCG--AFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGT 139 (536)
Q Consensus 62 ~~~~~~y~~~~~LG~G--~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~ 139 (536)
.....+|++++.||+| +||+||+|++..+|+.||||++.... ......+.+.+|+.+++.++||||++++++
T Consensus 21 ~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 94 (389)
T 3gni_B 21 LPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEA------CSNEMVTFLQGELHVSKLFNHPNIVPYRAT 94 (389)
T ss_dssp CCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGG------SCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccc------cChHHHHHHHHHHHHHHhCCCCCCCcEeEE
Confidence 3456789999999999 99999999999999999999984321 122445678899999999999999999999
Q ss_pred eecCCceeEEEEecCCCCcccccccC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCc
Q 009364 140 VREEESLNILLEFVPGGSISSLLGKF--GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGA 217 (536)
Q Consensus 140 ~~~~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGl 217 (536)
+.+.+.+++||||+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||.
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~ 174 (389)
T 3gni_B 95 FIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRS 174 (389)
T ss_dssp EEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGG
T ss_pred EEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEccccc
Confidence 99999999999999999999998765 6799999999999999999999999999999999999999999999999998
Q ss_pred chhhhhhhcc-----cCCcccCCCCCCCChhhhhh--cCCCccceEechhHHHHHHhhCCCCCchhhH--HHHHHHhhC-
Q 009364 218 SKQVAELATV-----SGAKSMKGTPYWMAPEVIRQ--TGHSYSADIWSVGCTVIEMATGKPPWSQQYQ--EVAALFHIG- 287 (536)
Q Consensus 218 a~~~~~~~~~-----~~~~~~~Gt~~Y~APEvl~~--~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~--~~~~~~~~~- 287 (536)
+......... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||..... .........
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 254 (389)
T 3gni_B 175 NLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTV 254 (389)
T ss_dssp CEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----
T ss_pred ceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC
Confidence 8654322111 11234579999999999987 5789999999999999999999999964321 111100000
Q ss_pred ----------------------------------------CCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 288 ----------------------------------------TTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 288 ----------------------------------------~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
......+++..+++++++||++||+.||.+|||+.|+|+|
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 255 PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ---------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 0000112455789999999999999999999999999999
Q ss_pred CCCcCCC
Q 009364 328 PFVTGDD 334 (536)
Q Consensus 328 p~~~~~~ 334 (536)
|||....
T Consensus 335 p~f~~~~ 341 (389)
T 3gni_B 335 SFFKQIK 341 (389)
T ss_dssp GGGGGC-
T ss_pred HHHHHHh
Confidence 9998653
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-49 Score=401.61 Aligned_cols=262 Identities=27% Similarity=0.490 Sum_probs=212.7
Q ss_pred CCCCceeeeEEcccCceEEEEEEEc---CCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeee
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNL---DSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTV 140 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~ 140 (536)
...+|++.+.||+|+||+||+|++. .+|+.||+|++..... .........+.+|+.+|+.++||||+++++++
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~----~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 90 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMI----VRNAKDTAHTKAERNILEEVKHPFIVDLIYAF 90 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC------------------HHHHHHHCCCTTBCCEEEEE
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHh----hhhhhHHHHHHHHHHHHHhCCCCCccceeEEE
Confidence 3468999999999999999999985 6899999999843211 01122345577899999999999999999999
Q ss_pred ecCCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchh
Q 009364 141 REEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQ 220 (536)
Q Consensus 141 ~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~ 220 (536)
...+.+++||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 91 QTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp ECSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EcCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 99999999999999999999998888899999999999999999999999999999999999999999999999999876
Q ss_pred hhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH-HHHHHhhCCCCCCCCCCCcC
Q 009364 221 VAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE-VAALFHIGTTKSHPPIPENL 299 (536)
Q Consensus 221 ~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~ 299 (536)
..... ......+||+.|+|||++.+..++.++|||||||++|+|++|.+||...... ....+... ...++..+
T Consensus 171 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~----~~~~p~~~ 244 (327)
T 3a62_A 171 SIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC----KLNLPPYL 244 (327)
T ss_dssp ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT----CCCCCTTS
T ss_pred cccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC----CCCCCCCC
Confidence 44322 1234678999999999999999999999999999999999999999754322 22222111 23456688
Q ss_pred cHHHHHHHHHhcccCCCCCC-----CHHHHHhCCCCcCCCC
Q 009364 300 SVKAKDFLLKCLEKEPDLRP-----TASELLKHPFVTGDDE 335 (536)
Q Consensus 300 s~~~~dLi~~cL~~dP~~Rp-----s~~eiL~hp~~~~~~~ 335 (536)
+.++++||.+||..||.+|| ++.++++||||....+
T Consensus 245 ~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~ 285 (327)
T 3a62_A 245 TQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINW 285 (327)
T ss_dssp CHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCH
T ss_pred CHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCH
Confidence 99999999999999999999 8999999999986543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=409.97 Aligned_cols=259 Identities=25% Similarity=0.421 Sum_probs=220.3
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEE 144 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 144 (536)
..+|++.+.||+|+||+||+|.+..+|+.||+|++.... ......+.+|+.+|+.++||||+++++++.+..
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--------~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~ 121 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--------PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY 121 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--------HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--------hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCC
Confidence 358999999999999999999999999999999884211 122346789999999999999999999999999
Q ss_pred ceeEEEEecCCCCcccccccCC-CCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCC--CCcEEEEecCcchhh
Q 009364 145 SLNILLEFVPGGSISSLLGKFG-PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDN--KGCIKLADFGASKQV 221 (536)
Q Consensus 145 ~~~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~--~~~vkL~DFGla~~~ 221 (536)
.+++||||+.||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++. .+.+||+|||+++..
T Consensus 122 ~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~ 201 (387)
T 1kob_A 122 EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL 201 (387)
T ss_dssp EEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceec
Confidence 9999999999999999987654 7999999999999999999999999999999999999974 468999999999876
Q ss_pred hhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhH-HHHHHHhhCCCCCCCCCCCcCc
Q 009364 222 AELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQ-EVAALFHIGTTKSHPPIPENLS 300 (536)
Q Consensus 222 ~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~s 300 (536)
.... .....+||+.|+|||++.+..++.++|||||||++|+|++|.+||..... .................+..++
T Consensus 202 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 278 (387)
T 1kob_A 202 NPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVS 278 (387)
T ss_dssp CTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSC
T ss_pred CCCc---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCC
Confidence 5322 23345799999999999999999999999999999999999999975432 2222222333333334456789
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCC
Q 009364 301 VKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDD 334 (536)
Q Consensus 301 ~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~ 334 (536)
.++++||.+||+.||.+|||+.|+|+||||....
T Consensus 279 ~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 279 PEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence 9999999999999999999999999999998653
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=394.16 Aligned_cols=265 Identities=29% Similarity=0.493 Sum_probs=206.6
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC---CCCceeeEeeee
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL---SHPNIVRYLGTV 140 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l---~HpnIv~l~~~~ 140 (536)
...+|++.+.||+|+||+||+|++..+|+.||+|++........... ....+.+|+.+++.+ +||||+++++++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~---~~~~~~~e~~~l~~l~~~~h~niv~~~~~~ 83 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGG---LPISTVREVALLRRLEAFEHPNVVRLMDVC 83 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSC---CCHHHHHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccc---cchhHHHHHHHHHHHhhcCCCCeEEeeeee
Confidence 35689999999999999999999999999999999854321111100 012334566666555 599999999999
Q ss_pred ecCC-----ceeEEEEecCCCCcccccccCCC--CCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEE
Q 009364 141 REEE-----SLNILLEFVPGGSISSLLGKFGP--FPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLA 213 (536)
Q Consensus 141 ~~~~-----~~~lV~E~~~gg~L~~~l~~~~~--l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~ 213 (536)
.... .+++||||+. |+|.+++..... +++..++.++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 84 ATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp EECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEEC
T ss_pred eccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEe
Confidence 8765 4899999996 699998876544 9999999999999999999999999999999999999999999999
Q ss_pred ecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH--HHHHHhhCCCCC
Q 009364 214 DFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE--VAALFHIGTTKS 291 (536)
Q Consensus 214 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~--~~~~~~~~~~~~ 291 (536)
|||+++..... ......+||+.|+|||++.+..++.++|||||||++|+|++|.+||...... ...+........
T Consensus 163 Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 239 (308)
T 3g33_A 163 DFGLARIYSYQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP 239 (308)
T ss_dssp SCSCTTTSTTC---CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred eCccccccCCC---cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 99999866432 2245678999999999999999999999999999999999999999654322 122221111111
Q ss_pred CCC----------------------CCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCCC
Q 009364 292 HPP----------------------IPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDE 335 (536)
Q Consensus 292 ~~~----------------------~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~~ 335 (536)
... ..+.++.++++||.+||+.||.+|||+.|+|+||||+....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~~ 305 (308)
T 3g33_A 240 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEG 305 (308)
T ss_dssp TTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC-----
T ss_pred hhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCCC
Confidence 111 12367899999999999999999999999999999987543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-49 Score=405.56 Aligned_cols=261 Identities=27% Similarity=0.450 Sum_probs=214.9
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCC--CceeeEeeeee
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH--PNIVRYLGTVR 141 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~H--pnIv~l~~~~~ 141 (536)
...+|++.+.||+|+||+||+|.+ .+++.||+|++.... ......+.+.+|+.+|+.++| |||+++++++.
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~ 79 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEE------ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI 79 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTT------CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccc------cchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEe
Confidence 356899999999999999999987 468999999984321 223445678899999999976 99999999999
Q ss_pred cCCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhh
Q 009364 142 EEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQV 221 (536)
Q Consensus 142 ~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~ 221 (536)
....+++||| +.+|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++..
T Consensus 80 ~~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 80 TDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp CSSEEEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred eCCEEEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 9999999999 55889999999888999999999999999999999999999999999999996 678999999999876
Q ss_pred hhhhcccCCcccCCCCCCCChhhhhh-----------cCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCC
Q 009364 222 AELATVSGAKSMKGTPYWMAPEVIRQ-----------TGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTK 290 (536)
Q Consensus 222 ~~~~~~~~~~~~~Gt~~Y~APEvl~~-----------~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~ 290 (536)
............+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.................
T Consensus 158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 237 (343)
T 3dbq_A 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 237 (343)
T ss_dssp ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTT
T ss_pred CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCC
Confidence 54433333446789999999999975 6789999999999999999999999976444433333333334
Q ss_pred CCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 291 SHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 291 ~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
....++...+.++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 238 ~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 238 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred cccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence 4455677788999999999999999999999999999999754
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=391.72 Aligned_cols=257 Identities=28% Similarity=0.498 Sum_probs=206.8
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
.+|++.+.||+|+||+||+|.+ .+|+.||+|++..... .......+.+|+.+++.++||||+++++++...+.
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 74 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE------DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR 74 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG------GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc------ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCe
Confidence 4799999999999999999998 6799999999843221 11122456789999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccC-CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhh
Q 009364 146 LNILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAEL 224 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 224 (536)
+++||||+++ +|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 75 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (288)
T 1ob3_A 75 LVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (288)
T ss_dssp EEEEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred EEEEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcc
Confidence 9999999975 888877653 67999999999999999999999999999999999999999999999999999866432
Q ss_pred hcccCCcccCCCCCCCChhhhhhc-CCCccceEechhHHHHHHhhCCCCCchhhHH--HHHHHhhCCCC---C-------
Q 009364 225 ATVSGAKSMKGTPYWMAPEVIRQT-GHSYSADIWSVGCTVIEMATGKPPWSQQYQE--VAALFHIGTTK---S------- 291 (536)
Q Consensus 225 ~~~~~~~~~~Gt~~Y~APEvl~~~-~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~--~~~~~~~~~~~---~------- 291 (536)
. .......||+.|+|||++.+. .++.++|||||||++|+|++|.+||...... ...+....... .
T Consensus 154 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T 1ob3_A 154 V--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231 (288)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred c--cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcc
Confidence 1 123456789999999999764 5899999999999999999999999754321 11221110000 0
Q ss_pred --------------CCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcC
Q 009364 292 --------------HPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTG 332 (536)
Q Consensus 292 --------------~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~ 332 (536)
.......++.++++||.+||+.||.+|||+.|+++||||+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 00122468999999999999999999999999999999975
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=401.04 Aligned_cols=264 Identities=25% Similarity=0.431 Sum_probs=208.0
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEE 144 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 144 (536)
..+|++.+.||+|+||+||+|.+..+|+.||+|++... .........+.+|+.+++.++||||+++++++.+..
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLE------HEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNH 106 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCC------C--------CHHHHHHGGGCCCTTBCCEEEEEEETT
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccc------ccccccchhHHHHHHHHHHcCCCCcceEEEEEecCC
Confidence 35899999999999999999999999999999988422 112233456678999999999999999999999999
Q ss_pred ceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccC-----CCCcEEEEecCcch
Q 009364 145 SLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVD-----NKGCIKLADFGASK 219 (536)
Q Consensus 145 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~-----~~~~vkL~DFGla~ 219 (536)
.+++||||+. |+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++
T Consensus 107 ~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~ 185 (329)
T 3gbz_A 107 RLHLIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185 (329)
T ss_dssp EEEEEEECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred EEEEEEecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence 9999999997 59999998888899999999999999999999999999999999999994 45569999999998
Q ss_pred hhhhhhcccCCcccCCCCCCCChhhhhhc-CCCccceEechhHHHHHHhhCCCCCchhhHH--HHHHHhhCCCCCCCCC-
Q 009364 220 QVAELATVSGAKSMKGTPYWMAPEVIRQT-GHSYSADIWSVGCTVIEMATGKPPWSQQYQE--VAALFHIGTTKSHPPI- 295 (536)
Q Consensus 220 ~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~-~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~--~~~~~~~~~~~~~~~~- 295 (536)
...... ......+||+.|+|||++.+. .++.++|||||||++|+|++|.+||...... ...+...........+
T Consensus 186 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (329)
T 3gbz_A 186 AFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWP 263 (329)
T ss_dssp HHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred ccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhh
Confidence 765321 223456789999999999874 4899999999999999999999999754322 1222211111100000
Q ss_pred ------------------------CCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCCCCc
Q 009364 296 ------------------------PENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDP 337 (536)
Q Consensus 296 ------------------------~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~~~~ 337 (536)
+..++.++++||.+||+.||.+|||+.|+|+||||+....+|
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~P 329 (329)
T 3gbz_A 264 GVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDFDP 329 (329)
T ss_dssp TGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCSCC
T ss_pred hhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCCCC
Confidence 112789999999999999999999999999999999876553
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-49 Score=420.85 Aligned_cols=261 Identities=28% Similarity=0.465 Sum_probs=214.9
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEE 144 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 144 (536)
..+|++.+.||+|+||+||+|.+..+|+.||+|++.... .........+.+|+.+++.++||||+++++++...+
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 221 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEV-----IVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD 221 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHH-----HC-------------CCCCCSCTTSCCEEEEEEETT
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhh-----hhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCC
Confidence 357999999999999999999999999999999984211 112233456778999999999999999999999999
Q ss_pred ceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHH-cCCccccCCCCCcccCCCCcEEEEecCcchhhhh
Q 009364 145 SLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHN-HGIMHRDIKGANILVDNKGCIKLADFGASKQVAE 223 (536)
Q Consensus 145 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~-~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 223 (536)
.+++||||++||+|.+++.+.+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+++....
T Consensus 222 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 222 RLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp EEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 999999999999999999888899999999999999999999998 9999999999999999999999999999976432
Q ss_pred hhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH-HHHHHhhCCCCCCCCCCCcCcHH
Q 009364 224 LATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE-VAALFHIGTTKSHPPIPENLSVK 302 (536)
Q Consensus 224 ~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~ 302 (536)
.. ......+||+.|+|||++.+..++.++|||||||++|+|++|.+||...... ....+... ...++..++++
T Consensus 302 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~----~~~~p~~~~~~ 375 (446)
T 4ejn_A 302 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME----EIRFPRTLGPE 375 (446)
T ss_dssp -------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC----CCCCCTTSCHH
T ss_pred CC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhC----CCCCCccCCHH
Confidence 21 2245678999999999999999999999999999999999999999754332 22222222 23456789999
Q ss_pred HHHHHHHhcccCCCCCC-----CHHHHHhCCCCcCCCCC
Q 009364 303 AKDFLLKCLEKEPDLRP-----TASELLKHPFVTGDDED 336 (536)
Q Consensus 303 ~~dLi~~cL~~dP~~Rp-----s~~eiL~hp~~~~~~~~ 336 (536)
+++||.+||++||.+|| ++.|+++||||....+.
T Consensus 376 ~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~ 414 (446)
T 4ejn_A 376 AKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQ 414 (446)
T ss_dssp HHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred HHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHH
Confidence 99999999999999999 99999999999876543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-49 Score=416.88 Aligned_cols=268 Identities=27% Similarity=0.444 Sum_probs=220.1
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE 143 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 143 (536)
...+|++.+.||+|+||+||+|+++.+|+.||+|++.... .......+.+.+|..++..++||||+++++++.+.
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~-----~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 133 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWD-----MLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDE 133 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH-----HHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHH-----hhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence 4568999999999999999999999999999999984211 11112234577899999999999999999999999
Q ss_pred CceeEEEEecCCCCcccccccC-CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhh
Q 009364 144 ESLNILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVA 222 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~ 222 (536)
+.+|+||||++||+|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++...
T Consensus 134 ~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~ 213 (412)
T 2vd5_A 134 NYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLR 213 (412)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred CEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheecc
Confidence 9999999999999999999765 479999999999999999999999999999999999999999999999999998765
Q ss_pred hhhcccCCcccCCCCCCCChhhhhh-------cCCCccceEechhHHHHHHhhCCCCCchhhHH-H-HHHHhhCCCCCCC
Q 009364 223 ELATVSGAKSMKGTPYWMAPEVIRQ-------TGHSYSADIWSVGCTVIEMATGKPPWSQQYQE-V-AALFHIGTTKSHP 293 (536)
Q Consensus 223 ~~~~~~~~~~~~Gt~~Y~APEvl~~-------~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~-~-~~~~~~~~~~~~~ 293 (536)
.... ......+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||...... . ..+.........+
T Consensus 214 ~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p 292 (412)
T 2vd5_A 214 ADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLP 292 (412)
T ss_dssp TTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC
T ss_pred CCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCC
Confidence 4222 12345689999999999973 46899999999999999999999999754322 1 2222111112223
Q ss_pred CCCCcCcHHHHHHHHHhcccCCCCC---CCHHHHHhCCCCcCCCCCcc
Q 009364 294 PIPENLSVKAKDFLLKCLEKEPDLR---PTASELLKHPFVTGDDEDPV 338 (536)
Q Consensus 294 ~~~~~~s~~~~dLi~~cL~~dP~~R---ps~~eiL~hp~~~~~~~~~~ 338 (536)
..+..++.++++||++||+ +|.+| |+++|+++||||....++..
T Consensus 293 ~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l 339 (412)
T 2vd5_A 293 LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGL 339 (412)
T ss_dssp ----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTS
T ss_pred ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHH
Confidence 3456899999999999999 99998 59999999999998776644
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=396.37 Aligned_cols=262 Identities=29% Similarity=0.481 Sum_probs=211.8
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
.+|++.+.||+|+||+||+|.+..+|+.||+|++... .......+.+.+|+.+++.++||||+++++++...+.
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 76 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLES------EDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRR 76 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCC------CC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecc------ccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCe
Confidence 4799999999999999999999999999999987422 1223345667889999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhh
Q 009364 146 LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA 225 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 225 (536)
.++||||+++++|.+++...+.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 77 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 77 LHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp EEEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 99999999999999998888889999999999999999999999999999999999999999999999999997655322
Q ss_pred cccCCcccCCCCCCCChhhhhh-cCCCccceEechhHHHHHHhhCCCCCchhhHHHH--HHHhh-C--------------
Q 009364 226 TVSGAKSMKGTPYWMAPEVIRQ-TGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVA--ALFHI-G-------------- 287 (536)
Q Consensus 226 ~~~~~~~~~Gt~~Y~APEvl~~-~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~--~~~~~-~-------------- 287 (536)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||........ ..... .
T Consensus 157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
T 4agu_A 157 --DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ 234 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred --cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccc
Confidence 12345679999999999986 5689999999999999999999999965432211 11100 0
Q ss_pred ---CCCC--CCC------CCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCCC
Q 009364 288 ---TTKS--HPP------IPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDE 335 (536)
Q Consensus 288 ---~~~~--~~~------~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~~ 335 (536)
.... ... ..+.++.++.+||.+||+.||.+|||+.|+++||||.+..+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 293 (311)
T 4agu_A 235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE 293 (311)
T ss_dssp GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC-
T ss_pred ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccC
Confidence 0000 000 01368899999999999999999999999999999987543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=398.58 Aligned_cols=256 Identities=34% Similarity=0.536 Sum_probs=216.8
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCce
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESL 146 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 146 (536)
.|+..+.||+|+||+||+|++..+|+.||||++.... ....+.+.+|+.+++.++||||+++++++...+..
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 117 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK--------QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEEL 117 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT--------CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc--------hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEE
Confidence 5788899999999999999999999999999884321 11234577899999999999999999999999999
Q ss_pred eEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhc
Q 009364 147 NILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELAT 226 (536)
Q Consensus 147 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 226 (536)
++||||++||+|.+++.+ ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 118 ~lv~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~- 195 (321)
T 2c30_A 118 WVLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV- 195 (321)
T ss_dssp EEEECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-
T ss_pred EEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCc-
Confidence 999999999999998875 579999999999999999999999999999999999999999999999999987665322
Q ss_pred ccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHH-HHHHhhCCCCCCCCCCCcCcHHHHH
Q 009364 227 VSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEV-AALFHIGTTKSHPPIPENLSVKAKD 305 (536)
Q Consensus 227 ~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~s~~~~d 305 (536)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||....... ....... .......+..+++.+++
T Consensus 196 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~ 273 (321)
T 2c30_A 196 -PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS-PPPKLKNSHKVSPVLRD 273 (321)
T ss_dssp -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-SCCCCTTGGGSCHHHHH
T ss_pred -cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-CCCCcCccccCCHHHHH
Confidence 12346689999999999999899999999999999999999999996543221 1112111 11122234568999999
Q ss_pred HHHHhcccCCCCCCCHHHHHhCCCCcCCC
Q 009364 306 FLLKCLEKEPDLRPTASELLKHPFVTGDD 334 (536)
Q Consensus 306 Li~~cL~~dP~~Rps~~eiL~hp~~~~~~ 334 (536)
||.+||+.||.+|||+.++++||||....
T Consensus 274 li~~~l~~dp~~Rps~~ell~hp~~~~~~ 302 (321)
T 2c30_A 274 FLERMLVRDPQERATAQELLDHPFLLQTG 302 (321)
T ss_dssp HHHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred HHHHHccCChhhCcCHHHHhcChhhccCC
Confidence 99999999999999999999999997543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-49 Score=406.65 Aligned_cols=254 Identities=27% Similarity=0.412 Sum_probs=216.4
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeEeeeeecC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRYLGTVREE 143 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~ 143 (536)
..+|++.+.||+|+||+||+|.++.+|+.||+|++.... ....+|++++.++ +||||+++++++.+.
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~------------~~~~~E~~~l~~~~~hp~iv~~~~~~~~~ 88 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK------------RDPTEEIEILLRYGQHPNIITLKDVYDDG 88 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT------------CCCHHHHHHHHHHTTSTTBCCEEEEEECS
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc------------CChHHHHHHHHHhcCCCCcCeEEEEEEcC
Confidence 357999999999999999999999999999999984321 1123577788777 799999999999999
Q ss_pred CceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCC-C---cEEEEecCcch
Q 009364 144 ESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNK-G---CIKLADFGASK 219 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~-~---~vkL~DFGla~ 219 (536)
..+|+|||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||+..+ + .+||+|||+++
T Consensus 89 ~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~ 168 (342)
T 2qr7_A 89 KYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168 (342)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence 9999999999999999999888899999999999999999999999999999999999998543 3 59999999998
Q ss_pred hhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchh----hHHHHHHHhhCCCCCCCCC
Q 009364 220 QVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQ----YQEVAALFHIGTTKSHPPI 295 (536)
Q Consensus 220 ~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~----~~~~~~~~~~~~~~~~~~~ 295 (536)
...... ......+||+.|+|||++.+..++.++|||||||++|+|++|.+||... ..+....+...........
T Consensus 169 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 246 (342)
T 2qr7_A 169 QLRAEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGY 246 (342)
T ss_dssp ECBCTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTT
T ss_pred cCcCCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccc
Confidence 664322 2234678999999999999888999999999999999999999999642 2333334444444444445
Q ss_pred CCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcC
Q 009364 296 PENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTG 332 (536)
Q Consensus 296 ~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~ 332 (536)
+..++.++++||++||..||.+|||+.++++||||..
T Consensus 247 ~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 247 WNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp TTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred cccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 5689999999999999999999999999999999964
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-49 Score=398.02 Aligned_cols=263 Identities=26% Similarity=0.391 Sum_probs=208.8
Q ss_pred CCCCceee-eEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeEeeeee
Q 009364 64 PPIRWRKG-ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRYLGTVR 141 (536)
Q Consensus 64 ~~~~y~~~-~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~ 141 (536)
...+|++. +.||+|+||+||+|.+..+|+.||||++.... ......+.+|+.+++++ +||||+++++++.
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~ 81 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP--------GHIRSRVFREVEMLYQCQGHRNVLELIEFFE 81 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS--------SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc--------chhHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 34679984 78999999999999999999999999984321 11234577899999885 7999999999999
Q ss_pred cCCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCc---EEEEecCcc
Q 009364 142 EEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGC---IKLADFGAS 218 (536)
Q Consensus 142 ~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~---vkL~DFGla 218 (536)
+.+.+++||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++
T Consensus 82 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~ 161 (316)
T 2ac3_A 82 EEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLG 161 (316)
T ss_dssp ETTEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCC
T ss_pred eCCEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCc
Confidence 99999999999999999999988888999999999999999999999999999999999999988775 999999998
Q ss_pred hhhhhhhc-----ccCCcccCCCCCCCChhhhhh-----cCCCccceEechhHHHHHHhhCCCCCchhh-----------
Q 009364 219 KQVAELAT-----VSGAKSMKGTPYWMAPEVIRQ-----TGHSYSADIWSVGCTVIEMATGKPPWSQQY----------- 277 (536)
Q Consensus 219 ~~~~~~~~-----~~~~~~~~Gt~~Y~APEvl~~-----~~~s~k~DIwSlGvil~eLltG~~Pf~~~~----------- 277 (536)
........ .......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 241 (316)
T 2ac3_A 162 SGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEA 241 (316)
T ss_dssp C-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----C
T ss_pred cccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccccc
Confidence 76542211 111234569999999999975 568899999999999999999999996531
Q ss_pred -----HHHHHHHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCC
Q 009364 278 -----QEVAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDD 334 (536)
Q Consensus 278 -----~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~ 334 (536)
.....................++.++++||.+||+.||.+|||+.|+++||||+...
T Consensus 242 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 242 CPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp CHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred chhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence 112222222221111111246889999999999999999999999999999998643
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=390.30 Aligned_cols=255 Identities=27% Similarity=0.435 Sum_probs=208.9
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
++|++.+.||+|+||+||+|.+..+|..+|+|++..... ....+.+.+|+++++.++||||+++++++.+...
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 94 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS-------QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHN 94 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-------CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc-------chhHHHHHHHHHHHHhCCCchHHhHHHheecCCe
Confidence 479999999999999999999999999999999843221 1224567899999999999999999999999999
Q ss_pred eeEEEEecCCCCccccccc----CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCccc---CCCCcEEEEecCcc
Q 009364 146 LNILLEFVPGGSISSLLGK----FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILV---DNKGCIKLADFGAS 218 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl---~~~~~vkL~DFGla 218 (536)
.++||||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a 174 (285)
T 3is5_A 95 MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA 174 (285)
T ss_dssp EEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred EEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence 9999999999999988843 3679999999999999999999999999999999999999 45578999999999
Q ss_pred hhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHH-HHHHhhCCCCCCCCCCC
Q 009364 219 KQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEV-AALFHIGTTKSHPPIPE 297 (536)
Q Consensus 219 ~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~ 297 (536)
....... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||....... ....... .........
T Consensus 175 ~~~~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~ 249 (285)
T 3is5_A 175 ELFKSDE---HSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYK-EPNYAVECR 249 (285)
T ss_dssp CC-------------CTTGGGCCHHHHTT-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-CCCCCC--C
T ss_pred eecCCcc---cCcCcccccCcCChHHhcc-CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccC-CcccccccC
Confidence 7655422 2345679999999999864 68999999999999999999999997654322 2222222 222222234
Q ss_pred cCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcC
Q 009364 298 NLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTG 332 (536)
Q Consensus 298 ~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~ 332 (536)
.+++++.+||.+||+.||.+|||+.|+|+||||++
T Consensus 250 ~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 250 PLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp CCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 57899999999999999999999999999999974
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=414.34 Aligned_cols=264 Identities=30% Similarity=0.494 Sum_probs=208.1
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEE 144 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 144 (536)
..+|++.+.||+|+||+||+|.+..+++.||+|++..................+.+|+.+|+.++||||+++++++.. +
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence 368999999999999999999999999999999985432211111222233457899999999999999999999864 4
Q ss_pred ceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCC---cEEEEecCcchhh
Q 009364 145 SLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKG---CIKLADFGASKQV 221 (536)
Q Consensus 145 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~---~vkL~DFGla~~~ 221 (536)
.+++||||+++|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~ 292 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 292 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceec
Confidence 5899999999999999999888999999999999999999999999999999999999997554 5999999999876
Q ss_pred hhhhcccCCcccCCCCCCCChhhhhh---cCCCccceEechhHHHHHHhhCCCCCchhhH--HHHHHHhhCCCCCCCCCC
Q 009364 222 AELATVSGAKSMKGTPYWMAPEVIRQ---TGHSYSADIWSVGCTVIEMATGKPPWSQQYQ--EVAALFHIGTTKSHPPIP 296 (536)
Q Consensus 222 ~~~~~~~~~~~~~Gt~~Y~APEvl~~---~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~--~~~~~~~~~~~~~~~~~~ 296 (536)
... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||..... ..............+..+
T Consensus 293 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~ 369 (419)
T 3i6u_A 293 GET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 369 (419)
T ss_dssp C--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHH
T ss_pred CCC---ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhh
Confidence 542 22346789999999999853 5678999999999999999999999964321 122222222222222333
Q ss_pred CcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcC
Q 009364 297 ENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTG 332 (536)
Q Consensus 297 ~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~ 332 (536)
..++..+++||.+||+.||.+|||+.|+|+||||+.
T Consensus 370 ~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 370 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred cccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 578999999999999999999999999999999974
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=418.01 Aligned_cols=256 Identities=27% Similarity=0.449 Sum_probs=221.1
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
.+|.+++.||+|+||+||+|.+..+|+.||||++.... .........+.+|+.+|+.++||||+++++++.....
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~-----~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~ 90 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQK-----IRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSD 90 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHH-----HHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhh-----ccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 58999999999999999999999999999999984211 1111234578899999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhh
Q 009364 146 LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA 225 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 225 (536)
+++||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 91 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~- 169 (476)
T 2y94_A 91 IFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG- 169 (476)
T ss_dssp EEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT-
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccc-
Confidence 9999999999999999998889999999999999999999999999999999999999999999999999999876432
Q ss_pred cccCCcccCCCCCCCChhhhhhcCC-CccceEechhHHHHHHhhCCCCCchhhH-HHHHHHhhCCCCCCCCCCCcCcHHH
Q 009364 226 TVSGAKSMKGTPYWMAPEVIRQTGH-SYSADIWSVGCTVIEMATGKPPWSQQYQ-EVAALFHIGTTKSHPPIPENLSVKA 303 (536)
Q Consensus 226 ~~~~~~~~~Gt~~Y~APEvl~~~~~-s~k~DIwSlGvil~eLltG~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~s~~~ 303 (536)
......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||..... .....+... ....+..+++++
T Consensus 170 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~----~~~~p~~~s~~~ 243 (476)
T 2y94_A 170 --EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDG----IFYTPQYLNPSV 243 (476)
T ss_dssp --CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTT----CCCCCTTCCHHH
T ss_pred --ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC----CcCCCccCCHHH
Confidence 22456789999999999998765 7899999999999999999999975432 222222211 223556789999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 304 KDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 304 ~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
++||++||+.||.+|||+.|+++||||...
T Consensus 244 ~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 244 ISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred HHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 999999999999999999999999999864
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=409.46 Aligned_cols=260 Identities=27% Similarity=0.442 Sum_probs=213.4
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCC--CCceeeEeeeeec
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS--HPNIVRYLGTVRE 142 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~--HpnIv~l~~~~~~ 142 (536)
..+|++.+.||+|+||+||+|.+.. |+.||||++.... ......+.+.+|+.+|+.+. ||||+++++++..
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~------~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~ 127 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEE------ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 127 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTT------CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEeccc------ccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec
Confidence 3469999999999999999999765 8999999985321 12344567889999999996 5999999999999
Q ss_pred CCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhh
Q 009364 143 EESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVA 222 (536)
Q Consensus 143 ~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~ 222 (536)
.+.+++||| +.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.+.
T Consensus 128 ~~~~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~ 205 (390)
T 2zmd_A 128 DQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 205 (390)
T ss_dssp SSEEEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred CCEEEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence 999999999 56899999998888999999999999999999999999999999999999995 5899999999998765
Q ss_pred hhhcccCCcccCCCCCCCChhhhhh-----------cCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCC
Q 009364 223 ELATVSGAKSMKGTPYWMAPEVIRQ-----------TGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKS 291 (536)
Q Consensus 223 ~~~~~~~~~~~~Gt~~Y~APEvl~~-----------~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~ 291 (536)
...........+||+.|+|||++.+ ..++.++||||||||+|+|++|.+||.........+........
T Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~ 285 (390)
T 2zmd_A 206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH 285 (390)
T ss_dssp --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTS
T ss_pred CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccc
Confidence 4333223456789999999999975 36899999999999999999999999764333222222222333
Q ss_pred CCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 292 HPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 292 ~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
...++...+.++++||.+||+.||.+|||+.|+|+||||+..
T Consensus 286 ~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 286 EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred cCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence 445566778999999999999999999999999999999754
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=389.06 Aligned_cols=257 Identities=30% Similarity=0.526 Sum_probs=217.9
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEE 144 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 144 (536)
..+|++++.||+|+||+||+|.+..+++.||+|++.... .........+.+|+.+++.++||||+++++++.+..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 82 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ-----LEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT 82 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH-----HHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccc-----cchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCC
Confidence 358999999999999999999999999999999884211 111122456889999999999999999999999999
Q ss_pred ceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhh
Q 009364 145 SLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAEL 224 (536)
Q Consensus 145 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 224 (536)
..++||||+++|+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 83 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 83 RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 99999999999999999988888999999999999999999999999999999999999999999999999998654432
Q ss_pred hcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH-HHHHHhhCCCCCCCCCCCcCcHHH
Q 009364 225 ATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE-VAALFHIGTTKSHPPIPENLSVKA 303 (536)
Q Consensus 225 ~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~ 303 (536)
......||+.|+|||++.+..++.++||||||+++|+|++|..||...... ....... ....++..++..+
T Consensus 163 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~~ 234 (279)
T 3fdn_A 163 ----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR----VEFTFPDFVTEGA 234 (279)
T ss_dssp ---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH----TCCCCCTTSCHHH
T ss_pred ----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHh----CCCCCCCcCCHHH
Confidence 234567999999999999999999999999999999999999999754322 2222221 2234566789999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHhCCCCcCCC
Q 009364 304 KDFLLKCLEKEPDLRPTASELLKHPFVTGDD 334 (536)
Q Consensus 304 ~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~ 334 (536)
++||.+||+.||.+|||+.|+++||||....
T Consensus 235 ~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 235 RDLISRLLKHNPSQRPMLREVLEHPWITANS 265 (279)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred HHHHHHHhccChhhCCCHHHHhhCccccCCc
Confidence 9999999999999999999999999997543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=408.01 Aligned_cols=260 Identities=27% Similarity=0.455 Sum_probs=201.3
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCC-CCceeeEeeeeecCC
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS-HPNIVRYLGTVREEE 144 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~ 144 (536)
.+|++.+.||+|+||+||+|.+..+|+.||||++... .........+.+|+.+|+.+. ||||+++++++...+
T Consensus 9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~------~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 82 (388)
T 3oz6_A 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA------FQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADN 82 (388)
T ss_dssp TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--------CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTT
T ss_pred CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccc------ccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCC
Confidence 5899999999999999999999999999999987321 112234456778999999997 999999999997544
Q ss_pred --ceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhh
Q 009364 145 --SLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVA 222 (536)
Q Consensus 145 --~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~ 222 (536)
.+|+|||||. |+|..++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.+.
T Consensus 83 ~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 160 (388)
T 3oz6_A 83 DRDVYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFV 160 (388)
T ss_dssp SSCEEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred CCEEEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence 7899999997 688888876 579999999999999999999999999999999999999999999999999997653
Q ss_pred hhh-------------------cccCCcccCCCCCCCChhhhhh-cCCCccceEechhHHHHHHhhCCCCCchhhHH--H
Q 009364 223 ELA-------------------TVSGAKSMKGTPYWMAPEVIRQ-TGHSYSADIWSVGCTVIEMATGKPPWSQQYQE--V 280 (536)
Q Consensus 223 ~~~-------------------~~~~~~~~~Gt~~Y~APEvl~~-~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~--~ 280 (536)
... ........+||++|+|||++.+ ..++.++||||||||+|+|++|++||.+.... .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~ 240 (388)
T 3oz6_A 161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQL 240 (388)
T ss_dssp SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred ccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 210 1112345689999999999986 67899999999999999999999999654321 1
Q ss_pred HHHHhhCCCCC-----------------------------CC-------------CCCCcCcHHHHHHHHHhcccCCCCC
Q 009364 281 AALFHIGTTKS-----------------------------HP-------------PIPENLSVKAKDFLLKCLEKEPDLR 318 (536)
Q Consensus 281 ~~~~~~~~~~~-----------------------------~~-------------~~~~~~s~~~~dLi~~cL~~dP~~R 318 (536)
..+........ .. ..+..+++++++||.+||+.||.+|
T Consensus 241 ~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R 320 (388)
T 3oz6_A 241 ERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKR 320 (388)
T ss_dssp HHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGS
T ss_pred HHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccC
Confidence 11111100000 00 0112678999999999999999999
Q ss_pred CCHHHHHhCCCCcCC
Q 009364 319 PTASELLKHPFVTGD 333 (536)
Q Consensus 319 ps~~eiL~hp~~~~~ 333 (536)
||+.|+|+||||...
T Consensus 321 ~t~~e~l~Hp~~~~~ 335 (388)
T 3oz6_A 321 ISANDALKHPFVSIF 335 (388)
T ss_dssp CCHHHHTTSTTTTTT
T ss_pred CCHHHHhCCHHHHHh
Confidence 999999999999753
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-49 Score=403.10 Aligned_cols=255 Identities=24% Similarity=0.369 Sum_probs=195.0
Q ss_pred Cceee---eEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCC-CCceeeEeeeeec
Q 009364 67 RWRKG---ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS-HPNIVRYLGTVRE 142 (536)
Q Consensus 67 ~y~~~---~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~ 142 (536)
+|++. +.||+|+||+||+|.+..+|+.||+|++.. . ....+.+|+.+++.+. ||||+++++++.+
T Consensus 9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-------~----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~ 77 (325)
T 3kn6_A 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK-------R----MEANTQKEITALKLCEGHPNIVKLHEVFHD 77 (325)
T ss_dssp HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEG-------G----GHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEECh-------h----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEc
Confidence 45553 789999999999999999999999999831 1 1234668999999997 9999999999999
Q ss_pred CCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCC---cEEEEecCcch
Q 009364 143 EESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKG---CIKLADFGASK 219 (536)
Q Consensus 143 ~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~---~vkL~DFGla~ 219 (536)
....++||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~ 157 (325)
T 3kn6_A 78 QLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFAR 157 (325)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCE
T ss_pred CCEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccce
Confidence 999999999999999999999888999999999999999999999999999999999999997766 89999999997
Q ss_pred hhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhH--------HHHHHHhhCCCCC
Q 009364 220 QVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQ--------EVAALFHIGTTKS 291 (536)
Q Consensus 220 ~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~--------~~~~~~~~~~~~~ 291 (536)
...... ......+||+.|+|||++.+..++.++|||||||++|+|++|.+||..... +....+.......
T Consensus 158 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~ 235 (325)
T 3kn6_A 158 LKPPDN--QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF 235 (325)
T ss_dssp ECCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCC
T ss_pred ecCCCC--CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCC
Confidence 654322 223466799999999999999999999999999999999999999975332 2222222222211
Q ss_pred CCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCC
Q 009364 292 HPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDD 334 (536)
Q Consensus 292 ~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~ 334 (536)
....+..++.++++||.+||+.||.+|||+.|+++||||+...
T Consensus 236 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~ 278 (325)
T 3kn6_A 236 EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS 278 (325)
T ss_dssp CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTC
T ss_pred CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCc
Confidence 2222246899999999999999999999999999999998643
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=398.60 Aligned_cols=260 Identities=31% Similarity=0.545 Sum_probs=198.6
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE 143 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 143 (536)
...+|++.+.||+|+||+||+|.+..+|+.||+|++..... ......+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 75 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-------EGTPSTAIREISLMKELKHENIVRLYDVIHTE 75 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCST-------TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCT
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc-------cccHHHHHHHHHHHHhcCCCCcceEEEEEEEC
Confidence 45689999999999999999999999999999999853221 11124567899999999999999999999999
Q ss_pred CceeEEEEecCCCCcccccccC------CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCc
Q 009364 144 ESLNILLEFVPGGSISSLLGKF------GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGA 217 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~~~------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGl 217 (536)
+.+++||||++ |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 76 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 154 (317)
T 2pmi_A 76 NKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGL 154 (317)
T ss_dssp TEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSS
T ss_pred CeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCcc
Confidence 99999999997 6888887542 4589999999999999999999999999999999999999999999999999
Q ss_pred chhhhhhhcccCCcccCCCCCCCChhhhhhc-CCCccceEechhHHHHHHhhCCCCCchhhHH--HHHHHhhCCCCC---
Q 009364 218 SKQVAELATVSGAKSMKGTPYWMAPEVIRQT-GHSYSADIWSVGCTVIEMATGKPPWSQQYQE--VAALFHIGTTKS--- 291 (536)
Q Consensus 218 a~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~-~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~--~~~~~~~~~~~~--- 291 (536)
++..... .......+||+.|+|||++.+. .++.++|||||||++|+|++|.+||...... ...+........
T Consensus 155 ~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 232 (317)
T 2pmi_A 155 ARAFGIP--VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESL 232 (317)
T ss_dssp CEETTSC--CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTT
T ss_pred ceecCCC--cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhH
Confidence 9865432 1223456799999999999864 6899999999999999999999999754322 111111100000
Q ss_pred --------------------------CCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 292 --------------------------HPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 292 --------------------------~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
.+..+..++.++++||.+||+.||.+|||+.|+|+||||...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 300 (317)
T 2pmi_A 233 WPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEY 300 (317)
T ss_dssp CGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred hhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcc
Confidence 001123578899999999999999999999999999999764
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-48 Score=387.38 Aligned_cols=258 Identities=26% Similarity=0.464 Sum_probs=216.5
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec-
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE- 142 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~- 142 (536)
....|++.+.||+|+||+||+|.+..++..||+|++... .......+.+.+|+.+++.++||||+++++++..
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~------~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 97 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDR------KLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST 97 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGG------GSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE
T ss_pred CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecch------hhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccc
Confidence 345689999999999999999999999999999988421 1123345678899999999999999999998865
Q ss_pred ---CCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--CccccCCCCCcccC-CCCcEEEEecC
Q 009364 143 ---EESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHG--IMHRDIKGANILVD-NKGCIKLADFG 216 (536)
Q Consensus 143 ---~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~--ivHrDLKp~NILl~-~~~~vkL~DFG 216 (536)
...+++||||+++|+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||
T Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg 177 (290)
T 1t4h_A 98 VKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLG 177 (290)
T ss_dssp SSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred cCCCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCC
Confidence 4568999999999999999988888999999999999999999999999 99999999999997 78899999999
Q ss_pred cchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCC
Q 009364 217 ASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIP 296 (536)
Q Consensus 217 la~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 296 (536)
++...... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||......................+
T Consensus 178 ~~~~~~~~----~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 252 (290)
T 1t4h_A 178 LATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD 252 (290)
T ss_dssp GGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGG
T ss_pred Cccccccc----ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccC
Confidence 98754332 2345679999999998875 599999999999999999999999975433222222222222333455
Q ss_pred CcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcC
Q 009364 297 ENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTG 332 (536)
Q Consensus 297 ~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~ 332 (536)
...++++.+||.+||+.||.+|||+.++++||||+.
T Consensus 253 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 253 KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred CCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 677899999999999999999999999999999975
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-48 Score=409.24 Aligned_cols=265 Identities=27% Similarity=0.436 Sum_probs=209.9
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE 142 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 142 (536)
..+.+|++.+.||+|+||+||+|.+..+|+.||||++... .......+.+.+|+.+|+.++||||+++++++..
T Consensus 23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~------~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 96 (432)
T 3n9x_A 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM------FEDLIDCKRILREITILNRLKSDYIIRLYDLIIP 96 (432)
T ss_dssp CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECST------TTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCC
T ss_pred eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCch------hcChHHHHHHHHHHHHHHHcCCCCcceEEEEEec
Confidence 4467899999999999999999999999999999998421 1222345678899999999999999999999976
Q ss_pred C-----CceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCc
Q 009364 143 E-----ESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGA 217 (536)
Q Consensus 143 ~-----~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGl 217 (536)
. ..+|+||||+. |+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 97 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGl 175 (432)
T 3n9x_A 97 DDLLKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGL 175 (432)
T ss_dssp SCTTTCCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred CCCCcCCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCC
Confidence 6 57999999995 69999998888899999999999999999999999999999999999999999999999999
Q ss_pred chhhhhhhcc--------------------cCCcccCCCCCCCChhhh-hhcCCCccceEechhHHHHHHhhCC------
Q 009364 218 SKQVAELATV--------------------SGAKSMKGTPYWMAPEVI-RQTGHSYSADIWSVGCTVIEMATGK------ 270 (536)
Q Consensus 218 a~~~~~~~~~--------------------~~~~~~~Gt~~Y~APEvl-~~~~~s~k~DIwSlGvil~eLltG~------ 270 (536)
++........ ......+||++|+|||++ .+..++.++||||||||+|+|++|.
T Consensus 176 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~ 255 (432)
T 3n9x_A 176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIND 255 (432)
T ss_dssp CEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSS
T ss_pred cccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccc
Confidence 9876542211 123567899999999986 5667999999999999999999854
Q ss_pred -----CCCchhh-------------------HHHHHHHhh-C--------------------CCCCCCC-----CCCcCc
Q 009364 271 -----PPWSQQY-------------------QEVAALFHI-G--------------------TTKSHPP-----IPENLS 300 (536)
Q Consensus 271 -----~Pf~~~~-------------------~~~~~~~~~-~--------------------~~~~~~~-----~~~~~s 300 (536)
++|.+.. .....+... + ......+ ..+.++
T Consensus 256 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 335 (432)
T 3n9x_A 256 PTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSIS 335 (432)
T ss_dssp GGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSC
T ss_pred cccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCC
Confidence 4442210 001111000 0 0001111 114689
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCC
Q 009364 301 VKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDD 334 (536)
Q Consensus 301 ~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~ 334 (536)
+++++||++||+.||.+|||+.|+|+||||....
T Consensus 336 ~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 369 (432)
T 3n9x_A 336 DDGINLLESMLKFNPNKRITIDQALDHPYLKDVR 369 (432)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTC
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhcChhhhhcc
Confidence 9999999999999999999999999999998654
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=398.14 Aligned_cols=256 Identities=22% Similarity=0.346 Sum_probs=208.9
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCC-
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEE- 144 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~- 144 (536)
.+|++.+.||+|+||+||+|++..+|+.||||++.... .....+.+.+|+.+|+.++||||+++++++.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 78 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-------RELAREKVMREVKALAKLEHPGIVRYFNAWLETPP 78 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-------TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCS
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-------chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEecc
Confidence 36999999999999999999999999999999985321 1123466889999999999999999999986543
Q ss_pred --------------------------------------------------------ceeEEEEecCCCCcccccccCCC-
Q 009364 145 --------------------------------------------------------SLNILLEFVPGGSISSLLGKFGP- 167 (536)
Q Consensus 145 --------------------------------------------------------~~~lV~E~~~gg~L~~~l~~~~~- 167 (536)
..++|||||+||+|.+++.....
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~ 158 (332)
T 3qd2_B 79 EKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL 158 (332)
T ss_dssp CHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG
T ss_pred chhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc
Confidence 27999999999999999976543
Q ss_pred --CCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhc----------ccCCcccCC
Q 009364 168 --FPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELAT----------VSGAKSMKG 235 (536)
Q Consensus 168 --l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~----------~~~~~~~~G 235 (536)
.++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .......+|
T Consensus 159 ~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g 238 (332)
T 3qd2_B 159 EDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG 238 (332)
T ss_dssp GGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred cchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence 45667899999999999999999999999999999999999999999999987654321 112345679
Q ss_pred CCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCC
Q 009364 236 TPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEP 315 (536)
Q Consensus 236 t~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP 315 (536)
|+.|+|||++.+..++.++|||||||++|+|++|..|+............ ...+..+...++++++||.+||+.||
T Consensus 239 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~li~~~l~~~p 314 (332)
T 3qd2_B 239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRN----LKFPLLFTQKYPQEHMMVQDMLSPSP 314 (332)
T ss_dssp CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHHHHHHHHT----TCCCHHHHHHCHHHHHHHHHHHCSSG
T ss_pred CcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHHHHHHhhc----cCCCcccccCChhHHHHHHHHccCCC
Confidence 99999999999999999999999999999999998887544332222211 12222234567888999999999999
Q ss_pred CCCCCHHHHHhCCCCcC
Q 009364 316 DLRPTASELLKHPFVTG 332 (536)
Q Consensus 316 ~~Rps~~eiL~hp~~~~ 332 (536)
.+|||+.|+++||||++
T Consensus 315 ~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 315 TERPEATDIIENAIFEN 331 (332)
T ss_dssp GGSCCHHHHHHSTTCCC
T ss_pred CcCCCHHHHhhchhhhc
Confidence 99999999999999974
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=424.11 Aligned_cols=262 Identities=28% Similarity=0.448 Sum_probs=223.1
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE 142 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 142 (536)
....+|++.+.||+|+||.||+|++..+|+.||+|++..... ........+.+|+.+|+.++||||+++++++.+
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~-----~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~ 255 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI-----KKRKGEAMALNEKQILEKVNSRFVVSLAYAYET 255 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhh-----hhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEee
Confidence 345679999999999999999999999999999999843211 111224557789999999999999999999999
Q ss_pred CCceeEEEEecCCCCcccccccCC--CCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchh
Q 009364 143 EESLNILLEFVPGGSISSLLGKFG--PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQ 220 (536)
Q Consensus 143 ~~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~ 220 (536)
.+.+|+||||++||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus 256 ~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~ 335 (576)
T 2acx_A 256 KDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVH 335 (576)
T ss_dssp SSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEeccccee
Confidence 999999999999999999887654 499999999999999999999999999999999999999999999999999987
Q ss_pred hhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhh-----HHHHHHHhhCCCCCCCCC
Q 009364 221 VAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQY-----QEVAALFHIGTTKSHPPI 295 (536)
Q Consensus 221 ~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~-----~~~~~~~~~~~~~~~~~~ 295 (536)
..... .....+||+.|+|||++.+..++.++|||||||++|+|++|.+||.... ..+...... ....+
T Consensus 336 ~~~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~----~~~~~ 408 (576)
T 2acx_A 336 VPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE----VPEEY 408 (576)
T ss_dssp CCTTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH----CCCCC
T ss_pred cccCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc----ccccC
Confidence 65422 2345689999999999999899999999999999999999999997532 222222222 12345
Q ss_pred CCcCcHHHHHHHHHhcccCCCCCC-----CHHHHHhCCCCcCCCCC
Q 009364 296 PENLSVKAKDFLLKCLEKEPDLRP-----TASELLKHPFVTGDDED 336 (536)
Q Consensus 296 ~~~~s~~~~dLi~~cL~~dP~~Rp-----s~~eiL~hp~~~~~~~~ 336 (536)
+..+++++++||++||++||.+|| ++.|+++||||....+.
T Consensus 409 p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~ 454 (576)
T 2acx_A 409 SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFK 454 (576)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHH
T ss_pred CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHH
Confidence 678999999999999999999999 89999999999876543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-48 Score=394.83 Aligned_cols=265 Identities=29% Similarity=0.430 Sum_probs=221.8
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEE 144 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 144 (536)
..+|++.+.||+|+||.||+|.+..+|+.||+|++.......... ....+.+.+|+.+++.++||||+++++++.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 88 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRR--GVSREEIEREVSILRQVLHHNVITLHDVYENRT 88 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSS--SBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEeccccccccc--chhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 357999999999999999999999999999999985432211100 012356789999999999999999999999999
Q ss_pred ceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCC----cEEEEecCcchh
Q 009364 145 SLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKG----CIKLADFGASKQ 220 (536)
Q Consensus 145 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~----~vkL~DFGla~~ 220 (536)
.+++||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~ 168 (321)
T 2a2a_A 89 DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (321)
T ss_dssp EEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCcccee
Confidence 9999999999999999998888899999999999999999999999999999999999999888 799999999976
Q ss_pred hhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH-HHHHHhhCCCCCCCCCCCcC
Q 009364 221 VAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE-VAALFHIGTTKSHPPIPENL 299 (536)
Q Consensus 221 ~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~ 299 (536)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ................+..+
T Consensus 169 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 245 (321)
T 2a2a_A 169 IEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHT 245 (321)
T ss_dssp CCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTC
T ss_pred cCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhccc
Confidence 65422 234567999999999999999999999999999999999999999754322 22222222222222233578
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCC
Q 009364 300 SVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDD 334 (536)
Q Consensus 300 s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~ 334 (536)
+..+++||.+||..||.+|||+.|+++||||....
T Consensus 246 ~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~ 280 (321)
T 2a2a_A 246 SELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280 (321)
T ss_dssp CHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence 99999999999999999999999999999997543
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=409.59 Aligned_cols=252 Identities=27% Similarity=0.428 Sum_probs=203.6
Q ss_pred CCceee-eEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHH-hCCCCceeeEeeeeec-
Q 009364 66 IRWRKG-ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLK-DLSHPNIVRYLGTVRE- 142 (536)
Q Consensus 66 ~~y~~~-~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~-~l~HpnIv~l~~~~~~- 142 (536)
.+|.+. +.||+|+||+||+|.+..+|+.||||++.. . ..+.+|+.++. ..+||||+++++++..
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~------~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~ 127 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------C-------PKARREVELHWRASQCPHIVRIVDVYENL 127 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC------S-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc------c-------hhHHHHHHHHHHhcCCCCcceEeEEEeec
Confidence 467776 799999999999999999999999998831 1 23456777764 4589999999999875
Q ss_pred ---CCceeEEEEecCCCCcccccccCC--CCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCC---CCcEEEEe
Q 009364 143 ---EESLNILLEFVPGGSISSLLGKFG--PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDN---KGCIKLAD 214 (536)
Q Consensus 143 ---~~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~---~~~vkL~D 214 (536)
...+|+|||||+||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|
T Consensus 128 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~D 207 (400)
T 1nxk_A 128 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD 207 (400)
T ss_dssp ETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECC
T ss_pred ccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEe
Confidence 667999999999999999997653 5999999999999999999999999999999999999987 78999999
Q ss_pred cCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhH-----HHHHHHhhCCC
Q 009364 215 FGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQ-----EVAALFHIGTT 289 (536)
Q Consensus 215 FGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~-----~~~~~~~~~~~ 289 (536)
||+++..... ......+||+.|+|||++.+..++.++|||||||++|+|++|.+||..... .....+.....
T Consensus 208 FG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~ 284 (400)
T 1nxk_A 208 FGFAKETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 284 (400)
T ss_dssp CTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCC
T ss_pred cccccccCCC---CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcc
Confidence 9999865432 123467899999999999999999999999999999999999999965321 11222222322
Q ss_pred CCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 290 KSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 290 ~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
....+.+..++.++++||++||+.||.+|||+.|+++||||...
T Consensus 285 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 285 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 22333345789999999999999999999999999999999754
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-48 Score=401.21 Aligned_cols=263 Identities=25% Similarity=0.464 Sum_probs=221.0
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeEeeeeecCC
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRYLGTVREEE 144 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~ 144 (536)
.+|++.+.||+|+||+||+|.+..+|+.||||++................+.+.+|+.+++.+ +||||+++++++....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 479999999999999999999999999999999854332222233344566788999999999 7999999999999999
Q ss_pred ceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhh
Q 009364 145 SLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAEL 224 (536)
Q Consensus 145 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 224 (536)
..++||||++|++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++..+...
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~ 253 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG 253 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCCC
Confidence 99999999999999999988788999999999999999999999999999999999999999999999999998776542
Q ss_pred hcccCCcccCCCCCCCChhhhhhc------CCCccceEechhHHHHHHhhCCCCCchhhHH-HHHHHhhCCCCCCCCCCC
Q 009364 225 ATVSGAKSMKGTPYWMAPEVIRQT------GHSYSADIWSVGCTVIEMATGKPPWSQQYQE-VAALFHIGTTKSHPPIPE 297 (536)
Q Consensus 225 ~~~~~~~~~~Gt~~Y~APEvl~~~------~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~ 297 (536)
. .....+||+.|+|||++.+. .++.++|||||||++|+|++|..||...... ....+.........+.+.
T Consensus 254 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 330 (365)
T 2y7j_A 254 E---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWD 330 (365)
T ss_dssp C---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHS
T ss_pred c---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccc
Confidence 2 23467899999999998743 5788999999999999999999999754322 222222222222222234
Q ss_pred cCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCc
Q 009364 298 NLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVT 331 (536)
Q Consensus 298 ~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~ 331 (536)
.++..+.+||.+||+.||.+|||+.++|+||||+
T Consensus 331 ~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 331 DRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp SSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 7889999999999999999999999999999996
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=386.50 Aligned_cols=256 Identities=25% Similarity=0.398 Sum_probs=216.8
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEE 144 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 144 (536)
..+|++.+.||+|+||+||+|.+..++..+|+|++..... ...+.+.+|+.+++.++||||+++++++.+..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 79 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV--------EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNT 79 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--------SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc--------chHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 3579999999999999999999999999999998842211 12356788999999999999999999999999
Q ss_pred ceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCccc---CCCCcEEEEecCcchhh
Q 009364 145 SLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILV---DNKGCIKLADFGASKQV 221 (536)
Q Consensus 145 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl---~~~~~vkL~DFGla~~~ 221 (536)
..++||||+++++|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~ 159 (277)
T 3f3z_A 80 DIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159 (277)
T ss_dssp EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred eEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence 999999999999999999888889999999999999999999999999999999999999 77889999999999765
Q ss_pred hhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH-HHHHHhhCCCCCCCCCCCcCc
Q 009364 222 AELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE-VAALFHIGTTKSHPPIPENLS 300 (536)
Q Consensus 222 ~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~s 300 (536)
.... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||...... ...................++
T Consensus 160 ~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (277)
T 3f3z_A 160 KPGK---MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVS 235 (277)
T ss_dssp CTTS---CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSC
T ss_pred cCcc---chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCC
Confidence 5322 2345679999999999876 4899999999999999999999999764332 222222222211111123689
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhCCCCcC
Q 009364 301 VKAKDFLLKCLEKEPDLRPTASELLKHPFVTG 332 (536)
Q Consensus 301 ~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~ 332 (536)
+.+++||.+||+.||.+|||+.++|+||||+.
T Consensus 236 ~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~ 267 (277)
T 3f3z_A 236 PQAESLIRRLLTKSPKQRITSLQALEHEWFEK 267 (277)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence 99999999999999999999999999999964
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-48 Score=413.42 Aligned_cols=256 Identities=27% Similarity=0.417 Sum_probs=202.1
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEE 144 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 144 (536)
..+|++++.||+|+||+||+|.+..+|+.||||++... .......+.+.+|+.+|+.++||||+++++++....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~------~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 134 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP------FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK 134 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESG------GGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECcc------ccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCC
Confidence 46899999999999999999999999999999998422 122344567889999999999999999999997553
Q ss_pred ------ceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcc
Q 009364 145 ------SLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGAS 218 (536)
Q Consensus 145 ------~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla 218 (536)
.+|+||||+.++ |.+.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 135 ~~~~~~~~~lv~E~~~~~-l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 135 TLEEFQDVYLVMELMDAN-LCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp STTTCCEEEEEEECCSEE-HHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred ccccCCeEEEEEeCCCCC-HHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEee
Confidence 569999999765 5555533 4899999999999999999999999999999999999999999999999999
Q ss_pred hhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH--HHHHHhh-CC-------
Q 009364 219 KQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE--VAALFHI-GT------- 288 (536)
Q Consensus 219 ~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~--~~~~~~~-~~------- 288 (536)
+..... ......+||++|+|||++.+..|+.++|||||||++|+|++|++||.+.... ...+... +.
T Consensus 212 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~ 288 (464)
T 3ttj_A 212 RTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 288 (464)
T ss_dssp -----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred eecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 876532 2245678999999999999999999999999999999999999999754311 1111110 00
Q ss_pred ------------CC--CCCC----CCC-----------cCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcC
Q 009364 289 ------------TK--SHPP----IPE-----------NLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTG 332 (536)
Q Consensus 289 ------------~~--~~~~----~~~-----------~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~ 332 (536)
.. .... ++. ..++++++||.+||+.||.+|||++|+|+||||..
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~ 361 (464)
T 3ttj_A 289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 361 (464)
T ss_dssp TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhh
Confidence 00 0000 010 11678999999999999999999999999999974
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-48 Score=396.05 Aligned_cols=266 Identities=28% Similarity=0.426 Sum_probs=213.2
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
.+|++.+.||+|+||+||+|.+..+++.||+|++...... .......+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 102 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIR---QINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQY 102 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH---C---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhc---ccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCe
Confidence 3699999999999999999999999999999998432110 0112345678899999999999999999999999999
Q ss_pred eeEEEEecCCCCccccccc----------------------------------------CCCCCHHHHHHHHHHHHHHHH
Q 009364 146 LNILLEFVPGGSISSLLGK----------------------------------------FGPFPEAVMRTYTKQLLLGLE 185 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~----------------------------------------~~~l~~~~~~~i~~qil~aL~ 185 (536)
.++||||++||+|.+++.. ...+++..++.++.||+.||+
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 182 (345)
T 3hko_A 103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182 (345)
T ss_dssp EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence 9999999999999998852 112467888999999999999
Q ss_pred HHHHcCCccccCCCCCcccCCCC--cEEEEecCcchhhhhhhcc--cCCcccCCCCCCCChhhhhh--cCCCccceEech
Q 009364 186 YLHNHGIMHRDIKGANILVDNKG--CIKLADFGASKQVAELATV--SGAKSMKGTPYWMAPEVIRQ--TGHSYSADIWSV 259 (536)
Q Consensus 186 yLH~~~ivHrDLKp~NILl~~~~--~vkL~DFGla~~~~~~~~~--~~~~~~~Gt~~Y~APEvl~~--~~~s~k~DIwSl 259 (536)
|||++||+||||||+|||++.++ .+||+|||+++.+...... .......||+.|+|||++.+ ..++.++|||||
T Consensus 183 ~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diwsl 262 (345)
T 3hko_A 183 YLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSA 262 (345)
T ss_dssp HHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHH
T ss_pred HHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHH
Confidence 99999999999999999998776 8999999999866432211 12346679999999999975 678999999999
Q ss_pred hHHHHHHhhCCCCCchhhHH-HHHHHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCC
Q 009364 260 GCTVIEMATGKPPWSQQYQE-VAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDD 334 (536)
Q Consensus 260 Gvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~ 334 (536)
||++|+|++|..||...... ..............+....+++++++||.+||+.||.+|||+.++|+||||....
T Consensus 263 G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 263 GVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS 338 (345)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred HHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence 99999999999999754322 2222222222222233346899999999999999999999999999999997653
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=402.08 Aligned_cols=256 Identities=22% Similarity=0.353 Sum_probs=216.7
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
.+|++.+.||+|+||+||+|.+..+|+.||+|++..................+.+|+.+|+.++||||+++++++.+.+.
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 47999999999999999999999999999999985432111000000112345679999999999999999999999999
Q ss_pred eeEEEEecCCC-CcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhh
Q 009364 146 LNILLEFVPGG-SISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAEL 224 (536)
Q Consensus 146 ~~lV~E~~~gg-~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 224 (536)
+++||||+.+| +|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 183 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG 183 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCCC
Confidence 99999999776 99999998889999999999999999999999999999999999999999999999999999866542
Q ss_pred hcccCCcccCCCCCCCChhhhhhcCC-CccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcHHH
Q 009364 225 ATVSGAKSMKGTPYWMAPEVIRQTGH-SYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKA 303 (536)
Q Consensus 225 ~~~~~~~~~~Gt~~Y~APEvl~~~~~-s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 303 (536)
. .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...... .......+..++.++
T Consensus 184 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------~~~~~~~~~~~~~~l 251 (335)
T 3dls_A 184 K---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET---------VEAAIHPPYLVSKEL 251 (335)
T ss_dssp C---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG---------TTTCCCCSSCCCHHH
T ss_pred C---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH---------HhhccCCCcccCHHH
Confidence 2 2345679999999999988776 88999999999999999999999763221 112223455789999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 304 KDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 304 ~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
++||.+||++||.+|||+.++++||||...
T Consensus 252 ~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 252 MSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred HHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 999999999999999999999999999754
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-48 Score=403.10 Aligned_cols=253 Identities=27% Similarity=0.419 Sum_probs=208.1
Q ss_pred eeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCceeE
Q 009364 69 RKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESLNI 148 (536)
Q Consensus 69 ~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 148 (536)
...+.||+|+||+||+|.+..+|+.||+|++... .....+.+.+|+.+|+.++||||+++++++...+.+++
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~--------~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 163 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR--------GMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVL 163 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECC--------SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEccc--------ccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 3367899999999999999999999999998421 11234568899999999999999999999999999999
Q ss_pred EEEecCCCCcccccccC-CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCccc--CCCCcEEEEecCcchhhhhhh
Q 009364 149 LLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILV--DNKGCIKLADFGASKQVAELA 225 (536)
Q Consensus 149 V~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl--~~~~~vkL~DFGla~~~~~~~ 225 (536)
||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 164 v~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~ 243 (373)
T 2x4f_A 164 VMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE 243 (373)
T ss_dssp EEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC
T ss_pred EEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc
Confidence 99999999999888543 469999999999999999999999999999999999999 567799999999998765432
Q ss_pred cccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH-HHHHHhhCCCCCCCCCCCcCcHHHH
Q 009364 226 TVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE-VAALFHIGTTKSHPPIPENLSVKAK 304 (536)
Q Consensus 226 ~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~~ 304 (536)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||...... ....+..............++++++
T Consensus 244 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 320 (373)
T 2x4f_A 244 ---KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAK 320 (373)
T ss_dssp ---BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHH
T ss_pred ---ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHH
Confidence 234567999999999999989999999999999999999999999754322 2222222222222223357899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhCCCCcC
Q 009364 305 DFLLKCLEKEPDLRPTASELLKHPFVTG 332 (536)
Q Consensus 305 dLi~~cL~~dP~~Rps~~eiL~hp~~~~ 332 (536)
+||.+||+.||.+|||+.|+|+||||..
T Consensus 321 ~li~~~L~~dp~~Rps~~e~l~hp~~~~ 348 (373)
T 2x4f_A 321 EFISKLLIKEKSWRISASEALKHPWLSD 348 (373)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred HHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence 9999999999999999999999999974
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=386.96 Aligned_cols=264 Identities=36% Similarity=0.625 Sum_probs=215.9
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE 142 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 142 (536)
.+..+|++.+.||+|+||+||+|.+..+|+.||+|++... .....+.+.+|+.+++.++||||+++++++..
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 87 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK--------SEEELEDYIVEIEILATCDHPYIVKLLGAYYH 87 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------------CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC--------CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeee
Confidence 5567899999999999999999999999999999987321 12234567889999999999999999999999
Q ss_pred CCceeEEEEecCCCCccccccc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhh
Q 009364 143 EESLNILLEFVPGGSISSLLGK-FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQV 221 (536)
Q Consensus 143 ~~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~ 221 (536)
.+..++||||+++++|.+++.. ...+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++...
T Consensus 88 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 167 (302)
T 2j7t_A 88 DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKN 167 (302)
T ss_dssp C-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHH
T ss_pred CCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccc
Confidence 9999999999999999998765 467999999999999999999999999999999999999999999999999998654
Q ss_pred hhhhcccCCcccCCCCCCCChhhhh-----hcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCC
Q 009364 222 AELATVSGAKSMKGTPYWMAPEVIR-----QTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIP 296 (536)
Q Consensus 222 ~~~~~~~~~~~~~Gt~~Y~APEvl~-----~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 296 (536)
.... .......||+.|+|||++. +..++.++|||||||++|+|++|..||......................+
T Consensus 168 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 245 (302)
T 2j7t_A 168 LKTL--QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTP 245 (302)
T ss_dssp HHHH--HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSG
T ss_pred cccc--cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCc
Confidence 3322 2234567999999999984 56788999999999999999999999975433221111111122222345
Q ss_pred CcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCCCC
Q 009364 297 ENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDED 336 (536)
Q Consensus 297 ~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~~~ 336 (536)
..++..+.+||.+||+.||.+|||+.++++||||......
T Consensus 246 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~ 285 (302)
T 2j7t_A 246 SKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSN 285 (302)
T ss_dssp GGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCCC
T ss_pred cccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhccc
Confidence 6789999999999999999999999999999999876544
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-48 Score=388.97 Aligned_cols=256 Identities=30% Similarity=0.485 Sum_probs=218.9
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
.+|++.+.||+|+||+||+|.+..+|+.||+|++.... ......+.+|+.+++.++||||+++++++.+...
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP--------AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTH 80 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------------HHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc--------ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCE
Confidence 47999999999999999999999999999999984221 1123457789999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCccc---CCCCcEEEEecCcchhhh
Q 009364 146 LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILV---DNKGCIKLADFGASKQVA 222 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl---~~~~~vkL~DFGla~~~~ 222 (536)
+++||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 81 YYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred EEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 99999999999999999887889999999999999999999999999999999999999 778899999999987543
Q ss_pred hhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhH-HHHHHHhhCCCCCCCCCCCcCcH
Q 009364 223 ELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQ-EVAALFHIGTTKSHPPIPENLSV 301 (536)
Q Consensus 223 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~s~ 301 (536)
.. .....+||+.|+|||++.+..++.++|||||||++|+|++|..||..... .....+.........+.+..++.
T Consensus 161 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 236 (304)
T 2jam_A 161 NG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISE 236 (304)
T ss_dssp CB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCH
T ss_pred CC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCH
Confidence 21 23345699999999999998999999999999999999999999975432 22233333333334445568999
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 302 KAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 302 ~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
++++||.+||..||.+|||+.++++||||...
T Consensus 237 ~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 237 SAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp HHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred HHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 99999999999999999999999999999764
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=397.56 Aligned_cols=260 Identities=31% Similarity=0.499 Sum_probs=217.9
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE 142 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 142 (536)
....+|++.+.||+|+||+||+|.+..+|+.||+|++... ......+.+.+|+.+++.++||||+++++++..
T Consensus 30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 102 (360)
T 3eqc_A 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-------IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 102 (360)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECC-------CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE
T ss_pred cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccc-------cCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE
Confidence 4456899999999999999999999999999999998432 122345678899999999999999999999999
Q ss_pred CCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHc-CCccccCCCCCcccCCCCcEEEEecCcchhh
Q 009364 143 EESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNH-GIMHRDIKGANILVDNKGCIKLADFGASKQV 221 (536)
Q Consensus 143 ~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~-~ivHrDLKp~NILl~~~~~vkL~DFGla~~~ 221 (536)
.+.+++||||++||+|.+++...+.+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++...
T Consensus 103 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 182 (360)
T 3eqc_A 103 DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 182 (360)
T ss_dssp TTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred CCEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccc
Confidence 999999999999999999998888899999999999999999999996 9999999999999999999999999999766
Q ss_pred hhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHh----------------
Q 009364 222 AELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFH---------------- 285 (536)
Q Consensus 222 ~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~---------------- 285 (536)
... ......||+.|+|||++.+..++.++|||||||++|+|++|..||............
T Consensus 183 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (360)
T 3eqc_A 183 IDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 258 (360)
T ss_dssp HHH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------
T ss_pred ccc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcc
Confidence 432 234568999999999999999999999999999999999999999643322111000
Q ss_pred -------------------------hCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 286 -------------------------IGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 286 -------------------------~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
.............++.++++||.+||+.||.+|||+.|+|+||||+..
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 259 TPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331 (360)
T ss_dssp ---------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred cCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence 000011111223578999999999999999999999999999999753
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=391.61 Aligned_cols=262 Identities=26% Similarity=0.373 Sum_probs=217.0
Q ss_pred Cceee-eEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCC-CCceeeEeeeeecCC
Q 009364 67 RWRKG-ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS-HPNIVRYLGTVREEE 144 (536)
Q Consensus 67 ~y~~~-~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~ 144 (536)
+|.+. +.||+|+||+||+|.+..+|+.||+|++...... ......+.+|+.+++.+. ||||+++++++.+..
T Consensus 29 ~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~ 102 (327)
T 3lm5_A 29 FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRG------QDCRAEILHEIAVLELAKSCPRVINLHEVYENTS 102 (327)
T ss_dssp HEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETT------EECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred EEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcc------hHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC
Confidence 57776 8999999999999999999999999988532211 112346778999999995 699999999999999
Q ss_pred ceeEEEEecCCCCcccccccC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCC---CCcEEEEecCcch
Q 009364 145 SLNILLEFVPGGSISSLLGKF--GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDN---KGCIKLADFGASK 219 (536)
Q Consensus 145 ~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~---~~~vkL~DFGla~ 219 (536)
.+++||||+.+|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++
T Consensus 103 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~ 182 (327)
T 3lm5_A 103 EIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR 182 (327)
T ss_dssp EEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCE
T ss_pred eEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCcccc
Confidence 999999999999999998543 67999999999999999999999999999999999999987 7899999999998
Q ss_pred hhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH-HHHHHhhCCCCCCCCCCCc
Q 009364 220 QVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE-VAALFHIGTTKSHPPIPEN 298 (536)
Q Consensus 220 ~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~ 298 (536)
...... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||...... ................+..
T Consensus 183 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 259 (327)
T 3lm5_A 183 KIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSS 259 (327)
T ss_dssp EC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTT
T ss_pred ccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcc
Confidence 765322 234567999999999999999999999999999999999999999654332 2222223333344445568
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCCCCc
Q 009364 299 LSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDP 337 (536)
Q Consensus 299 ~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~~~~ 337 (536)
++..+++||.+||+.||.+|||+.++|+||||+......
T Consensus 260 ~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~ 298 (327)
T 3lm5_A 260 VSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFEN 298 (327)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTC
T ss_pred cCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccccccc
Confidence 999999999999999999999999999999998765543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=394.80 Aligned_cols=254 Identities=30% Similarity=0.443 Sum_probs=208.9
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCC-----CCceeeEe
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS-----HPNIVRYL 137 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~-----HpnIv~l~ 137 (536)
....+|++.+.||+|+||+||+|++..+|+.||+|++.. ..........|+.+++.+. ||||++++
T Consensus 32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---------~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~ 102 (360)
T 3llt_A 32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN---------IKKYTRSAKIEADILKKIQNDDINNNNIVKYH 102 (360)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---------CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred EecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc---------chhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence 345689999999999999999999999999999998831 1123345677899999886 99999999
Q ss_pred eeeecCCceeEEEEecCCCCcccccccCC--CCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCC---------
Q 009364 138 GTVREEESLNILLEFVPGGSISSLLGKFG--PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDN--------- 206 (536)
Q Consensus 138 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~--------- 206 (536)
+++...+..++||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~ 181 (360)
T 3llt_A 103 GKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLIT 181 (360)
T ss_dssp EEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEE
T ss_pred ceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccc
Confidence 9999999999999999 999999987644 5999999999999999999999999999999999999975
Q ss_pred ----------------CCcEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCC
Q 009364 207 ----------------KGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGK 270 (536)
Q Consensus 207 ----------------~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~ 270 (536)
++.+||+|||+++.... .....+||+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~ 256 (360)
T 3llt_A 182 VRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD-----YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS 256 (360)
T ss_dssp EECTTTCCEEEEEEESCCCEEECCCTTCEETTS-----CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSS
T ss_pred hhcccccccccccccCCCCEEEEeccCceecCC-----CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCC
Confidence 78999999999975432 234668999999999999999999999999999999999999
Q ss_pred CCCchhhHH--HHHHHhhCCC---------------------CCCCCCC--------------------CcCcHHHHHHH
Q 009364 271 PPWSQQYQE--VAALFHIGTT---------------------KSHPPIP--------------------ENLSVKAKDFL 307 (536)
Q Consensus 271 ~Pf~~~~~~--~~~~~~~~~~---------------------~~~~~~~--------------------~~~s~~~~dLi 307 (536)
+||...... ...+...... .....++ ...++.+.+||
T Consensus 257 ~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 336 (360)
T 3llt_A 257 LLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFL 336 (360)
T ss_dssp CSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHH
T ss_pred CCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHH
Confidence 999653321 1111111000 0000011 11237788999
Q ss_pred HHhcccCCCCCCCHHHHHhCCCCc
Q 009364 308 LKCLEKEPDLRPTASELLKHPFVT 331 (536)
Q Consensus 308 ~~cL~~dP~~Rps~~eiL~hp~~~ 331 (536)
.+||+.||.+|||+.|+|+||||+
T Consensus 337 ~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 337 YSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred HHHhcCChhhCCCHHHHhcCcccC
Confidence 999999999999999999999985
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=399.88 Aligned_cols=257 Identities=29% Similarity=0.492 Sum_probs=208.5
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE 143 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 143 (536)
...+|++.+.||+|+||+||+|.+..+|+.||||++... .......+.+.+|+.+|+.++||||+++++++...
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~------~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 96 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP------FQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPD 96 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSST------TSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCcc------ccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecC
Confidence 456899999999999999999999999999999987321 11223456788999999999999999999999765
Q ss_pred C------ceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCc
Q 009364 144 E------SLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGA 217 (536)
Q Consensus 144 ~------~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGl 217 (536)
. .+|+||||+ +++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 97 ETLDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp SSTTTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred CccccCceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeec
Confidence 3 469999999 8899998876 6799999999999999999999999999999999999999999999999999
Q ss_pred chhhhhhhcccCCcccCCCCCCCChhhhhh-cCCCccceEechhHHHHHHhhCCCCCchhhH--HHHHHHhh-C------
Q 009364 218 SKQVAELATVSGAKSMKGTPYWMAPEVIRQ-TGHSYSADIWSVGCTVIEMATGKPPWSQQYQ--EVAALFHI-G------ 287 (536)
Q Consensus 218 a~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~-~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~--~~~~~~~~-~------ 287 (536)
++.... .....+||++|+|||++.+ ..++.++||||+||++|+|++|++||.+... ....+... +
T Consensus 175 a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~ 249 (367)
T 1cm8_A 175 ARQADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 249 (367)
T ss_dssp CEECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred cccccc-----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 986542 2345689999999999987 6799999999999999999999999975321 11111110 0
Q ss_pred -------------------CCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 288 -------------------TTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 288 -------------------~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
.......+...+++.+++||.+||+.||.+|||+.|+|+||||...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~ 314 (367)
T 1cm8_A 250 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314 (367)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence 0011122345789999999999999999999999999999999754
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=381.12 Aligned_cols=251 Identities=26% Similarity=0.408 Sum_probs=210.1
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeEeeeeecCC
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRYLGTVREEE 144 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~ 144 (536)
.+|++.+.||+|+||+||+|.+..+|+.||+|++.... ........+.+|+..+..+ +||||+++++++.+.+
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~ 84 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPL------AGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDD 84 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCC------TTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETT
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccc------cccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCC
Confidence 47999999999999999999999999999999884321 1112345677899999998 8999999999999999
Q ss_pred ceeEEEEecCCCCcccccccC----CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCC-------------
Q 009364 145 SLNILLEFVPGGSISSLLGKF----GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNK------------- 207 (536)
Q Consensus 145 ~~~lV~E~~~gg~L~~~l~~~----~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~------------- 207 (536)
..++||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~ 164 (289)
T 1x8b_A 85 HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDED 164 (289)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---------------
T ss_pred eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccc
Confidence 999999999999999999764 679999999999999999999999999999999999999844
Q ss_pred ------CcEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhc-CCCccceEechhHHHHHHhhCCCCCchhhHHH
Q 009364 208 ------GCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQT-GHSYSADIWSVGCTVIEMATGKPPWSQQYQEV 280 (536)
Q Consensus 208 ------~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~-~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~ 280 (536)
..+||+|||++..... .....||+.|+|||++.+. .++.++|||||||++|+|++|.+|+..... .
T Consensus 165 ~~~~~~~~~kl~Dfg~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~-~ 237 (289)
T 1x8b_A 165 DWASNKVMFKIGDLGHVTRISS------PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ-W 237 (289)
T ss_dssp -----CCCEEECCCTTCEETTC------SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH-H
T ss_pred cccCCceEEEEcccccccccCC------ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH-H
Confidence 4799999999876543 2345699999999999876 567899999999999999999988754422 1
Q ss_pred HHHHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 281 AALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
..+. . ...+.++..++.++++||.+||+.||.+|||+.++++||||...
T Consensus 238 ~~~~-~---~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 238 HEIR-Q---GRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp HHHH-T---TCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred HHHH-c---CCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 1221 1 22345667899999999999999999999999999999999753
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=382.77 Aligned_cols=258 Identities=29% Similarity=0.567 Sum_probs=195.7
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
.+|++.+.||+|+||+||+|.+..+|+.||+|++.... .......+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 85 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKA-----MYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNY 85 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH-----HHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhh-----hhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCe
Confidence 47999999999999999999999999999999984211 0111224668899999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccC-CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhh
Q 009364 146 LNILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAEL 224 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 224 (536)
.++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 86 VYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp EEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence 99999999999999998765 67999999999999999999999999999999999999999999999999998765432
Q ss_pred hcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcHHHH
Q 009364 225 ATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAK 304 (536)
Q Consensus 225 ~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 304 (536)
. .......||+.|+|||++.+..++.++|||||||++|+|++|.+||........ ... ........+..++.+++
T Consensus 166 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~ 240 (278)
T 3cok_A 166 H--EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT--LNK-VVLADYEMPSFLSIEAK 240 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------CCSSCCCCCTTSCHHHH
T ss_pred C--CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH--HHH-HhhcccCCccccCHHHH
Confidence 1 122356799999999999998999999999999999999999999965421110 000 11122345667899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 305 DFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 305 dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
+||.+||+.||.+|||+.++++||||...
T Consensus 241 ~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 241 DLIHQLLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp HHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred HHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence 99999999999999999999999999754
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=383.99 Aligned_cols=255 Identities=29% Similarity=0.504 Sum_probs=219.5
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
.+|++.+.||+|+||.||+|.+..+++.||+|++..... ........+.+|+.+++.++||||+++++++.+.+.
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 88 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQL-----EKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKR 88 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEccccc-----chHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCE
Confidence 589999999999999999999999999999998842110 111123567899999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhh
Q 009364 146 LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA 225 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 225 (536)
.++||||+++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~- 167 (284)
T 2vgo_A 89 IYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL- 167 (284)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-
T ss_pred EEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc-
Confidence 9999999999999999988888999999999999999999999999999999999999999999999999998654321
Q ss_pred cccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHH-HHHHhhCCCCCCCCCCCcCcHHHH
Q 009364 226 TVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEV-AALFHIGTTKSHPPIPENLSVKAK 304 (536)
Q Consensus 226 ~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~s~~~~ 304 (536)
......||+.|+|||++.+..++.++|||||||++|+|++|..||....... ...... ....++..++.+++
T Consensus 168 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~----~~~~~~~~~~~~~~ 240 (284)
T 2vgo_A 168 ---RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVN----VDLKFPPFLSDGSK 240 (284)
T ss_dssp ---CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT----TCCCCCTTSCHHHH
T ss_pred ---ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhc----cccCCCCcCCHHHH
Confidence 2345679999999999999899999999999999999999999997543222 111111 12345678899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 305 DFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 305 dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
+||.+||+.||.+|||+.++++||||...
T Consensus 241 ~li~~~l~~~p~~Rps~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 241 DLISKLLRYHPPQRLPLKGVMEHPWVKAN 269 (284)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred HHHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence 99999999999999999999999999743
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-48 Score=392.53 Aligned_cols=263 Identities=30% Similarity=0.501 Sum_probs=210.9
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
.+|++.+.||+|+||.||+|.+..+|+.||||++..................+.+|+.+|+.++||||+++++++....
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 4799999999999999999999999999999998432211111111223445789999999999999999999987655
Q ss_pred eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCc---EEEEecCcchhhh
Q 009364 146 LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGC---IKLADFGASKQVA 222 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~---vkL~DFGla~~~~ 222 (536)
+++||||+++|+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++...
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 168 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 168 (322)
T ss_dssp EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECC
T ss_pred eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceecc
Confidence 8999999999999999988889999999999999999999999999999999999999987664 9999999997654
Q ss_pred hhhcccCCcccCCCCCCCChhhhh---hcCCCccceEechhHHHHHHhhCCCCCchhhH--HHHHHHhhCCCCCCCCCCC
Q 009364 223 ELATVSGAKSMKGTPYWMAPEVIR---QTGHSYSADIWSVGCTVIEMATGKPPWSQQYQ--EVAALFHIGTTKSHPPIPE 297 (536)
Q Consensus 223 ~~~~~~~~~~~~Gt~~Y~APEvl~---~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~--~~~~~~~~~~~~~~~~~~~ 297 (536)
.... .....||+.|+|||++. ...++.++|||||||++|+|++|..||..... ..............+..+.
T Consensus 169 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (322)
T 2ycf_A 169 ETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 245 (322)
T ss_dssp CCHH---HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHT
T ss_pred cccc---cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhh
Confidence 3211 23457999999999985 45688999999999999999999999965321 1222222222222222335
Q ss_pred cCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcC
Q 009364 298 NLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTG 332 (536)
Q Consensus 298 ~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~ 332 (536)
.++..+++||.+||..||.+|||+.++++||||..
T Consensus 246 ~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 246 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred hcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 78999999999999999999999999999999975
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=383.80 Aligned_cols=259 Identities=29% Similarity=0.435 Sum_probs=200.1
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE 143 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 143 (536)
...+|++.+.||+|+||+||+|.+..+|+.||+|++... .......+.+.++...++.++||||+++++++.+.
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~ 78 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRAT------VNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFRE 78 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---------CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecc------cCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeecc
Confidence 346899999999999999999999999999999988421 11223334455566668889999999999999999
Q ss_pred CceeEEEEecCCCCcccccc----cCCCCCHHHHHHHHHHHHHHHHHHHHc-CCccccCCCCCcccCCCCcEEEEecCcc
Q 009364 144 ESLNILLEFVPGGSISSLLG----KFGPFPEAVMRTYTKQLLLGLEYLHNH-GIMHRDIKGANILVDNKGCIKLADFGAS 218 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~----~~~~l~~~~~~~i~~qil~aL~yLH~~-~ivHrDLKp~NILl~~~~~vkL~DFGla 218 (536)
+..++||||++ |+|.+++. ....+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++
T Consensus 79 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 157 (290)
T 3fme_A 79 GDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGIS 157 (290)
T ss_dssp SSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC---
T ss_pred CCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCc
Confidence 99999999997 47766653 456899999999999999999999998 9999999999999999999999999999
Q ss_pred hhhhhhhcccCCcccCCCCCCCChhhh----hhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCC
Q 009364 219 KQVAELATVSGAKSMKGTPYWMAPEVI----RQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPP 294 (536)
Q Consensus 219 ~~~~~~~~~~~~~~~~Gt~~Y~APEvl----~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 294 (536)
+...... ......||+.|+|||++ .+..++.++|||||||++|+|++|..||.....................
T Consensus 158 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 234 (290)
T 3fme_A 158 GYLVDDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQL 234 (290)
T ss_dssp ---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCC
T ss_pred ccccccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCc
Confidence 8765422 23345799999999996 5667899999999999999999999999642222111111111122222
Q ss_pred CCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcC
Q 009364 295 IPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTG 332 (536)
Q Consensus 295 ~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~ 332 (536)
.+..++.++++||.+||+.||.+|||+.|+++||||+.
T Consensus 235 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 235 PADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred ccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 33578999999999999999999999999999999974
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-47 Score=380.59 Aligned_cols=267 Identities=28% Similarity=0.403 Sum_probs=223.1
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhc-cchhHHHHHHHHHHHHHHHHHhCC-CCceeeEeeeeec
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANF-ASKEKAQDHIKELEEEVKLLKDLS-HPNIVRYLGTVRE 142 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~-~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~ 142 (536)
..+|++.+.||+|+||.||+|.+..+|+.||+|++...... ..........+.+.+|+.+++++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 46899999999999999999999999999999998533211 111222344567889999999995 9999999999999
Q ss_pred CCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhh
Q 009364 143 EESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVA 222 (536)
Q Consensus 143 ~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~ 222 (536)
....++||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 175 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 175 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhcC
Confidence 99999999999999999999887889999999999999999999999999999999999999999999999999987654
Q ss_pred hhhcccCCcccCCCCCCCChhhhh------hcCCCccceEechhHHHHHHhhCCCCCchhhHH-HHHHHhhCCCCCCCCC
Q 009364 223 ELATVSGAKSMKGTPYWMAPEVIR------QTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE-VAALFHIGTTKSHPPI 295 (536)
Q Consensus 223 ~~~~~~~~~~~~Gt~~Y~APEvl~------~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~ 295 (536)
... ......||+.|+|||++. ...++.++|||||||++|+|++|..||...... ..............+.
T Consensus 176 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (298)
T 1phk_A 176 PGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 252 (298)
T ss_dssp TTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred CCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCccc
Confidence 322 234567999999999986 346788999999999999999999999654322 2222222322222333
Q ss_pred CCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCC
Q 009364 296 PENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDD 334 (536)
Q Consensus 296 ~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~ 334 (536)
...++..+++||.+||+.||.+|||+.++++||||++..
T Consensus 253 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 253 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred ccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 357899999999999999999999999999999998654
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-48 Score=394.21 Aligned_cols=260 Identities=30% Similarity=0.466 Sum_probs=205.2
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
.+|++++.||+|+||+||+|.+..+|+.||+|++.... .......+.+|+.+++.++||||+++++++...+.
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 74 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEH-------EEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKS 74 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccc-------ccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCE
Confidence 47999999999999999999999999999999884211 11112234579999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccC-CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhh
Q 009364 146 LNILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAEL 224 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 224 (536)
.++||||+. |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 75 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 153 (324)
T 3mtl_A 75 LTLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP 153 (324)
T ss_dssp EEEEEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC---
T ss_pred EEEEecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCC
Confidence 999999997 5888777654 46999999999999999999999999999999999999999999999999998765432
Q ss_pred hcccCCcccCCCCCCCChhhhhh-cCCCccceEechhHHHHHHhhCCCCCchhhHHH--HHHHhhCCCCCCCC-------
Q 009364 225 ATVSGAKSMKGTPYWMAPEVIRQ-TGHSYSADIWSVGCTVIEMATGKPPWSQQYQEV--AALFHIGTTKSHPP------- 294 (536)
Q Consensus 225 ~~~~~~~~~~Gt~~Y~APEvl~~-~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~--~~~~~~~~~~~~~~------- 294 (536)
. ......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||....... ..+...........
T Consensus 154 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (324)
T 3mtl_A 154 T--KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 231 (324)
T ss_dssp -----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred c--cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcc
Confidence 1 22345678999999999976 568999999999999999999999997543221 11111111111111
Q ss_pred ------------------CCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCCC
Q 009364 295 ------------------IPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDE 335 (536)
Q Consensus 295 ------------------~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~~ 335 (536)
....++.++++||.+||+.||.+|||+.|+|+||||....+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290 (324)
T ss_dssp HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence 12357889999999999999999999999999999986543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-48 Score=420.52 Aligned_cols=262 Identities=26% Similarity=0.389 Sum_probs=221.9
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE 143 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 143 (536)
...+|++.+.||+|+||+||+|+++.+|+.||+|++..... ........+.+|+.+|+.++||||+++++++.+.
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~-----~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~ 257 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRL-----KKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETK 257 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHh-----hhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeC
Confidence 34689999999999999999999999999999999842211 1112345678899999999999999999999999
Q ss_pred CceeEEEEecCCCCcccccccC----CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcch
Q 009364 144 ESLNILLEFVPGGSISSLLGKF----GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASK 219 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~~~----~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~ 219 (536)
..+|+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++
T Consensus 258 ~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~ 337 (543)
T 3c4z_A 258 TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAV 337 (543)
T ss_dssp SEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceee
Confidence 9999999999999999988653 469999999999999999999999999999999999999999999999999998
Q ss_pred hhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhh-----HHHHHHHhhCCCCCCCC
Q 009364 220 QVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQY-----QEVAALFHIGTTKSHPP 294 (536)
Q Consensus 220 ~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~-----~~~~~~~~~~~~~~~~~ 294 (536)
.+.... ......+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.... ......... ....
T Consensus 338 ~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~----~~~~ 411 (543)
T 3c4z_A 338 ELKAGQ--TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLE----QAVT 411 (543)
T ss_dssp ECCTTC--CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHH----CCCC
T ss_pred eccCCC--cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhh----cccC
Confidence 765422 12345689999999999999999999999999999999999999997532 222222221 1234
Q ss_pred CCCcCcHHHHHHHHHhcccCCCCCCC-----HHHHHhCCCCcCCCCC
Q 009364 295 IPENLSVKAKDFLLKCLEKEPDLRPT-----ASELLKHPFVTGDDED 336 (536)
Q Consensus 295 ~~~~~s~~~~dLi~~cL~~dP~~Rps-----~~eiL~hp~~~~~~~~ 336 (536)
++..++.++++||++||++||.+||+ +.++++||||+...+.
T Consensus 412 ~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~ 458 (543)
T 3c4z_A 412 YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWR 458 (543)
T ss_dssp CCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHH
T ss_pred CCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHH
Confidence 56789999999999999999999996 5899999999876543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=393.91 Aligned_cols=263 Identities=25% Similarity=0.427 Sum_probs=212.4
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEE 144 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 144 (536)
..+|++.+.||+|+||+||+|.+..+|+.||+|++.... .........+.+|+.+++.++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 85 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADL-----ARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET 85 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTT-----TTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccc-----cCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC
Confidence 468999999999999999999999999999999984321 122344567889999999999999999999988765
Q ss_pred ce----eEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchh
Q 009364 145 SL----NILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQ 220 (536)
Q Consensus 145 ~~----~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~ 220 (536)
.. ++||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 86 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 86 PAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp TTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred CCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 44 99999999999999998888999999999999999999999999999999999999999999999999999987
Q ss_pred hhhhhc-ccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHH-HhhCCCCCCCCCCCc
Q 009364 221 VAELAT-VSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAAL-FHIGTTKSHPPIPEN 298 (536)
Q Consensus 221 ~~~~~~-~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~-~~~~~~~~~~~~~~~ 298 (536)
+..... .......+||+.|+|||++.+..++.++|||||||++|+|++|..||.......... ............+..
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG 245 (311)
T ss_dssp ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTT
T ss_pred ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCC
Confidence 654322 122345679999999999999999999999999999999999999997654332221 111111111122356
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcC
Q 009364 299 LSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTG 332 (536)
Q Consensus 299 ~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~ 332 (536)
++.++.+||.+||+.||.+||++.+++.|+|++.
T Consensus 246 ~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 246 LSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 8999999999999999999999999999999864
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-47 Score=381.52 Aligned_cols=261 Identities=28% Similarity=0.523 Sum_probs=223.7
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE 142 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 142 (536)
....+|++++.||+|+||+||+|.+..+++.||+|++..... ......+.+.+|+.+++.++||||+++++++.+
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 86 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL-----LKPHQREKMSMEISIHRSLAHQHVVGFHGFFED 86 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-----CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhc-----cCHHHHHHHHHHHHHHHhCCCCCEeeeeeeecc
Confidence 345689999999999999999999999999999998843211 112345678899999999999999999999999
Q ss_pred CCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhh
Q 009364 143 EESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVA 222 (536)
Q Consensus 143 ~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~ 222 (536)
.+..++||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 87 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 87 NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 99999999999999999999887889999999999999999999999999999999999999999999999999987654
Q ss_pred hhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHH-HHHHhhCCCCCCCCCCCcCcH
Q 009364 223 ELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEV-AALFHIGTTKSHPPIPENLSV 301 (536)
Q Consensus 223 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~s~ 301 (536)
... .......||+.|+|||++.+..++.++||||||+++|+|++|..||....... ...... ....++..++.
T Consensus 167 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~ 240 (294)
T 2rku_A 167 YDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK----NEYSIPKHINP 240 (294)
T ss_dssp STT--CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT----TCCCCCTTSCH
T ss_pred cCc--cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhh----ccCCCccccCH
Confidence 322 12345679999999999999889999999999999999999999997643222 111111 12345668899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCC
Q 009364 302 KAKDFLLKCLEKEPDLRPTASELLKHPFVTGDD 334 (536)
Q Consensus 302 ~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~ 334 (536)
.+.+||.+||+.||.+|||+.|+++||||....
T Consensus 241 ~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~ 273 (294)
T 2rku_A 241 VAASLIQKMLQTDPTARPTINELLNDEFFTSGY 273 (294)
T ss_dssp HHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred HHHHHHHHHcccChhhCcCHHHHhhChheecCC
Confidence 999999999999999999999999999997654
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=384.94 Aligned_cols=262 Identities=25% Similarity=0.464 Sum_probs=214.1
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE 143 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 143 (536)
...+|++.+.||+|+||+||+|.+..+++.||+|++.... .......+.+.+|+.+++.++||||+++++++...
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~ 83 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPP-----REKEETLKRFEREVHNSSQLSHQNIVSMIDVDEED 83 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCS-----SCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECS
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCc-----cccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeC
Confidence 3468999999999999999999999999999999885322 12234456788999999999999999999999999
Q ss_pred CceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhh
Q 009364 144 ESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAE 223 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 223 (536)
+.+++||||++|++|.+++...+++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 84 DCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred CeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 99999999999999999998888999999999999999999999999999999999999999999999999999987654
Q ss_pred hhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCC--CCCCCCCCcCcH
Q 009364 224 LATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTT--KSHPPIPENLSV 301 (536)
Q Consensus 224 ~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~--~~~~~~~~~~s~ 301 (536)
.. .......+||+.|+|||++.+..++.++|||||||++|+|++|..||................ ......+..++.
T Consensus 164 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (294)
T 4eqm_A 164 TS-LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQ 242 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCH
T ss_pred cc-ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCH
Confidence 22 122345679999999999999999999999999999999999999997654332222222111 111234567899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhCCCCc
Q 009364 302 KAKDFLLKCLEKEPDLRPTASELLKHPFVT 331 (536)
Q Consensus 302 ~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~ 331 (536)
.+.++|.+||++||.+||+..+.+.+.|..
T Consensus 243 ~l~~li~~~l~~dp~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 243 SLSNVILRATEKDKANRYKTIQEMKDDLSS 272 (294)
T ss_dssp HHHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred HHHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence 999999999999999999666666666543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=428.37 Aligned_cols=263 Identities=25% Similarity=0.402 Sum_probs=225.3
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeEeeeeecC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRYLGTVREE 143 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~ 143 (536)
..+|++.+.||+|+||+||+|++..+|+.||||++..... ......+.+..|..+|..+ +||||+++++++.+.
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~-----~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~ 414 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVV-----IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM 414 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHH-----HHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCS
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEecccc-----ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeC
Confidence 4589999999999999999999999999999999843211 1122345677889999887 799999999999999
Q ss_pred CceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhh
Q 009364 144 ESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAE 223 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 223 (536)
+.+|+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 415 ~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 494 (674)
T 3pfq_A 415 DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 494 (674)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred CEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence 99999999999999999999888999999999999999999999999999999999999999999999999999975432
Q ss_pred hhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH-HHHHHhhCCCCCCCCCCCcCcHH
Q 009364 224 LATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE-VAALFHIGTTKSHPPIPENLSVK 302 (536)
Q Consensus 224 ~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~ 302 (536)
.. ......+||+.|+|||++.+..|+.++|||||||++|||++|.+||...... ....+.. ....+|..++.+
T Consensus 495 ~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~----~~~~~p~~~s~~ 568 (674)
T 3pfq_A 495 DG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME----HNVAYPKSMSKE 568 (674)
T ss_dssp TT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHS----SCCCCCTTSCHH
T ss_pred CC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHh----CCCCCCccCCHH
Confidence 21 2345788999999999999999999999999999999999999999765432 2222221 234566789999
Q ss_pred HHHHHHHhcccCCCCCCCH-----HHHHhCCCCcCCCCCcc
Q 009364 303 AKDFLLKCLEKEPDLRPTA-----SELLKHPFVTGDDEDPV 338 (536)
Q Consensus 303 ~~dLi~~cL~~dP~~Rps~-----~eiL~hp~~~~~~~~~~ 338 (536)
+++||++||++||.+||++ .||++||||...+++..
T Consensus 569 ~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l 609 (674)
T 3pfq_A 569 AVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKL 609 (674)
T ss_dssp HHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHH
T ss_pred HHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHHH
Confidence 9999999999999999997 99999999998765443
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=388.76 Aligned_cols=252 Identities=28% Similarity=0.406 Sum_probs=203.1
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHh-CCCCceeeEeeeeecCC
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKD-LSHPNIVRYLGTVREEE 144 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~-l~HpnIv~l~~~~~~~~ 144 (536)
.+|++.+.||+|+||+||+|.+..+|+.||||++.... ..... ......|+..+.. .+||||+++++++.+.+
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~-~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~ 130 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPF-----RGPKD-RARKLAEVGSHEKVGQHPCCVRLEQAWEEGG 130 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSC-----CSHHH-HHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccc-----cChHH-HHHHHHHHHHHHHhcCCCcEEEEEEEEEeCC
Confidence 47999999999999999999999999999999873211 11112 2233344544444 48999999999999999
Q ss_pred ceeEEEEecCCCCccccccc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhh
Q 009364 145 SLNILLEFVPGGSISSLLGK-FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAE 223 (536)
Q Consensus 145 ~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 223 (536)
.+++||||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 131 ILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp EEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred EEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 999999999 6788877754 34699999999999999999999999999999999999999999999999999876543
Q ss_pred hhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcHHH
Q 009364 224 LATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKA 303 (536)
Q Consensus 224 ~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 303 (536)
.. ......||+.|+|||++.+ .++.++|||||||++|+|++|..||..... ...+ ......+.++..++.++
T Consensus 210 ~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~-~~~~---~~~~~~~~~~~~~~~~l 281 (311)
T 3p1a_A 210 AG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG-WQQL---RQGYLPPEFTAGLSSEL 281 (311)
T ss_dssp --------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH-HHHH---TTTCCCHHHHTTSCHHH
T ss_pred CC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH-HHHH---hccCCCcccccCCCHHH
Confidence 22 2345679999999999887 799999999999999999999766644321 1111 11222233456789999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHhCCCCcC
Q 009364 304 KDFLLKCLEKEPDLRPTASELLKHPFVTG 332 (536)
Q Consensus 304 ~dLi~~cL~~dP~~Rps~~eiL~hp~~~~ 332 (536)
.+||.+||++||.+|||+.|+|+||||++
T Consensus 282 ~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 282 RSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 99999999999999999999999999974
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=378.91 Aligned_cols=256 Identities=27% Similarity=0.463 Sum_probs=211.1
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
.+|++++.||+|+||.||+|.+..+|+.||+|++.... .......+.+.+|+.+++.++||||+++++++.....
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 85 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQK-----IRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTD 85 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH-----HHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEecccc-----ccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCe
Confidence 58999999999999999999999999999999984211 1111234578899999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhh
Q 009364 146 LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA 225 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 225 (536)
.++||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 86 FFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165 (276)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred EEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence 99999999999999999888889999999999999999999999999999999999999999999999999987654322
Q ss_pred cccCCcccCCCCCCCChhhhhhcCC-CccceEechhHHHHHHhhCCCCCchhhHH-HHHHHhhCCCCCCCCCCCcCcHHH
Q 009364 226 TVSGAKSMKGTPYWMAPEVIRQTGH-SYSADIWSVGCTVIEMATGKPPWSQQYQE-VAALFHIGTTKSHPPIPENLSVKA 303 (536)
Q Consensus 226 ~~~~~~~~~Gt~~Y~APEvl~~~~~-s~k~DIwSlGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~ 303 (536)
......||+.|+|||++.+..+ +.++||||||+++|+|++|..||...... ........ ...++..++..+
T Consensus 166 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~l 238 (276)
T 2h6d_A 166 ---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGG----VFYIPEYLNRSV 238 (276)
T ss_dssp --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC----CCCCCTTSCHHH
T ss_pred ---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC----cccCchhcCHHH
Confidence 1335679999999999988765 68999999999999999999999754322 22222221 223566789999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 304 KDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 304 ~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
.+||.+||+.||.+|||+.++++||||...
T Consensus 239 ~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 239 ATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred HHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 999999999999999999999999999754
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-48 Score=393.70 Aligned_cols=262 Identities=31% Similarity=0.483 Sum_probs=212.4
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE 143 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 143 (536)
.-.+|++.+.||+|+||+||+|.+..+|+.||+|++... .......+.+.+|+.+++.++||||+++++++.+.
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 96 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLES------DDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKK 96 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESC------SSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecC------CCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecC
Confidence 345899999999999999999999999999999987422 11223345677899999999999999999999999
Q ss_pred CceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhh
Q 009364 144 ESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAE 223 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 223 (536)
+..++||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 97 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 97 KRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp TEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred CEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 99999999999999999888778899999999999999999999999999999999999999999999999999976653
Q ss_pred hhcccCCcccCCCCCCCChhhhhhc-CCCccceEechhHHHHHHhhCCCCCchhhHHH--HHHHhh-C------------
Q 009364 224 LATVSGAKSMKGTPYWMAPEVIRQT-GHSYSADIWSVGCTVIEMATGKPPWSQQYQEV--AALFHI-G------------ 287 (536)
Q Consensus 224 ~~~~~~~~~~~Gt~~Y~APEvl~~~-~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~--~~~~~~-~------------ 287 (536)
.. .......||+.|+|||++.+. .++.++|||||||++|+|++|.+||....... ..+... .
T Consensus 177 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (331)
T 4aaa_A 177 PG--EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNK 254 (331)
T ss_dssp ---------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHH
T ss_pred Cc--cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhh
Confidence 22 223456799999999999875 68999999999999999999999996543211 111100 0
Q ss_pred ----CCCCCCC---------CCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 288 ----TTKSHPP---------IPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 288 ----~~~~~~~---------~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
.....+. ..+.++..+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred ccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence 0000000 113678999999999999999999999999999999753
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=395.29 Aligned_cols=263 Identities=26% Similarity=0.422 Sum_probs=208.4
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec---
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE--- 142 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--- 142 (536)
.+|++++.||+|+||+||+|++..+|+.||+|++....... .....+.+|+.+++.++||||+++++++..
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 90 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE------GFPITALREIKILQLLKHENVVNLIEICRTKAS 90 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSS------SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccc------cchHHHHHHHHHHHhccCCCcccHhheeecccc
Confidence 58999999999999999999999999999999874332111 112346689999999999999999999876
Q ss_pred -----CCceeEEEEecCCCCccccc-ccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecC
Q 009364 143 -----EESLNILLEFVPGGSISSLL-GKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFG 216 (536)
Q Consensus 143 -----~~~~~lV~E~~~gg~L~~~l-~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFG 216 (536)
.+.+++||||+.+ +|.+.+ .....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 91 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 91 PYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp ------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred ccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccch
Confidence 4468999999975 555554 444679999999999999999999999999999999999999999999999999
Q ss_pred cchhhhhhhc--ccCCcccCCCCCCCChhhhhh-cCCCccceEechhHHHHHHhhCCCCCchhhHHH--HHHHhhCCCCC
Q 009364 217 ASKQVAELAT--VSGAKSMKGTPYWMAPEVIRQ-TGHSYSADIWSVGCTVIEMATGKPPWSQQYQEV--AALFHIGTTKS 291 (536)
Q Consensus 217 la~~~~~~~~--~~~~~~~~Gt~~Y~APEvl~~-~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~--~~~~~~~~~~~ 291 (536)
+++.+..... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||....... ..+........
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 249 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 9986542211 122345679999999999976 458999999999999999999999997643221 11111111111
Q ss_pred CCCCCC---------------------------cCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCCC
Q 009364 292 HPPIPE---------------------------NLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDE 335 (536)
Q Consensus 292 ~~~~~~---------------------------~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~~ 335 (536)
...++. ..++.+++||.+||+.||.+|||+.|+|+||||.....
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 320 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPM 320 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSC
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCC
Confidence 111110 02678999999999999999999999999999986543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=392.79 Aligned_cols=259 Identities=36% Similarity=0.619 Sum_probs=215.7
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEE 144 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 144 (536)
..+|++.+.||+|+||+||+|++..+|+.||||++.... .......+.+.+|+.+++.++||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 127 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSG-----KQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH 127 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCS-----SCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEcccc-----ccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 356999999999999999999999999999999984321 122344567889999999999999999999999999
Q ss_pred ceeEEEEecCCCCcccccc-cCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhh
Q 009364 145 SLNILLEFVPGGSISSLLG-KFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAE 223 (536)
Q Consensus 145 ~~~lV~E~~~gg~L~~~l~-~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 223 (536)
..++||||+. |+|.+++. ...++++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 128 ~~~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 128 TAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp EEEEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred eEEEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 9999999997 57777664 456799999999999999999999999999999999999999999999999999876542
Q ss_pred hhcccCCcccCCCCCCCChhhhh---hcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCc
Q 009364 224 LATVSGAKSMKGTPYWMAPEVIR---QTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLS 300 (536)
Q Consensus 224 ~~~~~~~~~~~Gt~~Y~APEvl~---~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s 300 (536)
....+||+.|+|||++. +..++.++|||||||++|+|++|.+||......... ............+..++
T Consensus 207 ------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 279 (348)
T 1u5q_A 207 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-YHIAQNESPALQSGHWS 279 (348)
T ss_dssp ------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-HHHHHSCCCCCCCTTSC
T ss_pred ------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHhcCCCCCCCCCCC
Confidence 34567999999999985 467899999999999999999999999654322111 11111112223345789
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCCCC
Q 009364 301 VKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDED 336 (536)
Q Consensus 301 ~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~~~ 336 (536)
..+++||.+||+.||.+|||+.++++||||......
T Consensus 280 ~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~~ 315 (348)
T 1u5q_A 280 EYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP 315 (348)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCCT
T ss_pred HHHHHHHHHHcccChhhCcCHHHHhhChhhhccCCc
Confidence 999999999999999999999999999999765443
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=389.64 Aligned_cols=261 Identities=28% Similarity=0.525 Sum_probs=223.7
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE 142 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 142 (536)
....+|++++.||+|+||.||+|.+..+++.||+|++..... ......+.+.+|+.+++.++||||+++++++.+
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 112 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL-----LKPHQREKMSMEISIHRSLAHQHVVGFHGFFED 112 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-----CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhh-----cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 345689999999999999999999999999999998843211 112345668899999999999999999999999
Q ss_pred CCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhh
Q 009364 143 EESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVA 222 (536)
Q Consensus 143 ~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~ 222 (536)
.+.+++||||+.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 113 ~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 113 NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp SSEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred CCeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 99999999999999999999887889999999999999999999999999999999999999999999999999998654
Q ss_pred hhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH-HHHHHhhCCCCCCCCCCCcCcH
Q 009364 223 ELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE-VAALFHIGTTKSHPPIPENLSV 301 (536)
Q Consensus 223 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~s~ 301 (536)
... .......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ........ ...++..++.
T Consensus 193 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~----~~~~~~~~~~ 266 (335)
T 2owb_A 193 YDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN----EYSIPKHINP 266 (335)
T ss_dssp STT--CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT----CCCCCTTSCH
T ss_pred cCc--ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC----CCCCCccCCH
Confidence 322 2234567999999999999989999999999999999999999999754322 22222111 2345668899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCC
Q 009364 302 KAKDFLLKCLEKEPDLRPTASELLKHPFVTGDD 334 (536)
Q Consensus 302 ~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~ 334 (536)
.+++||.+||+.||.+|||+.|+++||||....
T Consensus 267 ~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~ 299 (335)
T 2owb_A 267 VAASLIQKMLQTDPTARPTINELLNDEFFTSGY 299 (335)
T ss_dssp HHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCccccCCC
Confidence 999999999999999999999999999998653
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=396.92 Aligned_cols=254 Identities=25% Similarity=0.448 Sum_probs=214.2
Q ss_pred CCCCceeeeEEcccCceEEEEEEEc-------CCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceee
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNL-------DSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVR 135 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~-------~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~ 135 (536)
...+|++++.||+|+||+||+|.+. .++..||+|++.. .......+.+.+|+.+|+.+ +||||++
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~-------~~~~~~~~~~~~E~~~l~~l~~hpnIv~ 151 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD-------DATEKDLSDLVSEMEMMKMIGKHKNIIN 151 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCT-------TCBHHHHHHHHHHHHHHHHSCCCTTBCC
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecC-------CcCHHHHHHHHHHHHHHHHhcCCCCEee
Confidence 4468999999999999999999875 3456899998732 12234456788999999999 8999999
Q ss_pred EeeeeecCCceeEEEEecCCCCcccccccCC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCccccCCC
Q 009364 136 YLGTVREEESLNILLEFVPGGSISSLLGKFG----------------PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKG 199 (536)
Q Consensus 136 l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~----------------~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp 199 (536)
+++++...+.+|+||||+++|+|.+++...+ .+++..++.++.||+.||.|||++||+||||||
T Consensus 152 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp 231 (370)
T 2psq_A 152 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAA 231 (370)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCG
T ss_pred EEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccch
Confidence 9999999999999999999999999987543 478999999999999999999999999999999
Q ss_pred CCcccCCCCcEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhH
Q 009364 200 ANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQ 278 (536)
Q Consensus 200 ~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~ 278 (536)
+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 232 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~ 311 (370)
T 2psq_A 232 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 311 (370)
T ss_dssp GGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred hhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 999999999999999999987654333233345567899999999999999999999999999999999 9999975432
Q ss_pred -HHHHHHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 279 -EVAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 279 -~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
+....... ......+..++.++.+||.+||+.||.+|||+.|++++
T Consensus 312 ~~~~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 312 EELFKLLKE---GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp GGHHHHHHT---TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhc---CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 22222222 22345667899999999999999999999999999975
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-47 Score=390.43 Aligned_cols=264 Identities=26% Similarity=0.439 Sum_probs=208.5
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEE 144 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 144 (536)
..+|++.+.||+|+||+||+|.+..+|+.||+|++...... .......+.+.+|+.+++.++||||+++++++....
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRS---EAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC---------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcc---hhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 46899999999999999999999999999999988432111 111112345778999999999999999999999999
Q ss_pred ceeEEEEecCCCCcccccccC-CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhh
Q 009364 145 SLNILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAE 223 (536)
Q Consensus 145 ~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 223 (536)
..++||||+.+ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+..
T Consensus 86 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 164 (346)
T ss_dssp CCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred ceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccC
Confidence 99999999975 777777654 4689999999999999999999999999999999999999999999999999987643
Q ss_pred hhcccCCcccCCCCCCCChhhhhhc-CCCccceEechhHHHHHHhhCCCCCchhhHH--HHHHHhhCCCCCCC-------
Q 009364 224 LATVSGAKSMKGTPYWMAPEVIRQT-GHSYSADIWSVGCTVIEMATGKPPWSQQYQE--VAALFHIGTTKSHP------- 293 (536)
Q Consensus 224 ~~~~~~~~~~~Gt~~Y~APEvl~~~-~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~--~~~~~~~~~~~~~~------- 293 (536)
.. ......+||+.|+|||++.+. .++.++|||||||++|+|++|.+||...... ...+..........
T Consensus 165 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 242 (346)
T 1ua2_A 165 PN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 242 (346)
T ss_dssp CC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred Cc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhcc
Confidence 22 224456899999999999764 5899999999999999999999999754321 12222211111000
Q ss_pred -----------C-----CCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCC
Q 009364 294 -----------P-----IPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDD 334 (536)
Q Consensus 294 -----------~-----~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~ 334 (536)
. ....++.++++||.+||+.||.+|||+.|+|+||||....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~ 299 (346)
T 1ua2_A 243 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 299 (346)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred CcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCC
Confidence 0 1145679999999999999999999999999999998653
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=384.70 Aligned_cols=264 Identities=33% Similarity=0.585 Sum_probs=195.3
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE 143 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 143 (536)
...+|++.+.||+|+||+||+|.+..+|+.||+|++.. .......+.+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 85 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINL-------EKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVK 85 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------------CCCCCCCTTBCCEEEEEESS
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEh-------hhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeec
Confidence 34689999999999999999999988999999998732 11223356678999999999999999999999999
Q ss_pred CceeEEEEecCCCCccccccc--------CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEec
Q 009364 144 ESLNILLEFVPGGSISSLLGK--------FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADF 215 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~~--------~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DF 215 (536)
+..++||||++|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+||
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~df 165 (303)
T 2vwi_A 86 DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADF 165 (303)
T ss_dssp SCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCC
T ss_pred CCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEec
Confidence 999999999999999998863 456999999999999999999999999999999999999999999999999
Q ss_pred Ccchhhhhhhc---ccCCcccCCCCCCCChhhhhh-cCCCccceEechhHHHHHHhhCCCCCchhhHH--HHHHHhhCCC
Q 009364 216 GASKQVAELAT---VSGAKSMKGTPYWMAPEVIRQ-TGHSYSADIWSVGCTVIEMATGKPPWSQQYQE--VAALFHIGTT 289 (536)
Q Consensus 216 Gla~~~~~~~~---~~~~~~~~Gt~~Y~APEvl~~-~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~--~~~~~~~~~~ 289 (536)
|++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||...... ..........
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 245 (303)
T 2vwi_A 166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPP 245 (303)
T ss_dssp HHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCC
T ss_pred cchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCC
Confidence 99876643221 112335679999999999976 57899999999999999999999999653221 1111111111
Q ss_pred C-----CCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCC
Q 009364 290 K-----SHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDD 334 (536)
Q Consensus 290 ~-----~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~ 334 (536)
. ........++.++++||.+||+.||.+|||+.++++||||....
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 295 (303)
T 2vwi_A 246 SLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK 295 (303)
T ss_dssp CTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred ccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence 0 11223457889999999999999999999999999999998654
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=396.56 Aligned_cols=257 Identities=26% Similarity=0.458 Sum_probs=194.7
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE 143 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 143 (536)
.+.+|++.+.||+|+||+||+|.+..+|+.||||++... .......+.+.+|+.+|+.++||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~------~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 100 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP------FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 100 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSST------TSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCcc------ccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC
Confidence 346899999999999999999999999999999987321 11223456678999999999999999999998654
Q ss_pred ------CceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCc
Q 009364 144 ------ESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGA 217 (536)
Q Consensus 144 ------~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGl 217 (536)
..+++|+||+ +++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 101 ~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 101 RSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp SSGGGCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC---
T ss_pred CccccCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccc
Confidence 5689999999 7899998876 6799999999999999999999999999999999999999999999999999
Q ss_pred chhhhhhhcccCCcccCCCCCCCChhhhhh-cCCCccceEechhHHHHHHhhCCCCCchhhHH--HHHHHhh-CC-----
Q 009364 218 SKQVAELATVSGAKSMKGTPYWMAPEVIRQ-TGHSYSADIWSVGCTVIEMATGKPPWSQQYQE--VAALFHI-GT----- 288 (536)
Q Consensus 218 a~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~-~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~--~~~~~~~-~~----- 288 (536)
++..... ....+||++|+|||++.+ ..++.++|||||||++|+|++|++||.+.... ...+... +.
T Consensus 179 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~ 253 (367)
T 2fst_X 179 ARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 253 (367)
T ss_dssp -----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred ccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 9865432 345689999999999987 67899999999999999999999999654321 1111110 00
Q ss_pred ---------------CCCCC-----CCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 289 ---------------TKSHP-----PIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 289 ---------------~~~~~-----~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
....+ ......++.+++||.+||+.||.+|||+.|+|+||||...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~ 318 (367)
T 2fst_X 254 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318 (367)
T ss_dssp HTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhc
Confidence 00001 1123578999999999999999999999999999999754
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-47 Score=392.31 Aligned_cols=262 Identities=25% Similarity=0.397 Sum_probs=213.4
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE 142 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 142 (536)
....+|++.+.||+|+||+||+|.+..+++.||+|++.. .........+.+|+++|+.++||||+++++++..
T Consensus 24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-------~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 96 (364)
T 3qyz_A 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP-------FEHQTYCQRTLREIKILLRFRHENIIGINDIIRA 96 (364)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC-------TTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECC
T ss_pred cccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecc-------ccCcHHHHHHHHHHHHHHhcCCCCCccceeEEec
Confidence 445789999999999999999999999999999998832 1223345678899999999999999999999875
Q ss_pred C-----CceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCc
Q 009364 143 E-----ESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGA 217 (536)
Q Consensus 143 ~-----~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGl 217 (536)
. ...++||||+. |+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 97 ~~~~~~~~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 174 (364)
T 3qyz_A 97 PTIEQMKDVYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGL 174 (364)
T ss_dssp SSTTTCCCEEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred CCccccceEEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcc
Confidence 5 36899999996 588888865 5699999999999999999999999999999999999999999999999999
Q ss_pred chhhhhhhccc-CCcccCCCCCCCChhhhhhc-CCCccceEechhHHHHHHhhCCCCCchhh--HHHHHHHhhC------
Q 009364 218 SKQVAELATVS-GAKSMKGTPYWMAPEVIRQT-GHSYSADIWSVGCTVIEMATGKPPWSQQY--QEVAALFHIG------ 287 (536)
Q Consensus 218 a~~~~~~~~~~-~~~~~~Gt~~Y~APEvl~~~-~~s~k~DIwSlGvil~eLltG~~Pf~~~~--~~~~~~~~~~------ 287 (536)
++......... .....+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.... .....+....
T Consensus 175 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 254 (364)
T 3qyz_A 175 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 254 (364)
T ss_dssp CEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHH
T ss_pred eEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 98765432221 23456899999999987654 58999999999999999999999996432 1111111100
Q ss_pred ---------------CCCCC-----CCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 288 ---------------TTKSH-----PPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 288 ---------------~~~~~-----~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
..... ......++.++++||.+||+.||.+|||+.|+|+||||...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred HHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence 00000 11224678999999999999999999999999999999764
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=385.54 Aligned_cols=261 Identities=36% Similarity=0.643 Sum_probs=215.4
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE 142 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 142 (536)
....+|++.+.||+|+||.||+|.+..+|+.||+|++.... ..+.+.+|+.+++.++||||+++++++..
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES----------DLQEIIKEISIMQQCDSPHVVKYYGSYFK 95 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS----------CCHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH----------HHHHHHHHHHHHHhCCCCCCccEEEEEEe
Confidence 45568999999999999999999999999999999884211 12457789999999999999999999999
Q ss_pred CCceeEEEEecCCCCcccccc-cCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhh
Q 009364 143 EESLNILLEFVPGGSISSLLG-KFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQV 221 (536)
Q Consensus 143 ~~~~~lV~E~~~gg~L~~~l~-~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~ 221 (536)
.+.+++||||+++++|.+++. ....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 96 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 175 (314)
T 3com_A 96 NTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQL 175 (314)
T ss_dssp TTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred CCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhh
Confidence 999999999999999999986 4567999999999999999999999999999999999999999999999999999765
Q ss_pred hhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcH
Q 009364 222 AELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSV 301 (536)
Q Consensus 222 ~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 301 (536)
.... .......||+.|+|||++.+..++.++|||||||++|+|++|..||......................+..++.
T Consensus 176 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (314)
T 3com_A 176 TDTM--AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSD 253 (314)
T ss_dssp BTTB--SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCH
T ss_pred hhhc--cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCH
Confidence 4321 22345679999999999999899999999999999999999999997643322221111222222334567899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCCC
Q 009364 302 KAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDE 335 (536)
Q Consensus 302 ~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~~ 335 (536)
.+.+||.+||..||.+|||+.++++||||.....
T Consensus 254 ~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~ 287 (314)
T 3com_A 254 NFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKG 287 (314)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCCC
T ss_pred HHHHHHHHHccCChhhCcCHHHHHhCHHHhcCCc
Confidence 9999999999999999999999999999986543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=380.86 Aligned_cols=262 Identities=28% Similarity=0.443 Sum_probs=216.3
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
.+|++.+.||+|+||+||+|.+..+|+.||+|++......... .....+.+.+|+.+++.++||||+++++++.+...
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 82 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSR--RGVSREEIEREVNILREIRHPNIITLHDIFENKTD 82 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCS--SSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccc--cchHHHHHHHHHHHHHhCCCCCeeehhheecCCCe
Confidence 4699999999999999999999999999999988543211110 00123567899999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCC----cEEEEecCcchhh
Q 009364 146 LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKG----CIKLADFGASKQV 221 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~----~vkL~DFGla~~~ 221 (536)
.++||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++...
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~ 162 (283)
T 3bhy_A 83 VVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI 162 (283)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence 999999999999999998878899999999999999999999999999999999999998877 8999999999765
Q ss_pred hhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH-HHHHHhhCCCCCCCCCCCcCc
Q 009364 222 AELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE-VAALFHIGTTKSHPPIPENLS 300 (536)
Q Consensus 222 ~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~s 300 (536)
.... ......||+.|+|||++.+..++.++||||||+++|+|++|..||...... ................+..++
T Consensus 163 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T 3bhy_A 163 EAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTS 239 (283)
T ss_dssp C-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCC
T ss_pred cCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCC
Confidence 4322 234567999999999999989999999999999999999999999754332 222222222222222335788
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhCCCCcC
Q 009364 301 VKAKDFLLKCLEKEPDLRPTASELLKHPFVTG 332 (536)
Q Consensus 301 ~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~ 332 (536)
..+++||.+||..||.+|||+.++++||||..
T Consensus 240 ~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 271 (283)
T 3bhy_A 240 ELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271 (283)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence 99999999999999999999999999999964
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-47 Score=385.79 Aligned_cols=267 Identities=22% Similarity=0.410 Sum_probs=195.3
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCCc---EEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeee
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGE---LLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGT 139 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~---~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~ 139 (536)
.+..+|++++.||+|+||+||+|.+..++. .||+|++... .......+.+.+|+.+++.++||||++++++
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~------~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 93 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKAD------IIASSDIEEFLREAACMKEFDHPHVAKLVGV 93 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------------CHHHHHHHHHHHHHTTCCCTTBCCCCEE
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccc------ccCHHHHHHHHHHHHHHHHCCCCceehhhce
Confidence 455689999999999999999999887765 8999987321 1122345678899999999999999999999
Q ss_pred eecCCce------eEEEEecCCCCcccccccCC------CCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCC
Q 009364 140 VREEESL------NILLEFVPGGSISSLLGKFG------PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNK 207 (536)
Q Consensus 140 ~~~~~~~------~lV~E~~~gg~L~~~l~~~~------~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~ 207 (536)
+...... ++||||+.+|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 94 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~ 173 (323)
T 3qup_A 94 SLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAED 173 (323)
T ss_dssp EECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT
T ss_pred eeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCC
Confidence 9877655 99999999999999885432 58999999999999999999999999999999999999999
Q ss_pred CcEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhH-HHHHHHh
Q 009364 208 GCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQ-EVAALFH 285 (536)
Q Consensus 208 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~-~~~~~~~ 285 (536)
+.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|+|++ |.+||..... .......
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~ 253 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI 253 (323)
T ss_dssp SCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH
T ss_pred CCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHh
Confidence 9999999999987654433333344567889999999999999999999999999999999 9999975432 2222221
Q ss_pred hCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCC-------HHHHHhCCCCcCCCCCcc
Q 009364 286 IGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPT-------ASELLKHPFVTGDDEDPV 338 (536)
Q Consensus 286 ~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps-------~~eiL~hp~~~~~~~~~~ 338 (536)
. ......+..++.++.+||.+||+.||.+||| ++++++|||+.....+|.
T Consensus 254 ~---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~pl 310 (323)
T 3qup_A 254 G---GNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPL 310 (323)
T ss_dssp T---TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-----------
T ss_pred c---CCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCCC
Confidence 1 2234456688999999999999999999999 778889999987665544
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-47 Score=380.34 Aligned_cols=257 Identities=43% Similarity=0.726 Sum_probs=211.1
Q ss_pred ceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCcee
Q 009364 68 WRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESLN 147 (536)
Q Consensus 68 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 147 (536)
|.....||+|+||+||+|.+..+++.||+|.+... .....+.+.+|+.+++.++||||+++++++...+..+
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 95 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER--------DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIK 95 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC--------CC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC--------chHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEE
Confidence 44455899999999999999999999999988421 1123456789999999999999999999999999999
Q ss_pred EEEEecCCCCcccccccC---CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCC-CCcEEEEecCcchhhhh
Q 009364 148 ILLEFVPGGSISSLLGKF---GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDN-KGCIKLADFGASKQVAE 223 (536)
Q Consensus 148 lV~E~~~gg~L~~~l~~~---~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~-~~~vkL~DFGla~~~~~ 223 (536)
+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++.....
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 96 IFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp EEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred EEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence 999999999999998754 25678999999999999999999999999999999999987 88999999999876543
Q ss_pred hhcccCCcccCCCCCCCChhhhhhcC--CCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcH
Q 009364 224 LATVSGAKSMKGTPYWMAPEVIRQTG--HSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSV 301 (536)
Q Consensus 224 ~~~~~~~~~~~Gt~~Y~APEvl~~~~--~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 301 (536)
... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||...................+.++..++.
T Consensus 176 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (295)
T 2clq_A 176 INP--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSA 253 (295)
T ss_dssp -------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCH
T ss_pred CCC--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCH
Confidence 221 234567999999999998754 8899999999999999999999996543222222222222334456778999
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCC
Q 009364 302 KAKDFLLKCLEKEPDLRPTASELLKHPFVTGDD 334 (536)
Q Consensus 302 ~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~ 334 (536)
++.+||.+||+.||.+|||+.++++||||+...
T Consensus 254 ~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 254 EAKAFILKCFEPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp HHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred HHHHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence 999999999999999999999999999997543
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=400.57 Aligned_cols=255 Identities=27% Similarity=0.452 Sum_probs=206.7
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC------CCCceeeEee
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL------SHPNIVRYLG 138 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l------~HpnIv~l~~ 138 (536)
..+|++.+.||+|+||+||+|.+..+++.||||++... ......+.+|+.+++.+ +|+||+++++
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---------~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~ 166 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---------KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLE 166 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---------HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---------cchHHHHHHHHHHHHHHhhccccCCcCEEEEEe
Confidence 45899999999999999999999999999999998321 12234566777777766 5779999999
Q ss_pred eeecCCceeEEEEecCCCCcccccccCC--CCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCc--EEEEe
Q 009364 139 TVREEESLNILLEFVPGGSISSLLGKFG--PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGC--IKLAD 214 (536)
Q Consensus 139 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~--vkL~D 214 (536)
++.....+++||||+. ++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|
T Consensus 167 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~D 245 (429)
T 3kvw_A 167 NFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVID 245 (429)
T ss_dssp EEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECC
T ss_pred ecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEee
Confidence 9999999999999995 68888886543 5999999999999999999999999999999999999999887 99999
Q ss_pred cCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH--HHHHHhhCCC---
Q 009364 215 FGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE--VAALFHIGTT--- 289 (536)
Q Consensus 215 FGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~--~~~~~~~~~~--- 289 (536)
||+++.... .....+||+.|+|||++.+..++.++|||||||++|+|++|.+||...... ...+......
T Consensus 246 FG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~ 320 (429)
T 3kvw_A 246 FGSSCYEHQ-----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQ 320 (429)
T ss_dssp CTTCEETTC-----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred cccceecCC-----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCH
Confidence 999865432 234678999999999999999999999999999999999999999654321 1111110000
Q ss_pred ---------------CCCC------------------------------------CCCCcCcHHHHHHHHHhcccCCCCC
Q 009364 290 ---------------KSHP------------------------------------PIPENLSVKAKDFLLKCLEKEPDLR 318 (536)
Q Consensus 290 ---------------~~~~------------------------------------~~~~~~s~~~~dLi~~cL~~dP~~R 318 (536)
...+ .++...++++++||++||++||.+|
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~R 400 (429)
T 3kvw_A 321 KLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVR 400 (429)
T ss_dssp HHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTS
T ss_pred HHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhC
Confidence 0000 0112347889999999999999999
Q ss_pred CCHHHHHhCCCCcCCC
Q 009364 319 PTASELLKHPFVTGDD 334 (536)
Q Consensus 319 ps~~eiL~hp~~~~~~ 334 (536)
||+.|+|+||||+...
T Consensus 401 pta~e~L~Hpw~~~~~ 416 (429)
T 3kvw_A 401 MTPGQALRHPWLRRRL 416 (429)
T ss_dssp CCHHHHHTSTTTC---
T ss_pred CCHHHHhCChhhccCC
Confidence 9999999999998653
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=384.54 Aligned_cols=255 Identities=25% Similarity=0.426 Sum_probs=209.9
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCC-CCceeeEeeeee
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS-HPNIVRYLGTVR 141 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~ 141 (536)
....+|++++.||+|+||+||+|.+..+|+.||+|++.. . ..+.+.+|+.+++.++ ||||+++++++.
T Consensus 33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-------~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~ 101 (330)
T 3nsz_A 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-------V----KKKKIKREIKILENLRGGPNIITLADIVK 101 (330)
T ss_dssp EEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-------C----CHHHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred cCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc-------c----chHHHHHHHHHHHHcCCCCCEEEeeeeec
Confidence 345689999999999999999999999999999998831 1 1245778999999997 999999999998
Q ss_pred c--CCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCC-cEEEEecCcc
Q 009364 142 E--EESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKG-CIKLADFGAS 218 (536)
Q Consensus 142 ~--~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~-~vkL~DFGla 218 (536)
+ ....++||||+.+++|.+++.. +++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++
T Consensus 102 ~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a 178 (330)
T 3nsz_A 102 DPVSRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA 178 (330)
T ss_dssp CTTTCCEEEEEECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred cCCCCceEEEEeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCc
Confidence 7 6678999999999999998854 89999999999999999999999999999999999999777 8999999999
Q ss_pred hhhhhhhcccCCcccCCCCCCCChhhhhh-cCCCccceEechhHHHHHHhhCCCCCchhhHH---HH------------H
Q 009364 219 KQVAELATVSGAKSMKGTPYWMAPEVIRQ-TGHSYSADIWSVGCTVIEMATGKPPWSQQYQE---VA------------A 282 (536)
Q Consensus 219 ~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~-~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~---~~------------~ 282 (536)
+...... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||...... .. .
T Consensus 179 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 255 (330)
T 3nsz_A 179 EFYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD 255 (330)
T ss_dssp EECCTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHH
T ss_pred eEcCCCC---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhh
Confidence 7655322 2345679999999999987 67899999999999999999999999422111 00 0
Q ss_pred HHhhCCCC--------------------CCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCC
Q 009364 283 LFHIGTTK--------------------SHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDD 334 (536)
Q Consensus 283 ~~~~~~~~--------------------~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~ 334 (536)
........ .....+..++.++++||.+||+.||.+|||++|+|+||||....
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 256 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp HHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred HHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 11100000 01112234799999999999999999999999999999998653
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-47 Score=384.39 Aligned_cols=255 Identities=25% Similarity=0.416 Sum_probs=208.4
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE 143 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 143 (536)
...+|++.+.||+|+||+||+|.+..+|+.||+|++.... .....+.+.+|+++++.++||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 79 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNIS-------FLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET 79 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGG-------GGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT
T ss_pred CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccc-------ccchHHHHHHHHHHHHhcCCCCcceEEEEeecC
Confidence 3468999999999999999999999999999999984211 112234567899999999999999999998865
Q ss_pred C--ceeEEEEecCCCCcccccccCC---CCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCccc----CCCCcEEEEe
Q 009364 144 E--SLNILLEFVPGGSISSLLGKFG---PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILV----DNKGCIKLAD 214 (536)
Q Consensus 144 ~--~~~lV~E~~~gg~L~~~l~~~~---~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl----~~~~~vkL~D 214 (536)
. ..++||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~D 159 (319)
T 4euu_A 80 TTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTD 159 (319)
T ss_dssp TTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECC
T ss_pred CCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEcc
Confidence 5 7899999999999999987643 39999999999999999999999999999999999999 7778899999
Q ss_pred cCcchhhhhhhcccCCcccCCCCCCCChhhhh--------hcCCCccceEechhHHHHHHhhCCCCCchh-----hHHH-
Q 009364 215 FGASKQVAELATVSGAKSMKGTPYWMAPEVIR--------QTGHSYSADIWSVGCTVIEMATGKPPWSQQ-----YQEV- 280 (536)
Q Consensus 215 FGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~--------~~~~s~k~DIwSlGvil~eLltG~~Pf~~~-----~~~~- 280 (536)
||+++...... ......||+.|+|||++. +..++.++|||||||++|+|++|..||... ....
T Consensus 160 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~ 236 (319)
T 4euu_A 160 FGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236 (319)
T ss_dssp CTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHH
T ss_pred CCCceecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHH
Confidence 99998765432 234567999999999987 467899999999999999999999999521 1122
Q ss_pred HHHHhhCC--------------------CCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCC
Q 009364 281 AALFHIGT--------------------TKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHP 328 (536)
Q Consensus 281 ~~~~~~~~--------------------~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp 328 (536)
..+..... ......++..++..+.+||++||+.||++|||+.|+|+||
T Consensus 237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp HHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred HHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 22221110 0111123345677899999999999999999999999996
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=381.76 Aligned_cols=258 Identities=33% Similarity=0.551 Sum_probs=208.0
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE 142 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 142 (536)
.+..+|++.+.||+|+||+||+|.+ +|+.||+|++... .......+.+.+|+.++++++||||+++++++..
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~------~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 105 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQ------DFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ 105 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCC------CCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCC------CCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence 3456899999999999999999976 6889999988421 1123345678899999999999999999999999
Q ss_pred CCceeEEEEecCCCCcccccccCCC---CCHHHHHHHHHHHHHHHHHHHHcC--CccccCCCCCcccCCCCcEEEEecCc
Q 009364 143 EESLNILLEFVPGGSISSLLGKFGP---FPEAVMRTYTKQLLLGLEYLHNHG--IMHRDIKGANILVDNKGCIKLADFGA 217 (536)
Q Consensus 143 ~~~~~lV~E~~~gg~L~~~l~~~~~---l~~~~~~~i~~qil~aL~yLH~~~--ivHrDLKp~NILl~~~~~vkL~DFGl 217 (536)
...+++||||+++|+|.+++...+. +++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+
T Consensus 106 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~ 185 (309)
T 3p86_A 106 PPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGL 185 (309)
T ss_dssp TTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-
T ss_pred CCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCC
Confidence 9999999999999999999987654 999999999999999999999999 99999999999999999999999999
Q ss_pred chhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCC
Q 009364 218 SKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPE 297 (536)
Q Consensus 218 a~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 297 (536)
++..... ........||+.|+|||++.+..++.++|||||||++|+|++|..||.......... ..........++.
T Consensus 186 a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~-~~~~~~~~~~~~~ 262 (309)
T 3p86_A 186 SRLKAST--FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVA-AVGFKCKRLEIPR 262 (309)
T ss_dssp ------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH-HHHHSCCCCCCCT
T ss_pred Ccccccc--ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhcCCCCCCCc
Confidence 9765432 122345679999999999999999999999999999999999999997654322111 1111233445677
Q ss_pred cCcHHHHHHHHHhcccCCCCCCCHHHHHh--CCCCc
Q 009364 298 NLSVKAKDFLLKCLEKEPDLRPTASELLK--HPFVT 331 (536)
Q Consensus 298 ~~s~~~~dLi~~cL~~dP~~Rps~~eiL~--hp~~~ 331 (536)
.+++++.+||.+||+.||.+|||+.++++ ++++.
T Consensus 263 ~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 263 NLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 89999999999999999999999999988 34443
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=395.16 Aligned_cols=254 Identities=31% Similarity=0.512 Sum_probs=202.2
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEE 144 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 144 (536)
..+|++.+.||+|+||+||+|++..+++ +|+|++...... ..+|+.+|+.++||||+++++++....
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~------------~~~E~~il~~l~h~niv~l~~~~~~~~ 105 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF------------KNRELQIMRIVKHPNVVDLKAFFYSNG 105 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS------------CCHHHHHHHTCCCTTBCCEEEEEEEES
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch------------HHHHHHHHHhCCCCCcceEEEEEEecC
Confidence 3579999999999999999999887666 888887432211 136899999999999999999986544
Q ss_pred c------eeEEEEecCCCCccccc---ccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccC-CCCcEEEEe
Q 009364 145 S------LNILLEFVPGGSISSLL---GKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVD-NKGCIKLAD 214 (536)
Q Consensus 145 ~------~~lV~E~~~gg~L~~~l---~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~-~~~~vkL~D 214 (536)
. +++||||++++.+..+. .....+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|
T Consensus 106 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~D 185 (394)
T 4e7w_A 106 DKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLID 185 (394)
T ss_dssp SSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECC
T ss_pred CCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEee
Confidence 3 88999999875443332 2356799999999999999999999999999999999999998 789999999
Q ss_pred cCcchhhhhhhcccCCcccCCCCCCCChhhhhhc-CCCccceEechhHHHHHHhhCCCCCchhhHH--HHHHHhhC----
Q 009364 215 FGASKQVAELATVSGAKSMKGTPYWMAPEVIRQT-GHSYSADIWSVGCTVIEMATGKPPWSQQYQE--VAALFHIG---- 287 (536)
Q Consensus 215 FGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~-~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~--~~~~~~~~---- 287 (536)
||+++...... .....+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.... ...+....
T Consensus 186 FG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~ 262 (394)
T 4e7w_A 186 FGSAKILIAGE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPS 262 (394)
T ss_dssp CTTCEECCTTC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred CCCcccccCCC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 99998764322 23456799999999999765 5899999999999999999999999754321 11111110
Q ss_pred -----------CCCCCC---------CCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCC
Q 009364 288 -----------TTKSHP---------PIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDD 334 (536)
Q Consensus 288 -----------~~~~~~---------~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~ 334 (536)
.....+ .++..+++++++||.+||+.||.+|||+.|+++||||....
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 329 (394)
T 4e7w_A 263 REQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR 329 (394)
T ss_dssp HHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred HHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence 000000 12345889999999999999999999999999999998653
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=397.97 Aligned_cols=263 Identities=31% Similarity=0.533 Sum_probs=216.1
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEc---CCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeEee
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNL---DSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRYLG 138 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~ 138 (536)
....+|++.+.||+|+||+||+|++. .+|+.||||++......... ...+.+.+|+.+|+.+ +||||+++++
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~~~E~~~l~~l~~h~~iv~~~~ 126 (355)
T 1vzo_A 51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKA----KTTEHTRTERQVLEHIRQSPFLVTLHY 126 (355)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEE----SSGGGCCCHHHHHHHHHTCTTBCCEEE
T ss_pred ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhh----hHHHHHHHHHHHHHHccCCCceeEEEE
Confidence 33468999999999999999999985 58999999988432211000 1123455788999999 6999999999
Q ss_pred eeecCCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcc
Q 009364 139 TVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGAS 218 (536)
Q Consensus 139 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla 218 (536)
++.....+++||||+++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 127 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 127 AFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred EEeeCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 99999999999999999999999988888999999999999999999999999999999999999999999999999999
Q ss_pred hhhhhhhcccCCcccCCCCCCCChhhhhh--cCCCccceEechhHHHHHHhhCCCCCchhh-----HHHHHHHhhCCCCC
Q 009364 219 KQVAELATVSGAKSMKGTPYWMAPEVIRQ--TGHSYSADIWSVGCTVIEMATGKPPWSQQY-----QEVAALFHIGTTKS 291 (536)
Q Consensus 219 ~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~--~~~s~k~DIwSlGvil~eLltG~~Pf~~~~-----~~~~~~~~~~~~~~ 291 (536)
+.+..... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.... ........ ..
T Consensus 207 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~----~~ 281 (355)
T 1vzo_A 207 KEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL----KS 281 (355)
T ss_dssp EECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH----HC
T ss_pred eecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHh----cc
Confidence 86543222 22345689999999999986 347899999999999999999999996321 12221111 12
Q ss_pred CCCCCCcCcHHHHHHHHHhcccCCCCCC-----CHHHHHhCCCCcCCC
Q 009364 292 HPPIPENLSVKAKDFLLKCLEKEPDLRP-----TASELLKHPFVTGDD 334 (536)
Q Consensus 292 ~~~~~~~~s~~~~dLi~~cL~~dP~~Rp-----s~~eiL~hp~~~~~~ 334 (536)
.+.++..++..+++||.+||..||.+|| ++.++++||||....
T Consensus 282 ~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~ 329 (355)
T 1vzo_A 282 EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 329 (355)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCC
Confidence 3456678999999999999999999999 999999999998654
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=388.09 Aligned_cols=248 Identities=25% Similarity=0.516 Sum_probs=210.1
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE 143 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 143 (536)
.+.+|++++.||+|+||+||+|.+..+|+.||+|++.. ......+.+.+|+.+++.++||||+++++++.+.
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~--------~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 79 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--------FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD 79 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC--------CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET
T ss_pred ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc--------CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC
Confidence 45689999999999999999999999999999998732 1223456788999999999999999999999999
Q ss_pred CceeEEEEecCCCCccccccc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhh
Q 009364 144 ESLNILLEFVPGGSISSLLGK-FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVA 222 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~ 222 (536)
...++||||+++|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 159 (310)
T 3s95_A 80 KRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMV 159 (310)
T ss_dssp TEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC
T ss_pred CeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecc
Confidence 999999999999999999976 5679999999999999999999999999999999999999999999999999997654
Q ss_pred hhhccc------------CCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH-------HHHH
Q 009364 223 ELATVS------------GAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE-------VAAL 283 (536)
Q Consensus 223 ~~~~~~------------~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~-------~~~~ 283 (536)
...... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||...... ....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~ 239 (310)
T 3s95_A 160 DEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGF 239 (310)
T ss_dssp --------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHH
T ss_pred cccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcc
Confidence 322111 112567999999999999999999999999999999999999998542110 0111
Q ss_pred HhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHh
Q 009364 284 FHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 284 ~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~ 326 (536)
.. ...+..+++.+.+||.+||+.||.+|||+.++++
T Consensus 240 ~~-------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 240 LD-------RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp HH-------HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cc-------ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 11 1234678889999999999999999999999987
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-47 Score=394.85 Aligned_cols=253 Identities=30% Similarity=0.541 Sum_probs=204.2
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec-
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE- 142 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~- 142 (536)
...+|++++.||+|+||+||+|.+..+|+.||+|++..... ...+|+.+|+.++||||+++++++..
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~------------~~~~E~~il~~l~hpnIv~l~~~~~~~ 72 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR------------YKNRELDIMKVLDHVNIIKLVDYFYTT 72 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT------------SCCHHHHHHTTCCCTTBCCEEEEEEEC
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc------------hHHHHHHHHHHcCCCCccchhheeeec
Confidence 45689999999999999999999999999999998843211 12368999999999999999999843
Q ss_pred -------------------------------------CCceeEEEEecCCCCccccc----ccCCCCCHHHHHHHHHHHH
Q 009364 143 -------------------------------------EESLNILLEFVPGGSISSLL----GKFGPFPEAVMRTYTKQLL 181 (536)
Q Consensus 143 -------------------------------------~~~~~lV~E~~~gg~L~~~l----~~~~~l~~~~~~~i~~qil 181 (536)
...+++||||++ |+|.+.+ .....+++..++.++.||+
T Consensus 73 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~ 151 (383)
T 3eb0_A 73 GDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLF 151 (383)
T ss_dssp -------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHH
T ss_pred CcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHH
Confidence 334889999997 4665554 4457899999999999999
Q ss_pred HHHHHHHHcCCccccCCCCCcccC-CCCcEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhc-CCCccceEech
Q 009364 182 LGLEYLHNHGIMHRDIKGANILVD-NKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQT-GHSYSADIWSV 259 (536)
Q Consensus 182 ~aL~yLH~~~ivHrDLKp~NILl~-~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~-~~s~k~DIwSl 259 (536)
.||+|||++||+||||||+|||++ .++.+||+|||+++...... ......||+.|+|||++.+. .++.++||||+
T Consensus 152 ~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 228 (383)
T 3eb0_A 152 RAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSI 228 (383)
T ss_dssp HHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHH
T ss_pred HHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhH
Confidence 999999999999999999999997 68899999999998664322 23456799999999998875 48999999999
Q ss_pred hHHHHHHhhCCCCCchhhHH--HHHHHhhCCC---------------CCCC---------CCCCcCcHHHHHHHHHhccc
Q 009364 260 GCTVIEMATGKPPWSQQYQE--VAALFHIGTT---------------KSHP---------PIPENLSVKAKDFLLKCLEK 313 (536)
Q Consensus 260 Gvil~eLltG~~Pf~~~~~~--~~~~~~~~~~---------------~~~~---------~~~~~~s~~~~dLi~~cL~~ 313 (536)
||++|+|++|.+||...... ...+...... ...+ .++..++.++++||.+||+.
T Consensus 229 G~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 308 (383)
T 3eb0_A 229 GCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRY 308 (383)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccC
Confidence 99999999999999754321 1112111000 0000 13456899999999999999
Q ss_pred CCCCCCCHHHHHhCCCCcC
Q 009364 314 EPDLRPTASELLKHPFVTG 332 (536)
Q Consensus 314 dP~~Rps~~eiL~hp~~~~ 332 (536)
||.+|||+.|+|+||||..
T Consensus 309 dP~~R~t~~e~l~hp~f~~ 327 (383)
T 3eb0_A 309 EPDLRINPYEAMAHPFFDH 327 (383)
T ss_dssp SGGGSCCHHHHHTSGGGHH
T ss_pred ChhhCCCHHHHhcCHHHHH
Confidence 9999999999999999964
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=380.04 Aligned_cols=258 Identities=38% Similarity=0.701 Sum_probs=220.9
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE 142 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 142 (536)
.+..+|++.+.||+|+||+||+|.+..+|+.||+|++..... ....+.+.+|+.+++.++||||+++++++..
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 91 (303)
T 3a7i_A 19 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-------EDEIEDIQQEITVLSQCDSPYVTKYYGSYLK 91 (303)
T ss_dssp CGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC-------STTHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred ChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc-------HHHHHHHHHHHHHHHhCCCCCEeEEEEEEec
Confidence 344579999999999999999999999999999998843211 1234568899999999999999999999999
Q ss_pred CCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhh
Q 009364 143 EESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVA 222 (536)
Q Consensus 143 ~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~ 222 (536)
...+++||||+++++|.+++.. +++++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 92 ~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 170 (303)
T 3a7i_A 92 DTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT 170 (303)
T ss_dssp TTEEEEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECB
T ss_pred CCeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecC
Confidence 9999999999999999999875 679999999999999999999999999999999999999999999999999997665
Q ss_pred hhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHH-HHHHhhCCCCCCCCCCCcCcH
Q 009364 223 ELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEV-AALFHIGTTKSHPPIPENLSV 301 (536)
Q Consensus 223 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~s~ 301 (536)
... .......||+.|+|||++.+..++.++|||||||++|+|++|.+||....... ...... ...+.++..++.
T Consensus 171 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 245 (303)
T 3a7i_A 171 DTQ--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPK---NNPPTLEGNYSK 245 (303)
T ss_dssp TTB--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---SCCCCCCSSCCH
T ss_pred ccc--cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhc---CCCCCCccccCH
Confidence 322 12345679999999999999899999999999999999999999997543222 111111 123345678899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 302 KAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 302 ~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
.+.+||.+||+.||.+|||+.++++||||...
T Consensus 246 ~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 246 PLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 99999999999999999999999999999653
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-47 Score=393.60 Aligned_cols=259 Identities=24% Similarity=0.371 Sum_probs=216.1
Q ss_pred CCCCCceeeeEEcccCceEEEEEE-----EcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEe
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGM-----NLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYL 137 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~-----~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~ 137 (536)
....+|++.+.||+|+||+||+|. +..+++.||||++.. .........+.+|+.+++.++||||++++
T Consensus 68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~-------~~~~~~~~~~~~E~~~l~~l~hpnIv~~~ 140 (367)
T 3l9p_A 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE-------VCSEQDELDFLMEALIISKFNHQNIVRCI 140 (367)
T ss_dssp CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCS-------SCCHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccc-------ccChhhHHHHHHHHHHHHhCCCCCCCeEE
Confidence 445789999999999999999999 445788999998731 11223345678899999999999999999
Q ss_pred eeeecCCceeEEEEecCCCCcccccccC-------CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCC--
Q 009364 138 GTVREEESLNILLEFVPGGSISSLLGKF-------GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKG-- 208 (536)
Q Consensus 138 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~-------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~-- 208 (536)
+++......++||||++||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|
T Consensus 141 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~ 220 (367)
T 3l9p_A 141 GVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPG 220 (367)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTT
T ss_pred EEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCC
Confidence 9999999999999999999999998653 3589999999999999999999999999999999999999655
Q ss_pred -cEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhHH-HHHHHh
Q 009364 209 -CIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQE-VAALFH 285 (536)
Q Consensus 209 -~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~~-~~~~~~ 285 (536)
.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |.+||...... ......
T Consensus 221 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~ 300 (367)
T 3l9p_A 221 RVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 300 (367)
T ss_dssp CCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred ceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 599999999987765444344456678999999999999999999999999999999998 99999765432 222222
Q ss_pred hCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCc
Q 009364 286 IGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVT 331 (536)
Q Consensus 286 ~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~ 331 (536)
. ......+..++..+.+||.+||+.||.+|||+.++++|.|+.
T Consensus 301 ~---~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 301 S---GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp T---TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred c---CCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 2 223345668899999999999999999999999999998764
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=383.36 Aligned_cols=261 Identities=34% Similarity=0.632 Sum_probs=209.7
Q ss_pred CCCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeEeeee
Q 009364 62 MSPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRYLGTV 140 (536)
Q Consensus 62 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~ 140 (536)
.....+|++.+.||+|+||.||+|.+..+|+.||+|++.... .....+.+|+.+++.+ +||||+++++++
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 90 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---------DEEEEIKQEINMLKKYSHHRNIATYYGAF 90 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---------STTHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc---------ccHHHHHHHHHHHHhccCCCCeeeeeeEE
Confidence 356779999999999999999999999999999999884321 1124577899999998 799999999999
Q ss_pred ec------CCceeEEEEecCCCCcccccccC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEE
Q 009364 141 RE------EESLNILLEFVPGGSISSLLGKF--GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKL 212 (536)
Q Consensus 141 ~~------~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL 212 (536)
.. ...+++||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl 170 (326)
T 2x7f_A 91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKL 170 (326)
T ss_dssp EECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEE
T ss_pred eeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEE
Confidence 76 46789999999999999998754 57999999999999999999999999999999999999999999999
Q ss_pred EecCcchhhhhhhcccCCcccCCCCCCCChhhhh-----hcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhC
Q 009364 213 ADFGASKQVAELATVSGAKSMKGTPYWMAPEVIR-----QTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIG 287 (536)
Q Consensus 213 ~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~-----~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~ 287 (536)
+|||++....... .......||+.|+|||++. +..++.++|||||||++|+|++|..||.......... ...
T Consensus 171 ~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-~~~ 247 (326)
T 2x7f_A 171 VDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF-LIP 247 (326)
T ss_dssp CCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-HHH
T ss_pred eeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHH-Hhh
Confidence 9999987664321 1234567999999999987 5678999999999999999999999997543322111 111
Q ss_pred CCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCC
Q 009364 288 TTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDD 334 (536)
Q Consensus 288 ~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~ 334 (536)
........+..++..+++||.+||..||.+|||+.++++||||....
T Consensus 248 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 294 (326)
T 2x7f_A 248 RNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP 294 (326)
T ss_dssp HSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred cCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence 11122233457899999999999999999999999999999998643
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=390.31 Aligned_cols=256 Identities=28% Similarity=0.409 Sum_probs=199.3
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEE 144 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 144 (536)
..+|++.+.||+|+||+||+|.+..+|+.||||++... .......+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 97 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP------FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQK 97 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECT------TSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccc------cCChHHHHHHHHHHHHHHhcCCCCccceEEeecccc
Confidence 35899999999999999999999999999999988431 112234566789999999999999999999997665
Q ss_pred ------ceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcc
Q 009364 145 ------SLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGAS 218 (536)
Q Consensus 145 ------~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla 218 (536)
.+++||||+. |+|.+++. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 98 ~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 98 SLEEFQDVYIVMELMD-ANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp STTTCCEEEEEEECCS-EEHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ccccccceEEEEEcCC-CCHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecc
Confidence 6899999997 46777765 45899999999999999999999999999999999999999999999999999
Q ss_pred hhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHH--HHHHhhCCCC------
Q 009364 219 KQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEV--AALFHIGTTK------ 290 (536)
Q Consensus 219 ~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~--~~~~~~~~~~------ 290 (536)
+...... .....+||+.|+|||++.+..++.++|||||||++|+|++|.+||....... ..+.......
T Consensus 175 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 251 (371)
T 2xrw_A 175 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 251 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHT
T ss_pred ccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 8654321 2345689999999999999999999999999999999999999997543211 1111100000
Q ss_pred -----------CCCC--------------CC------CcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcC
Q 009364 291 -----------SHPP--------------IP------ENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTG 332 (536)
Q Consensus 291 -----------~~~~--------------~~------~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~ 332 (536)
..+. ++ ...+.++++||.+||+.||.+|||+.|+|+||||..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 324 (371)
T 2xrw_A 252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 324 (371)
T ss_dssp TSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred HhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence 0000 00 112678999999999999999999999999999974
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=389.40 Aligned_cols=256 Identities=29% Similarity=0.478 Sum_probs=207.6
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE 143 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 143 (536)
.+.+|++.+.||+|+||+||+|.+..+|+.||+|++... .......+.+.+|+.+++.++||||+++++++...
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 113 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP------FQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPA 113 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECST------TSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEeccc------ccchhHHHHHHHHHHHHHhcCCCCchhhhhheecc
Confidence 346899999999999999999999999999999988421 11223456788999999999999999999999877
Q ss_pred Cce------eEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCc
Q 009364 144 ESL------NILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGA 217 (536)
Q Consensus 144 ~~~------~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGl 217 (536)
... ++||||+. ++|.+++. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 114 ~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 114 SSLRNFYDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp SSSTTCCCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred CCcccceeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCc
Confidence 655 99999996 67877774 3499999999999999999999999999999999999999999999999999
Q ss_pred chhhhhhhcccCCcccCCCCCCCChhhhhh-cCCCccceEechhHHHHHHhhCCCCCchhhHH--HHHHHhhC-------
Q 009364 218 SKQVAELATVSGAKSMKGTPYWMAPEVIRQ-TGHSYSADIWSVGCTVIEMATGKPPWSQQYQE--VAALFHIG------- 287 (536)
Q Consensus 218 a~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~-~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~--~~~~~~~~------- 287 (536)
++..... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...... ...+....
T Consensus 191 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 265 (371)
T 4exu_A 191 ARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF 265 (371)
T ss_dssp C-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred ccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHH
Confidence 9865432 345679999999999987 67899999999999999999999999754311 11111100
Q ss_pred ----------------CCCC---CCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 288 ----------------TTKS---HPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 288 ----------------~~~~---~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
.... ....+..+++++++||.+||+.||.+|||+.|+|+||||...
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 330 (371)
T 4exu_A 266 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 330 (371)
T ss_dssp HTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred HHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence 0000 011234679999999999999999999999999999999754
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=375.42 Aligned_cols=258 Identities=30% Similarity=0.519 Sum_probs=215.0
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeee--c
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVR--E 142 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~--~ 142 (536)
..+|++.+.||+|+||+||+|.+..+|+.||+|++.... ......+.+.+|+.+++.++||||+++++++. .
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 78 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGS------MTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT 78 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTT------CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGG
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEccc------CCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCC
Confidence 458999999999999999999999999999999984321 12234567889999999999999999999874 4
Q ss_pred CCceeEEEEecCCCCcccccccC----CCCCHHHHHHHHHHHHHHHHHHHHcC-----CccccCCCCCcccCCCCcEEEE
Q 009364 143 EESLNILLEFVPGGSISSLLGKF----GPFPEAVMRTYTKQLLLGLEYLHNHG-----IMHRDIKGANILVDNKGCIKLA 213 (536)
Q Consensus 143 ~~~~~lV~E~~~gg~L~~~l~~~----~~l~~~~~~~i~~qil~aL~yLH~~~-----ivHrDLKp~NILl~~~~~vkL~ 213 (536)
...+++||||+++++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+||+++.++.+||+
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~ 158 (279)
T 2w5a_A 79 NTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLG 158 (279)
T ss_dssp GTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEEC
T ss_pred CceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEe
Confidence 66899999999999999998643 34999999999999999999999999 9999999999999999999999
Q ss_pred ecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH-HHHHHhhCCCCCC
Q 009364 214 DFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE-VAALFHIGTTKSH 292 (536)
Q Consensus 214 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~ 292 (536)
|||+++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ........ ..
T Consensus 159 dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~---~~ 233 (279)
T 2w5a_A 159 DFGLARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG---KF 233 (279)
T ss_dssp CCCHHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT---CC
T ss_pred cCchheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhc---cc
Confidence 9999887643211 123456899999999999989999999999999999999999999764322 22222222 23
Q ss_pred CCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 293 PPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 293 ~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
..++..++.++++||.+||+.||.+|||+.|+++|+|+...
T Consensus 234 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 234 RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 35667899999999999999999999999999999999754
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=385.74 Aligned_cols=263 Identities=26% Similarity=0.441 Sum_probs=211.4
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE 142 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 142 (536)
....+|++.+.||+|+||+||+|.+..+|+.||||++.. .........+.+|+.+++.++||||+++++++..
T Consensus 8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-------~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 80 (353)
T 2b9h_A 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP-------FDKPLFALRTLREIKILKHFKHENIITIFNIQRP 80 (353)
T ss_dssp CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC-------CSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCC
T ss_pred ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecc-------cccchHHHHHHHHHHHHHhCcCCCcCCeeeeecc
Confidence 455789999999999999999999999999999998832 1122334567789999999999999999998765
Q ss_pred C-----CceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCc
Q 009364 143 E-----ESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGA 217 (536)
Q Consensus 143 ~-----~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGl 217 (536)
. ...++||||+. |+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 158 (353)
T 2b9h_A 81 DSFENFNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGL 158 (353)
T ss_dssp SCSTTCCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred cccCccceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccc
Confidence 4 67899999996 688888876 5799999999999999999999999999999999999999999999999999
Q ss_pred chhhhhhhcc--------cCCcccCCCCCCCChhhhhh-cCCCccceEechhHHHHHHhhCCCCCchhhHHH--HHHHhh
Q 009364 218 SKQVAELATV--------SGAKSMKGTPYWMAPEVIRQ-TGHSYSADIWSVGCTVIEMATGKPPWSQQYQEV--AALFHI 286 (536)
Q Consensus 218 a~~~~~~~~~--------~~~~~~~Gt~~Y~APEvl~~-~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~--~~~~~~ 286 (536)
++........ ......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||....... ..+...
T Consensus 159 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 238 (353)
T 2b9h_A 159 ARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGI 238 (353)
T ss_dssp CEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred ccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Confidence 9866432111 11234679999999998865 678999999999999999999999997543211 111111
Q ss_pred -CCC---------------------CCCC-----CCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCC
Q 009364 287 -GTT---------------------KSHP-----PIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDD 334 (536)
Q Consensus 287 -~~~---------------------~~~~-----~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~ 334 (536)
+.. ...+ ..+..+++++++||.+||+.||.+|||+.|+++||||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH 313 (353)
T ss_dssp HCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence 000 0000 11247899999999999999999999999999999998643
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=374.59 Aligned_cols=257 Identities=26% Similarity=0.420 Sum_probs=206.4
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec---
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE--- 142 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--- 142 (536)
.+|++.+.||+|+||+||+|++..+|+.||+|++.. .....+.+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 76 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH---------TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRN 76 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE---------EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCC
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec---------cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcc
Confidence 469999999999999999999999999999998832 12334678899999999999999999998754
Q ss_pred ----------CCceeEEEEecCCCCcccccccC-CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEE
Q 009364 143 ----------EESLNILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIK 211 (536)
Q Consensus 143 ----------~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vk 211 (536)
....++||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus 77 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~k 156 (303)
T 1zy4_A 77 FVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVK 156 (303)
T ss_dssp CCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEE
T ss_pred hhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEE
Confidence 45789999999999999999754 3678899999999999999999999999999999999999999999
Q ss_pred EEecCcchhhhhhhc------------ccCCcccCCCCCCCChhhhhhc-CCCccceEechhHHHHHHhhCCCCCchhhH
Q 009364 212 LADFGASKQVAELAT------------VSGAKSMKGTPYWMAPEVIRQT-GHSYSADIWSVGCTVIEMATGKPPWSQQYQ 278 (536)
Q Consensus 212 L~DFGla~~~~~~~~------------~~~~~~~~Gt~~Y~APEvl~~~-~~s~k~DIwSlGvil~eLltG~~Pf~~~~~ 278 (536)
|+|||++........ ........||+.|+|||++.+. .++.++|||||||++|+|++ ||.....
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~ 233 (303)
T 1zy4_A 157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME 233 (303)
T ss_dssp ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH
T ss_pred EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh
Confidence 999999976542210 1123456799999999999864 68999999999999999998 5543222
Q ss_pred --HHHHHHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCC
Q 009364 279 --EVAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDD 334 (536)
Q Consensus 279 --~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~ 334 (536)
..............+.++...+..+++||++||+.||.+|||+.++++||||....
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (303)
T 1zy4_A 234 RVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKH 291 (303)
T ss_dssp HHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCC
T ss_pred HHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCCC
Confidence 22222222333334456667888999999999999999999999999999997543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-47 Score=391.72 Aligned_cols=255 Identities=27% Similarity=0.448 Sum_probs=212.4
Q ss_pred CCCCCceeeeEEcccCceEEEEEE-----EcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeE
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGM-----NLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRY 136 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~-----~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l 136 (536)
.+..+|++++.||+|+||.||+|. +..+++.||||++.. .......+.+.+|+.+++.+ +||||+++
T Consensus 19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~-------~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKE-------GATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECT-------TCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecC-------cCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 345689999999999999999998 456779999998832 12223456788999999999 79999999
Q ss_pred eeeeecCC-ceeEEEEecCCCCcccccccCCC------------------------------------------------
Q 009364 137 LGTVREEE-SLNILLEFVPGGSISSLLGKFGP------------------------------------------------ 167 (536)
Q Consensus 137 ~~~~~~~~-~~~lV~E~~~gg~L~~~l~~~~~------------------------------------------------ 167 (536)
++++...+ .+++|||||+||+|.+++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 99988755 48999999999999999866432
Q ss_pred ------------------CCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhcccC
Q 009364 168 ------------------FPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSG 229 (536)
Q Consensus 168 ------------------l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 229 (536)
+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..........
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 251 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 251 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEE
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchh
Confidence 89999999999999999999999999999999999999999999999999986644333333
Q ss_pred CcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhh--HHHHHHHhhCCCCCCCCCCCcCcHHHHHH
Q 009364 230 AKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQY--QEVAALFHIGTTKSHPPIPENLSVKAKDF 306 (536)
Q Consensus 230 ~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~--~~~~~~~~~~~~~~~~~~~~~~s~~~~dL 306 (536)
.....||+.|+|||++.+..++.++|||||||++|+|++ |.+||.... ......... ......+..+++++.+|
T Consensus 252 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~l 328 (359)
T 3vhe_A 252 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE---GTRMRAPDYTTPEMYQT 328 (359)
T ss_dssp C--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHH---TCCCCCCTTCCHHHHHH
T ss_pred ccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHc---CCCCCCCCCCCHHHHHH
Confidence 445678999999999999999999999999999999998 999997543 222222222 22344567889999999
Q ss_pred HHHhcccCCCCCCCHHHHHhC
Q 009364 307 LLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 307 i~~cL~~dP~~Rps~~eiL~h 327 (536)
|.+||+.||.+|||+.|+++|
T Consensus 329 i~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 329 MLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHccCChhhCCCHHHHHHH
Confidence 999999999999999999987
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=381.88 Aligned_cols=261 Identities=27% Similarity=0.444 Sum_probs=211.4
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCC--CCceeeEeeeee
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS--HPNIVRYLGTVR 141 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~--HpnIv~l~~~~~ 141 (536)
...+|++.+.||+|+||.||+|.+. +|+.||+|++.... ........+.+|+.+++.++ ||||+++++++.
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~ 98 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEE------ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI 98 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSS------CCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEecccc------ccccchHHHHHHHHHHHhccccCCceEEEEEEee
Confidence 4467999999999999999999875 58999999884321 12234567889999999997 599999999999
Q ss_pred cCCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhh
Q 009364 142 EEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQV 221 (536)
Q Consensus 142 ~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~ 221 (536)
.....++||| +.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+++ +.+||+|||+++..
T Consensus 99 ~~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~ 176 (313)
T 3cek_A 99 TDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQM 176 (313)
T ss_dssp CSSEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSSSCC-
T ss_pred cCCEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeeccccccc
Confidence 9999999999 568999999988889999999999999999999999999999999999999964 89999999999876
Q ss_pred hhhhcccCCcccCCCCCCCChhhhhh-----------cCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCC
Q 009364 222 AELATVSGAKSMKGTPYWMAPEVIRQ-----------TGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTK 290 (536)
Q Consensus 222 ~~~~~~~~~~~~~Gt~~Y~APEvl~~-----------~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~ 290 (536)
.............||+.|+|||++.+ ..++.++|||||||++|+|++|..||.................
T Consensus 177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 256 (313)
T 3cek_A 177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 256 (313)
T ss_dssp -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTT
T ss_pred cCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcc
Confidence 54333223345679999999999875 4688999999999999999999999976433332222222333
Q ss_pred CCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 291 SHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 291 ~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
....++...+.++++||.+||+.||.+|||+.++++||||+..
T Consensus 257 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 257 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred cccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence 3445666788999999999999999999999999999999754
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-48 Score=403.05 Aligned_cols=251 Identities=16% Similarity=0.206 Sum_probs=201.6
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHH---HHHHhCCCCceeeEe--
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEV---KLLKDLSHPNIVRYL-- 137 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei---~iL~~l~HpnIv~l~-- 137 (536)
.+..+|++.+.||+|+||+||+|.+..+|+.||||++...... .....+.+.+|+ ++|+.++||||++++
T Consensus 70 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~ 144 (377)
T 3byv_A 70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERP-----PSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLR 144 (377)
T ss_dssp CCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-C-----CTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHC
T ss_pred CCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeecccc-----chHHHHHHHHHHHHHHhccccCCHHHHHHHhh
Confidence 3457899999999999999999999999999999998532111 112346678899 455556899999998
Q ss_pred -----eeeecCC-----------------ceeEEEEecCCCCcccccccCCCCCH-------HHHHHHHHHHHHHHHHHH
Q 009364 138 -----GTVREEE-----------------SLNILLEFVPGGSISSLLGKFGPFPE-------AVMRTYTKQLLLGLEYLH 188 (536)
Q Consensus 138 -----~~~~~~~-----------------~~~lV~E~~~gg~L~~~l~~~~~l~~-------~~~~~i~~qil~aL~yLH 188 (536)
+++.+.+ ..++||||+ +|+|.+++...+.+++ ..++.++.||+.||+|||
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 223 (377)
T 3byv_A 145 FIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH 223 (377)
T ss_dssp BCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 5555443 388999999 6899999976555555 778889999999999999
Q ss_pred HcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhc-----------CCCccceEe
Q 009364 189 NHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQT-----------GHSYSADIW 257 (536)
Q Consensus 189 ~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~-----------~~s~k~DIw 257 (536)
++||+||||||+|||++.++.+||+|||+++.... .....+| +.|+|||++.+. .++.++|||
T Consensus 224 ~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dvw 297 (377)
T 3byv_A 224 HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAW 297 (377)
T ss_dssp HTTEECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHH
T ss_pred hCCeecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHH
Confidence 99999999999999999999999999999985432 2345678 999999999988 899999999
Q ss_pred chhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcC
Q 009364 258 SVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTG 332 (536)
Q Consensus 258 SlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~ 332 (536)
||||++|+|++|..||........ .......+..++.++++||.+||+.||.+|||+.|+++||||..
T Consensus 298 SlG~il~elltg~~Pf~~~~~~~~-------~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 298 ALGLVIYWIWCADLPITKDAALGG-------SEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp HHHHHHHHHHHSSCCC------CC-------SGGGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred HHHHHHHHHHHCCCCCcccccccc-------hhhhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence 999999999999999965432110 00011123578999999999999999999999999999999964
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=375.20 Aligned_cols=260 Identities=25% Similarity=0.469 Sum_probs=211.9
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeee--ecC
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTV--REE 143 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~--~~~ 143 (536)
.+|++++.||+|+||.||+|.+..+++.||+|++...... ........+.+|+.+++.++||||+++++++ .+.
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLR----RIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEK 80 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHH----HSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC--
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEecccccc----ccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Confidence 5899999999999999999999999999999998422110 0112346788999999999999999999998 455
Q ss_pred CceeEEEEecCCCCccccccc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhh
Q 009364 144 ESLNILLEFVPGGSISSLLGK--FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQV 221 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~~--~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~ 221 (536)
...++||||+.++ |.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 81 ~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 81 QKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp -CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred CeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence 6899999999877 6666543 457999999999999999999999999999999999999999999999999999766
Q ss_pred hhhhcccCCcccCCCCCCCChhhhhhcCC--CccceEechhHHHHHHhhCCCCCchhhH-HHHHHHhhCCCCCCCCCCCc
Q 009364 222 AELATVSGAKSMKGTPYWMAPEVIRQTGH--SYSADIWSVGCTVIEMATGKPPWSQQYQ-EVAALFHIGTTKSHPPIPEN 298 (536)
Q Consensus 222 ~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~--s~k~DIwSlGvil~eLltG~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~ 298 (536)
.............||+.|+|||++.+... +.++|||||||++|+|++|..||..... ......... ...++..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~----~~~~~~~ 235 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG----SYAIPGD 235 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC----CCCCCSS
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcC----CCCCCCc
Confidence 43222222345679999999999986443 7899999999999999999999975432 222222222 2345678
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCC
Q 009364 299 LSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDD 334 (536)
Q Consensus 299 ~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~ 334 (536)
++..+.+||.+||..||.+|||+.|+++||||+...
T Consensus 236 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 271 (305)
T 2wtk_C 236 CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKH 271 (305)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCC
T ss_pred cCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCC
Confidence 899999999999999999999999999999998654
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=381.32 Aligned_cols=255 Identities=29% Similarity=0.486 Sum_probs=208.1
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEE 144 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 144 (536)
+.+|.+.+.||+|+||+||+|.+..+|+.||||++... .......+.+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 96 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP------FQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPAS 96 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESST------TSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEeccc------ccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccc
Confidence 46899999999999999999999999999999988421 112234567789999999999999999999998765
Q ss_pred c------eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcc
Q 009364 145 S------LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGAS 218 (536)
Q Consensus 145 ~------~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla 218 (536)
. +++||||+. ++|.+++.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 97 ~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 97 SLRNFYDFYLVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp SGGGCCCCEEEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred ccccceeEEEEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccc
Confidence 4 499999996 688888753 5999999999999999999999999999999999999999999999999999
Q ss_pred hhhhhhhcccCCcccCCCCCCCChhhhhh-cCCCccceEechhHHHHHHhhCCCCCchhhHH--HHHHHhh---------
Q 009364 219 KQVAELATVSGAKSMKGTPYWMAPEVIRQ-TGHSYSADIWSVGCTVIEMATGKPPWSQQYQE--VAALFHI--------- 286 (536)
Q Consensus 219 ~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~-~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~--~~~~~~~--------- 286 (536)
+..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...... ...+...
T Consensus 174 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 248 (353)
T 3coi_A 174 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV 248 (353)
T ss_dssp TC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHH
T ss_pred cCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 765432 345679999999999987 67899999999999999999999999754311 1111110
Q ss_pred -----------------CCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 287 -----------------GTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 287 -----------------~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
............+++++++||.+||+.||.+|||+.++++||||...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 312 (353)
T 3coi_A 249 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312 (353)
T ss_dssp TTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred HHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 00111223445789999999999999999999999999999999753
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=397.39 Aligned_cols=252 Identities=31% Similarity=0.507 Sum_probs=202.2
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC-
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE- 143 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~- 143 (536)
..+|++.+.||+|+||+||+|++..+|+.||||++.... ....+|+++|+.++||||+++++++...
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~il~~l~hpniv~l~~~~~~~~ 120 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------------RFKNRELQIMRKLDHCNIVRLRYFFYSSG 120 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT------------TSCCHHHHHHHTCCCTTBCCEEEEEEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc------------hhHHHHHHHHHHcCCCCccceeeEEeccC
Confidence 357999999999999999999999999999999884321 1123689999999999999999988532
Q ss_pred -----CceeEEEEecCCCCcccccc----cCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCC-CcEEEE
Q 009364 144 -----ESLNILLEFVPGGSISSLLG----KFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNK-GCIKLA 213 (536)
Q Consensus 144 -----~~~~lV~E~~~gg~L~~~l~----~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~-~~vkL~ 213 (536)
..+++||||+++ +|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+
T Consensus 121 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~ 199 (420)
T 1j1b_A 121 EKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLC 199 (420)
T ss_dssp TTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEEC
T ss_pred CCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEec
Confidence 236799999975 5554443 35679999999999999999999999999999999999999965 578999
Q ss_pred ecCcchhhhhhhcccCCcccCCCCCCCChhhhhhc-CCCccceEechhHHHHHHhhCCCCCchhhH--HHHHHHhh----
Q 009364 214 DFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQT-GHSYSADIWSVGCTVIEMATGKPPWSQQYQ--EVAALFHI---- 286 (536)
Q Consensus 214 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~-~~s~k~DIwSlGvil~eLltG~~Pf~~~~~--~~~~~~~~---- 286 (536)
|||+++.+.... .....+||+.|+|||++.+. .++.++||||||||+|||++|++||..... ....+...
T Consensus 200 DFG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p 276 (420)
T 1j1b_A 200 DFGSAKQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 276 (420)
T ss_dssp CCTTCEECCTTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSC
T ss_pred cchhhhhcccCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 999998654322 23456899999999999765 789999999999999999999999975431 11222111
Q ss_pred --------CCC---CCCCC---------CCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcC
Q 009364 287 --------GTT---KSHPP---------IPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTG 332 (536)
Q Consensus 287 --------~~~---~~~~~---------~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~ 332 (536)
... ...+. ++..++.++++||.+||+.||.+|||+.|+++||||..
T Consensus 277 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~ 342 (420)
T 1j1b_A 277 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE 342 (420)
T ss_dssp CHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGG
T ss_pred CHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcc
Confidence 000 00010 23467899999999999999999999999999999964
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=383.19 Aligned_cols=255 Identities=25% Similarity=0.414 Sum_probs=215.0
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEc-----CCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEe
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNL-----DSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYL 137 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~ 137 (536)
....+|++.+.||+|+||.||+|.+. .+++.||+|++.. .......+.+.+|+.+++.++||||++++
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~-------~~~~~~~~~~~~E~~~l~~l~hp~iv~~~ 116 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKE-------EASADMQADFQREAALMAEFDNPNIVKLL 116 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCT-------TCCHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecc-------ccCHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence 44578999999999999999999987 4568999998732 11233456788999999999999999999
Q ss_pred eeeecCCceeEEEEecCCCCcccccccC------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCc
Q 009364 138 GTVREEESLNILLEFVPGGSISSLLGKF------------------------GPFPEAVMRTYTKQLLLGLEYLHNHGIM 193 (536)
Q Consensus 138 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~------------------------~~l~~~~~~~i~~qil~aL~yLH~~~iv 193 (536)
+++.+.+..++||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+
T Consensus 117 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iv 196 (343)
T 1luf_A 117 GVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFV 196 (343)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 9999999999999999999999998653 5689999999999999999999999999
Q ss_pred cccCCCCCcccCCCCcEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCC
Q 009364 194 HRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPP 272 (536)
Q Consensus 194 HrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~P 272 (536)
||||||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus 197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 276 (343)
T 1luf_A 197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276 (343)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred cCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCc
Confidence 999999999999999999999999987654433333445678999999999999999999999999999999999 9999
Q ss_pred CchhhHH-HHHHHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 273 WSQQYQE-VAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 273 f~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
|...... ....... ......+..++.++.+||++||+.||.+|||+.+++++
T Consensus 277 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 277 YYGMAHEEVIYYVRD---GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp TTTSCHHHHHHHHHT---TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCChHHHHHHHhC---CCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 9765332 2222222 22334567899999999999999999999999999875
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=378.49 Aligned_cols=255 Identities=25% Similarity=0.442 Sum_probs=215.6
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEc-----CCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEe
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNL-----DSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYL 137 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~ 137 (536)
....+|++.+.||+|+||.||+|.+. .+++.||+|++.. .......+.+.+|+.+++.++||||++++
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~-------~~~~~~~~~~~~E~~~l~~l~hp~iv~~~ 92 (314)
T 2ivs_A 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKE-------NASPSELRDLLSEFNVLKQVNHPHVIKLY 92 (314)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCT-------TCCHHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccC-------CCCHHHHHHHHHHHHHHhhCCCCceeeEE
Confidence 34568999999999999999999983 4568999998732 12234456788999999999999999999
Q ss_pred eeeecCCceeEEEEecCCCCcccccccCCC------------------------CCHHHHHHHHHHHHHHHHHHHHcCCc
Q 009364 138 GTVREEESLNILLEFVPGGSISSLLGKFGP------------------------FPEAVMRTYTKQLLLGLEYLHNHGIM 193 (536)
Q Consensus 138 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~------------------------l~~~~~~~i~~qil~aL~yLH~~~iv 193 (536)
+++...+..++||||+++|+|.+++..... +++..++.++.||+.||.|||++||+
T Consensus 93 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iv 172 (314)
T 2ivs_A 93 GACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLV 172 (314)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred EEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCc
Confidence 999999999999999999999999876433 89999999999999999999999999
Q ss_pred cccCCCCCcccCCCCcEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCC
Q 009364 194 HRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPP 272 (536)
Q Consensus 194 HrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~P 272 (536)
||||||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus 173 H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 252 (314)
T 2ivs_A 173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252 (314)
T ss_dssp CCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred ccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999987654333333445668899999999999889999999999999999999 9999
Q ss_pred CchhhH-HHHHHHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 273 WSQQYQ-EVAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 273 f~~~~~-~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
|..... ........ ......+..++.++.+||.+||+.||.+|||+.+++++
T Consensus 253 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 253 YPGIPPERLFNLLKT---GHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp STTCCGGGHHHHHHT---TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCHHHHHHHhhc---CCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 975432 22222222 22344567899999999999999999999999999876
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=383.38 Aligned_cols=264 Identities=25% Similarity=0.394 Sum_probs=214.3
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchh---------HHHHHHHHHHHHHHHHHhCCCCceee
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKE---------KAQDHIKELEEEVKLLKDLSHPNIVR 135 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~---------~~~~~~~~~~~Ei~iL~~l~HpnIv~ 135 (536)
..+|++.+.||+|+||.||+|.+ +|+.||+|++.......... ......+.+.+|+.+++.++||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 35899999999999999999998 89999999984322111000 00011256889999999999999999
Q ss_pred EeeeeecCCceeEEEEecCCCCcccc------ccc--CCCCCHHHHHHHHHHHHHHHHHHHH-cCCccccCCCCCcccCC
Q 009364 136 YLGTVREEESLNILLEFVPGGSISSL------LGK--FGPFPEAVMRTYTKQLLLGLEYLHN-HGIMHRDIKGANILVDN 206 (536)
Q Consensus 136 l~~~~~~~~~~~lV~E~~~gg~L~~~------l~~--~~~l~~~~~~~i~~qil~aL~yLH~-~~ivHrDLKp~NILl~~ 206 (536)
+++++.+.+..++||||+++|+|.++ +.. ...+++..++.++.||+.||.|||+ +||+||||||+||+++.
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~ 187 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDK 187 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECT
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcC
Confidence 99999999999999999999999998 665 5789999999999999999999999 99999999999999999
Q ss_pred CCcEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhc-CCCc-cceEechhHHHHHHhhCCCCCchhhH--HHHH
Q 009364 207 KGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQT-GHSY-SADIWSVGCTVIEMATGKPPWSQQYQ--EVAA 282 (536)
Q Consensus 207 ~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~-~~s~-k~DIwSlGvil~eLltG~~Pf~~~~~--~~~~ 282 (536)
++.+||+|||++...... ......||+.|+|||++.+. .++. ++|||||||++|+|++|..||..... ....
T Consensus 188 ~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 263 (348)
T 2pml_X 188 NGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFN 263 (348)
T ss_dssp TSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHH
T ss_pred CCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Confidence 999999999999765432 23456799999999999877 5666 99999999999999999999975432 2222
Q ss_pred HHhhCCCCCCCC---------------CCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCC
Q 009364 283 LFHIGTTKSHPP---------------IPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDD 334 (536)
Q Consensus 283 ~~~~~~~~~~~~---------------~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~ 334 (536)
............ ....++.++.+||.+||+.||.+|||+.|+++||||....
T Consensus 264 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~ 330 (348)
T 2pml_X 264 NIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN 330 (348)
T ss_dssp HHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred HHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence 222211111100 1157899999999999999999999999999999998643
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=392.33 Aligned_cols=252 Identities=27% Similarity=0.449 Sum_probs=204.8
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCC--------CCceeeE
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS--------HPNIVRY 136 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~--------HpnIv~l 136 (536)
..+|++.+.||+|+||+||+|++..+|+.||||++... ....+.+.+|+.+++.++ |+||+++
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---------~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~ 106 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---------EHYTETALDEIRLLKSVRNSDPNDPNREMVVQL 106 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---------HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---------CcchHHHHHHHHHHHHHhhcCCCCCCcceeeee
Confidence 46899999999999999999999999999999998311 223456778999998885 7889999
Q ss_pred eeeee----cCCceeEEEEecCCCCcccccccC--CCCCHHHHHHHHHHHHHHHHHHHHc-CCccccCCCCCcccCCCC-
Q 009364 137 LGTVR----EEESLNILLEFVPGGSISSLLGKF--GPFPEAVMRTYTKQLLLGLEYLHNH-GIMHRDIKGANILVDNKG- 208 (536)
Q Consensus 137 ~~~~~----~~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~-~ivHrDLKp~NILl~~~~- 208 (536)
++++. ....+++||||+ +++|.+.+... ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 107 ~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~ 185 (397)
T 1wak_A 107 LDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQ 185 (397)
T ss_dssp EEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHH
T ss_pred ecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccch
Confidence 99987 566899999999 56665555433 5699999999999999999999998 999999999999998775
Q ss_pred ------------------------------------------------cEEEEecCcchhhhhhhcccCCcccCCCCCCC
Q 009364 209 ------------------------------------------------CIKLADFGASKQVAELATVSGAKSMKGTPYWM 240 (536)
Q Consensus 209 ------------------------------------------------~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~ 240 (536)
.+||+|||+++.... .....+||+.|+
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~-----~~~~~~gt~~y~ 260 (397)
T 1wak_A 186 YIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK-----HFTEDIQTRQYR 260 (397)
T ss_dssp HHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB-----CSCSCCSCGGGC
T ss_pred hhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc-----cCccCCCCCccc
Confidence 799999999976543 234567999999
Q ss_pred ChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhh--------HHHHHHHhh-CCCC---------------------
Q 009364 241 APEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQY--------QEVAALFHI-GTTK--------------------- 290 (536)
Q Consensus 241 APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~--------~~~~~~~~~-~~~~--------------------- 290 (536)
|||++.+..++.++|||||||++|+|++|.+||.... .....+... +...
T Consensus 261 aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 340 (397)
T 1wak_A 261 SLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLK 340 (397)
T ss_dssp CHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBS
T ss_pred CChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccc
Confidence 9999999999999999999999999999999996321 111111110 0000
Q ss_pred ---------------CCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCc
Q 009364 291 ---------------SHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVT 331 (536)
Q Consensus 291 ---------------~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~ 331 (536)
....++...+..+++||.+||+.||.+|||+.|+|+||||+
T Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 396 (397)
T 1wak_A 341 HITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396 (397)
T ss_dssp SCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred cccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence 00122345567899999999999999999999999999996
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-46 Score=380.18 Aligned_cols=255 Identities=25% Similarity=0.422 Sum_probs=211.3
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCCc---EEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeee
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGE---LLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGT 139 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~---~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~ 139 (536)
....+|++.+.||+|+||+||+|.+..+|+ .||||++.. .......+.+.+|+.+++.++||||++++++
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~-------~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 118 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKA-------GYTERQRRDFLSEASIMGQFDHPNIIRLEGV 118 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECT-------TCCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCC-------CCCHHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 345689999999999999999999986555 599998832 1123345678899999999999999999999
Q ss_pred eecCCceeEEEEecCCCCcccccccC-CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcc
Q 009364 140 VREEESLNILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGAS 218 (536)
Q Consensus 140 ~~~~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla 218 (536)
+.+.+..++||||++||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 198 (325)
T 3kul_A 119 VTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLS 198 (325)
T ss_dssp ECGGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSC
T ss_pred EEeCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcc
Confidence 99999999999999999999999654 67999999999999999999999999999999999999999999999999999
Q ss_pred hhhhhhhcc-cCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhHH-HHHHHhhCCCCCCCCC
Q 009364 219 KQVAELATV-SGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQE-VAALFHIGTTKSHPPI 295 (536)
Q Consensus 219 ~~~~~~~~~-~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~~-~~~~~~~~~~~~~~~~ 295 (536)
+........ .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||...... ....... ....+.
T Consensus 199 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~---~~~~~~ 275 (325)
T 3kul_A 199 RVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEE---GYRLPA 275 (325)
T ss_dssp EECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHT---TCCCCC
T ss_pred cccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc---CCCCCC
Confidence 876542211 11233456888999999999899999999999999999999 99999754332 2222221 233456
Q ss_pred CCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 296 PENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 296 ~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
+..++..+.+||.+||..||.+|||+.++++.
T Consensus 276 ~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~ 307 (325)
T 3kul_A 276 PMGCPHALHQLMLDCWHKDRAQRPRFSQIVSV 307 (325)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCcCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 67899999999999999999999999999874
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=380.24 Aligned_cols=253 Identities=28% Similarity=0.409 Sum_probs=207.5
Q ss_pred CCCceeeeEEcccCceEEEEEEE-cCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCC------ceeeEe
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMN-LDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHP------NIVRYL 137 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~-~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hp------nIv~l~ 137 (536)
..+|++.+.||+|+||+||+|.+ ..+|+.||+|++.. .....+.+.+|+.+++.++|+ +|++++
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~---------~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~ 83 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN---------VDRYCEAARSEIQVLEHLNTTDPNSTFRCVQML 83 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS---------SHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEec---------CCchhHHHHHHHHHHHHhhhcCCCCceeeEeee
Confidence 45899999999999999999998 56889999998831 112345677888888888655 499999
Q ss_pred eeeecCCceeEEEEecCCCCcccccccCC--CCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCC---------
Q 009364 138 GTVREEESLNILLEFVPGGSISSLLGKFG--PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDN--------- 206 (536)
Q Consensus 138 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~--------- 206 (536)
+++...+.+++||||+ +++|.+++...+ ++++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 84 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~ 162 (339)
T 1z57_A 84 EWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNP 162 (339)
T ss_dssp EEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC-
T ss_pred cccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCC
Confidence 9999999999999999 899999987654 6899999999999999999999999999999999999987
Q ss_pred ----------CCcEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchh
Q 009364 207 ----------KGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQ 276 (536)
Q Consensus 207 ----------~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~ 276 (536)
++.+||+|||+++.... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 237 (339)
T 1z57_A 163 KIKRDERTLINPDIKVVDFGSATYDDE-----HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTH 237 (339)
T ss_dssp ---CEEEEESCCCEEECCCSSCEETTS-----CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccCCCceEeeCcccccCcc-----ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 66899999999876432 234568999999999999999999999999999999999999999654
Q ss_pred hHHH-HH-HHhhCCC---------------------------------------CCCCCCCCcCcHHHHHHHHHhcccCC
Q 009364 277 YQEV-AA-LFHIGTT---------------------------------------KSHPPIPENLSVKAKDFLLKCLEKEP 315 (536)
Q Consensus 277 ~~~~-~~-~~~~~~~---------------------------------------~~~~~~~~~~s~~~~dLi~~cL~~dP 315 (536)
.... .. +...... ......+...+.++.+||.+||+.||
T Consensus 238 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 317 (339)
T 1z57_A 238 DSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDP 317 (339)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred ChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCc
Confidence 3211 11 1100000 00011123456789999999999999
Q ss_pred CCCCCHHHHHhCCCCcC
Q 009364 316 DLRPTASELLKHPFVTG 332 (536)
Q Consensus 316 ~~Rps~~eiL~hp~~~~ 332 (536)
.+|||+.|+++||||..
T Consensus 318 ~~Rpt~~ell~hp~f~~ 334 (339)
T 1z57_A 318 AKRITLREALKHPFFDL 334 (339)
T ss_dssp TTSCCHHHHTTSGGGGG
T ss_pred ccccCHHHHhcCHHHHH
Confidence 99999999999999974
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=377.64 Aligned_cols=260 Identities=27% Similarity=0.487 Sum_probs=204.2
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeee---
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVR--- 141 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~--- 141 (536)
..+|++.+.||+|+||+||+|.+..+|+.||+|++... .....+.+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 81 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--------DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSG 81 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--------SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTS
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--------ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccc
Confidence 46899999999999999999999999999999988421 1234567889999999999999999999873
Q ss_pred -----------cCCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccC-CCCc
Q 009364 142 -----------EEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVD-NKGC 209 (536)
Q Consensus 142 -----------~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~-~~~~ 209 (536)
.....++||||+. |+|.+++.+ +++++..++.++.||+.||+|||++||+||||||+|||++ .++.
T Consensus 82 ~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~ 159 (320)
T 2i6l_A 82 SQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLV 159 (320)
T ss_dssp CBCCC----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTE
T ss_pred cccccccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCe
Confidence 3467899999997 699998865 6799999999999999999999999999999999999997 5679
Q ss_pred EEEEecCcchhhhhhhc-ccCCcccCCCCCCCChhhhhh-cCCCccceEechhHHHHHHhhCCCCCchhhHH--HHHHHh
Q 009364 210 IKLADFGASKQVAELAT-VSGAKSMKGTPYWMAPEVIRQ-TGHSYSADIWSVGCTVIEMATGKPPWSQQYQE--VAALFH 285 (536)
Q Consensus 210 vkL~DFGla~~~~~~~~-~~~~~~~~Gt~~Y~APEvl~~-~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~--~~~~~~ 285 (536)
+||+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||...... ...+..
T Consensus 160 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 239 (320)
T 2i6l_A 160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILE 239 (320)
T ss_dssp EEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred EEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 99999999987643211 112344568999999999875 67899999999999999999999999754321 111111
Q ss_pred hCC----------------------CCCC---CCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCC
Q 009364 286 IGT----------------------TKSH---PPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDD 334 (536)
Q Consensus 286 ~~~----------------------~~~~---~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~ 334 (536)
... .... ...+..++.++++||++||+.||.+|||+.|+|+||||+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (320)
T 2i6l_A 240 SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYS 313 (320)
T ss_dssp HSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTC
T ss_pred hcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccccc
Confidence 100 0000 012346899999999999999999999999999999998643
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=375.92 Aligned_cols=258 Identities=31% Similarity=0.485 Sum_probs=215.6
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
.+|++.+.||+|+||+||+|.+..+++.||+|++...... ......+.+|+.+++.++||||+++++++.....
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 95 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK------NKDTSTILREVELLKKLDHPNIMKLFEILEDSSS 95 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS------SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc------hHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCe
Confidence 3799999999999999999999999999999998432211 1123567889999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCC---CcEEEEecCcchhhh
Q 009364 146 LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNK---GCIKLADFGASKQVA 222 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~---~~vkL~DFGla~~~~ 222 (536)
+++||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.+ +.+||+|||++....
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 99999999999999998877889999999999999999999999999999999999999764 479999999987654
Q ss_pred hhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhH-HHHHHHhhCCCCCCCCCCCcCcH
Q 009364 223 ELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQ-EVAALFHIGTTKSHPPIPENLSV 301 (536)
Q Consensus 223 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~s~ 301 (536)
... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||..... ...............+....++.
T Consensus 176 ~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (287)
T 2wei_A 176 QNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISD 251 (287)
T ss_dssp CCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCH
T ss_pred CCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCH
Confidence 321 2234568999999999876 489999999999999999999999975432 22222222322222223357899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 302 KAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 302 ~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
++++||.+||..||.+|||+.++++||||+..
T Consensus 252 ~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 252 DAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred HHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 99999999999999999999999999999753
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-46 Score=373.52 Aligned_cols=256 Identities=27% Similarity=0.483 Sum_probs=208.0
Q ss_pred CCCCceeeeEEcccCceEEEEEE----EcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeee
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGM----NLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGT 139 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~----~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~ 139 (536)
...+|++.+.||+|+||+||+|+ +..+|+.||+|++.. ......+.+.+|+.+++.++||||++++++
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~--------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 79 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH--------STEEHLRDFEREIEILKSLQHDNIVKYKGV 79 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESC--------CCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEccc--------CCHHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 44689999999999999999998 567899999998832 123345678899999999999999999999
Q ss_pred eec--CCceeEEEEecCCCCcccccccCC-CCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecC
Q 009364 140 VRE--EESLNILLEFVPGGSISSLLGKFG-PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFG 216 (536)
Q Consensus 140 ~~~--~~~~~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFG 216 (536)
+.. ...+++||||+++|+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 80 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg 159 (295)
T 3ugc_A 80 CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG 159 (295)
T ss_dssp ECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred EecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCc
Confidence 864 456899999999999999997654 59999999999999999999999999999999999999999999999999
Q ss_pred cchhhhhhhcc-cCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHH-------------
Q 009364 217 ASKQVAELATV-SGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAA------------- 282 (536)
Q Consensus 217 la~~~~~~~~~-~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~------------- 282 (536)
+++........ .......||+.|+|||++.+..++.++|||||||++|+|++|..||.........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T 3ugc_A 160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 239 (295)
T ss_dssp SCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHH
T ss_pred ccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHH
Confidence 99876543221 1223445788899999999999999999999999999999999998654332211
Q ss_pred -HHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 283 -LFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 283 -~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
...........+.+..++.++.+||.+||+.||.+|||+.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~ 285 (295)
T 3ugc_A 240 HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR 285 (295)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 111111223445677899999999999999999999999999863
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-46 Score=367.28 Aligned_cols=250 Identities=26% Similarity=0.439 Sum_probs=211.6
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE 143 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 143 (536)
.+.+|++.+.||+|+||+||+|.+. +++.||+|++..... ..+.+.+|+.++++++||||+++++++.+.
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 77 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM---------SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 77 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB---------CHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred ChhhceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc---------CHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 4568999999999999999999986 577899998842110 124578899999999999999999999999
Q ss_pred CceeEEEEecCCCCccccccc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhh
Q 009364 144 ESLNILLEFVPGGSISSLLGK-FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVA 222 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~ 222 (536)
...++||||+++++|.+++.. .+.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++...
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 157 (269)
T 4hcu_A 78 APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL 157 (269)
T ss_dssp SSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBC
T ss_pred CceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccc
Confidence 999999999999999999865 4568999999999999999999999999999999999999999999999999998665
Q ss_pred hhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhHHH-HHHHhhCCCCCCCCCCCcCc
Q 009364 223 ELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQEV-AALFHIGTTKSHPPIPENLS 300 (536)
Q Consensus 223 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~s 300 (536)
.... .......||+.|+|||++.+..++.++|||||||++|+|++ |.+||....... ...... ......+..++
T Consensus 158 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~ 233 (269)
T 4hcu_A 158 DDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST---GFRLYKPRLAS 233 (269)
T ss_dssp CHHH-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT---TCCCCCCTTSC
T ss_pred cccc-ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc---CccCCCCCcCC
Confidence 4322 22345567889999999999999999999999999999999 999997654322 222211 22334556789
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 301 VKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 301 ~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
.++.+||.+||+.||.+|||+.++++|
T Consensus 234 ~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 234 THVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 999999999999999999999999986
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-47 Score=393.63 Aligned_cols=257 Identities=16% Similarity=0.163 Sum_probs=192.6
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC--CCCceeeEe-----
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL--SHPNIVRYL----- 137 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l--~HpnIv~l~----- 137 (536)
+.+|++.+.||+|+||+||+|.+..+|+.||+|++.... .......+.+.+|+.+++.+ +||||++++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~ 135 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGA-----ENSRSELERLHEATFAAARLLGESPEEARDRRRLLL 135 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCS-----TTHHHHHHHHHHHHHHHHHHHC----------CBCC
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecc-----cccccHHHHHHHHHHHHHHhcccChhhhhhceeEEe
Confidence 446999999999999999999999999999999985321 11233445677775444444 699988755
Q ss_pred --eeeecC-----------------CceeEEEEecCCCCcccccccC-CCCCHHHH------HHHHHHHHHHHHHHHHcC
Q 009364 138 --GTVREE-----------------ESLNILLEFVPGGSISSLLGKF-GPFPEAVM------RTYTKQLLLGLEYLHNHG 191 (536)
Q Consensus 138 --~~~~~~-----------------~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~------~~i~~qil~aL~yLH~~~ 191 (536)
+++... ..+++||||++ |+|.+++... ..+++..+ ..++.||+.||+|||++|
T Consensus 136 p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ 214 (371)
T 3q60_A 136 PSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG 214 (371)
T ss_dssp CCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred eehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC
Confidence 444332 33899999998 8999998763 23444444 577799999999999999
Q ss_pred CccccCCCCCcccCCCCcEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhh--cCCCccceEechhHHHHHHhhC
Q 009364 192 IMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQ--TGHSYSADIWSVGCTVIEMATG 269 (536)
Q Consensus 192 ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~--~~~s~k~DIwSlGvil~eLltG 269 (536)
|+||||||+|||++.+|.+||+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 999999999999999999999999999866432 114457799999999987 7899999999999999999999
Q ss_pred CCCCchhhHHHHHHHh------hCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcC
Q 009364 270 KPPWSQQYQEVAALFH------IGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTG 332 (536)
Q Consensus 270 ~~Pf~~~~~~~~~~~~------~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~ 332 (536)
.+||............ ........+.+..++..+++||.+||+.||++|||+.++|+||||..
T Consensus 290 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 358 (371)
T 3q60_A 290 FLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358 (371)
T ss_dssp SCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred CCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence 9999765322111100 01111222233588999999999999999999999999999999964
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-46 Score=383.19 Aligned_cols=266 Identities=22% Similarity=0.376 Sum_probs=202.7
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccc---hhHHHHHHHHHHHHHHHHHhCCCCceeeEeeee
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFAS---KEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTV 140 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~---~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~ 140 (536)
...+|++.+.||+|+||.||+|.+.. |+.||||++........ ........+.+.+|+.+++.++||||+++++++
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 98 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF 98 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred hccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence 34689999999999999999999755 99999998853221111 112234457788999999999999999999998
Q ss_pred ec-----CCceeEEEEecCCCCccccccc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEe
Q 009364 141 RE-----EESLNILLEFVPGGSISSLLGK-FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLAD 214 (536)
Q Consensus 141 ~~-----~~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~D 214 (536)
.. ...+++||||+. |+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 99 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~D 177 (362)
T 3pg1_A 99 VHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICD 177 (362)
T ss_dssp EECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred EeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEe
Confidence 43 346899999997 566666654 45799999999999999999999999999999999999999999999999
Q ss_pred cCcchhhhhhhcccCCcccCCCCCCCChhhhhh-cCCCccceEechhHHHHHHhhCCCCCchhhHH--HHHHHhhC----
Q 009364 215 FGASKQVAELATVSGAKSMKGTPYWMAPEVIRQ-TGHSYSADIWSVGCTVIEMATGKPPWSQQYQE--VAALFHIG---- 287 (536)
Q Consensus 215 FGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~-~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~--~~~~~~~~---- 287 (536)
||+++...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...... ...+....
T Consensus 178 fg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 254 (362)
T 3pg1_A 178 FNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPK 254 (362)
T ss_dssp TTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred cCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 99997544322 2345679999999999987 67899999999999999999999999754311 11111100
Q ss_pred -----------------C-CCC-----CCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCC
Q 009364 288 -----------------T-TKS-----HPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDD 334 (536)
Q Consensus 288 -----------------~-~~~-----~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~ 334 (536)
. ... ....+..+++.+.+||.+||+.||.+|||+.|+++||||+...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 324 (362)
T 3pg1_A 255 IEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF 324 (362)
T ss_dssp HHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhcc
Confidence 0 000 0012346788999999999999999999999999999998653
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=376.17 Aligned_cols=262 Identities=31% Similarity=0.516 Sum_probs=209.8
Q ss_pred CCCCceeeeEEcccCceEEEEEEEc-CCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC---CCCceeeEeee
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNL-DSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL---SHPNIVRYLGT 139 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~-~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l---~HpnIv~l~~~ 139 (536)
...+|++.+.||+|+||+||+|.+. .+|+.||+|++........ ....+.+|+.+++.+ +||||++++++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~e~~~l~~l~~~~h~~i~~~~~~ 82 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG------MPLSTIREVAVLRHLETFEHPNVVRLFDV 82 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS------CBCTHHHHHHHHHHHHHTCCTTBCCEEEE
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccccc------CCchhhHHHHHHHhhhccCCCCeEeeeee
Confidence 3468999999999999999999995 6789999998854321110 011234566666555 89999999999
Q ss_pred ee-----cCCceeEEEEecCCCCcccccccC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEE
Q 009364 140 VR-----EEESLNILLEFVPGGSISSLLGKF--GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKL 212 (536)
Q Consensus 140 ~~-----~~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL 212 (536)
+. .....++||||+. |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl 161 (326)
T 1blx_A 83 CTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKL 161 (326)
T ss_dssp EEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEE
T ss_pred eeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEE
Confidence 87 5677999999997 6999988654 34999999999999999999999999999999999999999999999
Q ss_pred EecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH--HHHHHhhCCC-
Q 009364 213 ADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE--VAALFHIGTT- 289 (536)
Q Consensus 213 ~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~--~~~~~~~~~~- 289 (536)
+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||...... ...+......
T Consensus 162 ~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 238 (326)
T 1blx_A 162 ADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 238 (326)
T ss_dssp CSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ecCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 9999998665322 234567999999999999999999999999999999999999999754322 1122111000
Q ss_pred ---------------------CCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCCC
Q 009364 290 ---------------------KSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDE 335 (536)
Q Consensus 290 ---------------------~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~~ 335 (536)
.....+...++..+++||.+||+.||.+|||+.++++||||+....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 305 (326)
T 1blx_A 239 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 305 (326)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred CcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence 0011233578999999999999999999999999999999986543
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=386.44 Aligned_cols=255 Identities=25% Similarity=0.440 Sum_probs=215.5
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcC-------CCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCcee
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLD-------SGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIV 134 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~-------~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv 134 (536)
....+|++++.||+|+||+||+|.+.. .+..||+|++.. .........+.+|+++++.+ +||||+
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~-------~~~~~~~~~~~~E~~~l~~l~~hpnIv 138 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS-------DATEKDLSDLISEMEMMKMIGKHKNII 138 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECT-------TCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecc-------ccCHHHHHHHHHHHHHHHHhcCCchhh
Confidence 345689999999999999999999754 336899998832 12234456788999999999 899999
Q ss_pred eEeeeeecCCceeEEEEecCCCCcccccccCC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCccccCC
Q 009364 135 RYLGTVREEESLNILLEFVPGGSISSLLGKFG----------------PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIK 198 (536)
Q Consensus 135 ~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~----------------~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLK 198 (536)
++++++...+..++||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+|||||
T Consensus 139 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlk 218 (382)
T 3tt0_A 139 NLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLA 218 (382)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred hheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCC
Confidence 99999999999999999999999999987543 49999999999999999999999999999999
Q ss_pred CCCcccCCCCcEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhh
Q 009364 199 GANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQY 277 (536)
Q Consensus 199 p~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~ 277 (536)
|+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus 219 p~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~ 298 (382)
T 3tt0_A 219 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 298 (382)
T ss_dssp GGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999987654333333445668899999999999999999999999999999999 999997643
Q ss_pred H-HHHHHHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 278 Q-EVAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 278 ~-~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
. +....... ......+..++.++.+||.+||+.||.+|||+.|++++
T Consensus 299 ~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 299 VEELFKLLKE---GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHHHHHHT---TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHc---CCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2 22222222 22344567899999999999999999999999999986
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=395.23 Aligned_cols=257 Identities=24% Similarity=0.418 Sum_probs=188.6
Q ss_pred Ccee-eeEEcccCceEEEEEEEc--CCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeee--
Q 009364 67 RWRK-GELIGCGAFGRVYMGMNL--DSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVR-- 141 (536)
Q Consensus 67 ~y~~-~~~LG~G~fg~Vy~a~~~--~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~-- 141 (536)
.|++ +++||+|+||+||+|+++ .+++.||+|++.... ....+.+|+.+|+.++||||+++++++.
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~----------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 90 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG----------ISMSACREIALLRELKHPNVISLQKVFLSH 90 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS----------CCHHHHHHHHHHHHCCCTTBCCCCEEEEET
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC----------CCHHHHHHHHHHHhcCCCCeeeEeeEEecC
Confidence 4666 668999999999999976 568999999873211 1124668999999999999999999995
Q ss_pred cCCceeEEEEecCCCCccccccc---------CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCccc----CCCC
Q 009364 142 EEESLNILLEFVPGGSISSLLGK---------FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILV----DNKG 208 (536)
Q Consensus 142 ~~~~~~lV~E~~~gg~L~~~l~~---------~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl----~~~~ 208 (536)
....+++||||+. |+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++
T Consensus 91 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~ 169 (405)
T 3rgf_A 91 ADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERG 169 (405)
T ss_dssp TTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTT
T ss_pred CCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCC
Confidence 4678999999996 577766642 1259999999999999999999999999999999999999 6778
Q ss_pred cEEEEecCcchhhhhhhc-ccCCcccCCCCCCCChhhhhhc-CCCccceEechhHHHHHHhhCCCCCchhhH--------
Q 009364 209 CIKLADFGASKQVAELAT-VSGAKSMKGTPYWMAPEVIRQT-GHSYSADIWSVGCTVIEMATGKPPWSQQYQ-------- 278 (536)
Q Consensus 209 ~vkL~DFGla~~~~~~~~-~~~~~~~~Gt~~Y~APEvl~~~-~~s~k~DIwSlGvil~eLltG~~Pf~~~~~-------- 278 (536)
.+||+|||+++.+..... .......+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.....
T Consensus 170 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~ 249 (405)
T 3rgf_A 170 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY 249 (405)
T ss_dssp CEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCC
T ss_pred cEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccc
Confidence 999999999987653211 1223467899999999999874 589999999999999999999999964321
Q ss_pred ---HHHHHHhhCCCCCCCCC---------------------------------CCcCcHHHHHHHHHhcccCCCCCCCHH
Q 009364 279 ---EVAALFHIGTTKSHPPI---------------------------------PENLSVKAKDFLLKCLEKEPDLRPTAS 322 (536)
Q Consensus 279 ---~~~~~~~~~~~~~~~~~---------------------------------~~~~s~~~~dLi~~cL~~dP~~Rps~~ 322 (536)
....+...........+ ....+..+.+||.+||+.||.+|||+.
T Consensus 250 ~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~ 329 (405)
T 3rgf_A 250 HHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSE 329 (405)
T ss_dssp CHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHH
T ss_pred hHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHH
Confidence 11111111111111101 012267889999999999999999999
Q ss_pred HHHhCCCCcCCC
Q 009364 323 ELLKHPFVTGDD 334 (536)
Q Consensus 323 eiL~hp~~~~~~ 334 (536)
|+|+||||....
T Consensus 330 e~L~hp~f~~~~ 341 (405)
T 3rgf_A 330 QAMQDPYFLEDP 341 (405)
T ss_dssp HHHTSGGGTSSS
T ss_pred HHhcChhhccCC
Confidence 999999998653
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-46 Score=381.74 Aligned_cols=257 Identities=22% Similarity=0.336 Sum_probs=213.3
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEc-----CCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeE
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNL-----DSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRY 136 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l 136 (536)
.+..+|++++.||+|+||+||+|.+. .++..||+|++.. .......+.+.+|+.+++.+ +||||+++
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~-------~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 114 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKE-------KADSSEREALMSELKMMTQLGSHENIVNL 114 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------------CHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccc-------ccCHHHHHHHHHHHHHHHhhcCCCCeeeE
Confidence 34578999999999999999999973 4567899999842 11223446788999999999 89999999
Q ss_pred eeeeecCCceeEEEEecCCCCcccccccCC-----------------------CCCHHHHHHHHHHHHHHHHHHHHcCCc
Q 009364 137 LGTVREEESLNILLEFVPGGSISSLLGKFG-----------------------PFPEAVMRTYTKQLLLGLEYLHNHGIM 193 (536)
Q Consensus 137 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~-----------------------~l~~~~~~~i~~qil~aL~yLH~~~iv 193 (536)
++++...+..++||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+
T Consensus 115 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv 194 (344)
T 1rjb_A 115 LGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCV 194 (344)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred EEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 999999999999999999999999987543 378999999999999999999999999
Q ss_pred cccCCCCCcccCCCCcEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCC
Q 009364 194 HRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPP 272 (536)
Q Consensus 194 HrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~P 272 (536)
||||||+|||++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|+| |..|
T Consensus 195 H~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 274 (344)
T 1rjb_A 195 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274 (344)
T ss_dssp ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred cCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCC
Confidence 999999999999999999999999987654333222345567899999999999999999999999999999998 9999
Q ss_pred Cchhh--HHHHHHHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCC
Q 009364 273 WSQQY--QEVAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPF 329 (536)
Q Consensus 273 f~~~~--~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~ 329 (536)
|.... ......... ......+..++.++.+||.+||..||.+|||+.++++|..
T Consensus 275 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 330 (344)
T 1rjb_A 275 YPGIPVDANFYKLIQN---GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 330 (344)
T ss_dssp STTCCCSHHHHHHHHT---TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred cccCCcHHHHHHHHhc---CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 96543 222222222 2234456678999999999999999999999999998743
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=389.52 Aligned_cols=253 Identities=27% Similarity=0.446 Sum_probs=212.6
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE 143 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 143 (536)
...+|++++.||+|+||+||+|.+..+|+.||+|++.. .........+.+|+.+|+.++||||+++++++...
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-------~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 184 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRE-------TLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK 184 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCT-------TSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccc-------cCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC
Confidence 44689999999999999999999999999999998732 11223345678999999999999999999999999
Q ss_pred CceeEEEEecCCCCcccccccC-CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhh
Q 009364 144 ESLNILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVA 222 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~ 222 (536)
+.+++||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 185 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 185 QPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEA 264 (377)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred CCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence 9999999999999999998754 369999999999999999999999999999999999999999999999999997654
Q ss_pred hhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhHH-HHHHHhhCCCCCCCCCCCcCc
Q 009364 223 ELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQE-VAALFHIGTTKSHPPIPENLS 300 (536)
Q Consensus 223 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~s 300 (536)
............+++.|+|||++.+..++.++|||||||++|||++ |..||...... ....... ....+.+..++
T Consensus 265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~ 341 (377)
T 3cbl_A 265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEK---GGRLPCPELCP 341 (377)
T ss_dssp TSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHT---TCCCCCCTTCC
T ss_pred CCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc---CCCCCCCCCCC
Confidence 3221111222345778999999999899999999999999999998 99999764432 2222222 23345667899
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHh
Q 009364 301 VKAKDFLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 301 ~~~~dLi~~cL~~dP~~Rps~~eiL~ 326 (536)
.++.+||.+||+.||.+|||+.++++
T Consensus 342 ~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 342 DAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 99999999999999999999999986
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=378.38 Aligned_cols=254 Identities=25% Similarity=0.459 Sum_probs=204.2
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCCcEE----EEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEee
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGELL----AVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLG 138 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~v----AiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~ 138 (536)
....+|++.+.||+|+||+||+|++..+|+.+ |+|.+. ........+.+.+|+.+++.++||||+++++
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~-------~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 84 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-------EATSPKANKEILDEAYVMASVDNPHVCRLLG 84 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------------CHHHHHHHHHHHHHCCBTTBCCEEE
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecc-------cccCHHHHHHHHHHHHHHHhCCCCCEeEEEE
Confidence 34468999999999999999999998888766 555442 1122233467889999999999999999999
Q ss_pred eeecCCceeEEEEecCCCCccccccc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCc
Q 009364 139 TVREEESLNILLEFVPGGSISSLLGK-FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGA 217 (536)
Q Consensus 139 ~~~~~~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGl 217 (536)
++.... .++|+||+.+|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 85 ~~~~~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 163 (327)
T 3poz_A 85 ICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGL 163 (327)
T ss_dssp EEESSS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTH
T ss_pred EEecCC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcc
Confidence 998754 7899999999999999876 46799999999999999999999999999999999999999999999999999
Q ss_pred chhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhH-HHHHHHhhCCCCCCCCC
Q 009364 218 SKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQ-EVAALFHIGTTKSHPPI 295 (536)
Q Consensus 218 a~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~-~~~~~~~~~~~~~~~~~ 295 (536)
++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||..... ........ ....+.
T Consensus 164 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~---~~~~~~ 240 (327)
T 3poz_A 164 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK---GERLPQ 240 (327)
T ss_dssp HHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT---TCCCCC
T ss_pred eeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHc---CCCCCC
Confidence 987765433333345567889999999999999999999999999999999 9999975432 22222222 223345
Q ss_pred CCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 296 PENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 296 ~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
+..++.++.+|+.+||+.||.+|||+.+++++
T Consensus 241 ~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 241 PPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp CTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred CccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 66889999999999999999999999999986
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=372.68 Aligned_cols=255 Identities=23% Similarity=0.401 Sum_probs=214.4
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEc-----CCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEe
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNL-----DSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYL 137 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~ 137 (536)
....+|++.+.||+|+||+||+|.+. .+++.||+|++.. .........+.+|+.+++.++||||++++
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~-------~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE-------AASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCT-------TSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccc-------ccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 44568999999999999999999876 4678999998732 11223345688999999999999999999
Q ss_pred eeeecCCceeEEEEecCCCCcccccccC----------CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCC
Q 009364 138 GTVREEESLNILLEFVPGGSISSLLGKF----------GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNK 207 (536)
Q Consensus 138 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~----------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~ 207 (536)
+++.+....++||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~ 174 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED 174 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTT
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCC
Confidence 9999999999999999999999998642 457999999999999999999999999999999999999999
Q ss_pred CcEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhHH-HHHHHh
Q 009364 208 GCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQE-VAALFH 285 (536)
Q Consensus 208 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~~-~~~~~~ 285 (536)
+.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||...... ......
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 254 (322)
T 1p4o_A 175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 254 (322)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHH
Confidence 9999999999987654433333344567899999999999999999999999999999999 89999764332 222222
Q ss_pred hCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 286 IGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 286 ~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
. ......+..++..+.+||.+||+.||.+|||+.++++|
T Consensus 255 ~---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 255 E---GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp T---TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred c---CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 1 12334566899999999999999999999999999987
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=371.77 Aligned_cols=256 Identities=23% Similarity=0.365 Sum_probs=206.1
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEE 144 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 144 (536)
..+|++.+.||+|+||+||+|.+..+++.||+|++... ........+.+.+|+.+++.++||||+++++++...+
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSET-----LSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG 107 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGG-----GGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcc-----cccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCC
Confidence 35899999999999999999999999999999987321 1122334567889999999999999999999999999
Q ss_pred ceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhh
Q 009364 145 SLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAEL 224 (536)
Q Consensus 145 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 224 (536)
..++||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 108 QLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 99999999999999999988888999999999999999999999999999999999999999999999999998766542
Q ss_pred hcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcHHHH
Q 009364 225 ATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAK 304 (536)
Q Consensus 225 ~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 304 (536)
. ........||+.|+|||++.+..++.++|||||||++|+|++|..||......................+..++.++.
T Consensus 188 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 266 (309)
T 2h34_A 188 K-LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFD 266 (309)
T ss_dssp ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHH
T ss_pred c-cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHH
Confidence 2 122345679999999999999899999999999999999999999997655443222222222223345668899999
Q ss_pred HHHHHhcccCCCCCC-CHHHHHh
Q 009364 305 DFLLKCLEKEPDLRP-TASELLK 326 (536)
Q Consensus 305 dLi~~cL~~dP~~Rp-s~~eiL~ 326 (536)
+||.+||+.||.+|| ++.++++
T Consensus 267 ~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 267 AVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HHHHHHTCSSGGGSCSSHHHHHH
T ss_pred HHHHHhccCCHHHHHHhHHHHHH
Confidence 999999999999999 8888875
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=366.20 Aligned_cols=251 Identities=26% Similarity=0.392 Sum_probs=209.0
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE 142 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 142 (536)
..+.+|++.+.||+|+||+||+|.+. ++..||+|++..... ..+.+.+|+.+++.++||||+++++++.+
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 90 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM---------SEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB---------CHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC---------CHHHHHHHHHHHhcCCCCCEeeEEEEEec
Confidence 34568999999999999999999875 677899998842110 12457789999999999999999999999
Q ss_pred CCceeEEEEecCCCCccccccc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhh
Q 009364 143 EESLNILLEFVPGGSISSLLGK-FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQV 221 (536)
Q Consensus 143 ~~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~ 221 (536)
...+++||||+++++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 170 (283)
T 3gen_A 91 QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV 170 (283)
T ss_dssp SSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGB
T ss_pred CCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccc
Confidence 9999999999999999999876 567999999999999999999999999999999999999999999999999999876
Q ss_pred hhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhHHH-HHHHhhCCCCCCCCCCCcC
Q 009364 222 AELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQEV-AALFHIGTTKSHPPIPENL 299 (536)
Q Consensus 222 ~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~ 299 (536)
..... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||....... ...... ......+..+
T Consensus 171 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~ 246 (283)
T 3gen_A 171 LDDEY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ---GLRLYRPHLA 246 (283)
T ss_dssp CCHHH-HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT---TCCCCCCTTC
T ss_pred ccccc-ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhc---ccCCCCCCcC
Confidence 54322 22344567889999999999999999999999999999998 999997543322 222221 2233445678
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 300 SVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 300 s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
+..+.+||.+||+.||.+|||+.++++|
T Consensus 247 ~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 247 SEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 9999999999999999999999999987
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=361.61 Aligned_cols=252 Identities=31% Similarity=0.552 Sum_probs=201.7
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE 143 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 143 (536)
...+|++.+.||+|+||+||+|.+ +|+.||+|++..... .......+.+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~----~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 78 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPD----EDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKE 78 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC--------------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC
T ss_pred chhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCc----ccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 456899999999999999999987 488999998743211 11123346788999999999999999999999999
Q ss_pred CceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccccCCCCCcccCC--------CCcEEE
Q 009364 144 ESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHG---IMHRDIKGANILVDN--------KGCIKL 212 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~---ivHrDLKp~NILl~~--------~~~vkL 212 (536)
+..++||||+++++|.+++.. +.+++..++.++.|++.||.|||++| |+||||||+|||++. ++.+||
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl 157 (271)
T 3dtc_A 79 PNLCLVMEFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157 (271)
T ss_dssp --CEEEEECCTTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred CceEEEEEcCCCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence 999999999999999998864 67999999999999999999999999 899999999999986 678999
Q ss_pred EecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCC
Q 009364 213 ADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSH 292 (536)
Q Consensus 213 ~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~ 292 (536)
+|||+++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.......... ........
T Consensus 158 ~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~~~~~~ 232 (271)
T 3dtc_A 158 TDFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAY-GVAMNKLA 232 (271)
T ss_dssp CCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH-HHHTSCCC
T ss_pred ccCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-hhhcCCCC
Confidence 9999998655422 235579999999999999999999999999999999999999997654332221 12223334
Q ss_pred CCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 293 PPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 293 ~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
.+.+..++..+.+||.+||+.||.+|||+.|+++|
T Consensus 233 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 233 LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 45677899999999999999999999999999986
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=384.27 Aligned_cols=257 Identities=27% Similarity=0.427 Sum_probs=193.8
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
.+|++.+.||+|+||+||+|.+..+|+.||||++...... .....+++..++.++||||+++++++.....
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF---------RNRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp TTEEEC----------CEEEEETTTCCEEEEEEEECCTTC---------CCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc---------cHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence 4799999999999999999999999999999988432211 1234467778888999999999999875443
Q ss_pred -------eeEEEEecCCCCcc---cccccCCCCCHHHHHHHHHHHHHHHHHHH--HcCCccccCCCCCcccCC-CCcEEE
Q 009364 146 -------LNILLEFVPGGSIS---SLLGKFGPFPEAVMRTYTKQLLLGLEYLH--NHGIMHRDIKGANILVDN-KGCIKL 212 (536)
Q Consensus 146 -------~~lV~E~~~gg~L~---~~l~~~~~l~~~~~~~i~~qil~aL~yLH--~~~ivHrDLKp~NILl~~-~~~vkL 212 (536)
+++||||+.++.+. .++.....+++..++.++.|++.||.||| ++||+||||||+|||++. ++.+||
T Consensus 94 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl 173 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKL 173 (360)
T ss_dssp SCTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEE
T ss_pred ccccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEE
Confidence 88999999865332 33345678999999999999999999999 999999999999999986 899999
Q ss_pred EecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcC-CCccceEechhHHHHHHhhCCCCCchhhHH--HHHHHhhCCC
Q 009364 213 ADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTG-HSYSADIWSVGCTVIEMATGKPPWSQQYQE--VAALFHIGTT 289 (536)
Q Consensus 213 ~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~-~s~k~DIwSlGvil~eLltG~~Pf~~~~~~--~~~~~~~~~~ 289 (536)
+|||+++...... ......||+.|+|||++.+.. ++.++|||||||++|+|++|.+||...... ...+......
T Consensus 174 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 250 (360)
T 3e3p_A 174 CDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGC 250 (360)
T ss_dssp CCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred eeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCC
Confidence 9999998765422 234567999999999997654 899999999999999999999999754321 1111110000
Q ss_pred C---------------------------CCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCC
Q 009364 290 K---------------------------SHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDD 334 (536)
Q Consensus 290 ~---------------------------~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~ 334 (536)
. .....+...+.++++||.+||+.||.+|||+.|+|+||||....
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 251 PSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH 322 (360)
T ss_dssp CCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred CCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence 0 00112234688999999999999999999999999999998643
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=374.09 Aligned_cols=255 Identities=24% Similarity=0.401 Sum_probs=213.9
Q ss_pred CCCCCceeeeEEcccCceEEEEEEE-----cCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeE
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMN-----LDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRY 136 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~-----~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l 136 (536)
.+..+|++++.||+|+||+||+|.+ ..+++.||+|++... ......+.+.+|+.+++.+ +||||+++
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~~E~~~l~~l~~h~~i~~~ 92 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-------AHLTEREALMSELKVLSYLGNHMNIVNL 92 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-------CCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcc-------hhHHHHHHHHHHHHHHhhcccCCCeeeE
Confidence 3456899999999999999999985 457889999988421 1123346788999999999 89999999
Q ss_pred eeeeecCCceeEEEEecCCCCcccccccCC------------------CCCHHHHHHHHHHHHHHHHHHHHcCCccccCC
Q 009364 137 LGTVREEESLNILLEFVPGGSISSLLGKFG------------------PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIK 198 (536)
Q Consensus 137 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~------------------~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLK 198 (536)
++++...+..++||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+|||||
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlk 172 (313)
T 1t46_A 93 LGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLA 172 (313)
T ss_dssp EEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCc
Confidence 999999999999999999999999987543 48999999999999999999999999999999
Q ss_pred CCCcccCCCCcEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhh
Q 009364 199 GANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQY 277 (536)
Q Consensus 199 p~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~ 277 (536)
|+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus 173 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 9999999999999999999987654333222345567889999999999999999999999999999999 999996542
Q ss_pred --HHHHHHHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 278 --QEVAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 278 --~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
.......... .....+..++..+.+||.+||+.||.+|||+.+++++
T Consensus 253 ~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 253 VDSKFYKMIKEG---FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp SSHHHHHHHHHT---CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred chhHHHHHhccC---CCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 2222222222 2233456789999999999999999999999999975
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=368.05 Aligned_cols=253 Identities=27% Similarity=0.452 Sum_probs=199.3
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCC---CcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeee
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDS---GELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGT 139 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~ 139 (536)
....+|++++.||+|+||+||+|.+..+ +..||+|++.. .......+.+.+|+.+++.++||||++++++
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~-------~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 84 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN-------CTSDSVREKFLQEALTMRQFDHPHIVKLIGV 84 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTT-------TTSHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccc-------cCCHHHHHHHHHHHHHHHhCCCCccceEEEE
Confidence 3446899999999999999999998654 45799998731 1223345678899999999999999999999
Q ss_pred eecCCceeEEEEecCCCCcccccccCC-CCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcc
Q 009364 140 VREEESLNILLEFVPGGSISSLLGKFG-PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGAS 218 (536)
Q Consensus 140 ~~~~~~~~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla 218 (536)
+. ++..++||||+++|+|.+++...+ .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 85 ~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 163 (281)
T 1mp8_A 85 IT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 163 (281)
T ss_dssp EC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC----
T ss_pred Ec-cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccc
Confidence 85 567899999999999999987544 6999999999999999999999999999999999999999999999999999
Q ss_pred hhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhH-HHHHHHhhCCCCCCCCCC
Q 009364 219 KQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQ-EVAALFHIGTTKSHPPIP 296 (536)
Q Consensus 219 ~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~-~~~~~~~~~~~~~~~~~~ 296 (536)
+....... .......+|+.|+|||++.+..++.++|||||||++|+|++ |.+||..... +....... ....+.+
T Consensus 164 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~---~~~~~~~ 239 (281)
T 1mp8_A 164 RYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN---GERLPMP 239 (281)
T ss_dssp ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT---TCCCCCC
T ss_pred cccCcccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHc---CCCCCCC
Confidence 87654321 12234557889999999999999999999999999999996 9999975432 22222221 2234566
Q ss_pred CcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 297 ENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 297 ~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
..+++.+.+||.+||+.||.+|||+.+++++
T Consensus 240 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 240 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 7899999999999999999999999999875
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-46 Score=377.09 Aligned_cols=258 Identities=26% Similarity=0.379 Sum_probs=211.2
Q ss_pred CCCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeee
Q 009364 62 MSPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVR 141 (536)
Q Consensus 62 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~ 141 (536)
.....+|++.+.||+|+||+||+|.+ .+|+.||+|++... .....+.+.+|+.+++.++||||+++++++.
T Consensus 35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 105 (321)
T 2qkw_B 35 EEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPE--------SSQGIEEFETEIETLSFCRHPHLVSLIGFCD 105 (321)
T ss_dssp CCCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSC--------CSSHHHHHHHHHHGGGSCCCTTBCCEEEECC
T ss_pred HHHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEeccc--------ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence 34567999999999999999999985 46899999987321 1123456889999999999999999999999
Q ss_pred cCCceeEEEEecCCCCcccccccCC----CCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCc
Q 009364 142 EEESLNILLEFVPGGSISSLLGKFG----PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGA 217 (536)
Q Consensus 142 ~~~~~~lV~E~~~gg~L~~~l~~~~----~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGl 217 (536)
..+..++||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 106 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 106 ERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGI 185 (321)
T ss_dssp CTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTT
T ss_pred CCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccc
Confidence 9999999999999999999986543 589999999999999999999999999999999999999999999999999
Q ss_pred chhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhH-----HH---HHHHhhC--
Q 009364 218 SKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQ-----EV---AALFHIG-- 287 (536)
Q Consensus 218 a~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~-----~~---~~~~~~~-- 287 (536)
++...............||+.|+|||++.+..++.++|||||||++|+|++|+.||..... .. .......
T Consensus 186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (321)
T 2qkw_B 186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL 265 (321)
T ss_dssp CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCC
T ss_pred ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccH
Confidence 9765433222223455689999999999999999999999999999999999999964321 00 0011111
Q ss_pred ----CCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCC
Q 009364 288 ----TTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHP 328 (536)
Q Consensus 288 ----~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp 328 (536)
.......++..++..+.+++.+||+.||++|||+.|+++|.
T Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 266 EQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp CSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 01112233445678899999999999999999999999874
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-46 Score=380.68 Aligned_cols=253 Identities=25% Similarity=0.423 Sum_probs=183.8
Q ss_pred CCCCceeee-EEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec
Q 009364 64 PPIRWRKGE-LIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE 142 (536)
Q Consensus 64 ~~~~y~~~~-~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 142 (536)
...+|++.+ .||+|+||+||+|.+..+|+.||+|++.. .. .. ..+....++.++||||+++++++..
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~------~~---~~---~~e~~~~~~~~~h~~i~~~~~~~~~ 93 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD------SP---KA---RQEVDHHWQASGGPHIVCILDVYEN 93 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEES------SH---HH---HHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecC------cH---HH---HHHHHHHHHhcCCCChHHHHHHHhh
Confidence 345899854 69999999999999999999999999832 11 11 1122234566799999999999876
Q ss_pred ----CCceeEEEEecCCCCcccccccCC--CCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCC---CcEEEE
Q 009364 143 ----EESLNILLEFVPGGSISSLLGKFG--PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNK---GCIKLA 213 (536)
Q Consensus 143 ----~~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~---~~vkL~ 213 (536)
...+++||||++||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+
T Consensus 94 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~ 173 (336)
T 3fhr_A 94 MHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLT 173 (336)
T ss_dssp EETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred ccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEe
Confidence 456899999999999999997653 69999999999999999999999999999999999999764 459999
Q ss_pred ecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHH-----HHHhhCC
Q 009364 214 DFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVA-----ALFHIGT 288 (536)
Q Consensus 214 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~-----~~~~~~~ 288 (536)
|||+++..... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||........ .......
T Consensus 174 Dfg~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 249 (336)
T 3fhr_A 174 DFGFAKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQ 249 (336)
T ss_dssp CCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------
T ss_pred ccccceecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccc
Confidence 99999765432 23456789999999999888899999999999999999999999965432211 1111111
Q ss_pred CCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcC
Q 009364 289 TKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTG 332 (536)
Q Consensus 289 ~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~ 332 (536)
.....+....++.++++||.+||+.||.+|||+.|+++||||..
T Consensus 250 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 293 (336)
T 3fhr_A 250 YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 293 (336)
T ss_dssp -CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence 22222334578999999999999999999999999999999975
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=380.25 Aligned_cols=254 Identities=26% Similarity=0.460 Sum_probs=207.3
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCCcE----EEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEee
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGEL----LAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLG 138 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~----vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~ 138 (536)
....+|++.+.||+|+||+||+|.+..+|+. ||+|.+.... .......+.+|+.+++.++||||+++++
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 82 (325)
T 3kex_A 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-------GRQSFQAVTDHMLAIGSLDHAHIVRLLG 82 (325)
T ss_dssp CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT-------SCSCBCSCCHHHHHHHTCCCTTBCCEEE
T ss_pred cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc-------cHHHHHHHHHHHHHHhcCCCCCcCeEEE
Confidence 4456899999999999999999999988887 5555542111 1111234567899999999999999999
Q ss_pred eeecCCceeEEEEecCCCCcccccccC-CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCc
Q 009364 139 TVREEESLNILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGA 217 (536)
Q Consensus 139 ~~~~~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGl 217 (536)
++. ....++||||+.+|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 161 (325)
T 3kex_A 83 LCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGV 161 (325)
T ss_dssp EEC-BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSG
T ss_pred EEc-CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCc
Confidence 886 46689999999999999998764 5799999999999999999999999999999999999999999999999999
Q ss_pred chhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhh-HHHHHHHhhCCCCCCCCC
Q 009364 218 SKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQY-QEVAALFHIGTTKSHPPI 295 (536)
Q Consensus 218 a~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~-~~~~~~~~~~~~~~~~~~ 295 (536)
++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||.... .......... .....
T Consensus 162 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~---~~~~~ 238 (325)
T 3kex_A 162 ADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG---ERLAQ 238 (325)
T ss_dssp GGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTT---CBCCC
T ss_pred ccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcC---CCCCC
Confidence 987755433333455678899999999999999999999999999999999 999997543 2222222222 23345
Q ss_pred CCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 296 PENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 296 ~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
+..++.++.+||.+||..||.+|||+.++++|
T Consensus 239 ~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 239 PQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 56788899999999999999999999999987
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=376.55 Aligned_cols=255 Identities=26% Similarity=0.455 Sum_probs=213.4
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEc-------CCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCcee
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNL-------DSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIV 134 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~-------~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv 134 (536)
....+|++++.||+|+||+||+|.+. .++..||+|++.. .......+.+.+|+.+++.+ +||||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~-------~~~~~~~~~~~~E~~~l~~l~~hp~iv 104 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD-------DATEKDLSDLVSEMEMMKMIGKHKNII 104 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCT-------TCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeecc-------CCcHHHHHHHHHHHHHHHHhhcCCCEe
Confidence 34568999999999999999999986 4678899998732 12234456788999999999 899999
Q ss_pred eEeeeeecCCceeEEEEecCCCCcccccccCC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCccccCC
Q 009364 135 RYLGTVREEESLNILLEFVPGGSISSLLGKFG----------------PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIK 198 (536)
Q Consensus 135 ~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~----------------~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLK 198 (536)
++++++...+.+++||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+|||||
T Consensus 105 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlk 184 (334)
T 2pvf_A 105 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLA 184 (334)
T ss_dssp CEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred eEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCc
Confidence 99999999999999999999999999987643 38999999999999999999999999999999
Q ss_pred CCCcccCCCCcEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhh
Q 009364 199 GANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQY 277 (536)
Q Consensus 199 p~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~ 277 (536)
|+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus 185 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 264 (334)
T 2pvf_A 185 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 264 (334)
T ss_dssp GGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence 9999999999999999999987654333333445567899999999999889999999999999999999 999997543
Q ss_pred H-HHHHHHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 278 Q-EVAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 278 ~-~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
. +........ .....+..++.++.+||.+||..||.+|||+.+++++
T Consensus 265 ~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 265 VEELFKLLKEG---HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHHHHHHHHT---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhcC---CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 2 222222222 2334566889999999999999999999999999986
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=363.78 Aligned_cols=251 Identities=25% Similarity=0.397 Sum_probs=210.1
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE 143 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 143 (536)
...+|++.+.||+|+||+||+|.+. ++..||+|++..... ..+.+.+|+.+++.++||||+++++++.+.
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 75 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM---------SEDEFFQEAQTMMKLSHPKLVKFYGVCSKE 75 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB---------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC---------cHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 3468999999999999999999875 577899998842111 124577899999999999999999999999
Q ss_pred CceeEEEEecCCCCcccccccCC-CCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhh
Q 009364 144 ESLNILLEFVPGGSISSLLGKFG-PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVA 222 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~ 222 (536)
...++||||+++++|.+++...+ .+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 155 (268)
T 3sxs_A 76 YPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVL 155 (268)
T ss_dssp SSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECC
T ss_pred CceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecc
Confidence 99999999999999999987654 59999999999999999999999999999999999999999999999999998665
Q ss_pred hhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcH
Q 009364 223 ELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQEVAALFHIGTTKSHPPIPENLSV 301 (536)
Q Consensus 223 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 301 (536)
..... ......||+.|+|||++.+..++.++|||||||++|+|++ |..||............. .......+..+++
T Consensus 156 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 232 (268)
T 3sxs_A 156 DDQYV-SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS--QGHRLYRPHLASD 232 (268)
T ss_dssp TTCEE-ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH--TTCCCCCCTTSCH
T ss_pred hhhhh-cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHH--cCCCCCCCCcChH
Confidence 43221 2334557788999999999899999999999999999999 999997544332211111 1223344567899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 302 KAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 302 ~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
.+.+||.+||+.||.+|||+.++++|
T Consensus 233 ~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 233 TIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999999987
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=376.46 Aligned_cols=255 Identities=25% Similarity=0.362 Sum_probs=205.2
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCC-cEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCc------eeeEe
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSG-ELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPN------IVRYL 137 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g-~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hpn------Iv~l~ 137 (536)
..+|++.+.||+|+||+||+|.+..++ +.||+|++.. .....+.+.+|+.+++.++|++ ++.++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~---------~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~ 88 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN---------VGKYREAARLEINVLKKIKEKDKENKFLCVLMS 88 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS---------CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc---------cccchhHHHHHHHHHHHHhhcCCCCceeEEEee
Confidence 468999999999999999999998777 7899999831 1123456778899998887655 89999
Q ss_pred eeeecCCceeEEEEecCCCCcccccccC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCccc-----------
Q 009364 138 GTVREEESLNILLEFVPGGSISSLLGKF--GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILV----------- 204 (536)
Q Consensus 138 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl----------- 204 (536)
+++...+.+++||||+ +++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 89 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~ 167 (355)
T 2eu9_A 89 DWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNE 167 (355)
T ss_dssp EEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECC
T ss_pred eeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccc
Confidence 9999999999999999 66666666543 479999999999999999999999999999999999999
Q ss_pred --------CCCCcEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchh
Q 009364 205 --------DNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQ 276 (536)
Q Consensus 205 --------~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~ 276 (536)
+.++.+||+|||+++.... .....+||+.|+|||++.+..++.++|||||||++|+|++|.+||...
T Consensus 168 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (355)
T 2eu9_A 168 HKSCEEKSVKNTSIRVADFGSATFDHE-----HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH 242 (355)
T ss_dssp C-CCCEEEESCCCEEECCCTTCEETTS-----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccccCCCcEEEeecCccccccc-----cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 5678999999999975432 234568999999999999999999999999999999999999999754
Q ss_pred hHHH--HHHHhhCCCC---------------------------------------CCCCCCCcCcHHHHHHHHHhcccCC
Q 009364 277 YQEV--AALFHIGTTK---------------------------------------SHPPIPENLSVKAKDFLLKCLEKEP 315 (536)
Q Consensus 277 ~~~~--~~~~~~~~~~---------------------------------------~~~~~~~~~s~~~~dLi~~cL~~dP 315 (536)
.... ..+....... .........+.++.+||.+||+.||
T Consensus 243 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 322 (355)
T 2eu9_A 243 ENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDP 322 (355)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred CHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCCh
Confidence 3221 1111100000 0001112345689999999999999
Q ss_pred CCCCCHHHHHhCCCCcCCC
Q 009364 316 DLRPTASELLKHPFVTGDD 334 (536)
Q Consensus 316 ~~Rps~~eiL~hp~~~~~~ 334 (536)
.+|||+.|+|+||||....
T Consensus 323 ~~Rpt~~e~l~hp~f~~~~ 341 (355)
T 2eu9_A 323 AQRITLAEALLHPFFAGLT 341 (355)
T ss_dssp TTSCCHHHHTTSGGGGGCC
T ss_pred hhCcCHHHHhcChhhcCCC
Confidence 9999999999999998643
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=374.98 Aligned_cols=259 Identities=24% Similarity=0.371 Sum_probs=210.2
Q ss_pred CCCCCceeeeEEcccCceEEEEEE-----EcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEe
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGM-----NLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYL 137 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~-----~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~ 137 (536)
....+|++.+.||+|+||+||+|. +..+++.||+|++.. .........+.+|+.+++.++||||++++
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~-------~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 99 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE-------VCSEQDELDFLMEALIISKFNHQNIVRCI 99 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCS-------SCCHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecc-------ccchhhHHHHHHHHHHHhhCCCCCCCeEE
Confidence 455689999999999999999998 556788999998731 11223345678899999999999999999
Q ss_pred eeeecCCceeEEEEecCCCCcccccccC-------CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCC---
Q 009364 138 GTVREEESLNILLEFVPGGSISSLLGKF-------GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNK--- 207 (536)
Q Consensus 138 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~-------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~--- 207 (536)
+++......++||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 100 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~ 179 (327)
T 2yfx_A 100 GVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPG 179 (327)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTT
T ss_pred EEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCc
Confidence 9999999999999999999999998764 348999999999999999999999999999999999999844
Q ss_pred CcEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhHH-HHHHHh
Q 009364 208 GCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQE-VAALFH 285 (536)
Q Consensus 208 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~~-~~~~~~ 285 (536)
+.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||...... ......
T Consensus 180 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 259 (327)
T 2yfx_A 180 RVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 259 (327)
T ss_dssp CCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred ceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHh
Confidence 4699999999987654333333445678999999999999999999999999999999998 99999754332 222222
Q ss_pred hCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCc
Q 009364 286 IGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVT 331 (536)
Q Consensus 286 ~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~ 331 (536)
.. .....+..++..+.+||.+||+.||.+|||+.++++|.|+.
T Consensus 260 ~~---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 260 SG---GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp TT---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cC---CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 21 23345668899999999999999999999999999998864
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=368.04 Aligned_cols=255 Identities=27% Similarity=0.469 Sum_probs=210.1
Q ss_pred CCCceeeeEEcccCceEEEEEE----EcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeee
Q 009364 65 PIRWRKGELIGCGAFGRVYMGM----NLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTV 140 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~----~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~ 140 (536)
..+|++.+.||+|+||.||+|+ +..+|+.||+|++... ......+.+.+|+.+++.++||||+++++++
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 92 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE-------SGGNHIADLKKEIEILRNLYHENIVKYKGIC 92 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------------CCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccc-------ccchhHHHHHHHHHHHHhCCCCCeeeeeeEE
Confidence 3569999999999999999998 5678999999998421 1222346688999999999999999999999
Q ss_pred ecC--CceeEEEEecCCCCcccccc-cCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCc
Q 009364 141 REE--ESLNILLEFVPGGSISSLLG-KFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGA 217 (536)
Q Consensus 141 ~~~--~~~~lV~E~~~gg~L~~~l~-~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGl 217 (536)
... ..+++||||+++|+|.+++. ....+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 93 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 172 (302)
T 4e5w_A 93 TEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGL 172 (302)
T ss_dssp EC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred ecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccc
Confidence 876 67899999999999999984 446799999999999999999999999999999999999999999999999999
Q ss_pred chhhhhhhcc-cCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH-------------HHHH
Q 009364 218 SKQVAELATV-SGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE-------------VAAL 283 (536)
Q Consensus 218 a~~~~~~~~~-~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~-------------~~~~ 283 (536)
+......... .......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ....
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (302)
T 4e5w_A 173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL 252 (302)
T ss_dssp CEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHH
T ss_pred cccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHH
Confidence 9876543221 2234567899999999999999999999999999999999999987533211 1111
Q ss_pred HhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHh
Q 009364 284 FHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 284 ~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~ 326 (536)
..........+.+..+++++.+||.+||+.||.+|||+.++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 253 VNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 1112223344566789999999999999999999999999986
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=384.62 Aligned_cols=254 Identities=26% Similarity=0.421 Sum_probs=203.8
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCC-CC-----ceeeEee
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS-HP-----NIVRYLG 138 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~-Hp-----nIv~l~~ 138 (536)
..+|++.+.||+|+||+||+|.+..+|+.||||++.. .......+..|+.+++.++ |+ +|+++++
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~---------~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~ 123 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN---------KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKR 123 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS---------SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec---------cHHHHHHHHHHHHHHHHHHhcccccceeEEEeee
Confidence 4689999999999999999999999999999999832 1123455677888888774 44 4999999
Q ss_pred eeecCCceeEEEEecCCCCcccccccC--CCCCHHHHHHHHHHHHHHHHHHH--HcCCccccCCCCCcccC--CCCcEEE
Q 009364 139 TVREEESLNILLEFVPGGSISSLLGKF--GPFPEAVMRTYTKQLLLGLEYLH--NHGIMHRDIKGANILVD--NKGCIKL 212 (536)
Q Consensus 139 ~~~~~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH--~~~ivHrDLKp~NILl~--~~~~vkL 212 (536)
++...+..++||||+. |+|.+++... +.+++..++.++.||+.||.||| +.||+||||||+|||++ .++.+||
T Consensus 124 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL 202 (382)
T 2vx3_A 124 HFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKI 202 (382)
T ss_dssp EEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEE
T ss_pred eeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEE
Confidence 9999999999999995 5999988654 46999999999999999999999 57999999999999995 4678999
Q ss_pred EecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH--HHHHHhhCCCC
Q 009364 213 ADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE--VAALFHIGTTK 290 (536)
Q Consensus 213 ~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~--~~~~~~~~~~~ 290 (536)
+|||+++.... .....+||+.|+|||++.+..++.++|||||||++|+|++|.+||...... ...+.......
T Consensus 203 ~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~ 277 (382)
T 2vx3_A 203 VDFGSSCQLGQ-----RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIP 277 (382)
T ss_dssp CCCTTCEETTC-----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSC
T ss_pred EeccCceeccc-----ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 99999976643 234578999999999999999999999999999999999999999754321 11111100000
Q ss_pred ----------------------------------CCCCCCC-------------------------cCcHHHHHHHHHhc
Q 009364 291 ----------------------------------SHPPIPE-------------------------NLSVKAKDFLLKCL 311 (536)
Q Consensus 291 ----------------------------------~~~~~~~-------------------------~~s~~~~dLi~~cL 311 (536)
..++... ..+.++++||.+||
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL 357 (382)
T 2vx3_A 278 PAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRML 357 (382)
T ss_dssp CHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHT
T ss_pred CHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhc
Confidence 0000000 01247899999999
Q ss_pred ccCCCCCCCHHHHHhCCCCcCC
Q 009364 312 EKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 312 ~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
+.||++|||+.|+|+||||+..
T Consensus 358 ~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 358 DYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp CSCTTTSCCHHHHTTSGGGCC-
T ss_pred CCChhhCCCHHHHhcCcccccC
Confidence 9999999999999999999764
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=372.62 Aligned_cols=257 Identities=27% Similarity=0.506 Sum_probs=207.0
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC----CCCceeeEeee
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL----SHPNIVRYLGT 139 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l----~HpnIv~l~~~ 139 (536)
...+|++.+.||+|+||.||+|.+..+|+.||+|++....... .........+.+|+.+++.+ +||||++++++
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLG--WSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC----------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccc--cccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 3458999999999999999999999999999999884322111 01111233456788888888 89999999999
Q ss_pred eecCCceeEEEEe-cCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccC-CCCcEEEEecCc
Q 009364 140 VREEESLNILLEF-VPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVD-NKGCIKLADFGA 217 (536)
Q Consensus 140 ~~~~~~~~lV~E~-~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~-~~~~vkL~DFGl 217 (536)
+...+..++|||| +.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||+
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~ 186 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGS 186 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcch
Confidence 9999999999999 78999999998888899999999999999999999999999999999999998 789999999999
Q ss_pred chhhhhhhcccCCcccCCCCCCCChhhhhhcCC-CccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCC
Q 009364 218 SKQVAELATVSGAKSMKGTPYWMAPEVIRQTGH-SYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIP 296 (536)
Q Consensus 218 a~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~-s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 296 (536)
++..... ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||....... . ....++
T Consensus 187 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~-----~~~~~~ 253 (312)
T 2iwi_A 187 GALLHDE----PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEIL----E-----AELHFP 253 (312)
T ss_dssp CEECCSS----CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH----H-----TCCCCC
T ss_pred hhhcccC----cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHHh----h-----hccCCc
Confidence 8866432 2345679999999999987766 458999999999999999999997643211 1 122355
Q ss_pred CcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCCC
Q 009364 297 ENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDE 335 (536)
Q Consensus 297 ~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~~ 335 (536)
..++.++++||.+||+.||.+|||+.|+++||||+...+
T Consensus 254 ~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~ 292 (312)
T 2iwi_A 254 AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE 292 (312)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence 688999999999999999999999999999999986543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=375.81 Aligned_cols=250 Identities=24% Similarity=0.350 Sum_probs=201.5
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE 143 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 143 (536)
...+|++.+.||+|+||+||+|++. ++.||||++... . ........|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~-------~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 90 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ-------D--KQSWQNEYEVYSLPGMKHENILQFIGAEKRG 90 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGG-------G--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC--CCEEEEEEeecC-------c--hHHHHHHHHHHHHhcCCCCCchhhcceeccC
Confidence 3458999999999999999999874 799999998321 1 1223445689999999999999999999875
Q ss_pred Cc----eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHc----------CCccccCCCCCcccCCCCc
Q 009364 144 ES----LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNH----------GIMHRDIKGANILVDNKGC 209 (536)
Q Consensus 144 ~~----~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~----------~ivHrDLKp~NILl~~~~~ 209 (536)
.. +++||||+++|+|.+++.. +.+++..++.++.||+.||.|||+. ||+||||||+|||++.++.
T Consensus 91 ~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~ 169 (322)
T 3soc_A 91 TSVDVDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLT 169 (322)
T ss_dssp CSSSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCC
T ss_pred CCCCceEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCe
Confidence 43 6999999999999999976 5699999999999999999999999 9999999999999999999
Q ss_pred EEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhh-----cCCCccceEechhHHHHHHhhCCCCCchhh-------
Q 009364 210 IKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQ-----TGHSYSADIWSVGCTVIEMATGKPPWSQQY------- 277 (536)
Q Consensus 210 vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~-----~~~s~k~DIwSlGvil~eLltG~~Pf~~~~------- 277 (536)
+||+|||+++..............+||+.|+|||++.+ ..++.++|||||||++|+|++|..||....
T Consensus 170 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~ 249 (322)
T 3soc_A 170 ACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF 249 (322)
T ss_dssp EEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTT
T ss_pred EEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccch
Confidence 99999999987665433333445789999999999986 355678999999999999999999985321
Q ss_pred ----------HHHHHHHhhCCCCCCCCCCC-----cCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 278 ----------QEVAALFHIGTTKSHPPIPE-----NLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 278 ----------~~~~~~~~~~~~~~~~~~~~-----~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
........ .....+.++. ..+.++.+||.+||+.||.+|||+.++++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 312 (322)
T 3soc_A 250 EEEIGQHPSLEDMQEVVV--HKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER 312 (322)
T ss_dssp HHHHCSSCCHHHHHHHHT--TSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhhhccCCchhhhhhhhh--cccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 11111111 1122222222 345669999999999999999999999874
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=367.89 Aligned_cols=246 Identities=23% Similarity=0.365 Sum_probs=205.2
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCC-------cEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeE
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSG-------ELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRY 136 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g-------~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l 136 (536)
...+|++.+.||+|+||+||+|.+..++ ..||+|++... .....+.+.+|+.+++.++||||+++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv~~ 77 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA--------HRNYSESFFEAASMMSKLSHKHLVLN 77 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG--------GGGGHHHHHHHHHHHHTSCCTTBCCE
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc--------cHHHHHHHHHHHHHHHhCCCCCEeEE
Confidence 3468999999999999999999998877 47999987321 11234567899999999999999999
Q ss_pred eeeeecCCceeEEEEecCCCCcccccccCCC-CCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCc------
Q 009364 137 LGTVREEESLNILLEFVPGGSISSLLGKFGP-FPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGC------ 209 (536)
Q Consensus 137 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~-l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~------ 209 (536)
++++.+.+..++||||++||+|.+++...+. +++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 78 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~ 157 (289)
T 4fvq_A 78 YGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNP 157 (289)
T ss_dssp EEEECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBC
T ss_pred EEEEEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccc
Confidence 9999999999999999999999999977654 999999999999999999999999999999999999988886
Q ss_pred --EEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhh-cCCCccceEechhHHHHHHhhC-CCCCchhhHHHHHHHh
Q 009364 210 --IKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQ-TGHSYSADIWSVGCTVIEMATG-KPPWSQQYQEVAALFH 285 (536)
Q Consensus 210 --vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~-~~~s~k~DIwSlGvil~eLltG-~~Pf~~~~~~~~~~~~ 285 (536)
+||+|||++...... ....||+.|+|||++.+ ..++.++|||||||++|+|++| .+||............
T Consensus 158 ~~~kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~ 231 (289)
T 4fvq_A 158 PFIKLSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY 231 (289)
T ss_dssp CEEEECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred ceeeeccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh
Confidence 999999998765432 23457899999999987 6789999999999999999995 5555443322222111
Q ss_pred hCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 286 IGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 286 ~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
.. ....+...+.++.+||.+||+.||.+|||+.++++|
T Consensus 232 ~~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 232 ED----RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp HT----TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred hc----cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 11 233445667889999999999999999999999987
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=379.49 Aligned_cols=256 Identities=27% Similarity=0.460 Sum_probs=207.1
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCC-----------CCc
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS-----------HPN 132 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~-----------Hpn 132 (536)
...+|++.+.||+|+||+||+|.+..+|+.||||++... ......+.+|+.+++.+. |||
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 87 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---------KVYTEAAEDEIKLLQRVNDADNTKEDSMGANH 87 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---------HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTT
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---------ccchhhhhHHHHHHHHhhcccccchhccccch
Confidence 346899999999999999999999999999999998321 122355678888888876 899
Q ss_pred eeeEeeeeecCC----ceeEEEEecCCCCcccccccC--CCCCHHHHHHHHHHHHHHHHHHHHc-CCccccCCCCCcccC
Q 009364 133 IVRYLGTVREEE----SLNILLEFVPGGSISSLLGKF--GPFPEAVMRTYTKQLLLGLEYLHNH-GIMHRDIKGANILVD 205 (536)
Q Consensus 133 Iv~l~~~~~~~~----~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~-~ivHrDLKp~NILl~ 205 (536)
|+++++++.... .+++||||+ +++|.+++... ..+++..++.++.||+.||.|||++ ||+||||||+|||++
T Consensus 88 i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~ 166 (373)
T 1q8y_A 88 ILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLME 166 (373)
T ss_dssp BCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEE
T ss_pred HHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEe
Confidence 999999998654 789999999 89999998753 4599999999999999999999998 999999999999994
Q ss_pred ------CCCcEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhh--
Q 009364 206 ------NKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQY-- 277 (536)
Q Consensus 206 ------~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~-- 277 (536)
..+.+||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 167 ~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 241 (373)
T 1q8y_A 167 IVDSPENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGH 241 (373)
T ss_dssp EEETTTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC------
T ss_pred ccCCCcCcceEEEcccccccccCC-----CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCccc
Confidence 444899999999976543 2345679999999999999999999999999999999999999996432
Q ss_pred ------HHHHHHHhh-CCC------------------------------------CCCCCCCCcCcHHHHHHHHHhcccC
Q 009364 278 ------QEVAALFHI-GTT------------------------------------KSHPPIPENLSVKAKDFLLKCLEKE 314 (536)
Q Consensus 278 ------~~~~~~~~~-~~~------------------------------------~~~~~~~~~~s~~~~dLi~~cL~~d 314 (536)
.....+... +.. .....++..++.++++||.+||+.|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 321 (373)
T 1q8y_A 242 SYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLD 321 (373)
T ss_dssp ---CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSS
T ss_pred ccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccC
Confidence 111111110 000 0011234566789999999999999
Q ss_pred CCCCCCHHHHHhCCCCcCCC
Q 009364 315 PDLRPTASELLKHPFVTGDD 334 (536)
Q Consensus 315 P~~Rps~~eiL~hp~~~~~~ 334 (536)
|.+|||+.|+|+||||....
T Consensus 322 P~~Rpt~~ell~hp~f~~~~ 341 (373)
T 1q8y_A 322 PRKRADAGGLVNHPWLKDTL 341 (373)
T ss_dssp TTTCBCHHHHHTCGGGTTCT
T ss_pred ccccCCHHHHhhChhhhccc
Confidence 99999999999999998643
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=376.29 Aligned_cols=258 Identities=28% Similarity=0.456 Sum_probs=216.0
Q ss_pred CCCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCC--CCceeeEeee
Q 009364 62 MSPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS--HPNIVRYLGT 139 (536)
Q Consensus 62 ~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~--HpnIv~l~~~ 139 (536)
.....+|++++.||+|+||+||+|.+..+|+.||+|++.......... ......+.+|+.+++.++ |+||++++++
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~--~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE--LPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEE--CTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhh--hhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 345678999999999999999999999999999999985332111000 001133557889999996 5999999999
Q ss_pred eecCCceeEEEEecCC-CCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccC-CCCcEEEEecCc
Q 009364 140 VREEESLNILLEFVPG-GSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVD-NKGCIKLADFGA 217 (536)
Q Consensus 140 ~~~~~~~~lV~E~~~g-g~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~-~~~~vkL~DFGl 217 (536)
+...+..++|||++.+ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ +++.+||+|||+
T Consensus 117 ~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~ 196 (320)
T 3a99_A 117 FERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS 196 (320)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred EecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcc
Confidence 9999999999999976 89999998888999999999999999999999999999999999999998 788999999999
Q ss_pred chhhhhhhcccCCcccCCCCCCCChhhhhhcCC-CccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCC
Q 009364 218 SKQVAELATVSGAKSMKGTPYWMAPEVIRQTGH-SYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIP 296 (536)
Q Consensus 218 a~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~-s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 296 (536)
++..... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||....... . ....++
T Consensus 197 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~----~-----~~~~~~ 263 (320)
T 3a99_A 197 GALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII----R-----GQVFFR 263 (320)
T ss_dssp CEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH----H-----CCCCCS
T ss_pred ccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhh----c-----cccccc
Confidence 8766432 2345679999999999987766 788999999999999999999997653211 1 112345
Q ss_pred CcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCC
Q 009364 297 ENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDD 334 (536)
Q Consensus 297 ~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~ 334 (536)
..++.++++||.+||+.||.+|||+.++++||||....
T Consensus 264 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 264 QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 67899999999999999999999999999999998643
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-45 Score=368.27 Aligned_cols=257 Identities=30% Similarity=0.477 Sum_probs=192.8
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEE 144 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 144 (536)
..+|++.+.||+|+||+||+|.+..+|+.||||++.... ......+.+.++..+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~ 97 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG------NKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNT 97 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTS------CHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccc------cchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Confidence 357999999999999999999999999999999984221 11222344555666788889999999999999999
Q ss_pred ceeEEEEecCCCCccccccc-CCCCCHHHHHHHHHHHHHHHHHHHHc-CCccccCCCCCcccCCCCcEEEEecCcchhhh
Q 009364 145 SLNILLEFVPGGSISSLLGK-FGPFPEAVMRTYTKQLLLGLEYLHNH-GIMHRDIKGANILVDNKGCIKLADFGASKQVA 222 (536)
Q Consensus 145 ~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~-~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~ 222 (536)
.+++||||+ ++.+..+... ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++....
T Consensus 98 ~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 98 DVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp EEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred cEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 999999999 5555555443 46799999999999999999999995 99999999999999999999999999997654
Q ss_pred hhhcccCCcccCCCCCCCChhhhh-----hcCCCccceEechhHHHHHHhhCCCCCchhh--HHHHHHHhhCCCCCCCCC
Q 009364 223 ELATVSGAKSMKGTPYWMAPEVIR-----QTGHSYSADIWSVGCTVIEMATGKPPWSQQY--QEVAALFHIGTTKSHPPI 295 (536)
Q Consensus 223 ~~~~~~~~~~~~Gt~~Y~APEvl~-----~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~--~~~~~~~~~~~~~~~~~~ 295 (536)
... ......||+.|+|||++. +..++.++|||||||++|+|++|..||.... ........... ....+.
T Consensus 177 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~ 252 (318)
T 2dyl_A 177 DDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEE-PPLLPG 252 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSC-CCCCCS
T ss_pred CCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccC-CCCCCc
Confidence 322 233557999999999994 5568899999999999999999999997522 22222222221 112222
Q ss_pred CCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcC
Q 009364 296 PENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTG 332 (536)
Q Consensus 296 ~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~ 332 (536)
...++.++.+||.+||+.||.+|||+.++++||||..
T Consensus 253 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 253 HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289 (318)
T ss_dssp SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred cCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence 3468999999999999999999999999999999964
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=368.43 Aligned_cols=252 Identities=21% Similarity=0.290 Sum_probs=208.5
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeEeeeeecC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRYLGTVREE 143 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~ 143 (536)
..+|++.+.||+|+||+||+|.+..+|+.||+|++.... ....+.+|+.+++.+ +|+|++++++++...
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~ 78 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----------DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEG 78 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT----------TSCCHHHHHHHHHHTTTCTTCCCEEEEEEET
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC----------ccHHHHHHHHHHHHHhcCCCCCeEEeecCCC
Confidence 468999999999999999999999999999999874211 113466789999999 799999999999999
Q ss_pred CceeEEEEecCCCCcccccccCC-CCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCc-----EEEEecCc
Q 009364 144 ESLNILLEFVPGGSISSLLGKFG-PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGC-----IKLADFGA 217 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~-----vkL~DFGl 217 (536)
...++||||+ +++|.+++...+ ++++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+
T Consensus 79 ~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~ 157 (298)
T 1csn_A 79 LHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 157 (298)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred ceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcc
Confidence 9999999999 999999997654 6999999999999999999999999999999999999987775 99999999
Q ss_pred chhhhhhhcc-----cCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchh----hHH-HHHHHhhC
Q 009364 218 SKQVAELATV-----SGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQ----YQE-VAALFHIG 287 (536)
Q Consensus 218 a~~~~~~~~~-----~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~----~~~-~~~~~~~~ 287 (536)
++........ .......||+.|+|||++.+..++.++|||||||++|+|++|..||... ... ...+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (298)
T 1csn_A 158 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK 237 (298)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred ccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhc
Confidence 9876543221 1234667999999999999999999999999999999999999999652 111 11111111
Q ss_pred CCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 288 TTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 288 ~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
...........++.++++||.+||+.||.+|||+.++++.
T Consensus 238 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 238 QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred cCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 1111122334789999999999999999999999999864
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=373.05 Aligned_cols=255 Identities=27% Similarity=0.456 Sum_probs=211.9
Q ss_pred CCCCCceeeeEEcccCceEEEEEEE-----cCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeE
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMN-----LDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRY 136 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~-----~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l 136 (536)
....+|++.+.||+|+||+||+|.+ ..+++.||+|++.. .......+.+.+|+.+++.+ +||||+++
T Consensus 24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~-------~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKE-------GATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECT-------TCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEeccc-------CCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 3456899999999999999999985 35678999998832 11223446788999999999 69999999
Q ss_pred eeeeecCC-ceeEEEEecCCCCcccccccCCC----------------CCHHHHHHHHHHHHHHHHHHHHcCCccccCCC
Q 009364 137 LGTVREEE-SLNILLEFVPGGSISSLLGKFGP----------------FPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKG 199 (536)
Q Consensus 137 ~~~~~~~~-~~~lV~E~~~gg~L~~~l~~~~~----------------l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp 199 (536)
++++...+ .+++||||+++|+|.+++..... +++..++.++.||+.||.|||++||+||||||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp 176 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAA 176 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCcc
Confidence 99987654 59999999999999999976543 89999999999999999999999999999999
Q ss_pred CCcccCCCCcEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhh-
Q 009364 200 ANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQY- 277 (536)
Q Consensus 200 ~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~- 277 (536)
+||+++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus 177 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 256 (316)
T 2xir_A 177 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256 (316)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred ceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccch
Confidence 999999999999999999986654322222345568899999999999999999999999999999998 999996532
Q ss_pred -HHHHHHHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 278 -QEVAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 278 -~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
.......... .....+..+++++.++|.+||+.||.+|||+.++++|
T Consensus 257 ~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 257 DEEFCRRLKEG---TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp SHHHHHHHHHT---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHhccC---ccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2222222222 2234556789999999999999999999999999987
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-45 Score=363.89 Aligned_cols=257 Identities=27% Similarity=0.474 Sum_probs=209.1
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE 142 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 142 (536)
....+|++.+.||+|+||+||+|.+..+++.||+|++........ .......+.+.+|+.+++.++||||+++++++.+
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGE-TEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN 94 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCC-HHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccc-hhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC
Confidence 445789999999999999999999999999999998854322111 1111122678899999999999999999999976
Q ss_pred CCceeEEEEecCCCCccccccc-CCCCCHHHHHHHHHHHHHHHHHHHHcC--CccccCCCCCcccCCCCc-----EEEEe
Q 009364 143 EESLNILLEFVPGGSISSLLGK-FGPFPEAVMRTYTKQLLLGLEYLHNHG--IMHRDIKGANILVDNKGC-----IKLAD 214 (536)
Q Consensus 143 ~~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~--ivHrDLKp~NILl~~~~~-----vkL~D 214 (536)
.. ++||||+++|+|.+++.. ...+++..++.++.|++.||+|||++| |+||||||+|||++.++. +||+|
T Consensus 95 ~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 95 PP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp TT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred CC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 55 799999999999887754 457999999999999999999999999 999999999999988776 99999
Q ss_pred cCcchhhhhhhcccCCcccCCCCCCCChhhhh--hcCCCccceEechhHHHHHHhhCCCCCchhhH-HHHHHHhhCCCCC
Q 009364 215 FGASKQVAELATVSGAKSMKGTPYWMAPEVIR--QTGHSYSADIWSVGCTVIEMATGKPPWSQQYQ-EVAALFHIGTTKS 291 (536)
Q Consensus 215 FGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~--~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~-~~~~~~~~~~~~~ 291 (536)
||+++.... ......||+.|+|||++. ...++.++|||||||++|+|++|..||..... .............
T Consensus 173 fg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 247 (287)
T 4f0f_A 173 FGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL 247 (287)
T ss_dssp CTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCC
T ss_pred CCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCC
Confidence 999875432 234567999999999984 44578999999999999999999999965321 1111111222334
Q ss_pred CCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 292 HPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 292 ~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
.+.++..+++++.+||.+||+.||.+|||+.++++.
T Consensus 248 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 283 (287)
T 4f0f_A 248 RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKE 283 (287)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 455677899999999999999999999999999863
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=362.84 Aligned_cols=255 Identities=27% Similarity=0.510 Sum_probs=196.8
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE 142 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 142 (536)
....+|++.+.||+|+||+||+|.+. ..||+|++.... ......+.+.+|+.+++.++||||++++++. .
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~ 90 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTA------PTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T 90 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSS------CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-C
T ss_pred cCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccC------CCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-c
Confidence 45678999999999999999999753 359999884321 1234456788999999999999999999965 5
Q ss_pred CCceeEEEEecCCCCccccccc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhh
Q 009364 143 EESLNILLEFVPGGSISSLLGK-FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQV 221 (536)
Q Consensus 143 ~~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~ 221 (536)
....++||||+.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 170 (289)
T 3og7_A 91 APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEK 170 (289)
T ss_dssp SSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred CCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccc
Confidence 5678999999999999998854 457999999999999999999999999999999999999999999999999999866
Q ss_pred hhhhcccCCcccCCCCCCCChhhhh---hcCCCccceEechhHHHHHHhhCCCCCchhh--HHHHHHHhhCC-CCCCCCC
Q 009364 222 AELATVSGAKSMKGTPYWMAPEVIR---QTGHSYSADIWSVGCTVIEMATGKPPWSQQY--QEVAALFHIGT-TKSHPPI 295 (536)
Q Consensus 222 ~~~~~~~~~~~~~Gt~~Y~APEvl~---~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~--~~~~~~~~~~~-~~~~~~~ 295 (536)
.............||+.|+|||++. +..++.++|||||||++|+|++|..||.... ........... ......+
T Consensus 171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (289)
T 3og7_A 171 SRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKV 250 (289)
T ss_dssp -------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSS
T ss_pred ccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhc
Confidence 5433333345667999999999986 5678899999999999999999999996532 22222322222 2223345
Q ss_pred CCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 296 PENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 296 ~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
...++.++++||.+||+.||.+|||+.++++.
T Consensus 251 ~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 282 (289)
T 3og7_A 251 RSNCPKRMKRLMAECLKKKRDERPSFPRILAE 282 (289)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cccCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 56889999999999999999999999999863
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=373.39 Aligned_cols=258 Identities=30% Similarity=0.461 Sum_probs=188.4
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHH-HHHhCCCCceeeEeeeeec
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVK-LLKDLSHPNIVRYLGTVRE 142 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~-iL~~l~HpnIv~l~~~~~~ 142 (536)
...+|++.+.||+|+||.||+|.+..+|+.||||++.... .......+..|+. +++.++||||+++++++..
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~ 92 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV-------DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR 92 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC-------CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc-------CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe
Confidence 4468999999999999999999999999999999984321 1122233445555 7778899999999999999
Q ss_pred CCceeEEEEecCCCCccccccc-----CCCCCHHHHHHHHHHHHHHHHHHHHc-CCccccCCCCCcccCCCCcEEEEecC
Q 009364 143 EESLNILLEFVPGGSISSLLGK-----FGPFPEAVMRTYTKQLLLGLEYLHNH-GIMHRDIKGANILVDNKGCIKLADFG 216 (536)
Q Consensus 143 ~~~~~lV~E~~~gg~L~~~l~~-----~~~l~~~~~~~i~~qil~aL~yLH~~-~ivHrDLKp~NILl~~~~~vkL~DFG 216 (536)
.+..++||||+.+ +|.+++.. ...+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||
T Consensus 93 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 171 (327)
T 3aln_A 93 EGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFG 171 (327)
T ss_dssp SSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCS
T ss_pred CCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCC
Confidence 9999999999975 77766642 56799999999999999999999999 99999999999999999999999999
Q ss_pred cchhhhhhhcccCCcccCCCCCCCChhhh----hhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCC---
Q 009364 217 ASKQVAELATVSGAKSMKGTPYWMAPEVI----RQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTT--- 289 (536)
Q Consensus 217 la~~~~~~~~~~~~~~~~Gt~~Y~APEvl----~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~--- 289 (536)
+++...... ......||+.|+|||++ .+..++.++|||||||++|+|++|..||................
T Consensus 172 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 248 (327)
T 3aln_A 172 ISGQLVDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPP 248 (327)
T ss_dssp SSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCC
T ss_pred Cceeccccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCC
Confidence 997765322 12344799999999998 45678999999999999999999999997643222111111111
Q ss_pred CCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcC
Q 009364 290 KSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTG 332 (536)
Q Consensus 290 ~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~ 332 (536)
.........++..+++||.+||+.||.+|||+.++++||||..
T Consensus 249 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~ 291 (327)
T 3aln_A 249 QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291 (327)
T ss_dssp CCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred CCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHH
Confidence 1111123468999999999999999999999999999999964
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=373.76 Aligned_cols=255 Identities=24% Similarity=0.402 Sum_probs=212.8
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCCc-----EEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeE
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGE-----LLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRY 136 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~-----~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l 136 (536)
....+|++.+.||+|+||+||+|.+..+++ .||+|.+.. .......+.+.+|+.+++.+ +||||+++
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~-------~~~~~~~~~~~~E~~~l~~l~~h~~iv~~ 115 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKS-------TAHADEKEALMSELKIMSHLGQHENIVNL 115 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECT-------TCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccc-------ccChHHHHHHHHHHHHHHhhcCCCCeeeE
Confidence 445789999999999999999999977664 799998732 11223456788999999999 89999999
Q ss_pred eeeeecCCceeEEEEecCCCCccccccc--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCc
Q 009364 137 LGTVREEESLNILLEFVPGGSISSLLGK--------------FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANI 202 (536)
Q Consensus 137 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~--------------~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NI 202 (536)
++++...+.+++||||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 116 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NI 195 (333)
T 2i1m_A 116 LGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNV 195 (333)
T ss_dssp EEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGC
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceE
Confidence 9999999999999999999999998864 24589999999999999999999999999999999999
Q ss_pred ccCCCCcEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhh--HH
Q 009364 203 LVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQY--QE 279 (536)
Q Consensus 203 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~--~~ 279 (536)
|++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |.+||.... ..
T Consensus 196 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 275 (333)
T 2i1m_A 196 LLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK 275 (333)
T ss_dssp EEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH
T ss_pred EECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH
Confidence 999999999999999987654332222344567889999999999999999999999999999998 999996532 22
Q ss_pred HHHHHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 280 VAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
........ .....+..++..+.+||.+||+.||.+|||+.+++++
T Consensus 276 ~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 276 FYKLVKDG---YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp HHHHHHHT---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhcC---CCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 22222222 2234456789999999999999999999999999874
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=365.46 Aligned_cols=254 Identities=31% Similarity=0.548 Sum_probs=199.9
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEE 144 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 144 (536)
-.+|++.+.||+|+||.||+|.+..+|+.||+|++.... .........+.+|+.+++.++||||+++++++...+
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 105 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFD-----LMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN 105 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTS-----SCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhh-----ccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 357999999999999999999999999999999884211 111234567889999999999999999999999999
Q ss_pred ceeEEEEecCCCCccccccc----CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchh
Q 009364 145 SLNILLEFVPGGSISSLLGK----FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQ 220 (536)
Q Consensus 145 ~~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~ 220 (536)
..++||||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus 106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~ 185 (310)
T 2wqm_A 106 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF 185 (310)
T ss_dssp EEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC-----
T ss_pred cEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceee
Confidence 99999999999999998863 46799999999999999999999999999999999999999999999999999876
Q ss_pred hhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhH---HHHHHHhhCCCCCCCCCCC
Q 009364 221 VAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQ---EVAALFHIGTTKSHPPIPE 297 (536)
Q Consensus 221 ~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~---~~~~~~~~~~~~~~~~~~~ 297 (536)
..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ......... ......+.
T Consensus 186 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~ 261 (310)
T 2wqm_A 186 FSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC--DYPPLPSD 261 (310)
T ss_dssp ---------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTT--CSCCCCTT
T ss_pred ecCCC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcc--cCCCCccc
Confidence 55322 123356799999999999999999999999999999999999999965421 112222111 11222235
Q ss_pred cCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 298 NLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 298 ~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
.++.++++||.+||..||.+|||+.+++++
T Consensus 262 ~~~~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 262 HYSEELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 789999999999999999999999999874
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=375.95 Aligned_cols=250 Identities=24% Similarity=0.332 Sum_probs=205.0
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeEeeeeecC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRYLGTVREE 143 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~ 143 (536)
..+|++.+.||+|+||+||+|.+..+|+.||||++..... ...+.+|+.+++.+ +||||+++++++...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 77 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR----------APQLHLEYRFYKQLGSGDGIPQVYYFGPCG 77 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS----------SCCHHHHHHHHHHHCSCTTSCCEEEEEEET
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc----------hHHHHHHHHHHHHhhCCCCCCEEEEEEecC
Confidence 4689999999999999999999999999999998742211 12467899999999 899999999999999
Q ss_pred CceeEEEEecCCCCccccccc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCc-----EEEEecCc
Q 009364 144 ESLNILLEFVPGGSISSLLGK-FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGC-----IKLADFGA 217 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~-----vkL~DFGl 217 (536)
...++||||+ +++|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+
T Consensus 78 ~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~ 156 (330)
T 2izr_A 78 KYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFAL 156 (330)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTT
T ss_pred CccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEccc
Confidence 9999999999 9999999876 368999999999999999999999999999999999999998887 99999999
Q ss_pred chhhhhhhccc-----CCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhh----HHHH-HHHhhC
Q 009364 218 SKQVAELATVS-----GAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQY----QEVA-ALFHIG 287 (536)
Q Consensus 218 a~~~~~~~~~~-----~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~----~~~~-~~~~~~ 287 (536)
++.+....... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.... .+.. .+....
T Consensus 157 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~ 236 (330)
T 2izr_A 157 AKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTK 236 (330)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHH
T ss_pred ceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhh
Confidence 98754322211 1346789999999999999999999999999999999999999996521 1111 111110
Q ss_pred CCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHh
Q 009364 288 TTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 288 ~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~ 326 (536)
...........++ ++.+||.+||+.||.+||++.++++
T Consensus 237 ~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 237 RATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 0000111122355 9999999999999999999999876
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=357.26 Aligned_cols=250 Identities=27% Similarity=0.444 Sum_probs=211.0
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE 143 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 143 (536)
.+.+|++.+.||+|+||.||+|.+. +++.||+|++..... ..+.+.+|+.+++.++||||+++++++.+.
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 75 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM---------SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 75 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB---------CHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred chhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC---------CHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 3568999999999999999999986 678899999842110 124578899999999999999999999999
Q ss_pred CceeEEEEecCCCCcccccccC-CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhh
Q 009364 144 ESLNILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVA 222 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~ 222 (536)
+..++||||+++++|.+++... +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 76 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 155 (267)
T 3t9t_A 76 APICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL 155 (267)
T ss_dssp SSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBC
T ss_pred CCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccc
Confidence 9999999999999999998764 568999999999999999999999999999999999999999999999999998664
Q ss_pred hhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhHH-HHHHHhhCCCCCCCCCCCcCc
Q 009364 223 ELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQE-VAALFHIGTTKSHPPIPENLS 300 (536)
Q Consensus 223 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~s 300 (536)
... ........||+.|+|||++.+..++.++||||||+++|+|++ |.+||...... ....... ......+..++
T Consensus 156 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~---~~~~~~~~~~~ 231 (267)
T 3t9t_A 156 DDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST---GFRLYKPRLAS 231 (267)
T ss_dssp CHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT---TCCCCCCTTSC
T ss_pred ccc-ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhc---CCcCCCCccCc
Confidence 322 122345567889999999999999999999999999999999 89999754322 2222221 12334556789
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 301 VKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 301 ~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
..+.+||.+||+.||.+|||+.+++++
T Consensus 232 ~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 232 THVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999999999975
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-45 Score=379.04 Aligned_cols=254 Identities=23% Similarity=0.441 Sum_probs=199.7
Q ss_pred CCCCceeeeEEcccCceEEEEEEEc---CCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeee
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNL---DSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTV 140 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~ 140 (536)
...+|++.+.||+|+||+||+|++. .++..||||++... ......+.+.+|+.+++.++||||+++++++
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~-------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 115 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG-------YTEKQRRDFLGEASIMGQFDHPNIIRLEGVV 115 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTT-------CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCc-------cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 4468999999999999999999876 46778999987321 1223456788999999999999999999999
Q ss_pred ecCCceeEEEEecCCCCcccccccCC-CCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcch
Q 009364 141 REEESLNILLEFVPGGSISSLLGKFG-PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASK 219 (536)
Q Consensus 141 ~~~~~~~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~ 219 (536)
......++||||+++|+|.+++.+.+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 116 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 195 (373)
T 2qol_A 116 TKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGR 195 (373)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred eeCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccc
Confidence 99999999999999999999997654 69999999999999999999999999999999999999999999999999998
Q ss_pred hhhhhhcc-cCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhH-HHHHHHhhCCCCCCCCCC
Q 009364 220 QVAELATV-SGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQ-EVAALFHIGTTKSHPPIP 296 (536)
Q Consensus 220 ~~~~~~~~-~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~-~~~~~~~~~~~~~~~~~~ 296 (536)
........ .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||..... ........ ....+.+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~---~~~~~~~ 272 (373)
T 2qol_A 196 VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDE---GYRLPPP 272 (373)
T ss_dssp ------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHT---TEECCCC
T ss_pred ccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc---CCCCCCC
Confidence 76543211 11223346788999999999999999999999999999998 9999965432 22222221 1223445
Q ss_pred CcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 297 ENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 297 ~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
..++..+.+||.+||+.||.+||++.++++.
T Consensus 273 ~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~ 303 (373)
T 2qol_A 273 MDCPAALYQLMLDCWQKDRNNRPKFEQIVSI 303 (373)
T ss_dssp TTCBHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccccHHHHHHHHHHhCcChhhCcCHHHHHHH
Confidence 6789999999999999999999999999873
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=362.81 Aligned_cols=254 Identities=24% Similarity=0.357 Sum_probs=210.0
Q ss_pred CCCCCceeee-EEcccCceEEEEEEE--cCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeee
Q 009364 63 SPPIRWRKGE-LIGCGAFGRVYMGMN--LDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGT 139 (536)
Q Consensus 63 ~~~~~y~~~~-~LG~G~fg~Vy~a~~--~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~ 139 (536)
....+|++.+ .||+|+||+||+|.+ ..+++.||+|++... .......+.+.+|+.+++.++||||++++++
T Consensus 13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 86 (291)
T 1xbb_A 13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE------ANDPALKDELLAEANVMQQLDNPYIVRMIGI 86 (291)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----------CHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccc------ccCHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 4456899998 999999999999954 566889999988421 1122335678899999999999999999999
Q ss_pred eecCCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcch
Q 009364 140 VREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASK 219 (536)
Q Consensus 140 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~ 219 (536)
+ ..+..++||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.
T Consensus 87 ~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 165 (291)
T 1xbb_A 87 C-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSK 165 (291)
T ss_dssp E-ESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred E-CCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcce
Confidence 9 567789999999999999999888889999999999999999999999999999999999999999999999999997
Q ss_pred hhhhhhcc-cCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhHH-HHHHHhhCCCCCCCCCC
Q 009364 220 QVAELATV-SGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQE-VAALFHIGTTKSHPPIP 296 (536)
Q Consensus 220 ~~~~~~~~-~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~~-~~~~~~~~~~~~~~~~~ 296 (536)
........ .......||+.|+|||++.+..++.++|||||||++|+|++ |..||...... ....... ......+
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~---~~~~~~~ 242 (291)
T 1xbb_A 166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK---GERMGCP 242 (291)
T ss_dssp ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT---TCCCCCC
T ss_pred eeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc---CCCCCCC
Confidence 66432221 11233457789999999999889999999999999999999 99999764432 2222222 2234566
Q ss_pred CcCcHHHHHHHHHhcccCCCCCCCHHHHHh
Q 009364 297 ENLSVKAKDFLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 297 ~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~ 326 (536)
..++..+.++|.+||+.||.+|||+.++++
T Consensus 243 ~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 243 AGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 789999999999999999999999999986
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=366.41 Aligned_cols=251 Identities=26% Similarity=0.428 Sum_probs=213.2
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE 143 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 143 (536)
...+|++.+.||+|+||+||+|.+..++..||+|++... ....+.+.+|+.+++.++||||+++++++.+.
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 81 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---------TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 81 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC---------STHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC---------HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 456899999999999999999999999999999988321 11245678899999999999999999999999
Q ss_pred CceeEEEEecCCCCcccccccC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhh
Q 009364 144 ESLNILLEFVPGGSISSLLGKF--GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQV 221 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~ 221 (536)
...++||||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 82 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 82 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM 161 (288)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceec
Confidence 9999999999999999999753 45999999999999999999999999999999999999999999999999999866
Q ss_pred hhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhH-HHHHHHhhCCCCCCCCCCCcC
Q 009364 222 AELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQ-EVAALFHIGTTKSHPPIPENL 299 (536)
Q Consensus 222 ~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~ 299 (536)
.... ........||+.|+|||++.+..++.++|||||||++|+|++ |.+||..... ........ ......+..+
T Consensus 162 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~ 237 (288)
T 3kfa_A 162 TGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK---DYRMERPEGC 237 (288)
T ss_dssp CSSS-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT---TCCCCCCTTC
T ss_pred cCCc-cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc---cCCCCCCCCC
Confidence 5322 112334557889999999999999999999999999999999 9999965432 22222221 2233456788
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 300 SVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 300 s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
+..+.+||.+||..||.+|||+.++++.
T Consensus 238 ~~~l~~li~~~l~~dp~~Rps~~~~~~~ 265 (288)
T 3kfa_A 238 PEKVYELMRACWQWNPSDRPSFAEIHQA 265 (288)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHhCCChhhCcCHHHHHHH
Confidence 9999999999999999999999999873
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-45 Score=370.68 Aligned_cols=251 Identities=24% Similarity=0.406 Sum_probs=208.4
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEE--EEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeEeeee
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELL--AVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRYLGTV 140 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~v--AiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~ 140 (536)
...+|++.+.||+|+||.||+|++..+|..+ |+|.+.. .......+.+.+|+.+++++ +||||+++++++
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~-------~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 95 (327)
T 1fvr_A 23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-------YASKDDHRDFAGELEVLCKLGHHPNIINLLGAC 95 (327)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEEC-------C------CHHHHHHHHHTTCCCCTTBCCEEEEE
T ss_pred cHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecc-------ccchHHHHHHHHHHHHHHhccCCCchhhhceee
Confidence 3468999999999999999999999898866 8888732 11223445688999999999 899999999999
Q ss_pred ecCCceeEEEEecCCCCcccccccCC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCccc
Q 009364 141 REEESLNILLEFVPGGSISSLLGKFG----------------PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILV 204 (536)
Q Consensus 141 ~~~~~~~lV~E~~~gg~L~~~l~~~~----------------~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl 204 (536)
.+.+..++||||+++|+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~ 175 (327)
T 1fvr_A 96 EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV 175 (327)
T ss_dssp EETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred eeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEE
Confidence 99999999999999999999997654 79999999999999999999999999999999999999
Q ss_pred CCCCcEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhHH-HHH
Q 009364 205 DNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQE-VAA 282 (536)
Q Consensus 205 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~~-~~~ 282 (536)
+.++.+||+|||+++..... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||...... ...
T Consensus 176 ~~~~~~kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~ 252 (327)
T 1fvr_A 176 GENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 252 (327)
T ss_dssp CGGGCEEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred cCCCeEEEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHH
Confidence 99999999999998743321 12234567899999999999889999999999999999998 99999765432 222
Q ss_pred HHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 283 LFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 283 ~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
... .......+..++.++++||.+||+.||.+|||+.+++++
T Consensus 253 ~~~---~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 253 KLP---QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp HGG---GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred Hhh---cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 221 222344566889999999999999999999999999986
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=357.03 Aligned_cols=248 Identities=18% Similarity=0.343 Sum_probs=207.3
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE 143 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 143 (536)
...+|++.+.||+|+||+||+|.+ +|+.||+|++... .......+.+.+|+.+++.++||||+++++++.+.
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~------~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 79 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVR------DWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSP 79 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCT------TCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTT
T ss_pred CHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEeccc------ccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccC
Confidence 445899999999999999999987 4889999998432 11223446788999999999999999999999887
Q ss_pred --CceeEEEEecCCCCcccccccCC--CCCHHHHHHHHHHHHHHHHHHHHcC--CccccCCCCCcccCCCCcEEEEecCc
Q 009364 144 --ESLNILLEFVPGGSISSLLGKFG--PFPEAVMRTYTKQLLLGLEYLHNHG--IMHRDIKGANILVDNKGCIKLADFGA 217 (536)
Q Consensus 144 --~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~~--ivHrDLKp~NILl~~~~~vkL~DFGl 217 (536)
...++||||+++|+|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||++.++.++|+|||+
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~ 159 (271)
T 3kmu_A 80 PAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADV 159 (271)
T ss_dssp TSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGS
T ss_pred CCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccc
Confidence 78899999999999999997755 4899999999999999999999999 99999999999999999999999887
Q ss_pred chhhhhhhcccCCcccCCCCCCCChhhhhhcCCCc---cceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCC
Q 009364 218 SKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSY---SADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPP 294 (536)
Q Consensus 218 a~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~---k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 294 (536)
+.... .....||+.|+|||++.+..++. ++|||||||++|+|++|..||.......... ........+.
T Consensus 160 ~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~ 231 (271)
T 3kmu_A 160 KFSFQ-------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGM-KVALEGLRPT 231 (271)
T ss_dssp CCTTS-------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHH-HHHHSCCCCC
T ss_pred eeeec-------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHH-HHHhcCCCCC
Confidence 65422 23457899999999998755544 8999999999999999999997543322111 1112233445
Q ss_pred CCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 295 IPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 295 ~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
.+..++.++.+||.+||+.||.+|||+.++++.
T Consensus 232 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 264 (271)
T 3kmu_A 232 IPPGISPHVSKLMKICMNEDPAKRPKFDMIVPI 264 (271)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 677899999999999999999999999999863
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-45 Score=371.51 Aligned_cols=257 Identities=26% Similarity=0.437 Sum_probs=213.4
Q ss_pred CCCCCceeeeEEcccCceEEEEEE----EcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEee
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGM----NLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLG 138 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~----~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~ 138 (536)
....+|++.+.||+|+||+||+|+ +..+++.||+|++.. ......+.+.+|+.+++.++||||+++++
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~--------~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 91 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQH--------SGPDQQRDFQREIQILKALHSDFIVKYRG 91 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESS--------CCHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEecc--------CCHHHHHHHHHHHHHHHhcCCCceeEEEE
Confidence 345689999999999999999998 467899999998832 12233466889999999999999999999
Q ss_pred eee--cCCceeEEEEecCCCCccccccc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEec
Q 009364 139 TVR--EEESLNILLEFVPGGSISSLLGK-FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADF 215 (536)
Q Consensus 139 ~~~--~~~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DF 215 (536)
++. +....++||||+++++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 92 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Df 171 (327)
T 3lxl_A 92 VSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADF 171 (327)
T ss_dssp EEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCG
T ss_pred EEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEccc
Confidence 886 45668999999999999999876 356999999999999999999999999999999999999999999999999
Q ss_pred Ccchhhhhhhc-ccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHH-------------H
Q 009364 216 GASKQVAELAT-VSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEV-------------A 281 (536)
Q Consensus 216 Gla~~~~~~~~-~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~-------------~ 281 (536)
|+++....... ........||+.|+|||++.+..++.++|||||||++|+|++|..||....... .
T Consensus 172 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 251 (327)
T 3lxl_A 172 GLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALS 251 (327)
T ss_dssp GGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHH
T ss_pred ccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHH
Confidence 99987643222 112344568899999999999899999999999999999999999996544321 1
Q ss_pred HHHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 282 ALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
............+.+..++.++.+||.+||+.||.+|||+.+++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 252 RLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1111122233445667899999999999999999999999999765
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=372.13 Aligned_cols=258 Identities=24% Similarity=0.431 Sum_probs=203.2
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE 142 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 142 (536)
....+|++.+.||+|+||+||+|.+..+|+.+|+|+..+..... ......+.+.+|+.+++.++||||+++++++..
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 88 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA---TSPKANKEILDEAYVMASVDNPHVCRLLGICLT 88 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCC---SSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccc---cCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec
Confidence 34568999999999999999999999888877555432211111 111223567889999999999999999999987
Q ss_pred CCceeEEEEecCCCCccccccc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhh
Q 009364 143 EESLNILLEFVPGGSISSLLGK-FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQV 221 (536)
Q Consensus 143 ~~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~ 221 (536)
.. .++|+||+.+|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 89 ~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 89 ST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp SS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred CC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 64 7899999999999999875 457999999999999999999999999999999999999999999999999999876
Q ss_pred hhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhH-HHHHHHhhCCCCCCCCCCCcC
Q 009364 222 AELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQ-EVAALFHIGTTKSHPPIPENL 299 (536)
Q Consensus 222 ~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~ 299 (536)
.............||+.|+|||++.+..++.++|||||||++|+|++ |.+||..... ........ ....+.+..+
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~ 244 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK---GERLPQPPIC 244 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT---TCCCCCCTTB
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc---CCCCCCCccC
Confidence 54433333445567889999999999999999999999999999999 9999975432 22222222 2234456689
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 300 SVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 300 s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
+.++.+||.+||..||.+|||+.|+++.
T Consensus 245 ~~~l~~li~~~l~~dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 245 TIDVYMIMRKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 9999999999999999999999999974
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=366.76 Aligned_cols=256 Identities=26% Similarity=0.405 Sum_probs=201.1
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcC---CCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeee
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLD---SGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGT 139 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~---~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~ 139 (536)
....+|++++.||+|+||+||+|.+.. ++..||+|++... .......+.+.+|+.+++.++||||++++++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~------~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 104 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLD------NSSQREIEEFLSEAACMKDFSHPNVIRLLGV 104 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---------CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecc------ccchhHHHHHHHHHHHHhcCCCCCeeeeeEE
Confidence 345689999999999999999998765 4568999987421 1122345678899999999999999999999
Q ss_pred eecCC-----ceeEEEEecCCCCcccccc------cCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCC
Q 009364 140 VREEE-----SLNILLEFVPGGSISSLLG------KFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKG 208 (536)
Q Consensus 140 ~~~~~-----~~~lV~E~~~gg~L~~~l~------~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~ 208 (536)
+.... ..++||||+++|+|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 105 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~ 184 (313)
T 3brb_A 105 CIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDM 184 (313)
T ss_dssp EEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTS
T ss_pred EeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC
Confidence 97655 3599999999999999883 345799999999999999999999999999999999999999999
Q ss_pred cEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhHH-HHHHHhh
Q 009364 209 CIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQE-VAALFHI 286 (536)
Q Consensus 209 ~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~~-~~~~~~~ 286 (536)
.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|+|++ |.+||...... .......
T Consensus 185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 264 (313)
T 3brb_A 185 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLH 264 (313)
T ss_dssp CEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT
T ss_pred cEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHc
Confidence 999999999987654332223344567889999999999999999999999999999999 99999654322 2222221
Q ss_pred CCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 287 GTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 287 ~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
......+..++.++.+||.+||..||.+|||+.+++++
T Consensus 265 ---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 265 ---GHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp ---TCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ---CCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 22344567899999999999999999999999999976
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=366.21 Aligned_cols=246 Identities=28% Similarity=0.481 Sum_probs=198.7
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE 142 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 142 (536)
....+|++.+.||+|+||+||+|.+ .++.||+|++.. . ...+.+.+|+.++++++||||+++++++.+
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~-------~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 72 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIES-------E---SERKAFIVELRQLSRVNHPNIVKLYGACLN 72 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSS-------T---THHHHHHHHHHHHHHCCCTTBCCEEEBCTT
T ss_pred CCHhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecC-------h---hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC
Confidence 3456899999999999999999987 478999998731 1 123567889999999999999999998874
Q ss_pred CCceeEEEEecCCCCcccccccCC---CCCHHHHHHHHHHHHHHHHHHHH---cCCccccCCCCCcccCCCCc-EEEEec
Q 009364 143 EESLNILLEFVPGGSISSLLGKFG---PFPEAVMRTYTKQLLLGLEYLHN---HGIMHRDIKGANILVDNKGC-IKLADF 215 (536)
Q Consensus 143 ~~~~~lV~E~~~gg~L~~~l~~~~---~l~~~~~~~i~~qil~aL~yLH~---~~ivHrDLKp~NILl~~~~~-vkL~DF 215 (536)
..++||||++||+|.+++.... .+++..+..++.|++.||.|||+ +||+||||||+|||++.++. +||+||
T Consensus 73 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Df 150 (307)
T 2eva_A 73 --PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDF 150 (307)
T ss_dssp --TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCC
T ss_pred --CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccc
Confidence 4899999999999999997654 37899999999999999999999 89999999999999988886 799999
Q ss_pred CcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCC
Q 009364 216 GASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPI 295 (536)
Q Consensus 216 Gla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 295 (536)
|++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...................+..
T Consensus 151 g~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 225 (307)
T 2eva_A 151 GTACDIQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPL 225 (307)
T ss_dssp CC-----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCC
T ss_pred ccccccccc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCc
Confidence 999765432 234569999999999999999999999999999999999999997432211111111112234455
Q ss_pred CCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 296 PENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 296 ~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
+..++..+.+||.+||+.||.+|||+.+++++
T Consensus 226 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 226 IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 67899999999999999999999999999984
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=370.70 Aligned_cols=253 Identities=25% Similarity=0.366 Sum_probs=205.1
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeee--
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVR-- 141 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~-- 141 (536)
...+|++.+.||+|+||.||+|.+..+|+.||+|++... .....+.+.+|+.+++.++||||+++++++.
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 98 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--------EQQDREEAQREADMHRLFNHPNILRLVAYCLRE 98 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--------SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--------CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEec
Confidence 446899999999999999999999999999999988421 1234567889999999999999999999987
Q ss_pred --cCCceeEEEEecCCCCccccccc----CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEec
Q 009364 142 --EEESLNILLEFVPGGSISSLLGK----FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADF 215 (536)
Q Consensus 142 --~~~~~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DF 215 (536)
.....++||||+.+|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 99 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~df 178 (317)
T 2buj_A 99 RGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDL 178 (317)
T ss_dssp ETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCC
T ss_pred cCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEec
Confidence 34578999999999999998865 467999999999999999999999999999999999999999999999999
Q ss_pred Ccchhhhhhhc-------ccCCcccCCCCCCCChhhhhhcC---CCccceEechhHHHHHHhhCCCCCchhhH---HHHH
Q 009364 216 GASKQVAELAT-------VSGAKSMKGTPYWMAPEVIRQTG---HSYSADIWSVGCTVIEMATGKPPWSQQYQ---EVAA 282 (536)
Q Consensus 216 Gla~~~~~~~~-------~~~~~~~~Gt~~Y~APEvl~~~~---~s~k~DIwSlGvil~eLltG~~Pf~~~~~---~~~~ 282 (536)
|++........ ........||+.|+|||++.+.. ++.++|||||||++|+|++|..||..... ....
T Consensus 179 g~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~ 258 (317)
T 2buj_A 179 GSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL 258 (317)
T ss_dssp SSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHH
T ss_pred CcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhH
Confidence 98765432100 00112345899999999987544 68899999999999999999999964321 1111
Q ss_pred HHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 283 LFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 283 ~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
.... ....+.+..++.++.+||.+||+.||.+|||+.+++++
T Consensus 259 ~~~~---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 259 AVQN---QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp HHHC---C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred Hhhc---cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 1111 22233445789999999999999999999999999987
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=380.91 Aligned_cols=254 Identities=26% Similarity=0.423 Sum_probs=206.3
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE 143 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 143 (536)
...+|++.+.||+|+||+||+|.+..+|+.||||++.... .....+.+.+|+++++.++||||+++++++...
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 79 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNIS-------FLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET 79 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGG-------GGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccc-------ccchHHHHHHHHHHHHhcCCCCCCeEEEeeccC
Confidence 3468999999999999999999999999999999984211 112234567899999999999999999999865
Q ss_pred C--ceeEEEEecCCCCcccccccCC---CCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCccc----CCCCcEEEEe
Q 009364 144 E--SLNILLEFVPGGSISSLLGKFG---PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILV----DNKGCIKLAD 214 (536)
Q Consensus 144 ~--~~~lV~E~~~gg~L~~~l~~~~---~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl----~~~~~vkL~D 214 (536)
. ..++||||++||+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~D 159 (396)
T 4eut_A 80 TTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTD 159 (396)
T ss_dssp TTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECC
T ss_pred CCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEec
Confidence 5 7899999999999999997643 39999999999999999999999999999999999999 7777899999
Q ss_pred cCcchhhhhhhcccCCcccCCCCCCCChhhhhh--------cCCCccceEechhHHHHHHhhCCCCCchh-----hHHHH
Q 009364 215 FGASKQVAELATVSGAKSMKGTPYWMAPEVIRQ--------TGHSYSADIWSVGCTVIEMATGKPPWSQQ-----YQEVA 281 (536)
Q Consensus 215 FGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~--------~~~s~k~DIwSlGvil~eLltG~~Pf~~~-----~~~~~ 281 (536)
||+++...... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||... ..+..
T Consensus 160 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~ 236 (396)
T 4eut_A 160 FGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236 (396)
T ss_dssp GGGCEECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHH
T ss_pred CCCceEccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHH
Confidence 99998765432 2345679999999999875 56788999999999999999999999531 12222
Q ss_pred HHHhhCCC---------------------CCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 282 ALFHIGTT---------------------KSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 282 ~~~~~~~~---------------------~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
........ .....++..++..+.+||.+||+.||++|||+.+++++
T Consensus 237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp HHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred HHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 11111111 11112334567788999999999999999999999764
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=361.15 Aligned_cols=245 Identities=27% Similarity=0.412 Sum_probs=209.6
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec---
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE--- 142 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--- 142 (536)
.+|++.+.||+|+||.||+|.+..+|+.||+|++.... ..+.+|+.+++.++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 78 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------------EKAEREVKALAKLDHVNIVHYNGCWDGFDY 78 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEE
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------------HHHHHHHHHHHhCCCCCEEEEeeeEecccc
Confidence 47999999999999999999999999999999884321 235679999999999999999998854
Q ss_pred -------------CCceeEEEEecCCCCcccccccC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCC
Q 009364 143 -------------EESLNILLEFVPGGSISSLLGKF--GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNK 207 (536)
Q Consensus 143 -------------~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~ 207 (536)
...+++||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 79 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~ 158 (284)
T 2a19_B 79 DPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDT 158 (284)
T ss_dssp C---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET
T ss_pred CcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCC
Confidence 45689999999999999999643 579999999999999999999999999999999999999999
Q ss_pred CcEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhC
Q 009364 208 GCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIG 287 (536)
Q Consensus 208 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~ 287 (536)
+.+||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||........... .
T Consensus 159 ~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~-~- 233 (284)
T 2a19_B 159 KQVKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLR-D- 233 (284)
T ss_dssp TEEEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHHHHHHH-T-
T ss_pred CCEEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHHHHHHhh-c-
Confidence 999999999987665322 23456799999999999999999999999999999999999999865432222221 1
Q ss_pred CCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcC
Q 009364 288 TTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTG 332 (536)
Q Consensus 288 ~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~ 332 (536)
..++..++..+++||.+||..||.+|||+.++++|.|...
T Consensus 234 -----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 234 -----GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp -----TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred -----ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 1244678899999999999999999999999999988654
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=358.10 Aligned_cols=252 Identities=24% Similarity=0.437 Sum_probs=206.9
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCc---EEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGE---LLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE 142 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~---~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 142 (536)
.+|++++.||+|+||+||+|.+..++. .||+|.+.. .......+.+.+|+.+++.++||||+++++++.+
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~-------~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 93 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSR-------ITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLP 93 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETT-------CCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccc-------cccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEec
Confidence 368889999999999999999766554 799998731 2223445678899999999999999999999987
Q ss_pred CCce-eEEEEecCCCCccccccc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchh
Q 009364 143 EESL-NILLEFVPGGSISSLLGK-FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQ 220 (536)
Q Consensus 143 ~~~~-~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~ 220 (536)
.+.. ++||||+.+|+|.+++.. ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 94 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 173 (298)
T 3pls_A 94 PEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARD 173 (298)
T ss_dssp SSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCT
T ss_pred CCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCccc
Confidence 6655 999999999999999876 45789999999999999999999999999999999999999999999999999986
Q ss_pred hhhhhc--ccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCC-CCCchhhH-HHHHHHhhCCCCCCCCCC
Q 009364 221 VAELAT--VSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGK-PPWSQQYQ-EVAALFHIGTTKSHPPIP 296 (536)
Q Consensus 221 ~~~~~~--~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~-~Pf~~~~~-~~~~~~~~~~~~~~~~~~ 296 (536)
...... ........||+.|+|||++.+..++.++|||||||++|+|++|. +||..... ........ ....+.+
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~---~~~~~~~ 250 (298)
T 3pls_A 174 ILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ---GRRLPQP 250 (298)
T ss_dssp TTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHT---TCCCCCC
T ss_pred ccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhc---CCCCCCC
Confidence 654321 22234567889999999999999999999999999999999954 55543322 22222222 2233456
Q ss_pred CcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 297 ENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 297 ~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
..++..+.+||.+||+.||.+|||+.++++.
T Consensus 251 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 281 (298)
T 3pls_A 251 EYCPDSLYQVMQQCWEADPAVRPTFRVLVGE 281 (298)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccchHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 6789999999999999999999999999874
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=360.44 Aligned_cols=255 Identities=24% Similarity=0.407 Sum_probs=210.9
Q ss_pred CCCCceeee-EEcccCceEEEEEEEc--CCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeee
Q 009364 64 PPIRWRKGE-LIGCGAFGRVYMGMNL--DSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTV 140 (536)
Q Consensus 64 ~~~~y~~~~-~LG~G~fg~Vy~a~~~--~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~ 140 (536)
...+|.+.+ .||+|+||+||+|.+. .++..||+|++... ......+.+.+|+.+++.++||||+++++++
T Consensus 7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 79 (287)
T 1u59_A 7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-------TEKADTEEMMREAQIMHQLDNPYIVRLIGVC 79 (287)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-------CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc-------cchhHHHHHHHHHHHHHhCCCCCEeEEEEEe
Confidence 345777776 9999999999999864 46888999998421 1234456788999999999999999999999
Q ss_pred ecCCceeEEEEecCCCCccccccc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcch
Q 009364 141 REEESLNILLEFVPGGSISSLLGK-FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASK 219 (536)
Q Consensus 141 ~~~~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~ 219 (536)
..+..++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++
T Consensus 80 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~ 158 (287)
T 1u59_A 80 -QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSK 158 (287)
T ss_dssp -ESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCE
T ss_pred -cCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECccccee
Confidence 45679999999999999998864 3569999999999999999999999999999999999999999999999999998
Q ss_pred hhhhhhcc-cCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhH-HHHHHHhhCCCCCCCCCC
Q 009364 220 QVAELATV-SGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQ-EVAALFHIGTTKSHPPIP 296 (536)
Q Consensus 220 ~~~~~~~~-~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~-~~~~~~~~~~~~~~~~~~ 296 (536)
........ .......||+.|+|||++.+..++.++|||||||++|+|++ |..||..... ........ ......+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~---~~~~~~~ 235 (287)
T 1u59_A 159 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ---GKRMECP 235 (287)
T ss_dssp ECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT---TCCCCCC
T ss_pred eeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhc---CCcCCCC
Confidence 76432221 22334557899999999998889999999999999999998 9999975432 22222222 2234566
Q ss_pred CcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCC
Q 009364 297 ENLSVKAKDFLLKCLEKEPDLRPTASELLKHPF 329 (536)
Q Consensus 297 ~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~ 329 (536)
..+++++.+||.+||..||.+||++.++++|.+
T Consensus 236 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 236 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred CCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 789999999999999999999999999998744
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=366.49 Aligned_cols=255 Identities=25% Similarity=0.442 Sum_probs=205.1
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCC----cEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEee
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSG----ELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLG 138 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g----~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~ 138 (536)
..+.+|++.+.||+|+||+||+|.+..++ ..||+|++... ........+.+|+.+++.++||||+++++
T Consensus 41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 113 (333)
T 1mqb_A 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-------YTEKQRVDFLGEAGIMGQFSHHNIIRLEG 113 (333)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT-------CCHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCC-------CCHHHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence 45678999999999999999999887553 45999987321 12233456889999999999999999999
Q ss_pred eeecCCceeEEEEecCCCCcccccccC-CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCc
Q 009364 139 TVREEESLNILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGA 217 (536)
Q Consensus 139 ~~~~~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGl 217 (536)
++...+..++||||+++|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 114 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 193 (333)
T 1mqb_A 114 VISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGL 193 (333)
T ss_dssp EECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred EEecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCc
Confidence 999999999999999999999998754 6799999999999999999999999999999999999999999999999999
Q ss_pred chhhhhhhcc-cCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhH-HHHHHHhhCCCCCCCC
Q 009364 218 SKQVAELATV-SGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQ-EVAALFHIGTTKSHPP 294 (536)
Q Consensus 218 a~~~~~~~~~-~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~-~~~~~~~~~~~~~~~~ 294 (536)
++........ .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||..... +....... ....+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~---~~~~~ 270 (333)
T 1mqb_A 194 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND---GFRLP 270 (333)
T ss_dssp -----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT---TCCCC
T ss_pred chhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHC---CCcCC
Confidence 9876542211 11223456889999999999999999999999999999999 9999965432 22222221 22334
Q ss_pred CCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 295 IPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 295 ~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
.+..++..+.+||.+||+.||.+||++.+++++
T Consensus 271 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 271 TPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 566899999999999999999999999999875
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=375.41 Aligned_cols=258 Identities=24% Similarity=0.357 Sum_probs=208.3
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE 142 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 142 (536)
....+|++.+.||+|+||+||+|.+ .+|+.||+|++.... .......+.+|+.+++.++||||+++++++..
T Consensus 27 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 98 (326)
T 3uim_A 27 VASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEER-------TQGGELQFQTEVEMISMAVHRNLLRLRGFCMT 98 (326)
T ss_dssp TTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC------------CCCHHHHHHHGGGTCCCTTBCCCCEEECC
T ss_pred HHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEecccc-------CchHHHHHHHHHHHHHhccCCCccceEEEEec
Confidence 4567899999999999999999974 468999999884221 11112357889999999999999999999999
Q ss_pred CCceeEEEEecCCCCcccccccCC----CCCHHHHHHHHHHHHHHHHHHHHc---CCccccCCCCCcccCCCCcEEEEec
Q 009364 143 EESLNILLEFVPGGSISSLLGKFG----PFPEAVMRTYTKQLLLGLEYLHNH---GIMHRDIKGANILVDNKGCIKLADF 215 (536)
Q Consensus 143 ~~~~~lV~E~~~gg~L~~~l~~~~----~l~~~~~~~i~~qil~aL~yLH~~---~ivHrDLKp~NILl~~~~~vkL~DF 215 (536)
....++||||+.+|+|.+++.... .+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+||
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Df 178 (326)
T 3uim_A 99 PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 178 (326)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCC
T ss_pred CCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccC
Confidence 999999999999999999986543 499999999999999999999999 9999999999999999999999999
Q ss_pred CcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH------HHHHHhhC--
Q 009364 216 GASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE------VAALFHIG-- 287 (536)
Q Consensus 216 Gla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~------~~~~~~~~-- 287 (536)
|+++....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ........
T Consensus 179 g~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 257 (326)
T 3uim_A 179 GLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 257 (326)
T ss_dssp SSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTS
T ss_pred ccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhh
Confidence 99986643221 2234556999999999999989999999999999999999999999532100 01111100
Q ss_pred --------CCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCC
Q 009364 288 --------TTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPF 329 (536)
Q Consensus 288 --------~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~ 329 (536)
........+...+..+.+|+.+||+.||.+|||+.++++|-+
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 258 EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence 011112233455678999999999999999999999999854
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=373.09 Aligned_cols=263 Identities=22% Similarity=0.267 Sum_probs=202.5
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcC---CCcEEEEEEEeehhhccchhH---HHHHHHHHHHHHHHHHhCCCCceeeEe
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLD---SGELLAVKQVLIAANFASKEK---AQDHIKELEEEVKLLKDLSHPNIVRYL 137 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~---~g~~vAiK~i~~~~~~~~~~~---~~~~~~~~~~Ei~iL~~l~HpnIv~l~ 137 (536)
...+|++++.||+|+||+||+|.+.. ++..+|+|++.........+. .......+.+|+.+++.++||||++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence 34689999999999999999999987 788999998854321110000 001123466888999999999999999
Q ss_pred eeeec----CCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCC--cEE
Q 009364 138 GTVRE----EESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKG--CIK 211 (536)
Q Consensus 138 ~~~~~----~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~--~vk 211 (536)
+++.. ....++||||+ |++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+|
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~k 193 (345)
T 2v62_A 115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVY 193 (345)
T ss_dssp EEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEE
T ss_pred cccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEE
Confidence 99987 77899999999 999999998878999999999999999999999999999999999999998877 999
Q ss_pred EEecCcchhhhhhhccc-----CCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhh---HHHHHH
Q 009364 212 LADFGASKQVAELATVS-----GAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQY---QEVAAL 283 (536)
Q Consensus 212 L~DFGla~~~~~~~~~~-----~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~---~~~~~~ 283 (536)
|+|||+++.+....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.... ......
T Consensus 194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~ 273 (345)
T 2v62_A 194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTA 273 (345)
T ss_dssp ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHH
T ss_pred EEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHH
Confidence 99999998765432211 1245679999999999999999999999999999999999999995421 111111
Q ss_pred HhhCCCCCCC-----CCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 284 FHIGTTKSHP-----PIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 284 ~~~~~~~~~~-----~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
.......... .....++.++++||.+||..||.+|||+.++++.
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 274 KTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp HHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 1100000000 0112788999999999999999999999999874
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=357.77 Aligned_cols=252 Identities=27% Similarity=0.455 Sum_probs=205.2
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCC---CcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeee
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDS---GELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTV 140 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~ 140 (536)
...+|++.+.||+|+||+||+|.+... +..||+|++... ......+.+.+|+.+++.++||||+++++++
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 82 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD-------CTLDNKEKFMSEAVIMKNLDHPHIVKLIGII 82 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTT-------SCHHHHHHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccc-------cCchHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 446899999999999999999987543 456999987321 1223456788999999999999999999998
Q ss_pred ecCCceeEEEEecCCCCcccccccC-CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcch
Q 009364 141 REEESLNILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASK 219 (536)
Q Consensus 141 ~~~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~ 219 (536)
.+ +..++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.
T Consensus 83 ~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 161 (281)
T 3cc6_A 83 EE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSR 161 (281)
T ss_dssp CS-SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGG
T ss_pred cC-CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCc
Confidence 75 4578999999999999998654 459999999999999999999999999999999999999999999999999998
Q ss_pred hhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhh-HHHHHHHhhCCCCCCCCCCC
Q 009364 220 QVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQY-QEVAALFHIGTTKSHPPIPE 297 (536)
Q Consensus 220 ~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~-~~~~~~~~~~~~~~~~~~~~ 297 (536)
....... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||.... .......... ...+.+.
T Consensus 162 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~---~~~~~~~ 237 (281)
T 3cc6_A 162 YIEDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG---DRLPKPD 237 (281)
T ss_dssp CC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHT---CCCCCCT
T ss_pred ccccccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcC---CCCCCCC
Confidence 7654221 12334567889999999999999999999999999999998 999996432 2222222222 2234556
Q ss_pred cCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 298 NLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 298 ~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
.+++.+.+||.+||..||.+|||+.+++++
T Consensus 238 ~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 238 LCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 789999999999999999999999999976
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-44 Score=358.50 Aligned_cols=252 Identities=27% Similarity=0.450 Sum_probs=202.7
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCC---cEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeee-e
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSG---ELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTV-R 141 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g---~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~-~ 141 (536)
.+|++.+.||+|+||+||+|.+..++ ..+|+|.+.. .......+.+.+|+.+++.++||||+++++++ .
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~-------~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 97 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-------ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR 97 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETT-------CCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEeccc-------CCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEc
Confidence 47999999999999999999976443 3588898731 22234456788999999999999999999985 4
Q ss_pred cCCceeEEEEecCCCCccccccc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchh
Q 009364 142 EEESLNILLEFVPGGSISSLLGK-FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQ 220 (536)
Q Consensus 142 ~~~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~ 220 (536)
.++..++||||+++|+|.+++.. ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 98 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 98 SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred CCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccc
Confidence 56688999999999999999965 45689999999999999999999999999999999999999999999999999986
Q ss_pred hhhhhc--ccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhH-HHHHHHhhCCCCCCCCCC
Q 009364 221 VAELAT--VSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQ-EVAALFHIGTTKSHPPIP 296 (536)
Q Consensus 221 ~~~~~~--~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~-~~~~~~~~~~~~~~~~~~ 296 (536)
...... ........||+.|+|||++.+..++.++|||||||++|+|++ |.+||..... ........ ......+
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 254 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ---GRRLLQP 254 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHT---TCCCCCC
T ss_pred ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhc---CCCCCCC
Confidence 644321 122334567889999999999999999999999999999999 6677754322 11111111 1233445
Q ss_pred CcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 297 ENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 297 ~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
..++..+.++|.+||+.||.+|||+.++++.
T Consensus 255 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 285 (298)
T 3f66_A 255 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 285 (298)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 6789999999999999999999999999873
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=382.32 Aligned_cols=259 Identities=27% Similarity=0.395 Sum_probs=197.7
Q ss_pred CCCCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeEeee
Q 009364 61 KMSPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRYLGT 139 (536)
Q Consensus 61 ~~~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~ 139 (536)
.......|.+.+.||+|+||+||.+. ..+|+.||||++... . .+.+.+|+.+|+.+ +||||++++++
T Consensus 10 ~~~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~-------~----~~~~~~E~~~l~~l~~HpnIv~~~~~ 77 (434)
T 2rio_A 10 EQSLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLID-------F----CDIALMEIKLLTESDDHPNVIRYYCS 77 (434)
T ss_dssp SCSCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGG-------G----HHHHHHHHHHHHHHTTSTTBCCEEEE
T ss_pred hhhhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHH-------H----HHHHHHHHHHHHhccCCCCcCeEEEE
Confidence 33455678889999999999998754 567999999988421 1 23456899999876 89999999999
Q ss_pred eecCCceeEEEEecCCCCcccccccCCCCC-------HHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCC-----
Q 009364 140 VREEESLNILLEFVPGGSISSLLGKFGPFP-------EAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNK----- 207 (536)
Q Consensus 140 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~-------~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~----- 207 (536)
+.+...+++|||||. |+|.+++....... +..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 78 ~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~ 156 (434)
T 2rio_A 78 ETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTA 156 (434)
T ss_dssp EECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHS
T ss_pred EecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCccccc
Confidence 999999999999995 69999987654332 23456799999999999999999999999999999654
Q ss_pred --------CcEEEEecCcchhhhhhhcc--cCCcccCCCCCCCChhhhhh-------cCCCccceEechhHHHHHHhh-C
Q 009364 208 --------GCIKLADFGASKQVAELATV--SGAKSMKGTPYWMAPEVIRQ-------TGHSYSADIWSVGCTVIEMAT-G 269 (536)
Q Consensus 208 --------~~vkL~DFGla~~~~~~~~~--~~~~~~~Gt~~Y~APEvl~~-------~~~s~k~DIwSlGvil~eLlt-G 269 (536)
+.+||+|||+++........ ......+||+.|+|||++.+ ..++.++|||||||++|+|++ |
T Consensus 157 ~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g 236 (434)
T 2rio_A 157 DQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKG 236 (434)
T ss_dssp CCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTS
T ss_pred ccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCC
Confidence 48999999999876543211 11235679999999999976 568999999999999999999 9
Q ss_pred CCCCchhhHHHHHHHhhCCCCC--CCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcC
Q 009364 270 KPPWSQQYQEVAALFHIGTTKS--HPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTG 332 (536)
Q Consensus 270 ~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~ 332 (536)
..||.........+........ ....+..++.++++||.+||+.||.+|||+.++++||||..
T Consensus 237 ~~Pf~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 237 KHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp CCTTCSTTTHHHHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred CCCCCCchhhHHHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 9999765433333322211111 11112356789999999999999999999999999999964
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=364.44 Aligned_cols=253 Identities=28% Similarity=0.508 Sum_probs=207.6
Q ss_pred CCc-eeeeEEcccCceEEEEEEE----cCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeee
Q 009364 66 IRW-RKGELIGCGAFGRVYMGMN----LDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTV 140 (536)
Q Consensus 66 ~~y-~~~~~LG~G~fg~Vy~a~~----~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~ 140 (536)
.+| ++++.||+|+||+||++.. ..+|+.||+|++.. .......+.+.+|+.+++.++||||+++++++
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~-------~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 102 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKA-------DAGPQHRSGWKQEIDILRTLYHEHIIKYKGCC 102 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECT-------TCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecc-------ccChHHHHHHHHHHHHHHhCCCcchhhEEEEE
Confidence 355 9999999999999988754 45789999999842 12223456788999999999999999999999
Q ss_pred ecC--CceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcc
Q 009364 141 REE--ESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGAS 218 (536)
Q Consensus 141 ~~~--~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla 218 (536)
.+. ..+++||||+++|+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a 181 (318)
T 3lxp_A 103 EDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLA 181 (318)
T ss_dssp EETTTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGC
T ss_pred ecCCCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccc
Confidence 874 5789999999999999999764 5999999999999999999999999999999999999999999999999999
Q ss_pred hhhhhhhcc-cCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHH-------------HHH
Q 009364 219 KQVAELATV-SGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVA-------------ALF 284 (536)
Q Consensus 219 ~~~~~~~~~-~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~-------------~~~ 284 (536)
......... .......||+.|+|||++.+..++.++|||||||++|+|++|..||........ ...
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (318)
T 3lxp_A 182 KAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLT 261 (318)
T ss_dssp EECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHH
T ss_pred ccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHH
Confidence 876543221 123455688999999999998999999999999999999999999965432211 111
Q ss_pred hhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHh
Q 009364 285 HIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 285 ~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~ 326 (536)
.........+.+..++.++.+||++||+.||.+|||+.++++
T Consensus 262 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 262 ELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 111223345567789999999999999999999999999986
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=374.54 Aligned_cols=262 Identities=18% Similarity=0.243 Sum_probs=201.8
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCC-----CcEEEEEEEeehhhccchhHH---HHHHHHHHHHHHHHHhCCCCceee
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDS-----GELLAVKQVLIAANFASKEKA---QDHIKELEEEVKLLKDLSHPNIVR 135 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~-----g~~vAiK~i~~~~~~~~~~~~---~~~~~~~~~Ei~iL~~l~HpnIv~ 135 (536)
...+|++++.||+|+||+||+|.+..+ ++.||+|++.........+.. .........|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 345899999999999999999998765 588999987432211000000 001122445677788899999999
Q ss_pred EeeeeecC----CceeEEEEecCCCCcccccccC-CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccC--CCC
Q 009364 136 YLGTVREE----ESLNILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVD--NKG 208 (536)
Q Consensus 136 l~~~~~~~----~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~--~~~ 208 (536)
+++++... ...++||||+ |++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++ .++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~ 191 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD 191 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTT
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCC
Confidence 99998765 4589999999 99999999765 6799999999999999999999999999999999999998 889
Q ss_pred cEEEEecCcchhhhhhhccc-----CCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH--HH
Q 009364 209 CIKLADFGASKQVAELATVS-----GAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE--VA 281 (536)
Q Consensus 209 ~vkL~DFGla~~~~~~~~~~-----~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~--~~ 281 (536)
.+||+|||+++.+....... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||...... ..
T Consensus 192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~ 271 (364)
T 3op5_A 192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYV 271 (364)
T ss_dssp CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHH
T ss_pred eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHH
Confidence 99999999998765432211 123456999999999999999999999999999999999999999753211 11
Q ss_pred HHHhhCCCCCC------CCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHh
Q 009364 282 ALFHIGTTKSH------PPIPENLSVKAKDFLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 282 ~~~~~~~~~~~------~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~ 326 (536)
........... ......++.++.+||.+||..||.+||++.++++
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 272 RDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 00000000000 0012467899999999999999999999999986
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=353.83 Aligned_cols=248 Identities=26% Similarity=0.432 Sum_probs=207.0
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE 143 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 143 (536)
...+|++.+.||+|+||+||+|.+. ++..||+|++.... ...+.+.+|+++++.++||||+++++++..
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 79 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS---------MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ- 79 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS---------SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc---------ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-
Confidence 4468999999999999999999874 57789999884211 112467889999999999999999999874
Q ss_pred CceeEEEEecCCCCcccccccCC--CCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhh
Q 009364 144 ESLNILLEFVPGGSISSLLGKFG--PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQV 221 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~ 221 (536)
+..++||||+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 80 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 159 (279)
T 1qpc_A 80 EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLI 159 (279)
T ss_dssp SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccc
Confidence 56899999999999999997643 6999999999999999999999999999999999999999999999999999876
Q ss_pred hhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhHH-HHHHHhhCCCCCCCCCCCcC
Q 009364 222 AELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQE-VAALFHIGTTKSHPPIPENL 299 (536)
Q Consensus 222 ~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~ 299 (536)
.... ........||+.|+|||++.+..++.++|||||||++|+|++ |..||...... ....... ......+..+
T Consensus 160 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~ 235 (279)
T 1qpc_A 160 EDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER---GYRMVRPDNC 235 (279)
T ss_dssp SSSC-EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT---TCCCCCCTTC
T ss_pred cCcc-cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhc---ccCCCCcccc
Confidence 5322 122334567889999999998889999999999999999999 99999754322 2222221 2233456688
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHh
Q 009364 300 SVKAKDFLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 300 s~~~~dLi~~cL~~dP~~Rps~~eiL~ 326 (536)
+.++.+||.+||..||.+|||+.++++
T Consensus 236 ~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 236 PEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 999999999999999999999999986
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=381.01 Aligned_cols=249 Identities=26% Similarity=0.473 Sum_probs=208.6
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE 142 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 142 (536)
....+|++.+.||+|+||+||+|.+. ++..||||++.... ...+.+.+|+.+|+.++||||+++++++.
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---------~~~~~~~~E~~~l~~l~h~~iv~l~~~~~- 253 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS---------MSVEAFLAEANVMKTLQHDKLVKLHAVVT- 253 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS---------BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-
T ss_pred echHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC---------ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-
Confidence 34568999999999999999999875 47789999884211 12356789999999999999999999986
Q ss_pred CCceeEEEEecCCCCcccccccC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchh
Q 009364 143 EESLNILLEFVPGGSISSLLGKF--GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQ 220 (536)
Q Consensus 143 ~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~ 220 (536)
.+.+++||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 254 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 333 (454)
T 1qcf_A 254 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARV 333 (454)
T ss_dssp SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGG
T ss_pred CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceE
Confidence 56789999999999999999754 3689999999999999999999999999999999999999999999999999987
Q ss_pred hhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhH-HHHHHHhhCCCCCCCCCCCc
Q 009364 221 VAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQ-EVAALFHIGTTKSHPPIPEN 298 (536)
Q Consensus 221 ~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~ 298 (536)
...... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||..... +....+... ...+.+..
T Consensus 334 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~---~~~~~~~~ 409 (454)
T 1qcf_A 334 IEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG---YRMPRPEN 409 (454)
T ss_dssp BCCHHH-HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHT---CCCCCCTT
T ss_pred cCCCce-eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC---CCCCCCCC
Confidence 653221 22334557889999999999999999999999999999999 9999975432 222222222 23445678
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHh
Q 009364 299 LSVKAKDFLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 299 ~s~~~~dLi~~cL~~dP~~Rps~~eiL~ 326 (536)
++.++.+||.+||..||.+|||+.+|++
T Consensus 410 ~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 410 CPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 9999999999999999999999999976
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=359.71 Aligned_cols=253 Identities=22% Similarity=0.344 Sum_probs=201.0
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeee-e
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTV-R 141 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~-~ 141 (536)
....+|++.+.||+|+||+||+|.+..+|+.||+|++.... ....+.+|+.+++.++|++++..++.+ .
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~~~~e~~~l~~l~~~~~i~~~~~~~~ 75 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT----------KHPQLHIESKIYKMMQGGVGIPTIRWCGA 75 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-------------CCCHHHHHHHHHHHTTSTTCCCEEEEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc----------cchHHHHHHHHHHHhcCCCCCCeeeeecC
Confidence 45578999999999999999999999999999999863221 113467899999999988776666555 6
Q ss_pred cCCceeEEEEecCCCCccccccc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCccc---CCCCcEEEEecCc
Q 009364 142 EEESLNILLEFVPGGSISSLLGK-FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILV---DNKGCIKLADFGA 217 (536)
Q Consensus 142 ~~~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl---~~~~~vkL~DFGl 217 (536)
.....++||||+ +++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 76 ~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~ 154 (296)
T 4hgt_A 76 EGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGL 154 (296)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTT
T ss_pred CCCceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCcc
Confidence 677889999999 9999999874 4679999999999999999999999999999999999999 7888999999999
Q ss_pred chhhhhhhcc-----cCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhh-----HHHHHHHhhC
Q 009364 218 SKQVAELATV-----SGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQY-----QEVAALFHIG 287 (536)
Q Consensus 218 a~~~~~~~~~-----~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~-----~~~~~~~~~~ 287 (536)
++........ .......||+.|+|||++.+..++.++|||||||++|+|++|..||.... ..........
T Consensus 155 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 234 (296)
T 4hgt_A 155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK 234 (296)
T ss_dssp CEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH
T ss_pred ceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccc
Confidence 9876543221 12345689999999999999999999999999999999999999996421 1111111111
Q ss_pred CCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHh
Q 009364 288 TTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 288 ~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~ 326 (536)
...........++.++.+||.+||+.||.+|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 235 MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred ccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 111111223567899999999999999999999999987
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=389.44 Aligned_cols=251 Identities=25% Similarity=0.426 Sum_probs=212.7
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE 143 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 143 (536)
...+|++.+.||+|+||.||+|.+..++..||||++.... ...+.+.+|+.+|+.++||||+++++++...
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 288 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---------MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 288 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS---------SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc---------cchHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 3457999999999999999999999999999999874211 1235678999999999999999999999999
Q ss_pred CceeEEEEecCCCCcccccccC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhh
Q 009364 144 ESLNILLEFVPGGSISSLLGKF--GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQV 221 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~ 221 (536)
..+++||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 289 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 368 (495)
T 1opk_A 289 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLM 368 (495)
T ss_dssp SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred CcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceec
Confidence 9999999999999999999753 45899999999999999999999999999999999999999999999999999876
Q ss_pred hhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhH-HHHHHHhhCCCCCCCCCCCcC
Q 009364 222 AELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQ-EVAALFHIGTTKSHPPIPENL 299 (536)
Q Consensus 222 ~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~ 299 (536)
.... ........+|+.|+|||++.+..++.++|||||||++|+|++ |..||..... .+...... ......+..+
T Consensus 369 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~ 444 (495)
T 1opk_A 369 TGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK---DYRMERPEGC 444 (495)
T ss_dssp TTCC-EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT---TCCCCCCTTC
T ss_pred cCCc-eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc---CCCCCCCCCC
Confidence 4321 222334557789999999999899999999999999999999 9999965432 22222222 2234556789
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 300 SVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 300 s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
+.++.+||.+||+.||.+|||+.++++.
T Consensus 445 ~~~l~~li~~cl~~dP~~RPs~~el~~~ 472 (495)
T 1opk_A 445 PEKVYELMRACWQWNPSDRPSFAEIHQA 472 (495)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 9999999999999999999999999873
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-44 Score=358.00 Aligned_cols=249 Identities=27% Similarity=0.409 Sum_probs=197.2
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHh--CCCCceeeEeeee
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKD--LSHPNIVRYLGTV 140 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~--l~HpnIv~l~~~~ 140 (536)
....+|++.+.||+|+||+||+|.+ +|+.||||++.. .. ...+..|.+++.. ++||||+++++++
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~-------~~----~~~~~~e~~~~~~~~l~h~niv~~~~~~ 71 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSS-------RD----EKSWFRETELYNTVMLRHENILGFIASD 71 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECG-------GG----HHHHHHHHHHHHHTCCCCTTBCCEEEEE
T ss_pred cccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecc-------cc----chhhHHHHHHHHHhhccCcCeeeEEEee
Confidence 3456899999999999999999987 789999998732 11 1233445566655 7999999999986
Q ss_pred ec----CCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHH--------HcCCccccCCCCCcccCCCC
Q 009364 141 RE----EESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLH--------NHGIMHRDIKGANILVDNKG 208 (536)
Q Consensus 141 ~~----~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH--------~~~ivHrDLKp~NILl~~~~ 208 (536)
.. ...+++||||+++|+|.+++.. ..+++..++.++.||+.||+||| ++||+||||||+|||++.++
T Consensus 72 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~ 150 (301)
T 3q4u_A 72 MTSRHSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNG 150 (301)
T ss_dssp EEEETTEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTS
T ss_pred ccccCCCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCC
Confidence 54 3468999999999999999965 57999999999999999999999 99999999999999999999
Q ss_pred cEEEEecCcchhhhhhhcc--cCCcccCCCCCCCChhhhhhc------CCCccceEechhHHHHHHhhC----------C
Q 009364 209 CIKLADFGASKQVAELATV--SGAKSMKGTPYWMAPEVIRQT------GHSYSADIWSVGCTVIEMATG----------K 270 (536)
Q Consensus 209 ~vkL~DFGla~~~~~~~~~--~~~~~~~Gt~~Y~APEvl~~~------~~s~k~DIwSlGvil~eLltG----------~ 270 (536)
.+||+|||+++........ ......+||+.|+|||++.+. .++.++|||||||++|+|++| .
T Consensus 151 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~ 230 (301)
T 3q4u_A 151 QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK 230 (301)
T ss_dssp CEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccc
Confidence 9999999999765432221 113345899999999999876 445799999999999999999 8
Q ss_pred CCCchh------hHHHHHHHhhCCCCCCCCCC-----CcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 271 PPWSQQ------YQEVAALFHIGTTKSHPPIP-----ENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 271 ~Pf~~~------~~~~~~~~~~~~~~~~~~~~-----~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
+||... .......... ....+.++ ..++.++.+||.+||+.||.+|||+.++++.
T Consensus 231 ~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~ 296 (301)
T 3q4u_A 231 PPFYDVVPNDPSFEDMRKVVCV--DQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKT 296 (301)
T ss_dssp CTTTTTSCSSCCHHHHHHHHTT--SCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred ccccccCCCCcchhhhhHHHhc--cCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 888542 1222222221 12222222 3467889999999999999999999999863
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=382.57 Aligned_cols=255 Identities=27% Similarity=0.443 Sum_probs=198.0
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeEeeeeecC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRYLGTVREE 143 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~ 143 (536)
..+|++.+.||+|+||+||. ....+|+.||||++.... ...+.+|+.+|+.+ +||||+++++++.+.
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~-----------~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 90 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPEC-----------FSFADREVQLLRESDEHPNVIRYFCTEKDR 90 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTT-----------EEECHHHHHHHHHSCCCTTBCCEEEEEEET
T ss_pred cEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHH-----------HHHHHHHHHHHHhccCCCCcCeEEEEEecC
Confidence 34799999999999999764 345689999999883211 11245789999999 799999999999999
Q ss_pred CceeEEEEecCCCCcccccccCC-CCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCC---C--CcEEEEecCc
Q 009364 144 ESLNILLEFVPGGSISSLLGKFG-PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDN---K--GCIKLADFGA 217 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~---~--~~vkL~DFGl 217 (536)
...|+|||||. |+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. + ..+||+|||+
T Consensus 91 ~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~ 169 (432)
T 3p23_A 91 QFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGL 169 (432)
T ss_dssp TEEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTE
T ss_pred CEEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccc
Confidence 99999999995 68988886543 4566677899999999999999999999999999999953 2 2688999999
Q ss_pred chhhhhhhc-ccCCcccCCCCCCCChhhhh---hcCCCccceEechhHHHHHHhh-CCCCCchhhHHHHHHHhhCCCCCC
Q 009364 218 SKQVAELAT-VSGAKSMKGTPYWMAPEVIR---QTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQEVAALFHIGTTKSH 292 (536)
Q Consensus 218 a~~~~~~~~-~~~~~~~~Gt~~Y~APEvl~---~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~ 292 (536)
++....... .......+||+.|+|||++. +..++.++|||||||++|+|++ |.+||...................
T Consensus 170 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~ 249 (432)
T 3p23_A 170 CKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDC 249 (432)
T ss_dssp EECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTT
T ss_pred eeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccc
Confidence 987653321 12244578999999999997 4567889999999999999999 999997655444333322222222
Q ss_pred CCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcC
Q 009364 293 PPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTG 332 (536)
Q Consensus 293 ~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~ 332 (536)
...+...+..+++||.+||+.||.+|||+.++++||||..
T Consensus 250 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 250 LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 2223456778999999999999999999999999999975
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=355.44 Aligned_cols=253 Identities=22% Similarity=0.342 Sum_probs=203.9
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeee-ec
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTV-RE 142 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~-~~ 142 (536)
...+|++.+.||+|+||+||+|++..+|+.||+|++..... ...+.+|+.+++.++|++++..+..+ ..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------~~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----------HPQLHIESKIYKMMQGGVGIPTIRWCGAE 76 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS----------CCHHHHHHHHHHHHTTSTTCCCEEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc----------hhHHHHHHHHHHHhhcCCCCCccccccCC
Confidence 45689999999999999999999999999999998743211 12467899999999988766655554 56
Q ss_pred CCceeEEEEecCCCCcccccc-cCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccC---CCCcEEEEecCcc
Q 009364 143 EESLNILLEFVPGGSISSLLG-KFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVD---NKGCIKLADFGAS 218 (536)
Q Consensus 143 ~~~~~lV~E~~~gg~L~~~l~-~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~---~~~~vkL~DFGla 218 (536)
....++||||+ +++|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 77 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 155 (296)
T 3uzp_A 77 GDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155 (296)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred CCceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCc
Confidence 67789999999 999999987 346799999999999999999999999999999999999994 7889999999999
Q ss_pred hhhhhhhcc-----cCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhh-----HHHHHHHhhCC
Q 009364 219 KQVAELATV-----SGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQY-----QEVAALFHIGT 288 (536)
Q Consensus 219 ~~~~~~~~~-----~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~-----~~~~~~~~~~~ 288 (536)
+........ .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... .....+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 235 (296)
T 3uzp_A 156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 235 (296)
T ss_dssp EECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccccc
Confidence 876543221 12345679999999999999999999999999999999999999996421 11111111111
Q ss_pred CCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 289 TKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 289 ~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
.......+..+++++.+||.+||+.||.+|||+.++++.
T Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 274 (296)
T 3uzp_A 236 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQL 274 (296)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHH
T ss_pred CCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHH
Confidence 111112235788999999999999999999999999863
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=362.35 Aligned_cols=255 Identities=27% Similarity=0.481 Sum_probs=209.3
Q ss_pred CCCCceeeeEEcccCceEEEEEE----EcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeee
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGM----NLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGT 139 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~----~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~ 139 (536)
...+|++++.||+|+||.||+|. +..+|+.||+|++.. ......+.+.+|+.+++.++||||++++++
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~--------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 110 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH--------STEEHLRDFEREIEILKSLQHDNIVKYKGV 110 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESS--------CCSHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEecc--------CCHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Confidence 34579999999999999999998 456899999998832 112345678899999999999999999999
Q ss_pred eecCC--ceeEEEEecCCCCcccccccC-CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecC
Q 009364 140 VREEE--SLNILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFG 216 (536)
Q Consensus 140 ~~~~~--~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFG 216 (536)
+...+ .+++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 111 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg 190 (326)
T 2w1i_A 111 CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG 190 (326)
T ss_dssp ECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCT
T ss_pred EEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCc
Confidence 87544 789999999999999999765 469999999999999999999999999999999999999999999999999
Q ss_pred cchhhhhhhcc-cCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHH-------------
Q 009364 217 ASKQVAELATV-SGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAA------------- 282 (536)
Q Consensus 217 la~~~~~~~~~-~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~------------- 282 (536)
+++........ .......+|+.|+|||++.+..++.++|||||||++|+|++|..||.........
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (326)
T 2w1i_A 191 LTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 270 (326)
T ss_dssp TCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHH
T ss_pred chhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHH
Confidence 99876543221 1123456788899999999988999999999999999999999998644222111
Q ss_pred -HHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHh
Q 009364 283 -LFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 283 -~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~ 326 (536)
+..........+.+..++.++.+||.+||+.||.+|||+.++++
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 271 HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11111112234456789999999999999999999999999986
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=379.92 Aligned_cols=243 Identities=26% Similarity=0.454 Sum_probs=204.1
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE 143 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 143 (536)
...+|++.+.||+|+||+||+|.+ .|+.||||++.... ..+.+.+|+.+|+.++||||+++++++...
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~----------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 258 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----------TAQAFLAEASVMTQLRHSNLVQLLGVIVEE 258 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCT----------TSHHHHHHHHHHHTCCCTTBCCEEEEEECT
T ss_pred ChHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCch----------HHHHHHHHHHHHHhccCCCEEEEEEEEEcC
Confidence 346899999999999999999987 47899999883211 235678999999999999999999998765
Q ss_pred C-ceeEEEEecCCCCcccccccCCC--CCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchh
Q 009364 144 E-SLNILLEFVPGGSISSLLGKFGP--FPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQ 220 (536)
Q Consensus 144 ~-~~~lV~E~~~gg~L~~~l~~~~~--l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~ 220 (536)
. .+++||||+++|+|.+++...+. +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 259 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 338 (450)
T 1k9a_A 259 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE 338 (450)
T ss_dssp TSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccc
Confidence 5 79999999999999999976543 79999999999999999999999999999999999999999999999999875
Q ss_pred hhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhh-HHHHHHHhhCCCCCCCCCCCc
Q 009364 221 VAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQY-QEVAALFHIGTTKSHPPIPEN 298 (536)
Q Consensus 221 ~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~-~~~~~~~~~~~~~~~~~~~~~ 298 (536)
.... .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.... .+....... ....+.+..
T Consensus 339 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~---~~~~~~p~~ 410 (450)
T 1k9a_A 339 ASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK---GYKMDAPDG 410 (450)
T ss_dssp CC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHT---TCCCCCCTT
T ss_pred cccc-----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc---CCCCCCCCc
Confidence 4321 223467899999999999999999999999999999998 999996542 222222222 223456778
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHh
Q 009364 299 LSVKAKDFLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 299 ~s~~~~dLi~~cL~~dP~~Rps~~eiL~ 326 (536)
+++++.+||.+||+.||.+|||+.++++
T Consensus 411 ~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 411 CPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 9999999999999999999999999976
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=362.26 Aligned_cols=251 Identities=25% Similarity=0.436 Sum_probs=188.6
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCC-CCceeeEeeeee--
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS-HPNIVRYLGTVR-- 141 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~-- 141 (536)
..+|++.+.||+|+||+||+|.+..+|+.||+|++... .....+.+.+|+.+++.+. ||||+++++++.
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 98 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--------EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIG 98 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--------SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEEC
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--------chHHHHHHHHHHHHHHHhccCCChhhcccccccc
Confidence 45899999999999999999999999999999987321 1233456788999999996 999999999983
Q ss_pred ------cCCceeEEEEecCCCCccccccc---CCCCCHHHHHHHHHHHHHHHHHHHHcC--CccccCCCCCcccCCCCcE
Q 009364 142 ------EEESLNILLEFVPGGSISSLLGK---FGPFPEAVMRTYTKQLLLGLEYLHNHG--IMHRDIKGANILVDNKGCI 210 (536)
Q Consensus 142 ------~~~~~~lV~E~~~gg~L~~~l~~---~~~l~~~~~~~i~~qil~aL~yLH~~~--ivHrDLKp~NILl~~~~~v 210 (536)
....+++||||+. |+|.+++.. .+.+++..++.++.||+.||.|||++| |+||||||+|||++.++.+
T Consensus 99 ~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~ 177 (337)
T 3ll6_A 99 KEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTI 177 (337)
T ss_dssp TTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCE
T ss_pred ccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCE
Confidence 3445899999995 788887753 567999999999999999999999999 9999999999999999999
Q ss_pred EEEecCcchhhhhhhcc----------cCCcccCCCCCCCChhhh---hhcCCCccceEechhHHHHHHhhCCCCCchhh
Q 009364 211 KLADFGASKQVAELATV----------SGAKSMKGTPYWMAPEVI---RQTGHSYSADIWSVGCTVIEMATGKPPWSQQY 277 (536)
Q Consensus 211 kL~DFGla~~~~~~~~~----------~~~~~~~Gt~~Y~APEvl---~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~ 277 (536)
||+|||+++........ ......+||+.|+|||++ .+..++.++|||||||++|+|++|..||....
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 257 (337)
T 3ll6_A 178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA 257 (337)
T ss_dssp EBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence 99999999866432111 111245699999999998 56678999999999999999999999996543
Q ss_pred HHHHHHHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCC
Q 009364 278 QEVAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPF 329 (536)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~ 329 (536)
... .. ......+.+...+..+.+||.+||+.||.+|||+.|+++|-+
T Consensus 258 ~~~--~~---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 258 KLR--IV---NGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp -------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred HHH--hh---cCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 211 11 111222334567788999999999999999999999999844
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=367.09 Aligned_cols=249 Identities=17% Similarity=0.216 Sum_probs=201.8
Q ss_pred CCCceeeeEEcccCceEEEEEEEcC--------CCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceee-
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLD--------SGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVR- 135 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~--------~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~- 135 (536)
..+|++.+.||+|+||+||+|.+.. .++.||+|++... ..+.+|+.+++.++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------------~~~~~E~~~l~~l~h~niv~~ 107 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------------GRLFNEQNFFQRAAKPLQVNK 107 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------------STHHHHHHHHHHHCCHHHHHH
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------------chHHHHHHHHHHhcccchhhh
Confidence 4689999999999999999999987 4889999988321 34678999999999999987
Q ss_pred --------------Eeeeeec-CCceeEEEEecCCCCcccccccC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCC
Q 009364 136 --------------YLGTVRE-EESLNILLEFVPGGSISSLLGKF--GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIK 198 (536)
Q Consensus 136 --------------l~~~~~~-~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLK 198 (536)
+++++.. ....++||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+|||||
T Consensus 108 ~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dik 186 (352)
T 2jii_A 108 WKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVT 186 (352)
T ss_dssp HHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCC
T ss_pred hhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCC
Confidence 5566655 67889999999 99999999876 789999999999999999999999999999999
Q ss_pred CCCcccCCCC--cEEEEecCcchhhhhhhccc-----CCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCC
Q 009364 199 GANILVDNKG--CIKLADFGASKQVAELATVS-----GAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKP 271 (536)
Q Consensus 199 p~NILl~~~~--~vkL~DFGla~~~~~~~~~~-----~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~ 271 (536)
|+|||++.++ .+||+|||+++.+....... ......||+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus 187 p~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~ 266 (352)
T 2jii_A 187 AENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFL 266 (352)
T ss_dssp GGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCC
T ss_pred HHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 9999999998 99999999998765432211 1234579999999999999999999999999999999999999
Q ss_pred CCchhh---HHHHHHHh---hCCCCC--CCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 272 PWSQQY---QEVAALFH---IGTTKS--HPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 272 Pf~~~~---~~~~~~~~---~~~~~~--~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
||.... ........ ...... .......++.++.+||.+||+.||.+|||+.++++.
T Consensus 267 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 330 (352)
T 2jii_A 267 PWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN 330 (352)
T ss_dssp TTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred CcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence 997642 11211111 111100 011123578999999999999999999999999873
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=354.10 Aligned_cols=242 Identities=25% Similarity=0.451 Sum_probs=197.8
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC-
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE- 143 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~- 143 (536)
..+|++.+.||+|+||+||+|.+ +|+.||+|++... ...+.+.+|+.+++.++||||+++++++...
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~----------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND----------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 87 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC----------C--HHHHHTHHHHTTCCCTTBCCEEEEECCC-
T ss_pred hhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecch----------hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 45899999999999999999987 5889999987321 1235678899999999999999999987544
Q ss_pred CceeEEEEecCCCCcccccccCCC--CCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhh
Q 009364 144 ESLNILLEFVPGGSISSLLGKFGP--FPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQV 221 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~~~~~--l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~ 221 (536)
+..++||||+++|+|.+++...+. +++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~ 167 (278)
T 1byg_A 88 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 167 (278)
T ss_dssp -CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred CceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccc
Confidence 579999999999999999876543 899999999999999999999999999999999999999999999999998765
Q ss_pred hhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhH-HHHHHHhhCCCCCCCCCCCcC
Q 009364 222 AELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQ-EVAALFHIGTTKSHPPIPENL 299 (536)
Q Consensus 222 ~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~ 299 (536)
... .....+++.|+|||++.+..++.++|||||||++|+|++ |.+||..... ....... .......+..+
T Consensus 168 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~ 239 (278)
T 1byg_A 168 SST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE---KGYKMDAPDGC 239 (278)
T ss_dssp -------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT---TTCCCCCCTTC
T ss_pred ccc-----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh---cCCCCCCcccC
Confidence 432 223468899999999999999999999999999999998 9999975432 2222221 12234566789
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHh
Q 009364 300 SVKAKDFLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 300 s~~~~dLi~~cL~~dP~~Rps~~eiL~ 326 (536)
++.+.++|.+||..||.+|||+.++++
T Consensus 240 ~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 240 PPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 999999999999999999999999986
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=369.78 Aligned_cols=252 Identities=26% Similarity=0.437 Sum_probs=196.3
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCC---cEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeee-
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSG---ELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVR- 141 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g---~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~- 141 (536)
.+|++.+.||+|+||+||+|.+..++ ..||+|.+.. .......+.+.+|+.+++.++||||+++++++.
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~-------~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~ 161 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-------ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR 161 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCS-------CSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCC-------CCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEc
Confidence 46889999999999999999876443 4688997732 111234567889999999999999999999865
Q ss_pred cCCceeEEEEecCCCCcccccccC-CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchh
Q 009364 142 EEESLNILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQ 220 (536)
Q Consensus 142 ~~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~ 220 (536)
..+..++||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 241 (373)
T 3c1x_A 162 SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD 241 (373)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred CCCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccc
Confidence 456889999999999999999764 4589999999999999999999999999999999999999999999999999986
Q ss_pred hhhhhcc--cCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhH-HHHHHHhhCCCCCCCCCC
Q 009364 221 VAELATV--SGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQ-EVAALFHIGTTKSHPPIP 296 (536)
Q Consensus 221 ~~~~~~~--~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~-~~~~~~~~~~~~~~~~~~ 296 (536)
+...... .......||+.|+|||++.+..++.++|||||||++|+|++ |.+||..... +........ .....+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~---~~~~~p 318 (373)
T 3c1x_A 242 MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG---RRLLQP 318 (373)
T ss_dssp ----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTT---CCCCCC
T ss_pred ccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcC---CCCCCC
Confidence 6432211 11234567889999999999999999999999999999999 7888864321 122222221 233445
Q ss_pred CcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 297 ENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 297 ~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
..++..+.++|.+||+.||.+|||+.+++++
T Consensus 319 ~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 319 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 6789999999999999999999999999875
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=354.00 Aligned_cols=255 Identities=24% Similarity=0.413 Sum_probs=205.3
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
..|..++.||+|+||+||+|.+ +++.||+|++....... .....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 31 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 104 (307)
T 2nru_A 31 PISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDIT----TEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDD 104 (307)
T ss_dssp BTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSC----TTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred cccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcc----hHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCc
Confidence 3466679999999999999975 68899999884322111 12334568899999999999999999999999999
Q ss_pred eeEEEEecCCCCccccccc---CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhh
Q 009364 146 LNILLEFVPGGSISSLLGK---FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVA 222 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~---~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~ 222 (536)
.++||||+++|+|.+++.. ..++++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++...
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 184 (307)
T 2nru_A 105 LCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASE 184 (307)
T ss_dssp CEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred eEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccc
Confidence 9999999999999998863 3569999999999999999999999999999999999999999999999999987655
Q ss_pred hhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhH-----HHHHHHhhC-------CCC
Q 009364 223 ELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQ-----EVAALFHIG-------TTK 290 (536)
Q Consensus 223 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~-----~~~~~~~~~-------~~~ 290 (536)
............||+.|+|||++.+ .++.++|||||||++|+|++|.+||..... ......... ...
T Consensus 185 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (307)
T 2nru_A 185 KFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDK 263 (307)
T ss_dssp SCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCS
T ss_pred cccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccc
Confidence 4322222345679999999999876 488999999999999999999999964321 111111110 011
Q ss_pred CCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 291 SHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 291 ~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
.....+...+..+.++|.+||+.||.+|||+.+++++
T Consensus 264 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 264 KMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp SCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred cccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 1223445667889999999999999999999999875
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=377.74 Aligned_cols=254 Identities=26% Similarity=0.427 Sum_probs=205.0
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE 142 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 142 (536)
.+..+|++.+.||+|+||+||+|.+.. +..||||++.... ...+.+.+|+.+|+.++||||+++++++.+
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 250 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT---------MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS---------SCHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCC---------CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 344679999999999999999999864 5679999874211 112457899999999999999999999876
Q ss_pred CCceeEEEEecCCCCcccccccC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchh
Q 009364 143 EESLNILLEFVPGGSISSLLGKF--GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQ 220 (536)
Q Consensus 143 ~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~ 220 (536)
+..++||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 251 -~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 329 (452)
T 1fmk_A 251 -EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL 329 (452)
T ss_dssp -SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred -CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCcccee
Confidence 6789999999999999999743 5689999999999999999999999999999999999999999999999999987
Q ss_pred hhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhH-HHHHHHhhCCCCCCCCCCCc
Q 009364 221 VAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQ-EVAALFHIGTTKSHPPIPEN 298 (536)
Q Consensus 221 ~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~ 298 (536)
..... ........+|+.|+|||++.+..++.++|||||||++|+|++ |..||..... +....... ....+.+..
T Consensus 330 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~---~~~~~~~~~ 405 (452)
T 1fmk_A 330 IEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER---GYRMPCPPE 405 (452)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT---TCCCCCCTT
T ss_pred cCCCc-eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc---CCCCCCCCC
Confidence 65321 122234557889999999999999999999999999999999 9999976432 22222222 233456678
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHhC--CCCc
Q 009364 299 LSVKAKDFLLKCLEKEPDLRPTASELLKH--PFVT 331 (536)
Q Consensus 299 ~s~~~~dLi~~cL~~dP~~Rps~~eiL~h--p~~~ 331 (536)
++..+.+||.+||+.||.+|||+.++++. .++.
T Consensus 406 ~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 406 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 99999999999999999999999999873 4544
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=370.80 Aligned_cols=246 Identities=17% Similarity=0.187 Sum_probs=198.7
Q ss_pred CCCCceeeeEEcccCceEEEEE-----EEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCC---CCceee
Q 009364 64 PPIRWRKGELIGCGAFGRVYMG-----MNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS---HPNIVR 135 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a-----~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~---HpnIv~ 135 (536)
...+|++.+.||+|+||+||+| .+..+++.||+|++... . ...+..|+.+++.++ |+||++
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-------~----~~~~~~e~~~~~~l~~~~~~~iv~ 131 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-------N----PWEFYIGTQLMERLKPSMQHMFMK 131 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-------C----HHHHHHHHHHHHHSCGGGGGGBCC
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-------C----hhHHHHHHHHHHHhhhhhhhhhhh
Confidence 3467999999999999999999 46778999999988321 1 234566777777776 999999
Q ss_pred EeeeeecCCceeEEEEecCCCCccccccc-----CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCC----
Q 009364 136 YLGTVREEESLNILLEFVPGGSISSLLGK-----FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDN---- 206 (536)
Q Consensus 136 l~~~~~~~~~~~lV~E~~~gg~L~~~l~~-----~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~---- 206 (536)
+++++...+..++|||||+||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 132 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~ 211 (365)
T 3e7e_A 132 FYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLE 211 (365)
T ss_dssp EEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTC
T ss_pred hheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccC
Confidence 99999999999999999999999999963 467999999999999999999999999999999999999988
Q ss_pred -------CCcEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH
Q 009364 207 -------KGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE 279 (536)
Q Consensus 207 -------~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~ 279 (536)
++.+||+|||+|+.+............+||+.|+|||++.+..++.++|||||||++|+|++|+.||......
T Consensus 212 ~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 291 (365)
T 3e7e_A 212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG 291 (365)
T ss_dssp C------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT
T ss_pred ccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC
Confidence 8999999999997654332233345678999999999999999999999999999999999999999654321
Q ss_pred HHHHHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 280 VAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
.. .. ....... ..+..+.+++.+||+.+|.+|++..+.+.+
T Consensus 292 ~~---~~--~~~~~~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~ 332 (365)
T 3e7e_A 292 EC---KP--EGLFRRL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ 332 (365)
T ss_dssp EE---EE--CSCCTTC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred ce---ee--chhcccc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence 10 00 0111111 347788999999999999999765555543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=356.80 Aligned_cols=247 Identities=25% Similarity=0.415 Sum_probs=195.1
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHh--CCCCceeeEeeeeec
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKD--LSHPNIVRYLGTVRE 142 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~--l~HpnIv~l~~~~~~ 142 (536)
..+|++.+.||+|+||+||+|.+ +|+.||+|++... .. .....|.+++.. ++||||+++++++..
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-------~~----~~~~~e~~~~~~~~~~h~~i~~~~~~~~~ 102 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTT-------EE----ASWFRETEIYQTVLMRHENILGFIAADIK 102 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGG-------GH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred ccceEEEeEeecCCCeEEEEEEE--CCceEEEEEEecc-------cc----chhhhHHHHHHHHhhcCCCeeeEEEEEcc
Confidence 35899999999999999999987 4899999988321 11 122344455544 489999999999987
Q ss_pred C----CceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHc--------CCccccCCCCCcccCCCCcE
Q 009364 143 E----ESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNH--------GIMHRDIKGANILVDNKGCI 210 (536)
Q Consensus 143 ~----~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~--------~ivHrDLKp~NILl~~~~~v 210 (536)
. ...++||||+++|+|.+++.. ..+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+
T Consensus 103 ~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~ 181 (337)
T 3mdy_A 103 GTGSWTQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTC 181 (337)
T ss_dssp SCGGGCEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred CCCCCCceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCE
Confidence 7 689999999999999999966 4799999999999999999999999 99999999999999999999
Q ss_pred EEEecCcchhhhhhhccc--CCcccCCCCCCCChhhhhhcCCCcc------ceEechhHHHHHHhhC----------CCC
Q 009364 211 KLADFGASKQVAELATVS--GAKSMKGTPYWMAPEVIRQTGHSYS------ADIWSVGCTVIEMATG----------KPP 272 (536)
Q Consensus 211 kL~DFGla~~~~~~~~~~--~~~~~~Gt~~Y~APEvl~~~~~s~k------~DIwSlGvil~eLltG----------~~P 272 (536)
||+|||+++......... .....+||+.|+|||++.+..++.. +|||||||++|+|++| ..|
T Consensus 182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p 261 (337)
T 3mdy_A 182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP 261 (337)
T ss_dssp EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence 999999997654322211 1235679999999999988776665 9999999999999999 777
Q ss_pred Cchh------hHHHHHHHhhCCCCCCCCCC-----CcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 273 WSQQ------YQEVAALFHIGTTKSHPPIP-----ENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 273 f~~~------~~~~~~~~~~~~~~~~~~~~-----~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
|... .......... ....+.++ ..++.++.+||.+||+.||.+|||+.++++|
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 262 YHDLVPSDPSYEDMREIVCI--KKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp TTTTSCSSCCHHHHHHHHTT--SCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HhhhcCCCCchhhhHHHHhh--hccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 7432 1222222222 12222333 2577889999999999999999999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=353.16 Aligned_cols=257 Identities=27% Similarity=0.436 Sum_probs=200.7
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcC-CCc--EEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeee
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLD-SGE--LLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTV 140 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~-~g~--~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~ 140 (536)
...+|++.+.||+|+||+||+|.+.. +++ .||+|++.... .......+.+.+|+.+++.++||||+++++++
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 90 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDV-----LSQPEAMDDFIREVNAMHSLDHRNLIRLYGVV 90 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC-------------CHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCc-----cCCHHHHHHHHHHHHHHHhCCCCCcccEEEEE
Confidence 34589999999999999999998643 333 68999873211 11123456788999999999999999999999
Q ss_pred ecCCceeEEEEecCCCCcccccccC-CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcch
Q 009364 141 REEESLNILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASK 219 (536)
Q Consensus 141 ~~~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~ 219 (536)
.... .++||||+++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.
T Consensus 91 ~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 91 LTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp CSSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred ccCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccc
Confidence 8765 88999999999999988653 569999999999999999999999999999999999999999999999999987
Q ss_pred hhhhhhcc-cCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhHHHHHHHhhCCCCCCCCCCC
Q 009364 220 QVAELATV-SGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQEVAALFHIGTTKSHPPIPE 297 (536)
Q Consensus 220 ~~~~~~~~-~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 297 (536)
........ .......||+.|+|||++.+..++.++|||||||++|+|++ |..||......... ..........+.+.
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~ 248 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL-HKIDKEGERLPRPE 248 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH-HHHHTSCCCCCCCT
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHH-HHHHccCCCCCCCc
Confidence 76432211 12234568889999999999889999999999999999999 99999754332211 11112223344566
Q ss_pred cCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 298 NLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 298 ~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
.++.+++++|.+||..||.+|||+.+++++
T Consensus 249 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 249 DCPQDIYNVMVQCWAHKPEDRPTFVALRDF 278 (291)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CcCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 899999999999999999999999999974
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=385.37 Aligned_cols=246 Identities=24% Similarity=0.381 Sum_probs=201.8
Q ss_pred eeEEcccCceEEEEEEE--cCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCceeE
Q 009364 71 GELIGCGAFGRVYMGMN--LDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESLNI 148 (536)
Q Consensus 71 ~~~LG~G~fg~Vy~a~~--~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 148 (536)
.+.||+|+||+||+|.+ ..+++.||||++.... ......+.+.+|+.+|+.++||||+++++++.. +.+++
T Consensus 374 ~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~------~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~l 446 (635)
T 4fl3_A 374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA------NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWML 446 (635)
T ss_dssp EEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG------GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred CCEeccCCCEEEEEEEEcCCCcceEEEEEEecccc------CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEE
Confidence 34899999999999955 4567899999884211 111234668899999999999999999999964 56889
Q ss_pred EEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhcc-
Q 009364 149 LLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATV- 227 (536)
Q Consensus 149 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~- 227 (536)
||||+++|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+......
T Consensus 447 v~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 447 VMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred EEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 9999999999999988888999999999999999999999999999999999999999999999999999876543221
Q ss_pred cCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhHH-HHHHHhhCCCCCCCCCCCcCcHHHHH
Q 009364 228 SGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQE-VAALFHIGTTKSHPPIPENLSVKAKD 305 (536)
Q Consensus 228 ~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~~d 305 (536)
.......||+.|+|||++.+..++.++|||||||++|+|++ |..||...... ....+.. ......+..++.++.+
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~---~~~~~~p~~~~~~l~~ 603 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK---GERMGCPAGCPREMYD 603 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT---TCCCCCCTTCCHHHHH
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc---CCCCCCCCCCCHHHHH
Confidence 12234457889999999999999999999999999999998 99999765432 2233222 2244566789999999
Q ss_pred HHHHhcccCCCCCCCHHHHHh
Q 009364 306 FLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 306 Li~~cL~~dP~~Rps~~eiL~ 326 (536)
||.+||+.||.+|||+.++++
T Consensus 604 li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 604 LMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp HHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHH
Confidence 999999999999999999976
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=360.23 Aligned_cols=259 Identities=25% Similarity=0.333 Sum_probs=192.9
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeee--
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVR-- 141 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~-- 141 (536)
...+|++.+.||+|+||+||+|++ +|+.||||++... .... .....|+..+..++||||+++++.+.
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-------~~~~--~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 79 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFA-------NRQN--FINEKNIYRVPLMEHDNIARFIVGDERV 79 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGG-------GHHH--HHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred ChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeecc-------chhh--HHHHHHHHHHHhccCcchhhheeccccc
Confidence 346899999999999999999976 7899999998421 1111 11224444455689999999997543
Q ss_pred ---cCCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---------CCccccCCCCCcccCCCCc
Q 009364 142 ---EEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNH---------GIMHRDIKGANILVDNKGC 209 (536)
Q Consensus 142 ---~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~---------~ivHrDLKp~NILl~~~~~ 209 (536)
....+++||||+++|+|.+++... ..++..++.++.||+.||.|||+. ||+||||||+|||++.++.
T Consensus 80 ~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~ 158 (336)
T 3g2f_A 80 TADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT 158 (336)
T ss_dssp CTTSCEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSC
T ss_pred ccCCCceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCc
Confidence 233678999999999999999764 458999999999999999999999 9999999999999999999
Q ss_pred EEEEecCcchhhhhhh------cccCCcccCCCCCCCChhhhhh-------cCCCccceEechhHHHHHHhhCCCCCchh
Q 009364 210 IKLADFGASKQVAELA------TVSGAKSMKGTPYWMAPEVIRQ-------TGHSYSADIWSVGCTVIEMATGKPPWSQQ 276 (536)
Q Consensus 210 vkL~DFGla~~~~~~~------~~~~~~~~~Gt~~Y~APEvl~~-------~~~s~k~DIwSlGvil~eLltG~~Pf~~~ 276 (536)
+||+|||+++.+.... ........+||+.|+|||++.+ ..++.++|||||||++|+|++|..||...
T Consensus 159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~ 238 (336)
T 3g2f_A 159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238 (336)
T ss_dssp EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCc
Confidence 9999999997654321 1112335679999999999986 45678899999999999999997765321
Q ss_pred h-------------------HHHHHHHhhCCCCCCCCCCC------cCcHHHHHHHHHhcccCCCCCCCHHHHH------
Q 009364 277 Y-------------------QEVAALFHIGTTKSHPPIPE------NLSVKAKDFLLKCLEKEPDLRPTASELL------ 325 (536)
Q Consensus 277 ~-------------------~~~~~~~~~~~~~~~~~~~~------~~s~~~~dLi~~cL~~dP~~Rps~~eiL------ 325 (536)
. ........ .....+.++. .++.++.+||.+||+.||.+|||+.|++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l 316 (336)
T 3g2f_A 239 ESVPEYQMAFQTEVGNHPTFEDMQVLVS--REKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL 316 (336)
T ss_dssp SCCCCCCCTTHHHHCSSCCHHHHHHHHT--TSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred cchhHHHHhhhcccCCCchHHHHHhhhc--ccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence 0 11111111 1122222322 3566899999999999999999999995
Q ss_pred hCCCCcCCCCC
Q 009364 326 KHPFVTGDDED 336 (536)
Q Consensus 326 ~hp~~~~~~~~ 336 (536)
.++|-++....
T Consensus 317 l~~~~~~~~~~ 327 (336)
T 3g2f_A 317 MMIWERNKSVS 327 (336)
T ss_dssp HHCCCC-----
T ss_pred HHHHHhcccCC
Confidence 47777665443
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=369.33 Aligned_cols=251 Identities=20% Similarity=0.263 Sum_probs=193.2
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCC---------CCceee
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS---------HPNIVR 135 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~---------HpnIv~ 135 (536)
..+|++.+.||+|+||+||+|++ +|+.||||++................+.+.+|+.+|+.++ ||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 35799999999999999999987 7899999998643211000011112345677888888775 666555
Q ss_pred Eeee-----------------eec-------------CCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHH
Q 009364 136 YLGT-----------------VRE-------------EESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLE 185 (536)
Q Consensus 136 l~~~-----------------~~~-------------~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~ 185 (536)
+.++ +.+ ...+|+|||||++|++.+.+.+ +.+++..++.++.||+.||.
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHH
Confidence 5554 443 6789999999999987777654 67899999999999999999
Q ss_pred HHH-HcCCccccCCCCCcccCCCC--------------------cEEEEecCcchhhhhhhcccCCcccCCCCCCCChhh
Q 009364 186 YLH-NHGIMHRDIKGANILVDNKG--------------------CIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEV 244 (536)
Q Consensus 186 yLH-~~~ivHrDLKp~NILl~~~~--------------------~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEv 244 (536)
||| ++||+||||||+|||++.++ .+||+|||+|+.... ...+||+.|+|||+
T Consensus 176 ~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~aPE~ 248 (336)
T 2vuw_A 176 VAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSMDEDL 248 (336)
T ss_dssp HHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTTCSGG
T ss_pred HHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecccChhh
Confidence 999 99999999999999999887 899999999986543 24579999999999
Q ss_pred hhhcCCCccceEechhHH-HHHHhhCCCCCchhhH--HH-HHHHhhCCC--CCCCCCCCcCcHHHHHHHHHhcccCCCCC
Q 009364 245 IRQTGHSYSADIWSVGCT-VIEMATGKPPWSQQYQ--EV-AALFHIGTT--KSHPPIPENLSVKAKDFLLKCLEKEPDLR 318 (536)
Q Consensus 245 l~~~~~s~k~DIwSlGvi-l~eLltG~~Pf~~~~~--~~-~~~~~~~~~--~~~~~~~~~~s~~~~dLi~~cL~~dP~~R 318 (536)
+.+.. +.++||||+|++ .+++++|..||..... .. ..+...... ......+..+++++++||++||++|
T Consensus 249 ~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d---- 323 (336)
T 2vuw_A 249 FTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS---- 323 (336)
T ss_dssp GCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS----
T ss_pred hcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC----
Confidence 98766 899999998777 7889999999965321 11 122211111 1112223468999999999999976
Q ss_pred CCHHHHH-hCCCCc
Q 009364 319 PTASELL-KHPFVT 331 (536)
Q Consensus 319 ps~~eiL-~hp~~~ 331 (536)
|+.|+| +||||+
T Consensus 324 -sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 324 -SATDLLCQHSLFK 336 (336)
T ss_dssp -SHHHHHHHCGGGC
T ss_pred -CHHHHHhcCCCcC
Confidence 999999 999994
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=383.07 Aligned_cols=251 Identities=24% Similarity=0.417 Sum_probs=201.9
Q ss_pred CCCceeee-EEcccCceEEEEEEEc--CCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeee
Q 009364 65 PIRWRKGE-LIGCGAFGRVYMGMNL--DSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVR 141 (536)
Q Consensus 65 ~~~y~~~~-~LG~G~fg~Vy~a~~~--~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~ 141 (536)
..++.+.+ .||+|+||+||+|.+. .++..||||++.... .....+.+.+|+++|+.++||||+++++++.
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-------~~~~~~~~~~E~~il~~l~hpniv~l~~~~~ 406 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-------EKADTEEMMREAQIMHQLDNPYIVRLIGVCQ 406 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-------SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-------ChHHHHHHHHHHHHHHhCCCCCEeeEEEEec
Confidence 34556666 8999999999999876 356779999884221 1123456889999999999999999999997
Q ss_pred cCCceeEEEEecCCCCcccccccC-CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchh
Q 009364 142 EEESLNILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQ 220 (536)
Q Consensus 142 ~~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~ 220 (536)
. +.+++||||+.+|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 407 ~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~ 485 (613)
T 2ozo_A 407 A-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKA 485 (613)
T ss_dssp S-SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTT
T ss_pred c-CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCccc
Confidence 6 5699999999999999988643 5699999999999999999999999999999999999999999999999999987
Q ss_pred hhhhhcc-cCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhH-HHHHHHhhCCCCCCCCCCC
Q 009364 221 VAELATV-SGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQ-EVAALFHIGTTKSHPPIPE 297 (536)
Q Consensus 221 ~~~~~~~-~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~ 297 (536)
+...... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||..... +....+.. ......+.
T Consensus 486 ~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~---~~~~~~p~ 562 (613)
T 2ozo_A 486 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ---GKRMECPP 562 (613)
T ss_dssp CC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHT---TCCCCCCT
T ss_pred ccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc---CCCCCCCC
Confidence 6432221 11223446789999999999999999999999999999998 9999975432 22222222 22345667
Q ss_pred cCcHHHHHHHHHhcccCCCCCCCHHHHHh
Q 009364 298 NLSVKAKDFLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 298 ~~s~~~~dLi~~cL~~dP~~Rps~~eiL~ 326 (536)
.++.++.+||.+||..||.+||++.++++
T Consensus 563 ~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 563 ECPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp TCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 89999999999999999999999999864
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=351.14 Aligned_cols=231 Identities=26% Similarity=0.423 Sum_probs=188.0
Q ss_pred CCceee-eEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHH-HhCCCCceeeEeeeeec-
Q 009364 66 IRWRKG-ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLL-KDLSHPNIVRYLGTVRE- 142 (536)
Q Consensus 66 ~~y~~~-~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL-~~l~HpnIv~l~~~~~~- 142 (536)
.+|.+. +.||+|+||.||+|.+..+|+.||+|++.. .....+|+.++ +.++||||+++++++..
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-------------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~ 83 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------------CPKARREVELHWRASQCPHIVRIVDVYENL 83 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-------------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-------------cHHHHHHHHHHHHhccCCCchhHHhhhhhh
Confidence 467776 889999999999999999999999998831 12345677777 56689999999999876
Q ss_pred ---CCceeEEEEecCCCCcccccccCC--CCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCC---CCcEEEEe
Q 009364 143 ---EESLNILLEFVPGGSISSLLGKFG--PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDN---KGCIKLAD 214 (536)
Q Consensus 143 ---~~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~---~~~vkL~D 214 (536)
...+++||||++||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~D 163 (299)
T 3m2w_A 84 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD 163 (299)
T ss_dssp ETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred cCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEec
Confidence 678999999999999999997654 6999999999999999999999999999999999999998 78999999
Q ss_pred cCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHH-HhhCCCCCCC
Q 009364 215 FGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAAL-FHIGTTKSHP 293 (536)
Q Consensus 215 FGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~-~~~~~~~~~~ 293 (536)
||++.... +..++.++|||||||++|+|++|.+||.......... ..........
T Consensus 164 fg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 219 (299)
T 3m2w_A 164 FGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 219 (299)
T ss_dssp CTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCC
T ss_pred cccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccc
Confidence 99875432 1357789999999999999999999997643221110 0011111111
Q ss_pred CCC----CcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 294 PIP----ENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 294 ~~~----~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
..+ ..++.++++||.+||+.||.+|||+.|+++||||...
T Consensus 220 ~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~ 263 (299)
T 3m2w_A 220 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263 (299)
T ss_dssp SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence 222 4689999999999999999999999999999999754
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-44 Score=393.41 Aligned_cols=257 Identities=26% Similarity=0.386 Sum_probs=207.6
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec---
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE--- 142 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--- 142 (536)
.+|++.+.||+|+||+||+|.+..+|+.||||++.. .......+.+.+|+.+++.++||||+++++++..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~-------~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~ 86 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQ-------ELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQK 86 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCS-------CCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecc-------cCCHHHHHHHHHHHHHHHhCCCCCCCceeeeeccccc
Confidence 689999999999999999999999999999998732 1122345678899999999999999999998765
Q ss_pred ---CCceeEEEEecCCCCcccccccCC---CCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCc---EEEE
Q 009364 143 ---EESLNILLEFVPGGSISSLLGKFG---PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGC---IKLA 213 (536)
Q Consensus 143 ---~~~~~lV~E~~~gg~L~~~l~~~~---~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~---vkL~ 213 (536)
.+..++||||++||+|.+++.... .+++..++.++.||+.||+|||++||+||||||+||+++.++. +||+
T Consensus 87 ~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~ 166 (676)
T 3qa8_A 87 LAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKII 166 (676)
T ss_dssp CCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred ccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEc
Confidence 677899999999999999987654 6999999999999999999999999999999999999987764 9999
Q ss_pred ecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHH-----------H
Q 009364 214 DFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVA-----------A 282 (536)
Q Consensus 214 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~-----------~ 282 (536)
|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||........ .
T Consensus 167 DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~ 243 (676)
T 3qa8_A 167 DLGYAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEH 243 (676)
T ss_dssp SCCCCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------
T ss_pred cccccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchh
Confidence 999998765322 23456899999999999999999999999999999999999999965322111 0
Q ss_pred HHhhC----C------CCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcC
Q 009364 283 LFHIG----T------TKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTG 332 (536)
Q Consensus 283 ~~~~~----~------~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~ 332 (536)
..... . ......+...++..+.+||.+||..||.+|||+.++++||||..
T Consensus 244 ~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred hhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 00000 0 00111233457899999999999999999999999999999964
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=379.15 Aligned_cols=254 Identities=26% Similarity=0.427 Sum_probs=210.4
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE 142 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 142 (536)
....+|++.+.||+|+||+||+|.+.. +..||||++.... ...+.+.+|+.+|+.++||||+++++++.+
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 333 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT---------MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 333 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTS---------SCHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCC---------CCHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 344679999999999999999999864 5679999884211 112457899999999999999999999876
Q ss_pred CCceeEEEEecCCCCcccccccC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchh
Q 009364 143 EESLNILLEFVPGGSISSLLGKF--GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQ 220 (536)
Q Consensus 143 ~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~ 220 (536)
+.+++||||+.+|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 334 -~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 412 (535)
T 2h8h_A 334 -EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL 412 (535)
T ss_dssp -SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTT
T ss_pred -ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEccccccee
Confidence 6789999999999999999743 5689999999999999999999999999999999999999999999999999987
Q ss_pred hhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhH-HHHHHHhhCCCCCCCCCCCc
Q 009364 221 VAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQ-EVAALFHIGTTKSHPPIPEN 298 (536)
Q Consensus 221 ~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~ 298 (536)
..... ........+|..|+|||++.+..++.++|||||||++|+|++ |..||..... +....+.. ....+.+..
T Consensus 413 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~---~~~~~~~~~ 488 (535)
T 2h8h_A 413 IEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER---GYRMPCPPE 488 (535)
T ss_dssp CCCHH-HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHT---TCCCCCCTT
T ss_pred cCCCc-eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc---CCCCCCCCC
Confidence 65322 122334557889999999999999999999999999999999 9999976432 22222222 223445678
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHhC--CCCc
Q 009364 299 LSVKAKDFLLKCLEKEPDLRPTASELLKH--PFVT 331 (536)
Q Consensus 299 ~s~~~~dLi~~cL~~dP~~Rps~~eiL~h--p~~~ 331 (536)
++..+.+||.+||+.||++|||+.+|++. .++.
T Consensus 489 ~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 489 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 99999999999999999999999999874 4443
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=352.72 Aligned_cols=246 Identities=26% Similarity=0.351 Sum_probs=199.5
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHh--CCCCceeeEeeeeecC
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKD--LSHPNIVRYLGTVREE 143 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~--l~HpnIv~l~~~~~~~ 143 (536)
.+|++.+.||+|+||+||+|.+ +|+.||+|++.. .. ...+.+|+++++. ++||||+++++++...
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~-------~~----~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~ 108 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSS-------RE----ERSWFREAEIYQTVMLRHENILGFIAADNKD 108 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECG-------GG----HHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCc-------hh----HHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence 4799999999999999999987 589999998831 11 2345678888877 7899999999999877
Q ss_pred C----ceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHH--------HcCCccccCCCCCcccCCCCcEE
Q 009364 144 E----SLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLH--------NHGIMHRDIKGANILVDNKGCIK 211 (536)
Q Consensus 144 ~----~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH--------~~~ivHrDLKp~NILl~~~~~vk 211 (536)
. ..++||||+++|+|.+++.+ ..+++..++.++.||+.||.||| ++||+||||||+|||++.++.+|
T Consensus 109 ~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~k 187 (342)
T 1b6c_B 109 NGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 187 (342)
T ss_dssp CSSCCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEE
T ss_pred CCccceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEE
Confidence 6 78999999999999999976 57999999999999999999999 89999999999999999999999
Q ss_pred EEecCcchhhhhhhcc--cCCcccCCCCCCCChhhhhhcC------CCccceEechhHHHHHHhhC----------CCCC
Q 009364 212 LADFGASKQVAELATV--SGAKSMKGTPYWMAPEVIRQTG------HSYSADIWSVGCTVIEMATG----------KPPW 273 (536)
Q Consensus 212 L~DFGla~~~~~~~~~--~~~~~~~Gt~~Y~APEvl~~~~------~s~k~DIwSlGvil~eLltG----------~~Pf 273 (536)
|+|||++......... .......||+.|+|||++.+.. ++.++|||||||++|+|++| ..||
T Consensus 188 L~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~ 267 (342)
T 1b6c_B 188 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 267 (342)
T ss_dssp ECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCc
Confidence 9999999765543211 1234567999999999998752 33689999999999999999 7888
Q ss_pred chhh------HHHHHHHhhCCCCCCCCCC-----CcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 274 SQQY------QEVAALFHIGTTKSHPPIP-----ENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 274 ~~~~------~~~~~~~~~~~~~~~~~~~-----~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
.... ........ .....+.++ ..++..+.+||.+||+.||.+|||+.++++|
T Consensus 268 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 268 YDLVPSDPSVEEMRKVVC--EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp TTTSCSSCCHHHHHHHHT--TSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cccCcCcccHHHHHHHHH--HHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 6431 22222221 112222333 2455789999999999999999999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=372.58 Aligned_cols=251 Identities=22% Similarity=0.332 Sum_probs=203.6
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCC-CceeeEeeeeecC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH-PNIVRYLGTVREE 143 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~H-pnIv~l~~~~~~~ 143 (536)
..+|++++.||+|+||.||+|.+..+|+.||||++..... ...+.+|+++++.+.| ++|..+..++...
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----------~~~~~~E~~il~~L~~~~~i~~i~~~~~~~ 75 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----------HPQLLYESKIYRILQGGTGIPNVRWFGVEG 75 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS----------SCCHHHHHHHHHHTTTSTTCCCEEEEEEET
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc----------cHHHHHHHHHHHHhcCCCCCCeEEEEEeeC
Confidence 4689999999999999999999999999999998743211 1236689999999986 5666666667778
Q ss_pred CceeEEEEecCCCCccccccc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCccc---CCCCcEEEEecCcch
Q 009364 144 ESLNILLEFVPGGSISSLLGK-FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILV---DNKGCIKLADFGASK 219 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl---~~~~~vkL~DFGla~ 219 (536)
...++||||+ +++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||+++
T Consensus 76 ~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (483)
T 3sv0_A 76 DYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (483)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred CEEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcce
Confidence 8899999999 9999999974 4679999999999999999999999999999999999999 578899999999998
Q ss_pred hhhhhhcc-----cCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhh-----HHHHHHHhhCCC
Q 009364 220 QVAELATV-----SGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQY-----QEVAALFHIGTT 289 (536)
Q Consensus 220 ~~~~~~~~-----~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~-----~~~~~~~~~~~~ 289 (536)
.+...... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.... .....+......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (483)
T 3sv0_A 155 KYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA 234 (483)
T ss_dssp ECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHH
T ss_pred eccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccc
Confidence 76543221 12236789999999999999999999999999999999999999996421 111111111111
Q ss_pred CCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHh
Q 009364 290 KSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 290 ~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~ 326 (536)
.....++..++.++.+||.+||..||.+||++.+|++
T Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp SCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred ccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 1111233577899999999999999999999998775
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=381.92 Aligned_cols=252 Identities=27% Similarity=0.457 Sum_probs=205.9
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCC---CcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeee
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDS---GELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTV 140 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~ 140 (536)
...+|++++.||+|+||+||+|.+..+ +..||+|.+.. .......+.+.+|+.+++.++||||+++++++
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~-------~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 460 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN-------CTSDSVREKFLQEALTMRQFDHPHIVKLIGVI 460 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSS-------TTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecc-------cCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 346899999999999999999998654 46799998732 12223456788999999999999999999998
Q ss_pred ecCCceeEEEEecCCCCcccccccCC-CCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcch
Q 009364 141 REEESLNILLEFVPGGSISSLLGKFG-PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASK 219 (536)
Q Consensus 141 ~~~~~~~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~ 219 (536)
. ++..++||||+++|+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 461 ~-~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~ 539 (656)
T 2j0j_A 461 T-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 539 (656)
T ss_dssp C-SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred e-cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCe
Confidence 5 467899999999999999997543 68999999999999999999999999999999999999999999999999998
Q ss_pred hhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhH-HHHHHHhhCCCCCCCCCCC
Q 009364 220 QVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQ-EVAALFHIGTTKSHPPIPE 297 (536)
Q Consensus 220 ~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~ 297 (536)
....... .......||+.|+|||++.+..++.++|||||||++|+|++ |.+||..... +....+.. ....+.+.
T Consensus 540 ~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~---~~~~~~~~ 615 (656)
T 2j0j_A 540 YMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN---GERLPMPP 615 (656)
T ss_dssp SCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHH---TCCCCCCT
T ss_pred ecCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc---CCCCCCCc
Confidence 7643221 12234567889999999999999999999999999999997 9999975432 22222222 22345667
Q ss_pred cCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 298 NLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 298 ~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
.+++.+.+||.+||..||.+|||+.++++.
T Consensus 616 ~~~~~l~~li~~~l~~dP~~RPs~~el~~~ 645 (656)
T 2j0j_A 616 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 645 (656)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cccHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 899999999999999999999999999864
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-43 Score=353.94 Aligned_cols=253 Identities=26% Similarity=0.424 Sum_probs=200.6
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE 142 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 142 (536)
....+|++.+.||+|+||+||+|.+.. .+|+|++...... ....+.+.+|+.+++.++||||+++++++..
T Consensus 30 i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 100 (319)
T 2y4i_B 30 IPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDN------EDQLKAFKREVMAYRQTRHENVVLFMGACMS 100 (319)
T ss_dssp SCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCC------CCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC
T ss_pred CCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCC------HHHHHHHHHHHHHHhcCCCCCEeEEEEEEec
Confidence 345689999999999999999998753 4999987532211 1112345678999999999999999999999
Q ss_pred CCceeEEEEecCCCCcccccccCC-CCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhh
Q 009364 143 EESLNILLEFVPGGSISSLLGKFG-PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQV 221 (536)
Q Consensus 143 ~~~~~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~ 221 (536)
...+++||||++|++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++..
T Consensus 101 ~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~ 179 (319)
T 2y4i_B 101 PPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSIS 179 (319)
T ss_dssp SSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred CCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence 999999999999999999997754 699999999999999999999999999999999999998 679999999998765
Q ss_pred hhhh---cccCCcccCCCCCCCChhhhhh---------cCCCccceEechhHHHHHHhhCCCCCchhhHHHH-HHHhhCC
Q 009364 222 AELA---TVSGAKSMKGTPYWMAPEVIRQ---------TGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVA-ALFHIGT 288 (536)
Q Consensus 222 ~~~~---~~~~~~~~~Gt~~Y~APEvl~~---------~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~-~~~~~~~ 288 (536)
.... .........||+.|+|||++.+ ..++.++|||||||++|+|++|..||........ ......
T Consensus 180 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~- 258 (319)
T 2y4i_B 180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTG- 258 (319)
T ss_dssp --------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTT-
T ss_pred ccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccC-
Confidence 3221 1122334568999999999874 3578899999999999999999999976543322 122111
Q ss_pred CCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 289 TKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 289 ~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
......+..++.++.+||.+||..||.+|||+.++++.
T Consensus 259 -~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~ 296 (319)
T 2y4i_B 259 -MKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296 (319)
T ss_dssp -CCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred -CCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 12222234688899999999999999999999999974
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=365.02 Aligned_cols=250 Identities=17% Similarity=0.188 Sum_probs=191.7
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCC-Cceee-------
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH-PNIVR------- 135 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~H-pnIv~------- 135 (536)
....|+.++.||+|+||+||+|.+..+|+.||||++.... .......+.+.+|+.+++.+.| +|+..
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~-----~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~ 150 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTE-----RPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRF 150 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSC-----C----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCB
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCC-----CccHHHHHHHHHHHHHHHhhccCCCHHHHHHhccc
Confidence 3456899999999999999999999999999999874211 1112235668899999999977 32111
Q ss_pred --------------Eeeeeec-----CCceeEEEEecCCCCcccccc------c-CCCCCHHHHHHHHHHHHHHHHHHHH
Q 009364 136 --------------YLGTVRE-----EESLNILLEFVPGGSISSLLG------K-FGPFPEAVMRTYTKQLLLGLEYLHN 189 (536)
Q Consensus 136 --------------l~~~~~~-----~~~~~lV~E~~~gg~L~~~l~------~-~~~l~~~~~~~i~~qil~aL~yLH~ 189 (536)
+..++.. ...++++|+++ +++|.+++. . .+.+++..+..++.||+.||+|||+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 229 (413)
T 3dzo_A 151 IFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH 229 (413)
T ss_dssp CCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred ccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 1111111 22456777765 789988874 1 2357788899999999999999999
Q ss_pred cCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhh----------hhcCCCccceEech
Q 009364 190 HGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVI----------RQTGHSYSADIWSV 259 (536)
Q Consensus 190 ~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl----------~~~~~s~k~DIwSl 259 (536)
+||+||||||+|||++.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++|||||
T Consensus 230 ~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSl 303 (413)
T 3dzo_A 230 YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTL 303 (413)
T ss_dssp TTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHH
T ss_pred CCcccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHH
Confidence 99999999999999999999999999998765432 345678 999999999 44457889999999
Q ss_pred hHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcC
Q 009364 260 GCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTG 332 (536)
Q Consensus 260 Gvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~ 332 (536)
||++|+|++|+.||........ ..........++.++++||.+||+.||.+|||+.++++||||..
T Consensus 304 Gvil~elltg~~Pf~~~~~~~~-------~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 304 GLAIYWIWCADLPNTDDAALGG-------SEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369 (413)
T ss_dssp HHHHHHHHHSSCCCCTTGGGSC-------SGGGGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred HHHHHHHHHCCCCCCCcchhhh-------HHHHHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence 9999999999999976432110 00001112367899999999999999999999999999999964
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=378.90 Aligned_cols=241 Identities=23% Similarity=0.403 Sum_probs=199.6
Q ss_pred CCCceeeeEEcccCceEEEEEEEcC-CCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLD-SGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE 143 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~-~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 143 (536)
..+|++.+.||+|+||+||+|.+.. +|+.||||++.. .........+.+|+.+++.++||||+++++++...
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~-------~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 151 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVH-------SGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHT 151 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCS-------SCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCc-------cCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeec
Confidence 3689999999999999999999976 799999998732 11223445678999999999999999999999877
Q ss_pred Cc-----eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcc
Q 009364 144 ES-----LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGAS 218 (536)
Q Consensus 144 ~~-----~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla 218 (536)
+. .|+||||++|++|.+++.. .+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||++
T Consensus 152 ~~~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 152 DRHGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp CTTSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred CCCCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccc
Confidence 66 7999999999999988765 79999999999999999999999999999999999999875 8999999999
Q ss_pred hhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCc
Q 009364 219 KQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPEN 298 (536)
Q Consensus 219 ~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (536)
+.... ....+||+.|+|||++.+. ++.++|||||||++|+|++|.+||...... ... .......
T Consensus 229 ~~~~~------~~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~--------~~~-~~~~~~~ 292 (681)
T 2pzi_A 229 SRINS------FGYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVD--------GLP-EDDPVLK 292 (681)
T ss_dssp EETTC------CSCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECS--------SCC-TTCHHHH
T ss_pred hhccc------CCccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccc--------ccc-ccccccc
Confidence 76543 2456799999999999875 589999999999999999999998653210 000 0001113
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCc
Q 009364 299 LSVKAKDFLLKCLEKEPDLRPTASELLKHPFVT 331 (536)
Q Consensus 299 ~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~ 331 (536)
.++.+.+||.+||++||.+||+..+++.|+|+.
T Consensus 293 ~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 293 TYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp HCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred cCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 467899999999999999999999999998874
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=335.45 Aligned_cols=226 Identities=15% Similarity=0.162 Sum_probs=184.2
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEE 144 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 144 (536)
..+|++.+.||+|+||.||+|.+..+|+.||+|++.... .......+.+.+|+.+++.++||||+++++++...+
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~-----~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~ 104 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQG-----VLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRA 104 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTC-----CSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECccc-----ccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECC
Confidence 358999999999999999999999999999999884221 111334567889999999999999999999999999
Q ss_pred ceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhh
Q 009364 145 SLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAEL 224 (536)
Q Consensus 145 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 224 (536)
..|+||||++|++|.+++.. + .....+..++.||+.||.|||++||+||||||+|||++.+|.+||+++|
T Consensus 105 ~~~lv~e~~~g~~L~~~l~~-~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~-------- 174 (286)
T 3uqc_A 105 GGLVVAEWIRGGSLQEVADT-S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA-------- 174 (286)
T ss_dssp EEEEEEECCCEEEHHHHHTT-C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred cEEEEEEecCCCCHHHHHhc-C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc--------
Confidence 99999999999999999865 3 3566788999999999999999999999999999999999999998544
Q ss_pred hcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHH--HHh--hCCCCCCCCCCCcCc
Q 009364 225 ATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAA--LFH--IGTTKSHPPIPENLS 300 (536)
Q Consensus 225 ~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~--~~~--~~~~~~~~~~~~~~s 300 (536)
|++ .++.++|||||||++|+|++|+.||......... ... ..........+..++
T Consensus 175 --------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T 3uqc_A 175 --------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIP 233 (286)
T ss_dssp --------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSC
T ss_pred --------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCC
Confidence 333 3788999999999999999999999754321000 000 000000012335789
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 301 VKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 301 ~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
.++++||.+||++||.+| |+.++++.
T Consensus 234 ~~l~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 234 FQISAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp HHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred HHHHHHHHHHcccCCccC-CHHHHHHH
Confidence 999999999999999999 99999874
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-34 Score=312.39 Aligned_cols=236 Identities=17% Similarity=0.154 Sum_probs=162.7
Q ss_pred EEcccCceEEEEEEEcCCCcEEEEEEEeehhhc--cchhHHHHHHHHHHHHHHHHHhC-CCCceeeEeeeeecCCceeEE
Q 009364 73 LIGCGAFGRVYMGMNLDSGELLAVKQVLIAANF--ASKEKAQDHIKELEEEVKLLKDL-SHPNIVRYLGTVREEESLNIL 149 (536)
Q Consensus 73 ~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~--~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV 149 (536)
..+.|+.|.+..++....|+.||+|++.+.... ......+...+++.+|+++|+++ .|+||+++++++++++.+|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 367888888888888888999999998654322 22334455667899999999999 699999999999999999999
Q ss_pred EEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhcccC
Q 009364 150 LEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSG 229 (536)
Q Consensus 150 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 229 (536)
||||+|++|.++|.+.+++++. .|+.||+.||+|||++|||||||||+|||++.+|++||+|||+|+...... ..
T Consensus 321 MEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~--~~ 395 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC--SW 395 (569)
T ss_dssp EECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-----CC
T ss_pred EecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC--cc
Confidence 9999999999999998888865 489999999999999999999999999999999999999999998765432 23
Q ss_pred CcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcHHHHHHHHH
Q 009364 230 AKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKDFLLK 309 (536)
Q Consensus 230 ~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~ 309 (536)
..+.+||+.|||||++.+ .+..++|+||+|+++++|.++..+|... .... + .....+..+...
T Consensus 396 ~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~~~~------l~~~---------~-~~~~~~~~l~~~ 458 (569)
T 4azs_A 396 PTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNWLYA------VWQE---------P-VERWNFVLLLAL 458 (569)
T ss_dssp SHHHHHHHHHHHHHHC------------------CCCCTTHHHHHHH------HHTS---------C-GGGCSHHHHHHH
T ss_pred ccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchhHHH------hhcC---------C-CCCCcHHHHHHH
Confidence 456789999999999986 4678899999999999988776554211 1100 0 001113456666
Q ss_pred hcccCCCCCCCHHHHHhCCCC
Q 009364 310 CLEKEPDLRPTASELLKHPFV 330 (536)
Q Consensus 310 cL~~dP~~Rps~~eiL~hp~~ 330 (536)
+...+|..||.......|+|.
T Consensus 459 l~~~~~~~~~~~~~~~~~~~~ 479 (569)
T 4azs_A 459 FEKKAKLPSAEQQRGATEQWI 479 (569)
T ss_dssp HHTGGGSCCGGGSSCCHHHHH
T ss_pred HhCCCCCCCCChhhhccchhH
Confidence 667777777766665555554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-29 Score=275.47 Aligned_cols=193 Identities=14% Similarity=0.123 Sum_probs=149.2
Q ss_pred eeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCceeE
Q 009364 69 RKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESLNI 148 (536)
Q Consensus 69 ~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 148 (536)
...+.||+|+||+||+| ...++.+++|..................+.+.+|+++|++++||||+++..++...+..++
T Consensus 339 ~~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 34678999999999999 4467899999874422111112223345678999999999999999966656667778899
Q ss_pred EEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhccc
Q 009364 149 LLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVS 228 (536)
Q Consensus 149 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 228 (536)
||||++|++|.+++.. +..++.||+.||.|||++||+||||||+|||++. .+||+|||+++.........
T Consensus 417 VmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~ 486 (540)
T 3en9_A 417 MMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKA 486 (540)
T ss_dssp EEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHH
T ss_pred EEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccc
Confidence 9999999999999876 5689999999999999999999999999999998 99999999998765432211
Q ss_pred -----CCcccCCCCCCCChhhhhh--cCCCccceEechhHHHHHHhhCCCCC
Q 009364 229 -----GAKSMKGTPYWMAPEVIRQ--TGHSYSADIWSVGCTVIEMATGKPPW 273 (536)
Q Consensus 229 -----~~~~~~Gt~~Y~APEvl~~--~~~s~k~DIwSlGvil~eLltG~~Pf 273 (536)
.....+||+.|||||++.+ ..|+..+|+||..+-..+.+.++.+|
T Consensus 487 ~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 487 VDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 1246789999999999987 67888999999988888887777665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.3e-25 Score=225.23 Aligned_cols=153 Identities=18% Similarity=0.167 Sum_probs=119.4
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchh-H---------HHHHHHHHHHHHHHHHhCCCCceeeE
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKE-K---------AQDHIKELEEEVKLLKDLSHPNIVRY 136 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~-~---------~~~~~~~~~~Ei~iL~~l~HpnIv~l 136 (536)
.|.+++.||+|+||.||+|.+ .+|+.||+|++.......... . .......+.+|+.+|+.++ | +++
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v 166 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV 166 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence 455669999999999999999 889999999984322110000 0 0023566889999999998 5 666
Q ss_pred eeeeecCCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecC
Q 009364 137 LGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFG 216 (536)
Q Consensus 137 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFG 216 (536)
++++.. +..++||||++||+|.+ +.. .....++.||+.||.|||++||+||||||+|||++ +|.+||+|||
T Consensus 167 ~~~~~~-~~~~lvmE~~~g~~L~~-l~~------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG 237 (282)
T 1zar_A 167 PKVYAW-EGNAVLMELIDAKELYR-VRV------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFP 237 (282)
T ss_dssp CCEEEE-ETTEEEEECCCCEEGGG-CCC------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCT
T ss_pred CeEEec-cceEEEEEecCCCcHHH-cch------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECC
Confidence 665543 56799999999999998 422 23457999999999999999999999999999999 9999999999
Q ss_pred cchhhhhhhcccCCcccCCCCCCCChhhhhh
Q 009364 217 ASKQVAELATVSGAKSMKGTPYWMAPEVIRQ 247 (536)
Q Consensus 217 la~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~ 247 (536)
+|+. +..|+|||++.+
T Consensus 238 ~a~~---------------~~~~~a~e~l~r 253 (282)
T 1zar_A 238 QSVE---------------VGEEGWREILER 253 (282)
T ss_dssp TCEE---------------TTSTTHHHHHHH
T ss_pred CCeE---------------CCCCCHHHHHHH
Confidence 8752 455789999864
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=5e-21 Score=189.09 Aligned_cols=146 Identities=17% Similarity=0.194 Sum_probs=108.7
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcE--EEEEEEeehhhccch----------------hHHHHHHHHHHHHHHHHHhC
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGEL--LAVKQVLIAANFASK----------------EKAQDHIKELEEEVKLLKDL 128 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~--vAiK~i~~~~~~~~~----------------~~~~~~~~~~~~Ei~iL~~l 128 (536)
-|++.+.||+|+||.||+|.+..+|+. ||||++......... .........+.+|+.+|+.+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 478999999999999999998788999 999987432110000 00112234578899999999
Q ss_pred CCCce--eeEeeeeecCCceeEEEEecCC-C----CcccccccCCCCCHHHHHHHHHHHHHHHHHHH-HcCCccccCCCC
Q 009364 129 SHPNI--VRYLGTVREEESLNILLEFVPG-G----SISSLLGKFGPFPEAVMRTYTKQLLLGLEYLH-NHGIMHRDIKGA 200 (536)
Q Consensus 129 ~HpnI--v~l~~~~~~~~~~~lV~E~~~g-g----~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH-~~~ivHrDLKp~ 200 (536)
.|+++ +.+++. ...++||||+.+ | +|.++... .++..+..++.||+.||.||| +.||+||||||+
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~ 200 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEY 200 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTT
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHH
Confidence 87754 333332 367899999942 4 45544322 235577899999999999999 999999999999
Q ss_pred CcccCCCCcEEEEecCcchhh
Q 009364 201 NILVDNKGCIKLADFGASKQV 221 (536)
Q Consensus 201 NILl~~~~~vkL~DFGla~~~ 221 (536)
|||++. .++|+|||+|...
T Consensus 201 NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 201 NIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SEEESS--SEEECCCTTCEET
T ss_pred HEEEcC--cEEEEECcccccC
Confidence 999988 9999999998643
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.73 E-value=7.7e-18 Score=174.61 Aligned_cols=144 Identities=15% Similarity=0.158 Sum_probs=101.7
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhc----------cchhH--H--HHHHHHHHHHHHHHHhCCCCc
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANF----------ASKEK--A--QDHIKELEEEVKLLKDLSHPN 132 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~----------~~~~~--~--~~~~~~~~~Ei~iL~~l~Hpn 132 (536)
-|++++.||+|+||.||+|.+. +|+.||||++...... ..... . ........+|...|.++.+.+
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 4999999999999999999874 6999999987432110 00000 0 011112345777777775444
Q ss_pred eeeEeeeeecCCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCC----
Q 009364 133 IVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKG---- 208 (536)
Q Consensus 133 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~---- 208 (536)
+.- ...+.. ...+|||||++|++|..+... ..+..++.||+.+|.+||++|||||||||.|||++++|
T Consensus 175 v~v-p~p~~~-~~~~LVME~i~G~~L~~l~~~------~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d 246 (397)
T 4gyi_A 175 FPV-PEPIAQ-SRHTIVMSLVDALPMRQVSSV------PDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAED 246 (397)
T ss_dssp CSC-CCEEEE-ETTEEEEECCSCEEGGGCCCC------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSC
T ss_pred CCC-Ceeeec-cCceEEEEecCCccHhhhccc------HHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCccc
Confidence 321 111111 234799999999998776432 23467889999999999999999999999999998776
Q ss_pred ------cEEEEecCcch
Q 009364 209 ------CIKLADFGASK 219 (536)
Q Consensus 209 ------~vkL~DFGla~ 219 (536)
.+.|+||+-+.
T Consensus 247 ~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 247 PSSITLTPIIIXFPQMV 263 (397)
T ss_dssp TTSEEEEEEECCCTTCE
T ss_pred ccccccceEEEEeCCcc
Confidence 38999999664
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.32 E-value=1.4e-12 Score=127.85 Aligned_cols=138 Identities=18% Similarity=0.144 Sum_probs=108.2
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCC-CCceeeEeeeeecCCc
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS-HPNIVRYLGTVREEES 145 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~ 145 (536)
.|++...+|.|+.+.||++.. .|..+++|+...... .....+.+|+.+++.+. +..+.++++++...+.
T Consensus 15 ~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~--------~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~ 84 (263)
T 3tm0_A 15 KYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYK--------GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW 84 (263)
T ss_dssp TSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGT--------TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred cceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccC--------CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCc
Confidence 578888899999999999864 468899998732100 01124678899999884 6778889999988889
Q ss_pred eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------
Q 009364 146 LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHN------------------------------------ 189 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~------------------------------------ 189 (536)
.|+||||++|.+|.+.+. +......++.+++.+|..||+
T Consensus 85 ~~lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T 3tm0_A 85 SNLLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred eEEEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence 999999999999877532 122345788999999999998
Q ss_pred -----------------------cCCccccCCCCCcccCCCCcEEEEecCcch
Q 009364 190 -----------------------HGIMHRDIKGANILVDNKGCIKLADFGASK 219 (536)
Q Consensus 190 -----------------------~~ivHrDLKp~NILl~~~~~vkL~DFGla~ 219 (536)
..++|+|++|.|||++.++.+.|+||+.+.
T Consensus 160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 458999999999999876566799999764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.17 E-value=1.7e-11 Score=119.25 Aligned_cols=133 Identities=21% Similarity=0.177 Sum_probs=97.2
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCc--eeeEeeeeecCC
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPN--IVRYLGTVREEE 144 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hpn--Iv~l~~~~~~~~ 144 (536)
.|.+..+.+.|..+.||++. ..+|..+++|+.... ....+.+|+.+++.+.+.+ +.+++++....+
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~-~~~g~~~vlK~~~~~-----------~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~ 88 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLS-AQGRPVLFVKTDLSG-----------ALNELQDEAARLSWLATTGVPCAAVLDVVTEAG 88 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEE-CTTSCCEEEEEECSC-----------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSS
T ss_pred CCceEecccCCCCceEEEEe-cCCCCeEEEEeCCcc-----------cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCC
Confidence 34554444466679999985 456788999986311 1134567888888885444 556888888888
Q ss_pred ceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---------------------------------
Q 009364 145 SLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHG--------------------------------- 191 (536)
Q Consensus 145 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~--------------------------------- 191 (536)
..++||||++|.+|. ... .. ...++.+++..|..||+..
T Consensus 89 ~~~~v~e~i~G~~l~--~~~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (264)
T 1nd4_A 89 RDWLLLGEVPGQDLL--SSH---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDE 160 (264)
T ss_dssp CEEEEEECCSSEETT--TSC---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCG
T ss_pred CCEEEEEecCCcccC--cCc---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhh
Confidence 899999999998884 211 12 2357788888888888753
Q ss_pred -------------------------CccccCCCCCcccCCCCcEEEEecCcch
Q 009364 192 -------------------------IMHRDIKGANILVDNKGCIKLADFGASK 219 (536)
Q Consensus 192 -------------------------ivHrDLKp~NILl~~~~~vkL~DFGla~ 219 (536)
++|+|++|.||+++.++.+.|+|||.+.
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 161 EHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp GGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred hccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999876667799999864
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.16 E-value=9.3e-11 Score=120.56 Aligned_cols=142 Identities=15% Similarity=0.200 Sum_probs=104.8
Q ss_pred eeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCC--CCceeeEeeeeecC---C
Q 009364 70 KGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS--HPNIVRYLGTVREE---E 144 (536)
Q Consensus 70 ~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~--HpnIv~l~~~~~~~---~ 144 (536)
..+.|+.|.++.||++.. .+..+++|+.... ..........+.+|+.+++.+. +..+++++.++.+. +
T Consensus 42 ~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p-----~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g 114 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGP-----KSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIG 114 (359)
T ss_dssp EEEECCC-CCSCEEEEEC--SSCEEEEECCCC---------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTS
T ss_pred eEEEcCCcccceEEEEEE--CCceEEEEeCCCC-----CCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccC
Confidence 367799999999999864 3467888865200 0110112345778999999886 45578888888766 4
Q ss_pred ceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------
Q 009364 145 SLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHN----------------------------------- 189 (536)
Q Consensus 145 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~----------------------------------- 189 (536)
..++||||++|..+.+.. ...++......++.+++.+|+.||+
T Consensus 115 ~~~~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (359)
T 3dxp_A 115 RAFYIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE 192 (359)
T ss_dssp SCEEEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred CeEEEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence 589999999998885422 1346788889999999999999997
Q ss_pred -----------------------cCCccccCCCCCcccCCCCc--EEEEecCcchh
Q 009364 190 -----------------------HGIMHRDIKGANILVDNKGC--IKLADFGASKQ 220 (536)
Q Consensus 190 -----------------------~~ivHrDLKp~NILl~~~~~--vkL~DFGla~~ 220 (536)
.+++|||++|.|||++.++. +.|+||+.+..
T Consensus 193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 35899999999999987753 69999998764
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.01 E-value=7.7e-11 Score=118.38 Aligned_cols=183 Identities=20% Similarity=0.168 Sum_probs=122.8
Q ss_pred eeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCC-CCc--eeeEeeeeecCC---
Q 009364 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS-HPN--IVRYLGTVREEE--- 144 (536)
Q Consensus 71 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~-Hpn--Iv~l~~~~~~~~--- 144 (536)
.+.++.|....||++. ..+++|+.. .. .....+.+|..+|+.+. +.. +.+++.......
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~-------~~---~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~ 89 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPK-------HS---RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQ 89 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEES-------SH---HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCS
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecC-------Cc---chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCC
Confidence 4569999999999863 468899752 11 23456788999998873 332 334444433333
Q ss_pred ceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------
Q 009364 145 SLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHN----------------------------------- 189 (536)
Q Consensus 145 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~----------------------------------- 189 (536)
..|+||++++|.++..... ..++..+...++.|++..++.||+
T Consensus 90 ~~~~vm~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (304)
T 3sg8_A 90 MSFAGFTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKG 167 (304)
T ss_dssp CSCEEEECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCH
T ss_pred cceEEEcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCc
Confidence 4588999999988865322 346778888899999999999996
Q ss_pred -----------------------cCCccccCCCCCcccCC--CCcEEEEecCcchhhhhhhcccCCcccCCCCCC---CC
Q 009364 190 -----------------------HGIMHRDIKGANILVDN--KGCIKLADFGASKQVAELATVSGAKSMKGTPYW---MA 241 (536)
Q Consensus 190 -----------------------~~ivHrDLKp~NILl~~--~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y---~A 241 (536)
..++|+|++|.||+++. .+.+.|+||+.+..-....... ....+ ..
T Consensus 168 ~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~------~~~~~~~~~~ 241 (304)
T 3sg8_A 168 PQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFI------SLMEDDEEYG 241 (304)
T ss_dssp HHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHH------TTCCTTTSCC
T ss_pred ccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHH------HHHhhccccC
Confidence 13699999999999988 4568899999876432211110 11111 33
Q ss_pred hhhhh----hcCC----------CccceEechhHHHHHHhhCCCCCchh
Q 009364 242 PEVIR----QTGH----------SYSADIWSVGCTVIEMATGKPPWSQQ 276 (536)
Q Consensus 242 PEvl~----~~~~----------s~k~DIwSlGvil~eLltG~~Pf~~~ 276 (536)
|+... ..+. ..-.+.|++|.++|.+.+|.++|...
T Consensus 242 ~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~~~ 290 (304)
T 3sg8_A 242 MEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWYEE 290 (304)
T ss_dssp HHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHHHH
T ss_pred HHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHHHH
Confidence 44321 1111 11258999999999999999987543
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.51 E-value=2.1e-07 Score=91.18 Aligned_cols=132 Identities=18% Similarity=0.183 Sum_probs=95.0
Q ss_pred EEcccCce-EEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCC-CCceeeEeeeeecCCceeEEE
Q 009364 73 LIGCGAFG-RVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS-HPNIVRYLGTVREEESLNILL 150 (536)
Q Consensus 73 ~LG~G~fg-~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV~ 150 (536)
.+..|..| .||+......+..+++|+-.. .....+.+|..+|+.+. +--+.+++.++.+.+..++||
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-----------~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvm 99 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG-----------SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLT 99 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET-----------HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC-----------CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEE
Confidence 45556555 699987777788899997521 12345678888888874 334667888888888999999
Q ss_pred EecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHc----------------------------------------
Q 009364 151 EFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNH---------------------------------------- 190 (536)
Q Consensus 151 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~---------------------------------------- 190 (536)
|+++|.++.+..... ......+..++...|..||+.
T Consensus 100 e~l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (272)
T 4gkh_A 100 TAIPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWP 175 (272)
T ss_dssp ECCCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCC
T ss_pred EeeCCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchH
Confidence 999998776654321 122345666677777777730
Q ss_pred ------------------CCccccCCCCCcccCCCCcEEEEecCcch
Q 009364 191 ------------------GIMHRDIKGANILVDNKGCIKLADFGASK 219 (536)
Q Consensus 191 ------------------~ivHrDLKp~NILl~~~~~vkL~DFGla~ 219 (536)
.++|+|+++.|||++.++.+-|+||+.+.
T Consensus 176 ~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 176 VEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 27899999999999887777799999764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.51 E-value=5.7e-07 Score=90.28 Aligned_cols=133 Identities=19% Similarity=0.163 Sum_probs=94.1
Q ss_pred eeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCC---ceeeEeeeee-cCCce
Q 009364 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHP---NIVRYLGTVR-EEESL 146 (536)
Q Consensus 71 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hp---nIv~l~~~~~-~~~~~ 146 (536)
.+.++.|....||+. |..+++|+.. . ......+.+|..+|+.+.+. .+.+++.+.. ..+..
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~-------~---~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~ 88 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK-------S---QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNP 88 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES-------S---HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC-------C---chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCce
Confidence 456899999999987 5678888741 1 12245678999999998642 2455555553 45567
Q ss_pred eEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHc------------------------------------
Q 009364 147 NILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNH------------------------------------ 190 (536)
Q Consensus 147 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~------------------------------------ 190 (536)
++||||++|.++....- ..++......++.|+...|+.||+.
T Consensus 89 ~~v~e~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~ 166 (306)
T 3tdw_A 89 FVGYRKVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDE 166 (306)
T ss_dssp EEEEECCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCH
T ss_pred EEEEeccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccch
Confidence 89999999988765321 2345566666677777777666642
Q ss_pred ------------------------CCccccCCCCCcccCC---CCc-EEEEecCcchh
Q 009364 191 ------------------------GIMHRDIKGANILVDN---KGC-IKLADFGASKQ 220 (536)
Q Consensus 191 ------------------------~ivHrDLKp~NILl~~---~~~-vkL~DFGla~~ 220 (536)
.++|+|++|.||+++. ++. +.|+||+.+..
T Consensus 167 ~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 167 SLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred hhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2489999999999987 455 58999997654
|
| >2lv7_A Calcium-binding protein 7; metal binding protein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.28 E-value=6.5e-08 Score=80.73 Aligned_cols=54 Identities=15% Similarity=-0.130 Sum_probs=48.2
Q ss_pred CCCCCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 366 SPGSPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 366 ~~~sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
....|..+|.+++|.|+.+||+. .+.+|++.+++.+| .|++|.|+|+||+.++.
T Consensus 38 l~~~F~~~D~d~~G~I~~~El~~~l~~lg~~~~~~ei~~l~~~~D-~d~dG~I~~~EF~~~m~ 99 (100)
T 2lv7_A 38 IREAFKVFDRDGNGFISKQELGTAMRSLGYMPNEVELEVIIQRLD-MDGDGQVDFEEFVTLLG 99 (100)
T ss_dssp HHHHHHHTCSSCSSCBCHHHHHHHHHHHTCCCCTTTHHHHHHHHC-SSCSSSBCHHHHHHHTC
T ss_pred HHHHHHHHcCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHHC-CCCCCeEeHHHHHHHhC
Confidence 34469999999999999999986 57899999999999 89999999999997654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.16 E-value=1.5e-06 Score=90.29 Aligned_cols=84 Identities=19% Similarity=0.145 Sum_probs=48.3
Q ss_pred eeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCC--C-ceeeEeeeeecCCce
Q 009364 70 KGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH--P-NIVRYLGTVREEESL 146 (536)
Q Consensus 70 ~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~H--p-nIv~l~~~~~~~~~~ 146 (536)
..+.||.|..+.||++....+++.+++|........ ...........+..|.++|+.+.. + .+.+++.+ +.+..
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~-~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~ 110 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKV-VGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMA 110 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC--------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTT
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcc-cCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCcc
Confidence 356899999999999976556788999976311100 000000012345567888877632 3 34455543 34557
Q ss_pred eEEEEecCCC
Q 009364 147 NILLEFVPGG 156 (536)
Q Consensus 147 ~lV~E~~~gg 156 (536)
++||||++|.
T Consensus 111 ~lvmE~l~g~ 120 (397)
T 2olc_A 111 VTVMEDLSHL 120 (397)
T ss_dssp EEEECCCTTS
T ss_pred EEEEEeCCCc
Confidence 8999999764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.08 E-value=2e-06 Score=87.75 Aligned_cols=87 Identities=9% Similarity=0.049 Sum_probs=54.1
Q ss_pred eeeeEE-cccCceEEEEEEEc--C----CCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCC-C--CceeeEee
Q 009364 69 RKGELI-GCGAFGRVYMGMNL--D----SGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS-H--PNIVRYLG 138 (536)
Q Consensus 69 ~~~~~L-G~G~fg~Vy~a~~~--~----~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~-H--pnIv~l~~ 138 (536)
...+.| +.|....+|+.... . ++..+++|+.......... ....+.+|+.+++.+. + -.+.+++.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~-----~~~~~~~E~~~l~~L~~~~~vpvP~v~~ 97 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVF-----PTYRLDHQFEVIRLVGELTDVPVPRVRW 97 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSS-----SCCCHHHHHHHHHHHHHHCCSCCCCEEE
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccC-----chhHHHHHHHHHHHHhhcCCCCCCcEEE
Confidence 345678 89999999988643 1 2667888875321100000 0123456777777763 2 34667777
Q ss_pred eeecC---CceeEEEEecCCCCccc
Q 009364 139 TVREE---ESLNILLEFVPGGSISS 160 (536)
Q Consensus 139 ~~~~~---~~~~lV~E~~~gg~L~~ 160 (536)
+..+. +..++||||++|..+.+
T Consensus 98 ~~~~~~~~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 98 IETTGDVLGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp EECSSTTTSSCEEEEECCCCBCCCB
T ss_pred EccCCCccCCceEEEEecCCCChhh
Confidence 76554 35789999999877764
|
| >4drw_A Protein S100-A10/annexin A2 chimeric protein; atypical EF-hand, heteropentameric complex, membrane repair; 3.50A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.95 E-value=3.2e-06 Score=72.86 Aligned_cols=54 Identities=6% Similarity=-0.239 Sum_probs=46.4
Q ss_pred CCCCCCCccccCCCccchhhhhh-------------hhhhhhhhhhhccCCCCCCCccchhhhhhhccc
Q 009364 366 SPGSPGSVDICNLDSLSCSRVIV-------------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRK 421 (536)
Q Consensus 366 ~~~sf~~~D~~~~g~ls~~el~~-------------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~ 421 (536)
....|..||.+ +|.|+..||+. .+.++++.+++.+| .|+||.|||+||+.++..
T Consensus 17 l~~~F~~yd~d-dG~Is~~EL~~~l~~~~~~~l~~~~~~~~v~~~i~~~D-~d~DG~IdF~EF~~lm~~ 83 (121)
T 4drw_A 17 MMFTFHKFAGD-KGYLTKEDLRVLMEKEFPGFLENQKDPLAVDKIMKDLD-QCRDGKVGFQSFFSLIAG 83 (121)
T ss_dssp HHHTTGGGSCT-TCSCCHHHHHHHTTTSCHHHHTTSSCTTHHHHHHHHHC-TTCSSCCCHHHHHHHHHH
T ss_pred HHHHHHHHcCC-CCEEcHHHHHHHHHHHhhhhcccCCCHHHHHHHHHHHc-CCCCCcCcHHHHHHHHHH
Confidence 34569999988 79999999975 35789999999999 999999999999976553
|
| >3pm8_A PFCDPK2, calcium-dependent protein kinase 2; malaria, structural genomics, structural genomics CONS SGC; 2.00A {Plasmodium falciparum K1} | Back alignment and structure |
|---|
Probab=97.93 E-value=3.5e-07 Score=85.60 Aligned_cols=74 Identities=12% Similarity=0.011 Sum_probs=54.9
Q ss_pred ccCCCCCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcccccccCChhhhhhcc
Q 009364 364 LTSPGSPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSSILAPNDLEKSR 435 (536)
Q Consensus 364 ~t~~~sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~~~~~e~l~~aF 435 (536)
......|..+|.+++|.|+.+|+.. .+..+++.+++.+| .|++|.|+|+||+.++........++.++.+|
T Consensus 57 ~~l~~~F~~~D~d~~G~Is~~El~~~l~~~g~~~~~~~~~~l~~~~D-~d~~g~I~~~EF~~~~~~~~~~~~~~~l~~~F 135 (197)
T 3pm8_A 57 NNLRNIFIALDVDNSGTLSSQEILDGLKKIGYQKIPPDIHQVLRDID-SNASGQIHYTDFLAATIDKQTYLKKEVCLIPF 135 (197)
T ss_dssp HHHHHHHHHHCTTCSSEECHHHHHHHHHHHC----CHHHHHHHHC--------CEEHHHHHHTTCCHHHHCSHHHHHHHH
T ss_pred HHHHHHHHHHCCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHhC-CCCCCeEcHHHHHHHHHHHHhhhhHHHHHHHH
Confidence 3345569999999999999999976 46889999999999 89999999999998877766666777888888
Q ss_pred CCC
Q 009364 436 NPM 438 (536)
Q Consensus 436 ~~~ 438 (536)
+-.
T Consensus 136 ~~~ 138 (197)
T 3pm8_A 136 KFF 138 (197)
T ss_dssp HHH
T ss_pred HHH
Confidence 754
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.93 E-value=2.8e-05 Score=78.26 Aligned_cols=30 Identities=20% Similarity=0.297 Sum_probs=26.9
Q ss_pred cCCccccCCCCCcccCCCCcEEEEecCcch
Q 009364 190 HGIMHRDIKGANILVDNKGCIKLADFGASK 219 (536)
Q Consensus 190 ~~ivHrDLKp~NILl~~~~~vkL~DFGla~ 219 (536)
.+++|||+++.|||++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 479999999999999888899999999763
|
| >2kn2_A Calmodulin; S MAPK phosphatase 1, NTMKP1, tobacco MKP1, metal binding Pro; NMR {Glycine max} | Back alignment and structure |
|---|
Probab=97.92 E-value=1.3e-06 Score=70.81 Aligned_cols=67 Identities=13% Similarity=-0.058 Sum_probs=55.3
Q ss_pred CCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcccccc-c--CChhhhhhccC
Q 009364 369 SPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSS-I--LAPNDLEKSRN 436 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~-~--~~~e~l~~aF~ 436 (536)
.|..+|.+++|.|+..||.. .+.+++..++..+| .|++|.|+|+||+.++..... . ...++|+.||+
T Consensus 14 ~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~d-~~~dg~i~~~eF~~~~~~~~~~~~~~~~~~l~~aF~ 91 (92)
T 2kn2_A 14 AFKVFDKDQNGYISASELRHVMINLGEKLTDEEVEQMIKEAD-LDGDGQVNYEEFVKMMMTVRGGGGGNGWSRLRRKFS 91 (92)
T ss_dssp HHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHC-SSCCSSEEHHHHHHHHHHHTTTCCCHHHHHHHHHHT
T ss_pred HHHHHCCCCCCeEcHHHHHHHHHHhCCCCCHHHHHHHHHHhC-CCCCCcEeHHHHHHHHHhccCCCCCchHHHHHHHhc
Confidence 48899999999999999976 46889999999999 899999999999976654332 2 23467999986
|
| >1fi6_A EH domain protein REPS1; EPS15 homology domain, EF hand, calcium, RAS signal transduction, endocytosis/exocytosis complex; NMR {Mus musculus} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=97.89 E-value=3.6e-06 Score=68.72 Aligned_cols=52 Identities=15% Similarity=0.036 Sum_probs=46.6
Q ss_pred CCCCCccccCCCccchhhhhh------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 368 GSPGSVDICNLDSLSCSRVIV------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 368 ~sf~~~D~~~~g~ls~~el~~------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
..|..+|.+++|.|+.+|+.. .+.++++++|+..| .|++|.|+|+||+.++.
T Consensus 13 ~~F~~~D~d~dG~I~~~el~~~l~~~g~~~~~~~~i~~~~D-~d~dG~i~~~EF~~~~~ 70 (92)
T 1fi6_A 13 NQFKTIQPDLNGFIPGSAAKEFFTKSKLPILELSHIWELSD-FDKDGALTLDEFCAAFH 70 (92)
T ss_dssp HHHTTTCCSTTCEEEHHHHHHHHHHHSSCHHHHHHHHHHHC-TTCSSEEEHHHHHHHHH
T ss_pred HHHHHHCCCCCCcCcHHHHHHHHHHcCCCHHHHHHHHHHHC-CCCCCCCCHHHHHHHHH
Confidence 359999999999999999986 46789999999999 89999999999997654
|
| >1eh2_A EPS15; calcium binding, signaling domain, NPF binding, EF-hand, EH domain; NMR {Homo sapiens} SCOP: a.39.1.6 PDB: 2jxc_A 1f8h_A 1ff1_A | Back alignment and structure |
|---|
Probab=97.88 E-value=4.2e-06 Score=70.39 Aligned_cols=51 Identities=20% Similarity=0.066 Sum_probs=45.9
Q ss_pred CCCCCccccCCCccchhhhhh------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 368 GSPGSVDICNLDSLSCSRVIV------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 368 ~sf~~~D~~~~g~ls~~el~~------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
..|..+|. ++|.|+.+|++. .+.+++.+||+..| .|++|.|+|+||+.++.
T Consensus 19 ~~F~~~D~-~dG~Is~~el~~~l~~~gl~~~el~~i~~~~D-~d~dG~id~~EF~~~m~ 75 (106)
T 1eh2_A 19 AIFDSLSP-VNGFLSGDKVKPVLLNSKLPVDILGRVWELSD-IDHDGMLDRDEFAVAMF 75 (106)
T ss_dssp HHHTTSCC-SSSCCBHHHHHHHHHTTTCCHHHHHHHHHHHC-SSCSSBCCHHHHHHHHH
T ss_pred HHHHHhCC-CCCeEcHHHHHHHHHHcCCCHHHHHHHHHHHc-CCCCCcCcHHHHHHHHH
Confidence 34999999 999999999987 46889999999999 89999999999997664
|
| >1qjt_A EH1, epidermal growth factor receptor substrate substrate 15, EPS15; EH domain, EF-hand, solution structure, S100 protein; NMR {Mus musculus} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=97.85 E-value=2.9e-06 Score=70.40 Aligned_cols=52 Identities=13% Similarity=0.030 Sum_probs=46.8
Q ss_pred CCCCCccccCCCccchhhhhh------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 368 GSPGSVDICNLDSLSCSRVIV------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 368 ~sf~~~D~~~~g~ls~~el~~------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
..|..+|.+++|.|+.+|+.. .+.+++..+|+.+| .|++|.|+|+||+.++.
T Consensus 15 ~~F~~~D~d~dG~Is~~el~~~l~~~~l~~~~l~~i~~~~D-~d~dG~i~~~EF~~~~~ 72 (99)
T 1qjt_A 15 KYYRQVEAGNTGRVLALDAAAFLKKSGLPDLILGKIWDLAD-TDGKGVLSKQEFFVALR 72 (99)
T ss_dssp HHHHHHCCTTSSCCCSHHHHHHHHTSSSCHHHHHHHHHHHC-CSSSSSCCSHHHHHHHH
T ss_pred HHHHHHCCCCCCcCCHHHHHHHHHHcCCCHHHHHHHHHHHC-CCCCCcCCHHHHHHHHH
Confidence 359999999999999999986 46889999999999 89999999999997654
|
| >1c07_A Protein (epidermal growth factor receptor pathway substrate 15); calcium binding, signaling domain, NPF binding, FW binding, EF-hand, EH domain; NMR {Homo sapiens} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=97.81 E-value=3.4e-06 Score=69.28 Aligned_cols=51 Identities=16% Similarity=0.005 Sum_probs=46.1
Q ss_pred CCCCccccCCCccchhhhhh------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 369 SPGSVDICNLDSLSCSRVIV------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
.|..+|.+++|.|+.+|+.. .+.++++++|+..| .|++|.|+|+||+.++.
T Consensus 15 ~F~~~D~d~dG~I~~~el~~~l~~~g~~~~~~~~i~~~~D-~d~dG~i~~~EF~~~~~ 71 (95)
T 1c07_A 15 IFLKTDKDMDGFVSGLEVREIFLKTGLPSTLLAHIWSLCD-TKDCGKLSKDQFALAFH 71 (95)
T ss_dssp HHHHHCTTCSSEECHHHHHHHHHTTTCCHHHHHHHHHHHC-TTCSSSEETTTHHHHHH
T ss_pred HHHHhCCCCCCcEeHHHHHHHHHHcCCCHHHHHHHHHHHC-CCCCCcCCHHHHHHHHH
Confidence 49999999999999999986 46789999999999 89999999999997654
|
| >2opo_A Polcalcin CHE A 3; calcium-binding protein, dimer, domain-swapping, EF-hand; 1.75A {Chenopodium album} SCOP: a.39.1.10 PDB: 1h4b_A | Back alignment and structure |
|---|
Probab=97.80 E-value=1.3e-06 Score=69.81 Aligned_cols=65 Identities=12% Similarity=-0.044 Sum_probs=53.2
Q ss_pred CCCCCccccCCCccchhhhhh-------hhhhhhhhhhhccCCCCCCCccchhhhhhhcccccccCChhhhhhcc
Q 009364 368 GSPGSVDICNLDSLSCSRVIV-------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSSILAPNDLEKSR 435 (536)
Q Consensus 368 ~sf~~~D~~~~g~ls~~el~~-------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~~~~~e~l~~aF 435 (536)
..|..+|.+++|.|+.+|+.. .+.++++.+++..| .|++|.|+|+||+.++..... ..+++.+||
T Consensus 15 ~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~D-~~~dg~i~~~eF~~~~~~~~~--~~~~~~~aF 86 (86)
T 2opo_A 15 RIFKRFDTNGDGKISSSELGDALKTLGSVTPDEVRRMMAEID-TDGDGFISFDEFTDFARANRG--LVKDVSKIF 86 (86)
T ss_dssp HHHHHHCTTCSSEEEHHHHHHHHHTTTTCCHHHHHHHHHHHC-TTCSSEECHHHHHHHHHHCTT--THHHHHHHC
T ss_pred HHHHHHCCCCCCCcCHHHHHHHHHHcCCCCHHHHHHHHHHhC-CCCCCcCcHHHHHHHHHHCcc--HHHHHHHhC
Confidence 348999999999999999976 36789999999999 899999999999976654322 235677776
|
| >2h2k_A Protein S100-A13; calcium binding protein, metal binding protein; 2.00A {Homo sapiens} PDB: 1yur_A 1yus_A 1yut_A 1yuu_A 2egd_A 2k8m_B 2ki4_B* 2ki6_C* 2kot_A* 2l5x_B 2cxj_A | Back alignment and structure |
|---|
Probab=97.79 E-value=1.4e-06 Score=73.29 Aligned_cols=55 Identities=11% Similarity=-0.057 Sum_probs=45.7
Q ss_pred CCCCCCcc-ccCC-Cccchhhhhh---------h-hhhhhhhhhhccCCCCCCCccchhhhhhhcccc
Q 009364 367 PGSPGSVD-ICNL-DSLSCSRVIV---------E-KLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKL 422 (536)
Q Consensus 367 ~~sf~~~D-~~~~-g~ls~~el~~---------~-~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~ 422 (536)
..+|..|| .+++ |.|+.+||+. . +.++++.+++.+| .|++|.|+|+||+.++...
T Consensus 25 ~~aF~~fD~~dg~~G~Is~~EL~~~l~~~lg~~~~~~~ev~~li~~~D-~d~dG~Idf~EF~~~~~~~ 91 (106)
T 2h2k_A 25 VTTFFTFARQEGRKDSLSVNEFKELVTQQLPHLLKDVGSLDEKMKSLD-VNQDSELKFNEYWRLIGEL 91 (106)
T ss_dssp HHHHHHHHTSSSSTTEECHHHHHHHHHHHCTTTTTTCCCHHHHHHHHC-TTCSSSEEHHHHHHHHHHH
T ss_pred HHHHHHHcccCCCCCEECHHHHHHHHHHHcCcCCCCHHHHHHHHHHHC-CCCCCCCcHHHHHHHHHHH
Confidence 34599999 7886 7999999976 1 2368999999999 8999999999999766543
|
| >1iq3_A Ralbp1-interacting protein (partner of ralbp1); EF-hand domain, POB1 EH domain, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=97.78 E-value=3.3e-06 Score=71.52 Aligned_cols=52 Identities=17% Similarity=-0.003 Sum_probs=46.9
Q ss_pred CCCCCccccCCCccchhhhhh------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 368 GSPGSVDICNLDSLSCSRVIV------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 368 ~sf~~~D~~~~g~ls~~el~~------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
..|..||.+++|.|+.+|++. .+.+++++||+.+| .|++|.|+|+||+.++.
T Consensus 26 ~~F~~~D~d~dG~Is~~el~~~l~~~gl~~~el~~i~~~~D-~d~dG~I~~~EF~~~m~ 83 (110)
T 1iq3_A 26 NQFRSLQPDPSSFISGSVAKNFFTKSKLSIPELSYIWELSD-ADCDGALTLPEFCAAFH 83 (110)
T ss_dssp HHHHHHCCSSSSEEEHHHHHHHCCSSSCSSCCHHHHHHHHC-SSSCSEEEHHHHHHHHH
T ss_pred HHHHHHCCCCCCeEcHHHHHHHHHHcCCCHHHHHHHHHHHc-CCCCCcCcHHHHHHHHH
Confidence 359999999999999999987 46889999999999 89999999999997664
|
| >2lhi_A Calmodulin, serine/threonine-protein phosphatase catalytic subunit A1; yeast calmodulin, CNA1, metal binding protein; NMR {Saccharomyces cerevisiae} | Back alignment and structure |
|---|
Probab=97.77 E-value=2.3e-06 Score=78.72 Aligned_cols=75 Identities=16% Similarity=0.011 Sum_probs=60.4
Q ss_pred hcccCCCCCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhccccc-ccCChhhhh
Q 009364 362 QMLTSPGSPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLS-SILAPNDLE 432 (536)
Q Consensus 362 q~~t~~~sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~-~~~~~e~l~ 432 (536)
++......|..+|.+++|.|+..||.. ++..++..++..+| .|++|.|+|+||+.++.... ....+++++
T Consensus 9 qi~elk~~F~~~D~d~dG~I~~~El~~~l~~lg~~~~~~~~~~~~~~~d-~d~~~~i~~~ef~~~~~~~~~~~~~~~~l~ 87 (176)
T 2lhi_A 9 QIAEFKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEID-VDGNHQIEFSEFLALMSRQLKSNDSEQELL 87 (176)
T ss_dssp GGGHHHHHHHTTCSSCSSCBCHHHHHHHHHHHTCCCCHHHHHHHHTTTC-SSCSSSBCTTHHHHHHTSSCCSSHHHHHHH
T ss_pred HHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHcCCChhHHHHHHHHHHhC-cCCCccchHHHHHHHHHHhcccCCcHHHHH
Confidence 334445569999999999999999976 67899999999999 89999999999997665433 334456788
Q ss_pred hccCC
Q 009364 433 KSRNP 437 (536)
Q Consensus 433 ~aF~~ 437 (536)
+||+-
T Consensus 88 ~aF~~ 92 (176)
T 2lhi_A 88 EAFKV 92 (176)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 88874
|
| >3nso_A Protein S100-A3; EF-hand, Ca2+, Zn2+ binding, metal binding protein; 1.45A {Homo sapiens} SCOP: a.39.1.2 PDB: 3nsi_A 1kso_A 3nsk_A 3nsl_A | Back alignment and structure |
|---|
Probab=97.77 E-value=2.9e-06 Score=70.74 Aligned_cols=54 Identities=9% Similarity=-0.003 Sum_probs=45.6
Q ss_pred CCCCCCcc-ccCC-Cccchhhhhh-------------hhhhhhhhhhhccCCCCCCCccchhhhhhhccc
Q 009364 367 PGSPGSVD-ICNL-DSLSCSRVIV-------------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRK 421 (536)
Q Consensus 367 ~~sf~~~D-~~~~-g~ls~~el~~-------------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~ 421 (536)
..+|..|| .+++ |.|+.+||+. .+.++++.+++.+| .|+||.|+|+||+.++..
T Consensus 13 ~~aF~~fd~~dg~~G~Is~~EL~~~l~~~l~~~lg~~~~~~ev~~~i~~~D-~dgDG~Idf~EF~~~~~~ 81 (101)
T 3nso_A 13 VCTFQEYAGRCGDKYKLCQAELKELLQKELATWTPTEFRECDYNKFMSVLD-TNKDCEVDFVEYVRSLAC 81 (101)
T ss_dssp HHHHHHHHTTSSCTTEECHHHHHHHHHHHTTTCCCCTTCHHHHHHHHHHHH-HCCCSCEEHHHHHHHHHH
T ss_pred HHHHHHHhhcCCCCCEECHHHHHHHHHHHhhhhcCCCCCHHHHHHHHHHhC-CCCCCCCcHHHHHHHHHH
Confidence 34599997 7887 9999999976 13678999999999 899999999999976553
|
| >3u0k_A Rcamp; fluorescent protein, calcium binding, EF-hand, genetically E calcium indicator; HET: NFA CRK; 2.10A {Entacmaea quadricolor} | Back alignment and structure |
|---|
Probab=97.73 E-value=1.7e-06 Score=89.36 Aligned_cols=75 Identities=7% Similarity=-0.040 Sum_probs=59.1
Q ss_pred hcccCCCCCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcccc-cccCChhhhh
Q 009364 362 QMLTSPGSPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKL-SSILAPNDLE 432 (536)
Q Consensus 362 q~~t~~~sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~-~~~~~~e~l~ 432 (536)
++......|..+|.+++|.|+.+||.. ++++|++.+++.+| .|++|.|+|+||+.++... .....+++|+
T Consensus 300 EI~ELREaF~~fDkDgdG~IS~eELk~aLrsLG~~~TeeEI~~Lf~~~D-~DgDG~IdFeEFl~lms~~lk~~d~eeeLr 378 (440)
T 3u0k_A 300 QIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVD-ADGDGTIDFPEFLIMMARKMKDTDSEEEIR 378 (440)
T ss_dssp HHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHC-SSCSSSEEHHHHHHHHHTC------CHHHH
T ss_pred HHHHHHHHHHHHcCCCCCEECHHHHHHHHHHcCCCCCHHHHHHHHHHhC-CCCCCcCcHHHHHHHHHHHhcCCChHHHHH
Confidence 334445569999999999999999976 57899999999999 8999999999999766543 3455677899
Q ss_pred hccCC
Q 009364 433 KSRNP 437 (536)
Q Consensus 433 ~aF~~ 437 (536)
+||+-
T Consensus 379 eAFk~ 383 (440)
T 3u0k_A 379 EAFRV 383 (440)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99864
|
| >3nxa_A Protein S100-A16; S100 family, calcium binding protein, APO, EF-hand calcium binding proteins, S100 proteins, protein dynamics, binding protein; 2.10A {Homo sapiens} SCOP: a.39.1.0 PDB: 2l0u_A 2l0v_A 2l50_A 2l51_A | Back alignment and structure |
|---|
Probab=97.72 E-value=1.1e-05 Score=67.17 Aligned_cols=54 Identities=4% Similarity=-0.197 Sum_probs=45.1
Q ss_pred CCCCCCccccC---CCccchhhhhh-------------hhhhhhhhhhhccCCCCCCCccchhhhhhhccc
Q 009364 367 PGSPGSVDICN---LDSLSCSRVIV-------------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRK 421 (536)
Q Consensus 367 ~~sf~~~D~~~---~g~ls~~el~~-------------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~ 421 (536)
..+|..||.++ +|.|+.+||+. .+.++++.+++.+| .|++|.|+|+||+.++..
T Consensus 14 ~~~F~~fD~~~g~~~G~Is~~EL~~~l~~~~~~~l~~~~~~~ev~~~i~~~D-~d~DG~Idf~EF~~~m~~ 83 (100)
T 3nxa_A 14 VENFYKYVSKYSLVKNKISKSSFREMLQKELNHMLSDTGNRKAADKLIQNLD-ANHDGRISFDEYWTLIGG 83 (100)
T ss_dssp HHHHHHTSCTTCSCTTCBCHHHHHHHHHHHSTTTTCSSHHHHHHHHHHHHSC-CCSSCCBCHHHHHHHHHH
T ss_pred HHHHHHHcCcCCCCCCeEcHHHHHHHHHHHccccccccccHHHHHHHHHHhC-CCCCCCCcHHHHHHHHHH
Confidence 34599999863 79999999986 12578999999999 999999999999976654
|
| >3li6_A Calcium-binding protein; calcium signaling protein, assemble free energy, dynamic behaviour, cytoskeleton, metal binding; 2.50A {Entamoeba histolytica} | Back alignment and structure |
|---|
Probab=97.72 E-value=9.6e-06 Score=60.94 Aligned_cols=51 Identities=14% Similarity=0.051 Sum_probs=45.3
Q ss_pred CCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 369 SPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
.|..+|.+++|.|+.+|+.. .+.++++.+++..| .|++|.|+|+||+.++.
T Consensus 5 ~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~D-~~~~g~i~~~ef~~~~~ 63 (66)
T 3li6_A 5 LFKEIDVNGDGAVSYEEVKAFVSKKRAIKNEQLLQLIFKSID-ADGNGEIDQNEFAKFYG 63 (66)
T ss_dssp HHHHHCTTCSSSCCHHHHHHHHHHHHHHHHHHHHHHHHHHHC-TTCSSSCCHHHHHHHHT
T ss_pred HHHHHCCCCCCcccHHHHHHHHHHccCCCcHHHHHHHHHHHC-CCCCCCCCHHHHHHHHH
Confidence 47889999999999999976 46789999999999 89999999999997554
|
| >1k9u_A Polcalcin PHL P 7; pollen allergen, calcium-binding, EF-hand, cross-reactivity; 1.75A {Phleum pratense} SCOP: a.39.1.10 | Back alignment and structure |
|---|
Probab=97.72 E-value=4.4e-06 Score=65.30 Aligned_cols=64 Identities=13% Similarity=0.012 Sum_probs=51.6
Q ss_pred CCCCccccCCCccchhhhhh-------hhhhhhhhhhhccCCCCCCCccchhhhhhhcccccccCChhhhhhcc
Q 009364 369 SPGSVDICNLDSLSCSRVIV-------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSSILAPNDLEKSR 435 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~-------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~~~~~e~l~~aF 435 (536)
.|..+|.+++|.|+.+|+.. .+.++++.+++..| .|++|.|+|+||+.++...... .+++.+||
T Consensus 8 ~F~~~D~~~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~D-~~~dg~i~~~ef~~~~~~~~~~--~~~~~~aF 78 (78)
T 1k9u_A 8 IFKRFDTNGDGKISLSELTDALRTLGSTSADEVQRMMAEID-TDGDGFIDFNEFISFCNANPGL--MKDVAKVF 78 (78)
T ss_dssp HHHHHCTTCSSEECHHHHHHHHHHHHTCCHHHHHHHHHHHC-TTCSSSEEHHHHHHHHHHCHHH--HHHHHTTC
T ss_pred HHHHHCCCCCCcCcHHHHHHHHHHhCCCCHHHHHHHHHHhC-CCCCCeEcHHHHHHHHHHCchh--HHHHHhcC
Confidence 37889999999999999975 36789999999999 8999999999999766543222 24577766
|
| >2lmt_A Calmodulin-related protein 97A; spermatogenesis, metal binding protein; NMR {Drosophila melanogaster} PDB: 2lmu_A 2lmv_A | Back alignment and structure |
|---|
Probab=97.70 E-value=6.4e-06 Score=72.97 Aligned_cols=52 Identities=12% Similarity=-0.123 Sum_probs=46.8
Q ss_pred CCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhccc
Q 009364 369 SPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRK 421 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~ 421 (536)
+|..+|.+++|.|+.+||.. .+.++++.+++.+| .|++|.|+|+||+.++..
T Consensus 88 aF~~~D~d~~G~I~~~El~~~l~~~g~~~~~~e~~~l~~~~D-~d~dG~I~~~EF~~~m~~ 147 (148)
T 2lmt_A 88 AFKIFDRDGDGFISPAELRFVMINLGEKVTDEEIDEMIREAD-FDGDGMINYEEFVWMISQ 147 (148)
T ss_dssp HHHHHHSSCSSEECHHHHHHHHHHHTCCCCHHHHHHHHHHHC-CSCCSSEEHHHHHHHHTT
T ss_pred HHHHHCCCCcCcCcHHHHHHHHHHcCccccHHHHHHHHHHhC-CCCCCeEeHHHHHHHHhc
Confidence 49999999999999999976 47889999999999 899999999999976643
|
| >2jq6_A EH domain-containing protein 1; metal binding protein; NMR {Homo sapiens} PDB: 2kff_A 2kfg_A 2kfh_A 2ksp_A | Back alignment and structure |
|---|
Probab=97.68 E-value=7.3e-06 Score=72.28 Aligned_cols=52 Identities=12% Similarity=0.015 Sum_probs=46.3
Q ss_pred CCCCCCccccCCCccchhhhhh------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 367 PGSPGSVDICNLDSLSCSRVIV------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 367 ~~sf~~~D~~~~g~ls~~el~~------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
...|..|| +++|.|+.+|++. .+.+++.+||+.+| .|++|.|+|+||+.++.
T Consensus 54 ~~~F~~fD-d~dG~Is~~El~~~l~~~gl~~~el~~I~~~~D-~d~dG~Ld~~EF~~am~ 111 (139)
T 2jq6_A 54 DEIFYTLS-PVNGKITGANAKKEMVKSKLPNTVLGKIWKLAD-VDKDGLLDDEEFALANH 111 (139)
T ss_dssp HHHHHHSC-CSSSEEEHHHHHHHHHHTTCCHHHHHHHHHHHC-SSCCSEEEHHHHHHHHH
T ss_pred HHHHHHhC-CCCCeECHHHHHHHHHHhCcCHHHHHHHHHHhC-CCCCCcCcHHHHHHHHH
Confidence 33599999 9999999999986 56889999999999 89999999999997664
|
| >2b1u_A Calmodulin-like protein 5; CLSP, calmodulin-like SKIN protein, solution structure, backbone dynamic, structural genomics; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.67 E-value=1.5e-05 Score=60.71 Aligned_cols=51 Identities=8% Similarity=-0.087 Sum_probs=45.4
Q ss_pred CCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 369 SPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
.|..+|.+++|.|+..|+.. .+.++++.+++.+| .|++|.|+|+||+.++.
T Consensus 11 ~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d-~~~~g~i~~~eF~~~~~ 69 (71)
T 2b1u_A 11 AFRAFDQDGDGHITVDELRRAMAGLGQPLPQEELDAMIREAD-VDQDGRVNYEEFARMLA 69 (71)
T ss_dssp HHTTSCCSSSSEEEHHHHHHHGGGTTCSSCHHHHHHHHHHCC-SSSSSEEETTHHHHHHT
T ss_pred HHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhC-CCCCCcCcHHHHHHHHh
Confidence 48999999999999999976 46789999999999 89999999999996543
|
| >3zwh_A Protein S100-A4; Ca-binding protein-motor protein complex, S100 proteins, EF-; 1.94A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.66 E-value=8.8e-06 Score=68.18 Aligned_cols=54 Identities=6% Similarity=-0.140 Sum_probs=44.6
Q ss_pred CCCCCCcc-ccCC-Cccchhhhhh-------------hhhhhhhhhhhccCCCCCCCccchhhhhhhccc
Q 009364 367 PGSPGSVD-ICNL-DSLSCSRVIV-------------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRK 421 (536)
Q Consensus 367 ~~sf~~~D-~~~~-g~ls~~el~~-------------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~ 421 (536)
..+|..|| .+++ |.|+.+||+. .+.++++.+++.+| .|+||.|+|+||+.++..
T Consensus 16 ~~aF~~fD~~dgd~G~Is~~EL~~~l~~~lg~~l~~~~~~~ev~~~i~~~D-~dgDG~Idf~EF~~~m~~ 84 (104)
T 3zwh_A 16 VSTFHKYSGKEGDKFKLNKSELKELLTRELPSWLGKRTDEAAFQKLMSNLD-SNRDNEVDFQEYCVFLSS 84 (104)
T ss_dssp HHHHHHHHTSSSSTTSBCHHHHHHHHHHHCGGGSCSSCCHHHHHHHHHHHC-TTCSSSBCHHHHHHHHHH
T ss_pred HHHHHHHhccCCCCCeECHHHHHHHHHHHcchhccCCCCHHHHHHHHHHHc-CCCCCCCcHHHHHHHHHH
Confidence 34588897 6664 7999999976 13679999999999 999999999999976553
|
| >1wy9_A Allograft inflammatory factor 1; EF-hand, calucium binding, metal binding protein; 2.10A {Mus musculus} PDB: 2g2b_A | Back alignment and structure |
|---|
Probab=97.65 E-value=2e-05 Score=70.01 Aligned_cols=68 Identities=4% Similarity=-0.183 Sum_probs=56.5
Q ss_pred CCCCCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcccccccCChhhhhhccCC
Q 009364 366 SPGSPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSSILAPNDLEKSRNP 437 (536)
Q Consensus 366 ~~~sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~~~~~e~l~~aF~~ 437 (536)
....|..+|.+++|.|+..|+.. .+.++++.+++.+| .|++|.|+|+||+.++... .+++.++|+-
T Consensus 50 l~~~F~~~D~d~dG~I~~~El~~~l~~~g~~~~~~~~~~l~~~~D-~d~dg~I~~~eF~~~~~~~-----~~~~~~aF~~ 123 (147)
T 1wy9_A 50 FKVKYMEFDLNGNGDIDIMSLKRMLEKLGVPKTHLELKRLIREVS-SGSEETFSYSDFLRMMLGK-----RSAILRMILM 123 (147)
T ss_dssp HHHHHTTSCCCTTSSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHC-SSCTTEECHHHHHHHHCSS-----GGGGGGGGGG
T ss_pred HHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhC-CCCCCcEeHHHHHHHHHHh-----HHHHHHHHHH
Confidence 34459999999999999999976 46889999999999 8999999999999766543 4568888875
Q ss_pred CC
Q 009364 438 MC 439 (536)
Q Consensus 438 ~~ 439 (536)
.-
T Consensus 124 ~D 125 (147)
T 1wy9_A 124 YE 125 (147)
T ss_dssp CC
T ss_pred Hc
Confidence 53
|
| >4eto_A Protein S100-A4; calcium-binding protein, EF-hand, structural genomics, PSI-B protein structure initiative, NEW YORK structural genomics consortium; 1.54A {Homo sapiens} PDB: 1m31_A 2q91_A 3cga_A 3ko0_A* 3m0w_A* | Back alignment and structure |
|---|
Probab=97.65 E-value=9.3e-06 Score=66.53 Aligned_cols=54 Identities=6% Similarity=-0.157 Sum_probs=44.3
Q ss_pred CCCCCCcc-ccCC-Cccchhhhhh-------------hhhhhhhhhhhccCCCCCCCccchhhhhhhccc
Q 009364 367 PGSPGSVD-ICNL-DSLSCSRVIV-------------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRK 421 (536)
Q Consensus 367 ~~sf~~~D-~~~~-g~ls~~el~~-------------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~ 421 (536)
...|..|| .+++ |.|+.+||+. .+.++++.+++.+| .|+||.|+|+||+.++..
T Consensus 13 ~~~F~~fd~~dg~~G~Is~~EL~~~l~~~lg~~l~~~~~~~ev~~~i~~~D-~d~DG~Idf~EF~~~~~~ 81 (93)
T 4eto_A 13 VSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLD-SNRDNEVDFQEYCVFLSC 81 (93)
T ss_dssp HHHHHHHHTSSSSTTSBCHHHHHHHHHHHCGGGC---CCHHHHHHHHHHHC-TTSSSSBCHHHHHHHHHH
T ss_pred HHHHHHHcccCCCCCeECHHHHHHHHHHHhhhhccCCCCHHHHHHHHHHHC-CCCCCCCcHHHHHHHHHH
Confidence 34588897 5664 8999999975 14678999999999 999999999999976543
|
| >2kgr_A Intersectin-1; structure, alternative splicing, calcium, cell junction, cell projection, coiled coil, endocytosis, membrane, phosphoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.65 E-value=1.1e-05 Score=68.38 Aligned_cols=51 Identities=18% Similarity=0.091 Sum_probs=46.1
Q ss_pred CCCCccccCCCccchhhhhh------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 369 SPGSVDICNLDSLSCSRVIV------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
.|..+|.+++|.|+.+||.. .+.+++..+|+.+| .|++|.|+|+||+.++.
T Consensus 19 ~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~~i~~~~D-~d~dG~I~~~EF~~~~~ 75 (111)
T 2kgr_A 19 LFNSHDKTMSGHLTGPQARTILMQSSLPQAQLASIWNLSD-IDQDGKLTAEEFILAMH 75 (111)
T ss_dssp HHHTTSCSSCCEEEHHHHHHHHHTTCCCHHHHHHHHHHHC-SSCCSEEEHHHHHHHHH
T ss_pred HHHHHCCCCCCcCcHHHHHHHHHhCCCCHHHHHHHHHHHC-CCCCCCCcHHHHHHHHH
Confidence 49999999999999999986 46789999999999 89999999999997654
|
| >1m45_A MLC1P, myosin light chain; protein-peptide complex, myosin light chain, cell cycle protein; 1.65A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 1m46_A 1n2d_A 2fcd_A 2fce_A | Back alignment and structure |
|---|
Probab=97.64 E-value=1e-05 Score=70.93 Aligned_cols=74 Identities=7% Similarity=-0.122 Sum_probs=57.9
Q ss_pred ccCCCCCCCccccCCCccchhhhhh--------hhhhhhhhhhhcc-CCCCCCCccchhhhhhhcccc------cccCCh
Q 009364 364 LTSPGSPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTS-NSNDDLCQLDQEDFVAGDRKL------SSILAP 428 (536)
Q Consensus 364 ~t~~~sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~-d~~d~~g~Id~~EF~~~~~~~------~~~~~~ 428 (536)
......|..+|.+++|.|+..|+.. ++.+++..+++.+ | .+++|.|+|+||+.++... ......
T Consensus 4 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~~D-~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~ 82 (148)
T 1m45_A 4 RANKDIFTLFDKKGQGAIAKDSLGDYLRAIGYNPTNQLVQDIINADSS-LRDASSLTLDQITGLIEVNEKELDATTKAKT 82 (148)
T ss_dssp CCCTTCHHHHCTTCCSEEEGGGHHHHHHHTTCCCCHHHHHHHHHC--C-C--CCEEEHHHHHHHHHHTHHHHHGGGCCCT
T ss_pred HHHHHHHHHHCCCCCCCCCHHHHHHHHHHhCCCCCHHHHHHHHHHhhC-CCCCCeEcHHHHHHHHHHHHhhccccccccH
Confidence 4456679999999999999999976 4688999999999 9 8999999999999766654 334556
Q ss_pred hhhhhccCCC
Q 009364 429 NDLEKSRNPM 438 (536)
Q Consensus 429 e~l~~aF~~~ 438 (536)
+.++.+|+-.
T Consensus 83 ~~~~~~F~~~ 92 (148)
T 1m45_A 83 EDFVKAFQVF 92 (148)
T ss_dssp HHHHHHHHTT
T ss_pred HHHHHHHHHh
Confidence 6788888764
|
| >2lnk_A Protein S100-A4; EF-hand, calcium binding, all alpha, metal binding protein, binding protein; NMR {Homo sapiens} PDB: 3c1v_A | Back alignment and structure |
|---|
Probab=97.61 E-value=1.4e-05 Score=67.90 Aligned_cols=54 Identities=6% Similarity=-0.127 Sum_probs=45.8
Q ss_pred CCCCCCcc-ccCCC-ccchhhhhh-------------hhhhhhhhhhhccCCCCCCCccchhhhhhhccc
Q 009364 367 PGSPGSVD-ICNLD-SLSCSRVIV-------------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRK 421 (536)
Q Consensus 367 ~~sf~~~D-~~~~g-~ls~~el~~-------------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~ 421 (536)
..+|..|| .+++| .|+.+||+. .+.++++.+++.+| .|++|.|+|+||+.++..
T Consensus 25 ~~aF~~fD~~dgdGG~Is~~EL~~~l~~~l~~~lg~~~t~~ev~~li~~~D-~dgdG~Idf~EF~~~m~~ 93 (113)
T 2lnk_A 25 VSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLD-SNRDNEVDFQEYCVFLSC 93 (113)
T ss_dssp HHHHHHTTTTTSCTTCBCHHHHHHHHHHHCGGGGTTCCCTTHHHHHHHHHC-SSSSSCBCHHHHHHHHHH
T ss_pred HHHHHHHcccCCCCCEECHHHHHHHHHHHcchhcCCCCCHHHHHHHHHHhC-CCCCCcEeHHHHHHHHHH
Confidence 34599999 89997 999999976 14578999999999 899999999999976553
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.59 E-value=8.1e-05 Score=77.83 Aligned_cols=31 Identities=16% Similarity=0.301 Sum_probs=26.9
Q ss_pred HcCCccccCCCCCcccCCCCcEEEEecCcchh
Q 009364 189 NHGIMHRDIKGANILVDNKGCIKLADFGASKQ 220 (536)
Q Consensus 189 ~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~ 220 (536)
...++|||++|.|||++.++ ++|+||+.+..
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 45799999999999998776 99999997753
|
| >1s6j_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=97.59 E-value=1.1e-05 Score=64.43 Aligned_cols=55 Identities=13% Similarity=0.001 Sum_probs=48.1
Q ss_pred cCCCCCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 365 TSPGSPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 365 t~~~sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
.....|..+|.+++|.|+..|+.. .+.++++.+++.+| .+++|.|+|+||+.++.
T Consensus 24 ~~~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~l~~~~d-~~~~g~i~~~eF~~~~~ 86 (87)
T 1s6j_A 24 GLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAAD-IDKSGTIDYGEFIAATV 86 (87)
T ss_dssp TTTTHHHHHCTTCSSCEEHHHHHHHHHTTTSSCCHHHHHHHHHHHC-TTCSSEECHHHHTTCCC
T ss_pred HHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhC-CCCCCcCcHHHHHHHHh
Confidence 355669999999999999999986 46889999999999 89999999999986543
|
| >3k21_A PFCDPK3, calcium-dependent protein kinase 3; calcium kinase structural genomics malaria, structural genom consortium, SGC, ATP-binding; 1.15A {Plasmodium falciparum} PDB: 3o4y_A | Back alignment and structure |
|---|
Probab=97.59 E-value=2.4e-06 Score=79.34 Aligned_cols=72 Identities=8% Similarity=-0.087 Sum_probs=58.2
Q ss_pred ccCCCCCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcccccccCChhhhhhcc
Q 009364 364 LTSPGSPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSSILAPNDLEKSR 435 (536)
Q Consensus 364 ~t~~~sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~~~~~e~l~~aF 435 (536)
......|..+|.+++|.|+.+|+.. .+ .++..+++..| .|++|.|+|+||+.++.... ...++.++.+|
T Consensus 52 ~~l~~~F~~~D~d~~G~i~~~El~~~l~~~g~~~~-~~~~~l~~~~D-~d~~g~i~~~EF~~~~~~~~-~~~~~~l~~~F 128 (191)
T 3k21_A 52 EKLKSTFLVLDEDGKGYITKEQLKKGLEKDGLKLP-YNFDLLLDQID-SDGSGKIDYTEFIAAALDRK-QLSKKLIYCAF 128 (191)
T ss_dssp HHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCC-TTHHHHHHHHC-TTCSSSEEHHHHHHHHSCGG-GCCHHHHHHHH
T ss_pred HHHHHHHHHHCCCCCCCCcHHHHHHHHHHcCCCcH-HHHHHHHHHhC-CCCCCeEeHHHHHHHHHhhh-hccHHHHHHHH
Confidence 3344579999999999999999986 24 88999999999 89999999999997765543 25567788888
Q ss_pred CCC
Q 009364 436 NPM 438 (536)
Q Consensus 436 ~~~ 438 (536)
+-.
T Consensus 129 ~~~ 131 (191)
T 3k21_A 129 RVF 131 (191)
T ss_dssp HHH
T ss_pred HHh
Confidence 644
|
| >1tiz_A Calmodulin-related protein, putative; helix-turn-helix, structural genomics, protein structure initiative; NMR {Arabidopsis thaliana} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=97.59 E-value=1.2e-05 Score=60.52 Aligned_cols=51 Identities=12% Similarity=-0.002 Sum_probs=44.9
Q ss_pred CCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 369 SPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
.|..+|.+++|.|+.+|+.. .+.+++..+++..| .|++|.|+|+||+.++.
T Consensus 6 ~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D-~~~dg~i~~~ef~~~~~ 64 (67)
T 1tiz_A 6 VFEKFDKNKDGKLSLDEFREVALAFSPYFTQEDIVKFFEEID-VDGNGELNADEFTSCIE 64 (67)
T ss_dssp HHHHHCTTSSSCEEHHHHHHHHHHTCTTSCHHHHHHHHHHHC-CSSSSEECHHHHHHHHH
T ss_pred HHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHHC-CCCCCcCcHHHHHHHHH
Confidence 37789999999999999976 46789999999999 89999999999996543
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.55 E-value=0.00066 Score=68.15 Aligned_cols=76 Identities=16% Similarity=0.086 Sum_probs=57.5
Q ss_pred eeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCC---CCceeeEeeeeecCCce
Q 009364 70 KGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS---HPNIVRYLGTVREEESL 146 (536)
Q Consensus 70 ~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~---HpnIv~l~~~~~~~~~~ 146 (536)
-.+.|+.|....+|+... ++..+++|+... . ....+..|...|+.|. ...+++++.+....+..
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~-------~----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~ 106 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINER-------S----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHS 106 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEG-------G----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEE
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCc-------c----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCce
Confidence 356799999999999864 567888997621 1 1245677888888773 35677888888777889
Q ss_pred eEEEEecCCCCc
Q 009364 147 NILLEFVPGGSI 158 (536)
Q Consensus 147 ~lV~E~~~gg~L 158 (536)
++||||++|..+
T Consensus 107 ~lvme~l~G~~~ 118 (312)
T 3jr1_A 107 FLLLEALNKSKN 118 (312)
T ss_dssp EEEEECCCCCCC
T ss_pred EEEEEeccCCCC
Confidence 999999998765
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.53 E-value=0.00012 Score=72.79 Aligned_cols=71 Identities=7% Similarity=0.039 Sum_probs=42.4
Q ss_pred eeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCce-eeEeeeeecCCceeEE
Q 009364 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNI-VRYLGTVREEESLNIL 149 (536)
Q Consensus 71 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnI-v~l~~~~~~~~~~~lV 149 (536)
.+.|+.|....+|++ ..+++|+..... .......+|+.+++.+...++ .+++.. +.+.-++|
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~---------~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v 85 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGT---------EEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMV 85 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC-------------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEE
T ss_pred eeEcCCcccccccee------eeEEEECCCCCc---------cceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEE
Confidence 678999999999998 458888763211 000112356666666532222 345543 33445789
Q ss_pred EEec-CCCCc
Q 009364 150 LEFV-PGGSI 158 (536)
Q Consensus 150 ~E~~-~gg~L 158 (536)
+||+ +|.++
T Consensus 86 ~e~i~~g~~l 95 (301)
T 3dxq_A 86 TRYIAGAQTM 95 (301)
T ss_dssp EECCTTCEEC
T ss_pred EeecCCCccC
Confidence 9999 66554
|
| >2jjz_A Ionized calcium-binding adapter molecule 2; EF-hand, actin crosslinking, ionized calciu binding adapter molecule 2, metal-binding protein; 2.15A {Homo sapiens} PDB: 2jjz_B 2vtg_A | Back alignment and structure |
|---|
Probab=97.51 E-value=2e-05 Score=70.22 Aligned_cols=66 Identities=9% Similarity=-0.127 Sum_probs=54.0
Q ss_pred CCCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcccccccCChhhhhhccCCCC
Q 009364 368 GSPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSSILAPNDLEKSRNPMC 439 (536)
Q Consensus 368 ~sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~~~~~e~l~~aF~~~~ 439 (536)
..|..+|.+++|.|+..||.. .+.++++.+++.+| .|++|.|+|+||+.++... .++++++|+-.-
T Consensus 54 ~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~e~~~l~~~~D-~d~dg~I~~~eF~~~~~~~-----~~~i~~aF~~~D 127 (150)
T 2jjz_A 54 EKYMEFDLNNEGEIDLMSLKRMMEKLGVPKTHLEMKKMISEVT-GGVSDTISYRDFVNMMLGK-----RSAVLKLVMMFE 127 (150)
T ss_dssp HHHTTSCCCTTSSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHH-TTSCSSBCHHHHHHHHHSS-----SCCHHHHHHC--
T ss_pred HHHHHhCCCCcCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHHC-CCCCCcEeHHHHHHHHHHh-----HHHHHHHHHHHc
Confidence 349999999999999999976 46889999999999 8999999999999766543 356777777543
|
| >2lmt_A Calmodulin-related protein 97A; spermatogenesis, metal binding protein; NMR {Drosophila melanogaster} PDB: 2lmu_A 2lmv_A | Back alignment and structure |
|---|
Probab=97.51 E-value=3.8e-06 Score=74.47 Aligned_cols=72 Identities=8% Similarity=-0.019 Sum_probs=59.2
Q ss_pred CCCCCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcccc-cccCChhhhhhccC
Q 009364 366 SPGSPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKL-SSILAPNDLEKSRN 436 (536)
Q Consensus 366 ~~~sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~-~~~~~~e~l~~aF~ 436 (536)
....|..+|.+++|.|+..||.. ++.+++..++...| .+++|.|+|.||+..+... .....++++++||+
T Consensus 12 l~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~~~~~~~d-~~~~g~i~~~ef~~~~~~~~~~~~~~~~l~~aF~ 90 (148)
T 2lmt_A 12 FKDAFVQFDKEGTGKIATRELGTLMRTLGQNPTEAELQDLIAEAE-NNNNGQLNFTEFCGIMAKQMRETDTEEEMREAFK 90 (148)
T ss_dssp HHHHHHHHHCSSCCEEEGGGHHHHHHHHTCCCCHHHHHHHHHHHH-TTSTTEEEHHHHHHHHHHTTTTTTTHHHHHHHHH
T ss_pred HHHHHHHHcCCCCCeECHHHHHHHHHhcCCCchHHHHHHHHHhcc-cCCCCcccHHHHHHHHHHHhcccCcHHHHHHHHH
Confidence 34459999999999999999976 57889999999999 8999999999999665443 34556778999886
Q ss_pred CC
Q 009364 437 PM 438 (536)
Q Consensus 437 ~~ 438 (536)
-.
T Consensus 91 ~~ 92 (148)
T 2lmt_A 91 IF 92 (148)
T ss_dssp HH
T ss_pred HH
Confidence 43
|
| >2kz2_A Calmodulin, CAM; TR2C, metal binding protein; NMR {Gallus gallus} | Back alignment and structure |
|---|
Probab=97.51 E-value=2.2e-05 Score=64.17 Aligned_cols=51 Identities=14% Similarity=-0.076 Sum_probs=45.7
Q ss_pred CCCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhc
Q 009364 368 GSPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGD 419 (536)
Q Consensus 368 ~sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~ 419 (536)
..|..+|.+++|.|+.+||.. .+.++++.+++.+| .|++|.|+|+||+.++
T Consensus 33 ~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~e~~~l~~~~D-~d~dG~I~~~EF~~~~ 91 (94)
T 2kz2_A 33 EAFRVEDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREAD-IDGDGQVNYEEFVQMM 91 (94)
T ss_dssp HHHHHHCTTCCSCBCHHHHHHHHHHHTCCCCHHHHHHHHHHHC-TTCSSSBCHHHHHHHH
T ss_pred HHHHHHCCCCcCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHhC-CCCCCcEeHHHHHHHH
Confidence 359999999999999999976 46889999999999 8999999999999654
|
| >2joj_A Centrin protein; N-terminal domain, centrin solution structure, EF-hand calcium binding protein, cell cycle; NMR {Euplotes octocarinatus} | Back alignment and structure |
|---|
Probab=97.50 E-value=1.9e-05 Score=61.25 Aligned_cols=51 Identities=12% Similarity=0.024 Sum_probs=45.8
Q ss_pred CCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 369 SPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
.|..+|.+++|.|+..|+.. .+.++++.+++.+| .|++|.|+|+||+.++.
T Consensus 12 ~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~d-~~~~g~i~~~eF~~~~~ 70 (77)
T 2joj_A 12 AFDLFDTNKTGSIDYHELKVAMRALGFDVKKPEILELMNEYD-REGNGYIGFDDFLDIMT 70 (77)
T ss_dssp HHHHHCCSSSSEEEHHHHHHHHHHHTCCCHHHHHHHHHHHHC-CSSSSEEEHHHHHHHHT
T ss_pred HHHHhCCCCCCCCcHHHHHHHHHHhCCCCCHHHHHHHHHHHC-CCCCCcCcHHHHHHHHH
Confidence 48899999999999999976 47889999999999 89999999999997554
|
| >1s6i_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=97.50 E-value=1e-05 Score=74.83 Aligned_cols=55 Identities=15% Similarity=0.048 Sum_probs=46.2
Q ss_pred CCCCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcccc
Q 009364 367 PGSPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKL 422 (536)
Q Consensus 367 ~~sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~ 422 (536)
...|..+|.+++|.|+.+|+.. ++.+++..+++.+| .|++|.|+|+||+.++...
T Consensus 13 ~~~F~~~D~d~dG~I~~~E~~~~l~~~g~~~~~~~~~~l~~~~D-~d~dG~I~~~EF~~~~~~~ 75 (188)
T 1s6i_A 13 KELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAAD-IDKSGTIDYGEFIAATVHL 75 (188)
T ss_dssp HHHHHTTSSSSSSCEEHHHHHHHHTTTTCCCCHHHHHHHHHHTC-TTCSSEECHHHHHHHHTTS
T ss_pred HHHHHHHCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHcC-CCCCCeEeHHHHHHHHHHH
Confidence 3458899999999999999975 46788999999999 8999999999999765443
|
| >2obh_A Centrin-2; DNA repair complex EF hand superfamily protein-peptide compl cycle; 1.80A {Homo sapiens} SCOP: a.39.1.5 PDB: 3kf9_A 1m39_A 2a4j_A 2k2i_A 1oqp_A | Back alignment and structure |
|---|
Probab=97.49 E-value=9.6e-06 Score=71.26 Aligned_cols=70 Identities=9% Similarity=0.013 Sum_probs=55.5
Q ss_pred CCCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhccccc-ccCChhhhhhccCCC
Q 009364 368 GSPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLS-SILAPNDLEKSRNPM 438 (536)
Q Consensus 368 ~sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~-~~~~~e~l~~aF~~~ 438 (536)
..|..+|.+++|.|+..||.. ++.++++.+++.+| .|++|.|+|+||+.++.... .....++++++|+-.
T Consensus 10 ~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d-~~~~g~i~~~eF~~~~~~~~~~~~~~~~l~~~F~~~ 88 (143)
T 2obh_A 10 EAFDLFDADGTGTIDVKELKVAMRALGFEPKKEEIKKMISEID-KEGTGKMNFGDFLTVMTQKMSEKDTKEEILKAFKLF 88 (143)
T ss_dssp HHHHTTCTTCCSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHT-TTCCSEEEHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhC-CCCCCeeeHHHHHHHHHHHhccccHHHHHHHHHHHh
Confidence 348999999999999999975 57889999999999 89999999999997654321 122345688888643
|
| >3i5g_B Myosin regulatory light chain LC-2, mantle muscle; rigor-like, squid, muscle myosin, contractIle protein; 2.60A {Todarodes pacificus} PDB: 3i5f_B 3i5h_B 3i5i_B | Back alignment and structure |
|---|
Probab=97.47 E-value=2.4e-05 Score=70.10 Aligned_cols=52 Identities=10% Similarity=-0.064 Sum_probs=46.1
Q ss_pred CCCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhccc
Q 009364 368 GSPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRK 421 (536)
Q Consensus 368 ~sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~ 421 (536)
.+|..||.+++|.|+.+||+. .+.+|++.|++.+| .+ +|.|+|+||+.++..
T Consensus 89 ~aF~~fD~d~~G~I~~~el~~~l~~~g~~ls~~ei~~~~~~~D-~~-dG~I~y~EF~~~m~~ 148 (153)
T 3i5g_B 89 NAFSMFDEDGQGFIPEDYLKDLLENMGDNFSKEEIKNVWKDAP-LK-NKQFNYNKMVDIKGK 148 (153)
T ss_dssp HHHHTTCSSCSSCCCHHHHHHHHHSSSSCCCHHHHHHHHTTCC-EE-TTEECHHHHHHHHHC
T ss_pred HHHhccccCCCCeEeHHHHHHHHHHcCCcCCHHHHHHHHHHhC-CC-cCEEcHHHHHHHhcC
Confidence 359999999999999999986 57899999999999 66 899999999977654
|
| >3i5g_C Myosin catalytic light chain LC-1, mantle muscle; rigor-like, squid, muscle myosin, contractIle protein; 2.60A {Todarodes pacificus} PDB: 3i5f_C 3i5h_C 3i5i_C | Back alignment and structure |
|---|
Probab=97.46 E-value=6.6e-06 Score=74.27 Aligned_cols=72 Identities=8% Similarity=-0.050 Sum_probs=55.1
Q ss_pred cCCCCCCCccc--cCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhccccc---ccCChhhh
Q 009364 365 TSPGSPGSVDI--CNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLS---SILAPNDL 431 (536)
Q Consensus 365 t~~~sf~~~D~--~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~---~~~~~e~l 431 (536)
....+|..||. +++|.|+..||+. ++++|++.++.. + .+++|.|+|+||+.++.... .....++|
T Consensus 10 elre~F~~fD~~~d~dG~I~~~El~~~lr~lG~~~t~~el~~~~~~-d-~~~~g~i~f~eFl~~~~~~~~~~~~~~~~~l 87 (159)
T 3i5g_C 10 EVREVFDLFDFWDGRDGDVDAAKVGDLLRCLGMNPTEAQVHQHGGT-K-KMGEKAYKLEEILPIYEEMSSKDTGTAADEF 87 (159)
T ss_dssp HHHHHHHHHHHHTTSSSCEEGGGHHHHHHHTTCCCCHHHHHTTTCC-S-STTSCEECHHHHHHHHHHHTTCCTTCCHHHH
T ss_pred HHHHHHHHHCcCCCCCCeECHHHHHHHHHHcCCCCCHHHHHHHHcc-c-ccCCCcccHHHHHHHHHHhhcccccchHHHH
Confidence 34456999996 7899999999975 678999998764 5 67899999999997654322 24456789
Q ss_pred hhccCCC
Q 009364 432 EKSRNPM 438 (536)
Q Consensus 432 ~~aF~~~ 438 (536)
++||+-.
T Consensus 88 ~~aF~~f 94 (159)
T 3i5g_C 88 MEAFKTF 94 (159)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9998754
|
| >2lhi_A Calmodulin, serine/threonine-protein phosphatase catalytic subunit A1; yeast calmodulin, CNA1, metal binding protein; NMR {Saccharomyces cerevisiae} | Back alignment and structure |
|---|
Probab=97.44 E-value=3.3e-05 Score=70.83 Aligned_cols=53 Identities=13% Similarity=-0.068 Sum_probs=46.7
Q ss_pred CCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhccccc
Q 009364 369 SPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLS 423 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~ 423 (536)
+|..||.+++|.|+..||.. .+.+|++.+++..| |++|.|+|+||+.++.+..
T Consensus 89 aF~~fD~d~~G~I~~~el~~~l~~~g~~~~~~ei~~l~~~~d--d~dG~I~~~EF~~~m~k~~ 149 (176)
T 2lhi_A 89 AFKVFDKNGDGLISAAELKHVLTSIGEKLTDAEVDDMLREVS--DGSGEINIQQFAALLSKGS 149 (176)
T ss_dssp HHHHHCSSCSSSBCHHHHHHHHHTTTCCCCHHHHHHHHHHHH--TTSSCBCTTHHHHHHTCCS
T ss_pred HHHHhCCCCCCcCcHHHHHHHHHHcCcccchHHHHHHHHhhc--CCCCeEeHHHHHHHHHhcC
Confidence 48999999999999999986 47899999999988 7899999999998776543
|
| >2wcb_A Protein S100-A12; calcium signalling, HOST-parasite response, metal binding PR; 1.73A {Homo sapiens} PDB: 1odb_A* 2wc8_A 2wcf_A 2wce_A 1e8a_A 1gqm_A | Back alignment and structure |
|---|
Probab=97.43 E-value=2.7e-05 Score=63.87 Aligned_cols=53 Identities=9% Similarity=-0.100 Sum_probs=44.9
Q ss_pred CCCCCCcc-ccCCC-ccchhhhhh-------------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 367 PGSPGSVD-ICNLD-SLSCSRVIV-------------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 367 ~~sf~~~D-~~~~g-~ls~~el~~-------------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
..+|..|| .+++| .|+.+||+. .+.++++.+++.+| .|++|.|+|+||+.++.
T Consensus 15 ~~~F~~fD~~dg~gg~I~~~El~~~l~~~~~~~lg~~~~~~~v~~~~~~~D-~d~dG~I~f~EF~~~~~ 82 (95)
T 2wcb_A 15 VNIFHQYSVRKGHFDTLSKGELKQLLTKELANTIKNIKDKAVIDEIFQGLD-ANQDEQVDFQEFISLVA 82 (95)
T ss_dssp HHHHHHHHTSSSSTTEEEHHHHHHHHHHHTHHHHHHCCCHHHHHHHHTTSS-SSTTSEEEHHHHHHHHH
T ss_pred HHHHHHHhccCCCCCccCHHHHHHHHHHHhhhhccccccHHHHHHHHHHHc-CCCCCcCcHHHHHHHHH
Confidence 33599999 88887 999999976 14678999999999 89999999999997554
|
| >3fia_A Intersectin-1; EH 1 domain, NESG, structural genomics, PSI- 2, protein structure initiative, northeast structural genomics consortium; 1.45A {Homo sapiens} PDB: 2khn_A | Back alignment and structure |
|---|
Probab=97.41 E-value=2.8e-05 Score=66.58 Aligned_cols=50 Identities=10% Similarity=0.039 Sum_probs=44.6
Q ss_pred CCCCccccCCCccchhhhhh------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 369 SPGSVDICNLDSLSCSRVIV------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
.|..+|. ++|.|+.+|++. .+.+++.+||+..| .|++|.|||+||+.+|.
T Consensus 38 iF~~lD~-~dG~Isg~elr~~~~~sgLp~~~L~~Iw~laD-~d~dG~Ld~~EF~~aM~ 93 (121)
T 3fia_A 38 QFHSLKP-ISGFITGDQARNFFFQSGLPQPVLAQIWALAD-MNNDGRMDQVEFSIAMK 93 (121)
T ss_dssp HHHHTCC-BTTBEEHHHHHHHHGGGCCCHHHHHHHHHHHC-TTCSSEECHHHHHHHHH
T ss_pred HHHHhCC-CCCeECHHHHHHHHHHcCCCHHHHHHHHHHHc-CCCCCcCCHHHHHHHHH
Confidence 4888888 899999999987 46889999999999 89999999999997654
|
| >1avs_A Troponin C; muscle contraction, calcium-activated, E-F hand calcium-binding protein; 1.75A {Gallus gallus} SCOP: a.39.1.5 PDB: 1blq_A 1skt_A 1tnp_A 1tnq_A 1zac_A 1smg_A 1npq_A 1trf_A | Back alignment and structure |
|---|
Probab=97.40 E-value=3.1e-05 Score=62.30 Aligned_cols=54 Identities=11% Similarity=-0.060 Sum_probs=47.1
Q ss_pred CCCCCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 366 SPGSPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 366 ~~~sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
....|..+|.+++|.|+..|+.. .+.++++.++..+| .|++|.|+|+||+.++.
T Consensus 22 l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~D-~~~dg~i~~~eF~~~~~ 83 (90)
T 1avs_A 22 FKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVD-EDGSGTIDFEEFLVMMV 83 (90)
T ss_dssp HHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHC-TTCCSSEEHHHHHHHHH
T ss_pred HHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhC-CCCCCeEeHHHHHHHHH
Confidence 33459999999999999999976 46889999999999 89999999999996554
|
| >2d58_A Allograft inflammatory factor 1; EF-hand, metal binding protein; 1.90A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.39 E-value=5.9e-05 Score=62.90 Aligned_cols=54 Identities=6% Similarity=-0.146 Sum_probs=47.6
Q ss_pred CCCCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhccc
Q 009364 367 PGSPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRK 421 (536)
Q Consensus 367 ~~sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~ 421 (536)
...|..+|.+++|.|+..|+.. .+.+++..++..+| .|++|.|+|+||+.++..
T Consensus 35 ~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~l~~~~D-~d~dg~i~~~eF~~~~~~ 96 (107)
T 2d58_A 35 KEKYMEFDLNGNGDIDIMSLKRMLEKLGVPKTHLELKKLIGEVS-SGSGETFSYPDFLRMMLG 96 (107)
T ss_dssp HHHHTTSCCCTTSCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHC-SSSSSEECHHHHHHHHSS
T ss_pred HHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhC-CCCCCeEcHHHHHHHHHH
Confidence 3459999999999999999976 47889999999999 899999999999976654
|
| >2pmy_A RAS and EF-hand domain-containing protein; rasef, calcium-binding domain, structural genomics, structural genomics consortium, SGC; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.39 E-value=1.2e-05 Score=65.28 Aligned_cols=55 Identities=9% Similarity=0.010 Sum_probs=47.2
Q ss_pred ccCCCCCCCccccCCCccchhhhhh------hhhhhhhhhhhccCCCCCCCccchhhhhhhc
Q 009364 364 LTSPGSPGSVDICNLDSLSCSRVIV------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGD 419 (536)
Q Consensus 364 ~t~~~sf~~~D~~~~g~ls~~el~~------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~ 419 (536)
......|..+|.+++|.|+..|+.. .+.++++.+++.+| .|++|.|+|+||+.++
T Consensus 27 ~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~~~~~~~~D-~d~dg~I~~~EF~~~~ 87 (91)
T 2pmy_A 27 ARLRSVFAACDANRSGRLEREEFRALCTELRVRPADAEAVFQRLD-ADRDGAITFQEFARGF 87 (91)
T ss_dssp HHHHHHHHHHCTTCSSSEEHHHHHHHHHHTTCCHHHHHHHHHHHC-TTCSSEECHHHHTHHH
T ss_pred HHHHHHHHHHCCCCCCCCcHHHHHHHHHHcCcCHHHHHHHHHHhC-CCCCCCEeHHHHHHHH
Confidence 3344459999999999999999986 46789999999999 8999999999999654
|
| >3i5g_C Myosin catalytic light chain LC-1, mantle muscle; rigor-like, squid, muscle myosin, contractIle protein; 2.60A {Todarodes pacificus} PDB: 3i5f_C 3i5h_C 3i5i_C | Back alignment and structure |
|---|
Probab=97.39 E-value=3.2e-05 Score=69.69 Aligned_cols=53 Identities=9% Similarity=-0.046 Sum_probs=46.2
Q ss_pred CCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCC-CCCCCccchhhhhhhccc
Q 009364 369 SPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNS-NDDLCQLDQEDFVAGDRK 421 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~-~d~~g~Id~~EF~~~~~~ 421 (536)
+|..||.+++|.|+..||+. .+.+|++.|++..|. .|++|.|+|+||+.+++.
T Consensus 90 aF~~fD~d~~G~I~~~el~~~l~~~g~~ls~~e~~~l~~~~D~~~d~dG~I~~~EF~~~m~~ 151 (159)
T 3i5g_C 90 AFKTFDREGQGLISSAEIRNVLKMLGERITEDQCNDIFTFCDIREDIDGNIKYEDLMKKVMA 151 (159)
T ss_dssp HHHHHCTTSSSEECHHHHHHHHHHSSSCCCHHHHHHHHHHTTCCCCSSCCEEHHHHHHHHHH
T ss_pred HHHHHhcCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCcCCCCCCeEeHHHHHHHHHC
Confidence 59999999999999999986 478999999998883 488999999999965543
|
| >1qx2_A Vitamin D-dependent calcium-binding protein, INTE; EF-hand (helix-loop-helix) calcium binding protein, four-HEL domain, protein engineering; HET: FME; 1.44A {Bos taurus} SCOP: a.39.1.1 PDB: 1kcy_A 1kqv_A 1ksm_A 1n65_A 1ht9_A 4icb_A 1cdn_A 1clb_A 2bca_A 1ig5_A 1igv_A 3icb_A 1d1o_A 1b1g_A 2bcb_A 1boc_A 1bod_A | Back alignment and structure |
|---|
Probab=97.36 E-value=2.8e-05 Score=60.07 Aligned_cols=51 Identities=8% Similarity=-0.047 Sum_probs=45.3
Q ss_pred CCCCc-cccCC-Cccchhhhhh--------h--hhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 369 SPGSV-DICNL-DSLSCSRVIV--------E--KLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 369 sf~~~-D~~~~-g~ls~~el~~--------~--~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
.|..+ |.+++ |.|+..|+.. . +.++++.+++.+| .|++|.|+|+||+.++.
T Consensus 10 ~F~~~~D~d~~~G~i~~~el~~~l~~~g~~~~~~~~~~~~l~~~~D-~~~~g~i~~~eF~~~~~ 72 (76)
T 1qx2_A 10 AFEVFAAKEGDPNQISKEELKLVMQTLGPSLLKGMSTLDEMIEEVD-KNGDGEVSFEEFLVMMK 72 (76)
T ss_dssp HHHHHHTSSSCTTSEEHHHHHHHHHHHGGGSCTTSCSHHHHHHHHC-TTCSSEECHHHHHHHHH
T ss_pred HHHHHcccCCCcCeECHHHHHHHHHHhCCCcCCCHHHHHHHHHHhC-CCCCCcEeHHHHHHHHH
Confidence 48889 99999 9999999975 4 7789999999999 89999999999996543
|
| >2y5i_A S100Z, S100 calcium binding protein Z; metal-binding protein, EF-hand, calcium regulation, oligomer neuronal development, spine2; 2.03A {Danio rerio} | Back alignment and structure |
|---|
Probab=97.35 E-value=3.7e-05 Score=63.67 Aligned_cols=53 Identities=9% Similarity=-0.123 Sum_probs=44.7
Q ss_pred CCCCCcc-ccCCC-ccchhhhhh-------------hhhhhhhhhhhccCCCCCCCccchhhhhhhccc
Q 009364 368 GSPGSVD-ICNLD-SLSCSRVIV-------------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRK 421 (536)
Q Consensus 368 ~sf~~~D-~~~~g-~ls~~el~~-------------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~ 421 (536)
.+|..|| .+++| .|+.+||.. .+.++++.+++.+| .|++|.|+|+||+.++..
T Consensus 14 ~~F~~fDd~dg~gG~I~~~El~~~l~~~~~~~lg~~~~~~~v~~l~~~~D-~d~dG~I~f~EF~~~~~~ 81 (99)
T 2y5i_A 14 TVFHNYSGSEGDKYKLSKGELKELLNAELTDFLMSQKDPMLVEKIMNDLD-SNKDNEVDFNEFVVLVAA 81 (99)
T ss_dssp HHHHHHHTSSSSTTEECHHHHHHHHHHHSGGGGTTSCCHHHHHHHHHHHC-TTCSSSEEHHHHHHHHHH
T ss_pred HHHHHHhccCCCcCcCCHHHHHHHHHHHhhhhccccccHHHHHHHHHHHC-CCCCCcCcHHHHHHHHHH
Confidence 3588997 88887 999999975 14678999999999 899999999999976543
|
| >3rm1_A Protein S100-B; alpha-helical, EF hand, metal binding protein-protein bindin; 1.24A {Bos taurus} PDB: 3rlz_A 1cfp_A 3cr2_A 3cr4_X* 3cr5_X* 3gk1_A* 3gk2_A* 3gk4_X* 3iqo_A 3iqq_A 3lle_A* 1psb_A 3czt_X 2h61_A 3d0y_A* 3d10_A* 3hcm_A* 3lk1_A* 3lk0_A* 1b4c_A ... | Back alignment and structure |
|---|
Probab=97.33 E-value=4.2e-05 Score=62.23 Aligned_cols=52 Identities=12% Similarity=-0.084 Sum_probs=43.5
Q ss_pred CCCCCccccCCC---ccchhhhhh-------------hhhhhhhhhhhccCCCCCCCccchhhhhhhccc
Q 009364 368 GSPGSVDICNLD---SLSCSRVIV-------------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRK 421 (536)
Q Consensus 368 ~sf~~~D~~~~g---~ls~~el~~-------------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~ 421 (536)
..|..+| +++| .|+.+||+. .+.++++.+++.+| .|++|.|+|+||+.++..
T Consensus 13 ~~F~~~D-~~dG~~g~Is~~EL~~~l~~~~~~~lg~~~~~~~v~~~~~~~D-~d~dG~I~f~EF~~~~~~ 80 (92)
T 3rm1_A 13 DVFHQYS-GREGDKHKLKKSELKELINNELSHFLEEIKEQEVVDKVMETLD-SNGDGECDFQEFMAFVAM 80 (92)
T ss_dssp HHHHHHH-TSSSSTTSBCHHHHHHHHHHHCTTTSCCCCSHHHHHHHHHHHC-TTSSSSBCHHHHHHHHHH
T ss_pred HHHHHHc-cCCCCcCeECHHHHHHHHHHHhhhhccCcccHHHHHHHHHHHc-CCCCCCCcHHHHHHHHHH
Confidence 3488888 6666 999999975 24679999999999 899999999999976543
|
| >1j55_A S-100P protein; metal binding protein; 2.00A {Homo sapiens} SCOP: a.39.1.2 PDB: 1ozo_A | Back alignment and structure |
|---|
Probab=97.32 E-value=4.1e-05 Score=62.78 Aligned_cols=52 Identities=10% Similarity=-0.009 Sum_probs=42.7
Q ss_pred CCCCCcc-ccC-CCccchhhhhh-------------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 368 GSPGSVD-ICN-LDSLSCSRVIV-------------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 368 ~sf~~~D-~~~-~g~ls~~el~~-------------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
..|..|| .++ .|.|+.+||+. .+.++++.+++.+| .|++|.|+|+||+.++.
T Consensus 13 ~~F~~fD~~dgd~G~I~~~El~~~l~~~~~~~lg~~~~~~~v~~l~~~~D-~d~dG~I~f~EF~~~~~ 79 (95)
T 1j55_A 13 DVFSRYSGSEGSTQTLTKGELKVLMEKELPGFLQSGKDKDAVDKLLKDLD-ANGDAQVDFSEFIVFVA 79 (95)
T ss_dssp HHHHHHTTSSSCTTEECHHHHHHHHHHHSTTCC------CHHHHHHHHHC-SSSSSSEEHHHHHHHHH
T ss_pred HHHHHHhccCCCCCcCCHHHHHHHHHHHhHhhcccccCHHHHHHHHHHhC-CCCCCcCCHHHHHHHHH
Confidence 3599999 687 58999999975 14678999999999 89999999999997654
|
| >1xk4_A Calgranulin A; S100 family, heterotetramer, metal binding protein; HET: FLC; 1.80A {Homo sapiens} SCOP: a.39.1.2 PDB: 1mr8_A | Back alignment and structure |
|---|
Probab=97.32 E-value=5.2e-05 Score=61.60 Aligned_cols=51 Identities=4% Similarity=-0.129 Sum_probs=44.8
Q ss_pred CCCCccc-cCCC-ccchhhhhh---------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 369 SPGSVDI-CNLD-SLSCSRVIV---------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 369 sf~~~D~-~~~g-~ls~~el~~---------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
.|..+|. +++| .|+..||.. .+..+++.+++.+| .|++|.|+|+||+.++.
T Consensus 15 ~F~~~D~~d~dG~~I~~~El~~~l~~~~g~~~~~~~~~~l~~~~D-~d~dG~I~~~EF~~~~~ 76 (93)
T 1xk4_A 15 VYHKYSLIKGNFHAVYRDDLKKLLETESPQYIRKKGADVWFKELD-INTDGAVNFQEFLILVI 76 (93)
T ss_dssp HHHHHHTSSSCTTCBCHHHHHHHHHHHSCHHHHTTCHHHHHHHHC-TTCSSSBCHHHHHHHHH
T ss_pred HHHHHhhcCCCcCeECHHHHHHHHHHHCcccCCHHHHHHHHHHhC-CCCCCCCcHHHHHHHHH
Confidence 4889999 9999 999999975 35688999999999 89999999999996554
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.32 E-value=0.00044 Score=69.06 Aligned_cols=138 Identities=14% Similarity=0.116 Sum_probs=75.8
Q ss_pred eeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCc--eeeEeee------ee
Q 009364 70 KGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPN--IVRYLGT------VR 141 (536)
Q Consensus 70 ~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hpn--Iv~l~~~------~~ 141 (536)
-.+.|+.|....||++... +| .+++|+.... .....+..|+.+++.+...+ +.+++.. ..
T Consensus 26 ~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~----------~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~ 93 (322)
T 2ppq_A 26 SYKGIAEGVENSNFLLHTT-KD-PLILTLYEKR----------VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGE 93 (322)
T ss_dssp EEEEECC---EEEEEEEES-SC-CEEEEEECC-------------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEE
T ss_pred EeeccCCCcccceEEEEeC-Cc-cEEEEEeCCC----------CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEE
Confidence 3567888999999998753 34 6889987321 01123445667766663212 2333321 12
Q ss_pred cCCceeEEEEecCCCCcccc--------------cc----cCC-C----CCHHHHHH---------------HHHHHHHH
Q 009364 142 EEESLNILLEFVPGGSISSL--------------LG----KFG-P----FPEAVMRT---------------YTKQLLLG 183 (536)
Q Consensus 142 ~~~~~~lV~E~~~gg~L~~~--------------l~----~~~-~----l~~~~~~~---------------i~~qil~a 183 (536)
..+..+++++|++|..+... ++ ... + ........ +...+...
T Consensus 94 ~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~ 173 (322)
T 2ppq_A 94 LSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPE 173 (322)
T ss_dssp ETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHH
T ss_pred ECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHH
Confidence 23567899999998654221 00 000 0 11110000 00123445
Q ss_pred HHHHHH-------cCCccccCCCCCcccCCCCcEEEEecCcch
Q 009364 184 LEYLHN-------HGIMHRDIKGANILVDNKGCIKLADFGASK 219 (536)
Q Consensus 184 L~yLH~-------~~ivHrDLKp~NILl~~~~~vkL~DFGla~ 219 (536)
+.+++. .+++|+|+++.|||++.++.+.|+||+.+.
T Consensus 174 ~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 174 IDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 555553 368999999999999877666899999764
|
| >1wlz_A DJBP, CAP-binding protein complex interacting protein 1 isoform A; EF-hand like, unknown function; 1.60A {Homo sapiens} SCOP: a.39.1.7 | Back alignment and structure |
|---|
Probab=97.31 E-value=5.9e-05 Score=62.42 Aligned_cols=53 Identities=11% Similarity=0.028 Sum_probs=46.4
Q ss_pred CCCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhccc
Q 009364 368 GSPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRK 421 (536)
Q Consensus 368 ~sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~ 421 (536)
..|..+|.+++|.|+..||.. .+.++++.++..+| .|++|.|+|+||+.++..
T Consensus 28 ~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~e~~~l~~~~d-~~~~g~i~~~eF~~~~~~ 88 (105)
T 1wlz_A 28 QEFENFDTMKTNTISREEFRAICNRRVQILTDEQFDRLWNEMP-VNAKGRLKYPDFLSRFSS 88 (105)
T ss_dssp HHHHHHCTTCSSCBCHHHHHHHHHHHTCCCCHHHHHHHHTTSC-BCTTSCBCHHHHHHHHC-
T ss_pred HHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHcC-CCCCCCCcHHHHHHHHhc
Confidence 459999999999999999986 47889999999999 899999999999976553
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.30 E-value=0.00046 Score=68.06 Aligned_cols=78 Identities=17% Similarity=0.023 Sum_probs=50.9
Q ss_pred ceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCC---ceeeEeeeeecCC
Q 009364 68 WRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHP---NIVRYLGTVREEE 144 (536)
Q Consensus 68 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hp---nIv~l~~~~~~~~ 144 (536)
..-++.+|.|..+.||+... .+|+.|.+|+..... ......+..|...|+.|... -+.+++.+ +
T Consensus 17 v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~--------~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~ 83 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDA--------PALDGLFRAEALGLDWLGRSFGSPVPQVAGW----D 83 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTC--------CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----E
T ss_pred eEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCC--------cchhhHHHHHHHHHHHHHhhCCCCcceEEec----c
Confidence 44577899999999999874 678999999752110 00112356788888877421 23444443 2
Q ss_pred ceeEEEEecCCCCc
Q 009364 145 SLNILLEFVPGGSI 158 (536)
Q Consensus 145 ~~~lV~E~~~gg~L 158 (536)
.-++||||+.++..
T Consensus 84 ~~~lv~e~l~~~~~ 97 (288)
T 3f7w_A 84 DRTLAMEWVDERPP 97 (288)
T ss_dssp TTEEEEECCCCCCC
T ss_pred CceEEEEeecccCC
Confidence 34789999987643
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.30 E-value=0.00033 Score=66.12 Aligned_cols=134 Identities=18% Similarity=0.098 Sum_probs=88.0
Q ss_pred Cccccccc-CCCCCHHHHHHHHHHHHHHHHHHHH-cCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhcccCCcccC
Q 009364 157 SISSLLGK-FGPFPEAVMRTYTKQLLLGLEYLHN-HGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMK 234 (536)
Q Consensus 157 ~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~-~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~ 234 (536)
+|.++|.. ..+++|+++|.++.|.+.+|.-+-. ..-..+=+.|..|++..+|.|...+ +.+. .
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------------~ 98 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD--------------A 98 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc--------------c
Confidence 56777754 4689999999999999999887622 2222333456889999999887763 2110 1
Q ss_pred CCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcHHHHHHHHHhccc-
Q 009364 235 GTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEK- 313 (536)
Q Consensus 235 Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~- 313 (536)
....+.|||... ...+.+.=|||||+++|.-+-=.. .+..+..+|+.+.+||..|..-
T Consensus 99 ~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL--------------------~e~eE~eLS~~LE~LL~~Mt~~~ 157 (229)
T 2yle_A 99 GEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL--------------------KENEERELSPPLEQLIDHMANTV 157 (229)
T ss_dssp --------CCSS-SSSCHHHHHHHHHHHHHHHHTTTC--------------------CTTEEECCCHHHHHHHHHHTTCC
T ss_pred cccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC--------------------CcccchhhCHHHHHHHHHHHhcc
Confidence 123456887653 345678889999999998774222 2233457899999999999755
Q ss_pred ------------------------CCCCCCCHHHHHh
Q 009364 314 ------------------------EPDLRPTASELLK 326 (536)
Q Consensus 314 ------------------------dP~~Rps~~eiL~ 326 (536)
.+..|++..+|++
T Consensus 158 ~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~ 194 (229)
T 2yle_A 158 EADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMK 194 (229)
T ss_dssp C--------------------CCSCCCCCCSHHHHHH
T ss_pred cccccccccccccccccccccccccccCcCCHHHHHH
Confidence 2457788888876
|
| >2obh_A Centrin-2; DNA repair complex EF hand superfamily protein-peptide compl cycle; 1.80A {Homo sapiens} SCOP: a.39.1.5 PDB: 3kf9_A 1m39_A 2a4j_A 2k2i_A 1oqp_A | Back alignment and structure |
|---|
Probab=97.29 E-value=5.9e-05 Score=66.10 Aligned_cols=50 Identities=8% Similarity=-0.071 Sum_probs=45.3
Q ss_pred CCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhc
Q 009364 369 SPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGD 419 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~ 419 (536)
.|..+|.+++|.|+..||.. .+.++++.+++.+| .|++|.|+|+||+.++
T Consensus 84 ~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~D-~d~dG~I~~~eF~~~~ 141 (143)
T 2obh_A 84 AFKLFDDDETGKISFKNLKRVAKELGENLTDEELQEMIDEAD-RDGDGEVSEQEFLRIM 141 (143)
T ss_dssp HHHHHCTTCSSSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHC-TTSSSSBCHHHHHHHH
T ss_pred HHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhC-CCCCCcEeHHHHHHHH
Confidence 49999999999999999976 46889999999999 8999999999999654
|
| >3e3r_A Calcyphosin, calcyphosine; human calcyphosine, EF-hand, phosphoprotein, calcium binding; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.28 E-value=2.7e-05 Score=72.28 Aligned_cols=73 Identities=12% Similarity=-0.031 Sum_probs=57.4
Q ss_pred cCCCCCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcccccccCChhhhhhccC
Q 009364 365 TSPGSPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSSILAPNDLEKSRN 436 (536)
Q Consensus 365 t~~~sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~~~~~e~l~~aF~ 436 (536)
.....|..+|.+++|.|+..|+.. .+.++++.+++.+| .|++|.|+|+||+.++.........+.++.+|+
T Consensus 38 ~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~D-~d~dg~i~~~ef~~~~~~~~~~~~~~~~~~~F~ 116 (204)
T 3e3r_A 38 GLARFFRQLDRDGSRSLDADEFRQGLAKLGLVLDQAEAEGVCRKWD-RNGSGTLDLEEFLRALRPPMSQAREAVIAAAFA 116 (204)
T ss_dssp --CHHHHHHCTTCCSSBCHHHHHHHHHTTTCCCCHHHHHHHHHHHC-TTCSSSBCHHHHHHHTSCCCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHccCCCCCcCHHHHHHHHHHcCCCCCHHHHHHHHHHhc-cCCCCcCcHHHHHHHHHhhcCchHHHHHHHHHH
Confidence 345569999999999999999976 46889999999999 899999999999977665433334456777776
Q ss_pred CC
Q 009364 437 PM 438 (536)
Q Consensus 437 ~~ 438 (536)
-.
T Consensus 117 ~~ 118 (204)
T 3e3r_A 117 KL 118 (204)
T ss_dssp HH
T ss_pred Hh
Confidence 44
|
| >1j7q_A CAVP, calcium vector protein; EF-hand family, calcium binding protein, metal binding protein; NMR {Branchiostoma lanceolatum} SCOP: a.39.1.5 PDB: 1j7r_A | Back alignment and structure |
|---|
Probab=97.27 E-value=7.3e-05 Score=59.41 Aligned_cols=51 Identities=8% Similarity=-0.137 Sum_probs=44.9
Q ss_pred CCCCCccccCCCccchhhhhh--------hhhhh---hhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 368 GSPGSVDICNLDSLSCSRVIV--------EKLSG---SMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 368 ~sf~~~D~~~~g~ls~~el~~--------~~~~e---i~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
..|..+|.+++|.|+..||.. .+.++ +..++..+| .|++|.|+| ||+.++.
T Consensus 18 ~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~~~~d-~~~~g~i~~-eF~~~~~ 79 (86)
T 1j7q_A 18 KIFDIFDRNAENIAPVSDTMDMLTKLGQTYTKRETEAIMKEARGPK-GDKKNIGPE-EWLTLCS 79 (86)
T ss_dssp HHHHHHSTTTTSCBCHHHHHHHHHHTSCCCSHHHHHHHHHHHHCSS-CSSCCBCTT-HHHHHHH
T ss_pred HHHHHhCCCCCCcCcHHHHHHHHHHHcCCCCHHHHHHHHHHHHHhC-CCCCCcCCH-HHHHHHH
Confidence 359999999999999999976 46788 999999999 899999999 9996554
|
| >2bl0_C Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} | Back alignment and structure |
|---|
Probab=97.25 E-value=3.9e-05 Score=66.64 Aligned_cols=69 Identities=4% Similarity=-0.011 Sum_probs=56.0
Q ss_pred CCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhccc-ccccCChhhhhhccCCC
Q 009364 369 SPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRK-LSSILAPNDLEKSRNPM 438 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~-~~~~~~~e~l~~aF~~~ 438 (536)
.|..+|.+++|.|+.+|+.. ++..++..+++..| .|++|.|+|+||+.++.. .......+.++.+|+..
T Consensus 11 ~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~l~~~~d-~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~F~~~ 88 (142)
T 2bl0_C 11 AFELFDSERTGFITKEGLQTVLKQFGVRVEPAAFNEMFNEAD-ATGNGKIQFPEFLSMMGRRMKQTTSEDILRQAFRTF 88 (142)
T ss_dssp HHHHHCTTCSSEEEHHHHHHHHHHHTCCCCHHHHHHHHHHHC-TTCSSEEEHHHHHHHHHHHHTTCCCHHHHHHHHHHT
T ss_pred HHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhC-cCCCCeeeHHHHHHHHHHHhcCCChHHHHHHHHHHH
Confidence 48889999999999999976 46789999999999 899999999999976654 22334556777777654
|
| >3j04_B Myosin regulatory light chain 2, smooth muscle MA isoform; phosphorylation, 2D crystalline arrays, myosin regulation, M light chains, structural protein; 20.00A {Gallus gallus} | Back alignment and structure |
|---|
Probab=97.24 E-value=0.00011 Score=63.71 Aligned_cols=51 Identities=6% Similarity=-0.130 Sum_probs=46.2
Q ss_pred CCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 369 SPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
.|..+|.+++|.|+.+|+.. .+.++++.+++..| .|++|.|+|+||+.++.
T Consensus 81 ~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~~~~~~~~~~D-~d~dg~i~~~eF~~~~~ 139 (143)
T 3j04_B 81 AFACFDEEASGFIHEDHLRELLTTMGDRFTDEEVDEMYREAP-IDKKGNFNYVEFTRILK 139 (143)
T ss_dssp HHTTSCSSSCCCCCTTTHHHHHHTSSSCCCHHHHHHHHHHTT-CCSSSCCCSTHHHHHHH
T ss_pred HHHHHCCCCCCeEcHHHHHHHHHHcCCCCCHHHHHHHHHHcC-CCCCCcCcHHHHHHHHh
Confidence 49999999999999999986 47889999999999 89999999999997654
|
| >2jnf_A Troponin C; stretch activated muscle contraction, EF-hand, metal binding protein; NMR {Lethocerus indicus} PDB: 2k2a_A | Back alignment and structure |
|---|
Probab=97.23 E-value=1.6e-05 Score=70.47 Aligned_cols=69 Identities=7% Similarity=-0.056 Sum_probs=53.5
Q ss_pred CCCCCcc-ccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcccccc-c----CChhhhhh
Q 009364 368 GSPGSVD-ICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSS-I----LAPNDLEK 433 (536)
Q Consensus 368 ~sf~~~D-~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~-~----~~~e~l~~ 433 (536)
..|..+| .+++|.|+..|+.. ++..++..+++.+| .+++|.|+|+||+.++..... . ...+.++.
T Consensus 17 ~~F~~~D~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~l~~~~D-~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~~~ 95 (158)
T 2jnf_A 17 TAFRDFETPEGSGRVSTDQIGIILEVLGIQQTKSTIRQLIDEFD-PFGNGDIDFDSFKIIGARFLGEEVNPEQMQQELRE 95 (158)
T ss_dssp HHHHHSBCSSSCSSEEHHHHHHHHHHTTCSCSHHHHHHHHHHHC-TTCCSEECHHHHHHHHHHHCCCCCCTTTTSSTHHH
T ss_pred HHHHHhCCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhC-CCCCCcCcHHHHHHHHHHHhccccchhhHHHHHHH
Confidence 3489999 99999999999976 46789999999999 899999999999976543221 1 33445666
Q ss_pred ccCC
Q 009364 434 SRNP 437 (536)
Q Consensus 434 aF~~ 437 (536)
+|+-
T Consensus 96 ~F~~ 99 (158)
T 2jnf_A 96 AFRL 99 (158)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 6643
|
| >2kax_A Protein S100-A5; EF-hand, calcium binding protien, calcium, polymorphism, structural genomics, spine2, structural proteomics in europe, spine; NMR {Homo sapiens} PDB: 2kay_A | Back alignment and structure |
|---|
Probab=97.21 E-value=5.3e-05 Score=61.59 Aligned_cols=52 Identities=10% Similarity=-0.091 Sum_probs=45.0
Q ss_pred CCCCCcc-ccCCC-ccchhhhhh----------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 368 GSPGSVD-ICNLD-SLSCSRVIV----------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 368 ~sf~~~D-~~~~g-~ls~~el~~----------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
..|..+| .+++| .|+.+||.. .+..+++.+++.+| .|++|.|+|+||+.++.
T Consensus 14 ~~F~~~D~~d~dG~~I~~~El~~~l~~~~~~~~~~~~~i~~~~~~~D-~d~dG~I~f~EF~~~~~ 77 (92)
T 2kax_A 14 TTFHKYSGREGSKLTLSRKELKELIKKELCLGEMKESSIDDLMKSLD-KNSDQEIDFKEYSVFLT 77 (92)
T ss_dssp HHHHHHHTTSSCSSEEEHHHHHHHHHHHSCCTTTCCTTHHHHHHHHT-TTCSSEEEHHHHHHHHH
T ss_pred HHHHHHHhhCCCCCeeCHHHHHHHHHHHcCCCCCCHHHHHHHHHHhC-CCCCCcCcHHHHHHHHH
Confidence 3589999 99999 999999865 24678999999999 89999999999997654
|
| >2kyc_A Parvalbumin-3, parvalbumin, thymic CPV3; EF-hand protein, calcium binding protein; NMR {Gallus gallus} PDB: 2kyf_A | Back alignment and structure |
|---|
Probab=97.20 E-value=0.00016 Score=59.90 Aligned_cols=50 Identities=10% Similarity=-0.047 Sum_probs=44.5
Q ss_pred CCCCccccCCCccchhhhhh-----------hhhhhhhhhhhccCCCCCCCccchhhhhhhc
Q 009364 369 SPGSVDICNLDSLSCSRVIV-----------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGD 419 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~-----------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~ 419 (536)
.|..+|.+++|.|+..|+.. .+.++++.+++..| .|++|.|+|+||+.++
T Consensus 46 ~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~D-~d~dg~i~~~eF~~~~ 106 (108)
T 2kyc_A 46 IFRILDNDQSGFIEEDELKYFLQRFESGARVLTASETKTFLAAAD-HDGDGKIGAEEFQEMV 106 (108)
T ss_dssp HCSSSCSCCSSCCCGGGTTTSHHHHSSSCCCCCTTTTHHHHTTTC-CSSSSCCCSSHHHHHH
T ss_pred HHHHhCCCCCCeEcHHHHHHHHHHHhhccCCCCHHHHHHHHHHhC-CCCCCcCCHHHHHHHH
Confidence 59999999999999999864 35689999999999 8999999999998644
|
| >1yx7_A Calsensin, LAN3-6 antigen; calcium-binding protein EF-hand, helix-loop- helix, nervous system, metal binding protein; NMR {Haemopis marmorata} PDB: 1yx8_A | Back alignment and structure |
|---|
Probab=97.18 E-value=0.0001 Score=57.92 Aligned_cols=50 Identities=6% Similarity=0.039 Sum_probs=43.7
Q ss_pred CCCCccccCCCccchhhhhh----------hhhhhhhh----hhhccCCCCCCCccchhhhhhhc
Q 009364 369 SPGSVDICNLDSLSCSRVIV----------EKLSGSMH----GWVTSNSNDDLCQLDQEDFVAGD 419 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~----------~~~~ei~~----l~~~~d~~d~~g~Id~~EF~~~~ 419 (536)
.|..+|.+++|.|+.+|+.. .+.++++. +++..| .|++|.|+|+||+..+
T Consensus 12 ~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~~~~~~D-~~~dg~I~~~eF~~~~ 75 (83)
T 1yx7_A 12 AFKKLDANGDGYVTALELQTFMVTLDAYKALSKDKVKEASAKLIKMAD-KNSDGKISKEEFLNAN 75 (83)
T ss_dssp HHHHHSSSCSSSCSHHHHHHHHHHHTTCTTTTTTTTHHHHHHHHTTTC-SSSCSCCSHHHHHHHH
T ss_pred HHHHHCCCCCCcCcHHHHHHHHHHHccccCCCHHHHHHHHHHHHHHhC-CCCCCCCcHHHHHHhh
Confidence 48899999999999999864 35678889 999999 8999999999999543
|
| >1psr_A Psoriasin, S100A7; EF-hand protein, MAD phasing, psoriasis, S100 protein family; 1.05A {Homo sapiens} SCOP: a.39.1.2 PDB: 2psr_A 2wor_A* 2wos_A* 3psr_A 2wnd_A | Back alignment and structure |
|---|
Probab=97.18 E-value=9.1e-05 Score=61.31 Aligned_cols=53 Identities=6% Similarity=-0.031 Sum_probs=43.7
Q ss_pred CCCCCCccccCCCccchhhhhh---------------hhhhhhhhhhhccCCCCCCCccchhhhhhhccc
Q 009364 367 PGSPGSVDICNLDSLSCSRVIV---------------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRK 421 (536)
Q Consensus 367 ~~sf~~~D~~~~g~ls~~el~~---------------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~ 421 (536)
..+|..||.+ +|.|+.+||+. .+.++++.+++.+| .|++|.|+|+||+.++..
T Consensus 13 ~~~F~~fD~~-~g~Is~~El~~~l~~~~~~~lg~~~~~~~~ev~~l~~~~D-~d~dG~I~f~EF~~~~~~ 80 (100)
T 1psr_A 13 IDMFHKYTRR-DDKIDKPSLLTMMKENFPNFLSACDKKGTNYLADVFEKKD-KNEDKKIDFSEFLSLLGD 80 (100)
T ss_dssp HHHHHHTCCT-TSCBCHHHHHHHHHHHCHHHHHHHHHTTCCGGGTHHHHHC-TTCSSCBCHHHHHHHHHH
T ss_pred HHHHHHHhCC-CCeECHHHHHHHHHHHhHhhhccccccCHHHHHHHHHHhC-CCCCCcCcHHHHHHHHHH
Confidence 3458999976 78999999975 13568999999999 899999999999976543
|
| >2mys_B Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1i84_U* 1m8q_B* 1mvw_B* 1o18_E* 1o19_B* 1o1a_B* 1o1b_B* 1o1c_B* 1o1d_B* 1o1e_B* 1o1f_B* 1o1g_B* 2w4a_B 2w4g_B 2w4h_B | Back alignment and structure |
|---|
Probab=97.16 E-value=0.00012 Score=65.45 Aligned_cols=52 Identities=12% Similarity=-0.058 Sum_probs=46.8
Q ss_pred CCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhccc
Q 009364 369 SPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRK 421 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~ 421 (536)
.|..+|.+++|.|+..|+.. .+.++++.+++.+| .|++|.|+|+||+.++..
T Consensus 100 ~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~D-~d~dg~I~~~eF~~~~~~ 159 (166)
T 2mys_B 100 AFKVLDPDGKGSIKKSFLEELLTTGGGRFTPEEIKNMWAAFP-PDVAGNVDYKNICYVITH 159 (166)
T ss_pred HHHHhCCCCCcceeHHHHHHHHHHcCCCCCHHHHHHHHHhcC-CCCCCeEeHHHHHHHHHh
Confidence 59999999999999999976 46889999999999 899999999999976654
|
| >2kld_A Polycystin-2; PC2, PKD2, calcium binding domain, EF hand, cytosolic, calcium, coiled coil, disease mutation, glycoprotein, ION transport; NMR {Homo sapiens} PDB: 2kle_A 2kq6_A 2y4q_A | Back alignment and structure |
|---|
Probab=97.16 E-value=0.00023 Score=61.25 Aligned_cols=54 Identities=9% Similarity=-0.042 Sum_probs=45.9
Q ss_pred ccCCCCCCCccccCCCccchhhhhh------hhhhhhhhhhhccCCCCCCCccchhhhhhhcccc
Q 009364 364 LTSPGSPGSVDICNLDSLSCSRVIV------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKL 422 (536)
Q Consensus 364 ~t~~~sf~~~D~~~~g~ls~~el~~------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~ 422 (536)
.....+|..|| |.|+.+||.. .+.++++.+++..| .|++|.|+|+||+.++...
T Consensus 50 ~~l~~aF~~fD----G~I~~~El~~~l~~lG~t~~ei~~~~~~~D-~d~dG~I~~~EF~~~~~~~ 109 (123)
T 2kld_A 50 DDISESLRQGG----GKLNFDELRQDLKGKGHTDAEIEAIFTKYD-QDGDQELTEHEHQQMRDDL 109 (123)
T ss_dssp -CCSCSSTTTT----TCEEHHHHHHHTTTCCSSHHHHHHHHHHHS-SSSCCEECSHHHHHCSCTT
T ss_pred HHHHHHHHHhC----CCCCHHHHHHHHHHhCCCHHHHHHHHHHHc-CCCCCcCcHHHHHHHHHHH
Confidence 34566799998 9999999986 37889999999999 8999999999999876554
|
| >1c7v_A CAVP, calcium vector protein; EF-hand family, calcium binding protein, metal binding protein; NMR {Branchiostoma lanceolatum} SCOP: a.39.1.5 PDB: 1c7w_A | Back alignment and structure |
|---|
Probab=97.14 E-value=4.3e-05 Score=59.98 Aligned_cols=52 Identities=10% Similarity=-0.001 Sum_probs=45.8
Q ss_pred CCCCccccCCCccchhhhhh---------hhhhhhhhhhhccCCCCCCCccchhhhhhhccc
Q 009364 369 SPGSVDICNLDSLSCSRVIV---------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRK 421 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~---------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~ 421 (536)
.|..+|.+++|.|+..|+.. .+.++++.+++.+| .|++|.|+|+||+.++..
T Consensus 13 ~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~~D-~~~dg~i~~~eF~~~~~~ 73 (81)
T 1c7v_A 13 AFKVFDANGDGVIDFDEFKFIMQKVGEEPLTDAEVEEAMKEAD-EDGNGVIDIPEFMDLIKK 73 (81)
T ss_dssp HHHHHSCSGGGEECHHHHHHHSSTTTTCCCCHHHHHHHHHHHC-SSGGGSEEHHHHHHHHHC
T ss_pred HHHHHCCCCCCcCCHHHHHHHHHHhCCCCCCHHHHHHHHHHhC-CCCCCcCcHHHHHHHHHh
Confidence 48999999999999999975 35789999999999 899999999999976554
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.13 E-value=0.00061 Score=70.30 Aligned_cols=136 Identities=18% Similarity=0.166 Sum_probs=79.7
Q ss_pred eeEEcccCceEEEEEEEcC-------CCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCC-CCceeeEeeeeec
Q 009364 71 GELIGCGAFGRVYMGMNLD-------SGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS-HPNIVRYLGTVRE 142 (536)
Q Consensus 71 ~~~LG~G~fg~Vy~a~~~~-------~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~ 142 (536)
.+.|..|-...+|++.... +++.+++|+.-. .. .....+.+|..+++.+. +.-..++++.+.+
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~--------~~-~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~ 125 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA--------IL-QGVDSLVLESVMFAILAERSLGPQLYGVFPE 125 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC--------cc-chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC
Confidence 4568788899999987532 357899997511 00 11234457888887774 3223566666543
Q ss_pred CCceeEEEEecCCCCcccc-c----------------ccC-----CCC--CHHHHHHHHHHHHH----------------
Q 009364 143 EESLNILLEFVPGGSISSL-L----------------GKF-----GPF--PEAVMRTYTKQLLL---------------- 182 (536)
Q Consensus 143 ~~~~~lV~E~~~gg~L~~~-l----------------~~~-----~~l--~~~~~~~i~~qil~---------------- 182 (536)
.+||||++|.+|..- + +.. +.. -...+..+..|+-.
T Consensus 126 ----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~ 201 (379)
T 3feg_A 126 ----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYS 201 (379)
T ss_dssp ----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTT
T ss_pred ----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHH
Confidence 399999998665321 0 010 111 23455555554422
Q ss_pred ---HHHHHHH--------cCCccccCCCCCcccCCC----CcEEEEecCcch
Q 009364 183 ---GLEYLHN--------HGIMHRDIKGANILVDNK----GCIKLADFGASK 219 (536)
Q Consensus 183 ---aL~yLH~--------~~ivHrDLKp~NILl~~~----~~vkL~DFGla~ 219 (536)
.+..|.. ..++|+|+.+.||+++.+ +.+.|+||..+.
T Consensus 202 l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 202 LKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 2333332 248999999999999876 689999999764
|
| >1dtl_A Cardiac troponin C; helix-turn-helix, structural protein; HET: BEP; 2.15A {Gallus gallus} SCOP: a.39.1.5 PDB: 1j1d_A 1j1e_A 2jt3_A 2jt0_A 1la0_A 2jtz_A* 2jt8_A* 2kfx_T* 1wrk_A* 1wrl_A* 1ap4_A 1lxf_C* 1mxl_C 1spy_A 2krd_C* 2l1r_A* 3rv5_A* 2ctn_A 2kgb_C 2jxl_A ... | Back alignment and structure |
|---|
Probab=97.13 E-value=1.8e-05 Score=70.33 Aligned_cols=71 Identities=8% Similarity=-0.062 Sum_probs=54.7
Q ss_pred CCCCCCccccC-CCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhccccc----ccCChhhhhh
Q 009364 367 PGSPGSVDICN-LDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLS----SILAPNDLEK 433 (536)
Q Consensus 367 ~~sf~~~D~~~-~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~----~~~~~e~l~~ 433 (536)
...|..+|.++ +|.|+.+|+.. ++.+++..+++.+| .|++|.|+|+||+.++.... .....+.++.
T Consensus 21 ~~~F~~~D~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~D-~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~~ 99 (161)
T 1dtl_A 21 KAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEELQEMIDEVD-EDGSGTVDFDEFLVMMVRSMKDDSKGKSEEELSD 99 (161)
T ss_dssp HHHHHHHTTTCGGGSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHC-TTSSSSBCHHHHHHHHHHHHC-----CHHHHHHH
T ss_pred HHHHHHHcCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhC-CCCCCeEcHHHHHHHHHHHhcccccchHHHHHHH
Confidence 34588999999 99999999976 46789999999999 89999999999997655432 1223445667
Q ss_pred ccCCC
Q 009364 434 SRNPM 438 (536)
Q Consensus 434 aF~~~ 438 (536)
+|+-.
T Consensus 100 ~F~~~ 104 (161)
T 1dtl_A 100 LFRMF 104 (161)
T ss_dssp HHHHH
T ss_pred HHHHh
Confidence 77543
|
| >1wdc_C Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Z 1kqm_C* 1kwo_C* 1l2o_C* 1qvi_Z* 1s5g_Z* 1sr6_C 1b7t_Z 3jvt_C 3jtd_C 1kk8_C* 2ec6_C 1dfk_Z 1dfl_Z* 2w4t_Z 2w4v_Z 2w4w_Z 2otg_C* 2os8_C* 3pn7_C ... | Back alignment and structure |
|---|
Probab=97.13 E-value=2.3e-05 Score=69.36 Aligned_cols=69 Identities=9% Similarity=-0.054 Sum_probs=55.5
Q ss_pred CCCCCccc--cCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcccccc--cCChhhhhhcc
Q 009364 368 GSPGSVDI--CNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSS--ILAPNDLEKSR 435 (536)
Q Consensus 368 ~sf~~~D~--~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~--~~~~e~l~~aF 435 (536)
..|..+|. +++|.|+..|+.. ++..++..+ +.+| .+++|.|+|+||+.++..... ....+.++.+|
T Consensus 13 ~~F~~~D~~~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l-~~~D-~~~~g~i~~~eF~~~~~~~~~~~~~~~~~l~~~F 90 (156)
T 1wdc_C 13 DVFELFDFWDGRDGAVDAFKLGDVCRCLGINPRNEDVFAV-GGTH-KMGEKSLPFEEFLPAYEGLMDCEQGTFADYMEAF 90 (156)
T ss_dssp HHHHHHHHHTCSSSCEEGGGHHHHHHHTTCCCCHHHHHHT-TCCS-STTSCEECHHHHHHHHHHHTTSCCCCHHHHHHHH
T ss_pred HHHHHHccCCCCCCCCcHHHHHHHHHHcCCCCCHHHHHHH-HhhC-CCCCCeeeHHHHHHHHHHHhhccCChHHHHHHHH
Confidence 34889999 9999999999976 467889999 9999 899999999999976654332 44556788888
Q ss_pred CCC
Q 009364 436 NPM 438 (536)
Q Consensus 436 ~~~ 438 (536)
+-.
T Consensus 91 ~~~ 93 (156)
T 1wdc_C 91 KTF 93 (156)
T ss_dssp HTT
T ss_pred HHh
Confidence 754
|
| >3i5g_B Myosin regulatory light chain LC-2, mantle muscle; rigor-like, squid, muscle myosin, contractIle protein; 2.60A {Todarodes pacificus} PDB: 3i5f_B 3i5h_B 3i5i_B | Back alignment and structure |
|---|
Probab=97.12 E-value=3.9e-05 Score=68.69 Aligned_cols=72 Identities=10% Similarity=-0.104 Sum_probs=55.3
Q ss_pred hcccCCCCCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhccccc-ccCChhhhh
Q 009364 362 QMLTSPGSPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLS-SILAPNDLE 432 (536)
Q Consensus 362 q~~t~~~sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~-~~~~~e~l~ 432 (536)
++.....+|..||.+++|.|+..||.. ++.+++..++...+ |.|+|+||+.++.... ....+++|+
T Consensus 14 qi~elk~~F~~~D~d~dG~I~~~El~~~l~~lg~~~~~~~~~~~~~~~~-----~~i~f~ef~~~~~~~~~~~~~~~~l~ 88 (153)
T 3i5g_B 14 QMQELKEAFTMIDQDRDGFIGMEDLKDMFSSLGRVPPDDELNAMLKECP-----GQLNFTAFLTLFGEKVSGTDPEDALR 88 (153)
T ss_dssp HHHHHHHHHHHHCCSTTSCCCHHHHHHHHHHTTSCCCHHHHHHHHHTSS-----SCCCSHHHHHTTTTTTTTCCCHHHHH
T ss_pred HHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHcCCCccHHHHHHHHHhcc-----CCccHHHHHHHHHhhhcccccHHHHH
Confidence 334444569999999999999999976 56778887776544 6799999997766543 345677899
Q ss_pred hccCCC
Q 009364 433 KSRNPM 438 (536)
Q Consensus 433 ~aF~~~ 438 (536)
+||+-.
T Consensus 89 ~aF~~f 94 (153)
T 3i5g_B 89 NAFSMF 94 (153)
T ss_dssp HHHHTT
T ss_pred HHHhcc
Confidence 999865
|
| >1exr_A Calmodulin; high resolution, disorder, metal transport; 1.00A {Paramecium tetraurelia} SCOP: a.39.1.5 PDB: 1n0y_A 1osa_A 1clm_A 1mxe_A 2bbm_A 2bbn_A 4cln_A 4djc_A 2wel_D* 2x51_B 2vas_B* 2bkh_B 3gn4_B 3l9i_C 2ygg_B* 2w73_A 1lvc_D* 1wrz_A 2bki_B 2r28_A ... | Back alignment and structure |
|---|
Probab=97.10 E-value=3.6e-05 Score=67.70 Aligned_cols=69 Identities=7% Similarity=-0.046 Sum_probs=54.6
Q ss_pred CCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhccccc-ccCChhhhhhccCCC
Q 009364 369 SPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLS-SILAPNDLEKSRNPM 438 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~-~~~~~e~l~~aF~~~ 438 (536)
.|..+|.+++|.|+..|+.. ++..+++.+++..| .|++|.|+|+||+.++.... .....++++++|+..
T Consensus 15 ~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~d-~~~~g~i~~~eF~~~~~~~~~~~~~~~~l~~~F~~~ 92 (148)
T 1exr_A 15 AFALFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVD-ADGNGTIDFPEFLSLMARKMKEQDSEEELIEAFKVF 92 (148)
T ss_dssp HHHHHCTTCSSEECHHHHHHHHHHHTCCCCHHHHHHHHHHHC-TTCSSSEEHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHHC-CCCCCcCcHHHHHHHHHhcccCCCcHHHHHHHHHHh
Confidence 48899999999999999975 56789999999999 89999999999997654321 223345677777543
|
| >1exr_A Calmodulin; high resolution, disorder, metal transport; 1.00A {Paramecium tetraurelia} SCOP: a.39.1.5 PDB: 1n0y_A 1osa_A 1clm_A 1mxe_A 2bbm_A 2bbn_A 4cln_A 4djc_A 2wel_D* 2x51_B 2vas_B* 2bkh_B 3gn4_B 3l9i_C 2ygg_B* 2w73_A 1lvc_D* 1wrz_A 2bki_B 2r28_A ... | Back alignment and structure |
|---|
Probab=97.09 E-value=0.00011 Score=64.52 Aligned_cols=51 Identities=12% Similarity=-0.078 Sum_probs=45.8
Q ss_pred CCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 369 SPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
.|..+|.+++|.|+..|+.. .+.++++.+++..| .|++|.|+|+||+.++.
T Consensus 88 ~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d-~d~dg~i~~~eF~~~~~ 146 (148)
T 1exr_A 88 AFKVFDRDGNGLISAAELRHVMTNLGEKLTDDEVDEMIREAD-IDGDGHINYEEFVRMMV 146 (148)
T ss_dssp HHHHHSTTCSSCBCHHHHHHHHHHTTCCCCHHHHHHHHHHHC-SSSSSSBCHHHHHHHHH
T ss_pred HHHHhCCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHhC-CCCCCcEeHHHHHHHHc
Confidence 49999999999999999976 46789999999999 89999999999997553
|
| >2aao_A CDPK, calcium-dependent protein kinase, isoform AK1; calmodulin-like domain, EF calcium binding protein, transferase; 2.00A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.09 E-value=8.2e-05 Score=66.40 Aligned_cols=71 Identities=14% Similarity=0.108 Sum_probs=55.3
Q ss_pred CCCCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcccccccCChhhhhhccCCC
Q 009364 367 PGSPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSSILAPNDLEKSRNPM 438 (536)
Q Consensus 367 ~~sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~~~~~e~l~~aF~~~ 438 (536)
...|..+|.+++|.|+..|+.. ++..++..+++..| .|++|.|+|+||+.++.........+.++.+|+-.
T Consensus 30 ~~~F~~~D~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~d-~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~F~~~ 108 (166)
T 2aao_A 30 KEMFNMIDADKSGQITFEELKAGLKRVGANLKESEILDLMQAAD-VDNSGTIDYKEFIAATLHLNKIEREDHLFAAFTYF 108 (166)
T ss_dssp HHHHHHHCTTCCSSBCHHHHHHHGGGGTCCCCHHHHHHHHHHHC-TTCCSSBCHHHHHHHHTTCHHHHTTHHHHHHHHHH
T ss_pred HHHHHHhCCCCCCeEeHHHHHHHHHHhCCCCCHHHHHHHHHHhC-CCCCCeEcHHHHHHHHHHHhhcccHHHHHHHHHHh
Confidence 3458999999999999999975 46788999999999 89999999999997665443333445566666543
|
| >3fs7_A Parvalbumin, thymic; calcium-binding protein, EF-hand, acetylation, calcium, metal binding protein; 1.95A {Gallus gallus} SCOP: a.39.1.4 PDB: 2kqy_A | Back alignment and structure |
|---|
Probab=97.08 E-value=0.00013 Score=60.72 Aligned_cols=50 Identities=10% Similarity=0.001 Sum_probs=44.3
Q ss_pred CCCCccccCCCccchhhhhh-----------hhhhhhhhhhhccCCCCCCCccchhhhhhhc
Q 009364 369 SPGSVDICNLDSLSCSRVIV-----------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGD 419 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~-----------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~ 419 (536)
.|..+|.+++|.|+..|+.. .+.++++.+++..| .|++|.|+|+||+.++
T Consensus 47 ~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~~~D-~~~dg~i~~~EF~~~~ 107 (109)
T 3fs7_A 47 VFGILDQDKSGFIEEEELQLFLKNFSSSARVLTSAETKAFLAAGD-TDGDGKIGVEEFQSLV 107 (109)
T ss_dssp HHHHHSTTCSSSBCHHHHHTTGGGTCTTSCCCCHHHHHHHHHHHC-TTCSSSBCHHHHHHHH
T ss_pred HHHHHCCCCCCeEeHHHHHHHHHHHhcccccCCHHHHHHHHHHhC-CCCCCcCcHHHHHHHH
Confidence 38899999999999999975 35789999999999 8999999999999654
|
| >1m45_A MLC1P, myosin light chain; protein-peptide complex, myosin light chain, cell cycle protein; 1.65A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 1m46_A 1n2d_A 2fcd_A 2fce_A | Back alignment and structure |
|---|
Probab=97.07 E-value=0.00015 Score=63.33 Aligned_cols=51 Identities=10% Similarity=-0.053 Sum_probs=45.7
Q ss_pred CCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 369 SPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
.|..+|.+++|.|+..|+.. .+.+++..+++.+| .|++|.|+|+||+.++.
T Consensus 88 ~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d-~d~dg~i~~~eF~~~~~ 146 (148)
T 1m45_A 88 AFQVFDKESTGKVSVGDLRYMLTGLGEKLTDAEVDELLKGVE-VDSNGEIDYKKFIEDVL 146 (148)
T ss_dssp HHHTTCSSSSSEEEHHHHHHHHHHSTTCCCHHHHHHHHTTCC-CCTTSEEEHHHHHHHHH
T ss_pred HHHHhCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHhC-CCCCCeEeHHHHHHHHh
Confidence 48899999999999999976 46889999999999 89999999999997553
|
| >1cb1_A Calbindin D9K; calcium-binding protein; NMR {Sus scrofa} SCOP: a.39.1.1 | Back alignment and structure |
|---|
Probab=97.07 E-value=7.3e-05 Score=57.93 Aligned_cols=51 Identities=8% Similarity=-0.141 Sum_probs=44.4
Q ss_pred CCCCccc-cCCC-ccchhhhhh---------h-hhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 369 SPGSVDI-CNLD-SLSCSRVIV---------E-KLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 369 sf~~~D~-~~~g-~ls~~el~~---------~-~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
.|..+|. +++| .|+..|+.. . +.++++.+++.+| .|++|.|+|+||+.++.
T Consensus 12 ~F~~~D~~d~~G~~i~~~el~~~l~~~~g~~~~~~~~~~~~~~~~D-~~~dg~i~~~eF~~~~~ 74 (78)
T 1cb1_A 12 IFEKYAAKEGDPNQLSKEELKQLIQAEFPSLLKGPRTLDDLFQELD-KNGDGEVSFEEFQVLVK 74 (78)
T ss_dssp HHHHHHTTSSSTTEECHHHHHHHHHHHCSSCCSSCCCSSHHHHHTC-CCSSSSEEHHHHHHHHH
T ss_pred HHHHHhccCCCcCEeCHHHHHHHHHHHhhhhcccHHHHHHHHHHhc-CCCCCCCcHHHHHHHHH
Confidence 4888999 9999 999999875 2 6778999999999 89999999999996543
|
| >3mse_B Calcium-dependent protein kinase, putative; CDPKS, malaria, structural genomics consortium, SGC, transfe; 2.10A {Plasmodium falciparum} | Back alignment and structure |
|---|
Probab=97.05 E-value=0.0001 Score=67.23 Aligned_cols=72 Identities=15% Similarity=0.050 Sum_probs=56.0
Q ss_pred cCCCCCCCccccCCCccchhhhhh------hhhhhhhhhhhccCCCCCCCccchhhhhhhcccccccCChhhhhhccCCC
Q 009364 365 TSPGSPGSVDICNLDSLSCSRVIV------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSSILAPNDLEKSRNPM 438 (536)
Q Consensus 365 t~~~sf~~~D~~~~g~ls~~el~~------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~~~~~e~l~~aF~~~ 438 (536)
.....|..+|.+++|.|+.+|+.. .+..++..+++..| .|++|.|+|+||+.++..... ..++.++.+|+-.
T Consensus 40 ~l~~~F~~~D~d~~G~i~~~El~~~l~~~g~~~~~~~~~~~~~D-~d~~g~i~~~Ef~~~~~~~~~-~~~~~~~~~F~~~ 117 (180)
T 3mse_B 40 YINELFYKLDTNHNGSLSHREIYTVLASVGIKKWDINRILQALD-INDRGNITYTEFMAGCYRWKN-IESTFLKAAFNKI 117 (180)
T ss_dssp HHHHHHHHHCTTCSSSEEHHHHHHHHHHTTCCHHHHHHHHHHHC-TTCCSEECHHHHHHHHSCCTT-C--CHHHHHHHHH
T ss_pred HHHHHHHHhCCCCCCcCCHHHHHHHHHHcCCCHHHHHHHHHHhC-CCCCCcCcHHHHHHHHHhccc-CCHHHHHHHHHHH
Confidence 344469999999999999999986 34688999999999 899999999999976654332 2235677777643
|
| >1a4p_A S100A10; S100 family, EF-hand protein, ligand of annexin II, calcium/phospholipid binding protein, calcium-phospholipid protein complex; 2.25A {Homo sapiens} SCOP: a.39.1.2 PDB: 1bt6_A | Back alignment and structure |
|---|
Probab=97.05 E-value=0.0001 Score=60.51 Aligned_cols=52 Identities=6% Similarity=-0.189 Sum_probs=42.8
Q ss_pred CCCCCccccCCCccchhhhhh-------------hhhhhhhhhhhccCCCCCCCccchhhhhhhccc
Q 009364 368 GSPGSVDICNLDSLSCSRVIV-------------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRK 421 (536)
Q Consensus 368 ~sf~~~D~~~~g~ls~~el~~-------------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~ 421 (536)
.+|..||. .+|.|+.+||+. .+.++++.+++.+| .|++|.|+|+||+.++..
T Consensus 13 ~~F~~fD~-~dg~Is~~El~~~l~~~~~~~lg~~~~~~ev~~l~~~~D-~d~dG~I~f~EF~~~~~~ 77 (96)
T 1a4p_A 13 FTFHKFAG-DKGYLTKEDLRVLMEKEFPGFLENQKDPLAVDKIMKDLD-QCRDGKVGFQSFFSLIAG 77 (96)
T ss_dssp HHHHHHHG-GGCSBCHHHHHHHHHHHCHHHHHHSCCTTHHHHHHHHHC-TTSSSCBCHHHHHHHHHH
T ss_pred HHHHHHcC-CCCeECHHHHHHHHHHHcccccccccCHHHHHHHHHHhC-CCCCCcCcHHHHHHHHHH
Confidence 35888983 456999999975 15678999999999 899999999999976543
|
| >3h4s_E KCBP interacting Ca2+-binding protein; kinesin, motor protein, regulation, complex, calcium, EF- hand, calmodulin, ATP-binding, microtubule; HET: ADP; 2.40A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.05 E-value=0.00014 Score=63.45 Aligned_cols=53 Identities=9% Similarity=-0.063 Sum_probs=46.6
Q ss_pred CCCCccccCCCccchhhhhh---------hhhhhhhhhhhccCCCCCCCccchhhhhhhcccc
Q 009364 369 SPGSVDICNLDSLSCSRVIV---------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKL 422 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~---------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~ 422 (536)
.|..+|.+++|.|+..||.. .+.++++.+++.+| .|++|.|+|+||+.++...
T Consensus 45 ~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~e~~~~~~~~D-~d~dG~I~~~EF~~~~~~~ 106 (135)
T 3h4s_E 45 GFSLLADPERHLITAESLRRNSGILGIEGMSKEDAQGMVREGD-LDGDGALNQTEFCVLMVRL 106 (135)
T ss_dssp HHHHHSBTTTTBBCHHHHHHHGGGGTCCCCCHHHHHHHHHHHC-SSCSSSBCHHHHHHHHHHH
T ss_pred HHHHHCCCCCCcCCHHHHHHHHHHhCCCCCCHHHHHHHHHHhC-CCCCCCCcHHHHHHHHHHh
Confidence 48999999999999999975 35788999999999 8999999999999766543
|
| >1jfj_A Ehcabp, calcium-binding protein; EF-hand, helix-loop-helix, metal binding protein; NMR {Entamoeba histolytica} SCOP: a.39.1.5 PDB: 1jfk_A 2nxq_A 3px1_A 3qjk_A 2jnx_A 2i18_A | Back alignment and structure |
|---|
Probab=97.00 E-value=8.6e-05 Score=63.23 Aligned_cols=68 Identities=12% Similarity=-0.032 Sum_probs=51.3
Q ss_pred CCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhccc---ccccCChhhhhhccCC
Q 009364 369 SPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRK---LSSILAPNDLEKSRNP 437 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~---~~~~~~~e~l~~aF~~ 437 (536)
.|..+|.+++|.|+.+|+.. .+.+++..+++..| .+++|.|+|+||+.++.. .......++++.+|+.
T Consensus 5 ~F~~~D~~~~g~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~D-~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~~~f~~ 83 (134)
T 1jfj_A 5 LFKEIDVNGDGAVSYEEVKAFVSKKRAIKNEQLLQLIFKSID-ADGNGEIDQNEFAKFYGSIQGQDLSDDKIGLKVLYKL 83 (134)
T ss_dssp HHHHHCTTCSSEEEHHHHHHHHHTTCCSSHHHHHHHHHHHHC-SSCCSEEEHHHHHHHTTCSSCCSSHHHHHHHHHHHHH
T ss_pred HHHHHCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHHc-CCCCCeEcHHHHHHHHHHhcccccCCCHHHHHHHHHH
Confidence 37788999999999999976 46789999999999 899999999999976642 1111223346666553
|
| >5pal_A Parvalbumin; calcium-binding protein; 1.54A {Triakis semifasciata} SCOP: a.39.1.4 | Back alignment and structure |
|---|
Probab=97.00 E-value=0.00013 Score=60.57 Aligned_cols=50 Identities=6% Similarity=-0.072 Sum_probs=44.4
Q ss_pred CCCCccccCCCccchhhhhh-----------hhhhhhhhhhhccCCCCCCCccchhhhhhhc
Q 009364 369 SPGSVDICNLDSLSCSRVIV-----------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGD 419 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~-----------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~ 419 (536)
.|..+|.+++|.|+..|+.. .+.++++.+++..| .|++|.|+|+||+.++
T Consensus 46 ~F~~~D~d~~G~i~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~D-~~~dg~i~~~eF~~~~ 106 (109)
T 5pal_A 46 VFEILDKDQSGFIEEEELKGVLKGFSAHGRDLNDTETKALLAAGD-SDHDGKIGADEFAKMV 106 (109)
T ss_dssp HHHHHCTTCSSEECHHHHHTHHHHHCTTCCCCCHHHHHHHHHHHC-TTCSSSEEHHHHHHHH
T ss_pred HHHHHCCCCCCcCcHHHHHHHHHHHHHcCCCCCHHHHHHHHHHhC-CCCCCcCcHHHHHHHH
Confidence 48899999999999999975 25789999999999 8999999999999654
|
| >3khe_A Calmodulin-like domain protein kinase isoform 3; calcium dependent kinase, structural genomics, structural GE consortium, SGC, ATP-binding; 1.95A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=97.00 E-value=0.00013 Score=66.77 Aligned_cols=70 Identities=13% Similarity=0.012 Sum_probs=58.0
Q ss_pred CCCCCccccCCCccchhhhhh-------------------hhhhhhhhhhhccCCCCCCCccchhhhhhhcccccccCCh
Q 009364 368 GSPGSVDICNLDSLSCSRVIV-------------------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSSILAP 428 (536)
Q Consensus 368 ~sf~~~D~~~~g~ls~~el~~-------------------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~~~~~ 428 (536)
..|..+|.+++|.|+.+|+.. .+.+++..+++.+| .|++|.|+|+||+.++.........
T Consensus 44 ~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~D-~d~~g~i~~~ef~~~~~~~~~~~~~ 122 (191)
T 3khe_A 44 QIFRQLDNNGDGQLDRKELIEGYRKLMQWKGDTVSDLDSSQIEAEVDHILQSVD-FDRNGYIEYSEFVTVCMDKQLLLSR 122 (191)
T ss_dssp HHHHHHCTTCSSEECHHHHHHHHHHHHC-----CCHHHHHHHHHHHHHHHHHTC-TTCSSSEEHHHHHHHHSCHHHHCCH
T ss_pred HHHHHHcCCCCCCCcHHHHHHHHHHHHhhcccccccccchhhHHHHHHHHHHhC-CCCCCcCCHHHHHHHHHHhcccchH
Confidence 358899999999999999864 24678999999999 8999999999999877665556667
Q ss_pred hhhhhccCCC
Q 009364 429 NDLEKSRNPM 438 (536)
Q Consensus 429 e~l~~aF~~~ 438 (536)
+.++.+|+-.
T Consensus 123 ~~~~~~F~~~ 132 (191)
T 3khe_A 123 ERLLAAFQQF 132 (191)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 7888888754
|
| >1pva_A Parvalbumin; calcium binding; 1.65A {Esox lucius} SCOP: a.39.1.4 PDB: 2pas_A 3pat_A | Back alignment and structure |
|---|
Probab=96.99 E-value=0.00016 Score=60.14 Aligned_cols=50 Identities=6% Similarity=-0.068 Sum_probs=44.3
Q ss_pred CCCCccccCCCccchhhhhh-----------hhhhhhhhhhhccCCCCCCCccchhhhhhhc
Q 009364 369 SPGSVDICNLDSLSCSRVIV-----------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGD 419 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~-----------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~ 419 (536)
.|..+|.+++|.|+.+|+.. .+.++++.+++..| .|++|.|+|+||+.++
T Consensus 47 ~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~d-~~~dg~i~~~eF~~~~ 107 (110)
T 1pva_A 47 VFKAIDADASGFIEEEELKFVLKSFAADGRDLTDAETKAFLKAAD-KDGDGKIGIDEFETLV 107 (110)
T ss_dssp HHHHHCTTCSSSBCHHHHHTGGGGTCTTCCCCCHHHHHHHHHHHC-TTCSSSBCHHHHHHHH
T ss_pred HHHHhCCCCCCcCcHHHHHHHHHHHhhcCCCCCHHHHHHHHHHhC-CCCCCeEcHHHHHHHH
Confidence 48999999999999999974 35689999999999 8999999999999654
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.98 E-value=0.00078 Score=68.88 Aligned_cols=75 Identities=12% Similarity=0.071 Sum_probs=41.9
Q ss_pred eeEEcccCceEEEEEEEcC--------CCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCc-eeeEeeeee
Q 009364 71 GELIGCGAFGRVYMGMNLD--------SGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPN-IVRYLGTVR 141 (536)
Q Consensus 71 ~~~LG~G~fg~Vy~a~~~~--------~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hpn-Iv~l~~~~~ 141 (536)
.+.|+.|....+|++.... .+..+++|+...... . ......|..+++.+...+ +.++++..
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-----~----~~~~~~E~~~l~~L~~~g~~P~~~~~~- 107 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-----E----LYNTISEFEVYKTMSKYKIAPQLLNTF- 107 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-----G----TSCHHHHHHHHHHHHHTTSSCCEEEEE-
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-----c----eecHHHHHHHHHHHHhcCCCCceEEec-
Confidence 4578889999999987543 136788887521110 0 011245777777664223 34555544
Q ss_pred cCCceeEEEEecCCCCc
Q 009364 142 EEESLNILLEFVPGGSI 158 (536)
Q Consensus 142 ~~~~~~lV~E~~~gg~L 158 (536)
. -++||||++|.++
T Consensus 108 -~--~~~v~e~i~G~~l 121 (369)
T 3c5i_A 108 -N--GGRIEEWLYGDPL 121 (369)
T ss_dssp -T--TEEEEECCCSEEC
T ss_pred -C--CcEEEEEecCCcC
Confidence 1 3689999987644
|
| >1s6i_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=96.98 E-value=0.00025 Score=65.34 Aligned_cols=54 Identities=15% Similarity=-0.024 Sum_probs=47.5
Q ss_pred CCCCCccccCCCccchhhhhh------hhhhhhhhhhhccCCCCCCCccchhhhhhhcccc
Q 009364 368 GSPGSVDICNLDSLSCSRVIV------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKL 422 (536)
Q Consensus 368 ~sf~~~D~~~~g~ls~~el~~------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~ 422 (536)
..|..+|.+++|.|+.+|+.. .+.++++.+++.+| .|++|.|+|+||+.++...
T Consensus 86 ~~F~~~D~d~dG~Is~~El~~~l~~~g~~~~~~~~~~~~~D-~d~dG~Is~~EF~~~~~~~ 145 (188)
T 1s6i_A 86 SAFSYFDKDGSGYITLDEIQQACKDFGLDDIHIDDMIKEID-QDNDGQIDYGEFAAMMRKR 145 (188)
T ss_dssp HHHHHTTTTCSSEEEHHHHHHTTTTTTCCTTHHHHHHHHHC-SSSSSEEETTHHHHTTSCC
T ss_pred HHHHHHCCCCCCcCcHHHHHHHHHHcCCCHHHHHHHHHHHC-CCCCCcEeHHHHHHHHHHc
Confidence 358999999999999999986 35688999999999 8999999999999877654
|
| >2pvb_A Protein (parvalbumin); calcium binding protein, metal binding protein; 0.91A {Esox lucius} SCOP: a.39.1.4 PDB: 1pvb_A 2pal_A 1pal_A 3pal_A 4pal_A 4cpv_A 1cdp_A 5cpv_A 1b8r_A 1b9a_A 1b8l_A 1b8c_A 1a75_B 1a75_A | Back alignment and structure |
|---|
Probab=96.96 E-value=0.00018 Score=59.57 Aligned_cols=50 Identities=8% Similarity=-0.059 Sum_probs=44.2
Q ss_pred CCCCccccCCCccchhhhhh-----------hhhhhhhhhhhccCCCCCCCccchhhhhhhc
Q 009364 369 SPGSVDICNLDSLSCSRVIV-----------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGD 419 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~-----------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~ 419 (536)
.|..+|.+++|.|+..|+.. .+.++++.+++..| .|++|.|+|+||+.++
T Consensus 46 ~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~D-~~~dg~i~~~eF~~~~ 106 (108)
T 2pvb_A 46 AFYVIDQDKSGFIEEDELKLFLQNFSPSARALTDAETKAFLADGD-KDGDGMIGVDEFAAMI 106 (108)
T ss_dssp HHHHHCTTCSSSBCHHHHHTGGGGTCTTSCCCCHHHHHHHHHHHC-TTCSSSBCHHHHHHHH
T ss_pred HHHHHCCCCCCcCCHHHHHHHHHHHhccCCCCCHHHHHHHHHHhC-CCCCCcEeHHHHHHHH
Confidence 48999999999999999864 35689999999999 8999999999998643
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.95 E-value=0.0011 Score=69.68 Aligned_cols=75 Identities=13% Similarity=0.186 Sum_probs=48.1
Q ss_pred eeeEEcccCceEEEEEEEcC-------CCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCce-eeEeeeee
Q 009364 70 KGELIGCGAFGRVYMGMNLD-------SGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNI-VRYLGTVR 141 (536)
Q Consensus 70 ~~~~LG~G~fg~Vy~a~~~~-------~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnI-v~l~~~~~ 141 (536)
..+.|+.|....||++.... ++..+++|+... . .. ...+..|..+++.+...++ .++++.+.
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~------~-~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~ 146 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN------P-ET---ESHLVAESVIFTLLSERHLGPKLYGIFS 146 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS------C-CC---HHHHHHHHHHHHHHHHTTSSSCEEEEET
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCC------C-Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEeC
Confidence 35678999999999997642 257899997621 0 01 0223468888877743333 56666554
Q ss_pred cCCceeEEEEecCCCCc
Q 009364 142 EEESLNILLEFVPGGSI 158 (536)
Q Consensus 142 ~~~~~~lV~E~~~gg~L 158 (536)
+ .+|+||++|.++
T Consensus 147 ~----g~v~e~l~G~~l 159 (429)
T 1nw1_A 147 G----GRLEEYIPSRPL 159 (429)
T ss_dssp T----EEEECCCCEEEC
T ss_pred C----CEEEEEeCCccc
Confidence 2 389999987544
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.94 E-value=0.0011 Score=66.22 Aligned_cols=76 Identities=13% Similarity=0.086 Sum_probs=44.8
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCC--CceeeEeee-----eecCC
Q 009364 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH--PNIVRYLGT-----VREEE 144 (536)
Q Consensus 72 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~H--pnIv~l~~~-----~~~~~ 144 (536)
..|+ |....||++.. .+|+.+++|..... ... ...+..|..+++.+.. -.+++++.. ....+
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~------~~~---~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g 100 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPE------RWT---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQG 100 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTT------TSC---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETT
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCC------CCC---HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECC
Confidence 4577 88899998753 35667999987311 001 1234557777766632 123444433 12244
Q ss_pred ceeEEEEecCCCCc
Q 009364 145 SLNILLEFVPGGSI 158 (536)
Q Consensus 145 ~~~lV~E~~~gg~L 158 (536)
..++||+|++|..+
T Consensus 101 ~~~~l~~~i~G~~~ 114 (328)
T 1zyl_A 101 FYFAVFPSVGGRQF 114 (328)
T ss_dssp EEEEEEECCCCEEC
T ss_pred EEEEEEEecCCCCC
Confidence 56789999987554
|
| >2mys_C Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1m8q_C* 1mvw_C* 1o18_F* 1o19_C* 1o1a_C* 1o1b_C* 1o1c_C* 1o1d_C* 1o1e_C* 1o1f_C* 1o1g_C* | Back alignment and structure |
|---|
Probab=96.94 E-value=9.5e-05 Score=64.43 Aligned_cols=70 Identities=9% Similarity=-0.078 Sum_probs=55.3
Q ss_pred CCCCCCccccCCCccchhhhhh--------hhhhhhhhhhhcc---CCCCCCCccchhhhhhhcccc---cccCChhhhh
Q 009364 367 PGSPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTS---NSNDDLCQLDQEDFVAGDRKL---SSILAPNDLE 432 (536)
Q Consensus 367 ~~sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~---d~~d~~g~Id~~EF~~~~~~~---~~~~~~e~l~ 432 (536)
...|..+|.+++|.|+..|+.. ++.+++..+++.+ | .++ |.|+|+||+.++... ......+.++
T Consensus 11 ~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~l~~~~~~~d-~~~-g~i~~~eF~~~~~~~~~~~~~~~~~~~~ 88 (149)
T 2mys_C 11 KEAFLLFDRTGDAKITASQVGDIARALGQNPTNAEINKILGNPSKEE-MNA-AAITFEEFLPMLQAAANNKDQGTFEDFV 88 (149)
T ss_pred HHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhhhcc-ccC-CcCcHHHHHHHHHHHhccCCcchHHHHH
Confidence 3458999999999999999975 5688999999999 9 788 999999999766543 2233456677
Q ss_pred hccCCC
Q 009364 433 KSRNPM 438 (536)
Q Consensus 433 ~aF~~~ 438 (536)
.+|+-.
T Consensus 89 ~~F~~~ 94 (149)
T 2mys_C 89 EGLRVF 94 (149)
T ss_pred HHHHHh
Confidence 777654
|
| >1rro_A RAT oncomodulin; calcium-binding protein; 1.30A {Rattus rattus} SCOP: a.39.1.4 PDB: 1omd_A 2nln_A 1ttx_A | Back alignment and structure |
|---|
Probab=96.92 E-value=0.00017 Score=59.71 Aligned_cols=50 Identities=12% Similarity=-0.038 Sum_probs=44.2
Q ss_pred CCCCccccCCCccchhhhhh-----------hhhhhhhhhhhccCCCCCCCccchhhhhhhc
Q 009364 369 SPGSVDICNLDSLSCSRVIV-----------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGD 419 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~-----------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~ 419 (536)
.|..+|.+++|.|+..|+.. .+.++++.+++.+| .|++|.|+|+||+.++
T Consensus 46 ~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~D-~~~dg~i~~~eF~~~~ 106 (108)
T 1rro_A 46 IFRFIDNDQSGYLDGDELKYFLQKFQSDARELTESETKSLMDAAD-NDGDGKIGADEFQEMV 106 (108)
T ss_dssp HHHHHCTTCSSEECTHHHHTGGGGTCTTSCCCCHHHHHHHHHHHC-CSSSSSEEHHHHHHHH
T ss_pred HHHHhCCCCCCcCCHHHHHHHHHHHhhccCCCCHHHHHHHHHHhC-CCCCCcCcHHHHHHHH
Confidence 48999999999999999964 35789999999999 8999999999999654
|
| >1xk4_C Calgranulin B; S100 family, heterotetramer, metal binding protein; HET: FLC; 1.80A {Homo sapiens} SCOP: a.39.1.2 PDB: 1irj_A* | Back alignment and structure |
|---|
Probab=96.92 E-value=0.00021 Score=60.47 Aligned_cols=53 Identities=11% Similarity=-0.009 Sum_probs=44.8
Q ss_pred CCCCCccc-cCCC-ccchhhhhh--------------hhhhhhhhhhhccCCCCCCCccchhhhhhhccc
Q 009364 368 GSPGSVDI-CNLD-SLSCSRVIV--------------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRK 421 (536)
Q Consensus 368 ~sf~~~D~-~~~g-~ls~~el~~--------------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~ 421 (536)
..|..||. +++| .|+.+||.. .+.++++.+++.+| .|++|.|+|+||+.++..
T Consensus 16 ~~F~~fD~~dgdG~~Is~~El~~~l~~~lg~~~~~~~~~~~~v~~l~~~~D-~d~dG~I~f~EF~~~~~~ 84 (113)
T 1xk4_C 16 NTFHQYSVKLGHPDTLNQGEFKELVRKDLQNFLKKENKNEKVIEHIMEDLD-TNADKQLSFEEFIMLMAR 84 (113)
T ss_dssp HHHHHHHTTSSSTTSBCHHHHHHHHHHHTTTTTTTGGGCHHHHHHHHHHHC-TTCSSSBCHHHHHHHHHH
T ss_pred HHHHHHhhcCCCCCEECHHHHHHHHHHHhhhhhcccccCHHHHHHHHHHhC-CCCCCCEeHHHHHHHHHH
Confidence 35999995 9999 999999865 13578999999999 899999999999976543
|
| >1rwy_A Parvalbumin alpha; EF-hand, calcium-binding, calcium-binding protein; HET: PG4; 1.05A {Rattus norvegicus} SCOP: a.39.1.4 PDB: 1rtp_1* 2jww_A 3f45_A 1s3p_A 1xvj_A 1rjv_A 1rk9_A 1g33_A | Back alignment and structure |
|---|
Probab=96.91 E-value=0.00017 Score=59.89 Aligned_cols=50 Identities=8% Similarity=-0.080 Sum_probs=44.4
Q ss_pred CCCCccccCCCccchhhhhh-----------hhhhhhhhhhhccCCCCCCCccchhhhhhhc
Q 009364 369 SPGSVDICNLDSLSCSRVIV-----------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGD 419 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~-----------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~ 419 (536)
.|..+|.+++|.|+..|+.. .+.++++.+++..| .|++|.|+|+||+.++
T Consensus 46 ~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~D-~~~dg~i~~~eF~~~~ 106 (109)
T 1rwy_A 46 VFHILDKDKSGFIEEDELGSILKGFSSDARDLSAKETKTLMAAGD-KDGDGKIGVEEFSTLV 106 (109)
T ss_dssp HHHHHSTTCSSEECHHHHHTHHHHHCTTCCCCCHHHHHHHHHHHC-TTCSSSEEHHHHHHHH
T ss_pred HHHHHCCCCCCeEcHHHHHHHHHHHhccCCCCCHHHHHHHHHHHC-CCCCCcCCHHHHHHHH
Confidence 48999999999999999975 35688999999999 8999999999999654
|
| >1bu3_A Calcium-binding protein; 1.65A {Merluccius bilinearis} SCOP: a.39.1.4 | Back alignment and structure |
|---|
Probab=96.90 E-value=0.0002 Score=59.46 Aligned_cols=50 Identities=6% Similarity=-0.092 Sum_probs=44.2
Q ss_pred CCCCccccCCCccchhhhhh-----------hhhhhhhhhhhccCCCCCCCccchhhhhhhc
Q 009364 369 SPGSVDICNLDSLSCSRVIV-----------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGD 419 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~-----------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~ 419 (536)
.|..+|.+++|.|+.+|+.. .+.++++.+++..| .|++|.|+|+||+.++
T Consensus 47 ~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~D-~~~dg~i~~~eF~~~~ 107 (109)
T 1bu3_A 47 AFFVIDQDKSGFIEEDELKLFLQVFSAGARALTDAETKAFLKAGD-SDGDGAIGVDEWAALV 107 (109)
T ss_dssp HHHHHCTTCSSSEEHHHHHTHHHHHSTTCCCCCHHHHHHHHHHHC-TTCSSEECHHHHHHHH
T ss_pred HHHHHCCCCCCcCcHHHHHHHHHHHcccCCCCCHHHHHHHHHHhC-CCCCCcEeHHHHHHHH
Confidence 48899999999999999864 35689999999999 8999999999998643
|
| >2ggz_A Guanylyl cyclase-activating protein 3; EF hand, guanylate cyclase activating protein, GCAP, GCAP3, GCAP-3, lyase activator; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.88 E-value=0.00019 Score=67.28 Aligned_cols=72 Identities=7% Similarity=-0.128 Sum_probs=54.1
Q ss_pred CCCCCCCcccc-CCCccchhhhhh--------h-hhhhhhhhhhccCCCCCCCccchhhhhhhcccccccCChhhhhhcc
Q 009364 366 SPGSPGSVDIC-NLDSLSCSRVIV--------E-KLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSSILAPNDLEKSR 435 (536)
Q Consensus 366 ~~~sf~~~D~~-~~g~ls~~el~~--------~-~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~~~~~e~l~~aF 435 (536)
....|..||.+ ++|.|+..|+.. + ..++++.+++.+| .|++|.|+|+||+.++........++.++.+|
T Consensus 21 i~~~f~~fD~~~~~G~is~~El~~~l~~~~~~~~~~~~~~~~f~~~D-~d~dG~I~~~Ef~~~~~~~~~~~~~~~l~~~F 99 (211)
T 2ggz_A 21 THVWYRTFMMEYPSGLQTLHEFKTLLGLQGLNQKANKHIDQVYNTFD-TNKDGFVDFLEFIAAVNLIMQEKMEQKLKWYF 99 (211)
T ss_dssp ---CCCSHHHHCTTSEEEHHHHHHHTTCCSCCHHHHHHHHHHHHHHC-TTCSSEEEHHHHHHHHHHHSCSSHHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCcCCHHHHHHHHHHhCCCcchHHHHHHHHHHHc-CCCCCeEeHHHHHHHHHHhccCchHHHHHHHH
Confidence 45569999998 899999999986 1 2456999999999 89999999999997665433333455677777
Q ss_pred CCC
Q 009364 436 NPM 438 (536)
Q Consensus 436 ~~~ 438 (536)
+-.
T Consensus 100 ~~~ 102 (211)
T 2ggz_A 100 KLY 102 (211)
T ss_dssp HHH
T ss_pred HHh
Confidence 643
|
| >1jba_A GCAP-2, protein (guanylate cyclase activating protein 2); EF-hand, calcium-binding protein, guanylyl cyclase regulation, lyase; NMR {Bos taurus} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=96.88 E-value=0.00016 Score=67.24 Aligned_cols=68 Identities=9% Similarity=-0.145 Sum_probs=55.0
Q ss_pred CCCCcccc-CCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcccccccCChhhhhhccCC
Q 009364 369 SPGSVDIC-NLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSSILAPNDLEKSRNP 437 (536)
Q Consensus 369 sf~~~D~~-~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~~~~~e~l~~aF~~ 437 (536)
.|..+|.+ ++|.|+.+|+.. .+.++++.+++.+| .|++|.|+|+||+.++.........+.++.+|+.
T Consensus 27 ~f~~~D~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~f~~~D-~d~~G~i~~~Ef~~~~~~~~~~~~~~~~~~~F~~ 103 (204)
T 1jba_A 27 WYKKFLEECPSGTLFMHEFKRFFKVPDNEEATQYVEAMFRAFD-TNGDNTIDFLEYVAALNLVLRGTLEHKLKWTFKI 103 (204)
T ss_dssp HHHHHHSSSTTCCEEHHHHHHHHHCCSSSTTHHHHHHHHHHHC-CSSSSEECHHHHHHHHHHHSSCCCTHHHHHHHHH
T ss_pred HHHHHHhhCCCCCcCHHHHHHHHHHhcCCCcHHHHHHHHHHHc-CCCCCeEeHHHHHHHHHHHccCCHHHHHHHHHHH
Confidence 48889999 899999999986 35678999999999 8999999999999776554444455677777763
|
| >3u0k_A Rcamp; fluorescent protein, calcium binding, EF-hand, genetically E calcium indicator; HET: NFA CRK; 2.10A {Entacmaea quadricolor} | Back alignment and structure |
|---|
Probab=96.88 E-value=0.0002 Score=74.04 Aligned_cols=51 Identities=14% Similarity=-0.059 Sum_probs=46.3
Q ss_pred CCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 369 SPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
+|..||.+++|.|+.+||.. .+++|++.+++.+| .|++|.|+|+||+.++.
T Consensus 380 AFk~fDkDgdG~IS~eELr~vL~~lGe~LSdeEIdeLfke~D-~DgDGkIsyeEFvkmMt 438 (440)
T 3u0k_A 380 AFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREAD-IDGDGQVNYEEFVQMMT 438 (440)
T ss_dssp HHHHHCTTCSSEECHHHHHHHHHHHTCCCCHHHHHHHHHHHC-TTCSSSEEHHHHHHHHC
T ss_pred HHHHHCCCCcCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHhC-CCCCCcEeHHHHHHHhC
Confidence 59999999999999999976 46889999999999 89999999999997654
|
| >3ox6_A Calcium-binding protein 1; EF-hand, calcium-sensor; 2.40A {Homo sapiens} PDB: 3ox5_A 2lan_A 2lap_A 2k7b_A 2k7c_A 2k7d_A | Back alignment and structure |
|---|
Probab=96.86 E-value=0.0001 Score=64.38 Aligned_cols=70 Identities=11% Similarity=-0.027 Sum_probs=54.7
Q ss_pred CCCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhccccccc-----CChhhhhhc
Q 009364 368 GSPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSSI-----LAPNDLEKS 434 (536)
Q Consensus 368 ~sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~~-----~~~e~l~~a 434 (536)
..|..+|.+++|.|+.+|+.. ++..++..+++..| .+++|.|+|+||+.++...... ...+.++.+
T Consensus 15 ~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~l~~~~d-~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~~~~ 93 (153)
T 3ox6_A 15 EAFREFDKDKDGYINCRDLGNCMRTMGYMPTEMELIELSQQIN-MNLGGHVDFDDFVELMGPKLLAETADMIGVKELRDA 93 (153)
T ss_dssp HHHHHHHHHCSSSCCHHHHHHHHHHTTCCCCHHHHHHHHHHHH-TTSTTCCCHHHHHHHHHHHHTTCCHHHHCHHHHHHH
T ss_pred HHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhC-CCCCccCcHHHHHHHHHHHhhccccccccHHHHHHH
Confidence 348899999999999999976 56889999999999 8999999999999766432211 124567777
Q ss_pred cCCC
Q 009364 435 RNPM 438 (536)
Q Consensus 435 F~~~ 438 (536)
|+-.
T Consensus 94 F~~~ 97 (153)
T 3ox6_A 94 FREF 97 (153)
T ss_dssp HHHH
T ss_pred HHHh
Confidence 7643
|
| >2bl0_B Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} | Back alignment and structure |
|---|
Probab=96.85 E-value=0.00024 Score=61.58 Aligned_cols=51 Identities=10% Similarity=-0.101 Sum_probs=45.8
Q ss_pred CCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 369 SPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
.|..+|.+++|.|+.+|+.. .+.++++.+++.+| .|++|.|+|+||+.++.
T Consensus 81 ~F~~~D~d~~G~i~~~e~~~~l~~~g~~~~~~~~~~~~~~~d-~~~dg~i~~~eF~~~~~ 139 (145)
T 2bl0_B 81 AFRALDKEGNGTIQEAELRQLLLNLGDALTSSEVEELMKEVS-VSGDGAINYESFVDMLV 139 (145)
T ss_dssp HHHHHCSSSSSEEEHHHHHHHHHHSSSCCCHHHHHHHHTTCC-CCTTSEEEHHHHHHHHH
T ss_pred HHHHhCCCCCCeEcHHHHHHHHHHcCCCCCHHHHHHHHHHcC-CCCCCcEeHHHHHHHHH
Confidence 48899999999999999976 47789999999999 89999999999997554
|
| >1w7j_B Myosin light chain 1; motor protein, unconventional myosin, myosin V, chicken, molecular motor, ATPase, ELC, IQ motif, muscle protein, ATP-binding; HET: ADP; 2A {Homo sapiens} SCOP: a.39.1.5 PDB: 1w7i_B* 1oe9_B* 3j04_C 1br1_B* 1br4_B* 1i84_T* 3dtp_C 2w4a_C 2w4g_C 2w4h_C | Back alignment and structure |
|---|
Probab=96.83 E-value=3.4e-05 Score=67.81 Aligned_cols=71 Identities=10% Similarity=-0.039 Sum_probs=53.2
Q ss_pred CCCCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCC--CCCccchhhhhhhcccccc---cCChhhhhh
Q 009364 367 PGSPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSND--DLCQLDQEDFVAGDRKLSS---ILAPNDLEK 433 (536)
Q Consensus 367 ~~sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d--~~g~Id~~EF~~~~~~~~~---~~~~e~l~~ 433 (536)
...|..+|.+++|.|+..|+.. ++.+++..+++.+| .| ++|.|+|+||+.++..... ....+.+++
T Consensus 13 ~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~d-~~~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~l~~ 91 (151)
T 1w7j_B 13 KEAFELFDRVGDGKILYSQCGDVMRALGQNPTNAEVLKVLGNPK-SDELKSRRVDFETFLPMLQAVAKNRGQGTYEDYLE 91 (151)
T ss_dssp HHHHHHHCCSSSSEEESTTHHHHHHHTTCCCCHHHHHHHTTCCC-HHHHTTCEEEHHHHHHHHHHHCC--------CCHH
T ss_pred HHHHHHHCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhC-cCcCCCCcCcHHHHHHHHHHHhccCCCCcHHHHHH
Confidence 3458999999999999999975 46789999999999 78 9999999999976554321 123345666
Q ss_pred ccCCC
Q 009364 434 SRNPM 438 (536)
Q Consensus 434 aF~~~ 438 (536)
+|+-.
T Consensus 92 ~F~~~ 96 (151)
T 1w7j_B 92 GFRVF 96 (151)
T ss_dssp HHHTT
T ss_pred HHHHh
Confidence 77654
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.83 E-value=0.0013 Score=66.17 Aligned_cols=31 Identities=26% Similarity=0.367 Sum_probs=26.7
Q ss_pred cCCccccCCCCCcccCCC----CcEEEEecCcchh
Q 009364 190 HGIMHRDIKGANILVDNK----GCIKLADFGASKQ 220 (536)
Q Consensus 190 ~~ivHrDLKp~NILl~~~----~~vkL~DFGla~~ 220 (536)
..++|||+++.|||++.+ +.+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 368999999999999874 6899999998754
|
| >3sjs_A URE3-BP sequence specific DNA binding protein; EF-hand, structural genomics, seattle S genomics center for infectious disease, ssgcid; 1.90A {Entamoeba histolytica} PDB: 3sia_A 3sib_A | Back alignment and structure |
|---|
Probab=96.82 E-value=8.3e-05 Score=70.62 Aligned_cols=52 Identities=12% Similarity=-0.029 Sum_probs=46.4
Q ss_pred CCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhccc
Q 009364 369 SPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRK 421 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~ 421 (536)
.|..+|.+++|.|+..|+.. .+.++++.+++..| .|++|.|+|+||+.++..
T Consensus 56 ~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~~~~~l~~~~D-~d~dg~I~~~EF~~~~~~ 115 (220)
T 3sjs_A 56 WFMGVDRDRSGTLEINELMMGQFPGGIRLSPQTALRMMRIFD-TDFNGHISFYEFMAMYKF 115 (220)
T ss_dssp HHHHHCTTCCSSBCHHHHHHCCBGGGBCCCHHHHHHHHHHHC-TTCSSCBCHHHHHHHHHH
T ss_pred HHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhC-CCCCCcCCHHHHHHHHHH
Confidence 49999999999999999986 46789999999999 899999999999976543
|
| >3qrx_A Centrin; calcium-binding, EF-hand, cell division, calcium binding, ME binding protein-toxin complex; 2.20A {Chlamydomonas reinhardtii} PDB: 2ggm_A 2ami_A 1zmz_A | Back alignment and structure |
|---|
Probab=96.82 E-value=0.00029 Score=62.97 Aligned_cols=51 Identities=10% Similarity=0.050 Sum_probs=46.0
Q ss_pred CCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 369 SPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
.|..+|.+++|.|+.+|+.. .+.++++.+++.+| .|++|.|+|+||+.++.
T Consensus 106 ~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~D-~~~dg~i~~~eF~~~~~ 164 (169)
T 3qrx_A 106 AFRLFDDDNSGTITIKDLRRVAKELGENLTEEELQEMIAEAD-RNDDNEIDEDEFIRIMK 164 (169)
T ss_dssp HHHHHCTTCSSSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHC-CSSSSCBCHHHHHHHHC
T ss_pred HHHHhCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHhC-CCCCCCEeHHHHHHHHH
Confidence 49999999999999999976 46789999999999 89999999999997654
|
| >3a8r_A Putative uncharacterized protein; EF-hand, membrane, oxidoreductase, transmembrane, calcium BI protein; 2.40A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=96.81 E-value=0.00032 Score=64.30 Aligned_cols=52 Identities=15% Similarity=-0.086 Sum_probs=45.1
Q ss_pred CCCCccccCCCccchhhhhh----------h------hhhhhhhhhhccCCCCCCCccchhhhhhhccc
Q 009364 369 SPGSVDICNLDSLSCSRVIV----------E------KLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRK 421 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~----------~------~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~ 421 (536)
.|..||.+++|.|+.+||.. + +.++++.+++.+| .|++|.|+|+||+.++..
T Consensus 103 ~F~~~D~d~dG~Is~~El~~~l~~~~g~~~~~~~~~~~~~~~~~~~~~~D-~d~dG~I~~~EF~~~~~~ 170 (179)
T 3a8r_A 103 FFDMVDKNADGRLTAEEVKEIIALSASANKLSKIKERADEYTALIMEELD-PTNLGYIEMEDLEALLLQ 170 (179)
T ss_dssp HHHHHCTTCSSCBCHHHHHHHHHHHHHTTHHHHHHHHHHHHHHHHHHHHS-TTCCSEECHHHHHHHHC-
T ss_pred HHHHHCCCCCCcCCHHHHHHHHHHHhccccccccccchHHHHHHHHHHhC-CCCCCcCcHHHHHHHHHh
Confidence 49999999999999999864 1 5678999999999 899999999999976543
|
| >3fwb_A Cell division control protein 31; gene gating, complex, cell cycle, cell division, mitosis, MR transport, nuclear pore complex, nucleus, phosphoprotein; 2.50A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2gv5_A 2doq_A 3fwc_A | Back alignment and structure |
|---|
Probab=96.81 E-value=0.00013 Score=64.53 Aligned_cols=71 Identities=8% Similarity=-0.037 Sum_probs=55.4
Q ss_pred CCCCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhccccc-ccCChhhhhhccCC
Q 009364 367 PGSPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLS-SILAPNDLEKSRNP 437 (536)
Q Consensus 367 ~~sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~-~~~~~e~l~~aF~~ 437 (536)
...|..+|.+++|.|+.+|+.. .+.+++..+++..| .+++|.|+|+||+.++.... .....+.++.+|+-
T Consensus 26 ~~~F~~~D~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~l~~~~d-~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~F~~ 104 (161)
T 3fwb_A 26 YEAFSLFDMNNDGFLDYHELKVAMKALGFELPKREILDLIDEYD-SEGRHLMKYDDFYIVMGEKILKRDPLDEIKRAFQL 104 (161)
T ss_dssp HHHHHHHCTTSSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHC-TTSSSCEEHHHHHHHHHHHHHTCCHHHHHHHHHHH
T ss_pred HHHHHHHCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhC-cCCCCeEeHHHHHHHHHHHHhcCCcHHHHHHHHHH
Confidence 3358999999999999999976 46789999999999 89999999999997665432 22334567777764
Q ss_pred C
Q 009364 438 M 438 (536)
Q Consensus 438 ~ 438 (536)
.
T Consensus 105 ~ 105 (161)
T 3fwb_A 105 F 105 (161)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >2mys_C Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1m8q_C* 1mvw_C* 1o18_F* 1o19_C* 1o1a_C* 1o1b_C* 1o1c_C* 1o1d_C* 1o1e_C* 1o1f_C* 1o1g_C* | Back alignment and structure |
|---|
Probab=96.80 E-value=0.00036 Score=60.60 Aligned_cols=50 Identities=10% Similarity=-0.096 Sum_probs=44.8
Q ss_pred CCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 369 SPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
.|..+|.+++|.|+.+|+.. .+.+++..+++. | .|++|.|+|+||+.++.
T Consensus 90 ~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~-d-~~~dg~i~~~eF~~~~~ 147 (149)
T 2mys_C 90 GLRVFDKEGNGTVMGAELRHVLATLGEKMTEEEVEELMKG-Q-EDSNGCINYEAFVKHIM 147 (149)
T ss_pred HHHHhCCCCCceEcHHHHHHHHHHhCCCCCHHHHHHHHhh-C-CCCCCcEeHHHHHHHHh
Confidence 48999999999999999976 478899999999 9 89999999999997553
|
| >3ll8_B Calcineurin subunit B type 1; protein-peptide docking, protein targeting, AKA beta-augmentation, calmodulin-binding, membrane, hydrolase; 2.00A {Homo sapiens} PDB: 1mf8_B* 2p6b_B 1aui_B 1m63_B* 1tco_B* | Back alignment and structure |
|---|
Probab=96.79 E-value=0.00024 Score=62.38 Aligned_cols=69 Identities=16% Similarity=0.077 Sum_probs=54.0
Q ss_pred CCCCccccCCCccchhhhhh----hhhhhhhhhhhccCCCCCCCccchhhhhhhcccccc-cCChhhhhhccCCC
Q 009364 369 SPGSVDICNLDSLSCSRVIV----EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSS-ILAPNDLEKSRNPM 438 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~----~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~-~~~~e~l~~aF~~~ 438 (536)
.|..+|.+++|.|+.+|+.. ....++..+++.+| .+++|.|+|+||+.++..... ....+.++.+|+-.
T Consensus 11 ~F~~~D~d~~G~i~~~el~~l~~~~~~~~~~~~~~~~D-~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~F~~~ 84 (155)
T 3ll8_B 11 RFKKLDLDNSGSLSVEEFMSLPELQQNPLVQRVIDIFD-TDGNGEVDFKEFIEGVSQFSVKGDKEQKLRFAFRIY 84 (155)
T ss_dssp HHHHHCTTCSSSBCHHHHTTSGGGTTCTTHHHHHHHHC-TTCSSSBCHHHHHHHHGGGCSSCCHHHHHHHHHHHH
T ss_pred HHHHhCcCCCCeEcHHHHHHhhccccchHHHHHHHHHC-CCCCCcCcHHHHHHHHHHHcccCCHHHHHHHHHHHh
Confidence 48889999999999999955 23458999999999 899999999999977665432 23445777777643
|
| >3qrx_A Centrin; calcium-binding, EF-hand, cell division, calcium binding, ME binding protein-toxin complex; 2.20A {Chlamydomonas reinhardtii} PDB: 2ggm_A 2ami_A 1zmz_A | Back alignment and structure |
|---|
Probab=96.79 E-value=9.7e-05 Score=66.12 Aligned_cols=70 Identities=11% Similarity=0.022 Sum_probs=53.8
Q ss_pred CCCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhccccc-ccCChhhhhhccCCC
Q 009364 368 GSPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLS-SILAPNDLEKSRNPM 438 (536)
Q Consensus 368 ~sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~-~~~~~e~l~~aF~~~ 438 (536)
..|..+|.+++|.|+..|+.. .+.+++..++...| .|++|.|+|+||+.++.... .....+.+..+|+-.
T Consensus 32 ~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d-~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~F~~~ 110 (169)
T 3qrx_A 32 EAFDLFDTDGSGTIDAKELKVAMRALGFEPKKEEIKKMISEID-KDGSGTIDFEEFLTMMTAKMGERDSREEILKAFRLF 110 (169)
T ss_dssp HHHHHHCTTCCSEECHHHHHHHHHHTSCCCCHHHHHHHHHHHC-SSSSSSEEHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhc-CCCCCcCCHHHHHHHHHHHhcccCcHHHHHHHHHHh
Confidence 349999999999999999976 46789999999999 89999999999997655322 122234566666543
|
| >2jnf_A Troponin C; stretch activated muscle contraction, EF-hand, metal binding protein; NMR {Lethocerus indicus} PDB: 2k2a_A | Back alignment and structure |
|---|
Probab=96.79 E-value=0.0003 Score=62.04 Aligned_cols=52 Identities=12% Similarity=-0.110 Sum_probs=46.2
Q ss_pred CCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhccc
Q 009364 369 SPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRK 421 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~ 421 (536)
.|..+|.+++|.|+.+|+.. .+.+++..+++.+| .|++|.|+|+||+.++..
T Consensus 96 ~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~D-~d~dg~i~~~eF~~~~~~ 155 (158)
T 2jnf_A 96 AFRLYDKEGNGYISTDVMREILAELDETLSSEDLDAMIDEID-ADGSGTVDFEEFMGVMTG 155 (158)
T ss_dssp HHHHHCSSSSSSEEHHHHHHHHHHHCTTCCHHHHHHHHHHHC-SSCCSEECSHHHHHHTSS
T ss_pred HHHHhCCCCCCeEcHHHHHHHHHHhCCcCCHHHHHHHHHHhC-CCCCCcEeHHHHHHHHhc
Confidence 48899999999999999976 46789999999999 899999999999976543
|
| >3fwb_A Cell division control protein 31; gene gating, complex, cell cycle, cell division, mitosis, MR transport, nuclear pore complex, nucleus, phosphoprotein; 2.50A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2gv5_A 2doq_A 3fwc_A | Back alignment and structure |
|---|
Probab=96.77 E-value=0.0003 Score=62.12 Aligned_cols=50 Identities=10% Similarity=-0.086 Sum_probs=45.2
Q ss_pred CCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhc
Q 009364 369 SPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGD 419 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~ 419 (536)
.|..+|.+++|.|+.+|+.. .+.++++.+++.+| .|++|.|+|+||+.++
T Consensus 101 ~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d-~~~~g~i~~~eF~~~~ 158 (161)
T 3fwb_A 101 AFQLFDDDHTGKISIKNLRRVAKELGETLTDEELRAMIEEFD-LDGDGEINENEFIAIC 158 (161)
T ss_dssp HHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHTTC-SSSSSSEEHHHHHHHH
T ss_pred HHHHHcCCCCCeEeHHHHHHHHHHhCCCCCHHHHHHHHHHhC-CCCCCcCcHHHHHHHH
Confidence 48999999999999999986 47889999999999 8999999999999654
|
| >1k2h_A S100A1, S-100 protein, alpha chain; non-covalent homodimer, X-type four-helix bundle, metal binding protein; NMR {Rattus norvegicus} SCOP: a.39.1.2 PDB: 1zfs_A 2k2f_A 2kbm_A 2l0p_A 2jpt_A | Back alignment and structure |
|---|
Probab=96.76 E-value=0.0002 Score=57.66 Aligned_cols=53 Identities=9% Similarity=-0.081 Sum_probs=44.9
Q ss_pred CCCCCcc-ccCCC-ccchhhhhh-------------hhhhhhhhhhhccCCCCCCCccchhhhhhhccc
Q 009364 368 GSPGSVD-ICNLD-SLSCSRVIV-------------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRK 421 (536)
Q Consensus 368 ~sf~~~D-~~~~g-~ls~~el~~-------------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~ 421 (536)
..|..+| .+++| .|+..|+.. .+.++++.+++.+| .|++|.|+|+||+.++..
T Consensus 13 ~~F~~~D~~d~~G~~I~~~el~~~l~~~~~~~~g~~~~~~~~~~~~~~~D-~d~dg~i~~~eF~~~~~~ 80 (93)
T 1k2h_A 13 NVFHAHSGKEGDKYKLSKKELKDLLQTELSSFLDVQKDADAVDKIMKELD-ENGDGEVDFQEFVVLVAA 80 (93)
T ss_dssp HHHHHHHTTSSCCSSCCHHHHHHHHHHHTHHHHHCCCCHHHHHHHHHHHH-HCTTSCCCHHHHHHHHHH
T ss_pred HHHHHHcccCCCcCccCHHHHHHHHHHHHHHHhCCCCCHHHHHHHHHHhC-CCCCCcCcHHHHHHHHHH
Confidence 3488999 79999 999999864 24678999999999 899999999999976543
|
| >3ox6_A Calcium-binding protein 1; EF-hand, calcium-sensor; 2.40A {Homo sapiens} PDB: 3ox5_A 2lan_A 2lap_A 2k7b_A 2k7c_A 2k7d_A | Back alignment and structure |
|---|
Probab=96.76 E-value=0.00036 Score=60.81 Aligned_cols=50 Identities=14% Similarity=-0.044 Sum_probs=44.8
Q ss_pred CCCCccccCCCccchhhhhh---------hhhhhhhhhhhccCCCCCCCccchhhhhhhc
Q 009364 369 SPGSVDICNLDSLSCSRVIV---------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGD 419 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~---------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~ 419 (536)
.|..+|.+++|.|+.+|+.. .+.++++.+++.+| .|++|.|+|+||+.++
T Consensus 93 ~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d-~~~dg~i~~~eF~~~~ 151 (153)
T 3ox6_A 93 AFREFDTNGDGEISTSELREAMRALLGHQVGHRDIEEIIRDVD-LNGDGRVDFEEFVRMM 151 (153)
T ss_dssp HHHHHCTTCSSSBCHHHHHHHHHHHHSSCCCHHHHHHHHHHHC-SSSSSSBCHHHHHHHT
T ss_pred HHHHhCCCCCCcCcHHHHHHHHHHHhcCCCCHHHHHHHHHHhC-CCCCCeEeHHHHHHHH
Confidence 48899999999999999975 36789999999999 8999999999999754
|
| >1qls_A S100C protein, calgizzarin; metal-binding protein/inhibitor, S100 family, EF-hand protein, complex (ligand/annexin), ligand of annexin II; 2.3A {Sus scrofa} SCOP: a.39.1.2 PDB: 1nsh_A | Back alignment and structure |
|---|
Probab=96.75 E-value=0.00032 Score=57.21 Aligned_cols=51 Identities=12% Similarity=-0.062 Sum_probs=44.0
Q ss_pred CCCCcc-ccCCC-ccchhhhhh-------------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 369 SPGSVD-ICNLD-SLSCSRVIV-------------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 369 sf~~~D-~~~~g-~ls~~el~~-------------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
.|..+| .+++| .|+..||.. .+..+++.+++.+| .|++|.|+|+||+.++.
T Consensus 18 ~F~~~Dd~d~~G~~I~~~el~~~l~~~~~~~~~~~~~~~~~~~l~~~~D-~~~dg~I~~~EF~~~~~ 83 (99)
T 1qls_A 18 IFQKHAGRDGNNTKISKTEFLIFMNTELAAFTQNQKDPGVLDRMMKKLD-LDSDGQLDFQEFLNLIG 83 (99)
T ss_dssp HHHHHHTTSSCTTCBCHHHHHHHHTTTSHHHHHHCCCTHHHHHHHHHHC-TTCSSSBCHHHHHHHHH
T ss_pred HHHHHHhcCCCcCeeCHHHHHHHHHHHcchhccccCCHHHHHHHHHHhC-CCCCCcCcHHHHHHHHH
Confidence 488898 99999 999999865 24578999999999 89999999999996554
|
| >1djx_A PLC-D1, phosphoinositide-specific phospholipase C, isozyme delta1; phosphoric diester hydrolase, hydrolase, lipid degradation, transducer; HET: I3P; 2.30A {Rattus norvegicus} SCOP: a.39.1.7 b.7.1.1 c.1.18.1 PDB: 1djg_A 1dji_A 1djh_A* 1djw_A* 1djy_A* 1djz_A* 2isd_A 1qas_A 1qat_A | Back alignment and structure |
|---|
Probab=96.75 E-value=0.00016 Score=79.52 Aligned_cols=68 Identities=6% Similarity=0.019 Sum_probs=12.7
Q ss_pred CCCCCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcccccccCChhhhhhccCC
Q 009364 366 SPGSPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSSILAPNDLEKSRNP 437 (536)
Q Consensus 366 ~~~sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~~~~~e~l~~aF~~ 437 (536)
....|..+|.+++|.|+.+||.. .++++++.+++.+| .|++|.|+|+||+.++.... ..++++++|+.
T Consensus 13 l~~~F~~fD~d~dG~Is~~El~~~l~~lg~~~s~~el~~lf~~~D-~d~~G~I~f~EF~~~~~~l~---~~~el~~aF~~ 88 (624)
T 1djx_A 13 IHSCLRKADKNKDNKMNFKELKDFLKELNIQVDDGYARKIFRECD-HSQTDSLEDEEIETFYKMLT---QRAEIDRAFEE 88 (624)
T ss_dssp --------------------------------------------------------CTTHHHHHHT---CCHHHHHHHHH
T ss_pred HHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhC-CCCCCeEeHHHHHHHHHHhc---cHHHHHHHHHH
Confidence 45679999999999999999875 46788999999999 89999999999997665422 23567777764
|
| >1wdc_C Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Z 1kqm_C* 1kwo_C* 1l2o_C* 1qvi_Z* 1s5g_Z* 1sr6_C 1b7t_Z 3jvt_C 3jtd_C 1kk8_C* 2ec6_C 1dfk_Z 1dfl_Z* 2w4t_Z 2w4v_Z 2w4w_Z 2otg_C* 2os8_C* 3pn7_C ... | Back alignment and structure |
|---|
Probab=96.75 E-value=0.00038 Score=61.31 Aligned_cols=51 Identities=14% Similarity=-0.094 Sum_probs=45.7
Q ss_pred CCCCccccCCCccchhhhhh--------hhhhhhhhhhhc--cCCCCCCCccchhhhhhhcc
Q 009364 369 SPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVT--SNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~--~d~~d~~g~Id~~EF~~~~~ 420 (536)
.|..+|.+++|.|+..|+.. .+.+++..+++. +| .|++|.|+|+||+.++.
T Consensus 89 ~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~~~D-~d~dg~i~~~eF~~~~~ 149 (156)
T 1wdc_C 89 AFKTFDREGQGFISGAELRHVLTALGERLSDEDVDEIIKLTDLQ-EDLEGNVKYEDFVKKVM 149 (156)
T ss_dssp HHHTTCSSSSSEEEHHHHHHHHHHSSSCCCHHHHHHHHHHHTCC-CCTTSEEEHHHHHHHHH
T ss_pred HHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCCC-CCCCCcEeHHHHHHHHh
Confidence 48899999999999999976 467899999999 99 89999999999997554
|
| >1y1x_A Leishmania major homolog of programmed cell death protein; SGPP, structural genomics, PSI; 1.95A {Leishmania major} SCOP: a.39.1.8 | Back alignment and structure |
|---|
Probab=96.73 E-value=0.00023 Score=65.68 Aligned_cols=62 Identities=10% Similarity=-0.099 Sum_probs=51.3
Q ss_pred CCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcccccccCChhhhhhccCC
Q 009364 369 SPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSSILAPNDLEKSRNP 437 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~~~~~e~l~~aF~~ 437 (536)
.|..+|.+++|.|+..|+.. .+.++++.+++..| .|++|.|+|+||+.++... +.++++|+.
T Consensus 98 ~F~~~D~d~~G~i~~~e~~~~l~~~g~~~~~~~~~~~~~~~D-~d~dg~i~~~eF~~~~~~~------~~~~~~F~~ 167 (191)
T 1y1x_A 98 GFRKRDSSGDGRLDSNEVRAALLSSGYQVSEQTFQALMRKFD-RQRRGSLGFDDYVELSIFV------CRVRNVFAF 167 (191)
T ss_dssp HHHHHCTTSSSCBCHHHHHHHHHTTSCCCCHHHHHHHHHHHC-TTCSSSBCHHHHHHHHHHH------HHHHHHHHH
T ss_pred HHHHhCCCCCCeEcHHHHHHHHHHhCCCCCHHHHHHHHHHhC-CCCCCeEeHHHHHHHHHHH------HHHHHHHHH
Confidence 38889999999999999976 46789999999999 8999999999999765532 456666654
|
| >3pm8_A PFCDPK2, calcium-dependent protein kinase 2; malaria, structural genomics, structural genomics CONS SGC; 2.00A {Plasmodium falciparum K1} | Back alignment and structure |
|---|
Probab=96.73 E-value=0.00035 Score=64.92 Aligned_cols=51 Identities=10% Similarity=-0.101 Sum_probs=45.5
Q ss_pred CCCCccccCCCccchhhhhh----------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 369 SPGSVDICNLDSLSCSRVIV----------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~----------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
.|..+|.+++|.|+.+|+.. .+.++++.+++.+| .|++|.|+|+||+.++.
T Consensus 134 ~F~~~D~d~~G~Is~~El~~~l~~~~~~~~~~~~~~~~l~~~~D-~d~dG~Is~~EF~~~l~ 194 (197)
T 3pm8_A 134 PFKFFDIDGNGKISVEELKRIFGRDDIENPLIDKAIDSLLQEVD-LNGDGEIDFHEFMLMMS 194 (197)
T ss_dssp HHHHHCTTCSSEECHHHHHHHHC----CCHHHHHHHHHHHHHHC-TTCSSSEEHHHHHHHHH
T ss_pred HHHHHCCCCCCCCCHHHHHHHHHhcccCCCCCHHHHHHHHHHHc-CCCCCcCcHHHHHHHHH
Confidence 49999999999999999976 36788999999999 89999999999997654
|
| >1qv0_A Obelin, OBL; photoprotein, bioluminescence, atomic resolution, Ca binding, EF-hand, luminescent protein; HET: CZH; 1.10A {Obelia longissima} SCOP: a.39.1.5 PDB: 1qv1_A* 1sl9_A* 1el4_A* 2f8p_A* 1sl7_A 1jf2_A* 1s36_A* 1jf0_A* 3kpx_A* | Back alignment and structure |
|---|
Probab=96.72 E-value=0.00033 Score=64.15 Aligned_cols=52 Identities=8% Similarity=0.022 Sum_probs=42.2
Q ss_pred CCCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 368 GSPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 368 ~sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
..|..+|.+++|.|+.+|+.. .+.++++.+++.+| .|++|.|+|+||+.++.
T Consensus 117 ~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~~~~~~~~~~D-~d~dg~i~~~eF~~~~~ 176 (195)
T 1qv0_A 117 AVFDIFDKDGSGTITLDEWKAYGKISGISPSQEDCEATFRHCD-LDNAGDLDVDEMTRQHL 176 (195)
T ss_dssp HHHHHTC----CEECHHHHHHHHHHHSSCCCHHHHHHHHHHSC-CCTTSCEEHHHHHHHHH
T ss_pred HHHHHhcCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhC-CCCCCcCCHHHHHHHHH
Confidence 359999999999999999976 36889999999999 89999999999996544
|
| >2f2o_A Calmodulin fused with calmodulin-binding domain of calcineurin; EF-hands, calcium, metal binding protein; 2.17A {Bos taurus} PDB: 2f2p_A | Back alignment and structure |
|---|
Probab=96.71 E-value=0.00014 Score=65.72 Aligned_cols=68 Identities=6% Similarity=-0.038 Sum_probs=50.0
Q ss_pred CCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhccccc-ccCChhhhhhccCC
Q 009364 369 SPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLS-SILAPNDLEKSRNP 437 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~-~~~~~e~l~~aF~~ 437 (536)
.|..+|.+++|.|+.+|+.. ++..+++.+++.+| .|++|.|+|+||+.++.... .....+.++.+|+-
T Consensus 16 ~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~l~~~~D-~~~~g~i~~~EF~~~~~~~~~~~~~~~~~~~~F~~ 92 (179)
T 2f2o_A 16 AFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVD-ADGNGTIDFPEFLTMMARKMKDTDSEEEIREAFRV 92 (179)
T ss_dssp HHHHHCTTCSSCBCHHHHHHHHHHTTCCCCHHHHHHHHHHHC-TTCSSSBCHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhc-cCCCCCCcHHHHHHHHHHHccCcccHHHHHHHHHH
Confidence 48889999999999999876 46788999999999 89999999999986554321 11223445555543
|
| >1q80_A SCP, sarcoplasmic calcium-binding protein; all-alpha, metal binding protein; NMR {Neanthes diversicolor} SCOP: a.39.1.5 PDB: 2scp_A | Back alignment and structure |
|---|
Probab=96.71 E-value=0.0004 Score=62.25 Aligned_cols=50 Identities=14% Similarity=0.074 Sum_probs=45.4
Q ss_pred CCCCccccCCCccchhhhhh------hhhhhhhhhhhccCCCCCCCccchhhhhhhc
Q 009364 369 SPGSVDICNLDSLSCSRVIV------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGD 419 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~ 419 (536)
.|..+|.+++|.|+.+|+.. .+.++++.+++.+| .|++|.|+|+||+.++
T Consensus 99 ~F~~~D~d~~G~i~~~e~~~~l~~~g~~~~~~~~~~~~~D-~d~dg~i~~~ef~~~~ 154 (174)
T 1q80_A 99 FFRAVDTNEDNNISRDEYGIFFGMLGLDKTMAPASFDAID-TNNDGLLSLEEFVIAG 154 (174)
T ss_dssp HHHHHCTTSSSSBCHHHHHHHHHHHTCCGGGHHHHHHHHC-TTCSSSBCHHHHHHHH
T ss_pred HHHHhCCCCCCcccHHHHHHHHHHcCCCHHHHHHHHHHhC-CCCCceEeHHHHHHHH
Confidence 59999999999999999986 46789999999999 8999999999999654
|
| >1ggw_A Protein (CDC4P); light chain, cytokinesis, cell cycle, EF-hand; NMR {Schizosaccharomyces pombe} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=96.70 E-value=0.00049 Score=59.37 Aligned_cols=50 Identities=8% Similarity=-0.178 Sum_probs=44.4
Q ss_pred CCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 369 SPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
.|..+|.+++|.|+.+|+.. .+.++++.+++.+| . ++|.|+|+||+.++.
T Consensus 81 ~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~d-~-~dg~i~~~eF~~~~~ 138 (140)
T 1ggw_A 81 GFQVFDKDATGMIGVGELRYVLTSLGEKLSNEEMDELLKGVP-V-KDGMVNYHDFVQMIL 138 (140)
T ss_dssp HHHTTCSSCSSCCCHHHHHHHHHHHHSCSCHHHHHHHHHHTT-C-SSCCSTTTHHHHHHH
T ss_pred HHHHhCCCCCCcEeHHHHHHHHHHcCCCCCHHHHHHHHHhcc-C-CCCcEeHHHHHHHHh
Confidence 48999999999999999976 46789999999999 7 999999999996543
|
| >3j04_B Myosin regulatory light chain 2, smooth muscle MA isoform; phosphorylation, 2D crystalline arrays, myosin regulation, M light chains, structural protein; 20.00A {Gallus gallus} | Back alignment and structure |
|---|
Probab=96.70 E-value=0.00026 Score=61.35 Aligned_cols=66 Identities=3% Similarity=-0.194 Sum_probs=52.0
Q ss_pred CCCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcccc-cccCChhhhhhccCCC
Q 009364 368 GSPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKL-SSILAPNDLEKSRNPM 438 (536)
Q Consensus 368 ~sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~-~~~~~~e~l~~aF~~~ 438 (536)
..|..+|.+++|.|+.+|+.. ++..++..++.. ++|.|+|+||+.++... ......+.++.+|+-.
T Consensus 11 ~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~-----~~g~i~~~eF~~~~~~~~~~~~~~~~l~~~F~~~ 85 (143)
T 3j04_B 11 EAFNMIDQNRDGFIDKEDLHDMLASMGKNPTDEYLEGMMSE-----APGPINFTMFLTMFGEKLNGTDPEDVIRNAFACF 85 (143)
T ss_dssp HHHTTTCSSCTTCCCHHHHHHHHHHTSCCCCHHHHHTTTTT-----SSSCCCHHHHHHHHHHTTTSSCCHHHHHHHHTTS
T ss_pred HHHHHhCCCCCCCcCHHHHHHHHHHhCCCCCHHHHHHHHHh-----CCCCcCHHHHHHHHHHHhccCCcHHHHHHHHHHH
Confidence 349999999999999999986 467788888766 56899999999766643 3345567888999865
|
| >1ggw_A Protein (CDC4P); light chain, cytokinesis, cell cycle, EF-hand; NMR {Schizosaccharomyces pombe} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=96.69 E-value=0.00021 Score=61.74 Aligned_cols=68 Identities=10% Similarity=-0.018 Sum_probs=51.3
Q ss_pred CCCCCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcccccc---cCChhhhhhc
Q 009364 366 SPGSPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSS---ILAPNDLEKS 434 (536)
Q Consensus 366 ~~~sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~---~~~~e~l~~a 434 (536)
....|..+|.+++|.|+.+|+.. ++.+++..++. +++|.|+|+||+.++..... ....+.++.+
T Consensus 7 l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~-----~~~g~i~~~eF~~~~~~~~~~~~~~~~~~~~~~ 81 (140)
T 1ggw_A 7 YKQAFSLFDRHGTGRIPKTSIGDLLRACGQNPTLAEITEIES-----TLPAEVDMEQFLQVLNRPNGFDMPGDPEEFVKG 81 (140)
T ss_dssp THHHHHHTCSSSSSEECHHHHHHHHHHTSCCCCHHHHHHHHT-----TSCSSEEHHHHHHHHCTTSSSSSSCCHHHHHHH
T ss_pred HHHHHHHHCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHh-----CCCCcCcHHHHHHHHHHHhcccCcccHHHHHHH
Confidence 33458899999999999999976 46778888887 56789999999977665432 2233678888
Q ss_pred cCCC
Q 009364 435 RNPM 438 (536)
Q Consensus 435 F~~~ 438 (536)
|+-.
T Consensus 82 F~~~ 85 (140)
T 1ggw_A 82 FQVF 85 (140)
T ss_dssp HHTT
T ss_pred HHHh
Confidence 8754
|
| >1w7j_B Myosin light chain 1; motor protein, unconventional myosin, myosin V, chicken, molecular motor, ATPase, ELC, IQ motif, muscle protein, ATP-binding; HET: ADP; 2A {Homo sapiens} SCOP: a.39.1.5 PDB: 1w7i_B* 1oe9_B* 3j04_C 1br1_B* 1br4_B* 1i84_T* 3dtp_C 2w4a_C 2w4g_C 2w4h_C | Back alignment and structure |
|---|
Probab=96.68 E-value=0.0005 Score=60.09 Aligned_cols=50 Identities=8% Similarity=-0.119 Sum_probs=44.5
Q ss_pred CCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 369 SPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
.|..+|.+++|.|+.+|+.. .+.++++.+++.+| |++|.|+|+||+.++.
T Consensus 92 ~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d--~~dg~i~~~eF~~~~~ 149 (151)
T 1w7j_B 92 GFRVFDKEGNGKVMGAELRHVLTTLGEKMTEEEVETVLAGHE--DSNGCINYEAFLKHIL 149 (151)
T ss_dssp HHHTTCTTSSSEEEHHHHHHHHHHSSSCCCHHHHHHHHTTCC--CTTSEEEHHHHHHHTC
T ss_pred HHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHhcc--CCCCeEeHHHHHHHHh
Confidence 59999999999999999976 47889999999998 7899999999997553
|
| >1uhk_A Aequorin 2, aequorin; EF-hand motif, complex, luminescent protein; HET: CZN; 1.60A {Aequorea victoria} SCOP: a.39.1.5 PDB: 1ej3_A* 1uhi_A* 1uhj_A* 1uhh_A* 1sl8_A | Back alignment and structure |
|---|
Probab=96.67 E-value=0.00039 Score=63.38 Aligned_cols=52 Identities=12% Similarity=0.060 Sum_probs=46.1
Q ss_pred CCCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 368 GSPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 368 ~sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
..|..+|.+++|.|+.+|+.. .+.+++..+++.+| .|++|.|+|+||+.++.
T Consensus 113 ~~F~~~D~d~~G~Is~~El~~~l~~~g~~~~~~~~~~~~~~~D-~d~dG~i~~~eF~~~~~ 172 (191)
T 1uhk_A 113 ALFDIVDKDQNGAITLDEWKAYTKAAGIIQSSEDCEETFRVCD-IDESGQLDVDEMTRQHL 172 (191)
T ss_dssp HHHHHHCTTCSSEECHHHHHHHHHHHTSCCSHHHHHHHHHHSC-CCTTSCEEHHHHHHHHH
T ss_pred HHHHHhcCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhC-CCCCCcCcHHHHHHHHH
Confidence 348999999999999999976 36889999999999 89999999999996544
|
| >1dtl_A Cardiac troponin C; helix-turn-helix, structural protein; HET: BEP; 2.15A {Gallus gallus} SCOP: a.39.1.5 PDB: 1j1d_A 1j1e_A 2jt3_A 2jt0_A 1la0_A 2jtz_A* 2jt8_A* 2kfx_T* 1wrk_A* 1wrl_A* 1ap4_A 1lxf_C* 1mxl_C 1spy_A 2krd_C* 2l1r_A* 3rv5_A* 2ctn_A 2kgb_C 2jxl_A ... | Back alignment and structure |
|---|
Probab=96.67 E-value=0.00032 Score=61.99 Aligned_cols=51 Identities=6% Similarity=-0.035 Sum_probs=45.6
Q ss_pred CCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 369 SPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
.|..+|.+++|.|+..|+.. .+.+++..+++.+| .|++|.|+|+||+.++.
T Consensus 100 ~F~~~D~d~~G~i~~~El~~~l~~~g~~~~~~~~~~~~~~~D-~d~dg~i~~~eF~~~~~ 158 (161)
T 1dtl_A 100 LFRMFDKNADGYIDLEELKIMLQATGETITEDDIEELMKDGD-KNNDGRIDYDEFLEFMK 158 (161)
T ss_dssp HHHHHCTTCSSEEEHHHHGGGGTTC--CCCHHHHHHHHHHHC-TTSSSEEEHHHHHHHHH
T ss_pred HHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhC-CCCCCcEeHHHHHHHHH
Confidence 48999999999999999976 46789999999999 89999999999997553
|
| >2f2o_A Calmodulin fused with calmodulin-binding domain of calcineurin; EF-hands, calcium, metal binding protein; 2.17A {Bos taurus} PDB: 2f2p_A | Back alignment and structure |
|---|
Probab=96.66 E-value=0.00042 Score=62.59 Aligned_cols=53 Identities=13% Similarity=-0.072 Sum_probs=46.8
Q ss_pred CCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcccc
Q 009364 369 SPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKL 422 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~ 422 (536)
.|..+|.+++|.|+.+|+.. .+.+++..+++.+| .|++|.|+|+||+.++...
T Consensus 89 ~F~~~D~d~~G~I~~~E~~~~l~~~g~~~~~~~~~~~~~~~D-~~~dg~i~~~eF~~~~~~~ 149 (179)
T 2f2o_A 89 AFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREAD-IDGDGQVNYEEFVQMMTAK 149 (179)
T ss_dssp HHHHHCTTCSSEECHHHHHHHHHHC--CCCHHHHHHHHHHHC-TTCSSSEEHHHHHHHSCC-
T ss_pred HHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHcC-CCCCCcCcHHHHHHHHHHc
Confidence 48999999999999999976 46789999999999 8999999999999776653
|
| >2znd_A Programmed cell death protein 6; penta-EF-hand protein, calcium binding protein, apoptosis, calcium, endoplasmic reticulum, membrane, nucleus; 1.70A {Homo sapiens} PDB: 2zn9_A 2zn8_A 1hqv_A 3aak_A 2zne_A 2zrs_A 2zrt_A 3aaj_A | Back alignment and structure |
|---|
Probab=96.65 E-value=0.00024 Score=63.97 Aligned_cols=63 Identities=13% Similarity=-0.063 Sum_probs=52.1
Q ss_pred CCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcccccccCChhhhhhccCCC
Q 009364 369 SPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSSILAPNDLEKSRNPM 438 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~~~~~e~l~~aF~~~ 438 (536)
.|..+|.+++|.|+..|+.. .+.++++.+++..| .|++|.|+|+||+.++... +.++++|+..
T Consensus 79 ~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~d-~~~dg~i~~~eF~~~~~~~------~~~~~~F~~~ 149 (172)
T 2znd_A 79 VFRTYDRDNSGMIDKNELKQALSGFGYRLSDQFHDILIRKFD-RQGRGQIAFDDFIQGCIVL------QRLTDIFRRY 149 (172)
T ss_dssp HHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHC-TTCSSSEEHHHHHHHHHHH------HHHHHHHHHH
T ss_pred HHHHHCCCCCCccCHHHHHHHHHHcCCCCCHHHHHHHHHHhC-CCCCCcCcHHHHHHHHHHH------HHHHHHHHHh
Confidence 48899999999999999976 46789999999999 8999999999999765432 4566666644
|
| >2l2e_A Calcium-binding protein NCS-1; NCS1P, myristoylated, metal binding protein; HET: MYR; NMR {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=96.65 E-value=0.0003 Score=64.27 Aligned_cols=68 Identities=10% Similarity=-0.135 Sum_probs=52.7
Q ss_pred CCCCcccc-CCCccchhhhhh---------hhhhhhhhhhhccCCCCCCCccchhhhhhhcccccccCChhhhhhccCC
Q 009364 369 SPGSVDIC-NLDSLSCSRVIV---------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSSILAPNDLEKSRNP 437 (536)
Q Consensus 369 sf~~~D~~-~~g~ls~~el~~---------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~~~~~e~l~~aF~~ 437 (536)
.|..+|.+ ++|.|+.+|+.. .+.+++..+++.+| .|++|.|+++||+.++.........++++.+|+.
T Consensus 30 ~f~~~D~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~f~~~D-~d~~G~i~~~ef~~~~~~~~~~~~~~~~~~~f~~ 107 (190)
T 2l2e_A 30 WYKGFFKDCPSGHLNKSEFQKIYKQFFPFGDPSAFAEYVFNVFD-ADKNGYIDFKEFICALSVTSRGELNDKLIWAFQL 107 (190)
T ss_dssp HHHHHHHHSCCCEECHHHHHHHHHHHCCCSCHHHHHHHHHHHHC-SSSTTCEEHHHHHHHHTTSSCSCSHHHHHHHHHH
T ss_pred HHHHHHHhCCCCcCCHHHHHHHHHHhCCCCCccHHHHHHHHHhc-CCCCCeEeHHHHHHHHHHHcCCCHHHHHHHHHhH
Confidence 37778888 799999999875 24567888999999 8999999999999776655545556677777754
|
| >2bec_A Calcineurin B homologous protein 2; calcineurin-homologous protein, calcium-binding protein, NHE1 regulating protein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.64 E-value=0.00022 Score=66.10 Aligned_cols=56 Identities=13% Similarity=-0.150 Sum_probs=45.7
Q ss_pred CCCCCCCccccCCCccchhhhhhh----hhhhhhhhhhccCCCCCCCccchhhhhhhcccc
Q 009364 366 SPGSPGSVDICNLDSLSCSRVIVE----KLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKL 422 (536)
Q Consensus 366 ~~~sf~~~D~~~~g~ls~~el~~~----~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~ 422 (536)
....|..+|.+++|.|+..|+... ....++.+++.+| .|++|.|+|+||+.++...
T Consensus 31 l~~~F~~~D~d~dG~I~~~El~~~~~lg~~~~~~~l~~~~D-~d~dg~i~~~EF~~~~~~~ 90 (202)
T 2bec_A 31 LHHRFRALDRNKKGYLSRMDLQQIGALAVNPLGDRIIESFF-PDGSQRVDFPGFVRVLAHF 90 (202)
T ss_dssp HHHHHHHHCSSCSSCCCHHHHHTCHHHHHSTTHHHHHHTTS-CSSCCCCCHHHHHHHHGGG
T ss_pred HHHHHHHHCCCCCCCcCHHHHHHHHhcCCCccHHHHHHHhC-CCCCCcCcHHHHHHHHHHh
Confidence 344599999999999999999862 1223889999999 8999999999999766543
|
| >1y1x_A Leishmania major homolog of programmed cell death protein; SGPP, structural genomics, PSI; 1.95A {Leishmania major} SCOP: a.39.1.8 | Back alignment and structure |
|---|
Probab=96.64 E-value=0.0003 Score=64.89 Aligned_cols=51 Identities=10% Similarity=0.021 Sum_probs=45.4
Q ss_pred CCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 369 SPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
.|..+|.+++|.|+.+|+.. .+.++++.+++..| .|++|.|+|+||+.++.
T Consensus 32 ~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~~l~~~~D-~d~dG~I~~~EF~~~~~ 90 (191)
T 1y1x_A 32 WFRAVDTDGSGAISVPELNAALSSAGVPFSLATTEKLLHMYD-KNHSGEITFDEFKDLHH 90 (191)
T ss_dssp HHHHHCTTCSSSBCHHHHHHHHCBTTBCCCHHHHHHHHHHHC-TTCSSSBCHHHHHHHHH
T ss_pred HHHHHcCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhC-CCCCCeEcHHHHHHHHH
Confidence 48899999999999999976 46789999999999 89999999999996543
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.63 E-value=0.0039 Score=65.94 Aligned_cols=76 Identities=16% Similarity=0.118 Sum_probs=47.4
Q ss_pred eeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCce-eeEeeeeecCCceeE
Q 009364 70 KGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNI-VRYLGTVREEESLNI 148 (536)
Q Consensus 70 ~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnI-v~l~~~~~~~~~~~l 148 (536)
..+.|+.|-...+|++.....+..+++|+.-.... . .-.-.+|..+++.|...++ .++++.+.. .+
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~---~------~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~ 178 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD---E------IINREREKKISCILYNKNIAKKIYVFFTN----GR 178 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CC---S------CSCHHHHHHHHHHHTTSSSBCCEEEEETT----EE
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChh---h------hcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eE
Confidence 35678899999999998654457889997621110 0 0011468888888864444 466766632 36
Q ss_pred EEEecCCCCc
Q 009364 149 LLEFVPGGSI 158 (536)
Q Consensus 149 V~E~~~gg~L 158 (536)
||||++|.+|
T Consensus 179 v~e~I~G~~l 188 (458)
T 2qg7_A 179 IEEFMDGYAL 188 (458)
T ss_dssp EEECCCSEEC
T ss_pred EEEeeCCccC
Confidence 9999987554
|
| >4ds7_A Calmodulin, CAM; protein binding, metal binding, structura; 2.15A {Kluyveromyces lactis} PDB: 1lkj_A 2lhh_A 1f54_A 1f55_A | Back alignment and structure |
|---|
Probab=96.63 E-value=0.00015 Score=63.02 Aligned_cols=69 Identities=13% Similarity=0.010 Sum_probs=53.4
Q ss_pred CCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhccccc-ccCChhhhhhccCCC
Q 009364 369 SPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLS-SILAPNDLEKSRNPM 438 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~-~~~~~e~l~~aF~~~ 438 (536)
.|..+|.+++|.|+.+|+.. .+..++..+++..| .+++|.|+|+||+.++.... .....+.++.+|+-.
T Consensus 16 ~F~~~D~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~l~~~~d-~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~F~~~ 93 (147)
T 4ds7_A 16 AFALFDKDNSGSISASELATVMRSLGLSPSEAEVADLMNEID-VDGNHAIEFSEFLALMSRQLKCNDSEQELLEAFKVF 93 (147)
T ss_dssp HHHHHCTTCSSEEEHHHHHHHHHHTTCCCCHHHHHHHHHHHC-TTSSSEEEHHHHHHHHHHHHHTHHHHHHHHHHHHHH
T ss_pred HHHHHCCCCCCCcCHHHHHHHHHHhCCCCCHHHHHHHHHHhc-cCCCCcCcHHHHHHHHHHhccCCCcHHHHHHHHHHh
Confidence 48889999999999999975 46788999999999 89999999999997665432 222345677776533
|
| >1top_A Troponin C; contractIle system protein; 1.78A {Gallus gallus} SCOP: a.39.1.5 PDB: 1ncy_A 1ncz_A 1ncx_A 1ytz_C* 1yv0_C 1tnw_A 1tnx_A 5tnc_A 2w49_0 2w4u_0 4tnc_A 1a2x_A 1tcf_A 1tn4_A 2tn4_A 1aj4_A 1jc2_A 1fi5_A 1sbj_A 1scv_A ... | Back alignment and structure |
|---|
Probab=96.63 E-value=0.00048 Score=60.84 Aligned_cols=52 Identities=8% Similarity=-0.068 Sum_probs=45.8
Q ss_pred CCCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 368 GSPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 368 ~sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
..|..+|.+++|.|+..|+.. .+.+++..+++..| .|++|.|+|+||+.++.
T Consensus 100 ~~F~~~D~d~~G~I~~~e~~~~l~~~g~~~~~~~~~~~~~~~d-~~~dg~i~~~eF~~~~~ 159 (162)
T 1top_A 100 NCFRIFDKNADGFIDIEELGEILRATGEHVTEEDIEDLMKDSD-KNNDGRIDFDEFLKMME 159 (162)
T ss_dssp HHHHHHCTTCSSCBCHHHHHHHHHTTTCCCCHHHHHHHHHHHC-TTCSSSBCHHHHHHHHH
T ss_pred HHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhC-CCCCCcCcHHHHHHHHh
Confidence 348999999999999999975 46789999999999 89999999999997553
|
| >2f33_A Calbindin; EF-hand, Ca2+-binding, metal binding protein; NMR {Rattus norvegicus} PDB: 2g9b_A | Back alignment and structure |
|---|
Probab=96.61 E-value=0.00057 Score=65.67 Aligned_cols=71 Identities=7% Similarity=-0.156 Sum_probs=56.6
Q ss_pred CCCCCccccCCCccchhhhhh--------hhh------hhhhhhhhccCCCCCCCccchhhhhhhcccc---------cc
Q 009364 368 GSPGSVDICNLDSLSCSRVIV--------EKL------SGSMHGWVTSNSNDDLCQLDQEDFVAGDRKL---------SS 424 (536)
Q Consensus 368 ~sf~~~D~~~~g~ls~~el~~--------~~~------~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~---------~~ 424 (536)
..|..+|.+++|.|+..|+.. ++. .++..++..+| .|++|.|+|+||+..+... ..
T Consensus 20 ~~F~~~D~d~~G~i~~~El~~~l~~l~~~~~~~~~~~~~~~~~l~~~~D-~~~~g~i~~~Ef~~~~~~~~~~~~~~~~~~ 98 (263)
T 2f33_A 20 EIWLHFDADGSGYLEGKELQNLIQELLQARKKAGLELSPEMKTFVDQYG-QRDDGKIGIVELAHVLPTEENFLLLFRCQQ 98 (263)
T ss_dssp HHHHHHCTTCSSSBCSHHHHHHHHHHHHHHHHHTCCCCHHHHHHHHHHT-TGGGCCBCHHHHHHHTTSCTTHHHHHGGGT
T ss_pred HHHHHhCCCCCCCcCHHHHHHHHHHHHhhcCCCccchHHHHHHHHHHhC-CCCCCcCcHHHHHHHHhhhhhHHHHHHHhh
Confidence 349999999999999999976 233 67889999999 8999999999999776543 33
Q ss_pred cCChhhhhhccCCCC
Q 009364 425 ILAPNDLEKSRNPMC 439 (536)
Q Consensus 425 ~~~~e~l~~aF~~~~ 439 (536)
....++++++|+-.-
T Consensus 99 ~~~~~~l~~~F~~~D 113 (263)
T 2f33_A 99 LKSCEEFMKTWRKYD 113 (263)
T ss_dssp SSCHHHHHHHHTTSS
T ss_pred ccHHHHHHHHHHHHC
Confidence 445667888887663
|
| >2lvv_A Flagellar calcium-binding protein TB-24; EF-hand, metal binding protein; NMR {Trypanosoma brucei brucei} | Back alignment and structure |
|---|
Probab=96.56 E-value=0.00011 Score=70.10 Aligned_cols=70 Identities=14% Similarity=-0.011 Sum_probs=52.8
Q ss_pred CCCCCccccCCCccchhhhhh---------hhhhhhhhhhhcc---------CCCCCCCccchhhhhhhcccccccCChh
Q 009364 368 GSPGSVDICNLDSLSCSRVIV---------EKLSGSMHGWVTS---------NSNDDLCQLDQEDFVAGDRKLSSILAPN 429 (536)
Q Consensus 368 ~sf~~~D~~~~g~ls~~el~~---------~~~~ei~~l~~~~---------d~~d~~g~Id~~EF~~~~~~~~~~~~~e 429 (536)
..|..+|.+++|.|+..||.. ++..++..+++.+ | .|++|.|+|+||+.++........++
T Consensus 55 ~~F~~~D~d~dG~Is~~El~~~l~~~lg~~~~~~~~~~~~~~~f~~~~~~~~D-~d~~G~I~~~EF~~~~~~~~~~~~~~ 133 (226)
T 2lvv_A 55 ELFKQFDTNGTGKLGFREVLDGCYGILKLDEFTTHLPDIVQRAFDKAKDLGNK-VKGVGEEDLVEFLEFRLMLCYIYDIF 133 (226)
T ss_dssp HHHHHHGGGSCSCBCSHHHHHHHHHTTCCTTTSSSCHHHHHHHHHHHHHHHHH-HSCCCCCSCBCHHHHHHHHHHHHHHH
T ss_pred HHHHHHCCCCCCcCcHHHHHHHHHHHhCCCCCHHHHHHHHHHHHHHhcccCCC-CCCCCcCCHHHHHHHHHHHHhccCHH
Confidence 359999999999999999985 3567888888887 9 89999999999997543332222345
Q ss_pred hhhhccCCC
Q 009364 430 DLEKSRNPM 438 (536)
Q Consensus 430 ~l~~aF~~~ 438 (536)
.++.+|+-+
T Consensus 134 ~l~~~F~~~ 142 (226)
T 2lvv_A 134 ELTVMFDTM 142 (226)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 666776543
|
| >2bl0_C Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} | Back alignment and structure |
|---|
Probab=96.56 E-value=0.00054 Score=59.18 Aligned_cols=49 Identities=8% Similarity=-0.055 Sum_probs=43.4
Q ss_pred CCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhc
Q 009364 369 SPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGD 419 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~ 419 (536)
.|..+|.+++|.|+.+|+.. .+.++++.+++.+| |++|.|+|+||+.++
T Consensus 84 ~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~d--~~dg~i~~~eF~~~~ 140 (142)
T 2bl0_C 84 AFRTFDPEGTGYIPKAALQDALLNLGDRLKPHEFAEFLGITE--TEKGQIRYDNFINTM 140 (142)
T ss_dssp HHHHTCCSSCSCEEHHHHHHHHHHSSSCCCHHHHHHHHHHHC--CSSSEECSHHHHTTT
T ss_pred HHHHHCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhC--CCCCcEeHHHHHHHH
Confidence 48899999999999999976 46789999999999 889999999998654
|
| >1snl_A Nucleobindin 1, calnuc; EF-hand, calcium-binding, metal binding protein; NMR {Homo sapiens} SCOP: a.39.1.7 | Back alignment and structure |
|---|
Probab=96.54 E-value=0.00058 Score=56.44 Aligned_cols=51 Identities=14% Similarity=-0.032 Sum_probs=42.0
Q ss_pred CCCCccccCCCccchhhhhhh-h------------h-----------hhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 369 SPGSVDICNLDSLSCSRVIVE-K------------L-----------SGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~~-~------------~-----------~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
.|..+|.+++|.|+.+|+... . . ..+..+++.+| .|++|.|+|+||+.++.
T Consensus 25 ~F~~~D~d~dG~I~~~El~~~l~~~~~~~~g~~~~~~~~~~~~e~~~~~~~~~~~~~D-~d~dG~Is~~EF~~~~~ 99 (103)
T 1snl_A 25 FFILHDINSDGVLDEQELEALFTKELEKVYDPKNEEDDMREMEEERLRMREHVMKNVD-TNQDRLVTLEEFLASTQ 99 (103)
T ss_dssp HHHHHCSSCCSEEEHHHHHHHHHHHHHTTSCCSSCSSHHHHTTHHHHHHHHHHHHHTC-SSCSSEEEHHHHHHHHH
T ss_pred HHHHHcCCCCCcccHHHHHHHHHHHHHHHhccCCCCccHHHHHHHHHHHHHHHHHHcC-CCCCCcCCHHHHHHHHh
Confidence 488999999999999999651 1 1 13888999999 89999999999997553
|
| >1k8u_A S100A6, calcyclin, CACY; calcium regulatory protein, calcium free, signaling protein; HET: MSE; 1.15A {Homo sapiens} SCOP: a.39.1.2 PDB: 1k96_A 1k9k_A 1k9p_A 1a03_A 1cnp_A 1jwd_A 2cnp_A 2jtt_A | Back alignment and structure |
|---|
Probab=96.53 E-value=0.00031 Score=56.01 Aligned_cols=51 Identities=6% Similarity=-0.153 Sum_probs=43.6
Q ss_pred CCCCcc-ccCCC-ccchhhhhh-----------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 369 SPGSVD-ICNLD-SLSCSRVIV-----------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 369 sf~~~D-~~~~g-~ls~~el~~-----------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
.|..+| .+++| .|+..|+.. .+..+++.+++.+| .|++|.|+|+||+.++.
T Consensus 15 ~F~~~D~~d~~G~~i~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~D-~~~dg~i~~~eF~~~~~ 78 (90)
T 1k8u_A 15 IFHKYSGREGDKHTLSKKELKELIQKELTIGSKLQDAEIARLMEDLD-RNKDQEVNFQEYVTFLG 78 (90)
T ss_dssp HHHHHHTSSSCTTEEEHHHHHHHHHHHSCCGGGTTSHHHHHHHHHHH-HTTTCEEEHHHHHHHHH
T ss_pred HHHHHhccCCCCCcCCHHHHHHHHHHhcccCCCCCHHHHHHHHHHhC-CCCCCCCcHHHHHHHHH
Confidence 488999 59999 999999864 24568999999999 89999999999996554
|
| >3dtp_E RLC, myosin regulatory light chain; muscle protein, smooth muscle, myosin subfragment 2, heavy meromyosin, essential light chain; 20.00A {Avicularia avicularia} | Back alignment and structure |
|---|
Probab=96.52 E-value=0.00058 Score=63.20 Aligned_cols=52 Identities=10% Similarity=-0.139 Sum_probs=46.5
Q ss_pred CCCCccccCCCccchhhhhh-------hhhhhhhhhhhccCCCCCCCccchhhhhhhccc
Q 009364 369 SPGSVDICNLDSLSCSRVIV-------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRK 421 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~-------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~ 421 (536)
.|..+|.+++|.|+..||.. .+.+++..++..+| .|++|.|+|+||+.++..
T Consensus 131 ~F~~~D~d~~G~Is~~El~~~l~~g~~~~~~~~~~l~~~~D-~d~dG~I~~~EF~~~l~~ 189 (196)
T 3dtp_E 131 AFNLFDEGDGKCKEETLKRSLTTWGEKFSQDEVDQALSEAP-IDGNGLIDIKKFAQILTK 189 (196)
T ss_dssp HHHTTCSSSSCCBHHHHHHHHHHSSSCCCHHHHHHHHHSSC-EETTEECHHHHHHHHHSS
T ss_pred HHHHHCCCCCCcCcHHHHHHHHHcCCCCCHHHHHHHHHHcC-CCCCCEEeHHHHHHHHHc
Confidence 48999999999999999975 46789999999999 899999999999976654
|
| >1nya_A Calerythrin; EF-hand, metal binding protein; NMR {Saccharopolyspora erythraea} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=96.52 E-value=0.00046 Score=61.91 Aligned_cols=70 Identities=9% Similarity=-0.126 Sum_probs=51.7
Q ss_pred CCCCCccccCCCccchhhhhh------------hhhhhhh-----------hhhhccCCCCCCCccchhhhhhhcccccc
Q 009364 368 GSPGSVDICNLDSLSCSRVIV------------EKLSGSM-----------HGWVTSNSNDDLCQLDQEDFVAGDRKLSS 424 (536)
Q Consensus 368 ~sf~~~D~~~~g~ls~~el~~------------~~~~ei~-----------~l~~~~d~~d~~g~Id~~EF~~~~~~~~~ 424 (536)
..|..+|.+++|.|+.+|+.. ++.+++. .+++.+| .|++|.|+|+||+.++.....
T Consensus 11 ~~F~~~D~d~~G~i~~~el~~~~~~~l~~~g~~~~~~~~~~l~~~~~~~~~~lf~~~D-~d~dg~i~~~Ef~~~~~~~~~ 89 (176)
T 1nya_A 11 KRFDRWDFDGNGALERADFEKEAQHIAEAFGKDAGAAEVQTLKNAFGGLFDYLAKEAG-VGSDGSLTEEQFIRVTENLIF 89 (176)
T ss_dssp HHHHHCCSSCCSSBCSHHHHHHHHHHHHHTSSCSSSHHHHHHHHHHHHHHHHHHHHHT-SCTTCCBCHHHHHHHHHHHHS
T ss_pred HHHHHHcCCCCCcccHHHHHHHHHHHHHHcCCCCCcHHHHHHHHHHHHHHHHHHHHhC-CCCCCeEcHHHHHHHHHHHhc
Confidence 348899999999999999974 3455665 7889999 899999999999976554322
Q ss_pred cCC--------hhhhhhccCCC
Q 009364 425 ILA--------PNDLEKSRNPM 438 (536)
Q Consensus 425 ~~~--------~e~l~~aF~~~ 438 (536)
... .+.++.+|+..
T Consensus 90 ~~~~~~~~~~~~~~~~~~F~~~ 111 (176)
T 1nya_A 90 EQGEASFNRVLGPVVKGIVGMC 111 (176)
T ss_dssp SSCHHHHHHHHHHHHHHHHHHT
T ss_pred CCchhhHHHHHHHHHHHHHHHh
Confidence 222 24466666543
|
| >2hpk_A Photoprotein berovin; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics, secsg; 2.00A {Beroe abyssicola} | Back alignment and structure |
|---|
Probab=96.50 E-value=0.00062 Score=63.34 Aligned_cols=51 Identities=10% Similarity=0.041 Sum_probs=45.7
Q ss_pred CCCCccccCCCccchhhhhh------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 369 SPGSVDICNLDSLSCSRVIV------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
.|..+|.+++|.|+.+|+.. .+.++++.++..+| .|++|.|+|+||+.++.
T Consensus 133 ~F~~~D~d~~G~Is~~El~~~l~~~g~~~~~~~~~~~~~D-~d~dG~I~~~EF~~~~~ 189 (208)
T 2hpk_A 133 YYDVLDDDGDGTVDVDELKTMMKAFDVPQEAAYTFFEKAD-TDKSGKLERTELVHLFR 189 (208)
T ss_dssp HHHHHCTTCSSSBCHHHHHHHHHHTTSCTTHHHHHHHHHC-TTCCSSBCHHHHHHHHH
T ss_pred HHHHhCCCCCCcCCHHHHHHHHHHhCcCHHHHHHHHHHhC-CCCCCcCcHHHHHHHHH
Confidence 48999999999999999976 36789999999999 89999999999997554
|
| >1wdc_B Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Y 1kqm_B* 1kwo_B* 1l2o_B* 1qvi_Y* 1s5g_Y* 1sr6_B 1b7t_Y 3jtd_B 3jvt_B 1scm_B 1kk8_B* 1dfk_Y 1dfl_Y* 2w4t_Y 2w4v_Y 2w4w_Y 2otg_B* 2os8_B* 3pn7_B ... | Back alignment and structure |
|---|
Probab=96.50 E-value=0.00054 Score=60.39 Aligned_cols=51 Identities=10% Similarity=-0.059 Sum_probs=45.3
Q ss_pred CCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhccc
Q 009364 369 SPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRK 421 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~ 421 (536)
.|..+|.+++|.|+.+|+.. .+.++++.+++.+| .| +|.|+|+||+.++..
T Consensus 92 ~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d-~~-dg~i~~~eF~~~~~~ 150 (156)
T 1wdc_B 92 AFAMFDEQETKKLNIEYIKDLLENMGDNFNKDEMRMTFKEAP-VE-GGKFDYVKFTAMIKG 150 (156)
T ss_dssp HHHTTCTTCCSCEEHHHHHHHHHHSSSCCCHHHHHHHHHHCC-EE-TTEECHHHHHHHHHT
T ss_pred HHHHHCcCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHhcC-CC-CCEEeHHHHHHHHhc
Confidence 48999999999999999976 46889999999999 78 999999999976554
|
| >3akb_A Putative calcium binding protein; EF-hand, metal binding protein; 1.50A {Streptomyces coelicolor} PDB: 3aka_A | Back alignment and structure |
|---|
Probab=96.50 E-value=0.00063 Score=60.25 Aligned_cols=51 Identities=8% Similarity=0.006 Sum_probs=45.4
Q ss_pred CCCCccccCCCccchhhhhh------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 369 SPGSVDICNLDSLSCSRVIV------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
.|..+|.+++|.|+.+|+.. .+.++++.+++.+| .|++|.|+|+||+.++.
T Consensus 103 ~F~~~D~d~~G~i~~~E~~~~l~~~~~~~~~~~~~~~~~D-~d~dg~i~~~ef~~~~~ 159 (166)
T 3akb_A 103 ALGVADTDGDGAVTVADTARALTAFGVPEDLARQAAAALD-TDGDGKVGETEIVPAFA 159 (166)
T ss_dssp HHHHHCSSSSSCCBHHHHHHHHHHTTCCHHHHHHHHHHHC-TTCSSBCCHHHHHHHHH
T ss_pred HHHHhCCCCCCcCCHHHHHHHHHHhCCCHHHHHHHHHHhC-CCCCCcCcHHHHHHHHH
Confidence 48899999999999999976 36789999999999 89999999999996543
|
| >2ct9_A Calcium-binding protein P22; EF-hand, metal binding protein; 2.20A {Rattus norvegicus} PDB: 2e30_A | Back alignment and structure |
|---|
Probab=96.47 E-value=0.00063 Score=63.42 Aligned_cols=52 Identities=13% Similarity=-0.004 Sum_probs=44.9
Q ss_pred CCCCccccCCCccchhhhhh---------hhhhhhhhh----hhccCCCCCCCccchhhhhhhccc
Q 009364 369 SPGSVDICNLDSLSCSRVIV---------EKLSGSMHG----WVTSNSNDDLCQLDQEDFVAGDRK 421 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~---------~~~~ei~~l----~~~~d~~d~~g~Id~~EF~~~~~~ 421 (536)
.|..+|.+++|.|+.+|+.. .+.++++.+ ++.+| .|++|.|+|+||+.++..
T Consensus 118 ~F~~~D~d~dG~Is~~El~~~l~~~~g~~~s~~~~~~l~~~~~~~~D-~d~dG~Is~~EF~~~~~~ 182 (208)
T 2ct9_A 118 AFRLYDLDKDDKISRDELLQVLRMMVGVNISDEQLGSIADRTIQEAD-QDGDSAISFTEFVKVLEK 182 (208)
T ss_dssp HHHHHCTTCSSEECHHHHHHHHHHHSCTTCCHHHHHHHHHHHHHHHC-SSSSSSEEHHHHHHTTTT
T ss_pred HHHHHCCCCCCEEcHHHHHHHHHHHhCCCCCHHHHHHHHHHHHHHhC-CCCCCcCcHHHHHHHHhc
Confidence 48999999999999999975 356778777 99999 899999999999976654
|
| >2ccm_A Calexcitin; EF hand, calcium, signaling protein; 1.8A {Loligo pealeii} | Back alignment and structure |
|---|
Probab=96.47 E-value=0.00066 Score=62.02 Aligned_cols=51 Identities=10% Similarity=-0.096 Sum_probs=45.5
Q ss_pred CCCCccccCCCccchhhhhh------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 369 SPGSVDICNLDSLSCSRVIV------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
.|..+|.+++|.|+.+|+.. .+.++++.+++.+| .|++|.|+|+||+.++.
T Consensus 114 ~F~~~D~d~dG~I~~~E~~~~l~~~g~~~~~~~~~~~~~D-~d~dG~i~~~Ef~~~~~ 170 (191)
T 2ccm_A 114 MFDVNDTSGDNIIDKHEYSTVYMSYGIPKSDCDAAFDTLS-DGGKTMVTREIFARLWT 170 (191)
T ss_dssp HHHHHCTTCSSBCCHHHHHHHHHTTTCCHHHHHHHHHHHT-TTTTSCCBHHHHHHHHH
T ss_pred HHHHhCCCCCCcCcHHHHHHHHHHhCCCHHHHHHHHHHhC-CCCCCCcCHHHHHHHHH
Confidence 48999999999999999986 36789999999999 89999999999996554
|
| >3ll8_B Calcineurin subunit B type 1; protein-peptide docking, protein targeting, AKA beta-augmentation, calmodulin-binding, membrane, hydrolase; 2.00A {Homo sapiens} PDB: 1mf8_B* 2p6b_B 1aui_B 1m63_B* 1tco_B* | Back alignment and structure |
|---|
Probab=96.46 E-value=0.00076 Score=59.04 Aligned_cols=52 Identities=13% Similarity=-0.027 Sum_probs=45.0
Q ss_pred CCCCccccCCCccchhhhhh---------hhhhhhhhhhhc----cCCCCCCCccchhhhhhhccc
Q 009364 369 SPGSVDICNLDSLSCSRVIV---------EKLSGSMHGWVT----SNSNDDLCQLDQEDFVAGDRK 421 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~---------~~~~ei~~l~~~----~d~~d~~g~Id~~EF~~~~~~ 421 (536)
.|..+|.+++|.|+.+|+.. .+.++++.+++. .| .|++|.|+|+||+.++..
T Consensus 80 ~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~~~~~~D-~~~dg~i~~~eF~~~~~~ 144 (155)
T 3ll8_B 80 AFRIYDMDKDGYISNGELFQVLKMMVGNNLKDTQLQQIVDKTIINAD-KDGDGRISFEEFCAVVGG 144 (155)
T ss_dssp HHHHHCTTCSSCBCHHHHHHHHHHHHGGGSCHHHHHHHHHHHHHHHC-TTSSSSBCHHHHHHHHGG
T ss_pred HHHHhCCCCCCcCcHHHHHHHHHHHhccCCCHHHHHHHHHHHHHHhC-CCCCCcCcHHHHHHHHhc
Confidence 48899999999999999865 357788888888 99 899999999999976654
|
| >3k21_A PFCDPK3, calcium-dependent protein kinase 3; calcium kinase structural genomics malaria, structural genom consortium, SGC, ATP-binding; 1.15A {Plasmodium falciparum} PDB: 3o4y_A | Back alignment and structure |
|---|
Probab=96.46 E-value=0.00076 Score=62.18 Aligned_cols=50 Identities=8% Similarity=0.028 Sum_probs=43.2
Q ss_pred CCCCccccCCCccchhhhhhh----------h---hhhhhhhhhccCCCCCCCccchhhhhhhc
Q 009364 369 SPGSVDICNLDSLSCSRVIVE----------K---LSGSMHGWVTSNSNDDLCQLDQEDFVAGD 419 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~~----------~---~~ei~~l~~~~d~~d~~g~Id~~EF~~~~ 419 (536)
.|..+|.+++|.|+.+|+... + .+++..+++..| .|++|.|+|+||+.++
T Consensus 127 ~F~~~D~d~~G~Is~~El~~~l~~~~~~~~l~~~~~~~~~~~~~~~D-~d~dG~Is~~EF~~~~ 189 (191)
T 3k21_A 127 AFRVFDVDNDGEITTAELAHILYNGNKKGNITQRDVNRVKRMIRDVD-KNNDGKIDFHEFSEMM 189 (191)
T ss_dssp HHHHHSTTCSSCBCHHHHHHHHHHSSSCSCCCHHHHHHHHHHHHHHC-SSSSSSBCHHHHHHHH
T ss_pred HHHHhCCCCCCcCCHHHHHHHHHhcCCCCCCCHhHHHHHHHHHHHhc-CCCCCeECHHHHHHHH
Confidence 489999999999999999761 1 247999999999 8999999999999654
|
| >1gjy_A Sorcin, CP-22, V19; calcium binding, calcium-binding, phosphorylation; 2.2A {Chinese hamster} SCOP: a.39.1.8 | Back alignment and structure |
|---|
Probab=96.45 E-value=0.00043 Score=62.07 Aligned_cols=50 Identities=6% Similarity=-0.187 Sum_probs=42.9
Q ss_pred CCCccccCCCccchhhhhh-------------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 370 PGSVDICNLDSLSCSRVIV-------------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 370 f~~~D~~~~g~ls~~el~~-------------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
|..+|.+++|.|+.+|+.. .+.++++.+++..| .|++|.|+|+||+.++.
T Consensus 7 F~~~D~d~~G~i~~~el~~~l~~lg~~~~~~~~~~~~~~~l~~~~D-~~~~g~i~~~eF~~~~~ 69 (167)
T 1gjy_A 7 YFASVAGQDGQIDADELQRCLTQSGIAGGYKPFNLETCRLMVSMLD-RDMSGTMGFNEFKELWA 69 (167)
T ss_dssp HHHHHCCTTSCBCHHHHHHHHHHHTCSTTSCCCCHHHHHHHHHHHC-TTCCSCBCHHHHHHHHH
T ss_pred HHHHHcCCCCcCCHHHHHHHHHhhcccCCCCCcCHHHHHHHHHHHC-CCCCCcCCHHHHHHHHH
Confidence 7788999999999999975 25678999999999 89999999999996554
|
| >1k94_A Grancalcin; penta-EF-hand protein, calcium binding protein, metal binding protein; 1.70A {Homo sapiens} SCOP: a.39.1.8 PDB: 1k95_A 1f4q_A 1f4o_A | Back alignment and structure |
|---|
Probab=96.44 E-value=0.00033 Score=62.63 Aligned_cols=50 Identities=8% Similarity=-0.157 Sum_probs=41.1
Q ss_pred CCCccccCCCccchhhhhh-------------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 370 PGSVDICNLDSLSCSRVIV-------------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 370 f~~~D~~~~g~ls~~el~~-------------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
|..+|.+++|.|+.+|+.. ++.++++.+++..| .|++|.|+|+||+.++.
T Consensus 5 F~~~D~d~~G~i~~~el~~~l~~lg~~~~~~~~~~~~~~~l~~~~D-~~~~g~i~~~eF~~~~~ 67 (165)
T 1k94_A 5 YFSAVAGQDGEVDAEELQRCLTQSGINGTYSPFSLETCRIMIAMLD-RDHTGKMGFNAFKELWA 67 (165)
T ss_dssp HHHHHHGGGTSBCHHHHHHHHHHHTTTTTSCCCCHHHHHHHHHHHC-TTCSSCBCHHHHHHHHH
T ss_pred HHHHhCCCCCcCCHHHHHHHHHHhccccCCCCCCHHHHHHHHHHhC-CCCCCcCCHHHHHHHHH
Confidence 6678899999999999865 15678899999999 88999999999986543
|
| >2i7a_A Calpain 13; calcium-dependent cytoplasmic cysteine proteinases, like, EF-hand, structural genomics, structural genomics CON SGC, hydrolase; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.43 E-value=0.00038 Score=63.62 Aligned_cols=61 Identities=11% Similarity=-0.038 Sum_probs=49.3
Q ss_pred CCCCccccCCCccchhhhhh------------hhhhhhhhhhhccCCCCCCCccchhhhhhhcccccccCChhhhhhccC
Q 009364 369 SPGSVDICNLDSLSCSRVIV------------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSSILAPNDLEKSRN 436 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~------------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~~~~~e~l~~aF~ 436 (536)
+|..|| +++|.|+..||.. .+.++++.+++..| |++|.|+|+||+.++... +.+.++|+
T Consensus 81 aF~~fD-d~~G~I~~~El~~~l~~l~~~~G~~~~~~~~~~l~~~~d--d~dG~I~~~EF~~~~~~~------~~~~~~F~ 151 (174)
T 2i7a_A 81 VFQKVQ-TSPGVLLSSDLWKAIENTDFLRGIFISRELLHLVTLRYS--DSVGRVSFPSLVCFLMRL------EAMAKTFR 151 (174)
T ss_dssp HHHHHC-SBTTBEEGGGHHHHHHTCGGGTTCCCCHHHHHHHHHHHS--CTTSEECHHHHHHHHHHH------HHHHHHHH
T ss_pred HHHHhc-CCCCcCCHHHHHHHHHHhHhccCCCCCHHHHHHHHHHHc--CCCCeEcHHHHHHHHHHH------HHHHHHHH
Confidence 499999 9999999999975 25678999999998 689999999999766532 45777775
Q ss_pred CC
Q 009364 437 PM 438 (536)
Q Consensus 437 ~~ 438 (536)
.+
T Consensus 152 ~~ 153 (174)
T 2i7a_A 152 NL 153 (174)
T ss_dssp HH
T ss_pred Hh
Confidence 44
|
| >1s6c_A KV4 potassium channel-interacting protein kchip1B; EF-hand, transport protein; 2.00A {Rattus norvegicus} SCOP: a.39.1.5 PDB: 2nz0_A 2i2r_E | Back alignment and structure |
|---|
Probab=96.43 E-value=0.00027 Score=64.19 Aligned_cols=67 Identities=10% Similarity=-0.062 Sum_probs=45.1
Q ss_pred CCCccc-cCCCccchhhhhh---------hhhhhhhhhhhccCCCCCCCccchhhhhhhcccccccCChhhhhhccCC
Q 009364 370 PGSVDI-CNLDSLSCSRVIV---------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSSILAPNDLEKSRNP 437 (536)
Q Consensus 370 f~~~D~-~~~g~ls~~el~~---------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~~~~~e~l~~aF~~ 437 (536)
+..||. +++|.|+..|+.. .+..++..+++.+| .|++|.|+|+||+.++.........+.++.+|+-
T Consensus 24 ~~~fd~~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~f~~~D-~d~~g~i~~~Ef~~~~~~~~~~~~~~~~~~~f~~ 100 (183)
T 1s6c_A 24 YRGFKNEXPSGVVNEETFKQIYAQFFPHGDASTYAHYLFNAFD-TTQTGSVKFEDFVTALSILLRGTVHEKLRWTFNL 100 (183)
T ss_dssp HHHHHHHCTTSEECHHHHHHHHHHHSTTSCCHHHHHHHHHHHC-TTCSSCEEHHHHHHHHHHHHHCCHHHHHHHHHHH
T ss_pred HHHHHHhCCCCcCCHHHHHHHHHHHcCCCChHHHHHHHHHHhC-CCCCCcEeHHHHHHHHHHHcCCCHHHHHHHHHHH
Confidence 444555 6778888888765 24567788888888 7888888888888665543333344566666653
|
| >2hpk_A Photoprotein berovin; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics, secsg; 2.00A {Beroe abyssicola} | Back alignment and structure |
|---|
Probab=96.42 E-value=0.00018 Score=67.01 Aligned_cols=54 Identities=13% Similarity=0.087 Sum_probs=46.2
Q ss_pred CCCCCCCccccCCCccchhhhhh----------hhhhhhhhhh-------hccCCCCCCCccchhhhhhhcc
Q 009364 366 SPGSPGSVDICNLDSLSCSRVIV----------EKLSGSMHGW-------VTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 366 ~~~sf~~~D~~~~g~ls~~el~~----------~~~~ei~~l~-------~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
....|..+|.+++|.|+.+|+.. ++.+++..++ +.+| .|++|.|+|+||+.++.
T Consensus 38 l~~~F~~~D~d~~G~i~~~El~~~l~~~~~~~~~~~~~~~~l~~~~~~lf~~~D-~d~dg~i~~~EF~~~~~ 108 (208)
T 2hpk_A 38 LYKRFDTFDLDSDGKMEMDEVLYWPDRMRQLVNATDEQVEKMRDAVRVFFLHKG-VEPVNGLLREDWVEANR 108 (208)
T ss_dssp HHHHHHHHCTTCSSEECHHHHTHHHHHHHHHSCCCHHHHHHHHHHHHHHHHHTT-CBTTTBEEGGGHHHHHH
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHHhhcCCCHHHHHHHHHHHHHHHHHhC-CCCCCeEcHHHHHHHHH
Confidence 34459999999999999999965 3467899999 9999 89999999999997654
|
| >2bl0_B Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} | Back alignment and structure |
|---|
Probab=96.40 E-value=0.00047 Score=59.66 Aligned_cols=66 Identities=11% Similarity=-0.077 Sum_probs=50.1
Q ss_pred CCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcccc--cccCChhhhhhccCCC
Q 009364 369 SPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKL--SSILAPNDLEKSRNPM 438 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~--~~~~~~e~l~~aF~~~ 438 (536)
.|..+|.+++|.|+.+|+.. ++.+++..++.. +++|.|+|+||+.++... ......+.++.+|+-.
T Consensus 10 ~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~----~~~g~i~~~eF~~~~~~~~~~~~~~~~~l~~~F~~~ 85 (145)
T 2bl0_B 10 CFQIFDKDNDGKVSIEELGSALRSLGKNPTNAELNTIKGQ----LNAKEFDLATFKTVYRKPIKTPTEQSKEMLDAFRAL 85 (145)
T ss_dssp HHHHHCTTCSSCEEGGGHHHHHHHTTCCCCHHHHHHHHHH----HTSSEECHHHHHHHHTSCCCCGGGGHHHHHHHHHHH
T ss_pred HHHHhCCCCcCccCHHHHHHHHHHhCCCCCHHHHHHHHHh----cCCCeEcHHHHHHHHHHHhhcCcccHHHHHHHHHHh
Confidence 48889999999999999975 467888888887 467899999999766554 2333455677777643
|
| >3khe_A Calmodulin-like domain protein kinase isoform 3; calcium dependent kinase, structural genomics, structural GE consortium, SGC, ATP-binding; 1.95A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=96.40 E-value=0.00066 Score=61.87 Aligned_cols=51 Identities=10% Similarity=-0.019 Sum_probs=45.3
Q ss_pred CCCCccccCCCccchhhhhh------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 369 SPGSVDICNLDSLSCSRVIV------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
.|..+|.+++|.|+.+|+.. .+.++++.+++..| .|++|.|+|+||+.++.
T Consensus 128 ~F~~~D~d~~G~I~~~E~~~~l~~~~~~~~~~~~~~~~~D-~~~dg~i~~~eF~~~~~ 184 (191)
T 3khe_A 128 AFQQFDSDGSGKITNEELGRLFGVTEVDDETWHQVLQECD-KNNDGEVDFEEFVEMMQ 184 (191)
T ss_dssp HHHHHCTTCSSEECHHHHHHHTTSSCCCHHHHHHHHHHHC-TTCSSSEEHHHHHHHHH
T ss_pred HHHHHCCCCcCcCCHHHHHHHHccCCCCHHHHHHHHHHhC-CCCCCCCCHHHHHHHHH
Confidence 48899999999999999987 46789999999999 89999999999997554
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.40 E-value=0.013 Score=59.24 Aligned_cols=31 Identities=29% Similarity=0.465 Sum_probs=27.3
Q ss_pred CCccccCCCCCcccCCCCcEEEEecCcchhh
Q 009364 191 GIMHRDIKGANILVDNKGCIKLADFGASKQV 221 (536)
Q Consensus 191 ~ivHrDLKp~NILl~~~~~vkL~DFGla~~~ 221 (536)
.++|+|+.+.||+++.++.+.|+||+.+..-
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 5899999999999998888999999876543
|
| >1juo_A Sorcin; calcium-binding proteins, penta-EF-hand, PEF, X-RAY, metal transport; 2.20A {Homo sapiens} SCOP: a.39.1.8 PDB: 2jc2_A | Back alignment and structure |
|---|
Probab=96.37 E-value=0.00029 Score=65.26 Aligned_cols=68 Identities=9% Similarity=-0.133 Sum_probs=52.8
Q ss_pred cccCCCCCCCccccCCCccchhhhhh-------------hhhhhhhhhhhccCCCCCCCccchhhhhhhcccccccCChh
Q 009364 363 MLTSPGSPGSVDICNLDSLSCSRVIV-------------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSSILAPN 429 (536)
Q Consensus 363 ~~t~~~sf~~~D~~~~g~ls~~el~~-------------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~~~~~e 429 (536)
...... |..+|.+++|.|+.+|+.. .+.++++.+++..| .|++|.|+|+||+.++... +
T Consensus 32 ~~~l~~-F~~~D~d~~G~i~~~el~~~l~~lg~~~~~~~~~~~~~~~l~~~~D-~d~~g~i~~~eF~~~~~~~------~ 103 (198)
T 1juo_A 32 QDPLYG-YFAAVAGQDGQIDADELQRCLTQSGIAGGYKPFNLETCRLMVSMLD-RDMSGTMGFNEFKELWAVL------N 103 (198)
T ss_dssp CCTTHH-HHHHHHTTTTEECHHHHHHHHHHHTTTCSSCCCCHHHHHHHHHHHC-TTCSSCEEHHHHHHHHHHH------H
T ss_pred cHHHHH-HHHHhCCCCCcCCHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhC-CCCCCeECHHHHHHHHHHH------H
Confidence 344455 8889999999999999975 15678999999999 8999999999999655431 4
Q ss_pred hhhhccCCC
Q 009364 430 DLEKSRNPM 438 (536)
Q Consensus 430 ~l~~aF~~~ 438 (536)
.++++|+-.
T Consensus 104 ~~~~~F~~~ 112 (198)
T 1juo_A 104 GWRQHFISF 112 (198)
T ss_dssp HHHHHHHTT
T ss_pred HHHHHHHHh
Confidence 566666543
|
| >3cs1_A Flagellar calcium-binding protein; myristoylated, palmitoylated, SEN membrane targeting, EF-hand, cell projection, cilium; 2.00A {Trypanosoma cruzi} | Back alignment and structure |
|---|
Probab=96.37 E-value=0.00071 Score=63.84 Aligned_cols=54 Identities=7% Similarity=-0.009 Sum_probs=46.7
Q ss_pred CCCCCCccccCCCccchhhhhh---------hhhhhhhhhhhccCCCCCCCccchhhhhhhccc
Q 009364 367 PGSPGSVDICNLDSLSCSRVIV---------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRK 421 (536)
Q Consensus 367 ~~sf~~~D~~~~g~ls~~el~~---------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~ 421 (536)
...|..+|.+++|.|+..||.. .+.++++.+++.+| .|++|.|+|+||+.++..
T Consensus 133 ~~~F~~~D~d~~G~Is~~El~~~l~~~g~~~~~~~e~~~l~~~~D-~d~dG~I~~~EF~~~~~~ 195 (219)
T 3cs1_A 133 TVMFDEIDASGNMLVDEEEFKRAVPKLEAWGAKVEDPAALFKELD-KNGTGSVTFDEFAAWASA 195 (219)
T ss_dssp HHHHHTTCSSSSSEEEHHHHHHHHHHHHHHTCCCSCHHHHHHHHC-TTSSSEEEHHHHHHHHHH
T ss_pred HHHHHHHCCCCCCcCcHHHHHHHHHHhcccCCCHHHHHHHHHHhC-CCCCCcEeHHHHHHHHHH
Confidence 3459999999999999999975 35678999999999 899999999999976553
|
| >1top_A Troponin C; contractIle system protein; 1.78A {Gallus gallus} SCOP: a.39.1.5 PDB: 1ncy_A 1ncz_A 1ncx_A 1ytz_C* 1yv0_C 1tnw_A 1tnx_A 5tnc_A 2w49_0 2w4u_0 4tnc_A 1a2x_A 1tcf_A 1tn4_A 2tn4_A 1aj4_A 1jc2_A 1fi5_A 1sbj_A 1scv_A ... | Back alignment and structure |
|---|
Probab=96.37 E-value=0.00042 Score=61.21 Aligned_cols=72 Identities=10% Similarity=-0.044 Sum_probs=54.6
Q ss_pred CCCCCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcccccc-cC---Chhhhhh
Q 009364 366 SPGSPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSS-IL---APNDLEK 433 (536)
Q Consensus 366 ~~~sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~-~~---~~e~l~~ 433 (536)
....|..+|.+++|.|+..|+.. ++.+++..+++..| .+++|.|+|+||+.++..... .. ..+.++.
T Consensus 22 l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~d-~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~~~ 100 (162)
T 1top_A 22 FKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVD-EDGSGTIDFEEFLVMMVRQMKEDAKGKSEEELAN 100 (162)
T ss_dssp HHHHHHTTTCSCSSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHC-TTSCCEEEHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHHc-CCCCCcEeHHHHHHHHHHHhccccccccHHHHHH
Confidence 34459999999999999999976 46789999999999 899999999999976543211 11 3345666
Q ss_pred ccCCC
Q 009364 434 SRNPM 438 (536)
Q Consensus 434 aF~~~ 438 (536)
+|+-.
T Consensus 101 ~F~~~ 105 (162)
T 1top_A 101 CFRIF 105 (162)
T ss_dssp HHHHH
T ss_pred HHHHh
Confidence 66543
|
| >1uhk_A Aequorin 2, aequorin; EF-hand motif, complex, luminescent protein; HET: CZN; 1.60A {Aequorea victoria} SCOP: a.39.1.5 PDB: 1ej3_A* 1uhi_A* 1uhj_A* 1uhh_A* 1sl8_A | Back alignment and structure |
|---|
Probab=96.37 E-value=0.00052 Score=62.50 Aligned_cols=53 Identities=9% Similarity=0.065 Sum_probs=44.8
Q ss_pred CCCCCccccCCCccchhhhh-----h--------hhhh-----hhhhhhhccCCCCCCCccchhhhhhhccc
Q 009364 368 GSPGSVDICNLDSLSCSRVI-----V--------EKLS-----GSMHGWVTSNSNDDLCQLDQEDFVAGDRK 421 (536)
Q Consensus 368 ~sf~~~D~~~~g~ls~~el~-----~--------~~~~-----ei~~l~~~~d~~d~~g~Id~~EF~~~~~~ 421 (536)
..|..+|.+++|.|+.+|+. . ++.. +++.+++.+| .|++|.|+|+||+.++..
T Consensus 20 ~~F~~~D~d~~G~i~~~El~~~~~~~~l~~~g~~~~~~~~~~~~~~~l~~~~D-~d~~g~i~~~EF~~~~~~ 90 (191)
T 1uhk_A 20 HMFNFLDVNHNGKISLDEMVYKASDIVINNLGATPEQAKRHKDAVEAFFGGAG-MKYGVETDWPAYIEGWKK 90 (191)
T ss_dssp HHHHHHCTTCCSEEEHHHHHHHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHTT-CCTTCEEEHHHHHHHHHH
T ss_pred HHHhhccCCCCCcCcHHHHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHHHhC-cCCCCcCcHHHHHHHHHH
Confidence 34899999999999999998 3 3444 6899999999 899999999999975543
|
| >3h4s_E KCBP interacting Ca2+-binding protein; kinesin, motor protein, regulation, complex, calcium, EF- hand, calmodulin, ATP-binding, microtubule; HET: ADP; 2.40A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=96.36 E-value=0.0015 Score=56.69 Aligned_cols=70 Identities=9% Similarity=0.005 Sum_probs=42.2
Q ss_pred CCCCCCccccCCCccchhhhhh---------hhhhhhhhhhhccCCCCCCCccchhhhhhhccccc-ccCChhhhhhccC
Q 009364 367 PGSPGSVDICNLDSLSCSRVIV---------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLS-SILAPNDLEKSRN 436 (536)
Q Consensus 367 ~~sf~~~D~~~~g~ls~~el~~---------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~-~~~~~e~l~~aF~ 436 (536)
...|..+|.+++|.|+..|+.. ...+++..+|+.+| .|++|.|+.+||..++.... ...+++++.+.|+
T Consensus 6 ~~l~~~~D~d~~G~I~~~EF~~~~~~~~~~~~~~~~l~~~F~~~D-~d~~G~I~~~el~~~l~~~g~~~~~~~e~~~~~~ 84 (135)
T 3h4s_E 6 KSMLLETTSTTKMETKYEDMLPVMAEKMDVEEFVSELCKGFSLLA-DPERHLITAESLRRNSGILGIEGMSKEDAQGMVR 84 (135)
T ss_dssp -------------CCCC-----------CHHHHHHHHHHHHHHHS-BTTTTBBCHHHHHHHGGGGTCCCCCHHHHHHHHH
T ss_pred HHHHHHHcCCCCCcEeHHHHHHHHHHHccccchHHHHHHHHHHHC-CCCCCcCCHHHHHHHHHHhCCCCCCHHHHHHHHH
Confidence 4568899999999999999865 24678999999999 89999999999998776655 3667777777665
Q ss_pred C
Q 009364 437 P 437 (536)
Q Consensus 437 ~ 437 (536)
.
T Consensus 85 ~ 85 (135)
T 3h4s_E 85 E 85 (135)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >2znd_A Programmed cell death protein 6; penta-EF-hand protein, calcium binding protein, apoptosis, calcium, endoplasmic reticulum, membrane, nucleus; 1.70A {Homo sapiens} PDB: 2zn9_A 2zn8_A 1hqv_A 3aak_A 2zne_A 2zrs_A 2zrt_A 3aaj_A | Back alignment and structure |
|---|
Probab=96.36 E-value=0.00047 Score=62.05 Aligned_cols=51 Identities=8% Similarity=-0.089 Sum_probs=44.2
Q ss_pred CCCCccccCCCccchhhhhh---------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 369 SPGSVDICNLDSLSCSRVIV---------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~---------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
.|..+|.+++|.|+.+|+.. .+.++++.+++..| .|++|.|+|+||+.++.
T Consensus 12 ~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~l~~~~D-~~~~g~i~~~ef~~~~~ 71 (172)
T 2znd_A 12 VFQRVDKDRSGVISDTELQQALSNGTWTPFNPVTVRSIISMFD-RENKAGVNFSEFTGVWK 71 (172)
T ss_dssp HHHHHCTTCSSCEEHHHHHHHCCCSSSSCCCHHHHHHHHHHHC-SSSSSEECHHHHHHHHH
T ss_pred HHHHhCCCCCCcCcHHHHHHHHHhcCCCCCCHHHHHHHHHHhC-CCCCCcCCHHHHHHHHH
Confidence 48889999999999999976 46788999999999 89999999999996543
|
| >1nya_A Calerythrin; EF-hand, metal binding protein; NMR {Saccharopolyspora erythraea} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=96.35 E-value=0.00085 Score=60.07 Aligned_cols=52 Identities=8% Similarity=0.118 Sum_probs=46.1
Q ss_pred CCCCccccCCCccchhhhhh------hhhhhhhhhhhccCCCCCCCccchhhhhhhccc
Q 009364 369 SPGSVDICNLDSLSCSRVIV------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRK 421 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~ 421 (536)
.|..+|.+++|.|+..|+.. .+.+++..+++.+| .|++|.|+|+||+.++..
T Consensus 107 ~F~~~D~d~~G~I~~~e~~~~l~~~g~~~~~~~~~~~~~D-~d~dg~i~~~ef~~~~~~ 164 (176)
T 1nya_A 107 IVGMCDKNADGQINADEFAAWLTALGMSKAEAAEAFNQVD-TNGNGELSLDELLTAVRD 164 (176)
T ss_dssp HHHHTCSSCCSEEEHHHHHHHHHHTTCCHHHHHHHHHHHC-TTCSSEEEHHHHHHHHSC
T ss_pred HHHHhcCCCCCCCCHHHHHHHHHHhCCCHHHHHHHHHHhC-CCCCCCCcHHHHHHHHHH
Confidence 48999999999999999976 36789999999999 899999999999976543
|
| >2bec_A Calcineurin B homologous protein 2; calcineurin-homologous protein, calcium-binding protein, NHE1 regulating protein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.35 E-value=0.0008 Score=62.27 Aligned_cols=52 Identities=10% Similarity=-0.060 Sum_probs=45.3
Q ss_pred CCCCccccCCCccchhhhhh---------hhhhhhhhhhhc----cCCCCCCCccchhhhhhhccc
Q 009364 369 SPGSVDICNLDSLSCSRVIV---------EKLSGSMHGWVT----SNSNDDLCQLDQEDFVAGDRK 421 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~---------~~~~ei~~l~~~----~d~~d~~g~Id~~EF~~~~~~ 421 (536)
.|..+|.+++|.|+.+|+.. .+.++++.+++. +| .|++|.|+|+||+.++..
T Consensus 119 ~F~~~D~d~dG~Is~~El~~~l~~~~g~~~~~~~~~~~~~~~~~~~D-~d~dG~Is~~EF~~~~~~ 183 (202)
T 2bec_A 119 AFQLYDLDRDGKISRHEMLQVLRLMVGVQVTEEQLENIADRTVQEAD-EDGDGAVSFVEFTKSLEK 183 (202)
T ss_dssp HHHHHCTTCSSEECHHHHHHHHHHSCCSCCCHHHHHHHHHHHHHHHC-SSCSSSEEHHHHHHTTTT
T ss_pred HHHHhCCCCCCeEcHHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHcC-CCCCCcCcHHHHHHHHHH
Confidence 58999999999999999975 357788888888 99 899999999999976554
|
| >2r2i_A Guanylyl cyclase-activating protein 1; EF hand, GCAP, guanylate cyclase activating protein, GCAP1, GCAP-1, calcium, lipoprotein, myristate; HET: MYR; 2.00A {Gallus gallus} | Back alignment and structure |
|---|
Probab=96.34 E-value=0.00039 Score=64.21 Aligned_cols=68 Identities=9% Similarity=-0.173 Sum_probs=50.4
Q ss_pred CCCCcccc-CCCccchhhhhh--------hh-hhhhhhhhhccCCCCCCCccchhhhhhhcccccccCChhhhhhccCC
Q 009364 369 SPGSVDIC-NLDSLSCSRVIV--------EK-LSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSSILAPNDLEKSRNP 437 (536)
Q Consensus 369 sf~~~D~~-~~g~ls~~el~~--------~~-~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~~~~~e~l~~aF~~ 437 (536)
.|..||.+ ++|.|+..|+.. ++ .++++.+++.+| .|++|.|+|+||+.++.........+.++.+|+-
T Consensus 19 ~f~~fd~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~f~~~D-~d~~G~I~~~Ef~~~~~~~~~~~~~~~~~~~F~~ 96 (198)
T 2r2i_A 19 WYKKFMTECPSGQLTLYEFKQFFGLKNLSPSANKYVEQMFETFD-FNKDGYIDFMEYVAALSLVLKGKVDQKLRWYFKL 96 (198)
T ss_dssp HHHHHHHHCTTSEECHHHHHHHHTCCSCCHHHHHHHHHHHHHHC-TTCSSCEEHHHHHHHHHHHSSCCHHHHHHHHHHH
T ss_pred HHHHHHHhCCCCcCCHHHHHHHHHHhCCCcchHHHHHHHHHHHC-CCCCCeEcHHHHHHHHHHHccCchHHHHHHHHHH
Confidence 47788887 799999999876 22 356889999999 8999999999998766544333345567776653
|
| >4ds7_A Calmodulin, CAM; protein binding, metal binding, structura; 2.15A {Kluyveromyces lactis} PDB: 1lkj_A 2lhh_A 1f54_A 1f55_A | Back alignment and structure |
|---|
Probab=96.34 E-value=0.00082 Score=58.15 Aligned_cols=49 Identities=10% Similarity=-0.082 Sum_probs=42.9
Q ss_pred CCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhc
Q 009364 369 SPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGD 419 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~ 419 (536)
.|..+|.+++|.|+.+|+.. .+.++++.+++.+| |++|.|+|+||+.++
T Consensus 89 ~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~d--~~dg~i~~~eF~~~l 145 (147)
T 4ds7_A 89 AFKVFDKNGDGLISAAELKHVLTSIGEKLTDAEVDEMLREVS--DGSGEINIKQFAALL 145 (147)
T ss_dssp HHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHS--SSCSSEEHHHHHHHT
T ss_pred HHHHhCCCCCCeECHHHHHHHHHHcCCCCCHHHHHHHHHHhc--CCCCcCcHHHHHHHH
Confidence 48899999999999999976 46789999999998 788999999999654
|
| >2sas_A Sarcoplasmic calcium-binding protein; 2.40A {Branchiostoma lanceolatum} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=96.33 E-value=0.00065 Score=61.34 Aligned_cols=51 Identities=4% Similarity=-0.083 Sum_probs=45.5
Q ss_pred CCCCccccCCCccchhhhhh------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 369 SPGSVDICNLDSLSCSRVIV------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
.|..+|.+++|.|+.+|+.. .+.+++..+++.+| .|++|.|+|+||+.++.
T Consensus 110 ~F~~~D~d~dG~Is~~E~~~~l~~~g~~~~~~~~~~~~~D-~d~dG~i~~~ef~~~~~ 166 (185)
T 2sas_A 110 LFKGMDVSGDGIVDLEEFQNYCKNFQLQCADVPAVYNVIT-DGGKVTFDLNRYKELYY 166 (185)
T ss_dssp HHHHHCTTSSSCCCHHHHHHHTTSSCCCCSSHHHHHHHHH-TTTTSCCSHHHHHHHHH
T ss_pred HHHHHcCCCCCeEcHHHHHHHHHHhCCCHHHHHHHHHHhc-CCCCCcCcHHHHHHHHH
Confidence 48899999999999999987 35789999999999 89999999999996554
|
| >2qac_A Myosin A tail domain interacting protein MTIP; malaria invasion, structural genomics, PSI, protein structur initiative, structural genomics of pathogenic protozoa CONS SGPP; 1.70A {Plasmodium falciparum} PDB: 2auc_A | Back alignment and structure |
|---|
Probab=96.30 E-value=0.00096 Score=58.05 Aligned_cols=48 Identities=10% Similarity=-0.079 Sum_probs=42.2
Q ss_pred CCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhc
Q 009364 369 SPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGD 419 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~ 419 (536)
.|..+|.+++|.|+.+|+.. .+.++++.+++.+ |++|.|+|+||+.++
T Consensus 89 ~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~---d~dg~i~~~eF~~~l 144 (146)
T 2qac_A 89 MFAHFDNNCTGYLTKSQMKNILTTWGDALTDQEAIDALNAF---SSEDNIDYKLFCEDI 144 (146)
T ss_dssp HHHTTCTTCSSEEEHHHHHHHHHHSSSCCCHHHHHHHHHHH---CSSSEEEHHHHHHHH
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHhCCCCCHHHHHHHHHHc---CCCCcCcHHHHHHHH
Confidence 48899999999999999976 4678999999988 678999999999754
|
| >3mse_B Calcium-dependent protein kinase, putative; CDPKS, malaria, structural genomics consortium, SGC, transfe; 2.10A {Plasmodium falciparum} | Back alignment and structure |
|---|
Probab=96.28 E-value=0.00076 Score=61.37 Aligned_cols=51 Identities=8% Similarity=-0.031 Sum_probs=43.2
Q ss_pred CCCCccccCCCccchhhhhh------hhhhhhhhhhhccCCCCCC--------Cccchhhhhhhcc
Q 009364 369 SPGSVDICNLDSLSCSRVIV------EKLSGSMHGWVTSNSNDDL--------CQLDQEDFVAGDR 420 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~------~~~~ei~~l~~~~d~~d~~--------g~Id~~EF~~~~~ 420 (536)
.|..+|.+++|.|+.+|+.. .+.++++.+++.+| .|++ |.|+|+||+.++.
T Consensus 113 ~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~~~~~d-~~~d~~~~~~~~G~i~~~eF~~~l~ 177 (180)
T 3mse_B 113 AFNKIDKDEDGYISKSDIVSLVHDKVLDNNDIDNFFLSVH-SIKKGIPREHIINKISFQEFKDYML 177 (180)
T ss_dssp HHHHHCTTCSSCBCHHHHHHHTTTSSCCHHHHHHHHHHHH-TC---------CCCBCHHHHHHHHH
T ss_pred HHHHHCCCCCCCCCHHHHHHHHcCCCCCHHHHHHHHHHhh-hccCcccccccCCeeeHHHHHHHHH
Confidence 48889999999999999986 47889999999999 7777 9999999996543
|
| >3a4u_B Multiple coagulation factor deficiency protein 2; lectin, ergic, ER, golgi, transport, disulfide bond, endopla reticulum, ER-golgi transport; 1.84A {Homo sapiens} PDB: 2vrg_A 3lcp_C | Back alignment and structure |
|---|
Probab=96.27 E-value=0.00097 Score=58.70 Aligned_cols=49 Identities=8% Similarity=-0.045 Sum_probs=40.5
Q ss_pred CCCCccccCCCccchhhhhh----------------hhhhhhhhhh----hccCCCCCCCccchhhhhhh
Q 009364 369 SPGSVDICNLDSLSCSRVIV----------------EKLSGSMHGW----VTSNSNDDLCQLDQEDFVAG 418 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~----------------~~~~ei~~l~----~~~d~~d~~g~Id~~EF~~~ 418 (536)
.|..+|.+++|.|+.+|+.. .+.+++..++ +..| .|++|.|+|+||+.+
T Consensus 73 ~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~g~~~s~~e~~~~~~~~f~~~D-~d~dG~Is~~EF~~~ 141 (143)
T 3a4u_B 73 YFKMHDYDGNNLLDGLELSTAITHVHKEEGSEQAPLMSEDELINIIDGVLRDDD-KNNDGYIDYAEFAKS 141 (143)
T ss_dssp HHHHTCTTCSSCEEHHHHHHTCC-------------CCHHHHHHHHHHHHHHHC-TTCSSEECHHHHHC-
T ss_pred HHHHhCCCCCCccCHHHHHHHHHHHHhhhccccCCCCCHHHHHHHHHHHHHHcC-CCCCCcEeHHHHHHH
Confidence 38999999999999999975 2356776665 8899 899999999999864
|
| >1qv0_A Obelin, OBL; photoprotein, bioluminescence, atomic resolution, Ca binding, EF-hand, luminescent protein; HET: CZH; 1.10A {Obelia longissima} SCOP: a.39.1.5 PDB: 1qv1_A* 1sl9_A* 1el4_A* 2f8p_A* 1sl7_A 1jf2_A* 1s36_A* 1jf0_A* 3kpx_A* | Back alignment and structure |
|---|
Probab=96.27 E-value=0.00075 Score=61.70 Aligned_cols=53 Identities=8% Similarity=0.010 Sum_probs=44.4
Q ss_pred CCCCCccccCCCccchhhhh-----h--------hhhh-----hhhhhhhccCCCCCCCccchhhhhhhccc
Q 009364 368 GSPGSVDICNLDSLSCSRVI-----V--------EKLS-----GSMHGWVTSNSNDDLCQLDQEDFVAGDRK 421 (536)
Q Consensus 368 ~sf~~~D~~~~g~ls~~el~-----~--------~~~~-----ei~~l~~~~d~~d~~g~Id~~EF~~~~~~ 421 (536)
..|..+|.+++|.|+.+|+. . ++.. +++.+++..| .|++|.|+|+||+.++..
T Consensus 24 ~~F~~~D~d~~G~i~~~El~~~~~~~~l~~~g~~~~~~~~~~~~~~~l~~~~D-~d~~g~i~~~EF~~~~~~ 94 (195)
T 1qv0_A 24 HMFDFLDINGNGKITLDEIVSKASDDICAKLEATPEQTKRHQVCVEAFFRGCG-MEYGKEIAFPQFLDGWKQ 94 (195)
T ss_dssp HHHHHHCTTCSSCBCHHHHHHHHHHTHHHHTTCCHHHHHHHHHHHHHHHHHTT-CCTTCCBCHHHHHHHHHH
T ss_pred HHHhHcCCCCCCcCcHHHHHHHHHHHHHHHcCCCccHHHHHHHHHHHHHHHcC-CCCCceEcHHHHHHHHHH
Confidence 34899999999999999998 3 2333 6899999999 899999999999975543
|
| >2aao_A CDPK, calcium-dependent protein kinase, isoform AK1; calmodulin-like domain, EF calcium binding protein, transferase; 2.00A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=96.25 E-value=0.00086 Score=59.57 Aligned_cols=51 Identities=12% Similarity=-0.031 Sum_probs=40.9
Q ss_pred CCCCccccCCCccchhhhhh------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 369 SPGSVDICNLDSLSCSRVIV------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
.|..+|.+++|.|+.+|+.. .+.++++.+++..| .|++|.|+|+||+.++.
T Consensus 104 ~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~d-~~~dg~i~~~eF~~~~~ 160 (166)
T 2aao_A 104 AFTYFDKDGSGYITPDELQQACEEFGVEDVRIEELMRDVD-QDNDGRIDYNEFVAMMQ 160 (166)
T ss_dssp HHHHHCTTCSSSBCHHHHHHHTCC--------CCHHHHHC-TTCSSSBCHHHHHHHHC
T ss_pred HHHHhCCCCCCcCcHHHHHHHHHHcCCCHHHHHHHHHHhC-CCCCCcEeHHHHHHHHH
Confidence 48889999999999999986 46788999999999 89999999999997654
|
| >2lvv_A Flagellar calcium-binding protein TB-24; EF-hand, metal binding protein; NMR {Trypanosoma brucei brucei} | Back alignment and structure |
|---|
Probab=96.25 E-value=0.00073 Score=64.20 Aligned_cols=53 Identities=6% Similarity=-0.064 Sum_probs=45.9
Q ss_pred CCCCCccccCCCccchhhhhh---------hhhhhhhhhhhccCCCCCCCccchhhhhhhccc
Q 009364 368 GSPGSVDICNLDSLSCSRVIV---------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRK 421 (536)
Q Consensus 368 ~sf~~~D~~~~g~ls~~el~~---------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~ 421 (536)
..|..+|.+++|.|+..||.. .+.+++..+|+.+| .|++|.|+|+||+.++..
T Consensus 137 ~~F~~~D~d~dG~Is~~El~~~l~~~~~~g~~~~e~~~~~~~~D-~d~dG~Is~~EF~~~~~~ 198 (226)
T 2lvv_A 137 VMFDTMDKDGSLLLELQEFKEALPKLKEWGVDITDATTVFNEID-TNGSGVVTFDEFSCWAVT 198 (226)
T ss_dssp HHHHHHSCSSCCEECHHHHHHHHHHHHHHTCCCCSCHHHHHHHC-CSCSSCEEHHHHHHHHHH
T ss_pred HHHHHHcCCCCCeEcHHHHHHHHHHHhhcCCCHHHHHHHHHHhC-CCCCCcEeHHHHHHHHHh
Confidence 359999999999999999976 23467999999999 899999999999976654
|
| >3sg6_A Gcamp2, myosin light chain kinase, green fluorescent PROT calmodulin chimera; calcium sensor, fluorescent protein; HET: CRO; 1.70A {Gallus gallus} PDB: 3evu_A* 3ek4_A* 3ek7_A* 3evv_A* 3ek8_A* 3ekh_A* 3sg2_A* 3sg3_A* 3sg7_A* 3ekj_A* 3sg4_A* 3sg5_A* 3evr_A* 3o78_A* 3o77_A* 1trf_A | Back alignment and structure |
|---|
Probab=96.24 E-value=0.00083 Score=70.54 Aligned_cols=71 Identities=6% Similarity=-0.035 Sum_probs=55.4
Q ss_pred CCCCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhccccc-ccCChhhhhhccCC
Q 009364 367 PGSPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLS-SILAPNDLEKSRNP 437 (536)
Q Consensus 367 ~~sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~-~~~~~e~l~~aF~~ 437 (536)
...|..+|.+++|.|+.+||.. .+.++++.+++.+| .|++|.|+|+||+.++.... .....+.++.+|+-
T Consensus 315 ~~~F~~fD~D~dG~Is~~EL~~~L~~lg~~~s~eel~~Lf~~~D-~DgdG~IsfeEFl~ll~~~~~~~~~~e~l~~aFk~ 393 (450)
T 3sg6_A 315 KEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVD-ADGNGTIDFPEFLTMMARKMKDTDSEEEIREAFRV 393 (450)
T ss_dssp HHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHTTC-TTSSSSEEHHHHHHHHHC------CHHHHHHHHHH
T ss_pred HHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhc-cCCCCcccHHHHHHHHHhhccccchhhHHHHHHHH
Confidence 3459999999999999999976 46889999999999 89999999999997665432 34455667777764
Q ss_pred C
Q 009364 438 M 438 (536)
Q Consensus 438 ~ 438 (536)
.
T Consensus 394 f 394 (450)
T 3sg6_A 394 F 394 (450)
T ss_dssp H
T ss_pred h
Confidence 3
|
| >1sjj_A Actinin; 3-helix bundle, calponin homology domain, calmodulin-like domain, actin binding protein, contractIle protein; 20.00A {Gallus gallus} SCOP: i.15.1.1 | Back alignment and structure |
|---|
Probab=96.20 E-value=0.00082 Score=76.81 Aligned_cols=72 Identities=7% Similarity=-0.024 Sum_probs=59.4
Q ss_pred CCCCCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhccccc-ccCChhhhhhccC
Q 009364 366 SPGSPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLS-SILAPNDLEKSRN 436 (536)
Q Consensus 366 ~~~sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~-~~~~~e~l~~aF~ 436 (536)
....|..||.+++|.|+..||.. .+.++++.++..+| .|++|.|+|+||+.++.... .....+.++.+|+
T Consensus 727 ~~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~~~~~~~~~~D-~d~dG~I~~~EF~~~~~~~~~~~~~~~~l~~aF~ 805 (863)
T 1sjj_A 727 FRASFNHFDRKKTGMMDCEDFRACLISMGYNMGEAEFARIMSIVD-PNRMGVVTFQAFIDFMSRETADTDTADQVMASFK 805 (863)
T ss_dssp HHHHHTTTCSSSSSEEESTTHHHHHHHHTCCCCTHHHHHHHHHHC-TTSCSEEETTHHHHTHHHHSTTCSSSHHHHHHHH
T ss_pred HHHHHHHHCCCCCCCcCHHHHHHHHHHcCCCCCHHHHHHHHHHhC-CCCCCcCcHHHHHHHHHHHhcCCCCHHHHHHHHH
Confidence 34469999999999999999976 46789999999999 89999999999997665432 2445578999998
Q ss_pred CC
Q 009364 437 PM 438 (536)
Q Consensus 437 ~~ 438 (536)
-.
T Consensus 806 ~~ 807 (863)
T 1sjj_A 806 IL 807 (863)
T ss_dssp GG
T ss_pred HH
Confidence 76
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=96.19 E-value=0.0011 Score=70.83 Aligned_cols=53 Identities=9% Similarity=-0.026 Sum_probs=45.0
Q ss_pred CCCCCccccCCCccchhhhhh------hhhhhhhhhhhccCCCCCCCccchhhhhhhccc
Q 009364 368 GSPGSVDICNLDSLSCSRVIV------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRK 421 (536)
Q Consensus 368 ~sf~~~D~~~~g~ls~~el~~------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~ 421 (536)
..|..+|.+++|.|+.+|+.. .++++++.+++..| .|+||.|+|+||+.++..
T Consensus 439 ~~F~~~D~d~dG~Is~~El~~~l~~~~~~~~~~~~~~~~~D-~d~dG~I~~~EF~~~~~~ 497 (504)
T 3q5i_A 439 RAFNLFDTDKSGKITKEELANLFGLTSISEKTWNDVLGEAD-QNKDNMIDFDEFVSMMHK 497 (504)
T ss_dssp HHHHHHCTTCCSEECHHHHHHHTTCSCCCHHHHHHHHHTTC-SSCSSSEEHHHHHHHHHH
T ss_pred HHHHHhcCCCCCcCcHHHHHHHHhhCCCCHHHHHHHHHHhC-CCCCCcEeHHHHHHHHHH
Confidence 358889999999999999976 36788999999999 899999999999876543
|
| >2d8n_A Recoverin; structural genomics, NPPSFA, national project on protein STR and functional analyses, riken structural genomics/proteomi initiative; 2.20A {Homo sapiens} PDB: 2i94_A 1iku_A* 1jsa_A* 1omr_A 1rec_A 1la3_A* 1omv_A 2het_A | Back alignment and structure |
|---|
Probab=96.19 E-value=0.00053 Score=63.71 Aligned_cols=67 Identities=10% Similarity=-0.035 Sum_probs=46.5
Q ss_pred CCCcccc-CCCccchhhhhh---------hhhhhhhhhhhccCCCCCCCccchhhhhhhcccccccCChhhhhhccCC
Q 009364 370 PGSVDIC-NLDSLSCSRVIV---------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSSILAPNDLEKSRNP 437 (536)
Q Consensus 370 f~~~D~~-~~g~ls~~el~~---------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~~~~~e~l~~aF~~ 437 (536)
|..||.+ ++|.|+..|+.. .+.+++..+++.+| .|++|.|+|+||+.++........+++++.+|+.
T Consensus 39 f~~~d~~~~~G~i~~~ef~~~l~~~~~~~~~~~~~~~~f~~~D-~d~~G~i~~~Ef~~~~~~~~~~~~~~~~~~~f~~ 115 (207)
T 2d8n_A 39 YQSFLKDCPTGRITQQQFQSIYAKFFPDTDPKAYAQHVFRSFD-SNLDGTLDFKEYVIALHMTTAGKTNQKLEWAFSL 115 (207)
T ss_dssp HHHHHHHCTTSEEEHHHHHHHHHHTCTTSCCHHHHHHHHHHHC-TTCCSEEEHHHHHHHHHHHSCSSSSTTHHHHHHH
T ss_pred HHHHHhhCCCCCCCHHHHHHHHHHhccCCCcHHHHHHHHHHhc-CCCCCeEeHHHHHHHHHHHcCCCHHHHHHHHHHH
Confidence 5666777 588888888865 24567888888888 7888888888888665544333445566666653
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=96.15 E-value=0.00093 Score=70.86 Aligned_cols=53 Identities=11% Similarity=-0.001 Sum_probs=44.7
Q ss_pred CCCCCccccCCCccchhhhhh------hhhhhhhhhhhccCCCCCCCccchhhhhhhccc
Q 009364 368 GSPGSVDICNLDSLSCSRVIV------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRK 421 (536)
Q Consensus 368 ~sf~~~D~~~~g~ls~~el~~------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~ 421 (536)
..|..+|.+++|.|+.+|+.. .+.++++.+++..| .|++|.|+|+||+.++..
T Consensus 422 ~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~~~~~~~D-~d~dG~i~~~Ef~~~~~~ 480 (484)
T 3nyv_A 422 RAFRMFDSDNSGKISSTELATIFGVSDVDSETWKSVLSEVD-KNNDGEVDFDEFQQMLLK 480 (484)
T ss_dssp HHHHHHCTTCCSEEEHHHHHHHHHHTTCCHHHHHHHHHHHC-TTCCSEEEHHHHHHHHHH
T ss_pred HHHHHHCCCCCCcCCHHHHHHHHHhcCCCHHHHHHHHHHhc-CCCCCcCCHHHHHHHHHh
Confidence 358899999999999999876 36788999999999 899999999999876543
|
| >2ct9_A Calcium-binding protein P22; EF-hand, metal binding protein; 2.20A {Rattus norvegicus} PDB: 2e30_A | Back alignment and structure |
|---|
Probab=96.14 E-value=0.001 Score=61.95 Aligned_cols=55 Identities=11% Similarity=-0.167 Sum_probs=43.5
Q ss_pred CCCCCCCccccCCCccchhhhhhh----hhhhhhhhhhccCCCCCCCccchhhhhhhccc
Q 009364 366 SPGSPGSVDICNLDSLSCSRVIVE----KLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRK 421 (536)
Q Consensus 366 ~~~sf~~~D~~~~g~ls~~el~~~----~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~ 421 (536)
....|..+|.+++|.|+.+|+... -....+.+++.+| .+++|.|+|+||+.++..
T Consensus 31 l~~~F~~~D~d~dG~Is~~El~~~~~lg~~~~~~~l~~~~d-~~~~g~i~~~EF~~~~~~ 89 (208)
T 2ct9_A 31 LYSRFTSLDKGENGTLSREDFQRIPELAINPLGDRIINAFF-SEGEDQVNFRGFMRTLAH 89 (208)
T ss_dssp HHHHHHHHCTTCSSEECTGGGGGCHHHHTSTTHHHHHHTTS-CTTCSCEEHHHHHHHHHT
T ss_pred HHHHHHHHCCCCCCcCcHHHHHHHHHcCCCCcHHHHHHHHc-CCCCCcCcHHHHHHHHHh
Confidence 334599999999999999999872 1123457888899 899999999999976554
|
| >1alv_A Calpain, S-camld; calcium binding, calmodulin like, domain of cystein protease; 1.90A {Sus scrofa} SCOP: a.39.1.8 PDB: 1alw_A* 1nx0_A 1nx1_A 1nx2_A 1nx3_A* 1kfu_S 1kfx_S 3bow_B 1u5i_B 1df0_B 3df0_B 1aj5_A 1dvi_A 1np8_A | Back alignment and structure |
|---|
Probab=96.14 E-value=0.00076 Score=60.75 Aligned_cols=62 Identities=10% Similarity=0.023 Sum_probs=50.5
Q ss_pred CCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcccccccCChhhhhhccCCC
Q 009364 369 SPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSSILAPNDLEKSRNPM 438 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~~~~~e~l~~aF~~~ 438 (536)
.|..+|.+++|.|+..|+.. .+.++++.+++..| |++|.|+|+||+.++... +.+.++|+..
T Consensus 82 ~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~d--d~dg~i~~~eF~~~~~~~------~~~~~~F~~~ 151 (173)
T 1alv_A 82 IYKQFDVDRSGTIGSSELPGAFEAAGFHLNEHLYSMIIRRYS--DEGGNMDFDNFISCLVRL------DAMFRAFKSL 151 (173)
T ss_dssp HHHHHCTTCCSSBCTTTHHHHHHHHTCCCCHHHHHHHHHHHT--CSSSCBCHHHHHHHHHHH------HHHHHHHHHH
T ss_pred HHHHHCCCCCCCCCHHHHHHHHHHcCCCCCHHHHHHHHHHhc--CCCCcCcHHHHHHHHHHH------HHHHHHHHHh
Confidence 48899999999999999976 46789999999887 788999999999766532 4566777644
|
| >1bjf_A Neurocalcin delta; calcium-binding, myristoylation, neuronal specific guanylate cyclase activator; 2.40A {Bos taurus} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=96.13 E-value=0.00046 Score=63.11 Aligned_cols=66 Identities=12% Similarity=-0.057 Sum_probs=43.0
Q ss_pred CCCcccc-CCCccchhhhhh---------hhhhhhhhhhhccCCCCCCCccchhhhhhhcccccccCChhhhhhccC
Q 009364 370 PGSVDIC-NLDSLSCSRVIV---------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSSILAPNDLEKSRN 436 (536)
Q Consensus 370 f~~~D~~-~~g~ls~~el~~---------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~~~~~e~l~~aF~ 436 (536)
|..||.+ ++|.|+.+|+.. ....++..+|+.+| .|++|.|+|+||+.++........++.++.+|+
T Consensus 31 f~~fd~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~f~~~D-~d~~g~i~~~Ef~~~~~~~~~~~~~~~~~~~f~ 106 (193)
T 1bjf_A 31 YKGFLRDCPSGHLSMEEFKKIYGNFFPYGDASKFAEHVFRTFD-ANGDGTIDFREFIIALSVTSRGKLEQKLKWAFS 106 (193)
T ss_dssp HHHHHHHSTTSEEEHHHHHHHHTTTSSSSCCHHHHHHHHHHHC-SSCSSEEEHHHHHHHHHHHTSSCHHHHHHHHHH
T ss_pred HHHHHHHCCCCCcCHHHHHHHHHHhcCcCChHHHHHHHHHHhC-CCCCCcCcHHHHHHHHHHHcCCCHHHHHHHHHh
Confidence 6667766 678888888765 12455777788888 777888888888765543333333455666664
|
| >1fpw_A Yeast frequenin, calcium-binding protein NCS-1; EF-hand, metal binding protein; NMR {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2ju0_A | Back alignment and structure |
|---|
Probab=96.12 E-value=0.00072 Score=61.66 Aligned_cols=66 Identities=11% Similarity=-0.046 Sum_probs=37.3
Q ss_pred CCCcccc-CCCccchhhhhh---------hhhhhhhhhhhccCCCCCCCccchhhhhhhcccccccCChhhhhhccC
Q 009364 370 PGSVDIC-NLDSLSCSRVIV---------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSSILAPNDLEKSRN 436 (536)
Q Consensus 370 f~~~D~~-~~g~ls~~el~~---------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~~~~~e~l~~aF~ 436 (536)
|..||.+ ++|.|+.+|+.. .+.+++..+++.+| .|++|.|+++||+.++........+++++.+|+
T Consensus 31 ~~~fd~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~f~~~D-~d~~G~i~~~ef~~~~~~~~~~~~~~~~~~~f~ 106 (190)
T 1fpw_A 31 HKGFLRDCPSGQLAREDFVKIYKQFFPFGSPEDFANHLFTVFD-KDNNGFIHFEEFITVLSTTSRGTLEEKLSWAFE 106 (190)
T ss_dssp HHHHHHHCTTCCEEHHHHHHHHHHHCTTSCCSHHHHHHHHTCC-SSCSSEECHHHHHHHHHHHSCCCSTHHHHHHHH
T ss_pred HHHHHHHCCCCcCcHHHHHHHHHHHcCCCCcHHHHHHHHHHHC-CCCCCcEeHHHHHHHHHHHccCCcHHHHHHHHH
Confidence 4455554 566777776654 12345666666666 666677777777654443333334445555553
|
| >2i7a_A Calpain 13; calcium-dependent cytoplasmic cysteine proteinases, like, EF-hand, structural genomics, structural genomics CON SGC, hydrolase; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.10 E-value=0.0016 Score=59.43 Aligned_cols=60 Identities=15% Similarity=0.025 Sum_probs=45.1
Q ss_pred CCccccCCCccchhhhhh----h----------hhhhhhhhhhccCCCCCCCccchhhhhhhcccccccCChhhhhhccC
Q 009364 371 GSVDICNLDSLSCSRVIV----E----------KLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSSILAPNDLEKSRN 436 (536)
Q Consensus 371 ~~~D~~~~g~ls~~el~~----~----------~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~~~~~e~l~~aF~ 436 (536)
.+-+.+++|.|+..||+. . +.++++.+++.+| .|++|.|+|+||+.++... ++++++|+
T Consensus 11 ~~~~~~~dG~I~~~EL~~~l~~l~~~~~~g~~~~~~~~~~l~~~~D-~d~~G~I~f~EF~~~~~~~------~~l~~aF~ 83 (174)
T 2i7a_A 11 SSGLVPRGSDIDATQLQGLLNQELLTGPPGDMFSLDECRSLVALME-LKVNGRLDQEEFARLWKRL------VHYQHVFQ 83 (174)
T ss_dssp -CCSCC-CCCEEHHHHHHHHHHHHC-----CCCCHHHHHHHHHHHC-SSCSSEECHHHHHHHHHHH------HHHHHHHH
T ss_pred ccccCCCCCcCCHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHC-CCCCCcCCHHHHHHHHHHH------HHHHHHHH
Confidence 345678899999999965 1 3578999999999 8999999999999755422 45667776
Q ss_pred C
Q 009364 437 P 437 (536)
Q Consensus 437 ~ 437 (536)
-
T Consensus 84 ~ 84 (174)
T 2i7a_A 84 K 84 (174)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >2ehb_A Calcineurin B-like protein 4; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} PDB: 1v1g_A 1v1f_A | Back alignment and structure |
|---|
Probab=96.03 E-value=0.0011 Score=61.61 Aligned_cols=68 Identities=3% Similarity=-0.132 Sum_probs=52.3
Q ss_pred CCCCCcccc--CCCccchhhhhh-----hh--hhhhhhhhhccCCCCCCCccchhhhhhhcccccc-cCChhhhhhccC
Q 009364 368 GSPGSVDIC--NLDSLSCSRVIV-----EK--LSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSS-ILAPNDLEKSRN 436 (536)
Q Consensus 368 ~sf~~~D~~--~~g~ls~~el~~-----~~--~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~-~~~~e~l~~aF~ 436 (536)
..|..+|.+ ++|.|+.+|+.. .+ ...++.+++.+| .|++|.|+|+||+.++..... ....+.++.+|+
T Consensus 41 ~~F~~~D~d~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~f~~~D-~d~~g~i~~~Ef~~~~~~~~~~~~~~~~l~~~F~ 118 (207)
T 2ehb_A 41 ELFKKLSSSIIDDGLIHKEEFQLALFRNRNRRNLFADRIFDVFD-VKRNGVIEFGEFVRSLGVFHPSAPVHEKVKFAFK 118 (207)
T ss_dssp HHHHHHTTSSSCSSCEEHHHHHHHHHSCTTCCCHHHHHHHHHHC-TTCSSEECHHHHHHHHGGGSTTSCHHHHHHHHHH
T ss_pred HHHHHhccccCCCCccCHHHHHHHHhccccccHHHHHHHHHHhc-CCCCCeEeHHHHHHHHHHHccCCCHHHHHHHHHH
Confidence 348889999 999999999986 22 345677999999 899999999999976665432 234556888885
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=96.02 E-value=0.0014 Score=69.89 Aligned_cols=51 Identities=10% Similarity=-0.031 Sum_probs=41.5
Q ss_pred CCCCccccCCCccchhhhhh------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 369 SPGSVDICNLDSLSCSRVIV------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
.|..+|.+++|.|+.+||.. .+.++++.+++..| .|++|.|+|+||+.++.
T Consensus 431 ~F~~~D~d~~G~Is~~El~~~l~~~~~~~~~~~~~~~~~D-~d~dG~I~~~EF~~~~~ 487 (494)
T 3lij_A 431 AFQKFDQDGNGKISVDELASVFGLDHLESKTWKEMISGID-SNNDGDVDFEEFCKMIQ 487 (494)
T ss_dssp HHHHHCTTCSSEECHHHHHHHC-CCSCCCHHHHHHHHTTC-SSSSSSEEHHHHHHHHH
T ss_pred HHHHHCCCCCCcCCHHHHHHHHHhcCCCHHHHHHHHHHhC-CCCCCcCCHHHHHHHHH
Confidence 58888888888888888876 35678888888888 78888888888886554
|
| >1fpw_A Yeast frequenin, calcium-binding protein NCS-1; EF-hand, metal binding protein; NMR {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2ju0_A | Back alignment and structure |
|---|
Probab=96.02 E-value=0.0011 Score=60.32 Aligned_cols=52 Identities=6% Similarity=-0.121 Sum_probs=45.1
Q ss_pred CCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhccc
Q 009364 369 SPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRK 421 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~ 421 (536)
.|..+|.+++|.|+..|+.. .+.+++..+|+.+| .|++|.|+++||..++..
T Consensus 68 ~f~~~D~d~~G~i~~~ef~~~~~~~~~~~~~~~~~~~f~~~D-~d~~G~i~~~ef~~~~~~ 127 (190)
T 1fpw_A 68 LFTVFDKDNNGFIHFEEFITVLSTTSRGTLEEKLSWAFELYD-LNHDGYITFDEMLTIVAS 127 (190)
T ss_dssp HHHTCCSSCSSEECHHHHHHHHHHHSCCCSTHHHHHHHHHHC-SSCSSEEEHHHHHHHHHH
T ss_pred HHHHHCCCCCCcEeHHHHHHHHHHHccCCcHHHHHHHHHHhc-CCCCCcCcHHHHHHHHHH
Confidence 37889999999999999976 35678999999999 899999999999966543
|
| >1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A | Back alignment and structure |
|---|
Probab=96.02 E-value=8.8e-05 Score=74.95 Aligned_cols=120 Identities=13% Similarity=-0.015 Sum_probs=73.1
Q ss_pred cCcHHHHHHHHHhc---ccCCCCCCCHHHHHhC------CCCcCCCCCc--------------------chh-----hcc
Q 009364 298 NLSVKAKDFLLKCL---EKEPDLRPTASELLKH------PFVTGDDEDP--------------------VLH-----ASV 343 (536)
Q Consensus 298 ~~s~~~~dLi~~cL---~~dP~~Rps~~eiL~h------p~~~~~~~~~--------------------~~~-----~~~ 343 (536)
.++.++.+|.++.+ ..+|..|.+.++.+.| +|+....... ... ..+
T Consensus 16 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~a~g~~~~e~q~~~~v 95 (323)
T 1ij5_A 16 KVHENLEELQKKLDHTSFAHKEDRDRLEAQIAQKEQEQKAKLAEYDQKVQNEFDARERAEREREAARGDAAAEKQRLASL 95 (323)
T ss_dssp HHHHHHHHHHHHHTTCCCC-----CCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTTSCHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcChhhhhHHHHHHHHhhcCCCCCcchhhHHH
Confidence 45677889999988 8899999999999988 8875431100 000 000
Q ss_pred ccccc----cCCh--hHHhhhhhhhcccCCCCCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCc
Q 009364 344 MKSSE----ILSP--SHVANLESLQMLTSPGSPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQ 409 (536)
Q Consensus 344 ~~~~~----~~~~--~~~~~l~s~q~~t~~~sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~ 409 (536)
+.... ..+. .....+...+.......|..+|.+++|.|+.+|+.. ++..++..++..+| .|++|.
T Consensus 96 l~~l~~~f~~~~~lkk~~~~Ls~~e~~~l~~~F~~~D~d~dG~Is~~El~~~L~~lg~~~~~~~i~~l~~~~D-~d~~G~ 174 (323)
T 1ij5_A 96 LKDLEDDASGYNRLRPSKPMLSEEDTNILRQLFLSSAVSGSGKFSFQDLKQVLAKYADTIPEGPLKKLFVMVE-NDTKGR 174 (323)
T ss_dssp HHHC-------------CCCCCHHHHHHHHHHHTSSSSTTSSCCCHHHHHHHHHHHHTTSCSSHHHHHHHHHH-HCCSST
T ss_pred HHHHHHHHHHhhhHHHHHHhCCHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHcCCCCCHHHHHHHHHHhc-CCCCCc
Confidence 00000 0000 000011111222234469999999999999999976 46789999999999 899999
Q ss_pred cchhhhhhh
Q 009364 410 LDQEDFVAG 418 (536)
Q Consensus 410 Id~~EF~~~ 418 (536)
|+|.+|+.+
T Consensus 175 I~f~ef~~l 183 (323)
T 1ij5_A 175 MSYITLVAV 183 (323)
T ss_dssp HHHHHHTTS
T ss_pred CcHHHHHhh
Confidence 999999854
|
| >3sjs_A URE3-BP sequence specific DNA binding protein; EF-hand, structural genomics, seattle S genomics center for infectious disease, ssgcid; 1.90A {Entamoeba histolytica} PDB: 3sia_A 3sib_A | Back alignment and structure |
|---|
Probab=96.01 E-value=0.0012 Score=62.58 Aligned_cols=63 Identities=6% Similarity=-0.138 Sum_probs=50.1
Q ss_pred CCCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcccccccCChhhhhhccCCC
Q 009364 368 GSPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSSILAPNDLEKSRNPM 438 (536)
Q Consensus 368 ~sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~~~~~e~l~~aF~~~ 438 (536)
..|..+|.+++|.|+.+|+.. .+.++++.+++..| |++|.|+|+||+.++... ..++++|+..
T Consensus 121 ~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~~~~~l~~~~d--d~dg~I~~~eF~~~~~~l------~~~~~~F~~~ 191 (220)
T 3sjs_A 121 NLFVMNARARSGTLEPHEILPALQQLGFYINQRTSLLLHRLFA--RGMAFCDLNCWIAICAFA------AQTRSAYQMI 191 (220)
T ss_dssp HHHHHHCCSSTTEECHHHHHHHHHHHTCCCCHHHHHHHHHHHC----CCSEEHHHHHHHHHHH------HHHHHHHHHH
T ss_pred HHHHHHCCCCCCCCcHHHHHHHHHHhCCCCCHHHHHHHHHHhc--CCCCcCcHHHHHHHHHHH------HHHHHHHHHh
Confidence 348999999999999999976 46789999999999 788999999999766543 2466777665
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=96.01 E-value=0.0011 Score=70.42 Aligned_cols=51 Identities=12% Similarity=0.020 Sum_probs=30.7
Q ss_pred CCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 369 SPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
.|..+|.+++|.|+.+||.. .+.++++.+++..| .|+||.|+|+||+.++.
T Consensus 422 ~F~~~D~d~dG~Is~~El~~~l~~~g~~~~~~~~~~~~~~~D-~d~dG~I~~~EF~~~~~ 480 (486)
T 3mwu_A 422 AFKMFDKDGSGKISTKELFKLFSQADSSIQMEELESIIEQVD-NNKDGEVDFNEFVEMLQ 480 (486)
T ss_dssp HHHHHCSSCSSSBCSSCC--------------------CCCC-SSCSSSBCHHHHHHHHH
T ss_pred HHHHhCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHhC-CCCCCcEeHHHHHHHHH
Confidence 47778888888888888765 45677888888888 78888888888876443
|
| >3a4u_B Multiple coagulation factor deficiency protein 2; lectin, ergic, ER, golgi, transport, disulfide bond, endopla reticulum, ER-golgi transport; 1.84A {Homo sapiens} PDB: 2vrg_A 3lcp_C | Back alignment and structure |
|---|
Probab=95.99 E-value=0.0025 Score=55.96 Aligned_cols=55 Identities=13% Similarity=0.119 Sum_probs=25.8
Q ss_pred CCCCCCccccCCCccchhhhhh-------------hhhhhhhhhhhccCCCCCCCccchhhhhhhcccc
Q 009364 367 PGSPGSVDICNLDSLSCSRVIV-------------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKL 422 (536)
Q Consensus 367 ~~sf~~~D~~~~g~ls~~el~~-------------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~ 422 (536)
...|..+|.+++|.|+.+|+.. ...+++..+|+.+| .|++|.|+++||..++...
T Consensus 30 ~~~f~~~D~d~dG~I~~~Ef~~~l~~~~~~~~~~~~~~~~l~~~F~~~D-~d~dG~I~~~El~~~l~~~ 97 (143)
T 3a4u_B 30 FSQPGSMGLDKNTVHDQEHIMEHLEGVINKPEAEMSPQELQLHYFKMHD-YDGNNLLDGLELSTAITHV 97 (143)
T ss_dssp ---------------------------------CCCHHHHHHHHHHHTC-TTCSSCEEHHHHHHTCC--
T ss_pred HHHHHHhCCCCCCcCcHHHHHHHHHHHhcccccccCHHHHHHHHHHHhC-CCCCCccCHHHHHHHHHHH
Confidence 4469999999999999999975 12457888999999 8999999999999766554
|
| >2zfd_A Calcineurin B-like protein 2; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} SCOP: a.39.1.5 PDB: 1uhn_A | Back alignment and structure |
|---|
Probab=95.97 E-value=0.001 Score=63.03 Aligned_cols=71 Identities=7% Similarity=-0.094 Sum_probs=53.3
Q ss_pred CCCCCCcccc--CCCccchhhhhh-----hh--hhhhhhhhhccCCCCCCCccchhhhhhhccccc-ccCChhhhhhccC
Q 009364 367 PGSPGSVDIC--NLDSLSCSRVIV-----EK--LSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLS-SILAPNDLEKSRN 436 (536)
Q Consensus 367 ~~sf~~~D~~--~~g~ls~~el~~-----~~--~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~-~~~~~e~l~~aF~ 436 (536)
...|..+|.+ ++|.|+.+|+.. .+ ...++.+++.+| .|++|.|+|+||+.++.... .....+.++.+|+
T Consensus 51 ~~~F~~~D~d~~~~G~I~~~El~~~l~~~~~~~~~~~~~~f~~~D-~d~dG~I~~~Ef~~~~~~~~~~~~~~~~l~~~F~ 129 (226)
T 2zfd_A 51 YELFKKISSAVIDDGLINKEEFQLALFKTNKKESLFADRVFDLFD-TKHNGILGFEEFARALSVFHPNAPIDDKIHFSFQ 129 (226)
T ss_dssp HHHHHHHHTSSSCSSSBCHHHHHHHHHSCSSCCCHHHHHHHHHHC-SSCSSSBCHHHHHHHHHHTSTTSCHHHHHHHHHH
T ss_pred HHHHHHhCcccCCCCeEcHHHHHHHHhccCcccHHHHHHHHHHHc-CCCCCcCcHHHHHHHHHHHccCCCHHHHHHHHHH
Confidence 3458899999 999999999986 12 335677999999 89999999999997665443 2233556888885
Q ss_pred CC
Q 009364 437 PM 438 (536)
Q Consensus 437 ~~ 438 (536)
-.
T Consensus 130 ~~ 131 (226)
T 2zfd_A 130 LY 131 (226)
T ss_dssp HH
T ss_pred Hh
Confidence 43
|
| >1s1e_A KV channel interacting protein 1; kchip, calcium-binding protein, EF-finger, transport protein; 2.30A {Homo sapiens} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=95.96 E-value=0.0007 Score=64.28 Aligned_cols=66 Identities=12% Similarity=0.008 Sum_probs=39.2
Q ss_pred CCCccc-cCCCccchhhhhh---------hhhhhhhhhhhccCCCCCCCccchhhhhhhcccccccCChhhhhhccC
Q 009364 370 PGSVDI-CNLDSLSCSRVIV---------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSSILAPNDLEKSRN 436 (536)
Q Consensus 370 f~~~D~-~~~g~ls~~el~~---------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~~~~~e~l~~aF~ 436 (536)
|..||. +++|.|+..|+.. .+..+++.+++.+| .|++|.|+|+||+.++........+++++.+|+
T Consensus 57 ~~~Fd~~d~~G~I~~~E~~~~l~~l~~~~~~~~~~~~~f~~~D-~d~~G~I~~~Ef~~~l~~~~~~~~~~~l~~~F~ 132 (224)
T 1s1e_A 57 YRGFKNECPSGVVNEETFKQIYAQFFPHGDASTYAHYLFNAFD-TTQTGSVKFEDFVTALSILLRGTVHEKLRWTFN 132 (224)
T ss_dssp HHHHHHHCTTSCBCHHHHHHHHHTTCTTSCCHHHHHHHHHHHC-TTCSSCBCHHHHHHHHHHHHHCCHHHHHHHHHH
T ss_pred HHHHHhhCCCCCCCHHHHHHHHHHhcCCCCcHHHHHHHHHHhc-CCCCCcEeHHHHHHHHHHHccCCHHHHHHHHHH
Confidence 334444 3677777777754 24556677777777 677777777777755443332333445555554
|
| >1g8i_A Frequenin, neuronal calcium sensor 1; calcium binding-protein, EF-hand, calcium ION, metal binding protein; HET: 1PE P6G; 1.90A {Homo sapiens} SCOP: a.39.1.5 PDB: 2lcp_A | Back alignment and structure |
|---|
Probab=95.96 E-value=0.00058 Score=62.30 Aligned_cols=67 Identities=6% Similarity=-0.093 Sum_probs=45.4
Q ss_pred CCCcccc-CCCccchhhhhh---------hhhhhhhhhhhccCCCCCCCccchhhhhhhcccccccCChhhhhhccCC
Q 009364 370 PGSVDIC-NLDSLSCSRVIV---------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSSILAPNDLEKSRNP 437 (536)
Q Consensus 370 f~~~D~~-~~g~ls~~el~~---------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~~~~~e~l~~aF~~ 437 (536)
|..||.+ ++|.|+.+|+.. ....++..+++.+| .|++|.|+|+||+.++.........+.++.+|+-
T Consensus 31 f~~fd~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~f~~~D-~d~~g~i~~~ef~~~~~~~~~~~~~~~~~~~f~~ 107 (190)
T 1g8i_A 31 YKGFIKDCPSGQLDAAGFQKIYKQFFPFGDPTKFATFVFNVFD-ENKDGRIEFSEFIQALSVTSRGTLDEKLRWAFKL 107 (190)
T ss_dssp HHHHHHHCTTSEEEHHHHHHHHHHHCTTSCTHHHHHHHHHHHC-TTCSSEEEHHHHHHHHHHHHHCCHHHHHHHHHHH
T ss_pred HHHHHHhCCCCcCCHHHHHHHHHHhCCCCChHHHHHHHHHHHh-cCCCCeEeHHHHHHHHHHhcCCCHHHHHHHHHHh
Confidence 6667776 788888888765 13456788888888 7888888888888655443333344566666653
|
| >3e3r_A Calcyphosin, calcyphosine; human calcyphosine, EF-hand, phosphoprotein, calcium binding; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.92 E-value=0.0012 Score=60.94 Aligned_cols=54 Identities=7% Similarity=-0.096 Sum_probs=46.4
Q ss_pred CCCCccccCCCccchhhhhh---------------hhhhhhhhhhhccCCC-CCCCccchhhhhhhccccc
Q 009364 369 SPGSVDICNLDSLSCSRVIV---------------EKLSGSMHGWVTSNSN-DDLCQLDQEDFVAGDRKLS 423 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~---------------~~~~ei~~l~~~~d~~-d~~g~Id~~EF~~~~~~~~ 423 (536)
.|..+|.+++|.|+.+|+.. .+.++++.+++.+| . |++|.|+|+||+.++....
T Consensus 114 ~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~D-~~d~dg~Is~~EF~~~~~~~~ 183 (204)
T 3e3r_A 114 AFAKLDRSGDGVVTVDDLRGVYSGRAHPKVRSGEWTEDEVLRRFLDNFD-SSEKDGQVTLAEFQDYYSGVS 183 (204)
T ss_dssp HHHHHCTTCSSEECHHHHHHHCCCTTCHHHHTTSSCHHHHHHHHHHHHS-CSSCCSCEEHHHHHHHHHHHH
T ss_pred HHHHhCcCCCCeEeHHHHHHHHccccCCccccCCCChHHHHHHHHHHhh-ccCCCCcCcHHHHHHHHHHcC
Confidence 38889999999999999976 13467999999999 8 9999999999998776654
|
| >1s6c_A KV4 potassium channel-interacting protein kchip1B; EF-hand, transport protein; 2.00A {Rattus norvegicus} SCOP: a.39.1.5 PDB: 2nz0_A 2i2r_E | Back alignment and structure |
|---|
Probab=95.85 E-value=0.0024 Score=57.81 Aligned_cols=52 Identities=6% Similarity=-0.008 Sum_probs=44.6
Q ss_pred CCCCccccCCCccchhhhhhh--h------------------hhhhhhhhhccCCCCCCCccchhhhhhhccc
Q 009364 369 SPGSVDICNLDSLSCSRVIVE--K------------------LSGSMHGWVTSNSNDDLCQLDQEDFVAGDRK 421 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~~--~------------------~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~ 421 (536)
.|..+|.+++|.|+.+|+... . .+++..+++..| .|++|.|+|+||+.++..
T Consensus 97 ~f~~~D~d~~G~i~~~e~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D-~d~dG~i~~~Ef~~~~~~ 168 (183)
T 1s6c_A 97 TFNLYDINKDGYINKEEMMDIVKAIYDMMGKYTYPVLKEDTPRQHVDVFFQKMD-KNKDGIVTLDEFLESXQE 168 (183)
T ss_dssp HHHHHCTTCSSCEEHHHHHHHHHHHHHHTC-----------CHHHHHHHHHHHC-TTCSSEECHHHHHHHTTS
T ss_pred HHHHhCCCCCCeEcHHHHHHHHHHHHHHhccccCcCccHHHHHHHHHHHHHHhC-CCCCCcEeHHHHHHHHhc
Confidence 488999999999999999751 1 278999999999 899999999999976654
|
| >2hps_A Coelenterazine-binding protein with bound coelent; bioluminescence, southeast collabora structural genomics, secsg, structural genomics, PSI; HET: CTZ; 1.72A {Renilla muelleri} PDB: 2hq8_A | Back alignment and structure |
|---|
Probab=95.85 E-value=0.0028 Score=57.37 Aligned_cols=50 Identities=10% Similarity=0.081 Sum_probs=43.7
Q ss_pred CCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhccc
Q 009364 371 GSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRK 421 (536)
Q Consensus 371 ~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~ 421 (536)
..||.+++|.|+..|+.. .+.++++.+++.+| .|++|.|+|+||+.++..
T Consensus 109 ~~fD~d~~G~I~~~E~~~~l~~~g~~~~~~~~~~~~~~~D-~d~dG~i~~~ef~~~~~~ 166 (186)
T 2hps_A 109 DCIDTDKDGYVSLPEFKAFLQAVGPDLTDDKAITCFNTLD-FNKNGQISRDEFLVTVND 166 (186)
T ss_dssp HHHCTTCSSEEEHHHHHHHHHHHCTTCCHHHHHHHHHHHC-TTCSSEEEHHHHHHHHHH
T ss_pred HHccCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHHc-CCCCCcCcHHHHHHHHHH
Confidence 556999999999999976 46789999999999 899999999999976543
|
| >1jba_A GCAP-2, protein (guanylate cyclase activating protein 2); EF-hand, calcium-binding protein, guanylyl cyclase regulation, lyase; NMR {Bos taurus} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=95.84 E-value=0.0025 Score=58.96 Aligned_cols=51 Identities=14% Similarity=0.068 Sum_probs=43.9
Q ss_pred CCCCccccCCCccchhhhhh----h---------------------hhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 369 SPGSVDICNLDSLSCSRVIV----E---------------------KLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~----~---------------------~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
.|..+|.+++|.|+.+|+.. . +.+++..+|+.+| .|++|.|+|+||+.++.
T Consensus 100 ~F~~~D~d~~G~I~~~E~~~~l~~~~~~~g~~~~~~~~~~~g~~~~~~~~~~~~f~~~D-~d~dG~Is~~Ef~~~~~ 175 (204)
T 1jba_A 100 TFKIYDKDRNGCIDRQELLDIVESIYKLKKACSVEVEAEQQGKLLTPEEVVDRIFLLVD-ENGDGQLSLNEFVEGAR 175 (204)
T ss_dssp HHHHHCSSCSSCBCHHHHHHHHHHHHHHHHHSSCCTTSSTTTCCCCHHHHHHHHHHHHC-CSCCSCBCHHHHHHHHT
T ss_pred HHHHhCCCCCCcCcHHHHHHHHHHHHHHhCCCCccccccccCchhhHHHHHHHHHHHhC-CCCCCeEcHHHHHHHHH
Confidence 48889999999999999975 1 2357899999999 89999999999997665
|
| >2r2i_A Guanylyl cyclase-activating protein 1; EF hand, GCAP, guanylate cyclase activating protein, GCAP1, GCAP-1, calcium, lipoprotein, myristate; HET: MYR; 2.00A {Gallus gallus} | Back alignment and structure |
|---|
Probab=95.84 E-value=0.0014 Score=60.39 Aligned_cols=51 Identities=6% Similarity=-0.063 Sum_probs=44.9
Q ss_pred CCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhccc
Q 009364 370 PGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRK 421 (536)
Q Consensus 370 f~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~ 421 (536)
|..+|.+++|.|+..|+.. .+.+++..+|+.+| .|++|.|+++||..++..
T Consensus 58 f~~~D~d~~G~I~~~Ef~~~~~~~~~~~~~~~~~~~F~~~D-~d~~G~I~~~Ef~~~~~~ 116 (198)
T 2r2i_A 58 FETFDFNKDGYIDFMEYVAALSLVLKGKVDQKLRWYFKLYD-VDGNGCIDRGELLNIIKA 116 (198)
T ss_dssp HHHHCTTCSSCEEHHHHHHHHHHHSSCCHHHHHHHHHHHHC-TTCSSCEEHHHHHHHHHH
T ss_pred HHHHCCCCCCeEcHHHHHHHHHHHccCchHHHHHHHHHHhc-CCCCCcCcHHHHHHHHHH
Confidence 7788999999999999975 35678999999999 899999999999976554
|
| >1wdc_B Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Y 1kqm_B* 1kwo_B* 1l2o_B* 1qvi_Y* 1s5g_Y* 1sr6_B 1b7t_Y 3jtd_B 3jvt_B 1scm_B 1kk8_B* 1dfk_Y 1dfl_Y* 2w4t_Y 2w4v_Y 2w4w_Y 2otg_B* 2os8_B* 3pn7_B ... | Back alignment and structure |
|---|
Probab=95.79 E-value=0.0007 Score=59.65 Aligned_cols=67 Identities=7% Similarity=-0.100 Sum_probs=51.1
Q ss_pred CCCCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcccc-cccCChhhhhhccCC
Q 009364 367 PGSPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKL-SSILAPNDLEKSRNP 437 (536)
Q Consensus 367 ~~sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~-~~~~~~e~l~~aF~~ 437 (536)
...|..+|.+++|.|+.+|+.. ++..++..++.. ++|.|+|+||+.++... ......+.++.+|+-
T Consensus 21 ~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~-----~~g~i~~~eF~~~~~~~~~~~~~~~~l~~~F~~ 95 (156)
T 1wdc_B 21 KEAFSMIDVDRDGFVSKEDIKAISEQLGRAPDDKELTAMLKE-----APGPLNFTMFLSIFSDKLSGTDSEETIRNAFAM 95 (156)
T ss_dssp HHHHHHHCTTCSSSCCHHHHHHHHHHHSSCCCHHHHHHHHTT-----SSSCCCHHHHHHHHHHHTCSCCCHHHHHHHHHT
T ss_pred HHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHh-----CCCcCcHHHHHHHHHHHhcCCChHHHHHHHHHH
Confidence 3458999999999999999976 467788888853 45899999999766543 234456778888876
Q ss_pred C
Q 009364 438 M 438 (536)
Q Consensus 438 ~ 438 (536)
.
T Consensus 96 ~ 96 (156)
T 1wdc_B 96 F 96 (156)
T ss_dssp T
T ss_pred H
Confidence 5
|
| >2f33_A Calbindin; EF-hand, Ca2+-binding, metal binding protein; NMR {Rattus norvegicus} PDB: 2g9b_A | Back alignment and structure |
|---|
Probab=95.78 E-value=0.0036 Score=59.92 Aligned_cols=69 Identities=4% Similarity=-0.102 Sum_probs=52.8
Q ss_pred CCCCccccCCCccchhhhhh------------hhhhhhhh----hhhccCCCCCCCccchhhhhhhcccc--------cc
Q 009364 369 SPGSVDICNLDSLSCSRVIV------------EKLSGSMH----GWVTSNSNDDLCQLDQEDFVAGDRKL--------SS 424 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~------------~~~~ei~~----l~~~~d~~d~~g~Id~~EF~~~~~~~--------~~ 424 (536)
.|..+|.+++|.|+..|+.. .+.+++.. +++..| .+++|.|+|+||+.++... ..
T Consensus 108 ~F~~~D~d~~G~i~~~el~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~d-~~~dg~i~~~ef~~~~~~~~~~~~~~~~~ 186 (263)
T 2f33_A 108 TWRKYDTDHSGFIETEELKNFLKDLLEKANKTVDDTKLAEYTDLMLKLFD-SNNDGKLELTEMARLLPVQENFLLKFQGI 186 (263)
T ss_dssp HHTTSSTTTCSSBCHHHHHHHHHHHHHHHTSCCCHHHHHHHHHHHHHHTC-SSSSSCBCHHHHHHHSCTTTCSHHHHHHT
T ss_pred HHHHHCCCCCCCcCHHHHHHHHHHHHhhcCCCCCHHHHHHHHHHHHHhcC-CCCCCeEcHHHHHHHHHHHHHHHHHhcCc
Confidence 49999999999999999875 24556666 999999 8999999999999766531 12
Q ss_pred cCChhhhhhccCCC
Q 009364 425 ILAPNDLEKSRNPM 438 (536)
Q Consensus 425 ~~~~e~l~~aF~~~ 438 (536)
....+.++.+|+-.
T Consensus 187 ~~~~~~~~~~F~~~ 200 (263)
T 2f33_A 187 KMCGKEFNKAFELY 200 (263)
T ss_dssp CCCHHHHHHHHHHH
T ss_pred chHHHHHHHHHHHh
Confidence 34456777777643
|
| >1dgu_A Calcium-saturated CIB; helical, EF-hands, blood clotting; NMR {Homo sapiens} SCOP: a.39.1.5 PDB: 1dgv_A 1xo5_A 1y1a_A* | Back alignment and structure |
|---|
Probab=95.77 E-value=0.0022 Score=58.19 Aligned_cols=52 Identities=12% Similarity=-0.045 Sum_probs=44.0
Q ss_pred CCCCccccCCCccchhhhhh-------------hhhhhhhh----hhhccCCCCCCCccchhhhhhhccc
Q 009364 369 SPGSVDICNLDSLSCSRVIV-------------EKLSGSMH----GWVTSNSNDDLCQLDQEDFVAGDRK 421 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~-------------~~~~ei~~----l~~~~d~~d~~g~Id~~EF~~~~~~ 421 (536)
.|..+|.+++|.|+..|+.. .+.++++. +++..| .|++|.|+|+||+.++..
T Consensus 103 ~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~D-~d~dG~I~~~EF~~~~~~ 171 (183)
T 1dgu_A 103 AFRIFDFDDDGTLNREDLSRLVNCLTGEGEDTRLSASEMKQLIDNILEESD-IDRDGTINLSEFQHVISR 171 (183)
T ss_dssp HHHHHCTTCSSEEEHHHHHHHHHHHHSSSCCCHHHHHHHHHHHHHHHHHHC-TTSSSEEEHHHHHHHHCS
T ss_pred HHHHhCCCCCCcCCHHHHHHHHHHHhcccccCCCCHHHHHHHHHHHHHHhC-CCCCCeEcHHHHHHHHHh
Confidence 48999999999999999965 24566765 899999 899999999999976654
|
| >1g8i_A Frequenin, neuronal calcium sensor 1; calcium binding-protein, EF-hand, calcium ION, metal binding protein; HET: 1PE P6G; 1.90A {Homo sapiens} SCOP: a.39.1.5 PDB: 2lcp_A | Back alignment and structure |
|---|
Probab=95.74 E-value=0.0015 Score=59.54 Aligned_cols=51 Identities=8% Similarity=-0.070 Sum_probs=44.6
Q ss_pred CCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhccc
Q 009364 370 PGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRK 421 (536)
Q Consensus 370 f~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~ 421 (536)
|..+|.+++|.|+..|+.. .+.+++..+|+.+| .|++|.|+++||..++..
T Consensus 69 f~~~D~d~~g~i~~~ef~~~~~~~~~~~~~~~~~~~f~~~D-~d~~G~i~~~e~~~~l~~ 127 (190)
T 1g8i_A 69 FNVFDENKDGRIEFSEFIQALSVTSRGTLDEKLRWAFKLYD-LDNDGYITRNEMLDIVDA 127 (190)
T ss_dssp HHHHCTTCSSEEEHHHHHHHHHHHHHCCHHHHHHHHHHHHC-TTCSSEEEHHHHHHHHHH
T ss_pred HHHHhcCCCCeEeHHHHHHHHHHhcCCCHHHHHHHHHHhhc-CCCCCeECHHHHHHHHHH
Confidence 7788999999999999975 34678999999999 899999999999976544
|
| >2l4h_A Calcium and integrin-binding protein 1; metal binding protei; NMR {Homo sapiens} PDB: 2l4i_A 2lm5_A | Back alignment and structure |
|---|
Probab=95.72 E-value=0.0023 Score=60.19 Aligned_cols=52 Identities=12% Similarity=-0.045 Sum_probs=43.3
Q ss_pred CCCCccccCCCccchhhhhh-------------hhhhhhhh----hhhccCCCCCCCccchhhhhhhccc
Q 009364 369 SPGSVDICNLDSLSCSRVIV-------------EKLSGSMH----GWVTSNSNDDLCQLDQEDFVAGDRK 421 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~-------------~~~~ei~~----l~~~~d~~d~~g~Id~~EF~~~~~~ 421 (536)
.|..+|.+++|.|+.+||.. .+.++++. +++..| .|++|.|+|+||+.++..
T Consensus 134 ~F~~~D~d~dG~Is~~El~~~l~~~~~~~~~~~~s~~e~~~~~~~~~~~~D-~d~dG~Is~~EF~~~~~~ 202 (214)
T 2l4h_A 134 AFRIFDFDDDGTLNREDLSRLVNCLTGEGEDTRLSASEMKQLIDNILEESD-IDRDGTINLSEFQHVISR 202 (214)
T ss_dssp HHHHHCTTCSSCBCHHHHHHHHHHHHHSSSCTTCSCTHHHHHHHHHHHHHC-CSCCSSBCSHHHHHHHHT
T ss_pred HHHHhCCCCCCcCCHHHHHHHHHHHhccccCCCCCHHHHHHHHHHHHHHhC-CCCCCcCCHHHHHHHHHh
Confidence 48999999999999999975 13456664 899999 899999999999976543
|
| >2ccm_A Calexcitin; EF hand, calcium, signaling protein; 1.8A {Loligo pealeii} | Back alignment and structure |
|---|
Probab=95.68 E-value=0.001 Score=60.68 Aligned_cols=52 Identities=6% Similarity=-0.021 Sum_probs=43.9
Q ss_pred CCCCc-cccCCCccchhhhhh------------hhhhhhhhhh-----------hccCCCCCCCccchhhhhhhccc
Q 009364 369 SPGSV-DICNLDSLSCSRVIV------------EKLSGSMHGW-----------VTSNSNDDLCQLDQEDFVAGDRK 421 (536)
Q Consensus 369 sf~~~-D~~~~g~ls~~el~~------------~~~~ei~~l~-----------~~~d~~d~~g~Id~~EF~~~~~~ 421 (536)
.|..+ |.+++|.|+.+|+.. .+.++++.++ +..| .|++|.|+|+||+.++..
T Consensus 17 ~F~~~~D~d~dG~i~~~E~~~~l~~~~~~~g~~~~~~~~~~l~~~~~~~~~~~~~~~D-~d~dG~i~~~Ef~~~~~~ 92 (191)
T 2ccm_A 17 VFNTFYDCNHDGVIEWDDFELAIKKICNLHSWPTDGKKHNEARATLKLIWDGLRKYAD-ENEDEQVTKEEWLKMWAE 92 (191)
T ss_dssp HHHHHTCTTCSSEECHHHHHHHHHHHHHHHTCCTTSHHHHHHHHHHHHHHHHHHHHHC-TTCSSCEEHHHHHHHHHH
T ss_pred hccccccCCCCCeeeHHHHHHHHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC-CCCCCeECHHHHHHHHHH
Confidence 48899 999999999999964 3456788888 8999 899999999999966543
|
| >2l2e_A Calcium-binding protein NCS-1; NCS1P, myristoylated, metal binding protein; HET: MYR; NMR {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=95.67 E-value=0.0023 Score=58.31 Aligned_cols=51 Identities=8% Similarity=-0.013 Sum_probs=44.7
Q ss_pred CCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhccc
Q 009364 370 PGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRK 421 (536)
Q Consensus 370 f~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~ 421 (536)
|..+|.+++|.|+..|+.. .+.+++..+++.+| .|++|.|+++||..++..
T Consensus 69 f~~~D~d~~G~i~~~ef~~~~~~~~~~~~~~~~~~~f~~~D-~d~~G~i~~~e~~~~~~~ 127 (190)
T 2l2e_A 69 FNVFDADKNGYIDFKEFICALSVTSRGELNDKLIWAFQLYD-LDNNGLISYDEMLRIVDA 127 (190)
T ss_dssp HHHHCSSSTTCEEHHHHHHHHTTSSCSCSHHHHHHHHHHHC-TTSCSCBCHHHHHHHHHH
T ss_pred HHHhcCCCCCeEeHHHHHHHHHHHcCCCHHHHHHHHHhHcc-CCCCCcCcHHHHHHHHHH
Confidence 7889999999999999976 34678999999999 899999999999966543
|
| >1sra_A Sparc; extracellular matrix protein, calcium-binding protein; 2.00A {Homo sapiens} SCOP: a.39.1.3 | Back alignment and structure |
|---|
Probab=95.64 E-value=0.0041 Score=55.03 Aligned_cols=52 Identities=12% Similarity=-0.035 Sum_probs=45.0
Q ss_pred CCCCCcccc-CCCccchhhhhh------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 368 GSPGSVDIC-NLDSLSCSRVIV------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 368 ~sf~~~D~~-~~g~ls~~el~~------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
..|..+|.+ ++|.|+..||.. ..+.-+..+++..| .|+||.|+++||+....
T Consensus 81 W~F~~lD~n~~DG~Isr~EL~~i~~~l~~~e~cv~~ff~~cD-~d~Dg~ISl~Ew~~Clg 139 (151)
T 1sra_A 81 WQFGQLDQHPIDGYLSHTELAPLRAPLIPMEHCTTRFFETCD-LDNDKYIALDEWAGCFG 139 (151)
T ss_dssp HHHHHHCCTTCSSEECTTTTGGGGSTTSTTGGGHHHHHHHHC-TTCSSSEEHHHHHHHTT
T ss_pred hHHHHHCCCCCCCcCcHHHHHHHHHHhcChHHHHHHHHHHhC-CCCCCcCCHHHHHHHhC
Confidence 359999997 999999999987 24667899999999 99999999999996443
|
| >3sg6_A Gcamp2, myosin light chain kinase, green fluorescent PROT calmodulin chimera; calcium sensor, fluorescent protein; HET: CRO; 1.70A {Gallus gallus} PDB: 3evu_A* 3ek4_A* 3ek7_A* 3evv_A* 3ek8_A* 3ekh_A* 3sg2_A* 3sg3_A* 3sg7_A* 3ekj_A* 3sg4_A* 3sg5_A* 3evr_A* 3o78_A* 3o77_A* 1trf_A | Back alignment and structure |
|---|
Probab=95.54 E-value=0.0028 Score=66.60 Aligned_cols=51 Identities=14% Similarity=-0.059 Sum_probs=45.8
Q ss_pred CCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 369 SPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
.|..+|.+++|.|+.+||.. .+.++++.+++.+| .|++|.|+|+||+.++.
T Consensus 390 aFk~fD~D~dG~Is~eELr~~L~~lG~~ls~eei~~Lf~~~D-~D~DG~IsfdEFv~~L~ 448 (450)
T 3sg6_A 390 AFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREAD-IDGDGQVNYEEFVQMMT 448 (450)
T ss_dssp HHHHHCTTCSSEECHHHHHHHHHHHTCCCCHHHHHHHHHHHC-TTSSSSEEHHHHHHHHC
T ss_pred HHHHhCCCCCCeEeHHHHHHHHHHhCCCCCHHHHHHHHHHhC-CCCCCcEeHHHHHHHHh
Confidence 49999999999999999986 46789999999999 89999999999997553
|
| >3dd4_A KV channel-interacting protein 4; EF-hands protein, ION transport, ionic channel, membrane, PO potassium channel, potassium transport, transport; 3.00A {Mus musculus} PDB: 2e6w_A | Back alignment and structure |
|---|
Probab=95.50 E-value=0.0039 Score=59.20 Aligned_cols=60 Identities=15% Similarity=0.101 Sum_probs=29.6
Q ss_pred cCCCccchhhhhh---------hhhhhhhhhhhccCCCCCCCccchhhhhhhcccccccCChhhhhhccC
Q 009364 376 CNLDSLSCSRVIV---------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSSILAPNDLEKSRN 436 (536)
Q Consensus 376 ~~~g~ls~~el~~---------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~~~~~e~l~~aF~ 436 (536)
+++|.|+.+|+.. .+..+++.+++.+| .|++|.|+|+||+.++........++.++.+|+
T Consensus 77 d~~G~Is~~ef~~~l~~~~~~~~~~~~~~~lf~~~D-~d~~G~I~~~Ef~~~l~~~~~~~~~~~l~~~F~ 145 (229)
T 3dd4_A 77 CPSGVVNEETFKEIYSQFFPQGDSTTYAHFLFNAFD-TDHNGAVSFEDFIKGLSILLRGTVQEKLNWAFN 145 (229)
T ss_dssp CCSCCCCHHHHHHHHHHHSCSSSHHHHHHHHHHTTC-SSCCSSCCHHHHHHHHHHHHHSCHHHHHHHHHH
T ss_pred CCCCCcCHHHHHHHHHHHCCCCCcHHHHHHHHHHcC-CCCCCeEeHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 4455566665544 22344555566666 555666666666544333222222344455543
|
| >3dd4_A KV channel-interacting protein 4; EF-hands protein, ION transport, ionic channel, membrane, PO potassium channel, potassium transport, transport; 3.00A {Mus musculus} PDB: 2e6w_A | Back alignment and structure |
|---|
Probab=95.49 E-value=0.0033 Score=59.71 Aligned_cols=51 Identities=8% Similarity=-0.025 Sum_probs=44.3
Q ss_pred CCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhccc
Q 009364 370 PGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRK 421 (536)
Q Consensus 370 f~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~ 421 (536)
|..+|.+++|.|+..|+.. ...+++..+|+..| .|++|.|+++||..+...
T Consensus 108 f~~~D~d~~G~I~~~Ef~~~l~~~~~~~~~~~l~~~F~~~D-~d~dG~Is~~E~~~~l~~ 166 (229)
T 3dd4_A 108 FNAFDTDHNGAVSFEDFIKGLSILLRGTVQEKLNWAFNLYD-INKDGYITKEEMLDIMKA 166 (229)
T ss_dssp HHTTCSSCCSSCCHHHHHHHHHHHHHSCHHHHHHHHHHHHC-TTCSSCCBHHHHHHHHHH
T ss_pred HHHcCCCCCCeEeHHHHHHHHHHHcCCChHHHHHHHHHHhC-CCCCCeECHHHHHHHHHH
Confidence 7788999999999999876 34678999999999 999999999999965543
|
| >2ggz_A Guanylyl cyclase-activating protein 3; EF hand, guanylate cyclase activating protein, GCAP, GCAP3, GCAP-3, lyase activator; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.48 E-value=0.0021 Score=60.10 Aligned_cols=51 Identities=8% Similarity=-0.039 Sum_probs=44.7
Q ss_pred CCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhccc
Q 009364 370 PGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRK 421 (536)
Q Consensus 370 f~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~ 421 (536)
|..+|.+++|.|+..|+.. .+.+++..+|+.+| .|++|.|+++||..++..
T Consensus 63 f~~~D~d~dG~I~~~Ef~~~~~~~~~~~~~~~l~~~F~~~D-~d~~G~I~~~E~~~~l~~ 121 (211)
T 2ggz_A 63 YNTFDTNKDGFVDFLEFIAAVNLIMQEKMEQKLKWYFKLYD-ADGNGSIDKNELLDMFMA 121 (211)
T ss_dssp HHHHCTTCSSEEEHHHHHHHHHHHSCSSHHHHHHHHHHHHC-TTCSSSBCHHHHHHHHHH
T ss_pred HHHHcCCCCCeEeHHHHHHHHHHhccCchHHHHHHHHHHhc-CCCCCcCcHHHHHHHHHH
Confidence 7788999999999999975 35678999999999 899999999999976554
|
| >2jul_A Calsenilin; EF-hand, calcium, LXXLL, DNA binding protein, dimer, alternative splicing, apoptosis, cytoplasm, endoplasmic reticulum, golgi apparatus; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=95.45 E-value=0.0049 Score=59.54 Aligned_cols=52 Identities=10% Similarity=0.068 Sum_probs=45.1
Q ss_pred CCCCccccCCCccchhhhhh----h----------------hhhhhhhhhhccCCCCCCCccchhhhhhhccc
Q 009364 369 SPGSVDICNLDSLSCSRVIV----E----------------KLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRK 421 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~----~----------------~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~ 421 (536)
.|..+|.+++|.|+.+|+.. . +.++++.+|+.+| .|++|.|+|+||+.++..
T Consensus 170 ~F~~~D~d~dG~I~~~Ef~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D-~d~dG~Is~~Ef~~~~~~ 241 (256)
T 2jul_A 170 AFNLYDINKDGCITKEEMLAIMKSIYDMMGRHTYPILREDAPLEHVERFFQKMD-RNQDGVVTIDEFLETCQK 241 (256)
T ss_dssp HHHHTCCSSSSCBCHHHHHHHHHHHHHHCCCCCSCCSCCCCHHHHHHHHHHHSC-CSTTCSBCHHHHHHHHHH
T ss_pred HHHHhCCCCCCcCcHHHHHHHHHHHHHHhCCCCCcccchhhHHHHHHHHHHHHC-CCCCCcEeHHHHHHHHHh
Confidence 38889999999999999975 1 4678999999999 899999999999976553
|
| >3cs1_A Flagellar calcium-binding protein; myristoylated, palmitoylated, SEN membrane targeting, EF-hand, cell projection, cilium; 2.00A {Trypanosoma cruzi} | Back alignment and structure |
|---|
Probab=95.43 E-value=0.0007 Score=63.87 Aligned_cols=70 Identities=14% Similarity=-0.043 Sum_probs=49.4
Q ss_pred CCCCCccccCCCccchhhhhh---------hhhhhhhhhhhcc---------CCCCCCCccchhhhhhhcccccccCChh
Q 009364 368 GSPGSVDICNLDSLSCSRVIV---------EKLSGSMHGWVTS---------NSNDDLCQLDQEDFVAGDRKLSSILAPN 429 (536)
Q Consensus 368 ~sf~~~D~~~~g~ls~~el~~---------~~~~ei~~l~~~~---------d~~d~~g~Id~~EF~~~~~~~~~~~~~e 429 (536)
..|..+|.+++|.|+..||.. ++.+++..++..+ + .|++|.|+|+||+.++.........+
T Consensus 52 ~~F~~~D~d~dG~I~~~El~~~l~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~-~d~~g~I~~~EF~~~~~~~~~~~~~~ 130 (219)
T 3cs1_A 52 ELFKKFDKNETGKLCYDEVYSGCLEVLKLDEFTSRVRDITKRAFDKSRTLGSK-LENKGSEDFVEFLEFRLMLCYIYDFF 130 (219)
T ss_dssp HHHHHHCTTCSSCBCHHHHHHHHHHTTCGGGTCSCHHHHHHHHHHHHHHHHHH-HHTSCCCSSBCHHHHHHHHHHHHHHH
T ss_pred HHHHHhCCCCCCcCcHHHHHHHHHHHhCCCccHHHHHHHHHHHHHHHHhhhhc-cCCCCcCCHHHHHHHHHHHhccchHH
Confidence 359999999999999999974 3446676665533 3 36789999999997654332223345
Q ss_pred hhhhccCCC
Q 009364 430 DLEKSRNPM 438 (536)
Q Consensus 430 ~l~~aF~~~ 438 (536)
.++.+|+-.
T Consensus 131 ~l~~~F~~~ 139 (219)
T 3cs1_A 131 ELTVMFDEI 139 (219)
T ss_dssp HHHHHHHTT
T ss_pred HHHHHHHHH
Confidence 688888755
|
| >1s1e_A KV channel interacting protein 1; kchip, calcium-binding protein, EF-finger, transport protein; 2.30A {Homo sapiens} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=95.42 E-value=0.0036 Score=59.22 Aligned_cols=52 Identities=6% Similarity=-0.033 Sum_probs=44.6
Q ss_pred CCCCccccCCCccchhhhhhh--------------------hhhhhhhhhhccCCCCCCCccchhhhhhhccc
Q 009364 369 SPGSVDICNLDSLSCSRVIVE--------------------KLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRK 421 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~~--------------------~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~ 421 (536)
.|..+|.+++|.|+.+|+... ..+++..+++.+| .|++|.|+|+||+.++..
T Consensus 130 ~F~~~D~d~dG~Is~~E~~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D-~d~dG~Is~~EF~~~~~~ 201 (224)
T 1s1e_A 130 TFNLYDINKDGYINKEEMMDIVKAIYDMMGKYTYPVLKEDTPRQHVDVFFQKMD-KNKDGIVTLDEFLESCQE 201 (224)
T ss_dssp HHHHHCTTCCSEECHHHHHHHHHHHHHHHTTCCCGGGCSSSHHHHHHHHHHHHC-TTCSSCEEHHHHHHHHHT
T ss_pred HHHHHcCCCCCeECHHHHHHHHHHHHHHhcccCCCCCCHhHHHHHHHHHHHHhC-CCCCCcEeHHHHHHHHHh
Confidence 488999999999999999751 1277999999999 899999999999976654
|
| >2sas_A Sarcoplasmic calcium-binding protein; 2.40A {Branchiostoma lanceolatum} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=95.38 E-value=0.0038 Score=56.09 Aligned_cols=65 Identities=17% Similarity=0.079 Sum_probs=50.2
Q ss_pred CCCccccCCCccchhhhhh-----h------------hhhhhhhhhhccCCCCCCCccchhhhhhhcccccccCChhhhh
Q 009364 370 PGSVDICNLDSLSCSRVIV-----E------------KLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSSILAPNDLE 432 (536)
Q Consensus 370 f~~~D~~~~g~ls~~el~~-----~------------~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~~~~~e~l~ 432 (536)
|..+|.+++|.|+.+|+.. . ...++..+|+.+| .|++|.|+++||..+..... .+++++.
T Consensus 66 f~~~D~d~dG~I~~~Ef~~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D-~d~dG~Is~~E~~~~l~~~g--~~~~~~~ 142 (185)
T 2sas_A 66 KGRADINKDDVVSWEEYLAMWEKTIATCKSVADLPAWCQNRIPFLFKGMD-VSGDGIVDLEEFQNYCKNFQ--LQCADVP 142 (185)
T ss_dssp HHHHCTTCSSCEEHHHHHHHHHHHHHTCCSGGGSCTTHHHHHHHHHHHHC-TTSSSCCCHHHHHHHTTSSC--CCCSSHH
T ss_pred HHhcCCCCCCeEcHHHHHHHHHHHhccccchhhhhHHHHHHHHHHHHHHc-CCCCCeEcHHHHHHHHHHhC--CCHHHHH
Confidence 7788999999999999865 1 2367899999999 89999999999997665432 3445555
Q ss_pred hccCC
Q 009364 433 KSRNP 437 (536)
Q Consensus 433 ~aF~~ 437 (536)
+.|+.
T Consensus 143 ~~~~~ 147 (185)
T 2sas_A 143 AVYNV 147 (185)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 55543
|
| >3akb_A Putative calcium binding protein; EF-hand, metal binding protein; 1.50A {Streptomyces coelicolor} PDB: 3aka_A | Back alignment and structure |
|---|
Probab=95.36 E-value=0.0036 Score=55.15 Aligned_cols=52 Identities=15% Similarity=0.072 Sum_probs=42.4
Q ss_pred CCCCccccCCCccchhhhhh------------hhhhhhhhh-----------hhccCCCCCCCccchhhhhhhccc
Q 009364 369 SPGSVDICNLDSLSCSRVIV------------EKLSGSMHG-----------WVTSNSNDDLCQLDQEDFVAGDRK 421 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~------------~~~~ei~~l-----------~~~~d~~d~~g~Id~~EF~~~~~~ 421 (536)
.|..+|.+++|.|+.+|+.. ++.+++..+ ++..| .|++|.|+|+||+.++..
T Consensus 9 ~F~~~D~d~dG~i~~~E~~~~l~~~~~~~g~~~~~~~~~~l~~~~~~~~~~~f~~~D-~d~~g~i~~~ef~~~~~~ 83 (166)
T 3akb_A 9 RFTTFDQDGNGHIDRSDFSGAAKAMLAEFGVAARSDRGQALYGGAEALWQGLAGIAD-RDGDQRITREEFVTGAVK 83 (166)
T ss_dssp HHHHHCTTCSSEECHHHHHHHHHHHHHHHTCCTTSHHHHHHHHHHHHHHHHHHHHHC-TTSSSCEEHHHHHHTHHH
T ss_pred HHhHHcCCCCCCcCHHHHHHHHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHhC-CCCCCcCcHHHHHHHHHH
Confidence 48889999999999999975 345566644 68999 899999999999976554
|
| >2mys_B Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1i84_U* 1m8q_B* 1mvw_B* 1o18_E* 1o19_B* 1o1a_B* 1o1b_B* 1o1c_B* 1o1d_B* 1o1e_B* 1o1f_B* 1o1g_B* 2w4a_B 2w4g_B 2w4h_B | Back alignment and structure |
|---|
Probab=95.23 E-value=0.0027 Score=56.43 Aligned_cols=70 Identities=4% Similarity=-0.192 Sum_probs=51.5
Q ss_pred ccCCCCCCCccccCCCccchhhhhh---------hhhhhhhhhhhccCCCCCCCccchhhhhhhcccc-cccCChhhhhh
Q 009364 364 LTSPGSPGSVDICNLDSLSCSRVIV---------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKL-SSILAPNDLEK 433 (536)
Q Consensus 364 ~t~~~sf~~~D~~~~g~ls~~el~~---------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~-~~~~~~e~l~~ 433 (536)
......|..+|.+++|.|+..|+.. ++..++..++... +|.|+|+||+.++... ......+.++.
T Consensus 25 ~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~l~~~~-----dg~i~~~eF~~~~~~~~~~~~~~~~l~~ 99 (166)
T 2mys_B 25 EDFKEAFTVIDQNADGIIDKDDLRETFAAMGRLNVKNEELDAMIKEA-----SGPINFTVFLTMFGEKLKGADPEDVIMG 99 (166)
T ss_pred HHHHHHHHHHCCCCCCcCCHHHHHHHHHHhCCCCCCHHHHHHHHHHC-----CCCcCHHHHHHHHHHHhccCCcHHHHHH
Confidence 3344569999999999999999975 2456788888764 4889999999766543 23345567888
Q ss_pred ccCCC
Q 009364 434 SRNPM 438 (536)
Q Consensus 434 aF~~~ 438 (536)
+|+-.
T Consensus 100 ~F~~~ 104 (166)
T 2mys_B 100 AFKVL 104 (166)
T ss_pred HHHHh
Confidence 88754
|
| >2jul_A Calsenilin; EF-hand, calcium, LXXLL, DNA binding protein, dimer, alternative splicing, apoptosis, cytoplasm, endoplasmic reticulum, golgi apparatus; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=95.22 E-value=0.002 Score=62.38 Aligned_cols=67 Identities=13% Similarity=-0.008 Sum_probs=42.1
Q ss_pred CCCcccc-CCCccchhhhhh---------hhhhhhhhhhhccCCCCCCCccchhhhhhhcccccccCChhhhhhccCC
Q 009364 370 PGSVDIC-NLDSLSCSRVIV---------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSSILAPNDLEKSRNP 437 (536)
Q Consensus 370 f~~~D~~-~~g~ls~~el~~---------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~~~~~e~l~~aF~~ 437 (536)
|..||.+ ++|.|+.+|+.. .+..++..+|+.+| .|++|.|+|+||+.++........+++++.+|+-
T Consensus 97 ~~~fd~~~~~G~I~~~ef~~~l~~~~~~~~~~~~~~~~f~~~D-~d~dG~I~~~Ef~~~l~~~~~~~~~~~l~~~F~~ 173 (256)
T 2jul_A 97 YRGFKNECPTGLVDEDTFKLIYSQFFPQGDATTYAHFLFNAFD-ADGNGAIHFEDFVVGLSILLRGTVHEKLKWAFNL 173 (256)
T ss_dssp HHHHHHHCTTSSEEHHHHHHHHHHHCCSSCCHHHHHHHHHHSS-CSCCSEECSHHHHHHHHHHHSCCHHHHHHHHHHH
T ss_pred HHHHHhhCCCCcCCHHHHHHHHHHHcccCCcHHHHHHHHHHhc-cCCCCcCcHHHHHHHHHHHhccChHHHHHHHHHH
Confidence 4444443 677777777765 23456777777777 7777788888887655443333345566666653
|
| >2be4_A Hypothetical protein LOC449832; DR.36843, BC083168, calicium binding, EF-hand superfamily, S genomics, protein structure initiative, PSI; 2.10A {Danio rerio} PDB: 2q4u_A | Back alignment and structure |
|---|
Probab=95.20 E-value=0.0021 Score=62.00 Aligned_cols=66 Identities=8% Similarity=-0.134 Sum_probs=0.0
Q ss_pred CCCccccCCCccchhhhh--------------hhhhhhhhhhh----hccCCCCCCCccchhhhhhh-----------cc
Q 009364 370 PGSVDICNLDSLSCSRVI--------------VEKLSGSMHGW----VTSNSNDDLCQLDQEDFVAG-----------DR 420 (536)
Q Consensus 370 f~~~D~~~~g~ls~~el~--------------~~~~~ei~~l~----~~~d~~d~~g~Id~~EF~~~-----------~~ 420 (536)
|..+|.+++|.|+.+|+. .++.+++..++ ..+| .|++|.|+|+||+.+ ..
T Consensus 17 F~~~D~d~~G~i~~~El~~~l~~~~~~lg~~~~~~~~~~~~~~~~~f~~~D-~d~~g~i~~~Ef~~~~~~~~~~~~~~~~ 95 (272)
T 2be4_A 17 WQHFDADDNGYIEGKELDDFFRHMLKKLQPKDKITDERVQQIKKSFMSAYD-ATFDGRLQIEELANMILPQEENFLLIFR 95 (272)
T ss_dssp HHHHCTTCCSEEEGGGHHHHHHHHHHHHSTTSCCCHHHHHHHHHHHSCHHH-HTCCSEEEHHHHHHHHSCHHHHHHHHHH
T ss_pred HHHhcCCCCCCcCHHHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhc-CCCCCcEeHHHHHHHHhhhhHHHHHHHh
Q ss_pred cccccCChhhhhhccC
Q 009364 421 KLSSILAPNDLEKSRN 436 (536)
Q Consensus 421 ~~~~~~~~e~l~~aF~ 436 (536)
........++++.+|+
T Consensus 96 ~~~~~~~~~~l~~~F~ 111 (272)
T 2be4_A 96 REAPLDNSVEFMKIWR 111 (272)
T ss_dssp HHSCCCCHHHHHHHHH
T ss_pred hccCcccHHHHHHHHH
|
| >1jfj_A Ehcabp, calcium-binding protein; EF-hand, helix-loop-helix, metal binding protein; NMR {Entamoeba histolytica} SCOP: a.39.1.5 PDB: 1jfk_A 2nxq_A 3px1_A 3qjk_A 2jnx_A 2i18_A | Back alignment and structure |
|---|
Probab=95.19 E-value=0.0036 Score=52.82 Aligned_cols=50 Identities=12% Similarity=0.047 Sum_probs=41.5
Q ss_pred CCCCccccCCCccchhhhhhh-h---hhhhhhhhhccCCCCCCCccchhhhhhhc
Q 009364 369 SPGSVDICNLDSLSCSRVIVE-K---LSGSMHGWVTSNSNDDLCQLDQEDFVAGD 419 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~~-~---~~ei~~l~~~~d~~d~~g~Id~~EF~~~~ 419 (536)
.|..+|.+++|.|+.+|+... . ...+..+++.+| .|++|.|+|+||+.++
T Consensus 80 ~f~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~D-~~~dg~i~~~ef~~~l 133 (134)
T 1jfj_A 80 LYKLMDVDGDGKLTKEEVTSFFKKHGIEKVAEQVMKAD-ANGDGYITLEEFLEFS 133 (134)
T ss_dssp HHHHHCCSSSSEEEHHHHHHHHTTTTCHHHHHHHHHHH-CSSSSEEEHHHHHHHH
T ss_pred HHHHHCCCCCCccCHHHHHHHHHHhCHHHHHHHHHHhC-CCCCCcEeHHHHHHHh
Confidence 488899999999999999871 1 111889999999 8999999999998653
|
| >1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A | Back alignment and structure |
|---|
Probab=95.18 E-value=0.0051 Score=61.91 Aligned_cols=51 Identities=20% Similarity=0.057 Sum_probs=44.8
Q ss_pred CCCCccccCCCccchhhhhh---------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 369 SPGSVDICNLDSLSCSRVIV---------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~---------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
.|..+|.+++|.|+.+|+.. .+.+++..++..+| .|++|.|+|+||+.++.
T Consensus 258 ~F~~~D~d~dG~Is~~El~~~l~~~~g~~ls~~e~~~l~~~~D-~d~dG~Is~~EF~~~~~ 317 (323)
T 1ij5_A 258 LYAFADFDKSGQLSKEEVQKVLEDAHIPESARKKFEHQFSVVD-VDDSKSLSYQEFVMLVL 317 (323)
T ss_dssp HHHHTCSSSCSSEEHHHHHHHHHHTTCCGGGCSTHHHHHHHHT-TTTCSEECHHHHHHHHH
T ss_pred HHHHhCCCCCCCccHHHHHHHHHHHcCCCCCHHHHHHHHHHHC-CCCCCcEeHHHHHHHHH
Confidence 48899999999999999864 36789999999999 89999999999996543
|
| >3dtp_E RLC, myosin regulatory light chain; muscle protein, smooth muscle, myosin subfragment 2, heavy meromyosin, essential light chain; 20.00A {Avicularia avicularia} | Back alignment and structure |
|---|
Probab=95.16 E-value=0.0049 Score=56.84 Aligned_cols=67 Identities=6% Similarity=-0.159 Sum_probs=52.4
Q ss_pred CCCCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcccc-cccCChhhhhhccCC
Q 009364 367 PGSPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKL-SSILAPNDLEKSRNP 437 (536)
Q Consensus 367 ~~sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~-~~~~~~e~l~~aF~~ 437 (536)
...|..+|.+++|.|+..||.. ++..++..++... +|.|+|+||+.++... ......+.++.+|+-
T Consensus 60 ~~~F~~~D~d~~G~i~~~el~~~l~~lg~~~~~~~~~~l~~~~-----~g~i~~~eF~~~~~~~~~~~~~~~~l~~~F~~ 134 (196)
T 3dtp_E 60 KEAFQLIDQDKDGFISKNDIRATFDSLGRLCTEQELDSMVAEA-----PGPINFTMFLTIFGDRIAGTDEEDVIVNAFNL 134 (196)
T ss_dssp HHHHHHHCCSCSSBCCHHHHHHHHHTTSCCCCHHHHHHHHTTS-----SSCCBHHHHHHHHHHCCCSSCCHHHHHHHHHT
T ss_pred HHHHHHHCCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHc-----cCCCcHHHHHHHHHHHhcCCCcHHHHHHHHHH
Confidence 3359999999999999999976 5678888888876 4889999999766543 334556778888875
Q ss_pred C
Q 009364 438 M 438 (536)
Q Consensus 438 ~ 438 (536)
.
T Consensus 135 ~ 135 (196)
T 3dtp_E 135 F 135 (196)
T ss_dssp T
T ss_pred H
Confidence 4
|
| >3fs7_A Parvalbumin, thymic; calcium-binding protein, EF-hand, acetylation, calcium, metal binding protein; 1.95A {Gallus gallus} SCOP: a.39.1.4 PDB: 2kqy_A | Back alignment and structure |
|---|
Probab=95.12 E-value=0.0065 Score=50.02 Aligned_cols=65 Identities=9% Similarity=0.082 Sum_probs=49.7
Q ss_pred CCCccccCCCccchhhhhh------hhhhhhhhhhhccCCCCCCCccchhhhhhhcccc---cccCChhhhhhccCC
Q 009364 370 PGSVDICNLDSLSCSRVIV------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKL---SSILAPNDLEKSRNP 437 (536)
Q Consensus 370 f~~~D~~~~g~ls~~el~~------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~---~~~~~~e~l~~aF~~ 437 (536)
+..+| ++|.|+.+|+.. ...+++..+|+.+| .|++|.|+.+||..+.... ....+++++...|+.
T Consensus 16 ~~~~D--~~g~i~~~eF~~~~~~~~~~~~~l~~~F~~~D-~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~~ 89 (109)
T 3fs7_A 16 LSSCQ--AADSFNYKSFFSTVGLSSKTPDQIKKVFGILD-QDKSGFIEEEELQLFLKNFSSSARVLTSAETKAFLAA 89 (109)
T ss_dssp HHHTC--STTCCCHHHHHHHHTCTTCCHHHHHHHHHHHS-TTCSSSBCHHHHHTTGGGTCTTSCCCCHHHHHHHHHH
T ss_pred HHhcC--CCCcCcHHHHHHHHhcCCCcHHHHHHHHHHHC-CCCCCeEeHHHHHHHHHHHhcccccCCHHHHHHHHHH
Confidence 33445 789999999876 34678999999999 8999999999999766655 445666666666553
|
| >2zkm_X 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta-2; phospholipase C, phosphoinositide phospholipase, PLC-beta-2, calcium, coiled coil; 1.62A {Homo sapiens} SCOP: a.39.1.7 b.7.1.1 b.55.1.1 c.1.18.1 PDB: 2fju_B | Back alignment and structure |
|---|
Probab=95.07 E-value=0.0046 Score=69.68 Aligned_cols=66 Identities=2% Similarity=-0.074 Sum_probs=52.3
Q ss_pred CC--CccccCCCccchhhhhh---hhhhhhhhhhhccCC------CCCCCccchhhhhhhcccccccCChhhhhhccCCC
Q 009364 370 PG--SVDICNLDSLSCSRVIV---EKLSGSMHGWVTSNS------NDDLCQLDQEDFVAGDRKLSSILAPNDLEKSRNPM 438 (536)
Q Consensus 370 f~--~~D~~~~g~ls~~el~~---~~~~ei~~l~~~~d~------~d~~g~Id~~EF~~~~~~~~~~~~~e~l~~aF~~~ 438 (536)
|. .||.+++|.|+..||+. ..+++++++++++|. .+++|.|+|+||+.++... ...++|+++|+-.
T Consensus 152 F~~~~fD~d~dG~Is~~EL~~~l~~~~~ev~~li~~~d~~~~~~D~d~~g~idf~EF~~~~~~l---~~r~el~~aF~~f 228 (799)
T 2zkm_X 152 LVKLKMQLNSEGKIPVKNFFQMFPADRKRVEAALSACHLPKGKNDAINPEDFPEPVYKSFLMSL---CPRPEIDEIFTSY 228 (799)
T ss_dssp HHHHHHSCCTTSCEEHHHHHHHSCSCHHHHHHHHHHTTCCCCTTCEECGGGCCHHHHHHHHHHH---SCCHHHHTTCC--
T ss_pred hHHhccCCCCCCeECHHHHHHHHhhhHHHHHHHHHHhCcCccccccCCCCcCCHHHHHHHHHHc---cCHHHHHHHHHHh
Confidence 66 68999999999999987 357899999998882 3788999999999876543 2357899999876
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 536 | ||||
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-86 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-85 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-84 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-82 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-81 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 6e-80 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-79 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-79 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-78 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-78 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-77 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-76 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-75 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-73 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-72 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-72 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 9e-72 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-71 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-70 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 9e-69 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-68 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-67 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-66 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-66 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 7e-66 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 9e-66 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-65 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-65 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-64 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-64 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-63 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-63 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-63 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-63 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 8e-63 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-62 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-62 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-62 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-62 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-62 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 9e-62 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-61 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-61 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-61 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-61 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-60 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-60 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-59 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-59 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-59 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-59 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-59 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-59 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-58 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 9e-58 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-57 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-57 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 8e-57 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-54 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-51 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-50 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-44 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-23 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 265 bits (678), Expect = 3e-86
Identities = 79/267 (29%), Positives = 130/267 (48%), Gaps = 12/267 (4%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLK 126
+ G +G G FG VY+ S +LA+K + F ++ + +L EV++
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVL-----FKAQLEKAGVEHQLRREVEIQS 61
Query: 127 DLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEY 186
L HPNI+R G + + ++LE+ P G++ L K F E TY +L L Y
Sbjct: 62 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 121
Query: 187 LHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIR 246
H+ ++HRDIK N+L+ + G +K+ADFG S S ++ GT ++ PE+I
Sbjct: 122 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS----SRRTTLCGTLDYLPPEMIE 177
Query: 247 QTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKDF 306
H D+WS+G E GKPP+ I ++ P+ ++ A+D
Sbjct: 178 GRMHDEKVDLWSLGVLCYEFLVGKPPFEAN-TYQETYKRI--SRVEFTFPDFVTEGARDL 234
Query: 307 LLKCLEKEPDLRPTASELLKHPFVTGD 333
+ + L+ P RP E+L+HP++T +
Sbjct: 235 ISRLLKHNPSQRPMLREVLEHPWITAN 261
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 263 bits (674), Expect = 3e-85
Identities = 106/284 (37%), Positives = 151/284 (53%), Gaps = 16/284 (5%)
Query: 61 KMSPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEE 120
++P W +G GAFG+VY N ++ L A K + K+++ +++
Sbjct: 7 DLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVI--------DTKSEEELEDYMV 58
Query: 121 EVKLLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQ 179
E+ +L HPNIV+ L E +L IL+EF GG++ +++ + P E+ ++ KQ
Sbjct: 59 EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQ 118
Query: 180 LLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYW 239
L L YLH++ I+HRD+K NIL G IKLADFG S + T+ S GTPYW
Sbjct: 119 TLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR--TIQRRDSFIGTPYW 176
Query: 240 MAPEVI-----RQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPP 294
MAPEV+ + + Y AD+WS+G T+IEMA +PP + L +
Sbjct: 177 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLA 236
Query: 295 IPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDPV 338
P S KDFL KCLEK D R T S+LL+HPFVT D P+
Sbjct: 237 QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPI 280
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 261 bits (668), Expect = 1e-84
Identities = 73/266 (27%), Positives = 125/266 (46%), Gaps = 8/266 (3%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLK 126
W + +G GA+G V + +N + E +AVK V ++A D + +++E+ + K
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV-------DMKRAVDCPENIKKEICINK 58
Query: 127 DLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEY 186
L+H N+V++ G RE + LE+ GG + + PE + + QL+ G+ Y
Sbjct: 59 MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 118
Query: 187 LHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIR 246
LH GI HRDIK N+L+D + +K++DFG + M GT ++APE+++
Sbjct: 119 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 247 -QTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKD 305
+ H+ D+WS G + M G+ PW Q K++ + +
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 238
Query: 306 FLLKCLEKEPDLRPTASELLKHPFVT 331
L K L + P R T ++ K +
Sbjct: 239 LLHKILVENPSARITIPDIKKDRWYN 264
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 256 bits (655), Expect = 3e-82
Identities = 95/294 (32%), Positives = 155/294 (52%), Gaps = 15/294 (5%)
Query: 60 VKMSPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELE 119
K P + IG G+FG VY ++ + E++A+K++ S +++ + +++
Sbjct: 9 FKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSY-----SGKQSNEKWQDII 63
Query: 120 EEVKLLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQ 179
+EV+ L+ L HPN ++Y G E + +++E+ G + L P E + T
Sbjct: 64 KEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHG 123
Query: 180 LLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYW 239
L GL YLH+H ++HRD+K NIL+ G +KL DFG++ +A A S GTPYW
Sbjct: 124 ALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYW 177
Query: 240 MAPEVIR---QTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIP 296
MAPEVI + + D+WS+G T IE+A KPP ++AL+HI +S
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL-FNMNAMSALYHIAQNESPALQS 236
Query: 297 ENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDPVLHASVMKSSEIL 350
+ S ++F+ CL+K P RPT+ LLKH FV + V+ + ++ + +
Sbjct: 237 GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAV 290
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 254 bits (649), Expect = 5e-81
Identities = 90/322 (27%), Positives = 148/322 (45%), Gaps = 53/322 (16%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLK 126
+ K +G G G V+ + SG ++A K + E ++ E+++L
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLI-------HLEIKPAIRNQIIRELQVLH 59
Query: 127 DLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEY 186
+ + P IV + G + ++I +E + GGS+ +L K G PE ++ + ++ GL Y
Sbjct: 60 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTY 119
Query: 187 LHN-HGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVI 245
L H IMHRD+K +NILV+++G IKL DFG S Q+ + S A S GT +M+PE +
Sbjct: 120 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPERL 175
Query: 246 RQTGHSYSADIWSVGCTVIEMATGKPPW-------------------------------- 273
+ T +S +DIWS+G +++EMA G+ P
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235
Query: 274 --------SQQYQEVAALFHIGTTKSHPPIPEN-LSVKAKDFLLKCLEKEPDLRPTASEL 324
S+ + L + P +P S++ +DF+ KCL K P R +L
Sbjct: 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295
Query: 325 LKHPFVTGDDEDPVLHASVMKS 346
+ H F+ D + V A + S
Sbjct: 296 MVHAFIKRSDAEEVDFAGWLCS 317
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 249 bits (638), Expect = 6e-80
Identities = 89/285 (31%), Positives = 150/285 (52%), Gaps = 11/285 (3%)
Query: 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVK 123
P ++ + E IG GA G VY M++ +G+ +A++Q+ + Q + + E+
Sbjct: 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM--------NLQQQPKKELIINEIL 69
Query: 124 LLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLG 183
++++ +PNIV YL + + L +++E++ GGS++ ++ + E + ++ L
Sbjct: 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQA 128
Query: 184 LEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPE 243
LE+LH++ ++HRDIK NIL+ G +KL DFG Q+ S +M GTPYWMAPE
Sbjct: 129 LEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMVGTPYWMAPE 186
Query: 244 VIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKA 303
V+ + + DIWS+G IEM G+PP+ + A PE LS
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF 246
Query: 304 KDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDPVLHASVMKSSE 348
+DFL +CL+ + + R +A ELL+H F+ L + + E
Sbjct: 247 RDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKE 291
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 249 bits (637), Expect = 1e-79
Identities = 75/281 (26%), Positives = 132/281 (46%), Gaps = 14/281 (4%)
Query: 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKL 124
P ++ G+++G G+F V + L + A+K + ++ + + E +
Sbjct: 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEK-----RHIIKENKVPYVTRERDV 61
Query: 125 LKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGL 184
+ L HP V+ T +++E L L + G + + K G F E R YT +++ L
Sbjct: 62 MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSAL 121
Query: 185 EYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEV 244
EYLH GI+HRD+K NIL++ I++ DFG +K ++ + + A S GT +++PE+
Sbjct: 122 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181
Query: 245 IRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAK 304
+ + S+D+W++GC + ++ G PP+ + E I K PE KA+
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGLPPF-RAGNEYLIFQKI--IKLEYDFPEKFFPKAR 238
Query: 305 DFLLKCLEKEPDLRPTASE------LLKHPFVTGDDEDPVL 339
D + K L + R E L HPF + +
Sbjct: 239 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLH 279
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 247 bits (633), Expect = 2e-79
Identities = 77/279 (27%), Positives = 143/279 (51%), Gaps = 19/279 (6%)
Query: 59 SVKMSPPIRWRK-GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKE 117
+V MS R+ K IG G+F VY G++ ++ +A ++ ++ + +
Sbjct: 1 AVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCEL------QDRKLTKSERQR 54
Query: 118 LEEEVKLLKDLSHPNIVRYLG----TVREEESLNILLEFVPGGSISSLLGKFGPFPEAVM 173
+EE ++LK L HPNIVR+ TV+ ++ + ++ E + G++ + L +F V+
Sbjct: 55 FKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVL 114
Query: 174 RTYTKQLLLGLEYLHNHG--IMHRDIKGANILVDNK-GCIKLADFGASKQVAELATVSGA 230
R++ +Q+L GL++LH I+HRD+K NI + G +K+ D G + L S A
Sbjct: 115 RSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT----LKRASFA 170
Query: 231 KSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTK 290
K++ GTP +MAPE+ + + S D+++ G ++EMAT + P+S+ + +
Sbjct: 171 KAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV 229
Query: 291 SHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPF 329
+ + K+ + C+ + D R + +LL H F
Sbjct: 230 KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF 268
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 247 bits (631), Expect = 4e-78
Identities = 66/272 (24%), Positives = 114/272 (41%), Gaps = 15/272 (5%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLK 126
+ E +G GAFG V+ +G A K V + + + +E++ +
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFV--------MTPHESDKETVRKEIQTMS 78
Query: 127 DLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLG-KFGPFPEAVMRTYTKQLLLGLE 185
L HP +V ++ + ++ EF+ GG + + + E Y +Q+ GL
Sbjct: 79 VLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLC 138
Query: 186 YLHNHGIMHRDIKGANILVDNK--GCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPE 243
++H + +H D+K NI+ K +KL DFG + + + K GT + APE
Sbjct: 139 HMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS---VKVTTGTAEFAAPE 195
Query: 244 VIRQTGHSYSADIWSVGCTVIEMATGKPPW-SQQYQEVAALFHIGTTKSHPPIPENLSVK 302
V Y D+WSVG + +G P+ + E +S
Sbjct: 196 VAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED 255
Query: 303 AKDFLLKCLEKEPDLRPTASELLKHPFVTGDD 334
KDF+ K L +P+ R T + L+HP++T +
Sbjct: 256 GKDFIRKLLLADPNTRMTIHQALEHPWLTPGN 287
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 247 bits (631), Expect = 4e-78
Identities = 66/275 (24%), Positives = 126/275 (45%), Gaps = 15/275 (5%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLK 126
+ E +G GAFG V+ + +G + K + + D ++ E+ ++
Sbjct: 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFI-------NTPYPLDK-YTVKNEISIMN 81
Query: 127 DLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLL-GKFGPFPEAVMRTYTKQLLLGLE 185
L HP ++ ++ + ++LEF+ GG + + + EA + Y +Q GL+
Sbjct: 82 QLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLK 141
Query: 186 YLHNHGIMHRDIKGANILVDNK--GCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPE 243
++H H I+H DIK NI+ + K +K+ DFG + ++ K T + APE
Sbjct: 142 HMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPE 198
Query: 244 VIRQTGHSYSADIWSVGCTVIEMATGKPPW-SQQYQEVAALFHIGTTKSHPPIPENLSVK 302
++ + + D+W++G + +G P+ + E + ++S +
Sbjct: 199 IVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPE 258
Query: 303 AKDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDP 337
AKDF+ L+KEP R T + L+HP++ GD +
Sbjct: 259 AKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNL 293
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 244 bits (623), Expect = 2e-77
Identities = 79/284 (27%), Positives = 141/284 (49%), Gaps = 15/284 (5%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLK 126
+ +++G GAF V + + + +L+A+K + +K+ + +E E+ +L
Sbjct: 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCI-------AKKALEGKEGSMENEIAVLH 62
Query: 127 DLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEY 186
+ HPNIV L ++++ V GG + + + G + E Q+L ++Y
Sbjct: 63 KIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKY 122
Query: 187 LHNHGIMHRDIKGANILV---DNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPE 243
LH+ GI+HRD+K N+L D I ++DFG SK + + GTP ++APE
Sbjct: 123 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTPGYVAPE 179
Query: 244 VIRQTGHSYSADIWSVGCTVIEMATGKPPW-SQQYQEVAALFHIGTTKSHPPIPENLSVK 302
V+ Q +S + D WS+G + G PP+ + ++ + P +++S
Sbjct: 180 VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDS 239
Query: 303 AKDFLLKCLEKEPDLRPTASELLKHPFVTGDDE-DPVLHASVMK 345
AKDF+ +EK+P+ R T + L+HP++ GD D +H SV +
Sbjct: 240 AKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSE 283
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 239 bits (611), Expect = 4e-76
Identities = 75/272 (27%), Positives = 125/272 (45%), Gaps = 12/272 (4%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQV-LIAANFASKEKAQDHIKELEEEVKLL 125
+ E++G G V ++ + + AVK + + S E+ Q+ + +EV +L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 126 KDLS-HPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGL 184
+ +S HPNI++ T ++ + + G + L + E R + LL +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 123
Query: 185 EYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEV 244
LH I+HRD+K NIL+D+ IKL DFG S Q L + + GTP ++APE+
Sbjct: 124 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ---LDPGEKLREVCGTPSYLAPEI 180
Query: 245 IR------QTGHSYSADIWSVGCTVIEMATGKPPW-SQQYQEVAALFHIGTTKSHPPIPE 297
I G+ D+WS G + + G PP+ ++ + + G + P +
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD 240
Query: 298 NLSVKAKDFLLKCLEKEPDLRPTASELLKHPF 329
+ S KD + + L +P R TA E L HPF
Sbjct: 241 DYSDTVKDLVSRFLVVQPQKRYTAEEALAHPF 272
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 237 bits (606), Expect = 2e-75
Identities = 79/274 (28%), Positives = 134/274 (48%), Gaps = 21/274 (7%)
Query: 68 WRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKD 127
+ IG G++GR G++L K++ + + L EV LL++
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDY------GSMTEAEKQMLVSEVNLLRE 59
Query: 128 LSHPNIVRYLGTV--REEESLNILLEFVPGGSISSLLGKF----GPFPEAVMRTYTKQLL 181
L HPNIVRY + R +L I++E+ GG ++S++ K E + QL
Sbjct: 60 LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 119
Query: 182 LGLEYLH-----NHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGT 236
L L+ H H ++HRD+K AN+ +D K +KL DFG ++ + S AK+ GT
Sbjct: 120 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH--DTSFAKAFVGT 177
Query: 237 PYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIP 296
PY+M+PE + + ++ +DIWS+GC + E+ PP+ + + I K IP
Sbjct: 178 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF-TAFSQKELAGKIREGK-FRRIP 235
Query: 297 ENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFV 330
S + + + + L + RP+ E+L++P +
Sbjct: 236 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (591), Expect = 5e-73
Identities = 71/271 (26%), Positives = 124/271 (45%), Gaps = 17/271 (6%)
Query: 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVK 123
P + G+ IG G+FG VY G +AVK + + ++ + EV
Sbjct: 6 PDGQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNV------TAPTPQQLQAFKNEVG 56
Query: 124 LLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLL 182
+L+ H NI+ ++G L I+ ++ G S+ L F + +Q
Sbjct: 57 VLRKTRHVNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQ 115
Query: 183 GLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAP 242
G++YLH I+HRD+K NI + +K+ DFG + + + + + G+ WMAP
Sbjct: 116 GMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175
Query: 243 EVIR---QTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPP---IP 296
EVIR + +S+ +D+++ G + E+ TG+ P+S +F +G P +
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVR 235
Query: 297 ENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327
N K + +CL+K+ D RP ++L
Sbjct: 236 SNCPKAMKRLMAECLKKKRDERPLFPQILAS 266
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (592), Expect = 1e-72
Identities = 74/275 (26%), Positives = 135/275 (49%), Gaps = 10/275 (3%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLK 126
+ +++G G+FG+V++ + + A+K + D + E+ L
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKAL----KKDVVLMDDDVECTMVEKRVLSL 58
Query: 127 DLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEY 186
HP + T + +E+L ++E++ GG + + F + Y +++LGL++
Sbjct: 59 AWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQF 118
Query: 187 LHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIR 246
LH+ GI++RD+K NIL+D G IK+ADFG K+ + + GTP ++APE++
Sbjct: 119 LHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML--GDAKTNTFCGTPDYIAPEILL 176
Query: 247 QTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKDF 306
+++S D WS G + EM G+ P+ Q+ LFH +P P L +AKD
Sbjct: 177 GQKYNHSVDWWSFGVLLYEMLIGQSPF--HGQDEEELFHS-IRMDNPFYPRWLEKEAKDL 233
Query: 307 LLKCLEKEPDLRPTA-SELLKHPFVTGDDEDPVLH 340
L+K +EP+ R ++ +HP + + +
Sbjct: 234 LVKLFVREPEKRLGVRGDIRQHPLFREINWEELER 268
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (589), Expect = 3e-72
Identities = 71/269 (26%), Positives = 124/269 (46%), Gaps = 16/269 (5%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLK 126
++ E +G G FG V+ + S + K V K K D +++E+ +L
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV--------KVKGTDQ-VLVKKEISILN 56
Query: 127 DLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFG-PFPEAVMRTYTKQLLLGLE 185
H NI+ + E L ++ EF+ G I + E + +Y Q+ L+
Sbjct: 57 IARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQ 116
Query: 186 YLHNHGIMHRDIKGANILVDNKGC--IKLADFGASKQVAELATVSGAKSMKGTPYWMAPE 243
+LH+H I H DI+ NI+ + IK+ +FG ++Q L + + P + APE
Sbjct: 117 FLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ---LKPGDNFRLLFTAPEYYAPE 173
Query: 244 VIRQTGHSYSADIWSVGCTVIEMATGKPPW-SQQYQEVAALFHIGTTKSHPPIPENLSVK 302
V + S + D+WS+G V + +G P+ ++ Q++ + +S++
Sbjct: 174 VHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIE 233
Query: 303 AKDFLLKCLEKEPDLRPTASELLKHPFVT 331
A DF+ + L KE R TASE L+HP++
Sbjct: 234 AMDFVDRLLVKERKSRMTASEALQHPWLK 262
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 231 bits (590), Expect = 9e-72
Identities = 72/280 (25%), Positives = 131/280 (46%), Gaps = 12/280 (4%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLK 126
+ +IG G FG VY D+G++ A+K + ++ + + L+
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKC--LDKKRIKMKQGETLALNERIMLSLVS 62
Query: 127 DLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEY 186
P IV + L+ +L+ + GG + L + G F EA MR Y +++LGLE+
Sbjct: 63 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 122
Query: 187 LHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVI- 245
+HN +++RD+K ANIL+D G ++++D G + ++ + GT +MAPEV+
Sbjct: 123 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK----KKPHASVGTHGYMAPEVLQ 178
Query: 246 RQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKD 305
+ + SAD +S+GC + ++ G P+ Q + T +P++ S + +
Sbjct: 179 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 238
Query: 306 FLLKCLEKEPDLRPT-----ASELLKHPFVTGDDEDPVLH 340
L L+++ + R A E+ + PF D V
Sbjct: 239 LLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFL 278
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (581), Expect = 2e-71
Identities = 76/278 (27%), Positives = 126/278 (45%), Gaps = 10/278 (3%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLK 126
+ GE +G G F V +G A K I + +++E EV +LK
Sbjct: 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKF--IKKRRTKSSRRGVSREDIEREVSILK 68
Query: 127 DLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEY 186
++ HPN++ + + ++LE V GG + L + E + KQ+L G+ Y
Sbjct: 69 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYY 128
Query: 187 LHNHGIMHRDIKGANILVDNKGC----IKLADFGASKQVAELATVSGAKSMKGTPYWMAP 242
LH+ I H D+K NI++ ++ IK+ DFG + ++ K++ GTP ++AP
Sbjct: 129 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAP 185
Query: 243 EVIRQTGHSYSADIWSVGCTVIEMATGKPPW-SQQYQEVAALFHIGTTKSHPPIPENLSV 301
E++ AD+WS+G + +G P+ QE A + N S
Sbjct: 186 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 245
Query: 302 KAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDPVL 339
AKDF+ + L K+P R T + L+HP++ D L
Sbjct: 246 LAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQAL 283
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (573), Expect = 1e-70
Identities = 72/271 (26%), Positives = 124/271 (45%), Gaps = 20/271 (7%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLK 126
+++ G L+G G FG VY G+ + +A+K + + S + + EV LLK
Sbjct: 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKH--VEKDRISDWGELPNGTRVPMEVVLLK 62
Query: 127 DLS--HPNIVRYLGTVREEESLNILLEFVPGGS-ISSLLGKFGPFPEAVMRTYTKQLLLG 183
+S ++R L +S ++LE + + + G E + R++ Q+L
Sbjct: 63 KVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEA 122
Query: 184 LEYLHNHGIMHRDIKGANILVD-NKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAP 242
+ + HN G++HRDIK NIL+D N+G +KL DFG+ + + + GT + P
Sbjct: 123 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD----TVYTDFDGTRVYSPP 178
Query: 243 EVIR-QTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSV 301
E IR H SA +WS+G + +M G P+ + + + +S
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE---------IIRGQVFFRQRVSS 229
Query: 302 KAKDFLLKCLEKEPDLRPTASELLKHPFVTG 332
+ + + CL P RPT E+ HP++
Sbjct: 230 ECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 260
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 221 bits (565), Expect = 9e-69
Identities = 76/283 (26%), Positives = 139/283 (49%), Gaps = 22/283 (7%)
Query: 68 WRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDH--IKELEEEVKLL 125
++ +G G+FGRV++ + +G A+K + KE ++ +E +L
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVL-------KKEIVVRLKQVEHTNDERLML 58
Query: 126 KDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLE 185
++HP I+R GT ++ + + ++++++ GG + SLL K FP V + Y ++ L LE
Sbjct: 59 SIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALE 118
Query: 186 YLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVI 245
YLH+ I++RD+K NIL+D G IK+ DFG +K V ++ ++ GTP ++APEV+
Sbjct: 119 YLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY-----TLCGTPDYIAPEVV 173
Query: 246 RQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKD 305
++ S D WS G + EM G P+ + I + P + KD
Sbjct: 174 STKPYNKSIDWWSFGILIYEMLAGYTPFYDS-NTMKTYEKI--LNAELRFPPFFNEDVKD 230
Query: 306 FLLKCLEKEPDLR-----PTASELLKHPFVTGDDEDPVLHASV 343
L + + ++ R ++ HP+ + +L ++
Sbjct: 231 LLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNI 273
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (564), Expect = 2e-68
Identities = 70/282 (24%), Positives = 120/282 (42%), Gaps = 31/282 (10%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS- 129
+++G G G+V N + E A+K + + EV+L S
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKML-------------QDCPKARREVELHWRASQ 63
Query: 130 HPNIVRYLGTVR----EEESLNILLEFVPGGSISSLLGKFG--PFPEAVMRTYTKQLLLG 183
P+IVR + + L I++E + GG + S + G F E K +
Sbjct: 64 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 123
Query: 184 LEYLHNHGIMHRDIKGANILVD---NKGCIKLADFGASKQVAELATVSGAKSMKGTPYWM 240
++YLH+ I HRD+K N+L +KL DFG +K+ ++ + TPY++
Sbjct: 124 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL---TTPCYTPYYV 180
Query: 241 APEVIRQTGHSYSADIWSVGCTVIEMATGKPPWS-----QQYQEVAALFHIGTTKSHPPI 295
APEV+ + S D+WS+G + + G PP+ + +G + P
Sbjct: 181 APEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 240
Query: 296 PENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDP 337
+S + K + L+ EP R T +E + HP++ + P
Sbjct: 241 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP 282
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 215 bits (549), Expect = 7e-67
Identities = 69/271 (25%), Positives = 120/271 (44%), Gaps = 13/271 (4%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLK 126
R+ GE++G G V++ +L +AVK + A + E +
Sbjct: 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLR-----ADLARDPSFYLRFRREAQNAA 62
Query: 127 DLSHPNIVRYLGTVREEESLN----ILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLL 182
L+HP IV T E I++E+V G ++ ++ GP
Sbjct: 63 ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQ 122
Query: 183 GLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELAT-VSGAKSMKGTPYWMA 241
L + H +GI+HRD+K ANI++ +K+ DFG ++ +A+ V+ ++ GT +++
Sbjct: 123 ALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182
Query: 242 PEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPP--IPENL 299
PE R +D++S+GC + E+ TG+PP+ V+ + PP E L
Sbjct: 183 PEQARGDSVDARSDVYSLGCVLYEVLTGEPPF-TGDSPVSVAYQHVREDPIPPSARHEGL 241
Query: 300 SVKAKDFLLKCLEKEPDLRPTASELLKHPFV 330
S +LK L K P+ R + ++ V
Sbjct: 242 SADLDAVVLKALAKNPENRYQTAAEMRADLV 272
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (553), Expect = 1e-66
Identities = 75/278 (26%), Positives = 129/278 (46%), Gaps = 15/278 (5%)
Query: 68 WRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKD 127
+ +L+G G FG+V + +G A+K + A+D + E ++L++
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRK-----EVIIAKDEVAHTVTESRVLQN 61
Query: 128 LSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYL 187
HP + + + L ++E+ GG + L + F E R Y +++ LEYL
Sbjct: 62 TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 188 HNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQ 247
H+ +++RDIK N+++D G IK+ DFG K+ K+ GTP ++APEV+
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYLAPEVLED 179
Query: 248 TGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKDFL 307
+ + D W +G + EM G+ P+ Q+ LF + P LS +AK L
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLPFYN--QDHERLFEL-ILMEEIRFPRTLSPEAKSLL 236
Query: 308 LKCLEKEPDLRP-----TASELLKHPFVTGDDEDPVLH 340
L+K+P R A E+++H F + V+
Sbjct: 237 AGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQ 274
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (543), Expect = 3e-66
Identities = 60/264 (22%), Positives = 109/264 (41%), Gaps = 21/264 (7%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLK 126
+ + IG G FG V +G G +AVK + K + E ++
Sbjct: 8 ELKLLQTIGKGEFGDVMLGD--YRGNKVAVKCI----------KNDATAQAFLAEASVMT 55
Query: 127 DLSHPNIVRYLGTVREEES-LNILLEFVPGGSISSLLGKFG--PFPEAVMRTYTKQLLLG 183
L H N+V+ LG + EE+ L I+ E++ GS+ L G + ++ +
Sbjct: 56 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 115
Query: 184 LEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPE 243
+EYL + +HRD+ N+LV K++DFG +K+ + S + K W APE
Sbjct: 116 MEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-----STQDTGKLPVKWTAPE 170
Query: 244 VIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKA 303
+R+ S +D+WS G + E+ + + + + P+
Sbjct: 171 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-EKGYKMDAPDGCPPAV 229
Query: 304 KDFLLKCLEKEPDLRPTASELLKH 327
+ + C + +RP+ +L +
Sbjct: 230 YEVMKNCWHLDAAMRPSFLQLREQ 253
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (544), Expect = 7e-66
Identities = 71/288 (24%), Positives = 127/288 (44%), Gaps = 31/288 (10%)
Query: 72 ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHP 131
+ +G G F VY + ++ +++A+K++ + +K+ + E+KLL++LSHP
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGIN---RTALREIKLLQELSHP 60
Query: 132 NIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHG 191
NI+ L + +++++ +F+ + + ++ Y L GLEYLH H
Sbjct: 61 NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 192 IMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQ-TGH 250
I+HRD+K N+L+D G +KLADFG +K T ++ APE++ +
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGS--PNRAYTHQVVTRWYRAPELLFGARMY 178
Query: 251 SYSADIWSVGCTVIEMATGKPPW--------------------SQQYQEVAALFHIGTTK 290
D+W+VGC + E+ P +Q+ ++ +L T K
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238
Query: 291 SHPPIP-----ENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333
S P IP D + P R TA++ LK + +
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (542), Expect = 9e-66
Identities = 67/267 (25%), Positives = 121/267 (45%), Gaps = 20/267 (7%)
Query: 74 IGCGAFGRVYMGMN--LDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHP 131
+GCG FG V G+ +A+K + + + +E+ E +++ L +P
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVL-------KQGTEKADTEEMMREAQIMHQLDNP 69
Query: 132 NIVRYLGTVREEESLNILLEFVPGGSISSLL-GKFGPFPEAVMRTYTKQLLLGLEYLHNH 190
IVR +G V + E+L +++E GG + L GK P + + Q+ +G++YL
Sbjct: 70 YIVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK 128
Query: 191 GIMHRDIKGANILVDNKGCIKLADFGASKQV-AELATVSGAKSMKGTPYWMAPEVIRQTG 249
+HRD+ N+L+ N+ K++DFG SK + A+ + + + K W APE I
Sbjct: 129 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 188
Query: 250 HSYSADIWSVGCTVIEMAT-GKPPWSQQ-YQEVAALFHIGTTKSHPPIPENLSVKAKDFL 307
S +D+WS G T+ E + G+ P+ + EV A G P + +
Sbjct: 189 FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK---RMECPPECPPELYALM 245
Query: 308 LKCLEKEPDLRPTASEL---LKHPFVT 331
C + + RP + ++ + +
Sbjct: 246 SDCWIYKWEDRPDFLTVEQRMRACYYS 272
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 1e-65
Identities = 57/289 (19%), Positives = 109/289 (37%), Gaps = 28/289 (9%)
Query: 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVK 123
P G+++G GAFG+V + QV A ++ + L E+K
Sbjct: 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQV--AVKMLKEKADSSEREALMSELK 92
Query: 124 LLKDL-SHPNIVRYLGTVREEESLNILLEFVPGGSISSLL-------------------- 162
++ L SH NIV LG + ++ E+ G + + L
Sbjct: 93 MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 152
Query: 163 ---GKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASK 219
+ + Q+ G+E+L +HRD+ N+LV + +K+ DFG ++
Sbjct: 153 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLAR 212
Query: 220 QVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQ 278
+ + + + WMAPE + + ++ +D+WS G + E+ + G P+
Sbjct: 213 DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272
Query: 279 EVAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327
+ A + + P + + + C + RP+ L
Sbjct: 273 D-ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (540), Expect = 2e-65
Identities = 65/271 (23%), Positives = 116/271 (42%), Gaps = 18/271 (6%)
Query: 74 IGCGAFGRVYMGMNLD--SGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHP 131
+G G FG V G + +AVK + ++ EL E +++ L +P
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKIL------KNEANDPALKDELLAEANVMQQLDNP 68
Query: 132 NIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHG 191
IVR +G + E ES +++E G ++ L + + + Q+ +G++YL
Sbjct: 69 YIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 127
Query: 192 IMHRDIKGANILVDNKGCIKLADFGASKQV-AELATVSGAKSMKGTPYWMAPEVIRQTGH 250
+HRD+ N+L+ + K++DFG SK + A+ K W APE I
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 187
Query: 251 SYSADIWSVGCTVIEMAT-GKPPW-SQQYQEVAALFHIGTTKSHPPIPENLSVKAKDFLL 308
S +D+WS G + E + G+ P+ + EV A+ G P + D +
Sbjct: 188 SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG---ERMGCPAGCPREMYDLMN 244
Query: 309 KCLEKEPDLRPTASEL---LKHPFVTGDDED 336
C + + RP + + L++ + +E
Sbjct: 245 LCWTYDVENRPGFAAVELRLRNYYYDVVNEG 275
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 2e-64
Identities = 65/259 (25%), Positives = 116/259 (44%), Gaps = 15/259 (5%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH 130
+ +G G FG V G +A+K + ++ E EE K++ +LSH
Sbjct: 9 LKELGTGQFGVVKYGK-WRGQYDVAIKMI---------KEGSMSEDEFIEEAKVMMNLSH 58
Query: 131 PNIVRYLGTVREEESLNILLEFVPGGSISSLLG-KFGPFPEAVMRTYTKQLLLGLEYLHN 189
+V+ G ++ + I+ E++ G + + L F + K + +EYL +
Sbjct: 59 EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 118
Query: 190 HGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTG 249
+HRD+ N LV+++G +K++DFG S+ V + + + K W PEV+ +
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLMYSK 177
Query: 250 HSYSADIWSVGCTVIEMAT-GKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKDFLL 308
S +DIW+ G + E+ + GK P+ +++ HI P S K +
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGKMPY-ERFTNSETAEHIAQGL-RLYRPHLASEKVYTIMY 235
Query: 309 KCLEKEPDLRPTASELLKH 327
C ++ D RPT LL +
Sbjct: 236 SCWHEKADERPTFKILLSN 254
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 5e-64
Identities = 67/288 (23%), Positives = 121/288 (42%), Gaps = 6/288 (2%)
Query: 68 WRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKD 127
++K +++G GAFG VY G+ + GE + + +A + + KE+ +E ++
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIP---VAIKELREATSPKANKEILDEAYVMAS 67
Query: 128 LSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYL 187
+ +P++ R LG I G + + + + Q+ G+ YL
Sbjct: 68 VDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 127
Query: 188 HNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQ 247
+ ++HRD+ N+LV +K+ DFG +K + A+ K WMA E I
Sbjct: 128 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 187
Query: 248 TGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKDF 306
+++ +D+WS G TV E+ T G P+ + + I P P ++
Sbjct: 188 RIYTHQSDVWSYGVTVWELMTFGSKPYDG--IPASEISSILEKGERLPQPPICTIDVYMI 245
Query: 307 LLKCLEKEPDLRPTASELLKHPFVTGDDEDPVLHASVMKSSEILSPSH 354
++KC + D RP EL+ D L + + SP+
Sbjct: 246 MVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTD 293
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 1e-63
Identities = 68/265 (25%), Positives = 116/265 (43%), Gaps = 9/265 (3%)
Query: 67 RWRKGELIGCGAFGRVYMG-MNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLL 125
R E +G G+FG V G + SG+ ++V + + S+ +A + + EV +
Sbjct: 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEA---MDDFIREVNAM 65
Query: 126 KDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSL-LGKFGPFPEAVMRTYTKQLLLGL 184
L H N++R G V + ++ E P GS+ G F + Y Q+ G+
Sbjct: 66 HSLDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 124
Query: 185 EYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAE-LATVSGAKSMKGTPYWMAPE 243
YL + +HRD+ N+L+ + +K+ DFG + + + + K W APE
Sbjct: 125 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 244 VIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVK 302
++ S+++D W G T+ EM T G+ PW L I P PE+
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL-NGSQILHKIDKEGERLPRPEDCPQD 243
Query: 303 AKDFLLKCLEKEPDLRPTASELLKH 327
+ +++C +P+ RPT L
Sbjct: 244 IYNVMVQCWAHKPEDRPTFVALRDF 268
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (526), Expect = 2e-63
Identities = 63/272 (23%), Positives = 109/272 (40%), Gaps = 17/272 (6%)
Query: 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVK 123
P + E +G G FG V+MG + +AVK + ++ E
Sbjct: 11 PRETLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSL---------KQGSMSPDAFLAEAN 60
Query: 124 LLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFG--PFPEAVMRTYTKQLL 181
L+K L H +VR V +E + I+ E++ GS+ L + Q+
Sbjct: 61 LMKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 119
Query: 182 LGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMA 241
G+ ++ +HRD++ ANILV + K+ADFG ++ + + + + K W A
Sbjct: 120 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKWTA 178
Query: 242 PEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSV 301
PE I + +D+WS G + E+ T + ++ P+N
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL-ERGYRMVRPDNCPE 237
Query: 302 KAKDFLLKCLEKEPDLRPTASELLK--HPFVT 331
+ + C ++ P+ RPT L F T
Sbjct: 238 ELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 2e-63
Identities = 63/264 (23%), Positives = 114/264 (43%), Gaps = 13/264 (4%)
Query: 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKL 124
P + IG G FG V++G L+ + +A+K + + ++ EE ++
Sbjct: 4 PSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTI---------REGAMSEEDFIEEAEV 53
Query: 125 LKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSL-LGKFGPFPEAVMRTYTKQLLLG 183
+ LSHP +V+ G E+ + ++ EF+ G +S + G F + + G
Sbjct: 54 MMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEG 113
Query: 184 LEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPE 243
+ YL ++HRD+ N LV IK++DFG ++ V + + + K W +PE
Sbjct: 114 MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPE 172
Query: 244 VIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKA 303
V + +S +D+WS G + E+ + + + I T P S
Sbjct: 173 VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF-RLYKPRLASTHV 231
Query: 304 KDFLLKCLEKEPDLRPTASELLKH 327
+ C ++ P+ RP S LL+
Sbjct: 232 YQIMNHCWKERPEDRPAFSRLLRQ 255
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 6e-63
Identities = 59/287 (20%), Positives = 114/287 (39%), Gaps = 31/287 (10%)
Query: 64 PPIRWRKGELIGCGAFGRVYMG-----MNLDSGELLAVKQVLIAANFASKEKAQDHIKEL 118
P R G+ +G GAFG+V + D+ +AVK + + L
Sbjct: 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML-------KPSAHLTEREAL 73
Query: 119 EEEVKLLKDLS-HPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFG----------- 166
E+K+L L H NIV LG ++ E+ G + + L +
Sbjct: 74 MSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPA 133
Query: 167 -------PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASK 219
+ +++ Q+ G+ +L + +HRD+ NIL+ + K+ DFG ++
Sbjct: 134 IMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLAR 193
Query: 220 QVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE 279
+ + + + WMAPE I +++ +D+WS G + E+ +
Sbjct: 194 DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253
Query: 280 VAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLK 326
+ + + PE+ + D + C + +P RPT ++++
Sbjct: 254 DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 205 bits (523), Expect = 8e-63
Identities = 56/280 (20%), Positives = 107/280 (38%), Gaps = 27/280 (9%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLK 126
R+R G IG G+FG +Y+G ++ +GE +A+K E + +L E K+ K
Sbjct: 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK----------LECVKTKHPQLHIESKIYK 57
Query: 127 DLSHPNIVRYLGTVREEESLNILL-EFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLE 185
+ + + E N+++ E + F + Q++ +E
Sbjct: 58 MMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIE 117
Query: 186 YLHNHGIMHRDIKGANILVDNKGC---IKLADFGASKQVAELATVSG-----AKSMKGTP 237
Y+H+ +HRD+K N L+ + + DFG +K+ + T K++ GT
Sbjct: 118 YIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177
Query: 238 YWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIP- 296
+ + S D+ S+G ++ G PW + ++ P
Sbjct: 178 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 237
Query: 297 ----ENLSVKAKDFLLKCLEKEPDLRPTAS---ELLKHPF 329
+ + +L C D +P S +L ++ F
Sbjct: 238 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 205 bits (522), Expect = 1e-62
Identities = 60/269 (22%), Positives = 117/269 (43%), Gaps = 11/269 (4%)
Query: 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVK 123
+ ++IG G FG V G G+ +++ +A + ++ E
Sbjct: 24 DISCVKIEQVIGAGEFGEVCSGHLKLPGK----REIFVAIKTLKSGYTEKQRRDFLSEAS 79
Query: 124 LLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSL-LGKFGPFPEAVMRTYTKQLLL 182
++ HPN++ G V + + I+ EF+ GS+ S G F + + +
Sbjct: 80 IMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAA 139
Query: 183 GLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAE---LATVSGAKSMKGTPYW 239
G++YL + +HRD+ NILV++ K++DFG S+ + + T + A K W
Sbjct: 140 GMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRW 199
Query: 240 MAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQEVAALFHIGTTKSHPPIPEN 298
APE I+ + ++D+WS G + E+ + G+ P+ + + + P P +
Sbjct: 200 TAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ--DVINAIEQDYRLPPPMD 257
Query: 299 LSVKAKDFLLKCLEKEPDLRPTASELLKH 327
+L C +K+ + RP +++
Sbjct: 258 CPSALHQLMLDCWQKDRNHRPKFGQIVNT 286
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 205 bits (521), Expect = 2e-62
Identities = 60/289 (20%), Positives = 111/289 (38%), Gaps = 37/289 (12%)
Query: 67 RWRKGELIGCGAFGRVYMG-----MNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEE 121
IG GAFGRV+ + + ++AVK + +E + D + + E
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML-------KEEASADMQADFQRE 66
Query: 122 VKLLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFG--------------- 166
L+ + +PNIV+ LG + + +L E++ G ++ L
Sbjct: 67 AALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 126
Query: 167 ---------PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGA 217
P A +Q+ G+ YL +HRD+ N LV +K+ADFG
Sbjct: 127 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGL 186
Query: 218 SKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQY 277
S+ + + WM PE I ++ +D+W+ G + E+ +
Sbjct: 187 SRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 246
Query: 278 QEVAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLK 326
++++ + PEN ++ + + C K P RP+ + +
Sbjct: 247 AHEEVIYYV-RDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 2e-62
Identities = 69/268 (25%), Positives = 111/268 (41%), Gaps = 14/268 (5%)
Query: 64 PPIRWRKGELIGCGAFGRVYMGMNL---DSGELLAVKQVLIAANFASKEKAQDHIKELEE 120
R G IG G FG V+ G+ + + +A+K + ++ +
Sbjct: 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC-------KNCTSDSVREKFLQ 57
Query: 121 EVKLLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGK-FGPFPEAVMRTYTKQ 179
E ++ HP+IV+ +G + E + I++E G + S L A + Y Q
Sbjct: 58 EALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQ 116
Query: 180 LLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYW 239
L L YL + +HRDI N+LV + C+KL DFG S+ + + +T A K W
Sbjct: 117 LSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKW 175
Query: 240 MAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENL 299
MAPE I + ++D+W G + E+ Q + + I P+P N
Sbjct: 176 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-ENGERLPMPPNC 234
Query: 300 SVKAKDFLLKCLEKEPDLRPTASELLKH 327
+ KC +P RP +EL
Sbjct: 235 PPTLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 204 bits (519), Expect = 2e-62
Identities = 62/265 (23%), Positives = 111/265 (41%), Gaps = 13/265 (4%)
Query: 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVK 123
+G G +G VY G+ +AVK + ++ ++E +E
Sbjct: 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL---------KEDTMEVEEFLKEAA 65
Query: 124 LLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLL--GKFGPFPEAVMRTYTKQLL 181
++K++ HPN+V+ LG E I+ EF+ G++ L V+ Q+
Sbjct: 66 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQIS 125
Query: 182 LGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMA 241
+EYL +HRD+ N LV +K+ADFG S+ + T + K W A
Sbjct: 126 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTA 184
Query: 242 PEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSV 301
PE + S +D+W+ G + E+AT +++ ++ + PE
Sbjct: 185 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLEKDYRMERPEGCPE 243
Query: 302 KAKDFLLKCLEKEPDLRPTASELLK 326
K + + C + P RP+ +E+ +
Sbjct: 244 KVYELMRACWQWNPSDRPSFAEIHQ 268
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 205 bits (522), Expect = 5e-62
Identities = 74/279 (26%), Positives = 139/279 (49%), Gaps = 18/279 (6%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLK 126
++ + + +G G+FGRV + + +SG A+K + K I+ E ++L+
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL-----DKQKVVKLKQIEHTLNEKRILQ 96
Query: 127 DLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEY 186
++ P +V+ + ++ +L +++E+V GG + S L + G F E R Y Q++L EY
Sbjct: 97 AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 187 LHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIR 246
LH+ +++RD+K N+L+D +G I++ DFG +K+ ++ GTP +APE+I
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWTLCGTPEALAPEIIL 211
Query: 247 QTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAKDF 306
G++ + D W++G + EMA G PP+ Q + I P + S KD
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFAD-QPIQIYEKI--VSGKVRFPSHFSSDLKDL 268
Query: 307 LLKCLEKEP-----DLRPTASELLKHPFVTGDDEDPVLH 340
L L+ + +L+ +++ H + D +
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQ 307
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 9e-62
Identities = 62/265 (23%), Positives = 113/265 (42%), Gaps = 6/265 (2%)
Query: 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVK 123
P + ++IG G FG VY GM S K+V +A + + E
Sbjct: 5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGK---KEVPVAIKTLKAGYTEKQRVDFLGEAG 61
Query: 124 LLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSL-LGKFGPFPEAVMRTYTKQLLL 182
++ SH NI+R G + + + + I+ E++ G++ K G F + + +
Sbjct: 62 IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAA 121
Query: 183 GLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAE-LATVSGAKSMKGTPYWMA 241
G++YL N +HRD+ NILV++ K++DFG S+ + + K W A
Sbjct: 122 GMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181
Query: 242 PEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSV 301
PE I + ++D+WS G + E+ T + + I P P +
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI-NDGFRLPTPMDCPS 240
Query: 302 KAKDFLLKCLEKEPDLRPTASELLK 326
+++C ++E RP ++++
Sbjct: 241 AIYQLMMQCWQQERARRPKFADIVS 265
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 1e-61
Identities = 89/289 (30%), Positives = 151/289 (52%), Gaps = 17/289 (5%)
Query: 67 RWRKGELIGCGAFGRVYMGMNL---DSGELLAVKQVLIAANFASKEKAQDHIKELEEEVK 123
+ +++G GA+G+V++ + D+G+L A+K VL A K K +H + E +
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMK-VLKKATIVQKAKTTEHTRT---ERQ 80
Query: 124 LLKDLSH-PNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLL 182
+L+ + P +V + E L+++L+++ GG + + L + F E ++ Y +++L
Sbjct: 81 VLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVL 140
Query: 183 GLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAP 242
LE+LH GI++RDIK NIL+D+ G + L DFG SK+ T A GT +MAP
Sbjct: 141 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET-ERAYDFCGTIEYMAP 199
Query: 243 EVIR--QTGHSYSADIWSVGCTVIEMATGKPPWS-QQYQEVAALFHIGTTKSHPPIPENL 299
+++R +GH + D WS+G + E+ TG P++ + A KS PP P+ +
Sbjct: 200 DIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM 259
Query: 300 SVKAKDFLLKCLEKEPDLRP-----TASELLKHPFVTGDDEDPVLHASV 343
S AKD + + L K+P R A E+ +H F + D + V
Sbjct: 260 SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKV 308
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 1e-61
Identities = 63/278 (22%), Positives = 107/278 (38%), Gaps = 17/278 (6%)
Query: 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVK 123
P R +G G FG V+MG + +A+K + + + +E +
Sbjct: 15 PRESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTL---------KPGTMSPEAFLQEAQ 64
Query: 124 LLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSL--LGKFGPFPEAVMRTYTKQLL 181
++K L H +V+ V EE + I+ E++ GS+ + Q+
Sbjct: 65 VMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIA 123
Query: 182 LGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMA 241
G+ Y+ +HRD++ ANILV K+ADFG ++ + + + + K W A
Sbjct: 124 SGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTA 182
Query: 242 PEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSV 301
PE + +D+WS G + E+ T L + P P
Sbjct: 183 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-RMPCPPECPE 241
Query: 302 KAKDFLLKCLEKEPDLRPTASELLK--HPFVTGDDEDP 337
D + +C KEP+ RPT L + T +
Sbjct: 242 SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQY 279
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 2e-61
Identities = 71/300 (23%), Positives = 122/300 (40%), Gaps = 44/300 (14%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLK 126
R+ IG GA+G V + + +A+K++ S + Q + + E+K+L
Sbjct: 9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI-------SPFEHQTYCQRTLREIKILL 61
Query: 127 DLSHPNIVRYLGTVREEESLN----ILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLL 182
H NI+ +R L+ + G + LL K + + Q+L
Sbjct: 62 RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL-KTQHLSNDHICYFLYQILR 120
Query: 183 GLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVA-ELATVSGAKSMKGTPYWMA 241
GL+Y+H+ ++HRD+K +N+L++ +K+ DFG ++ + T ++ A
Sbjct: 121 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 180
Query: 242 PEVI-RQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPP------ 294
PE++ G++ S DIWSVGC + EM + +P + + L HI P
Sbjct: 181 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF-PGKHYLDQLNHILGILGSPSQEDLNC 239
Query: 295 -----------------------IPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVT 331
+ N KA D L K L P R + L HP++
Sbjct: 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 299
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 2e-61
Identities = 81/294 (27%), Positives = 130/294 (44%), Gaps = 37/294 (12%)
Query: 67 RWRKGELIGCGAFGRVYMGMNL-DSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLL 125
++ IG GA+G+V+ +L + G +A+K+ + + I+E+ ++ L
Sbjct: 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKR--VRVQTGEEGMPLSTIREVAV-LRHL 64
Query: 126 KDLSHPNIVRYLG-----TVREEESLNILLEFVPGGSISSLLG-KFGPFPEAVMRTYTKQ 179
+ HPN+VR E L ++ E V + L P ++ Q
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 180 LLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYW 239
LL GL++LH+H ++HRD+K NILV + G IKLADFG ++ + + S+ T ++
Sbjct: 125 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---TSVVVTLWY 181
Query: 240 MAPEVIRQTGHSYSADIWSVGCTVIEMATGKPP------------------------WSQ 275
APEV+ Q+ ++ D+WSVGC EM KP W +
Sbjct: 182 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 241
Query: 276 QYQEVAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPF 329
FH + + ++ KD LLKCL P R +A L HP+
Sbjct: 242 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 295
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (508), Expect = 2e-60
Identities = 71/307 (23%), Positives = 127/307 (41%), Gaps = 46/307 (14%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLK 126
++ K IG G FG V+ + +G+ +A+K+VL+ + + + E+K+L+
Sbjct: 11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLM------ENEKEGFPITALREIKILQ 64
Query: 127 DLSHPNIVRYLGTVREEES--------LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTK 178
L H N+V + R + S + ++ +F L F + ++ +
Sbjct: 65 LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQ 124
Query: 179 QLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQV--AELATVSGAKSMKGT 236
LL GL Y+H + I+HRD+K AN+L+ G +KLADFG ++ A+ + + + T
Sbjct: 125 MLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 184
Query: 237 PYWMAPEVIR-QTGHSYSADIWSVGCTVIEMATGKPPWS-----QQYQEVAALFHIGTTK 290
++ PE++ + + D+W GC + EM T P Q ++ L T +
Sbjct: 185 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 244
Query: 291 SHPPI------------------------PENLSVKAKDFLLKCLEKEPDLRPTASELLK 326
P + A D + K L +P R + + L
Sbjct: 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304
Query: 327 HPFVTGD 333
H F D
Sbjct: 305 HDFFWSD 311
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (508), Expect = 2e-60
Identities = 67/264 (25%), Positives = 119/264 (45%), Gaps = 15/264 (5%)
Query: 71 GELIGCGAFGRVYMGMNLDS---GELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKD 127
E+IG G FG VY G LD+ AVK + ++ + + E ++KD
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-------NRITDIGEVSQFLTEGIIMKD 84
Query: 128 LSHPNIVRYLGT-VREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRT-YTKQLLLGLE 185
SHPN++ LG +R E S ++L ++ G + + + P + Q+ G++
Sbjct: 85 FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 144
Query: 186 YLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVA--ELATVSGAKSMKGTPYWMAPE 243
+L + +HRD+ N ++D K +K+ADFG ++ + E +V K WMA E
Sbjct: 145 FLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 204
Query: 244 VIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKA 303
++ + +D+WS G + E+ T P ++ + PE
Sbjct: 205 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-RLLQPEYCPDPL 263
Query: 304 KDFLLKCLEKEPDLRPTASELLKH 327
+ +LKC + ++RP+ SEL+
Sbjct: 264 YEVMLKCWHPKAEMRPSFSELVSR 287
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 1e-59
Identities = 62/282 (21%), Positives = 120/282 (42%), Gaps = 20/282 (7%)
Query: 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVK 123
P R G+ +G GAFG+V + + + + +A + + + +L E++
Sbjct: 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEME 70
Query: 124 LLKDLS-HPNIVRYLGTVREEESLNILLEFVPGGSISSLL----------------GKFG 166
++K + H NI+ LG ++ L +++E+ G++ L
Sbjct: 71 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130
Query: 167 PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELAT 226
+ + Q+ G+EYL + +HRD+ N+LV +K+ADFG ++ + +
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190
Query: 227 VSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQEVAALFH 285
+ + WMAPE + +++ +D+WS G + E+ T G P+ V LF
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG--VPVEELFK 248
Query: 286 IGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327
+ P N + + + C P RPT +L++
Sbjct: 249 LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 1e-59
Identities = 82/320 (25%), Positives = 128/320 (40%), Gaps = 54/320 (16%)
Query: 49 SRVLSKHISPSVKMSPP--IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFA 106
S+V + +P P + + ++IG G+FG VY DSGEL+A+K+VL
Sbjct: 1 SKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL------ 54
Query: 107 SKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTV------REEESLNILLEFVPGGSISS 160
++K + E+++++ L H NIVR ++E LN++L++VP
Sbjct: 55 -QDK-----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV 108
Query: 161 LL---GKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKG-CIKLADFG 216
P ++ Y QL L Y+H+ GI HRDIK N+L+D +KL DFG
Sbjct: 109 ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFG 168
Query: 217 ASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQ 276
++KQ+ + Y + T ++ S D+WS GC + E+ G+P +
Sbjct: 169 SAKQLVR--GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 226
Query: 277 YQEVAALFHIGTTKSHPP---------------------------IPENLSVKAKDFLLK 309
V L I P +A +
Sbjct: 227 -SGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSR 285
Query: 310 CLEKEPDLRPTASELLKHPF 329
LE P R T E H F
Sbjct: 286 LLEYTPTARLTPLEACAHSF 305
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 2e-59
Identities = 72/293 (24%), Positives = 125/293 (42%), Gaps = 36/293 (12%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLK 126
++ K E IG G +G V+ N ++ E++A+K+V + + + E+ LLK
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRL------DDDDEGVPSSALREICLLK 56
Query: 127 DLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEY 186
+L H NIVR + ++ L ++ EF G +++++ QLL GL +
Sbjct: 57 ELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGF 116
Query: 187 LHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIR 246
H+ ++HRD+K N+L++ G +KLA+FG ++ V + T ++ P+V+
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI--PVRCYSAEVVTLWYRPPDVLF 174
Query: 247 QTG-HSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPP----------- 294
+S S D+WS GC E+A P L I P
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234
Query: 295 ----------------IPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVT 331
+ L+ +D L L+ P R +A E L+HP+ +
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 196 bits (498), Expect = 3e-59
Identities = 74/290 (25%), Positives = 131/290 (45%), Gaps = 36/290 (12%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLK 126
++ E IG G +G VY N + GE A+K++ + +++ + E+ +LK
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRL------EKEDEGIPSTTIREISILK 55
Query: 127 DLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEY 186
+L H NIV+ + ++ L ++ E + L G +++ QLL G+ Y
Sbjct: 56 ELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAY 115
Query: 187 LHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIR 246
H+ ++HRD+K N+L++ +G +K+ADFG ++ V T ++ AP+V+
Sbjct: 116 CHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGI--PVRKYTHEIVTLWYRAPDVLM 173
Query: 247 QTG-HSYSADIWSVGCTVIEMATGKPPW--SQQYQEVAALFHIGTTKSHPPIPE------ 297
+ +S + DIWSVGC EM G P + + ++ +F I T + P
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233
Query: 298 ------------------NLSVKAKDFLLKCLEKEPDLRPTASELLKHPF 329
L D L K L+ +P+ R TA + L+H +
Sbjct: 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 3e-59
Identities = 86/303 (28%), Positives = 138/303 (45%), Gaps = 39/303 (12%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLK 126
++K E IG G +G VY N +GE++A+K++ + + + E+ LLK
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL------DTETEGVPSTAIREISLLK 56
Query: 127 DLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLLGLE 185
+L+HPNIV+ L + E L ++ EF+ + P ++++Y QLL GL
Sbjct: 57 ELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 116
Query: 186 YLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVI 245
+ H+H ++HRD+K N+L++ +G IKLADFG ++ V T ++ APE++
Sbjct: 117 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYTHEVVTLWYRAPEIL 174
Query: 246 RQTGH-SYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPP---------- 294
+ S + DIWS+GC EM T + + E+ LF I T P
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALF-PGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233
Query: 295 -----------------IPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDEDP 337
+ L + L + L +P+ R +A L HPF D P
Sbjct: 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ-DVTKP 292
Query: 338 VLH 340
V H
Sbjct: 293 VPH 295
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 5e-59
Identities = 60/275 (21%), Positives = 110/275 (40%), Gaps = 28/275 (10%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS- 129
++IG G FG+V G + + + ++D ++ E+++L L
Sbjct: 15 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-----KEYASKDDHRDFAGELEVLCKLGH 69
Query: 130 HPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKF----------------GPFPEAVM 173
HPNI+ LG L + +E+ P G++ L K +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 174 RTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSM 233
+ + G++YL +HRD+ NILV K+ADFG S+
Sbjct: 130 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK---KTMG 186
Query: 234 KGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQEVAALFHIGTTKSH 292
+ WMA E + + ++ ++D+WS G + E+ + G P+ A L+
Sbjct: 187 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG--MTCAELYEKLPQGYR 244
Query: 293 PPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327
P N + D + +C ++P RP+ +++L
Sbjct: 245 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 193 bits (490), Expect = 5e-58
Identities = 59/276 (21%), Positives = 104/276 (37%), Gaps = 26/276 (9%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLK 126
++ G IG G+FG ++ G NL + + +A+K E + +L +E + K
Sbjct: 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIK----------FEPRRSDAPQLRDEYRTYK 55
Query: 127 DLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFG-PFPEAVMRTYTKQLLLGLE 185
L+ + + +E N+L+ + G S+ LL G F + KQ+L ++
Sbjct: 56 LLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQ 115
Query: 186 YLHNHGIMHRDIKGANILVDNK-----GCIKLADFGASKQVAELATVSG-----AKSMKG 235
+H +++RDIK N L+ I + DFG K + T K++ G
Sbjct: 116 SIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175
Query: 236 TPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPW--SQQYQEVAALFHIGTTKSHP 293
T +M+ S D+ ++G + G PW + IG K
Sbjct: 176 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235
Query: 294 PIPE---NLSVKAKDFLLKCLEKEPDLRPTASELLK 326
P+ E + ++ D P L
Sbjct: 236 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 9e-58
Identities = 65/282 (23%), Positives = 114/282 (40%), Gaps = 20/282 (7%)
Query: 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVK 123
P R + G+ +G GAFG+V + + V A + + L E+K
Sbjct: 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTV--AVKMLKEGATHSEHRALMSELK 68
Query: 124 -LLKDLSHPNIVRYLGTVREEES-LNILLEFVPGGSISSLLGKFG--------------- 166
L+ H N+V LG + L +++EF G++S+ L
Sbjct: 69 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 128
Query: 167 -PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA 225
+ Y+ Q+ G+E+L + +HRD+ NIL+ K +K+ DFG ++ + +
Sbjct: 129 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 188
Query: 226 TVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFH 285
+ WMAPE I ++ +D+WS G + E+ + +
Sbjct: 189 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 248
Query: 286 IGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327
+ P+ + + +L C EP RPT SEL++H
Sbjct: 249 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 193 bits (490), Expect = 1e-57
Identities = 67/310 (21%), Positives = 124/310 (40%), Gaps = 57/310 (18%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLK 126
++ +G G + V+ +N+ + E + VK + K+++ E+K+L+
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL-----------KPVKKKKIKREIKILE 84
Query: 127 DLS-HPNIVRYLGTVREEES--LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLG 183
+L PNI+ V++ S ++ E V L + +R Y ++L
Sbjct: 85 NLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKA 141
Query: 184 LEYLHNHGIMHRDIKGANILVDNKGC-IKLADFGASKQVAELATVSGAKSMKGTPYWMAP 242
L+Y H+ GIMHRD+K N+++D++ ++L D+G ++ + + Y+ P
Sbjct: 142 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYN---VRVASRYFKGP 198
Query: 243 EV-IRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHP-------- 293
E+ + + YS D+WS+GC + M K P+ + L I
Sbjct: 199 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258
Query: 294 ---------------------------PIPENLSVKAKDFLLKCLEKEPDLRPTASELLK 326
+S +A DFL K L + R TA E ++
Sbjct: 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318
Query: 327 HPFVTGDDED 336
HP+ +D
Sbjct: 319 HPYFYTVVKD 328
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 2e-57
Identities = 83/307 (27%), Positives = 132/307 (42%), Gaps = 48/307 (15%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLK 126
+R + +G GA+G V ++ +G +A+K++ +++ K E++LLK
Sbjct: 19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLY------RPFQSELFAKRAYRELRLLK 72
Query: 127 DLSHPNIVRYLGTVREEESLNILLEFV----PGGSISSLLGKFGPFPEAVMRTYTKQLLL 182
+ H N++ L +E+L+ +F G+ L K E ++ Q+L
Sbjct: 73 HMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLK 132
Query: 183 GLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAP 242
GL Y+H GI+HRD+K N+ V+ +K+ DFG ++Q T T ++ AP
Sbjct: 133 GLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT-----GYVVTRWYRAP 187
Query: 243 EVIRQTG-HSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPP------- 294
EVI ++ + DIWSVGC + EM TGK + + + L I PP
Sbjct: 188 EVILNWMRYTQTVDIWSVGCIMAEMITGKTLF-KGSDHLDQLKEIMKVTGTPPAEFVQRL 246
Query: 295 ----------------------IPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTG 332
I N S A + L K L + + R TA E L HP+
Sbjct: 247 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 306
Query: 333 --DDEDP 337
D ED
Sbjct: 307 LHDTEDE 313
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 8e-57
Identities = 57/279 (20%), Positives = 111/279 (39%), Gaps = 23/279 (8%)
Query: 64 PPIRWRKGELIGCGAFGRVYMGMN-----LDSGELLAVKQVLIAANFASKEKAQDHIKEL 118
+ +G G+FG VY G+ + +A+K V ++ + E
Sbjct: 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-------NEAASMRERIEF 70
Query: 119 EEEVKLLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLL----------GKFGPF 168
E ++K+ + ++VR LG V + + +++E + G + S L P
Sbjct: 71 LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPP 130
Query: 169 PEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVS 228
+ M ++ G+ YL+ + +HRD+ N +V +K+ DFG ++ + E
Sbjct: 131 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 190
Query: 229 GAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGT 288
WM+PE ++ + +D+WS G + E+AT Q L +
Sbjct: 191 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV-M 249
Query: 289 TKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327
P+N + + C + P +RP+ E++
Sbjct: 250 EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 5e-54
Identities = 70/299 (23%), Positives = 135/299 (45%), Gaps = 46/299 (15%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLK 126
R++ +G GA+G V + +G +AVK++ + ++ H K E++LLK
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL------SRPFQSIIHAKRTYRELRLLK 72
Query: 127 DLSHPNIVRYLGTVREEESLN-----ILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLL 181
+ H N++ L SL L+ + G ++++ K + ++ Q+L
Sbjct: 73 HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQIL 131
Query: 182 LGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMA 241
GL+Y+H+ I+HRD+K +N+ V+ +K+ DFG ++ + T T ++ A
Sbjct: 132 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRA 186
Query: 242 PEVIRQTGH-SYSADIWSVGCTVIEMATGKPPW--------------------SQQYQEV 280
PE++ H + + DIWSVGC + E+ TG+ + ++ +++
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246
Query: 281 AALFHIGTTKSHPPIPE--------NLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVT 331
++ +S +P+ + A D L K L + D R TA++ L H +
Sbjct: 247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 305
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 6e-51
Identities = 73/310 (23%), Positives = 129/310 (41%), Gaps = 57/310 (18%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLK 126
R++ + IG GA G V + +A+K++ + + Q H K E+ L+K
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL------SRPFQNQTHAKRAYRELVLMK 71
Query: 127 DLSHPNIVRYLG------TVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQL 180
++H NI+ L T+ E + + +++E + + + M Q+
Sbjct: 72 CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL---DHERMSYLLYQM 128
Query: 181 LLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWM 240
L G+++LH+ GI+HRD+K +NI+V + +K+ DFG ++ T Y+
Sbjct: 129 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYR 185
Query: 241 APEVIRQTGHSYSADIWSVGCTVIEMATGKPPW-----SQQYQEVAA------------- 282
APEVI G+ + DIWSVGC + EM K + Q+ +V
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245
Query: 283 ---------------------LFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTA 321
LF + + + +A+D L K L +P R +
Sbjct: 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 305
Query: 322 SELLKHPFVT 331
+ L+HP++
Sbjct: 306 DDALQHPYIN 315
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (438), Expect = 2e-50
Identities = 65/295 (22%), Positives = 104/295 (35%), Gaps = 51/295 (17%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH 130
E IG G FG V+ G GE +AVK S + + +E E + L H
Sbjct: 8 QESIGKGRFGEVWRGK--WRGEEVAVKIF-------SSREERSWFREAE--IYQTVMLRH 56
Query: 131 PNIVRYLGTVREEES----LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEY 186
NI+ ++ ++ L ++ ++ GS+ L ++ E +++ GL +
Sbjct: 57 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIK-LALSTASGLAH 115
Query: 187 LHNH--------GIMHRDIKGANILVDNKGCIKLADFGASKQV--AELATVSGAKSMKGT 236
LH I HRD+K NILV G +AD G + + A GT
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175
Query: 237 PYWMAPEVIRQTGH------SYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFH----- 285
+MAPEV+ + + ADI+++G E+A +
Sbjct: 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235
Query: 286 ---------IGTTKSHPPIPENLSV-----KAKDFLLKCLEKEPDLRPTASELLK 326
+ K P IP + +C R TA + K
Sbjct: 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 157 bits (397), Expect = 6e-44
Identities = 61/321 (19%), Positives = 111/321 (34%), Gaps = 58/321 (18%)
Query: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKEL----EEEV 122
R+ +G G F V++ ++ + +A+K + + E A+D IK L + +
Sbjct: 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKI--VRGDKVYTEAAEDEIKLLQRVNDADN 71
Query: 123 KLLKDLSHPNIVRYLGTVREEESLNILLEFVP-----GGSISSLLGKFGPFPEAVMRTYT 177
+ +I++ L + + + V + P ++ +
Sbjct: 72 TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS 131
Query: 178 KQLLLGLEYL-HNHGIMHRDIKGANILVDNKGCI-KLADFGASKQVAELATVSGAKSMKG 235
KQLLLGL+Y+ GI+H DIK N+L++ L + +
Sbjct: 132 KQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191
Query: 236 TPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWS--------------------- 274
T + +PEV+ ADIWS C + E+ TG +
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELL 251
Query: 275 ---------------QQYQEVAALFHIGTTKSHP---------PIPENLSVKAKDFLLKC 310
+ L +I K P ++ + + DFL
Sbjct: 252 GELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPM 311
Query: 311 LEKEPDLRPTASELLKHPFVT 331
L+ +P R A L+ HP++
Sbjct: 312 LQLDPRKRADAGGLVNHPWLK 332
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 94.5 bits (234), Expect = 5e-23
Identities = 34/208 (16%), Positives = 65/208 (31%), Gaps = 34/208 (16%)
Query: 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEE--------- 121
G+L+G G V+ + VK + K K + +L
Sbjct: 5 GKLMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63
Query: 122 -VKLLKDLSHPNIVRYLGTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQL 180
+ L+ L + + +L+E + + +
Sbjct: 64 EFRALQKLQGLAVPKVYAWEGNA----VLMELIDAKELY-------RVRVENPDEVLDMI 112
Query: 181 LLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWM 240
L + ++ GI+H D+ N+LV +G I + DF S +V E G + +
Sbjct: 113 LEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGE----EGWREI----LER 163
Query: 241 APEVIR---QTGHSYSADIWSVGCTVIE 265
I + DI S +++
Sbjct: 164 DVRNIITYFSRTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 536 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1s6ja_ | 87 | Calcium-dependent protein kinase sk5 CLD {Soybean | 98.4 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.37 | |
| d2opoa1 | 81 | Polcalcin Che a 3 {Pigweed (Chenopodium album) [Ta | 98.31 | |
| d1wrka1 | 82 | Troponin C {Human (Homo sapiens), cardiac isoform | 98.29 | |
| d1f54a_ | 77 | Calmodulin {Baker's yeast (Saccharomyces cerevisia | 98.21 | |
| d2pq3a1 | 73 | Calmodulin {Rattus norvegicus [TaxId: 10116]} | 98.16 | |
| d1fw4a_ | 65 | Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | 98.13 | |
| d1avsa_ | 81 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 98.11 | |
| d1tiza_ | 67 | Calmodulin-related protein T21P5.17 {Thale cress ( | 98.11 | |
| d2fcea1 | 61 | Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | 98.08 | |
| d1c7va_ | 68 | Calcium vector protein {Amphioxus (Branchiostoma l | 98.04 | |
| d1jc2a_ | 75 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 98.04 | |
| d1fi5a_ | 81 | Troponin C {Chicken (Gallus gallus), cardiac isofo | 98.0 | |
| d1oqpa_ | 77 | Caltractin (centrin 2) {Green algae (Chlamydomonas | 97.95 | |
| d5pala_ | 109 | Parvalbumin {Leopard shark (Triakis semifasciata) | 97.89 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.88 | |
| d1fi6a_ | 92 | Reps1 {Mouse (Mus musculus) [TaxId: 10090]} | 97.86 | |
| d1pvaa_ | 109 | Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | 97.84 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.79 | |
| d1qx2a_ | 76 | Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]} | 97.78 | |
| d1c07a_ | 95 | Eps15 {Human (Homo sapiens) [TaxId: 9606]} | 97.76 | |
| d1yuta1 | 98 | Calcyclin (S100) {Human (Homo sapiens), s100a13 [T | 97.73 | |
| d1rwya_ | 109 | Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]} | 97.72 | |
| d1rroa_ | 108 | Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116 | 97.69 | |
| d1cb1a_ | 78 | Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]} | 97.66 | |
| d1wlza1 | 83 | DJ-1-binding protein, DJBP {Human (Homo sapiens) [ | 97.65 | |
| d2pvba_ | 107 | Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | 97.63 | |
| d1snla_ | 99 | Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [Tax | 97.49 | |
| d1a4pa_ | 92 | Calcyclin (S100) {Human (Homo sapiens), P11 s100a1 | 97.46 | |
| d1zfsa1 | 93 | Calcyclin (S100) {Rat (Rattus norvegicus), s100a1 | 97.45 | |
| d1qjta_ | 99 | Eps15 {Mouse (Mus musculus) [TaxId: 10090]} | 97.42 | |
| d2jxca1 | 95 | Eps15 {Human (Homo sapiens) [TaxId: 9606]} | 97.4 | |
| d1k8ua_ | 89 | Calcyclin (S100) {Human (Homo sapiens), s100a6 [Ta | 97.36 | |
| d1iq3a_ | 110 | Pob1 {Human (Homo sapiens) [TaxId: 9606]} | 97.34 | |
| d1jfja_ | 134 | EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: | 97.32 | |
| d1xk4a1 | 87 | Calcyclin (S100) {Human (Homo sapiens), calgranuli | 97.31 | |
| d1ksoa_ | 93 | Calcyclin (S100) {Human (Homo sapiens), s100a3 [Ta | 97.29 | |
| d1m45a_ | 146 | Myosin Light Chain Mlc1p {Baker's yeast (Saccharom | 97.28 | |
| d1psra_ | 100 | Calcyclin (S100) {Human (Homo sapiens), psoriasin | 97.26 | |
| d3c1va1 | 93 | Calcyclin (S100) {Human (Homo sapiens), s100a4 [Ta | 97.19 | |
| d1dtla_ | 156 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 97.13 | |
| d1s6ia_ | 182 | Calcium-dependent protein kinase sk5 CLD {Soybean | 97.1 | |
| d1ggwa_ | 140 | Cdc4p {Fission yeast (Schizosaccharomyces pombe) [ | 97.08 | |
| d2mysc_ | 145 | Myosin Regulatory Chain {Chicken (Gallus gallus) [ | 97.06 | |
| d1lkja_ | 146 | Calmodulin {Baker's yeast (Saccharomyces cerevisia | 97.06 | |
| d1qv0a_ | 189 | Calcium-regulated photoprotein {Hydrozoa (Obelia l | 97.03 | |
| d1wdcb_ | 142 | Myosin Essential Chain {Bay scallop (Aequipecten i | 96.98 | |
| d1exra_ | 146 | Calmodulin {Ciliate (Paramecium tetraurelia) [TaxI | 96.95 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.94 | |
| d2mysb_ | 145 | Myosin Essential Chain {Chicken (Gallus gallus) [T | 96.93 | |
| d1w7jb1 | 139 | Myosin Essential Chain {Human (Homo sapiens) [TaxI | 96.9 | |
| d1topa_ | 162 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 96.9 | |
| d1nyaa_ | 176 | Calerythrin {Saccharopolyspora erythraea [TaxId: 1 | 96.87 | |
| d2obha1 | 141 | Calmodulin {Human (Homo sapiens) [TaxId: 9606]} | 96.85 | |
| d1e8aa_ | 87 | Calcyclin (S100) {Human (Homo sapiens), calgranuli | 96.84 | |
| d1wdcb_ | 142 | Myosin Essential Chain {Bay scallop (Aequipecten i | 96.82 | |
| d1uhka1 | 187 | Calcium-regulated photoprotein {Jellyfish (Aequore | 96.75 | |
| d2sasa_ | 185 | Sarcoplasmic calcium-binding protein {Amphioxus (B | 96.73 | |
| d2scpa_ | 174 | Sarcoplasmic calcium-binding protein {Sandworm (Ne | 96.64 | |
| d2mysc_ | 145 | Myosin Regulatory Chain {Chicken (Gallus gallus) [ | 96.63 | |
| d1wdcc_ | 152 | Myosin Regulatory Chain {Bay scallop (Aequipecten | 96.63 | |
| d1y1xa_ | 182 | Programmed cell death 6 protein-like protein {Leis | 96.6 | |
| d1df0a1 | 186 | Calpain large subunit, C-terminal domain (domain I | 96.58 | |
| d1exra_ | 146 | Calmodulin {Ciliate (Paramecium tetraurelia) [TaxI | 96.57 | |
| d1jbaa_ | 189 | Guanylate cyclase activating protein 2, GCAP-2 {Co | 96.57 | |
| d1qxpa2 | 188 | Calpain large subunit, C-terminal domain (domain I | 96.51 | |
| d1m45a_ | 146 | Myosin Light Chain Mlc1p {Baker's yeast (Saccharom | 96.5 | |
| d1jfja_ | 134 | EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: | 96.49 | |
| d1wdcc_ | 152 | Myosin Regulatory Chain {Bay scallop (Aequipecten | 96.48 | |
| d1s6ia_ | 182 | Calcium-dependent protein kinase sk5 CLD {Soybean | 96.45 | |
| d1ggwa_ | 140 | Cdc4p {Fission yeast (Schizosaccharomyces pombe) [ | 96.4 | |
| d1auib_ | 165 | Calcineurin regulatory subunit (B-chain) {Human (H | 96.39 | |
| d1g8ia_ | 187 | Frequenin (neuronal calcium sensor 1) {Human (Homo | 96.32 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.26 | |
| d1ij5a_ | 321 | Cbp40 (plasmodial specific CaII-binding protein LA | 96.24 | |
| d1bjfa_ | 181 | Neurocalcin {Cow (Bos taurus) [TaxId: 9913]} | 96.16 | |
| d1fpwa_ | 190 | Frequenin (neuronal calcium sensor 1) {Baker's yea | 96.07 | |
| d2obha1 | 141 | Calmodulin {Human (Homo sapiens) [TaxId: 9606]} | 96.06 | |
| d1y1xa_ | 182 | Programmed cell death 6 protein-like protein {Leis | 96.03 | |
| d1k94a_ | 165 | Grancalcin {Human (Homo sapiens) [TaxId: 9606]} | 96.02 | |
| d1alva_ | 173 | Calpain small (regulatory) subunit (domain VI) {Pi | 96.01 | |
| d1auib_ | 165 | Calcineurin regulatory subunit (B-chain) {Human (H | 95.97 | |
| d1hqva_ | 181 | Apoptosis-linked protein alg-2 {Mouse (Mus musculu | 95.93 | |
| d1xo5a_ | 180 | Calcium- and integrin-binding protein, CIB {Human | 95.91 | |
| d1hqva_ | 181 | Apoptosis-linked protein alg-2 {Mouse (Mus musculu | 95.91 | |
| d1lkja_ | 146 | Calmodulin {Baker's yeast (Saccharomyces cerevisia | 95.9 | |
| d1qlsa_ | 95 | Calcyclin (S100) {Pig (Sus scrofa), calgizzarin s1 | 95.89 | |
| d1jbaa_ | 189 | Guanylate cyclase activating protein 2, GCAP-2 {Co | 95.85 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.83 | |
| d3cr5x1 | 90 | Calcyclin (S100) {Cow (Bos taurus), s100b [TaxId: | 95.78 | |
| d1topa_ | 162 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 95.67 | |
| d1omra_ | 201 | Recoverin {Cow (Bos taurus) [TaxId: 9913]} | 95.64 | |
| d2mysb_ | 145 | Myosin Essential Chain {Chicken (Gallus gallus) [T | 95.62 | |
| d1omra_ | 201 | Recoverin {Cow (Bos taurus) [TaxId: 9913]} | 95.61 | |
| d2zfda1 | 183 | Calcineurin B-like protein 2 {Thale cress (Arabido | 95.58 | |
| d2zkmx1 | 170 | Phospholipase C-beta-2 {Human (Homo sapiens) [TaxI | 95.56 | |
| d1j55a_ | 94 | Calcyclin (S100) {Human (Homo sapiens), s100p [Tax | 95.55 | |
| d1qxpa2 | 188 | Calpain large subunit, C-terminal domain (domain I | 95.47 | |
| d1w7jb1 | 139 | Myosin Essential Chain {Human (Homo sapiens) [TaxI | 95.36 | |
| d1ij5a_ | 321 | Cbp40 (plasmodial specific CaII-binding protein LA | 95.35 | |
| d1xk4c1 | 83 | Calcyclin (S100) {Human (Homo sapiens), s100a9 (mr | 95.23 | |
| d1dtla_ | 156 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 95.11 | |
| d1pvaa_ | 109 | Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | 95.09 | |
| d1s6ca_ | 178 | Kchip1, Kv4 potassium channel-interacting protein | 94.87 | |
| d1juoa_ | 172 | Sorcin {Human (Homo sapiens) [TaxId: 9606]} | 94.71 | |
| d1s6ca_ | 178 | Kchip1, Kv4 potassium channel-interacting protein | 94.71 | |
| d1k94a_ | 165 | Grancalcin {Human (Homo sapiens) [TaxId: 9606]} | 94.61 | |
| d1fpwa_ | 190 | Frequenin (neuronal calcium sensor 1) {Baker's yea | 94.57 | |
| d1fw4a_ | 65 | Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | 94.57 | |
| d5pala_ | 109 | Parvalbumin {Leopard shark (Triakis semifasciata) | 94.02 | |
| d1bjfa_ | 181 | Neurocalcin {Cow (Bos taurus) [TaxId: 9913]} | 93.57 | |
| d2fcea1 | 61 | Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | 93.5 | |
| d2hf5a1 | 33 | Troponin C {Human (Homo sapiens), cardiac isoform | 93.47 | |
| d1rroa_ | 108 | Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116 | 93.13 | |
| d1fi5a_ | 81 | Troponin C {Chicken (Gallus gallus), cardiac isofo | 93.06 | |
| d2pvba_ | 107 | Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | 92.97 | |
| d1jc2a_ | 75 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 92.9 | |
| d1ctda_ | 34 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 92.83 | |
| d1tiza_ | 67 | Calmodulin-related protein T21P5.17 {Thale cress ( | 92.68 | |
| d1oqpa_ | 77 | Caltractin (centrin 2) {Green algae (Chlamydomonas | 92.65 | |
| d1alva_ | 173 | Calpain small (regulatory) subunit (domain VI) {Pi | 92.61 | |
| d1qv0a_ | 189 | Calcium-regulated photoprotein {Hydrozoa (Obelia l | 92.61 | |
| d2pq3a1 | 73 | Calmodulin {Rattus norvegicus [TaxId: 10116]} | 92.38 | |
| d1df0a1 | 186 | Calpain large subunit, C-terminal domain (domain I | 92.32 | |
| d1g8ia_ | 187 | Frequenin (neuronal calcium sensor 1) {Human (Homo | 92.32 | |
| d1s6ja_ | 87 | Calcium-dependent protein kinase sk5 CLD {Soybean | 92.25 | |
| d2zfda1 | 183 | Calcineurin B-like protein 2 {Thale cress (Arabido | 91.98 | |
| d1uhka1 | 187 | Calcium-regulated photoprotein {Jellyfish (Aequore | 91.86 | |
| d1juoa_ | 172 | Sorcin {Human (Homo sapiens) [TaxId: 9606]} | 91.59 | |
| d1xo5a_ | 180 | Calcium- and integrin-binding protein, CIB {Human | 91.25 | |
| d1rwya_ | 109 | Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]} | 91.24 | |
| d2scpa_ | 174 | Sarcoplasmic calcium-binding protein {Sandworm (Ne | 90.96 | |
| d1nyaa_ | 176 | Calerythrin {Saccharopolyspora erythraea [TaxId: 1 | 90.83 | |
| d2opoa1 | 81 | Polcalcin Che a 3 {Pigweed (Chenopodium album) [Ta | 90.63 | |
| d1f54a_ | 77 | Calmodulin {Baker's yeast (Saccharomyces cerevisia | 89.76 | |
| d1avsa_ | 81 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 89.43 | |
| d1wrka1 | 82 | Troponin C {Human (Homo sapiens), cardiac isoform | 88.86 | |
| d1c7va_ | 68 | Calcium vector protein {Amphioxus (Branchiostoma l | 88.57 | |
| d1wlza1 | 83 | DJ-1-binding protein, DJBP {Human (Homo sapiens) [ | 87.94 | |
| d2zkmx1 | 170 | Phospholipase C-beta-2 {Human (Homo sapiens) [TaxI | 84.93 | |
| d2sasa_ | 185 | Sarcoplasmic calcium-binding protein {Amphioxus (B | 82.17 | |
| d1c07a_ | 95 | Eps15 {Human (Homo sapiens) [TaxId: 9606]} | 81.42 | |
| d2hf5a1 | 33 | Troponin C {Human (Homo sapiens), cardiac isoform | 80.08 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-62 Score=483.42 Aligned_cols=261 Identities=28% Similarity=0.442 Sum_probs=222.1
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
++|++++.||+|+||+||+|+++.+|+.||||++... ...+..+.+.+|+++|+.++|||||++++++.+++.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~-------~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~ 77 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-------RAVDCPENIKKEICINKMLNHENVVKFYGHRREGNI 77 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------------CHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehh-------hcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCce
Confidence 5799999999999999999999999999999998432 122234568899999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhh
Q 009364 146 LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA 225 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 225 (536)
+|+|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.+....
T Consensus 78 ~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 78 QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp EEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred eEEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 99999999999999999988899999999999999999999999999999999999999999999999999998776544
Q ss_pred cccCCcccCCCCCCCChhhhhhcCC-CccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcHHHH
Q 009364 226 TVSGAKSMKGTPYWMAPEVIRQTGH-SYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKAK 304 (536)
Q Consensus 226 ~~~~~~~~~Gt~~Y~APEvl~~~~~-s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 304 (536)
........+||+.|||||++.+..+ +.++|||||||++|+|++|.+||......................+..++++++
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 237 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 237 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHH
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHH
Confidence 4444567889999999999988776 678999999999999999999996543222222222222223333457899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 305 DFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 305 dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
+||.+||+.||++|||++|+|+||||++.
T Consensus 238 ~li~~~L~~dP~~R~t~~eil~hpwf~~~ 266 (271)
T d1nvra_ 238 ALLHKILVENPSARITIPDIKKDRWYNKP 266 (271)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHHHHHcCCChhHCcCHHHHhcCHhhCcC
Confidence 99999999999999999999999999753
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-60 Score=475.94 Aligned_cols=259 Identities=33% Similarity=0.597 Sum_probs=222.1
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE 143 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 143 (536)
+..+|++.+.||+|+||+||+|+++.+|+.||||++..... ...+.+.+|+.+|+.++|||||++++++.+.
T Consensus 18 p~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~--------~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 89 (293)
T d1yhwa1 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--------PKKELIINEILVMRENKNPNIVNYLDSYLVG 89 (293)
T ss_dssp TTTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC--------SCHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred cccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC--------hHHHHHHHHHHHHHhCCCCCEeeEeEEEEEC
Confidence 44689999999999999999999999999999999853211 1134678999999999999999999999999
Q ss_pred CceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhh
Q 009364 144 ESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAE 223 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 223 (536)
+.+|+|||||+||+|.+++.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.+..
T Consensus 90 ~~~~ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~ 168 (293)
T d1yhwa1 90 DELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (293)
T ss_dssp TEEEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred CEEEEEEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecc
Confidence 999999999999999998765 5799999999999999999999999999999999999999999999999999987654
Q ss_pred hhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcHHH
Q 009364 224 LATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSVKA 303 (536)
Q Consensus 224 ~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 303 (536)
.. ......+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+....................+..++.++
T Consensus 169 ~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 246 (293)
T d1yhwa1 169 EQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF 246 (293)
T ss_dssp TT--CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHH
T ss_pred cc--ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHH
Confidence 22 2345678999999999999999999999999999999999999999754322211111111222334567899999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 304 KDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 304 ~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
++||.+||++||.+|||+.|+|+||||+..
T Consensus 247 ~~li~~~L~~dP~~R~s~~eil~Hp~~~~~ 276 (293)
T d1yhwa1 247 RDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (293)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 999999999999999999999999999743
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-60 Score=468.46 Aligned_cols=254 Identities=30% Similarity=0.533 Sum_probs=222.5
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
.+|++++.||+|+||+||+|+++.+|+.||+|++.... .......+.+.+|+++|+.++|||||++++++.+++.
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~ 80 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ-----LEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR 80 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH-----HHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHH-----ccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCE
Confidence 47999999999999999999999999999999984221 1112234567899999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhh
Q 009364 146 LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA 225 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 225 (536)
+|+|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 81 ~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~- 159 (263)
T d2j4za1 81 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS- 159 (263)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-
T ss_pred EEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC-
Confidence 9999999999999999998889999999999999999999999999999999999999999999999999999765432
Q ss_pred cccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH-HHHHHhhCCCCCCCCCCCcCcHHHH
Q 009364 226 TVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE-VAALFHIGTTKSHPPIPENLSVKAK 304 (536)
Q Consensus 226 ~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~~ 304 (536)
.....+||+.|+|||++.+..|+.++|||||||++|+|++|++||...... ....... ....+|..+|++++
T Consensus 160 ---~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~----~~~~~p~~~s~~~~ 232 (263)
T d2j4za1 160 ---RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR----VEFTFPDFVTEGAR 232 (263)
T ss_dssp ---CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT----TCCCCCTTSCHHHH
T ss_pred ---cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHc----CCCCCCccCCHHHH
Confidence 245678999999999999999999999999999999999999999765332 2222221 23456778999999
Q ss_pred HHHHHhcccCCCCCCCHHHHHhCCCCcC
Q 009364 305 DFLLKCLEKEPDLRPTASELLKHPFVTG 332 (536)
Q Consensus 305 dLi~~cL~~dP~~Rps~~eiL~hp~~~~ 332 (536)
+||.+||++||.+|||+.|+|+||||+.
T Consensus 233 ~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 233 DLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred HHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 9999999999999999999999999964
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-59 Score=471.06 Aligned_cols=264 Identities=27% Similarity=0.496 Sum_probs=223.7
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEE 144 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 144 (536)
+.+|++++.||+|+||+||+|+++.+|+.||||++.... .......+.+.+|+++|++++||||+++++++.+++
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-----~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 81 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRH-----IIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE 81 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH-----HHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSS
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHH-----ccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECC
Confidence 457999999999999999999999999999999984211 111223466889999999999999999999999999
Q ss_pred ceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhh
Q 009364 145 SLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAEL 224 (536)
Q Consensus 145 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 224 (536)
.+|+|||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.+...
T Consensus 82 ~~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 82 KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EEEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccC
Confidence 99999999999999999998899999999999999999999999999999999999999999999999999999877544
Q ss_pred hcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH-HHHHHhhCCCCCCCCCCCcCcHHH
Q 009364 225 ATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE-VAALFHIGTTKSHPPIPENLSVKA 303 (536)
Q Consensus 225 ~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~ 303 (536)
.........+||+.|+|||++.+..|+.++|||||||++|+|++|.+||...... ....+.. ....+|..+++++
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~----~~~~~p~~~s~~~ 237 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK----LEYDFPEKFFPKA 237 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHT----TCCCCCTTCCHHH
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHc----CCCCCCccCCHHH
Confidence 3333455678999999999999999999999999999999999999999765332 2222211 2235677899999
Q ss_pred HHHHHHhcccCCCCCCCHHH------HHhCCCCcCCCCCc
Q 009364 304 KDFLLKCLEKEPDLRPTASE------LLKHPFVTGDDEDP 337 (536)
Q Consensus 304 ~dLi~~cL~~dP~~Rps~~e------iL~hp~~~~~~~~~ 337 (536)
++||++||++||.+|||++| +++||||....++.
T Consensus 238 ~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~ 277 (288)
T d1uu3a_ 238 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWEN 277 (288)
T ss_dssp HHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTT
T ss_pred HHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHH
Confidence 99999999999999999987 68899998776553
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-59 Score=471.63 Aligned_cols=261 Identities=39% Similarity=0.622 Sum_probs=220.6
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE 142 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 142 (536)
.+.+.|++++.||+|+||+||+|+++.+|+.||+|++.... ....+.+.+|+++|+.++|||||++++++.+
T Consensus 9 ~p~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--------~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 80 (288)
T d2jfla1 9 NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--------EEELEDYMVEIDILASCDHPNIVKLLDAFYY 80 (288)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS--------SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred CcccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC--------HHHHHHHHHHHHHHHhCCCCCCCeEEEEEee
Confidence 45568999999999999999999999999999999984321 1223567789999999999999999999999
Q ss_pred CCceeEEEEecCCCCccccccc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhh
Q 009364 143 EESLNILLEFVPGGSISSLLGK-FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQV 221 (536)
Q Consensus 143 ~~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~ 221 (536)
++.+++|||||+||+|.+++.+ .+++++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+..
T Consensus 81 ~~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~ 160 (288)
T d2jfla1 81 ENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKN 160 (288)
T ss_dssp TTEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhcc
Confidence 9999999999999999998754 467999999999999999999999999999999999999999999999999999765
Q ss_pred hhhhcccCCcccCCCCCCCChhhhh-----hcCCCccceEechhHHHHHHhhCCCCCchhhH-HHHHHHhhCCCCCCCCC
Q 009364 222 AELATVSGAKSMKGTPYWMAPEVIR-----QTGHSYSADIWSVGCTVIEMATGKPPWSQQYQ-EVAALFHIGTTKSHPPI 295 (536)
Q Consensus 222 ~~~~~~~~~~~~~Gt~~Y~APEvl~-----~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~-~~~~~~~~~~~~~~~~~ 295 (536)
..... ...+.+||+.|+|||++. +..|+.++|||||||++|+|++|.+||.+... +........ .......
T Consensus 161 ~~~~~--~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~-~~~~~~~ 237 (288)
T d2jfla1 161 TRTIQ--RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS-EPPTLAQ 237 (288)
T ss_dssp HHHHH--HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHS-CCCCCSS
T ss_pred CCCcc--cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC-CCCCCCc
Confidence 54322 234678999999999984 45689999999999999999999999975432 221111111 2223344
Q ss_pred CCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCC
Q 009364 296 PENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDD 334 (536)
Q Consensus 296 ~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~ 334 (536)
+..+|+++++||++||++||.+|||+.|+|+||||+...
T Consensus 238 ~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~~ 276 (288)
T d2jfla1 238 PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDS 276 (288)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCCC
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 568999999999999999999999999999999997543
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-59 Score=462.08 Aligned_cols=257 Identities=27% Similarity=0.487 Sum_probs=215.8
Q ss_pred CCCCc-eeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec
Q 009364 64 PPIRW-RKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE 142 (536)
Q Consensus 64 ~~~~y-~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 142 (536)
...|| ++.+.||+|+||+||+|++..+++.||+|++... .......+.+.+|+++|++++|||||++++++.+
T Consensus 6 ~~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~------~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 79 (270)
T d1t4ha_ 6 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDR------KLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWES 79 (270)
T ss_dssp TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGG------GSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred CCCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchh------hCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEee
Confidence 34455 7888999999999999999999999999988432 1122345678899999999999999999999865
Q ss_pred ----CCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--CccccCCCCCcccC-CCCcEEEEec
Q 009364 143 ----EESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHG--IMHRDIKGANILVD-NKGCIKLADF 215 (536)
Q Consensus 143 ----~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~--ivHrDLKp~NILl~-~~~~vkL~DF 215 (536)
...+|+|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++| |+||||||+|||++ .++.+||+||
T Consensus 80 ~~~~~~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DF 159 (270)
T d1t4ha_ 80 TVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDL 159 (270)
T ss_dssp ESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCT
T ss_pred ccccCCEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeec
Confidence 3568999999999999999988889999999999999999999999998 99999999999996 4789999999
Q ss_pred CcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCC
Q 009364 216 GASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPI 295 (536)
Q Consensus 216 Gla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 295 (536)
|+|+.... ....+.+||+.|||||++.+ .|+.++|||||||++|+|++|++||.....................+
T Consensus 160 Gla~~~~~----~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~ 234 (270)
T d1t4ha_ 160 GLATLKRA----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASF 234 (270)
T ss_dssp TGGGGCCT----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGG
T ss_pred CcceeccC----CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCccc
Confidence 99975432 22456789999999999876 69999999999999999999999997543222222222222233345
Q ss_pred CCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCc
Q 009364 296 PENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVT 331 (536)
Q Consensus 296 ~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~ 331 (536)
+..+++++++||.+||++||++|||++|+|+||||+
T Consensus 235 ~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 235 DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred CccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 667899999999999999999999999999999995
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.7e-59 Score=471.25 Aligned_cols=259 Identities=29% Similarity=0.466 Sum_probs=209.7
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEE 144 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 144 (536)
.++|++.+.||+|+||+||+|+++.+|+.||||++.... .......+.+|+.+|+.++|||||++++++.+++
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-------~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 80 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKA-------LEGKEGSMENEIAVLHKIKHPNIVALDDIYESGG 80 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------------CHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHH-------hhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 457999999999999999999999999999999984321 1223356789999999999999999999999999
Q ss_pred ceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccC---CCCcEEEEecCcchhh
Q 009364 145 SLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVD---NKGCIKLADFGASKQV 221 (536)
Q Consensus 145 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~---~~~~vkL~DFGla~~~ 221 (536)
.+|+|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||+. .++.+||+|||+|+..
T Consensus 81 ~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 81 HLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp EEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred EEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 9999999999999999999888999999999999999999999999999999999999995 5789999999999876
Q ss_pred hhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhH-HHHHHHhhCCCCCCCCCCCcCc
Q 009364 222 AELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQ-EVAALFHIGTTKSHPPIPENLS 300 (536)
Q Consensus 222 ~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~s 300 (536)
.... ...+.+||+.|||||++.+..|+.++|||||||++|+|++|.+||.+... .....+.........+.+..+|
T Consensus 161 ~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 237 (307)
T d1a06a_ 161 DPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDIS 237 (307)
T ss_dssp ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSC
T ss_pred cCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCC
Confidence 5432 24567899999999999999999999999999999999999999976533 2333333333444445667899
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 301 VKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 301 ~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
+++++||.+||++||.+|||+.|+++||||++.
T Consensus 238 ~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 238 DSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 999999999999999999999999999999864
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-59 Score=472.99 Aligned_cols=259 Identities=32% Similarity=0.531 Sum_probs=217.1
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE 143 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 143 (536)
..++|++.+.||+|+||+||+|+++.+|+.||+|++.... .......+.+|+.+|+.++|||||+++++|.+.
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-------~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 76 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-------KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD 76 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-------CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECS
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-------CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 3568999999999999999999999999999999984321 112235678999999999999999999999999
Q ss_pred CceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHH-cCCccccCCCCCcccCCCCcEEEEecCcchhhh
Q 009364 144 ESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHN-HGIMHRDIKGANILVDNKGCIKLADFGASKQVA 222 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~-~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~ 222 (536)
+.+|+|||||+||+|.+++.+.+.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||+|+.+.
T Consensus 77 ~~~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 77 GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp SEEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred CEEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence 9999999999999999999888899999999999999999999997 599999999999999999999999999999765
Q ss_pred hhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhh----------------
Q 009364 223 ELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHI---------------- 286 (536)
Q Consensus 223 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~---------------- 286 (536)
.. ...+.+||+.|+|||++.+..|+.++||||+||++|||++|+.||.............
T Consensus 157 ~~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
T d1s9ja_ 157 DS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232 (322)
T ss_dssp HH----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------
T ss_pred CC----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccc
Confidence 42 2456799999999999999999999999999999999999999996432111000000
Q ss_pred ------------------------CCCCCCCCCC-CcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 287 ------------------------GTTKSHPPIP-ENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 287 ------------------------~~~~~~~~~~-~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
......+..+ ..+|.++++||.+||+.||.+|||++|+|+||||+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp -------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred ccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 0000111122 2468999999999999999999999999999999753
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-58 Score=459.43 Aligned_cols=254 Identities=31% Similarity=0.535 Sum_probs=207.1
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec--C
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE--E 143 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--~ 143 (536)
.+|++.+.||+|+||+||+|+++.+|+.||+|++.... ..+...+.+.+|+++|++++|||||++++++.+ .
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~------~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 77 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGS------MTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTN 77 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTT------SCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC---
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhh------CCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCC
Confidence 57999999999999999999999999999999984321 122345678899999999999999999999864 4
Q ss_pred CceeEEEEecCCCCccccccc----CCCCCHHHHHHHHHHHHHHHHHHHHcC-----CccccCCCCCcccCCCCcEEEEe
Q 009364 144 ESLNILLEFVPGGSISSLLGK----FGPFPEAVMRTYTKQLLLGLEYLHNHG-----IMHRDIKGANILVDNKGCIKLAD 214 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qil~aL~yLH~~~-----ivHrDLKp~NILl~~~~~vkL~D 214 (536)
+.+|+|||||+||+|.+++.+ .+.+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|
T Consensus 78 ~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~D 157 (269)
T d2java1 78 TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGD 157 (269)
T ss_dssp -CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECC
T ss_pred CEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEee
Confidence 568999999999999998853 467999999999999999999999976 99999999999999999999999
Q ss_pred cCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH-HHHHHhhCCCCCCC
Q 009364 215 FGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE-VAALFHIGTTKSHP 293 (536)
Q Consensus 215 FGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~ 293 (536)
||+|+.+.... ......+||+.|+|||++.+..|+.++|||||||++|+|+||.+||...... ....+... ..+
T Consensus 158 FG~a~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~---~~~ 232 (269)
T d2java1 158 FGLARILNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG---KFR 232 (269)
T ss_dssp HHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT---CCC
T ss_pred ccceeecccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcC---CCC
Confidence 99998875432 2245678999999999999999999999999999999999999999764332 22222222 234
Q ss_pred CCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCC
Q 009364 294 PIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFV 330 (536)
Q Consensus 294 ~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~ 330 (536)
.++..+|+++++||.+||+.||.+|||+.|+|+|||+
T Consensus 233 ~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 233 RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 5677899999999999999999999999999999996
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-58 Score=460.60 Aligned_cols=267 Identities=28% Similarity=0.435 Sum_probs=224.2
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEE 144 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 144 (536)
.++|++++.||+|+||+||+|+++.+|+.||||++......... .....+.+.+|+.+|+.++|||||++++++.+.+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 86 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSR--RGVSREDIEREVSILKEIQHPNVITLHEVYENKT 86 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCS--SSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhh--hhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 45899999999999999999999999999999998543221111 1112456889999999999999999999999999
Q ss_pred ceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCC----cEEEEecCcchh
Q 009364 145 SLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKG----CIKLADFGASKQ 220 (536)
Q Consensus 145 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~----~vkL~DFGla~~ 220 (536)
.+|+|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.
T Consensus 87 ~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~ 166 (293)
T d1jksa_ 87 DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166 (293)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhh
Confidence 9999999999999999998888999999999999999999999999999999999999998776 599999999987
Q ss_pred hhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhH-HHHHHHhhCCCCCCCCCCCcC
Q 009364 221 VAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQ-EVAALFHIGTTKSHPPIPENL 299 (536)
Q Consensus 221 ~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~ 299 (536)
..... .....+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+... +....+...........+..+
T Consensus 167 ~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (293)
T d1jksa_ 167 IDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT 243 (293)
T ss_dssp CTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTS
T ss_pred cCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCC
Confidence 65422 24567899999999999999999999999999999999999999975433 222222222222233344688
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCCCC
Q 009364 300 SVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDDED 336 (536)
Q Consensus 300 s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~~~ 336 (536)
|.++++||++||++||.+|||++|+|+||||+...+.
T Consensus 244 s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~ 280 (293)
T d1jksa_ 244 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQ 280 (293)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC----
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCChh
Confidence 9999999999999999999999999999999865443
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-58 Score=467.62 Aligned_cols=259 Identities=29% Similarity=0.468 Sum_probs=225.7
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
++|++++.||+|+||+||+|+++.+|+.||||++..... ......+.+.+|+.+|+.++||||+++++++.+.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~-----~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 79 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVI-----IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDR 79 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhc-----cCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccc
Confidence 369999999999999999999999999999999842211 112235667899999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhh
Q 009364 146 LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA 225 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 225 (536)
+|+|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus 80 ~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 80 LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred cccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 99999999999999999998999999999999999999999999999999999999999999999999999998654322
Q ss_pred cccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH-HHHHHhhCCCCCCCCCCCcCcHHHH
Q 009364 226 TVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE-VAALFHIGTTKSHPPIPENLSVKAK 304 (536)
Q Consensus 226 ~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~~ 304 (536)
......+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.... ........ ...+|..+|++++
T Consensus 160 --~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~----~~~~p~~~s~~~~ 233 (337)
T d1o6la_ 160 --ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME----EIRFPRTLSPEAK 233 (337)
T ss_dssp --CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC----CCCCCTTSCHHHH
T ss_pred --cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcC----CCCCCccCCHHHH
Confidence 2345688999999999999999999999999999999999999999765433 22222222 3456778999999
Q ss_pred HHHHHhcccCCCCCCC-----HHHHHhCCCCcCCCC
Q 009364 305 DFLLKCLEKEPDLRPT-----ASELLKHPFVTGDDE 335 (536)
Q Consensus 305 dLi~~cL~~dP~~Rps-----~~eiL~hp~~~~~~~ 335 (536)
+||++||++||.+||+ +.|+++||||....+
T Consensus 234 dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~ 269 (337)
T d1o6la_ 234 SLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW 269 (337)
T ss_dssp HHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred HHHHhhccCCchhhcccccccHHHHHcCcccccCCH
Confidence 9999999999999994 999999999987543
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.5e-57 Score=468.70 Aligned_cols=258 Identities=25% Similarity=0.418 Sum_probs=221.6
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
++|++++.||+|+||+||+|+++.+|+.||||++... .....+.+.+|+++|+.++|||||++++++.+++.
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~--------~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 97 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--------HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE 97 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC--------SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc--------chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 4799999999999999999999999999999998421 11234568899999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccc-cCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCC--CCcEEEEecCcchhhh
Q 009364 146 LNILLEFVPGGSISSLLG-KFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDN--KGCIKLADFGASKQVA 222 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~-~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~--~~~vkL~DFGla~~~~ 222 (536)
+|+|||||+||+|.+++. ..+++++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+.+.
T Consensus 98 ~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~ 177 (350)
T d1koaa2 98 MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 177 (350)
T ss_dssp EEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred EEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecc
Confidence 999999999999999885 4567999999999999999999999999999999999999964 5789999999998765
Q ss_pred hhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhH-HHHHHHhhCCCCCCCCCCCcCcH
Q 009364 223 ELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQ-EVAALFHIGTTKSHPPIPENLSV 301 (536)
Q Consensus 223 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~s~ 301 (536)
.. ......+||+.|||||++.+..|+.++|||||||++|+|++|.+||.+... +....+..............+|+
T Consensus 178 ~~---~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 254 (350)
T d1koaa2 178 PK---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE 254 (350)
T ss_dssp TT---SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCH
T ss_pred cc---cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCH
Confidence 42 224467899999999999999999999999999999999999999975432 22333333333333344467899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCC
Q 009364 302 KAKDFLLKCLEKEPDLRPTASELLKHPFVTGDD 334 (536)
Q Consensus 302 ~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~ 334 (536)
++++||.+||++||++|||++|+|+||||+...
T Consensus 255 ~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~ 287 (350)
T d1koaa2 255 DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN 287 (350)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 999999999999999999999999999998653
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.4e-58 Score=462.95 Aligned_cols=258 Identities=35% Similarity=0.608 Sum_probs=220.1
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEE 144 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 144 (536)
..+|++.+.||+|+||+||+|++..+|+.||||++.... .......+.+.+|+++|++++|||||++++++.+.+
T Consensus 14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-----~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~ 88 (309)
T d1u5ra_ 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSG-----KQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH 88 (309)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCS-----SCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred HHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhh-----ccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECC
Confidence 346999999999999999999999999999999984321 122344567889999999999999999999999999
Q ss_pred ceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhh
Q 009364 145 SLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAEL 224 (536)
Q Consensus 145 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 224 (536)
.+|+|||||.||+|..++...+++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 89 ~~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 89 TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (309)
T ss_dssp EEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EEEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence 9999999999999988877778999999999999999999999999999999999999999999999999999976543
Q ss_pred hcccCCcccCCCCCCCChhhhhh---cCCCccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcCcH
Q 009364 225 ATVSGAKSMKGTPYWMAPEVIRQ---TGHSYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENLSV 301 (536)
Q Consensus 225 ~~~~~~~~~~Gt~~Y~APEvl~~---~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 301 (536)
....+||+.|||||++.+ ..|+.++|||||||++|+|++|.+||.+...... +............+..+|+
T Consensus 168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~~s~ 241 (309)
T d1u5ra_ 168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQNESPALQSGHWSE 241 (309)
T ss_dssp -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHSCCCCCSCTTSCH
T ss_pred -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH-HHHHHhCCCCCCCCCCCCH
Confidence 345789999999999864 4589999999999999999999999975433211 1111112222334457899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCC
Q 009364 302 KAKDFLLKCLEKEPDLRPTASELLKHPFVTGDD 334 (536)
Q Consensus 302 ~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~ 334 (536)
++++||.+||++||.+|||++|+|+||||....
T Consensus 242 ~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~~ 274 (309)
T d1u5ra_ 242 YFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 274 (309)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred HHHHHHHHHCcCChhHCcCHHHHHhCHHhcCCC
Confidence 999999999999999999999999999997643
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.4e-57 Score=466.50 Aligned_cols=258 Identities=25% Similarity=0.422 Sum_probs=222.5
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
++|++.+.||+|+||+||+|+++.+|+.||||++.... ....+.+.+|+.+|+.++|||||+++++|.+++.
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--------~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~ 100 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--------PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE 100 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--------HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--------hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 47999999999999999999999999999999884311 1223567899999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccC-CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccC--CCCcEEEEecCcchhhh
Q 009364 146 LNILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVD--NKGCIKLADFGASKQVA 222 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~--~~~~vkL~DFGla~~~~ 222 (536)
+|+|||||+||+|.+++.+. .++++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+|+.+.
T Consensus 101 ~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~ 180 (352)
T d1koba_ 101 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 180 (352)
T ss_dssp EEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred EEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecC
Confidence 99999999999999877654 4799999999999999999999999999999999999997 56899999999998765
Q ss_pred hhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhH-HHHHHHhhCCCCCCCCCCCcCcH
Q 009364 223 ELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQ-EVAALFHIGTTKSHPPIPENLSV 301 (536)
Q Consensus 223 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~s~ 301 (536)
... .....+||+.|+|||++.+..|+.++|||||||++|+|+||.+||.+... +....+...........+..+|+
T Consensus 181 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 257 (352)
T d1koba_ 181 PDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP 257 (352)
T ss_dssp TTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCH
T ss_pred CCC---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCH
Confidence 422 24467899999999999999999999999999999999999999976433 22233333333344445668999
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCC
Q 009364 302 KAKDFLLKCLEKEPDLRPTASELLKHPFVTGDD 334 (536)
Q Consensus 302 ~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~ 334 (536)
++++||.+||++||.+|||+.|+|+||||+...
T Consensus 258 ~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 258 EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence 999999999999999999999999999998653
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.7e-57 Score=458.34 Aligned_cols=257 Identities=28% Similarity=0.479 Sum_probs=224.1
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
.+|++++.||+|+||+||+|+++.+|+.||||++..... ......+.+.+|+.+|+.++|||||++++++.+.+.
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-----~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 78 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV-----VRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQ 78 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHc-----cCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCe
Confidence 369999999999999999999999999999999842111 112235678899999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhh
Q 009364 146 LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA 225 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 225 (536)
+|+|||||.||+|..++.....+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 79 ~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~-- 156 (316)
T d1fota_ 79 IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-- 156 (316)
T ss_dssp EEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--
T ss_pred eeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc--
Confidence 999999999999999999989999999999999999999999999999999999999999999999999999987643
Q ss_pred cccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH-HHHHHhhCCCCCCCCCCCcCcHHHH
Q 009364 226 TVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE-VAALFHIGTTKSHPPIPENLSVKAK 304 (536)
Q Consensus 226 ~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~~ 304 (536)
...+.+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.... ....+... ...+|..++++++
T Consensus 157 ---~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~----~~~~p~~~s~~~~ 229 (316)
T d1fota_ 157 ---VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA----ELRFPPFFNEDVK 229 (316)
T ss_dssp ---CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC----CCCCCTTSCHHHH
T ss_pred ---ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcC----CCCCCCCCCHHHH
Confidence 234678999999999999999999999999999999999999999765432 22222222 2346678999999
Q ss_pred HHHHHhcccCCCCCC-----CHHHHHhCCCCcCCCCC
Q 009364 305 DFLLKCLEKEPDLRP-----TASELLKHPFVTGDDED 336 (536)
Q Consensus 305 dLi~~cL~~dP~~Rp-----s~~eiL~hp~~~~~~~~ 336 (536)
++|.+||++||.+|+ |++++++||||++..++
T Consensus 230 ~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~ 266 (316)
T d1fota_ 230 DLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE 266 (316)
T ss_dssp HHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred HHHHHHhhhCHHhccccchhhHHHHHcCcccccCCHH
Confidence 999999999999996 99999999999876543
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=6.1e-57 Score=466.73 Aligned_cols=264 Identities=27% Similarity=0.421 Sum_probs=221.5
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
++|++.+.||+|+||+||+|+++.+|+.||||++...... ............+++++++.++|||||++++++.+.+.
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~--~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIK--MKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH--HHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcc--hhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence 4799999999999999999999999999999998432111 11111222333456788888899999999999999999
Q ss_pred eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhh
Q 009364 146 LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA 225 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 225 (536)
+|+|||||+||+|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.+...
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~- 160 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK- 160 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS-
T ss_pred EEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC-
Confidence 9999999999999999998899999999999999999999999999999999999999999999999999999866532
Q ss_pred cccCCcccCCCCCCCChhhhh-hcCCCccceEechhHHHHHHhhCCCCCchhhHH-HHHHHhhCCCCCCCCCCCcCcHHH
Q 009364 226 TVSGAKSMKGTPYWMAPEVIR-QTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE-VAALFHIGTTKSHPPIPENLSVKA 303 (536)
Q Consensus 226 ~~~~~~~~~Gt~~Y~APEvl~-~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~ 303 (536)
.....+||+.|+|||++. +..|+.++|||||||++|+|+||.+||...... ...+. .........++..+|+++
T Consensus 161 ---~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~-~~~~~~~~~~~~~~s~~~ 236 (364)
T d1omwa3 161 ---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-RMTLTMAVELPDSFSPEL 236 (364)
T ss_dssp ---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH-HHSSSCCCCCCSSSCHHH
T ss_pred ---cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HhcccCCCCCCCCCCHHH
Confidence 245678999999999996 457899999999999999999999999754321 12222 223334456677899999
Q ss_pred HHHHHHhcccCCCCCCC-----HHHHHhCCCCcCCCCC
Q 009364 304 KDFLLKCLEKEPDLRPT-----ASELLKHPFVTGDDED 336 (536)
Q Consensus 304 ~dLi~~cL~~dP~~Rps-----~~eiL~hp~~~~~~~~ 336 (536)
++||.+||++||.+||| ++|+++||||++..+.
T Consensus 237 ~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~ 274 (364)
T d1omwa3 237 RSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQ 274 (364)
T ss_dssp HHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHH
T ss_pred HHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHH
Confidence 99999999999999999 8999999999876543
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.2e-56 Score=443.64 Aligned_cols=265 Identities=28% Similarity=0.409 Sum_probs=226.2
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccc-hhHHHHHHHHHHHHHHHHHhCC-CCceeeEeeeeec
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFAS-KEKAQDHIKELEEEVKLLKDLS-HPNIVRYLGTVRE 142 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~-~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~ 142 (536)
..+|++.+.||+|+||+||+|+++.+|+.||||++........ ....+...+.+.+|+.+|++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 3589999999999999999999999999999999865332221 1223445567889999999997 9999999999999
Q ss_pred CCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhh
Q 009364 143 EESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVA 222 (536)
Q Consensus 143 ~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~ 222 (536)
++.+|+|||||+||+|.+++...+++++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 161 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence 99999999999999999999888999999999999999999999999999999999999999999999999999998765
Q ss_pred hhhcccCCcccCCCCCCCChhhhhhc------CCCccceEechhHHHHHHhhCCCCCchhhHHH-HHHHhhCCCCCCCCC
Q 009364 223 ELATVSGAKSMKGTPYWMAPEVIRQT------GHSYSADIWSVGCTVIEMATGKPPWSQQYQEV-AALFHIGTTKSHPPI 295 (536)
Q Consensus 223 ~~~~~~~~~~~~Gt~~Y~APEvl~~~------~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~-~~~~~~~~~~~~~~~ 295 (536)
... .....+||+.|+|||++.+. .++.++||||+||++|+|++|++||.+..... ...+.........+.
T Consensus 162 ~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 238 (277)
T d1phka_ 162 PGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 238 (277)
T ss_dssp TTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred CCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence 432 24567899999999998643 46789999999999999999999998665332 222333333333344
Q ss_pred CCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcC
Q 009364 296 PENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTG 332 (536)
Q Consensus 296 ~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~ 332 (536)
..++|+++++||.+||++||++|||++|||+||||+.
T Consensus 239 ~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 239 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 5589999999999999999999999999999999974
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-56 Score=460.41 Aligned_cols=257 Identities=28% Similarity=0.486 Sum_probs=224.1
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
++|++++.||+|+||+||+|+++.+|+.||||++.... .......+.+.+|+++|+.++|||||++++++.+...
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~-----~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~ 115 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK-----VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN 115 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH-----HHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHH-----ccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccc
Confidence 68999999999999999999999999999999984211 1112234567899999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhh
Q 009364 146 LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA 225 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 225 (536)
+++||||+.||+|..++.+.+.+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+.+..
T Consensus 116 ~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~-- 193 (350)
T d1rdqe_ 116 LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-- 193 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS--
T ss_pred cccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc--
Confidence 999999999999999998888999999999999999999999999999999999999999999999999999987643
Q ss_pred cccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH-HHHHHhhCCCCCCCCCCCcCcHHHH
Q 009364 226 TVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE-VAALFHIGTTKSHPPIPENLSVKAK 304 (536)
Q Consensus 226 ~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~~ 304 (536)
.....+||+.|||||++.+..|+.++|||||||++|+|+||.+||.+.... ....+... ....+..++++++
T Consensus 194 ---~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~----~~~~p~~~s~~~~ 266 (350)
T d1rdqe_ 194 ---RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPSHFSSDLK 266 (350)
T ss_dssp ---CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC----CCCCCTTCCHHHH
T ss_pred ---ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcC----CCCCCccCCHHHH
Confidence 234678999999999999999999999999999999999999999765422 22222221 2345678999999
Q ss_pred HHHHHhcccCCCCCC-----CHHHHHhCCCCcCCCCC
Q 009364 305 DFLLKCLEKEPDLRP-----TASELLKHPFVTGDDED 336 (536)
Q Consensus 305 dLi~~cL~~dP~~Rp-----s~~eiL~hp~~~~~~~~ 336 (536)
+||++||++||.+|+ |++++++||||+...+.
T Consensus 267 ~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~ 303 (350)
T d1rdqe_ 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWI 303 (350)
T ss_dssp HHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHH
T ss_pred HHHHHHhhhCHHhccccccccHHHHHcCccccCCCHH
Confidence 999999999999994 99999999999876543
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-56 Score=453.44 Aligned_cols=257 Identities=26% Similarity=0.381 Sum_probs=218.9
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEE 144 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 144 (536)
-++|++++.||+|+||+||+|.++.+|+.||+|++... . .....+.+|+++|+.++|||||++++++.+.+
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~------~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~ 74 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK------G---TDQVLVKKEISILNIARHRNILHLHESFESME 74 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC------T---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETT
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC------c---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 35899999999999999999999999999999998431 1 11245779999999999999999999999999
Q ss_pred ceeEEEEecCCCCcccccccCC-CCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCC--CcEEEEecCcchhh
Q 009364 145 SLNILLEFVPGGSISSLLGKFG-PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNK--GCIKLADFGASKQV 221 (536)
Q Consensus 145 ~~~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~--~~vkL~DFGla~~~ 221 (536)
.+|+|||||+||+|.+++...+ ++++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++..
T Consensus 75 ~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~ 154 (321)
T d1tkia_ 75 ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp EEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhcc
Confidence 9999999999999999997655 79999999999999999999999999999999999999854 48999999999876
Q ss_pred hhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhH-HHHHHHhhCCCCCCCCCCCcCc
Q 009364 222 AELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQ-EVAALFHIGTTKSHPPIPENLS 300 (536)
Q Consensus 222 ~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~s 300 (536)
.... .....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||..... +....+...........+..+|
T Consensus 155 ~~~~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 231 (321)
T d1tkia_ 155 KPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEIS 231 (321)
T ss_dssp CTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSC
T ss_pred ccCC---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCC
Confidence 4322 23456799999999999999999999999999999999999999976543 2222222222222222334789
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 301 VKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 301 ~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
+++++||.+||++||.+|||+.|+|+||||.+.
T Consensus 232 ~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 232 IEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 999999999999999999999999999999753
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-55 Score=449.03 Aligned_cols=258 Identities=28% Similarity=0.494 Sum_probs=220.3
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHH-hCCCCceeeEeeeeecCC
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLK-DLSHPNIVRYLGTVREEE 144 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~-~l~HpnIv~l~~~~~~~~ 144 (536)
++|++++.||+|+||+||+|+++.+|+.||||++..... ......+.+..|..++. .++|||||++++++.+.+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~-----~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV-----LMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhc-----cChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCC
Confidence 479999999999999999999999999999999843211 11122344556666654 689999999999999999
Q ss_pred ceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhh
Q 009364 145 SLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAEL 224 (536)
Q Consensus 145 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 224 (536)
.+|+|||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.....
T Consensus 77 ~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 77 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred ceeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccc
Confidence 99999999999999999998899999999999999999999999999999999999999999999999999999865432
Q ss_pred hcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH-HHHHHhhCCCCCCCCCCCcCcHHH
Q 009364 225 ATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE-VAALFHIGTTKSHPPIPENLSVKA 303 (536)
Q Consensus 225 ~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~ 303 (536)
. ......+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.... ....+.. ..+.+|..+|+++
T Consensus 157 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~----~~~~~p~~~s~~~ 230 (320)
T d1xjda_ 157 D--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM----DNPFYPRWLEKEA 230 (320)
T ss_dssp T--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----CCCCCCTTSCHHH
T ss_pred c--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHc----CCCCCCccCCHHH
Confidence 2 2345678999999999999999999999999999999999999999765432 2222222 2345677899999
Q ss_pred HHHHHHhcccCCCCCCCHH-HHHhCCCCcCCC
Q 009364 304 KDFLLKCLEKEPDLRPTAS-ELLKHPFVTGDD 334 (536)
Q Consensus 304 ~dLi~~cL~~dP~~Rps~~-eiL~hp~~~~~~ 334 (536)
++||.+||++||.+|||+. ++++||||++..
T Consensus 231 ~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~ 262 (320)
T d1xjda_ 231 KDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 262 (320)
T ss_dssp HHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred HHHHHHhcccCCCCCcCHHHHHHhCchhccCC
Confidence 9999999999999999995 899999998643
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-55 Score=441.01 Aligned_cols=260 Identities=27% Similarity=0.429 Sum_probs=211.0
Q ss_pred eeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCceeEE
Q 009364 70 KGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESLNIL 149 (536)
Q Consensus 70 ~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 149 (536)
..++||+|+||+||+|+++.+|+.||||++...... .......+.+.+|+.+|+.++|||||++++++.+++.+|+|
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~iv 78 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRS---EAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLV 78 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC---------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhh---hhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeeh
Confidence 467899999999999999999999999988432111 11112235678999999999999999999999999999999
Q ss_pred EEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhcccC
Q 009364 150 LEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELATVSG 229 (536)
Q Consensus 150 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 229 (536)
||||.|+++..+......+++..++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+|+...... ..
T Consensus 79 mE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~--~~ 156 (299)
T d1ua2a_ 79 FDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN--RA 156 (299)
T ss_dssp EECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC--CC
T ss_pred hhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCc--cc
Confidence 9999999988888877889999999999999999999999999999999999999999999999999998765422 23
Q ss_pred CcccCCCCCCCChhhhhh-cCCCccceEechhHHHHHHhhCCCCCchhhHH--HHHHHhhCCCC----------------
Q 009364 230 AKSMKGTPYWMAPEVIRQ-TGHSYSADIWSVGCTVIEMATGKPPWSQQYQE--VAALFHIGTTK---------------- 290 (536)
Q Consensus 230 ~~~~~Gt~~Y~APEvl~~-~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~--~~~~~~~~~~~---------------- 290 (536)
....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||...... ...+.......
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (299)
T d1ua2a_ 157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236 (299)
T ss_dssp CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCC
T ss_pred ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhh
Confidence 446789999999999875 46799999999999999999999999754322 11221110000
Q ss_pred --CCCC-----CCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCC
Q 009364 291 --SHPP-----IPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDD 334 (536)
Q Consensus 291 --~~~~-----~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~ 334 (536)
..+. ....+++++++||.+||+.||++|||+.|+|+||||+...
T Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p 287 (299)
T d1ua2a_ 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 287 (299)
T ss_dssp CCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred hccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCC
Confidence 0000 1135789999999999999999999999999999998643
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-55 Score=436.84 Aligned_cols=254 Identities=28% Similarity=0.472 Sum_probs=213.8
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCC--CCceeeEeeeeec
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS--HPNIVRYLGTVRE 142 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~--HpnIv~l~~~~~~ 142 (536)
..+|++++.||+|+||+||+|+++.+|+.||||++.......... ......+.+|+.+|++++ |||||++++++.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~--~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~ 80 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE--LPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 80 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEE--CTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhh--hhHHHHHHHHHHHHHHhccCCCCccEEEEEEee
Confidence 458999999999999999999999999999999985322111000 011123557999999986 8999999999999
Q ss_pred CCceeEEEEecCC-CCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCC-CCcEEEEecCcchh
Q 009364 143 EESLNILLEFVPG-GSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDN-KGCIKLADFGASKQ 220 (536)
Q Consensus 143 ~~~~~lV~E~~~g-g~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~-~~~vkL~DFGla~~ 220 (536)
.+..++||||+.+ +++.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+.
T Consensus 81 ~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 81 PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred CCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECcccccee
Confidence 9999999999976 577888888889999999999999999999999999999999999999985 57999999999976
Q ss_pred hhhhhcccCCcccCCCCCCCChhhhhhcCC-CccceEechhHHHHHHhhCCCCCchhhHHHHHHHhhCCCCCCCCCCCcC
Q 009364 221 VAELATVSGAKSMKGTPYWMAPEVIRQTGH-SYSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPENL 299 (536)
Q Consensus 221 ~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~-s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (536)
... ....+.+||+.|+|||++.+..+ +.++|||||||++|+|++|++||..... +.. ....++..+
T Consensus 161 ~~~----~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~----i~~-----~~~~~~~~~ 227 (273)
T d1xwsa_ 161 LKD----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----IIR-----GQVFFRQRV 227 (273)
T ss_dssp CCS----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----HHH-----CCCCCSSCC
T ss_pred ccc----ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH----Hhh-----cccCCCCCC
Confidence 543 22456789999999999987765 6789999999999999999999976432 111 123456789
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 300 SVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 300 s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
|+++++||++||++||++|||++|+|+||||++.
T Consensus 228 s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 228 SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 9999999999999999999999999999999753
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-55 Score=450.96 Aligned_cols=252 Identities=27% Similarity=0.417 Sum_probs=207.4
Q ss_pred CCceee-eEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHh-CCCCceeeEeeeeec-
Q 009364 66 IRWRKG-ELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKD-LSHPNIVRYLGTVRE- 142 (536)
Q Consensus 66 ~~y~~~-~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~-l~HpnIv~l~~~~~~- 142 (536)
++|++. +.||+|+||+||+|+++.+|+.||||++.. ...+.+|+.++.+ ++|||||+++++|.+
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-------------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~ 77 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------------CPKARREVELHWRASQCPHIVRIVDVYENL 77 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-------------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-------------cHHHHHHHHHHHHhcCCCCCCeEEEEEeec
Confidence 479886 569999999999999999999999999831 1235678888655 589999999999875
Q ss_pred ---CCceeEEEEecCCCCcccccccC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCC---CCcEEEEe
Q 009364 143 ---EESLNILLEFVPGGSISSLLGKF--GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDN---KGCIKLAD 214 (536)
Q Consensus 143 ---~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~---~~~vkL~D 214 (536)
...+|+|||||+||+|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+|||++. .+.+||+|
T Consensus 78 ~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~D 157 (335)
T d2ozaa1 78 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD 157 (335)
T ss_dssp ETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECC
T ss_pred ccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccc
Confidence 46789999999999999999764 46999999999999999999999999999999999999985 45799999
Q ss_pred cCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhH-HH-HHHHhh---CCC
Q 009364 215 FGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQ-EV-AALFHI---GTT 289 (536)
Q Consensus 215 FGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~-~~-~~~~~~---~~~ 289 (536)
||+|+..... ......+||+.|+|||++.+..|+.++|||||||++|+|+||.+||.+... .. ..+... ...
T Consensus 158 FG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~ 234 (335)
T d2ozaa1 158 FGFAKETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 234 (335)
T ss_dssp CTTCEECCCC---CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSS
T ss_pred cceeeeccCC---CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCC
Confidence 9999876542 234567899999999999999999999999999999999999999975432 11 111111 111
Q ss_pred CCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 290 KSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 290 ~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
....+.+..+|+++++||++||++||.+|||+.|+++||||...
T Consensus 235 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 235 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 11111223689999999999999999999999999999999754
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-54 Score=433.22 Aligned_cols=255 Identities=27% Similarity=0.488 Sum_probs=204.9
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE 142 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 142 (536)
.+..+|++++.||+|+||+||+|+.. ..||||++..... .....+.+.+|+.+|++++|||||++++++..
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~------~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 75 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP------TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA 75 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSC------CTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred cccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccC------CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec
Confidence 34678999999999999999999743 3699998843211 12335678899999999999999999998754
Q ss_pred CCceeEEEEecCCCCcccccccC-CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhh
Q 009364 143 EESLNILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQV 221 (536)
Q Consensus 143 ~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~ 221 (536)
+.+++|||||+||+|.+++... .++++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+..
T Consensus 76 -~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~ 154 (276)
T d1uwha_ 76 -PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVK 154 (276)
T ss_dssp -SSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-
T ss_pred -cEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeec
Confidence 5689999999999999998654 57999999999999999999999999999999999999999999999999999877
Q ss_pred hhhhcccCCcccCCCCCCCChhhhhh---cCCCccceEechhHHHHHHhhCCCCCchhh--HHHHHHHhhCC-CCCCCCC
Q 009364 222 AELATVSGAKSMKGTPYWMAPEVIRQ---TGHSYSADIWSVGCTVIEMATGKPPWSQQY--QEVAALFHIGT-TKSHPPI 295 (536)
Q Consensus 222 ~~~~~~~~~~~~~Gt~~Y~APEvl~~---~~~s~k~DIwSlGvil~eLltG~~Pf~~~~--~~~~~~~~~~~-~~~~~~~ 295 (536)
............+||+.|||||++.+ ..|+.++|||||||++|||+||+.||.+.. ........... ......+
T Consensus 155 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~ 234 (276)
T d1uwha_ 155 SRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV 234 (276)
T ss_dssp -----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGS
T ss_pred cccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhc
Confidence 65444444567789999999999974 357999999999999999999999997543 22222222222 2223345
Q ss_pred CCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 296 PENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 296 ~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
+..+++++++||.+||+.||.+|||+.||+++
T Consensus 235 ~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 235 RSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 67899999999999999999999999999987
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-53 Score=429.44 Aligned_cols=260 Identities=30% Similarity=0.511 Sum_probs=210.4
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
++|++.+.||+|+||+||+|+++.+|+.||||++.... ..+...+.+.+|+++|++++|||||++++++.+.+.
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~------~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~ 75 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT------ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 75 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhh------cChHHHHHHHHHHHHHHhCCCCcEEEeccccccccc
Confidence 47999999999999999999999999999999984321 112234568899999999999999999999999999
Q ss_pred eeEEEEecCCCCccccc-ccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhh
Q 009364 146 LNILLEFVPGGSISSLL-GKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAEL 224 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l-~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 224 (536)
+|+||||+.++.+.... ...+.+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+.....
T Consensus 76 ~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 76 LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp EEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred eeEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCC
Confidence 99999999765554443 33467999999999999999999999999999999999999999999999999999876532
Q ss_pred hcccCCcccCCCCCCCChhhhhhcC-CCccceEechhHHHHHHhhCCCCCchhhHH--HHHHHhhCCCCC----------
Q 009364 225 ATVSGAKSMKGTPYWMAPEVIRQTG-HSYSADIWSVGCTVIEMATGKPPWSQQYQE--VAALFHIGTTKS---------- 291 (536)
Q Consensus 225 ~~~~~~~~~~Gt~~Y~APEvl~~~~-~s~k~DIwSlGvil~eLltG~~Pf~~~~~~--~~~~~~~~~~~~---------- 291 (536)
. ......+||+.|+|||++.... ++.++||||+||++|+|++|++||.+.... ............
T Consensus 156 ~--~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 233 (298)
T d1gz8a_ 156 V--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233 (298)
T ss_dssp S--BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred c--ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccc
Confidence 2 2345668999999999987765 488999999999999999999999754322 111111100000
Q ss_pred ---CCC-----------CCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 292 ---HPP-----------IPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 292 ---~~~-----------~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
... ....++.++++||++||++||++|||+.|+|+||||+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 000 113578899999999999999999999999999999764
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-54 Score=440.41 Aligned_cols=254 Identities=22% Similarity=0.359 Sum_probs=212.8
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCc-----EEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeEe
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGE-----LLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRYL 137 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~-----~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~ 137 (536)
+..+|++++.||+|+||+||+|++..+++ .||+|.+.. .........+.+|+.+|+++ +|||||+++
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~-------~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~ 107 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKE-------KADSSEREALMSELKMMTQLGSHENIVNLL 107 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecc-------ccCHHHHHHHHHHHHHHHHhcCCCcEeEEE
Confidence 44689999999999999999999876554 689998732 12223445678999999998 899999999
Q ss_pred eeeecCCceeEEEEecCCCCcccccccC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCcc
Q 009364 138 GTVREEESLNILLEFVPGGSISSLLGKF-----------------------GPFPEAVMRTYTKQLLLGLEYLHNHGIMH 194 (536)
Q Consensus 138 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~-----------------------~~l~~~~~~~i~~qil~aL~yLH~~~ivH 194 (536)
+++.+.+.+++|||||+||+|.+++... ..+++..++.++.||+.||+|||++||+|
T Consensus 108 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiH 187 (325)
T d1rjba_ 108 GACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVH 187 (325)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred EEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeee
Confidence 9999999999999999999999998654 24889999999999999999999999999
Q ss_pred ccCCCCCcccCCCCcEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCC
Q 009364 195 RDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPW 273 (536)
Q Consensus 195 rDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf 273 (536)
|||||+|||++.++.+||+|||+|+............+.+||+.|||||++.+..|+.++|||||||++|||+| |.+||
T Consensus 188 RDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf 267 (325)
T d1rjba_ 188 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 267 (325)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred ccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCC
Confidence 99999999999999999999999987665433333345678999999999999999999999999999999998 89999
Q ss_pred chhh--HHHHHHHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 274 SQQY--QEVAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 274 ~~~~--~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
.+.. ......... ...++.|..+|+++++||.+||+.||++|||++||++|
T Consensus 268 ~~~~~~~~~~~~~~~---~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 268 PGIPVDANFYKLIQN---GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp TTCCCSHHHHHHHHT---TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHhc---CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 7532 223333322 23456677899999999999999999999999999986
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.3e-54 Score=433.27 Aligned_cols=250 Identities=25% Similarity=0.391 Sum_probs=212.2
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE 143 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 143 (536)
...+|++.+.||+|+||+||+|++..+|+.||||++.... ...+++.+|+++|++++|||||++++++.+.
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~---------~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 85 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---------MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 85 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC---------SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc---------chHHHHHHHHHHHHhCCCCCEecCCccEeeC
Confidence 3457999999999999999999999999999999873211 1234678999999999999999999999999
Q ss_pred CceeEEEEecCCCCccccccc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhh
Q 009364 144 ESLNILLEFVPGGSISSLLGK--FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQV 221 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~~--~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~ 221 (536)
+.+++|||||++|+|.+++.+ ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 86 ~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~ 165 (287)
T d1opja_ 86 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM 165 (287)
T ss_dssp SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred CeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeec
Confidence 999999999999999999854 357899999999999999999999999999999999999999999999999999876
Q ss_pred hhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCc-hhh-HHHHHHHhhCCCCCCCCCCCcC
Q 009364 222 AELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWS-QQY-QEVAALFHIGTTKSHPPIPENL 299 (536)
Q Consensus 222 ~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~-~~~-~~~~~~~~~~~~~~~~~~~~~~ 299 (536)
..... .......||+.|+|||++.+..|+.++|||||||++|||++|..||. ... ........ ....++.+..+
T Consensus 166 ~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~---~~~~~~~~~~~ 241 (287)
T d1opja_ 166 TGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE---KDYRMERPEGC 241 (287)
T ss_dssp CSSSS-EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH---TTCCCCCCTTC
T ss_pred CCCCc-eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHh---cCCCCCCCccc
Confidence 54221 12234568999999999999999999999999999999999766653 322 22222222 23345677789
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHh
Q 009364 300 SVKAKDFLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 300 s~~~~dLi~~cL~~dP~~Rps~~eiL~ 326 (536)
++++++||.+||+.||++|||+.|+++
T Consensus 242 ~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 242 PEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 999999999999999999999999976
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-53 Score=430.69 Aligned_cols=254 Identities=24% Similarity=0.452 Sum_probs=201.6
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCc---EEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeee
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGE---LLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTV 140 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~---~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~ 140 (536)
...+|++.+.||+|+||+||+|.++.+|+ .||||.+.. .......+.+.+|+++|++++|||||+++|++
T Consensus 24 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~-------~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~ 96 (299)
T d1jpaa_ 24 DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKS-------GYTEKQRRDFLSEASIMGQFDHPNVIHLEGVV 96 (299)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCS-------SCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred ChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECc-------ccCHHHHHHHHHHHHHHHhCCCCCCccEEEEE
Confidence 34579999999999999999999987665 588887631 12223456788999999999999999999999
Q ss_pred ecCCceeEEEEecCCCCcccccccC-CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcch
Q 009364 141 REEESLNILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASK 219 (536)
Q Consensus 141 ~~~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~ 219 (536)
...+.+++|||||+||+|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+
T Consensus 97 ~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~ 176 (299)
T d1jpaa_ 97 TKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSR 176 (299)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred eeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccce
Confidence 9999999999999999999987664 579999999999999999999999999999999999999999999999999998
Q ss_pred hhhhhhccc---CCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhH-HHHHHHhhCCCCCCCC
Q 009364 220 QVAELATVS---GAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQ-EVAALFHIGTTKSHPP 294 (536)
Q Consensus 220 ~~~~~~~~~---~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~-~~~~~~~~~~~~~~~~ 294 (536)
.+....... ......||+.|||||++.+..++.++|||||||++|||+| |.+||.+... ++...+. .....+
T Consensus 177 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~---~~~~~~ 253 (299)
T d1jpaa_ 177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE---QDYRLP 253 (299)
T ss_dssp -------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH---TTCCCC
T ss_pred EccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHH---cCCCCC
Confidence 775432221 1223468999999999999999999999999999999998 8999976433 2222222 223445
Q ss_pred CCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 295 IPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 295 ~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
.+..++.++.+||.+||+.||.+|||+.||+++
T Consensus 254 ~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 254 PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 667899999999999999999999999999875
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-54 Score=423.86 Aligned_cols=250 Identities=27% Similarity=0.452 Sum_probs=201.0
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE 143 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 143 (536)
.+.+|++++.||+|+||+||+|++. +++.||||++.... ...+++.+|++++++++|||||+++|++..+
T Consensus 3 dp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~---------~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~ 72 (263)
T d1sm2a_ 3 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA---------MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 72 (263)
T ss_dssp CCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSS---------SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred ChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCc---------CcHHHHHHHHHHHHhcCCCCcccccceeccC
Confidence 4578999999999999999999975 57789999874211 1124578999999999999999999999999
Q ss_pred CceeEEEEecCCCCcccccccC-CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhh
Q 009364 144 ESLNILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVA 222 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~ 222 (536)
+.+++|||||++|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++...
T Consensus 73 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 152 (263)
T d1sm2a_ 73 APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL 152 (263)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC------
T ss_pred CceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheecc
Confidence 9999999999999999987544 568999999999999999999999999999999999999999999999999998765
Q ss_pred hhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhH-HHHHHHhhCCCCCCCCCCCcCc
Q 009364 223 ELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQ-EVAALFHIGTTKSHPPIPENLS 300 (536)
Q Consensus 223 ~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~s 300 (536)
.... .......||+.|+|||++.+..|+.++|||||||++|||+| |.+||..... +....+.. ......|..++
T Consensus 153 ~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~---~~~~~~p~~~~ 228 (263)
T d1sm2a_ 153 DDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST---GFRLYKPRLAS 228 (263)
T ss_dssp -------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHH---TCCCCCCTTSC
T ss_pred CCCc-eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHh---cCCCCCccccC
Confidence 4322 22345679999999999999999999999999999999999 5666654322 22222222 23345667889
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 301 VKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 301 ~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
+++.+||.+||+.||++|||++||++|
T Consensus 229 ~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 229 THVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 999999999999999999999999986
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.7e-53 Score=424.85 Aligned_cols=258 Identities=28% Similarity=0.470 Sum_probs=210.9
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
+||++.+.||+|+||+||+|+++ +|+.||||++..... .....+.+.+|+.+|++++||||+++++++...+.
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~------~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~ 74 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE------DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR 74 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG------GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc------ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCc
Confidence 48999999999999999999985 789999999844221 11223567899999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhh
Q 009364 146 LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA 225 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 225 (536)
.+++|||+.++.+..+....+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||.|.......
T Consensus 75 ~~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 75 LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp EEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred eeEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 99999999988888888888899999999999999999999999999999999999999999999999999998765322
Q ss_pred cccCCcccCCCCCCCChhhhhhc-CCCccceEechhHHHHHHhhCCCCCchhhHH--HHHHHhh-CC-------------
Q 009364 226 TVSGAKSMKGTPYWMAPEVIRQT-GHSYSADIWSVGCTVIEMATGKPPWSQQYQE--VAALFHI-GT------------- 288 (536)
Q Consensus 226 ~~~~~~~~~Gt~~Y~APEvl~~~-~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~--~~~~~~~-~~------------- 288 (536)
.......|++.|+|||++.+. .++.++|||||||++|+|++|++||.+.... ...+... +.
T Consensus 155 --~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (286)
T d1ob3a_ 155 --RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232 (286)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred --cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhh
Confidence 223456799999999998764 5699999999999999999999999654321 1111110 00
Q ss_pred ----------CCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcC
Q 009364 289 ----------TKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTG 332 (536)
Q Consensus 289 ----------~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~ 332 (536)
..........+++++++||++||++||++|||+.|+|+||||++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred hcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 00001233568899999999999999999999999999999973
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-54 Score=427.12 Aligned_cols=249 Identities=24% Similarity=0.388 Sum_probs=206.0
Q ss_pred eEEcccCceEEEEEEEc--CCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCceeEE
Q 009364 72 ELIGCGAFGRVYMGMNL--DSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEESLNIL 149 (536)
Q Consensus 72 ~~LG~G~fg~Vy~a~~~--~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 149 (536)
+.||+|+||+||+|.+. .+++.||||++... .......+.+.+|+++|++++|||||++++++.. +..++|
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~------~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lv 85 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE------ANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLV 85 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChh------hCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEE
Confidence 47999999999999865 35678999988321 1122345678899999999999999999999865 467899
Q ss_pred EEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhhc-cc
Q 009364 150 LEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELAT-VS 228 (536)
Q Consensus 150 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~-~~ 228 (536)
||||++|+|.+++.+...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+..... ..
T Consensus 86 mE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 86 MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred EEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 99999999999999889999999999999999999999999999999999999999999999999999987654322 22
Q ss_pred CCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhH-HHHHHHhhCCCCCCCCCCCcCcHHHHHH
Q 009364 229 GAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQ-EVAALFHIGTTKSHPPIPENLSVKAKDF 306 (536)
Q Consensus 229 ~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~s~~~~dL 306 (536)
......||+.|+|||++.+..++.++|||||||++|||+| |.+||.+... ++...+.. ...++.|..+|.++++|
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~---~~~~~~p~~~~~~~~~l 242 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK---GERMGCPAGCPREMYDL 242 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT---TCCCCCCTTCCHHHHHH
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHc---CCCCCCCcccCHHHHHH
Confidence 2345679999999999999999999999999999999998 8999976432 22333322 23456778899999999
Q ss_pred HHHhcccCCCCCCCHHHHH---hCCCC
Q 009364 307 LLKCLEKEPDLRPTASELL---KHPFV 330 (536)
Q Consensus 307 i~~cL~~dP~~Rps~~eiL---~hp~~ 330 (536)
|.+||+.||.+|||+++|+ +|+|+
T Consensus 243 i~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 243 MNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp HHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 9999999999999999984 56554
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-53 Score=428.55 Aligned_cols=260 Identities=31% Similarity=0.485 Sum_probs=206.9
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCC-CcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC---CCCceeeEeeee
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDS-GELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL---SHPNIVRYLGTV 140 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~-g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l---~HpnIv~l~~~~ 140 (536)
..+|++++.||+|+||+||+|++..+ ++.||||++........ ....+.+|+.+|+.+ +||||++++++|
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~------~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~ 79 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG------MPLSTIREVAVLRHLETFEHPNVVRLFDVC 79 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS------CBCTHHHHHHHHHHHHHTCCTTBCCEEEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccch------HHHHHHHHHHHHHHHhhcCCCCcceeeeee
Confidence 35899999999999999999999765 67899999854321111 111234566665554 899999999998
Q ss_pred ec-----CCceeEEEEecCCCCccccc-ccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEe
Q 009364 141 RE-----EESLNILLEFVPGGSISSLL-GKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLAD 214 (536)
Q Consensus 141 ~~-----~~~~~lV~E~~~gg~L~~~l-~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~D 214 (536)
.. ...++++|||+.++.+.... .....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|
T Consensus 80 ~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 80 TVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp EEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECS
T ss_pred cccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecc
Confidence 53 35689999999988775443 3446799999999999999999999999999999999999999999999999
Q ss_pred cCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH--HHHHHhhC-----
Q 009364 215 FGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE--VAALFHIG----- 287 (536)
Q Consensus 215 FGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~--~~~~~~~~----- 287 (536)
||+++...... .....+||+.|+|||++.+..|+.++||||+||++|||++|.+||...... ...+....
T Consensus 160 fg~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 236 (305)
T d1blxa_ 160 FGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 236 (305)
T ss_dssp CCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred hhhhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCch
Confidence 99987654332 245678999999999999999999999999999999999999999754322 11111110
Q ss_pred -----------------CCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 288 -----------------TTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 288 -----------------~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
.......++..+++.+++||.+||++||++|||+.|+|+||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred hcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence 0011112345789999999999999999999999999999999754
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-53 Score=424.98 Aligned_cols=253 Identities=26% Similarity=0.422 Sum_probs=210.3
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE 143 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 143 (536)
+..+|++.+.||+|+||+||+|.+. +++.||||++.... ...+.+.+|+.+|++++|||||++++++.+
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~---------~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~- 79 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS---------MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ- 79 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS---------SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred CHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc---------CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-
Confidence 4468999999999999999999975 67889999883211 112467899999999999999999998754
Q ss_pred CceeEEEEecCCCCcccccccC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhh
Q 009364 144 ESLNILLEFVPGGSISSLLGKF--GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQV 221 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~ 221 (536)
+.+++|||||++|+|.+++... .++++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+.+
T Consensus 80 ~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~ 159 (272)
T d1qpca_ 80 EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLI 159 (272)
T ss_dssp SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEc
Confidence 5679999999999999877543 36999999999999999999999999999999999999999999999999999876
Q ss_pred hhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCC-CCCchhhH-HHHHHHhhCCCCCCCCCCCcC
Q 009364 222 AELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGK-PPWSQQYQ-EVAALFHIGTTKSHPPIPENL 299 (536)
Q Consensus 222 ~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~-~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~ 299 (536)
.... ........||+.|+|||++.+..++.++|||||||++|||+||. +||..... +....+. ....+..|..+
T Consensus 160 ~~~~-~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~---~~~~~~~p~~~ 235 (272)
T d1qpca_ 160 EDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE---RGYRMVRPDNC 235 (272)
T ss_dssp SSSC-EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH---TTCCCCCCTTC
T ss_pred cCCc-cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHH---hcCCCCCcccC
Confidence 5432 22344567999999999999989999999999999999999965 45543322 2222222 22345567789
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHh--CCCCc
Q 009364 300 SVKAKDFLLKCLEKEPDLRPTASELLK--HPFVT 331 (536)
Q Consensus 300 s~~~~dLi~~cL~~dP~~Rps~~eiL~--hp~~~ 331 (536)
+.++++||.+||+.||++|||+.++++ |+||.
T Consensus 236 ~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 236 PEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 999999999999999999999999998 78875
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.7e-53 Score=424.53 Aligned_cols=262 Identities=25% Similarity=0.421 Sum_probs=208.7
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEE 144 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 144 (536)
.++|++.+.||+|+||+||+|++..+|+.||||++.... .........+.+|+.+|+.++||||+++++++...+
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-----~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~ 80 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADL-----ARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET 80 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-----TTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhh-----ccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc
Confidence 368999999999999999999999999999999984321 122344567889999999999999999999997654
Q ss_pred ----ceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchh
Q 009364 145 ----SLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQ 220 (536)
Q Consensus 145 ----~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~ 220 (536)
.+|+|||||+||+|.+++...+++++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||.+..
T Consensus 81 ~~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 81 PAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp SSSEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred CCCceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhh
Confidence 3889999999999999998888999999999999999999999999999999999999999999999999998865
Q ss_pred hhhhh-cccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHH-HHHHhhCCCCCCCCCCCc
Q 009364 221 VAELA-TVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEV-AALFHIGTTKSHPPIPEN 298 (536)
Q Consensus 221 ~~~~~-~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~ 298 (536)
..... ........+||+.|+|||++.+..++.++|||||||++|+|+||.+||....... ...............+..
T Consensus 161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (277)
T d1o6ya_ 161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG 240 (277)
T ss_dssp CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSS
T ss_pred hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccC
Confidence 43321 1223456789999999999999999999999999999999999999997654322 111222222222234568
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCc
Q 009364 299 LSVKAKDFLLKCLEKEPDLRPTASELLKHPFVT 331 (536)
Q Consensus 299 ~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~ 331 (536)
+|+++++||.+||++||.+||+..+.+.|+|.+
T Consensus 241 ~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 241 LSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 999999999999999999999554555566653
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-53 Score=425.16 Aligned_cols=255 Identities=24% Similarity=0.428 Sum_probs=212.4
Q ss_pred CCceeeeE-EcccCceEEEEEEEcC--CCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec
Q 009364 66 IRWRKGEL-IGCGAFGRVYMGMNLD--SGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE 142 (536)
Q Consensus 66 ~~y~~~~~-LG~G~fg~Vy~a~~~~--~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 142 (536)
.+|.+.+. ||+|+||+||+|.++. ++..||||++.. .......+.+.+|+++|++++|||||++++++..
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~-------~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~ 80 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQ-------GTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA 80 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECS-------SCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEECh-------hcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc
Confidence 46788885 9999999999998764 455899998832 1223445678899999999999999999999875
Q ss_pred CCceeEEEEecCCCCccccccc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhh
Q 009364 143 EESLNILLEFVPGGSISSLLGK-FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQV 221 (536)
Q Consensus 143 ~~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~ 221 (536)
+.+|+|||||+||+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 81 -~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 159 (285)
T d1u59a_ 81 -EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 159 (285)
T ss_dssp -SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred -CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcc
Confidence 468999999999999998754 467999999999999999999999999999999999999999999999999999876
Q ss_pred hhhhc-ccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhh-HHHHHHHhhCCCCCCCCCCCc
Q 009364 222 AELAT-VSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQY-QEVAALFHIGTTKSHPPIPEN 298 (536)
Q Consensus 222 ~~~~~-~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~-~~~~~~~~~~~~~~~~~~~~~ 298 (536)
..... .......+||+.|+|||++.+..++.++|||||||++|||+| |.+||.+.. .++...+.. ...++.|+.
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~---~~~~~~p~~ 236 (285)
T d1u59a_ 160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ---GKRMECPPE 236 (285)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT---TCCCCCCTT
T ss_pred cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHc---CCCCCCCCc
Confidence 54322 222345679999999999999999999999999999999998 999997543 233333322 234567789
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHH---HhCCCCc
Q 009364 299 LSVKAKDFLLKCLEKEPDLRPTASEL---LKHPFVT 331 (536)
Q Consensus 299 ~s~~~~dLi~~cL~~dP~~Rps~~ei---L~hp~~~ 331 (536)
+++++.+||.+||+.||++|||+.+| |+|+|+.
T Consensus 237 ~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 237 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 99999999999999999999999988 5677763
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-53 Score=415.84 Aligned_cols=249 Identities=26% Similarity=0.401 Sum_probs=213.7
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEE 144 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 144 (536)
+.+|++++.||+|+||+||+|+++ ++..||||++..... ..+.+.+|++++++++||||+++++++.+++
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~---------~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~ 72 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM---------SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR 72 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS---------CHHHHHHHHHHHHTCCCTTBCCEEEEECCSS
T ss_pred hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC---------CHHHHHHHHHHHHhcCCCceeeEEEEEeeCC
Confidence 568999999999999999999974 788999999843211 1245789999999999999999999999999
Q ss_pred ceeEEEEecCCCCcccccc-cCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhh
Q 009364 145 SLNILLEFVPGGSISSLLG-KFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAE 223 (536)
Q Consensus 145 ~~~lV~E~~~gg~L~~~l~-~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 223 (536)
.+++||||+++|+|..++. ....+++..+..++.||++||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 73 ~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~ 152 (258)
T d1k2pa_ 73 PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 152 (258)
T ss_dssp SEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSS
T ss_pred ceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccC
Confidence 9999999999999988854 456799999999999999999999999999999999999999999999999999987654
Q ss_pred hhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhHH-HHHHHhhCCCCCCCCCCCcCcH
Q 009364 224 LATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQE-VAALFHIGTTKSHPPIPENLSV 301 (536)
Q Consensus 224 ~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~s~ 301 (536)
.. ........||+.|+|||++.+..++.++|||||||++|||+| |+.||...... +...+. .......|..+++
T Consensus 153 ~~-~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~---~~~~~~~p~~~~~ 228 (258)
T d1k2pa_ 153 DE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA---QGLRLYRPHLASE 228 (258)
T ss_dssp SS-CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH---TTCCCCCCTTCCH
T ss_pred CC-ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHH---hCCCCCCcccccH
Confidence 32 223445679999999999999999999999999999999998 89999765432 222222 2234556778999
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 302 KAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 302 ~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
++++||.+||+.||++|||+.+|++|
T Consensus 229 ~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 229 KVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 99999999999999999999999987
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-52 Score=425.94 Aligned_cols=263 Identities=25% Similarity=0.391 Sum_probs=209.4
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec--
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE-- 142 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~-- 142 (536)
-.||++++.||+|+||+||+|++..+|+.||||++..... .......+.+|+.+|+.++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~------~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~ 82 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE------KEGFPITALREIKILQLLKHENVVNLIEICRTKA 82 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C------TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc------chHHHHHHHHHHHHHHHhcCCCccceEeeeeccc
Confidence 3689999999999999999999999999999998743211 11233557789999999999999999998854
Q ss_pred ------CCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecC
Q 009364 143 ------EESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFG 216 (536)
Q Consensus 143 ------~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFG 216 (536)
.+.+++|||||.++.+.........+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 83 ~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 83 SPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCT
T ss_pred ccccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecc
Confidence 45689999999988887777777889999999999999999999999999999999999999999999999999
Q ss_pred cchhhhhhh--cccCCcccCCCCCCCChhhhhhc-CCCccceEechhHHHHHHhhCCCCCchhhHHHH--HHHhhCCCCC
Q 009364 217 ASKQVAELA--TVSGAKSMKGTPYWMAPEVIRQT-GHSYSADIWSVGCTVIEMATGKPPWSQQYQEVA--ALFHIGTTKS 291 (536)
Q Consensus 217 la~~~~~~~--~~~~~~~~~Gt~~Y~APEvl~~~-~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~--~~~~~~~~~~ 291 (536)
+++.+.... ........+||+.|+|||++.+. .|+.++||||+||++|+|++|++||.+...... .+........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 242 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 997665322 12233456899999999998765 689999999999999999999999975432211 1111110000
Q ss_pred CCCC------------------C---------CcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 292 HPPI------------------P---------ENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 292 ~~~~------------------~---------~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
.... + ...++++++||.+||++||++|||+.|+|+||||+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~ 311 (318)
T d3blha1 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 311 (318)
T ss_dssp TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence 0000 0 0136788999999999999999999999999999854
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-52 Score=415.45 Aligned_cols=254 Identities=24% Similarity=0.406 Sum_probs=203.2
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcCCC----cEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEee
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLDSG----ELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLG 138 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~~g----~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~ 138 (536)
..+..|++.++||+|+||+||+|.++.++ ..||||++.. .........+.+|+++|++++|||||+++|
T Consensus 4 i~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~-------~~~~~~~~~~~~E~~il~~l~H~nIv~~~g 76 (283)
T d1mqba_ 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKA-------GYTEKQRVDFLGEAGIMGQFSHHNIIRLEG 76 (283)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECT-------TCCHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred CCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECc-------ccChHHHHHHHHHHHHHHhcCCCCEeeeeE
Confidence 34567999999999999999999987655 4799998732 112233456889999999999999999999
Q ss_pred eeecCCceeEEEEecCCCCccccccc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCc
Q 009364 139 TVREEESLNILLEFVPGGSISSLLGK-FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGA 217 (536)
Q Consensus 139 ~~~~~~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGl 217 (536)
++.+.+..++|||||.+|++.+++.. .+.+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+
T Consensus 77 ~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGl 156 (283)
T d1mqba_ 77 VISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGL 156 (283)
T ss_dssp EECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred EEecCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccch
Confidence 99999999999999999999887754 46799999999999999999999999999999999999999999999999999
Q ss_pred chhhhhhhcc-cCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCch-hh-HHHHHHHhhCCCCCCCC
Q 009364 218 SKQVAELATV-SGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQ-QY-QEVAALFHIGTTKSHPP 294 (536)
Q Consensus 218 a~~~~~~~~~-~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~-~~-~~~~~~~~~~~~~~~~~ 294 (536)
|+.+...... .......||+.|+|||++.+..++.++|||||||++|||++|..||.. .. .++...+. ....++
T Consensus 157 a~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~---~~~~~~ 233 (283)
T d1mqba_ 157 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN---DGFRLP 233 (283)
T ss_dssp -----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH---TTCCCC
T ss_pred hhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHh---ccCCCC
Confidence 9876543221 123345789999999999999999999999999999999996555433 22 22222222 234456
Q ss_pred CCCcCcHHHHHHHHHhcccCCCCCCCHHHHHh
Q 009364 295 IPENLSVKAKDFLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 295 ~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~ 326 (536)
.+..++.++++||.+||+.||++|||+.||++
T Consensus 234 ~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 234 TPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 67789999999999999999999999999987
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-52 Score=428.84 Aligned_cols=257 Identities=29% Similarity=0.461 Sum_probs=206.6
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE 143 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 143 (536)
...+|++++.||+|+||+||+|.++.+|+.||||++... .......+.+.+|+.+|+.++|||||+++++|...
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~------~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~ 89 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP------FQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPD 89 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSST------TSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchh------hcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccC
Confidence 457999999999999999999999999999999998421 12234456788999999999999999999999765
Q ss_pred C------ceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCc
Q 009364 144 E------SLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGA 217 (536)
Q Consensus 144 ~------~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGl 217 (536)
+ .+|+||||| +++|..++. .+++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 90 ~~~~~~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 90 ETLDDFTDFYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp SSTTTCCCCEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ccccccceEEEEEecc-cccHHHHHH-hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccc
Confidence 5 579999999 666766654 46899999999999999999999999999999999999999999999999999
Q ss_pred chhhhhhhcccCCcccCCCCCCCChhhhhhc-CCCccceEechhHHHHHHhhCCCCCchhhHHHH--HHHhh--------
Q 009364 218 SKQVAELATVSGAKSMKGTPYWMAPEVIRQT-GHSYSADIWSVGCTVIEMATGKPPWSQQYQEVA--ALFHI-------- 286 (536)
Q Consensus 218 a~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~-~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~~--~~~~~-------- 286 (536)
|+.... .....+||+.|+|||++.+. .++.++||||+||++|+|++|++||........ .....
T Consensus 168 a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (346)
T d1cm8a_ 168 ARQADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 242 (346)
T ss_dssp CEECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred eeccCC-----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHH
Confidence 986543 24567899999999998764 568999999999999999999999965422111 10000
Q ss_pred ------------------CCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 287 ------------------GTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 287 ------------------~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
............+++++++||.+||+.||.+|||+.|+|+||||+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 243 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 00111122345789999999999999999999999999999999764
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-52 Score=415.74 Aligned_cols=260 Identities=27% Similarity=0.455 Sum_probs=217.2
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCCc
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEES 145 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 145 (536)
.||++.+.||+|+||+||+|++..+|+.||||++.... ........+.+|+.+|+.++||||+++++++.+...
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~------~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 75 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD------DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK 75 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC------SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhh------CChHHHHHHHHHHHHHHhcCcCCEEeeccccccccc
Confidence 48999999999999999999999999999999984321 112345678899999999999999999999999999
Q ss_pred eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhhh
Q 009364 146 LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAELA 225 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 225 (536)
+++|++++.+++|..++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.++......
T Consensus 76 ~~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 76 LTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp EEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred eeEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 99999999999999998888999999999999999999999999999999999999999999999999999998765422
Q ss_pred cccCCcccCCCCCCCChhhhhhcC-CCccceEechhHHHHHHhhCCCCCchhhH---HHHHHHhhCC-------------
Q 009364 226 TVSGAKSMKGTPYWMAPEVIRQTG-HSYSADIWSVGCTVIEMATGKPPWSQQYQ---EVAALFHIGT------------- 288 (536)
Q Consensus 226 ~~~~~~~~~Gt~~Y~APEvl~~~~-~s~k~DIwSlGvil~eLltG~~Pf~~~~~---~~~~~~~~~~------------- 288 (536)
.......+++.|+|||++.+.. ++.++||||+||++|+|++|+.||..... ....+.....
T Consensus 156 --~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (292)
T d1unla_ 156 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp --SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred --ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhc
Confidence 2234556889999999987655 69999999999999999999999742211 1111111100
Q ss_pred -----------CCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 289 -----------TKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 289 -----------~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
..........+++.+++||++||++||++|||++|+|+||||++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence 011122345678999999999999999999999999999999753
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-52 Score=414.85 Aligned_cols=252 Identities=27% Similarity=0.456 Sum_probs=199.9
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCC---cEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeee
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSG---ELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTV 140 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g---~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~ 140 (536)
+..+|++++.||+|+||+||+|.+..++ ..||||.+. ........+.+.+|+.+|++++|||||++++++
T Consensus 5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~-------~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 77 (273)
T d1mp8a_ 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK-------NCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI 77 (273)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECT-------TTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEec-------cccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 3468999999999999999999987543 468888762 122234456788999999999999999999999
Q ss_pred ecCCceeEEEEecCCCCccccccc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcch
Q 009364 141 REEESLNILLEFVPGGSISSLLGK-FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASK 219 (536)
Q Consensus 141 ~~~~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~ 219 (536)
. ++.+++||||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+|+
T Consensus 78 ~-~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~ 156 (273)
T d1mp8a_ 78 T-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 156 (273)
T ss_dssp C-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred e-cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhhe
Confidence 6 5678999999999999987654 4579999999999999999999999999999999999999999999999999998
Q ss_pred hhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhh-HHHHHHHhhCCCCCCCCCCC
Q 009364 220 QVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQY-QEVAALFHIGTTKSHPPIPE 297 (536)
Q Consensus 220 ~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~-~~~~~~~~~~~~~~~~~~~~ 297 (536)
...... ........||+.|+|||++.+..++.++|||||||++|||++ |.+||.... .++...+.. ....+++.
T Consensus 157 ~~~~~~-~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~---~~~~~~~~ 232 (273)
T d1mp8a_ 157 YMEDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN---GERLPMPP 232 (273)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT---TCCCCCCT
T ss_pred eccCCc-ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHc---CCCCCCCC
Confidence 765432 223345678999999999999999999999999999999998 899997543 222222222 23446778
Q ss_pred cCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 298 NLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 298 ~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
.+|+++++||.+||+.||.+|||+.||++|
T Consensus 233 ~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 233 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999999999999999986
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-52 Score=425.11 Aligned_cols=261 Identities=25% Similarity=0.373 Sum_probs=208.0
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEE 144 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 144 (536)
..||++++.||+|+||+||+|+++.+|+.||||++.. .......+.+.+|+.+|+.++||||+++++++....
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~-------~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~ 79 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISP-------FEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPT 79 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECC-------TTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSS
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEeh-------hcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecc
Confidence 4589999999999999999999999999999999842 122344567889999999999999999999987653
Q ss_pred ----ceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchh
Q 009364 145 ----SLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQ 220 (536)
Q Consensus 145 ----~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~ 220 (536)
..+++++|+.||+|.+++.. +.+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+++.
T Consensus 80 ~~~~~~~~l~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 80 IEQMKDVYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp TTTCCCEEEEEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred ccccceEEEEEeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceee
Confidence 23455566779999999875 5799999999999999999999999999999999999999999999999999986
Q ss_pred hhhhhcc-cCCcccCCCCCCCChhhhhh-cCCCccceEechhHHHHHHhhCCCCCchhhHHH--HHHHh-----------
Q 009364 221 VAELATV-SGAKSMKGTPYWMAPEVIRQ-TGHSYSADIWSVGCTVIEMATGKPPWSQQYQEV--AALFH----------- 285 (536)
Q Consensus 221 ~~~~~~~-~~~~~~~Gt~~Y~APEvl~~-~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~--~~~~~----------- 285 (536)
....... ......+||+.|+|||++.. ..++.++||||+||++|+|++|.+||....... .....
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhh
Confidence 6543221 22456789999999999854 567999999999999999999999996432111 00000
Q ss_pred ------------hCCCCCCC---CCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 286 ------------IGTTKSHP---PIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 286 ------------~~~~~~~~---~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
........ .....+++++++||.+||+.||.+|||+.|+|+||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 00000011 1234678999999999999999999999999999999754
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-52 Score=420.52 Aligned_cols=253 Identities=26% Similarity=0.467 Sum_probs=204.6
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcE----EEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeee
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGEL----LAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTV 140 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~----vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~ 140 (536)
...|++++.||+|+||+||+|.+..+|+. ||+|.+.. .......+.+.+|+.+|++++|||||+++|++
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~-------~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~ 80 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE-------ATSPKANKEILDEAYVMASVDNPHVCRLLGIC 80 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----------CTHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecc-------ccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 35799999999999999999999888874 66666521 12223356788999999999999999999999
Q ss_pred ecCCceeEEEEecCCCCccccccc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcch
Q 009364 141 REEESLNILLEFVPGGSISSLLGK-FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASK 219 (536)
Q Consensus 141 ~~~~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~ 219 (536)
.++ ..++++||+.+|+|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+
T Consensus 81 ~~~-~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~ 159 (317)
T d1xkka_ 81 LTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 159 (317)
T ss_dssp ESS-SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHH
T ss_pred ecC-CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccce
Confidence 865 56788999999999887754 4679999999999999999999999999999999999999999999999999998
Q ss_pred hhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhh-HHHHHHHhhCCCCCCCCCCC
Q 009364 220 QVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQY-QEVAALFHIGTTKSHPPIPE 297 (536)
Q Consensus 220 ~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~-~~~~~~~~~~~~~~~~~~~~ 297 (536)
.+.............||+.|+|||++.+..|+.++|||||||++|||+| |.+||.... .++...+..+ ..++.|.
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~---~~~~~p~ 236 (317)
T d1xkka_ 160 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG---ERLPQPP 236 (317)
T ss_dssp HTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHT---CCCCCCT
T ss_pred ecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC---CCCCCCc
Confidence 8765433333445679999999999999999999999999999999998 899997543 2333333322 3445677
Q ss_pred cCcHHHHHHHHHhcccCCCCCCCHHHHHhCC
Q 009364 298 NLSVKAKDFLLKCLEKEPDLRPTASELLKHP 328 (536)
Q Consensus 298 ~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp 328 (536)
.+++++.+||.+||+.||.+|||+.||++|.
T Consensus 237 ~~~~~~~~li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 237 ICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ccCHHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence 8999999999999999999999999999983
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-52 Score=418.70 Aligned_cols=254 Identities=27% Similarity=0.450 Sum_probs=202.5
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcC-----CCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeEe
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLD-----SGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRYL 137 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~ 137 (536)
+..+|++++.||+|+||+||+|.+.. +++.||||++.. .......+.+.+|..++.++ +|+||+.++
T Consensus 11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~-------~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~ 83 (299)
T d1ywna1 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKE-------GATHSEHRALMSELKILIHIGHHLNVVNLL 83 (299)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----------CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcc-------ccCcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence 34589999999999999999999754 457899998732 12223345667777777776 689999999
Q ss_pred eeeecC-CceeEEEEecCCCCcccccccC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCC
Q 009364 138 GTVREE-ESLNILLEFVPGGSISSLLGKF----------------GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGA 200 (536)
Q Consensus 138 ~~~~~~-~~~~lV~E~~~gg~L~~~l~~~----------------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~ 200 (536)
+++... ..+++|||||++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+
T Consensus 84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~ 163 (299)
T d1ywna1 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 163 (299)
T ss_dssp EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCcc
Confidence 987654 5689999999999999998543 34889999999999999999999999999999999
Q ss_pred CcccCCCCcEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhC-CCCCchhh--
Q 009364 201 NILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATG-KPPWSQQY-- 277 (536)
Q Consensus 201 NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG-~~Pf~~~~-- 277 (536)
|||++.++++||+|||+|+..............+||+.|+|||++.+..++.++|||||||++|||+|| .+||....
T Consensus 164 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~ 243 (299)
T d1ywna1 164 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243 (299)
T ss_dssp GEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred ceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999999876654444445567899999999999999999999999999999999986 56786432
Q ss_pred HHHHHHHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 278 QEVAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
.........+ ..+..+..+++++++||.+||+.||.+|||+.|+++|
T Consensus 244 ~~~~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 244 EEFCRRLKEG---TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHHHHHHT---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhcC---CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 2222333222 3445677899999999999999999999999999987
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-52 Score=413.85 Aligned_cols=255 Identities=25% Similarity=0.395 Sum_probs=205.5
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE 143 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 143 (536)
+..+|++++.||+|+||+||+|++..+ +.||||++.... ...+.+.+|+.+|++++|||||++++++.+
T Consensus 15 ~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~---------~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~- 83 (285)
T d1fmka3 15 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT---------MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 83 (285)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTS---------SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred CHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECccc---------CCHHHHHHHHHHHHhcccCCEeEEEEEEec-
Confidence 346899999999999999999998654 679999984211 112467899999999999999999999854
Q ss_pred CceeEEEEecCCCCccccccc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhh
Q 009364 144 ESLNILLEFVPGGSISSLLGK--FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQV 221 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~~--~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~ 221 (536)
+.+++|||||++|+|..++.. .+.+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+
T Consensus 84 ~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~ 163 (285)
T d1fmka3 84 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI 163 (285)
T ss_dssp SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhc
Confidence 568899999999999888754 356999999999999999999999999999999999999999999999999999876
Q ss_pred hhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCC-chhh-HHHHHHHhhCCCCCCCCCCCcC
Q 009364 222 AELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPW-SQQY-QEVAALFHIGTTKSHPPIPENL 299 (536)
Q Consensus 222 ~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf-~~~~-~~~~~~~~~~~~~~~~~~~~~~ 299 (536)
..... .......||+.|+|||++.+..++.++|||||||++|||++|..|| .... .+....+. .....+.+..+
T Consensus 164 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~---~~~~~~~~~~~ 239 (285)
T d1fmka3 164 EDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE---RGYRMPCPPEC 239 (285)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH---TTCCCCCCTTS
T ss_pred cCCCc-eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH---hcCCCCCCccc
Confidence 54322 2334567999999999999999999999999999999999965555 3322 22222222 22344577899
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHh--CCCCcCC
Q 009364 300 SVKAKDFLLKCLEKEPDLRPTASELLK--HPFVTGD 333 (536)
Q Consensus 300 s~~~~dLi~~cL~~dP~~Rps~~eiL~--hp~~~~~ 333 (536)
+.++++||.+||+.||++|||+.+|++ |+||+..
T Consensus 240 ~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 240 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred CHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 999999999999999999999999998 8999764
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.5e-51 Score=418.45 Aligned_cols=254 Identities=26% Similarity=0.426 Sum_probs=207.6
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCC-CCceeeEeeeeec
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS-HPNIVRYLGTVRE 142 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~ 142 (536)
..++|++++.||+|+||+||+|+++.+|+.||||++.. . ..+.+.+|+.+|+.++ ||||+++++++..
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~-------~----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~ 101 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-------V----KKKKIKREIKILENLRGGPNIITLADIVKD 101 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-------S----CHHHHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECH-------H----HHHHHHHHHHHHHhccCCCCCcEEEEEEEe
Confidence 34689999999999999999999999999999999832 1 1245778999999995 9999999999974
Q ss_pred --CCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCC-cEEEEecCcch
Q 009364 143 --EESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKG-CIKLADFGASK 219 (536)
Q Consensus 143 --~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~-~vkL~DFGla~ 219 (536)
...+++|||||.+++|..+. +.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+
T Consensus 102 ~~~~~~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~ 178 (328)
T d3bqca1 102 PVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 178 (328)
T ss_dssp TTTCSEEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCE
T ss_pred cCCCceeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccce
Confidence 45699999999999998764 4699999999999999999999999999999999999998655 69999999998
Q ss_pred hhhhhhcccCCcccCCCCCCCChhhhhhc-CCCccceEechhHHHHHHhhCCCCCchhhHHH------HHH---------
Q 009364 220 QVAELATVSGAKSMKGTPYWMAPEVIRQT-GHSYSADIWSVGCTVIEMATGKPPWSQQYQEV------AAL--------- 283 (536)
Q Consensus 220 ~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~-~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~------~~~--------- 283 (536)
...... .....+||+.|+|||++.+. .++.++||||+||++|+|++|..||....... ...
T Consensus 179 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~ 255 (328)
T d3bqca1 179 FYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 255 (328)
T ss_dssp ECCTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHH
T ss_pred eccCCC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhh
Confidence 765432 24567899999999998765 57999999999999999999999995422111 000
Q ss_pred HhhCCCC--------------------CCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCCC
Q 009364 284 FHIGTTK--------------------SHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGDD 334 (536)
Q Consensus 284 ~~~~~~~--------------------~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~~ 334 (536)
....... ........+++++++||++||++||++|||++|+|+||||+...
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~ 326 (328)
T d3bqca1 256 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326 (328)
T ss_dssp HHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred hhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 0000000 01112245789999999999999999999999999999998643
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.6e-51 Score=412.68 Aligned_cols=254 Identities=25% Similarity=0.410 Sum_probs=213.7
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEc-----CCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEe
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNL-----DSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYL 137 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~ 137 (536)
.+.++|++.+.||+|+||+||+|+++ .+++.||||++.. .......+.+.+|+.+|+.++||||++++
T Consensus 10 ~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~-------~~~~~~~~~~~~E~~il~~l~h~niv~~~ 82 (301)
T d1lufa_ 10 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKE-------EASADMQADFQREAALMAEFDNPNIVKLL 82 (301)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCT-------TCCHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEECh-------hcChHHHHHHHHHHHHHHhcCCCCcccce
Confidence 35568999999999999999999875 3568899998732 12233456788999999999999999999
Q ss_pred eeeecCCceeEEEEecCCCCcccccccC------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCc
Q 009364 138 GTVREEESLNILLEFVPGGSISSLLGKF------------------------GPFPEAVMRTYTKQLLLGLEYLHNHGIM 193 (536)
Q Consensus 138 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~------------------------~~l~~~~~~~i~~qil~aL~yLH~~~iv 193 (536)
+++...+..++||||+++|+|.+++... ..+++..+..++.||+.||+|||++|||
T Consensus 83 ~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iv 162 (301)
T d1lufa_ 83 GVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFV 162 (301)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred eeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeE
Confidence 9999999999999999999999988542 2488999999999999999999999999
Q ss_pred cccCCCCCcccCCCCcEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCC-CC
Q 009364 194 HRDIKGANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGK-PP 272 (536)
Q Consensus 194 HrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~-~P 272 (536)
||||||+|||++.++.+||+|||+|+............+.+||+.|+|||++.+..|+.++|||||||++|||++|. +|
T Consensus 163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence 99999999999999999999999998776554444455678999999999999999999999999999999999985 67
Q ss_pred CchhhH-HHHHHHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHh
Q 009364 273 WSQQYQ-EVAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 273 f~~~~~-~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~ 326 (536)
|..... +....+. ....+++|..+++++.+||.+||+.||++|||+.||++
T Consensus 243 ~~~~~~~e~~~~v~---~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 243 YYGMAHEEVIYYVR---DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp TTTSCHHHHHHHHH---TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHH---cCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 765432 2222222 22345677889999999999999999999999999975
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-51 Score=421.84 Aligned_cols=253 Identities=30% Similarity=0.466 Sum_probs=203.6
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC--
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE-- 143 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~-- 143 (536)
.+|+..++||+|+||+||+|++..+|+.||||++..... ...+|+++|++++||||++++++|...
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------------~~~~Ei~il~~l~h~niv~~~~~~~~~~~ 87 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------------FKNRELQIMRKLDHCNIVRLRYFFYSSGE 87 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------------SCCHHHHHHHHCCCTTBCCEEEEEEEC--
T ss_pred CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------------HHHHHHHHHHhcCCCCCCcEEEEEEecCc
Confidence 369999999999999999999999999999999843211 123699999999999999999998532
Q ss_pred ----CceeEEEEecCCCCcccc---cccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCC-cEEEEec
Q 009364 144 ----ESLNILLEFVPGGSISSL---LGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKG-CIKLADF 215 (536)
Q Consensus 144 ----~~~~lV~E~~~gg~L~~~---l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~-~vkL~DF 215 (536)
..+++|||||+++.+..+ ......+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+||
T Consensus 88 ~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DF 167 (350)
T d1q5ka_ 88 KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDF 167 (350)
T ss_dssp CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCC
T ss_pred cCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecc
Confidence 347899999987644333 34556799999999999999999999999999999999999999775 8999999
Q ss_pred CcchhhhhhhcccCCcccCCCCCCCChhhhhh-cCCCccceEechhHHHHHHhhCCCCCchhhHH--HHHHHhh------
Q 009364 216 GASKQVAELATVSGAKSMKGTPYWMAPEVIRQ-TGHSYSADIWSVGCTVIEMATGKPPWSQQYQE--VAALFHI------ 286 (536)
Q Consensus 216 Gla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~-~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~--~~~~~~~------ 286 (536)
|+++.+.... ...+.+||+.|+|||++.+ ..|+.++||||+||++|||++|.+||...... ...+...
T Consensus 168 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~ 244 (350)
T d1q5ka_ 168 GSAKQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 244 (350)
T ss_dssp TTCEECCTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred cchhhccCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChH
Confidence 9998765422 2456789999999998875 57899999999999999999999999644321 1111110
Q ss_pred ------CC---CCCC---------CCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 287 ------GT---TKSH---------PPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 287 ------~~---~~~~---------~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
.. .... ......+++++++||.+||++||++|||+.|+|+||||+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 245 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp HHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred HhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 00 0000 01234679999999999999999999999999999999753
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-52 Score=424.00 Aligned_cols=264 Identities=31% Similarity=0.527 Sum_probs=217.2
Q ss_pred CCceeeeEEcccCceEEEEEEEc---CCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCC-CceeeEeeeee
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNL---DSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH-PNIVRYLGTVR 141 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~H-pnIv~l~~~~~ 141 (536)
++|++++.||+|+||+||+|++. .+|+.||||++......... ...+.+.+|+++|++++| |||+++++++.
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~----~~~~~~~~E~~il~~l~h~pnIv~~~~~~~ 99 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKA----KTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 99 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEE----SSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccch----HHHHHHHHHHHHHHhccCCCeEEEeeeeec
Confidence 57999999999999999999874 46899999988432211111 112446789999999976 89999999999
Q ss_pred cCCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhh
Q 009364 142 EEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQV 221 (536)
Q Consensus 142 ~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~ 221 (536)
+...+++||||+.+|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.+
T Consensus 100 ~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 100 TETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp ETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred cCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence 99999999999999999999998889999999999999999999999999999999999999999999999999999876
Q ss_pred hhhhcccCCcccCCCCCCCChhhhhhc--CCCccceEechhHHHHHHhhCCCCCchhhH-HHHHHHhhCCCCCCCCCCCc
Q 009364 222 AELATVSGAKSMKGTPYWMAPEVIRQT--GHSYSADIWSVGCTVIEMATGKPPWSQQYQ-EVAALFHIGTTKSHPPIPEN 298 (536)
Q Consensus 222 ~~~~~~~~~~~~~Gt~~Y~APEvl~~~--~~s~k~DIwSlGvil~eLltG~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~ 298 (536)
..... .......||+.|+|||++.+. .++.++|||||||+||+|++|..||..... .....+........++++..
T Consensus 180 ~~~~~-~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~ 258 (322)
T d1vzoa_ 180 VADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE 258 (322)
T ss_dssp CGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTT
T ss_pred ccccc-ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCccc
Confidence 54322 224567899999999999764 468899999999999999999999965321 11111111112234556778
Q ss_pred CcHHHHHHHHHhcccCCCCCC-----CHHHHHhCCCCcCCC
Q 009364 299 LSVKAKDFLLKCLEKEPDLRP-----TASELLKHPFVTGDD 334 (536)
Q Consensus 299 ~s~~~~dLi~~cL~~dP~~Rp-----s~~eiL~hp~~~~~~ 334 (536)
+++++++||++||++||.+|| |++|+++||||+...
T Consensus 259 ~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~ 299 (322)
T d1vzoa_ 259 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 299 (322)
T ss_dssp SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred CCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence 999999999999999999999 589999999998654
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-51 Score=409.98 Aligned_cols=253 Identities=25% Similarity=0.451 Sum_probs=210.9
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCC-------cEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceee
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSG-------ELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVR 135 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g-------~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~ 135 (536)
+.++|++++.||+|+||.||+|++..++ ..||||++.. .........+.+|...+.++ +|||||+
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~-------~~~~~~~~~~~~e~~~l~~~~~HpnIv~ 83 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS-------DATEKDLSDLISEMEMMKMIGKHKNIIN 83 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCT-------TCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECc-------ccChHHHHHHHHHHHHHHHhcCCCeEEe
Confidence 4568999999999999999999876554 4799998732 22233456678888888888 7999999
Q ss_pred EeeeeecCCceeEEEEecCCCCcccccccC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCC
Q 009364 136 YLGTVREEESLNILLEFVPGGSISSLLGKF----------------GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKG 199 (536)
Q Consensus 136 l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~----------------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp 199 (536)
+++++.+++..++|||||++|+|.+++... ..+++..+..++.||+.||+|||++|||||||||
T Consensus 84 ~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp 163 (299)
T d1fgka_ 84 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAA 163 (299)
T ss_dssp EEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred cccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecc
Confidence 999999999999999999999999998644 3589999999999999999999999999999999
Q ss_pred CCcccCCCCcEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhH
Q 009364 200 ANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQ 278 (536)
Q Consensus 200 ~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~ 278 (536)
+|||++.++.+||+|||+++..............+||+.|+|||++.+..|+.++|||||||++|||++ |.+||.....
T Consensus 164 ~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~ 243 (299)
T d1fgka_ 164 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243 (299)
T ss_dssp GGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred cceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH
Confidence 999999999999999999998776554444566789999999999999999999999999999999998 7899975443
Q ss_pred H-HHHHHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHh
Q 009364 279 E-VAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 279 ~-~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~ 326 (536)
. +...+. ....++.|..+++++++||.+||+.||.+|||+.||++
T Consensus 244 ~~~~~~i~---~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 244 EELFKLLK---EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHHHHH---TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHH---cCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 3 222222 23455677889999999999999999999999999987
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-51 Score=420.23 Aligned_cols=255 Identities=26% Similarity=0.365 Sum_probs=197.6
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec---
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE--- 142 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--- 142 (536)
.+|++.+.||+|+||+||+|+++.+|+.||||++... .........+.+|+.+|+.++||||++++++|..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~------~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~ 90 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP------FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKT 90 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEEST------TSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCS
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChh------hcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccc
Confidence 5899999999999999999999999999999998422 1123445678899999999999999999999964
Q ss_pred ---CCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcch
Q 009364 143 ---EESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASK 219 (536)
Q Consensus 143 ---~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~ 219 (536)
...+|+|||||.++.+..+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||+++
T Consensus 91 ~~~~~~~~iv~Ey~~~~l~~~~---~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 91 LEEFQDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp TTTCCEEEEEEECCSEEHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred cccCceeEEEEeccchHHHHhh---hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhh
Confidence 3678999999977665544 2468999999999999999999999999999999999999999999999999988
Q ss_pred hhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHHH--HHHH-------------
Q 009364 220 QVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQEV--AALF------------- 284 (536)
Q Consensus 220 ~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~--~~~~------------- 284 (536)
..... ......+||+.|+|||++.+..++.++||||+||++|+|++|++||.+..... ..+.
T Consensus 168 ~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 168 TAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred ccccc---cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence 66542 23456789999999999999999999999999999999999999996432111 1110
Q ss_pred ---------hhCCCCCCCC---------------CCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcC
Q 009364 285 ---------HIGTTKSHPP---------------IPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTG 332 (536)
Q Consensus 285 ---------~~~~~~~~~~---------------~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~ 332 (536)
.......... .+...++++++||++||.+||++||||+|+|+||||+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~ 316 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 316 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 0000000000 01235778999999999999999999999999999975
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-51 Score=419.84 Aligned_cols=257 Identities=25% Similarity=0.415 Sum_probs=206.6
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecC-
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREE- 143 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~- 143 (536)
+.||++.+.||+|+||+||+|+++.+|+.||||++... .......+.+.+|+.+|+.++|||||++++++...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~------~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~ 90 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP------FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 90 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCT------TSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECch------hcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecc
Confidence 56899999999999999999999999999999998421 11223445678999999999999999999998643
Q ss_pred ----CceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcch
Q 009364 144 ----ESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASK 219 (536)
Q Consensus 144 ----~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~ 219 (536)
...+++|+|+.||+|.+++.. +++++..++.++.||+.||+|||++||+||||||+|||++.+|.+|++|||++.
T Consensus 91 ~~~~~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 91 SLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp STTTCCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----
T ss_pred ccccCceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhc
Confidence 345677788889999998865 679999999999999999999999999999999999999999999999999987
Q ss_pred hhhhhhcccCCcccCCCCCCCChhhhhhc-CCCccceEechhHHHHHHhhCCCCCchhhHHH--HHHHhhC---------
Q 009364 220 QVAELATVSGAKSMKGTPYWMAPEVIRQT-GHSYSADIWSVGCTVIEMATGKPPWSQQYQEV--AALFHIG--------- 287 (536)
Q Consensus 220 ~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~-~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~~--~~~~~~~--------- 287 (536)
..... ..+..||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+..... ..+....
T Consensus 170 ~~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (348)
T d2gfsa1 170 HTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244 (348)
T ss_dssp CCTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred ccCcc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence 65432 3457799999999987765 46899999999999999999999996532211 1111100
Q ss_pred ------------CCCCCCC-----CCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhCCCCcCC
Q 009364 288 ------------TTKSHPP-----IPENLSVKAKDFLLKCLEKEPDLRPTASELLKHPFVTGD 333 (536)
Q Consensus 288 ------------~~~~~~~-----~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~hp~~~~~ 333 (536)
.....+. ....+++++++||++||+.||.+|||+.|+|+||||++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 0000000 124688999999999999999999999999999999864
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-50 Score=409.85 Aligned_cols=250 Identities=24% Similarity=0.395 Sum_probs=207.2
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcE--EEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeEeeeee
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGEL--LAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRYLGTVR 141 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~--vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~ 141 (536)
.++|++.+.||+|+||+||+|+++.+|.. ||||.+. ........+.+.+|+++|+++ +|||||++++++.
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~-------~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~ 81 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-------EYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE 81 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEE-------CC------CHHHHHHHHHTTCCCCTTBCCEEEEEE
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEEC-------cccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEe
Confidence 35899999999999999999999988875 5666652 112223456788999999998 7999999999999
Q ss_pred cCCceeEEEEecCCCCcccccccC----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccC
Q 009364 142 EEESLNILLEFVPGGSISSLLGKF----------------GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVD 205 (536)
Q Consensus 142 ~~~~~~lV~E~~~gg~L~~~l~~~----------------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~ 205 (536)
+.+.+++||||++||+|.+++.+. ..+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 82 ~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~ 161 (309)
T d1fvra_ 82 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG 161 (309)
T ss_dssp ETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred cCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEc
Confidence 999999999999999999998643 5789999999999999999999999999999999999999
Q ss_pred CCCcEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCC-CCCchhhHH-HHHH
Q 009364 206 NKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGK-PPWSQQYQE-VAAL 283 (536)
Q Consensus 206 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~-~Pf~~~~~~-~~~~ 283 (536)
.++.+||+|||+++..... .......||+.|+|||.+.+..++.++|||||||++|||++|. +||...... +...
T Consensus 162 ~~~~~kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~ 238 (309)
T d1fvra_ 162 ENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 238 (309)
T ss_dssp GGGCEEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH
T ss_pred CCCceEEcccccccccccc---ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 9999999999999765432 2234567999999999999999999999999999999999975 567654322 2222
Q ss_pred HhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 284 FHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 284 ~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
+. ....++.+..+++++++||.+||+.||++|||+.+|++|
T Consensus 239 i~---~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 239 LP---QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp GG---GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HH---hcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 22 233456777899999999999999999999999999987
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-50 Score=409.51 Aligned_cols=254 Identities=24% Similarity=0.396 Sum_probs=213.8
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEc-----CCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhC-CCCceeeE
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNL-----DSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDL-SHPNIVRY 136 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l 136 (536)
.+..+|++++.||+|+||.||+|++. .+++.||||++.. .........+.+|+.+++.+ +|||||++
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~-------~~~~~~~~~~~~E~~~~~~l~~HpnIv~~ 92 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP-------SAHLTEREALMSELKVLSYLGNHMNIVNL 92 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECT-------TCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECc-------ccCHHHHHHHHHHHHHHHhccCCCCEEEE
Confidence 34568999999999999999999863 4678999998842 12223445788999999999 69999999
Q ss_pred eeeeecCCceeEEEEecCCCCcccccccCC------------------CCCHHHHHHHHHHHHHHHHHHHHcCCccccCC
Q 009364 137 LGTVREEESLNILLEFVPGGSISSLLGKFG------------------PFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIK 198 (536)
Q Consensus 137 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~------------------~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLK 198 (536)
++++.+.+.+++|||||++|+|.+++.... .+++..+..++.||+.||+|||++|++|||||
T Consensus 93 ~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLK 172 (311)
T d1t46a_ 93 LGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLA 172 (311)
T ss_dssp EEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred EEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccc
Confidence 999999999999999999999999886432 58999999999999999999999999999999
Q ss_pred CCCcccCCCCcEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhh
Q 009364 199 GANILVDNKGCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQY 277 (536)
Q Consensus 199 p~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~ 277 (536)
|+|||++.++.+||+|||+++..............+||+.|+|||++.+..++.++|||||||++|||+| |.+||....
T Consensus 173 p~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~ 252 (311)
T d1t46a_ 173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (311)
T ss_dssp GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999987765444334456789999999999999999999999999999999999 566664432
Q ss_pred --HHHHHHHhhCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHh
Q 009364 278 --QEVAALFHIGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 278 --~~~~~~~~~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~ 326 (536)
.....+... ...+..+..++.++++||.+||+.||++|||+.||++
T Consensus 253 ~~~~~~~~i~~---~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 253 VDSKFYKMIKE---GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp SSHHHHHHHHH---TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHhc---CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 223333333 2344566788999999999999999999999999986
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-51 Score=401.61 Aligned_cols=243 Identities=24% Similarity=0.441 Sum_probs=199.6
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec-C
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE-E 143 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~-~ 143 (536)
..+|++++.||+|+||.||+|++ .|+.||||++.. . ...+.+.+|+++|++++||||++++|++.+ .
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~-------~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~ 73 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKN-------D---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 73 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCC-------C---C--HHHHHTHHHHTTCCCTTBCCEEEEECCC-
T ss_pred HHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECc-------H---HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecC
Confidence 45799999999999999999987 578999998831 1 123567899999999999999999998854 5
Q ss_pred CceeEEEEecCCCCcccccccC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhh
Q 009364 144 ESLNILLEFVPGGSISSLLGKF--GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQV 221 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~ 221 (536)
+.+++||||+++|+|.+++.+. ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++..
T Consensus 74 ~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~ 153 (262)
T d1byga_ 74 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 153 (262)
T ss_dssp -CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred CcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceec
Confidence 6789999999999999998654 35899999999999999999999999999999999999999999999999999865
Q ss_pred hhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhH-HHHHHHhhCCCCCCCCCCCcC
Q 009364 222 AELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQ-EVAALFHIGTTKSHPPIPENL 299 (536)
Q Consensus 222 ~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~ 299 (536)
... .....+|+.|+|||++.+..++.++|||||||++|||+| |++||..... ++...+ .....++++..+
T Consensus 154 ~~~-----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i---~~~~~~~~~~~~ 225 (262)
T d1byga_ 154 SST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV---EKGYKMDAPDGC 225 (262)
T ss_dssp -------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHH---TTTCCCCCCTTC
T ss_pred CCC-----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHH---HcCCCCCCCccC
Confidence 432 334578999999999999999999999999999999998 7888865432 222222 223455677889
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 300 SVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 300 s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
++++++||++||..||.+|||+.+++++
T Consensus 226 ~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 226 PPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 9999999999999999999999999875
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-50 Score=406.32 Aligned_cols=254 Identities=22% Similarity=0.394 Sum_probs=215.2
Q ss_pred CCCCCceeeeEEcccCceEEEEEEEcC-----CCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEe
Q 009364 63 SPPIRWRKGELIGCGAFGRVYMGMNLD-----SGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYL 137 (536)
Q Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~ 137 (536)
.++.+|++++.||+|+||+||+|.+.. ++..||||++.. .........+.+|++++++++||||++++
T Consensus 17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~-------~~~~~~~~~~~~E~~il~~l~h~nIv~~~ 89 (308)
T d1p4oa_ 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE-------AASMRERIEFLNEASVMKEFNCHHVVRLL 89 (308)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCT-------TSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECc-------ccChHHHHHHHHHHHHHHHcCCCCEeeee
Confidence 456789999999999999999998753 457899998731 12223445688999999999999999999
Q ss_pred eeeecCCceeEEEEecCCCCcccccccC----------CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCC
Q 009364 138 GTVREEESLNILLEFVPGGSISSLLGKF----------GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNK 207 (536)
Q Consensus 138 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~----------~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~ 207 (536)
+++..++..++|||||++|+|.+++... ..+++..+..++.|+++||.|||+++|+||||||+|||++.+
T Consensus 90 ~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~ 169 (308)
T d1p4oa_ 90 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED 169 (308)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTT
T ss_pred eEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCC
Confidence 9999999999999999999999987532 347889999999999999999999999999999999999999
Q ss_pred CcEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhC-CCCCchhhH-HHHHHHh
Q 009364 208 GCIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATG-KPPWSQQYQ-EVAALFH 285 (536)
Q Consensus 208 ~~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG-~~Pf~~~~~-~~~~~~~ 285 (536)
+++||+|||+|+...............||+.|+|||.+.+..++.++|||||||++|||+|| .+||..... +....+.
T Consensus 170 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~ 249 (308)
T d1p4oa_ 170 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 249 (308)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred ceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 99999999999887665544445566799999999999999999999999999999999998 477765432 2222222
Q ss_pred hCCCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHh
Q 009364 286 IGTTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 286 ~~~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~ 326 (536)
....++.+..+++.+++||.+||+.||.+|||+.+|++
T Consensus 250 ---~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 250 ---EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp ---TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---hCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 22345567789999999999999999999999999998
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-50 Score=402.09 Aligned_cols=255 Identities=27% Similarity=0.440 Sum_probs=200.7
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCC-C--cEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeee
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDS-G--ELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVR 141 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~-g--~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~ 141 (536)
..+|++.+.||+|+||+||+|++..+ + ..||||++.... .......+.+.+|+.+|++++||||++++|++.
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~-----~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~ 81 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDV-----LSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL 81 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC-------------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhh-----cCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 35799999999999999999986533 3 468999873211 112234567899999999999999999999997
Q ss_pred cCCceeEEEEecCCCCccccccc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchh
Q 009364 142 EEESLNILLEFVPGGSISSLLGK-FGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQ 220 (536)
Q Consensus 142 ~~~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~ 220 (536)
+ +..++|||||++|++.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 82 ~-~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 82 T-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp S-SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred e-cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhh
Confidence 6 567899999999999987654 45799999999999999999999999999999999999999999999999999987
Q ss_pred hhhhhcc-cCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhh-CCCCCchhhHHHHHHHhhCCCCCCCCCCCc
Q 009364 221 VAELATV-SGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMAT-GKPPWSQQYQEVAALFHIGTTKSHPPIPEN 298 (536)
Q Consensus 221 ~~~~~~~-~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (536)
+...... .......||+.|+|||++.+..++.++|||||||++|||+| |.+||.+...... ..........++.+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~ 239 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI-LHKIDKEGERLPRPED 239 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-HHHHHTSCCCCCCCTT
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHH-HHHHHhCCCCCCCccc
Confidence 6543222 22335568899999999999999999999999999999998 8999976543221 1122223344566778
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHh
Q 009364 299 LSVKAKDFLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 299 ~s~~~~dLi~~cL~~dP~~Rps~~eiL~ 326 (536)
++.++++||.+||..||++|||+.+|++
T Consensus 240 ~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 240 CPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 9999999999999999999999999974
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=396.26 Aligned_cols=248 Identities=25% Similarity=0.399 Sum_probs=203.6
Q ss_pred eeeEEcccCceEEEEEEEcCCC---cEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeec-CCc
Q 009364 70 KGELIGCGAFGRVYMGMNLDSG---ELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVRE-EES 145 (536)
Q Consensus 70 ~~~~LG~G~fg~Vy~a~~~~~g---~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~-~~~ 145 (536)
..++||+|+||+||+|++..++ ..||||.+.. .......+++.+|+++|++++||||++++|++.. ++.
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~-------~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~ 103 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-------ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 103 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECC-------CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTE
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECc-------ccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCc
Confidence 3688999999999999987643 3689998731 1223446779999999999999999999999765 568
Q ss_pred eeEEEEecCCCCcccccccC-CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCcchhhhhh
Q 009364 146 LNILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGASKQVAEL 224 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 224 (536)
+++|||||++|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||+++++.+||+|||+++.+...
T Consensus 104 ~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~ 183 (311)
T d1r0pa_ 104 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 183 (311)
T ss_dssp EEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred eEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence 99999999999999988654 46788889999999999999999999999999999999999999999999999876543
Q ss_pred hcc--cCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH--HHHHHhhCCCCCCCCCCCcCc
Q 009364 225 ATV--SGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE--VAALFHIGTTKSHPPIPENLS 300 (536)
Q Consensus 225 ~~~--~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~--~~~~~~~~~~~~~~~~~~~~s 300 (536)
... .......||+.|+|||++.+..++.++|||||||++|||+||..||...... ....+.. ...+..|..++
T Consensus 184 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~---g~~~~~p~~~~ 260 (311)
T d1r0pa_ 184 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ---GRRLLQPEYCP 260 (311)
T ss_dssp TCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHT---TCCCCCCTTCC
T ss_pred ccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHc---CCCCCCcccCc
Confidence 222 1233467899999999999999999999999999999999987777543322 1222222 23445677899
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 301 VKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 301 ~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
+++.+||.+||+.||++|||+.||++|
T Consensus 261 ~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 261 DPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999999999999987
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-47 Score=385.43 Aligned_cols=257 Identities=22% Similarity=0.319 Sum_probs=201.1
Q ss_pred CCCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCc-eeeEeeeeec
Q 009364 64 PPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPN-IVRYLGTVRE 142 (536)
Q Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~Hpn-Iv~l~~~~~~ 142 (536)
..++|++++.||+|+||+||+|++..+|+.||||++..... ...+..|+++++.++|+| |+.+.+++.+
T Consensus 5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----------~~~~~~E~~i~~~l~~~~~i~~~~~~~~~ 74 (299)
T d1ckia_ 5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----------HPQLHIESKIYKMMQGGVGIPTIRWCGAE 74 (299)
T ss_dssp ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT----------SCCHHHHHHHHHHSTTSTTCCCEEEEEEE
T ss_pred ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc----------CHHHHHHHHHHHHccCCCcccEEEEEEec
Confidence 34689999999999999999999999999999998743211 123668999999998766 4555666678
Q ss_pred CCceeEEEEecCCCCccccc-ccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCC---CCcEEEEecCcc
Q 009364 143 EESLNILLEFVPGGSISSLL-GKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDN---KGCIKLADFGAS 218 (536)
Q Consensus 143 ~~~~~lV~E~~~gg~L~~~l-~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~---~~~vkL~DFGla 218 (536)
.+..++||||+. +++.+.+ ...+.+++..+..++.|++.||+|||++||+||||||+|||++. +..+||+|||+|
T Consensus 75 ~~~~~ivme~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a 153 (299)
T d1ckia_ 75 GDYNVMVMELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 153 (299)
T ss_dssp TTEEEEEEECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSC
T ss_pred CCEEEEEEEEcC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcc
Confidence 888999999995 5555444 45568999999999999999999999999999999999998764 457999999999
Q ss_pred hhhhhhhcc-----cCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH-----HHHHHhhCC
Q 009364 219 KQVAELATV-----SGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE-----VAALFHIGT 288 (536)
Q Consensus 219 ~~~~~~~~~-----~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~-----~~~~~~~~~ 288 (536)
+.+...... ......+||+.|+|||++.+..++.++|||||||++|||++|.+||...... .........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~ 233 (299)
T d1ckia_ 154 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 233 (299)
T ss_dssp EECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHH
T ss_pred eeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccC
Confidence 876543221 1234678999999999999999999999999999999999999999643211 111111110
Q ss_pred CCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHH---HHhCCCCc
Q 009364 289 TKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASE---LLKHPFVT 331 (536)
Q Consensus 289 ~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~e---iL~hp~~~ 331 (536)
....+..+..+|+++.+||.+||+.||.+||++.+ +|+|+|.+
T Consensus 234 ~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 234 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred CCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 11112234578999999999999999999999875 46777653
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.2e-47 Score=381.35 Aligned_cols=251 Identities=21% Similarity=0.287 Sum_probs=204.1
Q ss_pred CCCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCC-CceeeEeeeeecC
Q 009364 65 PIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH-PNIVRYLGTVREE 143 (536)
Q Consensus 65 ~~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~H-pnIv~l~~~~~~~ 143 (536)
..+|++++.||+|+||+||+|++..+|+.||||++..... ...+.+|+++++.++| +||+.+++++...
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----------~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~ 73 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----------APQLRDEYRTYKLLAGCTGIPNVYYFGQEG 73 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----------SCCHHHHHHHHHHTTTCTTCCCEEEEEEET
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC----------cHHHHHHHHHHHHhcCCCCCCEEEEEeecC
Confidence 3589999999999999999999999999999998742211 1235678888988865 8999999999999
Q ss_pred CceeEEEEecCCCCcccccccC-CCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCC-----CCcEEEEecCc
Q 009364 144 ESLNILLEFVPGGSISSLLGKF-GPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDN-----KGCIKLADFGA 217 (536)
Q Consensus 144 ~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~-----~~~vkL~DFGl 217 (536)
...++||||+ +++|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++. ++.+||+|||+
T Consensus 74 ~~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~ 152 (293)
T d1csna_ 74 LHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 152 (293)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred CccEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccce
Confidence 9999999999 78998888654 47999999999999999999999999999999999999964 56899999999
Q ss_pred chhhhhhhc-----ccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhh-----HHHHHHHhhC
Q 009364 218 SKQVAELAT-----VSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQY-----QEVAALFHIG 287 (536)
Q Consensus 218 a~~~~~~~~-----~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~-----~~~~~~~~~~ 287 (536)
|+....... .......+||+.|||||++.+..++.++|||||||++|+|++|..||.... .....+....
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~ 232 (293)
T d1csna_ 153 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK 232 (293)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred eEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhcc
Confidence 987653221 122446789999999999999999999999999999999999999996321 1111111111
Q ss_pred CCCCCCCCCCcCcHHHHHHHHHhcccCCCCCCCHHHHHh
Q 009364 288 TTKSHPPIPENLSVKAKDFLLKCLEKEPDLRPTASELLK 326 (536)
Q Consensus 288 ~~~~~~~~~~~~s~~~~dLi~~cL~~dP~~Rps~~eiL~ 326 (536)
.......++..+|+++.+++..|+..+|++||++..+.+
T Consensus 233 ~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 233 QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred CCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 111122234578899999999999999999999887754
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-47 Score=383.53 Aligned_cols=247 Identities=26% Similarity=0.312 Sum_probs=192.4
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCceeeEeeeeecCC--
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNIVRYLGTVREEE-- 144 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~-- 144 (536)
+|.+.+.||+|+||+||+|++ +|+.||||++.. ..... ...+.|+..++.++||||+++++++.+.+
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~-------~~~~~--~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~ 72 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSS-------REERS--WFREAEIYQTVMLRHENILGFIAADNKDNGT 72 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECG-------GGHHH--HHHHHHHHTSTTCCCTTBCCEEEEEEEECSS
T ss_pred EEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECc-------cchhH--HHHHHHHHHHhhCCCCcCcceEEEEEeCCCc
Confidence 588899999999999999986 689999998731 11111 12234666667889999999999997654
Q ss_pred --ceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHH--------cCCccccCCCCCcccCCCCcEEEEe
Q 009364 145 --SLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHN--------HGIMHRDIKGANILVDNKGCIKLAD 214 (536)
Q Consensus 145 --~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~--------~~ivHrDLKp~NILl~~~~~vkL~D 214 (536)
.+++|||||++|+|.+++.+ ..+++..+..++.|++.||+|||+ +||+||||||+||||+.++.+||+|
T Consensus 73 ~~~~~lv~Ey~~~g~L~~~l~~-~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~D 151 (303)
T d1vjya_ 73 WTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 151 (303)
T ss_dssp SEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECC
T ss_pred ceEEEEEEecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEe
Confidence 57999999999999999976 468999999999999999999996 5999999999999999999999999
Q ss_pred cCcchhhhhhhcc--cCCcccCCCCCCCChhhhhhcC------CCccceEechhHHHHHHhhCCCCCch-----------
Q 009364 215 FGASKQVAELATV--SGAKSMKGTPYWMAPEVIRQTG------HSYSADIWSVGCTVIEMATGKPPWSQ----------- 275 (536)
Q Consensus 215 FGla~~~~~~~~~--~~~~~~~Gt~~Y~APEvl~~~~------~s~k~DIwSlGvil~eLltG~~Pf~~----------- 275 (536)
||+++........ ......+||+.|+|||++.+.. ++.++|||||||++|||+||.+||..
T Consensus 152 FGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~ 231 (303)
T d1vjya_ 152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 231 (303)
T ss_dssp CTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTT
T ss_pred cCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhc
Confidence 9999876543221 1234678999999999987643 56789999999999999999887732
Q ss_pred -----hhHHHHHHHhhCCCCCCCCCCC-----cCcHHHHHHHHHhcccCCCCCCCHHHHHhC
Q 009364 276 -----QYQEVAALFHIGTTKSHPPIPE-----NLSVKAKDFLLKCLEKEPDLRPTASELLKH 327 (536)
Q Consensus 276 -----~~~~~~~~~~~~~~~~~~~~~~-----~~s~~~~dLi~~cL~~dP~~Rps~~eiL~h 327 (536)
.......... .....+.++. .....+.+|+.+||+.||++|||+.||+++
T Consensus 232 ~~~~~~~~~~~~~~~--~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 232 VPSDPSVEEMRKVVC--EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp SCSSCCHHHHHHHHT--TSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred ccccchHHHHHHHHh--ccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 1112222221 1222233332 234568999999999999999999999874
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.2e-45 Score=374.72 Aligned_cols=254 Identities=26% Similarity=0.426 Sum_probs=196.1
Q ss_pred CCceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCC-----------CCcee
Q 009364 66 IRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS-----------HPNIV 134 (536)
Q Consensus 66 ~~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~-----------HpnIv 134 (536)
.||++++.||+|+||+||+|+++.+|+.||||++... ....+.+.+|+.+++.++ |+||+
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---------~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv 83 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---------KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHIL 83 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---------HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBC
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc---------ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceE
Confidence 5799999999999999999999999999999998421 122345667888877764 57899
Q ss_pred eEeeeeec--CCceeEEEEecCCCCcccc---cccCCCCCHHHHHHHHHHHHHHHHHHHH-cCCccccCCCCCcccCCCC
Q 009364 135 RYLGTVRE--EESLNILLEFVPGGSISSL---LGKFGPFPEAVMRTYTKQLLLGLEYLHN-HGIMHRDIKGANILVDNKG 208 (536)
Q Consensus 135 ~l~~~~~~--~~~~~lV~E~~~gg~L~~~---l~~~~~l~~~~~~~i~~qil~aL~yLH~-~~ivHrDLKp~NILl~~~~ 208 (536)
++++++.. ....+++++++..+..... ......+++..++.++.||+.||.|||+ .||+||||||+|||++.++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~ 163 (362)
T d1q8ya_ 84 KLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVD 163 (362)
T ss_dssp CCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEE
T ss_pred EEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccC
Confidence 99988764 3456777777765543322 2344678999999999999999999998 8999999999999998665
Q ss_pred ------cEEEEecCcchhhhhhhcccCCcccCCCCCCCChhhhhhcCCCccceEechhHHHHHHhhCCCCCchhhHH---
Q 009364 209 ------CIKLADFGASKQVAELATVSGAKSMKGTPYWMAPEVIRQTGHSYSADIWSVGCTVIEMATGKPPWSQQYQE--- 279 (536)
Q Consensus 209 ------~vkL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APEvl~~~~~s~k~DIwSlGvil~eLltG~~Pf~~~~~~--- 279 (536)
.+|++|||.+..... .....+||+.|+|||++.+..++.++||||+||++++|++|+.||......
T Consensus 164 ~~~~~~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~ 238 (362)
T d1q8ya_ 164 SPENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 238 (362)
T ss_dssp TTTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred cccccceeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCcccccc
Confidence 499999999875432 235678999999999999999999999999999999999999999632110
Q ss_pred -----HHHHHhh-CC---------------------CCC---------------CCCCCCcCcHHHHHHHHHhcccCCCC
Q 009364 280 -----VAALFHI-GT---------------------TKS---------------HPPIPENLSVKAKDFLLKCLEKEPDL 317 (536)
Q Consensus 280 -----~~~~~~~-~~---------------------~~~---------------~~~~~~~~s~~~~dLi~~cL~~dP~~ 317 (536)
....... +. ... ....+...++++++||.+||++||.+
T Consensus 239 ~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~ 318 (362)
T d1q8ya_ 239 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK 318 (362)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred chhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhH
Confidence 0000000 00 000 11123356788999999999999999
Q ss_pred CCCHHHHHhCCCCcCC
Q 009364 318 RPTASELLKHPFVTGD 333 (536)
Q Consensus 318 Rps~~eiL~hp~~~~~ 333 (536)
|||++|+|+||||+..
T Consensus 319 Rpta~e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 319 RADAGGLVNHPWLKDT 334 (362)
T ss_dssp CBCHHHHHTCGGGTTC
T ss_pred CcCHHHHhcCcccCCC
Confidence 9999999999999843
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=2.5e-25 Score=207.75 Aligned_cols=170 Identities=18% Similarity=0.120 Sum_probs=121.8
Q ss_pred ceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhc----------cchhHHHHHHHHHHHHHHHHHhCCCCceeeEe
Q 009364 68 WRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANF----------ASKEKAQDHIKELEEEVKLLKDLSHPNIVRYL 137 (536)
Q Consensus 68 y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~----------~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~ 137 (536)
|.++++||+|+||+||+|.+. +|+.||||++...... ...............|...+.++.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 468999999999999999874 6899999986432110 00011112234456788999999999999887
Q ss_pred eeeecCCceeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCCccccCCCCCcccCCCCcEEEEecCc
Q 009364 138 GTVREEESLNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHNHGIMHRDIKGANILVDNKGCIKLADFGA 217 (536)
Q Consensus 138 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~~ivHrDLKp~NILl~~~~~vkL~DFGl 217 (536)
++. ..+++|||++++.+.. +++..+..++.|++.+|.|||++||+||||||+|||++++ .++|+|||+
T Consensus 81 ~~~----~~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~ 148 (191)
T d1zara2 81 AWE----GNAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQ 148 (191)
T ss_dssp EEE----TTEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTT
T ss_pred Eec----CCEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCC
Confidence 653 2479999998866544 3445567899999999999999999999999999999865 589999999
Q ss_pred chhhhhhhcccCCcccCCCCCCCCh------hhhhhcCCCccceEechhH
Q 009364 218 SKQVAELATVSGAKSMKGTPYWMAP------EVIRQTGHSYSADIWSVGC 261 (536)
Q Consensus 218 a~~~~~~~~~~~~~~~~Gt~~Y~AP------Evl~~~~~s~k~DIwSlGv 261 (536)
|........ ..|... +. ....|+.++|+||+.-
T Consensus 149 a~~~~~~~~----------~~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~ 187 (191)
T d1zara2 149 SVEVGEEGW----------REILERDVRNIITY-FSRTYRTEKDINSAID 187 (191)
T ss_dssp CEETTSTTH----------HHHHHHHHHHHHHH-HHHHHCCCCCHHHHHH
T ss_pred cccCCCCCc----------HHHHHHHHHHHHHH-HcCCCCCcccHHHHHH
Confidence 865432110 011111 11 2346888999999754
|
| >d1s6ja_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-dependent protein kinase sk5 CLD species: Soybean (Glycine max) [TaxId: 3847]
Probab=98.40 E-value=1.7e-08 Score=80.03 Aligned_cols=59 Identities=12% Similarity=-0.016 Sum_probs=52.2
Q ss_pred hhcccCCCCCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 361 LQMLTSPGSPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 361 ~q~~t~~~sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
.+.......|..+|.+++|.|+..||.. ++.+|++.+++.+| .|++|.|+|+||+++|+
T Consensus 20 ~~i~~l~~~F~~~D~d~~G~I~~~el~~~l~~lg~~~s~~e~~~l~~~~D-~d~~g~I~~~EFl~am~ 86 (87)
T d1s6ja_ 20 EEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAAD-IDKSGTIDYGEFIAATV 86 (87)
T ss_dssp SSTTTTTTHHHHHCTTCSSCEEHHHHHHHHHTTTSSCCHHHHHHHHHHHC-TTCSSEECHHHHTTCCC
T ss_pred HHHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHcC-CCCCCeEeHHHHHHHHc
Confidence 3444567789999999999999999986 67899999999999 99999999999998775
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.37 E-value=1.6e-07 Score=89.10 Aligned_cols=138 Identities=17% Similarity=0.128 Sum_probs=90.3
Q ss_pred CceeeeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCC-CCceeeEeeeeecCCc
Q 009364 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS-HPNIVRYLGTVREEES 145 (536)
Q Consensus 67 ~y~~~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~ 145 (536)
.|+..+..+-|+.+.||+.. .++..+.+|....... .....+.+|...+..+. +--+.+++.+...++.
T Consensus 15 ~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~--------~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~ 84 (263)
T d1j7la_ 15 KYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYK--------GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW 84 (263)
T ss_dssp TSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGT--------TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred ceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcc--------cchhhHHHHHHHHHHHhccCCCCcEEEEEecCCc
Confidence 45666655555567999875 3566788887632111 11223567777777664 3335677778888888
Q ss_pred eeEEEEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------
Q 009364 146 LNILLEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLHN------------------------------------ 189 (536)
Q Consensus 146 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~------------------------------------ 189 (536)
.++||++++|.++....... .....++.++...+..||+
T Consensus 85 ~~lv~~~l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T d1j7la_ 85 SNLLMSEADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEEEECCSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred eEEEEEeccccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence 99999999988775543211 1122344555555555553
Q ss_pred -----------------------cCCccccCCCCCcccCCCCcEEEEecCcch
Q 009364 190 -----------------------HGIMHRDIKGANILVDNKGCIKLADFGASK 219 (536)
Q Consensus 190 -----------------------~~ivHrDLKp~NILl~~~~~vkL~DFGla~ 219 (536)
..++|+|+.|.|||+++++.+-|+||+.+.
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 127999999999999876666799999764
|
| >d2opoa1 a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Chenopodium album) [TaxId: 3559]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Polcalcin domain: Polcalcin Che a 3 species: Pigweed (Chenopodium album) [TaxId: 3559]
Probab=98.31 E-value=5e-08 Score=76.16 Aligned_cols=65 Identities=12% Similarity=-0.069 Sum_probs=53.4
Q ss_pred CCCCCccccCCCccchhhhhh-------hhhhhhhhhhhccCCCCCCCccchhhhhhhcccccccCChhhhhhcc
Q 009364 368 GSPGSVDICNLDSLSCSRVIV-------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSSILAPNDLEKSR 435 (536)
Q Consensus 368 ~sf~~~D~~~~g~ls~~el~~-------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~~~~~e~l~~aF 435 (536)
..|..+|.+++|.|+..||.. ++.++++.+++.+| .|++|.|+|+||+.++.... ...+++.++|
T Consensus 10 ~~F~~~D~d~~G~I~~~El~~~l~~lg~~~~~ei~~~~~~~D-~d~~G~I~~~EF~~~~~~~~--~~~~e~~~~F 81 (81)
T d2opoa1 10 RIFKRFDTNGDGKISSSELGDALKTLGSVTPDEVRRMMAEID-TDGDGFISFDEFTDFARANR--GLVKDVSKIF 81 (81)
T ss_dssp HHHHHHCTTCSSEEEHHHHHHHHHTTTTCCHHHHHHHHHHHC-TTCSSEECHHHHHHHHHHCT--TTHHHHHHHC
T ss_pred HHHHHHCCCCCCCCcHHHHHHHHHHhhcCCHHHHHHHHHHhC-CCCCCeEeHHHHHHHHHHCc--cchHHHHhhC
Confidence 359999999999999999976 67899999999999 89999999999997665432 2234566666
|
| >d1wrka1 a.39.1.5 (A:4-85) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]
Probab=98.29 E-value=2.8e-08 Score=77.82 Aligned_cols=63 Identities=11% Similarity=-0.062 Sum_probs=52.0
Q ss_pred hhhhhhcccCCCCCCCccccC-CCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 357 NLESLQMLTSPGSPGSVDICN-LDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 357 ~l~s~q~~t~~~sf~~~D~~~-~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
.+...+......+|..||.++ +|.|++.||+. +++++++.+++.+| .|++|.|+|+||+..+.
T Consensus 8 ~ls~eq~~~~~~~F~~fD~d~~~G~I~~~el~~~l~~lg~~~t~~el~~~i~~~D-~d~~G~I~f~eFl~im~ 79 (82)
T d1wrka1 8 QLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEELQEMIDEVD-EDGSGTVDFDEFLVMMV 79 (82)
T ss_dssp HCCHHHHHHHHHHHHHHTTTCTTSSBCHHHHHHHHHHTTCCCCHHHHHHHHHTTC-TTCCSSBCHHHHHHHHH
T ss_pred hCCHHHHHHHHHHHHHHcCcCCCCeEeHHHHHHHHHHcCCCCCHHHHHHHHHHhC-CCCCCeEeHHHHHHHHH
Confidence 344444444455699999995 79999999986 68999999999999 89999999999997654
|
| >d1f54a_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=98.21 E-value=4e-08 Score=75.89 Aligned_cols=55 Identities=16% Similarity=0.020 Sum_probs=48.9
Q ss_pred CCCCCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhccc
Q 009364 366 SPGSPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRK 421 (536)
Q Consensus 366 ~~~sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~ 421 (536)
...+|..||.+++|.|+..||.. ++..+++.+++.+| .+++|.|+|+||+.++..
T Consensus 12 l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~t~~e~~~~~~~~D-~~~~g~I~~~eF~~~m~~ 74 (77)
T d1f54a_ 12 FKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEID-VDGNHQIEFSEFLALMSR 74 (77)
T ss_dssp HHHHHHHTCTTCSSEEEHHHHHHHHHHHTCCCCHHHHHHHHHTTC-CSSCCEEEHHHHHHHHTT
T ss_pred HHHHHHHHcCCCCCeEChHHHHHHHHHhCCCCCHHHHHHHHHHhC-CCCCCeEeHHHHHHHHHH
Confidence 34459999999999999999986 57899999999999 899999999999976643
|
| >d2pq3a1 a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Rattus norvegicus [TaxId: 10116]
Probab=98.16 E-value=3.9e-08 Score=75.18 Aligned_cols=53 Identities=8% Similarity=-0.059 Sum_probs=47.7
Q ss_pred CCCCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 367 PGSPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 367 ~~sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
..+|..||.+++|.|+..||.. ++.+++..+++.+| .|++|.|+|+||+.++.
T Consensus 11 ~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~s~~~~~~~~~~~D-~d~~g~I~f~eF~~~m~ 71 (73)
T d2pq3a1 11 KEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVD-ADGNGTIDFPEFLTMMA 71 (73)
T ss_dssp HHHHHHTCTTSSSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHC-TTCSSEEEHHHHHHHHH
T ss_pred HHHHHHHcCCCCceEeHHHHHHHHHHhCCCCCHHHHHHHHHHhC-CCCCCeEeHHHHHHHHh
Confidence 3459999999999999999986 67899999999999 89999999999997653
|
| >d1fw4a_ a.39.1.5 (A:) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.13 E-value=2.4e-07 Score=68.94 Aligned_cols=51 Identities=14% Similarity=-0.063 Sum_probs=46.1
Q ss_pred CCCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhc
Q 009364 368 GSPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGD 419 (536)
Q Consensus 368 ~sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~ 419 (536)
.+|..||.+++|.|+..||+. .+.++++.+++..| .|++|.|+|+||+.++
T Consensus 7 ~aF~~fD~d~~G~I~~~el~~~l~~lg~~~~~~e~~~l~~~~D-~d~~g~I~~~eF~~~m 65 (65)
T d1fw4a_ 7 EAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREAD-IDGDGQVNYEEFVQMM 65 (65)
T ss_dssp HHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHTTC-TTCSSSEEHHHHHHHC
T ss_pred HHHHHHcCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHcC-CCCCCcEeHHHHHHHC
Confidence 358999999999999999986 57899999999999 8999999999999643
|
| >d1avsa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=98.11 E-value=5.7e-08 Score=75.82 Aligned_cols=54 Identities=11% Similarity=-0.060 Sum_probs=48.2
Q ss_pred CCCCCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 366 SPGSPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 366 ~~~sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
....|..||.+++|.|+..||.. .+.++++.++..+| .|++|.|+|+||+.++.
T Consensus 16 l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~s~~e~~~~~~~~D-~d~~g~I~~~eF~~~m~ 77 (81)
T d1avsa_ 16 FKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVD-EDGSGTIDFEEFLVMMV 77 (81)
T ss_dssp HHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHC-TTCCSSEEHHHHHHHHH
T ss_pred HHHHHHHHcCCCCCeEchhHHHHHHHHcCCCCCHHHHHHHHHHhC-CCCCCeEeHHHHHHHHH
Confidence 33459999999999999999986 67899999999999 89999999999997654
|
| >d1tiza_ a.39.1.5 (A:) Calmodulin-related protein T21P5.17 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin-related protein T21P5.17 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=98.11 E-value=2.2e-07 Score=69.51 Aligned_cols=51 Identities=12% Similarity=-0.002 Sum_probs=46.5
Q ss_pred CCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 369 SPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
.|..+|.+++|.|+..|+.. .+.++++.+++.+| .|++|.|+|+||+.++.
T Consensus 6 ~F~~~D~d~~G~I~~~El~~~l~~lg~~~~~~~i~~~~~~~D-~d~dg~I~~~EF~~~m~ 64 (67)
T d1tiza_ 6 VFEKFDKNKDGKLSLDEFREVALAFSPYFTQEDIVKFFEEID-VDGNGELNADEFTSCIE 64 (67)
T ss_dssp HHHHHCTTSSSCEEHHHHHHHHHHTCTTSCHHHHHHHHHHHC-CSSSSEECHHHHHHHHH
T ss_pred HHHHHCCCCcCcCcHHHHHHHHHHhccccchHHHHHHHHHhC-CCCCCeEeHHHHHHHHH
Confidence 48899999999999999986 57899999999999 89999999999997654
|
| >d2fcea1 a.39.1.5 (A:84-144) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.08 E-value=3.7e-07 Score=66.95 Aligned_cols=47 Identities=11% Similarity=-0.022 Sum_probs=44.1
Q ss_pred CCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhh
Q 009364 369 SPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFV 416 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~ 416 (536)
+|..||.+++|.|+..||+. .+.++++.+++.+| .|++|.|+|+||+
T Consensus 6 aF~~fD~~~~G~I~~~el~~~l~~~g~~~~~~ei~~l~~~~D-~d~dg~I~~~eFl 60 (61)
T d2fcea1 6 AFQVFDKESTGKVSVGDLRYMLTGLGEKLTDAEVDELLKGVE-VDSNGEIDYKKFI 60 (61)
T ss_dssp HHHHHCTTCCSCEEHHHHHHHHHHTTCCCCHHHHHHHHTTCC-CCTTSEECHHHHH
T ss_pred HHHHHCCCCCCeEeHHHHHHHHHHcCCCCCHHHHHHHHHHcC-CCCCCcEeHHHhc
Confidence 48899999999999999986 57899999999999 8999999999997
|
| >d1c7va_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium vector protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Probab=98.04 E-value=1.7e-07 Score=70.44 Aligned_cols=51 Identities=8% Similarity=-0.022 Sum_probs=46.0
Q ss_pred CCCCccccCCCccchhhhhh---------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 369 SPGSVDICNLDSLSCSRVIV---------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~---------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
.|..||.+++|.|+..||.. .+.++++.+++.+| .|++|.|+|+||+.++.
T Consensus 7 ~F~~~D~d~~G~I~~~el~~~l~~~g~~~~s~~e~~~~~~~~D-~d~dG~i~~~EF~~~m~ 66 (68)
T d1c7va_ 7 AFKVFDANGDGVIDFDEFKFIMQKVGEEPLTDAEVEEAMKEAD-EDGNGVIDIPEFMDLIK 66 (68)
T ss_dssp HHHHHSCSGGGEECHHHHHHHSSTTTTCCCCHHHHHHHHHHHC-SSGGGSEEHHHHHHHHH
T ss_pred HHHHHcCCCcCeEcHHHHHHHHHHhCCCCCCHHHHHHHHHHhC-CCCCCcEeHHHHHHHHH
Confidence 48899999999999999986 37899999999999 99999999999997553
|
| >d1jc2a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=98.04 E-value=3.8e-07 Score=69.88 Aligned_cols=51 Identities=8% Similarity=-0.087 Sum_probs=46.8
Q ss_pred CCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 369 SPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
+|..||.+++|.|+..||.. ++.++++.+++.+| .|++|.|+|+||+.++.
T Consensus 14 ~F~~fD~~~~G~I~~~el~~~l~~lg~~~~~~e~~~~~~~~D-~d~dg~I~~~EF~~~m~ 72 (75)
T d1jc2a_ 14 CFRIFDKNADGFIDIEELGEILRATGEHVIEEDIEDLMKDSD-KNNDGRIDFDEFLKMME 72 (75)
T ss_dssp HHHHHCCSTTSSEEHHHHHHHHHHSSSCCCHHHHHHHHHHHC-SSSCSEECHHHHHHHHH
T ss_pred HHHHHcCCCcCeEcHHHHHHHHHhcCCCccHHHHHHHHHHhC-CCCCCcEeHHHHHHHHH
Confidence 59999999999999999986 67899999999999 89999999999997654
|
| >d1fi5a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]
Probab=98.00 E-value=5.2e-07 Score=70.16 Aligned_cols=51 Identities=6% Similarity=-0.035 Sum_probs=46.8
Q ss_pred CCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 369 SPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
.|..||.+++|.|+..||.. ++.++++.++..+| .|++|.|+|+||+.++.
T Consensus 20 ~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~ev~~~~~~~D-~d~dg~I~~~EF~~~m~ 78 (81)
T d1fi5a_ 20 LFRMFDKNADGYIDLEELKIMLQATGETITEDDIEELMKDGD-KNNDGRIDYDEFLEFMK 78 (81)
T ss_dssp HHHHHCSSCSSEECHHHHHHHHHTSSSCCCHHHHHHHHHHHC-SSSSSSEEHHHHHHHHS
T ss_pred HHHHHcCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHHC-CCCCCcEeHHHHHHHHH
Confidence 49999999999999999986 57899999999999 89999999999997654
|
| >d1oqpa_ a.39.1.5 (A:) Caltractin (centrin 2) {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Caltractin (centrin 2) species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=97.95 E-value=6e-07 Score=69.04 Aligned_cols=51 Identities=10% Similarity=0.050 Sum_probs=46.6
Q ss_pred CCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 369 SPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
.|..+|.+++|.|+..||.. .+..++..+++.+| .|++|.|+|+||+.++.
T Consensus 14 ~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~e~~~~~~~~D-~d~~G~I~~~EF~~~m~ 72 (77)
T d1oqpa_ 14 AFRLFDDDNSGTITIKDLRRVAKELGENLTEEELQEMIAEAD-RNDDNEIDEDEFIRIMK 72 (77)
T ss_dssp HHHHHCTTCSSSEEHHHHHHHHHHHTCCCCHHHHHHHHHHHC-CSSSSEECHHHHHHHHH
T ss_pred HHHHHcCCCCCEechHHHHHHHHHhCCCCCHHHHHHHHHHhC-CCCCCcEeHHHHHHHHH
Confidence 49999999999999999986 57889999999999 89999999999997654
|
| >d5pala_ a.39.1.4 (A:) Parvalbumin {Leopard shark (Triakis semifasciata) [TaxId: 30493]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Leopard shark (Triakis semifasciata) [TaxId: 30493]
Probab=97.89 E-value=8.1e-07 Score=73.18 Aligned_cols=51 Identities=6% Similarity=-0.074 Sum_probs=45.6
Q ss_pred CCCCccccCCCccchhhhhh-----------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 369 SPGSVDICNLDSLSCSRVIV-----------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~-----------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
.|..||.+++|.|+.+||+. .+.++++.+++.+| .|++|.|+|+||+.++.
T Consensus 46 ~F~~~D~d~~G~I~~~El~~~l~~l~~~g~~~~~~e~~~~~~~~D-~d~dG~I~~~EF~~~m~ 107 (109)
T d5pala_ 46 VFEILDKDQSGFIEEEELKGVLKGFSAHGRDLNDTETKALLAAGD-SDHDGKIGADEFAKMVA 107 (109)
T ss_dssp HHHHHCTTCSSEECHHHHHTHHHHHCTTCCCCCHHHHHHHHHHHC-TTCSSSEEHHHHHHHHH
T ss_pred HHhhhcCCCCCeEcHHHHHHHHHHhhhccCcCCHHHHHHHHHHhC-CCCCCCEeHHHHHHHHH
Confidence 49999999999999999864 46789999999999 89999999999997653
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.88 E-value=7.3e-06 Score=76.82 Aligned_cols=127 Identities=24% Similarity=0.197 Sum_probs=80.5
Q ss_pred EEcccCc-eEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCC--CceeeEeeeeecCCceeEE
Q 009364 73 LIGCGAF-GRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSH--PNIVRYLGTVREEESLNIL 149 (536)
Q Consensus 73 ~LG~G~f-g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~H--pnIv~l~~~~~~~~~~~lV 149 (536)
.+..|.. +.||+.. ..++..+++|..... . ...+..|...|+.+.. -.+.+++.+..+.+..++|
T Consensus 17 ~~~~G~s~~~v~r~~-~~~~~~~vlK~~~~~-------~----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v 84 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLS-AQGRPVLFVKTDLSG-------A----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL 84 (255)
T ss_dssp ECSCTTSSCEEEEEE-CTTSCCEEEEEECSC-------T----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred EcCCcccCCeEEEEE-eCCCCEEEEEeCCcc-------C----HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEE
Confidence 4455554 6889886 356777888975211 0 1235567777776632 3356678888888899999
Q ss_pred EEecCCCCcccccccCCCCCHHHHHHHHHHHHHHHHHHH-----------------------------------------
Q 009364 150 LEFVPGGSISSLLGKFGPFPEAVMRTYTKQLLLGLEYLH----------------------------------------- 188 (536)
Q Consensus 150 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH----------------------------------------- 188 (536)
|++++|.++..... ... ..+.++...|.-||
T Consensus 85 ~~~i~G~~~~~~~~-----~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (255)
T d1nd4a_ 85 LGEVPGQDLLSSHL-----APA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 156 (255)
T ss_dssp EECCSSEETTTSCC-----CHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred EEeeeccccccccc-----cHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhh
Confidence 99998876644211 111 11222333333333
Q ss_pred ----------Hc-------CCccccCCCCCcccCCCCcEEEEecCcch
Q 009364 189 ----------NH-------GIMHRDIKGANILVDNKGCIKLADFGASK 219 (536)
Q Consensus 189 ----------~~-------~ivHrDLKp~NILl~~~~~vkL~DFGla~ 219 (536)
.. .++|+|+.|.|||++.++.+-|+||+.+.
T Consensus 157 ~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 157 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 21 27999999999999887667899999764
|
| >d1fi6a_ a.39.1.6 (A:) Reps1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Reps1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=97.86 E-value=2e-06 Score=68.43 Aligned_cols=50 Identities=16% Similarity=0.031 Sum_probs=45.6
Q ss_pred CCCCccccCCCccchhhhhh------hhhhhhhhhhhccCCCCCCCccchhhhhhhc
Q 009364 369 SPGSVDICNLDSLSCSRVIV------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGD 419 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~ 419 (536)
.|..+|.+++|.|+.+|+.. .+.+++.+||+.+| .|++|.|+|+||+.++
T Consensus 14 ~F~~~D~d~~G~i~~~e~~~~l~~~~l~~~~l~~i~~~~D-~d~dG~l~~~EF~~a~ 69 (92)
T d1fi6a_ 14 QFKTIQPDLNGFIPGSAAKEFFTKSKLPILELSHIWELSD-FDKDGALTLDEFCAAF 69 (92)
T ss_dssp HHTTTCCSTTCEEEHHHHHHHHHHHSSCHHHHHHHHHHHC-TTCSSEEEHHHHHHHH
T ss_pred HHHHhCCCcccchhHHHHHHHHHHccCCHHHHHHHHHHhC-CCCCCeecHHHHHHHH
Confidence 49999999999999999987 56789999999999 8999999999998654
|
| >d1pvaa_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Pike (Esox lucius) [TaxId: 8010]
Probab=97.84 E-value=1.5e-06 Score=71.53 Aligned_cols=51 Identities=6% Similarity=-0.063 Sum_probs=45.5
Q ss_pred CCCCccccCCCccchhhhhh-----------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 369 SPGSVDICNLDSLSCSRVIV-----------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~-----------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
.|..+|.+++|.|+.+||.. .+.+|++.+++..| .|++|.|+|+||+.++.
T Consensus 46 ~F~~~D~d~~G~I~~~El~~~l~~l~~~g~~ls~~ev~~~~~~~D-~d~dG~I~~~EF~~~m~ 107 (109)
T d1pvaa_ 46 VFKAIDADASGFIEEEELKFVLKSFAADGRDLTDAETKAFLKAAD-KDGDGKIGIDEFETLVH 107 (109)
T ss_dssp HHHHHCTTCSSSBCHHHHHTGGGGTCTTCCCCCHHHHHHHHHHHC-TTCSSSBCHHHHHHHHH
T ss_pred HhhCccCCCcCeEcHHHHHHHHHHhhhcCCCCCHHHHHHHHHHHC-CCCcCcEeHHHHHHHHH
Confidence 49999999999999999864 46789999999999 89999999999997553
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.79 E-value=6.4e-06 Score=83.17 Aligned_cols=84 Identities=18% Similarity=0.133 Sum_probs=47.7
Q ss_pred eeEEcccCceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCC-C--CceeeEeeeeecCCcee
Q 009364 71 GELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS-H--PNIVRYLGTVREEESLN 147 (536)
Q Consensus 71 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~-H--pnIv~l~~~~~~~~~~~ 147 (536)
.+.||.|....||++.+..+|+.+++|.-......... .......+...|...|+.+. + ..+++++.+ +....+
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~-~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~ 107 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGE-SWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 107 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--C-CCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCC-CCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCE
Confidence 45689999999999988777889999975321110000 00001223445777776552 2 345555543 455678
Q ss_pred EEEEecCCCC
Q 009364 148 ILLEFVPGGS 157 (536)
Q Consensus 148 lV~E~~~gg~ 157 (536)
+|||++.+..
T Consensus 108 lvmE~L~~~~ 117 (392)
T d2pula1 108 TVMEDLSHLK 117 (392)
T ss_dssp EEECCCTTSE
T ss_pred EEEeccCCcc
Confidence 9999997654
|
| >d1qx2a_ a.39.1.1 (A:) Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calbindin D9K domain: Calbindin D9K species: Cow (Bos taurus) [TaxId: 9913]
Probab=97.78 E-value=1.5e-06 Score=66.53 Aligned_cols=51 Identities=8% Similarity=-0.014 Sum_probs=41.9
Q ss_pred CCCCcccc--CCCccchhhhhh--------h--hhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 369 SPGSVDIC--NLDSLSCSRVIV--------E--KLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 369 sf~~~D~~--~~g~ls~~el~~--------~--~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
.|..||.+ +.|.|+..||+. . +..+++.+++.+| .|++|.|+|+||+.++.
T Consensus 10 ~F~~fd~~~~~~G~I~~~El~~~l~~lg~~~~~~~~ei~~~~~~~D-~d~dG~I~f~EF~~~m~ 72 (76)
T d1qx2a_ 10 AFEVFAAKEGDPNQISKEELKLVMQTLGPSLLKGMSTLDEMIEEVD-KNGDGEVSFEEFLVMMK 72 (76)
T ss_dssp HHHHHHTSSSCTTSEEHHHHHHHHHHHGGGSCTTSCSHHHHHHHHC-TTCSSEECHHHHHHHHH
T ss_pred HHHHHcccCCCCCEECHHHHHHHHHHhCCcCCCCHHHHHHHHHHhh-cCCCCcCcHHHHHHHHH
Confidence 47777554 579999999986 2 3458999999999 89999999999997654
|
| >d1c07a_ a.39.1.6 (A:) Eps15 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.76 E-value=2.1e-06 Score=68.70 Aligned_cols=50 Identities=16% Similarity=0.001 Sum_probs=45.4
Q ss_pred CCCCccccCCCccchhhhhh------hhhhhhhhhhhccCCCCCCCccchhhhhhhc
Q 009364 369 SPGSVDICNLDSLSCSRVIV------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGD 419 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~ 419 (536)
.|..+|.+++|.|+.+|+.. .+.++++++|+.+| .|++|.|+|+||+.++
T Consensus 15 ~F~~~D~d~~G~is~~e~~~~l~~~~l~~~~l~~i~~~~D-~d~dG~l~~~EF~~am 70 (95)
T d1c07a_ 15 IFLKTDKDMDGFVSGLEVREIFLKTGLPSTLLAHIWSLCD-TKDCGKLSKDQFALAF 70 (95)
T ss_dssp HHHHHCTTCSSEECHHHHHHHHHTTTCCHHHHHHHHHHHC-TTCSSSEETTTHHHHH
T ss_pred HHHHHCCCCCCCCcHHHHHHHHHhcCCCHHHHHHHHHHhC-CCCCCeEcHHHHHHHH
Confidence 48899999999999999986 46789999999999 8999999999999765
|
| >d1yuta1 a.39.1.2 (A:1-98) Calcyclin (S100) {Human (Homo sapiens), s100a13 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a13 [TaxId: 9606]
Probab=97.73 E-value=1.5e-06 Score=70.11 Aligned_cols=53 Identities=11% Similarity=-0.015 Sum_probs=43.5
Q ss_pred CCCCc-cccC-CCccchhhhhh----------hhhhhhhhhhhccCCCCCCCccchhhhhhhcccc
Q 009364 369 SPGSV-DICN-LDSLSCSRVIV----------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKL 422 (536)
Q Consensus 369 sf~~~-D~~~-~g~ls~~el~~----------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~ 422 (536)
.|..| |.++ .|.|+..||+. .+.++++.+++.+| .|+||.|||+||+.++...
T Consensus 19 vF~~y~d~dg~~g~is~~El~~~l~~~~~~~~~~~~~v~~l~~~~D-~d~DG~IdF~EF~~l~~~l 83 (98)
T d1yuta1 19 TFFTFARQEGRKDSLSVNEFKELVTQQLPHLLKDVGSLDEKMKSLD-VNQDSELKFNEYWRLIGEL 83 (98)
T ss_dssp HHHHHHTTSSSSSCBCHHHHHHHHHHHCTTTTCCSSCHHHHHHHHC-TTCCSCBCHHHHHHHHHHH
T ss_pred HHHHHcccCCCCCEEcHHHHHHHHHHhccccCCCHHHHHHHHHHhc-CCCCCcCCHHHHHHHHHHH
Confidence 47666 5665 59999999986 24567999999999 9999999999999776553
|
| >d1rwya_ a.39.1.4 (A:) Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Rat (Rattus rattus) [TaxId: 10117]
Probab=97.72 E-value=2.5e-06 Score=70.13 Aligned_cols=51 Identities=8% Similarity=-0.082 Sum_probs=45.9
Q ss_pred CCCCccccCCCccchhhhhh-----------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 369 SPGSVDICNLDSLSCSRVIV-----------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~-----------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
.|..+|.+++|.|+.+|+.. .+.++++.+++..| .|++|.|+|+||+.++.
T Consensus 46 ~F~~~D~d~~G~I~~~El~~~l~~l~~~~~~~~~~e~~~~~~~~D-~d~dG~i~~~EF~~~m~ 107 (109)
T d1rwya_ 46 VFHILDKDKSGFIEEDELGSILKGFSSDARDLSAKETKTLMAAGD-KDGDGKIGVEEFSTLVA 107 (109)
T ss_dssp HHHHHSTTCSSEECHHHHHTHHHHHCTTCCCCCHHHHHHHHHHHC-TTCSSSEEHHHHHHHHH
T ss_pred HhhcccCCCCCcCcHHHHHHHHHHhccccccCCHHHHHHHHHHhC-CCCCCeEeHHHHHHHHH
Confidence 49999999999999999975 35789999999999 89999999999997654
|
| >d1rroa_ a.39.1.4 (A:) Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Oncomodulin species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=97.69 E-value=3.1e-06 Score=69.44 Aligned_cols=51 Identities=12% Similarity=-0.037 Sum_probs=45.6
Q ss_pred CCCCCccccCCCccchhhhhh-----------hhhhhhhhhhhccCCCCCCCccchhhhhhhc
Q 009364 368 GSPGSVDICNLDSLSCSRVIV-----------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGD 419 (536)
Q Consensus 368 ~sf~~~D~~~~g~ls~~el~~-----------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~ 419 (536)
..|..+|.+++|.|+..|++. .+.++++.+++.+| .|++|.|+|+||+.++
T Consensus 45 ~~F~~~D~d~~G~I~~~El~~~l~~l~~~~~~l~~~~~~~~~~~~D-~d~dG~I~~~EF~~~m 106 (108)
T d1rroa_ 45 DIFRFIDNDQSGYLDGDELKYFLQKFQSDARELTESETKSLMDAAD-NDGDGKIGADEFQEMV 106 (108)
T ss_dssp HHHHHHCTTCSSEECTHHHHTGGGGTCTTSCCCCHHHHHHHHHHHC-CSSSSSEEHHHHHHHH
T ss_pred HHHhhhcCCCCCeEcHHHHHHHHHHHHhccCCCCHHHHHHHHHHhC-CCCCCeEeHHHHHHHH
Confidence 359999999999999999875 35789999999999 8999999999999754
|
| >d1cb1a_ a.39.1.1 (A:) Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calbindin D9K domain: Calbindin D9K species: Pig (Sus scrofa) [TaxId: 9823]
Probab=97.66 E-value=2.1e-06 Score=66.05 Aligned_cols=52 Identities=10% Similarity=-0.045 Sum_probs=42.8
Q ss_pred CCCCccc--cCCCccchhhhhh----------hhhhhhhhhhhccCCCCCCCccchhhhhhhccc
Q 009364 369 SPGSVDI--CNLDSLSCSRVIV----------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRK 421 (536)
Q Consensus 369 sf~~~D~--~~~g~ls~~el~~----------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~ 421 (536)
+|..||. ++.|+|+..||+. .+.++++.+++.+| .|+||.|||+||+.++..
T Consensus 12 ~F~~y~~~d~~~g~is~~Elk~ll~~~~~~~~~~~~~v~~~~~~~D-~d~dG~Idf~EF~~l~~~ 75 (78)
T d1cb1a_ 12 IFEKYAAKEGDPNQLSKEELKQLIQAEFPSLLKGPRTLDDLFQELD-KNGDGEVSFEEFQVLVKK 75 (78)
T ss_dssp HHHHHHTTSSSTTEECHHHHHHHHHHHCSSCCSSCCCSSHHHHHTC-CCSSSSEEHHHHHHHHHH
T ss_pred HHHHHccCCCCCCEECHHHHHHHHHHHcCCCCCCHHHHHHHHHHHc-CCCCCcCcHHHHHHHHHH
Confidence 4777764 4568999999986 24668999999999 999999999999976543
|
| >d1wlza1 a.39.1.7 (A:229-311) DJ-1-binding protein, DJBP {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: DJ-1-binding protein, DJBP species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.65 E-value=5.8e-06 Score=64.20 Aligned_cols=51 Identities=12% Similarity=0.060 Sum_probs=46.3
Q ss_pred CCCCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhh
Q 009364 367 PGSPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAG 418 (536)
Q Consensus 367 ~~sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~ 418 (536)
...|..+|.+++|.|+..|+.. .+++|++.+++.+| .|++|.|+|.||+.+
T Consensus 23 ~~~F~~~D~~~~G~i~~~ef~~~l~~~~~~l~~~e~~~l~~~~d-~~~~g~I~y~eFl~~ 81 (83)
T d1wlza1 23 TQEFENFDTMKTNTISREEFRAICNRRVQILTDEQFDRLWNEMP-VNAKGRLKYPDFLSR 81 (83)
T ss_dssp HHHHHHHCTTCSSCBCHHHHHHHHHHHTCCCCHHHHHHHHTTSC-BCTTSCBCHHHHHHH
T ss_pred HHHHHHHCCCCCceEChhHHHHHHHHhCCCCChhHHHHHhhccc-cCCCCcEeHHHHHHH
Confidence 3459999999999999999986 58999999999999 899999999999964
|
| >d2pvba_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Pike (Esox lucius) [TaxId: 8010]
Probab=97.63 E-value=5.4e-06 Score=67.82 Aligned_cols=50 Identities=8% Similarity=-0.059 Sum_probs=45.1
Q ss_pred CCCCccccCCCccchhhhhh-----------hhhhhhhhhhhccCCCCCCCccchhhhhhhc
Q 009364 369 SPGSVDICNLDSLSCSRVIV-----------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGD 419 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~-----------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~ 419 (536)
.|..+|.+++|.|+..|+.. .+.++++.+++.+| .|++|.|+|+||+.++
T Consensus 45 ~F~~~D~d~~G~I~~~el~~~l~~l~~~~~~~~~~~~~~l~~~~D-~d~dG~I~~~EF~~~m 105 (107)
T d2pvba_ 45 AFYVIDQDKSGFIEEDELKLFLQNFSPSARALTDAETKAFLADGD-KDGDGMIGVDEFAAMI 105 (107)
T ss_dssp HHHHHCTTCSSSBCHHHHHTGGGGTCTTSCCCCHHHHHHHHHHHC-TTCSSSBCHHHHHHHH
T ss_pred HHHhhccCCCCcCcHHHHHHHHHHhhcccccCCHHHHHHHHHHhC-CCCCCcEeHHHHHHHH
Confidence 59999999999999999975 36789999999999 8999999999999654
|
| >d1snla_ a.39.1.7 (A:) Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Nucleobindin 1 (CALNUC) species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.49 E-value=1.1e-05 Score=64.89 Aligned_cols=51 Identities=18% Similarity=0.071 Sum_probs=43.1
Q ss_pred CCCCccccCCCccchhhhhh------------------------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 369 SPGSVDICNLDSLSCSRVIV------------------------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~------------------------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
.|..+|.+++|.|+..||.. .....++.+++.+| .|+||.|+|+||+.++.
T Consensus 21 ~F~~~D~DgdG~i~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~~~~~D-~d~DG~Is~~EF~~~~~ 95 (99)
T d1snla_ 21 FFILHDINSDGVLDEQELEALFTKELEKVYDPKNEEDDMREMEEERLRMREHVMKNVD-TNQDRLVTLEEFLASTQ 95 (99)
T ss_dssp HHHHHCSSCCSEEEHHHHHHHHHHHHHTTSCCSSCSSHHHHTTHHHHHHHHHHHHHTC-SSCSSEEEHHHHHHHHH
T ss_pred HHHHHCCCCCCcCCHHHHHHHHHHHHHhcchhhhhhhhhhhhHHHHHHHHHHHHHHcC-CCCCCcCcHHHHHHHHh
Confidence 49999999999999999975 12345788999999 99999999999997643
|
| >d1a4pa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]
Probab=97.46 E-value=9.3e-06 Score=64.42 Aligned_cols=53 Identities=6% Similarity=-0.234 Sum_probs=44.1
Q ss_pred CCCCCCccccCCCccchhhhhh-------------hhhhhhhhhhhccCCCCCCCccchhhhhhhccc
Q 009364 367 PGSPGSVDICNLDSLSCSRVIV-------------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRK 421 (536)
Q Consensus 367 ~~sf~~~D~~~~g~ls~~el~~-------------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~ 421 (536)
...|..+|.+ +|.|+.+||.. .+.+.++.+++.+| .|+||.|+|+||+.++..
T Consensus 12 ~~~F~~yd~d-dG~is~~El~~~l~~~~~~~~~~~~~~~~v~~~~~~~D-~n~DG~I~F~EF~~li~~ 77 (92)
T d1a4pa_ 12 MFTFHKFAGD-KGYLTKEDLRVLMEKEFPGFLENQKDPLAVDKIMKDLD-QCRDGKVGFQSFFSLIAG 77 (92)
T ss_dssp HHHHHHHHGG-GCSBCHHHHHHHHHHHCHHHHHHSCCTTHHHHHHHHHC-TTSSSCBCHHHHHHHHHH
T ss_pred HHHHHHHcCC-CCEEcHHHHHHHHHHhccccccccCCHHHHHHHHHHHh-CCCCCCCcHHHHHHHHHH
Confidence 3348888877 79999999986 14568999999999 999999999999866543
|
| >d1zfsa1 a.39.1.2 (A:1-93) Calcyclin (S100) {Rat (Rattus norvegicus), s100a1 [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Rat (Rattus norvegicus), s100a1 [TaxId: 10116]
Probab=97.45 E-value=1.2e-05 Score=63.98 Aligned_cols=52 Identities=10% Similarity=-0.096 Sum_probs=43.0
Q ss_pred CCCCc-cccC-CCccchhhhhh-------------hhhhhhhhhhhccCCCCCCCccchhhhhhhccc
Q 009364 369 SPGSV-DICN-LDSLSCSRVIV-------------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRK 421 (536)
Q Consensus 369 sf~~~-D~~~-~g~ls~~el~~-------------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~ 421 (536)
.|..+ |.++ .|.|+.+||+. .+.++++.+|+.+| .|++|.|+|+||+.++..
T Consensus 14 ~F~~y~d~dg~~G~is~~El~~~L~~~~~~~~~~~~~~~~~~~~~~~~D-~d~dG~Idf~EF~~lm~~ 80 (93)
T d1zfsa1 14 VFHAHSGKEGDKYKLSKKELKDLLQTELSSFLDVQKDADAVDKIMKELD-ENGDGEVDFQEFVVLVAA 80 (93)
T ss_dssp HHHHHGGGSSCCSSEEHHHHHHHHHHHSTTTSCCSSCHHHHHHHHHHHT-TTCCSEECSHHHHHHHHH
T ss_pred HHHHHcccCCCCCEecHHHHHHHHHHhcccccccCCCHHHHHHHHHHHc-CCCCCCCcHHHHHHHHHH
Confidence 36665 7775 48999999976 25788999999999 999999999999976643
|
| >d1qjta_ a.39.1.6 (A:) Eps15 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=97.42 E-value=1.3e-05 Score=64.40 Aligned_cols=51 Identities=14% Similarity=0.038 Sum_probs=45.9
Q ss_pred CCCCccccCCCccchhhhhh------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 369 SPGSVDICNLDSLSCSRVIV------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
.|..+|.+++|.|+.+|+.. .+.+++.+||+..| .|++|.|+++||+.++.
T Consensus 16 ~F~~~D~d~~G~i~~~e~~~~l~~s~L~~~~L~~i~~~~D-~d~dG~L~~~EF~~am~ 72 (99)
T d1qjta_ 16 YYRQVEAGNTGRVLALDAAAFLKKSGLPDLILGKIWDLAD-TDGKGVLSKQEFFVALR 72 (99)
T ss_dssp HHHHHCCTTSSCCCSHHHHHHHHTSSSCHHHHHHHHHHHC-CSSSSSCCSHHHHHHHH
T ss_pred HHHHHCCCCCCcccHHHHHHHHHHcCCcHHHHHHHHHHHc-CCCCCccCHHHHHHHHH
Confidence 48889999999999999987 56889999999999 89999999999996653
|
| >d2jxca1 a.39.1.6 (A:121-215) Eps15 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.40 E-value=1.3e-05 Score=63.90 Aligned_cols=49 Identities=20% Similarity=0.084 Sum_probs=43.1
Q ss_pred CCCCccccCCCccchhhhhh------hhhhhhhhhhhccCCCCCCCccchhhhhhhc
Q 009364 369 SPGSVDICNLDSLSCSRVIV------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGD 419 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~ 419 (536)
.|..+| +++|.|+..|+.. .+.+++++||+.+| .|++|.|+++||+.++
T Consensus 15 ~F~~~D-~~~G~i~~~el~~~l~~~gl~~~~L~~Iw~~~D-~~~dG~l~~~EF~~a~ 69 (95)
T d2jxca1 15 IFDSLS-PVNGFLSGDKVKPVLLNSKLPVDILGRVWELSD-IDHDGMLDRDEFAVAM 69 (95)
T ss_dssp HHHHTC-CBTTEEEHHHHHHHHTTSSCCHHHHHHHHHHHC-TTCSSEEEHHHHHHHH
T ss_pred HHHHhC-CCCCceeHHHHHHHHHHcCCCHHHHHHHHHHhc-CCCCCeEcHHHHHHHH
Confidence 388889 7889999999987 46789999999999 8999999999998654
|
| >d1k8ua_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100a6 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a6 [TaxId: 9606]
Probab=97.36 E-value=1.1e-05 Score=63.60 Aligned_cols=52 Identities=6% Similarity=-0.155 Sum_probs=43.2
Q ss_pred CCCCc-cccCCC-ccchhhhhh-----------hhhhhhhhhhhccCCCCCCCccchhhhhhhccc
Q 009364 369 SPGSV-DICNLD-SLSCSRVIV-----------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRK 421 (536)
Q Consensus 369 sf~~~-D~~~~g-~ls~~el~~-----------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~ 421 (536)
.|..+ |+++++ +|+..|++. .+.++++.+++.+| .|+||.|||+||+.++..
T Consensus 14 vF~kya~~dg~~~~ls~~Elk~Ll~~e~~~~~~~~~~~~~~~~~~lD-~d~Dg~IdF~EF~~l~~~ 78 (89)
T d1k8ua_ 14 IFHKYSGREGDKHTLSKKELKELIQKELTIGSKLQDAEIARLMEDLD-RNKDQEVNFQEYVTFLGA 78 (89)
T ss_dssp HHHHHHTSSSCTTEEEHHHHHHHHHHHSCCGGGTTSHHHHHHHHHHH-HTTTCEEEHHHHHHHHHH
T ss_pred HHHHHcccCCCCCeecHHHHHHHHHHHHHhhccCCHHHHHHHHHHhc-CCCCCCCcHHHHHHHHHH
Confidence 36666 788888 799999876 35788999999999 999999999999976543
|
| >d1iq3a_ a.39.1.6 (A:) Pob1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Pob1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.34 E-value=1.4e-05 Score=65.51 Aligned_cols=51 Identities=18% Similarity=-0.006 Sum_probs=45.6
Q ss_pred CCCCccccCCCccchhhhhh------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 369 SPGSVDICNLDSLSCSRVIV------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
.|..+|.+++|.|+.+|+.. .+.+++++||+.+| .|++|.|+++||+.++.
T Consensus 27 lF~~~D~d~~G~Is~~e~~~~l~~s~L~~~~L~~Iw~l~D-~d~dG~l~~~EF~~am~ 83 (110)
T d1iq3a_ 27 QFRSLQPDPSSFISGSVAKNFFTKSKLSIPELSYIWELSD-ADCDGALTLPEFCAAFH 83 (110)
T ss_dssp HHHHHCCSSSSEEEHHHHHHHCCSSSCSSCCHHHHHHHHC-SSSCSEEEHHHHHHHHH
T ss_pred HHHHhCCCcccchhHHHHHHHHHhhccchHHHHHHHHHhc-cCCCCeECHHHHHHHHH
Confidence 38889999999999999987 56789999999999 89999999999996553
|
| >d1jfja_ a.39.1.5 (A:) EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: 5759]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: EHCABP species: Entamoeba (Entamoeba histolytica) [TaxId: 5759]
Probab=97.32 E-value=2.2e-05 Score=65.78 Aligned_cols=68 Identities=12% Similarity=0.000 Sum_probs=53.8
Q ss_pred CCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhccccccc---CChhhhhhccCC
Q 009364 369 SPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSSI---LAPNDLEKSRNP 437 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~~---~~~e~l~~aF~~ 437 (536)
.|..+|.+++|.|+..|+.. .+.++++.+++..| .+++|.|+|+||+.++...... ...+.++.+|+-
T Consensus 5 ~F~~~D~d~dG~is~~E~~~~l~~~~~~~~~~~~~~~~~~~D-~~~~g~i~~~Ef~~~~~~~~~~~~~~~~~~~~~~F~~ 83 (134)
T d1jfja_ 5 LFKEIDVNGDGAVSYEEVKAFVSKKRAIKNEQLLQLIFKSID-ADGNGEIDQNEFAKFYGSIQGQDLSDDKIGLKVLYKL 83 (134)
T ss_dssp HHHHHCTTCSSEEEHHHHHHHHHTTCCSSHHHHHHHHHHHHC-SSCCSEEEHHHHHHHTTCSSCCSSHHHHHHHHHHHHH
T ss_pred HHHHHcCCCcCCCcHHHHHHHHHHcCCCCCHHHHHHHHHHhh-hcccccccccccccccccccccccccccccccccccc
Confidence 37889999999999999976 46789999999999 8999999999999766543321 223456777764
|
| >d1xk4a1 a.39.1.2 (A:1-87) Calcyclin (S100) {Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]
Probab=97.31 E-value=2.8e-05 Score=60.84 Aligned_cols=51 Identities=6% Similarity=-0.159 Sum_probs=41.8
Q ss_pred CCCCc-cccCCCc-cchhhhhh---------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 369 SPGSV-DICNLDS-LSCSRVIV---------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 369 sf~~~-D~~~~g~-ls~~el~~---------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
.|..+ |.+++|. ++..||+. .+..+++.+++++| .|+||.|||+||+.++.
T Consensus 15 ~F~kya~~dG~~~~l~~~Elk~ll~~e~~~~~~~~~v~~i~~~~D-~n~DG~IdF~EF~~l~~ 76 (87)
T d1xk4a1 15 VYHKYSLIKGNFHAVYRDDLKKLLETESPQYIRKKGADVWFKELD-INTDGAVNFQEFLILVI 76 (87)
T ss_dssp HHHHHHTSSSCTTCBCHHHHHHHHHHHSCHHHHTTCHHHHHHHHC-TTCSSSBCHHHHHHHHH
T ss_pred HHHHHcccCCCCCccCHHHHHHHHHHhcCCccchHHHHHHHHHhC-CCCCCcCcHHHHHHHHH
Confidence 36555 7788874 58888875 46789999999999 99999999999997654
|
| >d1ksoa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100a3 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a3 [TaxId: 9606]
Probab=97.29 E-value=1.6e-05 Score=63.16 Aligned_cols=51 Identities=10% Similarity=0.036 Sum_probs=42.7
Q ss_pred CCCc-cccCCC-ccchhhhhh-------------hhhhhhhhhhhccCCCCCCCccchhhhhhhccc
Q 009364 370 PGSV-DICNLD-SLSCSRVIV-------------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRK 421 (536)
Q Consensus 370 f~~~-D~~~~g-~ls~~el~~-------------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~ 421 (536)
|..+ |.+++| +|+..||+. .+.+++..+++.+| .|+||.|||+||+.++..
T Consensus 15 F~kya~~dGd~~~ls~~Elk~ll~~~~~~~~~~~~~~~~~~~~~~~lD-~n~Dg~IdF~EF~~l~~~ 80 (93)
T d1ksoa_ 15 FQEYAGRCGDKYKLCQAELKELLQKELATWTPTEFRECDYNKFMSVLD-TNKDCEVDFVEYVRSLAC 80 (93)
T ss_dssp HHHHHTSSSCTTCEEHHHHHHHHHHHTTTCCCCTTCHHHHHHHHHHHH-HTTTCEECHHHHHHHHHH
T ss_pred HHHHcCcCCCCCeECHHHHHHHHHHhhhcccccCCCHHHHHHHHHHHc-CCCCCCCcHHHHHHHHHH
Confidence 6555 788888 699999986 24678999999999 999999999999965543
|
| >d1m45a_ a.39.1.5 (A:) Myosin Light Chain Mlc1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Light Chain Mlc1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=97.28 E-value=3.1e-05 Score=66.32 Aligned_cols=51 Identities=10% Similarity=-0.053 Sum_probs=46.1
Q ss_pred CCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 369 SPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
+|..+|.+++|.|+.+||.. .+.+++..++..+| .|++|.|+|+||+.+++
T Consensus 86 ~F~~~D~~~~G~I~~~el~~~l~~~g~~l~~~ei~~l~~~~D-~d~dG~I~y~eF~~~i~ 144 (146)
T d1m45a_ 86 AFQVFDKESTGKVSVGDLRYMLTGLGEKLTDAEVDELLKGVE-VDSNGEIDYKKFIEDVL 144 (146)
T ss_dssp HHHTTCSSSSSEEEHHHHHHHHHHSTTCCCHHHHHHHHTTCC-CCTTSEEEHHHHHHHHH
T ss_pred HHHhhccccccccchhhhhhhhcccCCcchHHHHHHHHHHhC-CCCCCcEEHHHHHHHHH
Confidence 49999999999999999986 56889999999999 89999999999996554
|
| >d1psra_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]
Probab=97.26 E-value=3.1e-05 Score=62.27 Aligned_cols=50 Identities=6% Similarity=0.011 Sum_probs=41.2
Q ss_pred CCCccccCCCccchhhhhh---------------hhhhhhhhhhhccCCCCCCCccchhhhhhhccc
Q 009364 370 PGSVDICNLDSLSCSRVIV---------------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRK 421 (536)
Q Consensus 370 f~~~D~~~~g~ls~~el~~---------------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~ 421 (536)
|..++ +++|.|+..||+. .+..+++.+|+.+| .|+||.|+|+||+.++..
T Consensus 16 F~~y~-~~dG~i~~~El~~ll~~~~~~~~~~~~~~~~~~v~~~~~~~D-~n~DG~I~F~EF~~li~~ 80 (100)
T d1psra_ 16 FHKYT-RRDDKIDKPSLLTMMKENFPNFLSACDKKGTNYLADVFEKKD-KNEDKKIDFSEFLSLLGD 80 (100)
T ss_dssp HHHTC-CTTSCBCHHHHHHHHHHHCHHHHHHHHHTTCCGGGTHHHHHC-TTCSSCBCHHHHHHHHHH
T ss_pred HHHHc-CCCCcccHHHHHHHHHHHccccccccccCCHHHHHHHHHHhc-CCCCCcCcHHHHHHHHHH
Confidence 66665 6789999999976 13457999999999 999999999999976654
|
| >d3c1va1 a.39.1.2 (A:2-94) Calcyclin (S100) {Human (Homo sapiens), s100a4 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a4 [TaxId: 9606]
Probab=97.19 E-value=3.4e-05 Score=61.21 Aligned_cols=53 Identities=6% Similarity=-0.140 Sum_probs=42.1
Q ss_pred CCCCCc-cccC-CCccchhhhhh-------------hhhhhhhhhhhccCCCCCCCccchhhhhhhccc
Q 009364 368 GSPGSV-DICN-LDSLSCSRVIV-------------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRK 421 (536)
Q Consensus 368 ~sf~~~-D~~~-~g~ls~~el~~-------------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~ 421 (536)
..|..| |.++ .|.|+.+||+. .+.++++.+++..| .|+||.|+|+||+.++..
T Consensus 13 ~~F~~ya~~dg~~~~L~~~Elk~~l~~~~~~~~~~~~~~~~~~~i~~~~D-~n~DG~I~F~EF~~lm~~ 80 (93)
T d3c1va1 13 STFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLD-SNRDNEVDFQEYCVFLSC 80 (93)
T ss_dssp HHHHHHHTSSSSTTEECHHHHHHHHHHHCHHHHTTCCSHHHHHHHHHHHC-TTCSSSEEHHHHHHHHHH
T ss_pred HHHHHHccCCCCCCeeCHHHHHHHHHHhchhccccCCCHHHHHHHHHHHc-CCCCCCCCHHHHHHHHHH
Confidence 347766 4554 45799999976 25788999999999 999999999999975543
|
| >d1dtla_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.13 E-value=3.8e-05 Score=66.51 Aligned_cols=50 Identities=6% Similarity=-0.054 Sum_probs=46.1
Q ss_pred CCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhc
Q 009364 369 SPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGD 419 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~ 419 (536)
.|..+|.+++|.|+..|+.. .+.++++.+++..| .|++|.|+|+||+.++
T Consensus 96 ~F~~~D~d~~G~I~~~e~~~~~~~~~~~ls~~e~~~i~~~~D-~d~dG~I~~~eF~~~l 153 (156)
T d1dtla_ 96 LFRMFDKNADGYIDLEELKIMLQATGETITEDDIEELMKDGD-KNNDGRIDYDEFLEFM 153 (156)
T ss_dssp HHHHHCTTCSSEEEHHHHGGGGTTC--CCCHHHHHHHHHHHC-TTSSSEEEHHHHHHHH
T ss_pred HHHHhCcCCCCcCcHHHHHHHHhhcCCCCCHHHHHHHHHHhC-CCCCCeEeHHHHHHHH
Confidence 49999999999999999986 57899999999999 8999999999999755
|
| >d1s6ia_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-dependent protein kinase sk5 CLD species: Soybean (Glycine max) [TaxId: 3847]
Probab=97.10 E-value=3e-05 Score=69.29 Aligned_cols=72 Identities=13% Similarity=0.039 Sum_probs=58.0
Q ss_pred CCCCCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcccccccCChhhhhhccCC
Q 009364 366 SPGSPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSSILAPNDLEKSRNP 437 (536)
Q Consensus 366 ~~~sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~~~~~e~l~~aF~~ 437 (536)
....|..+|.+++|.|+.+|+.. ++..+++.+++..| .+++|.|+|++|+.+..........+.++.+|+-
T Consensus 12 l~~~F~~~D~d~dG~Is~~e~~~~l~~l~~~~~~~~~~~~~~~~d-~~~~g~i~~~ef~~~~~~~~~~~~~e~l~~aF~~ 90 (182)
T d1s6ia_ 12 LKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAAD-IDKSGTIDYGEFIAATVHLNKLEREENLVSAFSY 90 (182)
T ss_dssp HHHHHHTTSSSSSSCEEHHHHHHHHTTTTCCCCHHHHHHHHHHTC-TTCSSEECHHHHHHHHTTSSSSCCCCSTHHHHHH
T ss_pred HHHHHHHHcCCCcCCCCHHHHHHHHHHcCCccccccchhhhhhhh-ccccccchHHHHHHHHHhhcccccHHHHHHHHHH
Confidence 34469999999999999999975 57889999999999 8999999999999766655555555667777654
Q ss_pred C
Q 009364 438 M 438 (536)
Q Consensus 438 ~ 438 (536)
.
T Consensus 91 ~ 91 (182)
T d1s6ia_ 91 F 91 (182)
T ss_dssp T
T ss_pred H
Confidence 3
|
| >d1ggwa_ a.39.1.5 (A:) Cdc4p {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Cdc4p species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=97.08 E-value=7.1e-05 Score=63.69 Aligned_cols=50 Identities=8% Similarity=-0.178 Sum_probs=44.4
Q ss_pred CCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 369 SPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
+|..+|.+++|.|+.+||.. .+.+|++.+++.+| .+ +|.|+|+||+..++
T Consensus 81 aF~~~D~d~~G~I~~~el~~~l~~~g~~lt~~e~~~l~~~~d-~~-dG~I~y~eF~~~m~ 138 (140)
T d1ggwa_ 81 GFQVFDKDATGMIGVGELRYVLTSLGEKLSNEEMDELLKGVP-VK-DGMVNYHDFVQMIL 138 (140)
T ss_dssp HHHTTCSSCSSCCCHHHHHHHHHHHHSCSCHHHHHHHHHHTT-CS-SCCSTTTHHHHHHH
T ss_pred HHHHHhccCCCcchHHHHHHHHHHcCCCCCHHHHHHHHHhhC-CC-CCEEeHHHHHHHHh
Confidence 49999999999999999986 57899999999999 66 79999999996543
|
| >d2mysc_ a.39.1.5 (C:) Myosin Regulatory Chain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Regulatory Chain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.06 E-value=7.4e-05 Score=63.73 Aligned_cols=52 Identities=10% Similarity=-0.109 Sum_probs=44.9
Q ss_pred CCCCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 367 PGSPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 367 ~~sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
..+|..+|.+++|.|+.+|+.. .+.+|++.+++. + .|++|.|+|+||+.+++
T Consensus 84 ~~aF~~~D~d~~G~I~~~el~~~l~~~g~~~~~~e~~~l~~~-~-~d~dG~I~y~eF~~~ll 143 (145)
T d2mysc_ 84 VEGLRVFDKEGNGTVMGAELRHVLATLGEKMTEEEVEELMKG-Q-EDSNGCINYEAFVKHIM 143 (145)
T ss_pred HHHHHHhhcCCCCEEcHHHHHHHHHHhCCCCCHHHHHHHHhh-c-CCCCCeEEHHHHHHHHh
Confidence 4469999999999999999976 578999999975 6 68999999999996543
|
| >d1lkja_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=97.06 E-value=4.9e-05 Score=65.01 Aligned_cols=50 Identities=10% Similarity=-0.078 Sum_probs=44.5
Q ss_pred CCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 369 SPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
+|..+|.+++|.|+.+||.. .+.++++.+++..| |++|.|+|+||+.++.
T Consensus 88 aF~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d--d~dG~I~~~eF~~~m~ 145 (146)
T d1lkja_ 88 AFKVFDKNGDGLISAAELKHVLTSIGEKLTDAEVDDMLREVS--DGSGEINIQQFAALLS 145 (146)
T ss_dssp HHHHHCSSSSCEEEHHHHHHHHHHHTCSCCHHHHHHHHHHHC--CSSSEEEHHHHHHHHC
T ss_pred HHHHhCCCCCCcCcHHHHHHHHHHcCCcccHHHHHHHHHhcc--CCCCeEeHHHHHHHhC
Confidence 49999999999999999976 57889999999988 7889999999997653
|
| >d1qv0a_ a.39.1.5 (A:) Calcium-regulated photoprotein {Hydrozoa (Obelia longissima), obelin [TaxId: 32570]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-regulated photoprotein species: Hydrozoa (Obelia longissima), obelin [TaxId: 32570]
Probab=97.03 E-value=5.8e-05 Score=67.31 Aligned_cols=51 Identities=8% Similarity=0.019 Sum_probs=42.0
Q ss_pred CCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 369 SPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
.|..+|.+++|.|+.+|+.. .+.++++.+|+.+| .|++|.|+|+||+.++.
T Consensus 112 ~F~~~D~d~~G~is~~E~~~~l~~~g~~~~~~~~~~lf~~~D-~d~dG~Is~~EF~~~~~ 170 (189)
T d1qv0a_ 112 VFDIFDKDGSGTITLDEWKAYGKISGISPSQEDCEATFRHCD-LDNAGDLDVDEMTRQHL 170 (189)
T ss_dssp HHHHTC----CEECHHHHHHHHHHHSSCCCHHHHHHHHHHSC-CCTTSCEEHHHHHHHHH
T ss_pred HHHHHccCCCCcccchhhHHHHHhcCCCCCHHHHHHHHHHhC-CCCCCcEeHHHHHHHHH
Confidence 48999999999999999976 57889999999999 89999999999996554
|
| >d1wdcb_ a.39.1.5 (B:) Myosin Essential Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Bay scallop (Aequipecten irradians) [TaxId: 31199]
Probab=96.98 E-value=6.9e-05 Score=63.88 Aligned_cols=50 Identities=10% Similarity=-0.053 Sum_probs=44.4
Q ss_pred CCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 369 SPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
+|..+|.+++|.|+..||.. .+.+|++.+++..| .| +|.|+|+||+.++.
T Consensus 81 aF~~~D~d~~G~I~~~el~~~l~~~g~~lt~~e~~~l~~~~d-~~-~G~I~y~eF~~~l~ 138 (142)
T d1wdcb_ 81 AFAMFDEQETKKLNIEYIKDLLENMGDNFNKDEMRMTFKEAP-VE-GGKFDYVKFTAMIK 138 (142)
T ss_dssp HHHTTCTTCCSCEEHHHHHHHHHHSSSCCCHHHHHHHHHHCC-EE-TTEECHHHHHHHHH
T ss_pred hhhhhcccCCCcccHHHHHHHHHHccccCCHHHHHHHHHHhC-CC-CCEEcHHHHHHHHh
Confidence 49999999999999999986 57899999999999 66 58999999997654
|
| >d1exra_ a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetraurelia) [TaxId: 5888]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Ciliate (Paramecium tetraurelia) [TaxId: 5888]
Probab=96.95 E-value=7.9e-05 Score=63.46 Aligned_cols=50 Identities=12% Similarity=-0.067 Sum_probs=45.6
Q ss_pred CCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhc
Q 009364 369 SPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGD 419 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~ 419 (536)
+|..+|.+++|.|+..|+.. .+.+++..+++.+| .|++|.|+|+||+..+
T Consensus 87 ~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~i~~~~D-~d~dG~i~~~eF~~~l 144 (146)
T d1exra_ 87 AFKVFDRDGNGLISAAELRHVMTNLGEKLTDDEVDEMIREAD-IDGDGHINYEEFVRMM 144 (146)
T ss_dssp HHHHHSTTCSSCBCHHHHHHHHHHTTCCCCHHHHHHHHHHHC-SSSSSSBCHHHHHHHH
T ss_pred HHHHhCCCCCCcCCHHHHHHHHHHHhhcCCHHHHHHHHHHhC-CCCCCeEeHHHHHHHh
Confidence 59999999999999999986 57889999999999 8999999999999654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.94 E-value=0.00038 Score=67.75 Aligned_cols=70 Identities=14% Similarity=0.081 Sum_probs=41.9
Q ss_pred CceEEEEEEEcCCCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCCCCce--eeEe-----eeeecCCceeEEE
Q 009364 78 AFGRVYMGMNLDSGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLSHPNI--VRYL-----GTVREEESLNILL 150 (536)
Q Consensus 78 ~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~HpnI--v~l~-----~~~~~~~~~~lV~ 150 (536)
.--.||++.. .+|+.|++|+.... . ...+++..|...+..|...+| +..+ ..+...+..+.++
T Consensus 34 ~EN~vy~v~~-~dg~~~VlK~~rp~------~---~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~ 103 (325)
T d1zyla1 34 YENRVYQFQD-EDRRRFVVKFYRPE------R---WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVF 103 (325)
T ss_dssp SSSEEEEECC-TTCCCEEEEEECTT------T---SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEE
T ss_pred ccceeEEEEc-CCCCEEEEEEeCCC------C---CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEE
Confidence 3468999864 67889999986211 0 012445677777777642222 1111 1234456688899
Q ss_pred EecCCCC
Q 009364 151 EFVPGGS 157 (536)
Q Consensus 151 E~~~gg~ 157 (536)
+++.|..
T Consensus 104 ~~~~G~~ 110 (325)
T d1zyla1 104 PSVGGRQ 110 (325)
T ss_dssp ECCCCEE
T ss_pred eecCCcC
Confidence 9997753
|
| >d2mysb_ a.39.1.5 (B:) Myosin Essential Chain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.93 E-value=0.00012 Score=62.56 Aligned_cols=53 Identities=13% Similarity=-0.016 Sum_probs=47.7
Q ss_pred CCCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhccc
Q 009364 368 GSPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRK 421 (536)
Q Consensus 368 ~sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~ 421 (536)
.+|..+|.++.|.|+..|+.. .+.+|++.+++..| .|++|.|+|.||+.++..
T Consensus 81 ~aF~~fD~~~~g~I~~~el~~~l~~~g~~ls~~e~~~~~~~~d-~d~dg~I~y~eF~~~l~~ 141 (145)
T d2mysb_ 81 GAFKVLDPDGKGSIKKSFLEELLTTGGGRFTPEEIKNMWAAFP-PDVAGNVDYKNICYVITH 141 (145)
T ss_pred HHHHhhhhcccchhhHHHHHHHHHHcCCCCCHHHHHHHHHHhC-CCCCCeEeHHHHHHHhcc
Confidence 359999999999999999986 57899999999999 899999999999976654
|
| >d1w7jb1 a.39.1.5 (B:11-149) Myosin Essential Chain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.90 E-value=0.00013 Score=61.57 Aligned_cols=50 Identities=8% Similarity=-0.100 Sum_probs=43.5
Q ss_pred CCCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhc
Q 009364 368 GSPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGD 419 (536)
Q Consensus 368 ~sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~ 419 (536)
.+|..+|.+++|.|+.+||+. .+.++++.+++. | .|++|.|+|+||+.++
T Consensus 81 ~aF~~~D~d~~G~I~~~el~~~l~~~g~~~~~~e~~~l~~~-~-~d~dg~I~~~eF~~~l 138 (139)
T d1w7jb1 81 EGFRVFDKEGNGKVMGAELRHVLTTLGEKMTEEEVETVLAG-H-EDSNGCINYEAFLKHI 138 (139)
T ss_dssp HHHHTTCTTSSSEEEHHHHHHHHHHSSSCCCHHHHHHHHTT-C-CCTTSEEEHHHHHHHT
T ss_pred HhhhhccCCCCCeEeHHHHHHHHHHhCCCCCHHHHHHHHhh-C-CCCCCeEeHHHHHHHh
Confidence 359999999999999999976 578899999975 7 7899999999999654
|
| >d1topa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.90 E-value=0.00011 Score=63.88 Aligned_cols=51 Identities=8% Similarity=-0.072 Sum_probs=46.0
Q ss_pred CCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 369 SPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
+|..+|.+++|.|+..|+.. .+.+++..+|+.+| .|++|.|+|+||+..+.
T Consensus 101 aF~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~l~~~~D-~d~dG~Is~~EF~~~l~ 159 (162)
T d1topa_ 101 CFRIFDKNADGFIDIEELGEILRATGEHVTEEDIEDLMKDSD-KNNDGRIDFDEFLKMME 159 (162)
T ss_dssp HHHHHCTTCSSCBCHHHHHHHHHTTTCCCCHHHHHHHHHHHC-TTCSSSBCHHHHHHHHH
T ss_pred HHHHHCCCCCCCCcHHHHHHHHHhhCCCCCHHHHHHHHHHhC-CCCCCcEEHHHHHHHHH
Confidence 49999999999999999986 46789999999999 89999999999997543
|
| >d1nyaa_ a.39.1.5 (A:) Calerythrin {Saccharopolyspora erythraea [TaxId: 1836]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calerythrin species: Saccharopolyspora erythraea [TaxId: 1836]
Probab=96.87 E-value=0.00011 Score=64.17 Aligned_cols=52 Identities=8% Similarity=0.118 Sum_probs=46.6
Q ss_pred CCCCccccCCCccchhhhhh------hhhhhhhhhhhccCCCCCCCccchhhhhhhccc
Q 009364 369 SPGSVDICNLDSLSCSRVIV------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRK 421 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~ 421 (536)
.|..+|.+++|.|+.+|+.. .+.++++.+|+.+| .|++|.|+|+||+.++..
T Consensus 107 ~F~~~D~d~dG~Is~~E~~~~~~~~~~~~~~~~~~f~~~D-~d~dG~i~~~Ef~~~~~~ 164 (176)
T d1nyaa_ 107 IVGMCDKNADGQINADEFAAWLTALGMSKAEAAEAFNQVD-TNGNGELSLDELLTAVRD 164 (176)
T ss_dssp HHHHTCSSCCSEEEHHHHHHHHHHTTCCHHHHHHHHHHHC-TTCSSEEEHHHHHHHHSC
T ss_pred HHHHHccCCChhhhHHHHHHHHHhcCCcHHHHHHHHHHHC-CCCCCcEeHHHHHHHHHH
Confidence 48899999999999999986 46889999999999 999999999999976543
|
| >d2obha1 a.39.1.5 (A:26-166) Calmodulin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.85 E-value=0.00012 Score=61.79 Aligned_cols=49 Identities=8% Similarity=-0.052 Sum_probs=45.0
Q ss_pred CCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhh
Q 009364 369 SPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAG 418 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~ 418 (536)
.|..+|.++.|.|+..+|.. .+.+++..+++.+| .|++|.|+|+||+.+
T Consensus 84 ~f~~~d~~~~G~i~~~el~~~l~~~g~~l~~~e~~~l~~~~D-~d~dG~i~~~EF~~~ 140 (141)
T d2obha1 84 AFKLFDDDETGKISFKNLKRVAKELGENLTDEELQEMIDEAD-RDGDGEVSEQEFLRI 140 (141)
T ss_dssp HHHHHCTTCSSSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHC-TTSSSSBCHHHHHHH
T ss_pred HHHHhcccCCCCccHHHHHHHHHHhCCCCCHHHHHHHHHHHC-CCCCCCEeHHHHHHh
Confidence 48999999999999999976 57899999999999 899999999999864
|
| >d1e8aa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]
Probab=96.84 E-value=0.00022 Score=55.55 Aligned_cols=50 Identities=12% Similarity=-0.024 Sum_probs=39.2
Q ss_pred CCCcc-ccCC-Cccchhhhhh-------------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 370 PGSVD-ICNL-DSLSCSRVIV-------------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 370 f~~~D-~~~~-g~ls~~el~~-------------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
|..++ .++. ++|+..||+. .+.+.++++++.+| .|+||.|||+||+.++.
T Consensus 14 F~kya~~~g~~~~Lsk~Elk~ll~~e~~~~~~~~~~~~~v~~~~~~lD-~n~Dg~idF~EF~~li~ 78 (87)
T d1e8aa_ 14 FHQYSVRKGHFDTLSKGELKQLLTKELANTIKNIKDKAVIDEIFQGLD-ANQDEQVDFQEFISLVA 78 (87)
T ss_dssp HHHHHTSSSSTTEECHHHHHHHHHHHSTTTSTTTTSHHHHHHHHHHHC-TTCSSCEEHHHHHHHHH
T ss_pred HHHHcccCCCCCeEcHHHHHHHHHHHccccccCCCCHHHHHHHHHHHc-CCCCCcCCHHHHHHHHH
Confidence 55553 3433 4799999986 23578999999999 99999999999996543
|
| >d1wdcb_ a.39.1.5 (B:) Myosin Essential Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Bay scallop (Aequipecten irradians) [TaxId: 31199]
Probab=96.82 E-value=3.9e-05 Score=65.54 Aligned_cols=68 Identities=7% Similarity=-0.105 Sum_probs=53.4
Q ss_pred CCCCCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcccc-cccCChhhhhhccC
Q 009364 366 SPGSPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKL-SSILAPNDLEKSRN 436 (536)
Q Consensus 366 ~~~sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~-~~~~~~e~l~~aF~ 436 (536)
...+|..+|.+++|.|+..|+.. ++.+++..+++. ++|.|+|+||+..+... .....++++++||+
T Consensus 9 ~~~~F~~~D~d~~G~I~~~el~~~l~~lg~~~~~~el~~~~~~-----~~~~i~~~eF~~~~~~~~~~~~~~~~l~~aF~ 83 (142)
T d1wdcb_ 9 MKEAFSMIDVDRDGFVSKEDIKAISEQLGRAPDDKELTAMLKE-----APGPLNFTMFLSIFSDKLSGTDSEETIRNAFA 83 (142)
T ss_dssp HHHHHHHHCTTCSSSCCHHHHHHHHHHHSSCCCHHHHHHHHTT-----SSSCCCHHHHHHHHHHHTCSCCCHHHHHHHHH
T ss_pred HHHHHHHHcCCCCCcCChHHHHHHHHHhhcCCCHHHHHHHHHh-----ccCccccccccccccccccccchhhhHHHhhh
Confidence 34459999999999999999976 577888888854 44789999999766543 34556788999998
Q ss_pred CC
Q 009364 437 PM 438 (536)
Q Consensus 437 ~~ 438 (536)
-.
T Consensus 84 ~~ 85 (142)
T d1wdcb_ 84 MF 85 (142)
T ss_dssp TT
T ss_pred hh
Confidence 75
|
| >d1uhka1 a.39.1.5 (A:3-189) Calcium-regulated photoprotein {Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-regulated photoprotein species: Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]
Probab=96.75 E-value=0.00016 Score=64.11 Aligned_cols=50 Identities=12% Similarity=0.074 Sum_probs=45.1
Q ss_pred CCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhc
Q 009364 369 SPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGD 419 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~ 419 (536)
.|..+|.+++|.|+..|+.. .+.++++.+++.+| .|++|.|+|+||+.+.
T Consensus 110 ~F~~~D~d~~G~Is~~El~~~l~~~g~~~~~~~~~~lf~~~D-~d~dG~Is~~EF~~~~ 167 (187)
T d1uhka1 110 LFDIVDKDQNGAITLDEWKAYTKAAGIIQSSEDCEETFRVCD-IDESGQLDVDEMTRQH 167 (187)
T ss_dssp HHHHHCTTCSSEECHHHHHHHHHHHTSCCSHHHHHHHHHHSC-CCTTSCEEHHHHHHHH
T ss_pred HHHHHccCCCcccchHHHHHHHHHhCCCccHHHHHHHHHHhC-CCCCCCEeHHHHHHHH
Confidence 58889999999999999975 46889999999999 8999999999998544
|
| >d2sasa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Sarcoplasmic calcium-binding protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Probab=96.73 E-value=0.00012 Score=64.71 Aligned_cols=51 Identities=4% Similarity=-0.083 Sum_probs=45.9
Q ss_pred CCCCccccCCCccchhhhhh------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 369 SPGSVDICNLDSLSCSRVIV------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
.|..+|.+++|.|+.+|+.. .+.++++.+++.+| .|++|.|+|+||..+..
T Consensus 110 ~F~~~D~d~~G~Is~~E~~~~l~~~~l~~~~~~~~f~~~D-~d~dG~i~~~EF~~~~~ 166 (185)
T d2sasa_ 110 LFKGMDVSGDGIVDLEEFQNYCKNFQLQCADVPAVYNVIT-DGGKVTFDLNRYKELYY 166 (185)
T ss_dssp HHHHHCTTSSSCCCHHHHHHHTTSSCCCCSSHHHHHHHHH-TTTTSCCSHHHHHHHHH
T ss_pred HHHHHccCCCccCCHHHHHHHHHHcCCCHHHHHHHHHHcC-CCCCCCCcHHHHHHHHH
Confidence 38899999999999999986 56789999999999 89999999999996553
|
| >d2scpa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Sandworm (Nereis diversicolor) [TaxId: 126592]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Sarcoplasmic calcium-binding protein species: Sandworm (Nereis diversicolor) [TaxId: 126592]
Probab=96.64 E-value=0.0002 Score=62.71 Aligned_cols=51 Identities=14% Similarity=0.071 Sum_probs=45.6
Q ss_pred CCCCccccCCCccchhhhhh------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 369 SPGSVDICNLDSLSCSRVIV------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
.|..+|.+++|.|+.+|+.. .+.+++..+++.+| .|++|.|+|+||+.+..
T Consensus 99 ~F~~~D~d~dG~Is~~E~~~~l~~~~~~~~~~~~~f~~~D-~d~dG~Is~~Ef~~~~~ 155 (174)
T d2scpa_ 99 FFRAVDTNEDNNISRDEYGIFFGMLGLDKTMAPASFDAID-TNNDGLLSLEEFVIAGS 155 (174)
T ss_dssp HHHHHCTTCSSSEEHHHHHHHHHHTTCCGGGHHHHHHHHC-TTCSSEECHHHHHHHHH
T ss_pred HHHHHCCCccccCCHHHHHHHHHHHhhhhHHHHHHHhhcC-CCCCCcEeHHHHHHHHH
Confidence 48899999999999999976 46789999999999 89999999999996543
|
| >d2mysc_ a.39.1.5 (C:) Myosin Regulatory Chain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Regulatory Chain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.63 E-value=0.00018 Score=61.16 Aligned_cols=74 Identities=8% Similarity=-0.081 Sum_probs=55.9
Q ss_pred CCCCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCC-CCCCCccchhhhhhhccccc---ccCChhhhhhc
Q 009364 367 PGSPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNS-NDDLCQLDQEDFVAGDRKLS---SILAPNDLEKS 434 (536)
Q Consensus 367 ~~sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~-~d~~g~Id~~EF~~~~~~~~---~~~~~e~l~~a 434 (536)
..+|..+|.+++|.|+..||.. ++.+++..++...+. .+++|.|+|+||+.++.... .....++++++
T Consensus 7 ke~F~~~D~d~~G~I~~~el~~~l~~lg~~~~~~e~~~~~~~~~~d~~~~g~i~~~eF~~~~~~~~~~~~~~~~~~l~~a 86 (145)
T d2mysc_ 7 KEAFLLFDRTGDAKITASQVGDIARALGQNPTNAEINKILGNPSKEEMNAAAITFEEFLPMLQAAANNKDQGTFEDFVEG 86 (145)
T ss_pred HHHHHHHcCCCCCeECHHHHHHHHHHhhhcchhhhhHHHHHHHhhcccccCccchhHHHHHHhhhhhccccchHHHHHHH
Confidence 3459999999999999999975 578899999987762 34678999999996654322 23445678888
Q ss_pred cCCCCC
Q 009364 435 RNPMCE 440 (536)
Q Consensus 435 F~~~~~ 440 (536)
|+-.-.
T Consensus 87 F~~~D~ 92 (145)
T d2mysc_ 87 LRVFDK 92 (145)
T ss_pred HHHhhc
Confidence 886643
|
| >d1wdcc_ a.39.1.5 (C:) Myosin Regulatory Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Regulatory Chain species: Bay scallop (Aequipecten irradians) [TaxId: 31199]
Probab=96.63 E-value=5e-05 Score=65.59 Aligned_cols=70 Identities=9% Similarity=-0.071 Sum_probs=53.3
Q ss_pred CCCCCCccc--cCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhccccc--ccCChhhhhhc
Q 009364 367 PGSPGSVDI--CNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLS--SILAPNDLEKS 434 (536)
Q Consensus 367 ~~sf~~~D~--~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~--~~~~~e~l~~a 434 (536)
..+|..||. +++|.|+..||.. ++.+++..+.. .+ .+++|.|+|+||+.++.... .....+++++|
T Consensus 10 ~~~F~~fD~~~~~dG~I~~~el~~~l~~lG~~~t~~e~~~~~~-~~-~~~~~~i~~~eFl~~~~~~~~~~~~~~~~l~~a 87 (152)
T d1wdcc_ 10 KDVFELFDFWDGRDGAVDAFKLGDVCRCLGINPRNEDVFAVGG-TH-KMGEKSLPFEEFLPAYEGLMDCEQGTFADYMEA 87 (152)
T ss_dssp HHHHHHHHHHTCSSSCEEGGGHHHHHHHTTCCCCHHHHHHTTC-CS-STTSCEECHHHHHHHHHHHTTSCCCCHHHHHHH
T ss_pred HHHHHHHCcCCCCCCeECHHHHHHHHHHhccCccHhhhhhhhh-hh-ccccccccccccccccccccccchhHHHhhhhh
Confidence 345888885 7889999999976 57888888754 56 67889999999997655432 34556789999
Q ss_pred cCCC
Q 009364 435 RNPM 438 (536)
Q Consensus 435 F~~~ 438 (536)
|+-.
T Consensus 88 F~~~ 91 (152)
T d1wdcc_ 88 FKTF 91 (152)
T ss_dssp HHTT
T ss_pred hhcc
Confidence 9865
|
| >d1y1xa_ a.39.1.8 (A:) Programmed cell death 6 protein-like protein {Leishmania major [TaxId: 5664]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Programmed cell death 6 protein-like protein species: Leishmania major [TaxId: 5664]
Probab=96.60 E-value=0.00015 Score=64.57 Aligned_cols=61 Identities=10% Similarity=-0.103 Sum_probs=50.5
Q ss_pred CCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcccccccCChhhhhhccCC
Q 009364 370 PGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSSILAPNDLEKSRNP 437 (536)
Q Consensus 370 f~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~~~~~e~l~~aF~~ 437 (536)
|..+|.+++|.|+..||.. .+.++++.+++.+| .|++|.|+|+||+.++... ..++++|+.
T Consensus 90 F~~~D~~~~g~I~~~el~~~l~~~g~~ls~~e~~~i~~~~d-~~~dg~I~~~eF~~~~~~l------~~~~~~F~~ 158 (182)
T d1y1xa_ 90 FRKRDSSGDGRLDSNEVRAALLSSGYQVSEQTFQALMRKFD-RQRRGSLGFDDYVELSIFV------CRVRNVFAF 158 (182)
T ss_dssp HHHHCTTSSSCBCHHHHHHHHHTTSCCCCHHHHHHHHHHHC-TTCSSSBCHHHHHHHHHHH------HHHHHHHHH
T ss_pred hhccccccchhhhhHHHHHHHHHhCCchhHHHHHHHHhhcc-cCCCCCcCHHHHHHHHHHH------HHHHHHHHH
Confidence 7788999999999999976 47899999999999 8999999999999876543 235555543
|
| >d1df0a1 a.39.1.8 (A:515-700) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), M-type [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain large subunit, C-terminal domain (domain IV) species: Rat (Rattus norvegicus), M-type [TaxId: 10116]
Probab=96.58 E-value=0.00012 Score=65.50 Aligned_cols=63 Identities=16% Similarity=0.060 Sum_probs=48.9
Q ss_pred CCCCccccCCCccchhhhhh-------hhhhhhhhhhhccCCCCCCCccchhhhhhhcccccccCChhhhhhccCCC
Q 009364 369 SPGSVDICNLDSLSCSRVIV-------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSSILAPNDLEKSRNPM 438 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~-------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~~~~~e~l~~aF~~~ 438 (536)
.|..+|.+++|.|+..||.. .-..++.+++...| .|++|.|+|+||+.++..+ +.++++|+..
T Consensus 96 ~F~~~D~d~sG~I~~~El~~~l~~~g~~~~~~~~~~~~~~d-~d~dg~I~f~eFi~~~~~l------~~~~~~F~~~ 165 (186)
T d1df0a1 96 IYREIDVDRSGTMNSYEMRKALEEAGFKLPCQLHQVIVARF-ADDELIIDFDNFVRCLVRL------EILFKIFKQL 165 (186)
T ss_dssp HHHHHCTTCCSCEEGGGHHHHHHHTTEECCHHHHHHHHHHH-CCSTTEECHHHHHHHHHHH------HHHHHHHHHH
T ss_pred HHHhhCCCCCCcccHHHHHHHHHHHHhcccHHHHHHHHHHH-cCCCCeEeHHHHHHHHHHH------HHHHHHHHHh
Confidence 48999999999999999986 11345566777789 8999999999999776543 4677777543
|
| >d1exra_ a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetraurelia) [TaxId: 5888]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Ciliate (Paramecium tetraurelia) [TaxId: 5888]
Probab=96.57 E-value=2.8e-05 Score=66.46 Aligned_cols=70 Identities=7% Similarity=-0.059 Sum_probs=55.0
Q ss_pred CCCCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhccccc-ccCChhhhhhccCC
Q 009364 367 PGSPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLS-SILAPNDLEKSRNP 437 (536)
Q Consensus 367 ~~sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~-~~~~~e~l~~aF~~ 437 (536)
...|..+|.+++|.|+.+|+.. ++..++..+++..| .+++|.|+|.||+.+..... .....+.++++|+.
T Consensus 12 ~~~F~~~D~~~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~d-~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~F~~ 90 (146)
T d1exra_ 12 KEAFALFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVD-ADGNGTIDFPEFLSLMARKMKEQDSEEELIEAFKV 90 (146)
T ss_dssp HHHHHHHCTTCSSEECHHHHHHHHHHHTCCCCHHHHHHHHHHHC-TTCSSSEEHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCCCeECHHHHHHHHHhcCCCCCHHHHHHHHHhcC-CCCCCcccHHHHHHHHHHHhhccChHHHHHHHHHH
Confidence 3459999999999999999976 46788999999999 89999999999997654322 23345577788763
|
| >d1jbaa_ a.39.1.5 (A:) Guanylate cyclase activating protein 2, GCAP-2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Guanylate cyclase activating protein 2, GCAP-2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=96.57 E-value=0.00034 Score=62.39 Aligned_cols=62 Identities=11% Similarity=-0.021 Sum_probs=49.1
Q ss_pred ccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcccccccCChhhhhhccCC
Q 009364 375 ICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSSILAPNDLEKSRNP 437 (536)
Q Consensus 375 ~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~~~~~e~l~~aF~~ 437 (536)
.|++|.|+..|+.. .+...++.+|+.+| .|++|.|+|.||+.++........++.++.+|+-
T Consensus 33 ~~~~G~i~~~Ef~~~l~~~~~~~~~~~~~~lf~~~D-~d~dG~I~f~Ef~~~l~~~~~~~~~~~~~~~F~~ 102 (189)
T d1jbaa_ 33 ECPSGTLFMHEFKRFFKVPDNEEATQYVEAMFRAFD-TNGDNTIDFLEYVAALNLVLRGTLEHKLKWTFKI 102 (189)
T ss_dssp SSTTCCEEHHHHHHHHHCCSSSTTHHHHHHHHHHHC-CSSSSEECHHHHHHHHHHHSSCCCTHHHHHHHHH
T ss_pred cCCCCeeeHHHHHHHHHHcCCCccHHHHHHHHHHhc-cCCCCeEeehhHHHHHHhhcccchHHHHHHHHhh
Confidence 45689999999976 35678999999999 8999999999999776655444455667777764
|
| >d1qxpa2 a.39.1.8 (A:515-702) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), mu-type [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain large subunit, C-terminal domain (domain IV) species: Rat (Rattus norvegicus), mu-type [TaxId: 10116]
Probab=96.51 E-value=0.00028 Score=63.29 Aligned_cols=61 Identities=18% Similarity=-0.007 Sum_probs=45.9
Q ss_pred CCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcccccccCChhhhhhccCC
Q 009364 369 SPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSSILAPNDLEKSRNP 437 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~~~~~e~l~~aF~~ 437 (536)
.|..+|.+++|.|+..||.. .+.+.++.|+. .+ .|++|.|+|+||+.++... +.+.++|+.
T Consensus 98 ~F~~~D~d~sG~i~~~El~~~l~~~g~~~~~~~~~~l~~-~~-~~~dg~i~f~eFi~~~~~l------~~~~~~F~~ 166 (188)
T d1qxpa2 98 IFRKFDLDKSGSMSAYEMRMAIEAAGFKLPCQLHQVIVA-RF-ADDELIIDFDNFVRCLVRL------EILFKIFKQ 166 (188)
T ss_dssp HHGGGCTTCCSCCBHHHHHHHHHHTTEECCHHHHHHHHH-HT-SCSSSBCCHHHHHHHHHHH------HHHHHHHHH
T ss_pred HHHHhCCCCCCEECHHHHHHHHHHhhhcCCHHHHHHHHH-Hh-cCCCCcCCHHHHHHHHHHH------HHHHHHHHH
Confidence 49999999999999999976 34555555554 46 6899999999999876643 345566654
|
| >d1m45a_ a.39.1.5 (A:) Myosin Light Chain Mlc1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Light Chain Mlc1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=96.50 E-value=0.00031 Score=59.76 Aligned_cols=74 Identities=8% Similarity=-0.103 Sum_probs=54.4
Q ss_pred cCCCCCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcccc------cccCChhh
Q 009364 365 TSPGSPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKL------SSILAPND 430 (536)
Q Consensus 365 t~~~sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~------~~~~~~e~ 430 (536)
...++|..+|.+++|.|+.+||.. ++.+|++.++......+++|.|+|+||+..+... ......++
T Consensus 3 ~~k~~F~~~D~d~~G~I~~~el~~~l~~lg~~~s~~ei~~l~~~~~~~~~~~~i~~~ef~~~~~~~~~~~~~~~~~~~~~ 82 (146)
T d1m45a_ 3 ANKDIFTLFDKKGQGAIAKDSLGDYLRAIGYNPTNQLVQDIINADSSLRDASSLTLDQITGLIEVNEKELDATTKAKTED 82 (146)
T ss_dssp CCTTCHHHHCTTCCSEEEGGGHHHHHHHTTCCCCHHHHHHHHHC--CC--CCEEEHHHHHHHHHHTHHHHHGGGCCCTHH
T ss_pred HHHHHHHHHcCCCcCCCCHHHHHHHHHHcCCchhHHHHhhhhccccccccccccccchhhhhhhhhcccccccccchHHH
Confidence 356789999999999999999975 5789999999765546777899999999654322 12345567
Q ss_pred hhhccCCC
Q 009364 431 LEKSRNPM 438 (536)
Q Consensus 431 l~~aF~~~ 438 (536)
+.+||+-.
T Consensus 83 l~~~F~~~ 90 (146)
T d1m45a_ 83 FVKAFQVF 90 (146)
T ss_dssp HHHHHHTT
T ss_pred HHHHHHhh
Confidence 88888754
|
| >d1jfja_ a.39.1.5 (A:) EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: 5759]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: EHCABP species: Entamoeba (Entamoeba histolytica) [TaxId: 5759]
Probab=96.49 E-value=0.00022 Score=59.40 Aligned_cols=50 Identities=10% Similarity=0.047 Sum_probs=44.0
Q ss_pred CCCCccccCCCccchhhhhh----hhhhhhhhhhhccCCCCCCCccchhhhhhhc
Q 009364 369 SPGSVDICNLDSLSCSRVIV----EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGD 419 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~----~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~ 419 (536)
.|..+|.+++|.|+.+|+.. ...+++..+++.+| .|++|.|+|+||+.++
T Consensus 80 ~F~~~D~~~~g~i~~~el~~~~~~~~~~~~~~~~~~~D-~d~dG~is~~EF~~~~ 133 (134)
T d1jfja_ 80 LYKLMDVDGDGKLTKEEVTSFFKKHGIEKVAEQVMKAD-ANGDGYITLEEFLEFS 133 (134)
T ss_dssp HHHHHCCSSSSEEEHHHHHHHHTTTTCHHHHHHHHHHH-CSSSSEEEHHHHHHHH
T ss_pred cccccccccCCcccHHHHHHHHHhcCcHHHHHHHHHHC-CCCCCCCCHHHHHHHh
Confidence 47889999999999999987 45678888999999 9999999999999755
|
| >d1wdcc_ a.39.1.5 (C:) Myosin Regulatory Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Regulatory Chain species: Bay scallop (Aequipecten irradians) [TaxId: 31199]
Probab=96.48 E-value=0.00031 Score=60.36 Aligned_cols=52 Identities=13% Similarity=-0.073 Sum_probs=44.4
Q ss_pred CCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCC-CCCCCccchhhhhhhcc
Q 009364 369 SPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNS-NDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~-~d~~g~Id~~EF~~~~~ 420 (536)
+|..+|.+++|.|+..||.. .+++|++.+++..|. .|++|.|+|+||+..++
T Consensus 87 aF~~~D~~~~G~I~~~el~~~l~~~g~~ls~~e~~~l~~~~d~~~d~~G~I~y~eF~~~~~ 147 (152)
T d1wdcc_ 87 AFKTFDREGQGFISGAELRHVLTALGERLSDEDVDEIIKLTDLQEDLEGNVKYEDFVKKVM 147 (152)
T ss_dssp HHHTTCSSSSSEEEHHHHHHHHHHSSSCCCHHHHHHHHHHHTCCCCTTSEEEHHHHHHHHH
T ss_pred hhhccccccCccchHHHHHHHHHHcCCCCCHHHHHHHHHHhccCCCCCCEEEHHHHHHHHh
Confidence 59999999999999999986 578999999998773 35678999999996544
|
| >d1s6ia_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-dependent protein kinase sk5 CLD species: Soybean (Glycine max) [TaxId: 3847]
Probab=96.45 E-value=0.00039 Score=61.71 Aligned_cols=53 Identities=15% Similarity=-0.027 Sum_probs=47.4
Q ss_pred CCCCccccCCCccchhhhhh------hhhhhhhhhhhccCCCCCCCccchhhhhhhcccc
Q 009364 369 SPGSVDICNLDSLSCSRVIV------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKL 422 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~ 422 (536)
+|..+|.+++|.|+.++|.. .+.+++..+++.+| .|++|.|+|+||+.++...
T Consensus 87 aF~~~D~d~~G~i~~~el~~~l~~~gl~~~ev~~~f~~~D-~d~DG~Is~~EF~~~m~~~ 145 (182)
T d1s6ia_ 87 AFSYFDKDGSGYITLDEIQQACKDFGLDDIHIDDMIKEID-QDNDGQIDYGEFAAMMRKR 145 (182)
T ss_dssp HHHHTTTTCSSEEEHHHHHHTTTTTTCCTTHHHHHHHHHC-SSSSSEEETTHHHHTTSCC
T ss_pred HHHHHhhcCCCccchhhhhhhhhhcCccHHHHHHHHHHhh-cCCCCeEeHHHHHHHHHhC
Confidence 48889999999999999976 46789999999999 8999999999999877654
|
| >d1ggwa_ a.39.1.5 (A:) Cdc4p {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Cdc4p species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=96.40 E-value=0.0002 Score=60.78 Aligned_cols=68 Identities=10% Similarity=0.008 Sum_probs=51.3
Q ss_pred CCCCCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhccccc---ccCChhhhhhc
Q 009364 366 SPGSPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLS---SILAPNDLEKS 434 (536)
Q Consensus 366 ~~~sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~---~~~~~e~l~~a 434 (536)
..++|..+|.+++|.|+..||.. ++.+++..+ + .+++|.|+|+||+.++.... .....+++++|
T Consensus 7 fke~F~~~D~d~dG~I~~~el~~~l~~lg~~~t~~ei~~~----~-~~~~~~i~~~eF~~~~~~~~~~~~~~~~~~l~~a 81 (140)
T d1ggwa_ 7 YKQAFSLFDRHGTGRIPKTSIGDLLRACGQNPTLAEITEI----E-STLPAEVDMEQFLQVLNRPNGFDMPGDPEEFVKG 81 (140)
T ss_dssp THHHHHHTCSSSSSEECHHHHHHHHHHTSCCCCHHHHHHH----H-TTSCSSEEHHHHHHHHCTTSSSSSSCCHHHHHHH
T ss_pred HHHHHHHHCCCCCCeECHHHHHHHHHHHHhhhHHHhhhhh----h-ccccccccchhhhhhhhhhhhcchhhHHHHHHHH
Confidence 34469999999999999999975 567777665 4 45668999999997665432 23456679999
Q ss_pred cCCC
Q 009364 435 RNPM 438 (536)
Q Consensus 435 F~~~ 438 (536)
|+-.
T Consensus 82 F~~~ 85 (140)
T d1ggwa_ 82 FQVF 85 (140)
T ss_dssp HHTT
T ss_pred HHHH
Confidence 9865
|
| >d1auib_ a.39.1.5 (B:) Calcineurin regulatory subunit (B-chain) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcineurin regulatory subunit (B-chain) species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.39 E-value=0.00026 Score=61.70 Aligned_cols=70 Identities=16% Similarity=0.076 Sum_probs=53.1
Q ss_pred CCCCCCccccCCCccchhhhhh----hhhhhhhhhhhccCCCCCCCccchhhhhhhccccccc-CChhhhhhccCC
Q 009364 367 PGSPGSVDICNLDSLSCSRVIV----EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSSI-LAPNDLEKSRNP 437 (536)
Q Consensus 367 ~~sf~~~D~~~~g~ls~~el~~----~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~~-~~~e~l~~aF~~ 437 (536)
...|..+|.+++|.|+.+||.. .....++.+++.+| .+++|.|+|+||+.++...... ...+.++.+|+-
T Consensus 19 ~~~F~~~D~d~~G~I~~~E~~~~~~~~~~~~~~~l~~~~d-~~~~g~i~~~EFl~~~~~~~~~~~~~~~~~~~f~~ 93 (165)
T d1auib_ 19 GKRFKKLDLDNSGSLSVEEFMSLPELQQNPLVQRVIDIFD-TDGNGEVDFKEFIEGVSQFSVKGDKEQKLRFAFRI 93 (165)
T ss_dssp HHHHHHHCTTCCSEECHHHHTTSHHHHTCTTHHHHHHHHC-TTCSSSEEHHHHHHHHGGGCTTCCHHHHHHHHHHH
T ss_pred HHHHHHHCCCCCCCCcHHHHHHhhhccCCHHHHHHHHHHc-cccchhhhhhhhhhhccccccchhhHHHHHHHHHH
Confidence 3349999999999999999976 34566788999999 8999999999999766654332 223456666643
|
| >d1g8ia_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Frequenin (neuronal calcium sensor 1) species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.32 E-value=0.00037 Score=62.02 Aligned_cols=52 Identities=10% Similarity=0.077 Sum_probs=44.0
Q ss_pred CCCCccccCCCccchhhhhh--------------------hhhhhhhhhhhccCCCCCCCccchhhhhhhccc
Q 009364 369 SPGSVDICNLDSLSCSRVIV--------------------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRK 421 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~--------------------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~ 421 (536)
.|..+|.+++|.|+.+|+.. ..++.++.+++.+| .|++|.|+|+||..++..
T Consensus 101 ~F~~~D~d~dG~i~~~El~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~if~~~D-~d~dG~Is~~EF~~~~~~ 172 (187)
T d1g8ia_ 101 AFKLYDLDNDGYITRNEMLDIVDAIYQMVGNTVELPEEENTPEKRVDRIFAMMD-KNADGKLTLQEFQEGSKA 172 (187)
T ss_dssp HHHHHCTTCSSEEEHHHHHHHHHHHHHHC-----CCGGGSSHHHHHHHHHHHHC-SSCSSEEEHHHHHHHHHH
T ss_pred HHHHHhcCCCCeEcHHHHHHHHHHHhhhhcccccCchhhccHHHHHHHHHHHhC-CCCCCcEeHHHHHHHHHH
Confidence 59999999999999999875 11356888999999 999999999999975543
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.26 E-value=0.0028 Score=62.98 Aligned_cols=74 Identities=15% Similarity=0.144 Sum_probs=47.5
Q ss_pred eeEEcccCceEEEEEEEcC-------CCcEEEEEEEeehhhccchhHHHHHHHHHHHHHHHHHhCC-CCceeeEeeeeec
Q 009364 71 GELIGCGAFGRVYMGMNLD-------SGELLAVKQVLIAANFASKEKAQDHIKELEEEVKLLKDLS-HPNIVRYLGTVRE 142 (536)
Q Consensus 71 ~~~LG~G~fg~Vy~a~~~~-------~g~~vAiK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~ 142 (536)
++.|+-|-.-.+|++.... ..+.|.+++.- . ... .....+|..+++.+. +.-..++++++.+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-----~~~----~idr~~E~~i~~~ls~~gl~Pkll~~~~~ 116 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-----PET----ESHLVAESVIFTLLSERHLGPKLYGIFSG 116 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-----CCC----HHHHHHHHHHHHHHHHTTSSSCEEEEETT
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C-----cch----hhHHHHHHHHHHHHHhCCCCCeEEEEcCC
Confidence 4678999999999987643 24567777652 1 011 112346778888774 3334467777643
Q ss_pred CCceeEEEEecCCCCc
Q 009364 143 EESLNILLEFVPGGSI 158 (536)
Q Consensus 143 ~~~~~lV~E~~~gg~L 158 (536)
.+|+||++|..+
T Consensus 117 ----g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 ----GRLEEYIPSRPL 128 (395)
T ss_dssp ----EEEECCCCEEEC
T ss_pred ----ceEEEEeccccC
Confidence 689999987554
|
| >d1ij5a_ a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-binding protein LAV1-2) {Physarum polycephalum [TaxId: 5791]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) domain: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) species: Physarum polycephalum [TaxId: 5791]
Probab=96.24 E-value=0.00048 Score=66.07 Aligned_cols=51 Identities=20% Similarity=0.057 Sum_probs=45.3
Q ss_pred CCCCccccCCCccchhhhhh---------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 369 SPGSVDICNLDSLSCSRVIV---------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~---------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
.|..+|.+++|.|+..|+.. .+.+++..+++.+| .|++|.|+|+||+.+++
T Consensus 258 ~F~~~D~d~~G~Is~~E~~~~l~~~~~~~~~~~~~~~l~~~~D-~d~dG~Is~~EF~~~ml 317 (321)
T d1ij5a_ 258 LYAFADFDKSGQLSKEEVQKVLEDAHIPESARKKFEHQFSVVD-VDDSKSLSYQEFVMLVL 317 (321)
T ss_dssp HHHHTCSSSCSSEEHHHHHHHHHHTTCCGGGCSTHHHHHHHHT-TTTCSEECHHHHHHHHH
T ss_pred HHHHHhcCCCCCCcHHHHHHHHHHcCCCcCcHHHHHHHHHHhC-CCCCCcCcHHHHHHHHH
Confidence 48889999999999999975 45679999999999 89999999999997664
|
| >d1bjfa_ a.39.1.5 (A:) Neurocalcin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Neurocalcin species: Cow (Bos taurus) [TaxId: 9913]
Probab=96.16 E-value=0.0006 Score=60.05 Aligned_cols=51 Identities=12% Similarity=0.136 Sum_probs=44.0
Q ss_pred CCCCccccCCCccchhhhhh--------------------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 369 SPGSVDICNLDSLSCSRVIV--------------------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~--------------------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
.|..+|.+++|.|+.+|+.. ..++.++.+++.+| .|++|.|+|+||..++.
T Consensus 100 ~f~~~D~d~dg~i~~~E~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~if~~~D-~d~dG~Is~~EF~~~~~ 170 (181)
T d1bjfa_ 100 AFSMYDLDGNGYISKAEMLEIVQAIYKMVSSVMKMPEDESTPEKRTEKIFRQMD-TNRDGKLSLEEFIRGAK 170 (181)
T ss_dssp HHHHHCTTCSSCEEHHHHHHHHHHHHTTCCCTTTSCGGGSSHHHHHHHHHHHSC-TTCSSEECHHHHHHHHH
T ss_pred HHHHhccCCCCeecHHHHHHHHHHHhhhccccccCCcccccHHHHHHHHHHHhC-CCCCCcEeHHHHHHHHH
Confidence 48999999999999999865 13457889999999 99999999999997554
|
| >d1fpwa_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Frequenin (neuronal calcium sensor 1) species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=96.07 E-value=0.00058 Score=60.92 Aligned_cols=52 Identities=6% Similarity=0.067 Sum_probs=44.0
Q ss_pred CCCCccccCCCccchhhhhh--------------------hhhhhhhhhhhccCCCCCCCccchhhhhhhccc
Q 009364 369 SPGSVDICNLDSLSCSRVIV--------------------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRK 421 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~--------------------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~ 421 (536)
.|..+|.+++|.|+.+|+.. ..++.++.+|+.+| .|++|.|+|+||..+...
T Consensus 104 ~F~~~D~d~dG~is~~E~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~if~~~D-~d~dG~Is~~EF~~~~~~ 175 (190)
T d1fpwa_ 104 AFELYDLNHDGYITFDEMLTIVASVYKMMGSMVTLNEDEATPEMRVKKIFKLMD-KNEDGYITLDEFREGSKV 175 (190)
T ss_dssp HHHHHCSSCSSEEEHHHHHHHHHHHHTTSCSTTSSSCCCCCHHHHHHHHHHHHT-TTCSSEEEHHHHHHHHHS
T ss_pred HHHHhccCCCCcCcHHHHHHHHHHHHHhcccccCCCchhhhHHHHHHHHHHHhC-CCCCCcCcHHHHHHHHHH
Confidence 59999999999999999865 01356889999999 999999999999975543
|
| >d2obha1 a.39.1.5 (A:26-166) Calmodulin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.06 E-value=0.00036 Score=58.64 Aligned_cols=71 Identities=8% Similarity=0.009 Sum_probs=54.6
Q ss_pred CCCCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhccccc-ccCChhhhhhccCC
Q 009364 367 PGSPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLS-SILAPNDLEKSRNP 437 (536)
Q Consensus 367 ~~sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~-~~~~~e~l~~aF~~ 437 (536)
...|..+|.+++|.|+.+|+.. .+.+++..++...| .+++|.|+++||+....... .....++++.+|..
T Consensus 9 k~~F~~~D~~~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~d-~~~~g~i~~~ef~~~~~~~~~~~~~~~~l~~~f~~ 87 (141)
T d2obha1 9 REAFDLFDADGTGTIDVKELKVAMRALGFEPKKEEIKKMISEID-KEGTGKMNFGDFLTVMTQKMSEKDTKEEILKAFKL 87 (141)
T ss_dssp HHHHHTTCTTCCSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHT-TTCCSEEEHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCCCeEeHHHHHHHHHhcCCchhHHHHHHHHHhhc-cCCCCeechHHHHHHHHHHHhhhccHHHHHHHHHH
Confidence 3458999999999999999986 46789999999999 88999999999996544322 22334567777764
Q ss_pred C
Q 009364 438 M 438 (536)
Q Consensus 438 ~ 438 (536)
.
T Consensus 88 ~ 88 (141)
T d2obha1 88 F 88 (141)
T ss_dssp H
T ss_pred h
Confidence 4
|
| >d1y1xa_ a.39.1.8 (A:) Programmed cell death 6 protein-like protein {Leishmania major [TaxId: 5664]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Programmed cell death 6 protein-like protein species: Leishmania major [TaxId: 5664]
Probab=96.03 E-value=0.00068 Score=60.06 Aligned_cols=51 Identities=10% Similarity=0.012 Sum_probs=45.2
Q ss_pred CCCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhc
Q 009364 368 GSPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGD 419 (536)
Q Consensus 368 ~sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~ 419 (536)
..|..+|.+++|.|+.+|+.. .+.++++.+++..| .|++|.|+|.||+..+
T Consensus 22 ~~F~~~D~d~dG~Is~~El~~~l~~l~~~~s~~~~~~l~~~~d-~d~~~~i~~~ef~~~~ 80 (182)
T d1y1xa_ 22 EWFRAVDTDGSGAISVPELNAALSSAGVPFSLATTEKLLHMYD-KNHSGEITFDEFKDLH 80 (182)
T ss_dssp HHHHHHCTTCSSSBCHHHHHHHHCBTTBCCCHHHHHHHHHHHC-TTCSSSBCHHHHHHHH
T ss_pred HHHHHHcCCCcCCCCHHHHHHHHHHhcccCchhhhhhhhcccc-cccccccccccccccc
Confidence 358999999999999999986 57889999999999 8999999999998644
|
| >d1k94a_ a.39.1.8 (A:) Grancalcin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Grancalcin species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.02 E-value=0.00046 Score=60.41 Aligned_cols=61 Identities=13% Similarity=-0.048 Sum_probs=49.2
Q ss_pred CCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcccccccCChhhhhhccCCC
Q 009364 369 SPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSSILAPNDLEKSRNPM 438 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~~~~~e~l~~aF~~~ 438 (536)
.|..+|.+++|.|+..||+. .+.++++.+++..| .| |.|+|+||+.++... +.+.++|+..
T Consensus 75 ~F~~fD~d~sG~I~~~El~~~l~~~G~~l~~~~~~~l~~~~d-~~--g~i~~~eFi~~~~~l------~~~~~~F~~~ 143 (165)
T d1k94a_ 75 NFMTVDQDGSGTVEHHELRQAIGLMGYRLSPQTLTTIVKRYS-KN--GRIFFDDYVACCVKL------RALTDFFRKR 143 (165)
T ss_dssp HHHHHCTTCCSBCCHHHHHHHHHHTTCCCCHHHHHHHHHHHC-BT--TBCBHHHHHHHHHHH------HHHHHHHHTT
T ss_pred HHHHhCCCCCCeEcHHHHHHHHHHhhhcCCHHHHHHHHHHcC-CC--CcCcHHHHHHHHHHH------HHHHHHHHHh
Confidence 49999999999999999986 47889999999987 44 789999999766543 3466677543
|
| >d1alva_ a.39.1.8 (A:) Calpain small (regulatory) subunit (domain VI) {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain small (regulatory) subunit (domain VI) species: Pig (Sus scrofa) [TaxId: 9823]
Probab=96.01 E-value=0.00038 Score=61.10 Aligned_cols=61 Identities=10% Similarity=0.050 Sum_probs=44.7
Q ss_pred CCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcccccccCChhhhhhccCC
Q 009364 369 SPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSSILAPNDLEKSRNP 437 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~~~~~e~l~~aF~~ 437 (536)
.|..+|.+++|.|+..|+.. .++++++ .+...| .|++|.|+|+||+.++... +.+.++|+.
T Consensus 82 ~f~~~D~d~~G~I~~~el~~~L~~~g~~~~~~~~~-~~~~~d-~d~~G~i~~~EF~~~~~~~------~~~~~~f~~ 150 (173)
T d1alva_ 82 IYKQFDVDRSGTIGSSELPGAFEAAGFHLNEHLYS-MIIRRY-SDEGGNMDFDNFISCLVRL------DAMFRAFKS 150 (173)
T ss_dssp HHHHHCTTCCSSBCTTTHHHHHHHHTCCCCHHHHH-HHHHHH-TCSSSCBCHHHHHHHHHHH------HHHHHHHHH
T ss_pred HHHHhccCCCCeecHHHHHHHHHHHHHhhHHHHHH-Hhhccc-cCCCCeEeHHHHHHHHHHH------HHHHHHHHH
Confidence 37789999999999999976 3444444 455677 6899999999999776532 345566554
|
| >d1auib_ a.39.1.5 (B:) Calcineurin regulatory subunit (B-chain) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcineurin regulatory subunit (B-chain) species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.97 E-value=0.00087 Score=58.14 Aligned_cols=52 Identities=12% Similarity=0.010 Sum_probs=44.4
Q ss_pred CCCCccccCCCccchhhhhh-------------hhhhhhhhhhhccCCCCCCCccchhhhhhhccc
Q 009364 369 SPGSVDICNLDSLSCSRVIV-------------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRK 421 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~-------------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~ 421 (536)
.|..+|.+++|.|+.+|+.. ..+..++.+++..| .|++|.|+|+||+.++..
T Consensus 90 ~f~~~d~d~~g~Is~~el~~~l~~~~~~~~~~~~~~~~~~~~~~~~D-~~~dG~Is~~EF~~i~~~ 154 (165)
T d1auib_ 90 AFRIYDMDKDGYISNGELFQVLKMMVGNNLKDTQLQQIVDKTIINAD-KDGDGRISFEEFCAVVGG 154 (165)
T ss_dssp HHHHHCTTCSSEECHHHHHHHHHHHHTTSSCHHHHHHHHHHHHHHHC-TTSSSSEEHHHHHHHHGG
T ss_pred HHHHhcccccccccHHHHHHHHHHhccccCchHHHHHHHHHHHHHcC-CCCCCcEeHHHHHHHHhc
Confidence 48889999999999999975 23566889999999 899999999999976654
|
| >d1hqva_ a.39.1.8 (A:) Apoptosis-linked protein alg-2 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Apoptosis-linked protein alg-2 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=95.93 E-value=0.00089 Score=59.21 Aligned_cols=51 Identities=8% Similarity=-0.093 Sum_probs=45.5
Q ss_pred CCCCccccCCCccchhhhhh---------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 369 SPGSVDICNLDSLSCSRVIV---------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~---------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
.|..+|.+++|.|+..|+.. .+.++++.+++.+| .|++|.|+|+||+..+.
T Consensus 24 iF~~~D~d~~G~Is~~E~~~~l~~~~~~~~~~~~~~~l~~~~D-~d~~g~i~~~EFl~~~~ 83 (181)
T d1hqva_ 24 VFQRVDKDRSGVISDNELQQALSNGTWTPFNPVTVRSIISMFD-RENKAGVNFSEFTGVWK 83 (181)
T ss_dssp HHHHHCTTCCSSBCHHHHHHHCCCSSSSCCCHHHHHHHHHHHC-CSSSSSBCHHHHHHHHH
T ss_pred HHHHHcCCCCCcCcHHHHHHHHHHcCCCcccHHHHHHHhhccc-cccccchhhhHHHhhhh
Confidence 49999999999999999975 36789999999999 89999999999997654
|
| >d1xo5a_ a.39.1.5 (A:) Calcium- and integrin-binding protein, CIB {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium- and integrin-binding protein, CIB species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.91 E-value=0.00085 Score=59.41 Aligned_cols=51 Identities=12% Similarity=-0.076 Sum_probs=41.9
Q ss_pred CCCCccccCCCccchhhhhh-------------hhhhh----hhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 369 SPGSVDICNLDSLSCSRVIV-------------EKLSG----SMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~-------------~~~~e----i~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
+|..+|.+++|.|+.+|+.. .+.++ +..+++..| .|++|.|+|+||..++.
T Consensus 100 ~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~v~~~~~~~D-~d~dG~Is~~EF~~~~~ 167 (180)
T d1xo5a_ 100 AFRIFDFDDDGTLNREDLSRLVNCLTGEGEDTRLSASEMKQLIDNILEESD-IDRDGTINLSEFQHVIS 167 (180)
T ss_dssp HHHHHCTTCSSSBCHHHHHHHHHHHC------CCCCTTHHHHHHHHHHHHC-TTCSSSBCHHHHHHHHH
T ss_pred hhccccCCCCCeeeHHHHHHHHHHHHhccccccccHHHHHHHHHHHHHHhC-CCCCCcCcHHHHHHHHH
Confidence 59999999999999999975 12344 445788899 89999999999997554
|
| >d1hqva_ a.39.1.8 (A:) Apoptosis-linked protein alg-2 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Apoptosis-linked protein alg-2 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=95.91 E-value=0.00054 Score=60.68 Aligned_cols=64 Identities=13% Similarity=-0.078 Sum_probs=52.3
Q ss_pred CCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcccccccCChhhhhhccCCCC
Q 009364 369 SPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSSILAPNDLEKSRNPMC 439 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~~~~~e~l~~aF~~~~ 439 (536)
.|..+|.+++|.|+.+|+.. .+.++++.+++.+| .+++|.|+|+||+.++... +++.+.|+.+.
T Consensus 91 ~f~~~D~~~~G~i~~~el~~~l~~~~~~l~~e~~~~~~~~~d-~~~dg~Is~~eF~~~~~~l------~~l~~~F~~~D 162 (181)
T d1hqva_ 91 VFRTYDRDNSGMIDKNELKQALSGFGYRLSDQFHDILIRKFD-RQGRGQIAFDDFIQGCIVL------QRLTDIFRRYD 162 (181)
T ss_dssp HHHHHCTTCCSSBCHHHHHHHHHHHTBCCCHHHHHHHHHHHC-SSCSSCBCHHHHHHHHHHH------HHHHHHHHHHC
T ss_pred ccccccccccchhhhHHHHHHHHHcCCcchhHHHHHHHHHhC-CCCCCcCcHHHHHHHHHHH------HHHHHHHHHhC
Confidence 47778999999999999976 57889999999999 8999999999999766532 45677776543
|
| >d1lkja_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=95.90 E-value=0.00017 Score=61.52 Aligned_cols=21 Identities=24% Similarity=0.101 Sum_probs=17.4
Q ss_pred CCCCCccccCCCccchhhhhh
Q 009364 368 GSPGSVDICNLDSLSCSRVIV 388 (536)
Q Consensus 368 ~sf~~~D~~~~g~ls~~el~~ 388 (536)
..|..+|.+++|.|+.+|+..
T Consensus 14 ~~F~~~D~d~~G~i~~~e~~~ 34 (146)
T d1lkja_ 14 EAFALFDKDNNGSISSSELAT 34 (146)
T ss_dssp HHHHHHCCSSSSEEEHHHHHH
T ss_pred HHHHHHCCCCCCcEeHHHHHH
Confidence 348888999999999999864
|
| >d1qlsa_ a.39.1.2 (A:) Calcyclin (S100) {Pig (Sus scrofa), calgizzarin s100c (s100a11) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Pig (Sus scrofa), calgizzarin s100c (s100a11) [TaxId: 9823]
Probab=95.89 E-value=0.0018 Score=50.90 Aligned_cols=42 Identities=14% Similarity=0.018 Sum_probs=34.5
Q ss_pred CCccchhhhhh-------------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 378 LDSLSCSRVIV-------------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 378 ~g~ls~~el~~-------------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
.++|+..||+. ...+.++.+|+.+| .|+||+|||+||+....
T Consensus 25 ~~tLsk~Elk~Ll~~El~~~l~~~~d~~~vd~im~~LD-~n~Dg~vdF~EF~~li~ 79 (95)
T d1qlsa_ 25 NTKISKTEFLIFMNTELAAFTQNQKDPGVLDRMMKKLD-LDSDGQLDFQEFLNLIG 79 (95)
T ss_dssp TTCBCHHHHHHHHTTTSHHHHHHCCCTHHHHHHHHHHC-TTCSSSBCHHHHHHHHH
T ss_pred cCcCCHHHHHHHHHHHHHHHhcCCCCHHHHHHHHHHhc-CCCCCcCcHHHHHHHHH
Confidence 36899999986 12456999999999 99999999999985443
|
| >d1jbaa_ a.39.1.5 (A:) Guanylate cyclase activating protein 2, GCAP-2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Guanylate cyclase activating protein 2, GCAP-2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=95.85 E-value=0.0012 Score=58.70 Aligned_cols=52 Identities=13% Similarity=0.084 Sum_probs=43.2
Q ss_pred CCCCccccCCCccchhhhhhh-------------------------hhhhhhhhhhccCCCCCCCccchhhhhhhccc
Q 009364 369 SPGSVDICNLDSLSCSRVIVE-------------------------KLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRK 421 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~~-------------------------~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~ 421 (536)
.|..+|.+++|.|+..|+... .++.++.+++.+| .|++|.|+|+||+.++..
T Consensus 99 ~F~~~D~d~~g~i~~~E~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~if~~~D-~d~dG~Is~~EF~~~~~~ 175 (189)
T d1jbaa_ 99 TFKIYDKDRNGCIDRQELLDIVESIYKLKKACSVEVEAEQQGKLLTPEEVVDRIFLLVD-ENGDGQLSLNEFVEGARR 175 (189)
T ss_dssp HHHHHCSSCSSCBCHHHHHHHHHHHHHHHHHSSCCTTSSTTTCCCCHHHHHHHHHHHHC-CSCCSCBCHHHHHHHHTT
T ss_pred HHhhhccCCCCcccHhHHHHHHHHHHHhhccccccchhhhhccccchHHHHHHHHHHhC-CCCCCcEeHHHHHHHHHh
Confidence 488899999999999998640 1345688999999 899999999999976653
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.83 E-value=0.0032 Score=60.23 Aligned_cols=30 Identities=23% Similarity=0.305 Sum_probs=26.6
Q ss_pred cCCccccCCCCCcccCCCCcEEEEecCcch
Q 009364 190 HGIMHRDIKGANILVDNKGCIKLADFGASK 219 (536)
Q Consensus 190 ~~ivHrDLKp~NILl~~~~~vkL~DFGla~ 219 (536)
.|+||+|+.+.||+++.+...-|+||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 479999999999999988777899999764
|
| >d3cr5x1 a.39.1.2 (X:0-89) Calcyclin (S100) {Cow (Bos taurus), s100b [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Cow (Bos taurus), s100b [TaxId: 9913]
Probab=95.78 E-value=0.0021 Score=49.99 Aligned_cols=41 Identities=17% Similarity=0.003 Sum_probs=33.8
Q ss_pred CCccchhhhhh-------------hhhhhhhhhhhccCCCCCCCccchhhhhhhc
Q 009364 378 LDSLSCSRVIV-------------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGD 419 (536)
Q Consensus 378 ~g~ls~~el~~-------------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~ 419 (536)
.++|+..||+. .....++.+++.+| .|+||+|||+||+...
T Consensus 25 ~~tLsk~Elk~Ll~~El~~~l~~~~d~~~~d~~m~~LD-~n~Dg~vdF~EF~~li 78 (90)
T d3cr5x1 25 KHKLKKSELKELINNELSHFLEEIKEQEVVDKVMETLD-SDGDGECDFQEFMAFV 78 (90)
T ss_dssp TTSBCHHHHHHHHHHHCTTTSCCCCSHHHHHHHHHHHC-TTSSSSBCHHHHHHHH
T ss_pred cCcCCHHHHHHHHHHHHHHHhcCCCCHHHHHHHHHHhc-CCCCCcCCHHHHHHHH
Confidence 35799999986 12456999999999 9999999999998544
|
| >d1topa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=95.67 E-value=0.0002 Score=62.11 Aligned_cols=71 Identities=10% Similarity=-0.048 Sum_probs=54.0
Q ss_pred cCCCCCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhccccc----ccCChhhhh
Q 009364 365 TSPGSPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLS----SILAPNDLE 432 (536)
Q Consensus 365 t~~~sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~----~~~~~e~l~ 432 (536)
.....|..+|.+++|.|+.+||.. .+..++..++..+| .+++|.++|.||+....... .....+.++
T Consensus 21 el~~~F~~~D~d~~G~Is~~el~~~l~~~~~~~~~~~~~~~~~~~d-~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~ 99 (162)
T d1topa_ 21 EFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVD-EDGSGTIDFEEFLVMMVRQMKEDAKGKSEEELA 99 (162)
T ss_dssp HHHHHHHTTTCSCSSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHC-TTSCCEEEHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCCCeEcHHHHHHHHhccCCchhHHHHHhhhheec-cCCCCCeeeehhhhhhhhhhhhhcccCcHHHHH
Confidence 344569999999999999999976 46789999999999 89999999999986544321 112334566
Q ss_pred hccC
Q 009364 433 KSRN 436 (536)
Q Consensus 433 ~aF~ 436 (536)
++|+
T Consensus 100 ~aF~ 103 (162)
T d1topa_ 100 NCFR 103 (162)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 6665
|
| >d1omra_ a.39.1.5 (A:) Recoverin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Recoverin species: Cow (Bos taurus) [TaxId: 9913]
Probab=95.64 E-value=0.0011 Score=59.30 Aligned_cols=62 Identities=13% Similarity=0.102 Sum_probs=41.0
Q ss_pred cccCCCccchhhhhh---------hhhhhhhhhhhccCCCCCCCccchhhhhhhcccccccCChhhhhhccC
Q 009364 374 DICNLDSLSCSRVIV---------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSSILAPNDLEKSRN 436 (536)
Q Consensus 374 D~~~~g~ls~~el~~---------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~~~~~e~l~~aF~ 436 (536)
+.+++|.|+.+|+.. .....++.+++.+| .+++|.|+|.||+.++........++.++.+|+
T Consensus 36 ~~~~~G~is~~EF~~~l~~~~~~~~~~~~~~~if~~~D-~~~~G~I~f~EF~~~~~~~~~~~~~~~l~~~F~ 106 (201)
T d1omra_ 36 KECPSGRITRQEFQTIYSKFFPEADPKAYAQHVFRSFD-ANSDGTLDFKEYVIALHMTSAGKTNQKLEWAFS 106 (201)
T ss_dssp HHCTTSEEEHHHHHHHHHHHCTTSCCHHHHHHHHHTTT-SCSSSEEEHHHHHHHHHHHHSSCGGGSHHHHHH
T ss_pred HHCcCCCccHHHHHHHHHHhcCCCCHHHHHHHHHHHhc-cCCCCeEeehhHHHHHHhhcccchHHHHHHHHH
Confidence 556778888888765 12344577888888 788888888888865544333334455666665
|
| >d2mysb_ a.39.1.5 (B:) Myosin Essential Chain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=95.62 E-value=0.00077 Score=57.21 Aligned_cols=68 Identities=4% Similarity=-0.145 Sum_probs=49.1
Q ss_pred CCCCCCCccccCCCccchhhhhh---------hhhhhhhhhhhccCCCCCCCccchhhhhhhcccc-cccCChhhhhhcc
Q 009364 366 SPGSPGSVDICNLDSLSCSRVIV---------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKL-SSILAPNDLEKSR 435 (536)
Q Consensus 366 ~~~sf~~~D~~~~g~ls~~el~~---------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~-~~~~~~e~l~~aF 435 (536)
....|..+|.+++|.|+.+|+.. ++.++ +...+ .+++|.|+|+||+.++... .....++++++||
T Consensus 9 l~e~F~~~D~~~~G~I~~~e~~~~l~~lg~~~~~~~~----~~~~~-~~~~g~i~~~eF~~~~~~~~~~~~~~~~l~~aF 83 (145)
T d2mysb_ 9 FKEAFTVIDQNADGIIDKDDLRETFAAMGRLNVKNEE----LDAMI-KEASGPINFTVFLTMFGEKLKGADPEDVIMGAF 83 (145)
T ss_pred HHHHHHHHCCCCCCCCCHHHHHHHHHHhCCCcchHHH----HHHHH-HhccCceeechhhhhhhhcccccchHHHHHHHH
Confidence 34469999999999999999976 22333 33444 4566899999999766553 3345566799998
Q ss_pred CCC
Q 009364 436 NPM 438 (536)
Q Consensus 436 ~~~ 438 (536)
+-.
T Consensus 84 ~~f 86 (145)
T d2mysb_ 84 KVL 86 (145)
T ss_pred Hhh
Confidence 866
|
| >d1omra_ a.39.1.5 (A:) Recoverin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Recoverin species: Cow (Bos taurus) [TaxId: 9913]
Probab=95.61 E-value=0.0017 Score=58.17 Aligned_cols=51 Identities=16% Similarity=0.181 Sum_probs=42.4
Q ss_pred CCCCccccCCCccchhhhhh----------------------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 369 SPGSVDICNLDSLSCSRVIV----------------------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~----------------------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
.|..+|.+++|.|+.+|+.. ..+..++.+|+.+| .|++|.|+|+||+.+..
T Consensus 104 ~F~~~D~d~~G~is~~E~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~if~~~D-~d~dG~Is~~EF~~~~~ 176 (201)
T d1omra_ 104 AFSLYDVDGNGTISKNEVLEIVTAIFKMISPEDTKHLPEDENTPEKRAEKIWGFFG-KKDDDKLTEKEFIEGTL 176 (201)
T ss_dssp HHHHHCTTCSSSBCHHHHHHHHHHHHTTSCHHHHTTSCGGGSSHHHHHHHHHHHTT-CCTTCCBCHHHHHHHHH
T ss_pred HHHHHccCCCCccCHHHHHHHHHHHHhhcChhhhhhhhhhhccHHHHHHHHHHHhC-CCCCCCCcHHHHHHHHH
Confidence 48999999999999999864 01235678999999 99999999999996554
|
| >d2zfda1 a.39.1.5 (A:32-214) Calcineurin B-like protein 2 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcineurin B-like protein 2 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=95.58 E-value=0.0013 Score=57.97 Aligned_cols=52 Identities=12% Similarity=-0.011 Sum_probs=42.5
Q ss_pred CCCCccccCCCccchhhhhh------------hh----hhhhhhhhhccCCCCCCCccchhhhhhhccc
Q 009364 369 SPGSVDICNLDSLSCSRVIV------------EK----LSGSMHGWVTSNSNDDLCQLDQEDFVAGDRK 421 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~------------~~----~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~ 421 (536)
.|..+|.+++|.|+.+|+.. .+ ++.+..+++..| .|++|.|+|+||..++..
T Consensus 96 ~F~~~D~d~~G~Is~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~if~~~D-~d~dG~Is~~EF~~~~~~ 163 (183)
T d2zfda1 96 SFQLYDLKQQGFIERQEVKQMVVATLAESGMNLKDTVIEDIIDKTFEEAD-TKHDGKIDKEEWRSLVLR 163 (183)
T ss_dssp HHHHHCTTSSSSEEHHHHHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHC-SSCSSEECHHHHHHHHHH
T ss_pred hhcccccCCCCCccHHHHHHHHHHHHhhhhcccchHHHHHHHHHHHHHhC-CCCCCeEcHHHHHHHHHH
Confidence 38999999999999999976 11 233667889999 899999999999976553
|
| >d2zkmx1 a.39.1.7 (X:142-311) Phospholipase C-beta-2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Phospholipase C-beta-2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.56 E-value=0.0015 Score=57.25 Aligned_cols=65 Identities=5% Similarity=-0.027 Sum_probs=48.1
Q ss_pred ccccCCCccchhhhhh----------hhhhhhhhhhhccCCCCCCCccchhhhhhhcccccccCChhhhhhccCCCCCC
Q 009364 373 VDICNLDSLSCSRVIV----------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSSILAPNDLEKSRNPMCEP 441 (536)
Q Consensus 373 ~D~~~~g~ls~~el~~----------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~~~~~e~l~~aF~~~~~~ 441 (536)
+|.+++|.|+.+||.. .+.+++..++...| .+++|.|+|+||..++... ...+++..+|+.....
T Consensus 16 ~d~n~dG~Is~~el~k~l~~~~~~~~~~~~~~~~~~~~~D-~~~~~~i~F~eF~~~~~~l---~~r~ei~~~F~~~d~d 90 (170)
T d2zkmx1 16 MQLNSEGKIPVKNFFQMFPADRKRVEAALSACHLPKGKND-AINPEDFPEPVYKSFLMSL---CPRPEIDEIFTSYHAK 90 (170)
T ss_dssp HSCCTTSCEEHHHHHHHSCSCHHHHHHHHHHTTCCCCTTC-EECGGGCCHHHHHHHHHHH---SCCHHHHTTCC-----
T ss_pred cccCCCCCCcHHHHHHHHHHhhhhHHHHHHHHhhhhcccc-ccCCCccCHHHHHHHHhcc---CCHHHHHHHHHHHcCC
Confidence 6899999999999976 24567888888999 8899999999999766543 2346788888877643
|
| >d1j55a_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100p [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100p [TaxId: 9606]
Probab=95.55 E-value=0.0027 Score=49.72 Aligned_cols=42 Identities=12% Similarity=0.064 Sum_probs=33.7
Q ss_pred CCccchhhhhh-------------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 378 LDSLSCSRVIV-------------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 378 ~g~ls~~el~~-------------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
.++|+..||+. .....++.+++..| .|+||.|||+||+....
T Consensus 25 ~~tLsk~Elk~Ll~~El~~~l~~~~d~~~vd~~m~~LD-~n~Dg~vdF~EF~~li~ 79 (94)
T d1j55a_ 25 TQTLTKGELKVLMEKELPGFLQSGKDKDAVDKLLKDLD-ANGDAQVDFSEFIVFVA 79 (94)
T ss_dssp TTEECHHHHHHHHHHHSTTCC------CHHHHHHHHHC-SSSSSSEEHHHHHHHHH
T ss_pred cccCCHHHHHHHHHHHHHHHhcCCCCHHHHHHHHHHhc-CCCCCcCCHHHHHHHHH
Confidence 35899999876 23567999999999 99999999999996543
|
| >d1qxpa2 a.39.1.8 (A:515-702) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), mu-type [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain large subunit, C-terminal domain (domain IV) species: Rat (Rattus norvegicus), mu-type [TaxId: 10116]
Probab=95.47 E-value=0.0014 Score=58.38 Aligned_cols=52 Identities=10% Similarity=-0.126 Sum_probs=36.5
Q ss_pred CCCCCCCccccCCCccchhhhhh----------------hhhhhhhhhhhccCCCCCCCccchhhhhhhc
Q 009364 366 SPGSPGSVDICNLDSLSCSRVIV----------------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGD 419 (536)
Q Consensus 366 ~~~sf~~~D~~~~g~ls~~el~~----------------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~ 419 (536)
....|..+| +.+|.|+..||.. .+.+.++.++..+| .|++|.|+|+||...+
T Consensus 22 ~r~~F~~~d-~~dG~Is~~EL~~~L~~~~~~~~~~~~~~~s~e~~~~li~~~D-~d~~G~i~~~EF~~l~ 89 (188)
T d1qxpa2 22 FKTLFSKLA-GDDMEISVKELQTILNRIISKHKDLRTNGFSLESCRSMVNLMD-RDGNGKLGLVEFNILW 89 (188)
T ss_dssp -----CCCC-CSSSSCCCSCTTTTTCC---------CCCCCHHHHHHHHHHHC-C--CCCCCSSSHHHHH
T ss_pred HHHHHHHHc-CCCCEECHHHHHHHHHHhCccccccccccCCHHHHHHHHHHhc-CCCCCcccHHHHHHHH
Confidence 345699999 4479999999865 13467889999999 8999999999998654
|
| >d1w7jb1 a.39.1.5 (B:11-149) Myosin Essential Chain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.36 E-value=0.00053 Score=57.57 Aligned_cols=71 Identities=10% Similarity=-0.076 Sum_probs=50.9
Q ss_pred CCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCC-CCCCCccchhhhhhhccccc---ccCChhhhhhccC
Q 009364 369 SPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNS-NDDLCQLDQEDFVAGDRKLS---SILAPNDLEKSRN 436 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~-~d~~g~Id~~EF~~~~~~~~---~~~~~e~l~~aF~ 436 (536)
+|..+|.+++|.|+.+||.. ++.+++..++...+. .+++|.|+|.||..++.... .....+++++||+
T Consensus 5 ~F~~~D~d~~G~I~~~el~~~l~~lg~~~t~~e~~~~~~~~~~~~~~~~~i~~~ef~~~~~~~~~~~~~~~~~~l~~aF~ 84 (139)
T d1w7jb1 5 AFELFDRVGDGKILYSQCGDVMRALGQNPTNAEVLKVLGNPKSDELKSRRVDFETFLPMLQAVAKNRGQGTYEDYLEGFR 84 (139)
T ss_dssp HHHHHCCSSSSEEESTTHHHHHHHTTCCCCHHHHHHHTTCCCHHHHTTCEEEHHHHHHHHHHHCC--------CCHHHHH
T ss_pred HHHHHhCCCCCeECHHHHHHHHHHhccCCCHHHHHHHHHHHhcccccCCceeeeccchhhHhhhhhccccHHHHHHHhhh
Confidence 48889999999999999876 678899999987762 25678999999986554322 2334556888886
Q ss_pred CCC
Q 009364 437 PMC 439 (536)
Q Consensus 437 ~~~ 439 (536)
-.-
T Consensus 85 ~~D 87 (139)
T d1w7jb1 85 VFD 87 (139)
T ss_dssp TTC
T ss_pred hcc
Confidence 553
|
| >d1ij5a_ a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-binding protein LAV1-2) {Physarum polycephalum [TaxId: 5791]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) domain: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) species: Physarum polycephalum [TaxId: 5791]
Probab=95.35 E-value=0.0016 Score=62.16 Aligned_cols=51 Identities=14% Similarity=-0.040 Sum_probs=45.7
Q ss_pred CCCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhc
Q 009364 368 GSPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGD 419 (536)
Q Consensus 368 ~sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~ 419 (536)
..|..+|.+++|.|+..|+.. ++.+++..++..+| .|++|.|+|.||+..+
T Consensus 126 ~~F~~~D~~~~g~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~d-~~~~g~i~~~ef~~~~ 184 (321)
T d1ij5a_ 126 QLFLSSAVSGSGKFSFQDLKQVLAKYADTIPEGPLKKLFVMVE-NDTKGRMSYITLVAVA 184 (321)
T ss_dssp HHHTSSSSTTSSCCCHHHHHHHHHHHHTTSCSSHHHHHHHHHH-HCCSSTHHHHHHTTSH
T ss_pred HHHHHHcCCCCCeEcHHHHHHHHHHcCCcccHHHHHHHHHHHh-hcCCccccchhhhhhh
Confidence 349999999999999999986 56889999999999 8999999999998643
|
| >d1xk4c1 a.39.1.2 (C:4-86) Calcyclin (S100) {Human (Homo sapiens), s100a9 (mrp14) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a9 (mrp14) [TaxId: 9606]
Probab=95.23 E-value=0.0049 Score=47.03 Aligned_cols=42 Identities=19% Similarity=0.052 Sum_probs=33.1
Q ss_pred CCCccchhhhhh------------h--hhhhhhhhhhccCCCCCCCccchhhhhhhc
Q 009364 377 NLDSLSCSRVIV------------E--KLSGSMHGWVTSNSNDDLCQLDQEDFVAGD 419 (536)
Q Consensus 377 ~~g~ls~~el~~------------~--~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~ 419 (536)
+.++|+..||+. . ....++.+|+..| .|+||.|||+||+...
T Consensus 25 ~~~tLsk~Elk~Ll~~El~~~l~~~~~d~~~vd~~m~~LD-~n~Dg~vdF~EF~~li 80 (83)
T d1xk4c1 25 HPDTLNQGEFKELVRKDLQNFLKKENKNEKVIEHIMEDLD-TNADKQLSFEEFIMLM 80 (83)
T ss_dssp STTSBCHHHHHHHHHHHTTTTTTTGGGCHHHHHHHHHHHC-TTCSSSBCHHHHHHHH
T ss_pred CcccCCHHHHHHHHHHHhHHHhcCCCCCHHHHHHHHHHhc-CCCCCcCcHHHHHHHH
Confidence 346899999876 1 1234789999999 9999999999999643
|
| >d1dtla_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=95.11 E-value=0.00098 Score=57.07 Aligned_cols=48 Identities=10% Similarity=-0.002 Sum_probs=28.0
Q ss_pred CCCCCccccC-CCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhh
Q 009364 368 GSPGSVDICN-LDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFV 416 (536)
Q Consensus 368 ~sf~~~D~~~-~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~ 416 (536)
..|..+|.++ +|.|+..|+.. .+..++..++...+ .+++|.|.+++|.
T Consensus 18 ~~F~~~D~d~~dG~I~~~e~~~~l~~lg~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 74 (156)
T d1dtla_ 18 AAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEELQEMIDEVD-EDGSGTVDFDEFL 74 (156)
T ss_dssp HHHHHHTTTCGGGSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHC-TTSSSSBCHHHHH
T ss_pred HHHHHHcCCCCCCeECHHHHHHHHHHcCCCCCHHHHHHHHHHhh-ccCCCccchhhhh
Confidence 3477777764 67777777653 34455555555555 4555555555554
|
| >d1pvaa_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Pike (Esox lucius) [TaxId: 8010]
Probab=95.09 E-value=0.0054 Score=49.41 Aligned_cols=60 Identities=7% Similarity=0.014 Sum_probs=45.7
Q ss_pred cCCCccchhhhhh------hhhhhhhhhhhccCCCCCCCccchhhhhhhcccc---cccCChhhhhhccC
Q 009364 376 CNLDSLSCSRVIV------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKL---SSILAPNDLEKSRN 436 (536)
Q Consensus 376 ~~~g~ls~~el~~------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~---~~~~~~e~l~~aF~ 436 (536)
+.+|+|++.|+.. .+.++++.+|+.+| .|++|.|+.+|+..++... ...++++++...|+
T Consensus 19 d~dG~idf~EF~~~~~~~~~~~~~~~~~F~~~D-~d~~G~I~~~El~~~l~~l~~~g~~ls~~ev~~~~~ 87 (109)
T d1pvaa_ 19 KAEGSFNHKKFFALVGLKAMSANDVKKVFKAID-ADASGFIEEEELKFVLKSFAADGRDLTDAETKAFLK 87 (109)
T ss_dssp CSTTCCCHHHHHHHHTCTTSCHHHHHHHHHHHC-TTCSSSBCHHHHHTGGGGTCTTCCCCCHHHHHHHHH
T ss_pred CCCCCCcHHHHHHHHHHccCCHHHHHHHhhCcc-CCCcCeEcHHHHHHHHHHhhhcCCCCCHHHHHHHHH
Confidence 4678999999864 45788999999999 9999999999998665443 23456666665554
|
| >d1s6ca_ a.39.1.5 (A:) Kchip1, Kv4 potassium channel-interacting protein {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Kchip1, Kv4 potassium channel-interacting protein species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=94.87 E-value=0.0033 Score=54.89 Aligned_cols=52 Identities=6% Similarity=-0.016 Sum_probs=42.7
Q ss_pred CCCCccccCCCccchhhhhh--------------------hhhhhhhhhhhccCCCCCCCccchhhhhhhccc
Q 009364 369 SPGSVDICNLDSLSCSRVIV--------------------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRK 421 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~--------------------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~ 421 (536)
.|..+|.+++|.|+.+|+.. ..+..++.+++.+| .|+||.|+|+||..+...
T Consensus 92 ~f~~~D~~~~g~i~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~if~~~D-~d~DG~Is~~EF~~~i~~ 163 (178)
T d1s6ca_ 92 TFNLYDINKDGYINKEEMMDIVKAIYDMMGKYTYPVLKEDTPRQHVDVFFQKMD-KNKDGIVTLDEFLESCQE 163 (178)
T ss_dssp HHHHHCTTCSSCEEHHHHHHHHHHHHHHTC-----------CHHHHHHHHHHHC-TTCSSEECHHHHHHHTTS
T ss_pred HHHhhccCCCCeecHHHHHHHHHHHHhhcccccccCCcHHHHHHHHHHHHHHhC-CCCCCcEeHHHHHHHHHH
Confidence 48899999999999999864 01344678999999 899999999999975553
|
| >d1juoa_ a.39.1.8 (A:) Sorcin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Sorcin species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.71 E-value=0.0029 Score=55.13 Aligned_cols=49 Identities=8% Similarity=-0.104 Sum_probs=39.3
Q ss_pred CCCccccCCCccchhhhhh-------------hhhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 370 PGSVDICNLDSLSCSRVIV-------------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 370 f~~~D~~~~g~ls~~el~~-------------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
|..++ +.+|.|+..||+. .+.++++.+++..| .|++|.|+|+||+.+..
T Consensus 13 F~~~~-~~dG~Is~~EL~~~L~~~g~~~~~~~~~~~~v~~l~~~~D-~d~~G~I~f~EF~~~~~ 74 (172)
T d1juoa_ 13 FAAVA-GQDGQIDADELQRCLTQSGIAGGYKPFNLETCRLMVSMLD-RDMSGTMGFNEFKELWA 74 (172)
T ss_dssp HHHHH-TTTTEECHHHHHHHHHHHTTTCSSCCCCHHHHHHHHHHHC-TTCSSCEEHHHHHHHHH
T ss_pred HHHhC-CCCCCCCHHHHHHHHHHcCCCCCcccCCHHHHHHHHHHHC-CCCCCceehHHHHHHHH
Confidence 55554 6789999999976 13577899999999 89999999999986543
|
| >d1s6ca_ a.39.1.5 (A:) Kchip1, Kv4 potassium channel-interacting protein {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Kchip1, Kv4 potassium channel-interacting protein species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=94.71 E-value=0.0025 Score=55.72 Aligned_cols=64 Identities=13% Similarity=0.023 Sum_probs=44.8
Q ss_pred cccCCCccchhhhhh---------hhhhhhhhhhhccCCCCCCCccchhhhhhhcccccccCChhhhhhccCCC
Q 009364 374 DICNLDSLSCSRVIV---------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSSILAPNDLEKSRNPM 438 (536)
Q Consensus 374 D~~~~g~ls~~el~~---------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~~~~~e~l~~aF~~~ 438 (536)
+.+++|.|+.+|+.. .....++.+++.+| .|++|.|+|.||+.+.........++.++.+|+-.
T Consensus 24 ~~~~~G~is~~ef~~~l~~~~~~~~~~~~~~~lf~~~D-~~~~g~I~~~EFl~~~~~~~~~~~~~~~~~~f~~~ 96 (178)
T d1s6ca_ 24 NECPSGVVNEETFKQIYAQFFPHGDASTYAHYLFNAFD-TTQTGSVKFEDFVTALSILLRGTVHEKLRWTFNLY 96 (178)
T ss_dssp HHCTTSEECHHHHHHHHHHHSTTSCCHHHHHHHHHHHC-TTCSSCEEHHHHHHHHHHHHHCCHHHHHHHHHHHH
T ss_pred HHCcCCCccHHHHHHHHHHhCCCCCHHHHHHHHHHHHC-CCCCCcccHHHHHHHHHHHhccchHHHHHHHHHhh
Confidence 456788999999875 12344688999999 89999999999986654433333445666666544
|
| >d1k94a_ a.39.1.8 (A:) Grancalcin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Grancalcin species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.61 E-value=0.007 Score=52.49 Aligned_cols=66 Identities=11% Similarity=0.119 Sum_probs=53.1
Q ss_pred CCCccccCCCccchhhhhh--hhhhhhhhhhhccCCCCCCCccchhhhhhhcccccccCChhhhhhccC
Q 009364 370 PGSVDICNLDSLSCSRVIV--EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSSILAPNDLEKSRN 436 (536)
Q Consensus 370 f~~~D~~~~g~ls~~el~~--~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~~~~~e~l~~aF~ 436 (536)
...+|.+++|.|+..|+.. ....+++.+|+..| .|++|.|+.+||..+.....-.++++++...++
T Consensus 46 i~~~D~~~~G~i~~~EF~~l~~~~~~~~~~F~~fD-~d~sG~I~~~El~~~l~~~G~~l~~~~~~~l~~ 113 (165)
T d1k94a_ 46 IAMLDRDHTGKMGFNAFKELWAALNAWKENFMTVD-QDGSGTVEHHELRQAIGLMGYRLSPQTLTTIVK 113 (165)
T ss_dssp HHHHCTTCSSCBCHHHHHHHHHHHHHHHHHHHHHC-TTCCSBCCHHHHHHHHHHTTCCCCHHHHHHHHH
T ss_pred HHHhCCCCCCcCcHHHHHHHhhccchhHHHHHHhC-CCCCCeEcHHHHHHHHHHhhhcCCHHHHHHHHH
Confidence 3447999999999999987 46778999999999 999999999999877766555566665555544
|
| >d1fpwa_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Frequenin (neuronal calcium sensor 1) species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=94.57 E-value=0.0046 Score=54.72 Aligned_cols=48 Identities=6% Similarity=-0.076 Sum_probs=27.5
Q ss_pred CCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhh
Q 009364 369 SPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVA 417 (536)
Q Consensus 369 sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~ 417 (536)
.|..+|.+++|.|+..|+.. ..++.++.+|+..| .|++|.|+++||..
T Consensus 68 if~~~D~~~~G~I~~~Ef~~~~~~~~~~~~~e~~~~~F~~~D-~d~dG~is~~E~~~ 123 (190)
T d1fpwa_ 68 LFTVFDKDNNGFIHFEEFITVLSTTSRGTLEEKLSWAFELYD-LNHDGYITFDEMLT 123 (190)
T ss_dssp HHHTCCSSCSSEECHHHHHHHHHHHSCCCSTHHHHHHHHHHC-SSCSSEEEHHHHHH
T ss_pred HHHHhCcCCCCcccHHHHHHHHHHHccCchHHHHHHHHHHhc-cCCCCcCcHHHHHH
Confidence 35556666666666666543 23455566666666 56666666666653
|
| >d1fw4a_ a.39.1.5 (A:) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Cow (Bos taurus) [TaxId: 9913]
Probab=94.57 E-value=0.0044 Score=44.84 Aligned_cols=48 Identities=6% Similarity=0.032 Sum_probs=40.5
Q ss_pred hhhhhhhhhhccCCCCCCCccchhhhhhhcccccccCChhhhhhccCCC
Q 009364 390 KLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSSILAPNDLEKSRNPM 438 (536)
Q Consensus 390 ~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~~~~~e~l~~aF~~~ 438 (536)
++++++.+|+..| .|++|.|+.+||..+........+++++...|+..
T Consensus 1 Seeel~~aF~~fD-~d~~G~I~~~el~~~l~~lg~~~~~~e~~~l~~~~ 48 (65)
T d1fw4a_ 1 SEEEIREAFRVFD-KDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREA 48 (65)
T ss_dssp CCHHHHHHHHHHC-TTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHTT
T ss_pred CHHHHHHHHHHHc-CCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHc
Confidence 4678999999999 99999999999998777777777878777777665
|
| >d5pala_ a.39.1.4 (A:) Parvalbumin {Leopard shark (Triakis semifasciata) [TaxId: 30493]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Leopard shark (Triakis semifasciata) [TaxId: 30493]
Probab=94.02 E-value=0.0084 Score=48.19 Aligned_cols=60 Identities=7% Similarity=0.051 Sum_probs=45.2
Q ss_pred CCCccchhhhhh------hhhhhhhhhhhccCCCCCCCccchhhhhhhcccc---cccCChhhhhhccCC
Q 009364 377 NLDSLSCSRVIV------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKL---SSILAPNDLEKSRNP 437 (536)
Q Consensus 377 ~~g~ls~~el~~------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~---~~~~~~e~l~~aF~~ 437 (536)
..|+|++.|+.. .+.++++.+|+.+| .|++|.|+.+|+..++... ...++++++.+.|+.
T Consensus 20 ~~G~idf~eF~~~~~~~~~~~~~l~~~F~~~D-~d~~G~I~~~El~~~l~~l~~~g~~~~~~e~~~~~~~ 88 (109)
T d5pala_ 20 DPGTFDYKRFFHLVGLKGKTDAQVKEVFEILD-KDQSGFIEEEELKGVLKGFSAHGRDLNDTETKALLAA 88 (109)
T ss_dssp STTCCCHHHHHHHHTCTTCCHHHHHHHHHHHC-TTCSSEECHHHHHTHHHHHCTTCCCCCHHHHHHHHHH
T ss_pred CCCcCcHHHHHHHHHhcCCCHHHHHHHHhhhc-CCCCCeEcHHHHHHHHHHhhhccCcCCHHHHHHHHHH
Confidence 458899999864 35689999999999 9999999999998655332 234566667666543
|
| >d1bjfa_ a.39.1.5 (A:) Neurocalcin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Neurocalcin species: Cow (Bos taurus) [TaxId: 9913]
Probab=93.57 E-value=0.0063 Score=53.09 Aligned_cols=63 Identities=14% Similarity=0.018 Sum_probs=46.9
Q ss_pred cccCCCccchhhhhh--------h-hhhhhhhhhhccCCCCCCCccchhhhhhhcccccccCChhhhhhccCC
Q 009364 374 DICNLDSLSCSRVIV--------E-KLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSSILAPNDLEKSRNP 437 (536)
Q Consensus 374 D~~~~g~ls~~el~~--------~-~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~~~~~e~l~~aF~~ 437 (536)
+.+++|.++..|+.. . +...++.+++..| .+++|.|+|+||+.++........++.++.+|+-
T Consensus 32 ~~~~~g~i~~~ef~~~l~~~~~~~~~~~~~~~lf~~~d-~~~~g~i~~~eFl~~~~~~~~~~~~~~~~~~f~~ 103 (181)
T d1bjfa_ 32 RDCPSGHLSMEEFKKIYGNFFPYGDASKFAEHVFRTFD-ANGDGTIDFREFIIALSVTSRGKLEQKLKWAFSM 103 (181)
T ss_dssp HHSTTSEEEHHHHHHHHTTTSSSSCCHHHHHHHHHHHC-SSCSSEEEHHHHHHHHHHHTSSCHHHHHHHHHHH
T ss_pred hhCCCCCcCHHHHHHHHHHhCCCCCHHHHHHHHHHhcC-CCCCCcEeHHHHHHHHHHHhhhchHHHHHHHHHH
Confidence 456889999999976 1 2345788999999 8999999999999766655444445667777763
|
| >d2fcea1 a.39.1.5 (A:84-144) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Cow (Bos taurus) [TaxId: 9913]
Probab=93.50 E-value=0.015 Score=41.23 Aligned_cols=46 Identities=7% Similarity=0.065 Sum_probs=39.1
Q ss_pred hhhhhhhhccCCCCCCCccchhhhhhhcccccccCChhhhhhccCCC
Q 009364 392 SGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSSILAPNDLEKSRNPM 438 (536)
Q Consensus 392 ~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~~~~~e~l~~aF~~~ 438 (536)
+|+.+.|+.+| .+++|.|+.+||..++.......+++++...|+..
T Consensus 1 Eel~~aF~~fD-~~~~G~I~~~el~~~l~~~g~~~~~~ei~~l~~~~ 46 (61)
T d2fcea1 1 EDFVKAFQVFD-KESTGKVSVGDLRYMLTGLGEKLTDAEVDELLKGV 46 (61)
T ss_dssp HHHHHHHHHHC-TTCCSCEEHHHHHHHHHHTTCCCCHHHHHHHHTTC
T ss_pred ChHHHHHHHHC-CCCCCeEeHHHHHHHHHHcCCCCCHHHHHHHHHHc
Confidence 47889999999 99999999999998877776677888888877654
|
| >d2hf5a1 a.39.1.5 (A:81-113) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]
Probab=93.47 E-value=0.017 Score=35.59 Aligned_cols=30 Identities=3% Similarity=-0.080 Sum_probs=24.0
Q ss_pred hhhhhhhhhhccCCCCCCCccchhhhhhhcc
Q 009364 390 KLSGSMHGWVTSNSNDDLCQLDQEDFVAGDR 420 (536)
Q Consensus 390 ~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~ 420 (536)
+++|+.+.|+..| .||+|.|+-+|+-.++.
T Consensus 1 seeel~eAF~~FD-kDg~G~Is~~EL~~vm~ 30 (33)
T d2hf5a1 1 SEEEIREAFRVFD-KDGNGYISAAELRHVMT 30 (33)
T ss_dssp CHHHHHHHHHHHS-SSCCSCBCHHHHHHHTT
T ss_pred CHHHHHHHHHHhC-CCCCCcCcHHHHHHHHH
Confidence 3578888888999 89999999888876554
|
| >d1rroa_ a.39.1.4 (A:) Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Oncomodulin species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=93.13 E-value=0.022 Score=45.50 Aligned_cols=60 Identities=13% Similarity=0.086 Sum_probs=42.8
Q ss_pred CCCccchhhhhh------hhhhhhhhhhhccCCCCCCCccchhhhhhhccccc---ccCChhhhhhccCC
Q 009364 377 NLDSLSCSRVIV------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLS---SILAPNDLEKSRNP 437 (536)
Q Consensus 377 ~~g~ls~~el~~------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~---~~~~~e~l~~aF~~ 437 (536)
..|+++..++.. .+.++++++|+.+| .|++|.|+++||..++.... ..++++++...|+.
T Consensus 20 ~~~s~~~~~F~~~~~~~~~~~~~l~~~F~~~D-~d~~G~I~~~El~~~l~~l~~~~~~l~~~~~~~~~~~ 88 (108)
T d1rroa_ 20 DPDTFEPQKFFQTSGLSKMSASQVKDIFRFID-NDQSGYLDGDELKYFLQKFQSDARELTESETKSLMDA 88 (108)
T ss_dssp STTCCCHHHHHHHHSGGGSCHHHHHHHHHHHC-TTCSSEECTHHHHTGGGGTCTTSCCCCHHHHHHHHHH
T ss_pred cCCCccHHHHHHHHccCcCCHHHHHHHHhhhc-CCCCCeEcHHHHHHHHHHHHhccCCCCHHHHHHHHHH
Confidence 345667776543 35678999999999 99999999999997665432 24566666665543
|
| >d1fi5a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]
Probab=93.06 E-value=0.016 Score=43.68 Aligned_cols=47 Identities=9% Similarity=0.019 Sum_probs=39.0
Q ss_pred hhhhhhhhhhccCCCCCCCccchhhhhhhcccccccCChhhhhhccCC
Q 009364 390 KLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSSILAPNDLEKSRNP 437 (536)
Q Consensus 390 ~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~~~~~e~l~~aF~~ 437 (536)
+++++.++|+.+| .|++|.|+.+||..++.......+++++.+.|+.
T Consensus 13 ~ee~l~~~F~~~D-~d~~G~I~~~el~~~l~~~g~~~~~~ev~~~~~~ 59 (81)
T d1fi5a_ 13 TEEELSDLFRMFD-KNADGYIDLEELKIMLQATGETITEDDIEELMKD 59 (81)
T ss_dssp CHHHHHHHHHHHC-SSCSSEECHHHHHHHHHTSSSCCCHHHHHHHHHH
T ss_pred CHHHHHHHHHHHc-CCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHH
Confidence 4678999999999 9999999999999887776666777777776653
|
| >d2pvba_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Pike (Esox lucius) [TaxId: 8010]
Probab=92.97 E-value=0.027 Score=44.85 Aligned_cols=60 Identities=10% Similarity=0.127 Sum_probs=45.2
Q ss_pred CCCccchhhhhh------hhhhhhhhhhhccCCCCCCCccchhhhhhhccccc---ccCChhhhhhccCC
Q 009364 377 NLDSLSCSRVIV------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLS---SILAPNDLEKSRNP 437 (536)
Q Consensus 377 ~~g~ls~~el~~------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~---~~~~~e~l~~aF~~ 437 (536)
..|+|+..|+.. .+.++++.+|+..| .|++|.|+.+||..++.... ..++++++++.|+.
T Consensus 19 ~~gsi~~~eF~~~~~l~~~~~~~l~~~F~~~D-~d~~G~I~~~el~~~l~~l~~~~~~~~~~~~~~l~~~ 87 (107)
T d2pvba_ 19 AADSFKHKEFFAKVGLASKSLDDVKKAFYVID-QDKSGFIEEDELKLFLQNFSPSARALTDAETKAFLAD 87 (107)
T ss_dssp STTCCCHHHHHHHHTGGGSCHHHHHHHHHHHC-TTCSSSBCHHHHHTGGGGTCTTSCCCCHHHHHHHHHH
T ss_pred CCCCcCHHHHHHHHhcccCCHHHHHHHHHhhc-cCCCCcCcHHHHHHHHHHhhcccccCCHHHHHHHHHH
Confidence 346788888754 35678999999999 99999999999997665542 24566777776643
|
| >d1jc2a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=92.90 E-value=0.013 Score=43.48 Aligned_cols=49 Identities=10% Similarity=0.004 Sum_probs=40.7
Q ss_pred hhhhhhhhhhhccCCCCCCCccchhhhhhhcccccccCChhhhhhccCCC
Q 009364 389 EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSSILAPNDLEKSRNPM 438 (536)
Q Consensus 389 ~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~~~~~e~l~~aF~~~ 438 (536)
.+++++..+|+.+| .+++|.|+.+||..++.......+++++.+.|+..
T Consensus 6 ~~eeel~~~F~~fD-~~~~G~I~~~el~~~l~~lg~~~~~~e~~~~~~~~ 54 (75)
T d1jc2a_ 6 KSEEELANCFRIFD-KNADGFIDIEELGEILRATGEHVIEEDIEDLMKDS 54 (75)
T ss_dssp CCHHHHHHHHHHHC-CSTTSSEEHHHHHHHHHHSSSCCCHHHHHHHHHHH
T ss_pred CcHHHHHHHHHHHc-CCCcCeEcHHHHHHHHHhcCCCccHHHHHHHHHHh
Confidence 35678999999999 99999999999998877777777878887776543
|
| >d1ctda_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=92.83 E-value=0.029 Score=33.45 Aligned_cols=27 Identities=7% Similarity=0.022 Sum_probs=24.1
Q ss_pred hhhhhhhhhhccCCCCCCCccchhhhhh
Q 009364 390 KLSGSMHGWVTSNSNDDLCQLDQEDFVA 417 (536)
Q Consensus 390 ~~~ei~~l~~~~d~~d~~g~Id~~EF~~ 417 (536)
+++|+...|+-.| .++||.||-+||..
T Consensus 2 sEeELae~FRifD-kNaDGyiD~eEl~~ 28 (34)
T d1ctda_ 2 SEEELANAFRIFD-KNADGYIDIEELGE 28 (34)
T ss_dssp HHHHHHHHHHTTC-CSSSSCBCHHHHHH
T ss_pred CHHHHHHHHHHHc-cCCcccccHHHHHH
Confidence 5788999999999 89999999999974
|
| >d1tiza_ a.39.1.5 (A:) Calmodulin-related protein T21P5.17 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin-related protein T21P5.17 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=92.68 E-value=0.014 Score=42.25 Aligned_cols=45 Identities=11% Similarity=0.132 Sum_probs=37.0
Q ss_pred hhhhhhhccCCCCCCCccchhhhhhhcccccccCChhhhhhccCCC
Q 009364 393 GSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSSILAPNDLEKSRNPM 438 (536)
Q Consensus 393 ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~~~~~e~l~~aF~~~ 438 (536)
.++.+|+.+| .|++|.|+.+||..++.......+++++...|+..
T Consensus 2 ~~r~~F~~~D-~d~~G~I~~~El~~~l~~lg~~~~~~~i~~~~~~~ 46 (67)
T d1tiza_ 2 SAKRVFEKFD-KNKDGKLSLDEFREVALAFSPYFTQEDIVKFFEEI 46 (67)
T ss_dssp THHHHHHHHC-TTSSSCEEHHHHHHHHHHTCTTSCHHHHHHHHHHH
T ss_pred hHHHHHHHHC-CCCcCcCcHHHHHHHHHHhccccchHHHHHHHHHh
Confidence 4678999999 99999999999998777766677778777776654
|
| >d1oqpa_ a.39.1.5 (A:) Caltractin (centrin 2) {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Caltractin (centrin 2) species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=92.65 E-value=0.015 Score=43.36 Aligned_cols=47 Identities=11% Similarity=0.161 Sum_probs=38.5
Q ss_pred hhhhhhhhhhccCCCCCCCccchhhhhhhcccccccCChhhhhhccCC
Q 009364 390 KLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSSILAPNDLEKSRNP 437 (536)
Q Consensus 390 ~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~~~~~e~l~~aF~~ 437 (536)
+++++..+|+.+| .|++|.|+.+||..++.......+.+++.+.|+.
T Consensus 7 ~~e~l~~~F~~~D-~d~~G~I~~~el~~~l~~~g~~~~~~e~~~~~~~ 53 (77)
T d1oqpa_ 7 SREEILKAFRLFD-DDNSGTITIKDLRRVAKELGENLTEEELQEMIAE 53 (77)
T ss_dssp HHHHHHHHHHHHC-TTCSSSEEHHHHHHHHHHHTCCCCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHc-CCCCCEechHHHHHHHHHhCCCCCHHHHHHHHHH
Confidence 4678999999999 9999999999999877766666777777776654
|
| >d1alva_ a.39.1.8 (A:) Calpain small (regulatory) subunit (domain VI) {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain small (regulatory) subunit (domain VI) species: Pig (Sus scrofa) [TaxId: 9823]
Probab=92.61 E-value=0.023 Score=49.08 Aligned_cols=49 Identities=8% Similarity=0.075 Sum_probs=41.1
Q ss_pred CCCccccCCCccchhhhhh--hhhhhhhhhhhccCCCCCCCcc--chhhhhhhc
Q 009364 370 PGSVDICNLDSLSCSRVIV--EKLSGSMHGWVTSNSNDDLCQL--DQEDFVAGD 419 (536)
Q Consensus 370 f~~~D~~~~g~ls~~el~~--~~~~ei~~l~~~~d~~d~~g~I--d~~EF~~~~ 419 (536)
+..+|.+++|.|+.+|+.. ...+.+..+|+..| .|++|.| +|+||+.++
T Consensus 118 ~~~~d~d~~G~i~~~EF~~~~~~~~~~~~~f~~~D-~d~~G~it~~~~efl~~~ 170 (173)
T d1alva_ 118 IIRRYSDEGGNMDFDNFISCLVRLDAMFRAFKSLD-KDGTGQIQVNIQEWLQLT 170 (173)
T ss_dssp HHHHHTCSSSCBCHHHHHHHHHHHHHHHHHHHHHS-SSCCSEEEEEHHHHHHHH
T ss_pred hhccccCCCCeEeHHHHHHHHHHHHHHHHHHHHhC-CCCCCcEEecHHHHHHHH
Confidence 4456779999999999987 45678889999999 9999987 789999654
|
| >d1qv0a_ a.39.1.5 (A:) Calcium-regulated photoprotein {Hydrozoa (Obelia longissima), obelin [TaxId: 32570]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-regulated photoprotein species: Hydrozoa (Obelia longissima), obelin [TaxId: 32570]
Probab=92.61 E-value=0.014 Score=50.97 Aligned_cols=45 Identities=9% Similarity=-0.034 Sum_probs=30.2
Q ss_pred hhhhhhhccCCCCCCCccchhhhhhhcccccccCChhhhhhccCCC
Q 009364 393 GSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSSILAPNDLEKSRNPM 438 (536)
Q Consensus 393 ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~~~~~e~l~~aF~~~ 438 (536)
.+..+++..| .|++|.|+.+||..++......++++++...|+.+
T Consensus 108 ~~~~~F~~~D-~d~~G~is~~E~~~~l~~~g~~~~~~~~~~lf~~~ 152 (189)
T d1qv0a_ 108 WGDAVFDIFD-KDGSGTITLDEWKAYGKISGISPSQEDCEATFRHC 152 (189)
T ss_dssp HHHHHHHHTC-----CEECHHHHHHHHHHHSSCCCHHHHHHHHHHS
T ss_pred HHHHHHHHHc-cCCCCcccchhhHHHHHhcCCCCCHHHHHHHHHHh
Confidence 3456788889 89999999999987766555557777777777655
|
| >d2pq3a1 a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Rattus norvegicus [TaxId: 10116]
Probab=92.38 E-value=0.019 Score=42.28 Aligned_cols=47 Identities=11% Similarity=0.101 Sum_probs=37.5
Q ss_pred hhhhhhhhhccCCCCCCCccchhhhhhhcccccccCChhhhhhccCCC
Q 009364 391 LSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSSILAPNDLEKSRNPM 438 (536)
Q Consensus 391 ~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~~~~~e~l~~aF~~~ 438 (536)
..+++.+|+.+| .|++|.|++.||..++.......+++++.+.|+..
T Consensus 7 i~el~~~F~~~D-~d~~G~I~~~el~~~l~~~g~~~s~~~~~~~~~~~ 53 (73)
T d2pq3a1 7 IAEFKEAFSLFD-KDGDGTITTKELGTVMRSLGQNPTEAELQDMINEV 53 (73)
T ss_dssp HHHHHHHHHHTC-TTSSSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHHc-CCCCceEeHHHHHHHHHHhCCCCCHHHHHHHHHHh
Confidence 357778899999 99999999999998777766667777777666543
|
| >d1df0a1 a.39.1.8 (A:515-700) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), M-type [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain large subunit, C-terminal domain (domain IV) species: Rat (Rattus norvegicus), M-type [TaxId: 10116]
Probab=92.32 E-value=0.026 Score=49.42 Aligned_cols=49 Identities=4% Similarity=-0.085 Sum_probs=42.1
Q ss_pred CCCccccCCCccchhhhhh--hhhhhhhhhhhccCCCCCCCcc--chhhhhhhc
Q 009364 370 PGSVDICNLDSLSCSRVIV--EKLSGSMHGWVTSNSNDDLCQL--DQEDFVAGD 419 (536)
Q Consensus 370 f~~~D~~~~g~ls~~el~~--~~~~ei~~l~~~~d~~d~~g~I--d~~EF~~~~ 419 (536)
+..+|.+++|.|+.+|+.. ...+++.++|+..| .|++|.| +|+||+.++
T Consensus 132 ~~~~d~d~dg~I~f~eFi~~~~~l~~~~~~F~~~D-~~~~G~i~l~~~ef~~~~ 184 (186)
T d1df0a1 132 IVARFADDELIIDFDNFVRCLVRLEILFKIFKQLD-PENTGTIQLDLISWLSFS 184 (186)
T ss_dssp HHHHHCCSTTEECHHHHHHHHHHHHHHHHHHHHHC-TTCCSEEEEEHHHHHHHH
T ss_pred HHHHHcCCCCeEeHHHHHHHHHHHHHHHHHHHHhC-CCCCCcEEecHHHHHHHh
Confidence 4456889999999999876 56788999999999 9999976 899999654
|
| >d1g8ia_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Frequenin (neuronal calcium sensor 1) species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.32 E-value=0.011 Score=51.81 Aligned_cols=46 Identities=9% Similarity=-0.018 Sum_probs=21.2
Q ss_pred CCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhh
Q 009364 370 PGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFV 416 (536)
Q Consensus 370 f~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~ 416 (536)
|..+|.+++|.|+..|+.. ...+.++.+|+..| .|++|.|+.+||.
T Consensus 66 f~~~d~~~dg~I~~~EF~~~l~~~~~~~~~e~l~~~F~~~D-~d~dG~i~~~El~ 119 (187)
T d1g8ia_ 66 FNVFDENKDGRIEFSEFIQALSVTSRGTLDEKLRWAFKLYD-LDNDGYITRNEML 119 (187)
T ss_dssp HHHHCTTCSSEEEHHHHHHHHHHHHHCCHHHHHHHHHHHHC-TTCSSEEEHHHHH
T ss_pred HHHhCcCCCCCCcHHHHHHHHHHhccCchhhhHHHHHHHHh-cCCCCeEcHHHHH
Confidence 4444455555555554432 12333444455555 4555555555544
|
| >d1s6ja_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-dependent protein kinase sk5 CLD species: Soybean (Glycine max) [TaxId: 3847]
Probab=92.25 E-value=0.022 Score=43.51 Aligned_cols=46 Identities=11% Similarity=0.210 Sum_probs=37.3
Q ss_pred hhhhhhhhccCCCCCCCccchhhhhhhcccccccCChhhhhhccCCC
Q 009364 392 SGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSSILAPNDLEKSRNPM 438 (536)
Q Consensus 392 ~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~~~~~e~l~~aF~~~ 438 (536)
.+++++|+.+| .|++|.|+.+||..++.......+++++.+.|+..
T Consensus 23 ~~l~~~F~~~D-~d~~G~I~~~el~~~l~~lg~~~s~~e~~~l~~~~ 68 (87)
T d1s6ja_ 23 GGLKELFKMID-TDNSGTITFDELKDGLKRVGSELMESEIKDLMDAA 68 (87)
T ss_dssp TTTTTHHHHHC-TTCSSCEEHHHHHHHHHTTTSSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHc-CCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHc
Confidence 45778899999 99999999999998887776667777777766544
|
| >d2zfda1 a.39.1.5 (A:32-214) Calcineurin B-like protein 2 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcineurin B-like protein 2 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=91.98 E-value=0.025 Score=49.25 Aligned_cols=66 Identities=6% Similarity=-0.069 Sum_probs=42.8
Q ss_pred CCCcccc--CCCccchhhhhh-------hhhhhhhhhhhccCCCCCCCccchhhhhhhcccccc-cCChhhhhhccC
Q 009364 370 PGSVDIC--NLDSLSCSRVIV-------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSS-ILAPNDLEKSRN 436 (536)
Q Consensus 370 f~~~D~~--~~g~ls~~el~~-------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~-~~~~e~l~~aF~ 436 (536)
|..+|.+ ++|.|+..|+.. .....++.+++..| .+++|.|+|.||+.+...... ...++.++.+|+
T Consensus 23 F~~~d~~~~~~G~i~~~ef~~~l~~~~~~~~~~~~~lf~~~d-~~~dg~I~f~EFl~~l~~~~~~~~~~~~~~~~F~ 98 (183)
T d2zfda1 23 FKKISSAVIDDGLINKEEFQLALFKTNKKESLFADRVFDLFD-TKHNGILGFEEFARALSVFHPNAPIDDKIHFSFQ 98 (183)
T ss_dssp HHHHHTSSSCSSSBCHHHHHHHHHSCSSCCCHHHHHHHHHHC-SSCSSSBCHHHHHHHHHHTSTTSCHHHHHHHHHH
T ss_pred HHHHCcCCCCCCcCcHHHHHHHHHhcCCCCCHHHHHHHHHHc-cCCCCcCcHHHHHHHHHhhhccCcHHHHHHHhhc
Confidence 5555543 578889988865 12335678888888 888889999999865433222 222345666655
|
| >d1uhka1 a.39.1.5 (A:3-189) Calcium-regulated photoprotein {Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-regulated photoprotein species: Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]
Probab=91.86 E-value=0.019 Score=49.92 Aligned_cols=44 Identities=11% Similarity=0.078 Sum_probs=31.1
Q ss_pred hhhhhhccCCCCCCCccchhhhhhhcccccccCChhhhhhccCCC
Q 009364 394 SMHGWVTSNSNDDLCQLDQEDFVAGDRKLSSILAPNDLEKSRNPM 438 (536)
Q Consensus 394 i~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~~~~~e~l~~aF~~~ 438 (536)
+..+++.+| .|++|.|+.+||..++.......+++++...|+.+
T Consensus 107 ~~~~F~~~D-~d~~G~Is~~El~~~l~~~g~~~~~~~~~~lf~~~ 150 (187)
T d1uhka1 107 GDALFDIVD-KDQNGAITLDEWKAYTKAAGIIQSSEDCEETFRVC 150 (187)
T ss_dssp HHHHHHHHC-TTCSSEECHHHHHHHHHHHTSCCSHHHHHHHHHHS
T ss_pred HHHHHHHHc-cCCCcccchHHHHHHHHHhCCCccHHHHHHHHHHh
Confidence 555677788 88999999999886665544456666676666544
|
| >d1juoa_ a.39.1.8 (A:) Sorcin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Sorcin species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.59 E-value=0.039 Score=47.49 Aligned_cols=62 Identities=13% Similarity=-0.028 Sum_probs=48.2
Q ss_pred CCCCCccccCCCccchhhhhh--------hhhhhhhhhhhccCCCCCCCccchhhhhhhcccccccCChhhhhhccCCC
Q 009364 368 GSPGSVDICNLDSLSCSRVIV--------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSSILAPNDLEKSRNPM 438 (536)
Q Consensus 368 ~sf~~~D~~~~g~ls~~el~~--------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~~~~~e~l~~aF~~~ 438 (536)
..|..+|.+++|.|+.+|+.. .+.++++.+++..| .+ |.|+|+||+.++... +.+.++|+..
T Consensus 81 ~~f~~~D~d~sG~i~~~El~~~l~~~g~~ls~~~~~~l~~~~d-~~--g~i~~~eF~~~~~~~------~~~~~~f~~~ 150 (172)
T d1juoa_ 81 QHFISFDTDRSGTVDPQELQKALTTMGFRLSPQAVNSIAKRYS-TN--GKITFDDYIACCVKL------RALTDSFRRR 150 (172)
T ss_dssp HHHHTTCTTCCSEECHHHHHHHHHHTTCCCCHHHHHHHHHHTC-SS--SSEEHHHHHHHHHHH------HHHHHHHHHT
T ss_pred HHHHHhCcCCCCcCCHHHHHHHHHHHHHhhhHHHHHHHHHHHH-hc--CCcCHHHHHHHHHHH------HHHHHHHHHh
Confidence 358899999999999999976 46788999999987 44 679999999766543 3566666543
|
| >d1xo5a_ a.39.1.5 (A:) Calcium- and integrin-binding protein, CIB {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium- and integrin-binding protein, CIB species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.25 E-value=0.018 Score=50.36 Aligned_cols=67 Identities=10% Similarity=-0.077 Sum_probs=31.7
Q ss_pred CCccccCCCccchhhhhhh----hhhhhhhhhhccCCCCCCCccchhhhhhhccccc-ccCChhhhhhccCC
Q 009364 371 GSVDICNLDSLSCSRVIVE----KLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLS-SILAPNDLEKSRNP 437 (536)
Q Consensus 371 ~~~D~~~~g~ls~~el~~~----~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~-~~~~~e~l~~aF~~ 437 (536)
+..+.+..+.++..++... ...-++.+++.+|..+++|.|+|.||+.+..... ....++.++.||+-
T Consensus 32 ~~~~~~~~~~i~~~e~~~~~~l~~~~~~~rif~~fd~~~~~g~I~f~EFv~~l~~~~~~~~~~~kl~~~F~~ 103 (180)
T d1xo5a_ 32 RSVESSLRAQVPFEQILSLPELKANPFKERICRVFSTSPAKDSLSFEDFLDLLSVFSDTATPDIKSHYAFRI 103 (180)
T ss_dssp CSHHHHHHCCEEHHHHHTSHHHHTCTTHHHHHHHHCCSTTCCEECHHHHHHHHHHHSTTSCHHHHHHHHHHH
T ss_pred ccccccccceEcHHHHhcCcccccChHHHHHHHhccCCCCCCcCcHHHHHHHHHHHhhcCCHHHHHHHhhcc
Confidence 3344444455555555431 1122455666666222566777777765443322 12223455555553
|
| >d1rwya_ a.39.1.4 (A:) Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Rat (Rattus rattus) [TaxId: 10117]
Probab=91.24 E-value=0.048 Score=43.42 Aligned_cols=58 Identities=9% Similarity=0.093 Sum_probs=42.6
Q ss_pred CCccchhhhhh------hhhhhhhhhhhccCCCCCCCccchhhhhhhccccc---ccCChhhhhhccC
Q 009364 378 LDSLSCSRVIV------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLS---SILAPNDLEKSRN 436 (536)
Q Consensus 378 ~g~ls~~el~~------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~---~~~~~e~l~~aF~ 436 (536)
.|+|+..|+.. .+.++++.+|+..| .|++|.|+.+||..++.... ..++++++...|+
T Consensus 21 ~~~i~f~eF~~~~~~~~~~~~~~~~~F~~~D-~d~~G~I~~~El~~~l~~l~~~~~~~~~~e~~~~~~ 87 (109)
T d1rwya_ 21 ADSFDHKKFFQMVGLKKKSADDVKKVFHILD-KDKSGFIEEDELGSILKGFSSDARDLSAKETKTLMA 87 (109)
T ss_dssp TTCCCHHHHHHHHTGGGSCHHHHHHHHHHHS-TTCSSEECHHHHHTHHHHHCTTCCCCCHHHHHHHHH
T ss_pred CCCcCHHHHHHHHccccCCHHHHHHHhhccc-CCCCCcCcHHHHHHHHHHhccccccCCHHHHHHHHH
Confidence 46788888754 35788999999999 99999999999997654322 2355555555444
|
| >d2scpa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Sandworm (Nereis diversicolor) [TaxId: 126592]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Sarcoplasmic calcium-binding protein species: Sandworm (Nereis diversicolor) [TaxId: 126592]
Probab=90.96 E-value=0.031 Score=47.87 Aligned_cols=26 Identities=0% Similarity=-0.100 Sum_probs=18.3
Q ss_pred hhhhhhhccCCCCCCCccchhhhhhhc
Q 009364 393 GSMHGWVTSNSNDDLCQLDQEDFVAGD 419 (536)
Q Consensus 393 ei~~l~~~~d~~d~~g~Id~~EF~~~~ 419 (536)
.+..+++.+| .|++|.|+.+||..+.
T Consensus 95 ~~~~~F~~~D-~d~dG~Is~~E~~~~l 120 (174)
T d2scpa_ 95 PLPLFFRAVD-TNEDNNISRDEYGIFF 120 (174)
T ss_dssp HHHHHHHHHC-TTCSSSEEHHHHHHHH
T ss_pred HHHHHHHHHC-CCccccCCHHHHHHHH
Confidence 4566777777 7777788877777543
|
| >d1nyaa_ a.39.1.5 (A:) Calerythrin {Saccharopolyspora erythraea [TaxId: 1836]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calerythrin species: Saccharopolyspora erythraea [TaxId: 1836]
Probab=90.83 E-value=0.038 Score=46.99 Aligned_cols=43 Identities=12% Similarity=-0.016 Sum_probs=26.6
Q ss_pred hhhhhhhhhccCCCCCCCccchhhhhhhcccccccCChhhhhhccC
Q 009364 391 LSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSSILAPNDLEKSRN 436 (536)
Q Consensus 391 ~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~~~~~e~l~~aF~ 436 (536)
...+..+|..+| .|++|.|+.+||..++... .++++++.+.|+
T Consensus 101 ~~~~~~~F~~~D-~d~dG~Is~~E~~~~~~~~--~~~~~~~~~~f~ 143 (176)
T d1nyaa_ 101 GPVVKGIVGMCD-KNADGQINADEFAAWLTAL--GMSKAEAAEAFN 143 (176)
T ss_dssp HHHHHHHHHHTC-SSCCSEEEHHHHHHHHHHT--TCCHHHHHHHHH
T ss_pred HHHHHHHHHHHc-cCCChhhhHHHHHHHHHhc--CCcHHHHHHHHH
Confidence 345667777788 7888888888887554322 134445554444
|
| >d2opoa1 a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Chenopodium album) [TaxId: 3559]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Polcalcin domain: Polcalcin Che a 3 species: Pigweed (Chenopodium album) [TaxId: 3559]
Probab=90.63 E-value=0.045 Score=41.06 Aligned_cols=46 Identities=4% Similarity=0.164 Sum_probs=36.3
Q ss_pred hhhhhhhhhccCCCCCCCccchhhhhhhcccccccCChhhhhhccCCC
Q 009364 391 LSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSSILAPNDLEKSRNPM 438 (536)
Q Consensus 391 ~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~~~~~e~l~~aF~~~ 438 (536)
.++++++|+.+| .|++|.|+.+||..++.... ..+++++.+.|+.+
T Consensus 5 ~~e~~~~F~~~D-~d~~G~I~~~El~~~l~~lg-~~~~~ei~~~~~~~ 50 (81)
T d2opoa1 5 IADRERIFKRFD-TNGDGKISSSELGDALKTLG-SVTPDEVRRMMAEI 50 (81)
T ss_dssp HHHHHHHHHHHC-TTCSSEEEHHHHHHHHHTTT-TCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHHC-CCCCCCCcHHHHHHHHHHhh-cCCHHHHHHHHHHh
Confidence 457889999999 99999999999987766554 35667777766554
|
| >d1f54a_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=89.76 E-value=0.046 Score=40.44 Aligned_cols=47 Identities=9% Similarity=0.133 Sum_probs=38.6
Q ss_pred hhhhhhhhhccCCCCCCCccchhhhhhhcccccccCChhhhhhccCCC
Q 009364 391 LSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSSILAPNDLEKSRNPM 438 (536)
Q Consensus 391 ~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~~~~~e~l~~aF~~~ 438 (536)
.++++.+|+.+| .|++|.|+..|+..++.......+++++.+.|+.+
T Consensus 9 i~el~~~F~~~D-~d~~G~I~~~el~~~l~~~g~~~t~~e~~~~~~~~ 55 (77)
T d1f54a_ 9 IAEFKEAFALFD-KDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEI 55 (77)
T ss_dssp HHHHHHHHHHTC-TTCSSEEEHHHHHHHHHHHTCCCCHHHHHHHHHTT
T ss_pred HHHHHHHHHHHc-CCCCCeEChHHHHHHHHHhCCCCCHHHHHHHHHHh
Confidence 346788899999 99999999999998777666667778888777665
|
| >d1avsa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=89.43 E-value=0.058 Score=40.37 Aligned_cols=46 Identities=9% Similarity=0.039 Sum_probs=37.1
Q ss_pred hhhhhhhhccCCCCCCCccchhhhhhhcccccccCChhhhhhccCCC
Q 009364 392 SGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSSILAPNDLEKSRNPM 438 (536)
Q Consensus 392 ~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~~~~~e~l~~aF~~~ 438 (536)
++++..|+.+| .||+|.|+..||..++.......+++++.+.|+.+
T Consensus 14 ~el~~~F~~~D-~d~~G~I~~~el~~~l~~~g~~~s~~e~~~~~~~~ 59 (81)
T d1avsa_ 14 AEFKAAFDMFD-ADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEV 59 (81)
T ss_dssp HHHHHHHHHHC-TTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHc-CCCCCeEchhHHHHHHHHcCCCCCHHHHHHHHHHh
Confidence 45677899999 99999999999998777666677777777776654
|
| >d1wrka1 a.39.1.5 (A:4-85) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]
Probab=88.86 E-value=0.071 Score=40.05 Aligned_cols=50 Identities=10% Similarity=0.014 Sum_probs=40.2
Q ss_pred hhhhhhhhhhhccCCCCC-CCccchhhhhhhcccccccCChhhhhhccCCCC
Q 009364 389 EKLSGSMHGWVTSNSNDD-LCQLDQEDFVAGDRKLSSILAPNDLEKSRNPMC 439 (536)
Q Consensus 389 ~~~~ei~~l~~~~d~~d~-~g~Id~~EF~~~~~~~~~~~~~e~l~~aF~~~~ 439 (536)
...+++++.|+..| .|| +|.|+..|+..++.......+++++++.|+...
T Consensus 12 eq~~~~~~~F~~fD-~d~~~G~I~~~el~~~l~~lg~~~t~~el~~~i~~~D 62 (82)
T d1wrka1 12 EQKNEFKAAFDIFV-LGAEDGSISTKELGKVMRMLGQNPTPEELQEMIDEVD 62 (82)
T ss_dssp HHHHHHHHHHHHHT-TTCTTSSBCHHHHHHHHHHTTCCCCHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHHc-CcCCCCeEeHHHHHHHHHHcCCCCCHHHHHHHHHHhC
Confidence 34567888899999 785 799999999988877776778888888887653
|
| >d1c7va_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium vector protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Probab=88.57 E-value=0.07 Score=38.49 Aligned_cols=45 Identities=11% Similarity=0.135 Sum_probs=35.8
Q ss_pred hhhhhhhhhccCCCCCCCccchhhhhhhcccccc-cCChhhhhhccC
Q 009364 391 LSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSS-ILAPNDLEKSRN 436 (536)
Q Consensus 391 ~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~-~~~~e~l~~aF~ 436 (536)
++|+..+|+.+| .|++|.|+.+||..++..... ..+++++...|+
T Consensus 1 eeel~~~F~~~D-~d~~G~I~~~el~~~l~~~g~~~~s~~e~~~~~~ 46 (68)
T d1c7va_ 1 EEEILRAFKVFD-ANGDGVIDFDEFKFIMQKVGEEPLTDAEVEEAMK 46 (68)
T ss_dssp CHHHHHHHHHHS-CSGGGEECHHHHHHHSSTTTTCCCCHHHHHHHHH
T ss_pred CHHHHHHHHHHc-CCCcCeEcHHHHHHHHHHhCCCCCCHHHHHHHHH
Confidence 368899999999 999999999999987777644 467776666553
|
| >d1wlza1 a.39.1.7 (A:229-311) DJ-1-binding protein, DJBP {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: DJ-1-binding protein, DJBP species: Human (Homo sapiens) [TaxId: 9606]
Probab=87.94 E-value=0.095 Score=39.15 Aligned_cols=50 Identities=14% Similarity=0.150 Sum_probs=42.1
Q ss_pred hhhhhhhhhhccCCCCCCCccchhhhhhhcccccccCChhhhhhccCCCCC
Q 009364 390 KLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSSILAPNDLEKSRNPMCE 440 (536)
Q Consensus 390 ~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~~~~~e~l~~aF~~~~~ 440 (536)
....+.++|+..| .+++|.|+.+||..++....-.++++++...|+.+..
T Consensus 18 ~~~~l~~~F~~~D-~~~~G~i~~~ef~~~l~~~~~~l~~~e~~~l~~~~d~ 67 (83)
T d1wlza1 18 HYHAITQEFENFD-TMKTNTISREEFRAICNRRVQILTDEQFDRLWNEMPV 67 (83)
T ss_dssp THHHHHHHHHHHC-TTCSSCBCHHHHHHHHHHHTCCCCHHHHHHHHTTSCB
T ss_pred HHHHHHHHHHHHC-CCCCceEChhHHHHHHHHhCCCCChhHHHHHhhcccc
Confidence 4567889999999 9999999999999877776667888888888887743
|
| >d2zkmx1 a.39.1.7 (X:142-311) Phospholipase C-beta-2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Phospholipase C-beta-2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=84.93 E-value=0.14 Score=43.99 Aligned_cols=89 Identities=7% Similarity=-0.020 Sum_probs=56.7
Q ss_pred HHhcccCCCCCCCHHHHHhCCCCcCCCCCcchhhccccccccCChhHHhhhhhhhcccCCCCCCCccccCCCccchhhhh
Q 009364 308 LKCLEKEPDLRPTASELLKHPFVTGDDEDPVLHASVMKSSEILSPSHVANLESLQMLTSPGSPGSVDICNLDSLSCSRVI 387 (536)
Q Consensus 308 ~~cL~~dP~~Rps~~eiL~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~s~q~~t~~~sf~~~D~~~~g~ls~~el~ 387 (536)
+.++..|..-|+|..++.+. |... ...+. .........|+..|.++.|.|+++|+.
T Consensus 13 k~~~d~n~dG~Is~~el~k~--l~~~------------------~~~~~----~~~~~~~~~~~~~D~~~~~~i~F~eF~ 68 (170)
T d2zkmx1 13 KLKMQLNSEGKIPVKNFFQM--FPAD------------------RKRVE----AALSACHLPKGKNDAINPEDFPEPVYK 68 (170)
T ss_dssp HHHHSCCTTSCEEHHHHHHH--SCSC------------------HHHHH----HHHHHTTCCCCTTCEECGGGCCHHHHH
T ss_pred HHhcccCCCCCCcHHHHHHH--HHHh------------------hhhHH----HHHHHHhhhhccccccCCCccCHHHHH
Confidence 33588899999999998764 2110 00000 011223345999999999999999987
Q ss_pred h-----hhhhhhhhhhhccCCCCCCCccchhhhhhhccc
Q 009364 388 V-----EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRK 421 (536)
Q Consensus 388 ~-----~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~ 421 (536)
. ....++..+|...| .|++|.|+.+||..++..
T Consensus 69 ~~~~~l~~r~ei~~~F~~~d-~d~~~~it~~el~~fL~~ 106 (170)
T d2zkmx1 69 SFLMSLCPRPEIDEIFTSYH-AKAKPYMTKEHLTKFINQ 106 (170)
T ss_dssp HHHHHHSCCHHHHTTCC---------CCCHHHHHHHHHH
T ss_pred HHHhccCCHHHHHHHHHHHc-CCCCCcccHHHHHHHHHH
Confidence 6 35689999999999 899999999999876543
|
| >d2sasa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Sarcoplasmic calcium-binding protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Probab=82.17 E-value=0.36 Score=40.97 Aligned_cols=64 Identities=17% Similarity=0.081 Sum_probs=44.6
Q ss_pred CCCccccCCCccchhhhhh-----------------hhhhhhhhhhhccCCCCCCCccchhhhhhhcccccccCChhhhh
Q 009364 370 PGSVDICNLDSLSCSRVIV-----------------EKLSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSSILAPNDLE 432 (536)
Q Consensus 370 f~~~D~~~~g~ls~~el~~-----------------~~~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~~~~~e~l~ 432 (536)
+...|.+++|.|+..++.. .....+..+++.+| .|++|.|+.+||..++.... ++++++.
T Consensus 66 ~~~~d~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~F~~~D-~d~~G~Is~~E~~~~l~~~~--l~~~~~~ 142 (185)
T d2sasa_ 66 KGRADINKDDVVSWEEYLAMWEKTIATCKSVADLPAWCQNRIPFLFKGMD-VSGDGIVDLEEFQNYCKNFQ--LQCADVP 142 (185)
T ss_dssp HHHHCTTCSSCEEHHHHHHHHHHHHHTCCSGGGSCTTHHHHHHHHHHHHC-TTSSSCCCHHHHHHHTTSSC--CCCSSHH
T ss_pred HHHhCcCCCCcEeeeHhhHHHHHHhhhhhhhhhhhHHHHHHHHHHHHHHc-cCCCccCCHHHHHHHHHHcC--CCHHHHH
Confidence 4445677888999988764 11334788999999 99999999999987654322 3444555
Q ss_pred hccC
Q 009364 433 KSRN 436 (536)
Q Consensus 433 ~aF~ 436 (536)
..|+
T Consensus 143 ~~f~ 146 (185)
T d2sasa_ 143 AVYN 146 (185)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 5443
|
| >d1c07a_ a.39.1.6 (A:) Eps15 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Human (Homo sapiens) [TaxId: 9606]
Probab=81.42 E-value=0.25 Score=37.91 Aligned_cols=43 Identities=9% Similarity=-0.146 Sum_probs=31.9
Q ss_pred hhhhhhhhhccCCCCCCCccchhhhhhhcccccccCChhhhhhccC
Q 009364 391 LSGSMHGWVTSNSNDDLCQLDQEDFVAGDRKLSSILAPNDLEKSRN 436 (536)
Q Consensus 391 ~~ei~~l~~~~d~~d~~g~Id~~EF~~~~~~~~~~~~~e~l~~aF~ 436 (536)
.+..+++|+.+| .|++|.|+.+|+..+.... .+..+.|.+.|+
T Consensus 9 ~~~~~~~F~~~D-~d~~G~is~~e~~~~l~~~--~l~~~~l~~i~~ 51 (95)
T d1c07a_ 9 KAKYDEIFLKTD-KDMDGFVSGLEVREIFLKT--GLPSTLLAHIWS 51 (95)
T ss_dssp HHHHHHHHHHHC-TTCSSEECHHHHHHHHHTT--TCCHHHHHHHHH
T ss_pred HHHHHHHHHHHC-CCCCCCCcHHHHHHHHHhc--CCCHHHHHHHHH
Confidence 456778999999 9999999999999766543 245555555554
|
| >d2hf5a1 a.39.1.5 (A:81-113) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]
Probab=80.08 E-value=0.15 Score=31.20 Aligned_cols=21 Identities=10% Similarity=-0.092 Sum_probs=18.5
Q ss_pred CCCCCccccCCCccchhhhhh
Q 009364 368 GSPGSVDICNLDSLSCSRVIV 388 (536)
Q Consensus 368 ~sf~~~D~~~~g~ls~~el~~ 388 (536)
++|..||.+++|.|+..||+.
T Consensus 7 eAF~~FDkDg~G~Is~~EL~~ 27 (33)
T d2hf5a1 7 EAFRVFDKDGNGYISAAELRH 27 (33)
T ss_dssp HHHHHHSSSCCSCBCHHHHHH
T ss_pred HHHHHhCCCCCCcCcHHHHHH
Confidence 358999999999999999874
|